data_2l02_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l02 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp . . . . . 0 CA--C 1.555 1.142 0 CA-C-O 120.652 0.263 . . . . 74.129999999999995 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.8 mt -65.55 -55.94 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.434 0.693 . . . . 74.200000000000003 110.888 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.3 m -69.34 -26.22 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.071 -0.968 . . . . 74.409999999999997 111.223 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.79 -40.24 95.54 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 116.491 -0.322 . . . . 51.149999999999999 113.138 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.97 -54.47 13.14 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.623 0.769 . . . . 70.040000000000006 112.527 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -71.82 -20.97 61.76 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.171 0.804 . . . . 62.219999999999999 113.171 -174.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 -30.41 70.55 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.462 0.705 . . . . 74.299999999999997 111.818 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.86 -35.84 90.19 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 116.239 -0.437 . . . . 62.32 113.063 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.86 -42.65 60.49 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.562 0.745 . . . . 73.200000000000003 111.791 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.618 ' HA ' HG13 ' A' ' 32' ' ' VAL . 35.0 m -68.49 -38.75 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 122.282 0.233 . . . . 75.299999999999997 111.503 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.592 ' HA ' HD11 ' A' ' 17' ' ' LEU . 69.7 t90 -64.29 -36.42 84.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.973 0.909 . . . . 73.239999999999995 111.561 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.18 -40.7 98.27 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.952 0.901 . . . . 70.109999999999999 111.282 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -68.59 -24.23 64.57 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.394 0.678 . . . . 72.519999999999996 112.556 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 14' ' ' TRP . 52.1 mt -73.49 -33.87 65.02 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.835 0.854 . . . . 63.399999999999999 112.078 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.54 -36.58 78.78 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.609 0.764 . . . . 74.120000000000005 110.983 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.19 -59.86 4.33 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.384 1.074 . . . . 71.310000000000002 111.497 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.37 114.18 0.76 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.198 0.999 . . . . 61.439999999999998 110.275 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -98.16 -179.21 4.31 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.751 0.82 . . . . 75.540000000000006 111.721 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.43 26.32 47.64 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 112.6 -170.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.4 tt -104.29 147.63 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 C-N-CA 123.658 0.783 . . . . 74.310000000000002 111.367 -172.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.4 t -76.51 160.0 29.87 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.246 1.018 . . . . 73.519999999999996 111.938 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.5 mm -55.76 -56.61 28.14 Favored Pre-proline 0 CA--C 1.575 1.937 0 N-CA-C 113.523 0.934 . . . . 74.329999999999998 113.523 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.8 -22.47 27.25 Favored 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 121.691 1.594 . . . . 74.450000000000003 113.909 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -75.85 -47.92 23.6 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 122.273 1.035 . . . . 74.150000000000006 110.227 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.48 -40.51 78.72 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 113.511 -1.677 . . . . 74.439999999999998 111.291 170.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.09 70.29 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.272 1.029 . . . . 71.409999999999997 113.039 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -73.62 -35.91 65.4 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.285 0.634 . . . . 73.239999999999995 112.287 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 45.0 mtmt -71.81 -43.99 64.7 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.255 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 13' ' ' VAL . 20.0 m -86.93 -11.56 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.037 0.535 . . . . 74.230000000000004 112.3 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 60.72 37.77 18.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.731 1.213 . . . . 73.150000000000006 113.12 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.5 mt -106.85 157.31 17.85 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.574 0.75 . . . . 75.140000000000001 110.585 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 m -61.05 150.18 34.6 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.226 0.611 . . . . 74.420000000000002 111.361 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.6 t -54.91 -48.89 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.547 0.739 . . . . 74.25 112.466 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -59.8 -39.77 86.12 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.128 0.571 . . . . 75.420000000000002 111.724 174.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.7 t -68.84 -37.31 79.05 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.527 0.731 . . . . 74.140000000000001 112.825 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.5 m -71.6 -47.89 51.71 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.618 0.767 . . . . 74.439999999999998 110.699 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.78 93.58 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.007 0.923 . . . . 74.319999999999993 112.174 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.77 -35.28 64.97 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.16 0.984 . . . . 74.340000000000003 111.345 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.32 98.85 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.464 0.65 . . . . 73.439999999999998 110.891 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.507 HG11 HD11 ' A' ' 63' ' ' ILE . 69.9 t -64.4 -31.47 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 C-N-CA 123.813 0.845 . . . . 72.510000000000005 111.672 172.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.34 -32.44 82.87 Favored Glycine 0 CA--C 1.544 1.87 0 N-CA-C 113.888 0.315 . . . . 72.340000000000003 113.888 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -68.58 -32.71 72.81 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.591 0.757 . . . . 73.200000000000003 111.282 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.53 -41.02 69.67 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.414 0.686 . . . . 74.299999999999997 110.89 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.59 -26.92 64.15 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.549 1.139 . . . . 72.25 112.6 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -52.95 -45.07 67.53 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.889 0.876 . . . . 63.299999999999997 112.102 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -103.87 3.78 34.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.031 0.932 . . . . 75.219999999999999 112.147 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.7 m120 54.7 36.63 26.66 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.149 0.98 . . . . 75.540000000000006 112.595 -170.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -67.66 -18.22 64.87 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.356 0.663 . . . . 75.109999999999999 110.441 166.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.15 148.44 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.207 1.003 . . . . 74.209999999999994 109.974 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 64' ' ' TYR . 20.3 m -128.96 134.75 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.906 0.882 . . . . 74.420000000000002 108.98 173.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.71 128.8 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 121.206 0.527 . . . . 72.140000000000001 112.278 -167.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -122.54 141.33 51.78 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.667 1.187 . . . . 70.540000000000006 109.54 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -117.25 110.54 18.24 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.819 0.342 . . . . 74.219999999999999 110.865 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -111.28 126.78 55.26 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.052 -0.721 . . . . 75.030000000000001 109.052 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 56.95 31.1 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.463 1.105 . . . . 72.019999999999996 112.103 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.29 -15.56 38.98 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 114.431 0.533 . . . . 73.540000000000006 114.431 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.9 mt -74.15 151.7 39.99 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.349 0.659 . . . . 75.450000000000003 111.469 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 mp -99.88 111.97 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 123.157 0.583 . . . . 71.200000000000003 110.055 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -98.38 141.06 31.73 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.492 0.717 . . . . 73.540000000000006 110.065 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.507 HD11 HG11 ' A' ' 43' ' ' VAL . 61.7 mt -116.04 113.32 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.046 0.538 . . . . 74.400000000000006 110.479 172.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.45 ' HB2' HG23 ' A' ' 53' ' ' VAL . 9.0 m-30 -97.29 150.15 21.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.685 0.794 . . . . 74.140000000000001 110.583 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 17.9 t-20 -92.71 141.57 28.32 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.264 0.626 . . . . 74.129999999999995 109.59 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 113.154 0.798 . . . . 74.319999999999993 113.154 179.129 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.493 ' HA ' HG23 ' B' ' 6' ' ' VAL . 9.8 mtmp? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 113.191 0.812 . . . . 75.129999999999995 113.191 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . 0.49 ' HB3' ' HZ3' ' B' ' 4' ' ' LYS . 2.4 mmmp? -69.04 -45.76 69.61 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.24 0.616 . . . . 74.349999999999994 110.497 175.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 79.1 mt -63.05 -56.7 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.119 0.968 . . . . 65.129999999999995 111.433 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.493 HG23 ' HA ' ' B' ' 3' ' ' LYS . 12.6 m -66.13 -27.61 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 122.848 0.459 . . . . 74.129999999999995 111.503 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.03 -41.0 97.46 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.233 0.333 . . . . 73.239999999999995 112.995 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.07 -50.27 62.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.452 0.701 . . . . 54.200000000000003 111.606 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -68.22 -27.49 66.42 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.795 0.838 . . . . 75.439999999999998 112.384 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.476 ' HA ' HG23 ' B' ' 13' ' ' VAL . . . -72.83 -34.35 66.76 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.101 0.56 . . . . 45.240000000000002 111.518 177.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -35.19 91.63 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 123.388 0.43 . . . . 73.239999999999995 112.34 174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' B' ' 32' ' ' VAL . 1.6 ttmp? -68.14 -50.32 55.35 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.24 1.016 . . . . 74.140000000000001 112.216 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.517 ' HA ' HG13 ' B' ' 32' ' ' VAL . 24.4 m -69.09 -34.76 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 111.886 0.328 . . . . 71.140000000000001 111.886 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -71.9 -34.97 69.57 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.269 0.627 . . . . 74.239999999999995 111.081 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -57.05 -41.64 79.05 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.069 0.548 . . . . 75.140000000000001 110.489 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.53 -32.74 74.51 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.504 -0.771 . . . . 74.540000000000006 111.841 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 13' ' ' VAL . 83.3 mt -71.74 -34.0 69.15 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.401 0.681 . . . . 74.129999999999995 111.759 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.04 -31.49 71.13 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.76 0.824 . . . . 72.239999999999995 111.34 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -105.11 -25.78 12.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.159 0.984 . . . . 70.400000000000006 112.133 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.02 87.87 0.66 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.217 0.607 . . . . 74.319999999999993 111.524 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.17 -179.03 3.92 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.359 0.664 . . . . 72.019999999999996 111.825 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.25 18.18 79.76 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.084 -0.507 . . . . 63.520000000000003 112.85 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.73 152.39 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.391 1.076 . . . . 74.530000000000001 110.02 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -69.04 148.28 50.31 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.797 0.439 . . . . 73.439999999999998 111.045 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.623 HG22 ' HB3' ' B' ' 40' ' ' ALA . 36.5 mm -54.69 -48.35 95.61 Favored Pre-proline 0 CA--C 1.578 2.027 0 N-CA-C 113.719 1.007 . . . . 75.299999999999997 113.719 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -65.42 -31.23 52.23 Favored 'Trans proline' 0 C--N 1.393 2.905 0 C-N-CA 121.969 1.78 . . . . 74.230000000000004 113.965 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -71.64 -46.66 58.36 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.357 1.075 . . . . 75.049999999999997 109.778 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.73 -38.7 82.43 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.301 -1.772 . . . . 75.010000000000005 111.51 172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.79 98.01 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.984 0.913 . . . . 64.239999999999995 111.939 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -64.43 -35.81 82.12 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.1 -0.955 . . . . 75.329999999999998 110.681 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -66.63 -45.92 77.47 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.391 0.676 . . . . 75.120000000000005 112.298 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' B' ' 13' ' ' VAL . 30.5 m -90.51 10.7 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 112.718 0.636 . . . . 74.430000000000007 112.718 -173.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.68 16.82 9.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.408 1.083 . . . . 73.120000000000005 113.08 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.2 mt -106.16 168.69 8.97 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.743 0.817 . . . . 73.25 110.603 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 43.6 t -81.12 165.47 21.56 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.612 0.365 . . . . 73.019999999999996 111.243 169.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 74.4 t -52.92 -48.51 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 123.619 0.768 . . . . 75.510000000000005 111.836 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.91 -52.84 64.03 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.405 0.682 . . . . 75.510000000000005 111.96 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 23.0 m -59.26 -38.91 81.24 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.961 0.904 . . . . 72.109999999999999 112.379 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -72.44 -48.52 40.46 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.776 0.831 . . . . 72.340000000000003 111.767 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.623 ' HB3' HG22 ' B' ' 25' ' ' ILE . . . -63.61 -32.46 73.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.329 0.652 . . . . 73.340000000000003 112.027 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -71.79 -38.32 70.29 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.697 1.199 . . . . 74.340000000000003 110.508 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.25 -37.76 81.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.174 0.59 . . . . 74.450000000000003 111.405 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.494 HG11 HG13 ' B' ' 52' ' ' VAL . 60.7 t -64.1 -30.98 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.243 1.017 . . . . 75.129999999999995 110.867 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.57 86.32 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.495 -0.32 . . . . 64.0 113.513 171.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -72.7 -23.67 60.9 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.317 0.58 . . . . 73.230000000000004 111.198 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.436 HD11 HG22 ' B' ' 13' ' ' VAL . 76.4 mt -74.45 -40.93 61.62 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 121.518 -0.739 . . . . 74.310000000000002 111.08 169.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.24 -31.19 69.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.474 1.11 . . . . 75.040000000000006 113.488 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.568 ' HD3' ' HG3' ' B' ' 49' ' ' GLU . 0.0 OUTLIER -72.41 -14.1 61.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 112.735 0.643 . . . . 75.450000000000003 112.735 176.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . 0.568 ' HG3' ' HD3' ' B' ' 48' ' ' ARG . 50.1 mt-10 -114.92 16.11 17.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.883 0.873 . . . . 73.450000000000003 110.965 169.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 47.53 28.38 1.17 Allowed 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 125.876 1.67 . . . . 70.540000000000006 114.314 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.442 ' HA ' ' HB2' ' B' ' 66' ' ' GLU . 53.0 mttp -71.52 -11.5 60.9 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.232 1.013 . . . . 75.109999999999999 112.95 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.494 HG13 HG11 ' B' ' 43' ' ' VAL . 12.6 m -124.52 145.85 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.637 0.775 . . . . 73.439999999999998 112.307 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 63.4 t -112.0 120.38 62.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 125.017 1.327 . . . . 73.310000000000002 108.949 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.21 110.59 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.703 -0.851 . . . . 74.030000000000001 108.703 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.28 112.49 18.67 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.794 0.438 . . . . 73.329999999999998 110.833 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.467 ' HG2' HG12 ' B' ' 61' ' ' ILE . 13.8 mtm-85 -93.36 96.89 10.23 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.746 0.819 . . . . 75.400000000000006 109.905 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -104.57 111.98 24.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.902 1.281 . . . . 73.420000000000002 109.414 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 57.74 30.45 18.95 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 111.747 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.68 -22.81 28.85 Favored Glycine 0 CA--C 1.546 2.012 0 CA-C-N 115.654 -0.703 . . . . 73.099999999999994 113.992 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 88.4 mt -79.24 126.13 30.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.987 0.915 . . . . 73.340000000000003 111.527 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.467 HG12 ' HG2' ' B' ' 56' ' ' ARG . 40.4 mt -92.19 123.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 121.059 0.457 . . . . 72.219999999999999 112.068 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -117.83 139.72 50.7 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.385 1.074 . . . . 72.430000000000007 109.187 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.413 HG21 HG13 ' B' ' 43' ' ' VAL . 1.5 pp -113.66 104.59 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.926 0.87 . . . . 75.310000000000002 112.064 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.461 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 74.9 m-85 -83.61 167.06 17.64 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.659 0.784 . . . . 73.409999999999997 110.875 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -93.25 164.08 13.37 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.121 0.486 . . . . 74.450000000000003 112.294 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' B' ' 51' ' ' LYS . 40.1 tt0 . . . . . 0 N--CA 1.489 1.521 0 C-N-CA 123.847 0.859 . . . . 75.409999999999997 112.149 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt . . . . . 0 CA--C 1.553 1.09 0 N-CA-C 112.072 0.397 . . . . 74.439999999999998 112.072 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.8 mt -69.0 -58.02 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.091 0.556 . . . . 73.439999999999998 110.966 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.67 -27.85 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.749 0.42 . . . . 64.299999999999997 111.711 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.23 -42.25 76.28 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 123.543 0.527 . . . . 70.420000000000002 112.875 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.78 96.02 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.012 0.925 . . . . 75.450000000000003 112.054 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 12' ' ' LYS . 57.2 m-80 -85.1 -21.26 29.39 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.166 0.586 . . . . 74.340000000000003 112.414 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.54 76.1 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 118.072 0.396 . . . . 73.0 111.448 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.0 -39.83 97.63 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 115.851 -0.613 . . . . 63.109999999999999 113.456 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 6.7 ptmm? -75.87 -30.63 58.94 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.5 -0.412 . . . . 74.340000000000003 111.488 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.564 ' HA ' HG12 ' A' ' 32' ' ' VAL . 71.4 t -67.37 -46.78 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.282 0.633 . . . . 74.209999999999994 110.84 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.434 ' HA ' HD11 ' A' ' 17' ' ' LEU . 21.7 t90 -64.07 -35.07 79.53 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.572 -0.74 . . . . 73.540000000000006 110.639 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.405 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 79.3 t60 -63.11 -40.55 97.95 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.845 0.458 . . . . 64.430000000000007 111.547 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.12 -31.66 72.93 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 120.862 0.363 . . . . 61.020000000000003 111.661 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.471 ' HB3' ' OD1' ' A' ' 65' ' ' ASN . 90.1 mt -69.34 -41.95 75.94 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.337 1.055 . . . . 74.340000000000003 111.733 170.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.74 -26.99 66.11 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.145 0.978 . . . . 72.150000000000006 111.425 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 15' ' ' HIS . 68.3 mt-10 -77.79 -49.85 13.52 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.225 0.61 . . . . 73.409999999999997 110.127 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.77 108.19 0.67 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.603 0.761 . . . . 73.019999999999996 111.264 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.432 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 11.1 p-10 -94.1 -178.79 4.74 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.146 0.978 . . . . 71.430000000000007 112.918 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.28 33.59 61.62 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-N 116.016 -0.538 . . . . 44.32 111.852 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 tt -113.12 145.09 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.026 0.931 . . . . 74.299999999999997 111.013 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.9 m -78.85 154.03 30.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.556 0.743 . . . . 64.450000000000003 110.943 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.703 HG22 ' HB2' ' A' ' 40' ' ' ALA . 44.7 mm -59.1 -44.34 98.52 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 114.777 1.399 . . . . 74.430000000000007 114.777 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -62.82 -32.61 77.5 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 121.942 1.761 . . . . 73.340000000000003 113.185 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -75.27 -37.46 60.93 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.587 1.184 . . . . 75.319999999999993 109.871 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.9 tp -70.73 -33.4 70.79 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 112.707 -2.042 . . . . 72.099999999999994 111.658 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.05 -37.06 81.27 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.086 0.954 . . . . 74.439999999999998 111.167 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -64.44 -39.22 93.41 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.175 0.99 . . . . 75.010000000000005 111.104 174.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -66.47 -43.72 84.71 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.663 0.785 . . . . 73.049999999999997 111.864 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 13' ' ' VAL . 7.0 m -98.17 9.99 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 113.315 0.858 . . . . 75.340000000000003 113.315 -170.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 m120 66.87 10.51 7.66 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.587 1.155 . . . . 64.409999999999997 113.428 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.9 mt -108.31 178.08 4.61 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.247 0.619 . . . . 75.219999999999999 111.479 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.4 t -88.48 165.68 14.72 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.17 0.588 . . . . 73.340000000000003 110.991 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.38 -47.33 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 124.312 1.045 . . . . 73.510000000000005 112.26 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -61.22 -53.0 62.43 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.214 0.606 . . . . 71.099999999999994 112.088 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -63.01 -28.6 70.22 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.733 0.813 . . . . 75.019999999999996 112.518 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.418 ' O ' HG22 ' A' ' 43' ' ' VAL . 88.0 m -80.08 -53.65 6.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.75 0.82 . . . . 72.109999999999999 111.441 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.703 ' HB2' HG22 ' A' ' 25' ' ' ILE . . . -60.1 -30.75 69.46 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.106 0.962 . . . . 53.509999999999998 112.315 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -52.86 63.07 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.714 1.206 . . . . 73.319999999999993 110.225 174.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.24 -26.75 68.24 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.886 -1.052 . . . . 73.409999999999997 111.39 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 39' ' ' THR . 94.7 t -66.04 -40.11 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.166 0.586 . . . . 72.239999999999995 110.889 172.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.07 -33.24 86.72 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 116.309 -0.405 . . . . 64.109999999999999 113.107 173.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.472 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 63.7 t-105 -74.22 -25.18 59.51 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.586 0.754 . . . . 75.129999999999995 111.605 176.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.27 -47.72 48.01 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 122.115 -0.366 . . . . 71.120000000000005 110.39 166.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.72 68.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.3 1.04 . . . . 71.25 113.19 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 26.6 ptt85 -59.4 -39.71 84.29 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 112.558 0.577 . . . . 70.409999999999997 112.558 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.538 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 47.0 mt-10 -96.61 11.62 34.63 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.886 0.875 . . . . 71.040000000000006 111.147 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 62.33 38.1 13.38 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.671 1.189 . . . . 64.120000000000005 111.198 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -80.51 -19.08 46.66 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.411 0.685 . . . . 75.519999999999996 112.195 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.87 151.57 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.314 0.646 . . . . 72.340000000000003 111.238 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.17 122.01 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.815 0.846 . . . . 75.209999999999994 109.298 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.775 HG12 HD12 ' B' ' 41' ' ' LEU . 3.6 mp -98.9 136.03 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.065 0.946 . . . . 73.340000000000003 110.86 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.7 117.98 15.62 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.569 0.747 . . . . 73.219999999999999 110.764 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -81.53 111.39 17.8 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.752 0.821 . . . . 72.549999999999997 110.556 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.85 130.61 47.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.969 0.908 . . . . 63.149999999999999 110.617 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.9 p30 44.48 41.18 4.45 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 126.059 1.744 . . . . 73.319999999999993 114.035 -175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.41 -27.44 7.74 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.374 -0.83 . . . . 74.439999999999998 114.125 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.67 160.4 28.51 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.732 0.813 . . . . 74.540000000000006 110.99 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.4 tt -121.19 118.33 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 109.683 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.87 142.68 46.24 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.116 0.966 . . . . 74.299999999999997 110.042 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.666 HG23 HG13 ' A' ' 54' ' ' ILE . 37.6 pt -115.07 140.36 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.555 0.693 . . . . 74.540000000000006 111.066 175.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.432 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 57.7 m-85 -123.8 167.8 13.58 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.681 1.192 . . . . 73.239999999999995 110.018 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 1.8 m-20 -76.06 152.37 36.88 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.337 0.255 . . . . 75.209999999999994 110.522 174.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 CA--C 1.554 1.106 0 CA-C-O 121.164 0.507 . . . . 71.420000000000002 110.327 167.283 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.562 1.424 0 CA-C-O 120.552 0.215 . . . . 73.409999999999997 111.249 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.78 -43.13 56.45 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.755 0.822 . . . . 74.409999999999997 111.668 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.58 -51.38 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 122.619 0.368 . . . . 73.109999999999999 110.813 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -66.49 -30.85 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 122.611 0.364 . . . . 75.420000000000002 111.936 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.68 45.4 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.424 0.452 . . . . 73.219999999999999 112.74 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.6 -52.93 61.45 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.087 0.955 . . . . 75.340000000000003 111.845 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -75.17 -13.9 60.5 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.753 -0.658 . . . . 70.140000000000001 112.464 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.453 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -68.06 -29.09 67.98 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 117.943 0.338 . . . . 64.109999999999999 110.504 171.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.46 -41.95 94.01 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.867 -0.606 . . . . 43.509999999999998 112.963 173.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -69.76 -47.78 61.72 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.391 0.676 . . . . 75.319999999999993 111.922 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.529 ' HA ' HG12 ' B' ' 32' ' ' VAL . 22.7 m -67.21 -32.47 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 111.886 0.328 . . . . 74.209999999999994 111.886 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 57.9 t90 -68.65 -41.1 79.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.716 0.406 . . . . 71.230000000000004 111.162 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -69.64 -40.64 76.39 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.857 0.463 . . . . 72.150000000000006 111.248 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.61 73.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.108 0.563 . . . . 75.310000000000002 111.264 176.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.592 HD22 HG23 ' B' ' 63' ' ' ILE . 1.0 OUTLIER -67.32 -44.18 79.78 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.926 0.89 . . . . 75.099999999999994 110.439 169.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.17 -36.61 84.19 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.655 0.782 . . . . 71.349999999999994 111.679 -174.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.46 -30.13 25.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.371 0.668 . . . . 65.219999999999999 111.622 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.511 ' HB1' ' HZ1' ' B' ' 31' ' ' LYS . . . -135.06 108.04 7.6 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.21 0.604 . . . . 74.010000000000005 110.942 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.99 175.78 10.26 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.868 1.267 . . . . 62.399999999999999 112.674 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.89 40.56 12.53 Favored Glycine 0 C--N 1.365 2.14 0 N-CA-C 115.144 0.817 . . . . 75.340000000000003 115.144 163.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' B' ' 27' ' ' GLU . 7.8 tp -112.95 127.97 69.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.363 0.665 . . . . 74.340000000000003 109.868 -168.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 92.5 p -68.06 158.44 32.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 122.083 -0.386 . . . . 73.230000000000004 111.162 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.635 HG23 ' HB1' ' B' ' 40' ' ' ALA . 69.6 mt -59.65 -44.38 97.36 Favored Pre-proline 0 CA--C 1.578 2.033 0 N-CA-C 114.422 1.268 . . . . 71.409999999999997 114.422 -171.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.49 -28.47 45.73 Favored 'Trans proline' 0 C--N 1.389 2.667 0 CA-C-N 121.744 1.659 . . . . 75.420000000000002 113.361 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . 0.459 ' HB3' HD11 ' B' ' 23' ' ' ILE . 14.0 mm-40 -79.96 -27.26 39.76 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.149 0.98 . . . . 73.409999999999997 111.419 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.568 ' HA ' ' HE2' ' B' ' 31' ' ' LYS . 58.3 tp -75.75 -37.82 58.98 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 125.255 1.422 . . . . 74.420000000000002 110.629 170.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.34 95.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.482 1.113 . . . . 75.310000000000002 112.842 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -67.65 -33.56 75.2 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.352 0.661 . . . . 71.349999999999994 112.248 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' B' ' 28' ' ' LEU . 48.9 mtmt -66.59 -43.38 85.05 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.217 0.532 . . . . 71.140000000000001 110.897 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' B' ' 13' ' ' VAL . 21.6 m -90.66 -4.83 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.662 0.785 . . . . 73.439999999999998 112.558 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 m120 64.99 22.62 12.46 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.63 1.172 . . . . 73.400000000000006 112.876 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 59.1 mt -104.65 162.04 13.62 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.621 0.769 . . . . 74.420000000000002 110.53 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 30.1 t -64.68 152.04 43.42 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.087 0.555 . . . . 75.439999999999998 110.822 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.95 -44.05 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 123.547 0.739 . . . . 72.319999999999993 111.19 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -58.52 -47.41 84.23 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 114.887 -1.051 . . . . 73.319999999999993 112.071 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 65.3 m -68.54 -36.53 78.96 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.934 0.893 . . . . 74.409999999999997 112.262 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 87.9 m -70.94 -52.24 21.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.918 0.887 . . . . 64.420000000000002 110.802 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.635 ' HB1' HG23 ' B' ' 25' ' ' ILE . . . -57.73 -32.36 67.35 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.956 0.902 . . . . 65.239999999999995 112.491 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.775 HD12 HG12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -64.65 -52.71 55.89 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.512 1.125 . . . . 72.519999999999996 110.281 176.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.59 -29.14 70.15 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.197 -0.91 . . . . 73.239999999999995 111.586 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.04 -39.93 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.627 0.771 . . . . 74.409999999999997 110.949 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -61.88 -27.75 69.1 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-N 116.341 -0.39 . . . . 74.010000000000005 113.125 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.439 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 61.1 t-105 -71.93 -34.53 69.13 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.546 0.738 . . . . 71.25 111.249 174.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.42 -32.88 68.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.25 0.62 . . . . 74.239999999999995 111.196 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.99 -32.02 71.6 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.672 0.789 . . . . 71.340000000000003 112.175 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 53.8 ttt180 -58.83 -50.43 74.01 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.517 0.675 . . . . 75.030000000000001 110.904 167.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -79.57 -6.59 57.36 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 114.64 -1.164 . . . . 63.229999999999997 112.27 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 63.62 23.2 13.47 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.025 1.33 . . . . 63.5 112.08 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -87.67 -4.31 58.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.486 1.114 . . . . 75.219999999999999 112.604 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.609 ' HB ' HD13 ' B' ' 63' ' ' ILE . 18.3 m -135.02 166.51 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 112.532 0.567 . . . . 71.319999999999993 112.532 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.732 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 24.7 t -116.1 131.75 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.067 0.947 . . . . 73.439999999999998 111.229 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 31.9 mm -113.5 133.05 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.696 0.798 . . . . 71.530000000000001 110.784 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' B' ' 57' ' ' LYS . 42.5 mt-10 -134.16 157.96 44.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.451 0.7 . . . . 53.399999999999999 111.31 167.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -111.55 106.94 15.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.211 1.004 . . . . 73.409999999999997 109.168 168.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' B' ' 55' ' ' GLU . 0.0 OUTLIER -119.54 114.91 22.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.303 1.041 . . . . 74.200000000000003 110.13 -178.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 56.25 30.54 16.84 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.804 1.241 . . . . 74.140000000000001 111.823 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.8 -25.04 23.41 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 115.959 -0.564 . . . . 62.520000000000003 114.238 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -90.46 158.52 17.01 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.701 0.8 . . . . 62.340000000000003 111.037 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 mm -107.15 131.29 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.962 0.505 . . . . 74.409999999999997 110.052 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -121.97 136.1 54.9 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.063 -1.088 . . . . 72.129999999999995 108.063 168.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.609 HD13 ' HB ' ' B' ' 52' ' ' VAL . 10.9 tp -92.65 130.79 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 122.982 0.513 . . . . 73.409999999999997 110.232 -177.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.732 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 84.8 m-85 -116.62 167.8 10.75 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.578 0.751 . . . . 74.299999999999997 110.974 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.518 ' HA ' HD12 ' B' ' 17' ' ' LEU . 9.7 m120 -88.06 114.21 24.46 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.0 0.741 . . . . 60.43 113.0 -169.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.505 2.289 0 N-CA-C 116.975 2.213 . . . . 74.439999999999998 116.975 157.205 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.623 0.249 . . . . 75.349999999999994 111.354 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.59 -56.67 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.731 0.813 . . . . 74.340000000000003 112.01 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.5 m -53.9 -44.34 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.621 1.169 . . . . 72.430000000000007 113.197 -170.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.81 -40.34 52.83 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.159 0.287 . . . . 54.149999999999999 113.025 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.22 79.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.647 0.779 . . . . 74.439999999999998 112.354 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -87.56 -20.95 25.74 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.769 0.655 . . . . 60.009999999999998 112.769 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.84 -38.98 73.23 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 123.097 0.559 . . . . 72.430000000000007 112.03 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.74 -32.52 81.51 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 116.124 -0.489 . . . . 62.340000000000003 112.623 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -71.45 -48.29 50.33 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.014 0.925 . . . . 75.239999999999995 112.188 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -75.16 -32.85 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 112.475 0.546 . . . . 75.209999999999994 112.475 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.442 ' HA ' HD11 ' A' ' 17' ' ' LEU . 26.1 t90 -70.56 -35.16 72.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 120.966 0.412 . . . . 75.120000000000005 110.457 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -62.24 -35.41 78.84 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.521 0.728 . . . . 70.430000000000007 111.306 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.02 70.09 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.367 0.667 . . . . 63.310000000000002 112.455 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.442 HD11 ' HA ' ' A' ' 14' ' ' TRP . 46.7 mt -68.36 -31.18 70.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.55 0.74 . . . . 75.129999999999995 111.255 170.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -75.04 -22.88 58.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.172 0.589 . . . . 72.040000000000006 111.704 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.31 -58.52 5.71 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 109.118 -0.697 . . . . 74.019999999999996 109.118 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.79 117.81 0.7 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.81 -1.087 . . . . 44.5 110.006 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.12 168.34 12.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.301 0.64 . . . . 63.340000000000003 109.845 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.76 60.53 1.96 Allowed Glycine 0 N--CA 1.475 1.294 0 N-CA-C 110.963 -0.855 . . . . 55.109999999999999 110.963 -170.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.6 tt -156.11 151.15 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.416 -0.892 . . . . 71.010000000000005 109.62 -173.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 t -85.96 158.9 19.77 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.874 0.469 . . . . 70.120000000000005 111.221 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.519 HG23 ' HB2' ' A' ' 40' ' ' ALA . 58.0 mt -56.81 -49.72 92.15 Favored Pre-proline 0 CA--C 1.575 1.936 0 N-CA-C 114.214 1.19 . . . . 75.340000000000003 114.214 -173.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -70.81 -21.9 27.99 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.083 1.855 . . . . 72.400000000000006 113.743 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.27 -39.28 40.55 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.441 1.115 . . . . 74.230000000000004 109.691 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.2 tp -68.65 -34.4 75.65 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-N 113.019 -1.901 . . . . 74.030000000000001 111.375 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.8 70.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.179 0.992 . . . . 73.340000000000003 112.131 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -66.38 -34.92 79.04 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.908 0.883 . . . . 74.420000000000002 111.365 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -69.19 -45.65 69.41 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.577 0.751 . . . . 71.140000000000001 111.509 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 34' ' ' LEU . 31.4 m -90.45 -5.59 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 114.026 1.121 . . . . 73.25 114.026 -170.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 67.81 8.79 6.67 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.38 1.072 . . . . 74.409999999999997 112.051 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.43 ' H ' HG23 ' A' ' 32' ' ' VAL . 60.5 mt -92.4 157.38 16.63 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.581 -0.699 . . . . 73.319999999999993 110.335 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -61.79 151.66 33.58 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.083 0.553 . . . . 74.140000000000001 111.202 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -53.47 -41.76 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.552 0.692 . . . . 74.409999999999997 110.656 174.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.24 -40.75 94.45 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.652 -1.158 . . . . 73.319999999999993 111.672 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -68.06 -41.49 81.92 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.634 0.773 . . . . 65.439999999999998 111.463 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.1 m -66.06 -49.58 67.15 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.16 0.984 . . . . 73.230000000000004 111.029 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.519 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -60.94 -43.01 99.28 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.742 0.817 . . . . 72.030000000000001 112.18 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -49.16 78.19 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.492 0.717 . . . . 75.340000000000003 110.371 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.51 -30.98 70.97 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.815 -1.084 . . . . 75.400000000000006 112.254 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -65.89 -41.62 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.356 0.663 . . . . 72.409999999999997 110.861 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.06 -28.63 73.12 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 116.583 -0.28 . . . . 55.329999999999998 113.563 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -74.26 -43.33 57.39 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.607 0.763 . . . . 73.040000000000006 111.482 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.45 -32.9 73.84 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.045 0.538 . . . . 64.120000000000005 111.624 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.91 -25.19 60.54 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.395 1.078 . . . . 64.540000000000006 113.402 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -69.31 -40.03 77.89 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.254 -0.647 . . . . 75.299999999999997 109.254 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.7 7.79 42.01 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.263 1.025 . . . . 64.150000000000006 111.727 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 56.5 23.91 8.05 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.086 1.355 . . . . 74.25 113.414 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -74.02 -9.66 58.85 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.819 0.847 . . . . 74.140000000000001 113.044 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 m -122.71 142.23 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.279 0.632 . . . . 64.299999999999997 111.492 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 55.1 t -109.07 107.68 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.09 0.956 . . . . 74.109999999999999 108.456 172.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.59 122.6 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 109.38 -0.6 . . . . 72.340000000000003 109.38 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -116.11 148.36 40.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.907 0.883 . . . . 73.109999999999999 109.888 174.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.423 ' HD2' HG23 ' B' ' 5' ' ' ILE . 45.2 mtp85 -118.96 114.65 22.89 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.757 0.423 . . . . 74.329999999999998 111.146 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -114.34 110.2 19.52 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.122 0.969 . . . . 74.450000000000003 109.785 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 58.4 30.02 19.04 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 124.795 1.238 . . . . 64.129999999999995 112.966 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.29 -13.3 62.2 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 113.944 0.338 . . . . 74.310000000000002 113.944 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.07 133.03 40.43 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.612 0.765 . . . . 75.120000000000005 110.686 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -87.52 111.32 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 121.481 0.658 . . . . 74.209999999999994 110.714 -173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -97.81 137.61 36.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.069 1.348 . . . . 73.25 108.901 171.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.436 ' H ' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -123.1 139.12 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.744 0.783 . . . . 75.329999999999998 109.913 171.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 73.8 m-85 -129.01 167.02 18.09 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.588 1.155 . . . . 74.409999999999997 109.295 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -85.15 151.99 23.71 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.378 -0.601 . . . . 75.129999999999995 109.378 167.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 CA--C 1.551 0.999 0 CA-C-O 120.855 0.36 . . . . 65.329999999999998 110.735 177.676 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp . . . . . 0 CA--C 1.559 1.324 0 CA-C-O 121.085 0.469 . . . . 73.0 110.76 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -77.3 -28.33 53.29 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.904 0.882 . . . . 74.510000000000005 111.837 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.423 HG23 ' HD2' ' A' ' 56' ' ' ARG . 67.0 mt -58.38 -55.32 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.348 0.659 . . . . 75.109999999999999 110.977 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 22.6 m -63.84 -28.42 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-N 115.034 -0.985 . . . . 71.439999999999998 111.976 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.23 -45.43 48.93 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 123.398 0.436 . . . . 63.299999999999997 113.057 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.72 93.18 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.669 0.788 . . . . 44.200000000000003 111.785 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -65.25 -45.26 85.31 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.216 0.606 . . . . 71.409999999999997 110.434 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.425 ' HB3' ' HG ' ' B' ' 46' ' ' LEU . . . -68.32 -32.03 71.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.658 0.783 . . . . 74.329999999999998 112.132 -174.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.68 96.76 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 116.712 -0.222 . . . . 60.229999999999997 113.125 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -71.53 -39.72 70.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.396 0.678 . . . . 75.430000000000007 111.241 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.544 HG12 HG23 ' B' ' 43' ' ' VAL . 74.3 t -61.85 -41.64 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.743 0.817 . . . . 53.420000000000002 111.15 174.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -67.79 -31.73 71.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.392 0.677 . . . . 61.5 111.598 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -61.36 -45.74 93.13 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.4 0.28 . . . . 73.219999999999999 111.003 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.13 -29.79 67.91 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.389 0.614 . . . . 71.540000000000006 111.23 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.71 ' HG ' HG11 ' B' ' 52' ' ' VAL . 2.5 tm? -72.73 -34.24 66.93 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.893 1.277 . . . . 75.129999999999995 110.541 174.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.1 -20.0 39.02 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.499 0.719 . . . . 71.329999999999998 110.643 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -76.63 -59.46 2.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.832 0.853 . . . . 74.349999999999994 109.889 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.42 110.72 3.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.199 1.0 . . . . 74.219999999999999 109.262 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -90.71 -179.82 5.62 Favored 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 112.566 0.58 . . . . 74.239999999999995 112.566 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.58 51.1 9.97 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.745 -0.661 . . . . 74.540000000000006 111.633 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tp -121.17 140.49 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.252 0.621 . . . . 74.310000000000002 111.71 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 17.0 m -72.23 144.68 48.36 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.863 0.865 . . . . 72.150000000000006 111.257 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 62.2 mt -53.46 -52.36 67.44 Favored Pre-proline 0 CA--C 1.573 1.844 0 N-CA-C 113.671 0.989 . . . . 74.349999999999994 113.671 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -68.96 -24.75 33.03 Favored 'Trans proline' 0 C--N 1.391 2.803 0 C-N-CA 121.692 1.595 . . . . 74.200000000000003 113.823 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -77.42 -47.21 20.35 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.959 0.885 . . . . 74.530000000000001 109.593 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 57.5 tp -56.32 -34.88 66.98 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 113.647 -1.615 . . . . 72.239999999999995 111.69 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.84 98.97 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.875 0.87 . . . . 72.120000000000005 111.708 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -66.26 -40.74 90.36 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.121 0.568 . . . . 73.439999999999998 110.571 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -60.4 -45.83 92.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.874 0.87 . . . . 62.219999999999999 111.405 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.67 4.2 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 112.56 0.578 . . . . 74.349999999999994 112.56 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 61.18 32.75 19.49 Favored 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 124.539 1.135 . . . . 52.43 112.195 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 85.8 mt -123.26 170.27 10.45 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.925 0.89 . . . . 75.439999999999998 111.034 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -69.14 155.26 40.68 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.453 0.701 . . . . 63.409999999999997 111.511 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.26 -48.85 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.514 0.725 . . . . 71.120000000000005 111.481 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.438 ' HB3' HD13 ' A' ' 25' ' ' ILE . 43.6 mt-10 -59.11 -52.54 65.26 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.882 0.873 . . . . 73.219999999999999 111.838 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.1 t -56.64 -32.49 65.4 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.339 1.056 . . . . 74.420000000000002 112.746 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.497 ' O ' HG22 ' B' ' 43' ' ' VAL . 89.5 m -81.48 -46.15 14.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.651 0.78 . . . . 73.519999999999996 110.853 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.48 -52.65 64.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.676 0.991 . . . . 75.209999999999994 113.676 -171.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -26.83 64.57 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 120.882 0.373 . . . . 72.420000000000002 111.092 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.85 -34.71 73.98 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.703 0.801 . . . . 72.200000000000003 111.538 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.544 HG23 HG12 ' B' ' 13' ' ' VAL . 51.2 t -63.18 -33.06 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 122.823 0.449 . . . . 75.400000000000006 109.843 169.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.4 83.59 Favored Glycine 0 CA--C 1.542 1.72 0 CA-C-N 116.535 -0.302 . . . . 64.329999999999998 113.131 172.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.475 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 70.5 t-105 -71.6 -25.26 62.1 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.546 0.738 . . . . 74.230000000000004 111.778 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.425 ' HG ' ' HB3' ' B' ' 10' ' ' ALA . 94.9 mt -76.68 -41.77 44.22 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.519 -0.738 . . . . 75.129999999999995 111.503 165.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.47 -26.76 68.11 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.674 1.189 . . . . 72.25 113.542 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.656 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 18.7 ptt180 -57.11 -31.5 65.35 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 122.715 0.406 . . . . 75.439999999999998 111.84 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . 0.656 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 40.2 mt-10 -106.51 1.57 25.55 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.237 1.015 . . . . 73.540000000000006 111.798 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.38 23.33 10.65 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.966 1.306 . . . . 70.120000000000005 111.707 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.507 ' HG3' ' HB2' ' B' ' 49' ' ' GLU . 52.7 mtpt -68.34 -17.57 64.28 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 122.934 0.494 . . . . 74.420000000000002 111.598 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.71 HG11 ' HG ' ' B' ' 17' ' ' LEU . 28.2 m -125.95 155.25 35.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.665 1.186 . . . . 64.109999999999999 109.762 170.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.91 129.66 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.185 0.994 . . . . 75.040000000000006 109.132 173.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.537 HD13 HG12 ' B' ' 43' ' ' VAL . 91.6 mt -120.82 112.83 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-O 121.357 0.598 . . . . 72.519999999999996 109.969 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -140.93 127.69 20.35 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.604 1.161 . . . . 72.209999999999994 109.499 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -81.4 111.98 18.25 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.458 0.647 . . . . 73.310000000000002 110.936 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.58 115.02 29.74 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.552 1.141 . . . . 75.340000000000003 109.682 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 54.06 31.77 14.35 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.861 1.264 . . . . 64.030000000000001 111.796 -167.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.49 -28.02 7.3 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-N 115.624 -0.717 . . . . 60.299999999999997 113.488 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.78 117.23 17.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.3 0.64 . . . . 75.120000000000005 110.296 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 19.5 tt -72.69 114.23 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 123.683 0.793 . . . . 64.209999999999994 111.726 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -116.53 127.67 54.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.863 0.465 . . . . 73.129999999999995 109.99 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.431 HG13 HG12 ' B' ' 54' ' ' ILE . 2.3 mp -94.51 101.93 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.624 0.77 . . . . 75.340000000000003 108.982 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -88.28 170.71 10.76 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.256 1.022 . . . . 72.25 111.978 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -85.66 146.81 26.67 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.939 0.896 . . . . 72.219999999999999 110.598 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.5 2.035 0 N-CA-C 112.678 0.622 . . . . 74.230000000000004 112.678 176.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.16 0.505 . . . . 74.209999999999994 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.5 -26.14 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 124.137 0.975 . . . . 74.299999999999997 111.649 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.15 -32.94 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.009 0.524 . . . . 71.129999999999995 110.711 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.32 -42.83 40.8 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.68 0.612 . . . . 70.150000000000006 112.903 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.19 77.69 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.212 0.605 . . . . 72.430000000000007 111.635 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -75.68 -35.69 60.29 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.548 0.739 . . . . 75.109999999999999 111.279 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.33 66.83 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.381 0.672 . . . . 71.129999999999995 111.488 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.67 -34.62 90.17 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 116.064 -0.516 . . . . 73.129999999999995 112.767 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -66.14 -41.39 90.5 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.041 0.936 . . . . 73.519999999999996 111.329 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.506 ' HA ' HG12 ' A' ' 32' ' ' VAL . 60.9 t -62.65 -47.7 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.597 0.759 . . . . 74.519999999999996 111.462 174.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.433 ' HA ' HD11 ' A' ' 17' ' ' LEU . 12.1 t90 -67.21 -33.08 74.6 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.98 0.512 . . . . 71.439999999999998 111.69 -176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -57.96 -37.8 74.83 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.539 0.735 . . . . 74.530000000000001 110.756 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.17 72.34 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.185 0.594 . . . . 64.430000000000007 111.141 174.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 14' ' ' TRP . 87.0 mt -64.8 -18.36 65.03 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.063 0.945 . . . . 72.219999999999999 113.438 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.21 -34.06 69.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.907 0.883 . . . . 75.340000000000003 112.458 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.85 -33.59 1.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.384 0.674 . . . . 75.230000000000004 111.838 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.9 92.27 7.32 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.433 0.693 . . . . 71.010000000000005 109.727 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -127.19 162.98 24.89 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.685 0.794 . . . . 70.129999999999995 111.411 -170.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.94 59.81 5.69 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 116.042 -0.526 . . . . 70.510000000000005 112.069 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.2 tt -142.42 130.68 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.409 0.684 . . . . 63.420000000000002 110.739 -167.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.0 t -73.87 160.13 31.86 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.049 0.54 . . . . 72.5 110.961 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.0 mt -49.15 -50.94 60.64 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 114.574 1.324 . . . . 73.200000000000003 114.574 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.94 -27.16 17.84 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 121.973 1.782 . . . . 75.129999999999995 113.731 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.19 -43.02 65.15 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.689 1.233 . . . . 73.129999999999995 109.121 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.06 -38.08 87.44 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 112.512 -2.131 . . . . 74.349999999999994 111.157 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.83 -39.39 81.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.726 1.211 . . . . 72.5 112.248 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -63.15 -44.01 96.71 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.325 0.65 . . . . 73.439999999999998 111.298 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -66.04 -42.74 89.14 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.437 0.695 . . . . 74.340000000000003 111.598 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 13' ' ' VAL . 33.0 m -87.55 2.22 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.865 -0.607 . . . . 70.310000000000002 112.286 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 t30 60.66 27.61 17.33 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 124.281 1.032 . . . . 74.209999999999994 112.004 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 44.2 mt -111.66 162.92 14.68 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.742 0.817 . . . . 74.150000000000006 109.561 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.2 t -77.11 164.78 25.37 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.592 0.357 . . . . 72.549999999999997 111.152 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.95 -53.32 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 124.277 1.031 . . . . 72.5 112.536 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.44 -42.9 88.36 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.361 0.664 . . . . 71.420000000000002 111.943 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -64.97 -37.37 87.41 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.998 0.919 . . . . 73.109999999999999 112.373 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 43' ' ' VAL . 87.9 m -77.98 -45.13 24.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.458 0.703 . . . . 73.049999999999997 111.402 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.71 -49.61 75.96 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.227 1.011 . . . . 71.030000000000001 112.071 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.51 -31.36 72.38 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 114.214 -1.357 . . . . 73.200000000000003 111.037 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.06 -36.69 72.38 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.296 0.638 . . . . 52.329999999999998 112.021 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 39' ' ' THR . 98.6 t -64.48 -33.02 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 123.064 0.546 . . . . 72.439999999999998 111.027 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.89 -31.27 79.89 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-N 116.634 -0.257 . . . . 71.400000000000006 113.421 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.45 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 64.6 t-105 -74.15 -28.36 61.29 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 123.639 0.776 . . . . 74.450000000000003 111.28 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.77 -35.5 64.97 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.227 0.611 . . . . 75.120000000000005 111.727 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.85 -30.77 70.32 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.791 0.836 . . . . 71.439999999999998 111.614 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 11.4 ttp180 -52.21 -49.61 63.56 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.771 0.829 . . . . 73.310000000000002 111.158 167.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -77.09 -12.47 59.94 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.896 -1.047 . . . . 74.430000000000007 112.568 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.3 m120 61.7 22.41 12.94 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.018 1.327 . . . . 70.040000000000006 112.488 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -89.01 -2.36 58.54 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.763 0.825 . . . . 71.510000000000005 111.752 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.64 154.41 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.811 0.845 . . . . 64.400000000000006 110.919 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 64' ' ' TYR . 6.8 m -134.46 132.35 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.399 1.08 . . . . 72.430000000000007 110.116 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.21 126.46 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.691 0.796 . . . . 71.329999999999998 109.909 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -110.84 139.82 45.83 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.81 0.844 . . . . 74.540000000000006 111.044 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.457 ' HG2' HG12 ' A' ' 61' ' ' ILE . 82.0 mtm180 -116.1 124.03 49.37 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.11 0.964 . . . . 74.310000000000002 109.61 173.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 118.13 12.71 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.948 0.899 . . . . 65.420000000000002 109.538 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.0 t30 58.29 31.88 21.38 Favored 'General case' 0 CA--C 1.577 2.004 0 CA-C-O 121.998 0.904 . . . . 75.540000000000006 111.363 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.94 -9.55 68.71 Favored Glycine 0 CA--C 1.542 1.762 0 CA-C-N 115.648 -0.705 . . . . 73.349999999999994 114.269 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.3 mt -83.33 122.16 28.09 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.126 0.971 . . . . 74.439999999999998 110.856 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.457 HG12 ' HG2' ' A' ' 56' ' ' ARG . 64.1 mt -95.39 126.79 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.283 0.633 . . . . 75.420000000000002 109.779 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -133.3 141.86 48.19 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.618 0.767 . . . . 70.349999999999994 110.434 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -96.91 117.93 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.002 0.921 . . . . 71.329999999999998 109.745 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.505 ' HB2' HG23 ' A' ' 53' ' ' VAL . 25.5 m-85 -108.05 164.21 12.48 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.595 1.158 . . . . 73.450000000000003 109.109 173.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . 20.1 p-10 -94.16 161.83 14.11 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.405 -0.591 . . . . 74.349999999999994 109.405 169.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 109.148 -0.686 . . . . 74.120000000000005 109.148 170.317 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 112.628 0.603 . . . . 65.230000000000004 112.628 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -77.45 -40.53 42.94 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.654 0.782 . . . . 74.439999999999998 111.546 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.73 -58.64 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.513 0.725 . . . . 75.129999999999995 111.218 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.429 HG11 HD23 ' B' ' 41' ' ' LEU . 32.7 m -61.45 -27.6 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.361 0.664 . . . . 74.209999999999994 111.998 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.96 -49.85 71.45 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 123.47 0.482 . . . . 73.239999999999995 112.83 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.17 88.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.784 0.834 . . . . 74.109999999999999 112.043 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -85.2 -13.01 51.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.26 0.837 . . . . 73.099999999999994 113.26 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 -39.45 69.85 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.857 0.463 . . . . 71.209999999999994 111.367 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.23 -31.04 71.54 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 112.378 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -70.0 -45.74 66.65 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.892 0.877 . . . . 74.450000000000003 111.429 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.534 ' HA ' HG13 ' B' ' 32' ' ' VAL . 30.1 m -71.62 -32.46 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 122.533 0.333 . . . . 75.120000000000005 111.538 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.518 ' HA ' HD12 ' B' ' 17' ' ' LEU . 21.0 t90 -69.98 -33.36 71.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.499 0.32 . . . . 74.310000000000002 110.718 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -58.07 -45.87 86.38 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.932 0.493 . . . . 72.120000000000005 110.563 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.584 ' HB3' ' HE3' ' B' ' 31' ' ' LYS . . . -67.92 -29.59 68.71 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.677 -0.692 . . . . 72.450000000000003 111.712 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.629 ' HB3' HD22 ' B' ' 65' ' ' ASN . 58.6 mt -69.69 -33.02 71.95 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.153 0.981 . . . . 71.310000000000002 111.516 170.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.0 -29.72 64.49 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.915 0.886 . . . . 72.400000000000006 110.942 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -76.68 -49.03 17.11 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.649 0.78 . . . . 73.349999999999994 110.729 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.02 131.7 31.09 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.133 0.973 . . . . 63.329999999999998 109.502 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -114.61 147.34 39.68 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 122.911 0.484 . . . . 63.329999999999998 112.07 -163.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 24.45 69.6 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 115.984 -0.553 . . . . 64.340000000000003 113.266 -172.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.415 HD13 ' HG3' ' B' ' 27' ' ' GLU . 11.5 tt -77.05 143.35 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 124.169 0.987 . . . . 74.319999999999993 111.833 -170.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.6 m -61.24 141.73 57.31 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.756 0.822 . . . . 75.340000000000003 111.353 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.505 HG21 ' HB2' ' B' ' 40' ' ' ALA . 69.6 mt -57.63 -46.09 99.79 Favored Pre-proline 0 CA--C 1.576 1.952 0 N-CA-C 113.777 1.028 . . . . 75.200000000000003 113.777 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.25 -26.47 41.94 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 121.785 1.657 . . . . 75.129999999999995 113.871 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . 0.415 ' HG3' HD13 ' B' ' 23' ' ' ILE . 11.7 tp10 -76.67 -43.51 37.57 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.766 1.269 . . . . 70.450000000000003 109.773 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 58.8 tp -58.38 -40.22 81.71 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 112.833 -1.985 . . . . 73.010000000000005 111.013 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.15 75.43 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.536 1.134 . . . . 74.049999999999997 112.552 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -65.57 -42.05 92.23 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.48 0.712 . . . . 75.409999999999997 111.983 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.584 ' HE3' ' HB3' ' B' ' 16' ' ' ALA . 44.1 mtmt -72.67 -30.72 64.49 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.067 0.395 . . . . 75.420000000000002 112.067 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.534 HG13 ' HA ' ' B' ' 13' ' ' VAL . 25.4 m -96.45 -4.8 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 112.876 0.695 . . . . 73.400000000000006 112.876 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 65.83 15.87 10.24 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.442 1.097 . . . . 70.209999999999994 112.594 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt -96.89 163.84 12.8 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.699 -0.625 . . . . 71.120000000000005 110.967 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 37.5 m -66.45 151.44 47.18 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.935 -0.575 . . . . 75.010000000000005 110.152 171.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 58.1 t -55.51 -45.79 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 123.268 0.627 . . . . 73.239999999999995 111.857 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.38 -44.06 97.8 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.874 0.87 . . . . 70.340000000000003 112.374 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t -63.46 -38.5 91.37 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.563 0.745 . . . . 72.450000000000003 111.417 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 89.6 m -68.36 -48.91 63.54 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.081 -0.963 . . . . 74.310000000000002 110.781 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.505 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -58.88 -36.85 75.32 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.0 0.92 . . . . 73.299999999999997 112.47 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.429 HD23 HG11 ' B' ' 6' ' ' VAL . 0.6 OUTLIER -66.28 -48.18 71.24 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.025 0.93 . . . . 75.450000000000003 110.078 178.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.04 68.9 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.53 -0.759 . . . . 62.299999999999997 111.62 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 73.8 t -77.63 -37.78 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 123.263 0.625 . . . . 63.130000000000003 111.057 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.46 -27.78 72.22 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 121.432 0.462 . . . . 52.240000000000002 112.326 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -73.39 -30.02 63.0 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.295 1.038 . . . . 73.140000000000001 110.956 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.445 HD12 ' HD1' ' B' ' 14' ' ' TRP . 96.2 mt -72.0 -34.17 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.199 0.6 . . . . 72.140000000000001 111.658 171.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.94 67.12 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.692 0.797 . . . . 61.030000000000001 111.926 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.421 ' HB2' ' HG3' ' A' ' 48' ' ' ARG . 10.0 ptt-85 -60.88 -37.24 81.48 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.66 0.784 . . . . 71.230000000000004 111.517 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . 0.528 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 41.4 mt-10 -93.9 5.24 52.31 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.861 0.864 . . . . 51.420000000000002 111.772 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 64.4 23.33 12.96 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.684 1.193 . . . . 73.519999999999996 112.931 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.528 ' HG3' ' HB2' ' B' ' 49' ' ' GLU . 28.3 mtpp -79.21 -13.08 59.92 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.752 0.649 . . . . 73.420000000000002 112.752 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' B' ' 64' ' ' TYR . 31.3 m -123.0 143.69 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.316 0.579 . . . . 72.150000000000006 112.185 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 33.4 t -113.11 105.1 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.307 0 C-N-CA 124.625 1.17 . . . . 74.430000000000007 109.959 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.495 HG21 HG23 ' B' ' 61' ' ' ILE . 3.4 mp -85.68 118.9 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 123.282 0.633 . . . . 71.230000000000004 110.925 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.17 117.38 19.82 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.899 0.88 . . . . 73.439999999999998 111.161 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -85.4 116.37 23.69 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.532 0.733 . . . . 72.140000000000001 110.352 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -125.03 115.4 20.47 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.577 1.151 . . . . 62.030000000000001 108.117 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 58.41 31.34 20.83 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.497 1.119 . . . . 74.219999999999999 111.163 -168.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.43 -19.37 32.37 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 115.442 -0.799 . . . . 72.140000000000001 113.867 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 mt -80.53 123.13 27.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.159 0.984 . . . . 54.25 111.206 -172.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.495 HG23 HG21 ' B' ' 54' ' ' ILE . 3.3 mp -80.65 127.85 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.666 0.786 . . . . 72.25 110.893 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.59 145.07 43.63 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.009 0.923 . . . . 74.299999999999997 109.3 168.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.495 HD13 ' H ' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -119.69 104.61 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-O 122.216 1.008 . . . . 73.430000000000007 109.876 174.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.588 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 77.5 m-85 -86.13 174.54 9.08 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.027 -0.988 . . . . 72.310000000000002 111.781 177.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.629 HD22 ' HB3' ' B' ' 17' ' ' LEU . 0.9 OUTLIER -86.49 159.07 19.41 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.362 0.601 . . . . 63.039999999999999 111.334 174.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 CA--C 1.56 1.337 0 C-N-CA 124.863 1.265 . . . . 72.230000000000004 112.073 170.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 112.923 0.712 . . . . 74.549999999999997 112.923 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.05 -40.27 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.221 0.609 . . . . 73.329999999999998 111.451 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG13 HD12 ' A' ' 41' ' ' LEU . 13.5 m -66.11 -33.45 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 122.177 0.191 . . . . 71.200000000000003 111.449 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.09 -43.37 33.37 Favored Glycine 0 C--N 1.353 1.513 0 O-C-N 123.479 0.487 . . . . 35.450000000000003 113.281 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 -46.48 76.33 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.557 0.743 . . . . 74.439999999999998 111.6 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.84 -26.56 66.11 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.812 0.845 . . . . 62.43 111.8 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.11 -34.44 73.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.003 0.521 . . . . 72.140000000000001 111.324 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.16 -38.76 94.18 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 116.183 -0.462 . . . . 72.540000000000006 113.152 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -69.49 -48.52 60.37 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.308 0.643 . . . . 75.310000000000002 111.733 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.86 -36.8 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 122.333 0.253 . . . . 74.549999999999997 111.462 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.536 ' HA ' HD13 ' A' ' 17' ' ' LEU . 54.4 t90 -64.92 -40.16 94.62 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.416 0.286 . . . . 75.340000000000003 111.052 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -60.94 -39.82 90.92 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.848 0.459 . . . . 73.200000000000003 110.904 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.82 69.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.469 0.708 . . . . 71.5 111.926 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.536 HD13 ' HA ' ' A' ' 14' ' ' TRP . 84.4 mt -66.11 -45.27 81.73 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.537 0.735 . . . . 74.230000000000004 111.663 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -62.39 -31.55 72.24 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 120.815 0.34 . . . . 62.409999999999997 111.283 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.36 -49.35 50.18 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.439 0.696 . . . . 74.340000000000003 110.698 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.64 105.09 0.51 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.748 0.819 . . . . 72.310000000000002 111.084 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.48 -179.6 3.92 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.847 0.859 . . . . 64.25 111.403 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.42 33.09 44.88 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.033 -0.53 . . . . 44.299999999999997 111.824 -171.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.4 tt -122.5 154.55 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 124.432 1.093 . . . . 65.310000000000002 110.096 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.9 m -63.16 145.98 54.32 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.838 0.455 . . . . 73.319999999999993 111.302 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' B' ' 37' ' ' GLU . 66.0 mt -58.33 -43.27 98.02 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 123.989 0.916 . . . . 73.409999999999997 113.363 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.495 ' HA ' HG21 ' A' ' 36' ' ' VAL . 36.6 Cg_endo -62.69 -35.2 70.76 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 122.244 1.963 . . . . 71.450000000000003 114.284 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -69.84 -51.26 35.02 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.25 1.024 . . . . 73.340000000000003 109.187 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.8 tp -54.26 -37.79 65.07 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 112.811 -1.995 . . . . 73.409999999999997 112.123 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.15 92.43 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.191 0.997 . . . . 63.219999999999999 112.136 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -67.5 -26.5 66.37 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.279 0.631 . . . . 75.329999999999998 111.82 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.14 -47.15 46.46 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.548 0.739 . . . . 75.239999999999995 111.094 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -84.29 0.96 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.216 0.606 . . . . 74.030000000000001 111.945 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 69.26 12.04 8.31 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.404 1.482 . . . . 70.209999999999994 113.632 174.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.3 mt -93.66 169.19 10.51 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.298 0.639 . . . . 74.239999999999995 110.523 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.6 p -78.06 162.93 26.33 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 110.24 -0.281 . . . . 74.319999999999993 110.24 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' A' ' 26' ' ' PRO . 40.8 t -56.19 -47.55 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.799 0.84 . . . . 75.340000000000003 111.418 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.19 -41.72 97.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.989 -1.005 . . . . 73.340000000000003 112.186 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -67.06 -39.19 86.84 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.404 0.682 . . . . 75.340000000000003 112.315 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 43' ' ' VAL . 78.4 m -69.15 -48.62 61.87 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.513 0.725 . . . . 73.430000000000007 111.615 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HB1' HG23 ' A' ' 25' ' ' ILE . . . -61.61 -38.38 87.4 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.38 0.672 . . . . 72.549999999999997 112.144 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.533 HD23 HG23 ' B' ' 43' ' ' VAL . 1.6 tm? -65.75 -39.09 90.74 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 124.95 1.3 . . . . 75.450000000000003 110.792 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.97 -33.32 70.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.433 0.693 . . . . 72.450000000000003 111.797 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.614 HG12 HD12 ' A' ' 63' ' ' ILE . 89.8 t -66.43 -31.04 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.072 0.549 . . . . 75.340000000000003 111.18 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.48 -30.11 73.54 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-N 116.751 -0.204 . . . . 64.329999999999998 113.535 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -73.99 -31.12 62.83 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.505 0.722 . . . . 74.010000000000005 110.982 173.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.67 -30.27 65.53 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.459 0.704 . . . . 52.130000000000003 111.609 172.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.09 -27.65 68.91 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.739 0.816 . . . . 74.239999999999995 111.655 169.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -65.96 -42.44 89.92 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.297 0.57 . . . . 75.530000000000001 110.15 169.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.81 -22.47 61.56 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.08 -0.964 . . . . 55.420000000000002 111.834 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 t30 65.71 22.4 11.58 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 125.171 1.388 . . . . 72.109999999999999 111.167 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -97.26 6.0 49.09 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.7 0.8 . . . . 74.049999999999997 112.87 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.8 151.16 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.808 0.843 . . . . 70.120000000000005 110.875 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.6 t -111.68 107.63 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.578 0.751 . . . . 71.439999999999998 109.381 172.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.5 mt -96.44 112.86 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.143 -0.688 . . . . 75.230000000000004 109.143 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -134.52 125.88 28.23 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 110.077 -0.342 . . . . 71.540000000000006 110.077 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -87.45 107.8 18.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.016 0.926 . . . . 75.530000000000001 111.155 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.415 ' O ' HD23 ' A' ' 60' ' ' LEU . 2.3 mptm? -105.19 141.61 36.43 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.294 1.038 . . . . 74.349999999999994 108.87 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.8 p30 44.18 29.33 0.34 Allowed 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 125.334 1.454 . . . . 71.319999999999993 113.76 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.07 -28.67 12.88 Favored Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.274 0.869 . . . . 70.129999999999995 115.274 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -90.73 154.33 19.62 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.757 1.278 . . . . 75.219999999999999 112.037 -174.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.32 116.29 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.899 0.88 . . . . 74.010000000000005 109.84 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.95 128.6 56.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.337 0.655 . . . . 74.439999999999998 110.235 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.614 HD12 HG12 ' A' ' 43' ' ' VAL . 23.0 mm -92.27 105.7 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.426 0.69 . . . . 75.040000000000006 110.221 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -97.6 172.64 7.59 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.234 1.014 . . . . 73.530000000000001 110.804 176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -98.93 170.58 8.63 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.23 0.612 . . . . 71.400000000000006 109.97 164.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 N--CA 1.489 1.502 0 C-N-CA 123.749 0.82 . . . . 72.420000000000002 112.351 175.076 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.773 0.32 . . . . 73.400000000000006 111.609 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -86.4 -25.82 25.09 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.764 0.426 . . . . 65.329999999999998 111.861 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 72.3 mt -66.77 -46.34 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.839 0.456 . . . . 75.109999999999999 110.877 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.2 m -64.6 -26.24 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 122.916 0.487 . . . . 72.129999999999995 111.078 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' B' ' 45' ' ' TRP . . . -65.57 -51.97 43.26 Favored Glycine 0 C--N 1.354 1.581 0 O-C-N 123.665 0.603 . . . . 72.150000000000006 113.543 172.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.64 85.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.48 0.712 . . . . 64.340000000000003 111.745 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . 0.47 ' HB3' HD13 ' B' ' 34' ' ' LEU . 5.7 m-20 -68.65 -29.02 67.41 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.22 1.008 . . . . 74.010000000000005 111.519 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.519 ' HB3' ' HG ' ' B' ' 46' ' ' LEU . . . -73.26 -39.0 65.75 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.857 0.463 . . . . 74.109999999999999 110.969 176.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.21 -32.34 82.21 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-O 121.358 0.421 . . . . 54.299999999999997 112.281 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.8 -35.66 77.3 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.675 1.19 . . . . 73.129999999999995 111.683 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.449 HG13 HG13 ' B' ' 43' ' ' VAL . 74.7 t -69.51 -40.41 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.488 0.715 . . . . 73.099999999999994 111.317 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -66.13 -32.5 73.98 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.264 0.626 . . . . 75.230000000000004 110.943 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -54.72 -42.28 71.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.776 0.83 . . . . 75.230000000000004 111.472 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.91 70.81 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.5 0.72 . . . . 52.310000000000002 112.528 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.643 HD13 HG12 ' B' ' 52' ' ' VAL . 82.7 mt -62.91 -42.67 99.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.531 0.733 . . . . 74.439999999999998 111.476 172.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -64.65 -22.11 66.9 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.377 0.671 . . . . 71.209999999999994 111.651 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.33 -50.73 13.51 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.48 0.712 . . . . 74.439999999999998 110.262 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.3 124.34 0.72 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.823 0.849 . . . . 55.439999999999998 111.137 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -74.81 175.1 8.33 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.439 0.695 . . . . 73.400000000000006 112.593 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.42 20.5 78.34 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.961 -0.563 . . . . 75.329999999999998 112.974 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' B' ' 28' ' ' LEU . 8.9 tp -84.73 124.39 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.946 0.899 . . . . 72.430000000000007 110.285 -176.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -85.38 147.03 26.7 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.845 0.458 . . . . 62.43 110.584 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 88.0 mt -49.74 -44.98 79.12 Favored Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 114.965 1.468 . . . . 74.120000000000005 114.965 -173.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.61 -48.17 21.71 Favored 'Trans proline' 0 C--N 1.392 2.819 0 C-N-CA 122.332 2.021 . . . . 71.150000000000006 114.374 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -72.09 -38.43 69.38 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.835 1.302 . . . . 75.5 110.072 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.456 ' HB2' HG13 ' B' ' 23' ' ' ILE . 56.0 tp -60.88 -33.95 73.89 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 112.642 -2.072 . . . . 75.219999999999999 111.34 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.7 -35.87 79.27 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.299 1.04 . . . . 63.439999999999998 112.484 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -64.91 -43.9 91.32 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 122.857 0.463 . . . . 73.409999999999997 110.523 173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -64.74 -39.39 93.54 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.429 -0.805 . . . . 63.43 112.137 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.433 HG11 HG23 ' B' ' 13' ' ' VAL . 23.4 m -97.53 -3.1 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 112.947 0.721 . . . . 72.150000000000006 112.947 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.7 28.5 14.94 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 124.558 1.143 . . . . 73.140000000000001 111.672 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.47 HD13 ' HB3' ' B' ' 9' ' ' ASN . 92.4 mt -109.49 166.11 11.14 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.533 0.733 . . . . 74.349999999999994 110.564 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 43.6 t -73.87 161.64 29.93 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.1 0.56 . . . . 64.140000000000001 110.615 170.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.5 -47.46 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.239 0.616 . . . . 73.510000000000005 111.741 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.53 ' HB3' HD11 ' A' ' 25' ' ' ILE . 42.7 mt-10 -61.05 -42.2 98.04 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.024 0.93 . . . . 72.239999999999995 112.339 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 39.4 t -67.24 -34.95 78.54 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.383 0.673 . . . . 75.239999999999995 111.665 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 45.0 m -79.94 -34.54 38.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.939 0.896 . . . . 71.329999999999998 110.982 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.86 -33.58 72.46 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.747 0.819 . . . . 75.319999999999993 111.139 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -75.4 -34.26 61.04 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 115.398 -0.819 . . . . 74.450000000000003 110.511 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.98 90.42 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.945 0.498 . . . . 72.409999999999997 111.767 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.533 HG23 HD23 ' A' ' 41' ' ' LEU . 20.2 m -68.75 -29.16 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 122.483 0.313 . . . . 74.319999999999993 110.916 172.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.4 -34.36 89.09 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.188 -0.46 . . . . 63.5 113.198 171.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.4 ' CD1' ' HA2' ' B' ' 7' ' ' GLY . 61.1 t-105 -72.51 -33.84 67.19 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.683 0.393 . . . . 72.140000000000001 110.372 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' B' ' 10' ' ' ALA . 53.2 mt -66.64 -27.93 68.07 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.633 0.373 . . . . 74.040000000000006 111.875 170.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.73 74.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.986 0.515 . . . . 73.329999999999998 111.609 168.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -64.68 -43.41 93.62 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.081 0.467 . . . . 73.420000000000002 110.164 170.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -67.8 -25.52 65.63 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.344 -0.844 . . . . 75.239999999999995 111.654 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 67.0 22.91 9.92 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.509 1.524 . . . . 70.319999999999993 111.797 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -95.58 3.55 53.98 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.882 1.067 . . . . 73.109999999999999 113.882 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.643 HG12 HD13 ' B' ' 17' ' ' LEU . 15.7 m -123.32 153.35 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.485 0.66 . . . . 71.450000000000003 112.407 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 91.4 t -108.72 125.84 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.494 1.118 . . . . 71.019999999999996 109.309 171.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 mm -104.8 116.52 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.129 0.572 . . . . 75.319999999999993 109.881 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -117.72 123.59 46.42 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.435 0.694 . . . . 64.239999999999995 110.1 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -93.57 97.19 10.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.082 0.553 . . . . 74.349999999999994 109.823 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . 0.602 ' HD3' ' HG3' ' B' ' 62' ' ' GLU . 8.7 mtpm? -105.11 113.2 26.65 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.041 0.936 . . . . 74.540000000000006 110.149 -175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 60.28 28.94 18.58 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.605 1.562 . . . . 65.150000000000006 111.733 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.62 -2.32 87.29 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 114.591 0.596 . . . . 73.319999999999993 114.591 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.67 149.37 22.88 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.009 0.905 . . . . 74.310000000000002 111.635 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.8 mm -87.14 119.1 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.178 0.591 . . . . 72.450000000000003 110.861 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . 0.602 ' HG3' ' HD3' ' B' ' 57' ' ' LYS . 7.2 mm-40 -116.1 121.63 42.73 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.286 1.034 . . . . 75.099999999999994 109.395 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.511 HG23 HD23 ' B' ' 17' ' ' LEU . 17.5 mm -100.75 122.35 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.19 0.596 . . . . 74.439999999999998 110.822 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.64 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 22.4 m-85 -116.18 169.15 9.5 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.109 0.964 . . . . 72.200000000000003 111.244 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -77.62 141.28 39.56 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.633 -0.712 . . . . 73.340000000000003 111.225 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.491 1.597 0 C-N-CA 124.899 1.28 . . . . 73.140000000000001 114.217 172.931 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.0 tptp . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.005 0.431 . . . . 75.420000000000002 110.673 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.4 mt -65.44 -41.3 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.725 0.81 . . . . 74.25 112.335 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.498 HG13 HD12 ' A' ' 41' ' ' LEU . 29.5 m -65.13 -30.39 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 122.993 0.517 . . . . 62.32 111.517 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -42.52 85.08 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 112.498 -0.241 . . . . 63.25 112.498 172.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.89 -45.82 69.99 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.795 0.838 . . . . 72.400000000000006 111.949 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -77.37 -23.06 50.86 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 122.971 0.508 . . . . 73.409999999999997 111.946 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.03 -35.58 59.45 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.91 0.484 . . . . 54.409999999999997 111.209 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.61 -31.57 78.96 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 121.613 0.563 . . . . 75.540000000000006 112.231 172.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -68.92 -45.01 71.95 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 125.136 1.374 . . . . 74.340000000000003 110.79 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.447 ' HA ' HG11 ' A' ' 32' ' ' VAL . 39.2 t -64.48 -36.58 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 124.534 1.134 . . . . 74.219999999999999 111.652 173.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.408 ' NE1' ' HB3' ' A' ' 51' ' ' LYS . 15.9 t90 -71.5 -32.23 68.0 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.442 0.697 . . . . 73.409999999999997 110.908 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -59.84 -32.93 71.14 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.563 0.745 . . . . 74.310000000000002 111.545 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.77 -22.86 65.78 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.804 0.668 . . . . 73.230000000000004 112.804 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.596 HD12 HG13 ' A' ' 52' ' ' VAL . 94.7 mt -68.8 -38.83 80.23 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.766 0.826 . . . . 73.230000000000004 112.687 173.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -56.86 -36.27 69.85 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.525 0.73 . . . . 74.340000000000003 111.303 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.62 -47.75 13.65 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.488 -0.778 . . . . 74.209999999999994 110.966 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.73 113.32 6.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.07 0.948 . . . . 65.329999999999998 111.392 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -94.94 128.3 41.63 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.404 -0.961 . . . . 75.150000000000006 108.404 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.8 47.81 4.66 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 111.896 -0.482 . . . . 74.120000000000005 111.896 -172.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.8 tp -114.35 137.27 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 C-N-CA 123.898 0.879 . . . . 73.299999999999997 110.731 -175.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.7 p -82.49 162.3 22.09 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.321 0.648 . . . . 61.420000000000002 111.99 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.9 mt -55.41 -54.34 52.1 Favored Pre-proline 0 CA--C 1.579 2.084 0 N-CA-C 113.84 1.052 . . . . 75.010000000000005 113.84 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.14 -30.61 20.24 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.03 1.82 . . . . 72.319999999999993 113.432 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -71.43 -44.33 65.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.265 0.626 . . . . 72.310000000000002 111.619 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.07 -30.65 63.86 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.91 0.484 . . . . 75.409999999999997 110.334 175.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.33 -41.86 76.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.551 0.74 . . . . 72.319999999999993 112.016 177.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -69.22 -30.82 69.06 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.079 0.552 . . . . 75.319999999999993 111.671 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -69.94 -40.48 75.44 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.079 0.552 . . . . 75.310000000000002 111.578 174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.447 HG11 ' HA ' ' A' ' 13' ' ' VAL . 21.5 m -96.72 7.74 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.365 0.666 . . . . 72.0 112.115 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.47 16.96 9.13 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.454 1.102 . . . . 72.540000000000006 113.935 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt -99.85 159.43 15.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.53 0.732 . . . . 74.400000000000006 110.414 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.7 t -68.8 161.02 29.38 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.761 0.425 . . . . 74.120000000000005 110.847 169.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -59.3 -42.92 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 122.705 0.402 . . . . 75.450000000000003 111.491 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -64.82 -48.35 74.69 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.214 0.606 . . . . 73.319999999999993 111.784 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 t -57.08 -39.18 74.48 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.016 0.926 . . . . 75.510000000000005 112.101 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 43' ' ' VAL . 79.8 m -71.0 -52.28 20.55 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 123.905 0.882 . . . . 65.439999999999998 110.741 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.34 -30.95 67.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.018 0.927 . . . . 71.120000000000005 112.807 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.498 HD12 HG13 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -68.76 -45.05 72.39 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.388 1.075 . . . . 64.450000000000003 110.351 172.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.46 -31.38 72.57 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.586 0.754 . . . . 72.140000000000001 111.965 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 39' ' ' THR . 75.2 t -62.82 -43.14 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.551 1.141 . . . . 62.030000000000001 111.466 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.25 -31.13 75.93 Favored Glycine 0 CA--C 1.541 1.691 0 O-C-N 123.342 0.401 . . . . 52.149999999999999 113.055 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.448 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 51.3 t-105 -75.07 -27.7 60.06 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.849 0.86 . . . . 74.129999999999995 112.323 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 98.2 mt -76.68 -42.13 42.9 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.892 -0.505 . . . . 73.340000000000003 111.826 168.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.83 71.36 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.718 1.207 . . . . 72.120000000000005 113.327 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.693 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 14.1 ptt180 -61.05 -34.49 74.97 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.681 0.392 . . . . 74.420000000000002 111.718 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.693 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 36.4 mt-10 -98.41 1.05 46.47 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.421 1.088 . . . . 74.530000000000001 111.923 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 t30 61.89 28.1 17.13 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.623 1.169 . . . . 73.239999999999995 111.529 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 92.1 mttt -72.81 -21.35 60.98 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.59 0.756 . . . . 75.329999999999998 112.316 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.596 HG13 HD12 ' A' ' 17' ' ' LEU . 27.9 m -125.8 148.55 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 72.239999999999995 111.199 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.744 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 44.4 t -100.12 100.5 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.782 0.833 . . . . 73.349999999999994 108.8 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.3 mm -78.43 123.26 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 109.936 -0.394 . . . . 72.299999999999997 109.936 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.37 116.57 17.01 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.727 -0.842 . . . . 75.209999999999994 108.727 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -93.9 103.53 15.63 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.387 0.675 . . . . 75.510000000000005 110.387 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.437 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -111.16 129.04 56.07 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.563 0.745 . . . . 74.420000000000002 109.904 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 56.03 28.37 12.71 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.574 1.149 . . . . 75.230000000000004 112.467 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.64 -21.27 14.84 Favored Glycine 0 CA--C 1.542 1.722 0 N-CA-C 114.242 0.457 . . . . 53.32 114.242 -174.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.02 143.84 35.25 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.462 0.705 . . . . 75.319999999999993 110.877 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.81 138.13 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.494 -0.558 . . . . 73.219999999999999 109.494 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -147.35 142.57 27.24 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.454 0.645 . . . . 75.010000000000005 111.027 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.1 mt -111.01 137.51 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.042 0.937 . . . . 75.439999999999998 110.862 -173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.744 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 90.1 m-85 -121.62 165.24 16.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.71 -1.132 . . . . 74.230000000000004 108.942 174.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' HA ' HD13 ' A' ' 17' ' ' LEU . 20.9 t-20 -83.05 152.04 25.54 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.914 -0.772 . . . . 74.129999999999995 108.914 173.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 113.602 0.964 . . . . 75.140000000000001 113.602 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.624 ' HA ' HG23 ' B' ' 6' ' ' VAL . 99.0 mttt . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 112.796 0.665 . . . . 72.040000000000006 112.796 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -70.05 -37.36 75.51 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.769 0.427 . . . . 71.319999999999993 110.81 171.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.93 -52.71 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 123.513 0.725 . . . . 73.549999999999997 111.438 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' B' ' 3' ' ' LYS . 19.5 m -70.52 -27.47 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 122.72 0.408 . . . . 74.540000000000006 111.741 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -38.87 89.17 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 116.783 -0.189 . . . . 73.239999999999995 112.764 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.03 32.02 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.437 0.695 . . . . 73.25 111.73 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . 0.573 ' HB2' HD13 ' B' ' 34' ' ' LEU . 31.3 p30 -73.29 -20.97 60.7 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 112.953 0.723 . . . . 73.310000000000002 112.953 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.97 -23.38 64.12 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.083 0.553 . . . . 64.510000000000005 111.178 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.04 -31.91 79.2 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 116.222 -0.445 . . . . 74.129999999999995 113.12 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.62 -47.02 64.89 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.438 0.695 . . . . 74.120000000000005 111.101 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.19 -36.88 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.276 1.03 . . . . 75.519999999999996 111.59 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -72.66 -34.32 67.16 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.263 0.625 . . . . 74.329999999999998 110.979 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -65.03 -31.03 72.06 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.666 0.387 . . . . 72.25 111.475 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.68 -30.23 67.21 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.05 0.54 . . . . 75.329999999999998 112.146 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.687 HD13 HG12 ' B' ' 52' ' ' VAL . 80.3 mt -65.59 -45.96 81.22 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.772 0.829 . . . . 72.239999999999995 111.659 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -59.66 -28.18 67.03 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.692 0.797 . . . . 74.099999999999994 111.266 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -81.91 -47.57 12.59 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.877 0.871 . . . . 72.430000000000007 111.217 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.09 151.98 16.52 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.783 0.833 . . . . 55.409999999999997 111.736 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -112.22 156.16 22.81 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.297 0.639 . . . . 74.349999999999994 109.649 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.01 38.66 84.68 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 114.359 0.503 . . . . 61.039999999999999 114.359 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 tt -102.36 137.54 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.23 0.612 . . . . 73.329999999999998 110.275 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -73.11 156.4 38.72 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.386 0.674 . . . . 73.319999999999993 111.594 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.82 -52.18 76.28 Favored Pre-proline 0 CA--C 1.575 1.933 0 N-CA-C 113.617 0.969 . . . . 74.129999999999995 113.617 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.75 -23.91 55.24 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.149 1.899 . . . . 65.109999999999999 113.501 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -78.91 -42.66 26.6 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.741 0.816 . . . . 74.430000000000007 111.496 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.1 -31.58 61.21 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 122.157 -0.34 . . . . 74.549999999999997 111.078 174.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.53 -45.38 73.35 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.573 1.149 . . . . 74.549999999999997 113.393 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -65.01 -30.83 71.83 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 115.999 -0.546 . . . . 74.239999999999995 112.22 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -78.41 -40.93 34.55 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.015 0.526 . . . . 75.010000000000005 111.058 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 m -81.58 -3.4 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.076 0.551 . . . . 72.519999999999996 111.683 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 65.83 29.41 10.51 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.321 1.448 . . . . 75.120000000000005 112.906 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' B' ' 9' ' ' ASN . 66.5 mt -109.28 158.07 18.23 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.693 0.797 . . . . 72.299999999999997 110.395 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 34.0 t -65.09 152.82 42.56 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.781 0.433 . . . . 75.329999999999998 110.581 166.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.34 -41.97 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 123.073 0.549 . . . . 72.510000000000005 111.579 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.66 -48.21 80.33 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.087 0.955 . . . . 75.230000000000004 112.015 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.5 t -66.56 -30.82 71.22 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.713 0.805 . . . . 71.409999999999997 111.601 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 96.8 m -74.87 -44.17 50.44 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.916 0.886 . . . . 73.319999999999993 110.92 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.51 -34.3 77.47 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.872 0.869 . . . . 73.329999999999998 111.648 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -67.2 -44.08 80.52 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 124.27 1.028 . . . . 75.219999999999999 110.496 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.81 76.75 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.14 0.576 . . . . 73.540000000000006 111.793 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.19 -44.35 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.585 1.154 . . . . 74.319999999999993 110.828 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.47 -28.04 73.16 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 116.378 -0.374 . . . . 65.209999999999994 113.155 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.434 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 49.9 t-105 -74.18 -29.9 61.98 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.967 0.907 . . . . 73.450000000000003 111.232 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.06 -36.59 58.94 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.358 0.663 . . . . 73.420000000000002 112.186 167.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.96 76.86 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.202 1.001 . . . . 61.43 113.543 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 20.3 ptt85 -63.92 -30.68 71.74 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.303 0.573 . . . . 74.219999999999999 111.097 173.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -86.03 -15.78 40.3 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.374 1.07 . . . . 70.209999999999994 111.572 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 t30 60.43 43.62 13.04 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.717 1.207 . . . . 73.200000000000003 110.769 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -95.83 -9.07 32.48 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.312 -0.858 . . . . 74.530000000000001 111.777 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.687 HG12 HD13 ' B' ' 17' ' ' LEU . 27.7 m -125.17 146.47 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.222 1.009 . . . . 60.509999999999998 111.149 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.564 HG22 ' HA ' ' B' ' 66' ' ' GLU . 85.9 t -103.95 104.08 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.133 -1.062 . . . . 74.0 108.133 167.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 70.8 mt -91.21 118.18 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.146 0.578 . . . . 72.340000000000003 109.827 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.69 123.28 45.7 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.003 -0.74 . . . . 73.439999999999998 109.003 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -89.13 96.85 10.89 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.596 0.712 . . . . 72.439999999999998 109.341 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -116.66 119.06 34.3 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.077 -0.965 . . . . 73.329999999999998 109.502 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 60.07 28.79 18.38 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.783 1.233 . . . . 74.030000000000001 111.731 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.85 -3.93 72.82 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 114.452 0.541 . . . . 44.329999999999998 114.452 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.59 134.7 34.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.341 0.656 . . . . 75.439999999999998 110.736 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.6 mm -87.07 103.12 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 123.562 0.745 . . . . 74.239999999999995 109.045 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -117.75 123.84 47.0 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.486 0.715 . . . . 64.209999999999994 109.919 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 40.2 pt -97.76 138.29 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.074 0.94 . . . . 73.299999999999997 112.177 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 77.0 m-85 -120.7 169.4 10.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.165 1.386 . . . . 60.25 108.347 175.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -85.43 145.99 27.19 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.682 -0.858 . . . . 65.030000000000001 108.682 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.564 ' HA ' HG22 ' B' ' 53' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 112.394 0.516 . . . . 70.420000000000002 112.394 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.481 0.182 . . . . 75.200000000000003 111.339 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.608 HD12 HH22 ' B' ' 56' ' ' ARG . 68.4 mt -62.82 -47.53 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.433 0.693 . . . . 75.409999999999997 110.947 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.48 -34.46 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.772 0.829 . . . . 74.150000000000006 111.352 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.41 -37.12 94.32 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 112.634 -0.186 . . . . 60.219999999999999 112.634 173.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.0 -55.74 8.78 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.699 0.8 . . . . 71.200000000000003 112.296 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.58 ' HB2' HD11 ' A' ' 34' ' ' LEU . 36.6 p30 -78.14 -13.46 59.86 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.756 1.021 . . . . 74.519999999999996 113.756 -170.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.16 -27.77 64.8 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.651 0.38 . . . . 64.430000000000007 111.598 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.23 -45.45 80.48 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 116.15 -0.477 . . . . 61.020000000000003 113.552 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HB3' ' HZ3' ' A' ' 12' ' ' LYS . 0.2 OUTLIER -70.13 -39.17 75.57 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.811 0.444 . . . . 74.109999999999999 112.185 -179.274 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.48 ' HA ' HG12 ' A' ' 32' ' ' VAL . 20.9 m -69.59 -36.19 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.72 0.236 . . . . 74.239999999999995 111.221 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.654 ' HA ' HD11 ' A' ' 17' ' ' LEU . 62.3 t90 -69.37 -33.64 73.37 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.91 0.484 . . . . 74.409999999999997 111.033 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.61 -33.96 77.12 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.048 0.539 . . . . 73.120000000000005 111.321 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.74 76.1 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.231 0.612 . . . . 74.010000000000005 111.551 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 14' ' ' TRP . 31.3 mt -71.91 -33.93 68.69 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.009 0.924 . . . . 74.099999999999994 111.641 174.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -30.3 65.23 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.734 0.814 . . . . 73.230000000000004 109.944 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -77.23 -41.39 41.36 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.018 0.527 . . . . 64.349999999999994 110.492 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.2 107.13 1.8 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.136 0.574 . . . . 74.140000000000001 111.612 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.98 174.91 11.15 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.331 0.652 . . . . 74.219999999999999 111.148 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.67 42.43 97.27 Favored Glycine 0 N--CA 1.479 1.518 0 CA-C-O 121.406 0.448 . . . . 74.0 112.366 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' A' ' 28' ' ' LEU . 21.1 tt -114.92 144.79 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.826 0.851 . . . . 74.439999999999998 110.996 -169.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -79.8 151.26 30.4 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.08 0.552 . . . . 74.109999999999999 110.889 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.81 -47.1 99.33 Favored Pre-proline 0 CA--C 1.58 2.119 0 N-CA-C 113.326 0.862 . . . . 64.140000000000001 113.326 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.05 -22.81 47.14 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.076 1.851 . . . . 71.439999999999998 113.468 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -71.91 -48.9 42.27 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.633 0.773 . . . . 64.510000000000005 111.673 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.437 ' HB3' HD13 ' A' ' 23' ' ' ILE . 2.2 pt? -74.9 -29.62 61.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.816 -0.553 . . . . 71.5 111.826 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.39 -44.88 65.58 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.385 0.883 . . . . 51.030000000000001 113.385 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -70.44 -30.38 67.2 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.922 0.489 . . . . 74.439999999999998 112.081 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 25.7 mtpp -68.33 -44.34 75.54 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.575 0.75 . . . . 74.140000000000001 110.592 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.48 HG12 ' HA ' ' A' ' 13' ' ' VAL . 16.9 m -86.41 -2.0 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.126 0.971 . . . . 73.299999999999997 111.805 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 m120 64.84 23.22 12.63 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.104 1.361 . . . . 74.420000000000002 112.946 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 9' ' ' ASN . 66.3 mt -101.63 168.2 9.63 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.67 0.788 . . . . 72.409999999999997 111.102 174.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 m -71.72 156.97 38.75 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.905 -0.589 . . . . 74.310000000000002 110.838 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.39 -48.37 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 123.235 0.614 . . . . 72.239999999999995 111.717 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.73 -38.64 91.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.38 0.672 . . . . 64.230000000000004 112.658 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.1 m -65.99 -31.14 71.88 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.606 0.762 . . . . 73.420000000000002 111.807 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.4 m -77.39 -44.18 30.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.802 0.841 . . . . 73.310000000000002 111.112 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.57 -33.55 72.87 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.305 0.642 . . . . 60.32 111.659 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -53.71 54.84 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.546 1.139 . . . . 75.140000000000001 110.04 171.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.28 -32.35 72.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.078 -0.965 . . . . 73.349999999999994 112.277 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.43 HG11 HD12 ' A' ' 63' ' ' ILE . 69.1 t -68.34 -39.71 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.24 0.616 . . . . 72.209999999999994 111.183 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.34 -31.8 81.99 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 116.633 -0.258 . . . . 61.340000000000003 113.108 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -71.18 -30.3 66.25 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.605 0.762 . . . . 72.200000000000003 111.685 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.445 HD21 ' HE2' ' A' ' 51' ' ' LYS . 77.5 mt -75.61 -38.07 59.28 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.578 0.751 . . . . 74.25 112.274 170.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.29 -37.01 74.16 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.807 1.243 . . . . 63.310000000000002 114.117 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.568 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 25.7 ptt85 -60.39 -26.67 66.84 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 122.935 0.494 . . . . 74.530000000000001 111.886 175.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.568 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 40.0 mt-10 -103.3 4.96 37.08 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.856 1.262 . . . . 74.209999999999994 112.228 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 62.71 21.7 12.9 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 125.031 1.332 . . . . 64.239999999999995 113.0 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HE2' HD21 ' A' ' 46' ' ' LEU . 50.8 mtpt -80.2 -13.45 59.23 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.235 0.614 . . . . 74.219999999999999 112.283 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.5 HG13 HD13 ' A' ' 17' ' ' LEU . 19.0 m -121.61 142.95 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.759 0.823 . . . . 64.400000000000006 111.22 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 94.7 t -112.73 104.98 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 123.846 0.859 . . . . 71.030000000000001 109.872 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 61' ' ' ILE . 2.6 mp -91.64 125.43 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.561 -0.533 . . . . 73.049999999999997 109.561 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.33 113.22 25.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.007 0.523 . . . . 73.319999999999993 109.644 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -87.23 96.22 10.25 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.77 -0.826 . . . . 75.420000000000002 108.77 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.54 118.12 34.86 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.825 0.85 . . . . 75.019999999999996 109.541 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.78 31.56 17.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.871 0.868 . . . . 75.030000000000001 111.569 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.52 2.36 74.53 Favored Glycine 0 CA--C 1.546 1.98 0 N-CA-C 114.472 0.549 . . . . 70.140000000000001 114.472 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.0 mt -94.92 133.07 39.05 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.945 0.898 . . . . 65.340000000000003 110.306 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.56 HG22 HG23 ' A' ' 54' ' ' ILE . 76.6 mt -96.87 118.07 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.489 0.715 . . . . 74.129999999999995 111.666 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.37 132.05 55.75 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.914 -0.773 . . . . 62.119999999999997 108.914 167.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.43 HD12 HG11 ' A' ' 43' ' ' VAL . 40.0 mt -102.04 132.05 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 121.325 0.583 . . . . 73.099999999999994 110.788 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.557 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 83.8 m-85 -124.55 173.55 8.41 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.318 1.047 . . . . 75.549999999999997 110.158 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -99.86 163.92 12.25 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.048 0.539 . . . . 74.5 109.727 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.49 1.574 0 C-N-CA 124.441 1.097 . . . . 73.019999999999996 112.324 175.106 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.498 ' HA ' HG21 ' B' ' 6' ' ' VAL . 37.5 ttmt . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 112.323 0.49 . . . . 72.519999999999996 112.323 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -55.25 -41.24 71.9 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.403 0.621 . . . . 72.150000000000006 110.478 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 47.6 mt -66.55 -51.97 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-N 114.677 -1.147 . . . . 72.540000000000006 111.457 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.498 HG21 ' HA ' ' B' ' 3' ' ' LYS . 4.5 m -67.18 -32.3 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 122.584 0.354 . . . . 73.409999999999997 111.896 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.47 -44.09 66.19 Favored Glycine 0 C--N 1.349 1.302 0 O-C-N 123.201 0.313 . . . . 75.329999999999998 112.749 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.26 69.83 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.505 0.722 . . . . 73.420000000000002 112.25 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . 0.402 ' OD1' HD13 ' B' ' 34' ' ' LEU . 9.0 t-20 -86.67 -28.05 23.4 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.637 0.775 . . . . 64.420000000000002 112.131 -175.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.25 72.36 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.275 0.63 . . . . 74.420000000000002 112.192 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.81 -42.31 95.17 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 116.11 -0.495 . . . . 71.219999999999999 112.373 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -65.11 -45.63 84.33 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.777 0.831 . . . . 73.239999999999995 111.479 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.604 ' HA ' HG12 ' B' ' 32' ' ' VAL . 30.9 m -68.83 -32.22 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 C-N-CA 122.772 0.429 . . . . 72.099999999999994 112.068 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.477 ' HA ' HD12 ' B' ' 17' ' ' LEU . 34.6 t90 -72.3 -35.77 68.75 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.834 0.454 . . . . 74.409999999999997 111.495 175.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -67.46 -32.24 72.95 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.069 0.548 . . . . 74.019999999999996 112.018 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.7 74.39 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 122.971 0.508 . . . . 65.430000000000007 111.939 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' B' ' 14' ' ' TRP . 82.6 mt -63.67 -30.89 71.94 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.944 0.898 . . . . 71.450000000000003 112.602 174.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -69.2 -5.48 22.89 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.158 0.799 . . . . 54.149999999999999 113.158 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -79.67 -61.48 1.98 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.022 0.529 . . . . 74.230000000000004 110.469 170.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.94 131.72 5.33 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.511 0.725 . . . . 65.129999999999995 110.947 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.524 ' HB3' ' HD1' ' B' ' 64' ' ' TYR . 4.6 m-20 -74.22 175.21 7.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.991 0.916 . . . . 74.420000000000002 112.468 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.72 54.81 5.24 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.535 -0.626 . . . . 72.409999999999997 111.535 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 tt -133.6 120.34 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.53 0.732 . . . . 74.329999999999998 110.994 -167.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -67.74 163.49 21.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.633 0.773 . . . . 65.319999999999993 111.911 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.401 HG21 ' HB2' ' B' ' 40' ' ' ALA . 48.5 mt -59.7 -47.12 98.26 Favored Pre-proline 0 CA--C 1.574 1.901 0 CA-C-O 118.525 -0.75 . . . . 73.019999999999996 112.434 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.02 -22.99 34.69 Favored 'Trans proline' 0 C--N 1.396 3.044 0 C-N-CA 121.871 1.714 . . . . 74.319999999999993 114.064 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -70.73 -50.45 36.08 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.686 1.231 . . . . 75.239999999999995 109.017 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.83 -39.1 83.97 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 112.612 -2.085 . . . . 75.310000000000002 111.679 175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.17 -43.11 87.28 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.105 0.962 . . . . 74.209999999999994 112.867 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -69.71 -36.93 76.34 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.003 0.521 . . . . 75.239999999999995 111.587 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -64.39 -44.85 90.04 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.244 0.618 . . . . 75.230000000000004 111.148 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' B' ' 13' ' ' VAL . 13.7 m -88.23 5.34 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.35 0.66 . . . . 73.129999999999995 112.727 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 69.32 17.81 8.14 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.798 1.239 . . . . 73.409999999999997 113.137 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.402 HD13 ' OD1' ' B' ' 9' ' ' ASN . 63.3 mt -110.65 174.95 5.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.627 0.771 . . . . 74.319999999999993 112.287 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -84.31 160.72 20.65 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.17 -0.923 . . . . 74.430000000000007 110.577 167.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 63.2 t -53.89 -49.82 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 124.1 0.96 . . . . 74.310000000000002 112.653 -175.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.37 -48.3 82.34 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.579 0.752 . . . . 74.510000000000005 111.985 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -62.67 -37.13 85.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.942 0.897 . . . . 64.549999999999997 111.892 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.473 ' O ' HG22 ' B' ' 43' ' ' VAL . 85.1 m -69.07 -51.31 40.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.578 0.751 . . . . 75.340000000000003 111.609 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.401 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -55.04 -44.51 74.73 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.802 0.841 . . . . 71.340000000000003 111.974 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.72 -36.19 82.91 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.393 1.077 . . . . 73.519999999999996 111.203 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.44 83.27 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.775 0.43 . . . . 74.349999999999994 112.151 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.473 HG22 ' O ' ' B' ' 39' ' ' THR . 24.8 t -67.54 -29.19 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.51 0.724 . . . . 72.329999999999998 111.449 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.73 -28.16 56.5 Favored Glycine 0 CA--C 1.551 2.282 0 N-CA-C 114.502 0.561 . . . . 52.130000000000003 114.502 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.476 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 72.6 t-105 -74.33 -24.69 59.23 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.443 0.697 . . . . 72.420000000000002 111.533 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.44 HD11 HG23 ' B' ' 13' ' ' VAL . 83.9 mt -72.77 -36.04 67.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.563 0.745 . . . . 73.209999999999994 111.636 173.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.97 -33.51 67.15 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.728 0.811 . . . . 74.439999999999998 112.363 172.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 33.1 ttt-85 -54.63 -49.78 69.7 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.971 0.908 . . . . 74.530000000000001 111.481 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.27 -1.35 57.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.51 0.724 . . . . 74.239999999999995 112.58 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 64.17 21.96 12.72 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.812 1.245 . . . . 71.349999999999994 113.177 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -86.61 1.37 52.02 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.08 0.77 . . . . 72.299999999999997 113.08 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.36 155.68 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 123.362 0.665 . . . . 73.219999999999999 112.027 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 45.8 t -120.43 96.57 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.532 -0.914 . . . . 65.439999999999998 108.532 169.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.43 HD13 HG12 ' B' ' 43' ' ' VAL . 35.7 mt -95.75 102.27 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.158 0.504 . . . . 74.219999999999999 109.676 -177.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -134.29 132.27 39.39 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.994 -0.441 . . . . 75.340000000000003 111.629 -166.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.618 ' HG2' HG13 ' B' ' 61' ' ' ILE . 6.7 mtm-85 -86.8 97.05 10.41 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.799 0.809 . . . . 63.240000000000002 110.405 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -108.35 128.31 54.64 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.653 -1.158 . . . . 72.209999999999994 109.151 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 59.31 29.9 19.54 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.492 1.117 . . . . 75.519999999999996 111.14 -170.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.99 -21.39 7.98 Favored Glycine 0 C--N 1.36 1.915 0 CA-C-N 115.879 -0.601 . . . . 71.510000000000005 114.514 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mp -89.7 135.52 33.57 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.453 0.701 . . . . 44.32 110.74 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.618 HG13 ' HG2' ' B' ' 56' ' ' ARG . 1.4 mp -73.93 107.99 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 C-N-CA 123.593 0.757 . . . . 74.030000000000001 109.682 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -107.53 120.27 41.74 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.014 0.926 . . . . 70.25 110.494 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.45 ' N ' HD12 ' B' ' 63' ' ' ILE . 2.2 mp -94.24 132.31 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 109.149 -0.685 . . . . 74.409999999999997 109.149 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.615 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 90.5 m-85 -123.5 174.0 7.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.473 1.109 . . . . 71.519999999999996 109.997 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -93.97 158.26 15.72 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 109.142 -0.688 . . . . 74.430000000000007 109.142 166.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 N--CA 1.488 1.46 0 C-N-CA 124.358 1.063 . . . . 73.319999999999993 113.397 -178.172 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 112.438 0.532 . . . . 73.519999999999996 112.438 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.4 mt -52.8 -58.13 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.118 0.967 . . . . 75.239999999999995 112.115 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -60.79 -37.47 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 112.926 0.713 . . . . 75.239999999999995 112.926 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.79 -38.84 41.2 Favored Glycine 0 N--CA 1.476 1.366 0 O-C-N 123.237 0.336 . . . . 70.329999999999998 113.041 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.72 -36.73 83.92 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.943 0.897 . . . . 74.129999999999995 111.971 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -84.15 -28.92 27.08 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.092 -0.504 . . . . 53.43 111.622 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.82 71.12 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 122.908 0.483 . . . . 73.409999999999997 111.986 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.7 97.23 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.245 -0.434 . . . . 72.219999999999999 112.975 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -72.67 -38.29 67.65 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.925 0.89 . . . . 75.400000000000006 111.579 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.742 ' HA ' HG13 ' A' ' 32' ' ' VAL . 54.2 t -62.98 -47.74 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.79 0.836 . . . . 75.420000000000002 111.28 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -66.17 -33.43 75.75 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.623 -0.717 . . . . 73.019999999999996 111.35 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -61.62 -42.42 98.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.402 0.681 . . . . 75.400000000000006 111.681 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.21 74.03 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.327 0.651 . . . . 72.140000000000001 111.491 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' A' ' 21' ' ' ASP . 2.5 tm? -70.73 -30.7 67.31 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.213 1.405 . . . . 73.049999999999997 111.536 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -64.24 -42.95 96.31 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.945 0.898 . . . . 73.120000000000005 112.816 -169.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -81.69 -15.22 55.17 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.005 0.743 . . . . 61.130000000000003 113.005 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.53 96.06 1.14 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.961 0.504 . . . . 64.209999999999994 110.738 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.48 ' HA ' HD21 ' A' ' 17' ' ' LEU . 8.7 p-10 -86.02 169.2 13.41 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.09 0.556 . . . . 75.120000000000005 112.009 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.86 55.06 3.94 Favored Glycine 0 C--N 1.344 1.009 0 N-CA-C 111.698 -0.561 . . . . 60.130000000000003 111.698 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 tt -130.13 136.43 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.979 0.911 . . . . 75.329999999999998 110.421 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.9 p -74.97 154.59 38.04 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.783 0.433 . . . . 74.430000000000007 111.242 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 40' ' ' ALA . 63.8 mt -52.36 -47.42 92.97 Favored Pre-proline 0 CA--C 1.573 1.837 0 N-CA-C 114.056 1.132 . . . . 74.519999999999996 114.056 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.69 -33.05 56.19 Favored 'Trans proline' 0 C--N 1.393 2.902 0 C-N-CA 121.714 1.609 . . . . 75.510000000000005 114.319 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 30' ' ' ARG . 37.6 mt-10 -76.74 -31.0 56.84 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.395 1.093 . . . . 73.329999999999998 110.453 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.81 -33.3 66.14 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 113.668 -1.605 . . . . 75.239999999999995 110.603 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.9 -39.4 87.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.895 0.878 . . . . 65.129999999999995 112.855 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 14.2 ptt180 -70.38 -28.08 64.82 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.401 0.28 . . . . 73.400000000000006 111.053 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -67.27 -37.74 83.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.961 0.904 . . . . 75.129999999999995 111.574 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.742 HG13 ' HA ' ' A' ' 13' ' ' VAL . 24.6 m -102.8 0.73 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 112.989 0.737 . . . . 73.0 112.989 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 65.71 28.47 11.06 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.808 1.243 . . . . 74.409999999999997 112.635 174.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.4 mt -109.0 175.12 5.57 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.943 0.897 . . . . 74.450000000000003 111.244 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 99.9 p -77.99 163.74 25.68 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.319 0.648 . . . . 75.430000000000007 110.37 168.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -58.18 -45.92 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.09 0.556 . . . . 72.230000000000004 111.17 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.71 -37.51 82.35 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.954 0.902 . . . . 73.530000000000001 112.648 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -69.69 -37.37 76.59 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.129 0.49 . . . . 71.109999999999999 111.563 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.442 ' O ' HG22 ' A' ' 43' ' ' VAL . 93.8 m -72.88 -44.66 61.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.494 0.717 . . . . 73.109999999999999 111.281 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -57.86 -35.63 71.22 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.966 0.906 . . . . 73.109999999999999 111.972 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -51.8 67.15 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 114.795 -1.093 . . . . 73.530000000000001 110.207 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.04 70.96 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.862 -1.063 . . . . 74.420000000000002 111.723 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 39' ' ' THR . 79.4 t -69.23 -38.25 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.367 0.667 . . . . 71.030000000000001 110.664 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.89 -31.77 82.02 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 116.359 -0.382 . . . . 74.540000000000006 113.459 172.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.498 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 66.9 t-105 -73.92 -30.15 62.42 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.449 0.699 . . . . 75.239999999999995 111.047 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.19 -37.44 69.29 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.922 0.489 . . . . 75.219999999999999 111.184 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.76 -30.09 71.19 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.95 0.9 . . . . 74.230000000000004 111.724 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 21.5 ttt180 -55.88 -50.6 70.2 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.564 0.745 . . . . 75.230000000000004 110.884 167.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -84.71 -3.23 58.46 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 115.197 -0.911 . . . . 75.019999999999996 111.961 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 62.25 22.22 13.02 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 125.258 1.423 . . . . 73.319999999999993 112.764 -175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -69.55 -24.82 63.77 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.41 1.084 . . . . 73.219999999999999 112.367 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.59 151.14 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.64 0.776 . . . . 75.129999999999995 110.813 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.461 HG13 ' HG3' ' A' ' 55' ' ' GLU . 44.6 t -116.92 111.45 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 123.712 0.805 . . . . 74.530000000000001 110.242 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.492 HG23 HG21 ' A' ' 61' ' ' ILE . 3.4 mp -86.56 107.98 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 N-CA-C 109.389 -0.596 . . . . 73.040000000000006 109.389 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HG3' HG13 ' A' ' 53' ' ' VAL . 54.3 mt-10 -118.44 118.03 30.65 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.538 0.735 . . . . 72.150000000000006 110.382 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -85.24 100.96 12.13 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.136 0.974 . . . . 72.540000000000006 110.076 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -114.63 109.15 17.8 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.069 0.948 . . . . 75.530000000000001 109.885 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 57.63 32.67 22.2 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.171 0.988 . . . . 73.040000000000006 111.831 -169.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.3 -9.92 62.74 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 115.557 -0.747 . . . . 72.109999999999999 114.311 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.5 mt -80.0 107.55 12.87 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.191 0.596 . . . . 72.230000000000004 109.997 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.492 HG21 HG23 ' A' ' 54' ' ' ILE . 76.7 mt -69.88 102.63 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.321 -0.622 . . . . 75.209999999999994 109.321 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -110.19 124.11 50.98 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.923 0.889 . . . . 71.430000000000007 109.847 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.72 103.25 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 108.602 -0.888 . . . . 74.030000000000001 108.602 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -91.81 175.77 6.77 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.073 0.949 . . . . 74.030000000000001 110.941 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.81 158.87 16.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.081 0.552 . . . . 74.349999999999994 110.525 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.483 1.218 0 C-N-CA 123.517 0.727 . . . . 74.420000000000002 110.379 171.564 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 113.063 0.764 . . . . 75.530000000000001 113.063 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.24 -35.02 14.03 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.259 0.623 . . . . 74.430000000000007 112.344 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 58.8 mt -61.52 -40.71 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.502 0.721 . . . . 62.509999999999998 111.841 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 28.6 m -61.49 -30.28 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.884 0.874 . . . . 74.299999999999997 112.091 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.03 -39.65 94.86 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 122.888 0.118 . . . . 51.009999999999998 113.057 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.94 -53.04 10.98 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.55 0.74 . . . . 74.439999999999998 112.496 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -70.29 -30.59 67.64 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.215 0.821 . . . . 65.219999999999999 113.215 -172.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.35 -25.21 61.45 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.265 0.626 . . . . 64.049999999999997 111.924 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.55 -38.71 96.08 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 116.166 -0.47 . . . . 73.400000000000006 112.816 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -70.85 -40.03 72.59 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.691 0.796 . . . . 74.430000000000007 111.174 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.411 ' HA ' HG13 ' B' ' 32' ' ' VAL . 92.3 t -63.03 -48.41 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.124 0.57 . . . . 64.319999999999993 111.332 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.478 ' HA ' HD12 ' B' ' 17' ' ' LEU . 40.4 t90 -65.55 -34.13 77.53 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.245 0.618 . . . . 74.530000000000001 110.989 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -62.46 -39.42 93.36 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.76 0.824 . . . . 73.219999999999999 110.636 173.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.15 -32.12 72.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.647 0.779 . . . . 73.120000000000005 111.683 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' B' ' 14' ' ' TRP . 69.3 mt -74.4 -31.91 62.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.455 0.702 . . . . 73.140000000000001 111.426 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.03 -25.97 62.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.008 0.523 . . . . 74.120000000000005 110.689 -177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -95.73 -29.41 14.28 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.521 0.728 . . . . 74.099999999999994 111.476 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.78 94.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.446 0.698 . . . . 70.120000000000005 111.74 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -96.87 179.4 4.97 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.286 0.634 . . . . 72.140000000000001 111.755 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.54 37.39 53.03 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.474 -0.33 . . . . 72.439999999999998 113.224 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 tt -119.27 151.17 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.064 0.946 . . . . 74.25 110.632 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -61.97 140.52 58.32 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.971 0.508 . . . . 74.409999999999997 111.348 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' B' ' 40' ' ' ALA . 64.8 mt -53.81 -45.9 98.65 Favored Pre-proline 0 CA--C 1.576 1.962 0 N-CA-C 113.219 0.822 . . . . 71.049999999999997 113.219 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' B' ' 36' ' ' VAL . 36.9 Cg_endo -63.13 -29.4 74.32 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.116 1.877 . . . . 74.040000000000006 115.072 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.22 -49.16 17.91 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.126 0.965 . . . . 71.099999999999994 109.759 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -55.05 -36.26 65.36 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 113.326 -1.761 . . . . 71.099999999999994 112.083 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.39 -42.79 87.85 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.007 0.923 . . . . 72.030000000000001 112.058 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -72.46 -24.7 61.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.832 -0.622 . . . . 64.230000000000004 111.28 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -76.09 -41.99 48.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.416 0.687 . . . . 71.150000000000006 111.391 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' B' ' 13' ' ' VAL . 24.1 m -89.77 3.76 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.168 0.587 . . . . 73.450000000000003 112.366 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 67.09 22.48 9.89 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.736 1.214 . . . . 73.530000000000001 112.424 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.85 171.29 7.68 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.337 0.655 . . . . 74.510000000000005 111.561 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.2 t -72.99 158.62 35.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.342 0.657 . . . . 72.439999999999998 111.093 170.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' B' ' 26' ' ' PRO . 41.7 t -57.33 -47.48 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.349 0.66 . . . . 75.439999999999998 111.306 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -64.0 -40.82 97.23 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.604 -0.726 . . . . 75.040000000000006 112.048 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -66.93 -34.08 77.0 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.367 0.667 . . . . 73.0 112.115 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.436 ' O ' HG22 ' B' ' 43' ' ' VAL . 90.3 m -76.6 -39.87 51.21 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.627 0.771 . . . . 61.340000000000003 111.07 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' B' ' 25' ' ' ILE . . . -63.78 -37.92 89.16 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.323 0.582 . . . . 74.400000000000006 111.127 174.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.97 -40.96 97.58 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.667 1.187 . . . . 72.400000000000006 110.519 172.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.48 -43.37 94.41 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.359 0.663 . . . . 42.200000000000003 112.005 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.606 HG13 HG21 ' B' ' 63' ' ' ILE . 84.5 t -61.24 -31.23 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.109 0.564 . . . . 72.530000000000001 111.321 176.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.36 -29.2 68.47 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 114.58 0.592 . . . . 74.430000000000007 114.58 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.443 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 76.9 t-105 -72.92 -34.34 66.55 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.712 0.805 . . . . 75.310000000000002 111.111 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 77.1 mt -71.42 -40.25 70.55 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.142 0.577 . . . . 65.209999999999994 110.322 174.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.91 -31.97 73.34 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.351 1.06 . . . . 73.409999999999997 111.708 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 16.1 ttp85 -52.64 -51.79 58.52 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.582 0.706 . . . . 61.340000000000003 110.945 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -83.89 -8.93 59.07 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.875 -1.057 . . . . 72.209999999999994 111.669 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 63.42 29.82 15.49 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.012 1.325 . . . . 73.400000000000006 112.115 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -69.28 -9.59 53.9 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.486 1.515 . . . . 71.510000000000005 113.009 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.26 150.05 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 124.127 0.971 . . . . 74.409999999999997 111.24 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 94.7 t -93.21 129.2 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.985 0.914 . . . . 74.5 109.455 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.63 120.85 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.87 -1.159 . . . . 75.409999999999997 107.87 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . 0.511 ' HG2' ' HZ1' ' B' ' 57' ' ' LYS . 8.9 tp10 -137.95 158.62 43.97 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.201 0.601 . . . . 73.040000000000006 110.487 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -118.83 114.14 22.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.992 0.517 . . . . 73.340000000000003 110.252 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . 0.511 ' HZ1' ' HG2' ' B' ' 55' ' ' GLU . 13.9 mptt -101.99 107.49 18.65 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.01 0.924 . . . . 74.340000000000003 108.618 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 57.96 31.99 21.35 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.473 1.109 . . . . 63.539999999999999 111.847 -175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.51 34.69 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 115.949 -0.569 . . . . 64.319999999999993 113.812 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 75.6 mt -75.57 136.89 40.52 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.453 0.701 . . . . 70.099999999999994 111.215 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.58 117.7 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-O 121.271 0.557 . . . . 74.109999999999999 110.463 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . 0.49 ' HG3' ' HD3' ' B' ' 57' ' ' LYS . 39.1 mm-40 -108.14 142.6 38.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.491 1.516 . . . . 73.200000000000003 110.491 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.606 HG21 HG13 ' B' ' 43' ' ' VAL . 2.0 pp -133.5 122.5 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 CA-C-O 121.783 0.801 . . . . 75.019999999999996 111.206 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.684 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 55.3 m-85 -115.4 171.28 7.81 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.864 0.866 . . . . 75.319999999999993 110.295 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -100.79 153.45 19.46 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.102 0.561 . . . . 75.439999999999998 109.914 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 . . . . . 0 N--CA 1.488 1.469 0 O-C-N 122.079 -0.388 . . . . 71.439999999999998 111.755 173.11 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 113.698 0.999 . . . . 73.239999999999995 113.698 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -49.1 -52.8 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 118.585 0.63 . . . . 71.099999999999994 111.083 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.71 -28.22 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.04 0.536 . . . . 71.439999999999998 112.265 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.41 -42.66 33.45 Favored Glycine 0 C--N 1.351 1.371 0 O-C-N 123.302 0.376 . . . . 71.340000000000003 113.558 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.7 -44.42 81.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.809 0.844 . . . . 72.349999999999994 111.209 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -71.64 -28.89 64.08 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.84 -0.618 . . . . 74.340000000000003 111.707 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.09 -29.03 63.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.679 0.392 . . . . 62.229999999999997 111.263 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.11 -37.28 92.92 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 115.997 -0.547 . . . . 71.030000000000001 112.46 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -75.26 -38.92 60.26 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 122.881 0.472 . . . . 75.209999999999994 111.271 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.46 HG13 HD11 ' A' ' 28' ' ' LEU . 53.1 t -64.14 -46.12 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.889 0.875 . . . . 74.349999999999994 111.284 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -67.67 -33.32 74.69 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.514 -0.312 . . . . 73.150000000000006 110.313 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -63.91 -33.0 74.72 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 122.416 -0.178 . . . . 73.299999999999997 111.027 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.469 ' HB1' HD13 ' A' ' 28' ' ' LEU . . . -67.22 -28.5 68.12 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.82 0.448 . . . . 73.230000000000004 111.846 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.4 -45.46 54.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.784 0.834 . . . . 75.129999999999995 110.633 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -59.71 -29.86 68.41 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.495 1.118 . . . . 75.510000000000005 111.559 173.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -82.06 -52.94 6.52 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.07 0.948 . . . . 73.140000000000001 110.26 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.35 96.59 2.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.467 1.107 . . . . 63.109999999999999 109.567 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -73.94 154.16 39.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.607 0.763 . . . . 63.420000000000002 113.016 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.6 65.37 2.43 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 116.076 -0.511 . . . . 51.439999999999998 112.935 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.494 HD12 ' HG3' ' A' ' 27' ' ' GLU . 20.7 tt -134.25 143.76 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 122.871 0.468 . . . . 74.239999999999995 111.819 -169.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 49.4 m -67.61 146.08 54.22 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.546 0.738 . . . . 75.430000000000007 111.815 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 40' ' ' ALA . 55.9 mt -53.4 -48.94 90.93 Favored Pre-proline 0 CA--C 1.577 1.994 0 C-N-CA 124.175 0.99 . . . . 75.430000000000007 113.581 -176.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.86 -27.59 43.54 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 121.765 1.643 . . . . 75.510000000000005 113.553 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.494 ' HG3' HD12 ' A' ' 23' ' ' ILE . 10.8 tp10 -73.12 -55.62 6.23 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 112.402 0.519 . . . . 73.219999999999999 112.402 -174.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 HD13 ' HB1' ' A' ' 16' ' ' ALA . 2.2 pt? -66.41 -29.31 69.44 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.078 0.399 . . . . 74.230000000000004 111.245 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.37 -42.67 53.67 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.719 0.808 . . . . 73.230000000000004 112.168 171.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -63.81 -40.4 96.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.074 0.55 . . . . 74.409999999999997 111.596 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.509 ' HB3' ' HZ2' ' A' ' 31' ' ' LYS . 6.4 mtpm? -69.04 -38.06 78.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.889 0.876 . . . . 74.510000000000005 111.473 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.1 m -94.85 4.66 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.524 0.73 . . . . 74.349999999999994 112.201 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 64.81 21.23 12.32 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 124.741 1.216 . . . . 64.040000000000006 112.336 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.6 mt -105.91 162.59 13.44 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.38 0.672 . . . . 75.409999999999997 111.527 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -69.81 158.48 35.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.433 -0.803 . . . . 73.5 111.249 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -56.91 -42.22 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.241 0.616 . . . . 74.319999999999993 110.744 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.16 -50.03 73.46 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.699 0.8 . . . . 75.349999999999994 111.497 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -58.15 -38.94 77.54 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.819 0.848 . . . . 71.510000000000005 111.856 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.425 ' O ' HG21 ' A' ' 43' ' ' VAL . 97.9 m -70.69 -52.69 19.37 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.661 0.785 . . . . 64.209999999999994 111.391 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.42 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.17 -32.58 74.2 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 123.797 0.839 . . . . 70.230000000000004 112.772 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -72.66 -41.17 65.71 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.171 0.988 . . . . 74.340000000000003 109.808 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.02 -30.52 71.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.307 0.643 . . . . 75.420000000000002 111.586 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 39' ' ' THR . 49.5 t -65.8 -43.97 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.339 1.056 . . . . 75.109999999999999 110.304 171.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.449 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.27 -28.37 72.89 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 116.11 -0.495 . . . . 74.329999999999998 112.713 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.426 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 77.2 t-105 -70.28 -44.4 68.47 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.207 0.603 . . . . 75.310000000000002 110.829 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.0 mt -60.9 -31.37 70.86 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.267 0.627 . . . . 73.510000000000005 111.735 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.07 -25.0 57.95 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.574 1.15 . . . . 73.219999999999999 113.63 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.733 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 23.6 ptt180 -57.12 -35.59 69.65 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 123.07 0.548 . . . . 75.439999999999998 111.519 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.733 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 28.9 mt-10 -106.28 8.39 31.83 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.64 1.176 . . . . 75.099999999999994 110.93 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 63.39 23.8 13.89 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.037 1.335 . . . . 74.230000000000004 112.698 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HG3' ' HB2' ' A' ' 49' ' ' GLU . 28.1 mtpp -70.16 -10.96 60.47 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.677 0.991 . . . . 75.319999999999993 113.677 -174.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 m -126.59 148.48 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.792 0.837 . . . . 71.319999999999993 111.545 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.604 HG23 ' HB2' ' A' ' 64' ' ' TYR . 6.7 m -131.0 112.41 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 C-N-CA 124.516 1.126 . . . . 74.420000000000002 109.84 170.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.583 HG13 HG21 ' A' ' 63' ' ' ILE . 3.0 mp -92.07 134.99 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.61 1.164 . . . . 74.409999999999997 110.745 -171.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -139.04 144.76 38.96 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.353 0.661 . . . . 73.230000000000004 110.486 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -116.06 112.61 22.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.504 0.669 . . . . 71.519999999999996 110.528 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -105.4 128.88 53.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.143 0.977 . . . . 73.329999999999998 109.447 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 58.64 31.76 21.45 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 124.635 1.174 . . . . 71.519999999999996 113.025 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.91 -9.86 54.81 Favored Glycine 0 CA--C 1.541 1.711 0 N-CA-C 114.469 0.548 . . . . 61.549999999999997 114.469 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.71 135.07 36.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.323 1.049 . . . . 74.049999999999997 109.342 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.651 HD11 ' HB2' ' B' ' 37' ' ' GLU . 19.5 mt -104.09 125.02 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 CA-C-O 121.544 0.688 . . . . 73.439999999999998 112.345 -170.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 8.8 mp0 -117.96 153.53 33.46 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.806 1.642 . . . . 51.219999999999999 109.725 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.583 HG21 HG13 ' A' ' 54' ' ' ILE . 48.1 pt -113.89 142.7 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.304 0.573 . . . . 73.329999999999998 110.69 171.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.604 ' HB2' HG23 ' A' ' 53' ' ' VAL . 80.9 m-85 -125.07 167.39 14.84 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.225 1.01 . . . . 73.439999999999998 110.135 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -86.87 148.9 25.17 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.539 0.736 . . . . 65.340000000000003 112.011 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.555 1.139 0 CA-C-N 115.766 -0.652 . . . . 74.310000000000002 110.093 166.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.545 ' HZ1' ' HB2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.364 0 CA-C-O 121.105 0.479 . . . . 75.439999999999998 111.738 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.26 -44.54 10.76 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.643 1.177 . . . . 75.219999999999999 110.119 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -56.18 -48.35 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 123.729 0.812 . . . . 74.299999999999997 111.612 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.6 m -63.38 -30.45 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.338 1.055 . . . . 74.129999999999995 112.297 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.43 -44.13 85.09 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.181 0.301 . . . . 72.129999999999995 112.78 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.66 69.23 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.513 0.725 . . . . 71.150000000000006 111.832 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -66.1 -48.65 70.24 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.733 1.213 . . . . 74.540000000000006 110.927 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 -20.93 63.8 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.365 0.666 . . . . 61.310000000000002 112.112 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.29 -43.74 94.72 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 123.172 0.295 . . . . 64.209999999999994 112.986 174.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -68.62 -45.93 70.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.706 0.802 . . . . 72.530000000000001 110.912 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.46 ' HA ' HG13 ' B' ' 32' ' ' VAL . 96.6 t -60.01 -49.65 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.808 0.843 . . . . 75.129999999999995 111.708 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -60.87 -44.35 97.18 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.581 0.753 . . . . 71.25 111.738 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -62.29 -43.68 98.27 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.025 0.53 . . . . 74.329999999999998 111.883 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.04 68.88 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.367 0.667 . . . . 73.239999999999995 111.407 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -72.42 -32.68 66.54 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.744 1.218 . . . . 74.439999999999998 110.578 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -81.77 -18.97 42.31 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.201 0.6 . . . . 64.120000000000005 110.6 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -67.54 -33.77 75.72 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.545 0.738 . . . . 75.239999999999995 110.227 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.12 108.59 1.12 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.256 1.022 . . . . 74.450000000000003 109.564 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -93.58 173.6 7.61 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 112.318 0.488 . . . . 73.540000000000006 112.318 -175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.26 44.68 8.63 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.969 -0.56 . . . . 70.319999999999993 111.943 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 tt -134.33 137.71 51.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.844 0.857 . . . . 72.450000000000003 110.116 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 70.3 m -78.13 160.17 28.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.438 0.695 . . . . 72.099999999999994 112.732 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.461 HG23 ' HB2' ' B' ' 40' ' ' ALA . 81.2 mt -49.32 -53.56 38.58 Favored Pre-proline 0 CA--C 1.572 1.804 0 C-N-CA 125.817 1.647 . . . . 73.519999999999996 114.037 -177.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.41 ' HA ' HG23 ' B' ' 36' ' ' VAL . 63.6 Cg_endo -69.68 -23.75 30.83 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 121.556 1.504 . . . . 71.530000000000001 113.387 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -76.5 -55.76 5.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.213 0.605 . . . . 73.120000000000005 110.596 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.3 -29.7 70.62 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.507 0.723 . . . . 72.510000000000005 111.601 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.501 ' HA ' HG22 ' B' ' 39' ' ' THR . . . -52.9 -37.75 61.0 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.803 0.841 . . . . 74.319999999999993 112.812 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -71.75 -34.79 69.78 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.25 0.833 . . . . 75.120000000000005 113.25 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -76.92 -31.43 56.68 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.548 0.613 . . . . 53.149999999999999 111.646 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' B' ' 13' ' ' VAL . 33.3 m -88.03 -4.72 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.555 0.342 . . . . 73.219999999999999 111.555 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t30 68.67 17.65 8.88 Favored 'General case' 0 CA--C 1.57 1.72 0 C-N-CA 124.779 1.232 . . . . 75.329999999999998 112.119 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 70.3 mt -102.8 163.75 12.03 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.548 0.739 . . . . 74.129999999999995 111.388 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 62.8 m -67.7 158.54 32.06 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.448 0.699 . . . . 71.340000000000003 111.785 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.432 HG12 HG22 ' B' ' 25' ' ' ILE . 61.8 t -64.43 -43.48 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.099 0.559 . . . . 74.430000000000007 111.946 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' A' ' 61' ' ' ILE . 45.8 mt-10 -62.97 -31.98 73.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.768 0.427 . . . . 72.120000000000005 111.946 175.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 42.3 m -63.63 -45.27 91.03 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.46 0.704 . . . . 72.340000000000003 111.114 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.501 HG22 ' HA ' ' B' ' 29' ' ' ALA . 17.0 p -76.46 -41.02 48.79 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.178 0.807 . . . . 75.239999999999995 113.178 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.461 ' HB2' HG23 ' B' ' 25' ' ' ILE . . . -56.0 -46.51 78.7 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 123.863 0.865 . . . . 41.43 111.974 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.9 -40.32 83.5 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 114.256 -1.338 . . . . 74.310000000000002 111.112 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.27 84.77 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.219 0.608 . . . . 73.5 112.102 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.479 HG11 HG22 ' B' ' 52' ' ' VAL . 55.3 t -65.87 -34.47 70.53 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.071 0.948 . . . . 64.319999999999993 110.601 174.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.449 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -65.71 -37.04 93.09 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 116.545 -0.298 . . . . 70.209999999999994 112.925 171.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.505 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 77.2 t-105 -67.18 -30.45 70.41 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.668 0.787 . . . . 75.310000000000002 111.474 175.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.5 -39.37 67.7 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.075 0.55 . . . . 75.219999999999999 110.936 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.9 -25.85 67.81 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.446 1.099 . . . . 74.430000000000007 113.397 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.6 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 16.5 ptt180 -58.93 -36.45 74.77 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.017 0.437 . . . . 73.140000000000001 111.015 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . 0.6 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 43.8 mt-10 -104.75 3.18 31.02 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.686 1.194 . . . . 72.450000000000003 111.033 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.1 t30 58.88 35.86 24.38 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 125.396 1.478 . . . . 70.109999999999999 111.584 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -70.59 -17.11 62.91 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.479 -0.782 . . . . 73.010000000000005 111.044 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.479 HG22 HG11 ' B' ' 43' ' ' VAL . 24.9 m -131.68 153.29 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.283 1.033 . . . . 75.310000000000002 109.304 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' B' ' 64' ' ' TYR . 7.2 m -115.51 116.63 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.537 0.735 . . . . 72.329999999999998 110.15 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 48.5 mm -81.3 104.96 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.849 0.859 . . . . 74.430000000000007 110.217 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -119.45 108.43 14.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.351 0.66 . . . . 54.539999999999999 109.807 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.488 ' HB3' HG13 ' B' ' 61' ' ' ILE . 29.0 ptt180 -92.03 106.34 18.38 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.955 0.883 . . . . 74.530000000000001 110.484 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -103.63 127.83 51.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.988 1.315 . . . . 74.349999999999994 109.607 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 57.74 29.66 17.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.711 1.204 . . . . 72.049999999999997 111.505 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.2 -27.65 6.71 Favored Glycine 0 CA--C 1.546 1.976 0 CA-C-N 115.231 -0.895 . . . . 51.219999999999999 113.858 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.87 123.43 27.75 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.874 0.87 . . . . 73.099999999999994 110.795 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.488 HG13 ' HB3' ' B' ' 56' ' ' ARG . 2.8 mp -74.57 123.21 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 122.739 0.416 . . . . 73.310000000000002 110.128 -174.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -119.53 138.33 53.24 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.204 1.002 . . . . 74.439999999999998 109.752 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.434 HD13 HG13 ' B' ' 25' ' ' ILE . 2.2 mp -107.09 112.09 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.075 0.55 . . . . 75.109999999999999 110.031 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.568 ' HB2' HG22 ' B' ' 53' ' ' VAL . 85.9 m-85 -107.11 159.29 16.42 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.321 1.048 . . . . 71.310000000000002 110.52 174.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -82.51 171.55 13.99 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.957 0.725 . . . . 72.010000000000005 112.957 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 CA--C 1.56 1.356 0 C-N-CA 124.172 0.989 . . . . 74.329999999999998 112.694 171.072 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.0 mttt . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.614 0.245 . . . . 74.200000000000003 111.067 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.8 mt -62.86 -47.53 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.613 0.765 . . . . 75.420000000000002 111.627 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.42 -30.42 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.099 0.56 . . . . 73.120000000000005 111.264 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.93 -51.25 47.22 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.825 0.703 . . . . 63.020000000000003 112.269 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.42 81.83 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.844 0.858 . . . . 64.450000000000003 112.284 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -65.82 -29.47 69.95 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.507 0.723 . . . . 73.239999999999995 112.182 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.12 -44.88 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.033 0.533 . . . . 75.230000000000004 111.367 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.17 94.65 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.48 -0.648 . . . . 64.129999999999995 111.48 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -61.76 -50.01 74.11 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.328 1.051 . . . . 75.150000000000006 112.583 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.659 ' HA ' HG11 ' A' ' 32' ' ' VAL . 32.9 m -67.55 -29.54 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 120.656 0.265 . . . . 73.340000000000003 111.711 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.593 ' HA ' HD11 ' A' ' 17' ' ' LEU . 24.4 t90 -68.6 -32.83 73.0 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.286 0.634 . . . . 73.140000000000001 111.546 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -58.68 -36.84 74.84 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 122.813 0.445 . . . . 71.129999999999995 111.666 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.91 69.49 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.218 0.607 . . . . 75.349999999999994 112.162 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 14' ' ' TRP . 81.2 mt -66.54 -22.58 66.16 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.727 0.811 . . . . 72.5 112.194 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -64.58 -28.08 69.39 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.417 0.687 . . . . 75.200000000000003 111.463 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -77.01 -57.4 3.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.24 0.616 . . . . 75.140000000000001 110.521 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.34 107.6 3.27 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.481 0.712 . . . . 64.510000000000005 110.765 -174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.414 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 6.2 p-10 -95.72 164.57 12.7 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.509 0.724 . . . . 75.310000000000002 110.842 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.15 26.67 51.93 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 121.475 0.486 . . . . 73.209999999999994 112.128 -166.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 tt -96.63 153.71 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 124.46 1.104 . . . . 74.310000000000002 110.139 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -79.17 156.4 28.24 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.902 -0.499 . . . . 73.230000000000004 111.458 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.458 HG23 ' HB2' ' A' ' 40' ' ' ALA . 80.2 mt -56.32 -50.36 88.04 Favored Pre-proline 0 CA--C 1.575 1.908 0 C-N-CA 124.468 1.107 . . . . 64.430000000000007 113.908 -173.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.25 -24.07 38.18 Favored 'Trans proline' 0 C--N 1.394 2.93 0 CA-C-N 121.399 1.535 . . . . 73.319999999999993 114.049 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -76.5 -45.1 32.45 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.43 1.11 . . . . 71.530000000000001 109.683 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.423 HD23 HD13 ' A' ' 63' ' ' ILE . 63.1 tp -59.34 -40.6 86.91 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 113.129 -1.85 . . . . 74.400000000000006 111.09 172.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.15 81.82 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.325 1.05 . . . . 72.109999999999999 111.917 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -65.09 -40.87 95.2 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.626 0.77 . . . . 75.25 111.446 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -63.9 -40.82 97.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.153 0.581 . . . . 74.200000000000003 111.67 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.6 m -95.83 -1.93 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 112.966 0.728 . . . . 71.409999999999997 112.966 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.0 t30 68.02 13.64 9.17 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 124.483 1.113 . . . . 70.0 112.506 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -92.74 166.25 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.463 -0.773 . . . . 72.430000000000007 111.062 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.0 t -64.43 154.01 36.97 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.102 0.561 . . . . 72.140000000000001 111.701 171.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.38 -48.01 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.808 0.843 . . . . 71.400000000000006 110.615 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -62.6 -42.37 99.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.327 1.051 . . . . 73.340000000000003 111.676 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.478 ' HA ' HH21 ' B' ' 56' ' ' ARG . 67.7 m -65.48 -30.62 71.42 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.596 0.758 . . . . 73.109999999999999 112.256 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.404 ' O ' HG21 ' A' ' 43' ' ' VAL . 63.2 m -82.08 -43.01 18.42 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.784 0.834 . . . . 74.140000000000001 111.512 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.458 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -58.69 -50.81 72.52 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.001 0.921 . . . . 75.120000000000005 112.142 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -66.28 -32.48 73.92 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 114.087 -1.415 . . . . 74.420000000000002 110.831 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.35 -38.7 71.61 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.26 0.624 . . . . 73.519999999999996 111.961 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 63' ' ' ILE . 69.3 t -64.89 -31.33 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.18 0.592 . . . . 73.219999999999999 110.835 175.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -58.79 -33.02 71.25 Favored Glycine 0 CA--C 1.544 1.858 0 CA-C-N 116.271 -0.422 . . . . 63.039999999999999 113.322 171.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -71.95 -30.63 65.5 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.543 0.737 . . . . 74.120000000000005 111.172 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.24 -38.79 71.94 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.675 0.39 . . . . 75.239999999999995 111.429 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.46 -34.95 78.88 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.562 0.745 . . . . 61.200000000000003 110.825 172.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.614 ' HG2' ' HB3' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -63.79 -43.97 94.75 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.013 1.325 . . . . 74.319999999999993 111.267 172.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -85.48 -1.14 56.74 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.606 0.762 . . . . 74.340000000000003 112.69 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 64.96 22.61 12.48 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.776 1.23 . . . . 75.109999999999999 112.729 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 61.5 mttp -77.49 -20.87 53.65 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.766 0.827 . . . . 72.319999999999993 112.454 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.92 154.74 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.48 0.657 . . . . 75.109999999999999 112.172 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 47.7 t -105.23 104.31 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.348 1.059 . . . . 71.129999999999995 109.065 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 mm -71.59 122.49 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 109.454 -0.572 . . . . 51.310000000000002 109.454 175.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.28 133.42 38.87 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.965 0.506 . . . . 74.200000000000003 110.385 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -116.94 141.91 47.63 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.402 0.681 . . . . 74.540000000000006 111.115 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 114.18 4.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.18 0.992 . . . . 74.450000000000003 109.892 -176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 54.07 30.81 12.58 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.4 1.08 . . . . 72.540000000000006 112.561 -173.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.26 -18.48 54.14 Favored Glycine 0 CA--C 1.545 1.968 0 CA-C-N 115.785 -0.643 . . . . 63.420000000000002 114.429 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -78.94 136.67 37.32 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.748 0.819 . . . . 74.129999999999995 111.275 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.1 mt -101.99 124.31 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 123.404 0.682 . . . . 73.340000000000003 111.081 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -123.48 124.92 43.93 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.895 1.278 . . . . 62.240000000000002 108.815 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.549 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -106.09 112.0 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-O 122.152 0.977 . . . . 72.219999999999999 110.051 177.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.511 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 95.0 m-85 -90.15 175.65 7.07 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.083 0.953 . . . . 75.409999999999997 111.202 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.54 150.97 21.54 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.972 0.509 . . . . 72.239999999999995 109.911 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.912 0.387 . . . . 75.340000000000003 110.644 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.496 ' O ' HG23 ' B' ' 6' ' ' VAL . 40.5 ttmt . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 110.483 -0.191 . . . . 75.409999999999997 110.483 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -61.26 -13.12 16.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.793 1.034 . . . . 74.109999999999999 113.793 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 70.3 mt -55.69 -45.93 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.616 0.766 . . . . 75.409999999999997 111.47 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 3' ' ' LYS . 16.3 m -66.46 -25.76 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 122.173 0.189 . . . . 74.129999999999995 111.064 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.28 -38.75 91.84 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.583 0.552 . . . . 63.130000000000003 113.259 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 -40.4 95.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.256 0.622 . . . . 75.400000000000006 110.939 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -70.53 -30.08 66.74 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.4 -0.818 . . . . 74.120000000000005 111.613 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.523 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -76.68 -36.35 57.33 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.603 0.761 . . . . 63.130000000000003 111.521 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.23 -30.97 79.3 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 115.809 -0.632 . . . . 63.530000000000001 112.55 172.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' B' ' 32' ' ' VAL . 4.3 ttmp? -72.59 -52.49 15.28 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.915 0.886 . . . . 75.400000000000006 112.006 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' B' ' 10' ' ' ALA . 33.0 m -68.53 -36.47 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 112.489 0.551 . . . . 74.140000000000001 112.489 -174.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.566 ' HA ' HD12 ' B' ' 17' ' ' LEU . 31.2 t90 -74.16 -32.55 63.17 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 111.903 0.334 . . . . 74.329999999999998 111.903 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -64.55 -33.49 76.02 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.001 0.429 . . . . 72.239999999999995 110.537 173.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.22 -32.45 71.72 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.928 0.891 . . . . 73.25 112.037 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' B' ' 14' ' ' TRP . 70.6 mt -70.99 -46.33 62.49 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.995 0.918 . . . . 75.299999999999997 111.097 173.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -63.11 -25.16 68.23 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.031 0.932 . . . . 74.430000000000007 110.609 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -76.08 -52.81 9.37 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.53 -0.759 . . . . 74.109999999999999 110.45 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.56 99.41 2.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.719 0.807 . . . . 65.439999999999998 110.657 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -98.35 -178.78 4.14 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.755 0.822 . . . . 74.400000000000006 111.335 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.84 37.39 44.71 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.743 -0.543 . . . . 74.219999999999999 111.743 -171.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 tt -122.61 139.85 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.891 0.877 . . . . 74.319999999999993 111.352 -168.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 20.4 m -64.09 151.24 43.66 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.163 0.985 . . . . 72.040000000000006 111.582 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.559 HG12 HD13 ' B' ' 63' ' ' ILE . 54.3 mt -53.63 -49.34 89.38 Favored Pre-proline 0 CA--C 1.579 2.071 0 N-CA-C 112.806 0.669 . . . . 73.120000000000005 112.806 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.64 -25.71 24.23 Favored 'Trans proline' 0 C--N 1.399 3.201 0 C-N-CA 121.926 1.75 . . . . 74.209999999999994 114.539 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.57 -41.88 37.29 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.61 1.195 . . . . 72.400000000000006 109.703 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.3 tp -61.26 -40.1 92.82 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.113 -1.858 . . . . 71.25 110.72 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.72 73.46 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.829 0.852 . . . . 73.200000000000003 111.962 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 64.2 mtp85 -65.06 -50.02 67.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.659 0.784 . . . . 72.219999999999999 111.916 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -73.84 -24.16 59.73 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 112.127 0.417 . . . . 73.540000000000006 112.127 -176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.514 HG13 ' HA ' ' B' ' 13' ' ' VAL . 13.9 m -94.85 -3.39 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 112.039 0.385 . . . . 72.140000000000001 112.039 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 65.05 21.64 12.28 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.233 1.013 . . . . 62.140000000000001 112.797 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.6 mt -108.56 169.26 8.77 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.81 0.844 . . . . 72.230000000000004 110.87 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 51.7 m -74.85 163.16 27.96 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.652 0.381 . . . . 61.439999999999998 111.336 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.3 -51.49 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.56 0.744 . . . . 73.450000000000003 111.86 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.63 -38.92 92.14 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.196 0.598 . . . . 73.409999999999997 111.989 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 29.4 t -64.43 -39.1 93.19 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.429 0.692 . . . . 53.009999999999998 111.525 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.419 ' O ' HG22 ' B' ' 43' ' ' VAL . 86.6 m -71.03 -48.5 52.61 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.768 0.827 . . . . 74.450000000000003 110.973 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.62 -35.34 72.33 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.789 0.836 . . . . 70.430000000000007 112.378 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.11 -48.51 70.65 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.183 0.993 . . . . 74.349999999999994 109.81 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.38 -30.36 70.49 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.259 -0.882 . . . . 72.129999999999995 111.681 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.419 HG22 ' O ' ' B' ' 39' ' ' THR . 95.2 t -72.87 -31.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 123.006 0.523 . . . . 61.439999999999998 110.615 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -66.11 -27.96 73.31 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 116.26 -0.427 . . . . 63.530000000000001 112.8 172.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -75.46 -25.75 57.68 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.976 0.51 . . . . 74.400000000000006 111.48 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.506 HD11 HG21 ' B' ' 13' ' ' VAL . 96.6 mt -71.6 -27.08 62.88 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.081 0.552 . . . . 52.140000000000001 111.686 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.3 -32.78 62.72 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.317 1.229 . . . . 73.439999999999998 114.317 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.614 ' HB3' ' HG2' ' A' ' 48' ' ' ARG . 13.5 ptm180 -72.27 -30.15 64.56 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 119.069 0.849 . . . . 74.519999999999996 111.512 171.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.76 -19.27 52.64 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.299 0.64 . . . . 74.040000000000006 110.758 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 60.42 21.83 11.44 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.744 1.618 . . . . 70.010000000000005 112.749 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.89 5.55 45.81 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 112.878 0.696 . . . . 74.540000000000006 112.878 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.81 146.17 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.344 0.657 . . . . 74.140000000000001 112.576 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 66.6 t -118.78 109.95 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 124.49 1.116 . . . . 74.319999999999993 109.5 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 39.6 mm -91.92 121.58 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.714 0.805 . . . . 74.310000000000002 111.401 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -117.16 141.53 48.15 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.506 -0.746 . . . . 72.310000000000002 111.787 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.562 ' HG2' HG12 ' B' ' 61' ' ' ILE . 84.0 mtt85 -113.51 111.6 22.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.077 0.951 . . . . 74.420000000000002 110.203 169.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' B' ' 57' ' ' LYS . 0.3 OUTLIER -144.6 126.94 15.82 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.315 1.046 . . . . 74.549999999999997 109.304 -178.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 60.74 28.68 18.4 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 125.027 1.331 . . . . 75.420000000000002 111.63 -171.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.19 -0.89 61.93 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-N 116.287 -0.415 . . . . 72.400000000000006 113.79 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.72 131.16 43.69 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.143 0.977 . . . . 70.340000000000003 110.936 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.562 HG12 ' HG2' ' B' ' 56' ' ' ARG . 43.8 mt -97.12 122.29 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.129 0.572 . . . . 73.209999999999994 110.339 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -125.74 139.98 53.08 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.35 0.66 . . . . 75.219999999999999 110.014 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.559 HD13 HG12 ' B' ' 25' ' ' ILE . 2.9 mp -100.54 126.97 54.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.666 0.786 . . . . 74.340000000000003 109.517 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.618 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 7.8 m-85 -111.15 169.59 8.68 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.913 1.285 . . . . 72.219999999999999 109.86 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -90.2 155.65 18.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.797 0.439 . . . . 73.140000000000001 111.405 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.483 1.186 0 C-N-CA 123.684 0.794 . . . . 74.349999999999994 110.428 173.126 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 112.74 0.644 . . . . 74.120000000000005 112.74 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -61.17 -47.64 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.444 0.698 . . . . 71.109999999999999 111.521 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.8 m -61.27 -28.06 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 122.519 0.328 . . . . 74.019999999999996 111.39 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.452 ' HA2' ' CD1' ' A' ' 45' ' ' TRP . . . -69.25 -49.68 37.97 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.544 0.528 . . . . 74.420000000000002 113.501 173.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.18 93.65 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.668 0.787 . . . . 74.129999999999995 112.382 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -75.03 -28.9 60.63 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.245 0.618 . . . . 63.130000000000003 112.339 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.99 82.6 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 112.464 0.542 . . . . 71.510000000000005 112.464 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.03 -34.54 81.93 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 116.413 -0.358 . . . . 72.019999999999996 113.127 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -67.17 -45.87 75.71 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.78 0.832 . . . . 75.219999999999999 110.644 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.598 ' HA ' HG11 ' A' ' 32' ' ' VAL . 63.8 t -60.97 -40.8 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 123.898 0.879 . . . . 65.230000000000004 111.212 175.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -64.67 -35.64 81.7 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.97 -0.559 . . . . 74.540000000000006 111.065 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.439 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 80.6 t60 -62.9 -44.81 95.09 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.78 0.432 . . . . 72.310000000000002 111.249 176.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.655 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . . . -67.46 -32.51 73.41 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.525 0.679 . . . . 62.439999999999998 111.284 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 65' ' ' ASN . 2.8 tm? -73.48 -29.92 62.82 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.925 1.29 . . . . 75.140000000000001 110.874 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -75.07 -47.15 30.25 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.96 0.904 . . . . 70.129999999999995 111.59 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 22.9 mm-40 -61.04 -33.19 72.9 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.13 0.572 . . . . 71.510000000000005 111.683 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.08 112.43 0.99 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.243 1.017 . . . . 74.450000000000003 109.54 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.8 178.4 5.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.25 0.62 . . . . 72.25 112.256 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.57 39.61 86.58 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 110.534 -1.026 . . . . 65.219999999999999 110.534 -167.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 tp -114.13 114.41 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 124.393 1.077 . . . . 75.010000000000005 110.044 -169.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -58.72 144.98 41.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.264 0.625 . . . . 71.25 112.594 -170.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.561 HG21 ' HB2' ' A' ' 40' ' ' ALA . 57.6 mt -55.38 -46.19 99.74 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 113.847 1.054 . . . . 75.450000000000003 113.847 -170.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HA ' HG23 ' A' ' 36' ' ' VAL . 32.6 Cg_endo -63.09 -25.05 73.25 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 121.819 1.679 . . . . 74.109999999999999 114.177 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -80.16 -55.15 5.13 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.994 0.739 . . . . 72.219999999999999 112.994 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -66.61 -26.03 66.89 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.45 0.568 . . . . 74.140000000000001 111.37 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.39 -37.31 16.57 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.745 0.818 . . . . 73.420000000000002 112.806 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -74.28 -35.02 63.73 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.305 0.642 . . . . 74.209999999999994 111.955 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.655 ' HE3' ' HB2' ' A' ' 16' ' ' ALA . 51.9 mtmt -67.06 -31.19 71.53 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 122.807 0.443 . . . . 75.209999999999994 111.513 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 13' ' ' VAL . 27.3 m -97.7 -9.47 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.701 0.801 . . . . 72.409999999999997 112.36 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.4 t30 64.7 28.11 13.08 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.347 1.459 . . . . 73.420000000000002 112.167 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.81 164.91 11.57 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.878 0.871 . . . . 74.0 111.198 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.7 m -65.21 153.11 41.94 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.139 0.576 . . . . 65.450000000000003 111.156 172.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 26' ' ' PRO . 64.6 t -53.97 -51.07 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.49 0.716 . . . . 73.510000000000005 111.104 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.556 ' HB3' HD12 ' B' ' 25' ' ' ILE . 36.3 mt-10 -60.32 -41.37 93.35 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.497 1.119 . . . . 74.540000000000006 112.557 176.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.8 m -62.28 -37.58 86.06 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 123.366 0.666 . . . . 74.420000000000002 111.798 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -71.78 -46.51 58.08 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.559 0.743 . . . . 74.450000000000003 111.182 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.72 -37.81 83.0 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 123.615 0.766 . . . . 72.420000000000002 112.493 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.69 -41.91 71.36 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.276 1.031 . . . . 71.540000000000006 110.554 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -31.85 73.18 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.158 0.583 . . . . 63.109999999999999 111.686 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.23 -35.69 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.899 0.88 . . . . 74.099999999999994 111.351 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -63.75 -32.28 83.64 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 114.049 0.38 . . . . 70.019999999999996 114.049 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.469 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 69.9 t-105 -73.89 -26.98 60.83 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.127 0.571 . . . . 75.439999999999998 111.361 175.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.98 -39.36 63.73 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 122.79 0.436 . . . . 74.019999999999996 111.173 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.87 69.81 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.261 1.024 . . . . 74.219999999999999 113.376 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 45' ' ' TRP . 5.7 ppt_? -71.45 -12.69 61.53 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.021 0.378 . . . . 65.409999999999997 112.021 174.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -110.35 -8.47 14.7 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.321 1.048 . . . . 73.329999999999998 111.915 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 63.51 28.73 15.35 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.625 1.17 . . . . 74.099999999999994 112.834 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -69.37 -13.9 62.62 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.375 0.67 . . . . 74.109999999999999 112.046 171.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.627 ' HB ' HD11 ' A' ' 63' ' ' ILE . 31.0 m -133.92 155.47 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.924 0.89 . . . . 75.120000000000005 110.855 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' A' ' 64' ' ' TYR . 31.2 m -127.37 143.19 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.179 0.991 . . . . 74.200000000000003 109.499 173.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.401 HG12 HD12 ' A' ' 63' ' ' ILE . 63.0 mt -120.72 134.57 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.186 0.595 . . . . 72.540000000000006 110.717 -172.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -120.63 127.13 51.79 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.757 0.823 . . . . 62.140000000000001 111.409 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HG2' HG12 ' A' ' 61' ' ' ILE . 84.8 mtt180 -95.45 102.62 14.43 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.209 0.528 . . . . 74.140000000000001 110.181 170.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -108.56 123.19 48.53 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.789 0.836 . . . . 74.430000000000007 109.99 178.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 55.98 29.38 14.22 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.792 1.237 . . . . 70.439999999999998 112.082 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.95 -25.92 9.24 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 114.116 -174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.77 141.04 39.48 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.617 0.767 . . . . 75.129999999999995 111.195 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' A' ' 56' ' ' ARG . 32.2 mt -93.37 133.96 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.337 0.655 . . . . 70.219999999999999 111.791 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -132.17 139.74 48.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.999 0.92 . . . . 74.439999999999998 110.286 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.627 HD11 ' HB ' ' A' ' 52' ' ' VAL . 6.8 tp -102.49 126.28 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.35 0 CA-C-O 121.772 0.796 . . . . 63.100000000000001 111.487 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.437 ' HB2' HG23 ' A' ' 53' ' ' VAL . 89.6 m-85 -118.11 169.28 9.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.186 1.394 . . . . 74.299999999999997 111.45 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.493 ' HA ' HD13 ' A' ' 17' ' ' LEU . 28.6 t-20 -81.38 145.97 30.55 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.663 0.785 . . . . 72.420000000000002 110.671 175.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HA ' HG13 ' A' ' 53' ' ' VAL . 10.9 pt-20 . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 115.521 1.675 . . . . 64.010000000000005 115.521 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 112.363 0.505 . . . . 74.129999999999995 112.363 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -74.03 -48.58 29.07 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.909 0.884 . . . . 73.109999999999999 111.297 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 65.3 mt -59.08 -60.0 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 114.935 -1.03 . . . . 74.450000000000003 111.844 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 m -59.4 -29.13 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.22 1.008 . . . . 72.129999999999995 112.65 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.72 -43.29 85.09 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 123.285 0.366 . . . . 75.510000000000005 112.758 173.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.28 96.67 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.919 0.887 . . . . 70.400000000000006 112.083 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -67.1 -40.95 86.99 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.051 0.54 . . . . 74.540000000000006 111.26 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.33 77.46 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.622 0.769 . . . . 64.430000000000007 112.808 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.62 -38.56 96.61 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 123.501 0.501 . . . . 63.100000000000001 112.853 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -69.29 -46.51 67.0 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.715 0.806 . . . . 73.439999999999998 111.792 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.606 ' HA ' HG13 ' B' ' 32' ' ' VAL . 72.7 t -59.25 -45.9 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.52 0.728 . . . . 75.109999999999999 111.644 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.59 ' HA ' HD11 ' B' ' 17' ' ' LEU . 21.1 t90 -68.45 -32.45 72.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.895 -0.593 . . . . 73.349999999999994 111.537 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . 0.4 ' HA ' ' OD1' ' B' ' 18' ' ' ASN . 8.1 t60 -59.01 -35.74 73.77 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.26 0.553 . . . . 73.349999999999994 110.834 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.03 -29.62 63.12 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.964 0.905 . . . . 74.510000000000005 112.093 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' B' ' 14' ' ' TRP . 84.7 mt -73.18 -39.86 65.26 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.067 0.947 . . . . 72.430000000000007 112.745 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' B' ' 15' ' ' HIS . 2.0 p-10 -74.64 -14.78 60.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.897 -0.502 . . . . 73.430000000000007 111.427 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.18 -45.59 16.15 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.337 0.655 . . . . 71.019999999999996 110.007 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.33 98.6 1.28 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.876 0.87 . . . . 75.239999999999995 110.599 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -85.93 159.99 19.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.29 0.636 . . . . 75.049999999999997 111.224 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.61 64.77 1.6 Allowed Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.555 -0.293 . . . . 73.030000000000001 112.634 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 tt -146.38 139.91 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.6 0.76 . . . . 75.0 110.841 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 37.5 m -62.8 145.79 54.12 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.756 0.423 . . . . 74.340000000000003 111.495 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.556 HD12 ' HB3' ' A' ' 37' ' ' GLU . 61.1 mt -52.28 -50.39 79.7 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 114.226 1.195 . . . . 65.430000000000007 114.226 -175.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.09 -23.44 39.9 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 121.828 1.685 . . . . 74.510000000000005 114.504 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -75.08 -52.43 11.06 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.141 0.972 . . . . 73.109999999999999 109.177 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -54.68 -37.1 65.35 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 113.122 -1.854 . . . . 75.219999999999999 112.048 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.65 95.38 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.3 1.04 . . . . 64.439999999999998 112.471 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -72.07 -28.7 63.49 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.264 0.625 . . . . 74.150000000000006 111.954 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.54 -35.03 65.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.414 0.686 . . . . 74.540000000000006 111.433 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' B' ' 13' ' ' VAL . 31.6 m -95.54 1.68 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.48 0.712 . . . . 62.229999999999997 112.109 177.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 61.9 16.27 7.89 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 124.553 1.141 . . . . 75.5 113.739 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 60.6 mt -102.66 158.37 16.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.752 0.821 . . . . 74.340000000000003 110.005 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 50.8 m -63.46 156.38 26.35 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.577 0.351 . . . . 64.239999999999995 111.313 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.0 t -49.4 -48.28 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 123.849 0.86 . . . . 74.109999999999999 111.713 171.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.62 -36.85 81.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.12 -0.946 . . . . 72.239999999999995 111.258 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -63.58 -43.04 98.15 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.461 0.704 . . . . 70.150000000000006 111.703 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.426 ' O ' HG22 ' B' ' 43' ' ' VAL . 92.1 m -74.71 -46.97 34.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.91 0.884 . . . . 74.510000000000005 111.445 -174.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.433 ' HB1' HG23 ' B' ' 25' ' ' ILE . . . -59.72 -46.12 90.09 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 124.235 1.014 . . . . 74.310000000000002 112.302 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -71.77 -35.22 69.99 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.672 -1.149 . . . . 75.25 111.001 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.84 81.89 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 122.574 0.349 . . . . 52.200000000000003 111.182 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.67 HG13 HD13 ' B' ' 63' ' ' ILE . 68.9 t -65.44 -31.87 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 123.585 0.754 . . . . 72.420000000000002 110.939 170.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -64.63 -33.57 87.58 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.909 -0.132 . . . . 73.140000000000001 113.425 171.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.478 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 73.8 t-105 -73.9 -29.78 62.24 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.479 0.712 . . . . 74.439999999999998 111.181 173.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.36 -34.58 70.58 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.839 0.456 . . . . 64.349999999999994 110.711 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.33 67.41 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.285 1.034 . . . . 74.439999999999998 111.753 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 20.1 ttt85 -56.68 -51.36 69.08 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.327 0.584 . . . . 74.200000000000003 110.882 167.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -80.07 -7.66 58.99 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.404 -0.816 . . . . 61.219999999999999 111.666 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 63.7 t30 63.91 32.9 12.92 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.577 1.551 . . . . 65.230000000000004 111.424 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -88.2 -1.68 58.16 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.744 0.818 . . . . 75.140000000000001 111.952 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.86 162.4 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.583 0.753 . . . . 73.549999999999997 112.306 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' B' ' 64' ' ' TYR . 11.7 m -128.22 156.79 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 124.45 1.1 . . . . 75.430000000000007 110.371 167.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 36.6 mm -116.97 119.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.447 0.699 . . . . 74.519999999999996 110.272 -175.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -115.49 115.02 25.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.147 0.579 . . . . 75.319999999999993 110.884 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -84.42 97.6 9.6 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.037 -0.727 . . . . 75.230000000000004 109.037 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.16 108.28 19.71 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.872 0.869 . . . . 64.109999999999999 110.163 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 54.65 31.45 15.22 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.369 1.067 . . . . 75.120000000000005 112.46 -173.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.77 -16.21 61.62 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-N 115.851 -0.613 . . . . 72.420000000000002 114.012 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -81.63 134.27 35.46 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.579 0.752 . . . . 75.120000000000005 110.845 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.555 HG13 ' HB2' ' A' ' 37' ' ' GLU . 23.1 mm -90.8 105.96 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.05 0.54 . . . . 73.230000000000004 109.816 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -115.72 130.5 56.87 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.845 0.858 . . . . 71.540000000000006 110.901 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.67 HD13 HG13 ' B' ' 43' ' ' VAL . 26.6 mm -93.22 115.7 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.052 0.941 . . . . 73.209999999999994 110.874 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.575 ' HB2' HG22 ' B' ' 53' ' ' VAL . 33.0 m-85 -107.06 158.98 16.65 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.005 0.922 . . . . 75.200000000000003 110.048 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -91.19 150.26 21.44 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.352 0.661 . . . . 70.319999999999993 109.6 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.537 ' HG2' HG12 ' B' ' 53' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 121.472 0.653 . . . . 72.209999999999994 110.664 176.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 111.454 0.168 . . . . 71.510000000000005 111.454 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.2 mt -61.04 -60.33 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.181 0.592 . . . . 75.409999999999997 110.792 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.585 HG12 HD12 ' A' ' 41' ' ' LEU . 34.8 m -64.0 -32.27 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.556 1.142 . . . . 73.409999999999997 112.192 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.6 69.8 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 123.353 0.408 . . . . 74.140000000000001 112.687 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.63 94.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.647 0.779 . . . . 72.040000000000006 111.651 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.39 -40.45 89.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.642 0.777 . . . . 61.43 111.421 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.84 -34.49 78.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.204 0.601 . . . . 61.409999999999997 111.913 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.77 -39.05 96.34 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 116.279 -0.419 . . . . 73.150000000000006 113.182 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -75.19 -41.12 58.62 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.752 0.821 . . . . 74.200000000000003 111.924 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.569 ' HA ' HG11 ' A' ' 32' ' ' VAL . 59.2 t -67.24 -45.5 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.496 0.719 . . . . 74.519999999999996 111.322 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.592 ' HA ' HD11 ' A' ' 17' ' ' LEU . 47.5 t90 -64.42 -34.63 78.62 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.504 0.502 . . . . 74.129999999999995 111.158 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -60.93 -45.09 96.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.362 0.665 . . . . 72.120000000000005 111.125 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.69 -36.17 75.74 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.753 -0.658 . . . . 74.319999999999993 111.654 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 14' ' ' TRP . 33.5 mt -59.51 -43.49 93.37 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.545 0.738 . . . . 75.409999999999997 111.474 175.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -59.34 -24.75 63.62 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.255 1.022 . . . . 73.209999999999994 112.254 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -66.02 -42.71 89.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.854 0.862 . . . . 74.329999999999998 111.062 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.73 110.57 2.19 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.44 0.696 . . . . 75.120000000000005 111.327 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -77.55 162.98 26.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.628 0.771 . . . . 73.219999999999999 111.27 174.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.87 61.91 3.15 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.999 -0.441 . . . . 71.430000000000007 111.999 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 tt -141.38 135.98 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.661 0.784 . . . . 62.439999999999998 111.06 -171.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -69.57 152.94 44.17 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.22 0.608 . . . . 74.219999999999999 111.413 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.535 HG21 ' HB3' ' A' ' 40' ' ' ALA . 57.0 mt -56.38 -47.11 99.53 Favored Pre-proline 0 CA--C 1.58 2.123 0 N-CA-C 113.458 0.91 . . . . 74.439999999999998 113.458 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.13 -30.29 46.91 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 122.145 1.896 . . . . 70.409999999999997 113.925 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.63 -46.52 66.0 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.422 1.105 . . . . 73.230000000000004 109.839 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.32 -36.87 78.92 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 113.152 -1.84 . . . . 73.109999999999999 112.175 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.3 80.21 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.567 0.747 . . . . 64.239999999999995 112.431 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -69.69 -38.73 77.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.807 0.443 . . . . 74.5 111.447 175.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -64.0 -41.77 97.37 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.538 0.335 . . . . 71.239999999999995 111.655 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 13' ' ' VAL . 22.4 m -84.24 -10.81 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.096 0.559 . . . . 64.140000000000001 111.573 175.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 69.26 16.9 8.38 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 125.53 1.532 . . . . 73.439999999999998 112.048 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.2 mt -99.68 175.61 5.75 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.837 0.855 . . . . 64.25 110.604 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 t -76.99 159.25 30.07 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.144 0.577 . . . . 73.510000000000005 111.524 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -57.87 -44.69 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.091 0.556 . . . . 71.209999999999994 111.51 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.79 -46.37 89.83 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.752 0.821 . . . . 73.230000000000004 112.02 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.8 p -69.0 -30.82 69.29 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.209 0.604 . . . . 64.140000000000001 112.063 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 43' ' ' VAL . 96.7 m -74.92 -48.45 24.52 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.351 0.661 . . . . 73.420000000000002 111.248 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HB3' HG21 ' A' ' 25' ' ' ILE . . . -61.77 -36.82 82.16 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 123.992 0.917 . . . . 72.25 111.831 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.585 HD12 HG12 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -61.33 -43.07 99.49 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.91 1.284 . . . . 74.230000000000004 110.802 173.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.59 71.73 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.228 0.611 . . . . 73.450000000000003 112.296 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.439 HG11 HD11 ' A' ' 63' ' ' ILE . 86.3 t -69.41 -33.73 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.33 0.652 . . . . 63.130000000000003 110.86 175.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.74 -32.7 85.08 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-N 116.501 -0.318 . . . . 55.219999999999999 112.745 172.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.408 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 71.5 t-105 -74.02 -31.1 62.77 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.606 0.762 . . . . 75.549999999999997 111.333 173.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.3 -34.89 75.38 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.727 0.411 . . . . 74.109999999999999 111.156 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.59 -28.95 69.72 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.37 0.668 . . . . 74.540000000000006 112.101 173.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.486 ' HD2' ' HA ' ' B' ' 48' ' ' ARG . 22.9 ttt180 -59.85 -51.16 70.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.763 0.825 . . . . 71.439999999999998 112.111 175.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -90.99 13.57 16.32 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.408 -0.815 . . . . 74.400000000000006 112.04 -173.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 51.33 47.45 24.82 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.001 1.32 . . . . 62.009999999999998 112.08 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -87.54 -32.95 19.11 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.757 -1.11 . . . . 74.420000000000002 111.921 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -132.74 148.27 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.637 0.775 . . . . 64.299999999999997 112.058 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.447 HG12 ' HG2' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -113.55 107.33 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.595 0.758 . . . . 74.219999999999999 108.957 171.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.464 HG23 HD13 ' A' ' 63' ' ' ILE . 60.1 mt -88.94 114.6 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 109.16 -0.681 . . . . 73.129999999999995 109.16 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -102.74 117.42 34.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.21 0.604 . . . . 75.329999999999998 111.107 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -81.9 108.18 15.21 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.957 -0.386 . . . . 72.450000000000003 109.957 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -104.09 106.15 16.56 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.658 0.783 . . . . 64.530000000000001 109.003 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 54.81 31.85 16.44 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 124.336 1.054 . . . . 73.430000000000007 112.423 -169.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.93 -20.12 50.64 Favored Glycine 0 CA--C 1.542 1.769 0 N-CA-C 114.408 0.523 . . . . 52.210000000000001 114.408 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.79 134.95 43.47 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.743 0.817 . . . . 74.209999999999994 111.076 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.25 103.78 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 122.995 0.518 . . . . 74.099999999999994 109.884 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -118.72 121.83 41.03 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.949 0.9 . . . . 72.329999999999998 109.914 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.464 HD13 HG23 ' A' ' 54' ' ' ILE . 10.5 mm -91.96 120.93 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.214 0.606 . . . . 71.019999999999996 111.938 -169.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -108.84 163.14 13.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.489 0.715 . . . . 73.319999999999993 111.043 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 11.1 m-20 -91.33 155.26 18.64 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.428 -0.806 . . . . 74.420000000000002 108.921 171.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.447 ' HG2' HG12 ' A' ' 53' ' ' VAL . 50.9 mt-10 . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 121.758 0.79 . . . . 74.430000000000007 110.022 169.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 120.732 0.301 . . . . 75.540000000000006 111.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -91.26 -41.82 10.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.077 0.951 . . . . 64.219999999999999 111.827 170.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.49 -45.33 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 122.993 0.517 . . . . 74.239999999999995 111.876 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.03 -26.84 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 122.633 0.373 . . . . 75.329999999999998 111.811 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.2 -48.36 80.24 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.135 0.272 . . . . 54.450000000000003 112.869 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.79 -43.28 93.72 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.601 0.76 . . . . 73.109999999999999 111.609 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.85 -36.53 80.48 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.169 0.988 . . . . 72.540000000000006 111.532 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' B' ' 42' ' ' ALA . . . -68.69 -39.66 80.44 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.099 0.56 . . . . 71.239999999999995 110.914 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.74 -45.98 92.79 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.68 -0.691 . . . . 75.409999999999997 112.341 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -63.28 -41.95 99.05 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.425 1.09 . . . . 62.210000000000001 111.845 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.681 ' HA ' HG13 ' B' ' 32' ' ' VAL . 72.8 t -65.14 -37.05 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.775 0.83 . . . . 73.129999999999995 111.622 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -74.04 -33.49 63.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.208 0.603 . . . . 75.209999999999994 111.587 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -60.84 -30.7 70.26 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.92 0.488 . . . . 75.109999999999999 111.353 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.71 69.96 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.191 0.596 . . . . 62.149999999999999 112.466 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.486 ' HB3' ' ND2' ' B' ' 65' ' ' ASN . 53.3 mt -63.49 -34.24 77.33 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.262 0.625 . . . . 75.109999999999999 112.51 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.75 -25.7 66.67 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.3 0.64 . . . . 63.549999999999997 111.729 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.92 -41.03 8.2 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.734 0.813 . . . . 75.239999999999995 111.077 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' B' ' 17' ' ' LEU . . . -153.75 141.28 19.83 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.405 0.682 . . . . 50.32 111.808 -171.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -127.08 168.97 13.9 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.616 0.766 . . . . 65.420000000000002 111.129 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.8 10.24 64.02 Favored Glycine 0 N--CA 1.474 1.167 0 N-CA-C 114.596 0.598 . . . . 71.109999999999999 114.596 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.3 tt -86.26 132.02 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 123.465 0.706 . . . . 75.329999999999998 110.809 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -71.89 158.35 36.21 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.518 0.562 . . . . 53.340000000000003 112.518 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.521 HG23 ' HB3' ' B' ' 40' ' ' ALA . 73.9 mt -56.33 -43.3 99.23 Favored Pre-proline 0 CA--C 1.582 2.177 0 N-CA-C 115.274 1.583 . . . . 73.349999999999994 115.274 -169.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.427 ' HA ' HG23 ' B' ' 36' ' ' VAL . 57.7 Cg_endo -67.54 -31.6 33.28 Favored 'Trans proline' 0 C--N 1.392 2.863 0 CA-C-N 122.448 1.91 . . . . 75.319999999999993 114.207 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -77.86 -41.32 37.23 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.313 1.054 . . . . 73.120000000000005 110.102 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.42 -39.61 84.06 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 113.206 -1.816 . . . . 73.120000000000005 111.125 171.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.01 88.91 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.985 0.914 . . . . 63.100000000000001 111.648 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -60.92 -43.42 98.59 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.584 0.754 . . . . 73.530000000000001 111.498 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -71.27 -37.97 71.88 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.284 0.634 . . . . 74.439999999999998 111.934 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.681 HG13 ' HA ' ' B' ' 13' ' ' VAL . 13.1 m -93.32 5.53 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.047 0.539 . . . . 65.439999999999998 112.15 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.4 t30 68.46 9.53 7.33 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.574 1.149 . . . . 74.209999999999994 113.303 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 47.8 mt -102.98 174.25 5.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.611 -0.68 . . . . 72.439999999999998 111.463 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 39.3 t -72.94 157.84 36.65 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.915 0.486 . . . . 73.209999999999994 111.264 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' B' ' 26' ' ' PRO . 60.3 t -58.14 -41.39 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.22 0.608 . . . . 74.239999999999995 111.198 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.19 -48.44 75.9 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.533 0.733 . . . . 74.310000000000002 112.207 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -71.04 -29.97 66.03 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.292 0.637 . . . . 73.430000000000007 111.98 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.402 ' O ' HG21 ' B' ' 43' ' ' VAL . 95.5 m -72.77 -46.23 54.46 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.182 0.593 . . . . 74.430000000000007 110.487 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.521 ' HB3' HG23 ' B' ' 25' ' ' ILE . . . -60.05 -36.35 77.1 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.528 0.731 . . . . 74.420000000000002 111.927 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -51.13 66.61 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.278 1.031 . . . . 71.329999999999998 109.606 174.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' B' ' 10' ' ' ALA . . . -61.39 -30.77 70.76 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.009 -0.996 . . . . 71.109999999999999 111.695 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.402 HG21 ' O ' ' B' ' 39' ' ' THR . 49.0 t -68.45 -37.51 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.76 0.824 . . . . 75.040000000000006 110.66 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.47 -33.3 86.04 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 113.037 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.426 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 61.9 t-105 -74.44 -25.63 59.55 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.398 0.679 . . . . 73.040000000000006 111.338 175.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.92 -36.73 70.04 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.875 0.47 . . . . 73.099999999999994 111.284 169.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.21 -33.02 75.01 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.959 0.503 . . . . 71.319999999999993 110.685 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.486 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 2.3 tmt_? -59.35 -45.29 91.82 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.246 1.018 . . . . 74.530000000000001 111.504 173.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -84.79 2.38 42.5 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.46 0.704 . . . . 74.519999999999996 112.508 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 63.2 22.41 13.35 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.148 1.379 . . . . 62.399999999999999 112.808 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -102.42 7.96 40.24 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.907 1.077 . . . . 74.319999999999993 113.907 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 20.9 m -131.87 151.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 123.093 0.557 . . . . 71.430000000000007 111.102 171.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 t -105.36 102.41 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.498 0.719 . . . . 74.349999999999994 109.492 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 27.8 mm -77.69 114.7 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 122.987 0.515 . . . . 61.530000000000001 110.274 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.18 156.5 38.33 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.89 0.876 . . . . 74.030000000000001 111.843 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -118.12 107.56 14.12 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.958 0.903 . . . . 74.219999999999999 110.864 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -119.07 129.86 55.3 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.02 0.528 . . . . 74.329999999999998 110.125 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 62.72 30.45 16.82 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.528 1.131 . . . . 73.530000000000001 112.115 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.05 12.97 81.33 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 115.979 -0.555 . . . . 73.239999999999995 113.465 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -122.52 136.66 54.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.178 0.991 . . . . 71.400000000000006 110.378 -172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mp -80.51 122.36 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 123.012 0.525 . . . . 75.030000000000001 110.244 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -124.94 132.36 53.3 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.278 1.031 . . . . 74.519999999999996 110.019 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 pp -100.06 126.53 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.434 0.694 . . . . 74.430000000000007 111.932 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -108.52 166.47 10.76 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.207 0.603 . . . . 70.519999999999996 111.252 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' B' ' 17' ' ' LEU . 15.0 m120 -67.43 141.45 57.01 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.632 0.773 . . . . 72.519999999999996 111.461 176.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 114.512 1.301 . . . . 72.439999999999998 114.512 178.647 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt . . . . . 0 CA--C 1.56 1.351 0 N-CA-C 112.682 0.623 . . . . 74.549999999999997 112.682 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -58.28 -55.52 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.158 0.583 . . . . 73.319999999999993 110.802 171.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.6 m -67.31 -25.54 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 122.682 0.393 . . . . 72.430000000000007 111.232 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.483 ' HA2' ' NE1' ' A' ' 45' ' ' TRP . . . -68.27 -41.39 86.15 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 116.676 -0.238 . . . . 70.439999999999998 113.646 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.01 -54.84 13.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.822 0.849 . . . . 71.430000000000007 112.031 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -68.07 -19.68 64.89 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 112.793 0.664 . . . . 72.010000000000005 112.793 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.32 -28.05 65.91 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.623 0.769 . . . . 75.319999999999993 112.205 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.68 -42.64 93.17 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 116.762 -0.199 . . . . 63.329999999999998 113.391 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -66.81 -46.65 74.51 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.797 0.839 . . . . 75.219999999999999 112.081 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 32' ' ' VAL . 10.6 p -69.13 -32.17 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.533 0.333 . . . . 71.510000000000005 111.708 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.475 ' NE1' ' HB3' ' A' ' 51' ' ' LYS . 66.9 t90 -72.14 -33.94 68.16 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.067 0.547 . . . . 72.409999999999997 111.328 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -61.49 -35.24 77.1 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.384 0.673 . . . . 75.450000000000003 111.315 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.41 -32.44 73.88 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.581 0.753 . . . . 63.119999999999997 112.088 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.402 HD11 ' HA ' ' A' ' 14' ' ' TRP . 50.9 mt -73.66 -33.04 64.3 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.869 0.867 . . . . 75.319999999999993 112.131 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -62.91 -33.26 74.95 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.208 0.603 . . . . 75.239999999999995 111.76 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -75.3 -54.3 7.32 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.283 0.633 . . . . 62.439999999999998 110.11 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.45 99.13 2.17 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.599 -0.728 . . . . 71.230000000000004 110.899 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 9.9 p-10 -93.5 150.84 20.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.7 0.4 . . . . 74.209999999999994 109.952 173.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.08 63.19 1.15 Allowed Glycine 0 N--CA 1.469 0.855 0 N-CA-C 110.758 -0.937 . . . . 61.329999999999998 110.758 -167.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.4 tt -145.17 125.44 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.479 1.112 . . . . 73.530000000000001 109.605 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.0 m -57.09 149.27 19.69 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.032 0.933 . . . . 71.5 112.097 -176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.605 HG12 HD11 ' A' ' 63' ' ' ILE . 21.2 mt -53.88 -48.07 94.88 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 113.419 0.896 . . . . 74.120000000000005 113.419 -174.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.46 -24.0 14.48 Favored 'Trans proline' 0 C--N 1.398 3.17 0 C-N-CA 121.881 1.721 . . . . 74.540000000000006 114.732 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -71.79 -45.86 60.21 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 123.037 1.398 . . . . 72.310000000000002 108.939 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.413 ' O ' HG21 ' A' ' 32' ' ' VAL . 60.5 tp -65.11 -40.14 94.11 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 112.443 -2.162 . . . . 75.450000000000003 111.466 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.25 93.93 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.048 0.939 . . . . 61.329999999999998 112.306 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -70.02 -39.26 75.92 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.287 0.635 . . . . 75.040000000000006 111.004 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -59.19 -52.12 67.07 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.577 0.751 . . . . 73.349999999999994 111.563 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 13' ' ' VAL . 24.9 m -85.89 0.37 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.357 0.663 . . . . 72.420000000000002 112.035 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 62.43 15.02 7.41 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 125.149 1.38 . . . . 73.140000000000001 114.196 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.7 mt -90.81 159.82 16.08 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.325 0.65 . . . . 74.129999999999995 110.0 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -66.66 151.86 46.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.486 0.314 . . . . 73.209999999999994 110.882 169.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.1 t -52.67 -47.03 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 123.835 0.854 . . . . 75.140000000000001 112.064 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.461 ' HB3' HD12 ' B' ' 25' ' ' ILE . 46.2 mt-10 -59.78 -44.63 93.81 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.726 0.81 . . . . 74.430000000000007 112.277 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.0 m -62.58 -36.74 83.68 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.722 0.809 . . . . 75.530000000000001 111.855 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -70.49 -52.34 22.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.786 0.835 . . . . 74.400000000000006 110.936 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.98 -33.91 72.6 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.801 0.84 . . . . 72.319999999999993 112.302 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -51.24 49.5 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.184 0.994 . . . . 74.519999999999996 110.354 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.94 70.06 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.331 -0.85 . . . . 71.109999999999999 111.686 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.22 -38.82 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 115.581 -0.736 . . . . 73.409999999999997 110.939 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.28 -28.06 72.47 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-O 121.116 0.287 . . . . 73.409999999999997 112.877 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.483 ' NE1' ' HA2' ' A' ' 7' ' ' GLY . 77.0 t-105 -70.02 -41.53 74.17 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.099 0.96 . . . . 74.109999999999999 111.265 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 76.4 mt -67.01 -34.09 76.99 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.512 0.725 . . . . 63.25 111.619 175.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.33 -27.22 63.93 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.361 1.064 . . . . 51.219999999999999 113.326 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -58.77 -31.87 68.76 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 112.244 0.461 . . . . 74.219999999999999 112.244 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -122.02 26.67 8.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.663 1.185 . . . . 64.420000000000002 111.063 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 61.43 22.61 12.99 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.329 1.451 . . . . 75.340000000000003 114.117 169.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 61.9 mttm -74.09 -18.05 60.87 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.85 0.685 . . . . 74.409999999999997 112.85 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.16 150.77 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.473 0.709 . . . . 74.219999999999999 111.93 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.736 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 42.5 t -107.7 123.93 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.991 0.917 . . . . 75.209999999999994 108.904 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.432 HG23 HG22 ' A' ' 61' ' ' ILE . 48.6 mm -103.81 118.66 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.595 0.758 . . . . 72.540000000000006 111.106 -173.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -124.61 112.05 16.35 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.298 0.639 . . . . 75.209999999999994 111.138 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HG2' HG12 ' A' ' 61' ' ' ILE . 56.7 mtt180 -81.25 98.01 7.91 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.567 0.699 . . . . 73.040000000000006 110.078 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -106.39 111.93 24.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.482 1.113 . . . . 70.25 109.601 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 60.72 32.35 20.23 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 124.605 1.162 . . . . 73.140000000000001 112.891 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.42 -11.57 67.61 Favored Glycine 0 CA--C 1.541 1.697 0 N-CA-C 114.041 0.377 . . . . 64.319999999999993 114.041 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.76 137.21 36.98 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.748 0.819 . . . . 71.540000000000006 110.329 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.432 HG22 HG23 ' A' ' 54' ' ' ILE . 50.7 mt -87.41 129.3 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.808 0.443 . . . . 73.510000000000005 111.173 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.04 136.34 49.44 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.308 1.043 . . . . 73.209999999999994 110.37 -178.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.605 HD11 HG12 ' A' ' 25' ' ' ILE . 3.0 mp -113.59 115.94 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.219 0.608 . . . . 75.109999999999999 110.194 -169.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.736 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 80.6 m-85 -113.54 173.74 6.26 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.994 0.918 . . . . 72.310000000000002 110.542 175.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -98.8 162.03 13.32 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.384 0.674 . . . . 75.030000000000001 110.862 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 51' ' ' LYS . 36.1 tt0 . . . . . 0 N--CA 1.49 1.538 0 C-N-CA 124.505 1.122 . . . . 75.040000000000006 111.895 170.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 111.788 0.292 . . . . 73.430000000000007 111.788 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -75.05 -31.77 61.38 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.449 0.7 . . . . 75.400000000000006 111.71 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.04 -54.09 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 122.697 0.399 . . . . 72.049999999999997 110.749 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -65.28 -26.2 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 122.864 0.466 . . . . 72.329999999999998 111.536 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.81 -39.97 96.99 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.282 0.364 . . . . 43.020000000000003 113.303 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.11 -36.97 69.59 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.73 0.812 . . . . 72.040000000000006 111.346 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -64.68 -40.61 95.71 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.589 -0.732 . . . . 73.310000000000002 110.583 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . . . -72.06 -41.45 67.39 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.869 0.868 . . . . 71.209999999999994 111.435 -176.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.01 -50.07 66.93 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.783 -0.644 . . . . 60.340000000000003 112.464 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.54 ' HG3' ' HB ' ' B' ' 32' ' ' VAL . 18.0 tppt? -60.0 -45.88 91.31 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.437 1.095 . . . . 75.239999999999995 112.065 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.473 ' HA ' HG13 ' B' ' 32' ' ' VAL . 53.0 t -56.99 -46.99 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.094 0.558 . . . . 74.430000000000007 111.346 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.501 ' HA ' HD12 ' B' ' 17' ' ' LEU . 69.7 t90 -68.34 -35.76 78.24 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.302 0.641 . . . . 74.299999999999997 112.015 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -63.97 -33.08 74.92 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.604 0.362 . . . . 61.539999999999999 110.553 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.09 -32.45 69.08 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.906 0.482 . . . . 62.409999999999997 111.582 171.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' B' ' 14' ' ' TRP . 69.2 mt -72.57 -30.51 64.47 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.347 0.659 . . . . 74.209999999999994 111.227 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.49 -29.4 68.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.644 0.778 . . . . 73.010000000000005 111.048 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.45 -29.24 12.86 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.523 0.729 . . . . 72.439999999999998 111.303 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.7 88.88 1.0 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.439 0.696 . . . . 72.109999999999999 111.812 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -92.28 173.44 7.82 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.183 0.593 . . . . 74.109999999999999 111.652 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.55 64.53 2.81 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.278 -0.419 . . . . 71.019999999999996 112.316 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 tt -144.02 143.27 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.315 0.646 . . . . 74.109999999999999 110.787 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -60.58 139.8 57.64 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.856 0.863 . . . . 73.340000000000003 111.418 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 37' ' ' GLU . 71.8 mt -52.31 -46.22 94.39 Favored Pre-proline 0 CA--C 1.581 2.14 0 N-CA-C 114.386 1.254 . . . . 75.340000000000003 114.386 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.11 -24.78 14.49 Favored 'Trans proline' 0 C--N 1.399 3.223 0 CA-C-N 121.856 1.699 . . . . 64.200000000000003 113.989 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 33.7 tt0 -77.1 -46.34 23.9 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 122.04 0.924 . . . . 60.130000000000003 108.846 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -55.65 -39.87 71.45 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.321 1.448 . . . . 70.230000000000004 111.263 170.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.85 92.19 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.874 0.869 . . . . 74.310000000000002 112.323 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' B' ' 27' ' ' GLU . 21.9 ptt180 -73.96 -23.36 59.48 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.384 0.274 . . . . 75.030000000000001 110.782 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' B' ' 27' ' ' GLU . 30.9 mmmt -78.41 -43.93 26.14 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.142 0.577 . . . . 74.329999999999998 111.06 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.54 ' HB ' ' HG3' ' B' ' 12' ' ' LYS . 23.6 m -87.16 3.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 112.954 0.724 . . . . 75.420000000000002 112.954 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 63.62 11.47 5.75 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 125.081 1.352 . . . . 74.219999999999999 113.904 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 74.2 mt -99.77 162.9 12.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.478 0.711 . . . . 73.439999999999998 111.071 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 16.7 m -66.0 155.59 36.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.561 0.744 . . . . 72.25 111.627 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.46 -49.83 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.488 0.715 . . . . 74.019999999999996 111.709 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.62 -43.65 84.94 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.121 0.969 . . . . 55.409999999999997 111.474 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 68.4 m -61.75 -37.56 84.74 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.957 0.903 . . . . 74.519999999999996 112.265 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.462 ' O ' HG22 ' B' ' 43' ' ' VAL . 97.3 m -72.26 -48.49 42.17 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.471 0.708 . . . . 74.140000000000001 111.241 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.404 ' HB1' HG23 ' B' ' 25' ' ' ILE . . . -59.24 -43.14 92.4 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.553 0.741 . . . . 55.299999999999997 112.573 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.06 -49.5 75.72 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.883 0.873 . . . . 71.010000000000005 109.963 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' B' ' 10' ' ' ALA . . . -57.96 -28.67 64.56 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.794 -1.094 . . . . 74.439999999999998 112.006 -178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.577 HG12 HD13 ' B' ' 63' ' ' ILE . 77.8 t -69.27 -38.33 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.139 0.576 . . . . 75.340000000000003 110.964 175.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.64 -30.58 77.67 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-O 121.077 0.265 . . . . 75.510000000000005 112.591 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -75.86 -26.37 57.05 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.662 0.785 . . . . 74.030000000000001 111.951 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.99 -35.25 62.03 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.207 0.527 . . . . 74.099999999999994 111.352 166.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.34 -34.15 77.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.304 1.042 . . . . 65.420000000000002 112.793 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -64.51 -34.95 79.42 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.922 0.392 . . . . 71.549999999999997 111.317 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.62 -2.52 56.27 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.737 0.815 . . . . 65.420000000000002 111.532 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 65.55 26.48 11.68 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.488 1.515 . . . . 74.549999999999997 112.43 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -95.36 -0.19 52.9 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.465 1.283 . . . . 75.420000000000002 114.465 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 17.6 m -127.95 151.5 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 118.566 0.621 . . . . 73.439999999999998 112.468 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.691 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 95.3 t -110.33 123.35 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.604 1.161 . . . . 74.430000000000007 108.465 168.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 76.0 mt -114.97 126.45 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.258 -0.645 . . . . 75.150000000000006 109.258 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . 0.567 ' HG3' ' HG3' ' B' ' 57' ' ' LYS . 10.6 tp10 -142.32 129.17 20.57 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.55 -0.75 . . . . 74.400000000000006 111.312 -169.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -95.12 98.86 10.95 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.51 0.672 . . . . 72.510000000000005 110.216 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . 0.567 ' HG3' ' HG3' ' B' ' 55' ' ' GLU . 29.1 mtpp -105.48 123.39 47.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.346 -0.843 . . . . 74.040000000000006 109.476 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 59.11 29.48 19.05 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.077 1.351 . . . . 73.099999999999994 111.157 -171.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.54 -27.87 8.22 Favored Glycine 0 CA--C 1.543 1.83 0 CA-C-N 115.729 -0.669 . . . . 73.299999999999997 114.136 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.08 138.07 31.86 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.65 0.78 . . . . 73.340000000000003 111.795 -171.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -79.56 136.42 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.926 0.891 . . . . 74.109999999999999 112.225 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -121.19 131.99 54.57 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.175 0.99 . . . . 75.129999999999995 109.118 167.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.577 HD13 HG12 ' B' ' 43' ' ' VAL . 25.0 mm -91.69 109.25 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.369 0.668 . . . . 71.219999999999999 110.431 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.691 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 67.0 m-85 -97.72 169.24 9.82 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.6 1.16 . . . . 74.299999999999997 110.589 175.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -100.39 155.29 17.89 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.429 0.692 . . . . 74.409999999999997 110.934 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 . . . . . 0 N--CA 1.486 1.351 0 C-N-CA 124.716 1.206 . . . . 74.329999999999998 111.158 173.515 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 111.782 0.29 . . . . 74.530000000000001 111.782 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.2 mt -64.44 -59.46 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.899 0.48 . . . . 71.310000000000002 110.694 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.53 -27.56 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.938 0.495 . . . . 71.409999999999997 111.764 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.76 -43.13 85.34 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.412 0.445 . . . . 44.43 113.283 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -46.36 80.97 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.644 0.778 . . . . 70.329999999999998 111.706 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -70.0 -27.95 65.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.972 -0.558 . . . . 62.420000000000002 112.362 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.58 76.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.24 0.616 . . . . 63.140000000000001 111.898 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.2 -37.65 94.88 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 116.074 -0.512 . . . . 64.400000000000006 113.071 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.642 ' HZ1' ' HA ' ' A' ' 32' ' ' VAL . 55.4 tttm -76.61 -42.56 41.91 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 112.474 0.546 . . . . 54.100000000000001 112.474 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 32' ' ' VAL . 26.0 m -64.56 -34.1 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 122.123 -0.36 . . . . 61.049999999999997 111.057 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.567 ' HA ' HD11 ' A' ' 17' ' ' LEU . 42.9 t90 -70.01 -33.28 71.81 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.086 0.555 . . . . 74.120000000000005 111.484 175.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -61.7 -39.14 90.41 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.127 0.571 . . . . 73.329999999999998 110.618 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.02 -32.53 70.72 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.49 0.716 . . . . 43.310000000000002 111.946 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.567 HD11 ' HA ' ' A' ' 14' ' ' TRP . 75.5 mt -69.87 -35.37 74.62 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.878 0.871 . . . . 75.319999999999993 111.746 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.06 -25.82 65.54 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.938 0.495 . . . . 71.299999999999997 110.307 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.15 -46.86 19.48 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.737 0.815 . . . . 73.349999999999994 110.694 169.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.06 97.15 1.77 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.575 0.75 . . . . 75.310000000000002 111.417 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.12 172.46 10.56 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.324 0.65 . . . . 72.209999999999994 111.316 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.51 9.79 82.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 116.614 -0.266 . . . . 65.109999999999999 113.456 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 tt -77.83 158.19 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 124.33 1.052 . . . . 74.510000000000005 109.338 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 m -79.1 150.75 31.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.752 -0.592 . . . . 71.120000000000005 110.392 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.554 HG22 ' HB2' ' A' ' 40' ' ' ALA . 70.7 mt -54.75 -47.19 98.79 Favored Pre-proline 0 CA--C 1.578 2.057 0 N-CA-C 113.82 1.044 . . . . 75.200000000000003 113.82 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.94 -23.74 34.29 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 122.117 1.878 . . . . 74.340000000000003 113.961 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.47 -48.24 23.56 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.094 0.95 . . . . 64.329999999999998 108.984 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.5 tp -57.28 -38.62 74.21 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 113.324 -1.762 . . . . 74.420000000000002 111.613 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.9 -41.92 88.37 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.935 0.894 . . . . 71.109999999999999 111.774 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -66.06 -37.44 85.83 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.812 0.845 . . . . 73.430000000000007 111.695 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.14 -35.64 77.61 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.457 0.646 . . . . 73.019999999999996 111.706 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.642 ' HA ' ' HZ1' ' A' ' 12' ' ' LYS . 29.7 m -105.15 5.38 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.71 0.804 . . . . 74.239999999999995 112.623 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 62.11 19.76 11.12 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 124.814 1.246 . . . . 73.030000000000001 114.05 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.4 mt -99.47 168.56 9.9 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.251 0.621 . . . . 71.349999999999994 110.615 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 t -75.89 157.02 33.76 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.762 0.425 . . . . 73.209999999999994 111.402 171.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 t -56.47 -44.14 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.076 0.95 . . . . 73.030000000000001 111.42 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.482 ' HB3' HD11 ' B' ' 25' ' ' ILE . 42.2 mt-10 -63.86 -39.41 94.14 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.039 0.936 . . . . 75.430000000000007 112.039 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.3 m -68.94 -35.39 76.72 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.663 0.785 . . . . 74.099999999999994 111.502 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.5 m -76.97 -46.98 22.1 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.544 0.738 . . . . 71.140000000000001 111.893 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' A' ' 25' ' ' ILE . . . -59.31 -35.92 74.68 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 123.565 0.746 . . . . 75.319999999999993 111.737 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.422 HD11 HD13 ' B' ' 54' ' ' ILE . 0.9 OUTLIER -65.04 -49.73 68.99 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 114.908 -1.042 . . . . 75.219999999999999 110.181 174.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.56 70.21 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.645 0.778 . . . . 74.319999999999993 111.713 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.539 HG11 HG22 ' A' ' 63' ' ' ILE . 53.5 t -68.27 -35.93 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.207 0.603 . . . . 72.310000000000002 110.495 173.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.64 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -63.96 -30.43 77.7 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 116.336 -0.393 . . . . 52.310000000000002 113.612 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.464 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 65.0 t-105 -70.62 -37.15 73.78 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.009 0.433 . . . . 75.239999999999995 110.923 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.17 -32.19 72.26 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 122.199 -0.313 . . . . 71.340000000000003 110.955 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.86 -31.05 71.78 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.672 0.789 . . . . 73.230000000000004 111.481 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.575 ' HA ' ' HD2' ' B' ' 48' ' ' ARG . 31.9 ttt180 -63.64 -50.62 68.6 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.985 0.514 . . . . 73.450000000000003 110.71 168.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -79.14 -2.02 38.8 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.171 0.988 . . . . 63.439999999999998 112.197 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 63.07 22.13 13.26 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.541 1.536 . . . . 75.400000000000006 112.688 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 63.1 mttp -78.7 -18.65 54.0 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.391 1.076 . . . . 74.349999999999994 112.961 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.55 157.86 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 112.807 0.669 . . . . 74.200000000000003 112.807 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 64' ' ' TYR . 7.3 m -129.78 120.22 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 124.694 1.198 . . . . 74.129999999999995 109.773 172.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.403 HG13 HG21 ' A' ' 63' ' ' ILE . 3.4 mp -96.95 107.38 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.636 0.774 . . . . 65.329999999999998 109.906 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.529 ' HB3' ' HZ3' ' A' ' 57' ' ' LYS . 39.7 mt-10 -117.38 137.34 52.53 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.909 0.484 . . . . 74.310000000000002 111.469 -172.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -89.11 100.96 13.63 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.846 0.859 . . . . 73.430000000000007 110.212 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.529 ' HZ3' ' HB3' ' A' ' 55' ' ' GLU . 12.3 mptt -107.64 119.35 39.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.702 0.801 . . . . 75.120000000000005 110.394 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 58.47 30.97 20.44 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.955 1.302 . . . . 72.519999999999996 112.268 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.07 -21.2 25.22 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-N 115.386 -0.825 . . . . 71.209999999999994 114.197 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.65 137.7 33.67 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.788 0.835 . . . . 73.409999999999997 111.266 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.06 114.25 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.59 0.756 . . . . 74.439999999999998 109.197 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.1 138.38 54.47 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.751 -0.833 . . . . 75.409999999999997 108.751 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.539 HG22 HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -103.38 124.4 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 122.265 1.031 . . . . 74.439999999999998 110.669 -177.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.594 ' HB2' HG23 ' A' ' 53' ' ' VAL . 89.0 m-85 -109.72 171.24 7.56 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.191 1.396 . . . . 65.200000000000003 109.582 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -93.75 168.25 11.12 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.576 0.703 . . . . 74.219999999999999 112.11 175.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 124.237 1.015 . . . . 72.349999999999994 111.837 170.629 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt . . . . . 0 CA--C 1.557 1.239 0 CA-C-O 121.063 0.458 . . . . 73.239999999999995 111.817 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -65.5 -24.09 67.06 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 113.145 0.794 . . . . 73.420000000000002 113.145 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 73.5 mt -64.34 -52.75 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.208 0.603 . . . . 74.540000000000006 111.348 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.48 -26.81 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 122.846 0.459 . . . . 71.409999999999997 111.887 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.38 -45.81 88.93 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 123.44 0.462 . . . . 74.109999999999999 112.984 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.92 91.9 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.701 0.8 . . . . 73.329999999999998 111.802 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.38 -41.85 97.78 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.678 0.791 . . . . 61.32 110.935 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.92 -24.05 55.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.95 0.9 . . . . 73.019999999999996 112.533 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.22 -41.51 99.51 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 121.354 0.419 . . . . 72.150000000000006 112.65 172.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -70.65 -41.1 72.58 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.081 0.953 . . . . 74.25 111.293 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.476 HG12 HD23 ' B' ' 28' ' ' LEU . 77.4 t -60.98 -46.1 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.887 0.875 . . . . 73.340000000000003 112.092 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -71.84 -31.79 66.87 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 116.286 -0.415 . . . . 75.120000000000005 111.424 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -56.62 -37.75 71.13 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.744 0.418 . . . . 74.219999999999999 111.471 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.18 75.4 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.038 0.535 . . . . 65.310000000000002 111.84 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.635 HD22 HG13 ' B' ' 63' ' ' ILE . 93.8 mt -73.83 -37.63 64.79 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.963 0.905 . . . . 70.230000000000004 112.158 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -59.08 -39.33 81.82 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.699 0.8 . . . . 73.209999999999994 110.636 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -79.17 -48.56 14.04 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.538 -0.755 . . . . 71.319999999999993 111.134 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.31 99.5 3.15 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.201 0.6 . . . . 73.329999999999998 111.566 -173.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.01 174.55 10.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.2 0.6 . . . . 65.439999999999998 112.272 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.94 13.32 83.52 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.224 -0.444 . . . . 63.32 113.977 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 tp -78.06 138.52 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 C-N-CA 123.15 0.58 . . . . 75.120000000000005 110.9 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.4 m -84.61 151.32 24.58 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.936 0.494 . . . . 64.140000000000001 111.015 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.482 HD11 ' HB3' ' A' ' 37' ' ' GLU . 54.2 mt -53.56 -45.84 98.45 Favored Pre-proline 0 CA--C 1.581 2.165 0 N-CA-C 114.711 1.375 . . . . 75.209999999999994 114.711 -172.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.451 ' HA ' HG23 ' B' ' 36' ' ' VAL . 65.8 Cg_endo -71.29 -29.15 17.47 Favored 'Trans proline' 0 C--N 1.396 3.038 0 CA-C-N 121.803 1.68 . . . . 71.5 113.415 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -73.6 -49.21 27.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.157 0.98 . . . . 72.239999999999995 109.863 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.476 HD23 HG12 ' B' ' 13' ' ' VAL . 62.5 tp -53.93 -36.24 62.56 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 113.013 -1.903 . . . . 74.349999999999994 111.775 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.05 83.35 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.658 0.783 . . . . 70.510000000000005 112.108 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -70.94 -39.88 72.37 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.942 0.497 . . . . 75.120000000000005 110.593 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.61 -43.18 93.84 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.311 0.644 . . . . 72.010000000000005 111.233 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.4 -5.88 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.58 0.752 . . . . 74.439999999999998 112.247 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 66.12 21.15 11.19 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.79 1.236 . . . . 63.549999999999997 113.01 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 68.5 mt -108.72 169.39 8.69 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.862 0.865 . . . . 73.099999999999994 110.553 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -72.34 155.5 40.09 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.003 0.521 . . . . 63.109999999999999 111.003 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' B' ' 26' ' ' PRO . 96.4 t -56.74 -44.04 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 123.579 0.751 . . . . 72.409999999999997 112.364 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.39 -49.25 78.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.626 0.77 . . . . 65.200000000000003 111.861 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -61.73 -38.68 88.81 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.556 1.142 . . . . 74.299999999999997 111.914 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.47 ' O ' HG22 ' B' ' 43' ' ' VAL . 92.4 m -70.08 -46.75 64.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.116 0.966 . . . . 73.510000000000005 111.037 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' B' ' 25' ' ' ILE . . . -62.09 -35.41 78.59 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.745 0.818 . . . . 64.140000000000001 112.137 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -69.64 -37.78 76.91 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.3 1.04 . . . . 74.530000000000001 110.156 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.55 -34.78 77.75 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.208 0.603 . . . . 73.540000000000006 111.428 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.47 HG22 ' O ' ' B' ' 39' ' ' THR . 98.4 t -61.8 -33.94 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.251 0.621 . . . . 74.420000000000002 110.921 172.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.64 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -62.05 -30.45 75.59 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 116.155 -0.475 . . . . 63.240000000000002 114.011 176.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.421 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 70.6 t-105 -68.49 -38.91 81.42 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.937 0.495 . . . . 72.530000000000001 110.899 172.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 93.1 mt -70.01 -33.07 71.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.926 0.491 . . . . 73.0 111.299 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.22 -31.27 72.34 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.923 0.889 . . . . 63.439999999999998 111.589 170.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.575 ' HD2' ' HA ' ' A' ' 48' ' ' ARG . 15.3 ttt180 -65.74 -44.84 84.76 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.742 0.817 . . . . 74.040000000000006 111.322 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -80.05 -3.99 50.83 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.409 0.683 . . . . 74.209999999999994 112.451 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 62.11 21.92 12.75 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.27 1.428 . . . . 74.5 112.983 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -86.5 -4.06 59.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.067 0.947 . . . . 65.099999999999994 113.074 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.74 146.69 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 112.41 0.522 . . . . 62.310000000000002 112.41 -177.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.68 120.15 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.227 -1.027 . . . . 72.219999999999999 108.227 172.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.53 HG12 HG22 ' B' ' 63' ' ' ILE . 62.4 mt -106.99 111.88 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-O 121.341 0.591 . . . . 74.239999999999995 110.973 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -114.02 140.71 48.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.144 0.978 . . . . 72.230000000000004 110.636 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -113.51 103.28 11.11 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.503 0.721 . . . . 64.530000000000001 110.8 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.9 113.72 26.22 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.587 1.155 . . . . 73.409999999999997 108.829 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 60.04 30.47 19.95 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.093 0.957 . . . . 73.329999999999998 112.653 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.58 -10.35 62.23 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 113.942 0.337 . . . . 74.340000000000003 113.942 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 44.5 tp -84.21 128.88 34.84 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.001 0.92 . . . . 73.040000000000006 110.281 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.8 126.85 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.076 0.55 . . . . 72.530000000000001 109.827 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.94 120.64 36.96 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.038 -1.097 . . . . 74.430000000000007 108.038 173.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.635 HG13 HD22 ' B' ' 17' ' ' LEU . 34.1 pt -103.48 138.94 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.245 0.545 . . . . 73.519999999999996 110.557 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -121.49 179.07 4.56 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.459 1.104 . . . . 63.149999999999999 110.025 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' B' ' 17' ' ' LEU . 1.6 m-20 -82.15 160.55 23.07 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.051 -0.351 . . . . 73.0 110.051 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 CA--C 1.56 1.335 0 C-N-CA 123.374 0.67 . . . . 74.239999999999995 111.187 172.063 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 112.837 0.68 . . . . 71.409999999999997 112.837 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.4 mt -49.15 -50.04 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 124.07 0.948 . . . . 65.329999999999998 112.215 173.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.4 m -61.78 -28.02 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 112.436 0.532 . . . . 72.310000000000002 112.436 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.52 -38.4 86.48 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 122.953 0.158 . . . . 41.409999999999997 113.073 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.59 -52.52 25.38 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.668 0.787 . . . . 70.129999999999995 111.785 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -59.26 -43.0 92.5 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.053 0.941 . . . . 64.340000000000003 112.155 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.4 -27.56 63.4 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.341 0.497 . . . . 70.420000000000002 112.341 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.79 -38.9 96.84 Favored Glycine 0 CA--C 1.538 1.485 0 O-C-N 123.332 0.395 . . . . 70.109999999999999 112.718 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -70.42 -43.82 69.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.502 0.721 . . . . 74.340000000000003 111.277 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.566 ' HA ' HG11 ' A' ' 32' ' ' VAL . 95.2 t -59.27 -42.75 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.433 0.693 . . . . 64.040000000000006 111.195 176.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 64.5 t90 -66.41 -32.98 74.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.851 0.86 . . . . 74.430000000000007 111.393 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -60.5 -53.73 53.98 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.068 0.147 . . . . 75.310000000000002 111.342 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.08 -30.91 71.94 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.172 0.589 . . . . 65.409999999999997 111.461 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.49 -50.71 50.32 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.99 1.316 . . . . 73.040000000000006 111.366 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.69 -23.87 59.87 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.361 0.664 . . . . 74.120000000000005 111.06 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -79.8 -37.06 36.04 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.393 1.077 . . . . 74.420000000000002 110.46 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.22 103.54 1.64 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.802 0.841 . . . . 74.120000000000005 110.705 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.668 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 10.7 p-10 -95.04 166.42 11.94 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.298 0.639 . . . . 73.420000000000002 112.148 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.68 64.16 1.11 Allowed Glycine 0 N--CA 1.473 1.133 0 CA-C-N 116.095 -0.502 . . . . 75.310000000000002 112.201 -175.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 tt -156.36 149.76 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 123.428 0.691 . . . . 71.030000000000001 111.116 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -86.17 158.58 19.72 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.232 0.613 . . . . 71.519999999999996 111.649 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.472 HG23 ' HB2' ' A' ' 40' ' ' ALA . 74.4 mt -53.68 -52.59 65.89 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 114.185 1.18 . . . . 72.010000000000005 114.185 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.0 -26.18 43.72 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 121.773 1.649 . . . . 71.129999999999995 114.188 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -76.22 -45.57 32.39 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.455 1.121 . . . . 70.400000000000006 109.423 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.9 tp -60.1 -34.35 73.36 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 113.284 -1.78 . . . . 74.010000000000005 111.973 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.66 95.36 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.007 0.923 . . . . 64.439999999999998 112.438 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -71.49 -27.94 63.57 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.856 0.462 . . . . 75.219999999999999 112.044 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -66.67 -52.28 46.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.222 0.534 . . . . 73.150000000000006 110.914 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.0 m -79.07 -5.87 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 115.184 -0.916 . . . . 70.040000000000006 111.838 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 69.28 16.35 8.42 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.239 1.415 . . . . 70.0 112.171 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.8 mt -97.23 164.21 12.58 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.555 0.742 . . . . 71.109999999999999 110.254 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -68.23 153.58 43.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.414 0.286 . . . . 70.120000000000005 111.323 172.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.68 -44.92 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 123.486 0.714 . . . . 74.239999999999995 111.887 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -60.25 -42.8 96.09 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.95 0.9 . . . . 73.420000000000002 111.797 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 t -64.91 -42.68 94.52 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.587 0.755 . . . . 65.230000000000004 111.369 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 43' ' ' VAL . 61.6 m -71.49 -37.9 71.24 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.805 0.842 . . . . 62.219999999999999 111.775 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -64.94 -44.86 88.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 123.747 0.819 . . . . 75.129999999999995 111.504 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.33 -37.33 87.13 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.461 -1.245 . . . . 73.25 110.357 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.04 -36.48 72.36 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.371 0.669 . . . . 73.099999999999994 112.449 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 39' ' ' THR . 88.0 t -66.75 -36.81 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.097 0.559 . . . . 63.530000000000001 110.452 173.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.51 -31.97 82.57 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-N 116.099 -0.5 . . . . 74.510000000000005 112.709 172.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.457 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 75.6 t-105 -74.03 -27.97 61.2 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.33 0.652 . . . . 74.299999999999997 111.582 173.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.76 -34.6 67.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.534 -0.729 . . . . 74.230000000000004 111.593 172.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.54 -26.59 55.33 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.11 0.964 . . . . 70.540000000000006 113.147 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.797 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 7.2 ptm180 -56.22 -36.65 68.7 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.387 0.884 . . . . 74.430000000000007 113.387 -174.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.797 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 39.3 mt-10 -112.22 15.76 20.32 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.117 0.967 . . . . 74.310000000000002 111.24 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.42 47.65 8.57 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.428 1.091 . . . . 72.25 110.048 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -87.68 -14.6 39.46 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.736 0.643 . . . . 72.040000000000006 112.736 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 m -133.23 150.64 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.92 0.888 . . . . 71.109999999999999 111.933 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 54.4 t -102.57 113.64 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.734 1.214 . . . . 63.439999999999998 108.772 171.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 61' ' ' ILE . 50.4 mm -100.17 108.85 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 118.061 0.391 . . . . 73.200000000000003 110.983 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HB3' ' HZ3' ' A' ' 57' ' ' LYS . 28.4 mm-40 -104.9 127.76 52.86 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.284 1.034 . . . . 72.019999999999996 110.356 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.514 HH22 ' HA ' ' B' ' 38' ' ' SER . 81.4 mtt-85 -113.61 105.55 13.47 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.872 -0.517 . . . . 72.040000000000006 111.529 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HZ3' ' HB3' ' A' ' 55' ' ' GLU . 14.4 mptt -112.48 119.47 38.33 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.877 0.871 . . . . 74.349999999999994 109.843 176.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 57.97 32.61 22.19 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.148 0.979 . . . . 73.409999999999997 112.27 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.23 -6.39 72.15 Favored Glycine 0 CA--C 1.543 1.844 0 N-CA-C 114.269 0.468 . . . . 75.120000000000005 114.269 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.8 mt -88.24 125.66 34.76 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.602 0.761 . . . . 73.25 110.192 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.459 HG22 HG23 ' A' ' 54' ' ' ILE . 2.8 mp -86.01 126.31 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.512 0.725 . . . . 74.430000000000007 110.048 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -109.92 128.64 55.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.682 1.193 . . . . 74.140000000000001 108.9 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.9 mp -107.83 106.86 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 108.832 -0.803 . . . . 72.010000000000005 108.832 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.668 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 96.7 m-85 -107.55 167.16 10.14 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.573 1.149 . . . . 74.409999999999997 110.596 175.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -90.54 147.31 23.44 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.894 0.378 . . . . 71.310000000000002 110.873 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 CA--C 1.565 1.522 0 CA-C-O 121.075 0.464 . . . . 73.340000000000003 112.239 -179.542 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 120.989 0.424 . . . . 74.219999999999999 111.417 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -91.68 -25.21 19.22 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.317 0.647 . . . . 74.129999999999995 112.112 175.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 75.2 mt -59.89 -46.19 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 122.97 0.508 . . . . 74.519999999999996 110.521 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 35.7 m -64.12 -30.95 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 122.884 0.473 . . . . 74.510000000000005 112.113 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.24 -41.54 59.34 Favored Glycine 0 CA--C 1.538 1.49 0 O-C-N 123.191 0.307 . . . . 73.329999999999998 113.174 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.76 -43.58 88.45 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.78 0.832 . . . . 63.100000000000001 111.469 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -65.55 -35.7 81.62 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.736 0.814 . . . . 73.519999999999996 111.27 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.45 70.96 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.164 0.586 . . . . 72.239999999999995 111.264 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.27 -36.87 92.32 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 116.299 -0.409 . . . . 74.140000000000001 112.57 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -63.97 -47.67 79.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.111 0.965 . . . . 72.439999999999998 111.878 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 75.8 t -62.32 -46.8 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.328 0.651 . . . . 74.310000000000002 111.153 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.542 ' HA ' HD13 ' B' ' 17' ' ' LEU . 17.9 t90 -64.02 -33.85 76.68 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.776 0.83 . . . . 74.409999999999997 111.436 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . 0.408 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 78.4 t60 -59.8 -47.99 83.48 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.974 0.509 . . . . 71.209999999999994 110.467 172.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.09 -26.84 68.73 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.23 0.612 . . . . 72.519999999999996 112.598 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' B' ' 14' ' ' TRP . 75.4 mt -68.84 -41.49 78.45 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.519 0.728 . . . . 75.5 111.166 172.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.411 HD21 ' N ' ' B' ' 18' ' ' ASN . 0.8 OUTLIER -68.01 -26.13 65.74 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.882 -0.599 . . . . 75.420000000000002 110.996 175.093 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 10.4 mm-40 -73.6 -47.18 42.24 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.413 0.685 . . . . 73.430000000000007 110.533 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.9 106.63 0.61 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.238 1.015 . . . . 71.439999999999998 110.554 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -95.6 179.67 5.05 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.485 0.714 . . . . 72.430000000000007 112.118 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.76 39.3 34.38 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 116.191 -0.459 . . . . 53.219999999999999 112.493 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 17.4 tt -124.29 153.45 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.954 0.902 . . . . 73.109999999999999 110.751 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' SER . . . . . 0.556 ' HG ' HD23 ' B' ' 60' ' ' LEU . 50.7 m -80.29 151.56 29.48 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.801 0.441 . . . . 75.200000000000003 111.462 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' B' ' 40' ' ' ALA . 87.3 mt -51.04 -49.14 82.79 Favored Pre-proline 0 CA--C 1.577 1.991 0 N-CA-C 114.451 1.278 . . . . 74.099999999999994 114.451 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 59.9 Cg_endo -67.33 -30.17 37.31 Favored 'Trans proline' 0 C--N 1.393 2.89 0 C-N-CA 121.711 1.607 . . . . 74.310000000000002 114.135 -176.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -76.68 -44.17 34.8 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.229 1.014 . . . . 63.219999999999999 110.307 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.33 -40.19 74.02 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 113.427 -1.715 . . . . 73.239999999999995 111.287 171.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.82 -38.33 85.05 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.102 0.961 . . . . 73.409999999999997 112.505 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' B' ' 26' ' ' PRO . 14.7 mmm-85 -63.29 -44.1 96.01 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.4 0.68 . . . . 75.439999999999998 110.651 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.533 ' HB3' ' HZ3' ' B' ' 31' ' ' LYS . 8.0 mtpm? -67.21 -43.27 82.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.864 0.866 . . . . 75.409999999999997 111.833 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.3 m -83.03 -5.27 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 122.875 0.47 . . . . 72.299999999999997 111.768 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 69.21 11.56 8.23 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.422 1.489 . . . . 72.299999999999997 112.682 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.7 mt -93.17 165.79 12.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.531 0.732 . . . . 74.420000000000002 110.019 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -65.94 153.55 41.77 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 122.239 -0.288 . . . . 72.439999999999998 110.59 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' B' ' 26' ' ' PRO . 54.9 t -49.88 -52.26 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.104 0.962 . . . . 73.439999999999998 112.171 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -71.12 -30.64 66.75 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.295 1.038 . . . . 74.340000000000003 111.436 -176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.514 ' HA ' HH22 ' A' ' 56' ' ' ARG . 41.7 m -64.97 -42.17 94.81 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.629 0.772 . . . . 73.409999999999997 110.775 173.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.429 ' O ' HG23 ' B' ' 43' ' ' VAL . 84.9 m -70.06 -43.19 71.72 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.103 0.961 . . . . 75.25 111.075 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -62.06 -42.66 99.43 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 123.975 0.91 . . . . 75.329999999999998 112.106 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -64.67 -38.26 90.39 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.698 1.199 . . . . 74.5 110.365 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.92 72.07 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.548 0.739 . . . . 74.400000000000006 111.958 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 39' ' ' THR . 75.0 t -63.7 -35.68 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.481 0.713 . . . . 72.409999999999997 110.67 172.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.35 -31.24 80.08 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 116.29 -0.414 . . . . 44.020000000000003 113.41 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.493 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 43.6 t-105 -74.39 -31.24 62.28 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.229 0.612 . . . . 74.109999999999999 111.331 176.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.27 -36.29 68.97 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.29 0.636 . . . . 75.129999999999995 111.433 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.31 82.9 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.825 0.85 . . . . 73.209999999999994 110.8 172.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.562 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 31.2 ttt180 -51.84 -50.6 60.58 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.636 0.775 . . . . 74.400000000000006 111.064 171.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -80.01 -2.31 43.58 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.947 -1.024 . . . . 72.140000000000001 112.737 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 64.75 26.63 13.05 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.754 1.222 . . . . 72.430000000000007 112.694 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -99.29 5.73 46.45 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.136 0.791 . . . . 74.540000000000006 113.136 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.412 ' HB ' HD11 ' B' ' 63' ' ' ILE . 28.5 m -135.31 156.8 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.398 0.618 . . . . 71.209999999999994 112.589 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 32.4 t -111.56 125.29 68.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 124.475 1.11 . . . . 72.439999999999998 109.262 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.83 103.42 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.42 -0.956 . . . . 74.340000000000003 108.42 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . 0.468 ' HB3' ' HE1' ' B' ' 64' ' ' TYR . 7.7 tp10 -118.86 115.79 25.15 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.938 0.399 . . . . 74.209999999999994 109.982 -173.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -84.69 107.05 16.69 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.544 0.687 . . . . 72.209999999999994 111.063 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -104.82 114.39 28.57 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.581 1.153 . . . . 73.230000000000004 109.912 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 58.44 32.44 22.11 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.063 0.945 . . . . 72.129999999999995 112.399 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.17 -20.02 31.88 Favored Glycine 0 CA--C 1.545 1.942 0 N-CA-C 114.06 0.384 . . . . 75.230000000000004 114.06 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.556 HD23 ' HG ' ' B' ' 24' ' ' SER . 7.3 tt -88.41 138.34 31.52 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.456 1.102 . . . . 73.329999999999998 109.9 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -87.8 122.95 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.753 0.421 . . . . 73.510000000000005 111.704 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -108.45 127.08 53.59 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.089 0.956 . . . . 75.129999999999995 108.633 171.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.412 HD11 ' HB ' ' B' ' 52' ' ' VAL . 0.0 OUTLIER -104.75 121.91 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-O 121.887 0.851 . . . . 74.5 110.154 -176.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.616 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 45.3 m-85 -107.71 157.76 17.84 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.624 1.17 . . . . 73.120000000000005 110.141 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -85.16 162.97 19.01 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.039 0.536 . . . . 75.420000000000002 111.48 -175.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.487 1.388 0 C-N-CA 124.227 1.011 . . . . 70.319999999999993 112.473 175.56 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 4' ' ' LYS . 11.2 mmpt? . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 112.37 0.507 . . . . 72.540000000000006 112.37 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.6 mt -65.28 -46.92 89.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.34 0.656 . . . . 75.340000000000003 111.579 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.81 -27.55 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 118.057 0.39 . . . . 73.420000000000002 111.676 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.04 -42.52 94.56 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.557 0.536 . . . . 64.409999999999997 112.491 172.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.11 81.1 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.487 0.715 . . . . 75.219999999999999 111.24 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -61.73 -36.12 80.03 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.569 0.747 . . . . 75.109999999999999 111.161 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.93 -36.61 69.97 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.533 0.733 . . . . 71.319999999999993 111.615 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.86 -31.41 75.54 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-N 116.41 -0.359 . . . . 74.430000000000007 112.545 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.543 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 53.8 tptt -71.0 -42.28 69.83 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.442 1.097 . . . . 73.299999999999997 111.186 175.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.59 -40.7 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.993 0.917 . . . . 71.140000000000001 111.343 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 13.4 t90 -69.33 -33.53 73.25 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 116.018 -0.537 . . . . 73.349999999999994 110.399 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -57.13 -46.05 83.01 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.134 0.573 . . . . 75.510000000000005 110.744 168.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.36 -29.57 66.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.517 0.727 . . . . 73.25 112.481 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.12 -49.1 60.1 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.627 0.771 . . . . 73.209999999999994 112.083 172.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -67.56 -22.31 65.4 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.067 0.461 . . . . 72.540000000000006 111.303 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -76.2 -48.72 19.37 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.292 1.037 . . . . 74.409999999999997 109.614 174.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.24 97.4 0.34 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.753 1.221 . . . . 73.430000000000007 110.263 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.98 173.75 11.5 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.732 0.813 . . . . 73.400000000000006 112.258 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.04 61.38 4.03 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.765 -0.534 . . . . 62.530000000000001 111.765 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.11 159.08 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 123.153 0.581 . . . . 72.340000000000003 111.185 -166.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 m -79.47 153.28 29.74 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.844 0.354 . . . . 72.439999999999998 111.09 174.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' A' ' 40' ' ' ALA . 95.8 mt -53.56 -54.8 41.73 Favored Pre-proline 0 CA--C 1.576 1.956 0 C-N-CA 124.494 1.118 . . . . 73.310000000000002 112.245 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.456 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 55.9 Cg_endo -66.36 -25.19 49.35 Favored 'Trans proline' 0 C--N 1.401 3.301 0 C-N-CA 121.764 1.643 . . . . 73.239999999999995 113.741 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -70.63 -51.84 25.36 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.383 0.673 . . . . 75.109999999999999 112.501 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.61 -33.01 74.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.312 0.245 . . . . 74.129999999999995 110.381 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.14 -41.25 64.91 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.622 1.169 . . . . 73.549999999999997 112.645 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 26' ' ' PRO . 46.9 mtt180 -62.62 -41.18 98.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.927 0.891 . . . . 72.409999999999997 111.553 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -72.61 -43.24 63.57 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.731 0.813 . . . . 75.430000000000007 111.243 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.543 ' HB ' ' HG3' ' A' ' 12' ' ' LYS . 26.2 m -85.69 -0.47 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 115.465 -0.789 . . . . 75.439999999999998 112.26 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.6 m120 67.08 11.21 8.26 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.897 1.279 . . . . 72.439999999999998 113.229 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.5 mt -89.24 148.01 23.83 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.374 -0.602 . . . . 74.400000000000006 109.374 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.3 t -63.25 153.4 34.84 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.45 0.3 . . . . 72.239999999999995 110.952 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.45 -42.44 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 123.278 0.631 . . . . 75.420000000000002 111.333 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.53 -43.39 98.94 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.417 0.687 . . . . 61.340000000000003 112.338 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.4 m -62.09 -33.02 73.65 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 123.302 0.641 . . . . 73.430000000000007 111.707 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 43' ' ' VAL . 79.0 m -77.4 -53.06 8.11 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.763 0.825 . . . . 75.310000000000002 111.641 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.612 ' HB2' HG22 ' A' ' 25' ' ' ILE . . . -59.73 -41.75 91.6 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.416 1.087 . . . . 73.340000000000003 112.884 -177.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -65.49 -39.02 91.42 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.405 1.082 . . . . 64.430000000000007 110.407 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.17 -31.12 69.53 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 123.241 0.616 . . . . 65.219999999999999 112.016 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 39' ' ' THR . 87.2 t -61.02 -38.13 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 123.765 0.826 . . . . 63.200000000000003 110.354 171.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.94 -32.03 82.88 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.794 -0.639 . . . . 75.299999999999997 113.943 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.429 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 70.8 t-105 -70.31 -37.38 74.73 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.059 0.457 . . . . 73.409999999999997 110.708 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.54 -35.63 79.44 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.774 0.43 . . . . 74.530000000000001 111.047 172.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.67 88.91 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.513 0.725 . . . . 74.540000000000006 111.421 172.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.432 ' NH1' ' HA ' ' B' ' 48' ' ' ARG . 22.7 ttt180 -55.61 -49.91 71.54 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.799 0.84 . . . . 62.450000000000003 111.128 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -78.4 -6.02 54.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.755 0.822 . . . . 71.420000000000002 111.718 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 62.07 22.87 13.42 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.601 1.56 . . . . 72.120000000000005 112.462 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -78.28 -5.63 52.61 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.458 1.103 . . . . 71.409999999999997 113.41 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.475 HG11 HD12 ' A' ' 63' ' ' ILE . 25.6 m -133.14 151.98 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.171 0.589 . . . . 64.129999999999995 112.294 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 64' ' ' TYR . 17.3 m -123.27 121.04 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 C-N-CA 124.108 0.963 . . . . 73.219999999999999 109.014 169.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.529 HG12 HD11 ' B' ' 41' ' ' LEU . 3.6 mp -100.99 124.29 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 109.154 -0.684 . . . . 72.239999999999995 109.154 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.42 148.59 44.92 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.253 0.621 . . . . 72.109999999999999 112.16 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -100.61 112.63 25.04 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.446 0.699 . . . . 73.420000000000002 110.267 171.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -105.44 112.77 26.0 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.846 0.859 . . . . 73.030000000000001 108.942 173.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 55.88 30.77 16.52 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.631 1.172 . . . . 75.5 112.067 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.96 -27.2 13.48 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 115.431 -0.804 . . . . 64.0 113.986 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.31 132.3 42.93 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.781 0.832 . . . . 73.040000000000006 111.394 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.0 mt -89.7 123.98 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.449 0.699 . . . . 74.540000000000006 111.511 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -127.58 139.05 53.01 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.458 1.103 . . . . 73.349999999999994 109.748 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.475 HD12 HG11 ' A' ' 52' ' ' VAL . 6.1 tt -95.07 136.34 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.287 0.635 . . . . 73.340000000000003 110.533 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.532 ' HB2' HG23 ' A' ' 53' ' ' VAL . 98.8 m-85 -130.37 169.39 15.54 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.546 1.138 . . . . 71.150000000000006 110.374 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.54 155.43 20.49 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.425 0.69 . . . . 71.030000000000001 110.264 171.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.935 0.398 . . . . 74.230000000000004 111.86 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 112.21 0.448 . . . . 72.510000000000005 112.21 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -65.25 -20.25 66.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.302 -0.249 . . . . 74.109999999999999 111.603 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.58 -59.55 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.084 0.554 . . . . 75.310000000000002 110.91 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.66 -29.84 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 111.842 0.312 . . . . 74.420000000000002 111.842 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.29 -47.5 63.48 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.366 0.416 . . . . 70.400000000000006 113.138 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.68 96.61 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.935 0.894 . . . . 51.549999999999997 111.296 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.57 -42.26 87.31 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.636 -0.711 . . . . 73.219999999999999 111.581 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.72 -35.32 72.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.089 0.556 . . . . 73.109999999999999 112.105 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.66 -38.13 95.26 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 116.332 -0.394 . . . . 62.130000000000003 112.994 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -75.72 -42.45 50.67 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.744 0.818 . . . . 74.109999999999999 110.943 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.573 ' HA ' HG12 ' B' ' 32' ' ' VAL . 34.3 t -62.78 -48.05 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.384 1.074 . . . . 65.310000000000002 111.47 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.423 ' NE1' ' HB3' ' B' ' 51' ' ' LYS . 48.3 t90 -64.92 -35.12 80.13 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.024 0.53 . . . . 65.349999999999994 111.735 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . 0.449 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 38.9 t60 -65.4 -46.79 78.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.567 0.347 . . . . 70.349999999999994 110.419 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.15 62.51 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.37 0.668 . . . . 73.129999999999995 112.149 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.433 HD11 ' ND2' ' B' ' 65' ' ' ASN . 1.4 tm? -72.87 -31.77 64.95 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.569 1.148 . . . . 75.109999999999999 110.397 171.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.68 -36.46 73.32 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.569 -0.53 . . . . 72.450000000000003 109.569 175.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 12.3 mm-40 -72.49 -49.88 29.89 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.326 0.65 . . . . 73.409999999999997 110.617 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.8 86.75 2.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.013 0.925 . . . . 73.329999999999998 110.206 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -68.67 124.61 24.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.633 0.773 . . . . 75.420000000000002 111.778 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.61 63.07 2.4 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.451 -0.34 . . . . 62.329999999999998 112.389 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.6 tp -117.3 137.96 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.594 0.758 . . . . 72.140000000000001 110.764 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -67.68 147.75 52.25 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.563 0.745 . . . . 73.329999999999998 110.901 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.497 HG21 ' HB2' ' B' ' 40' ' ' ALA . 60.8 mt -56.99 -49.89 91.35 Favored Pre-proline 0 CA--C 1.58 2.119 0 N-CA-C 113.422 0.897 . . . . 74.549999999999997 113.422 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.63 -27.38 32.48 Favored 'Trans proline' 0 C--N 1.399 3.203 0 C-N-CA 121.799 1.666 . . . . 73.299999999999997 114.026 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -70.91 -52.68 18.57 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.067 0.937 . . . . 71.239999999999995 109.245 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.453 HD23 HG11 ' B' ' 13' ' ' VAL . 60.6 tp -54.56 -38.34 66.53 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 113.249 -1.796 . . . . 75.310000000000002 112.15 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.72 -45.14 93.08 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.993 0.917 . . . . 70.030000000000001 111.915 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -67.7 -37.71 82.65 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.23 0.612 . . . . 74.420000000000002 110.861 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -64.12 -30.01 71.1 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.781 0.832 . . . . 74.430000000000007 112.243 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' B' ' 13' ' ' VAL . 34.1 m -103.09 1.91 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 112.769 0.655 . . . . 74.120000000000005 112.769 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 64.3 27.79 13.79 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 124.868 1.267 . . . . 73.409999999999997 113.132 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 72.4 mt -113.18 166.54 11.35 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.752 0.821 . . . . 74.120000000000005 111.448 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 31.6 t -69.43 155.74 39.96 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.664 -0.698 . . . . 63.310000000000002 111.61 170.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 67.8 t -56.37 -42.39 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.586 0.754 . . . . 74.230000000000004 111.033 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.83 -47.31 86.24 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.005 0.922 . . . . 75.519999999999996 111.457 175.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 41.5 t -63.72 -38.09 89.79 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.106 0.963 . . . . 72.430000000000007 112.089 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.447 ' O ' HG23 ' B' ' 43' ' ' VAL . 94.1 m -75.12 -49.44 19.59 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.863 0.865 . . . . 74.540000000000006 111.866 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.497 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -60.25 -39.59 87.28 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.69 0.796 . . . . 70.040000000000006 112.257 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.529 HD11 HG12 ' A' ' 54' ' ' ILE . 1.2 tt -62.2 -48.71 78.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.182 0.993 . . . . 74.030000000000001 110.064 173.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.72 -29.99 68.5 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.98 -1.009 . . . . 64.019999999999996 112.116 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.574 HG13 HD13 ' B' ' 63' ' ' ILE . 72.8 t -68.84 -37.17 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 123.061 0.544 . . . . 73.340000000000003 110.768 176.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -68.9 -30.25 72.43 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 116.431 -0.349 . . . . 62.109999999999999 112.79 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.451 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 72.6 t-105 -73.67 -21.07 60.38 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.304 0.642 . . . . 73.409999999999997 110.991 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.72 -33.8 58.15 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.645 0.778 . . . . 74.030000000000001 112.29 167.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.76 -25.53 60.61 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.057 1.132 . . . . 71.129999999999995 114.057 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.57 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 35.7 ptt85 -61.75 -36.38 80.85 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.036 0.446 . . . . 75.109999999999999 111.878 174.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 41.0 mt-10 -96.37 -2.7 45.13 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.35 1.06 . . . . 64.450000000000003 111.344 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 63.55 20.55 12.3 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 125.395 1.478 . . . . 75.439999999999998 113.065 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.423 ' HB3' ' NE1' ' B' ' 14' ' ' TRP . 49.5 mtmt -75.46 -8.18 56.04 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.378 0.881 . . . . 74.230000000000004 113.378 -173.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -128.57 151.58 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.915 0.886 . . . . 72.340000000000003 110.693 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.588 HG21 ' HB2' ' B' ' 64' ' ' TYR . 8.3 m -123.95 123.61 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.166 0.986 . . . . 75.349999999999994 109.884 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 61' ' ' ILE . 1.9 mp -91.3 119.77 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.224 1.01 . . . . 72.239999999999995 109.616 -176.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -116.98 136.55 52.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.348 0.659 . . . . 75.010000000000005 110.156 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -98.58 108.46 21.16 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.857 0.463 . . . . 71.129999999999995 111.297 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -104.88 109.33 21.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.924 0.89 . . . . 75.319999999999993 109.455 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 61.18 30.29 19.23 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.053 1.341 . . . . 74.209999999999994 112.25 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.96 -18.42 56.03 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 113.796 0.279 . . . . 64.010000000000005 113.796 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mp -89.84 149.11 22.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.935 0.894 . . . . 75.219999999999999 110.394 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 54' ' ' ILE . 27.1 mm -92.66 134.94 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.596 0.358 . . . . 72.340000000000003 111.278 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -123.19 133.16 54.25 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.607 -0.886 . . . . 74.120000000000005 108.607 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.574 HD13 HG13 ' B' ' 43' ' ' VAL . 25.5 mm -93.15 119.46 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.421 0.688 . . . . 74.140000000000001 110.016 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.588 ' HB2' HG21 ' B' ' 53' ' ' VAL . 57.0 m-85 -113.73 169.33 9.06 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.856 0.862 . . . . 75.299999999999997 110.688 175.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.433 ' ND2' HD11 ' B' ' 17' ' ' LEU . 5.8 m120 -79.99 154.38 28.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.533 0.733 . . . . 74.040000000000006 110.469 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.574 0.702 . . . . 73.409999999999997 112.061 172.603 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 112.887 0.699 . . . . 72.219999999999999 112.887 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.4 mt -44.69 -59.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 123.547 0.739 . . . . 63.32 111.101 166.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.0 m -65.67 -27.16 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 112.507 0.558 . . . . 74.209999999999994 112.507 -177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.49 -42.67 88.63 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 120.899 0.166 . . . . 71.129999999999995 112.718 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.57 84.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.002 0.921 . . . . 73.439999999999998 111.301 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -60.21 -47.76 84.61 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.098 0.959 . . . . 72.219999999999999 111.289 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.78 -29.81 64.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.525 0.73 . . . . 63.200000000000003 112.168 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.45 -40.77 99.12 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.231 0.332 . . . . 72.120000000000005 112.873 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 60.3 tttp -75.87 -37.91 58.44 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.592 0.757 . . . . 70.040000000000006 111.931 177.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.598 ' HA ' HG11 ' A' ' 32' ' ' VAL . 60.0 t -61.23 -48.59 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 123.487 0.715 . . . . 74.409999999999997 111.586 177.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.436 ' HA ' HD11 ' A' ' 17' ' ' LEU . 30.6 t90 -65.65 -39.01 90.94 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.667 -0.697 . . . . 73.230000000000004 111.311 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -60.62 -38.64 85.43 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.204 0.602 . . . . 70.219999999999999 111.151 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.82 -23.2 63.27 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.419 0.687 . . . . 75.120000000000005 112.257 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.436 HD11 ' HA ' ' A' ' 14' ' ' TRP . 70.2 mt -70.54 -44.88 66.6 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.332 0.653 . . . . 75.349999999999994 111.318 169.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -61.0 -32.79 72.36 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.002 0.521 . . . . 73.349999999999994 111.425 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.61 -52.31 32.92 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.383 0.673 . . . . 64.420000000000002 110.551 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.86 102.29 0.56 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.52 0.728 . . . . 63.450000000000003 111.206 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -97.12 -175.13 3.15 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.763 0.825 . . . . 72.019999999999996 110.819 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.05 49.85 7.27 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.365 -0.694 . . . . 75.409999999999997 111.365 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.4 tt -139.33 159.57 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.238 -0.981 . . . . 73.319999999999993 110.867 -163.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.9 m -72.99 146.28 46.1 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.66 0.384 . . . . 74.230000000000004 110.819 171.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' A' ' 40' ' ' ALA . 70.6 mt -55.96 -46.06 99.81 Favored Pre-proline 0 CA--C 1.58 2.106 0 C-N-CA 124.126 0.97 . . . . 74.310000000000002 112.998 176.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.542 ' HA ' HG23 ' A' ' 36' ' ' VAL . 35.7 Cg_endo -62.54 -29.43 78.38 Favored 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 122.19 1.926 . . . . 55.310000000000002 114.524 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -74.75 -46.62 36.05 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 122.39 1.09 . . . . 72.540000000000006 110.146 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.449 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 58.2 tp -58.45 -38.18 76.98 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 113.259 -1.791 . . . . 73.439999999999998 111.6 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.15 -37.74 75.24 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.237 1.015 . . . . 73.329999999999998 112.345 177.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -67.67 -38.27 83.5 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.415 0.686 . . . . 74.129999999999995 111.712 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 28' ' ' LEU . 42.4 mtmt -69.12 -38.4 78.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.217 0.607 . . . . 72.239999999999995 111.367 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 13' ' ' VAL . 32.3 m -90.86 -1.68 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.731 0.641 . . . . 75.219999999999999 112.731 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 68.09 9.89 7.47 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.175 1.39 . . . . 73.409999999999997 112.46 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.5 mt -95.86 167.55 11.18 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.347 0.659 . . . . 72.450000000000003 111.409 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.5 t -66.47 149.51 50.32 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.661 0.784 . . . . 73.420000000000002 110.845 168.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' A' ' 26' ' ' PRO . 55.6 t -55.14 -41.81 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.276 0.56 . . . . 72.349999999999994 110.921 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HB3' HD12 ' B' ' 25' ' ' ILE . 42.7 mt-10 -64.65 -39.06 93.03 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.37 1.068 . . . . 74.219999999999999 112.574 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 64.2 p -75.56 -26.56 58.06 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 122.616 0.367 . . . . 65.150000000000006 111.982 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 84.9 m -78.57 -43.47 26.46 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.418 0.687 . . . . 72.340000000000003 111.178 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.479 ' HB2' HG22 ' A' ' 25' ' ' ILE . . . -64.38 -36.86 85.52 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.376 0.671 . . . . 71.030000000000001 111.263 175.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.498 HD11 HG23 ' B' ' 54' ' ' ILE . 1.0 OUTLIER -58.3 -53.22 60.77 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.512 1.125 . . . . 75.230000000000004 109.94 170.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.86 -31.29 71.55 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.917 -1.038 . . . . 73.519999999999996 111.721 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.7 t -65.86 -37.98 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.565 0.746 . . . . 74.439999999999998 110.687 173.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.48 -31.74 81.21 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-N 116.753 -0.203 . . . . 63.119999999999997 113.499 172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.538 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 66.7 t-105 -73.55 -31.07 63.45 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.656 0.782 . . . . 74.319999999999993 111.47 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.31 -38.83 63.23 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.267 0.627 . . . . 73.040000000000006 111.317 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.54 81.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.37 1.068 . . . . 74.540000000000006 112.317 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.613 ' HB2' ' HD2' ' B' ' 48' ' ' ARG . 9.7 ptt180 -62.65 -34.19 76.57 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 121.196 0.522 . . . . 74.420000000000002 110.543 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -85.97 -1.43 57.32 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.233 1.013 . . . . 75.140000000000001 111.898 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 65.3 22.2 12.06 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.26 1.424 . . . . 75.310000000000002 112.301 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.36 -8.41 50.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 113.078 0.77 . . . . 74.030000000000001 113.078 -173.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.606 ' HB ' HD11 ' A' ' 63' ' ' ILE . 30.2 m -132.15 157.1 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.023 0.529 . . . . 73.299999999999997 112.07 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 64' ' ' TYR . 11.9 m -128.63 123.99 60.63 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 123.83 0.852 . . . . 74.129999999999995 110.41 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.18 125.03 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.848 0.859 . . . . 74.239999999999995 110.075 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -99.66 122.36 42.57 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.05 0.54 . . . . 73.310000000000002 110.976 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HG2' HG12 ' A' ' 61' ' ' ILE . 79.2 mtt85 -106.23 98.56 8.22 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.792 0.837 . . . . 74.430000000000007 110.111 173.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -127.59 128.67 45.97 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.596 0.758 . . . . 72.519999999999996 109.617 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 59.14 29.69 19.3 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.7 1.2 . . . . 75.430000000000007 112.137 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.19 1.83 64.97 Favored Glycine 0 CA--C 1.549 2.214 0 CA-C-N 116.05 -0.523 . . . . 72.329999999999998 114.224 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.4 mt -93.89 131.79 38.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.692 0.797 . . . . 53.509999999999998 111.19 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.452 HG12 ' HG2' ' A' ' 56' ' ' ARG . 72.4 mt -101.77 116.97 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 75.219999999999999 110.62 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -121.66 133.28 54.96 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.175 0.99 . . . . 72.310000000000002 109.828 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.606 HD11 ' HB ' ' A' ' 52' ' ' VAL . 7.0 tp -97.29 117.05 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 CA-C-O 121.801 0.81 . . . . 74.019999999999996 111.614 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.463 ' HB2' HG22 ' A' ' 53' ' ' VAL . 77.1 m-85 -109.07 165.88 11.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.957 1.303 . . . . 73.439999999999998 110.341 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.32 142.15 28.1 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.698 -0.853 . . . . 75.120000000000005 108.698 175.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.613 0 C-N-CA 123.831 0.853 . . . . 75.019999999999996 111.98 -176.813 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 112.634 0.605 . . . . 74.450000000000003 112.634 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -87.87 -22.74 24.25 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 122.502 0.321 . . . . 75.310000000000002 110.727 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.61 -50.96 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.071 0.549 . . . . 74.310000000000002 110.426 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.477 HG13 HD12 ' B' ' 41' ' ' LEU . 26.8 m -61.02 -30.52 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 122.531 0.333 . . . . 65.129999999999995 111.471 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.15 -49.19 16.9 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 123.31 0.381 . . . . 74.239999999999995 113.317 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.32 -49.18 72.78 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.696 0.799 . . . . 74.409999999999997 111.78 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -58.89 -41.38 87.03 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.07 0.948 . . . . 74.329999999999998 111.92 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.477 ' HB3' ' HG ' ' B' ' 46' ' ' LEU . . . -66.48 -39.65 88.89 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.173 0.589 . . . . 75.120000000000005 111.952 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.91 -43.75 98.95 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 116.059 -0.519 . . . . 71.349999999999994 112.549 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -68.06 -42.96 79.7 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.978 0.911 . . . . 65.25 111.77 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.727 ' HA ' HG11 ' B' ' 32' ' ' VAL . 37.7 t -57.94 -44.18 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 124.117 0.967 . . . . 75.430000000000007 111.78 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 45.8 t90 -63.4 -33.42 75.52 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 115.221 -0.9 . . . . 75.430000000000007 112.194 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -61.09 -30.6 70.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.095 0.776 . . . . 73.439999999999998 113.095 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.33 65.88 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.341 0.497 . . . . 73.430000000000007 112.341 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.479 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 96.5 mt -70.55 -21.65 62.68 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.504 0.722 . . . . 73.5 112.619 174.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -64.78 -30.34 71.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.799 0.839 . . . . 74.299999999999997 111.891 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -91.55 -35.83 14.05 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.85 0.46 . . . . 74.219999999999999 111.168 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.43 112.23 1.09 Allowed 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.38 0.511 . . . . 74.120000000000005 112.38 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.498 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 9.4 p-10 -80.53 179.36 7.78 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.599 0.76 . . . . 71.299999999999997 110.704 166.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.46 61.14 4.95 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.611 -0.596 . . . . 75.219999999999999 111.611 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 tt -140.84 140.67 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.106 0.963 . . . . 75.340000000000003 110.03 -172.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 68.6 m -83.84 161.0 21.05 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.973 0.509 . . . . 63.530000000000001 110.885 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' A' ' 37' ' ' GLU . 58.8 mt -59.54 -44.92 98.62 Favored Pre-proline 0 CA--C 1.579 2.087 0 N-CA-C 113.9 1.074 . . . . 71.549999999999997 113.9 -174.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.88 -29.38 41.6 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 121.936 1.758 . . . . 51.399999999999999 114.237 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -71.7 -46.77 57.72 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.744 1.259 . . . . 72.340000000000003 109.654 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.468 HD22 HD11 ' B' ' 63' ' ' ILE . 65.3 tp -58.35 -43.62 88.4 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 112.946 -1.934 . . . . 52.5 111.681 173.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.68 91.21 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.497 1.119 . . . . 72.140000000000001 113.37 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -71.2 -23.58 62.06 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.073 0.549 . . . . 73.409999999999997 111.73 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -78.53 -44.6 23.92 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.772 0.829 . . . . 71.510000000000005 111.171 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.727 HG11 ' HA ' ' B' ' 13' ' ' VAL . 17.9 m -86.32 4.84 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.324 0.65 . . . . 75.430000000000007 112.414 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 65.34 17.75 11.1 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.815 1.246 . . . . 72.540000000000006 112.571 171.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 71.4 mt -109.72 158.32 18.22 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.468 0.707 . . . . 75.319999999999993 110.698 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -66.18 153.16 43.2 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.98 0.512 . . . . 72.239999999999995 111.168 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -53.6 -43.44 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 123.571 0.748 . . . . 74.400000000000006 111.964 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.99 -49.67 75.14 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.619 0.767 . . . . 74.230000000000004 112.037 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -61.33 -30.76 70.71 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.716 0.806 . . . . 65.430000000000007 112.236 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 87.4 m -77.44 -47.41 19.78 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.052 0.941 . . . . 63.509999999999998 111.304 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.453 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.62 -39.23 93.34 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.545 0.738 . . . . 71.140000000000001 111.99 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.477 HD12 HG13 ' B' ' 6' ' ' VAL . 1.3 tm? -62.41 -38.54 90.06 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.061 1.344 . . . . 75.340000000000003 110.431 174.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.52 -33.59 67.0 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.38 0.672 . . . . 71.150000000000006 111.914 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.71 -35.55 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.801 0.84 . . . . 72.129999999999995 111.482 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.08 -31.86 74.14 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 113.835 0.294 . . . . 73.5 113.835 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -75.04 -36.7 61.85 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.426 0.691 . . . . 74.010000000000005 111.499 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' B' ' 10' ' ' ALA . 83.2 mt -66.4 -35.1 79.48 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.03 0.532 . . . . 73.219999999999999 111.311 173.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.73 -35.81 75.32 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.309 1.044 . . . . 50.119999999999997 112.449 172.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.613 ' HD2' ' HB2' ' A' ' 48' ' ' ARG . 49.4 ttt85 -57.17 -45.88 83.28 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.333 0.587 . . . . 74.109999999999999 110.691 171.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.38 -15.29 57.17 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 114.794 -1.093 . . . . 73.430000000000007 112.191 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 t30 65.37 26.7 12.01 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.868 1.267 . . . . 72.420000000000002 111.125 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -82.71 -19.11 38.67 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.507 -0.77 . . . . 75.349999999999994 111.854 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 24.4 m -114.53 140.04 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.19 0.596 . . . . 74.219999999999999 110.455 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 51.7 t -103.71 96.82 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.367 -0.975 . . . . 75.109999999999999 108.367 174.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.622 HG12 HG22 ' B' ' 63' ' ' ILE . 57.0 mt -81.93 123.68 38.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 115.783 -0.644 . . . . 73.299999999999997 109.766 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . 0.488 ' HB3' ' HE2' ' B' ' 64' ' ' TYR . 13.6 tt0 -143.14 127.65 17.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.882 -0.599 . . . . 62.100000000000001 110.525 -172.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -83.77 103.82 13.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.397 0.679 . . . . 73.129999999999995 110.055 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -106.1 122.82 46.95 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.503 1.121 . . . . 71.109999999999999 111.15 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 59.22 31.03 20.88 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 125.162 1.385 . . . . 73.150000000000006 112.772 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.13 -27.87 6.52 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 115.988 -0.551 . . . . 73.319999999999993 113.66 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mp -81.56 165.15 21.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.762 0.825 . . . . 74.230000000000004 109.562 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.71 136.48 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.867 -0.521 . . . . 62.520000000000003 110.684 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -134.47 168.24 19.3 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.175 0.99 . . . . 73.099999999999994 110.851 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.622 HG22 HG12 ' B' ' 54' ' ' ILE . 0.2 OUTLIER -120.53 147.53 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.329 1.052 . . . . 72.209999999999994 110.313 171.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 93.6 m-85 -124.86 169.53 11.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.471 1.108 . . . . 74.299999999999997 110.405 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' B' ' 21' ' ' ASP . 4.4 m-20 -71.97 148.84 45.58 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.049 0.452 . . . . 73.340000000000003 111.844 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 CA--C 1.55 0.974 0 C-N-CA 124.297 1.039 . . . . 64.150000000000006 111.651 171.084 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 112.439 0.533 . . . . 75.040000000000006 112.439 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.1 mt -53.87 -47.54 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 123.853 0.861 . . . . 75.120000000000005 111.524 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.3 m -61.06 -29.29 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.967 1.307 . . . . 73.329999999999998 112.356 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.04 -41.71 70.23 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.679 0.612 . . . . 72.510000000000005 112.7 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.54 -43.03 98.28 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.315 0.646 . . . . 63.530000000000001 111.262 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -67.51 -35.03 78.32 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.693 0.797 . . . . 73.340000000000003 111.633 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HB1' ' HG ' ' A' ' 46' ' ' LEU . . . -72.16 -35.03 68.92 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.496 0.718 . . . . 61.149999999999999 111.699 -177.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.54 -35.96 92.53 Favored Glycine 0 CA--C 1.539 1.535 0 O-C-N 123.497 0.498 . . . . 74.450000000000003 112.631 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.455 ' HB2' ' HZ2' ' A' ' 12' ' ' LYS . 3.7 ttmp? -67.74 -48.94 65.04 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.093 0.957 . . . . 75.040000000000006 111.64 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.93 -34.74 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.263 0.625 . . . . 73.409999999999997 111.9 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -71.03 -33.93 70.79 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.745 0.818 . . . . 75.299999999999997 110.959 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -66.92 -29.24 69.06 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 71.150000000000006 111.227 172.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.23 -31.35 67.46 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.991 0.516 . . . . 74.150000000000006 111.843 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.503 HD11 HG13 ' A' ' 52' ' ' VAL . 98.1 mt -59.35 -39.32 82.81 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.142 0.977 . . . . 73.340000000000003 113.521 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -11.54 58.79 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 112.445 0.535 . . . . 72.299999999999997 112.445 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -103.61 -39.3 6.76 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.499 1.12 . . . . 61.420000000000002 110.004 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.53 91.67 2.68 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.684 0.794 . . . . 73.140000000000001 112.624 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -85.14 133.89 34.19 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.095 0.558 . . . . 63.549999999999997 110.298 167.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.37 61.79 2.89 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-O 121.155 0.308 . . . . 74.409999999999997 112.733 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.6 tt -126.78 145.34 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.505 0.722 . . . . 72.010000000000005 110.975 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.4 m -68.09 138.43 55.76 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.904 0.881 . . . . 75.120000000000005 110.62 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.709 HG23 ' HB2' ' A' ' 40' ' ' ALA . 76.2 mt -58.36 -42.27 93.84 Favored Pre-proline 0 CA--C 1.583 2.221 0 N-CA-C 114.059 1.133 . . . . 64.040000000000006 114.059 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.491 ' HA ' HG23 ' A' ' 36' ' ' VAL . 29.8 Cg_endo -61.99 -32.36 84.29 Favored 'Trans proline' 0 C--N 1.394 2.961 0 C-N-CA 121.93 1.753 . . . . 75.099999999999994 114.123 174.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.17 -45.2 50.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.711 1.243 . . . . 74.109999999999999 109.47 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.56 HD23 HD12 ' A' ' 63' ' ' ILE . 66.7 tp -57.14 -38.89 74.15 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 112.75 -2.023 . . . . 75.400000000000006 111.818 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.17 78.05 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.323 1.049 . . . . 74.310000000000002 112.566 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.25 -42.85 87.98 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.255 0.622 . . . . 74.129999999999995 111.379 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -75.46 -35.13 60.93 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 112.473 0.546 . . . . 73.540000000000006 112.473 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 m -81.64 -9.89 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-O 120.772 0.32 . . . . 74.25 111.122 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 63.23 25.86 14.94 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.498 1.519 . . . . 73.109999999999999 113.203 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.3 mt -105.17 171.63 7.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.313 1.045 . . . . 74.450000000000003 109.887 173.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.7 m -68.07 158.98 31.78 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 122.551 0.34 . . . . 63.340000000000003 110.762 170.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 26' ' ' PRO . 79.5 t -51.23 -57.06 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 123.286 0.634 . . . . 75.450000000000003 112.095 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.65 -31.23 71.78 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.147 0.795 . . . . 73.140000000000001 113.147 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -61.67 -44.61 96.63 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.579 0.704 . . . . 74.530000000000001 110.881 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 43' ' ' VAL . 78.4 m -70.23 -41.57 73.42 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.629 -1.168 . . . . 73.129999999999995 111.385 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.709 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -67.5 -41.74 84.02 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.957 0.903 . . . . 64.349999999999994 112.071 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.06 -27.69 64.84 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.237 1.015 . . . . 75.010000000000005 110.518 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.85 -38.06 73.14 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.845 0.458 . . . . 70.530000000000001 111.261 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.52 HG11 HG21 ' A' ' 63' ' ' ILE . 90.3 t -61.88 -33.87 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.33 0.652 . . . . 75.329999999999998 110.089 169.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.48 90.17 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 115.918 -0.583 . . . . 73.340000000000003 113.802 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -67.92 -41.73 82.15 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.111 0.455 . . . . 74.010000000000005 110.229 173.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.405 ' HG ' ' HB1' ' A' ' 10' ' ' ALA . 97.3 mt -60.38 -38.21 83.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.051 0.541 . . . . 74.340000000000003 110.927 173.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.84 96.49 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.628 0.771 . . . . 62.340000000000003 111.522 175.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 -56.8 -45.01 82.48 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.88 0.472 . . . . 74.420000000000002 111.114 171.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.89 -6.03 56.65 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.217 0.821 . . . . 75.329999999999998 113.217 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 68.53 30.81 5.05 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.115 1.366 . . . . 74.219999999999999 112.417 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -95.78 -13.83 23.79 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.945 1.298 . . . . 73.109999999999999 113.597 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.503 HG13 HD11 ' A' ' 17' ' ' LEU . 8.0 m -120.93 141.39 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.252 0.549 . . . . 75.310000000000002 112.263 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 94.7 t -107.63 107.09 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 124.271 1.028 . . . . 72.540000000000006 109.815 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.556 HG13 HG23 ' A' ' 63' ' ' ILE . 2.9 mp -86.62 124.84 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 123.231 0.612 . . . . 63.240000000000002 110.001 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.23 116.0 13.06 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.755 0.822 . . . . 72.109999999999999 109.333 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -80.77 102.61 10.08 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.167 0.587 . . . . 73.150000000000006 110.029 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -112.74 124.98 53.81 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.481 0.712 . . . . 72.439999999999998 110.298 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 58.44 31.35 20.86 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.164 0.986 . . . . 74.519999999999996 112.112 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.06 -25.16 7.97 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 116.055 -0.521 . . . . 71.420000000000002 114.023 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.8 mt -79.14 146.22 33.28 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.905 0.882 . . . . 74.519999999999996 112.077 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.12 107.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.185 -0.672 . . . . 74.230000000000004 109.185 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.25 120.15 41.1 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.204 0.602 . . . . 74.209999999999994 109.725 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.56 HD12 HD23 ' A' ' 28' ' ' LEU . 2.7 pp -101.09 138.35 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.45 0.643 . . . . 71.120000000000005 111.032 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 93.5 m-85 -122.52 174.5 7.02 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.437 1.095 . . . . 75.420000000000002 110.19 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 63.6 t30 -90.64 158.28 17.02 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.91 0.484 . . . . 74.010000000000005 111.402 174.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.554 1.114 0 C-N-CA 123.992 0.917 . . . . 75.349999999999994 112.179 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 71.9 tttt . . . . . 0 CA--C 1.56 1.333 0 CA-C-O 120.641 0.258 . . . . 72.239999999999995 110.809 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -56.0 -24.35 38.4 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 124.37 1.068 . . . . 73.420000000000002 112.968 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 69.6 mt -55.63 -44.01 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 123.994 0.918 . . . . 71.430000000000007 111.322 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.71 -30.17 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 122.67 0.388 . . . . 75.109999999999999 111.461 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.32 92.15 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.485 0.491 . . . . 71.129999999999995 113.403 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.2 -38.11 87.2 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.641 0.776 . . . . 73.510000000000005 111.83 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -79.75 -19.62 48.27 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.159 0.583 . . . . 74.099999999999994 112.089 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.63 -39.5 52.16 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.305 0.642 . . . . 74.340000000000003 110.995 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.17 -30.92 75.09 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.435 -0.802 . . . . 75.439999999999998 112.472 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.608 ' HZ3' ' HB2' ' B' ' 12' ' ' LYS . 4.7 ttmp? -70.72 -49.32 48.24 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.054 0.942 . . . . 73.230000000000004 112.374 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.54 HG12 HD11 ' B' ' 46' ' ' LEU . 2.5 p -66.2 -36.01 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 112.158 0.429 . . . . 70.010000000000005 112.158 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.447 ' HA ' HD11 ' B' ' 17' ' ' LEU . 26.0 t90 -73.17 -32.21 64.71 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.991 -0.443 . . . . 74.349999999999994 111.132 176.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -62.47 -36.32 82.1 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.213 0.605 . . . . 73.519999999999996 110.524 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.63 -32.73 74.47 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.469 -0.787 . . . . 73.450000000000003 111.932 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.478 HD22 HD12 ' B' ' 63' ' ' ILE . 84.8 mt -69.16 -44.38 72.37 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.763 0.825 . . . . 75.129999999999995 111.777 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -56.77 -39.87 74.82 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.933 0.893 . . . . 73.340000000000003 111.79 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -74.02 -50.36 20.11 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.49 0.716 . . . . 71.140000000000001 110.817 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.83 102.91 0.9 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.828 0.851 . . . . 72.420000000000002 110.757 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.2 173.94 10.61 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.802 0.441 . . . . 63.229999999999997 111.47 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.99 65.25 1.77 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.559 -0.291 . . . . 51.439999999999998 112.554 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 tt -151.01 144.93 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.305 0.642 . . . . 72.439999999999998 110.389 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 31.4 t -70.82 150.29 45.97 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.188 0.595 . . . . 64.519999999999996 111.138 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.572 HG22 ' HB3' ' B' ' 40' ' ' ALA . 82.4 mt -58.39 -51.02 84.8 Favored Pre-proline 0 CA--C 1.576 1.959 0 CA-C-O 118.177 -0.916 . . . . 72.450000000000003 113.408 -176.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.449 ' HA ' HG23 ' B' ' 36' ' ' VAL . 20.3 Cg_endo -59.23 -34.77 98.24 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.233 1.956 . . . . 75.519999999999996 113.438 176.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -66.05 -50.92 62.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.326 0.65 . . . . 75.530000000000001 112.226 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.608 HD21 HD11 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -69.9 -32.55 70.94 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.714 0.406 . . . . 72.230000000000004 110.838 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.68 -41.63 77.64 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.887 0.875 . . . . 73.129999999999995 111.637 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -60.11 -40.19 88.83 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.092 0.957 . . . . 74.409999999999997 111.26 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -75.38 -33.13 61.0 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.964 0.906 . . . . 75.340000000000003 112.791 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.4 m -96.57 5.25 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 123.584 0.754 . . . . 72.340000000000003 111.897 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 t30 68.93 10.92 8.17 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 125.212 1.405 . . . . 73.140000000000001 112.642 173.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' B' ' 12' ' ' LYS . 54.0 mt -94.57 155.31 16.96 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.662 -0.649 . . . . 74.340000000000003 110.607 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 47.6 m -67.79 152.45 45.56 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.42 0.288 . . . . 74.319999999999993 110.499 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' B' ' 26' ' ' PRO . 64.1 t -51.69 -44.2 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.401 0.681 . . . . 74.239999999999995 111.329 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.96 -47.91 83.41 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 114.918 -1.037 . . . . 73.140000000000001 112.242 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -58.97 -41.37 87.39 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.975 0.91 . . . . 74.329999999999998 112.769 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 95.5 m -72.65 -46.68 52.74 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.332 0.653 . . . . 75.409999999999997 111.907 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' B' ' 25' ' ' ILE . . . -64.89 -48.61 73.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.0 1.111 . . . . 73.140000000000001 114.0 -168.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -26.53 62.38 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 120.796 0.332 . . . . 73.430000000000007 110.93 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.43 -26.33 65.47 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.697 0.799 . . . . 75.140000000000001 111.99 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.69 -31.65 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 123.005 0.522 . . . . 74.209999999999994 110.991 169.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.27 -28.36 73.65 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.308 -0.405 . . . . 73.120000000000005 113.99 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.543 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 66.0 t-105 -72.11 -27.52 62.69 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.143 0.577 . . . . 74.319999999999993 111.034 172.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.54 HD11 HG12 ' B' ' 13' ' ' VAL . 73.6 mt -73.22 -36.12 66.41 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.751 -0.593 . . . . 73.030000000000001 110.715 169.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.39 -26.88 68.65 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.46 1.104 . . . . 62.409999999999997 113.818 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 12.9 ptt180 -62.1 -35.85 79.94 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 118.817 0.735 . . . . 74.310000000000002 110.288 172.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 32.6 mt-10 -93.98 -6.27 45.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.819 1.248 . . . . 73.530000000000001 111.687 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 t30 63.08 31.21 16.02 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.841 1.256 . . . . 72.019999999999996 111.56 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -85.68 -6.5 59.13 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.865 0.691 . . . . 72.420000000000002 112.865 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.88 145.81 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.405 0.622 . . . . 72.329999999999998 112.356 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' B' ' 64' ' ' TYR . 4.8 m -120.08 128.61 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.048 1.339 . . . . 71.340000000000003 108.304 167.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.442 HG12 HG23 ' B' ' 63' ' ' ILE . 68.2 mt -109.29 137.82 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.928 0.491 . . . . 71.0 110.754 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -134.99 125.82 27.35 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.707 0.803 . . . . 74.400000000000006 109.565 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -108.01 115.5 30.25 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.493 0.663 . . . . 74.540000000000006 110.606 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.64 126.84 55.71 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.84 1.256 . . . . 74.439999999999998 109.173 -175.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 59.84 29.11 18.68 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.37 1.068 . . . . 71.230000000000004 111.525 -175.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.6 -19.1 16.18 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-N 116.343 -0.39 . . . . 65.049999999999997 113.808 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 tp -78.4 112.01 14.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.062 0.945 . . . . 73.430000000000007 110.455 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 mt -83.44 125.14 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 122.512 0.325 . . . . 74.120000000000005 110.848 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -127.42 145.75 50.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.703 0.801 . . . . 74.510000000000005 109.902 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.608 HD11 HD21 ' B' ' 28' ' ' LEU . 2.2 pp -105.83 141.25 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-O 121.552 0.691 . . . . 73.0 111.63 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.456 ' HB2' HG23 ' B' ' 53' ' ' VAL . 73.2 m-85 -132.13 157.14 45.01 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.502 1.121 . . . . 74.430000000000007 109.228 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -102.98 153.55 20.12 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.051 0.54 . . . . 60.340000000000003 110.421 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 112.224 0.453 . . . . 73.129999999999995 112.224 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 112.885 0.698 . . . . 73.010000000000005 112.885 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.4 mt -60.07 -42.74 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.264 0.626 . . . . 74.540000000000006 111.782 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.594 HG13 HD12 ' A' ' 41' ' ' LEU . 34.5 m -59.42 -33.6 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 111.77 0.285 . . . . 71.530000000000001 111.77 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.75 -39.53 93.62 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 123.213 0.321 . . . . 70.430000000000007 112.986 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.87 -50.51 62.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.254 0.622 . . . . 73.430000000000007 111.828 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -70.6 -31.96 69.14 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.352 0.661 . . . . 74.430000000000007 112.351 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.43 -33.24 60.9 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.856 0.462 . . . . 74.340000000000003 111.625 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.65 -31.35 79.68 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.922 -0.581 . . . . 74.400000000000006 113.265 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -75.25 -36.72 61.24 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.566 0.747 . . . . 75.420000000000002 111.549 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.8 t -63.29 -41.13 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.369 0.604 . . . . 74.040000000000006 110.92 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.411 ' CD1' ' HB3' ' A' ' 51' ' ' LYS . 77.6 t90 -72.26 -32.31 66.54 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.671 0.788 . . . . 73.230000000000004 111.54 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -61.79 -34.87 76.67 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.161 0.584 . . . . 75.420000000000002 110.679 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.99 -33.93 76.95 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.166 0.586 . . . . 73.129999999999995 111.753 174.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.404 HD13 HG13 ' A' ' 52' ' ' VAL . 92.2 mt -63.62 -27.34 69.17 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.635 0.774 . . . . 74.340000000000003 111.897 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.14 -35.04 77.46 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.299 0.64 . . . . 74.120000000000005 111.651 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -106.72 -65.84 1.06 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.528 0.731 . . . . 73.519999999999996 111.786 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . . . -127.53 84.54 2.26 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.452 0.644 . . . . 73.120000000000005 111.245 -175.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.73 -179.08 5.93 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.514 1.126 . . . . 74.439999999999998 112.972 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.17 52.36 48.01 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 115.698 -0.683 . . . . 74.219999999999999 113.247 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.407 HD13 ' HD2' ' A' ' 31' ' ' LYS . 13.7 tt -140.15 125.31 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.451 0.7 . . . . 75.209999999999994 110.719 -175.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.4 m -50.49 149.41 3.16 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.1 1.36 . . . . 72.519999999999996 113.31 -170.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 40' ' ' ALA . 80.6 mt -47.62 -48.89 58.22 Favored Pre-proline 0 CA--C 1.576 1.946 0 C-N-CA 124.414 1.086 . . . . 74.200000000000003 113.928 -172.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.495 ' HA ' HG23 ' A' ' 36' ' ' VAL . 48.7 Cg_endo -65.79 -37.6 27.11 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 121.847 1.698 . . . . 73.140000000000001 113.702 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -70.01 -46.92 64.09 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.46 1.124 . . . . 72.319999999999993 110.139 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.55 HD23 HG23 ' A' ' 63' ' ' ILE . 54.9 tp -57.61 -34.36 69.19 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 113.28 -1.782 . . . . 74.099999999999994 112.216 170.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 -38.12 82.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.031 0.532 . . . . 74.049999999999997 111.703 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -28.04 63.34 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 111.895 0.332 . . . . 74.439999999999998 111.895 173.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.466 ' HE2' ' HB3' ' A' ' 20' ' ' ALA . 26.8 mtpp -68.21 -45.87 72.16 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.016 0.436 . . . . 72.349999999999994 111.644 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.8 m -86.61 -1.91 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.178 0.591 . . . . 75.120000000000005 111.707 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.9 t30 65.92 27.07 10.93 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.147 1.379 . . . . 75.329999999999998 111.767 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.6 mt -114.99 173.05 6.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.098 0.959 . . . . 74.209999999999994 111.759 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 t -68.12 155.6 39.25 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.324 0.65 . . . . 63.030000000000001 111.869 170.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 26' ' ' PRO . 62.2 t -55.44 -41.42 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.484 0.714 . . . . 74.099999999999994 110.641 172.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.17 -49.0 79.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.66 -1.155 . . . . 63.539999999999999 111.427 176.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.8 m -58.18 -43.39 87.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.107 0.963 . . . . 72.409999999999997 111.464 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 43' ' ' VAL . 85.4 m -69.72 -48.06 60.88 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.104 -0.953 . . . . 73.219999999999999 111.811 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.439 ' HB2' HG22 ' A' ' 25' ' ' ILE . . . -62.09 -38.77 90.12 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 123.459 0.703 . . . . 72.230000000000004 112.32 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.594 HD12 HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -66.85 -40.83 88.05 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.798 1.239 . . . . 75.540000000000006 110.213 174.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.65 -34.73 74.41 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.488 0.715 . . . . 72.5 112.2 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 39' ' ' THR . 81.0 t -67.0 -32.95 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.56 0.744 . . . . 73.120000000000005 110.405 173.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.603 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -66.97 -33.34 83.57 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.141 -0.482 . . . . 70.0 113.316 173.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -69.35 -38.18 78.0 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.876 0.471 . . . . 63.420000000000002 110.644 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 51' ' ' LYS . 76.5 mt -67.57 -30.52 70.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.819 0.448 . . . . 72.450000000000003 111.437 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.29 75.35 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.309 0.643 . . . . 73.209999999999994 112.133 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -62.36 -49.64 74.77 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 122.886 0.474 . . . . 74.349999999999994 110.953 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -80.05 -8.86 59.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.513 -0.767 . . . . 74.209999999999994 111.547 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 63.42 27.04 15.13 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.9 1.28 . . . . 64.430000000000007 111.911 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 39.9 mmtm -69.86 -17.92 63.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.527 1.131 . . . . 71.310000000000002 112.308 175.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.404 HG13 HD13 ' A' ' 17' ' ' LEU . 34.6 m -129.24 154.48 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.145 0.578 . . . . 72.219999999999999 112.387 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 64' ' ' TYR . 34.9 m -120.77 132.27 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.494 0.718 . . . . 75.420000000000002 109.077 165.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 mm -110.45 123.63 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.206 0.602 . . . . 75.349999999999994 111.412 -173.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 49.5 mt-10 -106.16 155.62 19.27 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.166 0.586 . . . . 74.209999999999994 111.367 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.21 94.04 4.78 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.817 -1.549 . . . . 74.519999999999996 106.817 160.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.86 111.7 24.46 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.718 0.807 . . . . 75.329999999999998 108.886 -173.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 60.35 30.35 19.75 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.285 1.034 . . . . 74.129999999999995 110.114 -161.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.6 -12.98 25.26 Favored Glycine 0 C--N 1.36 1.904 0 CA-C-N 115.506 -0.77 . . . . 62.43 114.422 -173.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.79 117.48 19.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.299 0.64 . . . . 73.329999999999998 111.269 -177.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 67.1 mt -69.21 116.05 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.791 0.836 . . . . 75.450000000000003 111.254 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -126.01 140.49 52.56 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.891 0.876 . . . . 74.409999999999997 110.983 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.55 HG23 HD23 ' A' ' 28' ' ' LEU . 7.2 tt -92.74 133.17 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 124.235 1.014 . . . . 74.439999999999998 111.017 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.414 ' HB2' HG23 ' A' ' 53' ' ' VAL . 73.0 m-85 -131.63 173.22 11.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.492 1.117 . . . . 75.340000000000003 110.323 173.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -73.62 150.5 41.33 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.346 0.658 . . . . 72.439999999999998 111.196 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.484 1.271 0 C-N-CA 124.843 1.257 . . . . 64.400000000000006 113.607 171.704 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.556 1.201 0 N-CA-C 112.965 0.728 . . . . 64.030000000000001 112.965 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -84.05 -44.29 14.25 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.473 0.709 . . . . 74.400000000000006 111.034 173.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.66 -45.56 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.815 0.846 . . . . 74.140000000000001 111.93 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.505 HG11 HD12 ' B' ' 41' ' ' LEU . 34.8 m -61.28 -32.16 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.753 0.821 . . . . 74.230000000000004 112.157 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.83 62.26 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.27 0.356 . . . . 74.209999999999994 112.647 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.74 -45.78 88.34 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.589 0.756 . . . . 75.239999999999995 111.883 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -64.67 -41.08 96.32 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.773 0.829 . . . . 72.439999999999998 111.799 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.95 -31.3 70.08 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.885 0.474 . . . . 72.209999999999994 111.646 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.59 -38.38 96.2 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.847 -0.615 . . . . 72.349999999999994 112.882 174.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -75.1 -36.65 61.67 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.71 0.804 . . . . 71.310000000000002 111.434 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.565 ' HA ' HG13 ' B' ' 32' ' ' VAL . 92.7 t -67.63 -42.71 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.135 0.574 . . . . 63.450000000000003 111.368 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.471 ' HA ' HD11 ' B' ' 17' ' ' LEU . 19.5 t90 -68.56 -33.23 73.72 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.984 -0.553 . . . . 75.140000000000001 110.521 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . 0.401 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 66.3 t60 -62.34 -31.41 72.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.715 0.806 . . . . 72.5 111.638 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.43 67.31 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.706 0.402 . . . . 54.310000000000002 111.868 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.471 HD11 ' HA ' ' B' ' 14' ' ' TRP . 98.5 mt -64.14 -45.04 90.29 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.838 0.855 . . . . 73.329999999999998 113.137 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -12.77 61.88 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 111.733 0.272 . . . . 62.350000000000001 111.733 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 20.4 mm-40 -81.08 -57.71 3.4 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.398 0.679 . . . . 74.310000000000002 109.753 171.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.16 105.15 3.19 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.5 0.72 . . . . 73.140000000000001 110.756 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.95 168.56 14.06 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.723 0.809 . . . . 64.439999999999998 111.458 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.26 64.98 2.09 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 112.477 -0.249 . . . . 71.319999999999993 112.477 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.439 ' O ' HG22 ' B' ' 63' ' ' ILE . 18.1 tt -146.32 156.22 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 C-N-CA 123.663 0.785 . . . . 72.219999999999999 110.303 -175.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -81.18 156.64 25.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.806 -0.559 . . . . 74.510000000000005 111.547 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.543 HG22 ' HB1' ' B' ' 40' ' ' ALA . 59.8 mt -58.84 -48.37 96.93 Favored Pre-proline 0 CA--C 1.577 1.994 0 N-CA-C 113.598 0.962 . . . . 75.040000000000006 113.598 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.495 ' HA ' HG21 ' B' ' 36' ' ' VAL . 55.1 Cg_endo -66.41 -23.9 50.44 Favored 'Trans proline' 0 C--N 1.395 3.001 0 CA-C-N 121.951 1.733 . . . . 71.329999999999998 114.138 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.19 -46.36 18.06 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.015 0.912 . . . . 64.209999999999994 109.608 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.557 HD23 HG23 ' B' ' 63' ' ' ILE . 59.0 tp -58.23 -34.45 70.45 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 113.735 -1.575 . . . . 74.420000000000002 111.681 173.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.15 85.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.951 0.9 . . . . 65.219999999999999 111.898 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -69.33 -40.33 77.65 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.603 0.761 . . . . 75.010000000000005 110.349 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -62.34 -35.69 79.88 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.568 0.747 . . . . 72.400000000000006 111.741 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' B' ' 13' ' ' VAL . 19.6 m -97.52 -1.24 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.074 0.55 . . . . 72.420000000000002 112.457 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 69.38 11.12 8.02 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.853 1.261 . . . . 74.329999999999998 112.575 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt -101.37 171.15 7.76 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.421 0.688 . . . . 75.239999999999995 111.351 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 29.7 t -66.07 154.23 40.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.909 0.484 . . . . 60.520000000000003 111.144 169.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' B' ' 26' ' ' PRO . 55.0 t -56.84 -40.16 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.247 0.619 . . . . 73.129999999999995 111.096 177.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.08 -43.79 77.76 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.404 -0.816 . . . . 74.310000000000002 111.839 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -61.04 -32.29 71.91 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.464 0.706 . . . . 74.409999999999997 111.798 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.429 ' O ' HG22 ' B' ' 43' ' ' VAL . 74.5 m -80.74 -47.86 13.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.078 0.951 . . . . 73.0 111.496 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.543 ' HB1' HG22 ' B' ' 25' ' ' ILE . . . -64.1 -40.2 95.7 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.603 0.761 . . . . 75.310000000000002 112.41 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.505 HD12 HG11 ' B' ' 6' ' ' VAL . 1.1 tm? -64.2 -34.95 79.27 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 124.813 1.245 . . . . 64.010000000000005 110.368 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.0 -33.52 61.84 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.617 0.767 . . . . 71.120000000000005 112.11 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.429 HG22 ' O ' ' B' ' 39' ' ' THR . 54.3 t -62.53 -37.56 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.784 0.834 . . . . 72.319999999999993 110.361 172.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.603 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -64.38 -30.42 77.81 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-N 116.057 -0.519 . . . . 70.129999999999995 113.63 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.469 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 67.3 t-105 -74.1 -31.3 62.73 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.805 0.442 . . . . 74.310000000000002 111.304 175.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 96.2 mt -72.18 -38.19 69.14 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.813 0.445 . . . . 73.329999999999998 110.808 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.32 -28.82 69.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.094 0.958 . . . . 74.420000000000002 112.049 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 26.2 ttt-85 -53.34 -49.47 67.04 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.652 0.781 . . . . 75.129999999999995 110.841 168.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -94.46 6.15 49.64 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.903 0.881 . . . . 65.239999999999995 112.739 -175.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.38 23.8 14.13 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 124.66 1.184 . . . . 75.540000000000006 113.255 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -80.35 -0.67 37.86 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.17 0.804 . . . . 72.439999999999998 113.17 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.05 147.99 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.667 0.787 . . . . 72.510000000000005 111.739 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.745 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 39.0 t -106.77 118.99 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.567 0.747 . . . . 71.129999999999995 109.007 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 46.6 mm -113.59 130.79 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 123.129 0.572 . . . . 70.129999999999995 111.296 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -133.79 132.68 40.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.621 0.768 . . . . 74.340000000000003 111.06 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -88.04 103.91 16.16 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.253 0.621 . . . . 73.019999999999996 110.976 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -110.38 112.49 24.46 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.356 1.062 . . . . 75.219999999999999 110.006 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 62.03 30.4 17.92 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.921 1.289 . . . . 74.549999999999997 112.523 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.82 -15.59 60.28 Favored Glycine 0 CA--C 1.543 1.841 0 CA-C-N 116.458 -0.337 . . . . 75.519999999999996 113.717 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 mp -93.37 147.02 23.3 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.998 0.919 . . . . 74.25 111.059 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mm -82.64 126.96 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.164 0.586 . . . . 74.349999999999994 111.394 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -110.5 122.44 47.74 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.21 1.004 . . . . 65.239999999999995 109.459 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.557 HG23 HD23 ' B' ' 28' ' ' LEU . 10.2 tt -108.49 139.01 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.408 0.623 . . . . 74.310000000000002 111.829 -175.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.745 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 90.9 m-85 -128.53 170.41 13.23 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.459 1.104 . . . . 74.420000000000002 110.523 176.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -91.04 162.4 14.72 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.552 0.741 . . . . 73.129999999999995 110.226 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.569 1.674 0 C-N-CA 122.837 0.455 . . . . 73.409999999999997 111.469 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 111.747 0.277 . . . . 74.109999999999999 111.747 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.07 -50.93 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.539 0.736 . . . . 72.319999999999993 111.117 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.412 HG12 HD12 ' A' ' 41' ' ' LEU . 6.3 m -73.66 -27.71 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.787 1.235 . . . . 71.340000000000003 111.418 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.39 -35.67 87.75 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 112.421 -0.272 . . . . 64.209999999999994 112.421 171.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.79 -56.16 5.32 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.564 0.746 . . . . 63.25 111.954 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -71.12 -22.76 62.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.951 0.723 . . . . 73.25 112.951 -173.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HA ' HG21 ' A' ' 13' ' ' VAL . . . -67.14 -26.68 66.79 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.623 0.369 . . . . 64.219999999999999 111.12 174.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.67 -36.19 92.03 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.11 -0.496 . . . . 72.430000000000007 112.861 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -76.86 -41.99 41.78 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.564 0.746 . . . . 73.519999999999996 112.303 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.604 HG21 ' HA ' ' A' ' 10' ' ' ALA . 12.4 m -69.83 -34.93 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 122.141 -0.349 . . . . 74.129999999999995 110.82 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -71.67 -32.62 68.07 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.238 0.615 . . . . 74.129999999999995 111.083 172.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -61.54 -46.42 89.99 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.706 0.403 . . . . 74.129999999999995 110.967 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . . . -66.74 -34.58 78.16 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.913 0.885 . . . . 74.239999999999995 111.46 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.37 -45.45 72.75 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.609 1.164 . . . . 73.519999999999996 111.299 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -75.53 -25.76 57.47 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.358 0.663 . . . . 74.109999999999999 110.703 -175.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -71.25 -41.3 70.28 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.029 0.932 . . . . 74.230000000000004 110.283 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.9 107.03 2.28 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.657 0.783 . . . . 73.349999999999994 110.261 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.13 179.32 5.11 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.683 0.793 . . . . 71.349999999999994 112.363 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.51 56.43 7.58 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 111.956 -0.458 . . . . 45.130000000000003 111.956 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.476 HG13 ' HB2' ' A' ' 28' ' ' LEU . 9.4 tp -130.3 125.54 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 123.359 0.664 . . . . 73.439999999999998 110.768 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -80.57 153.59 27.97 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.215 0.606 . . . . 74.430000000000007 111.117 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 40' ' ' ALA . 62.5 mt -52.06 -53.3 53.37 Favored Pre-proline 0 CA--C 1.577 2.003 0 N-CA-C 114.324 1.231 . . . . 70.439999999999998 114.324 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.12 -21.88 23.28 Favored 'Trans proline' 0 C--N 1.39 2.753 0 CA-C-N 121.197 1.463 . . . . 74.230000000000004 114.179 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -78.59 -44.7 23.42 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 122.107 0.956 . . . . 74.319999999999993 109.326 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.476 ' HB2' HG13 ' A' ' 23' ' ' ILE . 50.3 tp -57.2 -37.48 72.24 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 113.524 -1.671 . . . . 73.219999999999999 111.149 172.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.56 -39.79 85.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.991 0.916 . . . . 62.210000000000001 112.005 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -73.21 -34.21 65.81 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.316 0.646 . . . . 75.239999999999995 111.48 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.52 ' HE2' ' HB3' ' A' ' 16' ' ' ALA . 55.5 mtpt -62.87 -44.11 96.99 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.323 0.649 . . . . 74.140000000000001 111.182 175.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 13' ' ' VAL . 19.2 m -93.05 -4.02 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.592 0.757 . . . . 72.109999999999999 112.315 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 68.67 13.89 8.95 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.272 1.429 . . . . 74.319999999999993 113.532 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 73.1 mt -95.9 170.65 9.15 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.377 0.671 . . . . 74.340000000000003 111.228 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -67.1 150.74 48.75 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.212 0.605 . . . . 74.200000000000003 111.538 170.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.8 t -56.11 -43.63 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.597 0.759 . . . . 75.409999999999997 111.14 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -60.74 -45.62 93.61 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.388 -0.824 . . . . 72.430000000000007 112.0 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.5 m -65.98 -30.79 71.4 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.453 0.701 . . . . 74.420000000000002 112.009 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -80.17 -39.26 29.65 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.474 0.71 . . . . 74.030000000000001 111.654 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.46 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -64.75 -38.74 92.0 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.67 0.748 . . . . 75.219999999999999 111.076 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 HG12 ' A' ' 6' ' ' VAL . 1.2 tm? -69.82 -38.01 76.42 Favored 'General case' 0 CA--C 1.562 1.44 0 CA-C-N 114.184 -1.371 . . . . 74.099999999999994 110.743 175.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.59 -39.62 84.81 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 122.995 0.518 . . . . 74.420000000000002 111.655 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.2 -38.51 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.905 0.882 . . . . 72.310000000000002 111.176 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.36 -33.0 86.08 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.365 -0.38 . . . . 75.25 112.823 174.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.428 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 74.1 t-105 -69.4 -40.53 77.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.548 0.739 . . . . 74.299999999999997 110.352 174.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.71 -32.92 74.54 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.948 0.499 . . . . 73.349999999999994 111.796 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.6 89.5 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.387 0.675 . . . . 63.32 110.968 171.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 12.4 ttt180 -59.69 -50.18 74.87 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.078 0.551 . . . . 74.409999999999997 111.216 168.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 45' ' ' TRP . 8.7 mm-40 -76.13 -1.43 26.14 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.917 0.887 . . . . 71.430000000000007 112.706 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.12 33.77 19.29 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.86 1.264 . . . . 73.219999999999999 112.526 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -93.28 -23.21 18.58 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.106 0.962 . . . . 73.109999999999999 112.25 177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.09 157.2 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 113.416 0.895 . . . . 64.450000000000003 113.416 -173.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 64' ' ' TYR . 2.3 m -133.4 144.21 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.162 1.385 . . . . 74.340000000000003 110.123 175.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.701 HG12 HD11 ' B' ' 41' ' ' LEU . 2.6 mp -108.82 128.3 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.609 0.763 . . . . 75.25 111.067 -171.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -115.21 119.09 35.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.457 1.103 . . . . 72.230000000000004 109.833 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.38 125.72 46.67 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.104 0.478 . . . . 74.409999999999997 111.156 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.87 131.11 13.6 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.979 0.912 . . . . 72.329999999999998 109.951 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 60.3 28.51 18.12 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.781 1.232 . . . . 75.430000000000007 111.802 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.49 -8.26 62.33 Favored Glycine 0 CA--C 1.544 1.844 0 N-CA-C 113.87 0.308 . . . . 71.219999999999999 113.87 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.38 160.91 14.05 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.95 0.9 . . . . 75.209999999999994 111.358 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.636 HG21 HG23 ' A' ' 54' ' ' ILE . 78.9 mt -112.64 127.96 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.866 0.866 . . . . 73.430000000000007 110.705 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -112.57 140.97 46.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.999 0.92 . . . . 74.530000000000001 109.544 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.85 133.76 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.018 0.927 . . . . 75.430000000000007 108.726 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.456 ' HB2' HG21 ' A' ' 53' ' ' VAL . 88.6 m-85 -129.91 169.31 15.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.91 1.284 . . . . 75.409999999999997 109.84 177.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -85.97 138.22 32.15 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.143 0.577 . . . . 65.219999999999999 110.311 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 CA--C 1.566 1.573 0 CA-C-O 121.457 0.646 . . . . 74.030000000000001 112.125 179.603 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.409 ' O ' HG23 ' B' ' 6' ' ' VAL . 87.7 tttt . . . . . 0 CA--C 1.565 1.548 0 CA-C-O 121.384 0.612 . . . . 65.0 110.679 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.36 -26.99 65.86 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.071 0.948 . . . . 75.239999999999995 111.935 173.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.11 -43.18 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.525 0.73 . . . . 72.340000000000003 111.712 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 3' ' ' LYS . 25.5 m -65.36 -28.91 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-N 117.641 0.201 . . . . 64.420000000000002 111.319 176.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' B' ' 45' ' ' TRP . . . -67.74 -46.36 68.64 Favored Glycine 0 C--N 1.354 1.534 0 O-C-N 123.519 0.512 . . . . 72.430000000000007 113.7 175.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.48 99.12 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.646 0.778 . . . . 63.539999999999999 111.162 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -70.34 -30.58 67.57 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.944 0.898 . . . . 64.049999999999997 112.238 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.7 66.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.066 0.546 . . . . 74.519999999999996 111.371 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.81 -36.23 93.07 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 116.006 -0.543 . . . . 63.509999999999998 112.839 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -70.11 -43.32 71.26 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.315 1.046 . . . . 75.409999999999997 111.155 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.598 ' HA ' HG13 ' B' ' 32' ' ' VAL . 42.9 t -60.48 -46.37 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 124.257 1.023 . . . . 72.329999999999998 111.727 176.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.562 ' HA ' HD11 ' B' ' 17' ' ' LEU . 66.8 t90 -66.97 -33.61 75.95 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.851 -0.613 . . . . 64.209999999999994 112.056 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -64.38 -35.15 79.97 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.812 0.445 . . . . 63.149999999999999 110.645 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.499 ' HB3' ' HE3' ' B' ' 31' ' ' LYS . . . -72.02 -23.87 61.46 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.663 0.785 . . . . 74.340000000000003 112.833 174.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' B' ' 14' ' ' TRP . 84.9 mt -70.2 -47.08 63.09 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.57 0.748 . . . . 74.349999999999994 110.692 169.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.87 -28.29 67.41 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.554 0.742 . . . . 70.099999999999994 111.305 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -72.22 -51.43 21.09 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.048 0.939 . . . . 75.120000000000005 110.396 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.47 118.37 2.21 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.079 0.551 . . . . 75.519999999999996 112.127 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -82.72 -178.06 6.95 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.301 1.04 . . . . 64.310000000000002 112.04 172.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.07 26.16 73.03 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.823 -0.626 . . . . 71.530000000000001 112.242 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 tp -106.76 146.4 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 124.042 0.937 . . . . 73.129999999999995 109.715 -173.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -95.0 162.37 13.76 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.31 0.644 . . . . 63.530000000000001 109.922 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' B' ' 40' ' ' ALA . 76.4 mt -56.35 -49.1 95.34 Favored Pre-proline 0 CA--C 1.58 2.118 0 N-CA-C 114.025 1.12 . . . . 70.209999999999994 114.025 -173.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.69 -30.31 42.01 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.027 1.818 . . . . 73.219999999999999 114.106 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -79.12 -42.35 26.47 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.203 1.001 . . . . 75.329999999999998 110.442 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.44 HD22 HG13 ' B' ' 13' ' ' VAL . 65.7 tp -58.04 -40.66 81.49 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.625 -1.625 . . . . 70.319999999999993 111.112 170.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.24 78.61 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.928 0.891 . . . . 72.150000000000006 111.83 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -67.03 -37.62 84.44 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.166 0.587 . . . . 74.430000000000007 111.51 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' B' ' 16' ' ' ALA . 44.4 mtmt -66.79 -39.95 87.95 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.826 0.45 . . . . 73.120000000000005 111.315 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' B' ' 13' ' ' VAL . 33.9 m -96.09 7.14 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.823 0.675 . . . . 71.25 112.823 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 65.8 t30 65.33 12.38 8.04 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.176 0.99 . . . . 75.310000000000002 112.783 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 59.8 mt -97.11 168.59 10.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.674 -0.641 . . . . 72.329999999999998 110.747 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 68.3 m -74.68 159.8 31.6 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.597 0.359 . . . . 73.349999999999994 110.998 170.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 70.1 t -52.49 -57.72 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.303 1.041 . . . . 60.5 112.589 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -68.61 -30.52 69.27 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.639 0.775 . . . . 73.219999999999999 111.669 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 56.0 m -61.17 -39.82 91.56 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.733 0.813 . . . . 74.340000000000003 111.408 173.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.428 ' O ' HG22 ' B' ' 43' ' ' VAL . 90.4 m -76.72 -42.37 41.55 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.722 0.809 . . . . 65.129999999999995 111.536 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.487 ' HB2' HG23 ' B' ' 25' ' ' ILE . . . -59.6 -39.74 85.21 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 123.81 0.844 . . . . 73.030000000000001 111.921 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 54' ' ' ILE . 1.1 tt -60.41 -50.32 74.07 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.808 1.243 . . . . 75.549999999999997 110.009 173.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 -27.06 68.65 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 114.843 -1.071 . . . . 63.119999999999997 112.089 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.428 HG22 ' O ' ' B' ' 39' ' ' THR . 65.7 t -68.48 -39.96 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 123.388 0.675 . . . . 75.239999999999995 110.649 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -66.12 -27.8 73.19 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-N 116.379 -0.373 . . . . 74.109999999999999 113.07 174.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' TRP . . . . . 0.51 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 64.6 t-105 -74.82 -32.22 61.9 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.494 0.718 . . . . 73.230000000000004 111.466 173.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.58 -27.15 62.95 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.243 0.617 . . . . 65.239999999999995 111.765 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.02 67.96 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 113.199 0.814 . . . . 51.399999999999999 113.199 172.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 36.8 ptt85 -74.31 -29.18 61.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.861 -0.524 . . . . 73.420000000000002 110.968 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . 0.494 ' HB3' ' HE2' ' B' ' 51' ' ' LYS . 21.7 mm-40 -72.22 -22.78 61.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.056 0.942 . . . . 73.120000000000005 112.359 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 59.41 35.06 22.94 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.275 1.03 . . . . 74.310000000000002 112.452 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.494 ' HE2' ' HB3' ' B' ' 49' ' ' GLU . 51.3 mtmt -108.49 0.44 20.94 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.683 0.623 . . . . 74.420000000000002 112.683 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.52 147.93 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 112.644 0.609 . . . . 75.430000000000007 112.644 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.66 108.25 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.798 0.839 . . . . 72.010000000000005 109.807 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 2.6 mp -89.97 112.34 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 108.499 -0.926 . . . . 73.420000000000002 108.499 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -102.21 126.51 49.21 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.835 0.454 . . . . 70.030000000000001 110.352 174.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -90.79 96.29 10.56 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.356 -0.979 . . . . 75.030000000000001 108.356 168.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -104.78 109.33 21.23 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.903 1.281 . . . . 71.540000000000006 109.093 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 55.15 29.16 12.12 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.559 1.144 . . . . 75.109999999999999 111.004 -164.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.17 -20.73 35.11 Favored Glycine 0 CA--C 1.549 2.197 0 CA-C-N 115.478 -0.783 . . . . 71.430000000000007 114.58 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.73 130.15 34.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 117.821 0.811 . . . . 65.340000000000003 111.83 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -84.05 114.96 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 123.458 0.703 . . . . 72.120000000000005 111.508 -173.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.28 142.94 46.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.017 0.927 . . . . 74.25 109.107 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 6.4 tp -106.74 128.3 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 CA-C-O 121.607 0.717 . . . . 72.140000000000001 110.709 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -126.63 171.48 11.1 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.692 1.197 . . . . 73.099999999999994 110.001 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.479 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 39.4 t30 -100.51 152.54 20.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.444 1.098 . . . . 74.239999999999995 108.889 170.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 . . . . . 0 N--CA 1.486 1.364 0 C-N-CA 123.819 0.847 . . . . 75.420000000000002 112.545 -177.626 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' A' ' 4' ' ' LYS . 17.1 tmm? . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 109.637 -0.505 . . . . 74.140000000000001 109.637 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.54 -44.32 0.28 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.707 0.803 . . . . 75.430000000000007 111.611 -173.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.486 ' HA ' HG21 ' A' ' 6' ' ' VAL . 51.5 mttp -66.9 -22.86 65.95 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.228 0.825 . . . . 71.510000000000005 113.228 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.426 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 29.3 mtpp -75.88 -38.67 57.62 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.19 0.596 . . . . 74.129999999999995 111.162 173.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.407 HG13 ' SD ' ' A' ' 1' ' ' MET . 57.8 mt -65.55 -55.94 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.434 0.693 . . . . 74.200000000000003 110.888 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 3' ' ' LYS . 11.3 m -69.34 -26.22 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.071 -0.968 . . . . 74.409999999999997 111.223 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.79 -40.24 95.54 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 116.491 -0.322 . . . . 51.149999999999999 113.138 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.97 -54.47 13.14 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.623 0.769 . . . . 70.040000000000006 112.527 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -71.82 -20.97 61.76 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.171 0.804 . . . . 62.219999999999999 113.171 -174.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 -30.41 70.55 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.462 0.705 . . . . 74.299999999999997 111.818 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.86 -35.84 90.19 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 116.239 -0.437 . . . . 62.32 113.063 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.86 -42.65 60.49 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.562 0.745 . . . . 73.200000000000003 111.791 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.618 ' HA ' HG13 ' A' ' 32' ' ' VAL . 35.0 m -68.49 -38.75 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 122.282 0.233 . . . . 75.299999999999997 111.503 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.592 ' HA ' HD11 ' A' ' 17' ' ' LEU . 69.7 t90 -64.29 -36.42 84.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.973 0.909 . . . . 73.239999999999995 111.561 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.18 -40.7 98.27 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.952 0.901 . . . . 70.109999999999999 111.282 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -68.59 -24.23 64.57 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.394 0.678 . . . . 72.519999999999996 112.556 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 14' ' ' TRP . 52.1 mt -73.49 -33.87 65.02 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.835 0.854 . . . . 63.399999999999999 112.078 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.54 -36.58 78.78 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.609 0.764 . . . . 74.120000000000005 110.983 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.19 -59.86 4.33 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.384 1.074 . . . . 71.310000000000002 111.497 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.37 114.18 0.76 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.198 0.999 . . . . 61.439999999999998 110.275 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -98.16 -179.21 4.31 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.751 0.82 . . . . 75.540000000000006 111.721 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.43 26.32 47.64 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 112.6 -170.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.4 tt -104.29 147.63 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 C-N-CA 123.658 0.783 . . . . 74.310000000000002 111.367 -172.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.4 t -76.51 160.0 29.87 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.246 1.018 . . . . 73.519999999999996 111.938 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.5 mm -55.76 -56.61 28.14 Favored Pre-proline 0 CA--C 1.575 1.937 0 N-CA-C 113.523 0.934 . . . . 74.329999999999998 113.523 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.8 -22.47 27.25 Favored 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 121.691 1.594 . . . . 74.450000000000003 113.909 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -75.85 -47.92 23.6 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 122.273 1.035 . . . . 74.150000000000006 110.227 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.48 -40.51 78.72 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 113.511 -1.677 . . . . 74.439999999999998 111.291 170.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.09 70.29 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.272 1.029 . . . . 71.409999999999997 113.039 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -73.62 -35.91 65.4 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.285 0.634 . . . . 73.239999999999995 112.287 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 45.0 mtmt -71.81 -43.99 64.7 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.255 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 13' ' ' VAL . 20.0 m -86.93 -11.56 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.037 0.535 . . . . 74.230000000000004 112.3 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 60.72 37.77 18.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.731 1.213 . . . . 73.150000000000006 113.12 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.5 mt -106.85 157.31 17.85 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.574 0.75 . . . . 75.140000000000001 110.585 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 m -61.05 150.18 34.6 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.226 0.611 . . . . 74.420000000000002 111.361 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.6 t -54.91 -48.89 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.547 0.739 . . . . 74.25 112.466 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -59.8 -39.77 86.12 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.128 0.571 . . . . 75.420000000000002 111.724 174.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.7 t -68.84 -37.31 79.05 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.527 0.731 . . . . 74.140000000000001 112.825 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.5 m -71.6 -47.89 51.71 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.618 0.767 . . . . 74.439999999999998 110.699 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.78 93.58 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.007 0.923 . . . . 74.319999999999993 112.174 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.77 -35.28 64.97 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.16 0.984 . . . . 74.340000000000003 111.345 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.32 98.85 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.464 0.65 . . . . 73.439999999999998 110.891 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.507 HG11 HD11 ' A' ' 63' ' ' ILE . 69.9 t -64.4 -31.47 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 C-N-CA 123.813 0.845 . . . . 72.510000000000005 111.672 172.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.34 -32.44 82.87 Favored Glycine 0 CA--C 1.544 1.87 0 N-CA-C 113.888 0.315 . . . . 72.340000000000003 113.888 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -68.58 -32.71 72.81 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.591 0.757 . . . . 73.200000000000003 111.282 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.53 -41.02 69.67 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.414 0.686 . . . . 74.299999999999997 110.89 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.59 -26.92 64.15 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.549 1.139 . . . . 72.25 112.6 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -52.95 -45.07 67.53 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.889 0.876 . . . . 63.299999999999997 112.102 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -103.87 3.78 34.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.031 0.932 . . . . 75.219999999999999 112.147 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.7 m120 54.7 36.63 26.66 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.149 0.98 . . . . 75.540000000000006 112.595 -170.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -67.66 -18.22 64.87 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.356 0.663 . . . . 75.109999999999999 110.441 166.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.15 148.44 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.207 1.003 . . . . 74.209999999999994 109.974 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 64' ' ' TYR . 20.3 m -128.96 134.75 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.906 0.882 . . . . 74.420000000000002 108.98 173.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.71 128.8 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 121.206 0.527 . . . . 72.140000000000001 112.278 -167.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -122.54 141.33 51.78 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.667 1.187 . . . . 70.540000000000006 109.54 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -117.25 110.54 18.24 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.819 0.342 . . . . 74.219999999999999 110.865 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -111.28 126.78 55.26 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.052 -0.721 . . . . 75.030000000000001 109.052 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 56.95 31.1 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.463 1.105 . . . . 72.019999999999996 112.103 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.29 -15.56 38.98 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 114.431 0.533 . . . . 73.540000000000006 114.431 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.9 mt -74.15 151.7 39.99 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.349 0.659 . . . . 75.450000000000003 111.469 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 mp -99.88 111.97 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 123.157 0.583 . . . . 71.200000000000003 110.055 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -98.38 141.06 31.73 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.492 0.717 . . . . 73.540000000000006 110.065 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.507 HD11 HG11 ' A' ' 43' ' ' VAL . 61.7 mt -116.04 113.32 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.046 0.538 . . . . 74.400000000000006 110.479 172.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.45 ' HB2' HG23 ' A' ' 53' ' ' VAL . 9.0 m-30 -97.29 150.15 21.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.685 0.794 . . . . 74.140000000000001 110.583 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 17.9 t-20 -92.71 141.57 28.32 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.264 0.626 . . . . 74.129999999999995 109.59 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.98 -18.56 46.67 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.154 0.798 . . . . 74.319999999999993 113.154 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.68 -32.28 73.57 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 115.278 0.871 . . . . 71.450000000000003 115.278 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -68.66 -8.83 45.95 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 118.245 1.022 . . . . 73.540000000000006 112.171 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -84.35 -54.16 4.97 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.283 0.633 . . . . 70.400000000000006 110.563 170.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -102.96 -76.1 0.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.342 0.657 . . . . 75.319999999999993 112.038 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -143.38 122.27 12.73 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.091 0.556 . . . . 73.219999999999999 111.362 -175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.1 t -138.44 147.15 42.97 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.64 0.776 . . . . 65.129999999999995 110.062 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -149.71 113.77 5.14 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.109 0.564 . . . . 75.209999999999994 110.714 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.84 41.6 3.06 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 112.372 -0.291 . . . . 64.439999999999998 112.372 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.37 -36.73 83.18 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.282 1.033 . . . . 73.530000000000001 111.225 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -69.07 109.39 3.98 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.867 -0.79 . . . . 73.310000000000002 108.867 169.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -71.79 84.37 0.92 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 122.775 0.43 . . . . 75.219999999999999 112.1 -170.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 50.29 99.9 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 125.628 1.571 . . . . 75.109999999999999 114.686 170.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -69.96 112.05 6.09 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.581 -0.526 . . . . 72.430000000000007 109.581 170.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -67.85 151.81 46.57 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.624 0.369 . . . . 74.439999999999998 110.895 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 44.8 p-80 -83.44 177.9 8.26 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.529 0.681 . . . . 75.420000000000002 112.382 -176.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.4 t60 . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 124.414 1.086 . . . . 75.049999999999997 109.577 172.039 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.556 1.209 0 CA-C-O 120.691 0.281 . . . . 72.200000000000003 111.013 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -48.66 -51.09 30.13 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 113.748 1.018 . . . . 75.25 113.748 -175.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.493 ' HA ' HG23 ' B' ' 6' ' ' VAL . 9.8 mtmp? -67.86 -28.09 67.24 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.191 0.812 . . . . 75.129999999999995 113.191 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.49 ' HB3' ' HZ3' ' B' ' 4' ' ' LYS . 2.4 mmmp? -69.04 -45.76 69.61 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.24 0.616 . . . . 74.349999999999994 110.497 175.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 79.1 mt -63.05 -56.7 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.119 0.968 . . . . 65.129999999999995 111.433 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.493 HG23 ' HA ' ' B' ' 3' ' ' LYS . 12.6 m -66.13 -27.61 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 122.848 0.459 . . . . 74.129999999999995 111.503 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.03 -41.0 97.46 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.233 0.333 . . . . 73.239999999999995 112.995 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.07 -50.27 62.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.452 0.701 . . . . 54.200000000000003 111.606 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -68.22 -27.49 66.42 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.795 0.838 . . . . 75.439999999999998 112.384 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.476 ' HA ' HG23 ' B' ' 13' ' ' VAL . . . -72.83 -34.35 66.76 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.101 0.56 . . . . 45.240000000000002 111.518 177.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -35.19 91.63 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 123.388 0.43 . . . . 73.239999999999995 112.34 174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' B' ' 32' ' ' VAL . 1.6 ttmp? -68.14 -50.32 55.35 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.24 1.016 . . . . 74.140000000000001 112.216 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.517 ' HA ' HG13 ' B' ' 32' ' ' VAL . 24.4 m -69.09 -34.76 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 111.886 0.328 . . . . 71.140000000000001 111.886 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -71.9 -34.97 69.57 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.269 0.627 . . . . 74.239999999999995 111.081 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -57.05 -41.64 79.05 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.069 0.548 . . . . 75.140000000000001 110.489 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.53 -32.74 74.51 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.504 -0.771 . . . . 74.540000000000006 111.841 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 13' ' ' VAL . 83.3 mt -71.74 -34.0 69.15 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.401 0.681 . . . . 74.129999999999995 111.759 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.04 -31.49 71.13 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.76 0.824 . . . . 72.239999999999995 111.34 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -105.11 -25.78 12.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.159 0.984 . . . . 70.400000000000006 112.133 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.02 87.87 0.66 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.217 0.607 . . . . 74.319999999999993 111.524 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.17 -179.03 3.92 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.359 0.664 . . . . 72.019999999999996 111.825 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.25 18.18 79.76 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.084 -0.507 . . . . 63.520000000000003 112.85 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.73 152.39 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.391 1.076 . . . . 74.530000000000001 110.02 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -69.04 148.28 50.31 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.797 0.439 . . . . 73.439999999999998 111.045 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.623 HG22 ' HB3' ' B' ' 40' ' ' ALA . 36.5 mm -54.69 -48.35 95.61 Favored Pre-proline 0 CA--C 1.578 2.027 0 N-CA-C 113.719 1.007 . . . . 75.299999999999997 113.719 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -65.42 -31.23 52.23 Favored 'Trans proline' 0 C--N 1.393 2.905 0 C-N-CA 121.969 1.78 . . . . 74.230000000000004 113.965 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -71.64 -46.66 58.36 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.357 1.075 . . . . 75.049999999999997 109.778 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.73 -38.7 82.43 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.301 -1.772 . . . . 75.010000000000005 111.51 172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.79 98.01 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.984 0.913 . . . . 64.239999999999995 111.939 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -64.43 -35.81 82.12 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.1 -0.955 . . . . 75.329999999999998 110.681 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -66.63 -45.92 77.47 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.391 0.676 . . . . 75.120000000000005 112.298 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' B' ' 13' ' ' VAL . 30.5 m -90.51 10.7 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 112.718 0.636 . . . . 74.430000000000007 112.718 -173.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.68 16.82 9.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.408 1.083 . . . . 73.120000000000005 113.08 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.2 mt -106.16 168.69 8.97 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.743 0.817 . . . . 73.25 110.603 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 43.6 t -81.12 165.47 21.56 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.612 0.365 . . . . 73.019999999999996 111.243 169.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 74.4 t -52.92 -48.51 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 123.619 0.768 . . . . 75.510000000000005 111.836 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.91 -52.84 64.03 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.405 0.682 . . . . 75.510000000000005 111.96 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 23.0 m -59.26 -38.91 81.24 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.961 0.904 . . . . 72.109999999999999 112.379 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -72.44 -48.52 40.46 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.776 0.831 . . . . 72.340000000000003 111.767 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.623 ' HB3' HG22 ' B' ' 25' ' ' ILE . . . -63.61 -32.46 73.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.329 0.652 . . . . 73.340000000000003 112.027 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -71.79 -38.32 70.29 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.697 1.199 . . . . 74.340000000000003 110.508 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.25 -37.76 81.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.174 0.59 . . . . 74.450000000000003 111.405 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.494 HG11 HG13 ' B' ' 52' ' ' VAL . 60.7 t -64.1 -30.98 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.243 1.017 . . . . 75.129999999999995 110.867 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.57 86.32 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.495 -0.32 . . . . 64.0 113.513 171.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -72.7 -23.67 60.9 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.317 0.58 . . . . 73.230000000000004 111.198 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.436 HD11 HG22 ' B' ' 13' ' ' VAL . 76.4 mt -74.45 -40.93 61.62 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 121.518 -0.739 . . . . 74.310000000000002 111.08 169.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.24 -31.19 69.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.474 1.11 . . . . 75.040000000000006 113.488 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.568 ' HD3' ' HG3' ' B' ' 49' ' ' GLU . 0.0 OUTLIER -72.41 -14.1 61.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 112.735 0.643 . . . . 75.450000000000003 112.735 176.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . 0.568 ' HG3' ' HD3' ' B' ' 48' ' ' ARG . 50.1 mt-10 -114.92 16.11 17.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.883 0.873 . . . . 73.450000000000003 110.965 169.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 47.53 28.38 1.17 Allowed 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 125.876 1.67 . . . . 70.540000000000006 114.314 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.442 ' HA ' ' HB2' ' B' ' 66' ' ' GLU . 53.0 mttp -71.52 -11.5 60.9 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.232 1.013 . . . . 75.109999999999999 112.95 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.494 HG13 HG11 ' B' ' 43' ' ' VAL . 12.6 m -124.52 145.85 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.637 0.775 . . . . 73.439999999999998 112.307 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 63.4 t -112.0 120.38 62.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 125.017 1.327 . . . . 73.310000000000002 108.949 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.21 110.59 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.703 -0.851 . . . . 74.030000000000001 108.703 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.28 112.49 18.67 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.794 0.438 . . . . 73.329999999999998 110.833 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.467 ' HG2' HG12 ' B' ' 61' ' ' ILE . 13.8 mtm-85 -93.36 96.89 10.23 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.746 0.819 . . . . 75.400000000000006 109.905 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -104.57 111.98 24.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.902 1.281 . . . . 73.420000000000002 109.414 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 57.74 30.45 18.95 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 111.747 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.68 -22.81 28.85 Favored Glycine 0 CA--C 1.546 2.012 0 CA-C-N 115.654 -0.703 . . . . 73.099999999999994 113.992 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 88.4 mt -79.24 126.13 30.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.987 0.915 . . . . 73.340000000000003 111.527 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.467 HG12 ' HG2' ' B' ' 56' ' ' ARG . 40.4 mt -92.19 123.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 121.059 0.457 . . . . 72.219999999999999 112.068 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -117.83 139.72 50.7 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.385 1.074 . . . . 72.430000000000007 109.187 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.413 HG21 HG13 ' B' ' 43' ' ' VAL . 1.5 pp -113.66 104.59 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.926 0.87 . . . . 75.310000000000002 112.064 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.461 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 74.9 m-85 -83.61 167.06 17.64 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.659 0.784 . . . . 73.409999999999997 110.875 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -93.25 164.08 13.37 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.121 0.486 . . . . 74.450000000000003 112.294 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' B' ' 51' ' ' LYS . 40.1 tt0 -64.62 -20.65 66.4 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.847 0.859 . . . . 75.409999999999997 112.149 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.83 -11.67 31.54 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 115.305 0.882 . . . . 72.140000000000001 115.305 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -85.08 -34.44 22.24 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.272 0.536 . . . . 74.349999999999994 111.425 173.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -104.59 85.14 2.28 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.619 0.724 . . . . 75.329999999999998 109.655 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -83.77 34.9 0.5 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.192 0.997 . . . . 43.350000000000001 112.186 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -97.37 26.68 4.69 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.152 0.981 . . . . 73.129999999999995 110.485 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 25.4 m -82.17 -10.99 58.97 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.725 0.81 . . . . 75.209999999999994 112.008 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -71.65 177.91 3.86 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.614 0.766 . . . . 73.349999999999994 111.486 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.54 -151.74 6.25 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 116.248 -0.433 . . . . 74.340000000000003 112.45 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.38 150.07 28.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.801 0.84 . . . . 75.409999999999997 109.517 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.61 144.02 44.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.647 0.779 . . . . 75.25 111.443 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -70.15 99.5 1.5 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 120.921 0.391 . . . . 73.200000000000003 109.986 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -65.96 118.96 10.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.831 0.852 . . . . 73.099999999999994 111.352 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -134.76 160.61 37.63 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.931 0.892 . . . . 75.109999999999999 110.149 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -72.75 127.69 33.3 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.133 0.573 . . . . 75.420000000000002 111.113 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -72.12 128.72 36.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.825 0.45 . . . . 71.430000000000007 111.367 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 . . . . . 0 N--CA 1.479 0.988 0 C-N-CA 123.532 0.733 . . . . 74.409999999999997 110.091 177.013 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 112.604 0.594 . . . . 74.200000000000003 112.604 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.73 -34.86 74.44 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.265 0.468 . . . . 64.230000000000004 112.265 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -62.15 -46.71 87.77 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.541 0.736 . . . . 74.420000000000002 111.833 -174.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -67.86 -33.6 75.07 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.827 -0.624 . . . . 74.439999999999998 112.072 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.8 mt -69.0 -58.02 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.091 0.556 . . . . 73.439999999999998 110.966 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.67 -27.85 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.749 0.42 . . . . 64.299999999999997 111.711 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.23 -42.25 76.28 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 123.543 0.527 . . . . 70.420000000000002 112.875 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.78 96.02 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.012 0.925 . . . . 75.450000000000003 112.054 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 12' ' ' LYS . 57.2 m-80 -85.1 -21.26 29.39 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.166 0.586 . . . . 74.340000000000003 112.414 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.54 76.1 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 118.072 0.396 . . . . 73.0 111.448 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.0 -39.83 97.63 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 115.851 -0.613 . . . . 63.109999999999999 113.456 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 6.7 ptmm? -75.87 -30.63 58.94 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.5 -0.412 . . . . 74.340000000000003 111.488 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.564 ' HA ' HG12 ' A' ' 32' ' ' VAL . 71.4 t -67.37 -46.78 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.282 0.633 . . . . 74.209999999999994 110.84 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.434 ' HA ' HD11 ' A' ' 17' ' ' LEU . 21.7 t90 -64.07 -35.07 79.53 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.572 -0.74 . . . . 73.540000000000006 110.639 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.405 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 79.3 t60 -63.11 -40.55 97.95 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.845 0.458 . . . . 64.430000000000007 111.547 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.12 -31.66 72.93 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 120.862 0.363 . . . . 61.020000000000003 111.661 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.471 ' HB3' ' OD1' ' A' ' 65' ' ' ASN . 90.1 mt -69.34 -41.95 75.94 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.337 1.055 . . . . 74.340000000000003 111.733 170.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.74 -26.99 66.11 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.145 0.978 . . . . 72.150000000000006 111.425 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 15' ' ' HIS . 68.3 mt-10 -77.79 -49.85 13.52 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.225 0.61 . . . . 73.409999999999997 110.127 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.77 108.19 0.67 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.603 0.761 . . . . 73.019999999999996 111.264 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.432 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 11.1 p-10 -94.1 -178.79 4.74 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.146 0.978 . . . . 71.430000000000007 112.918 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.28 33.59 61.62 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-N 116.016 -0.538 . . . . 44.32 111.852 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 tt -113.12 145.09 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.026 0.931 . . . . 74.299999999999997 111.013 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.9 m -78.85 154.03 30.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.556 0.743 . . . . 64.450000000000003 110.943 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.703 HG22 ' HB2' ' A' ' 40' ' ' ALA . 44.7 mm -59.1 -44.34 98.52 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 114.777 1.399 . . . . 74.430000000000007 114.777 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -62.82 -32.61 77.5 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 121.942 1.761 . . . . 73.340000000000003 113.185 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -75.27 -37.46 60.93 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.587 1.184 . . . . 75.319999999999993 109.871 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.9 tp -70.73 -33.4 70.79 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 112.707 -2.042 . . . . 72.099999999999994 111.658 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.05 -37.06 81.27 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.086 0.954 . . . . 74.439999999999998 111.167 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -64.44 -39.22 93.41 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.175 0.99 . . . . 75.010000000000005 111.104 174.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -66.47 -43.72 84.71 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.663 0.785 . . . . 73.049999999999997 111.864 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 13' ' ' VAL . 7.0 m -98.17 9.99 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 113.315 0.858 . . . . 75.340000000000003 113.315 -170.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 m120 66.87 10.51 7.66 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.587 1.155 . . . . 64.409999999999997 113.428 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.9 mt -108.31 178.08 4.61 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.247 0.619 . . . . 75.219999999999999 111.479 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.4 t -88.48 165.68 14.72 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.17 0.588 . . . . 73.340000000000003 110.991 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.38 -47.33 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 124.312 1.045 . . . . 73.510000000000005 112.26 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -61.22 -53.0 62.43 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.214 0.606 . . . . 71.099999999999994 112.088 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -63.01 -28.6 70.22 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.733 0.813 . . . . 75.019999999999996 112.518 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.418 ' O ' HG22 ' A' ' 43' ' ' VAL . 88.0 m -80.08 -53.65 6.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.75 0.82 . . . . 72.109999999999999 111.441 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.703 ' HB2' HG22 ' A' ' 25' ' ' ILE . . . -60.1 -30.75 69.46 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.106 0.962 . . . . 53.509999999999998 112.315 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -52.86 63.07 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.714 1.206 . . . . 73.319999999999993 110.225 174.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.24 -26.75 68.24 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.886 -1.052 . . . . 73.409999999999997 111.39 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 39' ' ' THR . 94.7 t -66.04 -40.11 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.166 0.586 . . . . 72.239999999999995 110.889 172.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.07 -33.24 86.72 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 116.309 -0.405 . . . . 64.109999999999999 113.107 173.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.472 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 63.7 t-105 -74.22 -25.18 59.51 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.586 0.754 . . . . 75.129999999999995 111.605 176.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.27 -47.72 48.01 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 122.115 -0.366 . . . . 71.120000000000005 110.39 166.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.72 68.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.3 1.04 . . . . 71.25 113.19 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 26.6 ptt85 -59.4 -39.71 84.29 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 112.558 0.577 . . . . 70.409999999999997 112.558 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.538 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 47.0 mt-10 -96.61 11.62 34.63 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.886 0.875 . . . . 71.040000000000006 111.147 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 62.33 38.1 13.38 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.671 1.189 . . . . 64.120000000000005 111.198 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -80.51 -19.08 46.66 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.411 0.685 . . . . 75.519999999999996 112.195 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.87 151.57 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.314 0.646 . . . . 72.340000000000003 111.238 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.17 122.01 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.815 0.846 . . . . 75.209999999999994 109.298 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.775 HG12 HD12 ' B' ' 41' ' ' LEU . 3.6 mp -98.9 136.03 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.065 0.946 . . . . 73.340000000000003 110.86 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.7 117.98 15.62 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.569 0.747 . . . . 73.219999999999999 110.764 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -81.53 111.39 17.8 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.752 0.821 . . . . 72.549999999999997 110.556 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.85 130.61 47.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.969 0.908 . . . . 63.149999999999999 110.617 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.9 p30 44.48 41.18 4.45 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 126.059 1.744 . . . . 73.319999999999993 114.035 -175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.41 -27.44 7.74 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.374 -0.83 . . . . 74.439999999999998 114.125 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.67 160.4 28.51 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.732 0.813 . . . . 74.540000000000006 110.99 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.4 tt -121.19 118.33 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 109.683 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.87 142.68 46.24 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.116 0.966 . . . . 74.299999999999997 110.042 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.666 HG23 HG13 ' A' ' 54' ' ' ILE . 37.6 pt -115.07 140.36 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.555 0.693 . . . . 74.540000000000006 111.066 175.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.432 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 57.7 m-85 -123.8 167.8 13.58 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.681 1.192 . . . . 73.239999999999995 110.018 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 1.8 m-20 -76.06 152.37 36.88 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.337 0.255 . . . . 75.209999999999994 110.522 174.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -77.75 160.71 28.23 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 121.164 0.507 . . . . 71.420000000000002 110.327 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.92 -16.61 5.27 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.844 -1.302 . . . . 74.340000000000003 109.844 -165.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -73.02 -34.18 66.2 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.566 1.146 . . . . 73.430000000000007 110.264 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -102.18 20.99 15.68 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.701 1.201 . . . . 73.329999999999998 110.382 171.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 74.24 -55.52 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 126.336 1.854 . . . . 74.209999999999994 114.158 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -71.89 86.61 0.99 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.428 0.691 . . . . 72.010000000000005 112.205 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 94.4 p -100.4 17.46 21.49 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.716 0.807 . . . . 74.019999999999996 111.286 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -68.37 170.06 9.57 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.963 0.905 . . . . 74.019999999999996 112.389 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.6 75.49 1.23 Allowed Glycine 0 N--CA 1.472 1.081 0 N-CA-C 111.772 -0.531 . . . . 74.349999999999994 111.772 -173.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.79 165.82 16.56 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.868 0.867 . . . . 64.030000000000001 111.628 -171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.66 148.6 23.15 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.069 172.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -98.03 -50.49 4.37 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.378 0.671 . . . . 74.349999999999994 112.406 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -160.93 165.57 29.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.038 0.755 . . . . 71.049999999999997 113.038 -172.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -61.56 145.42 52.09 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.061 0.944 . . . . 74.239999999999995 111.323 172.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -98.78 165.41 11.79 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.939 1.089 . . . . 74.439999999999998 113.939 -168.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -112.98 160.07 18.48 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.15 1.38 . . . . 73.219999999999999 108.858 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.653 0.739 . . . . 72.530000000000001 112.368 -179.867 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttp . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.115 0.483 . . . . 71.530000000000001 111.004 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.46 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 12.7 p-10 -65.51 -35.06 79.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.167 0.987 . . . . 74.420000000000002 113.26 -171.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -29.15 68.96 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.429 0.692 . . . . 73.409999999999997 111.249 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.78 -43.13 56.45 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.755 0.822 . . . . 74.409999999999997 111.668 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.58 -51.38 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 122.619 0.368 . . . . 73.109999999999999 110.813 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -66.49 -30.85 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 122.611 0.364 . . . . 75.420000000000002 111.936 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.68 45.4 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.424 0.452 . . . . 73.219999999999999 112.74 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.6 -52.93 61.45 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.087 0.955 . . . . 75.340000000000003 111.845 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -75.17 -13.9 60.5 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.753 -0.658 . . . . 70.140000000000001 112.464 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.453 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -68.06 -29.09 67.98 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 117.943 0.338 . . . . 64.109999999999999 110.504 171.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.46 -41.95 94.01 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.867 -0.606 . . . . 43.509999999999998 112.963 173.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -69.76 -47.78 61.72 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.391 0.676 . . . . 75.319999999999993 111.922 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.529 ' HA ' HG12 ' B' ' 32' ' ' VAL . 22.7 m -67.21 -32.47 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 111.886 0.328 . . . . 74.209999999999994 111.886 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 57.9 t90 -68.65 -41.1 79.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.716 0.406 . . . . 71.230000000000004 111.162 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -69.64 -40.64 76.39 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.857 0.463 . . . . 72.150000000000006 111.248 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.61 73.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.108 0.563 . . . . 75.310000000000002 111.264 176.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.592 HD22 HG23 ' B' ' 63' ' ' ILE . 1.0 OUTLIER -67.32 -44.18 79.78 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.926 0.89 . . . . 75.099999999999994 110.439 169.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.17 -36.61 84.19 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.655 0.782 . . . . 71.349999999999994 111.679 -174.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.46 -30.13 25.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.371 0.668 . . . . 65.219999999999999 111.622 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.511 ' HB1' ' HZ1' ' B' ' 31' ' ' LYS . . . -135.06 108.04 7.6 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.21 0.604 . . . . 74.010000000000005 110.942 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.99 175.78 10.26 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.868 1.267 . . . . 62.399999999999999 112.674 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.89 40.56 12.53 Favored Glycine 0 C--N 1.365 2.14 0 N-CA-C 115.144 0.817 . . . . 75.340000000000003 115.144 163.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' B' ' 27' ' ' GLU . 7.8 tp -112.95 127.97 69.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.363 0.665 . . . . 74.340000000000003 109.868 -168.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 92.5 p -68.06 158.44 32.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 122.083 -0.386 . . . . 73.230000000000004 111.162 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.635 HG23 ' HB1' ' B' ' 40' ' ' ALA . 69.6 mt -59.65 -44.38 97.36 Favored Pre-proline 0 CA--C 1.578 2.033 0 N-CA-C 114.422 1.268 . . . . 71.409999999999997 114.422 -171.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.49 -28.47 45.73 Favored 'Trans proline' 0 C--N 1.389 2.667 0 CA-C-N 121.744 1.659 . . . . 75.420000000000002 113.361 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . 0.459 ' HB3' HD11 ' B' ' 23' ' ' ILE . 14.0 mm-40 -79.96 -27.26 39.76 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.149 0.98 . . . . 73.409999999999997 111.419 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.568 ' HA ' ' HE2' ' B' ' 31' ' ' LYS . 58.3 tp -75.75 -37.82 58.98 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 125.255 1.422 . . . . 74.420000000000002 110.629 170.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.34 95.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.482 1.113 . . . . 75.310000000000002 112.842 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -67.65 -33.56 75.2 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.352 0.661 . . . . 71.349999999999994 112.248 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' B' ' 28' ' ' LEU . 48.9 mtmt -66.59 -43.38 85.05 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.217 0.532 . . . . 71.140000000000001 110.897 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' B' ' 13' ' ' VAL . 21.6 m -90.66 -4.83 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.662 0.785 . . . . 73.439999999999998 112.558 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 m120 64.99 22.62 12.46 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.63 1.172 . . . . 73.400000000000006 112.876 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 59.1 mt -104.65 162.04 13.62 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.621 0.769 . . . . 74.420000000000002 110.53 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 30.1 t -64.68 152.04 43.42 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.087 0.555 . . . . 75.439999999999998 110.822 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.95 -44.05 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 123.547 0.739 . . . . 72.319999999999993 111.19 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -58.52 -47.41 84.23 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 114.887 -1.051 . . . . 73.319999999999993 112.071 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 65.3 m -68.54 -36.53 78.96 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.934 0.893 . . . . 74.409999999999997 112.262 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 87.9 m -70.94 -52.24 21.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.918 0.887 . . . . 64.420000000000002 110.802 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.635 ' HB1' HG23 ' B' ' 25' ' ' ILE . . . -57.73 -32.36 67.35 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.956 0.902 . . . . 65.239999999999995 112.491 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.775 HD12 HG12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -64.65 -52.71 55.89 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.512 1.125 . . . . 72.519999999999996 110.281 176.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.59 -29.14 70.15 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.197 -0.91 . . . . 73.239999999999995 111.586 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.04 -39.93 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.627 0.771 . . . . 74.409999999999997 110.949 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -61.88 -27.75 69.1 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-N 116.341 -0.39 . . . . 74.010000000000005 113.125 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.439 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 61.1 t-105 -71.93 -34.53 69.13 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.546 0.738 . . . . 71.25 111.249 174.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.42 -32.88 68.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.25 0.62 . . . . 74.239999999999995 111.196 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.99 -32.02 71.6 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.672 0.789 . . . . 71.340000000000003 112.175 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 53.8 ttt180 -58.83 -50.43 74.01 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.517 0.675 . . . . 75.030000000000001 110.904 167.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -79.57 -6.59 57.36 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 114.64 -1.164 . . . . 63.229999999999997 112.27 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 63.62 23.2 13.47 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.025 1.33 . . . . 63.5 112.08 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -87.67 -4.31 58.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.486 1.114 . . . . 75.219999999999999 112.604 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.609 ' HB ' HD13 ' B' ' 63' ' ' ILE . 18.3 m -135.02 166.51 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 112.532 0.567 . . . . 71.319999999999993 112.532 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.732 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 24.7 t -116.1 131.75 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.067 0.947 . . . . 73.439999999999998 111.229 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 31.9 mm -113.5 133.05 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.696 0.798 . . . . 71.530000000000001 110.784 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' B' ' 57' ' ' LYS . 42.5 mt-10 -134.16 157.96 44.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.451 0.7 . . . . 53.399999999999999 111.31 167.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -111.55 106.94 15.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.211 1.004 . . . . 73.409999999999997 109.168 168.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' B' ' 55' ' ' GLU . 0.0 OUTLIER -119.54 114.91 22.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.303 1.041 . . . . 74.200000000000003 110.13 -178.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 56.25 30.54 16.84 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.804 1.241 . . . . 74.140000000000001 111.823 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.8 -25.04 23.41 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 115.959 -0.564 . . . . 62.520000000000003 114.238 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -90.46 158.52 17.01 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.701 0.8 . . . . 62.340000000000003 111.037 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 mm -107.15 131.29 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.962 0.505 . . . . 74.409999999999997 110.052 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -121.97 136.1 54.9 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.063 -1.088 . . . . 72.129999999999995 108.063 168.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.609 HD13 ' HB ' ' B' ' 52' ' ' VAL . 10.9 tp -92.65 130.79 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 122.982 0.513 . . . . 73.409999999999997 110.232 -177.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.732 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 84.8 m-85 -116.62 167.8 10.75 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.578 0.751 . . . . 74.299999999999997 110.974 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.518 ' HA ' HD12 ' B' ' 17' ' ' LEU . 9.7 m120 -88.06 114.21 24.46 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.0 0.741 . . . . 60.43 113.0 -169.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 36.86 -149.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 116.975 2.213 . . . . 74.439999999999998 116.975 157.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.34 73.85 1.09 Allowed Glycine 0 C--N 1.362 1.983 0 N-CA-C 115.134 0.814 . . . . 65.200000000000003 115.134 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.4 ' NE2' ' HB2' ' B' ' 65' ' ' ASN . 6.2 p-80 -161.21 44.32 0.17 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.114 1.366 . . . . 74.420000000000002 108.569 163.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -93.81 20.1 8.03 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.253 -1.34 . . . . 74.400000000000006 112.364 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.79 -44.7 96.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.61 0.764 . . . . 74.519999999999996 110.025 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -132.89 122.67 24.71 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.655 1.182 . . . . 74.299999999999997 108.826 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 60.0 p -73.8 112.69 10.15 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.295 -0.631 . . . . 74.439999999999998 109.295 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -70.34 86.06 0.59 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.447 0.906 . . . . 74.25 113.447 -166.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.5 -21.05 59.01 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.12 -0.792 . . . . 71.120000000000005 111.12 164.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 62.3 tp -69.56 81.3 0.41 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.575 1.15 . . . . 71.5 110.236 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 63.69 120.97 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 125.621 1.568 . . . . 72.450000000000003 113.856 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -166.61 110.91 0.77 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.816 0.846 . . . . 75.340000000000003 110.515 167.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -92.06 -44.0 9.09 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.652 0.781 . . . . 74.209999999999994 112.824 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 42.04 75.86 0.08 Allowed 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 124.59 1.156 . . . . 72.439999999999998 112.689 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -68.28 148.18 51.14 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.752 1.221 . . . . 64.319999999999993 112.916 -172.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -72.2 102.78 3.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.629 0.771 . . . . 74.219999999999999 110.616 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 N--CA 1.484 1.26 0 C-N-CA 124.389 1.076 . . . . 73.129999999999995 112.681 178.205 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 111.973 0.361 . . . . 72.340000000000003 111.973 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.719 ' HB3' ' HB ' ' B' ' 54' ' ' ILE . 3.9 p-10 -56.08 -39.3 71.89 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 114.245 1.202 . . . . 75.340000000000003 114.245 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -61.46 -25.0 66.95 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.149 0.796 . . . . 75.540000000000006 113.149 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -79.54 -45.45 19.22 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.419 0.687 . . . . 75.349999999999994 111.354 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.59 -56.67 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.731 0.813 . . . . 74.340000000000003 112.01 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.5 m -53.9 -44.34 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.621 1.169 . . . . 72.430000000000007 113.197 -170.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.81 -40.34 52.83 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.159 0.287 . . . . 54.149999999999999 113.025 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.22 79.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.647 0.779 . . . . 74.439999999999998 112.354 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -87.56 -20.95 25.74 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.769 0.655 . . . . 60.009999999999998 112.769 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.84 -38.98 73.23 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 123.097 0.559 . . . . 72.430000000000007 112.03 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.74 -32.52 81.51 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 116.124 -0.489 . . . . 62.340000000000003 112.623 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -71.45 -48.29 50.33 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.014 0.925 . . . . 75.239999999999995 112.188 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -75.16 -32.85 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 112.475 0.546 . . . . 75.209999999999994 112.475 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.442 ' HA ' HD11 ' A' ' 17' ' ' LEU . 26.1 t90 -70.56 -35.16 72.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 120.966 0.412 . . . . 75.120000000000005 110.457 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -62.24 -35.41 78.84 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.521 0.728 . . . . 70.430000000000007 111.306 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.02 70.09 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.367 0.667 . . . . 63.310000000000002 112.455 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.442 HD11 ' HA ' ' A' ' 14' ' ' TRP . 46.7 mt -68.36 -31.18 70.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.55 0.74 . . . . 75.129999999999995 111.255 170.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -75.04 -22.88 58.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.172 0.589 . . . . 72.040000000000006 111.704 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.31 -58.52 5.71 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 109.118 -0.697 . . . . 74.019999999999996 109.118 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.79 117.81 0.7 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.81 -1.087 . . . . 44.5 110.006 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.12 168.34 12.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.301 0.64 . . . . 63.340000000000003 109.845 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.76 60.53 1.96 Allowed Glycine 0 N--CA 1.475 1.294 0 N-CA-C 110.963 -0.855 . . . . 55.109999999999999 110.963 -170.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.6 tt -156.11 151.15 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.416 -0.892 . . . . 71.010000000000005 109.62 -173.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 t -85.96 158.9 19.77 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.874 0.469 . . . . 70.120000000000005 111.221 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.519 HG23 ' HB2' ' A' ' 40' ' ' ALA . 58.0 mt -56.81 -49.72 92.15 Favored Pre-proline 0 CA--C 1.575 1.936 0 N-CA-C 114.214 1.19 . . . . 75.340000000000003 114.214 -173.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -70.81 -21.9 27.99 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.083 1.855 . . . . 72.400000000000006 113.743 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.27 -39.28 40.55 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.441 1.115 . . . . 74.230000000000004 109.691 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.2 tp -68.65 -34.4 75.65 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-N 113.019 -1.901 . . . . 74.030000000000001 111.375 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.8 70.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.179 0.992 . . . . 73.340000000000003 112.131 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -66.38 -34.92 79.04 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.908 0.883 . . . . 74.420000000000002 111.365 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -69.19 -45.65 69.41 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.577 0.751 . . . . 71.140000000000001 111.509 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 34' ' ' LEU . 31.4 m -90.45 -5.59 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 114.026 1.121 . . . . 73.25 114.026 -170.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 67.81 8.79 6.67 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.38 1.072 . . . . 74.409999999999997 112.051 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.43 ' H ' HG23 ' A' ' 32' ' ' VAL . 60.5 mt -92.4 157.38 16.63 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.581 -0.699 . . . . 73.319999999999993 110.335 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -61.79 151.66 33.58 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.083 0.553 . . . . 74.140000000000001 111.202 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -53.47 -41.76 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.552 0.692 . . . . 74.409999999999997 110.656 174.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.24 -40.75 94.45 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.652 -1.158 . . . . 73.319999999999993 111.672 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -68.06 -41.49 81.92 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.634 0.773 . . . . 65.439999999999998 111.463 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.1 m -66.06 -49.58 67.15 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.16 0.984 . . . . 73.230000000000004 111.029 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.519 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -60.94 -43.01 99.28 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.742 0.817 . . . . 72.030000000000001 112.18 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -49.16 78.19 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.492 0.717 . . . . 75.340000000000003 110.371 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.51 -30.98 70.97 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.815 -1.084 . . . . 75.400000000000006 112.254 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -65.89 -41.62 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.356 0.663 . . . . 72.409999999999997 110.861 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.06 -28.63 73.12 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 116.583 -0.28 . . . . 55.329999999999998 113.563 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -74.26 -43.33 57.39 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.607 0.763 . . . . 73.040000000000006 111.482 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.45 -32.9 73.84 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.045 0.538 . . . . 64.120000000000005 111.624 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.91 -25.19 60.54 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.395 1.078 . . . . 64.540000000000006 113.402 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -69.31 -40.03 77.89 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.254 -0.647 . . . . 75.299999999999997 109.254 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.7 7.79 42.01 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.263 1.025 . . . . 64.150000000000006 111.727 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 56.5 23.91 8.05 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.086 1.355 . . . . 74.25 113.414 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -74.02 -9.66 58.85 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.819 0.847 . . . . 74.140000000000001 113.044 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 m -122.71 142.23 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.279 0.632 . . . . 64.299999999999997 111.492 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 55.1 t -109.07 107.68 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.09 0.956 . . . . 74.109999999999999 108.456 172.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.59 122.6 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 109.38 -0.6 . . . . 72.340000000000003 109.38 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -116.11 148.36 40.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.907 0.883 . . . . 73.109999999999999 109.888 174.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.423 ' HD2' HG23 ' B' ' 5' ' ' ILE . 45.2 mtp85 -118.96 114.65 22.89 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.757 0.423 . . . . 74.329999999999998 111.146 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -114.34 110.2 19.52 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.122 0.969 . . . . 74.450000000000003 109.785 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 58.4 30.02 19.04 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 124.795 1.238 . . . . 64.129999999999995 112.966 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.29 -13.3 62.2 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 113.944 0.338 . . . . 74.310000000000002 113.944 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.07 133.03 40.43 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.612 0.765 . . . . 75.120000000000005 110.686 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -87.52 111.32 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 121.481 0.658 . . . . 74.209999999999994 110.714 -173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -97.81 137.61 36.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.069 1.348 . . . . 73.25 108.901 171.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.436 ' H ' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -123.1 139.12 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.744 0.783 . . . . 75.329999999999998 109.913 171.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 73.8 m-85 -129.01 167.02 18.09 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.588 1.155 . . . . 74.409999999999997 109.295 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -85.15 151.99 23.71 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.378 -0.601 . . . . 75.129999999999995 109.378 167.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.63 145.23 55.8 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 120.855 0.36 . . . . 65.329999999999998 110.735 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.77 -15.28 4.9 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 116.199 -0.455 . . . . 70.129999999999995 112.289 -172.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -66.77 -33.54 75.85 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.117 0.567 . . . . 73.129999999999995 112.46 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -74.16 152.0 39.92 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.621 0.368 . . . . 74.450000000000003 110.5 170.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.08 -48.82 61.68 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.934 0.494 . . . . 63.5 111.465 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -133.27 95.22 3.48 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.911 0.884 . . . . 75.319999999999993 108.92 175.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.3 m -72.4 109.05 5.83 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.068 0.547 . . . . 72.030000000000001 110.855 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -68.75 102.08 1.45 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.546 0.738 . . . . 72.400000000000006 110.322 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -121.97 26.28 6.52 Favored Glycine 0 N--CA 1.474 1.215 0 CA-C-N 116.112 -0.495 . . . . 72.230000000000004 113.371 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 mp -85.83 138.39 32.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.475 0.71 . . . . 75.450000000000003 110.11 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.465 ' HG3' ' HD2' ' A' ' 78' ' ' HIS . 10.2 pt-20 -60.46 141.39 56.49 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.315 0.646 . . . . 71.510000000000005 111.677 175.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.4 ' HD2' ' HB2' ' A' ' 79' ' ' HIS . 28.8 t60 -80.29 -30.3 38.27 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.012 0.525 . . . . 73.140000000000001 110.61 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.465 ' HD2' ' HG3' ' A' ' 76' ' ' GLU . 26.7 p80 42.68 55.09 4.38 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 126.009 1.724 . . . . 73.200000000000003 114.24 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 77' ' ' HIS . 8.4 t-80 -76.45 79.53 3.16 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.746 0.784 . . . . 75.230000000000004 110.955 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -67.57 -45.69 74.87 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.448 1.099 . . . . 72.030000000000001 111.687 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -76.4 91.04 3.26 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.648 -0.501 . . . . 74.219999999999999 109.648 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 123.845 0.858 . . . . 73.340000000000003 111.589 -176.188 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.702 ' SD ' HD12 ' B' ' 5' ' ' ILE . 1.1 pmm? . . . . . 0 CA--C 1.548 0.888 0 CA-C-O 120.675 0.274 . . . . 71.310000000000002 111.608 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.79 155.83 22.93 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.901 0.858 . . . . 73.209999999999994 112.529 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -77.93 -5.24 50.47 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 114.606 -1.179 . . . . 73.0 110.76 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -77.3 -28.33 53.29 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.904 0.882 . . . . 74.510000000000005 111.837 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.702 HD12 ' SD ' ' B' ' 1' ' ' MET . 67.0 mt -58.38 -55.32 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.348 0.659 . . . . 75.109999999999999 110.977 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 22.6 m -63.84 -28.42 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-N 115.034 -0.985 . . . . 71.439999999999998 111.976 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.23 -45.43 48.93 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 123.398 0.436 . . . . 63.299999999999997 113.057 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.72 93.18 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.669 0.788 . . . . 44.200000000000003 111.785 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -65.25 -45.26 85.31 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.216 0.606 . . . . 71.409999999999997 110.434 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.425 ' HB3' ' HG ' ' B' ' 46' ' ' LEU . . . -68.32 -32.03 71.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.658 0.783 . . . . 74.329999999999998 112.132 -174.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.68 96.76 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 116.712 -0.222 . . . . 60.229999999999997 113.125 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -71.53 -39.72 70.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.396 0.678 . . . . 75.430000000000007 111.241 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.544 HG12 HG23 ' B' ' 43' ' ' VAL . 74.3 t -61.85 -41.64 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.743 0.817 . . . . 53.420000000000002 111.15 174.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -67.79 -31.73 71.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.392 0.677 . . . . 61.5 111.598 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -61.36 -45.74 93.13 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.4 0.28 . . . . 73.219999999999999 111.003 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.13 -29.79 67.91 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.389 0.614 . . . . 71.540000000000006 111.23 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.71 ' HG ' HG11 ' B' ' 52' ' ' VAL . 2.5 tm? -72.73 -34.24 66.93 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.893 1.277 . . . . 75.129999999999995 110.541 174.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.1 -20.0 39.02 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.499 0.719 . . . . 71.329999999999998 110.643 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -76.63 -59.46 2.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.832 0.853 . . . . 74.349999999999994 109.889 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.42 110.72 3.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.199 1.0 . . . . 74.219999999999999 109.262 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -90.71 -179.82 5.62 Favored 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 112.566 0.58 . . . . 74.239999999999995 112.566 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.58 51.1 9.97 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.745 -0.661 . . . . 74.540000000000006 111.633 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tp -121.17 140.49 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.252 0.621 . . . . 74.310000000000002 111.71 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 17.0 m -72.23 144.68 48.36 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.863 0.865 . . . . 72.150000000000006 111.257 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 62.2 mt -53.46 -52.36 67.44 Favored Pre-proline 0 CA--C 1.573 1.844 0 N-CA-C 113.671 0.989 . . . . 74.349999999999994 113.671 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -68.96 -24.75 33.03 Favored 'Trans proline' 0 C--N 1.391 2.803 0 C-N-CA 121.692 1.595 . . . . 74.200000000000003 113.823 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -77.42 -47.21 20.35 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.959 0.885 . . . . 74.530000000000001 109.593 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 57.5 tp -56.32 -34.88 66.98 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 113.647 -1.615 . . . . 72.239999999999995 111.69 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.84 98.97 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.875 0.87 . . . . 72.120000000000005 111.708 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -66.26 -40.74 90.36 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.121 0.568 . . . . 73.439999999999998 110.571 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -60.4 -45.83 92.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.874 0.87 . . . . 62.219999999999999 111.405 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.67 4.2 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 112.56 0.578 . . . . 74.349999999999994 112.56 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 61.18 32.75 19.49 Favored 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 124.539 1.135 . . . . 52.43 112.195 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 85.8 mt -123.26 170.27 10.45 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.925 0.89 . . . . 75.439999999999998 111.034 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -69.14 155.26 40.68 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.453 0.701 . . . . 63.409999999999997 111.511 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.26 -48.85 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.514 0.725 . . . . 71.120000000000005 111.481 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.438 ' HB3' HD13 ' A' ' 25' ' ' ILE . 43.6 mt-10 -59.11 -52.54 65.26 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.882 0.873 . . . . 73.219999999999999 111.838 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.1 t -56.64 -32.49 65.4 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.339 1.056 . . . . 74.420000000000002 112.746 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.497 ' O ' HG22 ' B' ' 43' ' ' VAL . 89.5 m -81.48 -46.15 14.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.651 0.78 . . . . 73.519999999999996 110.853 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.48 -52.65 64.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.676 0.991 . . . . 75.209999999999994 113.676 -171.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -26.83 64.57 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 120.882 0.373 . . . . 72.420000000000002 111.092 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.85 -34.71 73.98 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.703 0.801 . . . . 72.200000000000003 111.538 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.544 HG23 HG12 ' B' ' 13' ' ' VAL . 51.2 t -63.18 -33.06 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 122.823 0.449 . . . . 75.400000000000006 109.843 169.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.4 83.59 Favored Glycine 0 CA--C 1.542 1.72 0 CA-C-N 116.535 -0.302 . . . . 64.329999999999998 113.131 172.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.475 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 70.5 t-105 -71.6 -25.26 62.1 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.546 0.738 . . . . 74.230000000000004 111.778 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.425 ' HG ' ' HB3' ' B' ' 10' ' ' ALA . 94.9 mt -76.68 -41.77 44.22 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.519 -0.738 . . . . 75.129999999999995 111.503 165.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.47 -26.76 68.11 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.674 1.189 . . . . 72.25 113.542 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.656 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 18.7 ptt180 -57.11 -31.5 65.35 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 122.715 0.406 . . . . 75.439999999999998 111.84 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . 0.656 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 40.2 mt-10 -106.51 1.57 25.55 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.237 1.015 . . . . 73.540000000000006 111.798 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.38 23.33 10.65 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.966 1.306 . . . . 70.120000000000005 111.707 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.507 ' HG3' ' HB2' ' B' ' 49' ' ' GLU . 52.7 mtpt -68.34 -17.57 64.28 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 122.934 0.494 . . . . 74.420000000000002 111.598 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.71 HG11 ' HG ' ' B' ' 17' ' ' LEU . 28.2 m -125.95 155.25 35.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.665 1.186 . . . . 64.109999999999999 109.762 170.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.635 HG23 ' HB3' ' B' ' 69' ' ' PHE . 98.8 t -115.91 129.66 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.185 0.994 . . . . 75.040000000000006 109.132 173.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.719 ' HB ' ' HB3' ' A' ' 2' ' ' ASP . 91.6 mt -120.82 112.83 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-O 121.357 0.598 . . . . 72.519999999999996 109.969 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -140.93 127.69 20.35 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.604 1.161 . . . . 72.209999999999994 109.499 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -81.4 111.98 18.25 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.458 0.647 . . . . 73.310000000000002 110.936 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.58 115.02 29.74 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.552 1.141 . . . . 75.340000000000003 109.682 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 54.06 31.77 14.35 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.861 1.264 . . . . 64.030000000000001 111.796 -167.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.49 -28.02 7.3 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-N 115.624 -0.717 . . . . 60.299999999999997 113.488 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.78 117.23 17.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.3 0.64 . . . . 75.120000000000005 110.296 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 19.5 tt -72.69 114.23 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 123.683 0.793 . . . . 64.209999999999994 111.726 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -116.53 127.67 54.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.863 0.465 . . . . 73.129999999999995 109.99 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.431 HG13 HG12 ' B' ' 54' ' ' ILE . 2.3 mp -94.51 101.93 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.624 0.77 . . . . 75.340000000000003 108.982 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -88.28 170.71 10.76 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.256 1.022 . . . . 72.25 111.978 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -85.66 146.81 26.67 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.939 0.896 . . . . 72.219999999999999 110.598 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -57.94 -22.9 51.13 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 112.678 0.622 . . . . 74.230000000000004 112.678 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.95 -27.21 56.56 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 114.661 0.625 . . . . 73.329999999999998 114.661 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -149.63 123.24 9.16 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.394 0.678 . . . . 75.209999999999994 110.892 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.635 ' HB3' HG23 ' B' ' 53' ' ' VAL . 24.1 p90 -156.32 161.02 40.22 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.532 0.733 . . . . 70.519999999999996 111.374 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 27.1 t70 52.82 72.77 0.39 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.034 0.934 . . . . 71.040000000000006 111.927 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -85.86 155.77 20.82 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.007 0.523 . . . . 73.400000000000006 110.329 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.1 m -72.35 85.59 1.1 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.949 0.5 . . . . 75.409999999999997 110.236 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -74.45 -9.42 58.57 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.777 0.831 . . . . 74.140000000000001 112.91 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.33 -10.07 51.65 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.772 0.669 . . . . 51.409999999999997 114.772 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -64.76 -31.25 72.39 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 117.852 0.826 . . . . 74.209999999999994 111.747 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -95.22 -31.07 13.67 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.018 0.927 . . . . 74.439999999999998 110.821 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 64.92 -80.97 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.03 1.332 . . . . 75.239999999999995 110.769 -172.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 51.81 144.33 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 127.117 2.167 . . . . 70.409999999999997 114.217 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -71.57 163.14 28.29 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.369 -0.832 . . . . 73.219999999999999 111.607 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -95.21 169.23 10.23 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.755 0.822 . . . . 74.450000000000003 110.787 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -70.14 141.03 52.73 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.452 0.301 . . . . 75.150000000000006 110.977 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.483 1.206 0 C-N-CA 123.741 0.817 . . . . 73.030000000000001 112.55 -173.277 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 121.658 0.742 . . . . 62.530000000000001 111.056 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.556 ' O ' HG12 ' A' ' 6' ' ' VAL . 4.8 m-20 -94.51 9.83 36.99 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.532 0.938 . . . . 74.129999999999995 113.532 -165.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -65.09 -26.76 68.36 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 123.003 0.521 . . . . 74.150000000000006 112.369 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -87.67 -34.82 18.3 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.503 0.721 . . . . 74.209999999999994 111.146 170.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.5 -26.14 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 124.137 0.975 . . . . 74.299999999999997 111.649 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 2' ' ' ASP . 16.9 m -63.15 -32.94 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.009 0.524 . . . . 71.129999999999995 110.711 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.32 -42.83 40.8 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.68 0.612 . . . . 70.150000000000006 112.903 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.19 77.69 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.212 0.605 . . . . 72.430000000000007 111.635 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -75.68 -35.69 60.29 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.548 0.739 . . . . 75.109999999999999 111.279 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.33 66.83 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.381 0.672 . . . . 71.129999999999995 111.488 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.67 -34.62 90.17 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 116.064 -0.516 . . . . 73.129999999999995 112.767 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -66.14 -41.39 90.5 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.041 0.936 . . . . 73.519999999999996 111.329 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.506 ' HA ' HG12 ' A' ' 32' ' ' VAL . 60.9 t -62.65 -47.7 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.597 0.759 . . . . 74.519999999999996 111.462 174.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.433 ' HA ' HD11 ' A' ' 17' ' ' LEU . 12.1 t90 -67.21 -33.08 74.6 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.98 0.512 . . . . 71.439999999999998 111.69 -176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -57.96 -37.8 74.83 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.539 0.735 . . . . 74.530000000000001 110.756 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.17 72.34 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.185 0.594 . . . . 64.430000000000007 111.141 174.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 14' ' ' TRP . 87.0 mt -64.8 -18.36 65.03 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.063 0.945 . . . . 72.219999999999999 113.438 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.21 -34.06 69.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.907 0.883 . . . . 75.340000000000003 112.458 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.85 -33.59 1.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.384 0.674 . . . . 75.230000000000004 111.838 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.9 92.27 7.32 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.433 0.693 . . . . 71.010000000000005 109.727 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -127.19 162.98 24.89 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.685 0.794 . . . . 70.129999999999995 111.411 -170.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.94 59.81 5.69 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 116.042 -0.526 . . . . 70.510000000000005 112.069 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.2 tt -142.42 130.68 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.409 0.684 . . . . 63.420000000000002 110.739 -167.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.0 t -73.87 160.13 31.86 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.049 0.54 . . . . 72.5 110.961 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.0 mt -49.15 -50.94 60.64 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 114.574 1.324 . . . . 73.200000000000003 114.574 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.94 -27.16 17.84 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 121.973 1.782 . . . . 75.129999999999995 113.731 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.19 -43.02 65.15 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.689 1.233 . . . . 73.129999999999995 109.121 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.06 -38.08 87.44 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 112.512 -2.131 . . . . 74.349999999999994 111.157 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.83 -39.39 81.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.726 1.211 . . . . 72.5 112.248 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -63.15 -44.01 96.71 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.325 0.65 . . . . 73.439999999999998 111.298 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -66.04 -42.74 89.14 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.437 0.695 . . . . 74.340000000000003 111.598 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 13' ' ' VAL . 33.0 m -87.55 2.22 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.865 -0.607 . . . . 70.310000000000002 112.286 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 t30 60.66 27.61 17.33 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 124.281 1.032 . . . . 74.209999999999994 112.004 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 44.2 mt -111.66 162.92 14.68 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.742 0.817 . . . . 74.150000000000006 109.561 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.2 t -77.11 164.78 25.37 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.592 0.357 . . . . 72.549999999999997 111.152 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.95 -53.32 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 124.277 1.031 . . . . 72.5 112.536 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.44 -42.9 88.36 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.361 0.664 . . . . 71.420000000000002 111.943 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -64.97 -37.37 87.41 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.998 0.919 . . . . 73.109999999999999 112.373 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 43' ' ' VAL . 87.9 m -77.98 -45.13 24.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.458 0.703 . . . . 73.049999999999997 111.402 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.71 -49.61 75.96 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.227 1.011 . . . . 71.030000000000001 112.071 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.51 -31.36 72.38 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 114.214 -1.357 . . . . 73.200000000000003 111.037 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.06 -36.69 72.38 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.296 0.638 . . . . 52.329999999999998 112.021 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 39' ' ' THR . 98.6 t -64.48 -33.02 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 123.064 0.546 . . . . 72.439999999999998 111.027 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.89 -31.27 79.89 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-N 116.634 -0.257 . . . . 71.400000000000006 113.421 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.45 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 64.6 t-105 -74.15 -28.36 61.29 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 123.639 0.776 . . . . 74.450000000000003 111.28 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.77 -35.5 64.97 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.227 0.611 . . . . 75.120000000000005 111.727 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.85 -30.77 70.32 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.791 0.836 . . . . 71.439999999999998 111.614 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 11.4 ttp180 -52.21 -49.61 63.56 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.771 0.829 . . . . 73.310000000000002 111.158 167.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -77.09 -12.47 59.94 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.896 -1.047 . . . . 74.430000000000007 112.568 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.3 m120 61.7 22.41 12.94 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.018 1.327 . . . . 70.040000000000006 112.488 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -89.01 -2.36 58.54 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.763 0.825 . . . . 71.510000000000005 111.752 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.64 154.41 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.811 0.845 . . . . 64.400000000000006 110.919 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 64' ' ' TYR . 6.8 m -134.46 132.35 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.399 1.08 . . . . 72.430000000000007 110.116 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.21 126.46 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.691 0.796 . . . . 71.329999999999998 109.909 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -110.84 139.82 45.83 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.81 0.844 . . . . 74.540000000000006 111.044 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.457 ' HG2' HG12 ' A' ' 61' ' ' ILE . 82.0 mtm180 -116.1 124.03 49.37 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.11 0.964 . . . . 74.310000000000002 109.61 173.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 118.13 12.71 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.948 0.899 . . . . 65.420000000000002 109.538 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.0 t30 58.29 31.88 21.38 Favored 'General case' 0 CA--C 1.577 2.004 0 CA-C-O 121.998 0.904 . . . . 75.540000000000006 111.363 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.94 -9.55 68.71 Favored Glycine 0 CA--C 1.542 1.762 0 CA-C-N 115.648 -0.705 . . . . 73.349999999999994 114.269 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.3 mt -83.33 122.16 28.09 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.126 0.971 . . . . 74.439999999999998 110.856 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.457 HG12 ' HG2' ' A' ' 56' ' ' ARG . 64.1 mt -95.39 126.79 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.283 0.633 . . . . 75.420000000000002 109.779 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -133.3 141.86 48.19 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.618 0.767 . . . . 70.349999999999994 110.434 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -96.91 117.93 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.002 0.921 . . . . 71.329999999999998 109.745 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.505 ' HB2' HG23 ' A' ' 53' ' ' VAL . 25.5 m-85 -108.05 164.21 12.48 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.595 1.158 . . . . 73.450000000000003 109.109 173.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . 20.1 p-10 -94.16 161.83 14.11 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.405 -0.591 . . . . 74.349999999999994 109.405 169.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -77.52 133.65 38.49 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 109.148 -0.686 . . . . 74.120000000000005 109.148 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.07 -5.85 1.97 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.998 -0.546 . . . . 74.430000000000007 112.414 -170.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -92.72 -17.26 24.46 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.575 0.75 . . . . 75.230000000000004 111.992 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.445 ' HE2' HG22 ' A' ' 53' ' ' VAL . 84.1 m-85 -101.79 -36.77 8.57 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.196 0.599 . . . . 70.310000000000002 111.671 -173.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.22 152.57 23.24 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.48 0.657 . . . . 65.540000000000006 111.329 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -79.98 -18.0 51.46 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 115.098 -0.955 . . . . 75.209999999999994 111.631 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.3 m -65.12 -37.61 87.98 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.677 0.791 . . . . 71.329999999999998 112.988 -174.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -74.53 141.62 44.83 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.649 0.38 . . . . 74.109999999999999 111.623 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.7 -99.48 0.19 Allowed Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.841 -0.904 . . . . 72.439999999999998 110.841 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 mp 64.14 -72.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.381 1.472 . . . . 71.040000000000006 113.048 172.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -155.34 125.02 6.45 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.132 0.573 . . . . 73.319999999999993 112.025 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -87.13 124.47 33.3 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.957 -0.757 . . . . 74.319999999999993 108.957 166.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -86.56 -66.42 0.91 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.967 0.507 . . . . 75.230000000000004 109.734 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.1 t60 58.02 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.861 1.264 . . . . 74.129999999999995 112.938 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 71.14 0.89 3.59 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.782 1.233 . . . . 74.349999999999994 112.477 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -70.78 101.27 2.06 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.496 0.718 . . . . 73.510000000000005 109.391 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.3 t60 . . . . . 0 N--CA 1.481 1.105 0 C-N-CA 124.0 0.92 . . . . 75.5 111.81 -175.842 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 111.598 0.221 . . . . 73.120000000000005 111.598 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.423 ' O ' HG23 ' B' ' 6' ' ' VAL . 5.7 p-10 -52.9 -41.74 64.69 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.86 1.264 . . . . 71.439999999999998 112.855 -175.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -51.09 -44.83 61.31 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.251 1.42 . . . . 65.230000000000004 112.628 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -77.45 -40.53 42.94 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.654 0.782 . . . . 74.439999999999998 111.546 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.73 -58.64 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.513 0.725 . . . . 75.129999999999995 111.218 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.429 HG11 HD23 ' B' ' 41' ' ' LEU . 32.7 m -61.45 -27.6 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.361 0.664 . . . . 74.209999999999994 111.998 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.96 -49.85 71.45 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 123.47 0.482 . . . . 73.239999999999995 112.83 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.17 88.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.784 0.834 . . . . 74.109999999999999 112.043 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -85.2 -13.01 51.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.26 0.837 . . . . 73.099999999999994 113.26 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 -39.45 69.85 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.857 0.463 . . . . 71.209999999999994 111.367 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.23 -31.04 71.54 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 112.378 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -70.0 -45.74 66.65 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.892 0.877 . . . . 74.450000000000003 111.429 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.534 ' HA ' HG13 ' B' ' 32' ' ' VAL . 30.1 m -71.62 -32.46 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 122.533 0.333 . . . . 75.120000000000005 111.538 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.518 ' HA ' HD12 ' B' ' 17' ' ' LEU . 21.0 t90 -69.98 -33.36 71.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.499 0.32 . . . . 74.310000000000002 110.718 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -58.07 -45.87 86.38 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.932 0.493 . . . . 72.120000000000005 110.563 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.584 ' HB3' ' HE3' ' B' ' 31' ' ' LYS . . . -67.92 -29.59 68.71 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.677 -0.692 . . . . 72.450000000000003 111.712 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.629 ' HB3' HD22 ' B' ' 65' ' ' ASN . 58.6 mt -69.69 -33.02 71.95 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.153 0.981 . . . . 71.310000000000002 111.516 170.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.0 -29.72 64.49 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.915 0.886 . . . . 72.400000000000006 110.942 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -76.68 -49.03 17.11 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.649 0.78 . . . . 73.349999999999994 110.729 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.02 131.7 31.09 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.133 0.973 . . . . 63.329999999999998 109.502 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -114.61 147.34 39.68 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 122.911 0.484 . . . . 63.329999999999998 112.07 -163.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 24.45 69.6 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 115.984 -0.553 . . . . 64.340000000000003 113.266 -172.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.415 HD13 ' HG3' ' B' ' 27' ' ' GLU . 11.5 tt -77.05 143.35 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 124.169 0.987 . . . . 74.319999999999993 111.833 -170.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.6 m -61.24 141.73 57.31 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.756 0.822 . . . . 75.340000000000003 111.353 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.505 HG21 ' HB2' ' B' ' 40' ' ' ALA . 69.6 mt -57.63 -46.09 99.79 Favored Pre-proline 0 CA--C 1.576 1.952 0 N-CA-C 113.777 1.028 . . . . 75.200000000000003 113.777 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.25 -26.47 41.94 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 121.785 1.657 . . . . 75.129999999999995 113.871 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . 0.415 ' HG3' HD13 ' B' ' 23' ' ' ILE . 11.7 tp10 -76.67 -43.51 37.57 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.766 1.269 . . . . 70.450000000000003 109.773 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 58.8 tp -58.38 -40.22 81.71 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 112.833 -1.985 . . . . 73.010000000000005 111.013 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.15 75.43 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.536 1.134 . . . . 74.049999999999997 112.552 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -65.57 -42.05 92.23 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.48 0.712 . . . . 75.409999999999997 111.983 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.584 ' HE3' ' HB3' ' B' ' 16' ' ' ALA . 44.1 mtmt -72.67 -30.72 64.49 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.067 0.395 . . . . 75.420000000000002 112.067 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.534 HG13 ' HA ' ' B' ' 13' ' ' VAL . 25.4 m -96.45 -4.8 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 112.876 0.695 . . . . 73.400000000000006 112.876 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 65.83 15.87 10.24 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.442 1.097 . . . . 70.209999999999994 112.594 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt -96.89 163.84 12.8 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.699 -0.625 . . . . 71.120000000000005 110.967 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 37.5 m -66.45 151.44 47.18 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.935 -0.575 . . . . 75.010000000000005 110.152 171.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 58.1 t -55.51 -45.79 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 123.268 0.627 . . . . 73.239999999999995 111.857 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.38 -44.06 97.8 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.874 0.87 . . . . 70.340000000000003 112.374 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t -63.46 -38.5 91.37 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.563 0.745 . . . . 72.450000000000003 111.417 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 89.6 m -68.36 -48.91 63.54 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.081 -0.963 . . . . 74.310000000000002 110.781 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.505 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -58.88 -36.85 75.32 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.0 0.92 . . . . 73.299999999999997 112.47 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.429 HD23 HG11 ' B' ' 6' ' ' VAL . 0.6 OUTLIER -66.28 -48.18 71.24 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.025 0.93 . . . . 75.450000000000003 110.078 178.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.04 68.9 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.53 -0.759 . . . . 62.299999999999997 111.62 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 73.8 t -77.63 -37.78 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 123.263 0.625 . . . . 63.130000000000003 111.057 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.46 -27.78 72.22 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 121.432 0.462 . . . . 52.240000000000002 112.326 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -73.39 -30.02 63.0 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.295 1.038 . . . . 73.140000000000001 110.956 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.445 HD12 ' HD1' ' B' ' 14' ' ' TRP . 96.2 mt -72.0 -34.17 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.199 0.6 . . . . 72.140000000000001 111.658 171.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.94 67.12 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.692 0.797 . . . . 61.030000000000001 111.926 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.421 ' HB2' ' HG3' ' A' ' 48' ' ' ARG . 10.0 ptt-85 -60.88 -37.24 81.48 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.66 0.784 . . . . 71.230000000000004 111.517 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . 0.528 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 41.4 mt-10 -93.9 5.24 52.31 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.861 0.864 . . . . 51.420000000000002 111.772 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 64.4 23.33 12.96 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.684 1.193 . . . . 73.519999999999996 112.931 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.528 ' HG3' ' HB2' ' B' ' 49' ' ' GLU . 28.3 mtpp -79.21 -13.08 59.92 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.752 0.649 . . . . 73.420000000000002 112.752 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' B' ' 64' ' ' TYR . 31.3 m -123.0 143.69 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.316 0.579 . . . . 72.150000000000006 112.185 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 33.4 t -113.11 105.1 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.307 0 C-N-CA 124.625 1.17 . . . . 74.430000000000007 109.959 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.495 HG21 HG23 ' B' ' 61' ' ' ILE . 3.4 mp -85.68 118.9 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 123.282 0.633 . . . . 71.230000000000004 110.925 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.17 117.38 19.82 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.899 0.88 . . . . 73.439999999999998 111.161 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -85.4 116.37 23.69 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.532 0.733 . . . . 72.140000000000001 110.352 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -125.03 115.4 20.47 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.577 1.151 . . . . 62.030000000000001 108.117 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 58.41 31.34 20.83 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.497 1.119 . . . . 74.219999999999999 111.163 -168.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.43 -19.37 32.37 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 115.442 -0.799 . . . . 72.140000000000001 113.867 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 mt -80.53 123.13 27.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.159 0.984 . . . . 54.25 111.206 -172.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.495 HG23 HG21 ' B' ' 54' ' ' ILE . 3.3 mp -80.65 127.85 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.666 0.786 . . . . 72.25 110.893 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.59 145.07 43.63 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.009 0.923 . . . . 74.299999999999997 109.3 168.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.495 HD13 ' H ' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -119.69 104.61 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-O 122.216 1.008 . . . . 73.430000000000007 109.876 174.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.588 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 77.5 m-85 -86.13 174.54 9.08 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.027 -0.988 . . . . 72.310000000000002 111.781 177.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.629 HD22 ' HB3' ' B' ' 17' ' ' LEU . 0.9 OUTLIER -86.49 159.07 19.41 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.362 0.601 . . . . 63.039999999999999 111.334 174.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -50.78 96.12 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.863 1.265 . . . . 72.230000000000004 112.073 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.6 -40.15 0.24 Allowed Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.515 -0.766 . . . . 65.109999999999999 112.356 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -81.59 -10.27 59.47 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.629 0.772 . . . . 64.299999999999997 112.551 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -73.42 132.49 43.03 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.674 0.39 . . . . 74.439999999999998 111.856 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -129.82 147.74 51.62 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.15 0.58 . . . . 74.519999999999996 110.166 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -157.65 -74.5 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.636 0.775 . . . . 74.329999999999998 109.914 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 37.4 t -179.95 -170.5 0.15 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.742 1.217 . . . . 72.129999999999995 108.741 -171.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -64.97 143.08 58.19 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 110.002 -0.37 . . . . 73.329999999999998 110.002 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.74 26.66 3.8 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 112.122 -0.391 . . . . 71.25 112.122 -171.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 46.9 mt -76.7 132.53 39.4 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.407 1.083 . . . . 75.310000000000002 110.975 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -72.92 109.18 6.28 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.042 0.537 . . . . 72.329999999999998 109.61 173.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -75.07 85.65 2.33 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.635 0.774 . . . . 72.400000000000006 110.672 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -70.14 113.66 7.54 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.694 0.798 . . . . 75.219999999999999 111.066 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -93.58 128.41 39.72 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.353 1.061 . . . . 72.409999999999997 111.744 -171.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -159.39 162.93 35.87 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.204 1.001 . . . . 74.519999999999996 110.431 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -77.44 123.66 26.85 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.251 0.621 . . . . 64.319999999999993 111.193 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 p80 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 123.943 0.897 . . . . 72.430000000000007 111.832 176.082 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.76 -0.459 . . . . 74.099999999999994 109.76 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.63 125.05 18.28 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.959 0.903 . . . . 74.099999999999994 111.887 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 6' ' ' VAL . 86.1 tttt -80.19 -25.19 39.83 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.248 0.619 . . . . 73.25 111.616 -176.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.73 -15.88 62.14 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.923 0.712 . . . . 74.549999999999997 112.923 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.05 -40.27 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.221 0.609 . . . . 73.329999999999998 111.451 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 3' ' ' LYS . 13.5 m -66.11 -33.45 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 122.177 0.191 . . . . 71.200000000000003 111.449 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.09 -43.37 33.37 Favored Glycine 0 C--N 1.353 1.513 0 O-C-N 123.479 0.487 . . . . 35.450000000000003 113.281 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 -46.48 76.33 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.557 0.743 . . . . 74.439999999999998 111.6 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.84 -26.56 66.11 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.812 0.845 . . . . 62.43 111.8 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.11 -34.44 73.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.003 0.521 . . . . 72.140000000000001 111.324 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.16 -38.76 94.18 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 116.183 -0.462 . . . . 72.540000000000006 113.152 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -69.49 -48.52 60.37 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.308 0.643 . . . . 75.310000000000002 111.733 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.86 -36.8 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 122.333 0.253 . . . . 74.549999999999997 111.462 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.536 ' HA ' HD13 ' A' ' 17' ' ' LEU . 54.4 t90 -64.92 -40.16 94.62 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.416 0.286 . . . . 75.340000000000003 111.052 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -60.94 -39.82 90.92 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.848 0.459 . . . . 73.200000000000003 110.904 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.82 69.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.469 0.708 . . . . 71.5 111.926 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.536 HD13 ' HA ' ' A' ' 14' ' ' TRP . 84.4 mt -66.11 -45.27 81.73 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.537 0.735 . . . . 74.230000000000004 111.663 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -62.39 -31.55 72.24 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 120.815 0.34 . . . . 62.409999999999997 111.283 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.36 -49.35 50.18 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.439 0.696 . . . . 74.340000000000003 110.698 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.64 105.09 0.51 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.748 0.819 . . . . 72.310000000000002 111.084 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.48 -179.6 3.92 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.847 0.859 . . . . 64.25 111.403 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.42 33.09 44.88 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.033 -0.53 . . . . 44.299999999999997 111.824 -171.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.4 tt -122.5 154.55 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 124.432 1.093 . . . . 65.310000000000002 110.096 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.9 m -63.16 145.98 54.32 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.838 0.455 . . . . 73.319999999999993 111.302 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' B' ' 37' ' ' GLU . 66.0 mt -58.33 -43.27 98.02 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 123.989 0.916 . . . . 73.409999999999997 113.363 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.495 ' HA ' HG21 ' A' ' 36' ' ' VAL . 36.6 Cg_endo -62.69 -35.2 70.76 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 122.244 1.963 . . . . 71.450000000000003 114.284 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -69.84 -51.26 35.02 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.25 1.024 . . . . 73.340000000000003 109.187 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.8 tp -54.26 -37.79 65.07 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 112.811 -1.995 . . . . 73.409999999999997 112.123 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.15 92.43 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.191 0.997 . . . . 63.219999999999999 112.136 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -67.5 -26.5 66.37 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.279 0.631 . . . . 75.329999999999998 111.82 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.14 -47.15 46.46 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.548 0.739 . . . . 75.239999999999995 111.094 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -84.29 0.96 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.216 0.606 . . . . 74.030000000000001 111.945 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 69.26 12.04 8.31 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.404 1.482 . . . . 70.209999999999994 113.632 174.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.3 mt -93.66 169.19 10.51 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.298 0.639 . . . . 74.239999999999995 110.523 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.6 p -78.06 162.93 26.33 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 110.24 -0.281 . . . . 74.319999999999993 110.24 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' A' ' 26' ' ' PRO . 40.8 t -56.19 -47.55 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.799 0.84 . . . . 75.340000000000003 111.418 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.19 -41.72 97.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.989 -1.005 . . . . 73.340000000000003 112.186 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -67.06 -39.19 86.84 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.404 0.682 . . . . 75.340000000000003 112.315 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 43' ' ' VAL . 78.4 m -69.15 -48.62 61.87 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.513 0.725 . . . . 73.430000000000007 111.615 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HB1' HG23 ' A' ' 25' ' ' ILE . . . -61.61 -38.38 87.4 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.38 0.672 . . . . 72.549999999999997 112.144 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.533 HD23 HG23 ' B' ' 43' ' ' VAL . 1.6 tm? -65.75 -39.09 90.74 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 124.95 1.3 . . . . 75.450000000000003 110.792 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.97 -33.32 70.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.433 0.693 . . . . 72.450000000000003 111.797 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.614 HG12 HD12 ' A' ' 63' ' ' ILE . 89.8 t -66.43 -31.04 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.072 0.549 . . . . 75.340000000000003 111.18 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.48 -30.11 73.54 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-N 116.751 -0.204 . . . . 64.329999999999998 113.535 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -73.99 -31.12 62.83 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.505 0.722 . . . . 74.010000000000005 110.982 173.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.67 -30.27 65.53 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.459 0.704 . . . . 52.130000000000003 111.609 172.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.09 -27.65 68.91 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.739 0.816 . . . . 74.239999999999995 111.655 169.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -65.96 -42.44 89.92 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.297 0.57 . . . . 75.530000000000001 110.15 169.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.81 -22.47 61.56 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.08 -0.964 . . . . 55.420000000000002 111.834 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 t30 65.71 22.4 11.58 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 125.171 1.388 . . . . 72.109999999999999 111.167 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -97.26 6.0 49.09 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.7 0.8 . . . . 74.049999999999997 112.87 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.8 151.16 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.808 0.843 . . . . 70.120000000000005 110.875 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 69' ' ' PHE . 86.6 t -111.68 107.63 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.578 0.751 . . . . 71.439999999999998 109.381 172.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.5 mt -96.44 112.86 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.143 -0.688 . . . . 75.230000000000004 109.143 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -134.52 125.88 28.23 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 110.077 -0.342 . . . . 71.540000000000006 110.077 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -87.45 107.8 18.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.016 0.926 . . . . 75.530000000000001 111.155 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' O ' HD23 ' A' ' 60' ' ' LEU . 2.3 mptm? -105.19 141.61 36.43 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.294 1.038 . . . . 74.349999999999994 108.87 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.8 p30 44.18 29.33 0.34 Allowed 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 125.334 1.454 . . . . 71.319999999999993 113.76 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.07 -28.67 12.88 Favored Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.274 0.869 . . . . 70.129999999999995 115.274 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -90.73 154.33 19.62 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.757 1.278 . . . . 75.219999999999999 112.037 -174.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.32 116.29 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.899 0.88 . . . . 74.010000000000005 109.84 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.95 128.6 56.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.337 0.655 . . . . 74.439999999999998 110.235 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.614 HD12 HG12 ' A' ' 43' ' ' VAL . 23.0 mm -92.27 105.7 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.426 0.69 . . . . 75.040000000000006 110.221 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -97.6 172.64 7.59 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.234 1.014 . . . . 73.530000000000001 110.804 176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -98.93 170.58 8.63 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.23 0.612 . . . . 71.400000000000006 109.97 164.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.69 112.71 0.81 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.749 0.82 . . . . 72.420000000000002 112.351 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.87 -16.73 60.19 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 116.131 -0.486 . . . . 62.240000000000002 113.85 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -87.15 14.07 8.32 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.025 0.93 . . . . 74.439999999999998 113.036 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.576 ' HB3' HG11 ' A' ' 53' ' ' VAL . 49.6 p90 -60.46 -9.86 4.21 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.832 1.419 . . . . 64.219999999999999 114.832 -172.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -101.94 -32.99 9.93 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 112.838 0.681 . . . . 75.430000000000007 112.838 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -82.38 132.21 35.22 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 122.81 0.444 . . . . 73.0 112.073 -173.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.3 t -120.05 168.6 11.01 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.834 0.854 . . . . 74.420000000000002 112.132 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -79.02 169.83 17.6 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.761 1.224 . . . . 75.430000000000007 111.674 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.73 -135.99 7.43 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 116.383 -0.372 . . . . 61.100000000000001 112.931 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.6 mp -130.27 118.63 21.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 117.648 0.724 . . . . 74.409999999999997 110.569 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -146.0 137.45 24.83 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.675 1.19 . . . . 60.520000000000003 109.278 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -135.98 110.69 8.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.96 0.904 . . . . 72.099999999999994 109.8 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -68.6 141.13 55.53 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.846 0.858 . . . . 64.230000000000004 111.653 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.9 114.94 2.31 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.692 0.797 . . . . 74.510000000000005 110.656 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -74.84 -171.54 1.34 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.422 0.689 . . . . 64.010000000000005 111.671 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 67.99 78.42 0.23 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.514 1.126 . . . . 75.099999999999994 111.264 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 124.273 1.029 . . . . 73.150000000000006 110.003 176.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttp . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 120.88 0.371 . . . . 74.129999999999995 110.799 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -80.53 -6.41 58.17 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.925 1.083 . . . . 75.439999999999998 113.925 -172.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -60.52 -43.44 97.13 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.328 0.513 . . . . 73.400000000000006 111.609 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -86.4 -25.82 25.09 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.764 0.426 . . . . 65.329999999999998 111.861 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 72.3 mt -66.77 -46.34 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.839 0.456 . . . . 75.109999999999999 110.877 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.2 m -64.6 -26.24 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 122.916 0.487 . . . . 72.129999999999995 111.078 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' B' ' 45' ' ' TRP . . . -65.57 -51.97 43.26 Favored Glycine 0 C--N 1.354 1.581 0 O-C-N 123.665 0.603 . . . . 72.150000000000006 113.543 172.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.64 85.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.48 0.712 . . . . 64.340000000000003 111.745 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . 0.47 ' HB3' HD13 ' B' ' 34' ' ' LEU . 5.7 m-20 -68.65 -29.02 67.41 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.22 1.008 . . . . 74.010000000000005 111.519 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.519 ' HB3' ' HG ' ' B' ' 46' ' ' LEU . . . -73.26 -39.0 65.75 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.857 0.463 . . . . 74.109999999999999 110.969 176.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.21 -32.34 82.21 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-O 121.358 0.421 . . . . 54.299999999999997 112.281 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.8 -35.66 77.3 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.675 1.19 . . . . 73.129999999999995 111.683 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.449 HG13 HG13 ' B' ' 43' ' ' VAL . 74.7 t -69.51 -40.41 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.488 0.715 . . . . 73.099999999999994 111.317 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -66.13 -32.5 73.98 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.264 0.626 . . . . 75.230000000000004 110.943 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -54.72 -42.28 71.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.776 0.83 . . . . 75.230000000000004 111.472 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.91 70.81 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.5 0.72 . . . . 52.310000000000002 112.528 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.643 HD13 HG12 ' B' ' 52' ' ' VAL . 82.7 mt -62.91 -42.67 99.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.531 0.733 . . . . 74.439999999999998 111.476 172.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -64.65 -22.11 66.9 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.377 0.671 . . . . 71.209999999999994 111.651 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.33 -50.73 13.51 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.48 0.712 . . . . 74.439999999999998 110.262 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.3 124.34 0.72 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.823 0.849 . . . . 55.439999999999998 111.137 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -74.81 175.1 8.33 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.439 0.695 . . . . 73.400000000000006 112.593 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.42 20.5 78.34 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.961 -0.563 . . . . 75.329999999999998 112.974 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' B' ' 28' ' ' LEU . 8.9 tp -84.73 124.39 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.946 0.899 . . . . 72.430000000000007 110.285 -176.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -85.38 147.03 26.7 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.845 0.458 . . . . 62.43 110.584 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 88.0 mt -49.74 -44.98 79.12 Favored Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 114.965 1.468 . . . . 74.120000000000005 114.965 -173.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.61 -48.17 21.71 Favored 'Trans proline' 0 C--N 1.392 2.819 0 C-N-CA 122.332 2.021 . . . . 71.150000000000006 114.374 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -72.09 -38.43 69.38 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.835 1.302 . . . . 75.5 110.072 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.456 ' HB2' HG13 ' B' ' 23' ' ' ILE . 56.0 tp -60.88 -33.95 73.89 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 112.642 -2.072 . . . . 75.219999999999999 111.34 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.7 -35.87 79.27 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.299 1.04 . . . . 63.439999999999998 112.484 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -64.91 -43.9 91.32 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 122.857 0.463 . . . . 73.409999999999997 110.523 173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -64.74 -39.39 93.54 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.429 -0.805 . . . . 63.43 112.137 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.433 HG11 HG23 ' B' ' 13' ' ' VAL . 23.4 m -97.53 -3.1 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 112.947 0.721 . . . . 72.150000000000006 112.947 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.7 28.5 14.94 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 124.558 1.143 . . . . 73.140000000000001 111.672 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.47 HD13 ' HB3' ' B' ' 9' ' ' ASN . 92.4 mt -109.49 166.11 11.14 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.533 0.733 . . . . 74.349999999999994 110.564 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 43.6 t -73.87 161.64 29.93 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.1 0.56 . . . . 64.140000000000001 110.615 170.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.5 -47.46 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.239 0.616 . . . . 73.510000000000005 111.741 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.53 ' HB3' HD11 ' A' ' 25' ' ' ILE . 42.7 mt-10 -61.05 -42.2 98.04 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.024 0.93 . . . . 72.239999999999995 112.339 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 39.4 t -67.24 -34.95 78.54 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.383 0.673 . . . . 75.239999999999995 111.665 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 45.0 m -79.94 -34.54 38.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.939 0.896 . . . . 71.329999999999998 110.982 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.86 -33.58 72.46 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.747 0.819 . . . . 75.319999999999993 111.139 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -75.4 -34.26 61.04 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 115.398 -0.819 . . . . 74.450000000000003 110.511 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.98 90.42 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.945 0.498 . . . . 72.409999999999997 111.767 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.533 HG23 HD23 ' A' ' 41' ' ' LEU . 20.2 m -68.75 -29.16 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 122.483 0.313 . . . . 74.319999999999993 110.916 172.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.4 -34.36 89.09 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.188 -0.46 . . . . 63.5 113.198 171.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.4 ' CD1' ' HA2' ' B' ' 7' ' ' GLY . 61.1 t-105 -72.51 -33.84 67.19 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.683 0.393 . . . . 72.140000000000001 110.372 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' B' ' 10' ' ' ALA . 53.2 mt -66.64 -27.93 68.07 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.633 0.373 . . . . 74.040000000000006 111.875 170.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.73 74.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.986 0.515 . . . . 73.329999999999998 111.609 168.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -64.68 -43.41 93.62 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.081 0.467 . . . . 73.420000000000002 110.164 170.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -67.8 -25.52 65.63 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.344 -0.844 . . . . 75.239999999999995 111.654 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 67.0 22.91 9.92 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.509 1.524 . . . . 70.319999999999993 111.797 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -95.58 3.55 53.98 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.882 1.067 . . . . 73.109999999999999 113.882 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.643 HG12 HD13 ' B' ' 17' ' ' LEU . 15.7 m -123.32 153.35 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.485 0.66 . . . . 71.450000000000003 112.407 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 91.4 t -108.72 125.84 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.494 1.118 . . . . 71.019999999999996 109.309 171.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 mm -104.8 116.52 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.129 0.572 . . . . 75.319999999999993 109.881 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -117.72 123.59 46.42 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.435 0.694 . . . . 64.239999999999995 110.1 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -93.57 97.19 10.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.082 0.553 . . . . 74.349999999999994 109.823 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.602 ' HD3' ' HG3' ' B' ' 62' ' ' GLU . 8.7 mtpm? -105.11 113.2 26.65 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.041 0.936 . . . . 74.540000000000006 110.149 -175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 60.28 28.94 18.58 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.605 1.562 . . . . 65.150000000000006 111.733 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.62 -2.32 87.29 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 114.591 0.596 . . . . 73.319999999999993 114.591 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.67 149.37 22.88 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.009 0.905 . . . . 74.310000000000002 111.635 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.8 mm -87.14 119.1 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.178 0.591 . . . . 72.450000000000003 110.861 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . 0.602 ' HG3' ' HD3' ' B' ' 57' ' ' LYS . 7.2 mm-40 -116.1 121.63 42.73 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.286 1.034 . . . . 75.099999999999994 109.395 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.511 HG23 HD23 ' B' ' 17' ' ' LEU . 17.5 mm -100.75 122.35 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.19 0.596 . . . . 74.439999999999998 110.822 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.64 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 22.4 m-85 -116.18 169.15 9.5 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.109 0.964 . . . . 72.200000000000003 111.244 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -77.62 141.28 39.56 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.633 -0.712 . . . . 73.340000000000003 111.225 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -49.84 -25.96 3.58 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.899 1.28 . . . . 73.140000000000001 114.217 172.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.88 -18.81 66.9 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 115.077 0.791 . . . . 64.510000000000005 115.077 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -145.06 127.3 15.76 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.34 0.57 . . . . 74.109999999999999 110.508 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -144.02 158.02 43.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.554 0.742 . . . . 75.329999999999998 111.26 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.08 123.93 22.39 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.47 0.708 . . . . 74.150000000000006 110.703 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -87.78 -177.91 5.93 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.671 0.788 . . . . 74.439999999999998 111.745 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 39.6 t -59.99 -51.67 68.68 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.651 -0.704 . . . . 74.329999999999998 110.33 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -90.89 80.8 5.76 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.424 -0.807 . . . . 73.109999999999999 109.315 171.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.36 -6.36 55.31 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 115.462 -0.79 . . . . 54.009999999999998 112.608 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 48.9 tp 75.31 -35.88 0.29 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 126.249 1.82 . . . . 75.219999999999999 113.115 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -54.67 131.93 44.43 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.423 1.089 . . . . 74.439999999999998 113.246 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -154.52 85.79 1.13 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.454 1.102 . . . . 73.540000000000006 108.449 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -61.88 160.56 11.89 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.854 1.262 . . . . 74.209999999999994 112.6 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -42.86 133.59 3.57 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.587 1.155 . . . . 74.230000000000004 111.871 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -58.25 125.27 22.53 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.185 0.594 . . . . 74.420000000000002 111.555 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -88.73 149.18 23.59 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.111 0.564 . . . . 72.219999999999999 111.158 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 21.7 p80 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 121.903 0.859 . . . . 75.230000000000004 112.29 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.539 0.209 . . . . 70.430000000000007 110.722 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -20.27 62.19 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 112.991 0.737 . . . . 75.109999999999999 112.991 -168.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -60.12 -38.38 82.84 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 119.376 0.989 . . . . 75.150000000000006 112.801 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -79.58 -41.06 27.95 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.84 0.456 . . . . 75.420000000000002 110.673 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.4 mt -65.44 -41.3 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.725 0.81 . . . . 74.25 112.335 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.498 HG13 HD12 ' A' ' 41' ' ' LEU . 29.5 m -65.13 -30.39 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 122.993 0.517 . . . . 62.32 111.517 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -42.52 85.08 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 112.498 -0.241 . . . . 63.25 112.498 172.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.89 -45.82 69.99 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.795 0.838 . . . . 72.400000000000006 111.949 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -77.37 -23.06 50.86 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 122.971 0.508 . . . . 73.409999999999997 111.946 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.03 -35.58 59.45 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.91 0.484 . . . . 54.409999999999997 111.209 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.61 -31.57 78.96 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 121.613 0.563 . . . . 75.540000000000006 112.231 172.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -68.92 -45.01 71.95 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 125.136 1.374 . . . . 74.340000000000003 110.79 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.447 ' HA ' HG11 ' A' ' 32' ' ' VAL . 39.2 t -64.48 -36.58 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 124.534 1.134 . . . . 74.219999999999999 111.652 173.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.408 ' NE1' ' HB3' ' A' ' 51' ' ' LYS . 15.9 t90 -71.5 -32.23 68.0 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.442 0.697 . . . . 73.409999999999997 110.908 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -59.84 -32.93 71.14 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.563 0.745 . . . . 74.310000000000002 111.545 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.77 -22.86 65.78 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.804 0.668 . . . . 73.230000000000004 112.804 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.596 HD12 HG13 ' A' ' 52' ' ' VAL . 94.7 mt -68.8 -38.83 80.23 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.766 0.826 . . . . 73.230000000000004 112.687 173.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -56.86 -36.27 69.85 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.525 0.73 . . . . 74.340000000000003 111.303 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.62 -47.75 13.65 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.488 -0.778 . . . . 74.209999999999994 110.966 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.73 113.32 6.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.07 0.948 . . . . 65.329999999999998 111.392 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -94.94 128.3 41.63 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.404 -0.961 . . . . 75.150000000000006 108.404 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.8 47.81 4.66 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 111.896 -0.482 . . . . 74.120000000000005 111.896 -172.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.8 tp -114.35 137.27 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 C-N-CA 123.898 0.879 . . . . 73.299999999999997 110.731 -175.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.7 p -82.49 162.3 22.09 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.321 0.648 . . . . 61.420000000000002 111.99 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.9 mt -55.41 -54.34 52.1 Favored Pre-proline 0 CA--C 1.579 2.084 0 N-CA-C 113.84 1.052 . . . . 75.010000000000005 113.84 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.14 -30.61 20.24 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.03 1.82 . . . . 72.319999999999993 113.432 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -71.43 -44.33 65.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.265 0.626 . . . . 72.310000000000002 111.619 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.07 -30.65 63.86 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.91 0.484 . . . . 75.409999999999997 110.334 175.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.33 -41.86 76.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.551 0.74 . . . . 72.319999999999993 112.016 177.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -69.22 -30.82 69.06 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.079 0.552 . . . . 75.319999999999993 111.671 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -69.94 -40.48 75.44 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.079 0.552 . . . . 75.310000000000002 111.578 174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.447 HG11 ' HA ' ' A' ' 13' ' ' VAL . 21.5 m -96.72 7.74 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.365 0.666 . . . . 72.0 112.115 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.47 16.96 9.13 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.454 1.102 . . . . 72.540000000000006 113.935 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt -99.85 159.43 15.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.53 0.732 . . . . 74.400000000000006 110.414 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.7 t -68.8 161.02 29.38 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.761 0.425 . . . . 74.120000000000005 110.847 169.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -59.3 -42.92 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 122.705 0.402 . . . . 75.450000000000003 111.491 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -64.82 -48.35 74.69 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.214 0.606 . . . . 73.319999999999993 111.784 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 t -57.08 -39.18 74.48 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.016 0.926 . . . . 75.510000000000005 112.101 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 43' ' ' VAL . 79.8 m -71.0 -52.28 20.55 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 123.905 0.882 . . . . 65.439999999999998 110.741 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.34 -30.95 67.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.018 0.927 . . . . 71.120000000000005 112.807 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.498 HD12 HG13 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -68.76 -45.05 72.39 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.388 1.075 . . . . 64.450000000000003 110.351 172.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.46 -31.38 72.57 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.586 0.754 . . . . 72.140000000000001 111.965 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 39' ' ' THR . 75.2 t -62.82 -43.14 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.551 1.141 . . . . 62.030000000000001 111.466 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.25 -31.13 75.93 Favored Glycine 0 CA--C 1.541 1.691 0 O-C-N 123.342 0.401 . . . . 52.149999999999999 113.055 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.448 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 51.3 t-105 -75.07 -27.7 60.06 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.849 0.86 . . . . 74.129999999999995 112.323 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 98.2 mt -76.68 -42.13 42.9 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.892 -0.505 . . . . 73.340000000000003 111.826 168.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.83 71.36 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.718 1.207 . . . . 72.120000000000005 113.327 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.693 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 14.1 ptt180 -61.05 -34.49 74.97 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.681 0.392 . . . . 74.420000000000002 111.718 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.693 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 36.4 mt-10 -98.41 1.05 46.47 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.421 1.088 . . . . 74.530000000000001 111.923 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 t30 61.89 28.1 17.13 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.623 1.169 . . . . 73.239999999999995 111.529 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 92.1 mttt -72.81 -21.35 60.98 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.59 0.756 . . . . 75.329999999999998 112.316 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.596 HG13 HD12 ' A' ' 17' ' ' LEU . 27.9 m -125.8 148.55 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 72.239999999999995 111.199 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.744 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 44.4 t -100.12 100.5 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.782 0.833 . . . . 73.349999999999994 108.8 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.3 mm -78.43 123.26 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 109.936 -0.394 . . . . 72.299999999999997 109.936 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.37 116.57 17.01 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.727 -0.842 . . . . 75.209999999999994 108.727 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -93.9 103.53 15.63 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.387 0.675 . . . . 75.510000000000005 110.387 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -111.16 129.04 56.07 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.563 0.745 . . . . 74.420000000000002 109.904 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 56.03 28.37 12.71 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.574 1.149 . . . . 75.230000000000004 112.467 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.64 -21.27 14.84 Favored Glycine 0 CA--C 1.542 1.722 0 N-CA-C 114.242 0.457 . . . . 53.32 114.242 -174.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.02 143.84 35.25 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.462 0.705 . . . . 75.319999999999993 110.877 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.81 138.13 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.494 -0.558 . . . . 73.219999999999999 109.494 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -147.35 142.57 27.24 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.454 0.645 . . . . 75.010000000000005 111.027 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.1 mt -111.01 137.51 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.042 0.937 . . . . 75.439999999999998 110.862 -173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.744 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 90.1 m-85 -121.62 165.24 16.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.71 -1.132 . . . . 74.230000000000004 108.942 174.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' HA ' HD13 ' A' ' 17' ' ' LEU . 20.9 t-20 -83.05 152.04 25.54 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.914 -0.772 . . . . 74.129999999999995 108.914 173.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -23.48 36.4 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.602 0.964 . . . . 75.140000000000001 113.602 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.52 -19.09 72.48 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 114.262 0.465 . . . . 73.310000000000002 114.262 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -69.6 -12.34 61.56 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.955 0.902 . . . . 75.0 112.424 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -59.06 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.008 0.523 . . . . 74.319999999999993 111.939 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.43 109.3 18.95 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.513 -0.921 . . . . 64.299999999999997 108.513 167.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -65.42 98.71 0.36 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.185 0.594 . . . . 75.439999999999998 111.648 -173.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.0 p -127.24 147.63 50.22 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.766 0.826 . . . . 73.109999999999999 110.686 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.44 ' HB3' HD21 ' A' ' 75' ' ' LEU . 93.8 m-85 -88.93 110.83 21.43 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.393 0.677 . . . . 73.319999999999993 110.95 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.92 54.52 0.7 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 123.316 0.484 . . . . 74.530000000000001 113.068 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 73' ' ' PHE . 4.0 mm? -77.36 -19.76 55.8 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.64 0.776 . . . . 73.510000000000005 112.088 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.12 98.83 0.33 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.192 0.597 . . . . 73.450000000000003 111.065 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -56.29 128.07 33.99 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.448 1.099 . . . . 74.310000000000002 112.216 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -146.72 138.45 24.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.542 0.737 . . . . 61.43 110.479 -173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 60.59 16.74 6.79 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 124.137 0.975 . . . . 74.319999999999993 112.429 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -72.5 91.25 1.38 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.234 0.614 . . . . 73.239999999999995 110.567 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -67.98 128.38 36.32 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.347 -0.842 . . . . 73.140000000000001 111.332 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.3 m170 . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 121.603 0.716 . . . . 72.420000000000002 111.382 -176.302 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptm . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 111.999 0.37 . . . . 64.120000000000005 111.999 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.4 -39.71 81.57 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.793 0.837 . . . . 60.219999999999999 111.212 -173.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.624 ' HA ' HG23 ' B' ' 6' ' ' VAL . 99.0 mttt -70.37 -26.03 63.53 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.796 0.665 . . . . 72.040000000000006 112.796 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -70.05 -37.36 75.51 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.769 0.427 . . . . 71.319999999999993 110.81 171.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.93 -52.71 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 123.513 0.725 . . . . 73.549999999999997 111.438 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' B' ' 3' ' ' LYS . 19.5 m -70.52 -27.47 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 122.72 0.408 . . . . 74.540000000000006 111.741 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -38.87 89.17 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 116.783 -0.189 . . . . 73.239999999999995 112.764 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.03 32.02 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.437 0.695 . . . . 73.25 111.73 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . 0.573 ' HB2' HD13 ' B' ' 34' ' ' LEU . 31.3 p30 -73.29 -20.97 60.7 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 112.953 0.723 . . . . 73.310000000000002 112.953 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.97 -23.38 64.12 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.083 0.553 . . . . 64.510000000000005 111.178 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.04 -31.91 79.2 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 116.222 -0.445 . . . . 74.129999999999995 113.12 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.62 -47.02 64.89 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.438 0.695 . . . . 74.120000000000005 111.101 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.19 -36.88 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.276 1.03 . . . . 75.519999999999996 111.59 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -72.66 -34.32 67.16 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.263 0.625 . . . . 74.329999999999998 110.979 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -65.03 -31.03 72.06 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.666 0.387 . . . . 72.25 111.475 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.68 -30.23 67.21 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.05 0.54 . . . . 75.329999999999998 112.146 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.687 HD13 HG12 ' B' ' 52' ' ' VAL . 80.3 mt -65.59 -45.96 81.22 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.772 0.829 . . . . 72.239999999999995 111.659 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -59.66 -28.18 67.03 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.692 0.797 . . . . 74.099999999999994 111.266 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -81.91 -47.57 12.59 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.877 0.871 . . . . 72.430000000000007 111.217 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.09 151.98 16.52 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.783 0.833 . . . . 55.409999999999997 111.736 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -112.22 156.16 22.81 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.297 0.639 . . . . 74.349999999999994 109.649 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.01 38.66 84.68 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 114.359 0.503 . . . . 61.039999999999999 114.359 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 tt -102.36 137.54 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.23 0.612 . . . . 73.329999999999998 110.275 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -73.11 156.4 38.72 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.386 0.674 . . . . 73.319999999999993 111.594 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.82 -52.18 76.28 Favored Pre-proline 0 CA--C 1.575 1.933 0 N-CA-C 113.617 0.969 . . . . 74.129999999999995 113.617 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.75 -23.91 55.24 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.149 1.899 . . . . 65.109999999999999 113.501 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -78.91 -42.66 26.6 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.741 0.816 . . . . 74.430000000000007 111.496 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.1 -31.58 61.21 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 122.157 -0.34 . . . . 74.549999999999997 111.078 174.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.53 -45.38 73.35 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.573 1.149 . . . . 74.549999999999997 113.393 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -65.01 -30.83 71.83 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 115.999 -0.546 . . . . 74.239999999999995 112.22 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -78.41 -40.93 34.55 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.015 0.526 . . . . 75.010000000000005 111.058 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 m -81.58 -3.4 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.076 0.551 . . . . 72.519999999999996 111.683 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 65.83 29.41 10.51 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.321 1.448 . . . . 75.120000000000005 112.906 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' B' ' 9' ' ' ASN . 66.5 mt -109.28 158.07 18.23 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.693 0.797 . . . . 72.299999999999997 110.395 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 34.0 t -65.09 152.82 42.56 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.781 0.433 . . . . 75.329999999999998 110.581 166.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.34 -41.97 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 123.073 0.549 . . . . 72.510000000000005 111.579 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.66 -48.21 80.33 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.087 0.955 . . . . 75.230000000000004 112.015 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.5 t -66.56 -30.82 71.22 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.713 0.805 . . . . 71.409999999999997 111.601 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 96.8 m -74.87 -44.17 50.44 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.916 0.886 . . . . 73.319999999999993 110.92 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.51 -34.3 77.47 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.872 0.869 . . . . 73.329999999999998 111.648 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -67.2 -44.08 80.52 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 124.27 1.028 . . . . 75.219999999999999 110.496 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.81 76.75 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.14 0.576 . . . . 73.540000000000006 111.793 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.19 -44.35 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.585 1.154 . . . . 74.319999999999993 110.828 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.47 -28.04 73.16 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 116.378 -0.374 . . . . 65.209999999999994 113.155 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.434 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 49.9 t-105 -74.18 -29.9 61.98 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.967 0.907 . . . . 73.450000000000003 111.232 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.06 -36.59 58.94 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.358 0.663 . . . . 73.420000000000002 112.186 167.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.96 76.86 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.202 1.001 . . . . 61.43 113.543 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 20.3 ptt85 -63.92 -30.68 71.74 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.303 0.573 . . . . 74.219999999999999 111.097 173.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -86.03 -15.78 40.3 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.374 1.07 . . . . 70.209999999999994 111.572 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 t30 60.43 43.62 13.04 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.717 1.207 . . . . 73.200000000000003 110.769 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -95.83 -9.07 32.48 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.312 -0.858 . . . . 74.530000000000001 111.777 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.687 HG12 HD13 ' B' ' 17' ' ' LEU . 27.7 m -125.17 146.47 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.222 1.009 . . . . 60.509999999999998 111.149 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.564 HG22 ' HA ' ' B' ' 66' ' ' GLU . 85.9 t -103.95 104.08 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.133 -1.062 . . . . 74.0 108.133 167.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 70.8 mt -91.21 118.18 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.146 0.578 . . . . 72.340000000000003 109.827 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.69 123.28 45.7 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.003 -0.74 . . . . 73.439999999999998 109.003 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -89.13 96.85 10.89 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.596 0.712 . . . . 72.439999999999998 109.341 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -116.66 119.06 34.3 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.077 -0.965 . . . . 73.329999999999998 109.502 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 60.07 28.79 18.38 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.783 1.233 . . . . 74.030000000000001 111.731 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.85 -3.93 72.82 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 114.452 0.541 . . . . 44.329999999999998 114.452 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.59 134.7 34.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.341 0.656 . . . . 75.439999999999998 110.736 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.6 mm -87.07 103.12 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 123.562 0.745 . . . . 74.239999999999995 109.045 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -117.75 123.84 47.0 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.486 0.715 . . . . 64.209999999999994 109.919 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 40.2 pt -97.76 138.29 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.074 0.94 . . . . 73.299999999999997 112.177 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 77.0 m-85 -120.7 169.4 10.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.165 1.386 . . . . 60.25 108.347 175.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -85.43 145.99 27.19 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.682 -0.858 . . . . 65.030000000000001 108.682 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.564 ' HA ' HG22 ' B' ' 53' ' ' VAL . 1.0 OUTLIER -60.51 142.76 54.87 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 112.394 0.516 . . . . 70.420000000000002 112.394 -178.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.99 -18.27 45.62 Favored Glycine 0 CA--C 1.539 1.555 0 CA-C-O 119.451 -0.638 . . . . 45.219999999999999 114.373 -178.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -57.96 -51.03 71.35 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.815 0.846 . . . . 75.120000000000005 111.941 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -85.72 -28.61 24.52 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.153 0.581 . . . . 75.049999999999997 111.783 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 27.4 t70 62.78 -128.74 0.58 Allowed 'General case' 0 CA--C 1.574 1.895 0 C-N-CA 123.622 0.769 . . . . 74.019999999999996 110.363 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.57 25.08 8.84 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 119.625 1.102 . . . . 71.540000000000006 111.624 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -80.74 -173.04 3.96 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.215 0.606 . . . . 74.530000000000001 112.021 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -68.08 171.16 7.26 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 123.628 0.771 . . . . 75.230000000000004 111.61 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.08 -133.88 1.19 Allowed Glycine 0 C--N 1.353 1.495 0 N-CA-C 112.379 -0.288 . . . . 44.43 112.379 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 14.1 tp -158.94 17.67 0.19 Allowed 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 117.412 0.606 . . . . 73.319999999999993 111.233 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.22 104.66 2.7 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.088 0.555 . . . . 75.340000000000003 110.852 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -138.19 108.38 6.43 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.035 0.934 . . . . 74.109999999999999 109.443 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -93.11 107.91 19.61 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.493 0.553 . . . . 74.140000000000001 112.493 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -132.21 172.57 12.24 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.353 1.061 . . . . 54.240000000000002 110.262 165.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -153.88 119.53 5.24 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.683 0.793 . . . . 75.239999999999995 109.968 -171.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -80.75 106.68 12.94 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.147 0.579 . . . . 73.340000000000003 111.777 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 80.0 t60 . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 124.169 0.988 . . . . 75.209999999999994 110.038 175.928 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptm . . . . . 0 N--CA 1.499 2.009 0 CA-C-O 121.734 0.778 . . . . 73.209999999999994 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.84 -28.35 69.42 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.662 1.185 . . . . 74.129999999999995 114.026 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -65.92 -33.89 76.86 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 113.793 1.035 . . . . 74.420000000000002 113.793 -164.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.37 -32.48 29.24 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 122.506 0.322 . . . . 75.200000000000003 111.339 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.608 HD12 HH22 ' B' ' 56' ' ' ARG . 68.4 mt -62.82 -47.53 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.433 0.693 . . . . 75.409999999999997 110.947 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.48 -34.46 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.772 0.829 . . . . 74.150000000000006 111.352 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.41 -37.12 94.32 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 112.634 -0.186 . . . . 60.219999999999999 112.634 173.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.0 -55.74 8.78 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.699 0.8 . . . . 71.200000000000003 112.296 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.58 ' HB2' HD11 ' A' ' 34' ' ' LEU . 36.6 p30 -78.14 -13.46 59.86 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.756 1.021 . . . . 74.519999999999996 113.756 -170.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.16 -27.77 64.8 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.651 0.38 . . . . 64.430000000000007 111.598 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.23 -45.45 80.48 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 116.15 -0.477 . . . . 61.020000000000003 113.552 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HB3' ' HZ3' ' A' ' 12' ' ' LYS . 0.2 OUTLIER -70.13 -39.17 75.57 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.811 0.444 . . . . 74.109999999999999 112.185 -179.274 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.48 ' HA ' HG12 ' A' ' 32' ' ' VAL . 20.9 m -69.59 -36.19 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.72 0.236 . . . . 74.239999999999995 111.221 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.654 ' HA ' HD11 ' A' ' 17' ' ' LEU . 62.3 t90 -69.37 -33.64 73.37 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.91 0.484 . . . . 74.409999999999997 111.033 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.61 -33.96 77.12 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.048 0.539 . . . . 73.120000000000005 111.321 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.74 76.1 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.231 0.612 . . . . 74.010000000000005 111.551 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 14' ' ' TRP . 31.3 mt -71.91 -33.93 68.69 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.009 0.924 . . . . 74.099999999999994 111.641 174.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -30.3 65.23 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.734 0.814 . . . . 73.230000000000004 109.944 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -77.23 -41.39 41.36 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.018 0.527 . . . . 64.349999999999994 110.492 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.2 107.13 1.8 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.136 0.574 . . . . 74.140000000000001 111.612 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.98 174.91 11.15 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.331 0.652 . . . . 74.219999999999999 111.148 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.67 42.43 97.27 Favored Glycine 0 N--CA 1.479 1.518 0 CA-C-O 121.406 0.448 . . . . 74.0 112.366 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' A' ' 28' ' ' LEU . 21.1 tt -114.92 144.79 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.826 0.851 . . . . 74.439999999999998 110.996 -169.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -79.8 151.26 30.4 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.08 0.552 . . . . 74.109999999999999 110.889 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.81 -47.1 99.33 Favored Pre-proline 0 CA--C 1.58 2.119 0 N-CA-C 113.326 0.862 . . . . 64.140000000000001 113.326 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.05 -22.81 47.14 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.076 1.851 . . . . 71.439999999999998 113.468 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -71.91 -48.9 42.27 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.633 0.773 . . . . 64.510000000000005 111.673 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.437 ' HB3' HD13 ' A' ' 23' ' ' ILE . 2.2 pt? -74.9 -29.62 61.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.816 -0.553 . . . . 71.5 111.826 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.39 -44.88 65.58 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.385 0.883 . . . . 51.030000000000001 113.385 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -70.44 -30.38 67.2 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.922 0.489 . . . . 74.439999999999998 112.081 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 25.7 mtpp -68.33 -44.34 75.54 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.575 0.75 . . . . 74.140000000000001 110.592 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.48 HG12 ' HA ' ' A' ' 13' ' ' VAL . 16.9 m -86.41 -2.0 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.126 0.971 . . . . 73.299999999999997 111.805 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 m120 64.84 23.22 12.63 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.104 1.361 . . . . 74.420000000000002 112.946 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 9' ' ' ASN . 66.3 mt -101.63 168.2 9.63 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.67 0.788 . . . . 72.409999999999997 111.102 174.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 m -71.72 156.97 38.75 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.905 -0.589 . . . . 74.310000000000002 110.838 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.39 -48.37 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 123.235 0.614 . . . . 72.239999999999995 111.717 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.73 -38.64 91.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.38 0.672 . . . . 64.230000000000004 112.658 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.1 m -65.99 -31.14 71.88 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.606 0.762 . . . . 73.420000000000002 111.807 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.4 m -77.39 -44.18 30.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.802 0.841 . . . . 73.310000000000002 111.112 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.57 -33.55 72.87 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.305 0.642 . . . . 60.32 111.659 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -53.71 54.84 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.546 1.139 . . . . 75.140000000000001 110.04 171.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.28 -32.35 72.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.078 -0.965 . . . . 73.349999999999994 112.277 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.43 HG11 HD12 ' A' ' 63' ' ' ILE . 69.1 t -68.34 -39.71 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.24 0.616 . . . . 72.209999999999994 111.183 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.34 -31.8 81.99 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 116.633 -0.258 . . . . 61.340000000000003 113.108 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -71.18 -30.3 66.25 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.605 0.762 . . . . 72.200000000000003 111.685 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.445 HD21 ' HE2' ' A' ' 51' ' ' LYS . 77.5 mt -75.61 -38.07 59.28 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.578 0.751 . . . . 74.25 112.274 170.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.29 -37.01 74.16 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.807 1.243 . . . . 63.310000000000002 114.117 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.568 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 25.7 ptt85 -60.39 -26.67 66.84 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 122.935 0.494 . . . . 74.530000000000001 111.886 175.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.568 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 40.0 mt-10 -103.3 4.96 37.08 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.856 1.262 . . . . 74.209999999999994 112.228 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 62.71 21.7 12.9 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 125.031 1.332 . . . . 64.239999999999995 113.0 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HE2' HD21 ' A' ' 46' ' ' LEU . 50.8 mtpt -80.2 -13.45 59.23 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.235 0.614 . . . . 74.219999999999999 112.283 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.5 HG13 HD13 ' A' ' 17' ' ' LEU . 19.0 m -121.61 142.95 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.759 0.823 . . . . 64.400000000000006 111.22 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 94.7 t -112.73 104.98 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 123.846 0.859 . . . . 71.030000000000001 109.872 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 61' ' ' ILE . 2.6 mp -91.64 125.43 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.561 -0.533 . . . . 73.049999999999997 109.561 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.33 113.22 25.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.007 0.523 . . . . 73.319999999999993 109.644 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -87.23 96.22 10.25 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.77 -0.826 . . . . 75.420000000000002 108.77 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.54 118.12 34.86 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.825 0.85 . . . . 75.019999999999996 109.541 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.78 31.56 17.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.871 0.868 . . . . 75.030000000000001 111.569 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.52 2.36 74.53 Favored Glycine 0 CA--C 1.546 1.98 0 N-CA-C 114.472 0.549 . . . . 70.140000000000001 114.472 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.0 mt -94.92 133.07 39.05 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.945 0.898 . . . . 65.340000000000003 110.306 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.56 HG22 HG23 ' A' ' 54' ' ' ILE . 76.6 mt -96.87 118.07 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.489 0.715 . . . . 74.129999999999995 111.666 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.37 132.05 55.75 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.914 -0.773 . . . . 62.119999999999997 108.914 167.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.43 HD12 HG11 ' A' ' 43' ' ' VAL . 40.0 mt -102.04 132.05 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 121.325 0.583 . . . . 73.099999999999994 110.788 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.557 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 83.8 m-85 -124.55 173.55 8.41 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.318 1.047 . . . . 75.549999999999997 110.158 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -99.86 163.92 12.25 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.048 0.539 . . . . 74.5 109.727 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -53.17 148.41 8.35 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.441 1.097 . . . . 73.019999999999996 112.324 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.63 -6.09 33.3 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 116.469 -0.332 . . . . 65.019999999999996 112.979 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -81.88 3.69 25.23 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 123.945 0.898 . . . . 72.519999999999996 112.022 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -122.12 157.51 31.34 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.766 0.826 . . . . 71.430000000000007 111.522 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -103.04 118.52 37.0 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.569 0.748 . . . . 71.409999999999997 110.662 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -122.02 158.7 28.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.891 0.876 . . . . 73.0 110.327 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 t 67.71 -64.87 0.26 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.058 1.343 . . . . 74.129999999999995 111.465 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -69.01 111.62 5.12 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 109.265 -0.643 . . . . 75.549999999999997 109.265 168.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.26 79.56 1.04 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 115.251 0.86 . . . . 65.430000000000007 115.251 -167.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.1 mt -103.51 91.87 4.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.229 0.611 . . . . 74.310000000000002 109.706 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -89.43 128.69 35.97 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.893 -0.594 . . . . 74.450000000000003 109.784 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -75.82 105.9 7.1 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.272 0.629 . . . . 74.400000000000006 109.537 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -63.63 112.69 2.93 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.95 0.5 . . . . 75.140000000000001 111.168 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -72.55 139.84 47.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.452 0.701 . . . . 74.439999999999998 110.394 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -85.0 147.16 26.83 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.146 0.578 . . . . 75.430000000000007 111.421 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -71.11 138.22 49.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.941 0.496 . . . . 74.25 110.719 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.768 0.794 . . . . 64.239999999999995 111.137 -174.515 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 CA--C 1.546 0.813 0 CA-C-O 120.852 0.358 . . . . 71.120000000000005 110.908 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.415 ' O ' HG12 ' B' ' 6' ' ' VAL . 2.0 t70 -67.52 -33.05 74.28 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.458 0.703 . . . . 60.210000000000001 112.11 -171.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.498 ' HA ' HG21 ' B' ' 6' ' ' VAL . 37.5 ttmt -66.52 -35.19 79.65 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.323 0.49 . . . . 72.519999999999996 112.323 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -55.25 -41.24 71.9 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.403 0.621 . . . . 72.150000000000006 110.478 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 47.6 mt -66.55 -51.97 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-N 114.677 -1.147 . . . . 72.540000000000006 111.457 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.498 HG21 ' HA ' ' B' ' 3' ' ' LYS . 4.5 m -67.18 -32.3 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 122.584 0.354 . . . . 73.409999999999997 111.896 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.47 -44.09 66.19 Favored Glycine 0 C--N 1.349 1.302 0 O-C-N 123.201 0.313 . . . . 75.329999999999998 112.749 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.26 69.83 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.505 0.722 . . . . 73.420000000000002 112.25 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . 0.402 ' OD1' HD13 ' B' ' 34' ' ' LEU . 9.0 t-20 -86.67 -28.05 23.4 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.637 0.775 . . . . 64.420000000000002 112.131 -175.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.25 72.36 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.275 0.63 . . . . 74.420000000000002 112.192 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.81 -42.31 95.17 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 116.11 -0.495 . . . . 71.219999999999999 112.373 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -65.11 -45.63 84.33 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.777 0.831 . . . . 73.239999999999995 111.479 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.604 ' HA ' HG12 ' B' ' 32' ' ' VAL . 30.9 m -68.83 -32.22 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 C-N-CA 122.772 0.429 . . . . 72.099999999999994 112.068 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.477 ' HA ' HD12 ' B' ' 17' ' ' LEU . 34.6 t90 -72.3 -35.77 68.75 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.834 0.454 . . . . 74.409999999999997 111.495 175.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -67.46 -32.24 72.95 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.069 0.548 . . . . 74.019999999999996 112.018 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.7 74.39 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 122.971 0.508 . . . . 65.430000000000007 111.939 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' B' ' 14' ' ' TRP . 82.6 mt -63.67 -30.89 71.94 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.944 0.898 . . . . 71.450000000000003 112.602 174.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -69.2 -5.48 22.89 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.158 0.799 . . . . 54.149999999999999 113.158 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -79.67 -61.48 1.98 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.022 0.529 . . . . 74.230000000000004 110.469 170.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.94 131.72 5.33 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.511 0.725 . . . . 65.129999999999995 110.947 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.524 ' HB3' ' HD1' ' B' ' 64' ' ' TYR . 4.6 m-20 -74.22 175.21 7.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.991 0.916 . . . . 74.420000000000002 112.468 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.72 54.81 5.24 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.535 -0.626 . . . . 72.409999999999997 111.535 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 tt -133.6 120.34 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.53 0.732 . . . . 74.329999999999998 110.994 -167.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -67.74 163.49 21.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.633 0.773 . . . . 65.319999999999993 111.911 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.401 HG21 ' HB2' ' B' ' 40' ' ' ALA . 48.5 mt -59.7 -47.12 98.26 Favored Pre-proline 0 CA--C 1.574 1.901 0 CA-C-O 118.525 -0.75 . . . . 73.019999999999996 112.434 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.02 -22.99 34.69 Favored 'Trans proline' 0 C--N 1.396 3.044 0 C-N-CA 121.871 1.714 . . . . 74.319999999999993 114.064 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -70.73 -50.45 36.08 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.686 1.231 . . . . 75.239999999999995 109.017 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.83 -39.1 83.97 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 112.612 -2.085 . . . . 75.310000000000002 111.679 175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.17 -43.11 87.28 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.105 0.962 . . . . 74.209999999999994 112.867 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -69.71 -36.93 76.34 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.003 0.521 . . . . 75.239999999999995 111.587 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -64.39 -44.85 90.04 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.244 0.618 . . . . 75.230000000000004 111.148 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' B' ' 13' ' ' VAL . 13.7 m -88.23 5.34 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.35 0.66 . . . . 73.129999999999995 112.727 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 69.32 17.81 8.14 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.798 1.239 . . . . 73.409999999999997 113.137 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.402 HD13 ' OD1' ' B' ' 9' ' ' ASN . 63.3 mt -110.65 174.95 5.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.627 0.771 . . . . 74.319999999999993 112.287 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -84.31 160.72 20.65 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.17 -0.923 . . . . 74.430000000000007 110.577 167.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 63.2 t -53.89 -49.82 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 124.1 0.96 . . . . 74.310000000000002 112.653 -175.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.37 -48.3 82.34 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.579 0.752 . . . . 74.510000000000005 111.985 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -62.67 -37.13 85.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.942 0.897 . . . . 64.549999999999997 111.892 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.473 ' O ' HG22 ' B' ' 43' ' ' VAL . 85.1 m -69.07 -51.31 40.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.578 0.751 . . . . 75.340000000000003 111.609 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.401 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -55.04 -44.51 74.73 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.802 0.841 . . . . 71.340000000000003 111.974 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.72 -36.19 82.91 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.393 1.077 . . . . 73.519999999999996 111.203 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.44 83.27 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.775 0.43 . . . . 74.349999999999994 112.151 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.473 HG22 ' O ' ' B' ' 39' ' ' THR . 24.8 t -67.54 -29.19 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.51 0.724 . . . . 72.329999999999998 111.449 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.73 -28.16 56.5 Favored Glycine 0 CA--C 1.551 2.282 0 N-CA-C 114.502 0.561 . . . . 52.130000000000003 114.502 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.476 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 72.6 t-105 -74.33 -24.69 59.23 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.443 0.697 . . . . 72.420000000000002 111.533 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.44 HD11 HG23 ' B' ' 13' ' ' VAL . 83.9 mt -72.77 -36.04 67.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.563 0.745 . . . . 73.209999999999994 111.636 173.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.97 -33.51 67.15 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.728 0.811 . . . . 74.439999999999998 112.363 172.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 33.1 ttt-85 -54.63 -49.78 69.7 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.971 0.908 . . . . 74.530000000000001 111.481 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.27 -1.35 57.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.51 0.724 . . . . 74.239999999999995 112.58 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 64.17 21.96 12.72 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.812 1.245 . . . . 71.349999999999994 113.177 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -86.61 1.37 52.02 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.08 0.77 . . . . 72.299999999999997 113.08 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.36 155.68 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 123.362 0.665 . . . . 73.219999999999999 112.027 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 45.8 t -120.43 96.57 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.532 -0.914 . . . . 65.439999999999998 108.532 169.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.43 HD13 HG12 ' B' ' 43' ' ' VAL . 35.7 mt -95.75 102.27 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.158 0.504 . . . . 74.219999999999999 109.676 -177.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -134.29 132.27 39.39 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.994 -0.441 . . . . 75.340000000000003 111.629 -166.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.618 ' HG2' HG13 ' B' ' 61' ' ' ILE . 6.7 mtm-85 -86.8 97.05 10.41 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.799 0.809 . . . . 63.240000000000002 110.405 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -108.35 128.31 54.64 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.653 -1.158 . . . . 72.209999999999994 109.151 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 59.31 29.9 19.54 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.492 1.117 . . . . 75.519999999999996 111.14 -170.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.99 -21.39 7.98 Favored Glycine 0 C--N 1.36 1.915 0 CA-C-N 115.879 -0.601 . . . . 71.510000000000005 114.514 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mp -89.7 135.52 33.57 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.453 0.701 . . . . 44.32 110.74 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.618 HG13 ' HG2' ' B' ' 56' ' ' ARG . 1.4 mp -73.93 107.99 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 C-N-CA 123.593 0.757 . . . . 74.030000000000001 109.682 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -107.53 120.27 41.74 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.014 0.926 . . . . 70.25 110.494 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.45 ' N ' HD12 ' B' ' 63' ' ' ILE . 2.2 mp -94.24 132.31 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 109.149 -0.685 . . . . 74.409999999999997 109.149 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.615 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 90.5 m-85 -123.5 174.0 7.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.473 1.109 . . . . 71.519999999999996 109.997 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -93.97 158.26 15.72 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 109.142 -0.688 . . . . 74.430000000000007 109.142 166.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -46.0 -63.01 1.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.358 1.063 . . . . 73.319999999999993 113.397 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.52 18.73 8.08 Favored Glycine 0 CA--C 1.543 1.795 0 N-CA-C 115.354 0.902 . . . . 52.229999999999997 115.354 -172.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -90.1 -10.74 43.55 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.961 0.88 . . . . 74.040000000000006 111.838 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -59.42 -38.61 81.08 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.176 0.513 . . . . 75.420000000000002 111.242 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -90.63 94.44 9.7 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 108.777 -0.823 . . . . 73.140000000000001 108.777 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -134.38 140.77 46.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.115 0.966 . . . . 74.129999999999995 110.092 -173.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 45.5 t -66.7 147.24 53.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.025 0.53 . . . . 75.040000000000006 112.044 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -89.19 129.48 35.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.58 0.752 . . . . 71.019999999999996 110.865 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.77 80.87 0.05 OUTLIER Glycine 0 C--N 1.346 1.135 0 N-CA-C 112.188 -0.365 . . . . 71.25 112.188 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 mp -91.11 138.75 31.36 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.64 0.776 . . . . 63.350000000000001 111.293 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -66.2 121.35 15.01 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.225 1.01 . . . . 61.119999999999997 110.977 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -91.35 120.68 32.43 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.596 0.758 . . . . 74.439999999999998 110.148 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -74.76 159.45 31.98 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.853 0.461 . . . . 72.219999999999999 111.832 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -93.89 170.49 9.51 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.61 0.764 . . . . 73.040000000000006 112.221 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -113.72 -167.96 1.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.306 1.042 . . . . 74.530000000000001 110.724 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -144.35 137.15 26.92 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.345 0.658 . . . . 74.049999999999997 110.745 175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 9.2 t60 . . . . . 0 N--CA 1.483 1.196 0 C-N-CA 123.689 0.795 . . . . 74.409999999999997 110.884 -178.509 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptt? . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 111.768 0.284 . . . . 73.439999999999998 111.768 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -96.51 150.38 20.69 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.037 0.535 . . . . 75.439999999999998 112.038 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' O ' HG22 ' A' ' 6' ' ' VAL . 71.6 mmtt -79.23 -18.81 52.16 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.992 -0.549 . . . . 75.319999999999993 109.78 167.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -54.56 -34.03 61.19 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.324 1.05 . . . . 73.519999999999996 112.438 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.4 mt -52.8 -58.13 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.118 0.967 . . . . 75.239999999999995 112.115 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 3' ' ' LYS . 32.1 m -60.79 -37.47 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 112.926 0.713 . . . . 75.239999999999995 112.926 -172.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.79 -38.84 41.2 Favored Glycine 0 N--CA 1.476 1.366 0 O-C-N 123.237 0.336 . . . . 70.329999999999998 113.041 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.72 -36.73 83.92 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.943 0.897 . . . . 74.129999999999995 111.971 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -84.15 -28.92 27.08 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.092 -0.504 . . . . 53.43 111.622 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.82 71.12 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 122.908 0.483 . . . . 73.409999999999997 111.986 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.7 97.23 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.245 -0.434 . . . . 72.219999999999999 112.975 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -72.67 -38.29 67.65 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.925 0.89 . . . . 75.400000000000006 111.579 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.742 ' HA ' HG13 ' A' ' 32' ' ' VAL . 54.2 t -62.98 -47.74 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.79 0.836 . . . . 75.420000000000002 111.28 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -66.17 -33.43 75.75 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.623 -0.717 . . . . 73.019999999999996 111.35 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -61.62 -42.42 98.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.402 0.681 . . . . 75.400000000000006 111.681 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.21 74.03 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.327 0.651 . . . . 72.140000000000001 111.491 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' A' ' 21' ' ' ASP . 2.5 tm? -70.73 -30.7 67.31 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.213 1.405 . . . . 73.049999999999997 111.536 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -64.24 -42.95 96.31 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.945 0.898 . . . . 73.120000000000005 112.816 -169.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -81.69 -15.22 55.17 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.005 0.743 . . . . 61.130000000000003 113.005 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.53 96.06 1.14 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.961 0.504 . . . . 64.209999999999994 110.738 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.48 ' HA ' HD21 ' A' ' 17' ' ' LEU . 8.7 p-10 -86.02 169.2 13.41 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.09 0.556 . . . . 75.120000000000005 112.009 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.86 55.06 3.94 Favored Glycine 0 C--N 1.344 1.009 0 N-CA-C 111.698 -0.561 . . . . 60.130000000000003 111.698 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 tt -130.13 136.43 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.979 0.911 . . . . 75.329999999999998 110.421 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.9 p -74.97 154.59 38.04 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.783 0.433 . . . . 74.430000000000007 111.242 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 40' ' ' ALA . 63.8 mt -52.36 -47.42 92.97 Favored Pre-proline 0 CA--C 1.573 1.837 0 N-CA-C 114.056 1.132 . . . . 74.519999999999996 114.056 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.69 -33.05 56.19 Favored 'Trans proline' 0 C--N 1.393 2.902 0 C-N-CA 121.714 1.609 . . . . 75.510000000000005 114.319 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 30' ' ' ARG . 37.6 mt-10 -76.74 -31.0 56.84 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.395 1.093 . . . . 73.329999999999998 110.453 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.81 -33.3 66.14 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 113.668 -1.605 . . . . 75.239999999999995 110.603 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.9 -39.4 87.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.895 0.878 . . . . 65.129999999999995 112.855 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 14.2 ptt180 -70.38 -28.08 64.82 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.401 0.28 . . . . 73.400000000000006 111.053 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -67.27 -37.74 83.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.961 0.904 . . . . 75.129999999999995 111.574 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.742 HG13 ' HA ' ' A' ' 13' ' ' VAL . 24.6 m -102.8 0.73 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 112.989 0.737 . . . . 73.0 112.989 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 65.71 28.47 11.06 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.808 1.243 . . . . 74.409999999999997 112.635 174.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.4 mt -109.0 175.12 5.57 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.943 0.897 . . . . 74.450000000000003 111.244 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 99.9 p -77.99 163.74 25.68 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.319 0.648 . . . . 75.430000000000007 110.37 168.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -58.18 -45.92 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.09 0.556 . . . . 72.230000000000004 111.17 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.71 -37.51 82.35 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.954 0.902 . . . . 73.530000000000001 112.648 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -69.69 -37.37 76.59 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.129 0.49 . . . . 71.109999999999999 111.563 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.442 ' O ' HG22 ' A' ' 43' ' ' VAL . 93.8 m -72.88 -44.66 61.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.494 0.717 . . . . 73.109999999999999 111.281 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -57.86 -35.63 71.22 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.966 0.906 . . . . 73.109999999999999 111.972 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -51.8 67.15 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 114.795 -1.093 . . . . 73.530000000000001 110.207 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.04 70.96 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.862 -1.063 . . . . 74.420000000000002 111.723 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 39' ' ' THR . 79.4 t -69.23 -38.25 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.367 0.667 . . . . 71.030000000000001 110.664 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.89 -31.77 82.02 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 116.359 -0.382 . . . . 74.540000000000006 113.459 172.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.498 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 66.9 t-105 -73.92 -30.15 62.42 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.449 0.699 . . . . 75.239999999999995 111.047 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.19 -37.44 69.29 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.922 0.489 . . . . 75.219999999999999 111.184 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.76 -30.09 71.19 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.95 0.9 . . . . 74.230000000000004 111.724 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 21.5 ttt180 -55.88 -50.6 70.2 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.564 0.745 . . . . 75.230000000000004 110.884 167.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -84.71 -3.23 58.46 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 115.197 -0.911 . . . . 75.019999999999996 111.961 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 62.25 22.22 13.02 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 125.258 1.423 . . . . 73.319999999999993 112.764 -175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -69.55 -24.82 63.77 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.41 1.084 . . . . 73.219999999999999 112.367 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.59 151.14 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.64 0.776 . . . . 75.129999999999995 110.813 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.586 HG11 ' HB2' ' A' ' 68' ' ' HIS . 44.6 t -116.92 111.45 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 123.712 0.805 . . . . 74.530000000000001 110.242 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.492 HG23 HG21 ' A' ' 61' ' ' ILE . 3.4 mp -86.56 107.98 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 N-CA-C 109.389 -0.596 . . . . 73.040000000000006 109.389 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HG3' HG13 ' A' ' 53' ' ' VAL . 54.3 mt-10 -118.44 118.03 30.65 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.538 0.735 . . . . 72.150000000000006 110.382 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -85.24 100.96 12.13 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.136 0.974 . . . . 72.540000000000006 110.076 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -114.63 109.15 17.8 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.069 0.948 . . . . 75.530000000000001 109.885 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 57.63 32.67 22.2 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.171 0.988 . . . . 73.040000000000006 111.831 -169.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.3 -9.92 62.74 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 115.557 -0.747 . . . . 72.109999999999999 114.311 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.5 mt -80.0 107.55 12.87 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.191 0.596 . . . . 72.230000000000004 109.997 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.492 HG21 HG23 ' A' ' 54' ' ' ILE . 76.7 mt -69.88 102.63 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.321 -0.622 . . . . 75.209999999999994 109.321 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -110.19 124.11 50.98 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.923 0.889 . . . . 71.430000000000007 109.847 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.72 103.25 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 108.602 -0.888 . . . . 74.030000000000001 108.602 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -91.81 175.77 6.77 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.073 0.949 . . . . 74.030000000000001 110.941 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.81 158.87 16.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.081 0.552 . . . . 74.349999999999994 110.525 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -51.22 119.54 4.13 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.517 0.727 . . . . 74.420000000000002 110.379 171.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.42 10.86 0.27 Allowed Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.093 -0.503 . . . . 72.109999999999999 112.996 -171.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.586 ' HB2' HG11 ' A' ' 53' ' ' VAL . 39.6 m-70 -120.18 -22.4 6.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.782 0.66 . . . . 72.310000000000002 112.782 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -79.55 13.93 1.83 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.273 0.842 . . . . 74.299999999999997 113.273 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.78 -21.82 66.04 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.638 0.977 . . . . 73.099999999999994 113.638 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -92.88 2.97 56.5 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.254 0.464 . . . . 75.319999999999993 112.254 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 91.2 p -61.07 136.15 57.99 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.369 0.877 . . . . 73.420000000000002 113.369 -170.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -132.37 165.12 24.97 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.661 1.184 . . . . 73.349999999999994 110.031 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.48 63.01 0.49 Allowed Glycine 0 N--CA 1.473 1.111 0 CA-C-N 116.635 -0.257 . . . . 65.540000000000006 113.45 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.34 114.61 26.99 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.158 0.583 . . . . 73.239999999999995 110.754 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.51 152.24 28.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.425 0.69 . . . . 70.549999999999997 110.674 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -128.78 130.16 46.65 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.31 0.644 . . . . 75.219999999999999 111.897 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p80 32.74 78.27 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 126.307 1.843 . . . . 75.430000000000007 115.947 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -74.62 -38.98 62.41 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.043 0.537 . . . . 74.239999999999995 111.696 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -78.17 140.44 38.98 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.073 0.463 . . . . 74.310000000000002 111.59 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -138.18 179.79 6.24 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.322 1.049 . . . . 75.340000000000003 109.966 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 . . . . . 0 N--CA 1.486 1.36 0 C-N-CA 122.854 0.462 . . . . 55.530000000000001 110.799 178.632 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 CA--C 1.553 1.085 0 CA-C-O 120.425 0.155 . . . . 70.120000000000005 111.286 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.05 -8.9 3.68 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.374 1.25 . . . . 74.310000000000002 114.374 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.0 -40.56 31.23 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 119.086 0.857 . . . . 75.530000000000001 113.063 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.24 -35.02 14.03 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.259 0.623 . . . . 74.430000000000007 112.344 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 58.8 mt -61.52 -40.71 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.502 0.721 . . . . 62.509999999999998 111.841 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 28.6 m -61.49 -30.28 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.884 0.874 . . . . 74.299999999999997 112.091 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.03 -39.65 94.86 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 122.888 0.118 . . . . 51.009999999999998 113.057 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.94 -53.04 10.98 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.55 0.74 . . . . 74.439999999999998 112.496 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -70.29 -30.59 67.64 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.215 0.821 . . . . 65.219999999999999 113.215 -172.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.35 -25.21 61.45 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.265 0.626 . . . . 64.049999999999997 111.924 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.55 -38.71 96.08 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 116.166 -0.47 . . . . 73.400000000000006 112.816 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -70.85 -40.03 72.59 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.691 0.796 . . . . 74.430000000000007 111.174 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.411 ' HA ' HG13 ' B' ' 32' ' ' VAL . 92.3 t -63.03 -48.41 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.124 0.57 . . . . 64.319999999999993 111.332 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.478 ' HA ' HD12 ' B' ' 17' ' ' LEU . 40.4 t90 -65.55 -34.13 77.53 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.245 0.618 . . . . 74.530000000000001 110.989 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -62.46 -39.42 93.36 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.76 0.824 . . . . 73.219999999999999 110.636 173.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.15 -32.12 72.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.647 0.779 . . . . 73.120000000000005 111.683 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' B' ' 14' ' ' TRP . 69.3 mt -74.4 -31.91 62.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.455 0.702 . . . . 73.140000000000001 111.426 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.03 -25.97 62.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.008 0.523 . . . . 74.120000000000005 110.689 -177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -95.73 -29.41 14.28 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.521 0.728 . . . . 74.099999999999994 111.476 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.78 94.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.446 0.698 . . . . 70.120000000000005 111.74 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -96.87 179.4 4.97 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.286 0.634 . . . . 72.140000000000001 111.755 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.54 37.39 53.03 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.474 -0.33 . . . . 72.439999999999998 113.224 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 tt -119.27 151.17 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.064 0.946 . . . . 74.25 110.632 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -61.97 140.52 58.32 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.971 0.508 . . . . 74.409999999999997 111.348 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' B' ' 40' ' ' ALA . 64.8 mt -53.81 -45.9 98.65 Favored Pre-proline 0 CA--C 1.576 1.962 0 N-CA-C 113.219 0.822 . . . . 71.049999999999997 113.219 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' B' ' 36' ' ' VAL . 36.9 Cg_endo -63.13 -29.4 74.32 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.116 1.877 . . . . 74.040000000000006 115.072 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.22 -49.16 17.91 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.126 0.965 . . . . 71.099999999999994 109.759 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -55.05 -36.26 65.36 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 113.326 -1.761 . . . . 71.099999999999994 112.083 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.39 -42.79 87.85 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.007 0.923 . . . . 72.030000000000001 112.058 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -72.46 -24.7 61.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.832 -0.622 . . . . 64.230000000000004 111.28 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -76.09 -41.99 48.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.416 0.687 . . . . 71.150000000000006 111.391 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' B' ' 13' ' ' VAL . 24.1 m -89.77 3.76 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.168 0.587 . . . . 73.450000000000003 112.366 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 67.09 22.48 9.89 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.736 1.214 . . . . 73.530000000000001 112.424 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.85 171.29 7.68 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.337 0.655 . . . . 74.510000000000005 111.561 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.2 t -72.99 158.62 35.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.342 0.657 . . . . 72.439999999999998 111.093 170.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' B' ' 26' ' ' PRO . 41.7 t -57.33 -47.48 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.349 0.66 . . . . 75.439999999999998 111.306 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -64.0 -40.82 97.23 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.604 -0.726 . . . . 75.040000000000006 112.048 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -66.93 -34.08 77.0 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.367 0.667 . . . . 73.0 112.115 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.436 ' O ' HG22 ' B' ' 43' ' ' VAL . 90.3 m -76.6 -39.87 51.21 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.627 0.771 . . . . 61.340000000000003 111.07 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' B' ' 25' ' ' ILE . . . -63.78 -37.92 89.16 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.323 0.582 . . . . 74.400000000000006 111.127 174.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.97 -40.96 97.58 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.667 1.187 . . . . 72.400000000000006 110.519 172.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.48 -43.37 94.41 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.359 0.663 . . . . 42.200000000000003 112.005 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.606 HG13 HG21 ' B' ' 63' ' ' ILE . 84.5 t -61.24 -31.23 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.109 0.564 . . . . 72.530000000000001 111.321 176.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.36 -29.2 68.47 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 114.58 0.592 . . . . 74.430000000000007 114.58 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.443 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 76.9 t-105 -72.92 -34.34 66.55 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.712 0.805 . . . . 75.310000000000002 111.111 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 77.1 mt -71.42 -40.25 70.55 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.142 0.577 . . . . 65.209999999999994 110.322 174.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.91 -31.97 73.34 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.351 1.06 . . . . 73.409999999999997 111.708 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 16.1 ttp85 -52.64 -51.79 58.52 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.582 0.706 . . . . 61.340000000000003 110.945 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -83.89 -8.93 59.07 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.875 -1.057 . . . . 72.209999999999994 111.669 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 63.42 29.82 15.49 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.012 1.325 . . . . 73.400000000000006 112.115 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -69.28 -9.59 53.9 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.486 1.515 . . . . 71.510000000000005 113.009 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.26 150.05 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 124.127 0.971 . . . . 74.409999999999997 111.24 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 94.7 t -93.21 129.2 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.985 0.914 . . . . 74.5 109.455 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.63 120.85 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.87 -1.159 . . . . 75.409999999999997 107.87 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . 0.511 ' HG2' ' HZ1' ' B' ' 57' ' ' LYS . 8.9 tp10 -137.95 158.62 43.97 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.201 0.601 . . . . 73.040000000000006 110.487 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -118.83 114.14 22.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.992 0.517 . . . . 73.340000000000003 110.252 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.511 ' HZ1' ' HG2' ' B' ' 55' ' ' GLU . 13.9 mptt -101.99 107.49 18.65 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.01 0.924 . . . . 74.340000000000003 108.618 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 57.96 31.99 21.35 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.473 1.109 . . . . 63.539999999999999 111.847 -175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.51 34.69 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 115.949 -0.569 . . . . 64.319999999999993 113.812 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 75.6 mt -75.57 136.89 40.52 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.453 0.701 . . . . 70.099999999999994 111.215 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.58 117.7 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-O 121.271 0.557 . . . . 74.109999999999999 110.463 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . 0.49 ' HG3' ' HD3' ' B' ' 57' ' ' LYS . 39.1 mm-40 -108.14 142.6 38.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.491 1.516 . . . . 73.200000000000003 110.491 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.606 HG21 HG13 ' B' ' 43' ' ' VAL . 2.0 pp -133.5 122.5 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 CA-C-O 121.783 0.801 . . . . 75.019999999999996 111.206 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.684 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 55.3 m-85 -115.4 171.28 7.81 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.864 0.866 . . . . 75.319999999999993 110.295 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -100.79 153.45 19.46 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.102 0.561 . . . . 75.439999999999998 109.914 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.18 -29.18 67.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 122.079 -0.388 . . . . 71.439999999999998 111.755 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.59 -8.4 71.67 Favored Glycine 0 CA--C 1.54 1.625 0 CA-C-N 115.989 -0.551 . . . . 75.230000000000004 114.063 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -67.88 -40.94 83.47 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.567 0.747 . . . . 75.109999999999999 111.065 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -104.23 156.99 17.44 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.749 0.819 . . . . 71.340000000000003 109.834 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.464 ' HB2' ' NE2' ' B' ' 78' ' ' HIS . 8.4 p-10 -100.85 -43.98 5.92 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.969 -0.457 . . . . 75.299999999999997 111.511 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 69.9 t80 59.31 100.27 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.881 1.273 . . . . 75.329999999999998 112.458 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -118.64 166.59 12.56 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.268 0.627 . . . . 73.329999999999998 111.661 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -72.8 173.84 8.55 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.159 0.984 . . . . 73.329999999999998 110.381 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.55 58.41 3.36 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 114.189 0.436 . . . . 63.229999999999997 114.189 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.1 mt -130.74 -169.81 2.23 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.827 1.251 . . . . 74.019999999999996 109.739 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -93.22 -24.51 18.17 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.161 0.585 . . . . 75.540000000000006 111.692 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -70.9 121.59 18.38 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.303 0.641 . . . . 72.239999999999995 111.199 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.464 ' NE2' ' HB2' ' B' ' 70' ' ' ASP . 75.0 t60 66.53 10.79 7.64 Favored 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 124.962 1.305 . . . . 75.450000000000003 112.489 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -77.22 88.34 3.67 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.557 0.743 . . . . 72.430000000000007 111.361 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -136.53 -172.69 3.22 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.438 0.695 . . . . 70.219999999999999 112.646 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -101.95 -39.24 7.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.971 0.908 . . . . 73.510000000000005 111.762 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.467 0.651 . . . . 62.450000000000003 111.264 -173.963 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 110.272 -0.269 . . . . 75.209999999999994 110.272 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.72 100.69 0.41 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.539 0.736 . . . . 72.5 110.404 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -70.98 -19.02 62.59 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.458 0.703 . . . . 75.209999999999994 112.148 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -74.93 -11.98 60.25 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.698 0.999 . . . . 73.239999999999995 113.698 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -49.1 -52.8 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 118.585 0.63 . . . . 71.099999999999994 111.083 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.71 -28.22 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.04 0.536 . . . . 71.439999999999998 112.265 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.41 -42.66 33.45 Favored Glycine 0 C--N 1.351 1.371 0 O-C-N 123.302 0.376 . . . . 71.340000000000003 113.558 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.7 -44.42 81.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.809 0.844 . . . . 72.349999999999994 111.209 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -71.64 -28.89 64.08 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.84 -0.618 . . . . 74.340000000000003 111.707 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.09 -29.03 63.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.679 0.392 . . . . 62.229999999999997 111.263 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.11 -37.28 92.92 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 115.997 -0.547 . . . . 71.030000000000001 112.46 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -75.26 -38.92 60.26 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 122.881 0.472 . . . . 75.209999999999994 111.271 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.46 HG13 HD11 ' A' ' 28' ' ' LEU . 53.1 t -64.14 -46.12 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.889 0.875 . . . . 74.349999999999994 111.284 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -67.67 -33.32 74.69 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.514 -0.312 . . . . 73.150000000000006 110.313 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -63.91 -33.0 74.72 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 122.416 -0.178 . . . . 73.299999999999997 111.027 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.469 ' HB1' HD13 ' A' ' 28' ' ' LEU . . . -67.22 -28.5 68.12 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.82 0.448 . . . . 73.230000000000004 111.846 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.4 -45.46 54.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.784 0.834 . . . . 75.129999999999995 110.633 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -59.71 -29.86 68.41 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.495 1.118 . . . . 75.510000000000005 111.559 173.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -82.06 -52.94 6.52 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.07 0.948 . . . . 73.140000000000001 110.26 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.35 96.59 2.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.467 1.107 . . . . 63.109999999999999 109.567 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -73.94 154.16 39.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.607 0.763 . . . . 63.420000000000002 113.016 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.6 65.37 2.43 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 116.076 -0.511 . . . . 51.439999999999998 112.935 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.494 HD12 ' HG3' ' A' ' 27' ' ' GLU . 20.7 tt -134.25 143.76 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 122.871 0.468 . . . . 74.239999999999995 111.819 -169.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 49.4 m -67.61 146.08 54.22 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.546 0.738 . . . . 75.430000000000007 111.815 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 40' ' ' ALA . 55.9 mt -53.4 -48.94 90.93 Favored Pre-proline 0 CA--C 1.577 1.994 0 C-N-CA 124.175 0.99 . . . . 75.430000000000007 113.581 -176.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.86 -27.59 43.54 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 121.765 1.643 . . . . 75.510000000000005 113.553 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.494 ' HG3' HD12 ' A' ' 23' ' ' ILE . 10.8 tp10 -73.12 -55.62 6.23 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 112.402 0.519 . . . . 73.219999999999999 112.402 -174.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD13 ' HB1' ' A' ' 16' ' ' ALA . 2.2 pt? -66.41 -29.31 69.44 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.078 0.399 . . . . 74.230000000000004 111.245 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.37 -42.67 53.67 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.719 0.808 . . . . 73.230000000000004 112.168 171.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -63.81 -40.4 96.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.074 0.55 . . . . 74.409999999999997 111.596 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.509 ' HB3' ' HZ2' ' A' ' 31' ' ' LYS . 6.4 mtpm? -69.04 -38.06 78.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.889 0.876 . . . . 74.510000000000005 111.473 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.1 m -94.85 4.66 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.524 0.73 . . . . 74.349999999999994 112.201 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 64.81 21.23 12.32 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 124.741 1.216 . . . . 64.040000000000006 112.336 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.6 mt -105.91 162.59 13.44 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.38 0.672 . . . . 75.409999999999997 111.527 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -69.81 158.48 35.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.433 -0.803 . . . . 73.5 111.249 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -56.91 -42.22 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.241 0.616 . . . . 74.319999999999993 110.744 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.16 -50.03 73.46 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.699 0.8 . . . . 75.349999999999994 111.497 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -58.15 -38.94 77.54 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.819 0.848 . . . . 71.510000000000005 111.856 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.425 ' O ' HG21 ' A' ' 43' ' ' VAL . 97.9 m -70.69 -52.69 19.37 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.661 0.785 . . . . 64.209999999999994 111.391 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.42 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.17 -32.58 74.2 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 123.797 0.839 . . . . 70.230000000000004 112.772 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -72.66 -41.17 65.71 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.171 0.988 . . . . 74.340000000000003 109.808 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.02 -30.52 71.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.307 0.643 . . . . 75.420000000000002 111.586 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 39' ' ' THR . 49.5 t -65.8 -43.97 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.339 1.056 . . . . 75.109999999999999 110.304 171.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.449 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.27 -28.37 72.89 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 116.11 -0.495 . . . . 74.329999999999998 112.713 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.426 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 77.2 t-105 -70.28 -44.4 68.47 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.207 0.603 . . . . 75.310000000000002 110.829 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.0 mt -60.9 -31.37 70.86 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.267 0.627 . . . . 73.510000000000005 111.735 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.07 -25.0 57.95 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.574 1.15 . . . . 73.219999999999999 113.63 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.733 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 23.6 ptt180 -57.12 -35.59 69.65 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 123.07 0.548 . . . . 75.439999999999998 111.519 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.733 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 28.9 mt-10 -106.28 8.39 31.83 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.64 1.176 . . . . 75.099999999999994 110.93 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 63.39 23.8 13.89 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.037 1.335 . . . . 74.230000000000004 112.698 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HG3' ' HB2' ' A' ' 49' ' ' GLU . 28.1 mtpp -70.16 -10.96 60.47 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.677 0.991 . . . . 75.319999999999993 113.677 -174.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 m -126.59 148.48 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.792 0.837 . . . . 71.319999999999993 111.545 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG23 ' HB2' ' A' ' 64' ' ' TYR . 6.7 m -131.0 112.41 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 C-N-CA 124.516 1.126 . . . . 74.420000000000002 109.84 170.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.583 HG13 HG21 ' A' ' 63' ' ' ILE . 3.0 mp -92.07 134.99 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.61 1.164 . . . . 74.409999999999997 110.745 -171.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -139.04 144.76 38.96 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.353 0.661 . . . . 73.230000000000004 110.486 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -116.06 112.61 22.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.504 0.669 . . . . 71.519999999999996 110.528 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -105.4 128.88 53.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.143 0.977 . . . . 73.329999999999998 109.447 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 58.64 31.76 21.45 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 124.635 1.174 . . . . 71.519999999999996 113.025 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.91 -9.86 54.81 Favored Glycine 0 CA--C 1.541 1.711 0 N-CA-C 114.469 0.548 . . . . 61.549999999999997 114.469 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.71 135.07 36.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.323 1.049 . . . . 74.049999999999997 109.342 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.651 HD11 ' HB2' ' B' ' 37' ' ' GLU . 19.5 mt -104.09 125.02 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 CA-C-O 121.544 0.688 . . . . 73.439999999999998 112.345 -170.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 8.8 mp0 -117.96 153.53 33.46 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.806 1.642 . . . . 51.219999999999999 109.725 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.583 HG21 HG13 ' A' ' 54' ' ' ILE . 48.1 pt -113.89 142.7 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.304 0.573 . . . . 73.329999999999998 110.69 171.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.604 ' HB2' HG23 ' A' ' 53' ' ' VAL . 80.9 m-85 -125.07 167.39 14.84 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.225 1.01 . . . . 73.439999999999998 110.135 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -86.87 148.9 25.17 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.539 0.736 . . . . 65.340000000000003 112.011 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -19.14 63.74 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 115.766 -0.652 . . . . 74.310000000000002 110.093 166.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.58 -15.55 33.28 Favored Glycine 0 C--N 1.36 1.867 0 N-CA-C 115.792 1.077 . . . . 71.209999999999994 115.792 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -88.1 2.21 52.52 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 117.402 0.601 . . . . 74.140000000000001 111.627 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.419 ' HE2' HG22 ' A' ' 53' ' ' VAL . 75.8 m-85 -134.6 -70.6 0.5 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.661 1.184 . . . . 75.239999999999995 109.949 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -127.67 93.03 3.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.342 1.057 . . . . 73.140000000000001 109.343 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -72.36 132.74 44.37 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.173 0.511 . . . . 73.040000000000006 112.146 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.6 t -152.35 120.47 6.25 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.125 0.97 . . . . 55.020000000000003 109.285 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -77.25 -83.83 0.07 Allowed 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 122.807 0.443 . . . . 75.230000000000004 110.222 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.76 -22.16 9.76 Favored Glycine 0 CA--C 1.542 1.765 0 N-CA-C 115.225 0.85 . . . . 73.010000000000005 115.225 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.66 123.35 23.89 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.691 0.796 . . . . 65.319999999999993 112.14 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -85.82 150.35 24.61 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.69 0.396 . . . . 71.420000000000002 110.097 166.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -83.1 71.79 10.14 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.268 0.556 . . . . 74.420000000000002 109.693 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -70.78 129.54 39.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.362 0.665 . . . . 74.049999999999997 111.443 -174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -142.03 -170.28 3.11 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.544 1.137 . . . . 63.399999999999999 111.191 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -63.6 -37.35 86.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.521 0.728 . . . . 63.229999999999997 111.411 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -126.37 98.6 5.5 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.267 1.027 . . . . 75.219999999999999 109.21 172.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 N--CA 1.484 1.258 0 C-N-CA 124.487 1.115 . . . . 74.549999999999997 112.105 179.074 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 CA--C 1.55 0.945 0 CA-C-O 120.842 0.353 . . . . 73.019999999999996 110.963 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -58.43 -37.89 76.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.386 1.074 . . . . 75.420000000000002 112.935 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.545 ' HZ1' ' HB2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -65.43 -18.77 65.57 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.822 0.849 . . . . 75.439999999999998 111.738 -172.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.26 -44.54 10.76 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.643 1.177 . . . . 75.219999999999999 110.119 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -56.18 -48.35 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 123.729 0.812 . . . . 74.299999999999997 111.612 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.6 m -63.38 -30.45 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.338 1.055 . . . . 74.129999999999995 112.297 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.43 -44.13 85.09 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.181 0.301 . . . . 72.129999999999995 112.78 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.66 69.23 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.513 0.725 . . . . 71.150000000000006 111.832 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -66.1 -48.65 70.24 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.733 1.213 . . . . 74.540000000000006 110.927 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 -20.93 63.8 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.365 0.666 . . . . 61.310000000000002 112.112 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.29 -43.74 94.72 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 123.172 0.295 . . . . 64.209999999999994 112.986 174.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -68.62 -45.93 70.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.706 0.802 . . . . 72.530000000000001 110.912 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.46 ' HA ' HG13 ' B' ' 32' ' ' VAL . 96.6 t -60.01 -49.65 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.808 0.843 . . . . 75.129999999999995 111.708 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -60.87 -44.35 97.18 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.581 0.753 . . . . 71.25 111.738 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -62.29 -43.68 98.27 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.025 0.53 . . . . 74.329999999999998 111.883 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.04 68.88 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.367 0.667 . . . . 73.239999999999995 111.407 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -72.42 -32.68 66.54 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.744 1.218 . . . . 74.439999999999998 110.578 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -81.77 -18.97 42.31 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.201 0.6 . . . . 64.120000000000005 110.6 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -67.54 -33.77 75.72 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.545 0.738 . . . . 75.239999999999995 110.227 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.12 108.59 1.12 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.256 1.022 . . . . 74.450000000000003 109.564 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -93.58 173.6 7.61 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 112.318 0.488 . . . . 73.540000000000006 112.318 -175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.26 44.68 8.63 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.969 -0.56 . . . . 70.319999999999993 111.943 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 tt -134.33 137.71 51.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.844 0.857 . . . . 72.450000000000003 110.116 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 70.3 m -78.13 160.17 28.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.438 0.695 . . . . 72.099999999999994 112.732 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.461 HG23 ' HB2' ' B' ' 40' ' ' ALA . 81.2 mt -49.32 -53.56 38.58 Favored Pre-proline 0 CA--C 1.572 1.804 0 C-N-CA 125.817 1.647 . . . . 73.519999999999996 114.037 -177.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.41 ' HA ' HG23 ' B' ' 36' ' ' VAL . 63.6 Cg_endo -69.68 -23.75 30.83 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 121.556 1.504 . . . . 71.530000000000001 113.387 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -76.5 -55.76 5.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.213 0.605 . . . . 73.120000000000005 110.596 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.3 -29.7 70.62 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.507 0.723 . . . . 72.510000000000005 111.601 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.501 ' HA ' HG22 ' B' ' 39' ' ' THR . . . -52.9 -37.75 61.0 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.803 0.841 . . . . 74.319999999999993 112.812 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -71.75 -34.79 69.78 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.25 0.833 . . . . 75.120000000000005 113.25 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -76.92 -31.43 56.68 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.548 0.613 . . . . 53.149999999999999 111.646 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' B' ' 13' ' ' VAL . 33.3 m -88.03 -4.72 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.555 0.342 . . . . 73.219999999999999 111.555 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t30 68.67 17.65 8.88 Favored 'General case' 0 CA--C 1.57 1.72 0 C-N-CA 124.779 1.232 . . . . 75.329999999999998 112.119 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 70.3 mt -102.8 163.75 12.03 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.548 0.739 . . . . 74.129999999999995 111.388 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 62.8 m -67.7 158.54 32.06 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.448 0.699 . . . . 71.340000000000003 111.785 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.432 HG12 HG22 ' B' ' 25' ' ' ILE . 61.8 t -64.43 -43.48 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.099 0.559 . . . . 74.430000000000007 111.946 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' A' ' 61' ' ' ILE . 45.8 mt-10 -62.97 -31.98 73.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.768 0.427 . . . . 72.120000000000005 111.946 175.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 42.3 m -63.63 -45.27 91.03 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.46 0.704 . . . . 72.340000000000003 111.114 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.501 HG22 ' HA ' ' B' ' 29' ' ' ALA . 17.0 p -76.46 -41.02 48.79 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.178 0.807 . . . . 75.239999999999995 113.178 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.461 ' HB2' HG23 ' B' ' 25' ' ' ILE . . . -56.0 -46.51 78.7 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 123.863 0.865 . . . . 41.43 111.974 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.9 -40.32 83.5 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 114.256 -1.338 . . . . 74.310000000000002 111.112 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.27 84.77 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.219 0.608 . . . . 73.5 112.102 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.479 HG11 HG22 ' B' ' 52' ' ' VAL . 55.3 t -65.87 -34.47 70.53 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.071 0.948 . . . . 64.319999999999993 110.601 174.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.449 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -65.71 -37.04 93.09 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 116.545 -0.298 . . . . 70.209999999999994 112.925 171.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.505 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 77.2 t-105 -67.18 -30.45 70.41 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.668 0.787 . . . . 75.310000000000002 111.474 175.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.5 -39.37 67.7 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.075 0.55 . . . . 75.219999999999999 110.936 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.9 -25.85 67.81 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.446 1.099 . . . . 74.430000000000007 113.397 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.6 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 16.5 ptt180 -58.93 -36.45 74.77 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.017 0.437 . . . . 73.140000000000001 111.015 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . 0.6 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 43.8 mt-10 -104.75 3.18 31.02 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.686 1.194 . . . . 72.450000000000003 111.033 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.1 t30 58.88 35.86 24.38 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 125.396 1.478 . . . . 70.109999999999999 111.584 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -70.59 -17.11 62.91 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.479 -0.782 . . . . 73.010000000000005 111.044 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.479 HG22 HG11 ' B' ' 43' ' ' VAL . 24.9 m -131.68 153.29 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.283 1.033 . . . . 75.310000000000002 109.304 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' B' ' 64' ' ' TYR . 7.2 m -115.51 116.63 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.537 0.735 . . . . 72.329999999999998 110.15 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 48.5 mm -81.3 104.96 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.849 0.859 . . . . 74.430000000000007 110.217 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -119.45 108.43 14.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.351 0.66 . . . . 54.539999999999999 109.807 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.488 ' HB3' HG13 ' B' ' 61' ' ' ILE . 29.0 ptt180 -92.03 106.34 18.38 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.955 0.883 . . . . 74.530000000000001 110.484 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -103.63 127.83 51.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.988 1.315 . . . . 74.349999999999994 109.607 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 57.74 29.66 17.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.711 1.204 . . . . 72.049999999999997 111.505 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.2 -27.65 6.71 Favored Glycine 0 CA--C 1.546 1.976 0 CA-C-N 115.231 -0.895 . . . . 51.219999999999999 113.858 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.87 123.43 27.75 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.874 0.87 . . . . 73.099999999999994 110.795 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.488 HG13 ' HB3' ' B' ' 56' ' ' ARG . 2.8 mp -74.57 123.21 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 122.739 0.416 . . . . 73.310000000000002 110.128 -174.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -119.53 138.33 53.24 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.204 1.002 . . . . 74.439999999999998 109.752 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.434 HD13 HG13 ' B' ' 25' ' ' ILE . 2.2 mp -107.09 112.09 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.075 0.55 . . . . 75.109999999999999 110.031 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.568 ' HB2' HG22 ' B' ' 53' ' ' VAL . 85.9 m-85 -107.11 159.29 16.42 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.321 1.048 . . . . 71.310000000000002 110.52 174.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -82.51 171.55 13.99 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.957 0.725 . . . . 72.010000000000005 112.957 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -56.83 -30.99 64.29 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.172 0.989 . . . . 74.329999999999998 112.694 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.53 -8.01 36.85 Favored Glycine 0 CA--C 1.545 1.965 0 N-CA-C 114.435 0.534 . . . . 72.019999999999996 114.435 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -60.47 -32.88 71.83 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.081 0.952 . . . . 75.430000000000007 111.456 171.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -117.23 153.41 32.93 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.569 0.748 . . . . 64.340000000000003 110.25 171.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 26.7 t70 55.31 42.62 30.1 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.934 0.894 . . . . 75.439999999999998 110.932 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -61.92 102.3 0.27 Allowed 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.224 -0.898 . . . . 74.239999999999995 111.058 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 57.6 m -73.48 172.06 12.0 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.823 0.849 . . . . 62.420000000000002 111.919 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -69.52 -61.66 1.69 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.845 0.458 . . . . 75.329999999999998 111.423 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.88 76.48 0.45 Allowed Glycine 0 C--N 1.351 1.406 0 CA-C-N 116.259 -0.428 . . . . 74.010000000000005 113.022 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.64 -20.81 63.59 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.081 0.952 . . . . 72.450000000000003 112.346 -174.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.33 -76.32 0.08 Allowed 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 124.323 1.049 . . . . 74.120000000000005 112.091 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 33.0 p80 37.25 63.7 0.7 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 125.954 1.702 . . . . 75.439999999999998 115.391 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -106.95 138.69 42.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.672 -0.643 . . . . 74.129999999999995 110.942 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -120.55 104.4 9.92 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.453 0.701 . . . . 71.140000000000001 111.241 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -75.62 -15.67 60.31 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.49 0.716 . . . . 72.430000000000007 110.71 167.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -61.6 96.14 0.06 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.409 1.084 . . . . 74.420000000000002 110.615 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 17.2 p80 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.865 0.841 . . . . 75.340000000000003 111.447 -178.621 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 111.72 0.267 . . . . 72.030000000000001 111.72 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -48.37 -40.9 27.14 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.008 1.323 . . . . 73.150000000000006 114.381 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.41 -34.99 73.15 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.979 0.911 . . . . 75.329999999999998 112.36 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -77.73 -37.28 49.61 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.295 0.638 . . . . 74.200000000000003 111.067 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.8 mt -62.86 -47.53 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.613 0.765 . . . . 75.420000000000002 111.627 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.42 -30.42 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.099 0.56 . . . . 73.120000000000005 111.264 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.93 -51.25 47.22 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.825 0.703 . . . . 63.020000000000003 112.269 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.42 81.83 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.844 0.858 . . . . 64.450000000000003 112.284 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -65.82 -29.47 69.95 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.507 0.723 . . . . 73.239999999999995 112.182 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.12 -44.88 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.033 0.533 . . . . 75.230000000000004 111.367 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.17 94.65 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.48 -0.648 . . . . 64.129999999999995 111.48 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -61.76 -50.01 74.11 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.328 1.051 . . . . 75.150000000000006 112.583 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.659 ' HA ' HG11 ' A' ' 32' ' ' VAL . 32.9 m -67.55 -29.54 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 120.656 0.265 . . . . 73.340000000000003 111.711 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.593 ' HA ' HD11 ' A' ' 17' ' ' LEU . 24.4 t90 -68.6 -32.83 73.0 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.286 0.634 . . . . 73.140000000000001 111.546 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -58.68 -36.84 74.84 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 122.813 0.445 . . . . 71.129999999999995 111.666 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.91 69.49 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.218 0.607 . . . . 75.349999999999994 112.162 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 14' ' ' TRP . 81.2 mt -66.54 -22.58 66.16 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.727 0.811 . . . . 72.5 112.194 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -64.58 -28.08 69.39 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.417 0.687 . . . . 75.200000000000003 111.463 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -77.01 -57.4 3.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.24 0.616 . . . . 75.140000000000001 110.521 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.34 107.6 3.27 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.481 0.712 . . . . 64.510000000000005 110.765 -174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 6.2 p-10 -95.72 164.57 12.7 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.509 0.724 . . . . 75.310000000000002 110.842 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.15 26.67 51.93 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 121.475 0.486 . . . . 73.209999999999994 112.128 -166.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 tt -96.63 153.71 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 124.46 1.104 . . . . 74.310000000000002 110.139 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -79.17 156.4 28.24 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.902 -0.499 . . . . 73.230000000000004 111.458 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.458 HG23 ' HB2' ' A' ' 40' ' ' ALA . 80.2 mt -56.32 -50.36 88.04 Favored Pre-proline 0 CA--C 1.575 1.908 0 C-N-CA 124.468 1.107 . . . . 64.430000000000007 113.908 -173.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.25 -24.07 38.18 Favored 'Trans proline' 0 C--N 1.394 2.93 0 CA-C-N 121.399 1.535 . . . . 73.319999999999993 114.049 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -76.5 -45.1 32.45 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.43 1.11 . . . . 71.530000000000001 109.683 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.423 HD23 HD13 ' A' ' 63' ' ' ILE . 63.1 tp -59.34 -40.6 86.91 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 113.129 -1.85 . . . . 74.400000000000006 111.09 172.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.15 81.82 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.325 1.05 . . . . 72.109999999999999 111.917 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -65.09 -40.87 95.2 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.626 0.77 . . . . 75.25 111.446 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -63.9 -40.82 97.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.153 0.581 . . . . 74.200000000000003 111.67 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.6 m -95.83 -1.93 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 112.966 0.728 . . . . 71.409999999999997 112.966 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.0 t30 68.02 13.64 9.17 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 124.483 1.113 . . . . 70.0 112.506 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -92.74 166.25 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.463 -0.773 . . . . 72.430000000000007 111.062 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.0 t -64.43 154.01 36.97 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.102 0.561 . . . . 72.140000000000001 111.701 171.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.38 -48.01 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.808 0.843 . . . . 71.400000000000006 110.615 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -62.6 -42.37 99.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.327 1.051 . . . . 73.340000000000003 111.676 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.478 ' HA ' HH21 ' B' ' 56' ' ' ARG . 67.7 m -65.48 -30.62 71.42 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.596 0.758 . . . . 73.109999999999999 112.256 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.404 ' O ' HG21 ' A' ' 43' ' ' VAL . 63.2 m -82.08 -43.01 18.42 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.784 0.834 . . . . 74.140000000000001 111.512 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.458 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -58.69 -50.81 72.52 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.001 0.921 . . . . 75.120000000000005 112.142 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -66.28 -32.48 73.92 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 114.087 -1.415 . . . . 74.420000000000002 110.831 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.35 -38.7 71.61 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.26 0.624 . . . . 73.519999999999996 111.961 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 63' ' ' ILE . 69.3 t -64.89 -31.33 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.18 0.592 . . . . 73.219999999999999 110.835 175.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -58.79 -33.02 71.25 Favored Glycine 0 CA--C 1.544 1.858 0 CA-C-N 116.271 -0.422 . . . . 63.039999999999999 113.322 171.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -71.95 -30.63 65.5 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.543 0.737 . . . . 74.120000000000005 111.172 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.24 -38.79 71.94 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.675 0.39 . . . . 75.239999999999995 111.429 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.46 -34.95 78.88 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.562 0.745 . . . . 61.200000000000003 110.825 172.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.614 ' HG2' ' HB3' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -63.79 -43.97 94.75 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.013 1.325 . . . . 74.319999999999993 111.267 172.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -85.48 -1.14 56.74 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.606 0.762 . . . . 74.340000000000003 112.69 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 64.96 22.61 12.48 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.776 1.23 . . . . 75.109999999999999 112.729 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 61.5 mttp -77.49 -20.87 53.65 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.766 0.827 . . . . 72.319999999999993 112.454 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.92 154.74 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.48 0.657 . . . . 75.109999999999999 112.172 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 47.7 t -105.23 104.31 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.348 1.059 . . . . 71.129999999999995 109.065 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 mm -71.59 122.49 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 109.454 -0.572 . . . . 51.310000000000002 109.454 175.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.28 133.42 38.87 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.965 0.506 . . . . 74.200000000000003 110.385 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -116.94 141.91 47.63 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.402 0.681 . . . . 74.540000000000006 111.115 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 114.18 4.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.18 0.992 . . . . 74.450000000000003 109.892 -176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 54.07 30.81 12.58 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.4 1.08 . . . . 72.540000000000006 112.561 -173.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.26 -18.48 54.14 Favored Glycine 0 CA--C 1.545 1.968 0 CA-C-N 115.785 -0.643 . . . . 63.420000000000002 114.429 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -78.94 136.67 37.32 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.748 0.819 . . . . 74.129999999999995 111.275 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.1 mt -101.99 124.31 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 123.404 0.682 . . . . 73.340000000000003 111.081 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -123.48 124.92 43.93 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.895 1.278 . . . . 62.240000000000002 108.815 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.549 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -106.09 112.0 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-O 122.152 0.977 . . . . 72.219999999999999 110.051 177.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.511 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 95.0 m-85 -90.15 175.65 7.07 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.083 0.953 . . . . 75.409999999999997 111.202 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.54 150.97 21.54 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.972 0.509 . . . . 72.239999999999995 109.911 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.62 168.37 11.84 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 120.912 0.387 . . . . 75.340000000000003 110.644 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.89 12.93 8.14 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 123.42 0.533 . . . . 74.030000000000001 112.867 -173.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -136.79 -15.31 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.975 1.102 . . . . 75.519999999999996 113.975 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -83.49 115.27 22.0 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.721 0.691 . . . . 72.230000000000004 111.061 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -116.46 157.22 25.51 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.737 0.815 . . . . 73.219999999999999 111.172 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -152.7 12.16 0.51 Allowed 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.153 0.981 . . . . 73.150000000000006 109.906 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.3 t -92.91 152.69 19.23 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.817 0.847 . . . . 74.530000000000001 111.537 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -73.22 96.78 2.31 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.13 0.572 . . . . 74.5 110.4 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.16 81.61 1.74 Allowed Glycine 0 CA--C 1.534 1.272 0 CA-C-N 116.355 -0.384 . . . . 75.540000000000006 113.6 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -123.83 128.42 49.49 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.138 0.575 . . . . 75.420000000000002 110.27 170.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.15 -30.22 69.29 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.251 1.021 . . . . 73.519999999999996 112.958 -175.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -87.63 179.84 6.45 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.424 0.69 . . . . 72.239999999999995 111.996 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -59.85 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.087 0.955 . . . . 72.129999999999995 113.528 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -75.72 88.36 2.79 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.583 -0.895 . . . . 74.219999999999999 108.583 164.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -60.99 95.54 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.53 1.132 . . . . 72.310000000000002 112.685 -165.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 74.78 -19.84 0.36 Allowed 'General case' 0 CA--C 1.571 1.769 0 C-N-CA 125.497 1.519 . . . . 74.329999999999998 114.006 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 . . . . . 0 N--CA 1.488 1.444 0 C-N-CA 124.603 1.161 . . . . 74.340000000000003 111.625 -178.379 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 CA--C 1.551 0.999 0 CA-C-O 120.982 0.42 . . . . 74.150000000000006 111.477 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -124.0 151.37 43.78 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.3 1.04 . . . . 71.299999999999997 110.657 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.496 ' O ' HG23 ' B' ' 6' ' ' VAL . 40.5 ttmt -79.51 -33.37 42.12 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.527 0.331 . . . . 75.409999999999997 110.483 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -61.26 -13.12 16.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.793 1.034 . . . . 74.109999999999999 113.793 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 70.3 mt -55.69 -45.93 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.616 0.766 . . . . 75.409999999999997 111.47 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 3' ' ' LYS . 16.3 m -66.46 -25.76 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 122.173 0.189 . . . . 74.129999999999995 111.064 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.28 -38.75 91.84 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.583 0.552 . . . . 63.130000000000003 113.259 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 -40.4 95.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.256 0.622 . . . . 75.400000000000006 110.939 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -70.53 -30.08 66.74 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.4 -0.818 . . . . 74.120000000000005 111.613 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.523 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -76.68 -36.35 57.33 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.603 0.761 . . . . 63.130000000000003 111.521 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.23 -30.97 79.3 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 115.809 -0.632 . . . . 63.530000000000001 112.55 172.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' B' ' 32' ' ' VAL . 4.3 ttmp? -72.59 -52.49 15.28 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.915 0.886 . . . . 75.400000000000006 112.006 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' B' ' 10' ' ' ALA . 33.0 m -68.53 -36.47 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 112.489 0.551 . . . . 74.140000000000001 112.489 -174.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.566 ' HA ' HD12 ' B' ' 17' ' ' LEU . 31.2 t90 -74.16 -32.55 63.17 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 111.903 0.334 . . . . 74.329999999999998 111.903 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -64.55 -33.49 76.02 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.001 0.429 . . . . 72.239999999999995 110.537 173.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.22 -32.45 71.72 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.928 0.891 . . . . 73.25 112.037 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' B' ' 14' ' ' TRP . 70.6 mt -70.99 -46.33 62.49 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.995 0.918 . . . . 75.299999999999997 111.097 173.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -63.11 -25.16 68.23 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.031 0.932 . . . . 74.430000000000007 110.609 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -76.08 -52.81 9.37 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.53 -0.759 . . . . 74.109999999999999 110.45 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.56 99.41 2.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.719 0.807 . . . . 65.439999999999998 110.657 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -98.35 -178.78 4.14 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.755 0.822 . . . . 74.400000000000006 111.335 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.84 37.39 44.71 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.743 -0.543 . . . . 74.219999999999999 111.743 -171.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 tt -122.61 139.85 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.891 0.877 . . . . 74.319999999999993 111.352 -168.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 20.4 m -64.09 151.24 43.66 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.163 0.985 . . . . 72.040000000000006 111.582 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.559 HG12 HD13 ' B' ' 63' ' ' ILE . 54.3 mt -53.63 -49.34 89.38 Favored Pre-proline 0 CA--C 1.579 2.071 0 N-CA-C 112.806 0.669 . . . . 73.120000000000005 112.806 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.64 -25.71 24.23 Favored 'Trans proline' 0 C--N 1.399 3.201 0 C-N-CA 121.926 1.75 . . . . 74.209999999999994 114.539 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.57 -41.88 37.29 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.61 1.195 . . . . 72.400000000000006 109.703 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.3 tp -61.26 -40.1 92.82 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.113 -1.858 . . . . 71.25 110.72 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.72 73.46 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.829 0.852 . . . . 73.200000000000003 111.962 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 64.2 mtp85 -65.06 -50.02 67.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.659 0.784 . . . . 72.219999999999999 111.916 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -73.84 -24.16 59.73 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 112.127 0.417 . . . . 73.540000000000006 112.127 -176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.514 HG13 ' HA ' ' B' ' 13' ' ' VAL . 13.9 m -94.85 -3.39 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 112.039 0.385 . . . . 72.140000000000001 112.039 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 65.05 21.64 12.28 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.233 1.013 . . . . 62.140000000000001 112.797 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.6 mt -108.56 169.26 8.77 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.81 0.844 . . . . 72.230000000000004 110.87 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 51.7 m -74.85 163.16 27.96 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.652 0.381 . . . . 61.439999999999998 111.336 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.3 -51.49 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.56 0.744 . . . . 73.450000000000003 111.86 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.63 -38.92 92.14 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.196 0.598 . . . . 73.409999999999997 111.989 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 29.4 t -64.43 -39.1 93.19 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.429 0.692 . . . . 53.009999999999998 111.525 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.419 ' O ' HG22 ' B' ' 43' ' ' VAL . 86.6 m -71.03 -48.5 52.61 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.768 0.827 . . . . 74.450000000000003 110.973 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.62 -35.34 72.33 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.789 0.836 . . . . 70.430000000000007 112.378 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.11 -48.51 70.65 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.183 0.993 . . . . 74.349999999999994 109.81 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.38 -30.36 70.49 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.259 -0.882 . . . . 72.129999999999995 111.681 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.419 HG22 ' O ' ' B' ' 39' ' ' THR . 95.2 t -72.87 -31.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 123.006 0.523 . . . . 61.439999999999998 110.615 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -66.11 -27.96 73.31 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 116.26 -0.427 . . . . 63.530000000000001 112.8 172.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -75.46 -25.75 57.68 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.976 0.51 . . . . 74.400000000000006 111.48 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.506 HD11 HG21 ' B' ' 13' ' ' VAL . 96.6 mt -71.6 -27.08 62.88 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.081 0.552 . . . . 52.140000000000001 111.686 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.3 -32.78 62.72 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.317 1.229 . . . . 73.439999999999998 114.317 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.614 ' HB3' ' HG2' ' A' ' 48' ' ' ARG . 13.5 ptm180 -72.27 -30.15 64.56 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 119.069 0.849 . . . . 74.519999999999996 111.512 171.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.76 -19.27 52.64 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.299 0.64 . . . . 74.040000000000006 110.758 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 60.42 21.83 11.44 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.744 1.618 . . . . 70.010000000000005 112.749 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.89 5.55 45.81 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 112.878 0.696 . . . . 74.540000000000006 112.878 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.81 146.17 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.344 0.657 . . . . 74.140000000000001 112.576 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 66.6 t -118.78 109.95 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 124.49 1.116 . . . . 74.319999999999993 109.5 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 39.6 mm -91.92 121.58 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.714 0.805 . . . . 74.310000000000002 111.401 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -117.16 141.53 48.15 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.506 -0.746 . . . . 72.310000000000002 111.787 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.562 ' HG2' HG12 ' B' ' 61' ' ' ILE . 84.0 mtt85 -113.51 111.6 22.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.077 0.951 . . . . 74.420000000000002 110.203 169.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' B' ' 57' ' ' LYS . 0.3 OUTLIER -144.6 126.94 15.82 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.315 1.046 . . . . 74.549999999999997 109.304 -178.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 60.74 28.68 18.4 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 125.027 1.331 . . . . 75.420000000000002 111.63 -171.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.19 -0.89 61.93 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-N 116.287 -0.415 . . . . 72.400000000000006 113.79 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.72 131.16 43.69 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.143 0.977 . . . . 70.340000000000003 110.936 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.562 HG12 ' HG2' ' B' ' 56' ' ' ARG . 43.8 mt -97.12 122.29 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.129 0.572 . . . . 73.209999999999994 110.339 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -125.74 139.98 53.08 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.35 0.66 . . . . 75.219999999999999 110.014 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.559 HD13 HG12 ' B' ' 25' ' ' ILE . 2.9 mp -100.54 126.97 54.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.666 0.786 . . . . 74.340000000000003 109.517 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.618 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 7.8 m-85 -111.15 169.59 8.68 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.913 1.285 . . . . 72.219999999999999 109.86 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -90.2 155.65 18.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.797 0.439 . . . . 73.140000000000001 111.405 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.24 103.66 0.25 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.684 0.794 . . . . 74.349999999999994 110.428 173.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.27 -18.73 2.67 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 115.821 -0.627 . . . . 74.439999999999998 111.745 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -109.35 72.91 0.82 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.116 0.967 . . . . 64.209999999999994 109.553 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -160.37 -32.9 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.066 0.546 . . . . 73.140000000000001 112.439 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -48.73 -40.29 28.01 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.843 1.257 . . . . 74.109999999999999 113.653 -174.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.442 ' HE2' HD12 ' B' ' 75' ' ' LEU . 39.4 t80 -161.49 127.99 3.86 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.592 0.757 . . . . 73.299999999999997 109.937 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 88.7 p -73.96 129.02 37.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.199 0.6 . . . . 71.430000000000007 110.451 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -81.4 102.63 10.61 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.802 0.441 . . . . 74.420000000000002 110.681 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.92 46.19 0.65 Allowed Glycine 0 N--CA 1.469 0.896 0 N-CA-C 110.912 -0.875 . . . . 73.120000000000005 110.912 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.442 HD12 ' HE2' ' B' ' 71' ' ' PHE . 6.6 mp -84.15 120.76 26.56 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.727 0.811 . . . . 74.299999999999997 110.889 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.11 140.83 50.76 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.543 0.337 . . . . 72.510000000000005 110.354 174.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -127.27 141.24 51.77 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.952 0.901 . . . . 62.350000000000001 109.465 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -53.19 119.42 4.72 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.212 0.605 . . . . 74.219999999999999 111.761 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -68.96 101.47 1.39 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.799 0.84 . . . . 75.329999999999998 111.361 -173.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -75.27 143.92 42.78 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.986 0.515 . . . . 62.439999999999998 110.647 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -110.21 139.17 45.65 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.885 0.474 . . . . 74.219999999999999 111.019 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 15.9 t60 . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 121.752 0.787 . . . . 65.319999999999993 109.726 -179.115 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 119.255 -0.402 . . . . 74.430000000000007 111.062 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 46.27 104.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 125.585 1.554 . . . . 71.129999999999995 114.301 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' O ' HG22 ' A' ' 6' ' ' VAL . 21.4 tptm -63.42 -16.41 60.48 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 123.727 0.811 . . . . 72.319999999999993 112.401 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -72.12 -24.2 61.43 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.74 0.644 . . . . 74.120000000000005 112.74 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -61.17 -47.64 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.444 0.698 . . . . 71.109999999999999 111.521 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 3' ' ' LYS . 22.8 m -61.27 -28.06 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 122.519 0.328 . . . . 74.019999999999996 111.39 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.452 ' HA2' ' CD1' ' A' ' 45' ' ' TRP . . . -69.25 -49.68 37.97 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.544 0.528 . . . . 74.420000000000002 113.501 173.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.18 93.65 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.668 0.787 . . . . 74.129999999999995 112.382 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -75.03 -28.9 60.63 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.245 0.618 . . . . 63.130000000000003 112.339 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.99 82.6 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 112.464 0.542 . . . . 71.510000000000005 112.464 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.03 -34.54 81.93 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 116.413 -0.358 . . . . 72.019999999999996 113.127 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -67.17 -45.87 75.71 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.78 0.832 . . . . 75.219999999999999 110.644 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.598 ' HA ' HG11 ' A' ' 32' ' ' VAL . 63.8 t -60.97 -40.8 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 123.898 0.879 . . . . 65.230000000000004 111.212 175.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -64.67 -35.64 81.7 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.97 -0.559 . . . . 74.540000000000006 111.065 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.439 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 80.6 t60 -62.9 -44.81 95.09 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.78 0.432 . . . . 72.310000000000002 111.249 176.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.655 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . . . -67.46 -32.51 73.41 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.525 0.679 . . . . 62.439999999999998 111.284 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 65' ' ' ASN . 2.8 tm? -73.48 -29.92 62.82 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.925 1.29 . . . . 75.140000000000001 110.874 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -75.07 -47.15 30.25 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.96 0.904 . . . . 70.129999999999995 111.59 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 22.9 mm-40 -61.04 -33.19 72.9 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.13 0.572 . . . . 71.510000000000005 111.683 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.08 112.43 0.99 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.243 1.017 . . . . 74.450000000000003 109.54 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.8 178.4 5.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.25 0.62 . . . . 72.25 112.256 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.57 39.61 86.58 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 110.534 -1.026 . . . . 65.219999999999999 110.534 -167.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 tp -114.13 114.41 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 124.393 1.077 . . . . 75.010000000000005 110.044 -169.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -58.72 144.98 41.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.264 0.625 . . . . 71.25 112.594 -170.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.561 HG21 ' HB2' ' A' ' 40' ' ' ALA . 57.6 mt -55.38 -46.19 99.74 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 113.847 1.054 . . . . 75.450000000000003 113.847 -170.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HA ' HG23 ' A' ' 36' ' ' VAL . 32.6 Cg_endo -63.09 -25.05 73.25 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 121.819 1.679 . . . . 74.109999999999999 114.177 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -80.16 -55.15 5.13 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.994 0.739 . . . . 72.219999999999999 112.994 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -66.61 -26.03 66.89 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.45 0.568 . . . . 74.140000000000001 111.37 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.39 -37.31 16.57 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.745 0.818 . . . . 73.420000000000002 112.806 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -74.28 -35.02 63.73 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.305 0.642 . . . . 74.209999999999994 111.955 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.655 ' HE3' ' HB2' ' A' ' 16' ' ' ALA . 51.9 mtmt -67.06 -31.19 71.53 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 122.807 0.443 . . . . 75.209999999999994 111.513 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 13' ' ' VAL . 27.3 m -97.7 -9.47 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.701 0.801 . . . . 72.409999999999997 112.36 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.4 t30 64.7 28.11 13.08 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.347 1.459 . . . . 73.420000000000002 112.167 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.81 164.91 11.57 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.878 0.871 . . . . 74.0 111.198 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.7 m -65.21 153.11 41.94 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.139 0.576 . . . . 65.450000000000003 111.156 172.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 26' ' ' PRO . 64.6 t -53.97 -51.07 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.49 0.716 . . . . 73.510000000000005 111.104 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.556 ' HB3' HD12 ' B' ' 25' ' ' ILE . 36.3 mt-10 -60.32 -41.37 93.35 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.497 1.119 . . . . 74.540000000000006 112.557 176.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.8 m -62.28 -37.58 86.06 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 123.366 0.666 . . . . 74.420000000000002 111.798 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -71.78 -46.51 58.08 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.559 0.743 . . . . 74.450000000000003 111.182 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.72 -37.81 83.0 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 123.615 0.766 . . . . 72.420000000000002 112.493 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.69 -41.91 71.36 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.276 1.031 . . . . 71.540000000000006 110.554 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -31.85 73.18 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.158 0.583 . . . . 63.109999999999999 111.686 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.23 -35.69 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.899 0.88 . . . . 74.099999999999994 111.351 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -63.75 -32.28 83.64 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 114.049 0.38 . . . . 70.019999999999996 114.049 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.469 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 69.9 t-105 -73.89 -26.98 60.83 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.127 0.571 . . . . 75.439999999999998 111.361 175.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.98 -39.36 63.73 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 122.79 0.436 . . . . 74.019999999999996 111.173 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.87 69.81 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.261 1.024 . . . . 74.219999999999999 113.376 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 45' ' ' TRP . 5.7 ppt_? -71.45 -12.69 61.53 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.021 0.378 . . . . 65.409999999999997 112.021 174.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -110.35 -8.47 14.7 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.321 1.048 . . . . 73.329999999999998 111.915 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 63.51 28.73 15.35 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.625 1.17 . . . . 74.099999999999994 112.834 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -69.37 -13.9 62.62 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.375 0.67 . . . . 74.109999999999999 112.046 171.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.627 ' HB ' HD11 ' A' ' 63' ' ' ILE . 31.0 m -133.92 155.47 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.924 0.89 . . . . 75.120000000000005 110.855 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 69' ' ' PHE . 31.2 m -127.37 143.19 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.179 0.991 . . . . 74.200000000000003 109.499 173.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.401 HG12 HD12 ' A' ' 63' ' ' ILE . 63.0 mt -120.72 134.57 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.186 0.595 . . . . 72.540000000000006 110.717 -172.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -120.63 127.13 51.79 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.757 0.823 . . . . 62.140000000000001 111.409 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HG2' HG12 ' A' ' 61' ' ' ILE . 84.8 mtt180 -95.45 102.62 14.43 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.209 0.528 . . . . 74.140000000000001 110.181 170.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -108.56 123.19 48.53 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.789 0.836 . . . . 74.430000000000007 109.99 178.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 55.98 29.38 14.22 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.792 1.237 . . . . 70.439999999999998 112.082 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.95 -25.92 9.24 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 114.116 -174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.77 141.04 39.48 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.617 0.767 . . . . 75.129999999999995 111.195 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' A' ' 56' ' ' ARG . 32.2 mt -93.37 133.96 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.337 0.655 . . . . 70.219999999999999 111.791 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -132.17 139.74 48.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.999 0.92 . . . . 74.439999999999998 110.286 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.627 HD11 ' HB ' ' A' ' 52' ' ' VAL . 6.8 tp -102.49 126.28 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.35 0 CA-C-O 121.772 0.796 . . . . 63.100000000000001 111.487 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.437 ' HB2' HG23 ' A' ' 53' ' ' VAL . 89.6 m-85 -118.11 169.28 9.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.186 1.394 . . . . 74.299999999999997 111.45 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.493 ' HA ' HD13 ' A' ' 17' ' ' LEU . 28.6 t-20 -81.38 145.97 30.55 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.663 0.785 . . . . 72.420000000000002 110.671 175.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HA ' HG13 ' A' ' 53' ' ' VAL . 10.9 pt-20 -40.63 -32.58 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.521 1.675 . . . . 64.010000000000005 115.521 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.57 22.1 6.79 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 114.788 0.675 . . . . 50.409999999999997 114.788 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -126.59 27.39 6.12 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.309 1.044 . . . . 73.200000000000003 110.906 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.541 ' HB3' HG12 ' A' ' 53' ' ' VAL . 31.9 p90 -79.45 152.61 30.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.11 0.564 . . . . 72.340000000000003 111.034 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -77.19 144.05 38.61 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 109.215 -0.661 . . . . 75.299999999999997 109.215 171.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -73.82 4.41 5.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.749 0.648 . . . . 74.430000000000007 112.749 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.3 t -73.55 79.57 1.46 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.718 0.807 . . . . 73.5 109.831 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -82.09 -56.3 4.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.619 0.768 . . . . 70.310000000000002 111.01 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.44 73.93 1.28 Allowed Glycine 0 CA--C 1.533 1.202 0 N-CA-C 111.915 -0.474 . . . . 73.430000000000007 111.915 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.94 -33.6 70.79 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.027 0.931 . . . . 75.040000000000006 113.413 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -68.17 -30.15 69.19 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.962 0.905 . . . . 73.340000000000003 111.876 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -92.64 18.13 9.2 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.8 0.84 . . . . 70.310000000000002 112.733 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -69.01 87.01 0.37 Allowed 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 109.179 -0.674 . . . . 74.329999999999998 109.179 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -73.27 159.86 32.77 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.325 0.65 . . . . 73.400000000000006 111.895 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -122.28 -152.25 0.51 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.655 0.782 . . . . 74.209999999999994 109.455 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -72.21 -13.96 61.67 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.5 0.926 . . . . 74.439999999999998 113.5 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.615 0.722 . . . . 73.129999999999995 110.665 173.75 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.545 0.777 0 CA-C-O 120.449 0.166 . . . . 70.310000000000002 111.347 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.82 -23.48 67.29 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.695 0.998 . . . . 74.310000000000002 113.695 -173.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -38.68 55.32 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.282 0.633 . . . . 74.129999999999995 112.363 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -74.03 -48.58 29.07 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.909 0.884 . . . . 73.109999999999999 111.297 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 65.3 mt -59.08 -60.0 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 114.935 -1.03 . . . . 74.450000000000003 111.844 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 m -59.4 -29.13 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.22 1.008 . . . . 72.129999999999995 112.65 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.72 -43.29 85.09 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 123.285 0.366 . . . . 75.510000000000005 112.758 173.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.28 96.67 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.919 0.887 . . . . 70.400000000000006 112.083 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -67.1 -40.95 86.99 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.051 0.54 . . . . 74.540000000000006 111.26 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.33 77.46 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.622 0.769 . . . . 64.430000000000007 112.808 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.62 -38.56 96.61 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 123.501 0.501 . . . . 63.100000000000001 112.853 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -69.29 -46.51 67.0 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.715 0.806 . . . . 73.439999999999998 111.792 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.606 ' HA ' HG13 ' B' ' 32' ' ' VAL . 72.7 t -59.25 -45.9 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.52 0.728 . . . . 75.109999999999999 111.644 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.59 ' HA ' HD11 ' B' ' 17' ' ' LEU . 21.1 t90 -68.45 -32.45 72.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.895 -0.593 . . . . 73.349999999999994 111.537 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . 0.4 ' HA ' ' OD1' ' B' ' 18' ' ' ASN . 8.1 t60 -59.01 -35.74 73.77 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.26 0.553 . . . . 73.349999999999994 110.834 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.03 -29.62 63.12 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.964 0.905 . . . . 74.510000000000005 112.093 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' B' ' 14' ' ' TRP . 84.7 mt -73.18 -39.86 65.26 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.067 0.947 . . . . 72.430000000000007 112.745 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' B' ' 15' ' ' HIS . 2.0 p-10 -74.64 -14.78 60.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.897 -0.502 . . . . 73.430000000000007 111.427 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.18 -45.59 16.15 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.337 0.655 . . . . 71.019999999999996 110.007 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.33 98.6 1.28 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.876 0.87 . . . . 75.239999999999995 110.599 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -85.93 159.99 19.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.29 0.636 . . . . 75.049999999999997 111.224 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.61 64.77 1.6 Allowed Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.555 -0.293 . . . . 73.030000000000001 112.634 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 tt -146.38 139.91 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.6 0.76 . . . . 75.0 110.841 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 37.5 m -62.8 145.79 54.12 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.756 0.423 . . . . 74.340000000000003 111.495 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.556 HD12 ' HB3' ' A' ' 37' ' ' GLU . 61.1 mt -52.28 -50.39 79.7 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 114.226 1.195 . . . . 65.430000000000007 114.226 -175.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.09 -23.44 39.9 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 121.828 1.685 . . . . 74.510000000000005 114.504 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -75.08 -52.43 11.06 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.141 0.972 . . . . 73.109999999999999 109.177 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -54.68 -37.1 65.35 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 113.122 -1.854 . . . . 75.219999999999999 112.048 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.65 95.38 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.3 1.04 . . . . 64.439999999999998 112.471 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -72.07 -28.7 63.49 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.264 0.625 . . . . 74.150000000000006 111.954 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.54 -35.03 65.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.414 0.686 . . . . 74.540000000000006 111.433 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' B' ' 13' ' ' VAL . 31.6 m -95.54 1.68 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.48 0.712 . . . . 62.229999999999997 112.109 177.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 61.9 16.27 7.89 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 124.553 1.141 . . . . 75.5 113.739 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 60.6 mt -102.66 158.37 16.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.752 0.821 . . . . 74.340000000000003 110.005 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 50.8 m -63.46 156.38 26.35 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.577 0.351 . . . . 64.239999999999995 111.313 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.0 t -49.4 -48.28 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 123.849 0.86 . . . . 74.109999999999999 111.713 171.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.62 -36.85 81.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.12 -0.946 . . . . 72.239999999999995 111.258 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -63.58 -43.04 98.15 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.461 0.704 . . . . 70.150000000000006 111.703 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.426 ' O ' HG22 ' B' ' 43' ' ' VAL . 92.1 m -74.71 -46.97 34.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.91 0.884 . . . . 74.510000000000005 111.445 -174.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.433 ' HB1' HG23 ' B' ' 25' ' ' ILE . . . -59.72 -46.12 90.09 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 124.235 1.014 . . . . 74.310000000000002 112.302 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -71.77 -35.22 69.99 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.672 -1.149 . . . . 75.25 111.001 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.84 81.89 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 122.574 0.349 . . . . 52.200000000000003 111.182 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.67 HG13 HD13 ' B' ' 63' ' ' ILE . 68.9 t -65.44 -31.87 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 123.585 0.754 . . . . 72.420000000000002 110.939 170.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -64.63 -33.57 87.58 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.909 -0.132 . . . . 73.140000000000001 113.425 171.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.478 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 73.8 t-105 -73.9 -29.78 62.24 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.479 0.712 . . . . 74.439999999999998 111.181 173.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.36 -34.58 70.58 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.839 0.456 . . . . 64.349999999999994 110.711 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.33 67.41 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.285 1.034 . . . . 74.439999999999998 111.753 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 20.1 ttt85 -56.68 -51.36 69.08 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.327 0.584 . . . . 74.200000000000003 110.882 167.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -80.07 -7.66 58.99 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.404 -0.816 . . . . 61.219999999999999 111.666 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 63.7 t30 63.91 32.9 12.92 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.577 1.551 . . . . 65.230000000000004 111.424 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -88.2 -1.68 58.16 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.744 0.818 . . . . 75.140000000000001 111.952 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.86 162.4 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.583 0.753 . . . . 73.549999999999997 112.306 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' B' ' 64' ' ' TYR . 11.7 m -128.22 156.79 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 124.45 1.1 . . . . 75.430000000000007 110.371 167.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 36.6 mm -116.97 119.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.447 0.699 . . . . 74.519999999999996 110.272 -175.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -115.49 115.02 25.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.147 0.579 . . . . 75.319999999999993 110.884 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -84.42 97.6 9.6 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.037 -0.727 . . . . 75.230000000000004 109.037 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.16 108.28 19.71 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.872 0.869 . . . . 64.109999999999999 110.163 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 54.65 31.45 15.22 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.369 1.067 . . . . 75.120000000000005 112.46 -173.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.77 -16.21 61.62 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-N 115.851 -0.613 . . . . 72.420000000000002 114.012 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -81.63 134.27 35.46 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.579 0.752 . . . . 75.120000000000005 110.845 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.555 HG13 ' HB2' ' A' ' 37' ' ' GLU . 23.1 mm -90.8 105.96 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.05 0.54 . . . . 73.230000000000004 109.816 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -115.72 130.5 56.87 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.845 0.858 . . . . 71.540000000000006 110.901 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.67 HD13 HG13 ' B' ' 43' ' ' VAL . 26.6 mm -93.22 115.7 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.052 0.941 . . . . 73.209999999999994 110.874 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.575 ' HB2' HG22 ' B' ' 53' ' ' VAL . 33.0 m-85 -107.06 158.98 16.65 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.005 0.922 . . . . 75.200000000000003 110.048 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -91.19 150.26 21.44 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.352 0.661 . . . . 70.319999999999993 109.6 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.537 ' HG2' HG12 ' B' ' 53' ' ' VAL . 0.2 OUTLIER -93.45 157.0 16.43 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.472 0.653 . . . . 72.209999999999994 110.664 176.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.5 -9.65 3.75 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.012 -0.835 . . . . 71.150000000000006 111.012 -170.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -95.36 -26.78 15.75 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.901 0.88 . . . . 71.120000000000005 113.168 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -64.89 142.69 58.35 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 118.21 0.459 . . . . 74.400000000000006 110.845 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -60.97 103.62 0.29 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.372 0.669 . . . . 73.129999999999995 111.24 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -113.1 117.11 31.05 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.424 0.63 . . . . 74.099999999999994 111.64 -175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 91.3 p -160.68 166.91 27.99 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.719 1.208 . . . . 75.420000000000002 109.244 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.62 35.25 0.77 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.903 0.705 . . . . 74.340000000000003 112.903 -171.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.88 66.48 3.85 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 112.09 -0.404 . . . . 74.349999999999994 112.09 171.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 pp -137.5 155.19 49.56 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.822 0.849 . . . . 73.329999999999998 111.376 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -93.23 -171.89 2.79 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.047 0.539 . . . . 75.150000000000006 111.766 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 72.61 -59.58 0.56 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.317 1.447 . . . . 64.109999999999999 110.523 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -67.35 126.54 29.57 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.3 0.64 . . . . 62.350000000000001 110.58 168.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -127.74 158.76 36.78 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.197 0.999 . . . . 72.319999999999993 110.566 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -71.9 107.47 4.67 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.527 0.68 . . . . 72.209999999999994 110.602 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -84.38 116.91 23.29 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.994 0.518 . . . . 73.430000000000007 111.142 -175.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 N--CA 1.478 0.926 0 C-N-CA 123.507 0.723 . . . . 74.219999999999999 110.95 176.934 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' HE3' HD12 ' A' ' 5' ' ' ILE . 30.5 ttp . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.943 -0.391 . . . . 63.520000000000003 109.943 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 32.69 -81.71 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.766 2.506 . . . . 74.299999999999997 117.766 160.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -48.56 -49.19 37.52 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.928 1.825 . . . . 71.219999999999999 115.928 -159.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -71.71 -35.46 70.23 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 117.838 0.29 . . . . 71.510000000000005 111.454 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.513 HD12 ' HE3' ' A' ' 1' ' ' MET . 46.2 mt -61.04 -60.33 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.181 0.592 . . . . 75.409999999999997 110.792 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.585 HG12 HD12 ' A' ' 41' ' ' LEU . 34.8 m -64.0 -32.27 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.556 1.142 . . . . 73.409999999999997 112.192 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.6 69.8 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 123.353 0.408 . . . . 74.140000000000001 112.687 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.63 94.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.647 0.779 . . . . 72.040000000000006 111.651 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.39 -40.45 89.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.642 0.777 . . . . 61.43 111.421 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.84 -34.49 78.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.204 0.601 . . . . 61.409999999999997 111.913 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.77 -39.05 96.34 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 116.279 -0.419 . . . . 73.150000000000006 113.182 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -75.19 -41.12 58.62 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.752 0.821 . . . . 74.200000000000003 111.924 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.569 ' HA ' HG11 ' A' ' 32' ' ' VAL . 59.2 t -67.24 -45.5 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.496 0.719 . . . . 74.519999999999996 111.322 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.592 ' HA ' HD11 ' A' ' 17' ' ' LEU . 47.5 t90 -64.42 -34.63 78.62 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.504 0.502 . . . . 74.129999999999995 111.158 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.448 ' HE2' ' HB2' ' A' ' 76' ' ' GLU . 60.6 t60 -60.93 -45.09 96.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.362 0.665 . . . . 72.120000000000005 111.125 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.69 -36.17 75.74 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.753 -0.658 . . . . 74.319999999999993 111.654 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 14' ' ' TRP . 33.5 mt -59.51 -43.49 93.37 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.545 0.738 . . . . 75.409999999999997 111.474 175.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -59.34 -24.75 63.62 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.255 1.022 . . . . 73.209999999999994 112.254 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.538 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 59.4 mt-10 -66.02 -42.71 89.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.854 0.862 . . . . 74.329999999999998 111.062 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.73 110.57 2.19 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.44 0.696 . . . . 75.120000000000005 111.327 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -77.55 162.98 26.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.628 0.771 . . . . 73.219999999999999 111.27 174.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.87 61.91 3.15 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.999 -0.441 . . . . 71.430000000000007 111.999 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 tt -141.38 135.98 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.661 0.784 . . . . 62.439999999999998 111.06 -171.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -69.57 152.94 44.17 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.22 0.608 . . . . 74.219999999999999 111.413 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.535 HG21 ' HB3' ' A' ' 40' ' ' ALA . 57.0 mt -56.38 -47.11 99.53 Favored Pre-proline 0 CA--C 1.58 2.123 0 N-CA-C 113.458 0.91 . . . . 74.439999999999998 113.458 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.13 -30.29 46.91 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 122.145 1.896 . . . . 70.409999999999997 113.925 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.63 -46.52 66.0 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.422 1.105 . . . . 73.230000000000004 109.839 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.32 -36.87 78.92 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 113.152 -1.84 . . . . 73.109999999999999 112.175 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.3 80.21 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.567 0.747 . . . . 64.239999999999995 112.431 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -69.69 -38.73 77.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.807 0.443 . . . . 74.5 111.447 175.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -64.0 -41.77 97.37 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.538 0.335 . . . . 71.239999999999995 111.655 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 13' ' ' VAL . 22.4 m -84.24 -10.81 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.096 0.559 . . . . 64.140000000000001 111.573 175.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 69.26 16.9 8.38 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 125.53 1.532 . . . . 73.439999999999998 112.048 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.2 mt -99.68 175.61 5.75 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.837 0.855 . . . . 64.25 110.604 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 t -76.99 159.25 30.07 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.144 0.577 . . . . 73.510000000000005 111.524 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -57.87 -44.69 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.091 0.556 . . . . 71.209999999999994 111.51 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.79 -46.37 89.83 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.752 0.821 . . . . 73.230000000000004 112.02 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.8 p -69.0 -30.82 69.29 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.209 0.604 . . . . 64.140000000000001 112.063 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 43' ' ' VAL . 96.7 m -74.92 -48.45 24.52 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.351 0.661 . . . . 73.420000000000002 111.248 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HB3' HG21 ' A' ' 25' ' ' ILE . . . -61.77 -36.82 82.16 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 123.992 0.917 . . . . 72.25 111.831 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.585 HD12 HG12 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -61.33 -43.07 99.49 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.91 1.284 . . . . 74.230000000000004 110.802 173.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.59 71.73 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.228 0.611 . . . . 73.450000000000003 112.296 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.439 HG11 HD11 ' A' ' 63' ' ' ILE . 86.3 t -69.41 -33.73 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.33 0.652 . . . . 63.130000000000003 110.86 175.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.74 -32.7 85.08 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-N 116.501 -0.318 . . . . 55.219999999999999 112.745 172.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.408 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 71.5 t-105 -74.02 -31.1 62.77 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.606 0.762 . . . . 75.549999999999997 111.333 173.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.3 -34.89 75.38 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.727 0.411 . . . . 74.109999999999999 111.156 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.59 -28.95 69.72 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.37 0.668 . . . . 74.540000000000006 112.101 173.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.486 ' HD2' ' HA ' ' B' ' 48' ' ' ARG . 22.9 ttt180 -59.85 -51.16 70.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.763 0.825 . . . . 71.439999999999998 112.111 175.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -90.99 13.57 16.32 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.408 -0.815 . . . . 74.400000000000006 112.04 -173.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 51.33 47.45 24.82 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.001 1.32 . . . . 62.009999999999998 112.08 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -87.54 -32.95 19.11 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.757 -1.11 . . . . 74.420000000000002 111.921 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -132.74 148.27 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.637 0.775 . . . . 64.299999999999997 112.058 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.447 HG12 ' HG2' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -113.55 107.33 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.595 0.758 . . . . 74.219999999999999 108.957 171.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.464 HG23 HD13 ' A' ' 63' ' ' ILE . 60.1 mt -88.94 114.6 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 109.16 -0.681 . . . . 73.129999999999995 109.16 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -102.74 117.42 34.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.21 0.604 . . . . 75.329999999999998 111.107 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -81.9 108.18 15.21 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.957 -0.386 . . . . 72.450000000000003 109.957 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -104.09 106.15 16.56 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.658 0.783 . . . . 64.530000000000001 109.003 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 54.81 31.85 16.44 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 124.336 1.054 . . . . 73.430000000000007 112.423 -169.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.93 -20.12 50.64 Favored Glycine 0 CA--C 1.542 1.769 0 N-CA-C 114.408 0.523 . . . . 52.210000000000001 114.408 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.79 134.95 43.47 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.743 0.817 . . . . 74.209999999999994 111.076 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.25 103.78 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 122.995 0.518 . . . . 74.099999999999994 109.884 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -118.72 121.83 41.03 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.949 0.9 . . . . 72.329999999999998 109.914 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.464 HD13 HG23 ' A' ' 54' ' ' ILE . 10.5 mm -91.96 120.93 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.214 0.606 . . . . 71.019999999999996 111.938 -169.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -108.84 163.14 13.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.489 0.715 . . . . 73.319999999999993 111.043 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 11.1 m-20 -91.33 155.26 18.64 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.428 -0.806 . . . . 74.420000000000002 108.921 171.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 69' ' ' PHE . 50.9 mt-10 -84.4 78.91 9.72 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.758 0.79 . . . . 74.430000000000007 110.022 169.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.52 -18.12 79.92 Favored Glycine 0 C--N 1.358 1.75 0 CA-C-N 114.71 -1.132 . . . . 72.530000000000001 113.974 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -84.59 -12.21 54.5 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.124 0.57 . . . . 70.329999999999998 110.89 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 83.9 m-85 -118.63 17.5 13.6 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.0 1.32 . . . . 74.140000000000001 110.638 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.19 159.36 29.18 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.437 0.903 . . . . 73.340000000000003 113.437 -168.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -124.48 -59.54 1.45 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.69 0.796 . . . . 73.420000000000002 110.61 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 t -135.78 161.76 34.68 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.219 0.608 . . . . 74.109999999999999 111.726 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -124.29 152.48 43.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.99 0.916 . . . . 74.409999999999997 110.571 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.71 82.18 0.1 Allowed Glycine 0 C--N 1.344 0.972 0 CA-C-N 116.167 -0.47 . . . . 72.299999999999997 112.094 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.538 ' HG ' ' HA ' ' A' ' 19' ' ' GLU . 7.0 mp -79.86 113.42 18.0 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.689 0.796 . . . . 74.340000000000003 109.629 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HB2' ' HE2' ' A' ' 15' ' ' HIS . 36.9 tt0 -105.67 147.58 28.35 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.676 0.79 . . . . 74.530000000000001 111.326 -172.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -80.88 72.7 7.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.924 0.869 . . . . 65.439999999999998 109.169 164.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -57.63 106.47 0.35 Allowed 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 125.312 1.445 . . . . 72.519999999999996 112.346 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -78.35 82.99 4.61 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.656 0.741 . . . . 75.140000000000001 111.346 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -74.49 122.02 22.39 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.024 -0.989 . . . . 73.400000000000006 110.347 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -73.64 -51.15 17.75 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.433 -0.581 . . . . 74.430000000000007 109.433 172.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 65.9 t60 . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 124.135 0.974 . . . . 72.420000000000002 110.16 175.347 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 120.929 0.395 . . . . 75.030000000000001 110.465 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.08 -19.81 61.09 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.293 0.479 . . . . 74.230000000000004 112.293 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -61.48 -22.78 65.39 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.018 0.372 . . . . 75.540000000000006 111.475 172.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -91.26 -41.82 10.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.077 0.951 . . . . 64.219999999999999 111.827 170.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.49 -45.33 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 122.993 0.517 . . . . 74.239999999999995 111.876 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.03 -26.84 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 122.633 0.373 . . . . 75.329999999999998 111.811 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.2 -48.36 80.24 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.135 0.272 . . . . 54.450000000000003 112.869 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.79 -43.28 93.72 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.601 0.76 . . . . 73.109999999999999 111.609 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.85 -36.53 80.48 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.169 0.988 . . . . 72.540000000000006 111.532 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' B' ' 42' ' ' ALA . . . -68.69 -39.66 80.44 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.099 0.56 . . . . 71.239999999999995 110.914 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.74 -45.98 92.79 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.68 -0.691 . . . . 75.409999999999997 112.341 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -63.28 -41.95 99.05 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.425 1.09 . . . . 62.210000000000001 111.845 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.681 ' HA ' HG13 ' B' ' 32' ' ' VAL . 72.8 t -65.14 -37.05 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.775 0.83 . . . . 73.129999999999995 111.622 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -74.04 -33.49 63.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.208 0.603 . . . . 75.209999999999994 111.587 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -60.84 -30.7 70.26 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.92 0.488 . . . . 75.109999999999999 111.353 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.71 69.96 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.191 0.596 . . . . 62.149999999999999 112.466 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.486 ' HB3' ' ND2' ' B' ' 65' ' ' ASN . 53.3 mt -63.49 -34.24 77.33 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.262 0.625 . . . . 75.109999999999999 112.51 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.75 -25.7 66.67 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.3 0.64 . . . . 63.549999999999997 111.729 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.92 -41.03 8.2 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.734 0.813 . . . . 75.239999999999995 111.077 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' B' ' 17' ' ' LEU . . . -153.75 141.28 19.83 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.405 0.682 . . . . 50.32 111.808 -171.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -127.08 168.97 13.9 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.616 0.766 . . . . 65.420000000000002 111.129 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.8 10.24 64.02 Favored Glycine 0 N--CA 1.474 1.167 0 N-CA-C 114.596 0.598 . . . . 71.109999999999999 114.596 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.3 tt -86.26 132.02 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 123.465 0.706 . . . . 75.329999999999998 110.809 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -71.89 158.35 36.21 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.518 0.562 . . . . 53.340000000000003 112.518 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.521 HG23 ' HB3' ' B' ' 40' ' ' ALA . 73.9 mt -56.33 -43.3 99.23 Favored Pre-proline 0 CA--C 1.582 2.177 0 N-CA-C 115.274 1.583 . . . . 73.349999999999994 115.274 -169.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.427 ' HA ' HG23 ' B' ' 36' ' ' VAL . 57.7 Cg_endo -67.54 -31.6 33.28 Favored 'Trans proline' 0 C--N 1.392 2.863 0 CA-C-N 122.448 1.91 . . . . 75.319999999999993 114.207 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -77.86 -41.32 37.23 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.313 1.054 . . . . 73.120000000000005 110.102 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.42 -39.61 84.06 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 113.206 -1.816 . . . . 73.120000000000005 111.125 171.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.01 88.91 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.985 0.914 . . . . 63.100000000000001 111.648 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -60.92 -43.42 98.59 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.584 0.754 . . . . 73.530000000000001 111.498 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -71.27 -37.97 71.88 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.284 0.634 . . . . 74.439999999999998 111.934 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.681 HG13 ' HA ' ' B' ' 13' ' ' VAL . 13.1 m -93.32 5.53 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.047 0.539 . . . . 65.439999999999998 112.15 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.4 t30 68.46 9.53 7.33 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.574 1.149 . . . . 74.209999999999994 113.303 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 47.8 mt -102.98 174.25 5.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.611 -0.68 . . . . 72.439999999999998 111.463 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 39.3 t -72.94 157.84 36.65 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.915 0.486 . . . . 73.209999999999994 111.264 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' B' ' 26' ' ' PRO . 60.3 t -58.14 -41.39 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.22 0.608 . . . . 74.239999999999995 111.198 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.19 -48.44 75.9 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.533 0.733 . . . . 74.310000000000002 112.207 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -71.04 -29.97 66.03 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.292 0.637 . . . . 73.430000000000007 111.98 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.402 ' O ' HG21 ' B' ' 43' ' ' VAL . 95.5 m -72.77 -46.23 54.46 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.182 0.593 . . . . 74.430000000000007 110.487 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.521 ' HB3' HG23 ' B' ' 25' ' ' ILE . . . -60.05 -36.35 77.1 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.528 0.731 . . . . 74.420000000000002 111.927 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -51.13 66.61 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.278 1.031 . . . . 71.329999999999998 109.606 174.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' B' ' 10' ' ' ALA . . . -61.39 -30.77 70.76 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.009 -0.996 . . . . 71.109999999999999 111.695 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.402 HG21 ' O ' ' B' ' 39' ' ' THR . 49.0 t -68.45 -37.51 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.76 0.824 . . . . 75.040000000000006 110.66 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.47 -33.3 86.04 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 113.037 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.426 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 61.9 t-105 -74.44 -25.63 59.55 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.398 0.679 . . . . 73.040000000000006 111.338 175.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.92 -36.73 70.04 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.875 0.47 . . . . 73.099999999999994 111.284 169.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.21 -33.02 75.01 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.959 0.503 . . . . 71.319999999999993 110.685 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.486 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 2.3 tmt_? -59.35 -45.29 91.82 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.246 1.018 . . . . 74.530000000000001 111.504 173.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -84.79 2.38 42.5 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.46 0.704 . . . . 74.519999999999996 112.508 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 63.2 22.41 13.35 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.148 1.379 . . . . 62.399999999999999 112.808 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -102.42 7.96 40.24 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.907 1.077 . . . . 74.319999999999993 113.907 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 20.9 m -131.87 151.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 123.093 0.557 . . . . 71.430000000000007 111.102 171.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 t -105.36 102.41 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.498 0.719 . . . . 74.349999999999994 109.492 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 27.8 mm -77.69 114.7 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 122.987 0.515 . . . . 61.530000000000001 110.274 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.18 156.5 38.33 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.89 0.876 . . . . 74.030000000000001 111.843 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -118.12 107.56 14.12 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.958 0.903 . . . . 74.219999999999999 110.864 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -119.07 129.86 55.3 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.02 0.528 . . . . 74.329999999999998 110.125 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 62.72 30.45 16.82 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.528 1.131 . . . . 73.530000000000001 112.115 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.05 12.97 81.33 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 115.979 -0.555 . . . . 73.239999999999995 113.465 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -122.52 136.66 54.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.178 0.991 . . . . 71.400000000000006 110.378 -172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mp -80.51 122.36 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 123.012 0.525 . . . . 75.030000000000001 110.244 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -124.94 132.36 53.3 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.278 1.031 . . . . 74.519999999999996 110.019 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 pp -100.06 126.53 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.434 0.694 . . . . 74.430000000000007 111.932 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -108.52 166.47 10.76 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.207 0.603 . . . . 70.519999999999996 111.252 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' B' ' 17' ' ' LEU . 15.0 m120 -67.43 141.45 57.01 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.632 0.773 . . . . 72.519999999999996 111.461 176.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -48.18 -39.81 22.09 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.512 1.301 . . . . 72.439999999999998 114.512 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.66 -16.29 7.19 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 117.426 1.73 . . . . 53.049999999999997 117.426 -166.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -99.16 -37.39 9.33 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 118.297 1.048 . . . . 74.340000000000003 111.953 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 52.07 40.98 29.6 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 123.989 0.916 . . . . 73.230000000000004 112.745 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.82 22.49 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 125.869 1.668 . . . . 75.129999999999995 114.87 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -149.32 114.96 5.61 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.126 0.97 . . . . 74.230000000000004 110.201 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 20.4 t -79.23 132.38 36.49 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.692 0.397 . . . . 74.230000000000004 110.824 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -142.39 147.52 36.37 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.963 0.505 . . . . 75.409999999999997 110.935 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.51 71.5 0.07 OUTLIER Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.337 -0.392 . . . . 71.150000000000006 112.984 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.6 mt -124.62 -64.81 1.08 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.388 0.675 . . . . 74.510000000000005 111.86 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -94.39 163.37 13.45 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.703 1.001 . . . . 74.349999999999994 113.703 -166.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -139.58 114.85 9.76 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.466 1.106 . . . . 73.319999999999993 110.248 172.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -73.97 -9.64 58.84 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.176 0.99 . . . . 75.219999999999999 112.549 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -68.49 5.41 1.04 Allowed 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 124.461 1.105 . . . . 75.099999999999994 113.543 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -64.09 84.68 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 O-C-N 121.601 -0.687 . . . . 75.540000000000006 111.902 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -172.19 137.67 0.92 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.371 1.068 . . . . 74.120000000000005 110.051 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 . . . . . 0 N--CA 1.489 1.509 0 C-N-CA 123.49 0.716 . . . . 72.019999999999996 111.593 175.855 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HG3' HD12 ' A' ' 5' ' ' ILE . 19.3 ptt? . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.784 -0.627 . . . . 73.409999999999997 110.478 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -44.99 130.55 7.46 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.804 1.242 . . . . 72.230000000000004 113.678 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.532 ' HE2' ' HA ' ' B' ' 50' ' ' ASN . 27.0 ttpp -75.66 -8.5 56.95 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.86 0.864 . . . . 75.430000000000007 110.415 169.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -63.18 -15.74 57.86 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.748 1.219 . . . . 74.549999999999997 112.682 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.419 HD12 ' HG3' ' A' ' 1' ' ' MET . 80.6 mt -58.28 -55.52 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.158 0.583 . . . . 73.319999999999993 110.802 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.6 m -67.31 -25.54 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 122.682 0.393 . . . . 72.430000000000007 111.232 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.483 ' HA2' ' NE1' ' A' ' 45' ' ' TRP . . . -68.27 -41.39 86.15 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 116.676 -0.238 . . . . 70.439999999999998 113.646 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.01 -54.84 13.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.822 0.849 . . . . 71.430000000000007 112.031 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -68.07 -19.68 64.89 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 112.793 0.664 . . . . 72.010000000000005 112.793 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.32 -28.05 65.91 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.623 0.769 . . . . 75.319999999999993 112.205 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.68 -42.64 93.17 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 116.762 -0.199 . . . . 63.329999999999998 113.391 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -66.81 -46.65 74.51 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.797 0.839 . . . . 75.219999999999999 112.081 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 32' ' ' VAL . 10.6 p -69.13 -32.17 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.533 0.333 . . . . 71.510000000000005 111.708 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.475 ' NE1' ' HB3' ' A' ' 51' ' ' LYS . 66.9 t90 -72.14 -33.94 68.16 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.067 0.547 . . . . 72.409999999999997 111.328 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -61.49 -35.24 77.1 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.384 0.673 . . . . 75.450000000000003 111.315 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.41 -32.44 73.88 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.581 0.753 . . . . 63.119999999999997 112.088 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.402 HD11 ' HA ' ' A' ' 14' ' ' TRP . 50.9 mt -73.66 -33.04 64.3 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.869 0.867 . . . . 75.319999999999993 112.131 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -62.91 -33.26 74.95 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.208 0.603 . . . . 75.239999999999995 111.76 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -75.3 -54.3 7.32 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.283 0.633 . . . . 62.439999999999998 110.11 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.45 99.13 2.17 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.599 -0.728 . . . . 71.230000000000004 110.899 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 9.9 p-10 -93.5 150.84 20.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.7 0.4 . . . . 74.209999999999994 109.952 173.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.08 63.19 1.15 Allowed Glycine 0 N--CA 1.469 0.855 0 N-CA-C 110.758 -0.937 . . . . 61.329999999999998 110.758 -167.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.4 tt -145.17 125.44 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.479 1.112 . . . . 73.530000000000001 109.605 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.0 m -57.09 149.27 19.69 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.032 0.933 . . . . 71.5 112.097 -176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.605 HG12 HD11 ' A' ' 63' ' ' ILE . 21.2 mt -53.88 -48.07 94.88 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 113.419 0.896 . . . . 74.120000000000005 113.419 -174.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.46 -24.0 14.48 Favored 'Trans proline' 0 C--N 1.398 3.17 0 C-N-CA 121.881 1.721 . . . . 74.540000000000006 114.732 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -71.79 -45.86 60.21 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 123.037 1.398 . . . . 72.310000000000002 108.939 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.413 ' O ' HG21 ' A' ' 32' ' ' VAL . 60.5 tp -65.11 -40.14 94.11 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 112.443 -2.162 . . . . 75.450000000000003 111.466 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.25 93.93 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.048 0.939 . . . . 61.329999999999998 112.306 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -70.02 -39.26 75.92 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.287 0.635 . . . . 75.040000000000006 111.004 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -59.19 -52.12 67.07 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.577 0.751 . . . . 73.349999999999994 111.563 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 13' ' ' VAL . 24.9 m -85.89 0.37 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.357 0.663 . . . . 72.420000000000002 112.035 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 62.43 15.02 7.41 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 125.149 1.38 . . . . 73.140000000000001 114.196 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.7 mt -90.81 159.82 16.08 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.325 0.65 . . . . 74.129999999999995 110.0 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -66.66 151.86 46.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.486 0.314 . . . . 73.209999999999994 110.882 169.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.1 t -52.67 -47.03 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 123.835 0.854 . . . . 75.140000000000001 112.064 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.461 ' HB3' HD12 ' B' ' 25' ' ' ILE . 46.2 mt-10 -59.78 -44.63 93.81 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.726 0.81 . . . . 74.430000000000007 112.277 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.0 m -62.58 -36.74 83.68 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.722 0.809 . . . . 75.530000000000001 111.855 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -70.49 -52.34 22.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.786 0.835 . . . . 74.400000000000006 110.936 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.98 -33.91 72.6 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.801 0.84 . . . . 72.319999999999993 112.302 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -51.24 49.5 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.184 0.994 . . . . 74.519999999999996 110.354 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.94 70.06 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.331 -0.85 . . . . 71.109999999999999 111.686 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.22 -38.82 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 115.581 -0.736 . . . . 73.409999999999997 110.939 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.28 -28.06 72.47 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-O 121.116 0.287 . . . . 73.409999999999997 112.877 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.483 ' NE1' ' HA2' ' A' ' 7' ' ' GLY . 77.0 t-105 -70.02 -41.53 74.17 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.099 0.96 . . . . 74.109999999999999 111.265 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 76.4 mt -67.01 -34.09 76.99 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.512 0.725 . . . . 63.25 111.619 175.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.33 -27.22 63.93 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.361 1.064 . . . . 51.219999999999999 113.326 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -58.77 -31.87 68.76 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 112.244 0.461 . . . . 74.219999999999999 112.244 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -122.02 26.67 8.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.663 1.185 . . . . 64.420000000000002 111.063 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 61.43 22.61 12.99 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.329 1.451 . . . . 75.340000000000003 114.117 169.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 61.9 mttm -74.09 -18.05 60.87 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.85 0.685 . . . . 74.409999999999997 112.85 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.16 150.77 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.473 0.709 . . . . 74.219999999999999 111.93 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.736 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 42.5 t -107.7 123.93 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.991 0.917 . . . . 75.209999999999994 108.904 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.432 HG23 HG22 ' A' ' 61' ' ' ILE . 48.6 mm -103.81 118.66 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.595 0.758 . . . . 72.540000000000006 111.106 -173.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -124.61 112.05 16.35 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.298 0.639 . . . . 75.209999999999994 111.138 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HG2' HG12 ' A' ' 61' ' ' ILE . 56.7 mtt180 -81.25 98.01 7.91 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.567 0.699 . . . . 73.040000000000006 110.078 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -106.39 111.93 24.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.482 1.113 . . . . 70.25 109.601 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 60.72 32.35 20.23 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 124.605 1.162 . . . . 73.140000000000001 112.891 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.42 -11.57 67.61 Favored Glycine 0 CA--C 1.541 1.697 0 N-CA-C 114.041 0.377 . . . . 64.319999999999993 114.041 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.76 137.21 36.98 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.748 0.819 . . . . 71.540000000000006 110.329 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.432 HG22 HG23 ' A' ' 54' ' ' ILE . 50.7 mt -87.41 129.3 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.808 0.443 . . . . 73.510000000000005 111.173 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.04 136.34 49.44 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.308 1.043 . . . . 73.209999999999994 110.37 -178.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.605 HD11 HG12 ' A' ' 25' ' ' ILE . 3.0 mp -113.59 115.94 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.219 0.608 . . . . 75.109999999999999 110.194 -169.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.736 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 80.6 m-85 -113.54 173.74 6.26 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.994 0.918 . . . . 72.310000000000002 110.542 175.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -98.8 162.03 13.32 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.384 0.674 . . . . 75.030000000000001 110.862 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 51' ' ' LYS . 36.1 tt0 -55.75 -35.23 65.96 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.505 1.122 . . . . 75.040000000000006 111.895 170.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.44 1.18 37.25 Favored Glycine 0 CA--C 1.547 2.059 0 N-CA-C 114.626 0.61 . . . . 73.409999999999997 114.626 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -73.26 -24.71 60.49 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.52 0.66 . . . . 73.049999999999997 110.893 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -69.53 166.03 19.77 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.11 0.564 . . . . 75.219999999999999 112.345 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -61.51 148.84 40.71 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.953 0.901 . . . . 75.439999999999998 112.63 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.27 -15.55 63.76 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.47 0.915 . . . . 74.25 113.47 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 t -73.4 -53.56 10.41 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.803 0.441 . . . . 74.549999999999997 111.156 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 59.33 111.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.695 1.198 . . . . 72.5 111.939 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.97 -6.18 51.13 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 114.744 0.658 . . . . 64.209999999999994 114.744 -177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.17 107.86 0.97 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.833 0.853 . . . . 72.400000000000006 110.809 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 63.23 17.81 10.5 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.569 1.148 . . . . 74.420000000000002 111.741 -177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -123.62 22.11 9.16 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.787 0.835 . . . . 75.409999999999997 111.989 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -141.68 149.62 40.81 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.206 0.527 . . . . 75.5 111.559 171.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -138.47 161.24 37.51 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.564 1.146 . . . . 73.329999999999998 109.802 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -80.01 121.89 26.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.156 -1.053 . . . . 74.340000000000003 108.156 167.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -55.83 89.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.611 1.164 . . . . 72.340000000000003 113.899 -162.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 N--CA 1.487 1.375 0 C-N-CA 124.95 1.3 . . . . 75.549999999999997 109.868 174.983 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 120.659 0.266 . . . . 73.310000000000002 111.343 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -54.35 -33.29 58.75 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.65 1.18 . . . . 55.399999999999999 113.809 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -63.38 -38.24 90.38 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.846 0.858 . . . . 73.430000000000007 111.788 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -75.05 -31.77 61.38 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.449 0.7 . . . . 75.400000000000006 111.71 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.04 -54.09 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 122.697 0.399 . . . . 72.049999999999997 110.749 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -65.28 -26.2 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 122.864 0.466 . . . . 72.329999999999998 111.536 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.81 -39.97 96.99 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.282 0.364 . . . . 43.020000000000003 113.303 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.11 -36.97 69.59 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.73 0.812 . . . . 72.040000000000006 111.346 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -64.68 -40.61 95.71 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.589 -0.732 . . . . 73.310000000000002 110.583 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . . . -72.06 -41.45 67.39 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.869 0.868 . . . . 71.209999999999994 111.435 -176.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.01 -50.07 66.93 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.783 -0.644 . . . . 60.340000000000003 112.464 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.54 ' HG3' ' HB ' ' B' ' 32' ' ' VAL . 18.0 tppt? -60.0 -45.88 91.31 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.437 1.095 . . . . 75.239999999999995 112.065 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.473 ' HA ' HG13 ' B' ' 32' ' ' VAL . 53.0 t -56.99 -46.99 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.094 0.558 . . . . 74.430000000000007 111.346 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.501 ' HA ' HD12 ' B' ' 17' ' ' LEU . 69.7 t90 -68.34 -35.76 78.24 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.302 0.641 . . . . 74.299999999999997 112.015 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -63.97 -33.08 74.92 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.604 0.362 . . . . 61.539999999999999 110.553 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.09 -32.45 69.08 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.906 0.482 . . . . 62.409999999999997 111.582 171.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' B' ' 14' ' ' TRP . 69.2 mt -72.57 -30.51 64.47 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.347 0.659 . . . . 74.209999999999994 111.227 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.49 -29.4 68.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.644 0.778 . . . . 73.010000000000005 111.048 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.45 -29.24 12.86 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.523 0.729 . . . . 72.439999999999998 111.303 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.7 88.88 1.0 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.439 0.696 . . . . 72.109999999999999 111.812 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -92.28 173.44 7.82 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.183 0.593 . . . . 74.109999999999999 111.652 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.55 64.53 2.81 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.278 -0.419 . . . . 71.019999999999996 112.316 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 tt -144.02 143.27 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.315 0.646 . . . . 74.109999999999999 110.787 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -60.58 139.8 57.64 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.856 0.863 . . . . 73.340000000000003 111.418 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 37' ' ' GLU . 71.8 mt -52.31 -46.22 94.39 Favored Pre-proline 0 CA--C 1.581 2.14 0 N-CA-C 114.386 1.254 . . . . 75.340000000000003 114.386 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.11 -24.78 14.49 Favored 'Trans proline' 0 C--N 1.399 3.223 0 CA-C-N 121.856 1.699 . . . . 64.200000000000003 113.989 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 33.7 tt0 -77.1 -46.34 23.9 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 122.04 0.924 . . . . 60.130000000000003 108.846 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -55.65 -39.87 71.45 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.321 1.448 . . . . 70.230000000000004 111.263 170.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.85 92.19 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.874 0.869 . . . . 74.310000000000002 112.323 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' B' ' 27' ' ' GLU . 21.9 ptt180 -73.96 -23.36 59.48 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.384 0.274 . . . . 75.030000000000001 110.782 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' B' ' 27' ' ' GLU . 30.9 mmmt -78.41 -43.93 26.14 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.142 0.577 . . . . 74.329999999999998 111.06 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.54 ' HB ' ' HG3' ' B' ' 12' ' ' LYS . 23.6 m -87.16 3.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 112.954 0.724 . . . . 75.420000000000002 112.954 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 63.62 11.47 5.75 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 125.081 1.352 . . . . 74.219999999999999 113.904 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 74.2 mt -99.77 162.9 12.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.478 0.711 . . . . 73.439999999999998 111.071 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 16.7 m -66.0 155.59 36.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.561 0.744 . . . . 72.25 111.627 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.46 -49.83 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.488 0.715 . . . . 74.019999999999996 111.709 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.62 -43.65 84.94 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.121 0.969 . . . . 55.409999999999997 111.474 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 68.4 m -61.75 -37.56 84.74 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.957 0.903 . . . . 74.519999999999996 112.265 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.462 ' O ' HG22 ' B' ' 43' ' ' VAL . 97.3 m -72.26 -48.49 42.17 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.471 0.708 . . . . 74.140000000000001 111.241 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.404 ' HB1' HG23 ' B' ' 25' ' ' ILE . . . -59.24 -43.14 92.4 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.553 0.741 . . . . 55.299999999999997 112.573 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.06 -49.5 75.72 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.883 0.873 . . . . 71.010000000000005 109.963 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' B' ' 10' ' ' ALA . . . -57.96 -28.67 64.56 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.794 -1.094 . . . . 74.439999999999998 112.006 -178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.577 HG12 HD13 ' B' ' 63' ' ' ILE . 77.8 t -69.27 -38.33 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.139 0.576 . . . . 75.340000000000003 110.964 175.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.64 -30.58 77.67 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-O 121.077 0.265 . . . . 75.510000000000005 112.591 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -75.86 -26.37 57.05 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.662 0.785 . . . . 74.030000000000001 111.951 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.99 -35.25 62.03 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.207 0.527 . . . . 74.099999999999994 111.352 166.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.34 -34.15 77.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.304 1.042 . . . . 65.420000000000002 112.793 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -64.51 -34.95 79.42 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.922 0.392 . . . . 71.549999999999997 111.317 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.62 -2.52 56.27 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.737 0.815 . . . . 65.420000000000002 111.532 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . 0.532 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . 36.6 m-80 65.55 26.48 11.68 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.488 1.515 . . . . 74.549999999999997 112.43 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -95.36 -0.19 52.9 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.465 1.283 . . . . 75.420000000000002 114.465 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 17.6 m -127.95 151.5 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 118.566 0.621 . . . . 73.439999999999998 112.468 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.691 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 95.3 t -110.33 123.35 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.604 1.161 . . . . 74.430000000000007 108.465 168.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 76.0 mt -114.97 126.45 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.258 -0.645 . . . . 75.150000000000006 109.258 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . 0.567 ' HG3' ' HG3' ' B' ' 57' ' ' LYS . 10.6 tp10 -142.32 129.17 20.57 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.55 -0.75 . . . . 74.400000000000006 111.312 -169.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -95.12 98.86 10.95 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.51 0.672 . . . . 72.510000000000005 110.216 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.567 ' HG3' ' HG3' ' B' ' 55' ' ' GLU . 29.1 mtpp -105.48 123.39 47.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.346 -0.843 . . . . 74.040000000000006 109.476 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 59.11 29.48 19.05 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.077 1.351 . . . . 73.099999999999994 111.157 -171.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.54 -27.87 8.22 Favored Glycine 0 CA--C 1.543 1.83 0 CA-C-N 115.729 -0.669 . . . . 73.299999999999997 114.136 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.08 138.07 31.86 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.65 0.78 . . . . 73.340000000000003 111.795 -171.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -79.56 136.42 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.926 0.891 . . . . 74.109999999999999 112.225 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -121.19 131.99 54.57 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.175 0.99 . . . . 75.129999999999995 109.118 167.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.577 HD13 HG12 ' B' ' 43' ' ' VAL . 25.0 mm -91.69 109.25 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.369 0.668 . . . . 71.219999999999999 110.431 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.691 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 67.0 m-85 -97.72 169.24 9.82 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.6 1.16 . . . . 74.299999999999997 110.589 175.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -100.39 155.29 17.89 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.429 0.692 . . . . 74.409999999999997 110.934 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.63 -39.74 95.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.716 1.206 . . . . 74.329999999999998 111.158 173.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.16 58.4 3.62 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 121.191 0.328 . . . . 62.119999999999997 113.187 177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -143.4 -35.07 0.4 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.121 0.968 . . . . 73.019999999999996 109.496 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -102.17 24.05 10.74 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.246 0.618 . . . . 70.439999999999998 112.265 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -64.81 -12.82 52.11 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.295 1.22 . . . . 75.209999999999994 114.295 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.6 -28.69 45.76 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.168 0.587 . . . . 74.310000000000002 110.737 171.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 35.7 t -72.96 91.28 1.54 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.367 0.667 . . . . 73.439999999999998 109.559 171.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -74.49 82.68 1.98 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.608 0.763 . . . . 74.400000000000006 111.493 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -134.22 44.9 1.15 Allowed Glycine 0 CA--C 1.531 1.035 0 CA-C-N 114.934 -1.03 . . . . 75.340000000000003 111.339 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.16 7.63 37.02 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.146 0.978 . . . . 75.200000000000003 112.852 -173.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.96 121.11 15.38 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 118.506 0.594 . . . . 75.530000000000001 111.036 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -122.6 25.22 8.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.112 0.965 . . . . 73.409999999999997 111.15 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -69.02 86.24 0.36 Allowed 'General case' 0 CA--C 1.555 1.147 0 CA-C-O 121.588 0.709 . . . . 74.340000000000003 110.774 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -94.76 -179.43 4.86 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.989 0.916 . . . . 74.439999999999998 110.076 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -76.8 132.99 39.52 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.934 -0.395 . . . . 60.130000000000003 109.934 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -147.44 141.61 26.13 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.782 0.833 . . . . 73.400000000000006 110.348 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 N--CA 1.483 1.203 0 C-N-CA 123.428 0.691 . . . . 72.109999999999999 109.803 -177.998 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 120.966 0.412 . . . . 72.239999999999995 111.468 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -54.88 -32.69 61.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.218 1.407 . . . . 73.109999999999999 114.316 -174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.557 ' HB2' ' HZ2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -63.9 -40.79 97.31 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.665 0.786 . . . . 74.439999999999998 112.203 -171.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -81.65 -25.78 35.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.477 0.311 . . . . 74.530000000000001 111.782 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.2 mt -64.44 -59.46 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.899 0.48 . . . . 71.310000000000002 110.694 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.53 -27.56 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.938 0.495 . . . . 71.409999999999997 111.764 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.76 -43.13 85.34 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.412 0.445 . . . . 44.43 113.283 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -46.36 80.97 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.644 0.778 . . . . 70.329999999999998 111.706 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -70.0 -27.95 65.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.972 -0.558 . . . . 62.420000000000002 112.362 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.58 76.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.24 0.616 . . . . 63.140000000000001 111.898 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.2 -37.65 94.88 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 116.074 -0.512 . . . . 64.400000000000006 113.071 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.642 ' HZ1' ' HA ' ' A' ' 32' ' ' VAL . 55.4 tttm -76.61 -42.56 41.91 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 112.474 0.546 . . . . 54.100000000000001 112.474 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 32' ' ' VAL . 26.0 m -64.56 -34.1 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 122.123 -0.36 . . . . 61.049999999999997 111.057 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.567 ' HA ' HD11 ' A' ' 17' ' ' LEU . 42.9 t90 -70.01 -33.28 71.81 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.086 0.555 . . . . 74.120000000000005 111.484 175.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -61.7 -39.14 90.41 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.127 0.571 . . . . 73.329999999999998 110.618 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.02 -32.53 70.72 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.49 0.716 . . . . 43.310000000000002 111.946 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.567 HD11 ' HA ' ' A' ' 14' ' ' TRP . 75.5 mt -69.87 -35.37 74.62 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.878 0.871 . . . . 75.319999999999993 111.746 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.06 -25.82 65.54 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.938 0.495 . . . . 71.299999999999997 110.307 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.15 -46.86 19.48 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.737 0.815 . . . . 73.349999999999994 110.694 169.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.06 97.15 1.77 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.575 0.75 . . . . 75.310000000000002 111.417 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.12 172.46 10.56 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.324 0.65 . . . . 72.209999999999994 111.316 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.51 9.79 82.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 116.614 -0.266 . . . . 65.109999999999999 113.456 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 tt -77.83 158.19 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 124.33 1.052 . . . . 74.510000000000005 109.338 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 m -79.1 150.75 31.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.752 -0.592 . . . . 71.120000000000005 110.392 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.554 HG22 ' HB2' ' A' ' 40' ' ' ALA . 70.7 mt -54.75 -47.19 98.79 Favored Pre-proline 0 CA--C 1.578 2.057 0 N-CA-C 113.82 1.044 . . . . 75.200000000000003 113.82 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.94 -23.74 34.29 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 122.117 1.878 . . . . 74.340000000000003 113.961 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.47 -48.24 23.56 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.094 0.95 . . . . 64.329999999999998 108.984 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.5 tp -57.28 -38.62 74.21 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 113.324 -1.762 . . . . 74.420000000000002 111.613 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.9 -41.92 88.37 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.935 0.894 . . . . 71.109999999999999 111.774 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -66.06 -37.44 85.83 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.812 0.845 . . . . 73.430000000000007 111.695 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.14 -35.64 77.61 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.457 0.646 . . . . 73.019999999999996 111.706 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.642 ' HA ' ' HZ1' ' A' ' 12' ' ' LYS . 29.7 m -105.15 5.38 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.71 0.804 . . . . 74.239999999999995 112.623 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 62.11 19.76 11.12 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 124.814 1.246 . . . . 73.030000000000001 114.05 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.4 mt -99.47 168.56 9.9 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.251 0.621 . . . . 71.349999999999994 110.615 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 t -75.89 157.02 33.76 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.762 0.425 . . . . 73.209999999999994 111.402 171.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 t -56.47 -44.14 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.076 0.95 . . . . 73.030000000000001 111.42 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.482 ' HB3' HD11 ' B' ' 25' ' ' ILE . 42.2 mt-10 -63.86 -39.41 94.14 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.039 0.936 . . . . 75.430000000000007 112.039 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.3 m -68.94 -35.39 76.72 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.663 0.785 . . . . 74.099999999999994 111.502 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.5 m -76.97 -46.98 22.1 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.544 0.738 . . . . 71.140000000000001 111.893 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' A' ' 25' ' ' ILE . . . -59.31 -35.92 74.68 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 123.565 0.746 . . . . 75.319999999999993 111.737 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.422 HD11 HD13 ' B' ' 54' ' ' ILE . 0.9 OUTLIER -65.04 -49.73 68.99 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 114.908 -1.042 . . . . 75.219999999999999 110.181 174.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.56 70.21 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.645 0.778 . . . . 74.319999999999993 111.713 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.539 HG11 HG22 ' A' ' 63' ' ' ILE . 53.5 t -68.27 -35.93 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.207 0.603 . . . . 72.310000000000002 110.495 173.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.64 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -63.96 -30.43 77.7 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 116.336 -0.393 . . . . 52.310000000000002 113.612 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.464 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 65.0 t-105 -70.62 -37.15 73.78 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.009 0.433 . . . . 75.239999999999995 110.923 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.17 -32.19 72.26 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 122.199 -0.313 . . . . 71.340000000000003 110.955 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.86 -31.05 71.78 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.672 0.789 . . . . 73.230000000000004 111.481 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.575 ' HA ' ' HD2' ' B' ' 48' ' ' ARG . 31.9 ttt180 -63.64 -50.62 68.6 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.985 0.514 . . . . 73.450000000000003 110.71 168.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -79.14 -2.02 38.8 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.171 0.988 . . . . 63.439999999999998 112.197 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 63.07 22.13 13.26 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.541 1.536 . . . . 75.400000000000006 112.688 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 63.1 mttp -78.7 -18.65 54.0 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.391 1.076 . . . . 74.349999999999994 112.961 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.55 157.86 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 112.807 0.669 . . . . 74.200000000000003 112.807 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 64' ' ' TYR . 7.3 m -129.78 120.22 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 124.694 1.198 . . . . 74.129999999999995 109.773 172.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.403 HG13 HG21 ' A' ' 63' ' ' ILE . 3.4 mp -96.95 107.38 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.636 0.774 . . . . 65.329999999999998 109.906 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.529 ' HB3' ' HZ3' ' A' ' 57' ' ' LYS . 39.7 mt-10 -117.38 137.34 52.53 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.909 0.484 . . . . 74.310000000000002 111.469 -172.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -89.11 100.96 13.63 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.846 0.859 . . . . 73.430000000000007 110.212 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.529 ' HZ3' ' HB3' ' A' ' 55' ' ' GLU . 12.3 mptt -107.64 119.35 39.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.702 0.801 . . . . 75.120000000000005 110.394 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 58.47 30.97 20.44 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.955 1.302 . . . . 72.519999999999996 112.268 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.07 -21.2 25.22 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-N 115.386 -0.825 . . . . 71.209999999999994 114.197 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.65 137.7 33.67 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.788 0.835 . . . . 73.409999999999997 111.266 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.06 114.25 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.59 0.756 . . . . 74.439999999999998 109.197 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.1 138.38 54.47 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.751 -0.833 . . . . 75.409999999999997 108.751 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.539 HG22 HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -103.38 124.4 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 122.265 1.031 . . . . 74.439999999999998 110.669 -177.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.594 ' HB2' HG23 ' A' ' 53' ' ' VAL . 89.0 m-85 -109.72 171.24 7.56 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.191 1.396 . . . . 65.200000000000003 109.582 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -93.75 168.25 11.12 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.576 0.703 . . . . 74.219999999999999 112.11 175.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -61.75 -20.64 63.77 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.237 1.015 . . . . 72.349999999999994 111.837 170.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.23 0.89 44.94 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 116.007 -0.542 . . . . 74.319999999999993 113.997 173.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -63.94 -32.65 74.25 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.94 0.896 . . . . 75.019999999999996 110.8 173.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -109.81 173.17 6.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.935 0.894 . . . . 65.040000000000006 110.488 173.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -74.51 90.58 2.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.863 0.465 . . . . 64.140000000000001 110.122 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -77.21 -45.78 25.45 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 122.874 0.47 . . . . 74.010000000000005 110.876 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -68.75 164.34 22.0 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.722 0.809 . . . . 70.540000000000006 111.89 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.49 -17.31 28.89 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.392 0.677 . . . . 74.530000000000001 111.943 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.58 48.37 29.67 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 121.047 0.249 . . . . 70.540000000000006 113.534 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.7 mt -84.45 -12.2 54.79 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.804 0.841 . . . . 73.319999999999993 113.246 -170.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.99 111.18 8.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.875 0.47 . . . . 73.349999999999994 110.963 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -113.85 120.19 39.88 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.653 0.781 . . . . 74.519999999999996 109.738 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -83.53 113.86 21.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.975 0.51 . . . . 74.140000000000001 111.053 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -145.75 127.21 15.02 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.024 0.93 . . . . 73.319999999999993 109.548 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -77.58 -26.5 50.84 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.074 0.549 . . . . 75.349999999999994 111.102 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -101.74 134.23 45.23 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.168 0.987 . . . . 72.310000000000002 108.72 168.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.9 p80 . . . . . 0 N--CA 1.492 1.646 0 C-N-CA 123.899 0.88 . . . . 74.439999999999998 112.994 -173.774 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 CA--C 1.549 0.909 0 CA-C-O 120.46 0.171 . . . . 74.340000000000003 111.394 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.43 ' HB3' ' HG2' ' B' ' 4' ' ' LYS . 53.6 m-20 -90.67 128.41 36.62 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.234 0.54 . . . . 62.210000000000001 111.215 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -69.76 -26.06 64.12 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 124.223 1.009 . . . . 73.239999999999995 111.817 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' B' ' 2' ' ' ASP . 21.7 ptmt -65.5 -24.09 67.06 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 113.145 0.794 . . . . 73.420000000000002 113.145 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 73.5 mt -64.34 -52.75 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.208 0.603 . . . . 74.540000000000006 111.348 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.48 -26.81 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 122.846 0.459 . . . . 71.409999999999997 111.887 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.38 -45.81 88.93 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 123.44 0.462 . . . . 74.109999999999999 112.984 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.92 91.9 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.701 0.8 . . . . 73.329999999999998 111.802 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.38 -41.85 97.78 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.678 0.791 . . . . 61.32 110.935 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.92 -24.05 55.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.95 0.9 . . . . 73.019999999999996 112.533 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.22 -41.51 99.51 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 121.354 0.419 . . . . 72.150000000000006 112.65 172.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -70.65 -41.1 72.58 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.081 0.953 . . . . 74.25 111.293 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.476 HG12 HD23 ' B' ' 28' ' ' LEU . 77.4 t -60.98 -46.1 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.887 0.875 . . . . 73.340000000000003 112.092 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -71.84 -31.79 66.87 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 116.286 -0.415 . . . . 75.120000000000005 111.424 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -56.62 -37.75 71.13 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.744 0.418 . . . . 74.219999999999999 111.471 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.18 75.4 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.038 0.535 . . . . 65.310000000000002 111.84 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.635 HD22 HG13 ' B' ' 63' ' ' ILE . 93.8 mt -73.83 -37.63 64.79 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.963 0.905 . . . . 70.230000000000004 112.158 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -59.08 -39.33 81.82 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.699 0.8 . . . . 73.209999999999994 110.636 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -79.17 -48.56 14.04 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.538 -0.755 . . . . 71.319999999999993 111.134 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.31 99.5 3.15 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.201 0.6 . . . . 73.329999999999998 111.566 -173.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.01 174.55 10.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.2 0.6 . . . . 65.439999999999998 112.272 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.94 13.32 83.52 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.224 -0.444 . . . . 63.32 113.977 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 tp -78.06 138.52 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 C-N-CA 123.15 0.58 . . . . 75.120000000000005 110.9 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.4 m -84.61 151.32 24.58 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.936 0.494 . . . . 64.140000000000001 111.015 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.482 HD11 ' HB3' ' A' ' 37' ' ' GLU . 54.2 mt -53.56 -45.84 98.45 Favored Pre-proline 0 CA--C 1.581 2.165 0 N-CA-C 114.711 1.375 . . . . 75.209999999999994 114.711 -172.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.451 ' HA ' HG23 ' B' ' 36' ' ' VAL . 65.8 Cg_endo -71.29 -29.15 17.47 Favored 'Trans proline' 0 C--N 1.396 3.038 0 CA-C-N 121.803 1.68 . . . . 71.5 113.415 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -73.6 -49.21 27.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.157 0.98 . . . . 72.239999999999995 109.863 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.476 HD23 HG12 ' B' ' 13' ' ' VAL . 62.5 tp -53.93 -36.24 62.56 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 113.013 -1.903 . . . . 74.349999999999994 111.775 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.05 83.35 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.658 0.783 . . . . 70.510000000000005 112.108 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -70.94 -39.88 72.37 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.942 0.497 . . . . 75.120000000000005 110.593 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.61 -43.18 93.84 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.311 0.644 . . . . 72.010000000000005 111.233 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.4 -5.88 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.58 0.752 . . . . 74.439999999999998 112.247 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 66.12 21.15 11.19 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.79 1.236 . . . . 63.549999999999997 113.01 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 68.5 mt -108.72 169.39 8.69 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.862 0.865 . . . . 73.099999999999994 110.553 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -72.34 155.5 40.09 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.003 0.521 . . . . 63.109999999999999 111.003 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' B' ' 26' ' ' PRO . 96.4 t -56.74 -44.04 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 123.579 0.751 . . . . 72.409999999999997 112.364 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.39 -49.25 78.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.626 0.77 . . . . 65.200000000000003 111.861 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -61.73 -38.68 88.81 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.556 1.142 . . . . 74.299999999999997 111.914 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.47 ' O ' HG22 ' B' ' 43' ' ' VAL . 92.4 m -70.08 -46.75 64.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.116 0.966 . . . . 73.510000000000005 111.037 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' B' ' 25' ' ' ILE . . . -62.09 -35.41 78.59 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.745 0.818 . . . . 64.140000000000001 112.137 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -69.64 -37.78 76.91 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.3 1.04 . . . . 74.530000000000001 110.156 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.55 -34.78 77.75 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.208 0.603 . . . . 73.540000000000006 111.428 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.47 HG22 ' O ' ' B' ' 39' ' ' THR . 98.4 t -61.8 -33.94 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.251 0.621 . . . . 74.420000000000002 110.921 172.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.64 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -62.05 -30.45 75.59 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 116.155 -0.475 . . . . 63.240000000000002 114.011 176.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.421 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 70.6 t-105 -68.49 -38.91 81.42 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.937 0.495 . . . . 72.530000000000001 110.899 172.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 93.1 mt -70.01 -33.07 71.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.926 0.491 . . . . 73.0 111.299 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.22 -31.27 72.34 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.923 0.889 . . . . 63.439999999999998 111.589 170.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.575 ' HD2' ' HA ' ' A' ' 48' ' ' ARG . 15.3 ttt180 -65.74 -44.84 84.76 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.742 0.817 . . . . 74.040000000000006 111.322 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -80.05 -3.99 50.83 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.409 0.683 . . . . 74.209999999999994 112.451 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 62.11 21.92 12.75 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.27 1.428 . . . . 74.5 112.983 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -86.5 -4.06 59.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.067 0.947 . . . . 65.099999999999994 113.074 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.74 146.69 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 112.41 0.522 . . . . 62.310000000000002 112.41 -177.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.68 120.15 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.227 -1.027 . . . . 72.219999999999999 108.227 172.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.53 HG12 HG22 ' B' ' 63' ' ' ILE . 62.4 mt -106.99 111.88 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-O 121.341 0.591 . . . . 74.239999999999995 110.973 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -114.02 140.71 48.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.144 0.978 . . . . 72.230000000000004 110.636 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -113.51 103.28 11.11 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.503 0.721 . . . . 64.530000000000001 110.8 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.9 113.72 26.22 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.587 1.155 . . . . 73.409999999999997 108.829 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 60.04 30.47 19.95 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.093 0.957 . . . . 73.329999999999998 112.653 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.58 -10.35 62.23 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 113.942 0.337 . . . . 74.340000000000003 113.942 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 44.5 tp -84.21 128.88 34.84 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.001 0.92 . . . . 73.040000000000006 110.281 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.8 126.85 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.076 0.55 . . . . 72.530000000000001 109.827 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.94 120.64 36.96 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.038 -1.097 . . . . 74.430000000000007 108.038 173.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.635 HG13 HD22 ' B' ' 17' ' ' LEU . 34.1 pt -103.48 138.94 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.245 0.545 . . . . 73.519999999999996 110.557 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -121.49 179.07 4.56 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.459 1.104 . . . . 63.149999999999999 110.025 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' B' ' 17' ' ' LEU . 1.6 m-20 -82.15 160.55 23.07 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.051 -0.351 . . . . 73.0 110.051 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -53.3 98.96 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.374 0.67 . . . . 74.239999999999995 111.187 172.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.52 -36.29 0.07 OUTLIER Glycine 0 C--N 1.349 1.25 0 CA-C-N 116.293 -0.412 . . . . 75.349999999999994 112.925 -175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -74.91 -2.62 27.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 112.156 0.428 . . . . 74.420000000000002 112.156 173.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -65.58 -44.45 86.62 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.595 -0.521 . . . . 74.120000000000005 109.595 163.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.77 146.28 51.57 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.392 -0.822 . . . . 75.430000000000007 110.284 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -139.96 147.99 41.29 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.246 0.546 . . . . 74.299999999999997 111.47 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 88.1 p -102.14 -173.76 2.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.074 0.949 . . . . 73.340000000000003 109.252 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -75.85 94.96 3.41 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 109.475 -0.565 . . . . 75.140000000000001 109.475 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.89 94.36 0.15 Allowed Glycine 0 C--N 1.344 1.025 0 CA-C-N 116.193 -0.458 . . . . 74.420000000000002 112.025 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.14 102.98 5.13 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.321 0.649 . . . . 75.439999999999998 110.598 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' B' ' 77' ' ' HIS . 22.6 tt0 -78.9 174.91 11.02 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.269 0.628 . . . . 75.150000000000006 109.834 176.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.445 ' H ' ' HG2' ' B' ' 76' ' ' GLU . 31.4 p80 -52.44 139.05 25.94 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.328 0.651 . . . . 75.530000000000001 111.885 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -63.95 135.37 56.44 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.969 0.508 . . . . 74.340000000000003 110.0 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -60.4 145.11 49.19 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.407 0.683 . . . . 74.25 111.843 -170.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -53.45 119.73 5.2 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.204 1.002 . . . . 73.129999999999995 113.185 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -71.04 137.15 48.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.93 0.892 . . . . 74.030000000000001 110.577 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 45.2 m80 . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.621 0.724 . . . . 75.310000000000002 112.336 -178.283 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.635 ' HE1' ' HA ' ' A' ' 3' ' ' LYS . 18.7 ptm . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 112.924 0.713 . . . . 75.129999999999995 112.924 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 64.45 89.46 0.09 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.036 1.334 . . . . 73.230000000000004 110.39 -173.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.635 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 62.2 tttm -70.28 -15.14 62.86 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.773 1.397 . . . . 75.209999999999994 114.773 -162.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -67.69 -14.49 62.99 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.837 0.68 . . . . 71.409999999999997 112.837 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.4 mt -49.15 -50.04 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 124.07 0.948 . . . . 65.329999999999998 112.215 173.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 3' ' ' LYS . 33.4 m -61.78 -28.02 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 112.436 0.532 . . . . 72.310000000000002 112.436 -177.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.52 -38.4 86.48 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 122.953 0.158 . . . . 41.409999999999997 113.073 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.59 -52.52 25.38 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.668 0.787 . . . . 70.129999999999995 111.785 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -59.26 -43.0 92.5 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.053 0.941 . . . . 64.340000000000003 112.155 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.4 -27.56 63.4 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.341 0.497 . . . . 70.420000000000002 112.341 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.79 -38.9 96.84 Favored Glycine 0 CA--C 1.538 1.485 0 O-C-N 123.332 0.395 . . . . 70.109999999999999 112.718 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -70.42 -43.82 69.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.502 0.721 . . . . 74.340000000000003 111.277 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.566 ' HA ' HG11 ' A' ' 32' ' ' VAL . 95.2 t -59.27 -42.75 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.433 0.693 . . . . 64.040000000000006 111.195 176.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 64.5 t90 -66.41 -32.98 74.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.851 0.86 . . . . 74.430000000000007 111.393 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -60.5 -53.73 53.98 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.068 0.147 . . . . 75.310000000000002 111.342 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.08 -30.91 71.94 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.172 0.589 . . . . 65.409999999999997 111.461 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.49 -50.71 50.32 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.99 1.316 . . . . 73.040000000000006 111.366 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.69 -23.87 59.87 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.361 0.664 . . . . 74.120000000000005 111.06 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -79.8 -37.06 36.04 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.393 1.077 . . . . 74.420000000000002 110.46 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.22 103.54 1.64 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.802 0.841 . . . . 74.120000000000005 110.705 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.668 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 10.7 p-10 -95.04 166.42 11.94 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.298 0.639 . . . . 73.420000000000002 112.148 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.68 64.16 1.11 Allowed Glycine 0 N--CA 1.473 1.133 0 CA-C-N 116.095 -0.502 . . . . 75.310000000000002 112.201 -175.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 tt -156.36 149.76 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 123.428 0.691 . . . . 71.030000000000001 111.116 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -86.17 158.58 19.72 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.232 0.613 . . . . 71.519999999999996 111.649 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.472 HG23 ' HB2' ' A' ' 40' ' ' ALA . 74.4 mt -53.68 -52.59 65.89 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 114.185 1.18 . . . . 72.010000000000005 114.185 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.0 -26.18 43.72 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 121.773 1.649 . . . . 71.129999999999995 114.188 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -76.22 -45.57 32.39 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.455 1.121 . . . . 70.400000000000006 109.423 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.9 tp -60.1 -34.35 73.36 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 113.284 -1.78 . . . . 74.010000000000005 111.973 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.66 95.36 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.007 0.923 . . . . 64.439999999999998 112.438 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -71.49 -27.94 63.57 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.856 0.462 . . . . 75.219999999999999 112.044 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -66.67 -52.28 46.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.222 0.534 . . . . 73.150000000000006 110.914 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.0 m -79.07 -5.87 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 115.184 -0.916 . . . . 70.040000000000006 111.838 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 69.28 16.35 8.42 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.239 1.415 . . . . 70.0 112.171 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.8 mt -97.23 164.21 12.58 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.555 0.742 . . . . 71.109999999999999 110.254 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -68.23 153.58 43.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.414 0.286 . . . . 70.120000000000005 111.323 172.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.68 -44.92 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 123.486 0.714 . . . . 74.239999999999995 111.887 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -60.25 -42.8 96.09 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.95 0.9 . . . . 73.420000000000002 111.797 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 t -64.91 -42.68 94.52 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.587 0.755 . . . . 65.230000000000004 111.369 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 43' ' ' VAL . 61.6 m -71.49 -37.9 71.24 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.805 0.842 . . . . 62.219999999999999 111.775 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -64.94 -44.86 88.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 123.747 0.819 . . . . 75.129999999999995 111.504 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.33 -37.33 87.13 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.461 -1.245 . . . . 73.25 110.357 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.04 -36.48 72.36 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.371 0.669 . . . . 73.099999999999994 112.449 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 39' ' ' THR . 88.0 t -66.75 -36.81 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.097 0.559 . . . . 63.530000000000001 110.452 173.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.51 -31.97 82.57 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-N 116.099 -0.5 . . . . 74.510000000000005 112.709 172.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.457 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 75.6 t-105 -74.03 -27.97 61.2 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.33 0.652 . . . . 74.299999999999997 111.582 173.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.76 -34.6 67.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.534 -0.729 . . . . 74.230000000000004 111.593 172.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.54 -26.59 55.33 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.11 0.964 . . . . 70.540000000000006 113.147 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.797 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 7.2 ptm180 -56.22 -36.65 68.7 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.387 0.884 . . . . 74.430000000000007 113.387 -174.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.797 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 39.3 mt-10 -112.22 15.76 20.32 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.117 0.967 . . . . 74.310000000000002 111.24 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.42 47.65 8.57 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.428 1.091 . . . . 72.25 110.048 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -87.68 -14.6 39.46 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.736 0.643 . . . . 72.040000000000006 112.736 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 m -133.23 150.64 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.92 0.888 . . . . 71.109999999999999 111.933 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 54.4 t -102.57 113.64 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.734 1.214 . . . . 63.439999999999998 108.772 171.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 61' ' ' ILE . 50.4 mm -100.17 108.85 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 118.061 0.391 . . . . 73.200000000000003 110.983 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HB3' ' HZ3' ' A' ' 57' ' ' LYS . 28.4 mm-40 -104.9 127.76 52.86 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.284 1.034 . . . . 72.019999999999996 110.356 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.514 HH22 ' HA ' ' B' ' 38' ' ' SER . 81.4 mtt-85 -113.61 105.55 13.47 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.872 -0.517 . . . . 72.040000000000006 111.529 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HZ3' ' HB3' ' A' ' 55' ' ' GLU . 14.4 mptt -112.48 119.47 38.33 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.877 0.871 . . . . 74.349999999999994 109.843 176.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 57.97 32.61 22.19 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.148 0.979 . . . . 73.409999999999997 112.27 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.23 -6.39 72.15 Favored Glycine 0 CA--C 1.543 1.844 0 N-CA-C 114.269 0.468 . . . . 75.120000000000005 114.269 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.8 mt -88.24 125.66 34.76 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.602 0.761 . . . . 73.25 110.192 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.459 HG22 HG23 ' A' ' 54' ' ' ILE . 2.8 mp -86.01 126.31 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.512 0.725 . . . . 74.430000000000007 110.048 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -109.92 128.64 55.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.682 1.193 . . . . 74.140000000000001 108.9 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.9 mp -107.83 106.86 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 108.832 -0.803 . . . . 72.010000000000005 108.832 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.668 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 96.7 m-85 -107.55 167.16 10.14 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.573 1.149 . . . . 74.409999999999997 110.596 175.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -90.54 147.31 23.44 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.894 0.378 . . . . 71.310000000000002 110.873 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -85.05 5.03 31.21 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.075 0.464 . . . . 73.340000000000003 112.239 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.85 -58.51 11.74 Favored Glycine 0 C--N 1.351 1.363 0 N-CA-C 110.331 -1.108 . . . . 64.209999999999994 110.331 163.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -175.9 121.63 0.18 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.926 1.29 . . . . 64.040000000000006 109.573 166.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -68.71 145.65 53.66 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.106 0.562 . . . . 74.430000000000007 110.382 171.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -101.44 -58.85 1.8 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.061 0.457 . . . . 74.25 110.463 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -91.94 172.14 8.65 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.47 0.708 . . . . 75.409999999999997 111.957 -174.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.5 m -166.83 96.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.892 1.677 . . . . 52.329999999999998 108.182 166.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.603 ' HB2' HD23 ' A' ' 75' ' ' LEU . 16.6 p90 -129.22 -69.34 0.7 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 112.782 0.66 . . . . 75.430000000000007 112.782 -167.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 49.3 42.6 33.23 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 114.503 0.561 . . . . 52.109999999999999 114.503 -173.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.603 HD23 ' HB2' ' A' ' 73' ' ' PHE . 2.0 pt? -103.46 142.56 34.04 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.252 0.549 . . . . 74.400000000000006 112.431 -171.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -170.18 142.07 2.19 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.014 1.326 . . . . 74.099999999999994 109.412 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -81.88 52.53 1.96 Allowed 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.548 0.69 . . . . 74.099999999999994 111.547 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -144.79 115.52 7.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.852 0.861 . . . . 71.439999999999998 110.116 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -78.46 175.58 10.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.888 0.875 . . . . 75.129999999999995 112.295 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -82.51 164.57 20.82 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.261 -0.881 . . . . 74.540000000000006 111.266 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -84.07 6.74 21.05 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 113.052 0.76 . . . . 73.420000000000002 113.052 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 N--CA 1.481 1.078 0 C-N-CA 123.666 0.787 . . . . 63.539999999999999 110.008 174.657 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 120.462 0.172 . . . . 74.430000000000007 110.877 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -54.28 -38.0 65.36 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.368 1.067 . . . . 73.310000000000002 112.754 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -23.96 62.17 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.925 -1.034 . . . . 74.219999999999999 111.417 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -91.68 -25.21 19.22 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.317 0.647 . . . . 74.129999999999995 112.112 175.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 75.2 mt -59.89 -46.19 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 122.97 0.508 . . . . 74.519999999999996 110.521 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 35.7 m -64.12 -30.95 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 122.884 0.473 . . . . 74.510000000000005 112.113 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.24 -41.54 59.34 Favored Glycine 0 CA--C 1.538 1.49 0 O-C-N 123.191 0.307 . . . . 73.329999999999998 113.174 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.76 -43.58 88.45 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.78 0.832 . . . . 63.100000000000001 111.469 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -65.55 -35.7 81.62 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.736 0.814 . . . . 73.519999999999996 111.27 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.45 70.96 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.164 0.586 . . . . 72.239999999999995 111.264 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.27 -36.87 92.32 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 116.299 -0.409 . . . . 74.140000000000001 112.57 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -63.97 -47.67 79.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.111 0.965 . . . . 72.439999999999998 111.878 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 75.8 t -62.32 -46.8 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.328 0.651 . . . . 74.310000000000002 111.153 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.542 ' HA ' HD13 ' B' ' 17' ' ' LEU . 17.9 t90 -64.02 -33.85 76.68 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.776 0.83 . . . . 74.409999999999997 111.436 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . 0.408 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 78.4 t60 -59.8 -47.99 83.48 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.974 0.509 . . . . 71.209999999999994 110.467 172.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.09 -26.84 68.73 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.23 0.612 . . . . 72.519999999999996 112.598 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' B' ' 14' ' ' TRP . 75.4 mt -68.84 -41.49 78.45 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.519 0.728 . . . . 75.5 111.166 172.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.411 HD21 ' N ' ' B' ' 18' ' ' ASN . 0.8 OUTLIER -68.01 -26.13 65.74 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.882 -0.599 . . . . 75.420000000000002 110.996 175.093 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 10.4 mm-40 -73.6 -47.18 42.24 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.413 0.685 . . . . 73.430000000000007 110.533 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.9 106.63 0.61 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.238 1.015 . . . . 71.439999999999998 110.554 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -95.6 179.67 5.05 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.485 0.714 . . . . 72.430000000000007 112.118 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.76 39.3 34.38 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 116.191 -0.459 . . . . 53.219999999999999 112.493 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 17.4 tt -124.29 153.45 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.954 0.902 . . . . 73.109999999999999 110.751 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.556 ' HG ' HD23 ' B' ' 60' ' ' LEU . 50.7 m -80.29 151.56 29.48 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.801 0.441 . . . . 75.200000000000003 111.462 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' B' ' 40' ' ' ALA . 87.3 mt -51.04 -49.14 82.79 Favored Pre-proline 0 CA--C 1.577 1.991 0 N-CA-C 114.451 1.278 . . . . 74.099999999999994 114.451 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 59.9 Cg_endo -67.33 -30.17 37.31 Favored 'Trans proline' 0 C--N 1.393 2.89 0 C-N-CA 121.711 1.607 . . . . 74.310000000000002 114.135 -176.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -76.68 -44.17 34.8 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.229 1.014 . . . . 63.219999999999999 110.307 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.33 -40.19 74.02 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 113.427 -1.715 . . . . 73.239999999999995 111.287 171.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.82 -38.33 85.05 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.102 0.961 . . . . 73.409999999999997 112.505 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' B' ' 26' ' ' PRO . 14.7 mmm-85 -63.29 -44.1 96.01 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.4 0.68 . . . . 75.439999999999998 110.651 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.533 ' HB3' ' HZ3' ' B' ' 31' ' ' LYS . 8.0 mtpm? -67.21 -43.27 82.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.864 0.866 . . . . 75.409999999999997 111.833 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.3 m -83.03 -5.27 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 122.875 0.47 . . . . 72.299999999999997 111.768 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 69.21 11.56 8.23 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.422 1.489 . . . . 72.299999999999997 112.682 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.7 mt -93.17 165.79 12.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.531 0.732 . . . . 74.420000000000002 110.019 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -65.94 153.55 41.77 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 122.239 -0.288 . . . . 72.439999999999998 110.59 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' B' ' 26' ' ' PRO . 54.9 t -49.88 -52.26 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.104 0.962 . . . . 73.439999999999998 112.171 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -71.12 -30.64 66.75 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.295 1.038 . . . . 74.340000000000003 111.436 -176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.514 ' HA ' HH22 ' A' ' 56' ' ' ARG . 41.7 m -64.97 -42.17 94.81 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.629 0.772 . . . . 73.409999999999997 110.775 173.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.429 ' O ' HG23 ' B' ' 43' ' ' VAL . 84.9 m -70.06 -43.19 71.72 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.103 0.961 . . . . 75.25 111.075 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -62.06 -42.66 99.43 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 123.975 0.91 . . . . 75.329999999999998 112.106 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -64.67 -38.26 90.39 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.698 1.199 . . . . 74.5 110.365 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.92 72.07 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.548 0.739 . . . . 74.400000000000006 111.958 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 39' ' ' THR . 75.0 t -63.7 -35.68 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.481 0.713 . . . . 72.409999999999997 110.67 172.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.35 -31.24 80.08 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 116.29 -0.414 . . . . 44.020000000000003 113.41 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.493 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 43.6 t-105 -74.39 -31.24 62.28 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.229 0.612 . . . . 74.109999999999999 111.331 176.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.27 -36.29 68.97 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.29 0.636 . . . . 75.129999999999995 111.433 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.31 82.9 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.825 0.85 . . . . 73.209999999999994 110.8 172.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.562 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 31.2 ttt180 -51.84 -50.6 60.58 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.636 0.775 . . . . 74.400000000000006 111.064 171.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -80.01 -2.31 43.58 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.947 -1.024 . . . . 72.140000000000001 112.737 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . 0.514 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 57.2 m-20 64.75 26.63 13.05 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.754 1.222 . . . . 72.430000000000007 112.694 176.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -99.29 5.73 46.45 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.136 0.791 . . . . 74.540000000000006 113.136 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.412 ' HB ' HD11 ' B' ' 63' ' ' ILE . 28.5 m -135.31 156.8 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.398 0.618 . . . . 71.209999999999994 112.589 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 32.4 t -111.56 125.29 68.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 124.475 1.11 . . . . 72.439999999999998 109.262 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.83 103.42 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.42 -0.956 . . . . 74.340000000000003 108.42 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . 0.468 ' HB3' ' HE1' ' B' ' 64' ' ' TYR . 7.7 tp10 -118.86 115.79 25.15 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.938 0.399 . . . . 74.209999999999994 109.982 -173.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -84.69 107.05 16.69 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.544 0.687 . . . . 72.209999999999994 111.063 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -104.82 114.39 28.57 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.581 1.153 . . . . 73.230000000000004 109.912 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 58.44 32.44 22.11 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.063 0.945 . . . . 72.129999999999995 112.399 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.17 -20.02 31.88 Favored Glycine 0 CA--C 1.545 1.942 0 N-CA-C 114.06 0.384 . . . . 75.230000000000004 114.06 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.556 HD23 ' HG ' ' B' ' 24' ' ' SER . 7.3 tt -88.41 138.34 31.52 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.456 1.102 . . . . 73.329999999999998 109.9 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -87.8 122.95 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.753 0.421 . . . . 73.510000000000005 111.704 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -108.45 127.08 53.59 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.089 0.956 . . . . 75.129999999999995 108.633 171.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.412 HD11 ' HB ' ' B' ' 52' ' ' VAL . 0.0 OUTLIER -104.75 121.91 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-O 121.887 0.851 . . . . 74.5 110.154 -176.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.616 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 45.3 m-85 -107.71 157.76 17.84 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.624 1.17 . . . . 73.120000000000005 110.141 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -85.16 162.97 19.01 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.039 0.536 . . . . 75.420000000000002 111.48 -175.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -52.99 121.8 8.09 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.227 1.011 . . . . 70.319999999999993 112.473 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.19 -71.9 0.28 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 111.551 -0.62 . . . . 74.140000000000001 111.551 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -93.49 73.62 4.43 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.318 0.647 . . . . 75.340000000000003 110.309 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.57 -38.39 55.03 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.521 0.728 . . . . 75.329999999999998 111.157 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.04 81.24 3.56 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.268 -0.641 . . . . 74.349999999999994 109.268 170.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.48 -46.46 76.23 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.81 -0.632 . . . . 73.329999999999998 110.662 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 73.4 p -87.56 108.94 19.29 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.398 -0.819 . . . . 65.239999999999995 110.208 170.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -81.08 80.5 7.53 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-O 121.586 0.708 . . . . 75.439999999999998 109.725 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.03 79.49 1.62 Allowed Glycine 0 C--N 1.354 1.56 0 CA-C-N 115.326 -0.852 . . . . 62.329999999999998 113.975 -170.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.06 -60.82 2.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.493 0.717 . . . . 74.030000000000001 111.287 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -91.17 29.25 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.031 0.92 . . . . 74.450000000000003 112.293 -173.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -72.65 105.15 4.15 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.026 -1.101 . . . . 73.409999999999997 108.026 166.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -52.44 130.49 31.65 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.188 0.995 . . . . 73.310000000000002 113.206 -168.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -147.05 155.8 42.5 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.19 0.996 . . . . 72.409999999999997 111.319 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -163.79 157.89 19.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.794 0.838 . . . . 73.409999999999997 110.173 173.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -129.17 164.35 23.58 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.591 0.757 . . . . 72.120000000000005 111.562 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 124.303 1.041 . . . . 74.530000000000001 111.153 -174.27 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.559 ' HG2' HD12 ' A' ' 5' ' ' ILE . 51.8 ttm . . . . . 0 CA--C 1.551 1.016 0 N-CA-C 109.986 -0.376 . . . . 74.349999999999994 109.986 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -54.99 146.58 17.49 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.549 1.14 . . . . 74.219999999999999 113.86 -175.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.46 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -78.13 -33.5 50.43 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.495 0.718 . . . . 74.340000000000003 112.815 -173.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 4' ' ' LYS . 11.2 mmpt? -67.04 -17.12 64.76 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 112.37 0.507 . . . . 72.540000000000006 112.37 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.559 HD12 ' HG2' ' A' ' 1' ' ' MET . 54.6 mt -65.28 -46.92 89.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.34 0.656 . . . . 75.340000000000003 111.579 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 3' ' ' LYS . 9.9 m -68.81 -27.55 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 118.057 0.39 . . . . 73.420000000000002 111.676 177.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.04 -42.52 94.56 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.557 0.536 . . . . 64.409999999999997 112.491 172.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.11 81.1 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.487 0.715 . . . . 75.219999999999999 111.24 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -61.73 -36.12 80.03 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.569 0.747 . . . . 75.109999999999999 111.161 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.93 -36.61 69.97 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.533 0.733 . . . . 71.319999999999993 111.615 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.86 -31.41 75.54 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-N 116.41 -0.359 . . . . 74.430000000000007 112.545 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.543 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 53.8 tptt -71.0 -42.28 69.83 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.442 1.097 . . . . 73.299999999999997 111.186 175.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.59 -40.7 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.993 0.917 . . . . 71.140000000000001 111.343 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 13.4 t90 -69.33 -33.53 73.25 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 116.018 -0.537 . . . . 73.349999999999994 110.399 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -57.13 -46.05 83.01 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.134 0.573 . . . . 75.510000000000005 110.744 168.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.36 -29.57 66.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.517 0.727 . . . . 73.25 112.481 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.12 -49.1 60.1 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.627 0.771 . . . . 73.209999999999994 112.083 172.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -67.56 -22.31 65.4 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.067 0.461 . . . . 72.540000000000006 111.303 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -76.2 -48.72 19.37 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.292 1.037 . . . . 74.409999999999997 109.614 174.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.24 97.4 0.34 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.753 1.221 . . . . 73.430000000000007 110.263 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.98 173.75 11.5 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.732 0.813 . . . . 73.400000000000006 112.258 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.04 61.38 4.03 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.765 -0.534 . . . . 62.530000000000001 111.765 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.11 159.08 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 123.153 0.581 . . . . 72.340000000000003 111.185 -166.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 m -79.47 153.28 29.74 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.844 0.354 . . . . 72.439999999999998 111.09 174.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' A' ' 40' ' ' ALA . 95.8 mt -53.56 -54.8 41.73 Favored Pre-proline 0 CA--C 1.576 1.956 0 C-N-CA 124.494 1.118 . . . . 73.310000000000002 112.245 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.456 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 55.9 Cg_endo -66.36 -25.19 49.35 Favored 'Trans proline' 0 C--N 1.401 3.301 0 C-N-CA 121.764 1.643 . . . . 73.239999999999995 113.741 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -70.63 -51.84 25.36 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.383 0.673 . . . . 75.109999999999999 112.501 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.61 -33.01 74.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.312 0.245 . . . . 74.129999999999995 110.381 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.14 -41.25 64.91 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.622 1.169 . . . . 73.549999999999997 112.645 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 26' ' ' PRO . 46.9 mtt180 -62.62 -41.18 98.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.927 0.891 . . . . 72.409999999999997 111.553 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -72.61 -43.24 63.57 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.731 0.813 . . . . 75.430000000000007 111.243 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.543 ' HB ' ' HG3' ' A' ' 12' ' ' LYS . 26.2 m -85.69 -0.47 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 115.465 -0.789 . . . . 75.439999999999998 112.26 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.6 m120 67.08 11.21 8.26 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.897 1.279 . . . . 72.439999999999998 113.229 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.5 mt -89.24 148.01 23.83 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.374 -0.602 . . . . 74.400000000000006 109.374 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.3 t -63.25 153.4 34.84 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.45 0.3 . . . . 72.239999999999995 110.952 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.45 -42.44 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 123.278 0.631 . . . . 75.420000000000002 111.333 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.53 -43.39 98.94 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.417 0.687 . . . . 61.340000000000003 112.338 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.4 m -62.09 -33.02 73.65 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 123.302 0.641 . . . . 73.430000000000007 111.707 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 43' ' ' VAL . 79.0 m -77.4 -53.06 8.11 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.763 0.825 . . . . 75.310000000000002 111.641 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.612 ' HB2' HG22 ' A' ' 25' ' ' ILE . . . -59.73 -41.75 91.6 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.416 1.087 . . . . 73.340000000000003 112.884 -177.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -65.49 -39.02 91.42 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.405 1.082 . . . . 64.430000000000007 110.407 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.17 -31.12 69.53 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 123.241 0.616 . . . . 65.219999999999999 112.016 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 39' ' ' THR . 87.2 t -61.02 -38.13 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 123.765 0.826 . . . . 63.200000000000003 110.354 171.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.94 -32.03 82.88 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.794 -0.639 . . . . 75.299999999999997 113.943 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.429 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 70.8 t-105 -70.31 -37.38 74.73 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.059 0.457 . . . . 73.409999999999997 110.708 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.54 -35.63 79.44 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.774 0.43 . . . . 74.530000000000001 111.047 172.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.67 88.91 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.513 0.725 . . . . 74.540000000000006 111.421 172.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.432 ' NH1' ' HA ' ' B' ' 48' ' ' ARG . 22.7 ttt180 -55.61 -49.91 71.54 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.799 0.84 . . . . 62.450000000000003 111.128 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -78.4 -6.02 54.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.755 0.822 . . . . 71.420000000000002 111.718 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 62.07 22.87 13.42 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.601 1.56 . . . . 72.120000000000005 112.462 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -78.28 -5.63 52.61 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.458 1.103 . . . . 71.409999999999997 113.41 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.475 HG11 HD12 ' A' ' 63' ' ' ILE . 25.6 m -133.14 151.98 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.171 0.589 . . . . 64.129999999999995 112.294 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 64' ' ' TYR . 17.3 m -123.27 121.04 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 C-N-CA 124.108 0.963 . . . . 73.219999999999999 109.014 169.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.529 HG12 HD11 ' B' ' 41' ' ' LEU . 3.6 mp -100.99 124.29 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 109.154 -0.684 . . . . 72.239999999999995 109.154 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.42 148.59 44.92 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.253 0.621 . . . . 72.109999999999999 112.16 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -100.61 112.63 25.04 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.446 0.699 . . . . 73.420000000000002 110.267 171.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -105.44 112.77 26.0 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.846 0.859 . . . . 73.030000000000001 108.942 173.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 55.88 30.77 16.52 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.631 1.172 . . . . 75.5 112.067 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.96 -27.2 13.48 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 115.431 -0.804 . . . . 64.0 113.986 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.31 132.3 42.93 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.781 0.832 . . . . 73.040000000000006 111.394 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.0 mt -89.7 123.98 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.449 0.699 . . . . 74.540000000000006 111.511 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -127.58 139.05 53.01 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.458 1.103 . . . . 73.349999999999994 109.748 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.475 HD12 HG11 ' A' ' 52' ' ' VAL . 6.1 tt -95.07 136.34 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.287 0.635 . . . . 73.340000000000003 110.533 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.532 ' HB2' HG23 ' A' ' 53' ' ' VAL . 98.8 m-85 -130.37 169.39 15.54 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.546 1.138 . . . . 71.150000000000006 110.374 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.54 155.43 20.49 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.425 0.69 . . . . 71.030000000000001 110.264 171.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -173.01 1.0 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 120.935 0.398 . . . . 74.230000000000004 111.86 169.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.33 25.89 71.77 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 116.612 -0.267 . . . . 72.239999999999995 112.903 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -111.27 -49.71 2.99 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.117 0.967 . . . . 73.420000000000002 109.626 176.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -92.26 123.85 35.9 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.375 0.67 . . . . 74.540000000000006 110.006 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.13 124.61 28.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.783 0.833 . . . . 73.219999999999999 112.202 -170.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -79.44 145.93 33.04 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.169 0.588 . . . . 73.519999999999996 110.42 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 t 66.6 29.99 8.59 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.63 1.172 . . . . 70.140000000000001 111.357 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -113.46 1.89 15.21 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.806 0.842 . . . . 73.230000000000004 111.38 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.28 -84.26 0.35 Allowed Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.993 -0.843 . . . . 64.349999999999994 110.993 -172.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.7 mt 71.68 -50.39 0.69 Allowed 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 125.822 1.649 . . . . 74.430000000000007 113.979 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -62.53 120.43 11.11 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.744 0.818 . . . . 64.450000000000003 111.704 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -117.06 135.18 53.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.361 1.064 . . . . 73.430000000000007 108.514 169.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -60.15 106.72 0.55 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.176 0.59 . . . . 75.049999999999997 110.827 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -64.9 157.19 28.67 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.638 . . . . 73.530000000000001 111.867 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -75.11 121.33 21.89 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.023 -0.535 . . . . 72.109999999999999 110.562 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -77.06 93.22 3.83 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.814 0.846 . . . . 75.439999999999998 110.074 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.6 t60 . . . . . 0 N--CA 1.483 1.203 0 C-N-CA 124.375 1.07 . . . . 74.310000000000002 111.486 -179.222 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 CA--C 1.55 0.945 0 N-CA-C 112.086 0.402 . . . . 74.129999999999995 112.086 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -144.2 154.42 43.11 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.61 0.764 . . . . 70.329999999999998 111.09 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -80.9 -25.87 37.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.166 0.586 . . . . 72.510000000000005 112.21 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -65.25 -20.25 66.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.302 -0.249 . . . . 74.109999999999999 111.603 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.58 -59.55 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.084 0.554 . . . . 75.310000000000002 110.91 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.66 -29.84 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 111.842 0.312 . . . . 74.420000000000002 111.842 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.29 -47.5 63.48 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.366 0.416 . . . . 70.400000000000006 113.138 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.68 96.61 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.935 0.894 . . . . 51.549999999999997 111.296 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.57 -42.26 87.31 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.636 -0.711 . . . . 73.219999999999999 111.581 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.72 -35.32 72.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.089 0.556 . . . . 73.109999999999999 112.105 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.66 -38.13 95.26 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 116.332 -0.394 . . . . 62.130000000000003 112.994 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -75.72 -42.45 50.67 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.744 0.818 . . . . 74.109999999999999 110.943 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.573 ' HA ' HG12 ' B' ' 32' ' ' VAL . 34.3 t -62.78 -48.05 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.384 1.074 . . . . 65.310000000000002 111.47 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.423 ' NE1' ' HB3' ' B' ' 51' ' ' LYS . 48.3 t90 -64.92 -35.12 80.13 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.024 0.53 . . . . 65.349999999999994 111.735 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . 0.449 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 38.9 t60 -65.4 -46.79 78.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.567 0.347 . . . . 70.349999999999994 110.419 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.15 62.51 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.37 0.668 . . . . 73.129999999999995 112.149 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.433 HD11 ' ND2' ' B' ' 65' ' ' ASN . 1.4 tm? -72.87 -31.77 64.95 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.569 1.148 . . . . 75.109999999999999 110.397 171.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.68 -36.46 73.32 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.569 -0.53 . . . . 72.450000000000003 109.569 175.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 12.3 mm-40 -72.49 -49.88 29.89 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.326 0.65 . . . . 73.409999999999997 110.617 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.8 86.75 2.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.013 0.925 . . . . 73.329999999999998 110.206 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -68.67 124.61 24.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.633 0.773 . . . . 75.420000000000002 111.778 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.61 63.07 2.4 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.451 -0.34 . . . . 62.329999999999998 112.389 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.6 tp -117.3 137.96 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.594 0.758 . . . . 72.140000000000001 110.764 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -67.68 147.75 52.25 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.563 0.745 . . . . 73.329999999999998 110.901 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.497 HG21 ' HB2' ' B' ' 40' ' ' ALA . 60.8 mt -56.99 -49.89 91.35 Favored Pre-proline 0 CA--C 1.58 2.119 0 N-CA-C 113.422 0.897 . . . . 74.549999999999997 113.422 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.63 -27.38 32.48 Favored 'Trans proline' 0 C--N 1.399 3.203 0 C-N-CA 121.799 1.666 . . . . 73.299999999999997 114.026 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -70.91 -52.68 18.57 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.067 0.937 . . . . 71.239999999999995 109.245 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.453 HD23 HG11 ' B' ' 13' ' ' VAL . 60.6 tp -54.56 -38.34 66.53 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 113.249 -1.796 . . . . 75.310000000000002 112.15 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.72 -45.14 93.08 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.993 0.917 . . . . 70.030000000000001 111.915 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -67.7 -37.71 82.65 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.23 0.612 . . . . 74.420000000000002 110.861 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -64.12 -30.01 71.1 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.781 0.832 . . . . 74.430000000000007 112.243 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' B' ' 13' ' ' VAL . 34.1 m -103.09 1.91 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 112.769 0.655 . . . . 74.120000000000005 112.769 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 64.3 27.79 13.79 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 124.868 1.267 . . . . 73.409999999999997 113.132 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 72.4 mt -113.18 166.54 11.35 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.752 0.821 . . . . 74.120000000000005 111.448 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 31.6 t -69.43 155.74 39.96 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.664 -0.698 . . . . 63.310000000000002 111.61 170.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 67.8 t -56.37 -42.39 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.586 0.754 . . . . 74.230000000000004 111.033 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.83 -47.31 86.24 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.005 0.922 . . . . 75.519999999999996 111.457 175.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 41.5 t -63.72 -38.09 89.79 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.106 0.963 . . . . 72.430000000000007 112.089 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.447 ' O ' HG23 ' B' ' 43' ' ' VAL . 94.1 m -75.12 -49.44 19.59 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.863 0.865 . . . . 74.540000000000006 111.866 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.497 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -60.25 -39.59 87.28 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.69 0.796 . . . . 70.040000000000006 112.257 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.529 HD11 HG12 ' A' ' 54' ' ' ILE . 1.2 tt -62.2 -48.71 78.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.182 0.993 . . . . 74.030000000000001 110.064 173.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.72 -29.99 68.5 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.98 -1.009 . . . . 64.019999999999996 112.116 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.574 HG13 HD13 ' B' ' 63' ' ' ILE . 72.8 t -68.84 -37.17 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 123.061 0.544 . . . . 73.340000000000003 110.768 176.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -68.9 -30.25 72.43 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 116.431 -0.349 . . . . 62.109999999999999 112.79 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.451 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 72.6 t-105 -73.67 -21.07 60.38 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.304 0.642 . . . . 73.409999999999997 110.991 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.72 -33.8 58.15 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.645 0.778 . . . . 74.030000000000001 112.29 167.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.76 -25.53 60.61 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.057 1.132 . . . . 71.129999999999995 114.057 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.57 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 35.7 ptt85 -61.75 -36.38 80.85 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.036 0.446 . . . . 75.109999999999999 111.878 174.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 41.0 mt-10 -96.37 -2.7 45.13 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.35 1.06 . . . . 64.450000000000003 111.344 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 63.55 20.55 12.3 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 125.395 1.478 . . . . 75.439999999999998 113.065 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.423 ' HB3' ' NE1' ' B' ' 14' ' ' TRP . 49.5 mtmt -75.46 -8.18 56.04 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.378 0.881 . . . . 74.230000000000004 113.378 -173.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -128.57 151.58 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.915 0.886 . . . . 72.340000000000003 110.693 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.588 HG21 ' HB2' ' B' ' 64' ' ' TYR . 8.3 m -123.95 123.61 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.166 0.986 . . . . 75.349999999999994 109.884 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 61' ' ' ILE . 1.9 mp -91.3 119.77 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.224 1.01 . . . . 72.239999999999995 109.616 -176.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -116.98 136.55 52.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.348 0.659 . . . . 75.010000000000005 110.156 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -98.58 108.46 21.16 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.857 0.463 . . . . 71.129999999999995 111.297 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -104.88 109.33 21.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.924 0.89 . . . . 75.319999999999993 109.455 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 61.18 30.29 19.23 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.053 1.341 . . . . 74.209999999999994 112.25 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.96 -18.42 56.03 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 113.796 0.279 . . . . 64.010000000000005 113.796 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mp -89.84 149.11 22.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.935 0.894 . . . . 75.219999999999999 110.394 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 54' ' ' ILE . 27.1 mm -92.66 134.94 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.596 0.358 . . . . 72.340000000000003 111.278 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -123.19 133.16 54.25 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.607 -0.886 . . . . 74.120000000000005 108.607 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.574 HD13 HG13 ' B' ' 43' ' ' VAL . 25.5 mm -93.15 119.46 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.421 0.688 . . . . 74.140000000000001 110.016 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.588 ' HB2' HG21 ' B' ' 53' ' ' VAL . 57.0 m-85 -113.73 169.33 9.06 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.856 0.862 . . . . 75.299999999999997 110.688 175.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.433 ' ND2' HD11 ' B' ' 17' ' ' LEU . 5.8 m120 -79.99 154.38 28.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.533 0.733 . . . . 74.040000000000006 110.469 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -53.52 139.13 32.15 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.574 0.702 . . . . 73.409999999999997 112.061 172.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.82 -142.57 14.01 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 114.396 -1.274 . . . . 75.519999999999996 110.893 -171.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.416 ' CD2' HG23 ' B' ' 53' ' ' VAL 0.258 10.7 p80 39.27 -53.48 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 127.287 2.235 . . . . 73.010000000000005 114.646 -158.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.474 ' HE2' ' H3 ' ' A' ' 1' ' ' MET . 62.4 m-85 -59.21 143.7 48.22 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.618 0.767 . . . . 75.219999999999999 110.721 158.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.43 142.51 32.71 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.354 0.662 . . . . 72.25 110.086 175.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.97 127.12 29.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.623 0.769 . . . . 75.030000000000001 111.511 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.9 t 78.78 -28.95 0.15 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.839 1.656 . . . . 74.150000000000006 112.785 -173.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 54.1 t80 74.11 -27.08 0.19 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.974 1.709 . . . . 75.420000000000002 113.374 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.27 4.29 3.66 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.373 0.511 . . . . 74.510000000000005 112.637 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.84 136.94 38.15 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.151 0.58 . . . . 74.450000000000003 110.388 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.59 89.82 2.23 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.848 0.859 . . . . 72.420000000000002 111.835 -177.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -90.64 88.23 7.03 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.503 -0.925 . . . . 72.209999999999994 108.503 170.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -70.02 81.75 0.49 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.994 0.918 . . . . 75.140000000000001 111.826 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -145.41 -41.23 0.23 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.853 1.261 . . . . 63.229999999999997 109.882 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -154.97 156.97 36.98 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.844 0.857 . . . . 75.219999999999999 110.497 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -80.02 162.45 24.86 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.555 0.742 . . . . 74.430000000000007 111.595 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 123.714 0.806 . . . . 74.329999999999998 110.015 -177.18 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.555 ' HB2' ' HG3' ' B' ' 55' ' ' GLU . 62.0 ttp . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 120.312 0.101 . . . . 73.230000000000004 110.958 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -124.76 144.15 50.4 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.762 0.825 . . . . 74.209999999999994 110.459 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 6' ' ' VAL . 37.1 ttmt -82.08 -45.09 15.7 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.656 0.782 . . . . 74.129999999999995 112.081 -178.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -68.32 -11.0 58.79 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.887 0.699 . . . . 72.219999999999999 112.887 -173.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.4 mt -44.69 -59.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 123.547 0.739 . . . . 63.32 111.101 166.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 3' ' ' LYS . 34.0 m -65.67 -27.16 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 112.507 0.558 . . . . 74.209999999999994 112.507 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.49 -42.67 88.63 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 120.899 0.166 . . . . 71.129999999999995 112.718 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.57 84.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.002 0.921 . . . . 73.439999999999998 111.301 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -60.21 -47.76 84.61 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.098 0.959 . . . . 72.219999999999999 111.289 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.78 -29.81 64.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.525 0.73 . . . . 63.200000000000003 112.168 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.45 -40.77 99.12 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.231 0.332 . . . . 72.120000000000005 112.873 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 60.3 tttp -75.87 -37.91 58.44 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.592 0.757 . . . . 70.040000000000006 111.931 177.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.598 ' HA ' HG11 ' A' ' 32' ' ' VAL . 60.0 t -61.23 -48.59 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 123.487 0.715 . . . . 74.409999999999997 111.586 177.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.436 ' HA ' HD11 ' A' ' 17' ' ' LEU . 30.6 t90 -65.65 -39.01 90.94 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.667 -0.697 . . . . 73.230000000000004 111.311 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -60.62 -38.64 85.43 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.204 0.602 . . . . 70.219999999999999 111.151 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.82 -23.2 63.27 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.419 0.687 . . . . 75.120000000000005 112.257 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.436 HD11 ' HA ' ' A' ' 14' ' ' TRP . 70.2 mt -70.54 -44.88 66.6 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.332 0.653 . . . . 75.349999999999994 111.318 169.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -61.0 -32.79 72.36 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.002 0.521 . . . . 73.349999999999994 111.425 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.61 -52.31 32.92 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.383 0.673 . . . . 64.420000000000002 110.551 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.86 102.29 0.56 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.52 0.728 . . . . 63.450000000000003 111.206 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -97.12 -175.13 3.15 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.763 0.825 . . . . 72.019999999999996 110.819 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.05 49.85 7.27 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.365 -0.694 . . . . 75.409999999999997 111.365 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.4 tt -139.33 159.57 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.238 -0.981 . . . . 73.319999999999993 110.867 -163.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.9 m -72.99 146.28 46.1 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.66 0.384 . . . . 74.230000000000004 110.819 171.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' A' ' 40' ' ' ALA . 70.6 mt -55.96 -46.06 99.81 Favored Pre-proline 0 CA--C 1.58 2.106 0 C-N-CA 124.126 0.97 . . . . 74.310000000000002 112.998 176.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.542 ' HA ' HG23 ' A' ' 36' ' ' VAL . 35.7 Cg_endo -62.54 -29.43 78.38 Favored 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 122.19 1.926 . . . . 55.310000000000002 114.524 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -74.75 -46.62 36.05 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 122.39 1.09 . . . . 72.540000000000006 110.146 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 58.2 tp -58.45 -38.18 76.98 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 113.259 -1.791 . . . . 73.439999999999998 111.6 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.15 -37.74 75.24 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.237 1.015 . . . . 73.329999999999998 112.345 177.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -67.67 -38.27 83.5 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.415 0.686 . . . . 74.129999999999995 111.712 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 28' ' ' LEU . 42.4 mtmt -69.12 -38.4 78.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.217 0.607 . . . . 72.239999999999995 111.367 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 13' ' ' VAL . 32.3 m -90.86 -1.68 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.731 0.641 . . . . 75.219999999999999 112.731 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 68.09 9.89 7.47 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.175 1.39 . . . . 73.409999999999997 112.46 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.5 mt -95.86 167.55 11.18 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.347 0.659 . . . . 72.450000000000003 111.409 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.5 t -66.47 149.51 50.32 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.661 0.784 . . . . 73.420000000000002 110.845 168.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' A' ' 26' ' ' PRO . 55.6 t -55.14 -41.81 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.276 0.56 . . . . 72.349999999999994 110.921 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HB3' HD12 ' B' ' 25' ' ' ILE . 42.7 mt-10 -64.65 -39.06 93.03 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.37 1.068 . . . . 74.219999999999999 112.574 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 64.2 p -75.56 -26.56 58.06 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 122.616 0.367 . . . . 65.150000000000006 111.982 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 84.9 m -78.57 -43.47 26.46 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.418 0.687 . . . . 72.340000000000003 111.178 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.479 ' HB2' HG22 ' A' ' 25' ' ' ILE . . . -64.38 -36.86 85.52 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.376 0.671 . . . . 71.030000000000001 111.263 175.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.498 HD11 HG23 ' B' ' 54' ' ' ILE . 1.0 OUTLIER -58.3 -53.22 60.77 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.512 1.125 . . . . 75.230000000000004 109.94 170.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.86 -31.29 71.55 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.917 -1.038 . . . . 73.519999999999996 111.721 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.7 t -65.86 -37.98 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.565 0.746 . . . . 74.439999999999998 110.687 173.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.48 -31.74 81.21 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-N 116.753 -0.203 . . . . 63.119999999999997 113.499 172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.538 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 66.7 t-105 -73.55 -31.07 63.45 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.656 0.782 . . . . 74.319999999999993 111.47 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.31 -38.83 63.23 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.267 0.627 . . . . 73.040000000000006 111.317 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.54 81.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.37 1.068 . . . . 74.540000000000006 112.317 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.613 ' HB2' ' HD2' ' B' ' 48' ' ' ARG . 9.7 ptt180 -62.65 -34.19 76.57 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 121.196 0.522 . . . . 74.420000000000002 110.543 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -85.97 -1.43 57.32 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.233 1.013 . . . . 75.140000000000001 111.898 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 65.3 22.2 12.06 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.26 1.424 . . . . 75.310000000000002 112.301 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.36 -8.41 50.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 113.078 0.77 . . . . 74.030000000000001 113.078 -173.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.606 ' HB ' HD11 ' A' ' 63' ' ' ILE . 30.2 m -132.15 157.1 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.023 0.529 . . . . 73.299999999999997 112.07 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 64' ' ' TYR . 11.9 m -128.63 123.99 60.63 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 123.83 0.852 . . . . 74.129999999999995 110.41 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.18 125.03 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.848 0.859 . . . . 74.239999999999995 110.075 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -99.66 122.36 42.57 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.05 0.54 . . . . 73.310000000000002 110.976 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HG2' HG12 ' A' ' 61' ' ' ILE . 79.2 mtt85 -106.23 98.56 8.22 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.792 0.837 . . . . 74.430000000000007 110.111 173.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -127.59 128.67 45.97 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.596 0.758 . . . . 72.519999999999996 109.617 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 59.14 29.69 19.3 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.7 1.2 . . . . 75.430000000000007 112.137 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.19 1.83 64.97 Favored Glycine 0 CA--C 1.549 2.214 0 CA-C-N 116.05 -0.523 . . . . 72.329999999999998 114.224 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.4 mt -93.89 131.79 38.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.692 0.797 . . . . 53.509999999999998 111.19 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.452 HG12 ' HG2' ' A' ' 56' ' ' ARG . 72.4 mt -101.77 116.97 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 75.219999999999999 110.62 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -121.66 133.28 54.96 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.175 0.99 . . . . 72.310000000000002 109.828 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.606 HD11 ' HB ' ' A' ' 52' ' ' VAL . 7.0 tp -97.29 117.05 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 CA-C-O 121.801 0.81 . . . . 74.019999999999996 111.614 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.463 ' HB2' HG22 ' A' ' 53' ' ' VAL . 77.1 m-85 -109.07 165.88 11.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.957 1.303 . . . . 73.439999999999998 110.341 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.32 142.15 28.1 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.698 -0.853 . . . . 75.120000000000005 108.698 175.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -55.32 135.84 49.65 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.831 0.853 . . . . 75.019999999999996 111.98 -176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.35 -27.15 6.15 Favored Glycine 0 N--CA 1.476 1.321 0 CA-C-N 116.242 -0.435 . . . . 72.140000000000001 112.782 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -135.88 111.04 8.95 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.428 0.691 . . . . 71.439999999999998 111.158 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -147.12 21.3 1.23 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.878 1.271 . . . . 64.209999999999994 110.169 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -83.28 43.04 0.85 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.736 0.814 . . . . 74.230000000000004 111.609 -172.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 57.09 92.71 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.975 1.31 . . . . 75.219999999999999 113.11 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.1 t -52.3 99.62 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.286 0.634 . . . . 75.420000000000002 110.911 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -72.09 95.9 1.69 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.996 0.918 . . . . 74.150000000000006 111.283 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.05 70.52 0.24 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.728 -0.669 . . . . 63.420000000000002 111.934 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.36 89.22 6.56 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.093 0.949 . . . . 74.319999999999993 111.314 -177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -111.87 135.52 52.38 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.068 1.347 . . . . 74.140000000000001 109.91 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -87.32 62.76 7.39 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.828 0.823 . . . . 71.230000000000004 109.582 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -72.13 136.63 46.58 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.743 -1.117 . . . . 73.530000000000001 110.049 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -61.12 107.85 0.8 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.11 0.564 . . . . 74.340000000000003 110.457 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -147.3 128.78 14.97 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.59 0.756 . . . . 73.239999999999995 110.415 -175.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -72.41 125.26 26.96 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.192 0.597 . . . . 74.030000000000001 111.393 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.4 p80 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.849 0.833 . . . . 72.140000000000001 111.675 -178.416 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptm . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 120.807 0.337 . . . . 72.219999999999999 111.15 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.94 -28.41 62.42 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.958 0.903 . . . . 71.409999999999997 112.011 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.94 -23.69 58.36 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.335 0.654 . . . . 74.450000000000003 112.634 -173.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -87.87 -22.74 24.25 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 122.502 0.321 . . . . 75.310000000000002 110.727 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.61 -50.96 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.071 0.549 . . . . 74.310000000000002 110.426 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.477 HG13 HD12 ' B' ' 41' ' ' LEU . 26.8 m -61.02 -30.52 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 122.531 0.333 . . . . 65.129999999999995 111.471 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.15 -49.19 16.9 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 123.31 0.381 . . . . 74.239999999999995 113.317 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.32 -49.18 72.78 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.696 0.799 . . . . 74.409999999999997 111.78 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -58.89 -41.38 87.03 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.07 0.948 . . . . 74.329999999999998 111.92 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.477 ' HB3' ' HG ' ' B' ' 46' ' ' LEU . . . -66.48 -39.65 88.89 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.173 0.589 . . . . 75.120000000000005 111.952 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.91 -43.75 98.95 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 116.059 -0.519 . . . . 71.349999999999994 112.549 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -68.06 -42.96 79.7 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.978 0.911 . . . . 65.25 111.77 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.727 ' HA ' HG11 ' B' ' 32' ' ' VAL . 37.7 t -57.94 -44.18 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 124.117 0.967 . . . . 75.430000000000007 111.78 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 45.8 t90 -63.4 -33.42 75.52 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 115.221 -0.9 . . . . 75.430000000000007 112.194 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -61.09 -30.6 70.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.095 0.776 . . . . 73.439999999999998 113.095 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.33 65.88 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.341 0.497 . . . . 73.430000000000007 112.341 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.479 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 96.5 mt -70.55 -21.65 62.68 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.504 0.722 . . . . 73.5 112.619 174.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -64.78 -30.34 71.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.799 0.839 . . . . 74.299999999999997 111.891 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -91.55 -35.83 14.05 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.85 0.46 . . . . 74.219999999999999 111.168 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.43 112.23 1.09 Allowed 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.38 0.511 . . . . 74.120000000000005 112.38 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.498 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 9.4 p-10 -80.53 179.36 7.78 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.599 0.76 . . . . 71.299999999999997 110.704 166.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.46 61.14 4.95 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.611 -0.596 . . . . 75.219999999999999 111.611 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 tt -140.84 140.67 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.106 0.963 . . . . 75.340000000000003 110.03 -172.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 68.6 m -83.84 161.0 21.05 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.973 0.509 . . . . 63.530000000000001 110.885 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' A' ' 37' ' ' GLU . 58.8 mt -59.54 -44.92 98.62 Favored Pre-proline 0 CA--C 1.579 2.087 0 N-CA-C 113.9 1.074 . . . . 71.549999999999997 113.9 -174.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.88 -29.38 41.6 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 121.936 1.758 . . . . 51.399999999999999 114.237 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -71.7 -46.77 57.72 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.744 1.259 . . . . 72.340000000000003 109.654 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.468 HD22 HD11 ' B' ' 63' ' ' ILE . 65.3 tp -58.35 -43.62 88.4 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 112.946 -1.934 . . . . 52.5 111.681 173.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.68 91.21 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.497 1.119 . . . . 72.140000000000001 113.37 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -71.2 -23.58 62.06 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.073 0.549 . . . . 73.409999999999997 111.73 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -78.53 -44.6 23.92 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.772 0.829 . . . . 71.510000000000005 111.171 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.727 HG11 ' HA ' ' B' ' 13' ' ' VAL . 17.9 m -86.32 4.84 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.324 0.65 . . . . 75.430000000000007 112.414 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 65.34 17.75 11.1 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.815 1.246 . . . . 72.540000000000006 112.571 171.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 71.4 mt -109.72 158.32 18.22 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.468 0.707 . . . . 75.319999999999993 110.698 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -66.18 153.16 43.2 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.98 0.512 . . . . 72.239999999999995 111.168 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -53.6 -43.44 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 123.571 0.748 . . . . 74.400000000000006 111.964 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.99 -49.67 75.14 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.619 0.767 . . . . 74.230000000000004 112.037 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -61.33 -30.76 70.71 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.716 0.806 . . . . 65.430000000000007 112.236 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 87.4 m -77.44 -47.41 19.78 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.052 0.941 . . . . 63.509999999999998 111.304 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.453 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.62 -39.23 93.34 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.545 0.738 . . . . 71.140000000000001 111.99 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.477 HD12 HG13 ' B' ' 6' ' ' VAL . 1.3 tm? -62.41 -38.54 90.06 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.061 1.344 . . . . 75.340000000000003 110.431 174.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.52 -33.59 67.0 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.38 0.672 . . . . 71.150000000000006 111.914 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.71 -35.55 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.801 0.84 . . . . 72.129999999999995 111.482 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.08 -31.86 74.14 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 113.835 0.294 . . . . 73.5 113.835 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -75.04 -36.7 61.85 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.426 0.691 . . . . 74.010000000000005 111.499 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' B' ' 10' ' ' ALA . 83.2 mt -66.4 -35.1 79.48 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.03 0.532 . . . . 73.219999999999999 111.311 173.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.73 -35.81 75.32 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.309 1.044 . . . . 50.119999999999997 112.449 172.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.613 ' HD2' ' HB2' ' A' ' 48' ' ' ARG . 49.4 ttt85 -57.17 -45.88 83.28 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.333 0.587 . . . . 74.109999999999999 110.691 171.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.38 -15.29 57.17 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 114.794 -1.093 . . . . 73.430000000000007 112.191 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 t30 65.37 26.7 12.01 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.868 1.267 . . . . 72.420000000000002 111.125 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -82.71 -19.11 38.67 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.507 -0.77 . . . . 75.349999999999994 111.854 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 24.4 m -114.53 140.04 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.19 0.596 . . . . 74.219999999999999 110.455 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 51.7 t -103.71 96.82 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.367 -0.975 . . . . 75.109999999999999 108.367 174.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.622 HG12 HG22 ' B' ' 63' ' ' ILE . 57.0 mt -81.93 123.68 38.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 115.783 -0.644 . . . . 73.299999999999997 109.766 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 13.6 tt0 -143.14 127.65 17.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.882 -0.599 . . . . 62.100000000000001 110.525 -172.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -83.77 103.82 13.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.397 0.679 . . . . 73.129999999999995 110.055 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -106.1 122.82 46.95 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.503 1.121 . . . . 71.109999999999999 111.15 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 59.22 31.03 20.88 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 125.162 1.385 . . . . 73.150000000000006 112.772 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.13 -27.87 6.52 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 115.988 -0.551 . . . . 73.319999999999993 113.66 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mp -81.56 165.15 21.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.762 0.825 . . . . 74.230000000000004 109.562 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.71 136.48 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.867 -0.521 . . . . 62.520000000000003 110.684 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -134.47 168.24 19.3 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.175 0.99 . . . . 73.099999999999994 110.851 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.622 HG22 HG12 ' B' ' 54' ' ' ILE . 0.2 OUTLIER -120.53 147.53 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.329 1.052 . . . . 72.209999999999994 110.313 171.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 93.6 m-85 -124.86 169.53 11.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.471 1.108 . . . . 74.299999999999997 110.405 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' B' ' 21' ' ' ASP . 4.4 m-20 -71.97 148.84 45.58 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.049 0.452 . . . . 73.340000000000003 111.844 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -50.66 103.66 0.06 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.297 1.039 . . . . 64.150000000000006 111.651 171.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.66 -32.05 0.83 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.332 -0.849 . . . . 72.530000000000001 112.511 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -77.29 -7.51 56.11 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.349 0.66 . . . . 73.409999999999997 112.372 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -78.33 178.22 7.83 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.67 0.788 . . . . 75.349999999999994 110.958 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 58.67 28.49 17.29 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.454 0.702 . . . . 72.150000000000006 110.99 -163.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -75.21 161.72 29.1 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 124.15 0.98 . . . . 75.109999999999999 111.047 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.5 t -61.31 138.56 58.24 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.444 0.698 . . . . 65.510000000000005 111.627 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -105.84 111.31 23.92 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.168 0.587 . . . . 74.310000000000002 111.283 -173.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -104.77 90.38 0.71 Allowed Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.387 -0.685 . . . . 74.450000000000003 111.387 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.9 100.29 0.4 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.1 0.56 . . . . 74.409999999999997 109.656 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -157.77 136.55 11.41 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.094 0.557 . . . . 75.439999999999998 110.879 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -166.49 131.4 2.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.674 1.589 . . . . 73.129999999999995 107.051 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -72.08 -5.26 34.02 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 113.327 0.862 . . . . 72.239999999999995 113.327 -166.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 41.86 97.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 126.255 1.822 . . . . 62.009999999999998 115.462 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -83.1 99.81 10.12 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.948 0.499 . . . . 72.239999999999995 110.049 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -148.39 141.63 25.1 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.201 1.0 . . . . 72.340000000000003 110.722 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 . . . . . 0 N--CA 1.483 1.186 0 C-N-CA 123.202 0.601 . . . . 71.319999999999993 110.796 177.196 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 112.251 0.463 . . . . 75.310000000000002 112.251 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.0 -34.55 75.46 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.604 0.964 . . . . 70.209999999999994 113.604 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -51.85 -30.1 22.32 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.382 1.253 . . . . 75.450000000000003 114.382 -164.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -92.54 -42.54 9.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.865 0.866 . . . . 75.040000000000006 112.439 172.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.1 mt -53.87 -47.54 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 123.853 0.861 . . . . 75.120000000000005 111.524 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.3 m -61.06 -29.29 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.967 1.307 . . . . 73.329999999999998 112.356 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.04 -41.71 70.23 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.679 0.612 . . . . 72.510000000000005 112.7 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.54 -43.03 98.28 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.315 0.646 . . . . 63.530000000000001 111.262 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -67.51 -35.03 78.32 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.693 0.797 . . . . 73.340000000000003 111.633 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HB1' ' HG ' ' A' ' 46' ' ' LEU . . . -72.16 -35.03 68.92 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.496 0.718 . . . . 61.149999999999999 111.699 -177.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.54 -35.96 92.53 Favored Glycine 0 CA--C 1.539 1.535 0 O-C-N 123.497 0.498 . . . . 74.450000000000003 112.631 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.455 ' HB2' ' HZ2' ' A' ' 12' ' ' LYS . 3.7 ttmp? -67.74 -48.94 65.04 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.093 0.957 . . . . 75.040000000000006 111.64 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.93 -34.74 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.263 0.625 . . . . 73.409999999999997 111.9 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -71.03 -33.93 70.79 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.745 0.818 . . . . 75.299999999999997 110.959 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -66.92 -29.24 69.06 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 71.150000000000006 111.227 172.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.23 -31.35 67.46 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.991 0.516 . . . . 74.150000000000006 111.843 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.503 HD11 HG13 ' A' ' 52' ' ' VAL . 98.1 mt -59.35 -39.32 82.81 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.142 0.977 . . . . 73.340000000000003 113.521 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -11.54 58.79 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 112.445 0.535 . . . . 72.299999999999997 112.445 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -103.61 -39.3 6.76 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.499 1.12 . . . . 61.420000000000002 110.004 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.53 91.67 2.68 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.684 0.794 . . . . 73.140000000000001 112.624 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -85.14 133.89 34.19 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.095 0.558 . . . . 63.549999999999997 110.298 167.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.37 61.79 2.89 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-O 121.155 0.308 . . . . 74.409999999999997 112.733 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.6 tt -126.78 145.34 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.505 0.722 . . . . 72.010000000000005 110.975 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.4 m -68.09 138.43 55.76 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.904 0.881 . . . . 75.120000000000005 110.62 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.709 HG23 ' HB2' ' A' ' 40' ' ' ALA . 76.2 mt -58.36 -42.27 93.84 Favored Pre-proline 0 CA--C 1.583 2.221 0 N-CA-C 114.059 1.133 . . . . 64.040000000000006 114.059 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.491 ' HA ' HG23 ' A' ' 36' ' ' VAL . 29.8 Cg_endo -61.99 -32.36 84.29 Favored 'Trans proline' 0 C--N 1.394 2.961 0 C-N-CA 121.93 1.753 . . . . 75.099999999999994 114.123 174.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.17 -45.2 50.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.711 1.243 . . . . 74.109999999999999 109.47 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.56 HD23 HD12 ' A' ' 63' ' ' ILE . 66.7 tp -57.14 -38.89 74.15 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 112.75 -2.023 . . . . 75.400000000000006 111.818 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.17 78.05 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.323 1.049 . . . . 74.310000000000002 112.566 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.25 -42.85 87.98 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.255 0.622 . . . . 74.129999999999995 111.379 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -75.46 -35.13 60.93 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 112.473 0.546 . . . . 73.540000000000006 112.473 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 m -81.64 -9.89 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-O 120.772 0.32 . . . . 74.25 111.122 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 63.23 25.86 14.94 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.498 1.519 . . . . 73.109999999999999 113.203 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.3 mt -105.17 171.63 7.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.313 1.045 . . . . 74.450000000000003 109.887 173.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.7 m -68.07 158.98 31.78 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 122.551 0.34 . . . . 63.340000000000003 110.762 170.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 26' ' ' PRO . 79.5 t -51.23 -57.06 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 123.286 0.634 . . . . 75.450000000000003 112.095 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.65 -31.23 71.78 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.147 0.795 . . . . 73.140000000000001 113.147 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -61.67 -44.61 96.63 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.579 0.704 . . . . 74.530000000000001 110.881 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 43' ' ' VAL . 78.4 m -70.23 -41.57 73.42 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.629 -1.168 . . . . 73.129999999999995 111.385 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.709 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -67.5 -41.74 84.02 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.957 0.903 . . . . 64.349999999999994 112.071 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.06 -27.69 64.84 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.237 1.015 . . . . 75.010000000000005 110.518 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.85 -38.06 73.14 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.845 0.458 . . . . 70.530000000000001 111.261 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.52 HG11 HG21 ' A' ' 63' ' ' ILE . 90.3 t -61.88 -33.87 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.33 0.652 . . . . 75.329999999999998 110.089 169.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.48 90.17 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 115.918 -0.583 . . . . 73.340000000000003 113.802 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -67.92 -41.73 82.15 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.111 0.455 . . . . 74.010000000000005 110.229 173.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.405 ' HG ' ' HB1' ' A' ' 10' ' ' ALA . 97.3 mt -60.38 -38.21 83.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.051 0.541 . . . . 74.340000000000003 110.927 173.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.84 96.49 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.628 0.771 . . . . 62.340000000000003 111.522 175.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 -56.8 -45.01 82.48 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.88 0.472 . . . . 74.420000000000002 111.114 171.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.89 -6.03 56.65 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.217 0.821 . . . . 75.329999999999998 113.217 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 68.53 30.81 5.05 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.115 1.366 . . . . 74.219999999999999 112.417 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -95.78 -13.83 23.79 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.945 1.298 . . . . 73.109999999999999 113.597 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.503 HG13 HD11 ' A' ' 17' ' ' LEU . 8.0 m -120.93 141.39 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.252 0.549 . . . . 75.310000000000002 112.263 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.613 HG23 ' HB3' ' A' ' 68' ' ' HIS . 94.7 t -107.63 107.09 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 124.271 1.028 . . . . 72.540000000000006 109.815 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.556 HG13 HG23 ' A' ' 63' ' ' ILE . 2.9 mp -86.62 124.84 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 123.231 0.612 . . . . 63.240000000000002 110.001 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.23 116.0 13.06 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.755 0.822 . . . . 72.109999999999999 109.333 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -80.77 102.61 10.08 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.167 0.587 . . . . 73.150000000000006 110.029 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -112.74 124.98 53.81 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.481 0.712 . . . . 72.439999999999998 110.298 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 58.44 31.35 20.86 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.164 0.986 . . . . 74.519999999999996 112.112 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.06 -25.16 7.97 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 116.055 -0.521 . . . . 71.420000000000002 114.023 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.8 mt -79.14 146.22 33.28 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.905 0.882 . . . . 74.519999999999996 112.077 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.12 107.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.185 -0.672 . . . . 74.230000000000004 109.185 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.25 120.15 41.1 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.204 0.602 . . . . 74.209999999999994 109.725 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.56 HD12 HD23 ' A' ' 28' ' ' LEU . 2.7 pp -101.09 138.35 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.45 0.643 . . . . 71.120000000000005 111.032 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 93.5 m-85 -122.52 174.5 7.02 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.437 1.095 . . . . 75.420000000000002 110.19 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 63.6 t30 -90.64 158.28 17.02 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.91 0.484 . . . . 74.010000000000005 111.402 174.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.41 154.43 16.95 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.992 0.917 . . . . 75.349999999999994 112.179 173.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.1 62.02 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 115.396 -0.82 . . . . 63.210000000000001 112.594 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.613 ' HB3' HG23 ' A' ' 53' ' ' VAL . 48.8 t60 -74.84 -27.22 60.19 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.36 0.664 . . . . 75.150000000000006 110.832 175.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -95.79 143.57 26.91 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.309 0.643 . . . . 73.319999999999993 109.775 167.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.29 177.14 9.18 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.197 0.599 . . . . 61.350000000000001 112.047 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -103.93 92.49 4.42 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.193 0.597 . . . . 74.530000000000001 110.679 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.0 m -86.16 93.15 8.96 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.604 0.762 . . . . 60.520000000000003 111.58 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -90.49 91.21 8.35 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.919 0.488 . . . . 72.150000000000006 110.748 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.86 8.85 2.27 Favored Glycine 0 N--CA 1.478 1.488 0 CA-C-N 115.954 -0.566 . . . . 74.120000000000005 112.953 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.5 84.12 7.49 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.858 0.837 . . . . 72.340000000000003 111.592 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -79.55 90.85 5.13 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.217 -0.901 . . . . 74.540000000000006 109.397 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -82.43 95.94 7.83 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.315 -0.857 . . . . 72.319999999999993 109.945 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -89.92 48.18 1.55 Allowed 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.233 1.013 . . . . 74.540000000000006 110.983 -171.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -58.64 143.8 45.24 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.768 1.227 . . . . 74.510000000000005 113.717 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -131.51 -36.25 1.27 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.468 1.107 . . . . 73.450000000000003 110.479 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -101.21 129.36 47.12 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.459 0.704 . . . . 72.400000000000006 110.696 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.675 0.75 . . . . 70.519999999999996 110.23 177.926 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 121.028 0.442 . . . . 73.299999999999997 110.084 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.61 147.53 23.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.306 0.642 . . . . 71.329999999999998 110.678 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -69.35 -23.46 63.76 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 115.191 -0.913 . . . . 72.239999999999995 110.809 169.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -56.0 -24.35 38.4 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 124.37 1.068 . . . . 73.420000000000002 112.968 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 69.6 mt -55.63 -44.01 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 123.994 0.918 . . . . 71.430000000000007 111.322 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.71 -30.17 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 122.67 0.388 . . . . 75.109999999999999 111.461 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.32 92.15 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.485 0.491 . . . . 71.129999999999995 113.403 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.2 -38.11 87.2 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.641 0.776 . . . . 73.510000000000005 111.83 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -79.75 -19.62 48.27 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.159 0.583 . . . . 74.099999999999994 112.089 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.63 -39.5 52.16 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.305 0.642 . . . . 74.340000000000003 110.995 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.17 -30.92 75.09 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.435 -0.802 . . . . 75.439999999999998 112.472 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.608 ' HZ3' ' HB2' ' B' ' 12' ' ' LYS . 4.7 ttmp? -70.72 -49.32 48.24 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.054 0.942 . . . . 73.230000000000004 112.374 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.54 HG12 HD11 ' B' ' 46' ' ' LEU . 2.5 p -66.2 -36.01 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 112.158 0.429 . . . . 70.010000000000005 112.158 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.447 ' HA ' HD11 ' B' ' 17' ' ' LEU . 26.0 t90 -73.17 -32.21 64.71 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.991 -0.443 . . . . 74.349999999999994 111.132 176.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -62.47 -36.32 82.1 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.213 0.605 . . . . 73.519999999999996 110.524 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.63 -32.73 74.47 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.469 -0.787 . . . . 73.450000000000003 111.932 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.478 HD22 HD12 ' B' ' 63' ' ' ILE . 84.8 mt -69.16 -44.38 72.37 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.763 0.825 . . . . 75.129999999999995 111.777 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -56.77 -39.87 74.82 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.933 0.893 . . . . 73.340000000000003 111.79 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -74.02 -50.36 20.11 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.49 0.716 . . . . 71.140000000000001 110.817 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.83 102.91 0.9 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.828 0.851 . . . . 72.420000000000002 110.757 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.2 173.94 10.61 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.802 0.441 . . . . 63.229999999999997 111.47 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.99 65.25 1.77 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.559 -0.291 . . . . 51.439999999999998 112.554 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 tt -151.01 144.93 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.305 0.642 . . . . 72.439999999999998 110.389 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 31.4 t -70.82 150.29 45.97 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.188 0.595 . . . . 64.519999999999996 111.138 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.572 HG22 ' HB3' ' B' ' 40' ' ' ALA . 82.4 mt -58.39 -51.02 84.8 Favored Pre-proline 0 CA--C 1.576 1.959 0 CA-C-O 118.177 -0.916 . . . . 72.450000000000003 113.408 -176.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.449 ' HA ' HG23 ' B' ' 36' ' ' VAL . 20.3 Cg_endo -59.23 -34.77 98.24 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.233 1.956 . . . . 75.519999999999996 113.438 176.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -66.05 -50.92 62.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.326 0.65 . . . . 75.530000000000001 112.226 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.608 HD21 HD11 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -69.9 -32.55 70.94 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.714 0.406 . . . . 72.230000000000004 110.838 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.68 -41.63 77.64 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.887 0.875 . . . . 73.129999999999995 111.637 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -60.11 -40.19 88.83 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.092 0.957 . . . . 74.409999999999997 111.26 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -75.38 -33.13 61.0 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.964 0.906 . . . . 75.340000000000003 112.791 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.4 m -96.57 5.25 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 123.584 0.754 . . . . 72.340000000000003 111.897 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 t30 68.93 10.92 8.17 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 125.212 1.405 . . . . 73.140000000000001 112.642 173.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' B' ' 12' ' ' LYS . 54.0 mt -94.57 155.31 16.96 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.662 -0.649 . . . . 74.340000000000003 110.607 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 47.6 m -67.79 152.45 45.56 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.42 0.288 . . . . 74.319999999999993 110.499 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' B' ' 26' ' ' PRO . 64.1 t -51.69 -44.2 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.401 0.681 . . . . 74.239999999999995 111.329 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.96 -47.91 83.41 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 114.918 -1.037 . . . . 73.140000000000001 112.242 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -58.97 -41.37 87.39 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.975 0.91 . . . . 74.329999999999998 112.769 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 95.5 m -72.65 -46.68 52.74 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.332 0.653 . . . . 75.409999999999997 111.907 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' B' ' 25' ' ' ILE . . . -64.89 -48.61 73.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.0 1.111 . . . . 73.140000000000001 114.0 -168.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -26.53 62.38 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 120.796 0.332 . . . . 73.430000000000007 110.93 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.43 -26.33 65.47 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.697 0.799 . . . . 75.140000000000001 111.99 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.69 -31.65 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 123.005 0.522 . . . . 74.209999999999994 110.991 169.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.27 -28.36 73.65 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.308 -0.405 . . . . 73.120000000000005 113.99 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.543 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 66.0 t-105 -72.11 -27.52 62.69 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.143 0.577 . . . . 74.319999999999993 111.034 172.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.54 HD11 HG12 ' B' ' 13' ' ' VAL . 73.6 mt -73.22 -36.12 66.41 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.751 -0.593 . . . . 73.030000000000001 110.715 169.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.39 -26.88 68.65 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.46 1.104 . . . . 62.409999999999997 113.818 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 12.9 ptt180 -62.1 -35.85 79.94 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 118.817 0.735 . . . . 74.310000000000002 110.288 172.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 32.6 mt-10 -93.98 -6.27 45.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.819 1.248 . . . . 73.530000000000001 111.687 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 t30 63.08 31.21 16.02 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.841 1.256 . . . . 72.019999999999996 111.56 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -85.68 -6.5 59.13 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.865 0.691 . . . . 72.420000000000002 112.865 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.88 145.81 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.405 0.622 . . . . 72.329999999999998 112.356 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' B' ' 64' ' ' TYR . 4.8 m -120.08 128.61 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.048 1.339 . . . . 71.340000000000003 108.304 167.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.442 HG12 HG23 ' B' ' 63' ' ' ILE . 68.2 mt -109.29 137.82 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.928 0.491 . . . . 71.0 110.754 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -134.99 125.82 27.35 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.707 0.803 . . . . 74.400000000000006 109.565 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -108.01 115.5 30.25 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.493 0.663 . . . . 74.540000000000006 110.606 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.64 126.84 55.71 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.84 1.256 . . . . 74.439999999999998 109.173 -175.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 59.84 29.11 18.68 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.37 1.068 . . . . 71.230000000000004 111.525 -175.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.6 -19.1 16.18 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-N 116.343 -0.39 . . . . 65.049999999999997 113.808 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 tp -78.4 112.01 14.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.062 0.945 . . . . 73.430000000000007 110.455 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 mt -83.44 125.14 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 122.512 0.325 . . . . 74.120000000000005 110.848 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -127.42 145.75 50.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.703 0.801 . . . . 74.510000000000005 109.902 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.608 HD11 HD21 ' B' ' 28' ' ' LEU . 2.2 pp -105.83 141.25 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-O 121.552 0.691 . . . . 73.0 111.63 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.456 ' HB2' HG23 ' B' ' 53' ' ' VAL . 73.2 m-85 -132.13 157.14 45.01 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.502 1.121 . . . . 74.430000000000007 109.228 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -102.98 153.55 20.12 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.051 0.54 . . . . 60.340000000000003 110.421 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -17.93 61.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 112.224 0.453 . . . . 73.129999999999995 112.224 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.96 -33.38 87.02 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.264 0.353 . . . . 73.5 113.602 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -70.48 -37.06 74.18 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.524 0.73 . . . . 74.120000000000005 111.369 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -87.45 86.11 7.2 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.557 0.743 . . . . 74.340000000000003 110.291 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -140.4 133.98 30.16 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.373 0.669 . . . . 65.329999999999998 109.948 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -129.08 27.57 5.38 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 122.992 0.517 . . . . 74.510000000000005 111.234 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 46.7 t -67.52 -60.49 2.52 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 112.864 0.69 . . . . 72.310000000000002 112.864 -175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.05 170.98 15.54 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.468 0.707 . . . . 74.409999999999997 112.398 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.9 61.49 1.35 Allowed Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.637 -0.711 . . . . 72.109999999999999 111.714 -172.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.47 HD23 ' H ' ' B' ' 75' ' ' LEU . 2.2 pt? -122.18 146.48 47.21 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.965 0.906 . . . . 71.310000000000002 110.465 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.84 131.95 38.91 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.519 0.728 . . . . 73.340000000000003 110.639 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -88.71 -63.57 1.28 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.39 0.676 . . . . 72.400000000000006 109.354 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 57.21 87.42 0.06 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.938 1.295 . . . . 74.439999999999998 112.637 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -69.75 133.07 47.06 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.164 0.586 . . . . 65.030000000000001 111.199 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -105.53 128.28 53.49 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.047 0.939 . . . . 75.129999999999995 110.911 -173.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -75.13 133.58 41.47 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.95 0.5 . . . . 75.439999999999998 110.838 174.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 N--CA 1.479 1.012 0 C-N-CA 123.518 0.727 . . . . 73.299999999999997 110.317 175.089 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.46 0.171 . . . . 72.510000000000005 110.646 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.488 ' HB2' HG13 ' A' ' 5' ' ' ILE . 4.8 m-20 -66.65 156.48 35.09 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.718 0.807 . . . . 71.230000000000004 112.243 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -65.69 -25.09 67.17 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.807 -1.088 . . . . 74.540000000000006 111.484 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -77.32 -24.76 50.79 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.885 0.698 . . . . 73.010000000000005 112.885 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.488 HG13 ' HB2' ' A' ' 2' ' ' ASP . 59.4 mt -60.07 -42.74 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.264 0.626 . . . . 74.540000000000006 111.782 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.594 HG13 HD12 ' A' ' 41' ' ' LEU . 34.5 m -59.42 -33.6 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 111.77 0.285 . . . . 71.530000000000001 111.77 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.75 -39.53 93.62 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 123.213 0.321 . . . . 70.430000000000007 112.986 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.87 -50.51 62.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.254 0.622 . . . . 73.430000000000007 111.828 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -70.6 -31.96 69.14 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.352 0.661 . . . . 74.430000000000007 112.351 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.43 -33.24 60.9 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.856 0.462 . . . . 74.340000000000003 111.625 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.65 -31.35 79.68 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.922 -0.581 . . . . 74.400000000000006 113.265 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -75.25 -36.72 61.24 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.566 0.747 . . . . 75.420000000000002 111.549 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.8 t -63.29 -41.13 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.369 0.604 . . . . 74.040000000000006 110.92 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.411 ' CD1' ' HB3' ' A' ' 51' ' ' LYS . 77.6 t90 -72.26 -32.31 66.54 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.671 0.788 . . . . 73.230000000000004 111.54 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -61.79 -34.87 76.67 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.161 0.584 . . . . 75.420000000000002 110.679 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.99 -33.93 76.95 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.166 0.586 . . . . 73.129999999999995 111.753 174.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.404 HD13 HG13 ' A' ' 52' ' ' VAL . 92.2 mt -63.62 -27.34 69.17 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.635 0.774 . . . . 74.340000000000003 111.897 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.14 -35.04 77.46 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.299 0.64 . . . . 74.120000000000005 111.651 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -106.72 -65.84 1.06 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.528 0.731 . . . . 73.519999999999996 111.786 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . . . -127.53 84.54 2.26 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.452 0.644 . . . . 73.120000000000005 111.245 -175.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.73 -179.08 5.93 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.514 1.126 . . . . 74.439999999999998 112.972 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.17 52.36 48.01 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 115.698 -0.683 . . . . 74.219999999999999 113.247 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.407 HD13 ' HD2' ' A' ' 31' ' ' LYS . 13.7 tt -140.15 125.31 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.451 0.7 . . . . 75.209999999999994 110.719 -175.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.4 m -50.49 149.41 3.16 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.1 1.36 . . . . 72.519999999999996 113.31 -170.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 40' ' ' ALA . 80.6 mt -47.62 -48.89 58.22 Favored Pre-proline 0 CA--C 1.576 1.946 0 C-N-CA 124.414 1.086 . . . . 74.200000000000003 113.928 -172.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.495 ' HA ' HG23 ' A' ' 36' ' ' VAL . 48.7 Cg_endo -65.79 -37.6 27.11 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 121.847 1.698 . . . . 73.140000000000001 113.702 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -70.01 -46.92 64.09 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.46 1.124 . . . . 72.319999999999993 110.139 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.55 HD23 HG23 ' A' ' 63' ' ' ILE . 54.9 tp -57.61 -34.36 69.19 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 113.28 -1.782 . . . . 74.099999999999994 112.216 170.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 -38.12 82.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.031 0.532 . . . . 74.049999999999997 111.703 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -28.04 63.34 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 111.895 0.332 . . . . 74.439999999999998 111.895 173.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.466 ' HE2' ' HB3' ' A' ' 20' ' ' ALA . 26.8 mtpp -68.21 -45.87 72.16 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.016 0.436 . . . . 72.349999999999994 111.644 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.8 m -86.61 -1.91 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.178 0.591 . . . . 75.120000000000005 111.707 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.9 t30 65.92 27.07 10.93 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.147 1.379 . . . . 75.329999999999998 111.767 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.6 mt -114.99 173.05 6.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.098 0.959 . . . . 74.209999999999994 111.759 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 t -68.12 155.6 39.25 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.324 0.65 . . . . 63.030000000000001 111.869 170.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 26' ' ' PRO . 62.2 t -55.44 -41.42 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.484 0.714 . . . . 74.099999999999994 110.641 172.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.17 -49.0 79.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.66 -1.155 . . . . 63.539999999999999 111.427 176.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.8 m -58.18 -43.39 87.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.107 0.963 . . . . 72.409999999999997 111.464 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 43' ' ' VAL . 85.4 m -69.72 -48.06 60.88 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.104 -0.953 . . . . 73.219999999999999 111.811 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.439 ' HB2' HG22 ' A' ' 25' ' ' ILE . . . -62.09 -38.77 90.12 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 123.459 0.703 . . . . 72.230000000000004 112.32 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.594 HD12 HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -66.85 -40.83 88.05 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.798 1.239 . . . . 75.540000000000006 110.213 174.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.65 -34.73 74.41 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.488 0.715 . . . . 72.5 112.2 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 39' ' ' THR . 81.0 t -67.0 -32.95 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.56 0.744 . . . . 73.120000000000005 110.405 173.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.603 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -66.97 -33.34 83.57 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.141 -0.482 . . . . 70.0 113.316 173.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -69.35 -38.18 78.0 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.876 0.471 . . . . 63.420000000000002 110.644 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 51' ' ' LYS . 76.5 mt -67.57 -30.52 70.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.819 0.448 . . . . 72.450000000000003 111.437 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.29 75.35 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.309 0.643 . . . . 73.209999999999994 112.133 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -62.36 -49.64 74.77 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 122.886 0.474 . . . . 74.349999999999994 110.953 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -80.05 -8.86 59.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.513 -0.767 . . . . 74.209999999999994 111.547 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 72' ' ' SER . 19.9 m-80 63.42 27.04 15.13 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.9 1.28 . . . . 64.430000000000007 111.911 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 39.9 mmtm -69.86 -17.92 63.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.527 1.131 . . . . 71.310000000000002 112.308 175.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.404 HG13 HD13 ' A' ' 17' ' ' LEU . 34.6 m -129.24 154.48 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.145 0.578 . . . . 72.219999999999999 112.387 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 64' ' ' TYR . 34.9 m -120.77 132.27 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.494 0.718 . . . . 75.420000000000002 109.077 165.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 mm -110.45 123.63 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.206 0.602 . . . . 75.349999999999994 111.412 -173.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 49.5 mt-10 -106.16 155.62 19.27 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.166 0.586 . . . . 74.209999999999994 111.367 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.21 94.04 4.78 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.817 -1.549 . . . . 74.519999999999996 106.817 160.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.86 111.7 24.46 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.718 0.807 . . . . 75.329999999999998 108.886 -173.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 60.35 30.35 19.75 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.285 1.034 . . . . 74.129999999999995 110.114 -161.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.6 -12.98 25.26 Favored Glycine 0 C--N 1.36 1.904 0 CA-C-N 115.506 -0.77 . . . . 62.43 114.422 -173.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.79 117.48 19.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.299 0.64 . . . . 73.329999999999998 111.269 -177.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 67.1 mt -69.21 116.05 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.791 0.836 . . . . 75.450000000000003 111.254 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -126.01 140.49 52.56 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.891 0.876 . . . . 74.409999999999997 110.983 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.55 HG23 HD23 ' A' ' 28' ' ' LEU . 7.2 tt -92.74 133.17 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 124.235 1.014 . . . . 74.439999999999998 111.017 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.414 ' HB2' HG23 ' A' ' 53' ' ' VAL . 73.0 m-85 -131.63 173.22 11.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.492 1.117 . . . . 75.340000000000003 110.323 173.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -73.62 150.5 41.33 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.346 0.658 . . . . 72.439999999999998 111.196 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . 7.5 pt-20 -37.99 -53.52 1.36 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.843 1.257 . . . . 64.400000000000006 113.607 171.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.13 -82.83 0.01 OUTLIER Glycine 0 C--N 1.354 1.558 0 N-CA-C 115.223 0.849 . . . . 74.510000000000005 115.223 171.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -119.34 -20.2 7.97 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.025 0.93 . . . . 71.5 111.979 -172.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -112.04 33.34 4.89 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.822 0.849 . . . . 75.5 111.839 -171.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.5 p-10 -79.77 9.57 5.04 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.696 0.998 . . . . 72.420000000000002 113.696 -176.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -67.21 98.92 0.64 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.47 0.708 . . . . 73.420000000000002 111.616 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.466 ' HA ' ' ND2' ' A' ' 50' ' ' ASN . 67.5 p -88.43 12.74 13.47 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.907 0.883 . . . . 73.450000000000003 112.938 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -86.52 101.59 13.33 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.098 0.559 . . . . 63.5 110.846 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.46 ' H ' HD12 ' A' ' 75' ' ' LEU . . . 168.75 78.27 0.04 OUTLIER Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.388 -0.369 . . . . 75.420000000000002 112.453 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.46 HD12 ' H ' ' A' ' 74' ' ' GLY . 4.6 mp -120.36 100.79 7.37 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.718 0.807 . . . . 74.120000000000005 110.452 -176.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -141.15 119.14 11.9 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.036 0.446 . . . . 63.32 111.752 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -128.38 163.25 25.27 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.651 1.18 . . . . 74.409999999999997 109.57 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -65.57 131.55 46.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.889 0.475 . . . . 74.439999999999998 111.107 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -140.88 49.28 1.68 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.575 0.703 . . . . 61.229999999999997 111.875 -174.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -121.93 133.98 54.85 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.402 -0.592 . . . . 73.209999999999994 109.402 173.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -67.92 -4.06 11.76 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 114.388 1.255 . . . . 75.099999999999994 114.388 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 21.0 m80 . . . . . 0 N--CA 1.493 1.686 0 C-N-CA 124.288 1.035 . . . . 75.209999999999994 110.775 169.341 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 C--O 1.24 0.594 0 N-CA-C 111.63 0.233 . . . . 73.340000000000003 111.63 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -58.3 -33.66 69.7 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.2 0.6 . . . . 70.219999999999999 112.598 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -27.91 68.47 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.092 0.957 . . . . 64.030000000000001 112.965 -171.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -84.05 -44.29 14.25 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.473 0.709 . . . . 74.400000000000006 111.034 173.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.66 -45.56 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.815 0.846 . . . . 74.140000000000001 111.93 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.505 HG11 HD12 ' B' ' 41' ' ' LEU . 34.8 m -61.28 -32.16 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.753 0.821 . . . . 74.230000000000004 112.157 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.83 62.26 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.27 0.356 . . . . 74.209999999999994 112.647 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.74 -45.78 88.34 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.589 0.756 . . . . 75.239999999999995 111.883 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -64.67 -41.08 96.32 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.773 0.829 . . . . 72.439999999999998 111.799 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.95 -31.3 70.08 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.885 0.474 . . . . 72.209999999999994 111.646 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.59 -38.38 96.2 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.847 -0.615 . . . . 72.349999999999994 112.882 174.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -75.1 -36.65 61.67 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.71 0.804 . . . . 71.310000000000002 111.434 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.565 ' HA ' HG13 ' B' ' 32' ' ' VAL . 92.7 t -67.63 -42.71 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.135 0.574 . . . . 63.450000000000003 111.368 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.471 ' HA ' HD11 ' B' ' 17' ' ' LEU . 19.5 t90 -68.56 -33.23 73.72 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.984 -0.553 . . . . 75.140000000000001 110.521 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . 0.401 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 66.3 t60 -62.34 -31.41 72.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.715 0.806 . . . . 72.5 111.638 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.43 67.31 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.706 0.402 . . . . 54.310000000000002 111.868 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.471 HD11 ' HA ' ' B' ' 14' ' ' TRP . 98.5 mt -64.14 -45.04 90.29 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.838 0.855 . . . . 73.329999999999998 113.137 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -12.77 61.88 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 111.733 0.272 . . . . 62.350000000000001 111.733 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 20.4 mm-40 -81.08 -57.71 3.4 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.398 0.679 . . . . 74.310000000000002 109.753 171.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.16 105.15 3.19 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.5 0.72 . . . . 73.140000000000001 110.756 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.95 168.56 14.06 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.723 0.809 . . . . 64.439999999999998 111.458 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.26 64.98 2.09 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 112.477 -0.249 . . . . 71.319999999999993 112.477 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.439 ' O ' HG22 ' B' ' 63' ' ' ILE . 18.1 tt -146.32 156.22 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 C-N-CA 123.663 0.785 . . . . 72.219999999999999 110.303 -175.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -81.18 156.64 25.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.806 -0.559 . . . . 74.510000000000005 111.547 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.543 HG22 ' HB1' ' B' ' 40' ' ' ALA . 59.8 mt -58.84 -48.37 96.93 Favored Pre-proline 0 CA--C 1.577 1.994 0 N-CA-C 113.598 0.962 . . . . 75.040000000000006 113.598 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.495 ' HA ' HG21 ' B' ' 36' ' ' VAL . 55.1 Cg_endo -66.41 -23.9 50.44 Favored 'Trans proline' 0 C--N 1.395 3.001 0 CA-C-N 121.951 1.733 . . . . 71.329999999999998 114.138 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.19 -46.36 18.06 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.015 0.912 . . . . 64.209999999999994 109.608 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.557 HD23 HG23 ' B' ' 63' ' ' ILE . 59.0 tp -58.23 -34.45 70.45 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 113.735 -1.575 . . . . 74.420000000000002 111.681 173.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.15 85.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.951 0.9 . . . . 65.219999999999999 111.898 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -69.33 -40.33 77.65 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.603 0.761 . . . . 75.010000000000005 110.349 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -62.34 -35.69 79.88 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.568 0.747 . . . . 72.400000000000006 111.741 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' B' ' 13' ' ' VAL . 19.6 m -97.52 -1.24 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.074 0.55 . . . . 72.420000000000002 112.457 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 69.38 11.12 8.02 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.853 1.261 . . . . 74.329999999999998 112.575 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt -101.37 171.15 7.76 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.421 0.688 . . . . 75.239999999999995 111.351 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 29.7 t -66.07 154.23 40.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.909 0.484 . . . . 60.520000000000003 111.144 169.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' B' ' 26' ' ' PRO . 55.0 t -56.84 -40.16 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.247 0.619 . . . . 73.129999999999995 111.096 177.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.08 -43.79 77.76 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.404 -0.816 . . . . 74.310000000000002 111.839 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -61.04 -32.29 71.91 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.464 0.706 . . . . 74.409999999999997 111.798 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.429 ' O ' HG22 ' B' ' 43' ' ' VAL . 74.5 m -80.74 -47.86 13.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.078 0.951 . . . . 73.0 111.496 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.543 ' HB1' HG22 ' B' ' 25' ' ' ILE . . . -64.1 -40.2 95.7 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.603 0.761 . . . . 75.310000000000002 112.41 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.505 HD12 HG11 ' B' ' 6' ' ' VAL . 1.1 tm? -64.2 -34.95 79.27 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 124.813 1.245 . . . . 64.010000000000005 110.368 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.0 -33.52 61.84 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.617 0.767 . . . . 71.120000000000005 112.11 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.429 HG22 ' O ' ' B' ' 39' ' ' THR . 54.3 t -62.53 -37.56 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.784 0.834 . . . . 72.319999999999993 110.361 172.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.603 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -64.38 -30.42 77.81 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-N 116.057 -0.519 . . . . 70.129999999999995 113.63 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.469 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 67.3 t-105 -74.1 -31.3 62.73 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.805 0.442 . . . . 74.310000000000002 111.304 175.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 96.2 mt -72.18 -38.19 69.14 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.813 0.445 . . . . 73.329999999999998 110.808 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.32 -28.82 69.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.094 0.958 . . . . 74.420000000000002 112.049 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 26.2 ttt-85 -53.34 -49.47 67.04 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.652 0.781 . . . . 75.129999999999995 110.841 168.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -94.46 6.15 49.64 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.903 0.881 . . . . 65.239999999999995 112.739 -175.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.38 23.8 14.13 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 124.66 1.184 . . . . 75.540000000000006 113.255 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -80.35 -0.67 37.86 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.17 0.804 . . . . 72.439999999999998 113.17 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.05 147.99 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.667 0.787 . . . . 72.510000000000005 111.739 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.745 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 39.0 t -106.77 118.99 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.567 0.747 . . . . 71.129999999999995 109.007 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 46.6 mm -113.59 130.79 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 123.129 0.572 . . . . 70.129999999999995 111.296 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -133.79 132.68 40.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.621 0.768 . . . . 74.340000000000003 111.06 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -88.04 103.91 16.16 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.253 0.621 . . . . 73.019999999999996 110.976 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -110.38 112.49 24.46 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.356 1.062 . . . . 75.219999999999999 110.006 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 62.03 30.4 17.92 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.921 1.289 . . . . 74.549999999999997 112.523 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.82 -15.59 60.28 Favored Glycine 0 CA--C 1.543 1.841 0 CA-C-N 116.458 -0.337 . . . . 75.519999999999996 113.717 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 mp -93.37 147.02 23.3 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.998 0.919 . . . . 74.25 111.059 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mm -82.64 126.96 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.164 0.586 . . . . 74.349999999999994 111.394 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -110.5 122.44 47.74 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.21 1.004 . . . . 65.239999999999995 109.459 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.557 HG23 HD23 ' B' ' 28' ' ' LEU . 10.2 tt -108.49 139.01 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.408 0.623 . . . . 74.310000000000002 111.829 -175.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.745 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 90.9 m-85 -128.53 170.41 13.23 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.459 1.104 . . . . 74.420000000000002 110.523 176.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -91.04 162.4 14.72 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.552 0.741 . . . . 73.129999999999995 110.226 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -170.28 1.83 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 122.837 0.455 . . . . 73.409999999999997 111.469 172.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.49 16.86 78.87 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 111.625 -0.59 . . . . 52.340000000000003 111.625 -160.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -115.17 -40.11 3.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.412 1.085 . . . . 75.439999999999998 111.033 -171.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -69.0 141.21 54.95 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.247 0.619 . . . . 63.450000000000003 111.442 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.86 160.46 28.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.731 0.812 . . . . 72.219999999999999 112.78 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -81.94 15.62 2.2 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.425 0.69 . . . . 64.230000000000004 112.676 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 53.8 p -65.9 99.08 0.46 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.116 0.966 . . . . 71.519999999999996 111.479 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -87.05 159.77 18.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.226 0.61 . . . . 72.549999999999997 111.017 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.39 -129.69 1.88 Allowed Glycine 0 N--CA 1.475 1.269 0 CA-C-N 116.432 -0.349 . . . . 52.009999999999998 113.251 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.47 -16.67 26.91 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.313 0.645 . . . . 74.219999999999999 110.604 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -72.94 99.88 2.81 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.523 1.129 . . . . 72.239999999999995 110.287 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -100.6 149.85 23.31 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.68 1.192 . . . . 70.439999999999998 110.954 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -83.77 82.1 8.47 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.667 0.746 . . . . 73.329999999999998 111.814 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -93.53 37.54 1.06 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.026 0.917 . . . . 74.540000000000006 110.549 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -135.2 134.94 40.61 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.799 0.84 . . . . 75.430000000000007 109.802 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -100.96 109.68 21.63 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.576 0.75 . . . . 75.340000000000003 110.823 -173.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 7.1 t60 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.46 0.647 . . . . 75.219999999999999 109.834 177.817 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.669 0.271 . . . . 75.109999999999999 110.992 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.84 -34.76 71.94 Favored 'General case' 0 C--O 1.206 -1.225 0 N-CA-C 114.877 1.436 . . . . 65.230000000000004 114.877 -171.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -53.46 -32.78 51.53 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 115.013 1.486 . . . . 64.400000000000006 115.013 -169.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -79.9 -39.74 29.76 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.605 0.362 . . . . 74.109999999999999 111.747 173.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.07 -50.93 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.539 0.736 . . . . 72.319999999999993 111.117 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.412 HG12 HD12 ' A' ' 41' ' ' LEU . 6.3 m -73.66 -27.71 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.787 1.235 . . . . 71.340000000000003 111.418 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.39 -35.67 87.75 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 112.421 -0.272 . . . . 64.209999999999994 112.421 171.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.79 -56.16 5.32 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.564 0.746 . . . . 63.25 111.954 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -71.12 -22.76 62.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.951 0.723 . . . . 73.25 112.951 -173.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HA ' HG21 ' A' ' 13' ' ' VAL . . . -67.14 -26.68 66.79 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.623 0.369 . . . . 64.219999999999999 111.12 174.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.67 -36.19 92.03 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.11 -0.496 . . . . 72.430000000000007 112.861 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -76.86 -41.99 41.78 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.564 0.746 . . . . 73.519999999999996 112.303 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.604 HG21 ' HA ' ' A' ' 10' ' ' ALA . 12.4 m -69.83 -34.93 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 122.141 -0.349 . . . . 74.129999999999995 110.82 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -71.67 -32.62 68.07 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.238 0.615 . . . . 74.129999999999995 111.083 172.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -61.54 -46.42 89.99 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.706 0.403 . . . . 74.129999999999995 110.967 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . . . -66.74 -34.58 78.16 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.913 0.885 . . . . 74.239999999999995 111.46 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.37 -45.45 72.75 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.609 1.164 . . . . 73.519999999999996 111.299 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -75.53 -25.76 57.47 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.358 0.663 . . . . 74.109999999999999 110.703 -175.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -71.25 -41.3 70.28 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.029 0.932 . . . . 74.230000000000004 110.283 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.9 107.03 2.28 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.657 0.783 . . . . 73.349999999999994 110.261 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.13 179.32 5.11 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.683 0.793 . . . . 71.349999999999994 112.363 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.51 56.43 7.58 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 111.956 -0.458 . . . . 45.130000000000003 111.956 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.476 HG13 ' HB2' ' A' ' 28' ' ' LEU . 9.4 tp -130.3 125.54 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 123.359 0.664 . . . . 73.439999999999998 110.768 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -80.57 153.59 27.97 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.215 0.606 . . . . 74.430000000000007 111.117 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 40' ' ' ALA . 62.5 mt -52.06 -53.3 53.37 Favored Pre-proline 0 CA--C 1.577 2.003 0 N-CA-C 114.324 1.231 . . . . 70.439999999999998 114.324 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.12 -21.88 23.28 Favored 'Trans proline' 0 C--N 1.39 2.753 0 CA-C-N 121.197 1.463 . . . . 74.230000000000004 114.179 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -78.59 -44.7 23.42 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 122.107 0.956 . . . . 74.319999999999993 109.326 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.476 ' HB2' HG13 ' A' ' 23' ' ' ILE . 50.3 tp -57.2 -37.48 72.24 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 113.524 -1.671 . . . . 73.219999999999999 111.149 172.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.56 -39.79 85.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.991 0.916 . . . . 62.210000000000001 112.005 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -73.21 -34.21 65.81 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.316 0.646 . . . . 75.239999999999995 111.48 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.52 ' HE2' ' HB3' ' A' ' 16' ' ' ALA . 55.5 mtpt -62.87 -44.11 96.99 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.323 0.649 . . . . 74.140000000000001 111.182 175.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 13' ' ' VAL . 19.2 m -93.05 -4.02 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.592 0.757 . . . . 72.109999999999999 112.315 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 68.67 13.89 8.95 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.272 1.429 . . . . 74.319999999999993 113.532 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 73.1 mt -95.9 170.65 9.15 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.377 0.671 . . . . 74.340000000000003 111.228 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -67.1 150.74 48.75 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.212 0.605 . . . . 74.200000000000003 111.538 170.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.8 t -56.11 -43.63 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.597 0.759 . . . . 75.409999999999997 111.14 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -60.74 -45.62 93.61 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.388 -0.824 . . . . 72.430000000000007 112.0 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.5 m -65.98 -30.79 71.4 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.453 0.701 . . . . 74.420000000000002 112.009 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -80.17 -39.26 29.65 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.474 0.71 . . . . 74.030000000000001 111.654 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.46 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -64.75 -38.74 92.0 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.67 0.748 . . . . 75.219999999999999 111.076 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 HG12 ' A' ' 6' ' ' VAL . 1.2 tm? -69.82 -38.01 76.42 Favored 'General case' 0 CA--C 1.562 1.44 0 CA-C-N 114.184 -1.371 . . . . 74.099999999999994 110.743 175.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.59 -39.62 84.81 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 122.995 0.518 . . . . 74.420000000000002 111.655 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.2 -38.51 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.905 0.882 . . . . 72.310000000000002 111.176 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.36 -33.0 86.08 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.365 -0.38 . . . . 75.25 112.823 174.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.428 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 74.1 t-105 -69.4 -40.53 77.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.548 0.739 . . . . 74.299999999999997 110.352 174.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.71 -32.92 74.54 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.948 0.499 . . . . 73.349999999999994 111.796 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.6 89.5 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.387 0.675 . . . . 63.32 110.968 171.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 12.4 ttt180 -59.69 -50.18 74.87 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.078 0.551 . . . . 74.409999999999997 111.216 168.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 45' ' ' TRP . 8.7 mm-40 -76.13 -1.43 26.14 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.917 0.887 . . . . 71.430000000000007 112.706 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.12 33.77 19.29 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.86 1.264 . . . . 73.219999999999999 112.526 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -93.28 -23.21 18.58 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.106 0.962 . . . . 73.109999999999999 112.25 177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.09 157.2 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 113.416 0.895 . . . . 64.450000000000003 113.416 -173.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 64' ' ' TYR . 2.3 m -133.4 144.21 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.162 1.385 . . . . 74.340000000000003 110.123 175.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.701 HG12 HD11 ' B' ' 41' ' ' LEU . 2.6 mp -108.82 128.3 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.609 0.763 . . . . 75.25 111.067 -171.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -115.21 119.09 35.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.457 1.103 . . . . 72.230000000000004 109.833 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HB2' ' SD ' ' B' ' 1' ' ' MET . 98.6 mtt180 -100.38 125.72 46.67 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.104 0.478 . . . . 74.409999999999997 111.156 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.87 131.11 13.6 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.979 0.912 . . . . 72.329999999999998 109.951 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 60.3 28.51 18.12 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.781 1.232 . . . . 75.430000000000007 111.802 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.49 -8.26 62.33 Favored Glycine 0 CA--C 1.544 1.844 0 N-CA-C 113.87 0.308 . . . . 71.219999999999999 113.87 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.38 160.91 14.05 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.95 0.9 . . . . 75.209999999999994 111.358 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.636 HG21 HG23 ' A' ' 54' ' ' ILE . 78.9 mt -112.64 127.96 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.866 0.866 . . . . 73.430000000000007 110.705 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -112.57 140.97 46.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.999 0.92 . . . . 74.530000000000001 109.544 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.85 133.76 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.018 0.927 . . . . 75.430000000000007 108.726 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.456 ' HB2' HG21 ' A' ' 53' ' ' VAL . 88.6 m-85 -129.91 169.31 15.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.91 1.284 . . . . 75.409999999999997 109.84 177.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -85.97 138.22 32.15 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.143 0.577 . . . . 65.219999999999999 110.311 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.25 10.84 4.01 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-O 121.457 0.646 . . . . 74.030000000000001 112.125 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.664 ' HA2' ' HB2' ' A' ' 71' ' ' PHE . . . -60.0 -11.18 17.19 Favored Glycine 0 CA--C 1.541 1.692 0 N-CA-C 114.376 0.511 . . . . 71.409999999999997 114.376 169.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.57 -48.99 79.33 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.941 0.896 . . . . 74.310000000000002 111.535 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -86.13 -79.62 0.25 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.491 0.717 . . . . 72.230000000000004 111.146 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.11 120.9 13.47 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.902 0.881 . . . . 74.040000000000006 109.057 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.664 ' HB2' ' HA2' ' A' ' 67' ' ' GLY . 53.8 t80 -118.03 130.28 56.07 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.264 0.554 . . . . 65.430000000000007 110.952 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 p -137.01 161.97 34.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.467 1.107 . . . . 72.299999999999997 109.522 171.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.8 t80 66.32 111.19 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.661 1.184 . . . . 75.420000000000002 111.501 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -134.71 123.19 3.09 Favored Glycine 0 C--N 1.345 1.047 0 C-N-CA 123.282 0.468 . . . . 73.340000000000003 112.086 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.2 mp -70.01 117.14 11.2 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.928 0.891 . . . . 73.030000000000001 110.103 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.64 -172.99 3.0 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.524 0.564 . . . . 63.329999999999998 112.524 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -79.77 116.89 20.2 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.063 0.945 . . . . 74.120000000000005 110.911 -170.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -92.02 -6.99 50.08 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.281 0.632 . . . . 73.510000000000005 112.404 -177.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 69.99 -67.31 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.632 1.573 . . . . 74.519999999999996 111.867 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -81.45 145.82 30.56 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.217 0.607 . . . . 71.049999999999997 110.407 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -65.73 123.98 21.18 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.734 0.814 . . . . 72.099999999999994 112.57 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.9 m170 . . . . . 0 N--CA 1.484 1.246 0 C-N-CA 124.91 1.284 . . . . 74.310000000000002 109.76 171.829 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 56' ' ' ARG . 18.6 ttt . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 110.068 -0.345 . . . . 64.25 110.068 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.544 ' HB2' HG13 ' B' ' 5' ' ' ILE . 21.9 m-20 -63.28 126.31 27.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.814 0.445 . . . . 71.430000000000007 111.804 -175.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.409 ' O ' HG23 ' B' ' 6' ' ' VAL . 87.7 tttt -73.62 -12.46 60.75 Favored 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 123.665 0.786 . . . . 65.0 110.679 174.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.36 -26.99 65.86 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.071 0.948 . . . . 75.239999999999995 111.935 173.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.544 HG13 ' HB2' ' B' ' 2' ' ' ASP . 88.4 mt -59.11 -43.18 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.525 0.73 . . . . 72.340000000000003 111.712 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 3' ' ' LYS . 25.5 m -65.36 -28.91 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-N 117.641 0.201 . . . . 64.420000000000002 111.319 176.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' B' ' 45' ' ' TRP . . . -67.74 -46.36 68.64 Favored Glycine 0 C--N 1.354 1.534 0 O-C-N 123.519 0.512 . . . . 72.430000000000007 113.7 175.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.48 99.12 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.646 0.778 . . . . 63.539999999999999 111.162 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -70.34 -30.58 67.57 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.944 0.898 . . . . 64.049999999999997 112.238 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.7 66.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.066 0.546 . . . . 74.519999999999996 111.371 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.81 -36.23 93.07 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 116.006 -0.543 . . . . 63.509999999999998 112.839 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -70.11 -43.32 71.26 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.315 1.046 . . . . 75.409999999999997 111.155 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.598 ' HA ' HG13 ' B' ' 32' ' ' VAL . 42.9 t -60.48 -46.37 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 124.257 1.023 . . . . 72.329999999999998 111.727 176.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.562 ' HA ' HD11 ' B' ' 17' ' ' LEU . 66.8 t90 -66.97 -33.61 75.95 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.851 -0.613 . . . . 64.209999999999994 112.056 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -64.38 -35.15 79.97 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.812 0.445 . . . . 63.149999999999999 110.645 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.499 ' HB3' ' HE3' ' B' ' 31' ' ' LYS . . . -72.02 -23.87 61.46 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.663 0.785 . . . . 74.340000000000003 112.833 174.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' B' ' 14' ' ' TRP . 84.9 mt -70.2 -47.08 63.09 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.57 0.748 . . . . 74.349999999999994 110.692 169.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.87 -28.29 67.41 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.554 0.742 . . . . 70.099999999999994 111.305 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -72.22 -51.43 21.09 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.048 0.939 . . . . 75.120000000000005 110.396 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.47 118.37 2.21 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.079 0.551 . . . . 75.519999999999996 112.127 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -82.72 -178.06 6.95 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.301 1.04 . . . . 64.310000000000002 112.04 172.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.07 26.16 73.03 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.823 -0.626 . . . . 71.530000000000001 112.242 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 tp -106.76 146.4 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 124.042 0.937 . . . . 73.129999999999995 109.715 -173.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -95.0 162.37 13.76 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.31 0.644 . . . . 63.530000000000001 109.922 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' B' ' 40' ' ' ALA . 76.4 mt -56.35 -49.1 95.34 Favored Pre-proline 0 CA--C 1.58 2.118 0 N-CA-C 114.025 1.12 . . . . 70.209999999999994 114.025 -173.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.69 -30.31 42.01 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.027 1.818 . . . . 73.219999999999999 114.106 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -79.12 -42.35 26.47 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.203 1.001 . . . . 75.329999999999998 110.442 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.44 HD22 HG13 ' B' ' 13' ' ' VAL . 65.7 tp -58.04 -40.66 81.49 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.625 -1.625 . . . . 70.319999999999993 111.112 170.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.24 78.61 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.928 0.891 . . . . 72.150000000000006 111.83 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -67.03 -37.62 84.44 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.166 0.587 . . . . 74.430000000000007 111.51 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' B' ' 16' ' ' ALA . 44.4 mtmt -66.79 -39.95 87.95 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.826 0.45 . . . . 73.120000000000005 111.315 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' B' ' 13' ' ' VAL . 33.9 m -96.09 7.14 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.823 0.675 . . . . 71.25 112.823 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 65.8 t30 65.33 12.38 8.04 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.176 0.99 . . . . 75.310000000000002 112.783 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 59.8 mt -97.11 168.59 10.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.674 -0.641 . . . . 72.329999999999998 110.747 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 68.3 m -74.68 159.8 31.6 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.597 0.359 . . . . 73.349999999999994 110.998 170.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 70.1 t -52.49 -57.72 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.303 1.041 . . . . 60.5 112.589 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -68.61 -30.52 69.27 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.639 0.775 . . . . 73.219999999999999 111.669 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 56.0 m -61.17 -39.82 91.56 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.733 0.813 . . . . 74.340000000000003 111.408 173.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.428 ' O ' HG22 ' B' ' 43' ' ' VAL . 90.4 m -76.72 -42.37 41.55 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.722 0.809 . . . . 65.129999999999995 111.536 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.487 ' HB2' HG23 ' B' ' 25' ' ' ILE . . . -59.6 -39.74 85.21 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 123.81 0.844 . . . . 73.030000000000001 111.921 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 54' ' ' ILE . 1.1 tt -60.41 -50.32 74.07 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.808 1.243 . . . . 75.549999999999997 110.009 173.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 -27.06 68.65 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 114.843 -1.071 . . . . 63.119999999999997 112.089 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.428 HG22 ' O ' ' B' ' 39' ' ' THR . 65.7 t -68.48 -39.96 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 123.388 0.675 . . . . 75.239999999999995 110.649 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -66.12 -27.8 73.19 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-N 116.379 -0.373 . . . . 74.109999999999999 113.07 174.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' TRP . . . . . 0.51 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 64.6 t-105 -74.82 -32.22 61.9 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.494 0.718 . . . . 73.230000000000004 111.466 173.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.58 -27.15 62.95 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.243 0.617 . . . . 65.239999999999995 111.765 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.02 67.96 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 113.199 0.814 . . . . 51.399999999999999 113.199 172.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 36.8 ptt85 -74.31 -29.18 61.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.861 -0.524 . . . . 73.420000000000002 110.968 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . 0.494 ' HB3' ' HE2' ' B' ' 51' ' ' LYS . 21.7 mm-40 -72.22 -22.78 61.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.056 0.942 . . . . 73.120000000000005 112.359 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 59.41 35.06 22.94 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.275 1.03 . . . . 74.310000000000002 112.452 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.494 ' HE2' ' HB3' ' B' ' 49' ' ' GLU . 51.3 mtmt -108.49 0.44 20.94 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.683 0.623 . . . . 74.420000000000002 112.683 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.52 147.93 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 112.644 0.609 . . . . 75.430000000000007 112.644 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.66 108.25 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.798 0.839 . . . . 72.010000000000005 109.807 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 2.6 mp -89.97 112.34 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 108.499 -0.926 . . . . 73.420000000000002 108.499 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -102.21 126.51 49.21 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.835 0.454 . . . . 70.030000000000001 110.352 174.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -90.79 96.29 10.56 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.356 -0.979 . . . . 75.030000000000001 108.356 168.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -104.78 109.33 21.23 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.903 1.281 . . . . 71.540000000000006 109.093 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 55.15 29.16 12.12 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.559 1.144 . . . . 75.109999999999999 111.004 -164.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.17 -20.73 35.11 Favored Glycine 0 CA--C 1.549 2.197 0 CA-C-N 115.478 -0.783 . . . . 71.430000000000007 114.58 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.73 130.15 34.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 117.821 0.811 . . . . 65.340000000000003 111.83 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -84.05 114.96 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 123.458 0.703 . . . . 72.120000000000005 111.508 -173.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.28 142.94 46.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.017 0.927 . . . . 74.25 109.107 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 6.4 tp -106.74 128.3 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 CA-C-O 121.607 0.717 . . . . 72.140000000000001 110.709 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -126.63 171.48 11.1 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.692 1.197 . . . . 73.099999999999994 110.001 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.479 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 39.4 t30 -100.51 152.54 20.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.444 1.098 . . . . 74.239999999999995 108.889 170.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -61.45 -41.22 96.88 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.819 0.847 . . . . 75.420000000000002 112.545 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.71 3.42 49.81 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 114.923 0.729 . . . . 64.329999999999998 114.923 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -72.42 -49.69 31.8 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.643 0.777 . . . . 72.099999999999994 111.914 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.55 120.99 22.52 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.43 0.692 . . . . 73.25 111.581 -171.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -129.38 156.78 43.51 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.43 0.692 . . . . 73.120000000000005 110.718 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -76.11 -18.22 59.25 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.986 0.914 . . . . 64.510000000000005 113.215 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 44.9 t -70.38 88.97 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.316 0.579 . . . . 75.209999999999994 110.675 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -65.95 -35.84 81.7 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.978 0.911 . . . . 73.340000000000003 112.505 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.47 58.78 0.08 OUTLIER Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.236 -0.438 . . . . 75.420000000000002 113.283 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -94.71 115.83 28.01 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.064 -0.717 . . . . 71.310000000000002 109.064 174.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -74.54 91.0 2.26 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.494 0.717 . . . . 74.209999999999994 112.189 -169.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -90.03 -23.24 21.52 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.105 -0.952 . . . . 74.099999999999994 109.995 166.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -66.29 114.95 5.74 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.141 0.576 . . . . 72.120000000000005 110.345 174.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -108.38 -172.2 2.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.62 0.768 . . . . 72.109999999999999 110.941 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -92.28 160.9 14.92 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.527 0.731 . . . . 73.409999999999997 112.139 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -64.84 110.7 2.51 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.74 1.216 . . . . 72.209999999999994 110.614 170.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.447 0.642 . . . . 74.439999999999998 111.893 -178.348 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp . . . . . 0 CA--C 1.555 1.142 0 CA-C-O 120.652 0.263 . . . . 73.14 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.8 mt -65.55 -55.94 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.434 0.693 . . . . 74.2 110.888 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.3 m -69.34 -26.22 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.071 -0.968 . . . . 74.41 111.223 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.79 -40.24 95.54 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 116.491 -0.322 . . . . 42.04 113.138 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.97 -54.47 13.14 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.623 0.769 . . . . 70.04 112.527 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -71.82 -20.97 61.76 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.171 0.804 . . . . 61.14 113.171 -174.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 -30.41 70.55 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.462 0.705 . . . . 74.3 111.818 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.86 -35.84 90.19 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 116.239 -0.437 . . . . 62.32 113.063 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.86 -42.65 60.49 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.562 0.745 . . . . 52.53 111.791 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.63 ' HA ' HG11 ' A' ' 32' ' ' VAL . 35.0 m -68.49 -38.75 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 122.282 0.233 . . . . 75.3 111.503 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.618 ' HA ' HD12 ' A' ' 17' ' ' LEU . 69.7 t90 -64.29 -36.42 84.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.973 0.909 . . . . 73.24 111.561 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.18 -40.7 98.27 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.952 0.901 . . . . 70.11 111.282 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.423 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -68.59 -24.23 64.57 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.394 0.678 . . . . 72.52 112.556 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 14' ' ' TRP . 52.1 mt -73.49 -33.87 65.02 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.835 0.854 . . . . 63.13 112.078 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.54 -36.58 78.78 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.609 0.764 . . . . 74.12 110.983 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.19 -59.86 4.33 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.384 1.074 . . . . 71.31 111.497 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.37 114.18 0.76 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.198 0.999 . . . . 61.44 110.275 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -98.16 -179.21 4.31 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.751 0.82 . . . . 75.54 111.721 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.43 26.32 47.64 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 116.17 -0.468 . . . . 74.41 112.6 -170.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.4 tt -104.29 147.63 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 C-N-CA 123.658 0.783 . . . . 74.31 111.367 -172.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.4 t -76.51 160.0 29.87 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.246 1.018 . . . . 73.24 111.938 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.5 mm -55.76 -56.61 28.14 Favored Pre-proline 0 CA--C 1.575 1.937 0 N-CA-C 113.523 0.934 . . . . 74.33 113.523 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.8 -22.47 27.25 Favored 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 121.691 1.594 . . . . 61.21 113.909 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -75.85 -47.92 23.6 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 122.273 1.035 . . . . 73.45 110.227 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.48 -40.51 78.72 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 113.511 -1.677 . . . . 71.2 111.291 170.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.09 70.29 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.272 1.029 . . . . 52.2 113.039 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -73.62 -35.91 65.4 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.285 0.634 . . . . 73.24 112.287 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.423 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 45.0 mtmt -71.81 -43.99 64.7 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 120.905 0.383 . . . . 72.2 111.255 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 13' ' ' VAL . 20.0 m -86.93 -11.56 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.037 0.535 . . . . 63.35 112.3 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 60.72 37.77 18.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.731 1.213 . . . . 73.15 113.12 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.5 mt -106.85 157.31 17.85 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.574 0.75 . . . . 72.24 110.585 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 m -61.05 150.18 34.6 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.226 0.611 . . . . 64.1 111.361 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.6 t -54.91 -48.89 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.547 0.739 . . . . 71.23 112.466 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -59.8 -39.77 86.12 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.128 0.571 . . . . 75.42 111.724 174.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.7 t -68.84 -37.31 79.05 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.527 0.731 . . . . 64.2 112.825 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.5 m -71.6 -47.89 51.71 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.618 0.767 . . . . 61.23 110.699 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.78 93.58 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.007 0.923 . . . . 74.32 112.174 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.77 -35.28 64.97 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.16 0.984 . . . . 72.21 111.345 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.32 98.85 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.464 0.65 . . . . 73.31 110.891 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.574 HG11 HD13 ' A' ' 63' ' ' ILE . 69.9 t -64.4 -31.47 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 C-N-CA 123.813 0.845 . . . . 71.24 111.672 172.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.34 -32.44 82.87 Favored Glycine 0 CA--C 1.544 1.87 0 N-CA-C 113.888 0.315 . . . . 23.51 113.888 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -68.58 -32.71 72.81 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.591 0.757 . . . . 64.43 111.282 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.53 -41.02 69.67 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.414 0.686 . . . . 74.14 110.89 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.59 -26.92 64.15 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.549 1.139 . . . . 72.25 112.6 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -52.95 -45.07 67.53 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.889 0.876 . . . . 63.3 112.102 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -103.87 3.78 34.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.031 0.932 . . . . 74.31 112.147 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.7 m120 54.7 36.63 26.66 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.149 0.98 . . . . 71.22 112.595 -170.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -67.66 -18.22 64.87 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.356 0.663 . . . . 75.11 110.441 166.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.15 148.44 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.207 1.003 . . . . 74.11 109.974 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 64' ' ' TYR . 20.3 m -128.96 134.75 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.906 0.882 . . . . 73.32 108.98 173.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.71 128.8 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 121.206 0.527 . . . . 72.14 112.278 -167.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -122.54 141.33 51.78 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.667 1.187 . . . . 70.54 109.54 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -117.25 110.54 18.24 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.819 0.342 . . . . 71.12 110.865 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -111.28 126.78 55.26 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.052 -0.721 . . . . 70.22 109.052 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 56.95 31.1 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.463 1.105 . . . . 71.55 112.103 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.29 -15.56 38.98 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 114.431 0.533 . . . . 73.54 114.431 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.9 mt -74.15 151.7 39.99 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.349 0.659 . . . . 75.45 111.469 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 mp -99.88 111.97 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 123.157 0.583 . . . . 71.1 110.055 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -98.38 141.06 31.73 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.492 0.717 . . . . 73.21 110.065 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.574 HD13 HG11 ' A' ' 43' ' ' VAL . 61.7 mt -116.04 113.32 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.046 0.538 . . . . 63.41 110.479 172.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.461 ' HB2' HG23 ' A' ' 53' ' ' VAL . 9.0 m-30 -97.29 150.15 21.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.685 0.794 . . . . 74.14 110.583 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 6.4 t30 -92.71 141.57 28.32 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.264 0.626 . . . . 74.13 109.59 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 113.154 0.798 . . . . 64.23 113.154 179.129 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.513 ' HA ' HG22 ' B' ' 6' ' ' VAL . 9.8 mtmp? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 113.191 0.812 . . . . 73.21 113.191 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -69.04 -45.76 69.61 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.24 0.616 . . . . 63.03 110.497 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 79.1 mt -63.05 -56.7 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.119 0.968 . . . . 65.13 111.433 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' B' ' 3' ' ' LYS . 12.6 m -66.13 -27.61 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 122.848 0.459 . . . . 54.11 111.503 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.03 -41.0 97.46 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.233 0.333 . . . . 73.24 112.995 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.07 -50.27 62.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.452 0.701 . . . . 53.34 111.606 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -68.22 -27.49 66.42 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.795 0.838 . . . . 71.32 112.384 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.485 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -72.83 -34.35 66.76 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.101 0.56 . . . . 44.42 111.518 177.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -35.19 91.63 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 123.388 0.43 . . . . 73.24 112.34 174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' B' ' 32' ' ' VAL . 1.6 ttmp? -68.14 -50.32 55.35 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.24 1.016 . . . . 74.14 112.216 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.525 ' HA ' HG11 ' B' ' 32' ' ' VAL . 24.4 m -69.09 -34.76 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 111.886 0.328 . . . . 71.14 111.886 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -71.9 -34.97 69.57 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.269 0.627 . . . . 74.24 111.081 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -57.05 -41.64 79.05 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.069 0.548 . . . . 64.34 110.489 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.53 -32.74 74.51 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.504 -0.771 . . . . 74.54 111.841 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 13' ' ' VAL . 83.3 mt -71.74 -34.0 69.15 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.401 0.681 . . . . 62.21 111.759 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.04 -31.49 71.13 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.76 0.824 . . . . 62.14 111.34 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -105.11 -25.78 12.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.159 0.984 . . . . 70.4 112.133 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.02 87.87 0.66 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.217 0.607 . . . . 74.32 111.524 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.17 -179.03 3.92 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.359 0.664 . . . . 72.02 111.825 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.25 18.18 79.76 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.084 -0.507 . . . . 63.52 112.85 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.73 152.39 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.391 1.076 . . . . 63.14 110.02 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -69.04 148.28 50.31 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.797 0.439 . . . . 52.23 111.045 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.624 HG21 ' HB2' ' B' ' 40' ' ' ALA . 36.5 mm -54.69 -48.35 95.61 Favored Pre-proline 0 CA--C 1.578 2.027 0 N-CA-C 113.719 1.007 . . . . 74.24 113.719 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -65.42 -31.23 52.23 Favored 'Trans proline' 0 C--N 1.393 2.905 0 C-N-CA 121.969 1.78 . . . . 74.23 113.965 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -71.64 -46.66 58.36 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.357 1.075 . . . . 75.05 109.778 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.406 HD22 HD11 ' B' ' 63' ' ' ILE . 60.9 tp -59.73 -38.7 82.43 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.301 -1.772 . . . . 64.12 111.51 172.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.79 98.01 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.984 0.913 . . . . 55.03 111.939 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -64.43 -35.81 82.12 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.1 -0.955 . . . . 75.33 110.681 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -66.63 -45.92 77.47 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.391 0.676 . . . . 64.42 112.298 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' B' ' 13' ' ' VAL . 30.5 m -90.51 10.7 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 112.718 0.636 . . . . 52.13 112.718 -173.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.68 16.82 9.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.408 1.083 . . . . 64.43 113.08 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.2 mt -106.16 168.69 8.97 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.743 0.817 . . . . 64.15 110.603 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 43.6 t -81.12 165.47 21.56 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.612 0.365 . . . . 64.25 111.243 169.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 74.4 t -52.92 -48.51 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 123.619 0.768 . . . . 53.21 111.836 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.91 -52.84 64.03 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.405 0.682 . . . . 64.31 111.96 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 23.0 m -59.26 -38.91 81.24 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.961 0.904 . . . . 50.41 112.379 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -72.44 -48.52 40.46 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.776 0.831 . . . . 72.34 111.767 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.624 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -63.61 -32.46 73.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.329 0.652 . . . . 73.34 112.027 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -71.79 -38.32 70.29 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.697 1.199 . . . . 74.23 110.508 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.25 -37.76 81.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.174 0.59 . . . . 74.45 111.405 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.512 HG13 HG11 ' B' ' 52' ' ' VAL . 60.7 t -64.1 -30.98 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.243 1.017 . . . . 75.13 110.867 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.57 86.32 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.495 -0.32 . . . . 61.11 113.513 171.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -72.7 -23.67 60.9 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.317 0.58 . . . . 73.12 111.198 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.44 HD11 HG23 ' B' ' 13' ' ' VAL . 76.4 mt -74.45 -40.93 61.62 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 121.518 -0.739 . . . . 54.3 111.08 169.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.24 -31.19 69.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.474 1.11 . . . . 63.41 113.488 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.59 ' HD3' ' HG3' ' B' ' 49' ' ' GLU . 0.0 OUTLIER -72.41 -14.1 61.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 112.735 0.643 . . . . 75.45 112.735 176.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.59 ' HG3' ' HD3' ' B' ' 48' ' ' ARG . 50.1 mt-10 -114.92 16.11 17.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.883 0.873 . . . . 61.2 110.965 169.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 47.53 28.38 1.17 Allowed 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 125.876 1.67 . . . . 41.13 114.314 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' B' ' 66' ' ' GLU . 53.0 mttp -71.52 -11.5 60.9 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.232 1.013 . . . . 72.32 112.95 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.512 HG11 HG13 ' B' ' 43' ' ' VAL . 12.6 m -124.52 145.85 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.637 0.775 . . . . 73.44 112.307 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 63.4 t -112.0 120.38 62.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 125.017 1.327 . . . . 64.31 108.949 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.21 110.59 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.703 -0.851 . . . . 72.54 108.703 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.28 112.49 18.67 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.794 0.438 . . . . 73.33 110.833 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.477 ' HG2' HG12 ' B' ' 61' ' ' ILE . 13.8 mtm-85 -93.36 96.89 10.23 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.746 0.819 . . . . 75.4 109.905 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -104.57 111.98 24.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.902 1.281 . . . . 73.42 109.414 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 57.74 30.45 18.95 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.295 1.038 . . . . 74.41 111.747 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.68 -22.81 28.85 Favored Glycine 0 CA--C 1.546 2.012 0 CA-C-N 115.654 -0.703 . . . . 73.1 113.992 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 88.4 mt -79.24 126.13 30.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.987 0.915 . . . . 45.01 111.527 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.477 HG12 ' HG2' ' B' ' 56' ' ' ARG . 40.4 mt -92.19 123.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 121.059 0.457 . . . . 44.34 112.068 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -117.83 139.72 50.7 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.385 1.074 . . . . 72.43 109.187 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.42 HG21 HG11 ' B' ' 43' ' ' VAL . 1.5 pp -113.66 104.59 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.926 0.87 . . . . 61.23 112.064 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 74.9 m-85 -83.61 167.06 17.64 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.659 0.784 . . . . 54.31 110.875 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -93.25 164.08 13.37 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.121 0.486 . . . . 74.45 112.294 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' B' ' 51' ' ' LYS . 40.1 tt0 . . . . . 0 N--CA 1.489 1.521 0 C-N-CA 123.847 0.859 . . . . 75.41 112.149 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt . . . . . 0 CA--C 1.553 1.09 0 N-CA-C 112.072 0.397 . . . . 74.44 112.072 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.8 mt -69.0 -58.02 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.091 0.556 . . . . 62.22 110.966 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.67 -27.85 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.749 0.42 . . . . 61.43 111.711 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.23 -42.25 76.28 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 123.543 0.527 . . . . 41.0 112.875 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.78 96.02 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.012 0.925 . . . . 61.31 112.054 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.417 ' O ' ' HG2' ' A' ' 12' ' ' LYS . 57.2 m-80 -85.1 -21.26 29.39 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.166 0.586 . . . . 60.54 112.414 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.54 76.1 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 118.072 0.396 . . . . 73.0 111.448 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.0 -39.83 97.63 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 115.851 -0.613 . . . . 61.22 113.456 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.481 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 6.7 ptmm? -75.87 -30.63 58.94 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.5 -0.412 . . . . 71.44 111.488 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.575 ' HA ' HG11 ' A' ' 32' ' ' VAL . 71.4 t -67.37 -46.78 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.282 0.633 . . . . 74.21 110.84 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.438 ' HA ' HD12 ' A' ' 17' ' ' LEU . 21.7 t90 -64.07 -35.07 79.53 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.572 -0.74 . . . . 73.44 110.639 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.405 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 79.3 t60 -63.11 -40.55 97.95 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.845 0.458 . . . . 43.3 111.547 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.12 -31.66 72.93 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 120.862 0.363 . . . . 54.14 111.661 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.481 ' HB3' ' OD1' ' A' ' 65' ' ' ASN . 90.1 mt -69.34 -41.95 75.94 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.337 1.055 . . . . 74.34 111.733 170.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.74 -26.99 66.11 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.145 0.978 . . . . 72.15 111.425 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 15' ' ' HIS . 68.3 mt-10 -77.79 -49.85 13.52 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.225 0.61 . . . . 64.4 110.127 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.77 108.19 0.67 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.603 0.761 . . . . 73.02 111.264 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 11.1 p-10 -94.1 -178.79 4.74 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.146 0.978 . . . . 71.43 112.918 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.28 33.59 61.62 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-N 116.016 -0.538 . . . . 44.32 111.852 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 tt -113.12 145.09 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.026 0.931 . . . . 73.33 111.013 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.9 m -78.85 154.03 30.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.556 0.743 . . . . 64.45 110.943 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.732 HG21 ' HB2' ' A' ' 40' ' ' ALA . 44.7 mm -59.1 -44.34 98.52 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 114.777 1.399 . . . . 73.35 114.777 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -62.82 -32.61 77.5 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 121.942 1.761 . . . . 73.34 113.185 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -75.27 -37.46 60.93 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.587 1.184 . . . . 72.04 109.871 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.9 tp -70.73 -33.4 70.79 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 112.707 -2.042 . . . . 72.1 111.658 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.05 -37.06 81.27 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.086 0.954 . . . . 74.0 111.167 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -64.44 -39.22 93.41 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.175 0.99 . . . . 75.01 111.104 174.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -66.47 -43.72 84.71 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.663 0.785 . . . . 73.05 111.864 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.575 HG11 ' HA ' ' A' ' 13' ' ' VAL . 7.0 m -98.17 9.99 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 113.315 0.858 . . . . 73.21 113.315 -170.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 m120 66.87 10.51 7.66 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.587 1.155 . . . . 64.41 113.428 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.9 mt -108.31 178.08 4.61 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.247 0.619 . . . . 74.22 111.479 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.4 t -88.48 165.68 14.72 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.17 0.588 . . . . 73.34 110.991 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.38 -47.33 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 124.312 1.045 . . . . 51.23 112.26 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -61.22 -53.0 62.43 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.214 0.606 . . . . 71.1 112.088 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -63.01 -28.6 70.22 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.733 0.813 . . . . 72.52 112.518 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 43' ' ' VAL . 88.0 m -80.08 -53.65 6.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.75 0.82 . . . . 72.11 111.441 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.1 -30.75 69.46 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.106 0.962 . . . . 43.34 112.315 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -52.86 63.07 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.714 1.206 . . . . 73.32 110.225 174.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.24 -26.75 68.24 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.886 -1.052 . . . . 73.41 111.39 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 39' ' ' THR . 94.7 t -66.04 -40.11 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.166 0.586 . . . . 72.24 110.889 172.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.07 -33.24 86.72 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 116.309 -0.405 . . . . 64.11 113.107 173.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.485 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 63.7 t-105 -74.22 -25.18 59.51 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.586 0.754 . . . . 75.13 111.605 176.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.27 -47.72 48.01 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 122.115 -0.366 . . . . 61.2 110.39 166.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.72 68.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.3 1.04 . . . . 54.01 113.19 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.547 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 26.6 ptt85 -59.4 -39.71 84.29 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 112.558 0.577 . . . . 64.03 112.558 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.547 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 47.0 mt-10 -96.61 11.62 34.63 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.886 0.875 . . . . 65.55 111.147 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 62.33 38.1 13.38 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.671 1.189 . . . . 64.12 111.198 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -80.51 -19.08 46.66 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.411 0.685 . . . . 75.52 112.195 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.87 151.57 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.314 0.646 . . . . 72.34 111.238 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.17 122.01 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.815 0.846 . . . . 74.43 109.298 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.789 HG12 HD11 ' B' ' 41' ' ' LEU . 3.6 mp -98.9 136.03 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.065 0.946 . . . . 73.34 110.86 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.7 117.98 15.62 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.569 0.747 . . . . 55.43 110.764 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -81.53 111.39 17.8 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.752 0.821 . . . . 65.24 110.556 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.85 130.61 47.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.969 0.908 . . . . 63.15 110.617 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.9 p30 44.48 41.18 4.45 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 126.059 1.744 . . . . 73.32 114.035 -175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.41 -27.44 7.74 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.374 -0.83 . . . . 74.44 114.125 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.67 160.4 28.51 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.732 0.813 . . . . 71.45 110.99 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.4 tt -121.19 118.33 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 123.792 0.837 . . . . 75.13 109.683 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.87 142.68 46.24 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.116 0.966 . . . . 74.3 110.042 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.705 HG22 HG13 ' A' ' 54' ' ' ILE . 37.6 pt -115.07 140.36 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.555 0.693 . . . . 61.53 111.066 175.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 57.7 m-85 -123.8 167.8 13.58 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.681 1.192 . . . . 73.24 110.018 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.481 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 1.8 m-20 -76.06 152.37 36.88 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.337 0.255 . . . . 73.11 110.522 174.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 CA--C 1.554 1.106 0 CA-C-O 121.164 0.507 . . . . 70.2 110.327 167.283 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.562 1.424 0 CA-C-O 120.552 0.215 . . . . 70.0 111.249 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.78 -43.13 56.45 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.755 0.822 . . . . 64.53 111.668 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.58 -51.38 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 122.619 0.368 . . . . 73.11 110.813 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -66.49 -30.85 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 122.611 0.364 . . . . 75.42 111.936 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.68 45.4 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.424 0.452 . . . . 73.22 112.74 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.6 -52.93 61.45 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.087 0.955 . . . . 72.51 111.845 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -75.17 -13.9 60.5 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.753 -0.658 . . . . 70.14 112.464 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -68.06 -29.09 67.98 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 117.943 0.338 . . . . 64.11 110.504 171.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.46 -41.95 94.01 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.867 -0.606 . . . . 43.51 112.963 173.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -69.76 -47.78 61.72 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.391 0.676 . . . . 62.5 111.922 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.547 ' HA ' HG11 ' B' ' 32' ' ' VAL . 22.7 m -67.21 -32.47 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 111.886 0.328 . . . . 53.52 111.886 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 57.9 t90 -68.65 -41.1 79.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.716 0.406 . . . . 71.23 111.162 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -69.64 -40.64 76.39 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.857 0.463 . . . . 72.15 111.248 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.61 73.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.108 0.563 . . . . 75.31 111.264 176.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.631 HD23 HG23 ' B' ' 63' ' ' ILE . 1.0 OUTLIER -67.32 -44.18 79.78 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.926 0.89 . . . . 75.1 110.439 169.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.17 -36.61 84.19 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.655 0.782 . . . . 62.54 111.679 -174.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.46 -30.13 25.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.371 0.668 . . . . 65.22 111.622 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.424 ' HB3' ' HZ2' ' B' ' 31' ' ' LYS . . . -135.06 108.04 7.6 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.21 0.604 . . . . 74.01 110.942 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.99 175.78 10.26 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.868 1.267 . . . . 62.4 112.674 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.89 40.56 12.53 Favored Glycine 0 C--N 1.365 2.14 0 N-CA-C 115.144 0.817 . . . . 75.34 115.144 163.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.549 HG21 ' HZ1' ' B' ' 31' ' ' LYS . 7.8 tp -112.95 127.97 69.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.363 0.665 . . . . 74.34 109.868 -168.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 92.5 p -68.06 158.44 32.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 122.083 -0.386 . . . . 63.14 111.162 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.662 HG21 ' HB2' ' B' ' 40' ' ' ALA . 69.6 mt -59.65 -44.38 97.36 Favored Pre-proline 0 CA--C 1.578 2.033 0 N-CA-C 114.422 1.268 . . . . 71.41 114.422 -171.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.49 -28.47 45.73 Favored 'Trans proline' 0 C--N 1.389 2.667 0 CA-C-N 121.744 1.659 . . . . 75.42 113.361 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLU . . . . . 0.478 ' HB3' HD11 ' B' ' 23' ' ' ILE . 14.0 mm-40 -79.96 -27.26 39.76 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.149 0.98 . . . . 71.04 111.419 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.574 ' HA ' ' HE2' ' B' ' 31' ' ' LYS . 58.3 tp -75.75 -37.82 58.98 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 125.255 1.422 . . . . 74.15 110.629 170.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.34 95.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.482 1.113 . . . . 75.31 112.842 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -67.65 -33.56 75.2 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.352 0.661 . . . . 71.3 112.248 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.574 ' HE2' ' HA ' ' B' ' 28' ' ' LEU . 48.9 mtmt -66.59 -43.38 85.05 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.217 0.532 . . . . 71.14 110.897 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' B' ' 13' ' ' VAL . 21.6 m -90.66 -4.83 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.662 0.785 . . . . 73.44 112.558 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 m120 64.99 22.62 12.46 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.63 1.172 . . . . 73.4 112.876 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 59.1 mt -104.65 162.04 13.62 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.621 0.769 . . . . 73.31 110.53 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 30.1 t -64.68 152.04 43.42 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.087 0.555 . . . . 54.43 110.822 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.95 -44.05 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 123.547 0.739 . . . . 72.32 111.19 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -58.52 -47.41 84.23 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 114.887 -1.051 . . . . 73.32 112.071 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 65.3 m -68.54 -36.53 78.96 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.934 0.893 . . . . 74.41 112.262 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 87.9 m -70.94 -52.24 21.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.918 0.887 . . . . 64.42 110.802 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.662 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -57.73 -32.36 67.35 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.956 0.902 . . . . 34.5 112.491 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.789 HD11 HG12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -64.65 -52.71 55.89 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.512 1.125 . . . . 72.52 110.281 176.269 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.59 -29.14 70.15 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.197 -0.91 . . . . 73.24 111.586 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.04 -39.93 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.627 0.771 . . . . 74.41 110.949 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -61.88 -27.75 69.1 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-N 116.341 -0.39 . . . . 74.01 113.125 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.448 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 61.1 t-105 -71.93 -34.53 69.13 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.546 0.738 . . . . 71.25 111.249 174.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.42 -32.88 68.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.25 0.62 . . . . 60.15 111.196 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.99 -32.02 71.6 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.672 0.789 . . . . 62.05 112.175 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 53.8 ttt180 -58.83 -50.43 74.01 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.517 0.675 . . . . 75.03 110.904 167.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -79.57 -6.59 57.36 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 114.64 -1.164 . . . . 63.23 112.27 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 63.62 23.2 13.47 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.025 1.33 . . . . 60.24 112.08 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -87.67 -4.31 58.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.486 1.114 . . . . 74.54 112.604 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.712 ' HB ' HD11 ' B' ' 63' ' ' ILE . 18.3 m -135.02 166.51 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 112.532 0.567 . . . . 62.21 112.532 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.746 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 24.7 t -116.1 131.75 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.067 0.947 . . . . 71.34 111.229 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 31.9 mm -113.5 133.05 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.696 0.798 . . . . 62.01 110.784 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' GLU . . . . . 0.458 ' HB2' ' HE2' ' B' ' 57' ' ' LYS . 42.5 mt-10 -134.16 157.96 44.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.451 0.7 . . . . 43.13 111.31 167.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -111.55 106.94 15.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.211 1.004 . . . . 73.14 109.168 168.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' B' ' 55' ' ' GLU . 0.0 OUTLIER -119.54 114.91 22.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.303 1.041 . . . . 63.3 110.13 -178.57 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 56.25 30.54 16.84 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.804 1.241 . . . . 74.14 111.823 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.8 -25.04 23.41 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 115.959 -0.564 . . . . 62.52 114.238 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -90.46 158.52 17.01 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.701 0.8 . . . . 60.23 111.037 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 mm -107.15 131.29 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.962 0.505 . . . . 74.41 110.052 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -121.97 136.1 54.9 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.063 -1.088 . . . . 72.13 108.063 168.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' B' ' 52' ' ' VAL . 10.9 tp -92.65 130.79 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 122.982 0.513 . . . . 73.41 110.232 -177.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.746 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 84.8 m-85 -116.62 167.8 10.75 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.578 0.751 . . . . 73.34 110.974 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.537 ' HA ' HD11 ' B' ' 17' ' ' LEU . 9.7 m120 -88.06 114.21 24.46 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.0 0.741 . . . . 54.12 113.0 -169.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.505 2.289 0 N-CA-C 116.975 2.213 . . . . 72.21 116.975 157.205 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.623 0.249 . . . . 75.35 111.354 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.59 -56.67 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.731 0.813 . . . . 72.53 112.01 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.449 HG12 HD22 ' A' ' 41' ' ' LEU . 28.5 m -53.9 -44.34 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.621 1.169 . . . . 72.43 113.197 -170.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.81 -40.34 52.83 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.159 0.287 . . . . 54.15 113.025 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.22 79.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.647 0.779 . . . . 74.44 112.354 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -87.56 -20.95 25.74 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.769 0.655 . . . . 43.42 112.769 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.84 -38.98 73.23 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 123.097 0.559 . . . . 61.35 112.03 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.74 -32.52 81.51 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 116.124 -0.489 . . . . 62.03 112.623 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -71.45 -48.29 50.33 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.014 0.925 . . . . 75.24 112.188 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -75.16 -32.85 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 112.475 0.546 . . . . 75.21 112.475 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.469 ' HA ' HD12 ' A' ' 17' ' ' LEU . 26.1 t90 -70.56 -35.16 72.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 120.966 0.412 . . . . 75.12 110.457 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -62.24 -35.41 78.84 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.521 0.728 . . . . 70.43 111.306 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.02 70.09 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.367 0.667 . . . . 52.51 112.455 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 14' ' ' TRP . 46.7 mt -68.36 -31.18 70.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.55 0.74 . . . . 61.02 111.255 170.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -75.04 -22.88 58.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.172 0.589 . . . . 72.04 111.704 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.31 -58.52 5.71 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 109.118 -0.697 . . . . 74.02 109.118 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.79 117.81 0.7 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.81 -1.087 . . . . 44.12 110.006 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.12 168.34 12.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.301 0.64 . . . . 63.34 109.845 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.76 60.53 1.96 Allowed Glycine 0 N--CA 1.475 1.294 0 N-CA-C 110.963 -0.855 . . . . 55.11 110.963 -170.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.6 tt -156.11 151.15 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.416 -0.892 . . . . 71.01 109.62 -173.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 t -85.96 158.9 19.77 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.874 0.469 . . . . 70.12 111.221 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.549 HG21 ' HB2' ' A' ' 40' ' ' ALA . 58.0 mt -56.81 -49.72 92.15 Favored Pre-proline 0 CA--C 1.575 1.936 0 N-CA-C 114.214 1.19 . . . . 75.34 114.214 -173.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 71.4 Cg_endo -70.81 -21.9 27.99 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.083 1.855 . . . . 63.23 113.743 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.27 -39.28 40.55 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.441 1.115 . . . . 74.23 109.691 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.2 tp -68.65 -34.4 75.65 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-N 113.019 -1.901 . . . . 73.22 111.375 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.8 70.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.179 0.992 . . . . 70.44 112.131 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 26' ' ' PRO . 79.8 mtt-85 -66.38 -34.92 79.04 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.908 0.883 . . . . 74.24 111.365 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -69.19 -45.65 69.41 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.577 0.751 . . . . 62.25 111.509 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.505 HG23 ' H ' ' A' ' 34' ' ' LEU . 31.4 m -90.45 -5.59 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 114.026 1.121 . . . . 73.25 114.026 -170.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 67.81 8.79 6.67 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.38 1.072 . . . . 74.41 112.051 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.505 ' H ' HG23 ' A' ' 32' ' ' VAL . 60.5 mt -92.4 157.38 16.63 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.581 -0.699 . . . . 63.23 110.335 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -61.79 151.66 33.58 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.083 0.553 . . . . 74.14 111.202 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -53.47 -41.76 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.552 0.692 . . . . 74.41 110.656 174.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.24 -40.75 94.45 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.652 -1.158 . . . . 71.3 111.672 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -68.06 -41.49 81.92 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.634 0.773 . . . . 65.44 111.463 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 43' ' ' VAL . 91.1 m -66.06 -49.58 67.15 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.16 0.984 . . . . 73.23 111.029 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.94 -43.01 99.28 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.742 0.817 . . . . 32.45 112.18 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.449 HD22 HG12 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -58.35 -49.16 78.19 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.492 0.717 . . . . 64.53 110.371 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.51 -30.98 70.97 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.815 -1.084 . . . . 75.4 112.254 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 39' ' ' THR . 60.7 t -65.89 -41.62 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.356 0.663 . . . . 72.41 110.861 174.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.06 -28.63 73.12 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 116.583 -0.28 . . . . 34.21 113.563 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -74.26 -43.33 57.39 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.607 0.763 . . . . 72.02 111.482 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.45 -32.9 73.84 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.045 0.538 . . . . 64.12 111.624 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.91 -25.19 60.54 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.395 1.078 . . . . 64.51 113.402 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -69.31 -40.03 77.89 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.254 -0.647 . . . . 75.3 109.254 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.7 7.79 42.01 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.263 1.025 . . . . 64.15 111.727 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 56.5 23.91 8.05 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.086 1.355 . . . . 74.25 113.414 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -74.02 -9.66 58.85 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.819 0.847 . . . . 71.12 113.044 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 m -122.71 142.23 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.279 0.632 . . . . 64.3 111.492 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 55.1 t -109.07 107.68 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.09 0.956 . . . . 74.0 108.456 172.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.414 HG13 HG22 ' A' ' 63' ' ' ILE . 3.0 mp -89.59 122.6 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 109.38 -0.6 . . . . 72.34 109.38 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -116.11 148.36 40.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.907 0.883 . . . . 73.11 109.888 174.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.437 ' HD2' HG21 ' B' ' 5' ' ' ILE . 45.2 mtp85 -118.96 114.65 22.89 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.757 0.423 . . . . 62.13 111.146 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -114.34 110.2 19.52 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.122 0.969 . . . . 74.45 109.785 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 58.4 30.02 19.04 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 124.795 1.238 . . . . 64.13 112.966 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.29 -13.3 62.2 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 113.944 0.338 . . . . 51.24 113.944 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.07 133.03 40.43 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.612 0.765 . . . . 75.12 110.686 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.428 HD13 ' HB2' ' B' ' 37' ' ' GLU . 3.0 mp -87.52 111.32 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 121.481 0.658 . . . . 74.21 110.714 -173.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -97.81 137.61 36.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.069 1.348 . . . . 73.13 108.901 171.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -123.1 139.12 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.744 0.783 . . . . 75.33 109.913 171.447 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.495 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 73.8 m-85 -129.01 167.02 18.09 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.588 1.155 . . . . 74.41 109.295 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -85.15 151.99 23.71 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.378 -0.601 . . . . 75.13 109.378 167.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 CA--C 1.551 0.999 0 CA-C-O 120.855 0.36 . . . . 65.33 110.735 177.676 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp . . . . . 0 CA--C 1.559 1.324 0 CA-C-O 121.085 0.469 . . . . 73.0 110.76 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -77.3 -28.33 53.29 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.904 0.882 . . . . 72.24 111.837 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.437 HG21 ' HD2' ' A' ' 56' ' ' ARG . 67.0 mt -58.38 -55.32 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.348 0.659 . . . . 75.11 110.977 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 22.6 m -63.84 -28.42 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-N 115.034 -0.985 . . . . 63.55 111.976 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.23 -45.43 48.93 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 123.398 0.436 . . . . 63.3 113.057 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.72 93.18 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.669 0.788 . . . . 34.41 111.785 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -65.25 -45.26 85.31 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.216 0.606 . . . . 65.23 110.434 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.402 ' HB1' ' HG ' ' B' ' 46' ' ' LEU . . . -68.32 -32.03 71.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.658 0.783 . . . . 62.14 112.132 -174.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.68 96.76 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 116.712 -0.222 . . . . 60.23 113.125 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -71.53 -39.72 70.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.396 0.678 . . . . 75.43 111.241 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.571 HG11 HG22 ' B' ' 43' ' ' VAL . 74.3 t -61.85 -41.64 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.743 0.817 . . . . 53.42 111.15 174.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -67.79 -31.73 71.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.392 0.677 . . . . 61.5 111.598 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -61.36 -45.74 93.13 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.4 0.28 . . . . 73.22 111.003 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.13 -29.79 67.91 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.389 0.614 . . . . 71.54 111.23 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.71 ' HG ' HG12 ' B' ' 52' ' ' VAL . 2.5 tm? -72.73 -34.24 66.93 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.893 1.277 . . . . 65.43 110.541 174.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.1 -20.0 39.02 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.499 0.719 . . . . 71.33 110.643 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -76.63 -59.46 2.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.832 0.853 . . . . 63.42 109.889 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.42 110.72 3.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.199 1.0 . . . . 63.11 109.262 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -90.71 -179.82 5.62 Favored 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 112.566 0.58 . . . . 52.52 112.566 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.58 51.1 9.97 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.745 -0.661 . . . . 74.54 111.633 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tp -121.17 140.49 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.252 0.621 . . . . 71.33 111.71 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 17.0 m -72.23 144.68 48.36 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.863 0.865 . . . . 72.15 111.257 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.45 HG21 ' HB2' ' B' ' 40' ' ' ALA . 62.2 mt -53.46 -52.36 67.44 Favored Pre-proline 0 CA--C 1.573 1.844 0 N-CA-C 113.671 0.989 . . . . 74.35 113.671 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -68.96 -24.75 33.03 Favored 'Trans proline' 0 C--N 1.391 2.803 0 C-N-CA 121.692 1.595 . . . . 74.2 113.823 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -77.42 -47.21 20.35 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.959 0.885 . . . . 60.23 109.593 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 57.5 tp -56.32 -34.88 66.98 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 113.647 -1.615 . . . . 63.33 111.69 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.84 98.97 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.875 0.87 . . . . 45.42 111.708 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -66.26 -40.74 90.36 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.121 0.568 . . . . 73.44 110.571 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -60.4 -45.83 92.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.874 0.87 . . . . 62.22 111.405 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.67 4.2 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 112.56 0.578 . . . . 74.35 112.56 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 61.18 32.75 19.49 Favored 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 124.539 1.135 . . . . 52.43 112.195 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 85.8 mt -123.26 170.27 10.45 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.925 0.89 . . . . 75.44 111.034 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -69.14 155.26 40.68 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.453 0.701 . . . . 63.34 111.511 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.26 -48.85 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.514 0.725 . . . . 71.12 111.481 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.449 ' HB3' HD12 ' A' ' 25' ' ' ILE . 43.6 mt-10 -59.11 -52.54 65.26 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.882 0.873 . . . . 72.13 111.838 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.1 t -56.64 -32.49 65.4 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.339 1.056 . . . . 73.11 112.746 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.508 ' O ' HG23 ' B' ' 43' ' ' VAL . 89.5 m -81.48 -46.15 14.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.651 0.78 . . . . 64.32 110.853 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -58.48 -52.65 64.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.676 0.991 . . . . 75.21 113.676 -171.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -26.83 64.57 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 120.882 0.373 . . . . 72.32 111.092 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.85 -34.71 73.98 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.703 0.801 . . . . 62.01 111.538 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.573 HG12 HD11 ' B' ' 54' ' ' ILE . 51.2 t -63.18 -33.06 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 122.823 0.449 . . . . 75.4 109.843 169.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.4 83.59 Favored Glycine 0 CA--C 1.542 1.72 0 CA-C-N 116.535 -0.302 . . . . 64.33 113.131 172.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.482 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 70.5 t-105 -71.6 -25.26 62.1 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.546 0.738 . . . . 71.11 111.778 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.402 ' HG ' ' HB1' ' B' ' 10' ' ' ALA . 94.9 mt -76.68 -41.77 44.22 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.519 -0.738 . . . . 63.11 111.503 165.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.47 -26.76 68.11 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.674 1.189 . . . . 70.31 113.542 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.665 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 18.7 ptt180 -57.11 -31.5 65.35 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 122.715 0.406 . . . . 75.44 111.84 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.665 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 40.2 mt-10 -106.51 1.57 25.55 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.237 1.015 . . . . 73.54 111.798 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 66.38 23.33 10.65 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.966 1.306 . . . . 70.12 111.707 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.525 ' HG3' ' HB2' ' B' ' 49' ' ' GLU . 52.7 mtpt -68.34 -17.57 64.28 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 122.934 0.494 . . . . 74.42 111.598 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.71 HG12 ' HG ' ' B' ' 17' ' ' LEU . 28.2 m -125.95 155.25 35.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.665 1.186 . . . . 64.11 109.762 170.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.91 129.66 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.185 0.994 . . . . 71.44 109.132 173.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.573 HD11 HG12 ' B' ' 43' ' ' VAL . 91.6 mt -120.82 112.83 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-O 121.357 0.598 . . . . 72.52 109.969 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -140.93 127.69 20.35 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.604 1.161 . . . . 72.03 109.499 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -81.4 111.98 18.25 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.458 0.647 . . . . 73.31 110.936 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.58 115.02 29.74 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.552 1.141 . . . . 72.24 109.682 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 54.06 31.77 14.35 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.861 1.264 . . . . 64.03 111.796 -167.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.49 -28.02 7.3 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-N 115.624 -0.717 . . . . 60.3 113.488 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.78 117.23 17.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.3 0.64 . . . . 75.12 110.296 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 19.5 tt -72.69 114.23 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 123.683 0.793 . . . . 63.25 111.726 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -116.53 127.67 54.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.863 0.465 . . . . 64.03 109.99 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.444 HG13 HG12 ' B' ' 54' ' ' ILE . 2.3 mp -94.51 101.93 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.624 0.77 . . . . 61.3 108.982 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -88.28 170.71 10.76 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.256 1.022 . . . . 72.25 111.978 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -85.66 146.81 26.67 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.939 0.896 . . . . 72.22 110.598 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.5 2.035 0 N-CA-C 112.678 0.622 . . . . 74.23 112.678 176.949 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.16 0.505 . . . . 74.21 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.5 -26.14 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 124.137 0.975 . . . . 74.3 111.649 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.15 -32.94 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.009 0.524 . . . . 70.13 110.711 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.32 -42.83 40.8 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.68 0.612 . . . . 70.15 112.903 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.19 77.69 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.212 0.605 . . . . 72.14 111.635 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -75.68 -35.69 60.29 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.548 0.739 . . . . 74.21 111.279 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.33 66.83 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.381 0.672 . . . . 61.0 111.488 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.67 -34.62 90.17 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 116.064 -0.516 . . . . 51.51 112.767 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -66.14 -41.39 90.5 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.041 0.936 . . . . 73.12 111.329 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.502 ' HA ' HG11 ' A' ' 32' ' ' VAL . 60.9 t -62.65 -47.7 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.597 0.759 . . . . 74.52 111.462 174.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.431 ' HA ' HD12 ' A' ' 17' ' ' LEU . 12.1 t90 -67.21 -33.08 74.6 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.98 0.512 . . . . 71.44 111.69 -176.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -57.96 -37.8 74.83 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.539 0.735 . . . . 74.53 110.756 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.17 72.34 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.185 0.594 . . . . 64.43 111.141 174.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 14' ' ' TRP . 87.0 mt -64.8 -18.36 65.03 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.063 0.945 . . . . 63.54 113.438 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -58.21 -34.06 69.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.907 0.883 . . . . 61.12 112.458 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.85 -33.59 1.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.384 0.674 . . . . 75.23 111.838 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.9 92.27 7.32 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.433 0.693 . . . . 70.44 109.727 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -127.19 162.98 24.89 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.685 0.794 . . . . 65.12 111.411 -170.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.94 59.81 5.69 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 116.042 -0.526 . . . . 70.51 112.069 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.2 tt -142.42 130.68 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.409 0.684 . . . . 54.4 110.739 -167.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.0 t -73.87 160.13 31.86 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.049 0.54 . . . . 62.42 110.961 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 40' ' ' ALA . 79.0 mt -49.15 -50.94 60.64 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 114.574 1.324 . . . . 60.24 114.574 -174.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.94 -27.16 17.84 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 121.973 1.782 . . . . 75.13 113.731 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.19 -43.02 65.15 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.689 1.233 . . . . 54.12 109.121 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.06 -38.08 87.44 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 112.512 -2.131 . . . . 70.24 111.157 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.83 -39.39 81.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.726 1.211 . . . . 63.32 112.248 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -63.15 -44.01 96.71 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.325 0.65 . . . . 64.31 111.298 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -66.04 -42.74 89.14 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.437 0.695 . . . . 74.3 111.598 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.0 m -87.55 2.22 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.865 -0.607 . . . . 64.31 112.286 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 t30 60.66 27.61 17.33 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 124.281 1.032 . . . . 74.21 112.004 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 44.2 mt -111.66 162.92 14.68 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.742 0.817 . . . . 74.15 109.561 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.2 t -77.11 164.78 25.37 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.592 0.357 . . . . 72.44 111.152 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.95 -53.32 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 124.277 1.031 . . . . 51.23 112.536 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.44 -42.9 88.36 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.361 0.664 . . . . 71.42 111.943 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -64.97 -37.37 87.41 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.998 0.919 . . . . 73.11 112.373 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 43' ' ' VAL . 87.9 m -77.98 -45.13 24.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.458 0.703 . . . . 71.44 111.402 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -57.71 -49.61 75.96 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.227 1.011 . . . . 60.42 112.071 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.51 -31.36 72.38 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 114.214 -1.357 . . . . 73.2 111.037 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.06 -36.69 72.38 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.296 0.638 . . . . 40.32 112.021 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 39' ' ' THR . 98.6 t -64.48 -33.02 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 123.064 0.546 . . . . 71.24 111.027 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.89 -31.27 79.89 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-N 116.634 -0.257 . . . . 53.21 113.421 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.46 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 64.6 t-105 -74.15 -28.36 61.29 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 123.639 0.776 . . . . 71.42 111.28 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.77 -35.5 64.97 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.227 0.611 . . . . 72.33 111.727 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.85 -30.77 70.32 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.791 0.836 . . . . 71.44 111.614 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 11.4 ttp180 -52.21 -49.61 63.56 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.771 0.829 . . . . 73.31 111.158 167.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -77.09 -12.47 59.94 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.896 -1.047 . . . . 74.23 112.568 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 61.7 22.41 12.94 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.018 1.327 . . . . 70.04 112.488 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -89.01 -2.36 58.54 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.763 0.825 . . . . 71.51 111.752 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.64 154.41 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.811 0.845 . . . . 64.12 110.919 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 64' ' ' TYR . 6.8 m -134.46 132.35 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.399 1.08 . . . . 72.43 110.116 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.21 126.46 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.691 0.796 . . . . 51.23 109.909 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -110.84 139.82 45.83 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.81 0.844 . . . . 74.54 111.044 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.471 ' HG2' HG12 ' A' ' 61' ' ' ILE . 82.0 mtm180 -116.1 124.03 49.37 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.11 0.964 . . . . 74.31 109.61 173.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 118.13 12.71 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.948 0.899 . . . . 62.54 109.538 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.0 t30 58.29 31.88 21.38 Favored 'General case' 0 CA--C 1.577 2.004 0 CA-C-O 121.998 0.904 . . . . 72.02 111.363 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.94 -9.55 68.71 Favored Glycine 0 CA--C 1.542 1.762 0 CA-C-N 115.648 -0.705 . . . . 72.4 114.269 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.3 mt -83.33 122.16 28.09 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.126 0.971 . . . . 74.44 110.856 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.471 HG12 ' HG2' ' A' ' 56' ' ' ARG . 64.1 mt -95.39 126.79 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.283 0.633 . . . . 63.22 109.779 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -133.3 141.86 48.19 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.618 0.767 . . . . 70.35 110.434 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -96.91 117.93 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.002 0.921 . . . . 51.14 109.745 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.529 ' HB2' HG23 ' A' ' 53' ' ' VAL . 25.5 m-85 -108.05 164.21 12.48 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.595 1.158 . . . . 73.45 109.109 173.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . 20.1 p-10 -94.16 161.83 14.11 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.405 -0.591 . . . . 74.35 109.405 169.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 109.148 -0.686 . . . . 74.12 109.148 170.317 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 112.628 0.603 . . . . 61.43 112.628 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -77.45 -40.53 42.94 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.654 0.782 . . . . 74.44 111.546 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.73 -58.64 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.513 0.725 . . . . 63.54 111.218 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.429 HG11 HD22 ' B' ' 41' ' ' LEU . 32.7 m -61.45 -27.6 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.361 0.664 . . . . 74.11 111.998 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.96 -49.85 71.45 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 123.47 0.482 . . . . 73.24 112.83 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.17 88.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.784 0.834 . . . . 70.42 112.043 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -85.2 -13.01 51.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.26 0.837 . . . . 55.32 113.26 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 -39.45 69.85 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.857 0.463 . . . . 71.21 111.367 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.23 -31.04 71.54 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 116.179 -0.464 . . . . 51.12 112.378 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -70.0 -45.74 66.65 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.892 0.877 . . . . 74.45 111.429 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.544 ' HA ' HG11 ' B' ' 32' ' ' VAL . 30.1 m -71.62 -32.46 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 122.533 0.333 . . . . 75.12 111.538 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.514 ' HA ' HD12 ' B' ' 17' ' ' LEU . 21.0 t90 -69.98 -33.36 71.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.499 0.32 . . . . 72.25 110.718 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -58.07 -45.87 86.38 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.932 0.493 . . . . 72.12 110.563 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.585 ' HB1' ' HE3' ' B' ' 31' ' ' LYS . . . -67.92 -29.59 68.71 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.677 -0.692 . . . . 64.52 111.712 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' B' ' 14' ' ' TRP . 58.6 mt -69.69 -33.02 71.95 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.153 0.981 . . . . 63.43 111.516 170.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.0 -29.72 64.49 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.915 0.886 . . . . 62.15 110.942 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -76.68 -49.03 17.11 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.649 0.78 . . . . 53.11 110.729 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.02 131.7 31.09 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.133 0.973 . . . . 63.33 109.502 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -114.61 147.34 39.68 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 122.911 0.484 . . . . 63.33 112.07 -163.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 24.45 69.6 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 115.984 -0.553 . . . . 64.34 113.266 -172.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.409 HD11 ' HG3' ' B' ' 27' ' ' GLU . 11.5 tt -77.05 143.35 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 124.169 0.987 . . . . 73.34 111.833 -170.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.6 m -61.24 141.73 57.31 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.756 0.822 . . . . 62.24 111.353 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' B' ' 40' ' ' ALA . 69.6 mt -57.63 -46.09 99.79 Favored Pre-proline 0 CA--C 1.576 1.952 0 N-CA-C 113.777 1.028 . . . . 75.2 113.777 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.25 -26.47 41.94 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 121.785 1.657 . . . . 63.42 113.871 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLU . . . . . 0.409 ' HG3' HD11 ' B' ' 23' ' ' ILE . 11.7 tp10 -76.67 -43.51 37.57 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.766 1.269 . . . . 70.45 109.773 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 58.8 tp -58.38 -40.22 81.71 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 112.833 -1.985 . . . . 73.01 111.013 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.15 75.43 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.536 1.134 . . . . 72.14 112.552 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -65.57 -42.05 92.23 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.48 0.712 . . . . 75.41 111.983 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.585 ' HE3' ' HB1' ' B' ' 16' ' ' ALA . 44.1 mtmt -72.67 -30.72 64.49 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.067 0.395 . . . . 75.42 112.067 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' B' ' 13' ' ' VAL . 25.4 m -96.45 -4.8 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 112.876 0.695 . . . . 52.45 112.876 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 65.83 15.87 10.24 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.442 1.097 . . . . 70.21 112.594 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt -96.89 163.84 12.8 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.699 -0.625 . . . . 63.24 110.967 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 37.5 m -66.45 151.44 47.18 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.935 -0.575 . . . . 75.01 110.152 171.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 58.1 t -55.51 -45.79 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 123.268 0.627 . . . . 64.44 111.857 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.38 -44.06 97.8 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.874 0.87 . . . . 70.34 112.374 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t -63.46 -38.5 91.37 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.563 0.745 . . . . 72.45 111.417 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.409 ' O ' HG23 ' B' ' 43' ' ' VAL . 89.6 m -68.36 -48.91 63.54 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.081 -0.963 . . . . 74.31 110.781 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.529 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -58.88 -36.85 75.32 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.0 0.92 . . . . 62.35 112.47 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.429 HD22 HG11 ' B' ' 6' ' ' VAL . 0.6 OUTLIER -66.28 -48.18 71.24 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.025 0.93 . . . . 75.45 110.078 178.003 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.04 68.9 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.53 -0.759 . . . . 62.3 111.62 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 39' ' ' THR . 73.8 t -77.63 -37.78 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 123.263 0.625 . . . . 61.21 111.057 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.46 -27.78 72.22 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 121.432 0.462 . . . . 50.1 112.326 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -73.39 -30.02 63.0 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.295 1.038 . . . . 73.14 110.956 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.451 HD13 ' HD1' ' B' ' 14' ' ' TRP . 96.2 mt -72.0 -34.17 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.199 0.6 . . . . 72.14 111.658 171.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.94 67.12 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.692 0.797 . . . . 61.03 111.926 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 48' ' ' ARG . 10.0 ptt-85 -60.88 -37.24 81.48 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.66 0.784 . . . . 71.23 111.517 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.547 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 41.4 mt-10 -93.9 5.24 52.31 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.861 0.864 . . . . 51.33 111.772 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 64.4 23.33 12.96 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.684 1.193 . . . . 73.52 112.931 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.547 ' HG3' ' HB2' ' B' ' 49' ' ' GLU . 28.3 mtpp -79.21 -13.08 59.92 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.752 0.649 . . . . 71.43 112.752 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' B' ' 64' ' ' TYR . 31.3 m -123.0 143.69 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.316 0.579 . . . . 64.41 112.185 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 33.4 t -113.11 105.1 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.307 0 C-N-CA 124.625 1.17 . . . . 73.3 109.959 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.504 HG23 HG23 ' B' ' 61' ' ' ILE . 3.4 mp -85.68 118.9 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 123.282 0.633 . . . . 62.51 110.925 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.17 117.38 19.82 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.899 0.88 . . . . 73.44 111.161 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -85.4 116.37 23.69 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.532 0.733 . . . . 72.14 110.352 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -125.03 115.4 20.47 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.577 1.151 . . . . 62.03 108.117 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 58.41 31.34 20.83 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.497 1.119 . . . . 65.43 111.163 -168.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.43 -19.37 32.37 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 115.442 -0.799 . . . . 63.51 113.867 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 mt -80.53 123.13 27.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.159 0.984 . . . . 51.0 111.206 -172.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.504 HG23 HG23 ' B' ' 54' ' ' ILE . 3.3 mp -80.65 127.85 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.666 0.786 . . . . 51.01 110.893 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.59 145.07 43.63 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.009 0.923 . . . . 74.3 109.3 168.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.538 HD13 ' H ' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -119.69 104.61 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-O 122.216 1.008 . . . . 73.4 109.876 174.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 77.5 m-85 -86.13 174.54 9.08 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.027 -0.988 . . . . 65.41 111.781 177.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -86.49 159.07 19.41 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.362 0.601 . . . . 63.04 111.334 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 CA--C 1.56 1.337 0 C-N-CA 124.863 1.265 . . . . 72.23 112.073 170.961 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 112.923 0.712 . . . . 74.55 112.923 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.05 -40.27 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.221 0.609 . . . . 72.33 111.451 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 41' ' ' LEU . 13.5 m -66.11 -33.45 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 122.177 0.191 . . . . 61.14 111.449 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.09 -43.37 33.37 Favored Glycine 0 C--N 1.353 1.513 0 O-C-N 123.479 0.487 . . . . 35.45 113.281 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 -46.48 76.33 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.557 0.743 . . . . 72.42 111.6 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.84 -26.56 66.11 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.812 0.845 . . . . 62.43 111.8 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.11 -34.44 73.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.003 0.521 . . . . 55.03 111.324 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.16 -38.76 94.18 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 116.183 -0.462 . . . . 72.54 113.152 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -69.49 -48.52 60.37 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.308 0.643 . . . . 73.21 111.733 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.86 -36.8 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 122.333 0.253 . . . . 74.55 111.462 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.562 ' HA ' HD12 ' A' ' 17' ' ' LEU . 54.4 t90 -64.92 -40.16 94.62 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.416 0.286 . . . . 61.33 111.052 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -60.94 -39.82 90.92 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.848 0.459 . . . . 72.04 110.904 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.82 69.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.469 0.708 . . . . 63.22 111.926 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 14' ' ' TRP . 84.4 mt -66.11 -45.27 81.73 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.537 0.735 . . . . 52.21 111.663 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -62.39 -31.55 72.24 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 120.815 0.34 . . . . 62.41 111.283 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.36 -49.35 50.18 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.439 0.696 . . . . 62.24 110.698 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.64 105.09 0.51 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.748 0.819 . . . . 72.31 111.084 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.48 -179.6 3.92 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.847 0.859 . . . . 64.25 111.403 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.42 33.09 44.88 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.033 -0.53 . . . . 44.3 111.824 -171.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.4 tt -122.5 154.55 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 124.432 1.093 . . . . 52.35 110.096 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.9 m -63.16 145.98 54.32 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.838 0.455 . . . . 43.55 111.302 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' B' ' 37' ' ' GLU . 66.0 mt -58.33 -43.27 98.02 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 123.989 0.916 . . . . 72.22 113.363 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HA ' HG22 ' A' ' 36' ' ' VAL . 36.6 Cg_endo -62.69 -35.2 70.76 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 122.244 1.963 . . . . 71.45 114.284 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -69.84 -51.26 35.02 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.25 1.024 . . . . 73.15 109.187 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.8 tp -54.26 -37.79 65.07 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 112.811 -1.995 . . . . 73.41 112.123 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.15 92.43 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.191 0.997 . . . . 63.22 112.136 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -67.5 -26.5 66.37 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.279 0.631 . . . . 75.33 111.82 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.14 -47.15 46.46 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.548 0.739 . . . . 71.34 111.094 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -84.29 0.96 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.216 0.606 . . . . 74.03 111.945 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 69.26 12.04 8.31 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.404 1.482 . . . . 70.21 113.632 174.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.3 mt -93.66 169.19 10.51 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.298 0.639 . . . . 73.45 110.523 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.6 p -78.06 162.93 26.33 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 110.24 -0.281 . . . . 74.32 110.24 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 26' ' ' PRO . 40.8 t -56.19 -47.55 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.799 0.84 . . . . 74.33 111.418 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.19 -41.72 97.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.989 -1.005 . . . . 73.34 112.186 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -67.06 -39.19 86.84 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.404 0.682 . . . . 75.34 112.315 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . 78.4 m -69.15 -48.62 61.87 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.513 0.725 . . . . 73.43 111.615 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -61.61 -38.38 87.4 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.38 0.672 . . . . 72.55 112.144 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.554 HD23 HG23 ' B' ' 43' ' ' VAL . 1.6 tm? -65.75 -39.09 90.74 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 124.95 1.3 . . . . 72.33 110.792 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.97 -33.32 70.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.433 0.693 . . . . 72.45 111.797 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.651 HG11 HD12 ' A' ' 63' ' ' ILE . 89.8 t -66.43 -31.04 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.072 0.549 . . . . 64.0 111.18 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.48 -30.11 73.54 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-N 116.751 -0.204 . . . . 64.33 113.535 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -73.99 -31.12 62.83 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.505 0.722 . . . . 54.44 110.982 173.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.67 -30.27 65.53 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.459 0.704 . . . . 51.42 111.609 172.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.09 -27.65 68.91 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.739 0.816 . . . . 74.24 111.655 169.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.404 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 13.0 ttp180 -65.96 -42.44 89.92 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.297 0.57 . . . . 74.53 110.15 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.81 -22.47 61.56 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.08 -0.964 . . . . 55.42 111.834 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 t30 65.71 22.4 11.58 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 125.171 1.388 . . . . 72.11 111.167 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -97.26 6.0 49.09 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.7 0.8 . . . . 64.22 112.87 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.8 151.16 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.808 0.843 . . . . 61.41 110.875 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.6 t -111.68 107.63 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.578 0.751 . . . . 71.44 109.381 172.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.5 mt -96.44 112.86 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.143 -0.688 . . . . 73.22 109.143 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -134.52 125.88 28.23 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 110.077 -0.342 . . . . 71.54 110.077 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -87.45 107.8 18.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.016 0.926 . . . . 75.53 111.155 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.432 ' O ' HD23 ' A' ' 60' ' ' LEU . 2.3 mptm? -105.19 141.61 36.43 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.294 1.038 . . . . 74.35 108.87 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.8 p30 44.18 29.33 0.34 Allowed 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 125.334 1.454 . . . . 71.32 113.76 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.07 -28.67 12.88 Favored Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.274 0.869 . . . . 70.13 115.274 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -90.73 154.33 19.62 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.757 1.278 . . . . 74.25 112.037 -174.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.32 116.29 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.899 0.88 . . . . 72.23 109.84 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.95 128.6 56.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.337 0.655 . . . . 74.44 110.235 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.651 HD12 HG11 ' A' ' 43' ' ' VAL . 23.0 mm -92.27 105.7 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.426 0.69 . . . . 75.04 110.221 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -97.6 172.64 7.59 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.234 1.014 . . . . 73.42 110.804 176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -98.93 170.58 8.63 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.23 0.612 . . . . 71.4 109.97 164.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 N--CA 1.489 1.502 0 C-N-CA 123.749 0.82 . . . . 72.42 112.351 175.076 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.773 0.32 . . . . 64.45 111.609 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -86.4 -25.82 25.09 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.764 0.426 . . . . 62.23 111.861 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 72.3 mt -66.77 -46.34 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.839 0.456 . . . . 54.41 110.877 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.2 m -64.6 -26.24 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 122.916 0.487 . . . . 70.13 111.078 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' B' ' 45' ' ' TRP . . . -65.57 -51.97 43.26 Favored Glycine 0 C--N 1.354 1.581 0 O-C-N 123.665 0.603 . . . . 72.15 113.543 172.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.64 85.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.48 0.712 . . . . 34.5 111.745 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ASN . . . . . 0.478 ' HB3' HD11 ' B' ' 34' ' ' LEU . 5.7 m-20 -68.65 -29.02 67.41 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.22 1.008 . . . . 63.5 111.519 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.513 ' HB1' ' HG ' ' B' ' 46' ' ' LEU . . . -73.26 -39.0 65.75 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.857 0.463 . . . . 74.11 110.969 176.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.21 -32.34 82.21 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-O 121.358 0.421 . . . . 51.25 112.281 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.8 -35.66 77.3 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.675 1.19 . . . . 73.13 111.683 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.479 HG22 HG11 ' B' ' 32' ' ' VAL . 74.7 t -69.51 -40.41 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.488 0.715 . . . . 62.44 111.317 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -66.13 -32.5 73.98 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.264 0.626 . . . . 71.2 110.943 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -54.72 -42.28 71.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.776 0.83 . . . . 75.23 111.472 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.91 70.81 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.5 0.72 . . . . 52.31 112.528 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.652 HD11 HG12 ' B' ' 52' ' ' VAL . 82.7 mt -62.91 -42.67 99.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.531 0.733 . . . . 65.3 111.476 172.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -64.65 -22.11 66.9 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.377 0.671 . . . . 64.33 111.651 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.33 -50.73 13.51 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.48 0.712 . . . . 63.4 110.262 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.3 124.34 0.72 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.823 0.849 . . . . 55.44 111.137 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.404 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 7.9 p-10 -74.81 175.1 8.33 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.439 0.695 . . . . 71.34 112.593 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.42 20.5 78.34 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.961 -0.563 . . . . 75.33 112.974 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.468 HG13 ' HB2' ' B' ' 28' ' ' LEU . 8.9 tp -84.73 124.39 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.946 0.899 . . . . 63.11 110.285 -176.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -85.38 147.03 26.7 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.845 0.458 . . . . 62.43 110.584 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 88.0 mt -49.74 -44.98 79.12 Favored Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 114.965 1.468 . . . . 72.05 114.965 -173.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.61 -48.17 21.71 Favored 'Trans proline' 0 C--N 1.392 2.819 0 C-N-CA 122.332 2.021 . . . . 71.15 114.374 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -72.09 -38.43 69.38 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.835 1.302 . . . . 50.02 110.072 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.468 ' HB2' HG13 ' B' ' 23' ' ' ILE . 56.0 tp -60.88 -33.95 73.89 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 112.642 -2.072 . . . . 75.22 111.34 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.7 -35.87 79.27 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.299 1.04 . . . . 63.44 112.484 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -64.91 -43.9 91.32 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 122.857 0.463 . . . . 73.41 110.523 173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -64.74 -39.39 93.54 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.429 -0.805 . . . . 63.43 112.137 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.479 HG11 HG22 ' B' ' 13' ' ' VAL . 23.4 m -97.53 -3.1 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 112.947 0.721 . . . . 71.51 112.947 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.7 28.5 14.94 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 124.558 1.143 . . . . 72.34 111.672 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' B' ' 9' ' ' ASN . 92.4 mt -109.49 166.11 11.14 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.533 0.733 . . . . 74.35 110.564 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 43.6 t -73.87 161.64 29.93 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.1 0.56 . . . . 55.25 110.615 170.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.5 -47.46 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.239 0.616 . . . . 72.32 111.741 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.538 ' HB3' HD12 ' A' ' 25' ' ' ILE . 42.7 mt-10 -61.05 -42.2 98.04 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.024 0.93 . . . . 72.24 112.339 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 39.4 t -67.24 -34.95 78.54 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.383 0.673 . . . . 75.24 111.665 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 45.0 m -79.94 -34.54 38.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.939 0.896 . . . . 71.33 110.982 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.86 -33.58 72.46 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.747 0.819 . . . . 75.32 111.139 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -75.4 -34.26 61.04 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 115.398 -0.819 . . . . 61.44 110.511 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.98 90.42 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.945 0.498 . . . . 63.1 111.767 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.554 HG23 HD23 ' A' ' 41' ' ' LEU . 20.2 m -68.75 -29.16 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 122.483 0.313 . . . . 71.43 110.916 172.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.4 -34.36 89.09 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.188 -0.46 . . . . 63.5 113.198 171.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.408 ' CD1' ' HA2' ' B' ' 7' ' ' GLY . 61.1 t-105 -72.51 -33.84 67.19 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.683 0.393 . . . . 71.12 110.372 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.513 ' HG ' ' HB1' ' B' ' 10' ' ' ALA . 53.2 mt -66.64 -27.93 68.07 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.633 0.373 . . . . 74.04 111.875 170.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.73 74.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.986 0.515 . . . . 72.3 111.609 168.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.404 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 27.8 ttp85 -64.68 -43.41 93.62 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.081 0.467 . . . . 63.12 110.164 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -67.8 -25.52 65.63 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.344 -0.844 . . . . 65.42 111.654 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 67.0 22.91 9.92 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.509 1.524 . . . . 70.32 111.797 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -95.58 3.55 53.98 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.882 1.067 . . . . 73.11 113.882 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.652 HG12 HD11 ' B' ' 17' ' ' LEU . 15.7 m -123.32 153.35 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.485 0.66 . . . . 53.12 112.407 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 91.4 t -108.72 125.84 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.494 1.118 . . . . 62.23 109.309 171.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 mm -104.8 116.52 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.129 0.572 . . . . 74.01 109.881 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -117.72 123.59 46.42 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.435 0.694 . . . . 64.24 110.1 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -93.57 97.19 10.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.082 0.553 . . . . 74.35 109.823 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' LYS . . . . . 0.6 ' HD3' ' HG3' ' B' ' 62' ' ' GLU . 8.7 mtpm? -105.11 113.2 26.65 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.041 0.936 . . . . 74.54 110.149 -175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 60.28 28.94 18.58 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.605 1.562 . . . . 44.55 111.733 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.62 -2.32 87.29 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 114.591 0.596 . . . . 73.32 114.591 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.67 149.37 22.88 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.009 0.905 . . . . 51.22 111.635 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.8 mm -87.14 119.1 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.178 0.591 . . . . 70.15 110.861 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLU . . . . . 0.6 ' HG3' ' HD3' ' B' ' 57' ' ' LYS . 7.2 mm-40 -116.1 121.63 42.73 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.286 1.034 . . . . 75.1 109.395 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.529 HG22 HD21 ' B' ' 17' ' ' LEU . 17.5 mm -100.75 122.35 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.19 0.596 . . . . 74.44 110.822 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.665 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 22.4 m-85 -116.18 169.15 9.5 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.109 0.964 . . . . 64.12 111.244 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.404 ' OD1' ' HB3' ' B' ' 21' ' ' ASP . 1.8 m-20 -77.62 141.28 39.56 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.633 -0.712 . . . . 73.34 111.225 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.491 1.597 0 C-N-CA 124.899 1.28 . . . . 65.31 114.217 172.931 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.0 tptp . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.005 0.431 . . . . 75.42 110.673 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.4 mt -65.44 -41.3 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.725 0.81 . . . . 71.31 112.335 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.536 HG12 HD11 ' A' ' 41' ' ' LEU . 29.5 m -65.13 -30.39 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 122.993 0.517 . . . . 45.24 111.517 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -42.52 85.08 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 112.498 -0.241 . . . . 63.25 112.498 172.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.89 -45.82 69.99 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.795 0.838 . . . . 72.4 111.949 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.412 ' HB2' HD11 ' A' ' 34' ' ' LEU . 31.7 p30 -77.37 -23.06 50.86 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 122.971 0.508 . . . . 73.41 111.946 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.03 -35.58 59.45 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.91 0.484 . . . . 54.41 111.209 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.61 -31.57 78.96 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 121.613 0.563 . . . . 75.32 112.231 172.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -68.92 -45.01 71.95 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 125.136 1.374 . . . . 74.34 110.79 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.45 ' HA ' HG11 ' A' ' 32' ' ' VAL . 39.2 t -64.48 -36.58 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 124.534 1.134 . . . . 72.14 111.652 173.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.411 ' NE1' ' HB3' ' A' ' 51' ' ' LYS . 15.9 t90 -71.5 -32.23 68.0 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.442 0.697 . . . . 72.22 110.908 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -59.84 -32.93 71.14 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.563 0.745 . . . . 71.32 111.545 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.77 -22.86 65.78 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.804 0.668 . . . . 73.23 112.804 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 52' ' ' VAL . 94.7 mt -68.8 -38.83 80.23 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.766 0.826 . . . . 64.41 112.687 173.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -56.86 -36.27 69.85 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.525 0.73 . . . . 74.34 111.303 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.62 -47.75 13.65 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.488 -0.778 . . . . 71.32 110.966 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.73 113.32 6.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.07 0.948 . . . . 54.21 111.392 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -94.94 128.3 41.63 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.404 -0.961 . . . . 72.2 108.404 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.8 47.81 4.66 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 111.896 -0.482 . . . . 74.12 111.896 -172.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.8 tp -114.35 137.27 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 C-N-CA 123.898 0.879 . . . . 73.3 110.731 -175.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.7 p -82.49 162.3 22.09 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.321 0.648 . . . . 61.42 111.99 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.9 mt -55.41 -54.34 52.1 Favored Pre-proline 0 CA--C 1.579 2.084 0 N-CA-C 113.84 1.052 . . . . 75.01 113.84 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.14 -30.61 20.24 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.03 1.82 . . . . 60.33 113.432 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -71.43 -44.33 65.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.265 0.626 . . . . 72.31 111.619 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.07 -30.65 63.86 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.91 0.484 . . . . 62.35 110.334 175.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.33 -41.86 76.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.551 0.74 . . . . 64.42 112.016 177.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -69.22 -30.82 69.06 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.079 0.552 . . . . 74.35 111.671 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -69.94 -40.48 75.44 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.079 0.552 . . . . 75.31 111.578 174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' ' 13' ' ' VAL . 21.5 m -96.72 7.74 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.365 0.666 . . . . 72.0 112.115 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.47 16.96 9.13 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.454 1.102 . . . . 53.11 113.935 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 9' ' ' ASN . 76.2 mt -99.85 159.43 15.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.53 0.732 . . . . 73.43 110.414 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.7 t -68.8 161.02 29.38 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.761 0.425 . . . . 74.12 110.847 169.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -59.3 -42.92 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 122.705 0.402 . . . . 65.33 111.491 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -64.82 -48.35 74.69 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.214 0.606 . . . . 73.32 111.784 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 t -57.08 -39.18 74.48 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.016 0.926 . . . . 75.51 112.101 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 43' ' ' VAL . 79.8 m -71.0 -52.28 20.55 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 123.905 0.882 . . . . 51.34 110.741 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.34 -30.95 67.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.018 0.927 . . . . 71.12 112.807 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.536 HD11 HG12 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -68.76 -45.05 72.39 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.388 1.075 . . . . 64.45 110.351 172.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.46 -31.38 72.57 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.586 0.754 . . . . 72.14 111.965 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 39' ' ' THR . 75.2 t -62.82 -43.14 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.551 1.141 . . . . 44.54 111.466 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.25 -31.13 75.93 Favored Glycine 0 CA--C 1.541 1.691 0 O-C-N 123.342 0.401 . . . . 52.15 113.055 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.461 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 51.3 t-105 -75.07 -27.7 60.06 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.849 0.86 . . . . 74.13 112.323 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 98.2 mt -76.68 -42.13 42.9 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.892 -0.505 . . . . 62.3 111.826 168.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.83 71.36 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.718 1.207 . . . . 72.12 113.327 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.701 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 14.1 ptt180 -61.05 -34.49 74.97 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.681 0.392 . . . . 64.41 111.718 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.701 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 36.4 mt-10 -98.41 1.05 46.47 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.421 1.088 . . . . 74.53 111.923 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 t30 61.89 28.1 17.13 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.623 1.169 . . . . 73.24 111.529 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.411 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 92.1 mttt -72.81 -21.35 60.98 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.59 0.756 . . . . 62.3 112.316 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.604 HG12 HD11 ' A' ' 17' ' ' LEU . 27.9 m -125.8 148.55 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 64.21 111.199 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.748 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 44.4 t -100.12 100.5 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.782 0.833 . . . . 73.15 108.8 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.3 mm -78.43 123.26 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 109.936 -0.394 . . . . 71.5 109.936 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.37 116.57 17.01 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.727 -0.842 . . . . 75.21 108.727 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -93.9 103.53 15.63 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.387 0.675 . . . . 63.24 110.387 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -111.16 129.04 56.07 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.563 0.745 . . . . 74.42 109.904 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 56.03 28.37 12.71 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.574 1.149 . . . . 72.05 112.467 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.64 -21.27 14.84 Favored Glycine 0 CA--C 1.542 1.722 0 N-CA-C 114.242 0.457 . . . . 53.32 114.242 -174.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.02 143.84 35.25 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.462 0.705 . . . . 54.13 110.877 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.81 138.13 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.494 -0.558 . . . . 52.3 109.494 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -147.35 142.57 27.24 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.454 0.645 . . . . 75.01 111.027 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.1 mt -111.01 137.51 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.042 0.937 . . . . 73.44 110.862 -173.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.748 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 90.1 m-85 -121.62 165.24 16.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.71 -1.132 . . . . 74.23 108.942 174.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HA ' HD13 ' A' ' 17' ' ' LEU . 20.9 t-20 -83.05 152.04 25.54 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.914 -0.772 . . . . 61.34 108.914 173.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 113.602 0.964 . . . . 75.14 113.602 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.644 ' HA ' HG22 ' B' ' 6' ' ' VAL . 99.0 mttt . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 112.796 0.665 . . . . 63.31 112.796 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -70.05 -37.36 75.51 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.769 0.427 . . . . 71.15 110.81 171.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.93 -52.71 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 123.513 0.725 . . . . 72.34 111.438 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.644 HG22 ' HA ' ' B' ' 3' ' ' LYS . 19.5 m -70.52 -27.47 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 122.72 0.408 . . . . 61.22 111.741 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -38.87 89.17 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 116.783 -0.189 . . . . 32.41 112.764 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.03 32.02 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.437 0.695 . . . . 60.05 111.73 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ASN . . . . . 0.604 ' HB2' HD11 ' B' ' 34' ' ' LEU . 31.3 p30 -73.29 -20.97 60.7 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 112.953 0.723 . . . . 73.31 112.953 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.97 -23.38 64.12 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.083 0.553 . . . . 64.51 111.178 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.04 -31.91 79.2 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 116.222 -0.445 . . . . 64.1 113.12 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.62 -47.02 64.89 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.438 0.695 . . . . 71.1 111.101 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.19 -36.88 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.276 1.03 . . . . 75.52 111.59 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -72.66 -34.32 67.16 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.263 0.625 . . . . 74.33 110.979 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -65.03 -31.03 72.06 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.666 0.387 . . . . 62.24 111.475 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.68 -30.23 67.21 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.05 0.54 . . . . 75.33 112.146 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.705 HD11 HG12 ' B' ' 52' ' ' VAL . 80.3 mt -65.59 -45.96 81.22 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.772 0.829 . . . . 61.25 111.659 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -59.66 -28.18 67.03 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.692 0.797 . . . . 74.1 111.266 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -81.91 -47.57 12.59 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.877 0.871 . . . . 72.43 111.217 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.09 151.98 16.52 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.783 0.833 . . . . 44.35 111.736 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -112.22 156.16 22.81 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.297 0.639 . . . . 74.35 109.649 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.01 38.66 84.68 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 114.359 0.503 . . . . 61.04 114.359 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 tt -102.36 137.54 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.23 0.612 . . . . 73.33 110.275 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -73.11 156.4 38.72 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.386 0.674 . . . . 62.52 111.594 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.82 -52.18 76.28 Favored Pre-proline 0 CA--C 1.575 1.933 0 N-CA-C 113.617 0.969 . . . . 72.35 113.617 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.75 -23.91 55.24 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.149 1.899 . . . . 65.11 113.501 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -78.91 -42.66 26.6 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.741 0.816 . . . . 74.43 111.496 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.1 -31.58 61.21 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 122.157 -0.34 . . . . 74.55 111.078 174.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.53 -45.38 73.35 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.573 1.149 . . . . 74.55 113.393 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -65.01 -30.83 71.83 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 115.999 -0.546 . . . . 74.24 112.22 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -78.41 -40.93 34.55 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.015 0.526 . . . . 72.41 111.058 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 m -81.58 -3.4 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.076 0.551 . . . . 61.44 111.683 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 65.83 29.41 10.51 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.321 1.448 . . . . 73.14 112.906 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' B' ' 9' ' ' ASN . 66.5 mt -109.28 158.07 18.23 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.693 0.797 . . . . 72.3 110.395 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 34.0 t -65.09 152.82 42.56 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.781 0.433 . . . . 73.12 110.581 166.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.34 -41.97 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 123.073 0.549 . . . . 72.51 111.579 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.66 -48.21 80.33 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.087 0.955 . . . . 75.23 112.015 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.5 t -66.56 -30.82 71.22 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.713 0.805 . . . . 71.23 111.601 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 96.8 m -74.87 -44.17 50.44 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.916 0.886 . . . . 73.32 110.92 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.51 -34.3 77.47 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.872 0.869 . . . . 73.33 111.648 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -67.2 -44.08 80.52 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 124.27 1.028 . . . . 71.31 110.496 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.81 76.75 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.14 0.576 . . . . 73.54 111.793 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.19 -44.35 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.585 1.154 . . . . 74.32 110.828 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.47 -28.04 73.16 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 116.378 -0.374 . . . . 65.21 113.155 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 49.9 t-105 -74.18 -29.9 61.98 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.967 0.907 . . . . 73.45 111.232 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.06 -36.59 58.94 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.358 0.663 . . . . 73.42 112.186 167.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.96 76.86 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.202 1.001 . . . . 44.53 113.543 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 20.3 ptt85 -63.92 -30.68 71.74 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.303 0.573 . . . . 73.22 111.097 173.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -86.03 -15.78 40.3 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.374 1.07 . . . . 64.35 111.572 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 t30 60.43 43.62 13.04 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.717 1.207 . . . . 73.2 110.769 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -95.83 -9.07 32.48 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.312 -0.858 . . . . 64.42 111.777 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.705 HG12 HD11 ' B' ' 17' ' ' LEU . 27.7 m -125.17 146.47 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.222 1.009 . . . . 60.51 111.149 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' B' ' 66' ' ' GLU . 85.9 t -103.95 104.08 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.133 -1.062 . . . . 74.0 108.133 167.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 70.8 mt -91.21 118.18 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.146 0.578 . . . . 70.51 109.827 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.69 123.28 45.7 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.003 -0.74 . . . . 70.34 109.003 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -89.13 96.85 10.89 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.596 0.712 . . . . 64.41 109.341 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -116.66 119.06 34.3 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.077 -0.965 . . . . 72.43 109.502 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 60.07 28.79 18.38 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.783 1.233 . . . . 65.52 111.731 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.85 -3.93 72.82 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 114.452 0.541 . . . . 43.13 114.452 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.59 134.7 34.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.341 0.656 . . . . 75.44 110.736 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.6 mm -87.07 103.12 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 123.562 0.745 . . . . 74.24 109.045 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -117.75 123.84 47.0 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.486 0.715 . . . . 64.21 109.919 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 40.2 pt -97.76 138.29 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.074 0.94 . . . . 73.14 112.177 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.523 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 77.0 m-85 -120.7 169.4 10.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.165 1.386 . . . . 51.34 108.347 175.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -85.43 145.99 27.19 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.682 -0.858 . . . . 65.03 108.682 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.555 ' HA ' HG23 ' B' ' 53' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 112.394 0.516 . . . . 65.23 112.394 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.481 0.182 . . . . 74.33 111.339 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.658 HD13 HH22 ' B' ' 56' ' ' ARG . 68.4 mt -62.82 -47.53 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.433 0.693 . . . . 75.41 110.947 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.48 -34.46 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.772 0.829 . . . . 74.11 111.352 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.41 -37.12 94.32 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 112.634 -0.186 . . . . 60.22 112.634 173.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.0 -55.74 8.78 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.699 0.8 . . . . 71.2 112.296 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.615 ' HB2' HD11 ' A' ' 34' ' ' LEU . 36.6 p30 -78.14 -13.46 59.86 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.756 1.021 . . . . 74.52 113.756 -170.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.16 -27.77 64.8 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.651 0.38 . . . . 64.43 111.598 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.23 -45.45 80.48 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 116.15 -0.477 . . . . 21.53 113.552 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -39.17 75.57 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.811 0.444 . . . . 74.11 112.185 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.498 ' HA ' HG11 ' A' ' 32' ' ' VAL . 20.9 m -69.59 -36.19 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.72 0.236 . . . . 74.24 111.221 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.677 ' HA ' HD12 ' A' ' 17' ' ' LEU . 62.3 t90 -69.37 -33.64 73.37 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.91 0.484 . . . . 74.41 111.033 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.61 -33.96 77.12 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.048 0.539 . . . . 65.34 111.321 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.74 76.1 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.231 0.612 . . . . 72.22 111.551 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.677 HD12 ' HA ' ' A' ' 14' ' ' TRP . 31.3 mt -71.91 -33.93 68.69 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.009 0.924 . . . . 60.11 111.641 174.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -30.3 65.23 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.734 0.814 . . . . 65.55 109.944 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -77.23 -41.39 41.36 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.018 0.527 . . . . 64.35 110.492 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.2 107.13 1.8 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.136 0.574 . . . . 73.43 111.612 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.98 174.91 11.15 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.331 0.652 . . . . 63.31 111.148 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.67 42.43 97.27 Favored Glycine 0 N--CA 1.479 1.518 0 CA-C-O 121.406 0.448 . . . . 72.0 112.366 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.433 HD13 ' HB3' ' A' ' 28' ' ' LEU . 21.1 tt -114.92 144.79 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.826 0.851 . . . . 54.14 110.996 -169.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -79.8 151.26 30.4 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.08 0.552 . . . . 72.32 110.889 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.81 -47.1 99.33 Favored Pre-proline 0 CA--C 1.58 2.119 0 N-CA-C 113.326 0.862 . . . . 64.14 113.326 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.05 -22.81 47.14 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.076 1.851 . . . . 71.44 113.468 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -71.91 -48.9 42.27 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.633 0.773 . . . . 64.51 111.673 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.433 ' HB3' HD13 ' A' ' 23' ' ' ILE . 2.2 pt? -74.9 -29.62 61.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.816 -0.553 . . . . 71.5 111.826 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.39 -44.88 65.58 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.385 0.883 . . . . 51.03 113.385 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -70.44 -30.38 67.2 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.922 0.489 . . . . 73.12 112.081 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 25.7 mtpp -68.33 -44.34 75.54 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.575 0.75 . . . . 71.12 110.592 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 13' ' ' VAL . 16.9 m -86.41 -2.0 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.126 0.971 . . . . 64.24 111.805 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 m120 64.84 23.22 12.63 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.104 1.361 . . . . 74.24 112.946 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 9' ' ' ASN . 66.3 mt -101.63 168.2 9.63 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.67 0.788 . . . . 72.41 111.102 174.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 m -71.72 156.97 38.75 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.905 -0.589 . . . . 74.31 110.838 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.39 -48.37 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 123.235 0.614 . . . . 72.24 111.717 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.406 ' HB3' HD12 ' B' ' 25' ' ' ILE . 51.7 mt-10 -63.73 -38.64 91.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.38 0.672 . . . . 54.31 112.658 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.1 m -65.99 -31.14 71.88 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.606 0.762 . . . . 62.43 111.807 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.4 m -77.39 -44.18 30.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.802 0.841 . . . . 73.31 111.112 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.57 -33.55 72.87 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.305 0.642 . . . . 60.32 111.659 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -53.71 54.84 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.546 1.139 . . . . 71.24 110.04 171.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.28 -32.35 72.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.078 -0.965 . . . . 54.14 112.277 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.46 HG11 HD13 ' A' ' 63' ' ' ILE . 69.1 t -68.34 -39.71 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.24 0.616 . . . . 70.24 111.183 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.34 -31.8 81.99 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 116.633 -0.258 . . . . 61.34 113.108 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.403 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 69.2 t-105 -71.18 -30.3 66.25 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.605 0.762 . . . . 72.2 111.685 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.447 HD22 ' HE2' ' A' ' 51' ' ' LYS . 77.5 mt -75.61 -38.07 59.28 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.578 0.751 . . . . 74.25 112.274 170.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.29 -37.01 74.16 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.807 1.243 . . . . 63.31 114.117 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.599 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 25.7 ptt85 -60.39 -26.67 66.84 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 122.935 0.494 . . . . 72.22 111.886 175.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 40.0 mt-10 -103.3 4.96 37.08 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.856 1.262 . . . . 74.21 112.228 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 62.71 21.7 12.9 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 125.031 1.332 . . . . 64.24 113.0 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HE2' HD22 ' A' ' 46' ' ' LEU . 50.8 mtpt -80.2 -13.45 59.23 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.235 0.614 . . . . 74.22 112.283 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.488 HG12 HD13 ' A' ' 17' ' ' LEU . 19.0 m -121.61 142.95 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.759 0.823 . . . . 54.41 111.22 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 94.7 t -112.73 104.98 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 123.846 0.859 . . . . 71.03 109.872 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.583 HG23 HG23 ' A' ' 61' ' ' ILE . 2.6 mp -91.64 125.43 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.561 -0.533 . . . . 64.33 109.561 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.33 113.22 25.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.007 0.523 . . . . 72.32 109.644 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -87.23 96.22 10.25 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.77 -0.826 . . . . 73.44 108.77 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.54 118.12 34.86 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.825 0.85 . . . . 75.02 109.541 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.78 31.56 17.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.871 0.868 . . . . 63.24 111.569 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.52 2.36 74.53 Favored Glycine 0 CA--C 1.546 1.98 0 N-CA-C 114.472 0.549 . . . . 42.44 114.472 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.0 mt -94.92 133.07 39.05 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.945 0.898 . . . . 53.42 110.306 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.583 HG23 HG23 ' A' ' 54' ' ' ILE . 76.6 mt -96.87 118.07 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.489 0.715 . . . . 61.25 111.666 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.37 132.05 55.75 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.914 -0.773 . . . . 62.12 108.914 167.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.46 HD13 HG11 ' A' ' 43' ' ' VAL . 40.0 mt -102.04 132.05 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 121.325 0.583 . . . . 65.14 110.788 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.57 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 83.8 m-85 -124.55 173.55 8.41 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.318 1.047 . . . . 75.55 110.158 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -99.86 163.92 12.25 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.048 0.539 . . . . 74.22 109.727 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.49 1.574 0 C-N-CA 124.441 1.097 . . . . 72.31 112.324 175.106 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.507 ' HA ' HG22 ' B' ' 6' ' ' VAL . 37.5 ttmt . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 112.323 0.49 . . . . 72.52 112.323 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -55.25 -41.24 71.9 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.403 0.621 . . . . 72.15 110.478 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 47.6 mt -66.55 -51.97 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-N 114.677 -1.147 . . . . 64.24 111.457 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' B' ' 3' ' ' LYS . 4.5 m -67.18 -32.3 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 122.584 0.354 . . . . 73.41 111.896 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.47 -44.09 66.19 Favored Glycine 0 C--N 1.349 1.302 0 O-C-N 123.201 0.313 . . . . 53.24 112.749 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.26 69.83 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.505 0.722 . . . . 73.42 112.25 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ASN . . . . . 0.408 ' OD1' HD11 ' B' ' 34' ' ' LEU . 9.0 t-20 -86.67 -28.05 23.4 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.637 0.775 . . . . 61.11 112.131 -175.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.25 72.36 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.275 0.63 . . . . 54.33 112.192 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.81 -42.31 95.17 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 116.11 -0.495 . . . . 64.21 112.373 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -65.11 -45.63 84.33 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.777 0.831 . . . . 73.21 111.479 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.617 ' HA ' HG11 ' B' ' 32' ' ' VAL . 30.9 m -68.83 -32.22 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 C-N-CA 122.772 0.429 . . . . 72.1 112.068 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.501 ' HA ' HD12 ' B' ' 17' ' ' LEU . 34.6 t90 -72.3 -35.77 68.75 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.834 0.454 . . . . 74.41 111.495 175.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -67.46 -32.24 72.95 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.069 0.548 . . . . 74.02 112.018 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.7 74.39 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 122.971 0.508 . . . . 62.23 111.939 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' B' ' 14' ' ' TRP . 82.6 mt -63.67 -30.89 71.94 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.944 0.898 . . . . 52.33 112.602 174.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.2 -5.48 22.89 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.158 0.799 . . . . 51.11 113.158 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -79.67 -61.48 1.98 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.022 0.529 . . . . 74.23 110.469 170.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.94 131.72 5.33 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.511 0.725 . . . . 63.32 110.947 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.525 ' HB3' ' HD1' ' B' ' 64' ' ' TYR . 4.6 m-20 -74.22 175.21 7.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.991 0.916 . . . . 74.42 112.468 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.72 54.81 5.24 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.535 -0.626 . . . . 72.41 111.535 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 tt -133.6 120.34 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.53 0.732 . . . . 71.13 110.994 -167.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -67.74 163.49 21.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.633 0.773 . . . . 54.01 111.911 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' B' ' 40' ' ' ALA . 48.5 mt -59.7 -47.12 98.26 Favored Pre-proline 0 CA--C 1.574 1.901 0 CA-C-O 118.525 -0.75 . . . . 73.02 112.434 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.02 -22.99 34.69 Favored 'Trans proline' 0 C--N 1.396 3.044 0 C-N-CA 121.871 1.714 . . . . 50.41 114.064 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -70.73 -50.45 36.08 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.686 1.231 . . . . 75.24 109.017 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.83 -39.1 83.97 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 112.612 -2.085 . . . . 72.51 111.679 175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.17 -43.11 87.28 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.105 0.962 . . . . 74.05 112.867 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -69.71 -36.93 76.34 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.003 0.521 . . . . 74.25 111.587 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -64.39 -44.85 90.04 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.244 0.618 . . . . 73.14 111.148 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' B' ' 13' ' ' VAL . 13.7 m -88.23 5.34 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.35 0.66 . . . . 73.13 112.727 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 69.32 17.81 8.14 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.798 1.239 . . . . 71.31 113.137 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.408 HD11 ' OD1' ' B' ' 9' ' ' ASN . 63.3 mt -110.65 174.95 5.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.627 0.771 . . . . 74.32 112.287 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -84.31 160.72 20.65 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.17 -0.923 . . . . 74.43 110.577 167.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 63.2 t -53.89 -49.82 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 124.1 0.96 . . . . 73.44 112.653 -175.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.37 -48.3 82.34 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.579 0.752 . . . . 73.51 111.985 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -62.67 -37.13 85.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.942 0.897 . . . . 64.55 111.892 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.485 ' O ' HG23 ' B' ' 43' ' ' VAL . 85.1 m -69.07 -51.31 40.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.578 0.751 . . . . 75.34 111.609 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -55.04 -44.51 74.73 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.802 0.841 . . . . 44.24 111.974 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.72 -36.19 82.91 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.393 1.077 . . . . 62.43 111.203 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.44 83.27 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.775 0.43 . . . . 74.35 112.151 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.485 HG23 ' O ' ' B' ' 39' ' ' THR . 24.8 t -67.54 -29.19 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.51 0.724 . . . . 72.33 111.449 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.73 -28.16 56.5 Favored Glycine 0 CA--C 1.551 2.282 0 N-CA-C 114.502 0.561 . . . . 40.41 114.502 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.488 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 72.6 t-105 -74.33 -24.69 59.23 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.443 0.697 . . . . 70.41 111.533 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.443 HD11 HG23 ' B' ' 13' ' ' VAL . 83.9 mt -72.77 -36.04 67.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.563 0.745 . . . . 42.13 111.636 173.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.97 -33.51 67.15 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.728 0.811 . . . . 74.44 112.363 172.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 33.1 ttt-85 -54.63 -49.78 69.7 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.971 0.908 . . . . 64.23 111.481 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.27 -1.35 57.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.51 0.724 . . . . 73.44 112.58 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 64.17 21.96 12.72 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.812 1.245 . . . . 63.52 113.177 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -86.61 1.37 52.02 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.08 0.77 . . . . 65.33 113.08 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.36 155.68 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 123.362 0.665 . . . . 73.22 112.027 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 45.8 t -120.43 96.57 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.532 -0.914 . . . . 63.13 108.532 169.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.475 HD11 HG12 ' B' ' 43' ' ' VAL . 35.7 mt -95.75 102.27 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.158 0.504 . . . . 63.32 109.676 -177.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -134.29 132.27 39.39 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.994 -0.441 . . . . 63.52 111.629 -166.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.658 HH22 HD13 ' A' ' 5' ' ' ILE . 6.7 mtm-85 -86.8 97.05 10.41 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.799 0.809 . . . . 63.03 110.405 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -108.35 128.31 54.64 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.653 -1.158 . . . . 72.21 109.151 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 59.31 29.9 19.54 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.492 1.117 . . . . 75.52 111.14 -170.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.99 -21.39 7.98 Favored Glycine 0 C--N 1.36 1.915 0 CA-C-N 115.879 -0.601 . . . . 44.22 114.514 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mp -89.7 135.52 33.57 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.453 0.701 . . . . 43.22 110.74 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.639 HG13 ' HG2' ' B' ' 56' ' ' ARG . 1.4 mp -73.93 107.99 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 C-N-CA 123.593 0.757 . . . . 63.44 109.682 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -107.53 120.27 41.74 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.014 0.926 . . . . 70.25 110.494 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.444 ' N ' HD12 ' B' ' 63' ' ' ILE . 2.2 mp -94.24 132.31 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 109.149 -0.685 . . . . 55.54 109.149 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.625 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 90.5 m-85 -123.5 174.0 7.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.473 1.109 . . . . 71.52 109.997 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -93.97 158.26 15.72 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 109.142 -0.688 . . . . 74.43 109.142 166.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 N--CA 1.488 1.46 0 C-N-CA 124.358 1.063 . . . . 73.32 113.397 -178.172 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 112.438 0.532 . . . . 72.33 112.438 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.4 mt -52.8 -58.13 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.118 0.967 . . . . 64.22 112.115 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -60.79 -37.47 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 112.926 0.713 . . . . 75.24 112.926 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.79 -38.84 41.2 Favored Glycine 0 N--CA 1.476 1.366 0 O-C-N 123.237 0.336 . . . . 24.21 113.041 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.72 -36.73 83.92 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.943 0.897 . . . . 74.13 111.971 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -84.15 -28.92 27.08 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.092 -0.504 . . . . 31.31 111.622 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.82 71.12 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 122.908 0.483 . . . . 72.34 111.986 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.7 97.23 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.245 -0.434 . . . . 72.22 112.975 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -72.67 -38.29 67.65 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.925 0.89 . . . . 75.4 111.579 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.741 ' HA ' HG11 ' A' ' 32' ' ' VAL . 54.2 t -62.98 -47.74 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.79 0.836 . . . . 75.0 111.28 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -66.17 -33.43 75.75 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.623 -0.717 . . . . 73.02 111.35 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -61.62 -42.42 98.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.402 0.681 . . . . 75.4 111.681 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.21 74.03 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.327 0.651 . . . . 72.14 111.491 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 21' ' ' ASP . 2.5 tm? -70.73 -30.7 67.31 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.213 1.405 . . . . 72.3 111.536 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -64.24 -42.95 96.31 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.945 0.898 . . . . 73.12 112.816 -169.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -81.69 -15.22 55.17 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.005 0.743 . . . . 53.14 113.005 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.53 96.06 1.14 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.961 0.504 . . . . 64.21 110.738 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.451 ' HA ' HD22 ' A' ' 17' ' ' LEU . 8.7 p-10 -86.02 169.2 13.41 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.09 0.556 . . . . 75.12 112.009 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.86 55.06 3.94 Favored Glycine 0 C--N 1.344 1.009 0 N-CA-C 111.698 -0.561 . . . . 60.13 111.698 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 tt -130.13 136.43 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.979 0.911 . . . . 75.33 110.421 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.9 p -74.97 154.59 38.04 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.783 0.433 . . . . 70.11 111.242 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.564 HG21 ' HB2' ' A' ' 40' ' ' ALA . 63.8 mt -52.36 -47.42 92.97 Favored Pre-proline 0 CA--C 1.573 1.837 0 N-CA-C 114.056 1.132 . . . . 64.15 114.056 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.69 -33.05 56.19 Favored 'Trans proline' 0 C--N 1.393 2.902 0 C-N-CA 121.714 1.609 . . . . 75.51 114.319 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 30' ' ' ARG . 37.6 mt-10 -76.74 -31.0 56.84 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.395 1.093 . . . . 73.33 110.453 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.81 -33.3 66.14 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 113.668 -1.605 . . . . 74.32 110.603 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.9 -39.4 87.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.895 0.878 . . . . 65.13 112.855 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 14.2 ptt180 -70.38 -28.08 64.82 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.401 0.28 . . . . 64.24 111.053 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -67.27 -37.74 83.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.961 0.904 . . . . 75.13 111.574 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.741 HG11 ' HA ' ' A' ' 13' ' ' VAL . 24.6 m -102.8 0.73 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 112.989 0.737 . . . . 73.0 112.989 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 65.71 28.47 11.06 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.808 1.243 . . . . 74.41 112.635 174.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.4 mt -109.0 175.12 5.57 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.943 0.897 . . . . 53.41 111.244 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 99.9 p -77.99 163.74 25.68 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.319 0.648 . . . . 70.4 110.37 168.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -58.18 -45.92 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.09 0.556 . . . . 63.42 111.17 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.71 -37.51 82.35 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.954 0.902 . . . . 73.11 112.648 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -69.69 -37.37 76.59 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.129 0.49 . . . . 62.54 111.563 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 43' ' ' VAL . 93.8 m -72.88 -44.66 61.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.494 0.717 . . . . 70.11 111.281 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -57.86 -35.63 71.22 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.966 0.906 . . . . 73.11 111.972 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -51.8 67.15 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 114.795 -1.093 . . . . 60.43 110.207 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.04 70.96 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.862 -1.063 . . . . 72.22 111.723 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 39' ' ' THR . 79.4 t -69.23 -38.25 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.367 0.667 . . . . 71.03 110.664 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.89 -31.77 82.02 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 116.359 -0.382 . . . . 74.24 113.459 172.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.507 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 66.9 t-105 -73.92 -30.15 62.42 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.449 0.699 . . . . 73.23 111.047 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.19 -37.44 69.29 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.922 0.489 . . . . 72.21 111.184 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.76 -30.09 71.19 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.95 0.9 . . . . 73.41 111.724 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 21.5 ttt180 -55.88 -50.6 70.2 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.564 0.745 . . . . 75.23 110.884 167.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -84.71 -3.23 58.46 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 115.197 -0.911 . . . . 75.02 111.961 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 62.25 22.22 13.02 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 125.258 1.423 . . . . 73.32 112.764 -175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -69.55 -24.82 63.77 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.41 1.084 . . . . 64.3 112.367 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.59 151.14 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.64 0.776 . . . . 63.44 110.813 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.494 HG12 ' HG3' ' A' ' 55' ' ' GLU . 44.6 t -116.92 111.45 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 123.712 0.805 . . . . 74.53 110.242 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.497 HG23 HG23 ' A' ' 61' ' ' ILE . 3.4 mp -86.56 107.98 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 N-CA-C 109.389 -0.596 . . . . 72.22 109.389 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG3' HG12 ' A' ' 53' ' ' VAL . 54.3 mt-10 -118.44 118.03 30.65 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.538 0.735 . . . . 65.12 110.382 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -85.24 100.96 12.13 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.136 0.974 . . . . 72.54 110.076 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -114.63 109.15 17.8 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.069 0.948 . . . . 62.52 109.885 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 57.63 32.67 22.2 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.171 0.988 . . . . 73.04 111.831 -169.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.3 -9.92 62.74 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 115.557 -0.747 . . . . 50.11 114.311 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.5 mt -80.0 107.55 12.87 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.191 0.596 . . . . 43.51 109.997 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.497 HG23 HG23 ' A' ' 54' ' ' ILE . 76.7 mt -69.88 102.63 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.321 -0.622 . . . . 75.21 109.321 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -110.19 124.11 50.98 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.923 0.889 . . . . 71.43 109.847 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.1 mp -91.72 103.25 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 108.602 -0.888 . . . . 74.03 108.602 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -91.81 175.77 6.77 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.073 0.949 . . . . 74.03 110.941 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -90.81 158.87 16.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.081 0.552 . . . . 74.35 110.525 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.483 1.218 0 C-N-CA 123.517 0.727 . . . . 74.42 110.379 171.564 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 113.063 0.764 . . . . 75.53 113.063 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.24 -35.02 14.03 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.259 0.623 . . . . 74.43 112.344 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 58.8 mt -61.52 -40.71 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.502 0.721 . . . . 62.51 111.841 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 28.6 m -61.49 -30.28 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.884 0.874 . . . . 74.3 112.091 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.03 -39.65 94.86 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 122.888 0.118 . . . . 24.11 113.057 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.94 -53.04 10.98 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.55 0.74 . . . . 72.12 112.496 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -70.29 -30.59 67.64 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.215 0.821 . . . . 65.22 113.215 -172.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.35 -25.21 61.45 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.265 0.626 . . . . 64.05 111.924 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.55 -38.71 96.08 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 116.166 -0.47 . . . . 73.4 112.816 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -70.85 -40.03 72.59 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.691 0.796 . . . . 74.34 111.174 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.4 ' HA ' HG11 ' B' ' 32' ' ' VAL . 92.3 t -63.03 -48.41 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.124 0.57 . . . . 34.35 111.332 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.475 ' HA ' HD12 ' B' ' 17' ' ' LEU . 40.4 t90 -65.55 -34.13 77.53 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.245 0.618 . . . . 74.53 110.989 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -62.46 -39.42 93.36 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.76 0.824 . . . . 73.22 110.636 173.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.15 -32.12 72.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.647 0.779 . . . . 63.41 111.683 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' B' ' 14' ' ' TRP . 69.3 mt -74.4 -31.91 62.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.455 0.702 . . . . 63.31 111.426 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.03 -25.97 62.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.008 0.523 . . . . 74.12 110.689 -177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -95.73 -29.41 14.28 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.521 0.728 . . . . 74.1 111.476 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.78 94.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.446 0.698 . . . . 70.12 111.74 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -96.87 179.4 4.97 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.286 0.634 . . . . 72.14 111.755 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.54 37.39 53.03 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.474 -0.33 . . . . 62.32 113.224 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 tt -119.27 151.17 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.064 0.946 . . . . 74.25 110.632 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -61.97 140.52 58.32 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.971 0.508 . . . . 73.23 111.348 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' B' ' 40' ' ' ALA . 64.8 mt -53.81 -45.9 98.65 Favored Pre-proline 0 CA--C 1.576 1.962 0 N-CA-C 113.219 0.822 . . . . 63.43 113.219 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.438 ' HA ' HG22 ' B' ' 36' ' ' VAL . 36.9 Cg_endo -63.13 -29.4 74.32 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.116 1.877 . . . . 71.44 115.072 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.22 -49.16 17.91 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.126 0.965 . . . . 71.1 109.759 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -55.05 -36.26 65.36 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 113.326 -1.761 . . . . 62.45 112.083 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.39 -42.79 87.85 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.007 0.923 . . . . 72.03 112.058 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -72.46 -24.7 61.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.832 -0.622 . . . . 61.51 111.28 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -76.09 -41.99 48.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.416 0.687 . . . . 54.24 111.391 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' B' ' 13' ' ' VAL . 24.1 m -89.77 3.76 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.168 0.587 . . . . 64.24 112.366 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 67.09 22.48 9.89 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.736 1.214 . . . . 71.22 112.424 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.85 171.29 7.68 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.337 0.655 . . . . 74.32 111.561 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.2 t -72.99 158.62 35.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.342 0.657 . . . . 42.21 111.093 170.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' B' ' 26' ' ' PRO . 41.7 t -57.33 -47.48 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.349 0.66 . . . . 52.04 111.306 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -64.0 -40.82 97.23 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.604 -0.726 . . . . 75.04 112.048 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -66.93 -34.08 77.0 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.367 0.667 . . . . 72.51 112.115 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.452 ' O ' HG23 ' B' ' 43' ' ' VAL . 90.3 m -76.6 -39.87 51.21 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.627 0.771 . . . . 61.34 111.07 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.435 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -63.78 -37.92 89.16 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.323 0.582 . . . . 55.34 111.127 174.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.97 -40.96 97.58 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.667 1.187 . . . . 63.45 110.519 172.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.48 -43.37 94.41 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.359 0.663 . . . . 42.2 112.005 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.618 HG11 HG21 ' B' ' 63' ' ' ILE . 84.5 t -61.24 -31.23 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.109 0.564 . . . . 71.33 111.321 176.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.36 -29.2 68.47 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 114.58 0.592 . . . . 74.43 114.58 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.454 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 76.9 t-105 -72.92 -34.34 66.55 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.712 0.805 . . . . 72.02 111.111 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 77.1 mt -71.42 -40.25 70.55 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.142 0.577 . . . . 41.54 110.322 174.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.91 -31.97 73.34 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.351 1.06 . . . . 73.33 111.708 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 16.1 ttp85 -52.64 -51.79 58.52 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.582 0.706 . . . . 61.21 110.945 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.434 ' HB2' ' HG2' ' B' ' 51' ' ' LYS . 35.2 mt-10 -83.89 -8.93 59.07 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.875 -1.057 . . . . 72.21 111.669 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 63.42 29.82 15.49 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.012 1.325 . . . . 73.4 112.115 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' B' ' 49' ' ' GLU . 8.4 mmmm -69.28 -9.59 53.9 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.486 1.515 . . . . 64.35 113.009 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.26 150.05 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 124.127 0.971 . . . . 73.04 111.24 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 94.7 t -93.21 129.2 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.985 0.914 . . . . 51.14 109.455 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.63 120.85 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.87 -1.159 . . . . 73.41 107.87 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' GLU . . . . . 0.436 ' HG2' ' NZ ' ' B' ' 57' ' ' LYS . 8.9 tp10 -137.95 158.62 43.97 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.201 0.601 . . . . 73.04 110.487 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -118.83 114.14 22.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.992 0.517 . . . . 64.44 110.252 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' LYS . . . . . 0.493 ' HD3' ' HG3' ' B' ' 62' ' ' GLU . 13.9 mptt -101.99 107.49 18.65 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.01 0.924 . . . . 74.34 108.618 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 57.96 31.99 21.35 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.473 1.109 . . . . 63.54 111.847 -175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.51 34.69 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 115.949 -0.569 . . . . 62.41 113.812 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 75.6 mt -75.57 136.89 40.52 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.453 0.701 . . . . 62.41 111.215 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.58 117.7 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-O 121.271 0.557 . . . . 60.44 110.463 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLU . . . . . 0.493 ' HG3' ' HD3' ' B' ' 57' ' ' LYS . 39.1 mm-40 -108.14 142.6 38.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.491 1.516 . . . . 73.2 110.491 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.618 HG21 HG11 ' B' ' 43' ' ' VAL . 2.0 pp -133.5 122.5 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 CA-C-O 121.783 0.801 . . . . 75.02 111.206 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.671 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 55.3 m-85 -115.4 171.28 7.81 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.864 0.866 . . . . 75.25 110.295 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -100.79 153.45 19.46 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.102 0.561 . . . . 75.44 109.914 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 . . . . . 0 N--CA 1.488 1.469 0 O-C-N 122.079 -0.388 . . . . 61.35 111.755 173.11 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 113.698 0.999 . . . . 73.24 113.698 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -49.1 -52.8 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 118.585 0.63 . . . . 71.1 111.083 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.71 -28.22 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.04 0.536 . . . . 54.51 112.265 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.41 -42.66 33.45 Favored Glycine 0 C--N 1.351 1.371 0 O-C-N 123.302 0.376 . . . . 55.51 113.558 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.7 -44.42 81.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.809 0.844 . . . . 64.23 111.209 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -71.64 -28.89 64.08 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.84 -0.618 . . . . 61.21 111.707 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.402 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . . . -72.09 -29.03 63.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.679 0.392 . . . . 62.23 111.263 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.11 -37.28 92.92 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 115.997 -0.547 . . . . 70.32 112.46 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -75.26 -38.92 60.26 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 122.881 0.472 . . . . 75.21 111.271 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.445 HG13 HD11 ' A' ' 28' ' ' LEU . 53.1 t -64.14 -46.12 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.889 0.875 . . . . 74.35 111.284 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -67.67 -33.32 74.69 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.514 -0.312 . . . . 71.01 110.313 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -63.91 -33.0 74.72 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 122.416 -0.178 . . . . 73.3 111.027 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HB3' HD12 ' A' ' 28' ' ' LEU . . . -67.22 -28.5 68.12 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.82 0.448 . . . . 64.42 111.846 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.4 -45.46 54.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.784 0.834 . . . . 75.13 110.633 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -59.71 -29.86 68.41 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.495 1.118 . . . . 75.51 111.559 173.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -82.06 -52.94 6.52 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.07 0.948 . . . . 72.31 110.26 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.35 96.59 2.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.467 1.107 . . . . 34.42 109.567 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -73.94 154.16 39.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.607 0.763 . . . . 63.42 113.016 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.6 65.37 2.43 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 116.076 -0.511 . . . . 43.12 112.935 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.504 HD11 ' HG3' ' A' ' 27' ' ' GLU . 20.7 tt -134.25 143.76 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 122.871 0.468 . . . . 62.34 111.819 -169.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 49.4 m -67.61 146.08 54.22 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.546 0.738 . . . . 75.43 111.815 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.441 HG21 ' HB2' ' A' ' 40' ' ' ALA . 55.9 mt -53.4 -48.94 90.93 Favored Pre-proline 0 CA--C 1.577 1.994 0 C-N-CA 124.175 0.99 . . . . 75.42 113.581 -176.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.86 -27.59 43.54 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 121.765 1.643 . . . . 75.51 113.553 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.504 ' HG3' HD11 ' A' ' 23' ' ' ILE . 10.8 tp10 -73.12 -55.62 6.23 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 112.402 0.519 . . . . 73.22 112.402 -174.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 16' ' ' ALA . 2.2 pt? -66.41 -29.31 69.44 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.078 0.399 . . . . 74.23 111.245 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.37 -42.67 53.67 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.719 0.808 . . . . 73.23 112.168 171.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -63.81 -40.4 96.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.074 0.55 . . . . 74.41 111.596 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -69.04 -38.06 78.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.889 0.876 . . . . 74.51 111.473 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.1 m -94.85 4.66 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.524 0.73 . . . . 74.35 112.201 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 64.81 21.23 12.32 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 124.741 1.216 . . . . 64.04 112.336 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.6 mt -105.91 162.59 13.44 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.38 0.672 . . . . 75.41 111.527 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -69.81 158.48 35.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.433 -0.803 . . . . 73.5 111.249 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -56.91 -42.22 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.241 0.616 . . . . 74.32 110.744 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.16 -50.03 73.46 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.699 0.8 . . . . 75.35 111.497 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -58.15 -38.94 77.54 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.819 0.848 . . . . 71.51 111.856 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 43' ' ' VAL . 97.9 m -70.69 -52.69 19.37 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.661 0.785 . . . . 63.12 111.391 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.17 -32.58 74.2 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 123.797 0.839 . . . . 70.23 112.772 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -72.66 -41.17 65.71 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.171 0.988 . . . . 74.34 109.808 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -66.02 -30.52 71.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.307 0.643 . . . . 62.51 111.586 175.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 39' ' ' THR . 49.5 t -65.8 -43.97 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.339 1.056 . . . . 74.23 110.304 171.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.27 -28.37 72.89 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 116.11 -0.495 . . . . 71.3 112.713 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.424 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 77.2 t-105 -70.28 -44.4 68.47 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.207 0.603 . . . . 75.31 110.829 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 51' ' ' LYS . 88.0 mt -60.9 -31.37 70.86 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.267 0.627 . . . . 72.21 111.735 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.07 -25.0 57.95 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.574 1.15 . . . . 73.11 113.63 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.745 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 23.6 ptt180 -57.12 -35.59 69.65 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 123.07 0.548 . . . . 51.53 111.519 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.745 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 28.9 mt-10 -106.28 8.39 31.83 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.64 1.176 . . . . 75.1 110.93 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 63.39 23.8 13.89 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.037 1.335 . . . . 74.23 112.698 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG3' ' HB2' ' A' ' 49' ' ' GLU . 28.1 mtpp -70.16 -10.96 60.47 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.677 0.991 . . . . 75.32 113.677 -174.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 m -126.59 148.48 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.792 0.837 . . . . 65.21 111.545 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.629 HG23 ' HB2' ' A' ' 64' ' ' TYR . 6.7 m -131.0 112.41 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 C-N-CA 124.516 1.126 . . . . 74.42 109.84 170.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.606 HG13 HG22 ' A' ' 63' ' ' ILE . 3.0 mp -92.07 134.99 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.61 1.164 . . . . 73.04 110.745 -171.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -139.04 144.76 38.96 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.353 0.661 . . . . 73.23 110.486 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -116.06 112.61 22.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.504 0.669 . . . . 71.52 110.528 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -105.4 128.88 53.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.143 0.977 . . . . 64.41 109.447 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 58.64 31.76 21.45 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 124.635 1.174 . . . . 62.43 113.025 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.91 -9.86 54.81 Favored Glycine 0 CA--C 1.541 1.711 0 N-CA-C 114.469 0.548 . . . . 61.55 114.469 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.71 135.07 36.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.323 1.049 . . . . 74.05 109.342 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' B' ' 37' ' ' GLU . 19.5 mt -104.09 125.02 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 CA-C-O 121.544 0.688 . . . . 73.44 112.345 -170.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 8.8 mp0 -117.96 153.53 33.46 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.806 1.642 . . . . 45.34 109.725 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.606 HG22 HG13 ' A' ' 54' ' ' ILE . 48.1 pt -113.89 142.7 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.304 0.573 . . . . 63.35 110.69 171.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.629 ' HB2' HG23 ' A' ' 53' ' ' VAL . 80.9 m-85 -125.07 167.39 14.84 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.225 1.01 . . . . 52.13 110.135 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -86.87 148.9 25.17 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.539 0.736 . . . . 65.34 112.011 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.555 1.139 0 CA-C-N 115.766 -0.652 . . . . 74.31 110.093 166.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.364 0 CA-C-O 121.105 0.479 . . . . 75.3 111.738 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.26 -44.54 10.76 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.643 1.177 . . . . 62.3 110.119 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -56.18 -48.35 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 123.729 0.812 . . . . 64.45 111.612 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.444 HG12 HD11 ' B' ' 41' ' ' LEU . 32.6 m -63.38 -30.45 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.338 1.055 . . . . 74.13 112.297 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.43 -44.13 85.09 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.181 0.301 . . . . 72.13 112.78 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.66 69.23 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.513 0.725 . . . . 61.44 111.832 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -66.1 -48.65 70.24 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.733 1.213 . . . . 74.54 110.927 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 -20.93 63.8 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.365 0.666 . . . . 52.13 112.112 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.29 -43.74 94.72 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 123.172 0.295 . . . . 64.21 112.986 174.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -68.62 -45.93 70.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.706 0.802 . . . . 72.53 110.912 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.46 ' HA ' HG11 ' B' ' 32' ' ' VAL . 96.6 t -60.01 -49.65 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.808 0.843 . . . . 75.13 111.708 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -60.87 -44.35 97.18 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.581 0.753 . . . . 71.25 111.738 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -62.29 -43.68 98.27 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.025 0.53 . . . . 53.32 111.883 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.04 68.88 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.367 0.667 . . . . 73.24 111.407 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -72.42 -32.68 66.54 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.744 1.218 . . . . 73.55 110.578 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -81.77 -18.97 42.31 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.201 0.6 . . . . 54.13 110.6 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -67.54 -33.77 75.72 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.545 0.738 . . . . 64.2 110.227 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.12 108.59 1.12 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.256 1.022 . . . . 64.14 109.564 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -93.58 173.6 7.61 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 112.318 0.488 . . . . 73.54 112.318 -175.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.26 44.68 8.63 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.969 -0.56 . . . . 70.32 111.943 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 tt -134.33 137.71 51.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.844 0.857 . . . . 64.13 110.116 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 70.3 m -78.13 160.17 28.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.438 0.695 . . . . 72.1 112.732 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.484 HG21 ' HB2' ' B' ' 40' ' ' ALA . 81.2 mt -49.32 -53.56 38.58 Favored Pre-proline 0 CA--C 1.572 1.804 0 C-N-CA 125.817 1.647 . . . . 65.52 114.037 -177.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.68 -23.75 30.83 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 121.556 1.504 . . . . 71.53 113.387 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -76.5 -55.76 5.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.213 0.605 . . . . 73.12 110.596 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.3 -29.7 70.62 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.507 0.723 . . . . 64.34 111.601 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' B' ' 39' ' ' THR . . . -52.9 -37.75 61.0 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.803 0.841 . . . . 74.32 112.812 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -71.75 -34.79 69.78 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.25 0.833 . . . . 74.04 113.25 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -76.92 -31.43 56.68 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.548 0.613 . . . . 53.15 111.646 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' B' ' 13' ' ' VAL . 33.3 m -88.03 -4.72 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.555 0.342 . . . . 73.22 111.555 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t30 68.67 17.65 8.88 Favored 'General case' 0 CA--C 1.57 1.72 0 C-N-CA 124.779 1.232 . . . . 60.41 112.119 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 70.3 mt -102.8 163.75 12.03 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.548 0.739 . . . . 74.13 111.388 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 62.8 m -67.7 158.54 32.06 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.448 0.699 . . . . 63.44 111.785 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.424 HG13 HG22 ' B' ' 25' ' ' ILE . 61.8 t -64.43 -43.48 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.099 0.559 . . . . 74.43 111.946 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.678 ' HB2' HD12 ' A' ' 61' ' ' ILE . 45.8 mt-10 -62.97 -31.98 73.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.768 0.427 . . . . 72.12 111.946 175.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 42.3 m -63.63 -45.27 91.03 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.46 0.704 . . . . 72.34 111.114 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.501 HG21 ' HA ' ' B' ' 29' ' ' ALA . 17.0 p -76.46 -41.02 48.79 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.178 0.807 . . . . 75.24 113.178 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -56.0 -46.51 78.7 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 123.863 0.865 . . . . 41.43 111.974 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.444 HD11 HG12 ' B' ' 6' ' ' VAL . 0.9 OUTLIER -67.9 -40.32 83.5 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 114.256 -1.338 . . . . 74.31 111.112 177.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.27 84.77 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.219 0.608 . . . . 73.5 112.102 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.509 HG13 HG21 ' B' ' 52' ' ' VAL . 55.3 t -65.87 -34.47 70.53 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.071 0.948 . . . . 64.32 110.601 174.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -65.71 -37.04 93.09 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 116.545 -0.298 . . . . 70.21 112.925 171.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.511 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 77.2 t-105 -67.18 -30.45 70.41 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.668 0.787 . . . . 75.31 111.474 175.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.5 -39.37 67.7 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.075 0.55 . . . . 73.51 110.936 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.9 -25.85 67.81 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.446 1.099 . . . . 74.43 113.397 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.619 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 16.5 ptt180 -58.93 -36.45 74.77 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.017 0.437 . . . . 61.22 111.015 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.619 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 43.8 mt-10 -104.75 3.18 31.02 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.686 1.194 . . . . 65.05 111.033 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.1 t30 58.88 35.86 24.38 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 125.396 1.478 . . . . 70.11 111.584 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -70.59 -17.11 62.91 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.479 -0.782 . . . . 63.45 111.044 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.509 HG21 HG13 ' B' ' 43' ' ' VAL . 24.9 m -131.68 153.29 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.283 1.033 . . . . 74.22 109.304 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.579 HG23 ' HB2' ' B' ' 64' ' ' TYR . 7.2 m -115.51 116.63 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.537 0.735 . . . . 71.03 110.15 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 48.5 mm -81.3 104.96 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.849 0.859 . . . . 63.33 110.217 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -119.45 108.43 14.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.351 0.66 . . . . 44.33 109.807 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.511 ' HB3' HG13 ' B' ' 61' ' ' ILE . 29.0 ptt180 -92.03 106.34 18.38 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.955 0.883 . . . . 74.53 110.484 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -103.63 127.83 51.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.988 1.315 . . . . 71.4 109.607 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 57.74 29.66 17.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.711 1.204 . . . . 72.05 111.505 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.2 -27.65 6.71 Favored Glycine 0 CA--C 1.546 1.976 0 CA-C-N 115.231 -0.895 . . . . 33.52 113.858 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.87 123.43 27.75 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.874 0.87 . . . . 61.41 110.795 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.511 HG13 ' HB3' ' B' ' 56' ' ' ARG . 2.8 mp -74.57 123.21 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 122.739 0.416 . . . . 73.31 110.128 -174.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -119.53 138.33 53.24 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.204 1.002 . . . . 73.55 109.752 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.432 HD11 HG13 ' B' ' 25' ' ' ILE . 2.2 mp -107.09 112.09 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.075 0.55 . . . . 75.11 110.031 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.579 ' HB2' HG23 ' B' ' 53' ' ' VAL . 85.9 m-85 -107.11 159.29 16.42 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.321 1.048 . . . . 63.52 110.52 174.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -82.51 171.55 13.99 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.957 0.725 . . . . 71.41 112.957 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 CA--C 1.56 1.356 0 C-N-CA 124.172 0.989 . . . . 74.33 112.694 171.072 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.0 mttt . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.614 0.245 . . . . 74.2 111.067 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.8 mt -62.86 -47.53 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.613 0.765 . . . . 75.42 111.627 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.42 -30.42 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.099 0.56 . . . . 73.12 111.264 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.93 -51.25 47.22 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.825 0.703 . . . . 63.02 112.269 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.42 81.83 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.844 0.858 . . . . 64.45 112.284 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -65.82 -29.47 69.95 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.507 0.723 . . . . 73.24 112.182 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.12 -44.88 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.033 0.533 . . . . 52.44 111.367 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.17 94.65 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.48 -0.648 . . . . 64.13 111.48 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -61.76 -50.01 74.11 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.328 1.051 . . . . 64.4 112.583 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.673 ' HA ' HG11 ' A' ' 32' ' ' VAL . 32.9 m -67.55 -29.54 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 120.656 0.265 . . . . 73.21 111.711 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.607 ' HA ' HD12 ' A' ' 17' ' ' LEU . 24.4 t90 -68.6 -32.83 73.0 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.286 0.634 . . . . 71.45 111.546 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -58.68 -36.84 74.84 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 122.813 0.445 . . . . 71.13 111.666 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.91 69.49 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.218 0.607 . . . . 75.35 112.162 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 14' ' ' TRP . 81.2 mt -66.54 -22.58 66.16 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.727 0.811 . . . . 72.25 112.194 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -64.58 -28.08 69.39 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.417 0.687 . . . . 71.13 111.463 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -77.01 -57.4 3.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.24 0.616 . . . . 75.05 110.521 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.34 107.6 3.27 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.481 0.712 . . . . 64.51 110.765 -174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 6.2 p-10 -95.72 164.57 12.7 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.509 0.724 . . . . 75.31 110.842 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.15 26.67 51.93 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 121.475 0.486 . . . . 73.21 112.128 -166.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 tt -96.63 153.71 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 124.46 1.104 . . . . 74.31 110.139 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -79.17 156.4 28.24 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.902 -0.499 . . . . 62.11 111.458 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.487 HG21 ' HB2' ' A' ' 40' ' ' ALA . 80.2 mt -56.32 -50.36 88.04 Favored Pre-proline 0 CA--C 1.575 1.908 0 C-N-CA 124.468 1.107 . . . . 64.43 113.908 -173.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.25 -24.07 38.18 Favored 'Trans proline' 0 C--N 1.394 2.93 0 CA-C-N 121.399 1.535 . . . . 73.21 114.049 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -76.5 -45.1 32.45 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.43 1.11 . . . . 71.53 109.683 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.442 HD22 HD11 ' A' ' 63' ' ' ILE . 63.1 tp -59.34 -40.6 86.91 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 113.129 -1.85 . . . . 74.4 111.09 172.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.15 81.82 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.325 1.05 . . . . 72.11 111.917 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -65.09 -40.87 95.2 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.626 0.77 . . . . 75.25 111.446 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -63.9 -40.82 97.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.153 0.581 . . . . 74.2 111.67 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.6 m -95.83 -1.93 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 112.966 0.728 . . . . 71.41 112.966 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.0 t30 68.02 13.64 9.17 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 124.483 1.113 . . . . 70.0 112.506 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -92.74 166.25 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.463 -0.773 . . . . 64.5 111.062 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.0 t -64.43 154.01 36.97 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.102 0.561 . . . . 65.44 111.701 171.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.38 -48.01 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.808 0.843 . . . . 71.4 110.615 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -62.6 -42.37 99.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.327 1.051 . . . . 73.34 111.676 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.494 ' HA ' HH21 ' B' ' 56' ' ' ARG . 67.7 m -65.48 -30.62 71.42 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.596 0.758 . . . . 31.44 112.256 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 43' ' ' VAL . 63.2 m -82.08 -43.01 18.42 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.784 0.834 . . . . 73.04 111.512 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.487 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -58.69 -50.81 72.52 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.001 0.921 . . . . 75.12 112.142 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -66.28 -32.48 73.92 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 114.087 -1.415 . . . . 71.35 110.831 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.35 -38.7 71.61 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.26 0.624 . . . . 73.52 111.961 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.569 HG11 HG21 ' A' ' 63' ' ' ILE . 69.3 t -64.89 -31.33 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.18 0.592 . . . . 61.11 110.835 175.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -58.79 -33.02 71.25 Favored Glycine 0 CA--C 1.544 1.858 0 CA-C-N 116.271 -0.422 . . . . 33.35 113.322 171.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -71.95 -30.63 65.5 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.543 0.737 . . . . 74.12 111.172 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.24 -38.79 71.94 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.675 0.39 . . . . 74.32 111.429 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.46 -34.95 78.88 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.562 0.745 . . . . 52.42 110.825 172.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.645 ' HG2' ' HB3' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -63.79 -43.97 94.75 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.013 1.325 . . . . 74.32 111.267 172.632 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -85.48 -1.14 56.74 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.606 0.762 . . . . 74.34 112.69 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 64.96 22.61 12.48 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.776 1.23 . . . . 75.11 112.729 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 61.5 mttp -77.49 -20.87 53.65 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.766 0.827 . . . . 72.01 112.454 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.92 154.74 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.48 0.657 . . . . 74.23 112.172 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 47.7 t -105.23 104.31 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.348 1.059 . . . . 71.13 109.065 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 mm -71.59 122.49 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 109.454 -0.572 . . . . 50.33 109.454 175.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.28 133.42 38.87 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.965 0.506 . . . . 74.2 110.385 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -116.94 141.91 47.63 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.402 0.681 . . . . 74.54 111.115 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 114.18 4.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.18 0.992 . . . . 74.45 109.892 -176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 54.07 30.81 12.58 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.4 1.08 . . . . 72.54 112.561 -173.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.26 -18.48 54.14 Favored Glycine 0 CA--C 1.545 1.968 0 CA-C-N 115.785 -0.643 . . . . 35.35 114.429 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -78.94 136.67 37.32 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.748 0.819 . . . . 63.31 111.275 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.1 mt -101.99 124.31 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 123.404 0.682 . . . . 73.34 111.081 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -123.48 124.92 43.93 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.895 1.278 . . . . 62.24 108.815 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.569 HG21 HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -106.09 112.0 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-O 122.152 0.977 . . . . 55.15 110.051 177.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 95.0 m-85 -90.15 175.65 7.07 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.083 0.953 . . . . 72.41 111.202 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.54 150.97 21.54 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.972 0.509 . . . . 72.24 109.911 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.912 0.387 . . . . 75.34 110.644 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.505 ' O ' HG22 ' B' ' 6' ' ' VAL . 40.5 ttmt . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 110.483 -0.191 . . . . 75.01 110.483 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -61.26 -13.12 16.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.793 1.034 . . . . 73.31 113.793 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 70.3 mt -55.69 -45.93 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.616 0.766 . . . . 75.41 111.47 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.505 HG22 ' O ' ' B' ' 3' ' ' LYS . 16.3 m -66.46 -25.76 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 122.173 0.189 . . . . 64.42 111.064 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.28 -38.75 91.84 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.583 0.552 . . . . 63.13 113.259 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 -40.4 95.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.256 0.622 . . . . 71.42 110.939 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -70.53 -30.08 66.74 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.4 -0.818 . . . . 74.12 111.613 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -76.68 -36.35 57.33 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.603 0.761 . . . . 63.13 111.521 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.23 -30.97 79.3 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 115.809 -0.632 . . . . 63.53 112.55 172.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' B' ' 32' ' ' VAL . 4.3 ttmp? -72.59 -52.49 15.28 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.915 0.886 . . . . 73.01 112.006 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' B' ' 10' ' ' ALA . 33.0 m -68.53 -36.47 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 112.489 0.551 . . . . 74.14 112.489 -174.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.578 ' HA ' HD12 ' B' ' 17' ' ' LEU . 31.2 t90 -74.16 -32.55 63.17 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 111.903 0.334 . . . . 72.24 111.903 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -64.55 -33.49 76.02 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.001 0.429 . . . . 72.24 110.537 173.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.22 -32.45 71.72 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.928 0.891 . . . . 73.25 112.037 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' B' ' 14' ' ' TRP . 70.6 mt -70.99 -46.33 62.49 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.995 0.918 . . . . 71.41 111.097 173.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -63.11 -25.16 68.23 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.031 0.932 . . . . 74.43 110.609 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -76.08 -52.81 9.37 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.53 -0.759 . . . . 74.11 110.45 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.56 99.41 2.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.719 0.807 . . . . 41.03 110.657 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -98.35 -178.78 4.14 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.755 0.822 . . . . 74.4 111.335 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.84 37.39 44.71 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.743 -0.543 . . . . 74.22 111.743 -171.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 tt -122.61 139.85 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.891 0.877 . . . . 74.32 111.352 -168.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 20.4 m -64.09 151.24 43.66 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.163 0.985 . . . . 72.04 111.582 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.583 HG12 HD11 ' B' ' 63' ' ' ILE . 54.3 mt -53.63 -49.34 89.38 Favored Pre-proline 0 CA--C 1.579 2.071 0 N-CA-C 112.806 0.669 . . . . 72.23 112.806 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.64 -25.71 24.23 Favored 'Trans proline' 0 C--N 1.399 3.201 0 C-N-CA 121.926 1.75 . . . . 73.15 114.539 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.57 -41.88 37.29 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.61 1.195 . . . . 72.4 109.703 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.3 tp -61.26 -40.1 92.82 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.113 -1.858 . . . . 70.04 110.72 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.72 73.46 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.829 0.852 . . . . 73.2 111.962 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 64.2 mtp85 -65.06 -50.02 67.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.659 0.784 . . . . 71.32 111.916 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -73.84 -24.16 59.73 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 112.127 0.417 . . . . 61.22 112.127 -176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' B' ' 13' ' ' VAL . 13.9 m -94.85 -3.39 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 112.039 0.385 . . . . 72.14 112.039 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 65.05 21.64 12.28 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.233 1.013 . . . . 62.14 112.797 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.6 mt -108.56 169.26 8.77 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.81 0.844 . . . . 72.23 110.87 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 51.7 m -74.85 163.16 27.96 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.652 0.381 . . . . 54.21 111.336 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.3 -51.49 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.56 0.744 . . . . 65.34 111.86 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.63 -38.92 92.14 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.196 0.598 . . . . 73.41 111.989 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 29.4 t -64.43 -39.1 93.19 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.429 0.692 . . . . 41.43 111.525 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.439 ' O ' HG23 ' B' ' 43' ' ' VAL . 86.6 m -71.03 -48.5 52.61 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.768 0.827 . . . . 50.15 110.973 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.62 -35.34 72.33 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.789 0.836 . . . . 43.42 112.378 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.11 -48.51 70.65 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.183 0.993 . . . . 74.35 109.81 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.38 -30.36 70.49 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.259 -0.882 . . . . 72.13 111.681 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 39' ' ' THR . 95.2 t -72.87 -31.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 123.006 0.523 . . . . 61.44 110.615 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -66.11 -27.96 73.31 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 116.26 -0.427 . . . . 63.53 112.8 172.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -75.46 -25.75 57.68 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.976 0.51 . . . . 74.4 111.48 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.509 HD11 HG23 ' B' ' 13' ' ' VAL . 96.6 mt -71.6 -27.08 62.88 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.081 0.552 . . . . 34.51 111.686 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.3 -32.78 62.72 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.317 1.229 . . . . 63.03 114.317 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.645 ' HB3' ' HG2' ' A' ' 48' ' ' ARG . 13.5 ptm180 -72.27 -30.15 64.56 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 119.069 0.849 . . . . 72.01 111.512 171.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.76 -19.27 52.64 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.299 0.64 . . . . 74.04 110.758 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 60.42 21.83 11.44 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.744 1.618 . . . . 70.01 112.749 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.89 5.55 45.81 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 112.878 0.696 . . . . 74.44 112.878 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.81 146.17 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.344 0.657 . . . . 74.14 112.576 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.633 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 66.6 t -118.78 109.95 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 124.49 1.116 . . . . 74.32 109.5 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 39.6 mm -91.92 121.58 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.714 0.805 . . . . 63.23 111.401 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -117.16 141.53 48.15 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.506 -0.746 . . . . 71.21 111.787 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.58 ' HG2' HG12 ' B' ' 61' ' ' ILE . 84.0 mtt85 -113.51 111.6 22.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.077 0.951 . . . . 74.42 110.203 169.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' B' ' 57' ' ' LYS . 0.3 OUTLIER -144.6 126.94 15.82 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.315 1.046 . . . . 74.55 109.304 -178.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 60.74 28.68 18.4 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 125.027 1.331 . . . . 62.12 111.63 -171.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.19 -0.89 61.93 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-N 116.287 -0.415 . . . . 72.4 113.79 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.72 131.16 43.69 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.143 0.977 . . . . 70.34 110.936 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.58 HG12 ' HG2' ' B' ' 56' ' ' ARG . 43.8 mt -97.12 122.29 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.129 0.572 . . . . 61.51 110.339 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -125.74 139.98 53.08 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.35 0.66 . . . . 70.04 110.014 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.583 HD11 HG12 ' B' ' 25' ' ' ILE . 2.9 mp -100.54 126.97 54.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.666 0.786 . . . . 74.34 109.517 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.633 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 7.8 m-85 -111.15 169.59 8.68 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.913 1.285 . . . . 65.42 109.86 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -90.2 155.65 18.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.797 0.439 . . . . 73.14 111.405 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.483 1.186 0 C-N-CA 123.684 0.794 . . . . 74.35 110.428 173.126 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 112.74 0.644 . . . . 74.12 112.74 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -61.17 -47.64 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.444 0.698 . . . . 62.2 111.521 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.8 m -61.27 -28.06 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 122.519 0.328 . . . . 73.15 111.39 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.461 ' HA2' ' CD1' ' A' ' 45' ' ' TRP . . . -69.25 -49.68 37.97 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.544 0.528 . . . . 74.42 113.501 173.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.18 93.65 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.668 0.787 . . . . 74.13 112.382 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -75.03 -28.9 60.63 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.245 0.618 . . . . 63.13 112.339 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.99 82.6 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 112.464 0.542 . . . . 71.51 112.464 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.03 -34.54 81.93 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 116.413 -0.358 . . . . 72.02 113.127 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -67.17 -45.87 75.71 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.78 0.832 . . . . 43.24 110.644 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.594 ' HA ' HG11 ' A' ' 32' ' ' VAL . 63.8 t -60.97 -40.8 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 123.898 0.879 . . . . 64.55 111.212 175.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -64.67 -35.64 81.7 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.97 -0.559 . . . . 74.54 111.065 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.443 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 80.6 t60 -62.9 -44.81 95.09 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.78 0.432 . . . . 61.23 111.249 176.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.657 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -67.46 -32.51 73.41 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.525 0.679 . . . . 33.34 111.284 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.515 HD11 ' HA ' ' A' ' 65' ' ' ASN . 2.8 tm? -73.48 -29.92 62.82 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.925 1.29 . . . . 74.51 110.874 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -75.07 -47.15 30.25 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.96 0.904 . . . . 70.13 111.59 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 22.9 mm-40 -61.04 -33.19 72.9 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.13 0.572 . . . . 71.51 111.683 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.08 112.43 0.99 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.243 1.017 . . . . 74.45 109.54 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.8 178.4 5.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.25 0.62 . . . . 72.25 112.256 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.57 39.61 86.58 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 110.534 -1.026 . . . . 45.51 110.534 -167.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 tp -114.13 114.41 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 124.393 1.077 . . . . 75.01 110.044 -169.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -58.72 144.98 41.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.264 0.625 . . . . 62.25 112.594 -170.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.582 HG21 ' HB2' ' A' ' 40' ' ' ALA . 57.6 mt -55.38 -46.19 99.74 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 113.847 1.054 . . . . 63.41 113.847 -170.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HA ' HG22 ' A' ' 36' ' ' VAL . 32.6 Cg_endo -63.09 -25.05 73.25 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 121.819 1.679 . . . . 65.33 114.177 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -80.16 -55.15 5.13 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.994 0.739 . . . . 64.44 112.994 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -66.61 -26.03 66.89 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.45 0.568 . . . . 65.34 111.37 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.39 -37.31 16.57 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.745 0.818 . . . . 73.42 112.806 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -74.28 -35.02 63.73 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.305 0.642 . . . . 74.21 111.955 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.657 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 51.9 mtmt -67.06 -31.19 71.53 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 122.807 0.443 . . . . 62.42 111.513 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 13' ' ' VAL . 27.3 m -97.7 -9.47 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.701 0.801 . . . . 25.32 112.36 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.4 t30 64.7 28.11 13.08 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.347 1.459 . . . . 73.42 112.167 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.81 164.91 11.57 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.878 0.871 . . . . 61.0 111.198 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.7 m -65.21 153.11 41.94 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.139 0.576 . . . . 42.13 111.156 172.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 26' ' ' PRO . 64.6 t -53.97 -51.07 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.49 0.716 . . . . 24.11 111.104 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.591 ' HB2' HG13 ' B' ' 61' ' ' ILE . 36.3 mt-10 -60.32 -41.37 93.35 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.497 1.119 . . . . 54.04 112.557 176.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.8 m -62.28 -37.58 86.06 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 123.366 0.666 . . . . 73.41 111.798 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 43' ' ' VAL . 88.2 m -71.78 -46.51 58.08 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.559 0.743 . . . . 53.44 111.182 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.582 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.72 -37.81 83.0 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 123.615 0.766 . . . . 70.4 112.493 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.69 -41.91 71.36 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.276 1.031 . . . . 71.11 110.554 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -31.85 73.18 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.158 0.583 . . . . 63.11 111.686 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 39' ' ' THR . 41.4 t -59.23 -35.69 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.899 0.88 . . . . 74.1 111.351 170.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -63.75 -32.28 83.64 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 114.049 0.38 . . . . 70.02 114.049 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.478 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 69.9 t-105 -73.89 -26.98 60.83 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.127 0.571 . . . . 75.02 111.361 175.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.98 -39.36 63.73 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 122.79 0.436 . . . . 70.43 111.173 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.87 69.81 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.261 1.024 . . . . 74.22 113.376 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 45' ' ' TRP . 5.7 ppt_? -71.45 -12.69 61.53 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.021 0.378 . . . . 63.35 112.021 174.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -110.35 -8.47 14.7 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.321 1.048 . . . . 73.33 111.915 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 63.51 28.73 15.35 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.625 1.17 . . . . 74.1 112.834 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -69.37 -13.9 62.62 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.375 0.67 . . . . 73.31 112.046 171.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.711 ' HB ' HD11 ' A' ' 63' ' ' ILE . 31.0 m -133.92 155.47 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.924 0.89 . . . . 72.24 110.855 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 64' ' ' TYR . 31.2 m -127.37 143.19 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.179 0.991 . . . . 74.2 109.499 173.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.0 mt -120.72 134.57 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.186 0.595 . . . . 64.31 110.717 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -120.63 127.13 51.79 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.757 0.823 . . . . 62.14 111.409 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.508 ' HG2' HG12 ' A' ' 61' ' ' ILE . 84.8 mtt180 -95.45 102.62 14.43 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.209 0.528 . . . . 73.3 110.181 170.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -108.56 123.19 48.53 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.789 0.836 . . . . 71.55 109.99 178.006 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 55.98 29.38 14.22 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.792 1.237 . . . . 70.21 112.082 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.95 -25.92 9.24 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-N 116.154 -0.475 . . . . 74.34 114.116 -174.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.77 141.04 39.48 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.617 0.767 . . . . 75.13 111.195 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.508 HG12 ' HG2' ' A' ' 56' ' ' ARG . 32.2 mt -93.37 133.96 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.337 0.655 . . . . 65.03 111.791 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -132.17 139.74 48.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.999 0.92 . . . . 64.11 110.286 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.711 HD11 ' HB ' ' A' ' 52' ' ' VAL . 6.8 tp -102.49 126.28 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.35 0 CA-C-O 121.772 0.796 . . . . 63.1 111.487 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.454 ' HB2' HG23 ' A' ' 53' ' ' VAL . 89.6 m-85 -118.11 169.28 9.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.186 1.394 . . . . 74.13 111.45 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.515 ' HA ' HD11 ' A' ' 17' ' ' LEU . 28.6 t-20 -81.38 145.97 30.55 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.663 0.785 . . . . 72.42 110.671 175.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.422 ' HA ' HG13 ' A' ' 53' ' ' VAL . 10.9 pt-20 . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 115.521 1.675 . . . . 62.23 115.521 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 112.363 0.505 . . . . 74.13 112.363 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -74.03 -48.58 29.07 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.909 0.884 . . . . 54.11 111.297 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 65.3 mt -59.08 -60.0 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 114.935 -1.03 . . . . 71.5 111.844 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 m -59.4 -29.13 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.22 1.008 . . . . 71.25 112.65 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.72 -43.29 85.09 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 123.285 0.366 . . . . 75.51 112.758 173.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.28 96.67 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.919 0.887 . . . . 70.4 112.083 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -67.1 -40.95 86.99 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.051 0.54 . . . . 74.54 111.26 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.33 77.46 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.622 0.769 . . . . 64.43 112.808 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.62 -38.56 96.61 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 123.501 0.501 . . . . 34.04 112.853 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -69.29 -46.51 67.0 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.715 0.806 . . . . 71.23 111.792 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.604 ' HA ' HG11 ' B' ' 32' ' ' VAL . 72.7 t -59.25 -45.9 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.52 0.728 . . . . 74.04 111.644 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.6 ' HA ' HD12 ' B' ' 17' ' ' LEU . 21.1 t90 -68.45 -32.45 72.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.895 -0.593 . . . . 55.44 111.537 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' HIS . . . . . 0.408 ' HA ' ' OD1' ' B' ' 18' ' ' ASN . 8.1 t60 -59.01 -35.74 73.77 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.26 0.553 . . . . 70.34 110.834 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.03 -29.62 63.12 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.964 0.905 . . . . 51.53 112.093 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' B' ' 14' ' ' TRP . 84.7 mt -73.18 -39.86 65.26 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.067 0.947 . . . . 72.43 112.745 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' B' ' 15' ' ' HIS . 2.0 p-10 -74.64 -14.78 60.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.897 -0.502 . . . . 73.43 111.427 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.18 -45.59 16.15 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.337 0.655 . . . . 71.02 110.007 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.33 98.6 1.28 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.876 0.87 . . . . 75.24 110.599 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -85.93 159.99 19.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.29 0.636 . . . . 75.05 111.224 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.61 64.77 1.6 Allowed Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.555 -0.293 . . . . 45.32 112.634 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 tt -146.38 139.91 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.6 0.76 . . . . 75.0 110.841 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 37.5 m -62.8 145.79 54.12 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.756 0.423 . . . . 74.34 111.495 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.569 HD12 ' HB3' ' A' ' 37' ' ' GLU . 61.1 mt -52.28 -50.39 79.7 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 114.226 1.195 . . . . 62.13 114.226 -175.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.09 -23.44 39.9 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 121.828 1.685 . . . . 74.51 114.504 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -75.08 -52.43 11.06 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.141 0.972 . . . . 73.11 109.177 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -54.68 -37.1 65.35 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 113.122 -1.854 . . . . 75.22 112.048 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.65 95.38 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.3 1.04 . . . . 62.44 112.471 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -72.07 -28.7 63.49 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.264 0.625 . . . . 74.15 111.954 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.54 -35.03 65.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.414 0.686 . . . . 74.54 111.433 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' B' ' 13' ' ' VAL . 31.6 m -95.54 1.68 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.48 0.712 . . . . 50.24 112.109 177.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 61.9 16.27 7.89 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 124.553 1.141 . . . . 75.5 113.739 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 60.6 mt -102.66 158.37 16.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.752 0.821 . . . . 74.34 110.005 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 50.8 m -63.46 156.38 26.35 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.577 0.351 . . . . 64.24 111.313 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.0 t -49.4 -48.28 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 123.849 0.86 . . . . 62.22 111.713 171.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.62 -36.85 81.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.12 -0.946 . . . . 72.24 111.258 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -63.58 -43.04 98.15 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.461 0.704 . . . . 42.42 111.703 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.456 ' O ' HG23 ' B' ' 43' ' ' VAL . 92.1 m -74.71 -46.97 34.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.91 0.884 . . . . 74.51 111.445 -174.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -59.72 -46.12 90.09 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 124.235 1.014 . . . . 74.31 112.302 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -71.77 -35.22 69.99 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.672 -1.149 . . . . 75.25 111.001 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.84 81.89 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 122.574 0.349 . . . . 52.2 111.182 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.734 HG11 HD12 ' B' ' 63' ' ' ILE . 68.9 t -65.44 -31.87 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 123.585 0.754 . . . . 72.42 110.939 170.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -64.63 -33.57 87.58 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.909 -0.132 . . . . 73.14 113.425 171.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.484 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 73.8 t-105 -73.9 -29.78 62.24 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.479 0.712 . . . . 74.44 111.181 173.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.36 -34.58 70.58 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.839 0.456 . . . . 64.34 110.711 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.33 67.41 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.285 1.034 . . . . 74.4 111.753 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 20.1 ttt85 -56.68 -51.36 69.08 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.327 0.584 . . . . 74.2 110.882 167.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -80.07 -7.66 58.99 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.404 -0.816 . . . . 61.22 111.666 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 63.7 t30 63.91 32.9 12.92 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.577 1.551 . . . . 51.21 111.424 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -88.2 -1.68 58.16 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.744 0.818 . . . . 75.14 111.952 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.86 162.4 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.583 0.753 . . . . 73.55 112.306 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' B' ' 64' ' ' TYR . 11.7 m -128.22 156.79 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 124.45 1.1 . . . . 75.43 110.371 167.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 36.6 mm -116.97 119.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.447 0.699 . . . . 74.52 110.272 -175.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -115.49 115.02 25.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.147 0.579 . . . . 75.32 110.884 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -84.42 97.6 9.6 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.037 -0.727 . . . . 51.53 109.037 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.16 108.28 19.71 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.872 0.869 . . . . 63.0 110.163 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 54.65 31.45 15.22 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.369 1.067 . . . . 75.12 112.46 -173.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.77 -16.21 61.62 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-N 115.851 -0.613 . . . . 42.21 114.012 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -81.63 134.27 35.46 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.579 0.752 . . . . 63.24 110.845 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.591 HG13 ' HB2' ' A' ' 37' ' ' GLU . 23.1 mm -90.8 105.96 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.05 0.54 . . . . 65.13 109.816 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -115.72 130.5 56.87 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.845 0.858 . . . . 71.4 110.901 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.734 HD12 HG11 ' B' ' 43' ' ' VAL . 26.6 mm -93.22 115.7 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.052 0.941 . . . . 60.14 110.874 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.595 ' HB2' HG23 ' B' ' 53' ' ' VAL . 33.0 m-85 -107.06 158.98 16.65 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.005 0.922 . . . . 75.2 110.048 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -91.19 150.26 21.44 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.352 0.661 . . . . 62.24 109.6 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.551 ' HG2' HG13 ' B' ' 53' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 121.472 0.653 . . . . 72.21 110.664 176.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 111.454 0.168 . . . . 71.51 111.454 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.2 mt -61.04 -60.33 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.181 0.592 . . . . 45.1 110.792 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 41' ' ' LEU . 34.8 m -64.0 -32.27 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.556 1.142 . . . . 35.55 112.192 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.6 69.8 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 123.353 0.408 . . . . 74.14 112.687 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.63 94.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.647 0.779 . . . . 43.21 111.651 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.39 -40.45 89.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.642 0.777 . . . . 51.03 111.421 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.84 -34.49 78.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.204 0.601 . . . . 61.12 111.913 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.77 -39.05 96.34 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 116.279 -0.419 . . . . 44.22 113.182 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -75.19 -41.12 58.62 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.752 0.821 . . . . 74.2 111.924 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.578 ' HA ' HG11 ' A' ' 32' ' ' VAL . 59.2 t -67.24 -45.5 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.496 0.719 . . . . 72.42 111.322 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.572 ' HA ' HD12 ' A' ' 17' ' ' LEU . 47.5 t90 -64.42 -34.63 78.62 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.504 0.502 . . . . 62.43 111.158 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -60.93 -45.09 96.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.362 0.665 . . . . 65.01 111.125 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -69.69 -36.17 75.74 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.753 -0.658 . . . . 74.32 111.654 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 14' ' ' TRP . 33.5 mt -59.51 -43.49 93.37 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.545 0.738 . . . . 75.41 111.474 175.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -59.34 -24.75 63.62 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.255 1.022 . . . . 63.53 112.254 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -66.02 -42.71 89.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.854 0.862 . . . . 74.33 111.062 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.73 110.57 2.19 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.44 0.696 . . . . 72.34 111.327 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -77.55 162.98 26.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.628 0.771 . . . . 73.22 111.27 174.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.87 61.91 3.15 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.999 -0.441 . . . . 71.43 111.999 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 tt -141.38 135.98 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.661 0.784 . . . . 62.44 111.06 -171.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -69.57 152.94 44.17 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.22 0.608 . . . . 65.25 111.413 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 40' ' ' ALA . 57.0 mt -56.38 -47.11 99.53 Favored Pre-proline 0 CA--C 1.58 2.123 0 N-CA-C 113.458 0.91 . . . . 41.14 113.458 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 55.9 Cg_endo -66.13 -30.29 46.91 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 122.145 1.896 . . . . 64.13 113.925 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.63 -46.52 66.0 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.422 1.105 . . . . 73.23 109.839 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.32 -36.87 78.92 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 113.152 -1.84 . . . . 70.3 112.175 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.3 80.21 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.567 0.747 . . . . 62.35 112.431 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 26' ' ' PRO . 2.8 mpt_? -69.69 -38.73 77.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.807 0.443 . . . . 61.23 111.447 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.43 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 40.8 mtmt -64.0 -41.77 97.37 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.538 0.335 . . . . 71.24 111.655 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 13' ' ' VAL . 22.4 m -84.24 -10.81 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.096 0.559 . . . . 62.43 111.573 175.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.9 t30 69.26 16.9 8.38 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 125.53 1.532 . . . . 73.44 112.048 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.421 ' H ' HG23 ' A' ' 32' ' ' VAL . 70.2 mt -99.68 175.61 5.75 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.837 0.855 . . . . 61.41 110.604 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 t -76.99 159.25 30.07 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.144 0.577 . . . . 64.33 111.524 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -57.87 -44.69 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.091 0.556 . . . . 71.21 111.51 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.79 -46.37 89.83 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.752 0.821 . . . . 73.23 112.02 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.8 p -69.0 -30.82 69.29 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.209 0.604 . . . . 64.14 112.063 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . 96.7 m -74.92 -48.45 24.52 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.351 0.661 . . . . 73.42 111.248 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -61.77 -36.82 82.16 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 123.992 0.917 . . . . 31.05 111.831 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.651 HD11 HG12 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -61.33 -43.07 99.49 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.91 1.284 . . . . 74.23 110.802 173.609 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.59 71.73 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.228 0.611 . . . . 73.45 112.296 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.451 HG11 HD12 ' A' ' 63' ' ' ILE . 86.3 t -69.41 -33.73 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.33 0.652 . . . . 52.11 110.86 175.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.74 -32.7 85.08 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-N 116.501 -0.318 . . . . 55.22 112.745 172.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.419 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 71.5 t-105 -74.02 -31.1 62.77 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.606 0.762 . . . . 74.12 111.333 173.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.3 -34.89 75.38 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.727 0.411 . . . . 72.42 111.156 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.59 -28.95 69.72 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.37 0.668 . . . . 74.54 112.101 173.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' B' ' 48' ' ' ARG . 22.9 ttt180 -59.85 -51.16 70.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.763 0.825 . . . . 60.02 112.111 175.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -90.99 13.57 16.32 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.408 -0.815 . . . . 51.43 112.04 -173.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 51.33 47.45 24.82 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.001 1.32 . . . . 52.35 112.08 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -87.54 -32.95 19.11 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.757 -1.11 . . . . 64.33 111.921 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -132.74 148.27 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.637 0.775 . . . . 51.23 112.058 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG13 ' HG2' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -113.55 107.33 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.595 0.758 . . . . 63.23 108.957 171.779 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.48 HG23 HD13 ' A' ' 63' ' ' ILE . 60.1 mt -88.94 114.6 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 109.16 -0.681 . . . . 73.13 109.16 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -102.74 117.42 34.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.21 0.604 . . . . 75.33 111.107 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -81.9 108.18 15.21 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.957 -0.386 . . . . 72.45 109.957 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -104.09 106.15 16.56 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.658 0.783 . . . . 64.53 109.003 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 54.81 31.85 16.44 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 124.336 1.054 . . . . 73.43 112.423 -169.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.93 -20.12 50.64 Favored Glycine 0 CA--C 1.542 1.769 0 N-CA-C 114.408 0.523 . . . . 50.32 114.408 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.79 134.95 43.47 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.743 0.817 . . . . 74.21 111.076 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.25 103.78 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 122.995 0.518 . . . . 74.1 109.884 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -118.72 121.83 41.03 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.949 0.9 . . . . 72.33 109.914 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 54' ' ' ILE . 10.5 mm -91.96 120.93 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.214 0.606 . . . . 71.02 111.938 -169.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -108.84 163.14 13.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.489 0.715 . . . . 73.21 111.043 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 11.1 m-20 -91.33 155.26 18.64 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.428 -0.806 . . . . 74.42 108.921 171.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.449 ' HG2' HG13 ' A' ' 53' ' ' VAL . 50.9 mt-10 . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 121.758 0.79 . . . . 74.43 110.022 169.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 120.732 0.301 . . . . 75.54 111.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -91.26 -41.82 10.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.077 0.951 . . . . 62.5 111.827 170.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.49 -45.33 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 122.993 0.517 . . . . 74.01 111.876 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.03 -26.84 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 122.633 0.373 . . . . 71.11 111.811 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.2 -48.36 80.24 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.135 0.272 . . . . 54.45 112.869 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.79 -43.28 93.72 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.601 0.76 . . . . 73.11 111.609 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.85 -36.53 80.48 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.169 0.988 . . . . 72.54 111.532 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.427 ' HA ' ' HB1' ' B' ' 42' ' ' ALA . . . -68.69 -39.66 80.44 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.099 0.56 . . . . 71.24 110.914 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.74 -45.98 92.79 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.68 -0.691 . . . . 75.41 112.341 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -63.28 -41.95 99.05 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.425 1.09 . . . . 62.21 111.845 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.694 ' HA ' HG11 ' B' ' 32' ' ' VAL . 72.8 t -65.14 -37.05 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.775 0.83 . . . . 63.44 111.622 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -74.04 -33.49 63.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.208 0.603 . . . . 75.21 111.587 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -60.84 -30.7 70.26 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.92 0.488 . . . . 75.11 111.353 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.71 69.96 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.191 0.596 . . . . 44.12 112.466 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.489 ' HB3' ' ND2' ' B' ' 65' ' ' ASN . 53.3 mt -63.49 -34.24 77.33 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.262 0.625 . . . . 75.11 112.51 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.75 -25.7 66.67 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.3 0.64 . . . . 63.55 111.729 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.92 -41.03 8.2 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.734 0.813 . . . . 61.35 111.077 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' B' ' 17' ' ' LEU . . . -153.75 141.28 19.83 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.405 0.682 . . . . 50.32 111.808 -171.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -127.08 168.97 13.9 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.616 0.766 . . . . 65.42 111.129 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.8 10.24 64.02 Favored Glycine 0 N--CA 1.474 1.167 0 N-CA-C 114.596 0.598 . . . . 71.11 114.596 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.3 tt -86.26 132.02 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 123.465 0.706 . . . . 75.33 110.809 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -71.89 158.35 36.21 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.518 0.562 . . . . 45.34 112.518 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.551 HG21 ' HB2' ' B' ' 40' ' ' ALA . 73.9 mt -56.33 -43.3 99.23 Favored Pre-proline 0 CA--C 1.582 2.177 0 N-CA-C 115.274 1.583 . . . . 73.35 115.274 -169.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.54 -31.6 33.28 Favored 'Trans proline' 0 C--N 1.392 2.863 0 CA-C-N 122.448 1.91 . . . . 75.32 114.207 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -77.86 -41.32 37.23 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.313 1.054 . . . . 73.12 110.102 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.42 -39.61 84.06 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 113.206 -1.816 . . . . 52.25 111.125 171.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.01 88.91 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.985 0.914 . . . . 63.1 111.648 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -60.92 -43.42 98.59 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.584 0.754 . . . . 73.53 111.498 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -71.27 -37.97 71.88 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.284 0.634 . . . . 74.44 111.934 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.694 HG11 ' HA ' ' B' ' 13' ' ' VAL . 13.1 m -93.32 5.53 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.047 0.539 . . . . 61.02 112.15 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.4 t30 68.46 9.53 7.33 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.574 1.149 . . . . 74.21 113.303 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 47.8 mt -102.98 174.25 5.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.611 -0.68 . . . . 72.44 111.463 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 39.3 t -72.94 157.84 36.65 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.915 0.486 . . . . 73.21 111.264 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.14 -41.39 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.22 0.608 . . . . 71.23 111.198 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.19 -48.44 75.9 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.533 0.733 . . . . 74.11 112.207 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -71.04 -29.97 66.03 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.292 0.637 . . . . 62.53 111.98 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.422 ' O ' HG23 ' B' ' 43' ' ' VAL . 95.5 m -72.77 -46.23 54.46 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.182 0.593 . . . . 74.43 110.487 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.551 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -60.05 -36.35 77.1 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.528 0.731 . . . . 74.02 111.927 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -51.13 66.61 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.278 1.031 . . . . 71.33 109.606 174.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.427 ' HB1' ' HA ' ' B' ' 10' ' ' ALA . . . -61.39 -30.77 70.76 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.009 -0.996 . . . . 64.23 111.695 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.422 HG23 ' O ' ' B' ' 39' ' ' THR . 49.0 t -68.45 -37.51 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.76 0.824 . . . . 64.01 110.66 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.47 -33.3 86.04 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.216 -0.447 . . . . 53.42 113.037 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.437 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 61.9 t-105 -74.44 -25.63 59.55 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.398 0.679 . . . . 73.04 111.338 175.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.92 -36.73 70.04 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.875 0.47 . . . . 73.1 111.284 169.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.21 -33.02 75.01 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.959 0.503 . . . . 64.03 110.685 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.497 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 2.3 tmt_? -59.35 -45.29 91.82 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.246 1.018 . . . . 65.53 111.504 173.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.421 ' HG3' ' HD3' ' B' ' 48' ' ' ARG . 37.6 mt-10 -84.79 2.38 42.5 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.46 0.704 . . . . 60.3 112.508 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 63.2 22.41 13.35 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.148 1.379 . . . . 62.4 112.808 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -102.42 7.96 40.24 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.907 1.077 . . . . 45.2 113.907 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.403 HG12 HD11 ' B' ' 17' ' ' LEU . 20.9 m -131.87 151.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 123.093 0.557 . . . . 71.43 111.102 171.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 t -105.36 102.41 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.498 0.719 . . . . 74.35 109.492 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 27.8 mm -77.69 114.7 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 122.987 0.515 . . . . 43.12 110.274 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.18 156.5 38.33 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.89 0.876 . . . . 64.43 111.843 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -118.12 107.56 14.12 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.958 0.903 . . . . 73.01 110.864 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -119.07 129.86 55.3 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.02 0.528 . . . . 71.31 110.125 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 62.72 30.45 16.82 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.528 1.131 . . . . 73.53 112.115 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.05 12.97 81.33 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 115.979 -0.555 . . . . 73.24 113.465 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -122.52 136.66 54.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.178 0.991 . . . . 71.1 110.378 -172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mp -80.51 122.36 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 123.012 0.525 . . . . 75.03 110.244 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -124.94 132.36 53.3 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.278 1.031 . . . . 74.52 110.019 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 pp -100.06 126.53 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.434 0.694 . . . . 74.43 111.932 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -108.52 166.47 10.76 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.207 0.603 . . . . 61.53 111.252 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.489 ' ND2' ' HB3' ' B' ' 17' ' ' LEU . 15.0 m120 -67.43 141.45 57.01 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.632 0.773 . . . . 72.52 111.461 176.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 114.512 1.301 . . . . 72.44 114.512 178.647 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt . . . . . 0 CA--C 1.56 1.351 0 N-CA-C 112.682 0.623 . . . . 74.55 112.682 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -58.28 -55.52 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.158 0.583 . . . . 73.32 110.802 171.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.6 m -67.31 -25.54 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 122.682 0.393 . . . . 72.43 111.232 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.491 ' HA2' ' NE1' ' A' ' 45' ' ' TRP . . . -68.27 -41.39 86.15 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 116.676 -0.238 . . . . 70.44 113.646 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.01 -54.84 13.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.822 0.849 . . . . 71.2 112.031 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -68.07 -19.68 64.89 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 112.793 0.664 . . . . 72.01 112.793 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 13' ' ' VAL . . . -69.32 -28.05 65.91 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.623 0.769 . . . . 24.4 112.205 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.68 -42.64 93.17 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 116.762 -0.199 . . . . 63.33 113.391 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -66.81 -46.65 74.51 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.797 0.839 . . . . 74.2 112.081 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.537 ' HA ' HG11 ' A' ' 32' ' ' VAL . 10.6 p -69.13 -32.17 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.533 0.333 . . . . 63.1 111.708 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.475 ' NE1' ' HB3' ' A' ' 51' ' ' LYS . 66.9 t90 -72.14 -33.94 68.16 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.067 0.547 . . . . 72.41 111.328 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -61.49 -35.24 77.1 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.384 0.673 . . . . 73.23 111.315 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.41 -32.44 73.88 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.581 0.753 . . . . 42.05 112.088 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 14' ' ' TRP . 50.9 mt -73.66 -33.04 64.3 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.869 0.867 . . . . 75.32 112.131 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -62.91 -33.26 74.95 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.208 0.603 . . . . 74.51 111.76 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -75.3 -54.3 7.32 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.283 0.633 . . . . 62.44 110.11 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.45 99.13 2.17 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.599 -0.728 . . . . 65.25 110.899 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.529 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 9.9 p-10 -93.5 150.84 20.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.7 0.4 . . . . 74.21 109.952 173.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.08 63.19 1.15 Allowed Glycine 0 N--CA 1.469 0.855 0 N-CA-C 110.758 -0.937 . . . . 61.33 110.758 -167.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.4 tt -145.17 125.44 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.479 1.112 . . . . 73.53 109.605 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.0 m -57.09 149.27 19.69 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.032 0.933 . . . . 63.23 112.097 -176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.618 HG12 HD11 ' A' ' 63' ' ' ILE . 21.2 mt -53.88 -48.07 94.88 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 113.419 0.896 . . . . 51.23 113.419 -174.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.46 -24.0 14.48 Favored 'Trans proline' 0 C--N 1.398 3.17 0 C-N-CA 121.881 1.721 . . . . 74.54 114.732 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -71.79 -45.86 60.21 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 123.037 1.398 . . . . 70.42 108.939 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 32' ' ' VAL . 60.5 tp -65.11 -40.14 94.11 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 112.443 -2.162 . . . . 72.52 111.466 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.25 93.93 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.048 0.939 . . . . 61.33 112.306 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -70.02 -39.26 75.92 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.287 0.635 . . . . 75.04 111.004 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -59.19 -52.12 67.07 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.577 0.751 . . . . 70.43 111.563 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 13' ' ' VAL . 24.9 m -85.89 0.37 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.357 0.663 . . . . 72.14 112.035 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 62.43 15.02 7.41 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 125.149 1.38 . . . . 73.14 114.196 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.7 mt -90.81 159.82 16.08 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.325 0.65 . . . . 63.42 110.0 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -66.66 151.86 46.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.486 0.314 . . . . 73.21 110.882 169.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.1 t -52.67 -47.03 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 123.835 0.854 . . . . 75.14 112.064 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.456 ' HB3' HD12 ' B' ' 25' ' ' ILE . 46.2 mt-10 -59.78 -44.63 93.81 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.726 0.81 . . . . 74.43 112.277 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.0 m -62.58 -36.74 83.68 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.722 0.809 . . . . 64.21 111.855 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -70.49 -52.34 22.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.786 0.835 . . . . 74.4 110.936 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' HD13 ' A' ' 25' ' ' ILE . . . -59.98 -33.91 72.6 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.801 0.84 . . . . 72.32 112.302 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -51.24 49.5 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.184 0.994 . . . . 74.31 110.354 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.94 70.06 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.331 -0.85 . . . . 52.23 111.686 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.22 -38.82 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 115.581 -0.736 . . . . 65.11 110.939 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.28 -28.06 72.47 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-O 121.116 0.287 . . . . 73.41 112.877 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.491 ' NE1' ' HA2' ' A' ' 7' ' ' GLY . 77.0 t-105 -70.02 -41.53 74.17 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.099 0.96 . . . . 72.52 111.265 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 76.4 mt -67.01 -34.09 76.99 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.512 0.725 . . . . 63.25 111.619 175.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.33 -27.22 63.93 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.361 1.064 . . . . 51.22 113.326 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -58.77 -31.87 68.76 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 112.244 0.461 . . . . 74.22 112.244 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -122.02 26.67 8.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.663 1.185 . . . . 64.42 111.063 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 61.43 22.61 12.99 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.329 1.451 . . . . 74.14 114.117 169.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 61.9 mttm -74.09 -18.05 60.87 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.85 0.685 . . . . 73.2 112.85 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.16 150.77 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.473 0.709 . . . . 74.22 111.93 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 42.5 t -107.7 123.93 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.991 0.917 . . . . 75.21 108.904 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.437 HG23 HG23 ' A' ' 61' ' ' ILE . 48.6 mm -103.81 118.66 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.595 0.758 . . . . 72.54 111.106 -173.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -124.61 112.05 16.35 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.298 0.639 . . . . 75.21 111.138 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.462 ' HG2' HG12 ' A' ' 61' ' ' ILE . 56.7 mtt180 -81.25 98.01 7.91 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.567 0.699 . . . . 71.24 110.078 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -106.39 111.93 24.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.482 1.113 . . . . 63.05 109.601 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 60.72 32.35 20.23 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 124.605 1.162 . . . . 64.14 112.891 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.42 -11.57 67.61 Favored Glycine 0 CA--C 1.541 1.697 0 N-CA-C 114.041 0.377 . . . . 41.43 114.041 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.76 137.21 36.98 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.748 0.819 . . . . 71.54 110.329 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 56' ' ' ARG . 50.7 mt -87.41 129.3 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.808 0.443 . . . . 62.1 111.173 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.04 136.34 49.44 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.308 1.043 . . . . 73.21 110.37 -178.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.618 HD11 HG12 ' A' ' 25' ' ' ILE . 3.0 mp -113.59 115.94 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.219 0.608 . . . . 75.11 110.194 -169.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.733 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 80.6 m-85 -113.54 173.74 6.26 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.994 0.918 . . . . 72.31 110.542 175.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -98.8 162.03 13.32 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.384 0.674 . . . . 63.34 110.862 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 51' ' ' LYS . 36.1 tt0 . . . . . 0 N--CA 1.49 1.538 0 C-N-CA 124.505 1.122 . . . . 75.04 111.895 170.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 111.788 0.292 . . . . 65.53 111.788 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -75.05 -31.77 61.38 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.449 0.7 . . . . 65.02 111.71 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.04 -54.09 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 122.697 0.399 . . . . 72.05 110.749 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -65.28 -26.2 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 122.864 0.466 . . . . 65.02 111.536 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.81 -39.97 96.99 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.282 0.364 . . . . 43.02 113.303 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.11 -36.97 69.59 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.73 0.812 . . . . 55.54 111.346 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -64.68 -40.61 95.71 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.589 -0.732 . . . . 73.31 110.583 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.502 ' HA ' ' HB1' ' B' ' 42' ' ' ALA . . . -72.06 -41.45 67.39 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.869 0.868 . . . . 71.21 111.435 -176.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.01 -50.07 66.93 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.783 -0.644 . . . . 60.34 112.464 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.548 ' HG3' ' HB ' ' B' ' 32' ' ' VAL . 18.0 tppt? -60.0 -45.88 91.31 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.437 1.095 . . . . 75.24 112.065 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.469 ' HA ' HG11 ' B' ' 32' ' ' VAL . 53.0 t -56.99 -46.99 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.094 0.558 . . . . 74.43 111.346 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.511 ' HA ' HD12 ' B' ' 17' ' ' LEU . 69.7 t90 -68.34 -35.76 78.24 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.302 0.641 . . . . 74.3 112.015 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -63.97 -33.08 74.92 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.604 0.362 . . . . 55.33 110.553 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.09 -32.45 69.08 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.906 0.482 . . . . 61.23 111.582 171.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' B' ' 14' ' ' TRP . 69.2 mt -72.57 -30.51 64.47 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.347 0.659 . . . . 74.21 111.227 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.49 -29.4 68.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.644 0.778 . . . . 73.01 111.048 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.45 -29.24 12.86 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.523 0.729 . . . . 72.44 111.303 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.7 88.88 1.0 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.439 0.696 . . . . 44.0 111.812 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -92.28 173.44 7.82 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.183 0.593 . . . . 74.11 111.652 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.55 64.53 2.81 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.278 -0.419 . . . . 71.02 112.316 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 tt -144.02 143.27 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.315 0.646 . . . . 72.54 110.787 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -60.58 139.8 57.64 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.856 0.863 . . . . 63.13 111.418 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 37' ' ' GLU . 71.8 mt -52.31 -46.22 94.39 Favored Pre-proline 0 CA--C 1.581 2.14 0 N-CA-C 114.386 1.254 . . . . 63.54 114.386 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.11 -24.78 14.49 Favored 'Trans proline' 0 C--N 1.399 3.223 0 CA-C-N 121.856 1.699 . . . . 64.2 113.989 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 33.7 tt0 -77.1 -46.34 23.9 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 122.04 0.924 . . . . 60.13 108.846 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -55.65 -39.87 71.45 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.321 1.448 . . . . 61.43 111.263 170.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.85 92.19 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.874 0.869 . . . . 54.14 112.323 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' B' ' 27' ' ' GLU . 21.9 ptt180 -73.96 -23.36 59.48 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.384 0.274 . . . . 75.03 110.782 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 27' ' ' GLU . 30.9 mmmt -78.41 -43.93 26.14 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.142 0.577 . . . . 73.25 111.06 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' B' ' 12' ' ' LYS . 23.6 m -87.16 3.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 112.954 0.724 . . . . 74.32 112.954 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 63.62 11.47 5.75 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 125.081 1.352 . . . . 74.22 113.904 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 74.2 mt -99.77 162.9 12.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.478 0.711 . . . . 73.44 111.071 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 16.7 m -66.0 155.59 36.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.561 0.744 . . . . 72.25 111.627 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.46 -49.83 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.488 0.715 . . . . 61.13 111.709 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.62 -43.65 84.94 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.121 0.969 . . . . 55.41 111.474 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 68.4 m -61.75 -37.56 84.74 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.957 0.903 . . . . 73.53 112.265 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.479 ' O ' HG23 ' B' ' 43' ' ' VAL . 97.3 m -72.26 -48.49 42.17 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.471 0.708 . . . . 74.14 111.241 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -59.24 -43.14 92.4 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.553 0.741 . . . . 54.55 112.573 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.06 -49.5 75.72 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.883 0.873 . . . . 71.01 109.963 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' B' ' 10' ' ' ALA . . . -57.96 -28.67 64.56 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.794 -1.094 . . . . 73.13 112.006 -178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.647 HG11 HD12 ' B' ' 63' ' ' ILE . 77.8 t -69.27 -38.33 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.139 0.576 . . . . 74.32 110.964 175.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.64 -30.58 77.67 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-O 121.077 0.265 . . . . 74.52 112.591 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -75.86 -26.37 57.05 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.662 0.785 . . . . 73.23 111.951 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.99 -35.25 62.03 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.207 0.527 . . . . 74.1 111.352 166.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.34 -34.15 77.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.304 1.042 . . . . 65.22 112.793 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -64.51 -34.95 79.42 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.922 0.392 . . . . 71.55 111.317 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.62 -2.52 56.27 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.737 0.815 . . . . 61.3 111.532 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 65.55 26.48 11.68 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.488 1.515 . . . . 73.04 112.43 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -95.36 -0.19 52.9 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.465 1.283 . . . . 75.42 114.465 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 17.6 m -127.95 151.5 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 118.566 0.621 . . . . 73.44 112.468 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.699 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 95.3 t -110.33 123.35 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.604 1.161 . . . . 74.43 108.465 168.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 76.0 mt -114.97 126.45 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.258 -0.645 . . . . 54.44 109.258 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' GLU . . . . . 0.588 ' HG3' ' HG3' ' B' ' 57' ' ' LYS . 10.6 tp10 -142.32 129.17 20.57 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.55 -0.75 . . . . 72.32 111.312 -169.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.404 ' HG2' HG12 ' B' ' 61' ' ' ILE . 92.7 mtt180 -95.12 98.86 10.95 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.51 0.672 . . . . 72.51 110.216 176.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' LYS . . . . . 0.588 ' HG3' ' HG3' ' B' ' 55' ' ' GLU . 29.1 mtpp -105.48 123.39 47.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.346 -0.843 . . . . 74.04 109.476 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 59.11 29.48 19.05 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.077 1.351 . . . . 73.1 111.157 -171.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.54 -27.87 8.22 Favored Glycine 0 CA--C 1.543 1.83 0 CA-C-N 115.729 -0.669 . . . . 73.3 114.136 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.08 138.07 31.86 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.65 0.78 . . . . 55.14 111.795 -171.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.404 HG12 ' HG2' ' B' ' 56' ' ' ARG . 55.4 mt -79.56 136.42 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.926 0.891 . . . . 74.11 112.225 -177.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -121.19 131.99 54.57 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.175 0.99 . . . . 75.13 109.118 167.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.647 HD12 HG11 ' B' ' 43' ' ' VAL . 25.0 mm -91.69 109.25 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.369 0.668 . . . . 71.22 110.431 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.699 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 67.0 m-85 -97.72 169.24 9.82 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.6 1.16 . . . . 71.45 110.589 175.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -100.39 155.29 17.89 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.429 0.692 . . . . 74.41 110.934 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 . . . . . 0 N--CA 1.486 1.351 0 C-N-CA 124.716 1.206 . . . . 74.33 111.158 173.515 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 111.782 0.29 . . . . 63.35 111.782 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.2 mt -64.44 -59.46 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.899 0.48 . . . . 71.31 110.694 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.53 -27.56 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.938 0.495 . . . . 62.52 111.764 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.76 -43.13 85.34 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.412 0.445 . . . . 44.35 113.283 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -46.36 80.97 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.644 0.778 . . . . 70.33 111.706 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -70.0 -27.95 65.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.972 -0.558 . . . . 60.32 112.362 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.58 76.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.24 0.616 . . . . 51.22 111.898 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.2 -37.65 94.88 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 116.074 -0.512 . . . . 64.4 113.071 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -76.61 -42.56 41.91 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 112.474 0.546 . . . . 42.04 112.474 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.592 HG12 HG21 ' A' ' 32' ' ' VAL . 26.0 m -64.56 -34.1 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 122.123 -0.36 . . . . 41.11 111.057 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.572 ' HA ' HD12 ' A' ' 17' ' ' LEU . 42.9 t90 -70.01 -33.28 71.81 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.086 0.555 . . . . 74.12 111.484 175.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -61.7 -39.14 90.41 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.127 0.571 . . . . 61.12 110.618 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.02 -32.53 70.72 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.49 0.716 . . . . 43.31 111.946 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 14' ' ' TRP . 75.5 mt -69.87 -35.37 74.62 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.878 0.871 . . . . 75.32 111.746 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.06 -25.82 65.54 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.938 0.495 . . . . 71.3 110.307 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.15 -46.86 19.48 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.737 0.815 . . . . 73.35 110.694 169.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.06 97.15 1.77 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.575 0.75 . . . . 74.13 111.417 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.12 172.46 10.56 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.324 0.65 . . . . 72.21 111.316 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.51 9.79 82.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 116.614 -0.266 . . . . 52.31 113.456 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 tt -77.83 158.19 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 124.33 1.052 . . . . 74.51 109.338 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 m -79.1 150.75 31.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.752 -0.592 . . . . 60.53 110.392 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.592 HG21 ' HB2' ' A' ' 40' ' ' ALA . 70.7 mt -54.75 -47.19 98.79 Favored Pre-proline 0 CA--C 1.578 2.057 0 N-CA-C 113.82 1.044 . . . . 72.14 113.82 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.94 -23.74 34.29 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 122.117 1.878 . . . . 74.32 113.961 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.47 -48.24 23.56 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.094 0.95 . . . . 62.21 108.984 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.431 HD22 HD11 ' A' ' 63' ' ' ILE . 64.5 tp -57.28 -38.62 74.21 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 113.324 -1.762 . . . . 60.52 111.613 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.9 -41.92 88.37 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.935 0.894 . . . . 32.0 111.774 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -66.06 -37.44 85.83 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.812 0.845 . . . . 73.43 111.695 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.14 -35.64 77.61 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.457 0.646 . . . . 64.35 111.706 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.592 HG21 HG12 ' A' ' 13' ' ' VAL . 29.7 m -105.15 5.38 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.71 0.804 . . . . 74.24 112.623 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 62.11 19.76 11.12 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 124.814 1.246 . . . . 73.03 114.05 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.4 mt -99.47 168.56 9.9 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.251 0.621 . . . . 62.03 110.615 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 t -75.89 157.02 33.76 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.762 0.425 . . . . 72.33 111.402 171.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 t -56.47 -44.14 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.076 0.95 . . . . 70.23 111.42 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.475 ' HB3' HD12 ' B' ' 25' ' ' ILE . 42.2 mt-10 -63.86 -39.41 94.14 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.039 0.936 . . . . 75.43 112.039 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.3 m -68.94 -35.39 76.72 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.663 0.785 . . . . 74.1 111.502 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 43' ' ' VAL . 99.5 m -76.97 -46.98 22.1 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.544 0.738 . . . . 63.04 111.893 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.592 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -59.31 -35.92 74.68 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 123.565 0.746 . . . . 75.32 111.737 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.451 HD11 HD13 ' B' ' 54' ' ' ILE . 0.9 OUTLIER -65.04 -49.73 68.99 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 114.908 -1.042 . . . . 44.5 110.181 174.335 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.56 70.21 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.645 0.778 . . . . 74.32 111.713 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 63' ' ' ILE . 53.5 t -68.27 -35.93 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.207 0.603 . . . . 72.31 110.495 173.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.654 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -63.96 -30.43 77.7 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 116.336 -0.393 . . . . 52.31 113.612 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.47 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 65.0 t-105 -70.62 -37.15 73.78 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.009 0.433 . . . . 75.24 110.923 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.17 -32.19 72.26 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 122.199 -0.313 . . . . 64.33 110.955 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.86 -31.05 71.78 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.672 0.789 . . . . 61.34 111.481 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.578 ' HA ' ' HD2' ' B' ' 48' ' ' ARG . 31.9 ttt180 -63.64 -50.62 68.6 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.985 0.514 . . . . 73.45 110.71 168.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -79.14 -2.02 38.8 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.171 0.988 . . . . 60.34 112.197 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 63.07 22.13 13.26 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.541 1.536 . . . . 75.4 112.688 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 63.1 mttp -78.7 -18.65 54.0 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.391 1.076 . . . . 71.31 112.961 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.55 157.86 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 112.807 0.669 . . . . 63.03 112.807 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.62 HG23 ' HB2' ' A' ' 64' ' ' TYR . 7.3 m -129.78 120.22 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 124.694 1.198 . . . . 72.32 109.773 172.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.427 HG13 HG22 ' A' ' 63' ' ' ILE . 3.4 mp -96.95 107.38 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.636 0.774 . . . . 62.43 109.906 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -117.38 137.34 52.53 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.909 0.484 . . . . 74.31 111.469 -172.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -89.11 100.96 13.63 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.846 0.859 . . . . 72.33 110.212 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -107.64 119.35 39.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.702 0.801 . . . . 73.53 110.394 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 58.47 30.97 20.44 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.955 1.302 . . . . 72.52 112.268 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.07 -21.2 25.22 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-N 115.386 -0.825 . . . . 71.21 114.197 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.65 137.7 33.67 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.788 0.835 . . . . 73.32 111.266 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.06 114.25 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.59 0.756 . . . . 72.43 109.197 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.1 138.38 54.47 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.751 -0.833 . . . . 74.32 108.751 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -103.38 124.4 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 122.265 1.031 . . . . 73.14 110.669 -177.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.62 ' HB2' HG23 ' A' ' 53' ' ' VAL . 89.0 m-85 -109.72 171.24 7.56 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.191 1.396 . . . . 65.2 109.582 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -93.75 168.25 11.12 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.576 0.703 . . . . 74.22 112.11 175.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 124.237 1.015 . . . . 72.35 111.837 170.629 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt . . . . . 0 CA--C 1.557 1.239 0 CA-C-O 121.063 0.458 . . . . 73.24 111.817 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -65.5 -24.09 67.06 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 113.145 0.794 . . . . 73.33 113.145 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 73.5 mt -64.34 -52.75 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.208 0.603 . . . . 54.42 111.348 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.48 -26.81 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 122.846 0.459 . . . . 71.41 111.887 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.38 -45.81 88.93 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 123.44 0.462 . . . . 74.11 112.984 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.92 91.9 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.701 0.8 . . . . 63.34 111.802 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.38 -41.85 97.78 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.678 0.791 . . . . 61.32 110.935 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.92 -24.05 55.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.95 0.9 . . . . 64.33 112.533 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.22 -41.51 99.51 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 121.354 0.419 . . . . 32.35 112.65 172.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -70.65 -41.1 72.58 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.081 0.953 . . . . 71.3 111.293 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.501 HG13 HD21 ' B' ' 28' ' ' LEU . 77.4 t -60.98 -46.1 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.887 0.875 . . . . 70.44 112.092 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -71.84 -31.79 66.87 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 116.286 -0.415 . . . . 75.12 111.424 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -56.62 -37.75 71.13 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.744 0.418 . . . . 72.14 111.471 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.18 75.4 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.038 0.535 . . . . 65.31 111.84 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.632 HD21 HG13 ' B' ' 63' ' ' ILE . 93.8 mt -73.83 -37.63 64.79 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.963 0.905 . . . . 55.22 112.158 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -59.08 -39.33 81.82 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.699 0.8 . . . . 73.21 110.636 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -79.17 -48.56 14.04 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.538 -0.755 . . . . 71.32 111.134 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.31 99.5 3.15 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.201 0.6 . . . . 63.33 111.566 -173.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.01 174.55 10.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.2 0.6 . . . . 65.44 112.272 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.94 13.32 83.52 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.224 -0.444 . . . . 63.32 113.977 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.402 HG21 HD13 ' B' ' 28' ' ' LEU . 11.0 tp -78.06 138.52 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 C-N-CA 123.15 0.58 . . . . 71.32 110.9 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.4 m -84.61 151.32 24.58 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.936 0.494 . . . . 64.14 111.015 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' A' ' 37' ' ' GLU . 54.2 mt -53.56 -45.84 98.45 Favored Pre-proline 0 CA--C 1.581 2.165 0 N-CA-C 114.711 1.375 . . . . 63.15 114.711 -172.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' B' ' 36' ' ' VAL . 65.8 Cg_endo -71.29 -29.15 17.47 Favored 'Trans proline' 0 C--N 1.396 3.038 0 CA-C-N 121.803 1.68 . . . . 71.5 113.415 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -73.6 -49.21 27.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.157 0.98 . . . . 72.24 109.863 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.501 HD21 HG13 ' B' ' 13' ' ' VAL . 62.5 tp -53.93 -36.24 62.56 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 113.013 -1.903 . . . . 74.35 111.775 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.05 83.35 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.658 0.783 . . . . 70.51 112.108 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' B' ' 26' ' ' PRO . 10.3 mpt_? -70.94 -39.88 72.37 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.942 0.497 . . . . 75.12 110.593 175.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.61 -43.18 93.84 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.311 0.644 . . . . 71.32 111.233 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.4 -5.88 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.58 0.752 . . . . 74.44 112.247 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 66.12 21.15 11.19 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.79 1.236 . . . . 63.55 113.01 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 68.5 mt -108.72 169.39 8.69 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.862 0.865 . . . . 73.1 110.553 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -72.34 155.5 40.09 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.003 0.521 . . . . 62.21 111.003 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' B' ' 26' ' ' PRO . 96.4 t -56.74 -44.04 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 123.579 0.751 . . . . 32.21 112.364 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.39 -49.25 78.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.626 0.77 . . . . 65.2 111.861 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -61.73 -38.68 88.81 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.556 1.142 . . . . 71.15 111.914 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.485 ' O ' HG23 ' B' ' 43' ' ' VAL . 92.4 m -70.08 -46.75 64.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.116 0.966 . . . . 71.23 111.037 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.472 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -62.09 -35.41 78.59 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.745 0.818 . . . . 64.14 112.137 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -69.64 -37.78 76.91 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.3 1.04 . . . . 74.53 110.156 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.55 -34.78 77.75 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.208 0.603 . . . . 73.54 111.428 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.485 HG23 ' O ' ' B' ' 39' ' ' THR . 98.4 t -61.8 -33.94 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.251 0.621 . . . . 74.42 110.921 172.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.654 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -62.05 -30.45 75.59 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 116.155 -0.475 . . . . 63.24 114.011 176.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.426 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 70.6 t-105 -68.49 -38.91 81.42 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.937 0.495 . . . . 54.22 110.899 172.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 93.1 mt -70.01 -33.07 71.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.926 0.491 . . . . 70.13 111.299 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.22 -31.27 72.34 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.923 0.889 . . . . 62.33 111.589 170.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' A' ' 48' ' ' ARG . 15.3 ttt180 -65.74 -44.84 84.76 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.742 0.817 . . . . 74.04 111.322 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -80.05 -3.99 50.83 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.409 0.683 . . . . 74.21 112.451 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 62.11 21.92 12.75 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.27 1.428 . . . . 74.5 112.983 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -86.5 -4.06 59.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.067 0.947 . . . . 65.1 113.074 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.74 146.69 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 112.41 0.522 . . . . 61.22 112.41 -177.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.68 120.15 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.227 -1.027 . . . . 72.22 108.227 172.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.558 HG12 HG22 ' B' ' 63' ' ' ILE . 62.4 mt -106.99 111.88 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-O 121.341 0.591 . . . . 65.02 110.973 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -114.02 140.71 48.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.144 0.978 . . . . 72.23 110.636 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -113.51 103.28 11.11 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.503 0.721 . . . . 64.53 110.8 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.9 113.72 26.22 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.587 1.155 . . . . 62.13 108.829 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 60.04 30.47 19.95 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.093 0.957 . . . . 73.33 112.653 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.58 -10.35 62.23 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 113.942 0.337 . . . . 74.34 113.942 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 44.5 tp -84.21 128.88 34.84 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.001 0.92 . . . . 73.04 110.281 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.8 126.85 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.076 0.55 . . . . 51.52 109.827 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.94 120.64 36.96 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.038 -1.097 . . . . 73.23 108.038 173.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.632 HG13 HD21 ' B' ' 17' ' ' LEU . 34.1 pt -103.48 138.94 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.245 0.545 . . . . 70.53 110.557 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -121.49 179.07 4.56 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.459 1.104 . . . . 63.15 110.025 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.421 ' OD1' ' HB3' ' B' ' 17' ' ' LEU . 1.6 m-20 -82.15 160.55 23.07 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.051 -0.351 . . . . 73.0 110.051 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 CA--C 1.56 1.335 0 C-N-CA 123.374 0.67 . . . . 52.32 111.187 172.063 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 112.837 0.68 . . . . 64.33 112.837 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.4 mt -49.15 -50.04 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 124.07 0.948 . . . . 62.2 112.215 173.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.418 HG12 HD11 ' A' ' 41' ' ' LEU . 33.4 m -61.78 -28.02 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 112.436 0.532 . . . . 50.32 112.436 -177.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.52 -38.4 86.48 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 122.953 0.158 . . . . 32.44 113.073 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.59 -52.52 25.38 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.668 0.787 . . . . 62.34 111.785 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -59.26 -43.0 92.5 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.053 0.941 . . . . 55.41 112.155 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.4 -27.56 63.4 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.341 0.497 . . . . 70.42 112.341 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.79 -38.9 96.84 Favored Glycine 0 CA--C 1.538 1.485 0 O-C-N 123.332 0.395 . . . . 60.31 112.718 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -70.42 -43.82 69.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.502 0.721 . . . . 62.25 111.277 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.563 ' HA ' HG11 ' A' ' 32' ' ' VAL . 95.2 t -59.27 -42.75 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.433 0.693 . . . . 64.04 111.195 176.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 64.5 t90 -66.41 -32.98 74.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.851 0.86 . . . . 74.43 111.393 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -60.5 -53.73 53.98 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.068 0.147 . . . . 70.42 111.342 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.08 -30.91 71.94 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.172 0.589 . . . . 61.12 111.461 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.49 -50.71 50.32 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.99 1.316 . . . . 72.44 111.366 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.69 -23.87 59.87 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.361 0.664 . . . . 74.12 111.06 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -79.8 -37.06 36.04 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.393 1.077 . . . . 74.42 110.46 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.22 103.54 1.64 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.802 0.841 . . . . 61.22 110.705 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.674 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 10.7 p-10 -95.04 166.42 11.94 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.298 0.639 . . . . 72.15 112.148 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.68 64.16 1.11 Allowed Glycine 0 N--CA 1.473 1.133 0 CA-C-N 116.095 -0.502 . . . . 50.04 112.201 -175.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 tt -156.36 149.76 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 123.428 0.691 . . . . 71.03 111.116 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -86.17 158.58 19.72 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.232 0.613 . . . . 71.52 111.649 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.502 HG21 ' HB2' ' A' ' 40' ' ' ALA . 74.4 mt -53.68 -52.59 65.89 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 114.185 1.18 . . . . 55.11 114.185 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.0 -26.18 43.72 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 121.773 1.649 . . . . 71.13 114.188 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -76.22 -45.57 32.39 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.455 1.121 . . . . 54.15 109.423 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.9 tp -60.1 -34.35 73.36 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 113.284 -1.78 . . . . 60.44 111.973 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.66 95.36 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.007 0.923 . . . . 64.44 112.438 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -71.49 -27.94 63.57 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.856 0.462 . . . . 63.43 112.044 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -66.67 -52.28 46.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.222 0.534 . . . . 63.13 110.914 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.563 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.0 m -79.07 -5.87 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 115.184 -0.916 . . . . 52.42 111.838 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 69.28 16.35 8.42 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.239 1.415 . . . . 70.0 112.171 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.8 mt -97.23 164.21 12.58 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.555 0.742 . . . . 71.11 110.254 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -68.23 153.58 43.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.414 0.286 . . . . 70.12 111.323 172.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.68 -44.92 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 123.486 0.714 . . . . 61.3 111.887 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -60.25 -42.8 96.09 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.95 0.9 . . . . 54.0 111.797 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 t -64.91 -42.68 94.52 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.587 0.755 . . . . 54.34 111.369 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 43' ' ' VAL . 61.6 m -71.49 -37.9 71.24 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.805 0.842 . . . . 54.25 111.775 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.94 -44.86 88.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 123.747 0.819 . . . . 75.13 111.504 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 6' ' ' VAL . 1.3 tm? -64.33 -37.33 87.13 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.461 -1.245 . . . . 61.33 110.357 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.04 -36.48 72.36 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.371 0.669 . . . . 73.1 112.449 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 39' ' ' THR . 88.0 t -66.75 -36.81 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.097 0.559 . . . . 52.42 110.452 173.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.51 -31.97 82.57 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-N 116.099 -0.5 . . . . 74.51 112.709 172.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.457 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 75.6 t-105 -74.03 -27.97 61.2 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.33 0.652 . . . . 72.24 111.582 173.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.76 -34.6 67.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.534 -0.729 . . . . 74.21 111.593 172.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.54 -26.59 55.33 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.11 0.964 . . . . 64.31 113.147 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.814 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 7.2 ptm180 -56.22 -36.65 68.7 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.387 0.884 . . . . 71.22 113.387 -174.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.814 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 39.3 mt-10 -112.22 15.76 20.32 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.117 0.967 . . . . 64.01 111.24 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.42 47.65 8.57 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.428 1.091 . . . . 54.2 110.048 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -87.68 -14.6 39.46 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.736 0.643 . . . . 64.53 112.736 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 m -133.23 150.64 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.92 0.888 . . . . 71.11 111.933 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 54.4 t -102.57 113.64 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.734 1.214 . . . . 60.2 108.772 171.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.458 HG23 HG23 ' A' ' 61' ' ' ILE . 50.4 mm -100.17 108.85 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 118.061 0.391 . . . . 73.2 110.983 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB3' ' NZ ' ' A' ' 57' ' ' LYS . 28.4 mm-40 -104.9 127.76 52.86 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.284 1.034 . . . . 72.02 110.356 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.535 HH22 ' HA ' ' B' ' 38' ' ' SER . 81.4 mtt-85 -113.61 105.55 13.47 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.872 -0.517 . . . . 71.25 111.529 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' NZ ' ' HB3' ' A' ' 55' ' ' GLU . 14.4 mptt -112.48 119.47 38.33 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.877 0.871 . . . . 61.43 109.843 176.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 57.97 32.61 22.19 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.148 0.979 . . . . 72.23 112.27 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.23 -6.39 72.15 Favored Glycine 0 CA--C 1.543 1.844 0 N-CA-C 114.269 0.468 . . . . 75.12 114.269 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.8 mt -88.24 125.66 34.76 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.602 0.761 . . . . 73.25 110.192 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.458 HG23 HG23 ' A' ' 54' ' ' ILE . 2.8 mp -86.01 126.31 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.512 0.725 . . . . 65.03 110.048 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -109.92 128.64 55.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.682 1.193 . . . . 74.14 108.9 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.9 mp -107.83 106.86 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 108.832 -0.803 . . . . 72.01 108.832 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.674 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 96.7 m-85 -107.55 167.16 10.14 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.573 1.149 . . . . 74.41 110.596 175.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.54 147.31 23.44 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.894 0.378 . . . . 71.31 110.873 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 CA--C 1.565 1.522 0 CA-C-O 121.075 0.464 . . . . 73.34 112.239 -179.542 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 120.989 0.424 . . . . 74.22 111.417 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -91.68 -25.21 19.22 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.317 0.647 . . . . 61.11 112.112 175.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 75.2 mt -59.89 -46.19 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 122.97 0.508 . . . . 70.34 110.521 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.408 HG12 HD11 ' B' ' 41' ' ' LEU . 35.7 m -64.12 -30.95 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 122.884 0.473 . . . . 62.34 112.113 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.24 -41.54 59.34 Favored Glycine 0 CA--C 1.538 1.49 0 O-C-N 123.191 0.307 . . . . 73.33 113.174 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.76 -43.58 88.45 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.78 0.832 . . . . 53.25 111.469 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -65.55 -35.7 81.62 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.736 0.814 . . . . 63.44 111.27 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.45 70.96 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.164 0.586 . . . . 51.43 111.264 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.27 -36.87 92.32 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 116.299 -0.409 . . . . 74.14 112.57 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -63.97 -47.67 79.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.111 0.965 . . . . 65.32 111.878 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 75.8 t -62.32 -46.8 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.328 0.651 . . . . 62.41 111.153 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.571 ' HA ' HD12 ' B' ' 17' ' ' LEU . 17.9 t90 -64.02 -33.85 76.68 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.776 0.83 . . . . 74.41 111.436 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' HIS . . . . . 0.415 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 78.4 t60 -59.8 -47.99 83.48 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.974 0.509 . . . . 71.21 110.467 172.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.09 -26.84 68.73 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.23 0.612 . . . . 72.52 112.598 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' B' ' 14' ' ' TRP . 75.4 mt -68.84 -41.49 78.45 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.519 0.728 . . . . 63.43 111.166 172.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.01 -26.13 65.74 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.882 -0.599 . . . . 72.14 110.996 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 10.4 mm-40 -73.6 -47.18 42.24 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.413 0.685 . . . . 61.04 110.533 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.9 106.63 0.61 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.238 1.015 . . . . 71.44 110.554 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -95.6 179.67 5.05 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.485 0.714 . . . . 72.43 112.118 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.76 39.3 34.38 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 116.191 -0.459 . . . . 53.22 112.493 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.402 ' O ' HG22 ' B' ' 63' ' ' ILE . 17.4 tt -124.29 153.45 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.954 0.902 . . . . 63.13 110.751 -172.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -80.29 151.56 29.48 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.801 0.441 . . . . 75.2 111.462 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' B' ' 40' ' ' ALA . 87.3 mt -51.04 -49.14 82.79 Favored Pre-proline 0 CA--C 1.577 1.991 0 N-CA-C 114.451 1.278 . . . . 74.1 114.451 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.477 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 59.9 Cg_endo -67.33 -30.17 37.31 Favored 'Trans proline' 0 C--N 1.393 2.89 0 C-N-CA 121.711 1.607 . . . . 71.22 114.135 -176.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -76.68 -44.17 34.8 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.229 1.014 . . . . 60.53 110.307 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.33 -40.19 74.02 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 113.427 -1.715 . . . . 72.42 111.287 171.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.82 -38.33 85.05 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.102 0.961 . . . . 65.24 112.505 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' B' ' 26' ' ' PRO . 14.7 mmm-85 -63.29 -44.1 96.01 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.4 0.68 . . . . 75.44 110.651 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -67.21 -43.27 82.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.864 0.866 . . . . 75.41 111.833 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.3 m -83.03 -5.27 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 122.875 0.47 . . . . 64.13 111.768 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.21 11.56 8.23 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.422 1.489 . . . . 60.45 112.682 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.7 mt -93.17 165.79 12.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.531 0.732 . . . . 71.45 110.019 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -65.94 153.55 41.77 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 122.239 -0.288 . . . . 72.44 110.59 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 54.9 t -49.88 -52.26 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.104 0.962 . . . . 45.04 112.171 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -71.12 -30.64 66.75 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.295 1.038 . . . . 74.34 111.436 -176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.535 ' HA ' HH22 ' A' ' 56' ' ' ARG . 41.7 m -64.97 -42.17 94.81 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.629 0.772 . . . . 73.41 110.775 173.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.449 ' O ' HG23 ' B' ' 43' ' ' VAL . 84.9 m -70.06 -43.19 71.72 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.103 0.961 . . . . 75.25 111.075 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.522 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -62.06 -42.66 99.43 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 123.975 0.91 . . . . 75.33 112.106 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.408 HD11 HG12 ' B' ' 6' ' ' VAL . 1.5 tm? -64.67 -38.26 90.39 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.698 1.199 . . . . 74.5 110.365 176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.92 72.07 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.548 0.739 . . . . 74.4 111.958 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 39' ' ' THR . 75.0 t -63.7 -35.68 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.481 0.713 . . . . 72.41 110.67 172.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.35 -31.24 80.08 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 116.29 -0.414 . . . . 44.02 113.41 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.499 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 43.6 t-105 -74.39 -31.24 62.28 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.229 0.612 . . . . 73.01 111.331 176.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.27 -36.29 68.97 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.29 0.636 . . . . 65.14 111.433 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.31 82.9 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.825 0.85 . . . . 73.21 110.8 172.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.562 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 31.2 ttt180 -51.84 -50.6 60.58 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.636 0.775 . . . . 64.24 111.064 171.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -80.01 -2.31 43.58 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.947 -1.024 . . . . 72.14 112.737 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 64.75 26.63 13.05 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.754 1.222 . . . . 60.31 112.694 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -99.29 5.73 46.45 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.136 0.791 . . . . 61.1 113.136 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.492 ' HB ' HD11 ' B' ' 63' ' ' ILE . 28.5 m -135.31 156.8 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.398 0.618 . . . . 71.21 112.589 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 32.4 t -111.56 125.29 68.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 124.475 1.11 . . . . 72.44 109.262 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.83 103.42 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.42 -0.956 . . . . 74.02 108.42 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' GLU . . . . . 0.471 ' HB3' ' HE1' ' B' ' 64' ' ' TYR . 7.7 tp10 -118.86 115.79 25.15 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.938 0.399 . . . . 63.1 109.982 -173.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -84.69 107.05 16.69 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.544 0.687 . . . . 72.21 111.063 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -104.82 114.39 28.57 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.581 1.153 . . . . 62.01 109.912 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 58.44 32.44 22.11 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.063 0.945 . . . . 72.13 112.399 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.17 -20.02 31.88 Favored Glycine 0 CA--C 1.545 1.942 0 N-CA-C 114.06 0.384 . . . . 75.23 114.06 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 tt -88.41 138.34 31.52 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.456 1.102 . . . . 51.33 109.9 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -87.8 122.95 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.753 0.421 . . . . 62.43 111.704 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -108.45 127.08 53.59 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.089 0.956 . . . . 74.25 108.633 171.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.492 HD11 ' HB ' ' B' ' 52' ' ' VAL . 0.0 OUTLIER -104.75 121.91 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-O 121.887 0.851 . . . . 72.35 110.154 -176.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.62 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 45.3 m-85 -107.71 157.76 17.84 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.624 1.17 . . . . 73.12 110.141 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -85.16 162.97 19.01 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.039 0.536 . . . . 72.51 111.48 -175.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.487 1.388 0 C-N-CA 124.227 1.011 . . . . 70.03 112.473 175.56 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 11.2 mmpt? . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 112.37 0.507 . . . . 72.54 112.37 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.6 mt -65.28 -46.92 89.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.34 0.656 . . . . 71.14 111.579 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.81 -27.55 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 118.057 0.39 . . . . 70.21 111.676 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.04 -42.52 94.56 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.557 0.536 . . . . 33.51 112.491 172.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.11 81.1 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.487 0.715 . . . . 75.22 111.24 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -61.73 -36.12 80.03 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.569 0.747 . . . . 75.11 111.161 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.93 -36.61 69.97 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.533 0.733 . . . . 63.15 111.615 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.86 -31.41 75.54 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-N 116.41 -0.359 . . . . 74.43 112.545 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.554 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 53.8 tptt -71.0 -42.28 69.83 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.442 1.097 . . . . 63.42 111.186 175.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.59 -40.7 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.993 0.917 . . . . 44.23 111.343 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 13.4 t90 -69.33 -33.53 73.25 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 116.018 -0.537 . . . . 73.35 110.399 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -57.13 -46.05 83.01 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.134 0.573 . . . . 72.21 110.744 168.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.36 -29.57 66.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.517 0.727 . . . . 73.25 112.481 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.12 -49.1 60.1 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.627 0.771 . . . . 41.54 112.083 172.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -67.56 -22.31 65.4 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.067 0.461 . . . . 35.23 111.303 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -76.2 -48.72 19.37 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.292 1.037 . . . . 72.54 109.614 174.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.24 97.4 0.34 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.753 1.221 . . . . 52.54 110.263 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.98 173.75 11.5 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.732 0.813 . . . . 73.4 112.258 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.04 61.38 4.03 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.765 -0.534 . . . . 62.53 111.765 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.11 159.08 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 123.153 0.581 . . . . 71.11 111.185 -166.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 58.8 m -79.47 153.28 29.74 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.844 0.354 . . . . 72.44 111.09 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.645 HG21 ' HB2' ' A' ' 40' ' ' ALA . 95.8 mt -53.56 -54.8 41.73 Favored Pre-proline 0 CA--C 1.576 1.956 0 C-N-CA 124.494 1.118 . . . . 44.35 112.245 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 55.9 Cg_endo -66.36 -25.19 49.35 Favored 'Trans proline' 0 C--N 1.401 3.301 0 C-N-CA 121.764 1.643 . . . . 73.24 113.741 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -70.63 -51.84 25.36 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.383 0.673 . . . . 75.11 112.501 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.61 -33.01 74.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.312 0.245 . . . . 73.11 110.381 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.14 -41.25 64.91 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.622 1.169 . . . . 61.21 112.645 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 26' ' ' PRO . 46.9 mtt180 -62.62 -41.18 98.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.927 0.891 . . . . 72.25 111.553 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -72.61 -43.24 63.57 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.731 0.813 . . . . 75.43 111.243 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.554 ' HB ' ' HG3' ' A' ' 12' ' ' LYS . 26.2 m -85.69 -0.47 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 115.465 -0.789 . . . . 75.43 112.26 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.6 m120 67.08 11.21 8.26 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.897 1.279 . . . . 72.44 113.229 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.5 mt -89.24 148.01 23.83 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.374 -0.602 . . . . 63.23 109.374 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.3 t -63.25 153.4 34.84 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.45 0.3 . . . . 32.24 110.952 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.45 -42.44 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 123.278 0.631 . . . . 75.42 111.333 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.53 -43.39 98.94 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.417 0.687 . . . . 61.34 112.338 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.4 m -62.09 -33.02 73.65 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 123.302 0.641 . . . . 73.43 111.707 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 43' ' ' VAL . 79.0 m -77.4 -53.06 8.11 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.763 0.825 . . . . 71.01 111.641 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -59.73 -41.75 91.6 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.416 1.087 . . . . 43.11 112.884 -177.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -65.49 -39.02 91.42 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.405 1.082 . . . . 63.13 110.407 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.17 -31.12 69.53 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 123.241 0.616 . . . . 64.12 112.016 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 39' ' ' THR . 87.2 t -61.02 -38.13 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 123.765 0.826 . . . . 61.32 110.354 171.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.94 -32.03 82.88 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.794 -0.639 . . . . 75.3 113.943 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.437 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 70.8 t-105 -70.31 -37.38 74.73 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.059 0.457 . . . . 73.41 110.708 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.54 -35.63 79.44 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.774 0.43 . . . . 71.13 111.047 172.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.67 88.91 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.513 0.725 . . . . 74.04 111.421 172.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 22.7 ttt180 -55.61 -49.91 71.54 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.799 0.84 . . . . 62.0 111.128 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -78.4 -6.02 54.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.755 0.822 . . . . 71.42 111.718 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 62.07 22.87 13.42 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.601 1.56 . . . . 42.02 112.462 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -78.28 -5.63 52.61 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.458 1.103 . . . . 55.31 113.41 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 63' ' ' ILE . 25.6 m -133.14 151.98 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.171 0.589 . . . . 61.34 112.294 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 64' ' ' TYR . 17.3 m -123.27 121.04 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 C-N-CA 124.108 0.963 . . . . 55.1 109.014 169.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.532 HG12 HD11 ' B' ' 41' ' ' LEU . 3.6 mp -100.99 124.29 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 109.154 -0.684 . . . . 62.52 109.154 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.42 148.59 44.92 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.253 0.621 . . . . 72.11 112.16 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -100.61 112.63 25.04 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.446 0.699 . . . . 71.52 110.267 171.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -105.44 112.77 26.0 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.846 0.859 . . . . 71.4 108.942 173.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 55.88 30.77 16.52 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.631 1.172 . . . . 73.23 112.067 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.96 -27.2 13.48 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 115.431 -0.804 . . . . 54.12 113.986 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.31 132.3 42.93 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.781 0.832 . . . . 73.04 111.394 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.0 mt -89.7 123.98 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.449 0.699 . . . . 65.21 111.511 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -127.58 139.05 53.01 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.458 1.103 . . . . 73.35 109.748 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.46 HD11 HG11 ' A' ' 52' ' ' VAL . 6.1 tt -95.07 136.34 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.287 0.635 . . . . 73.34 110.533 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.56 ' HB2' HG23 ' A' ' 53' ' ' VAL . 98.8 m-85 -130.37 169.39 15.54 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.546 1.138 . . . . 64.53 110.374 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.54 155.43 20.49 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.425 0.69 . . . . 71.03 110.264 171.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.935 0.398 . . . . 73.22 111.86 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 112.21 0.448 . . . . 65.2 112.21 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -65.25 -20.25 66.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.302 -0.249 . . . . 71.21 111.603 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.58 -59.55 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.084 0.554 . . . . 75.31 110.91 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.66 -29.84 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 111.842 0.312 . . . . 74.42 111.842 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.29 -47.5 63.48 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.366 0.416 . . . . 70.4 113.138 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.68 96.61 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.935 0.894 . . . . 43.02 111.296 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.57 -42.26 87.31 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.636 -0.711 . . . . 73.22 111.581 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.72 -35.32 72.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.089 0.556 . . . . 64.45 112.105 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.66 -38.13 95.26 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 116.332 -0.394 . . . . 61.24 112.994 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -75.72 -42.45 50.67 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.744 0.818 . . . . 74.11 110.943 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.572 ' HA ' HG11 ' B' ' 32' ' ' VAL . 34.3 t -62.78 -48.05 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.384 1.074 . . . . 65.31 111.47 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.436 ' NE1' ' HB3' ' B' ' 51' ' ' LYS . 48.3 t90 -64.92 -35.12 80.13 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.024 0.53 . . . . 65.35 111.735 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' HIS . . . . . 0.451 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 38.9 t60 -65.4 -46.79 78.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.567 0.347 . . . . 70.35 110.419 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.15 62.51 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.37 0.668 . . . . 73.13 112.149 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.408 HD13 ' ND2' ' B' ' 65' ' ' ASN . 1.4 tm? -72.87 -31.77 64.95 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.569 1.148 . . . . 64.41 110.397 171.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.68 -36.46 73.32 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.569 -0.53 . . . . 65.13 109.569 175.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 12.3 mm-40 -72.49 -49.88 29.89 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.326 0.65 . . . . 73.13 110.617 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.8 86.75 2.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.013 0.925 . . . . 73.33 110.206 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -68.67 124.61 24.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.633 0.773 . . . . 54.5 111.778 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.61 63.07 2.4 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.451 -0.34 . . . . 62.33 112.389 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.6 tp -117.3 137.96 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.594 0.758 . . . . 71.23 110.764 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -67.68 147.75 52.25 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.563 0.745 . . . . 73.33 110.901 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.523 HG21 ' HB2' ' B' ' 40' ' ' ALA . 60.8 mt -56.99 -49.89 91.35 Favored Pre-proline 0 CA--C 1.58 2.119 0 N-CA-C 113.422 0.897 . . . . 61.35 113.422 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.63 -27.38 32.48 Favored 'Trans proline' 0 C--N 1.399 3.203 0 C-N-CA 121.799 1.666 . . . . 65.31 114.026 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -70.91 -52.68 18.57 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.067 0.937 . . . . 71.24 109.245 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.446 HD21 HG13 ' B' ' 13' ' ' VAL . 60.6 tp -54.56 -38.34 66.53 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 113.249 -1.796 . . . . 73.52 112.15 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.72 -45.14 93.08 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.993 0.917 . . . . 63.04 111.915 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -67.7 -37.71 82.65 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.23 0.612 . . . . 74.34 110.861 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -64.12 -30.01 71.1 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.781 0.832 . . . . 61.45 112.243 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' B' ' 13' ' ' VAL . 34.1 m -103.09 1.91 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 112.769 0.655 . . . . 74.12 112.769 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 64.3 27.79 13.79 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 124.868 1.267 . . . . 63.32 113.132 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 72.4 mt -113.18 166.54 11.35 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.752 0.821 . . . . 74.12 111.448 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 31.6 t -69.43 155.74 39.96 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.664 -0.698 . . . . 63.31 111.61 170.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 67.8 t -56.37 -42.39 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.586 0.754 . . . . 72.42 111.033 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.83 -47.31 86.24 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.005 0.922 . . . . 65.42 111.457 175.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 41.5 t -63.72 -38.09 89.79 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.106 0.963 . . . . 72.43 112.089 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.46 ' O ' HG23 ' B' ' 43' ' ' VAL . 94.1 m -75.12 -49.44 19.59 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.863 0.865 . . . . 74.54 111.866 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.523 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -60.25 -39.59 87.28 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.69 0.796 . . . . 63.12 112.257 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.532 HD11 HG12 ' A' ' 54' ' ' ILE . 1.2 tt -62.2 -48.71 78.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.182 0.993 . . . . 74.03 110.064 173.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.72 -29.99 68.5 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.98 -1.009 . . . . 64.02 112.116 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.616 HG11 HD12 ' B' ' 63' ' ' ILE . 72.8 t -68.84 -37.17 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 123.061 0.544 . . . . 73.34 110.768 176.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -68.9 -30.25 72.43 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 116.431 -0.349 . . . . 32.3 112.79 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.456 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 72.6 t-105 -73.67 -21.07 60.38 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.304 0.642 . . . . 70.35 110.991 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.72 -33.8 58.15 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.645 0.778 . . . . 52.14 112.29 167.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.76 -25.53 60.61 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.057 1.132 . . . . 71.13 114.057 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.582 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 35.7 ptt85 -61.75 -36.38 80.85 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.036 0.446 . . . . 70.31 111.878 174.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.582 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 41.0 mt-10 -96.37 -2.7 45.13 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.35 1.06 . . . . 64.25 111.344 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 63.55 20.55 12.3 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 125.395 1.478 . . . . 70.13 113.065 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.436 ' HB3' ' NE1' ' B' ' 14' ' ' TRP . 49.5 mtmt -75.46 -8.18 56.04 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.378 0.881 . . . . 74.23 113.378 -173.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -128.57 151.58 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.915 0.886 . . . . 71.41 110.693 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.606 HG23 ' HB2' ' B' ' 64' ' ' TYR . 8.3 m -123.95 123.61 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.166 0.986 . . . . 62.43 109.884 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.582 HG23 HG23 ' B' ' 61' ' ' ILE . 1.9 mp -91.3 119.77 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.224 1.01 . . . . 72.24 109.616 -176.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -116.98 136.55 52.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.348 0.659 . . . . 75.01 110.156 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -98.58 108.46 21.16 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.857 0.463 . . . . 71.13 111.297 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -104.88 109.33 21.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.924 0.89 . . . . 72.12 109.455 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 61.18 30.29 19.23 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.053 1.341 . . . . 74.21 112.25 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.96 -18.42 56.03 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 113.796 0.279 . . . . 43.22 113.796 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mp -89.84 149.11 22.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.935 0.894 . . . . 75.22 110.394 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.582 HG23 HG23 ' B' ' 54' ' ' ILE . 27.1 mm -92.66 134.94 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.596 0.358 . . . . 64.22 111.278 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -123.19 133.16 54.25 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.607 -0.886 . . . . 73.13 108.607 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.616 HD12 HG11 ' B' ' 43' ' ' VAL . 25.5 mm -93.15 119.46 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.421 0.688 . . . . 74.14 110.016 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.606 ' HB2' HG23 ' B' ' 53' ' ' VAL . 57.0 m-85 -113.73 169.33 9.06 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.856 0.862 . . . . 75.3 110.688 175.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.408 ' ND2' HD13 ' B' ' 17' ' ' LEU . 5.8 m120 -79.99 154.38 28.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.533 0.733 . . . . 63.14 110.469 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.574 0.702 . . . . 62.54 112.061 172.603 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 112.887 0.699 . . . . 65.11 112.887 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.4 mt -44.69 -59.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 123.547 0.739 . . . . 63.32 111.101 166.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.0 m -65.67 -27.16 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 112.507 0.558 . . . . 64.41 112.507 -177.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.49 -42.67 88.63 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 120.899 0.166 . . . . 61.13 112.718 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.57 84.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.002 0.921 . . . . 61.34 111.301 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -60.21 -47.76 84.61 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.098 0.959 . . . . 72.22 111.289 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.78 -29.81 64.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.525 0.73 . . . . 63.2 112.168 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.45 -40.77 99.12 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.231 0.332 . . . . 72.12 112.873 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 60.3 tttp -75.87 -37.91 58.44 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.592 0.757 . . . . 63.13 111.931 177.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.599 ' HA ' HG11 ' A' ' 32' ' ' VAL . 60.0 t -61.23 -48.59 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 123.487 0.715 . . . . 65.51 111.586 177.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.46 ' HA ' HD12 ' A' ' 17' ' ' LEU . 30.6 t90 -65.65 -39.01 90.94 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.667 -0.697 . . . . 73.23 111.311 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -60.62 -38.64 85.43 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.204 0.602 . . . . 62.34 111.151 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.82 -23.2 63.27 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.419 0.687 . . . . 75.12 112.257 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 14' ' ' TRP . 70.2 mt -70.54 -44.88 66.6 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.332 0.653 . . . . 64.22 111.318 169.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -61.0 -32.79 72.36 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.002 0.521 . . . . 73.35 111.425 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.61 -52.31 32.92 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.383 0.673 . . . . 64.42 110.551 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.86 102.29 0.56 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.52 0.728 . . . . 63.45 111.206 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -97.12 -175.13 3.15 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.763 0.825 . . . . 72.02 110.819 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.05 49.85 7.27 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.365 -0.694 . . . . 75.41 111.365 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.4 tt -139.33 159.57 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.238 -0.981 . . . . 72.2 110.867 -163.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.9 m -72.99 146.28 46.1 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.66 0.384 . . . . 74.23 110.819 171.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 40' ' ' ALA . 70.6 mt -55.96 -46.06 99.81 Favored Pre-proline 0 CA--C 1.58 2.106 0 C-N-CA 124.126 0.97 . . . . 74.31 112.998 176.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.494 ' HA ' HG22 ' A' ' 36' ' ' VAL . 35.7 Cg_endo -62.54 -29.43 78.38 Favored 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 122.19 1.926 . . . . 53.02 114.524 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -74.75 -46.62 36.05 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 122.39 1.09 . . . . 72.54 110.146 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.468 HD22 HG21 ' A' ' 63' ' ' ILE . 58.2 tp -58.45 -38.18 76.98 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 113.259 -1.791 . . . . 73.44 111.6 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.15 -37.74 75.24 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.237 1.015 . . . . 73.33 112.345 177.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -67.67 -38.27 83.5 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.415 0.686 . . . . 74.13 111.712 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 28' ' ' LEU . 42.4 mtmt -69.12 -38.4 78.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.217 0.607 . . . . 52.31 111.367 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 13' ' ' VAL . 32.3 m -90.86 -1.68 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.731 0.641 . . . . 75.22 112.731 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 68.09 9.89 7.47 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.175 1.39 . . . . 73.41 112.46 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.5 mt -95.86 167.55 11.18 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.347 0.659 . . . . 65.33 111.409 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.5 t -66.47 149.51 50.32 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.661 0.784 . . . . 73.42 110.845 168.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 26' ' ' PRO . 55.6 t -55.14 -41.81 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.276 0.56 . . . . 72.35 110.921 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HB3' HD12 ' B' ' 25' ' ' ILE . 42.7 mt-10 -64.65 -39.06 93.03 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.37 1.068 . . . . 63.35 112.574 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 64.2 p -75.56 -26.56 58.06 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 122.616 0.367 . . . . 65.15 111.982 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 43' ' ' VAL . 84.9 m -78.57 -43.47 26.46 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.418 0.687 . . . . 63.42 111.178 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.38 -36.86 85.52 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.376 0.671 . . . . 71.03 111.263 175.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.511 HD11 HG21 ' B' ' 54' ' ' ILE . 1.0 OUTLIER -58.3 -53.22 60.77 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.512 1.125 . . . . 74.12 109.94 170.573 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.86 -31.29 71.55 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.917 -1.038 . . . . 73.52 111.721 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 39' ' ' THR . 41.7 t -65.86 -37.98 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.565 0.746 . . . . 74.44 110.687 173.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.48 -31.74 81.21 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-N 116.753 -0.203 . . . . 63.12 113.499 172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.549 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 66.7 t-105 -73.55 -31.07 63.45 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.656 0.782 . . . . 74.3 111.47 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.31 -38.83 63.23 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.267 0.627 . . . . 73.04 111.317 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.54 81.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.37 1.068 . . . . 74.11 112.317 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.618 ' HB2' ' HD2' ' B' ' 48' ' ' ARG . 9.7 ptt180 -62.65 -34.19 76.57 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 121.196 0.522 . . . . 74.42 110.543 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -85.97 -1.43 57.32 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.233 1.013 . . . . 64.22 111.898 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 65.3 22.2 12.06 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.26 1.424 . . . . 75.31 112.301 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.36 -8.41 50.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 113.078 0.77 . . . . 63.41 113.078 -173.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.633 ' HB ' HD11 ' A' ' 63' ' ' ILE . 30.2 m -132.15 157.1 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.023 0.529 . . . . 72.42 112.07 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 64' ' ' TYR . 11.9 m -128.63 123.99 60.63 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 123.83 0.852 . . . . 72.53 110.41 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.18 125.03 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.848 0.859 . . . . 65.02 110.075 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -99.66 122.36 42.57 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.05 0.54 . . . . 73.31 110.976 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.477 ' HG2' HG12 ' A' ' 61' ' ' ILE . 79.2 mtt85 -106.23 98.56 8.22 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.792 0.837 . . . . 74.43 110.111 173.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -127.59 128.67 45.97 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.596 0.758 . . . . 72.52 109.617 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 59.14 29.69 19.3 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.7 1.2 . . . . 75.43 112.137 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.19 1.83 64.97 Favored Glycine 0 CA--C 1.549 2.214 0 CA-C-N 116.05 -0.523 . . . . 63.52 114.224 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.4 mt -93.89 131.79 38.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.692 0.797 . . . . 53.44 111.19 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.477 HG12 ' HG2' ' A' ' 56' ' ' ARG . 72.4 mt -101.77 116.97 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 72.35 110.62 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -121.66 133.28 54.96 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.175 0.99 . . . . 72.31 109.828 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.633 HD11 ' HB ' ' A' ' 52' ' ' VAL . 7.0 tp -97.29 117.05 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 CA-C-O 121.801 0.81 . . . . 74.02 111.614 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.482 ' HB2' HG23 ' A' ' 53' ' ' VAL . 77.1 m-85 -109.07 165.88 11.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.957 1.303 . . . . 73.44 110.341 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.32 142.15 28.1 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.698 -0.853 . . . . 74.44 108.698 175.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.613 0 C-N-CA 123.831 0.853 . . . . 72.43 111.98 -176.813 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 112.634 0.605 . . . . 70.11 112.634 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -87.87 -22.74 24.25 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 122.502 0.321 . . . . 75.31 110.727 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.61 -50.96 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.071 0.549 . . . . 73.42 110.426 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.534 HG12 HD11 ' B' ' 41' ' ' LEU . 26.8 m -61.02 -30.52 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 122.531 0.333 . . . . 64.24 111.471 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.15 -49.19 16.9 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 123.31 0.381 . . . . 74.24 113.317 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.32 -49.18 72.78 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.696 0.799 . . . . 70.34 111.78 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -58.89 -41.38 87.03 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.07 0.948 . . . . 74.33 111.92 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.449 ' HB1' ' HG ' ' B' ' 46' ' ' LEU . . . -66.48 -39.65 88.89 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.173 0.589 . . . . 72.12 111.952 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.91 -43.75 98.95 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 116.059 -0.519 . . . . 34.34 112.549 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -68.06 -42.96 79.7 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.978 0.911 . . . . 62.03 111.77 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.746 ' HA ' HG11 ' B' ' 32' ' ' VAL . 37.7 t -57.94 -44.18 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 124.117 0.967 . . . . 75.43 111.78 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 45.8 t90 -63.4 -33.42 75.52 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 115.221 -0.9 . . . . 73.22 112.194 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -61.09 -30.6 70.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.095 0.776 . . . . 73.44 113.095 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.33 65.88 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.341 0.497 . . . . 54.11 112.341 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.484 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 96.5 mt -70.55 -21.65 62.68 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.504 0.722 . . . . 73.5 112.619 174.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -64.78 -30.34 71.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.799 0.839 . . . . 65.41 111.891 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -91.55 -35.83 14.05 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.85 0.46 . . . . 51.1 111.168 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.43 112.23 1.09 Allowed 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.38 0.511 . . . . 73.52 112.38 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 9.4 p-10 -80.53 179.36 7.78 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.599 0.76 . . . . 71.3 110.704 166.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.46 61.14 4.95 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.611 -0.596 . . . . 75.22 111.611 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 tt -140.84 140.67 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.106 0.963 . . . . 65.32 110.03 -172.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 68.6 m -83.84 161.0 21.05 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.973 0.509 . . . . 52.32 110.885 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.483 HG21 ' HB2' ' B' ' 40' ' ' ALA . 58.8 mt -59.54 -44.92 98.62 Favored Pre-proline 0 CA--C 1.579 2.087 0 N-CA-C 113.9 1.074 . . . . 71.55 113.9 -174.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.88 -29.38 41.6 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 121.936 1.758 . . . . 43.2 114.237 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -71.7 -46.77 57.72 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.744 1.259 . . . . 70.13 109.654 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.499 HD22 HD11 ' B' ' 63' ' ' ILE . 65.3 tp -58.35 -43.62 88.4 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 112.946 -1.934 . . . . 52.11 111.681 173.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.68 91.21 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.497 1.119 . . . . 72.14 113.37 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -71.2 -23.58 62.06 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.073 0.549 . . . . 60.54 111.73 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -78.53 -44.6 23.92 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.772 0.829 . . . . 71.51 111.171 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' B' ' 13' ' ' VAL . 17.9 m -86.32 4.84 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.324 0.65 . . . . 64.44 112.414 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 65.34 17.75 11.1 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.815 1.246 . . . . 72.54 112.571 171.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 71.4 mt -109.72 158.32 18.22 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.468 0.707 . . . . 74.4 110.698 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -66.18 153.16 43.2 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.98 0.512 . . . . 44.04 111.168 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -53.6 -43.44 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 123.571 0.748 . . . . 61.52 111.964 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.402 ' HB2' HD12 ' A' ' 61' ' ' ILE . 45.7 mt-10 -61.99 -49.67 75.14 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.619 0.767 . . . . 74.23 112.037 175.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -61.33 -30.76 70.71 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.716 0.806 . . . . 65.43 112.236 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 87.4 m -77.44 -47.41 19.78 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.052 0.941 . . . . 63.51 111.304 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.483 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.62 -39.23 93.34 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.545 0.738 . . . . 42.1 111.99 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.534 HD11 HG12 ' B' ' 6' ' ' VAL . 1.3 tm? -62.41 -38.54 90.06 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.061 1.344 . . . . 75.34 110.431 174.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.52 -33.59 67.0 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.38 0.672 . . . . 53.13 111.914 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.71 -35.55 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.801 0.84 . . . . 71.45 111.482 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.08 -31.86 74.14 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 113.835 0.294 . . . . 60.24 113.835 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.404 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 72.2 t-105 -75.04 -36.7 61.85 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.426 0.691 . . . . 72.22 111.499 175.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.449 ' HG ' ' HB1' ' B' ' 10' ' ' ALA . 83.2 mt -66.4 -35.1 79.48 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.03 0.532 . . . . 60.22 111.311 173.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.73 -35.81 75.32 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.309 1.044 . . . . 41.31 112.449 172.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.618 ' HD2' ' HB2' ' A' ' 48' ' ' ARG . 49.4 ttt85 -57.17 -45.88 83.28 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.333 0.587 . . . . 73.23 110.691 171.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.38 -15.29 57.17 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 114.794 -1.093 . . . . 61.35 112.191 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 t30 65.37 26.7 12.01 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.868 1.267 . . . . 71.43 111.125 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -82.71 -19.11 38.67 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.507 -0.77 . . . . 75.35 111.854 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 24.4 m -114.53 140.04 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.19 0.596 . . . . 74.22 110.455 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 51.7 t -103.71 96.82 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.367 -0.975 . . . . 75.11 108.367 174.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.651 HG12 HG22 ' B' ' 63' ' ' ILE . 57.0 mt -81.93 123.68 38.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 115.783 -0.644 . . . . 65.4 109.766 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' GLU . . . . . 0.489 ' HB3' ' HE2' ' B' ' 64' ' ' TYR . 13.6 tt0 -143.14 127.65 17.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.882 -0.599 . . . . 62.1 110.525 -172.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -83.77 103.82 13.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.397 0.679 . . . . 71.31 110.055 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -106.1 122.82 46.95 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.503 1.121 . . . . 71.11 111.15 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 59.22 31.03 20.88 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 125.162 1.385 . . . . 73.15 112.772 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.13 -27.87 6.52 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 115.988 -0.551 . . . . 73.32 113.66 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mp -81.56 165.15 21.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.762 0.825 . . . . 74.23 109.562 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.71 136.48 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.867 -0.521 . . . . 62.52 110.684 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -134.47 168.24 19.3 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.175 0.99 . . . . 73.1 110.851 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.651 HG22 HG12 ' B' ' 54' ' ' ILE . 0.2 OUTLIER -120.53 147.53 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.329 1.052 . . . . 62.53 110.313 171.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.555 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 93.6 m-85 -124.86 169.53 11.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.471 1.108 . . . . 74.3 110.405 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' B' ' 21' ' ' ASP . 4.4 m-20 -71.97 148.84 45.58 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.049 0.452 . . . . 64.04 111.844 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 CA--C 1.55 0.974 0 C-N-CA 124.297 1.039 . . . . 64.15 111.651 171.084 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 112.439 0.533 . . . . 75.04 112.439 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.1 mt -53.87 -47.54 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 123.853 0.861 . . . . 74.44 111.524 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.3 m -61.06 -29.29 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.967 1.307 . . . . 73.33 112.356 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.04 -41.71 70.23 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.679 0.612 . . . . 72.51 112.7 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.54 -43.03 98.28 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.315 0.646 . . . . 63.53 111.262 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -67.51 -35.03 78.32 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.693 0.797 . . . . 52.45 111.633 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.16 -35.03 68.92 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.496 0.718 . . . . 43.12 111.699 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.54 -35.96 92.53 Favored Glycine 0 CA--C 1.539 1.535 0 O-C-N 123.497 0.498 . . . . 74.45 112.631 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -67.74 -48.94 65.04 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.093 0.957 . . . . 73.44 111.64 175.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.93 -34.74 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.263 0.625 . . . . 50.41 111.9 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -71.03 -33.93 70.79 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.745 0.818 . . . . 74.14 110.959 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -66.92 -29.24 69.06 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 71.15 111.227 172.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.23 -31.35 67.46 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.991 0.516 . . . . 65.35 111.843 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.533 HD11 HG12 ' A' ' 52' ' ' VAL . 98.1 mt -59.35 -39.32 82.81 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.142 0.977 . . . . 73.02 113.521 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -67.84 -11.54 58.79 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 112.445 0.535 . . . . 71.02 112.445 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -103.61 -39.3 6.76 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.499 1.12 . . . . 61.42 110.004 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.53 91.67 2.68 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.684 0.794 . . . . 64.13 112.624 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -85.14 133.89 34.19 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.095 0.558 . . . . 63.55 110.298 167.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.37 61.79 2.89 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-O 121.155 0.308 . . . . 74.41 112.733 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.6 tt -126.78 145.34 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.505 0.722 . . . . 71.03 110.975 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.4 m -68.09 138.43 55.76 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.904 0.881 . . . . 74.1 110.62 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.744 HG21 ' HB2' ' A' ' 40' ' ' ALA . 76.2 mt -58.36 -42.27 93.84 Favored Pre-proline 0 CA--C 1.583 2.221 0 N-CA-C 114.059 1.133 . . . . 54.3 114.059 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 36' ' ' VAL . 29.8 Cg_endo -61.99 -32.36 84.29 Favored 'Trans proline' 0 C--N 1.394 2.961 0 C-N-CA 121.93 1.753 . . . . 65.43 114.123 174.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.17 -45.2 50.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.711 1.243 . . . . 74.11 109.47 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.588 HD22 HD11 ' A' ' 63' ' ' ILE . 66.7 tp -57.14 -38.89 74.15 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 112.75 -2.023 . . . . 75.12 111.818 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.17 78.05 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.323 1.049 . . . . 74.31 112.566 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.25 -42.85 87.98 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.255 0.622 . . . . 74.13 111.379 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -75.46 -35.13 60.93 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 112.473 0.546 . . . . 72.23 112.473 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 m -81.64 -9.89 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-O 120.772 0.32 . . . . 74.25 111.122 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 63.23 25.86 14.94 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.498 1.519 . . . . 71.43 113.203 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.3 mt -105.17 171.63 7.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.313 1.045 . . . . 74.23 109.887 173.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.7 m -68.07 158.98 31.78 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 122.551 0.34 . . . . 63.34 110.762 170.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.435 HG22 ' HA ' ' A' ' 26' ' ' PRO . 79.5 t -51.23 -57.06 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 123.286 0.634 . . . . 51.54 112.095 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.414 ' HG2' ' HB ' ' B' ' 25' ' ' ILE . 2.9 mp0 -66.65 -31.23 71.78 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.147 0.795 . . . . 73.14 113.147 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -61.67 -44.61 96.63 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.579 0.704 . . . . 74.53 110.881 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 43' ' ' VAL . 78.4 m -70.23 -41.57 73.42 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.629 -1.168 . . . . 62.01 111.385 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.744 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -67.5 -41.74 84.02 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.957 0.903 . . . . 64.35 112.071 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.06 -27.69 64.84 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.237 1.015 . . . . 75.01 110.518 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.85 -38.06 73.14 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.845 0.458 . . . . 70.53 111.261 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.531 HG11 HG21 ' A' ' 63' ' ' ILE . 90.3 t -61.88 -33.87 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.33 0.652 . . . . 75.33 110.089 169.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.48 90.17 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 115.918 -0.583 . . . . 73.34 113.802 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -67.92 -41.73 82.15 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.111 0.455 . . . . 71.24 110.229 173.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.38 -38.21 83.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.051 0.541 . . . . 72.24 110.927 173.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.84 96.49 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.628 0.771 . . . . 62.34 111.522 175.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 -56.8 -45.01 82.48 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.88 0.472 . . . . 74.42 111.114 171.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.89 -6.03 56.65 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.217 0.821 . . . . 75.33 113.217 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 68.53 30.81 5.05 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.115 1.366 . . . . 74.22 112.417 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -95.78 -13.83 23.79 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.945 1.298 . . . . 70.13 113.597 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.533 HG12 HD11 ' A' ' 17' ' ' LEU . 8.0 m -120.93 141.39 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.252 0.549 . . . . 75.31 112.263 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 94.7 t -107.63 107.09 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 124.271 1.028 . . . . 72.54 109.815 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 63' ' ' ILE . 2.9 mp -86.62 124.84 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 123.231 0.612 . . . . 63.24 110.001 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.23 116.0 13.06 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.755 0.822 . . . . 72.11 109.333 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -80.77 102.61 10.08 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.167 0.587 . . . . 64.04 110.029 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -112.74 124.98 53.81 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.481 0.712 . . . . 72.44 110.298 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 58.44 31.35 20.86 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.164 0.986 . . . . 74.52 112.112 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.06 -25.16 7.97 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 116.055 -0.521 . . . . 71.11 114.023 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.8 mt -79.14 146.22 33.28 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.905 0.882 . . . . 74.32 112.077 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.12 107.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.185 -0.672 . . . . 71.25 109.185 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.25 120.15 41.1 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.204 0.602 . . . . 64.52 109.725 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.588 HD11 HD22 ' A' ' 28' ' ' LEU . 2.7 pp -101.09 138.35 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.45 0.643 . . . . 71.12 111.032 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 93.5 m-85 -122.52 174.5 7.02 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.437 1.095 . . . . 72.32 110.19 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 63.6 t30 -90.64 158.28 17.02 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.91 0.484 . . . . 64.2 111.402 174.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.554 1.114 0 C-N-CA 123.992 0.917 . . . . 74.53 112.179 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.402 ' O ' HG22 ' B' ' 6' ' ' VAL . 71.9 tttt . . . . . 0 CA--C 1.56 1.333 0 CA-C-O 120.641 0.258 . . . . 72.24 110.809 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -56.0 -24.35 38.4 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 124.37 1.068 . . . . 63.43 112.968 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 69.6 mt -55.63 -44.01 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 123.994 0.918 . . . . 71.43 111.322 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 3' ' ' LYS . 2.9 m -61.71 -30.17 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 122.67 0.388 . . . . 43.04 111.461 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.32 92.15 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.485 0.491 . . . . 71.13 113.403 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.2 -38.11 87.2 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.641 0.776 . . . . 73.51 111.83 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -79.75 -19.62 48.27 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.159 0.583 . . . . 74.1 112.089 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.63 -39.5 52.16 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.305 0.642 . . . . 74.34 110.995 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.17 -30.92 75.09 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.435 -0.802 . . . . 74.02 112.472 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.452 ' HD2' HD11 ' B' ' 34' ' ' LEU . 4.7 ttmp? -70.72 -49.32 48.24 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.054 0.942 . . . . 71.32 112.374 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.534 HG13 HD11 ' B' ' 46' ' ' LEU . 2.5 p -66.2 -36.01 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 112.158 0.429 . . . . 70.01 112.158 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.458 ' HA ' HD12 ' B' ' 17' ' ' LEU . 26.0 t90 -73.17 -32.21 64.71 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.991 -0.443 . . . . 73.34 111.132 176.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -62.47 -36.32 82.1 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.213 0.605 . . . . 65.45 110.524 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.63 -32.73 74.47 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.469 -0.787 . . . . 54.11 111.932 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.49 HD21 HD13 ' B' ' 63' ' ' ILE . 84.8 mt -69.16 -44.38 72.37 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.763 0.825 . . . . 71.34 111.777 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -56.77 -39.87 74.82 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.933 0.893 . . . . 73.34 111.79 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -74.02 -50.36 20.11 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.49 0.716 . . . . 71.14 110.817 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.83 102.91 0.9 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.828 0.851 . . . . 71.51 110.757 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.2 173.94 10.61 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.802 0.441 . . . . 63.23 111.47 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.99 65.25 1.77 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.559 -0.291 . . . . 22.14 112.554 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 tt -151.01 144.93 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.305 0.642 . . . . 70.51 110.389 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 31.4 t -70.82 150.29 45.97 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.188 0.595 . . . . 64.52 111.138 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.633 HG21 ' HB2' ' B' ' 40' ' ' ALA . 82.4 mt -58.39 -51.02 84.8 Favored Pre-proline 0 CA--C 1.576 1.959 0 CA-C-O 118.177 -0.916 . . . . 72.45 113.408 -176.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.408 ' HA ' HG22 ' B' ' 36' ' ' VAL . 20.3 Cg_endo -59.23 -34.77 98.24 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.233 1.956 . . . . 75.52 113.438 176.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -66.05 -50.92 62.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.326 0.65 . . . . 75.24 112.226 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.618 HD22 HD11 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -69.9 -32.55 70.94 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.714 0.406 . . . . 71.53 110.838 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.68 -41.63 77.64 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.887 0.875 . . . . 53.14 111.637 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -60.11 -40.19 88.83 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.092 0.957 . . . . 74.41 111.26 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -75.38 -33.13 61.0 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.964 0.906 . . . . 55.14 112.791 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.4 m -96.57 5.25 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 123.584 0.754 . . . . 72.34 111.897 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 t30 68.93 10.92 8.17 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 125.212 1.405 . . . . 73.14 112.642 173.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.452 HD11 ' HD2' ' B' ' 12' ' ' LYS . 54.0 mt -94.57 155.31 16.96 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.662 -0.649 . . . . 74.24 110.607 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 47.6 m -67.79 152.45 45.56 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.42 0.288 . . . . 74.32 110.499 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' B' ' 26' ' ' PRO . 64.1 t -51.69 -44.2 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.401 0.681 . . . . 52.32 111.329 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.96 -47.91 83.41 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 114.918 -1.037 . . . . 70.01 112.242 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -58.97 -41.37 87.39 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.975 0.91 . . . . 44.13 112.769 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 95.5 m -72.65 -46.68 52.74 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.332 0.653 . . . . 71.31 111.907 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.633 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.89 -48.61 73.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.0 1.111 . . . . 73.14 114.0 -168.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -26.53 62.38 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 120.796 0.332 . . . . 71.22 110.93 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.43 -26.33 65.47 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.697 0.799 . . . . 75.14 111.99 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.69 -31.65 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 123.005 0.522 . . . . 61.11 110.991 169.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.27 -28.36 73.65 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.308 -0.405 . . . . 73.12 113.99 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.552 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 66.0 t-105 -72.11 -27.52 62.69 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.143 0.577 . . . . 63.3 111.034 172.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.534 HD11 HG13 ' B' ' 13' ' ' VAL . 73.6 mt -73.22 -36.12 66.41 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.751 -0.593 . . . . 65.34 110.715 169.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.39 -26.88 68.65 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.46 1.104 . . . . 62.41 113.818 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 12.9 ptt180 -62.1 -35.85 79.94 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 118.817 0.735 . . . . 74.03 110.288 172.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.472 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 32.6 mt-10 -93.98 -6.27 45.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.819 1.248 . . . . 73.53 111.687 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 t30 63.08 31.21 16.02 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.841 1.256 . . . . 72.02 111.56 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -85.68 -6.5 59.13 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.865 0.691 . . . . 50.34 112.865 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.88 145.81 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.405 0.622 . . . . 63.43 112.356 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' B' ' 64' ' ' TYR . 4.8 m -120.08 128.61 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.048 1.339 . . . . 71.34 108.304 167.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.436 HG12 HG22 ' B' ' 63' ' ' ILE . 68.2 mt -109.29 137.82 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.928 0.491 . . . . 41.12 110.754 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -134.99 125.82 27.35 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.707 0.803 . . . . 62.55 109.565 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -108.01 115.5 30.25 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.493 0.663 . . . . 55.44 110.606 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.64 126.84 55.71 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.84 1.256 . . . . 74.42 109.173 -175.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 59.84 29.11 18.68 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.37 1.068 . . . . 64.11 111.525 -175.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.6 -19.1 16.18 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-N 116.343 -0.39 . . . . 65.05 113.808 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 tp -78.4 112.01 14.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.062 0.945 . . . . 62.25 110.455 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 mt -83.44 125.14 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 122.512 0.325 . . . . 74.12 110.848 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -127.42 145.75 50.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.703 0.801 . . . . 74.51 109.902 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.618 HD11 HD22 ' B' ' 28' ' ' LEU . 2.2 pp -105.83 141.25 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-O 121.552 0.691 . . . . 43.04 111.63 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.472 ' HB2' HG23 ' B' ' 53' ' ' VAL . 73.2 m-85 -132.13 157.14 45.01 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.502 1.121 . . . . 73.02 109.228 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -102.98 153.55 20.12 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.051 0.54 . . . . 44.54 110.421 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 112.224 0.453 . . . . 73.13 112.224 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 112.885 0.698 . . . . 73.01 112.885 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.4 mt -60.07 -42.74 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.264 0.626 . . . . 74.54 111.782 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.626 HG12 HD11 ' A' ' 41' ' ' LEU . 34.5 m -59.42 -33.6 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 111.77 0.285 . . . . 71.53 111.77 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.75 -39.53 93.62 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 123.213 0.321 . . . . 64.24 112.986 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.87 -50.51 62.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.254 0.622 . . . . 52.02 111.828 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -70.6 -31.96 69.14 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.352 0.661 . . . . 74.43 112.351 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.43 -33.24 60.9 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.856 0.462 . . . . 53.43 111.625 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.65 -31.35 79.68 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.922 -0.581 . . . . 41.31 113.265 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -75.25 -36.72 61.24 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.566 0.747 . . . . 75.25 111.549 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.8 t -63.29 -41.13 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.369 0.604 . . . . 62.45 110.92 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 51' ' ' LYS . 77.6 t90 -72.26 -32.31 66.54 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.671 0.788 . . . . 73.23 111.54 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -61.79 -34.87 76.67 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.161 0.584 . . . . 75.42 110.679 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.99 -33.93 76.95 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.166 0.586 . . . . 73.13 111.753 174.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.417 HD11 HG12 ' A' ' 52' ' ' VAL . 92.2 mt -63.62 -27.34 69.17 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.635 0.774 . . . . 74.34 111.897 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.14 -35.04 77.46 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.299 0.64 . . . . 71.01 111.651 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -106.72 -65.84 1.06 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.528 0.731 . . . . 73.52 111.786 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . . . -127.53 84.54 2.26 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.452 0.644 . . . . 72.35 111.245 -175.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.73 -179.08 5.93 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.514 1.126 . . . . 73.1 112.972 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.17 52.36 48.01 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 115.698 -0.683 . . . . 62.21 113.247 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.496 HD13 ' HD2' ' A' ' 31' ' ' LYS . 13.7 tt -140.15 125.31 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.451 0.7 . . . . 72.15 110.719 -175.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.4 m -50.49 149.41 3.16 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.1 1.36 . . . . 61.22 113.31 -170.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.456 HG21 ' HB2' ' A' ' 40' ' ' ALA . 80.6 mt -47.62 -48.89 58.22 Favored Pre-proline 0 CA--C 1.576 1.946 0 C-N-CA 124.414 1.086 . . . . 72.11 113.928 -172.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 36' ' ' VAL . 48.7 Cg_endo -65.79 -37.6 27.11 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 121.847 1.698 . . . . 73.14 113.702 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -70.01 -46.92 64.09 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.46 1.124 . . . . 72.32 110.139 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.563 HD22 HG21 ' A' ' 63' ' ' ILE . 54.9 tp -57.61 -34.36 69.19 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 113.28 -1.782 . . . . 74.1 112.216 170.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 -38.12 82.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.031 0.532 . . . . 74.05 111.703 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -28.04 63.34 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 111.895 0.332 . . . . 74.44 111.895 173.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HD2' HD13 ' A' ' 23' ' ' ILE . 26.8 mtpp -68.21 -45.87 72.16 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.016 0.436 . . . . 71.13 111.644 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.8 m -86.61 -1.91 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.178 0.591 . . . . 61.42 111.707 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.9 t30 65.92 27.07 10.93 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.147 1.379 . . . . 75.33 111.767 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.6 mt -114.99 173.05 6.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.098 0.959 . . . . 74.21 111.759 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 t -68.12 155.6 39.25 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.324 0.65 . . . . 52.1 111.869 170.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 26' ' ' PRO . 62.2 t -55.44 -41.42 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.484 0.714 . . . . 72.32 110.641 172.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.17 -49.0 79.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.66 -1.155 . . . . 63.54 111.427 176.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.8 m -58.18 -43.39 87.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.107 0.963 . . . . 63.2 111.464 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 43' ' ' VAL . 85.4 m -69.72 -48.06 60.88 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.104 -0.953 . . . . 72.22 111.811 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -62.09 -38.77 90.12 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 123.459 0.703 . . . . 70.31 112.32 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.626 HD11 HG12 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -66.85 -40.83 88.05 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.798 1.239 . . . . 74.14 110.213 174.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.65 -34.73 74.41 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.488 0.715 . . . . 70.2 112.2 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 39' ' ' THR . 81.0 t -67.0 -32.95 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.56 0.744 . . . . 51.45 110.405 173.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -66.97 -33.34 83.57 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.141 -0.482 . . . . 31.54 113.316 173.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -69.35 -38.18 78.0 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.876 0.471 . . . . 63.42 110.644 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 51' ' ' LYS . 76.5 mt -67.57 -30.52 70.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.819 0.448 . . . . 72.45 111.437 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.29 75.35 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.309 0.643 . . . . 61.32 112.133 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -62.36 -49.64 74.77 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 122.886 0.474 . . . . 74.35 110.953 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 64.1 mt-10 -80.05 -8.86 59.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.513 -0.767 . . . . 74.21 111.547 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 63.42 27.04 15.13 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.9 1.28 . . . . 52.12 111.911 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 39.9 mmtm -69.86 -17.92 63.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.527 1.131 . . . . 61.42 112.308 175.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.417 HG12 HD11 ' A' ' 17' ' ' LEU . 34.6 m -129.24 154.48 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.145 0.578 . . . . 63.43 112.387 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 64' ' ' TYR . 34.9 m -120.77 132.27 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.494 0.718 . . . . 75.32 109.077 165.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 mm -110.45 123.63 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.206 0.602 . . . . 75.35 111.412 -173.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 49.5 mt-10 -106.16 155.62 19.27 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.166 0.586 . . . . 74.21 111.367 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.21 94.04 4.78 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.817 -1.549 . . . . 63.52 106.817 160.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.86 111.7 24.46 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.718 0.807 . . . . 73.24 108.886 -173.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 60.35 30.35 19.75 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.285 1.034 . . . . 64.14 110.114 -161.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.6 -12.98 25.26 Favored Glycine 0 C--N 1.36 1.904 0 CA-C-N 115.506 -0.77 . . . . 62.43 114.422 -173.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.79 117.48 19.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.299 0.64 . . . . 73.33 111.269 -177.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 67.1 mt -69.21 116.05 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.791 0.836 . . . . 72.32 111.254 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -126.01 140.49 52.56 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.891 0.876 . . . . 74.41 110.983 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.563 HG21 HD22 ' A' ' 28' ' ' LEU . 7.2 tt -92.74 133.17 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 124.235 1.014 . . . . 74.44 111.017 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.446 ' HB2' HG23 ' A' ' 53' ' ' VAL . 73.0 m-85 -131.63 173.22 11.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.492 1.117 . . . . 64.52 110.323 173.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -73.62 150.5 41.33 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.346 0.658 . . . . 72.44 111.196 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.484 1.271 0 C-N-CA 124.843 1.257 . . . . 64.4 113.607 171.704 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.556 1.201 0 N-CA-C 112.965 0.728 . . . . 63.34 112.965 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -84.05 -44.29 14.25 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.473 0.709 . . . . 70.11 111.034 173.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.66 -45.56 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.815 0.846 . . . . 65.5 111.93 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.563 HG12 HD11 ' B' ' 41' ' ' LEU . 34.8 m -61.28 -32.16 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.753 0.821 . . . . 72.2 112.157 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.83 62.26 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.27 0.356 . . . . 74.21 112.647 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.74 -45.78 88.34 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.589 0.756 . . . . 64.43 111.883 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -64.67 -41.08 96.32 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.773 0.829 . . . . 72.44 111.799 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.95 -31.3 70.08 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.885 0.474 . . . . 72.21 111.646 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.59 -38.38 96.2 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.847 -0.615 . . . . 72.35 112.882 174.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -75.1 -36.65 61.67 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.71 0.804 . . . . 71.31 111.434 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.552 ' HA ' HG11 ' B' ' 32' ' ' VAL . 92.7 t -67.63 -42.71 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.135 0.574 . . . . 63.45 111.368 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.494 ' HA ' HD12 ' B' ' 17' ' ' LEU . 19.5 t90 -68.56 -33.23 73.72 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.984 -0.553 . . . . 61.23 110.521 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' HIS . . . . . 0.413 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 66.3 t60 -62.34 -31.41 72.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.715 0.806 . . . . 64.13 111.638 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.43 67.31 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.706 0.402 . . . . 52.23 111.868 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' B' ' 14' ' ' TRP . 98.5 mt -64.14 -45.04 90.29 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.838 0.855 . . . . 70.02 113.137 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -69.78 -12.77 61.88 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 111.733 0.272 . . . . 62.35 111.733 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 20.4 mm-40 -81.08 -57.71 3.4 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.398 0.679 . . . . 71.32 109.753 171.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.16 105.15 3.19 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.5 0.72 . . . . 73.14 110.756 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.95 168.56 14.06 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.723 0.809 . . . . 64.44 111.458 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.26 64.98 2.09 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 112.477 -0.249 . . . . 45.32 112.477 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.432 ' O ' HG22 ' B' ' 63' ' ' ILE . 18.1 tt -146.32 156.22 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 C-N-CA 123.663 0.785 . . . . 71.4 110.303 -175.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -81.18 156.64 25.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.806 -0.559 . . . . 73.44 111.547 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.58 HG21 ' HB2' ' B' ' 40' ' ' ALA . 59.8 mt -58.84 -48.37 96.93 Favored Pre-proline 0 CA--C 1.577 1.994 0 N-CA-C 113.598 0.962 . . . . 75.04 113.598 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.468 ' HA ' HG22 ' B' ' 36' ' ' VAL . 55.1 Cg_endo -66.41 -23.9 50.44 Favored 'Trans proline' 0 C--N 1.395 3.001 0 CA-C-N 121.951 1.733 . . . . 71.33 114.138 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.19 -46.36 18.06 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.015 0.912 . . . . 64.21 109.608 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.56 HD22 HG21 ' B' ' 63' ' ' ILE . 59.0 tp -58.23 -34.45 70.45 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 113.735 -1.575 . . . . 74.22 111.681 173.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.15 85.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.951 0.9 . . . . 65.22 111.898 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -69.33 -40.33 77.65 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.603 0.761 . . . . 74.45 110.349 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -62.34 -35.69 79.88 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.568 0.747 . . . . 72.4 111.741 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.552 HG11 ' HA ' ' B' ' 13' ' ' VAL . 19.6 m -97.52 -1.24 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.074 0.55 . . . . 72.42 112.457 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 69.38 11.12 8.02 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.853 1.261 . . . . 70.42 112.575 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt -101.37 171.15 7.76 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.421 0.688 . . . . 73.34 111.351 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 29.7 t -66.07 154.23 40.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.909 0.484 . . . . 32.44 111.144 169.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' B' ' 26' ' ' PRO . 55.0 t -56.84 -40.16 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.247 0.619 . . . . 72.35 111.096 177.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.08 -43.79 77.76 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.404 -0.816 . . . . 74.31 111.839 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -61.04 -32.29 71.91 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.464 0.706 . . . . 74.41 111.798 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.45 ' O ' HG23 ' B' ' 43' ' ' VAL . 74.5 m -80.74 -47.86 13.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.078 0.951 . . . . 45.15 111.496 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.58 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.1 -40.2 95.7 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.603 0.761 . . . . 75.31 112.41 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.563 HD11 HG12 ' B' ' 6' ' ' VAL . 1.1 tm? -64.2 -34.95 79.27 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 124.813 1.245 . . . . 60.41 110.368 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.0 -33.52 61.84 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.617 0.767 . . . . 60.12 112.11 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 39' ' ' THR . 54.3 t -62.53 -37.56 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.784 0.834 . . . . 71.1 110.361 172.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -64.38 -30.42 77.81 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-N 116.057 -0.519 . . . . 70.13 113.63 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.477 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 67.3 t-105 -74.1 -31.3 62.73 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.805 0.442 . . . . 74.14 111.304 175.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 96.2 mt -72.18 -38.19 69.14 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.813 0.445 . . . . 61.02 110.808 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.32 -28.82 69.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.094 0.958 . . . . 74.42 112.049 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 26.2 ttt-85 -53.34 -49.47 67.04 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.652 0.781 . . . . 75.13 110.841 168.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -94.46 6.15 49.64 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.903 0.881 . . . . 65.24 112.739 -175.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.38 23.8 14.13 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 124.66 1.184 . . . . 75.11 113.255 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -80.35 -0.67 37.86 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.17 0.804 . . . . 72.44 113.17 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.05 147.99 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.667 0.787 . . . . 72.51 111.739 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.749 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 39.0 t -106.77 118.99 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.567 0.747 . . . . 71.13 109.007 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 46.6 mm -113.59 130.79 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 123.129 0.572 . . . . 64.1 111.296 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -133.79 132.68 40.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.621 0.768 . . . . 74.34 111.06 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -88.04 103.91 16.16 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.253 0.621 . . . . 52.13 110.976 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -110.38 112.49 24.46 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.356 1.062 . . . . 75.22 110.006 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 62.03 30.4 17.92 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.921 1.289 . . . . 74.55 112.523 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.82 -15.59 60.28 Favored Glycine 0 CA--C 1.543 1.841 0 CA-C-N 116.458 -0.337 . . . . 40.31 113.717 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 mp -93.37 147.02 23.3 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.998 0.919 . . . . 54.14 111.059 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mm -82.64 126.96 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.164 0.586 . . . . 74.35 111.394 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -110.5 122.44 47.74 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.21 1.004 . . . . 64.04 109.459 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.56 HG21 HD22 ' B' ' 28' ' ' LEU . 10.2 tt -108.49 139.01 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.408 0.623 . . . . 61.13 111.829 -175.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.749 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 90.9 m-85 -128.53 170.41 13.23 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.459 1.104 . . . . 71.44 110.523 176.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -91.04 162.4 14.72 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.552 0.741 . . . . 73.13 110.226 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.569 1.674 0 C-N-CA 122.837 0.455 . . . . 73.41 111.469 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 111.747 0.277 . . . . 70.13 111.747 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.07 -50.93 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.539 0.736 . . . . 63.42 111.117 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.428 HG11 HD11 ' A' ' 41' ' ' LEU . 6.3 m -73.66 -27.71 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.787 1.235 . . . . 65.34 111.418 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.39 -35.67 87.75 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 112.421 -0.272 . . . . 35.21 112.421 171.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.79 -56.16 5.32 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.564 0.746 . . . . 55.25 111.954 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -71.12 -22.76 62.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.951 0.723 . . . . 73.25 112.951 -173.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.612 ' HA ' HG22 ' A' ' 13' ' ' VAL . . . -67.14 -26.68 66.79 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.623 0.369 . . . . 64.22 111.12 174.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.67 -36.19 92.03 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.11 -0.496 . . . . 72.43 112.861 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -76.86 -41.99 41.78 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.564 0.746 . . . . 73.52 112.303 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' A' ' 10' ' ' ALA . 12.4 m -69.83 -34.93 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 122.141 -0.349 . . . . 72.44 110.82 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -71.67 -32.62 68.07 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.238 0.615 . . . . 74.13 111.083 172.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -61.54 -46.42 89.99 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.706 0.403 . . . . 73.01 110.967 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB1' ' HE2' ' A' ' 31' ' ' LYS . . . -66.74 -34.58 78.16 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.913 0.885 . . . . 74.24 111.46 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.37 -45.45 72.75 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.609 1.164 . . . . 54.45 111.299 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -75.53 -25.76 57.47 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.358 0.663 . . . . 74.11 110.703 -175.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -71.25 -41.3 70.28 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.029 0.932 . . . . 73.43 110.283 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.9 107.03 2.28 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.657 0.783 . . . . 65.13 110.261 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.13 179.32 5.11 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.683 0.793 . . . . 71.35 112.363 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.51 56.43 7.58 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 111.956 -0.458 . . . . 44.01 111.956 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 28' ' ' LEU . 9.4 tp -130.3 125.54 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 123.359 0.664 . . . . 73.44 110.768 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -80.57 153.59 27.97 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.215 0.606 . . . . 72.32 111.117 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 40' ' ' ALA . 62.5 mt -52.06 -53.3 53.37 Favored Pre-proline 0 CA--C 1.577 2.003 0 N-CA-C 114.324 1.231 . . . . 70.21 114.324 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.12 -21.88 23.28 Favored 'Trans proline' 0 C--N 1.39 2.753 0 CA-C-N 121.197 1.463 . . . . 51.54 114.179 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -78.59 -44.7 23.42 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 122.107 0.956 . . . . 74.32 109.326 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.496 ' HB2' HG13 ' A' ' 23' ' ' ILE . 50.3 tp -57.2 -37.48 72.24 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 113.524 -1.671 . . . . 64.12 111.149 172.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.56 -39.79 85.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.991 0.916 . . . . 62.21 112.005 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -73.21 -34.21 65.81 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.316 0.646 . . . . 75.24 111.48 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HE2' ' HB1' ' A' ' 16' ' ' ALA . 55.5 mtpt -62.87 -44.11 96.99 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.323 0.649 . . . . 64.23 111.182 175.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 13' ' ' VAL . 19.2 m -93.05 -4.02 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.592 0.757 . . . . 71.14 112.315 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 68.67 13.89 8.95 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.272 1.429 . . . . 70.51 113.532 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 73.1 mt -95.9 170.65 9.15 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.377 0.671 . . . . 74.15 111.228 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -67.1 150.74 48.75 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.212 0.605 . . . . 74.11 111.538 170.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.8 t -56.11 -43.63 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.597 0.759 . . . . 73.34 111.14 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -60.74 -45.62 93.61 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.388 -0.824 . . . . 70.14 112.0 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.5 m -65.98 -30.79 71.4 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.453 0.701 . . . . 64.13 112.009 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -80.17 -39.26 29.65 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.474 0.71 . . . . 63.44 111.654 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.75 -38.74 92.0 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.67 0.748 . . . . 74.34 111.076 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.428 HD11 HG11 ' A' ' 6' ' ' VAL . 1.2 tm? -69.82 -38.01 76.42 Favored 'General case' 0 CA--C 1.562 1.44 0 CA-C-N 114.184 -1.371 . . . . 74.1 110.743 175.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.59 -39.62 84.81 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 122.995 0.518 . . . . 71.41 111.655 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.2 -38.51 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.905 0.882 . . . . 72.31 111.176 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.36 -33.0 86.08 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.365 -0.38 . . . . 61.44 112.823 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.43 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 74.1 t-105 -69.4 -40.53 77.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.548 0.739 . . . . 74.3 110.352 174.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.71 -32.92 74.54 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.948 0.499 . . . . 71.02 111.796 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.6 89.5 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.387 0.675 . . . . 51.11 110.968 171.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 12.4 ttt180 -59.69 -50.18 74.87 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.078 0.551 . . . . 74.41 111.216 168.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 45' ' ' TRP . 8.7 mm-40 -76.13 -1.43 26.14 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.917 0.887 . . . . 71.43 112.706 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.12 33.77 19.29 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.86 1.264 . . . . 73.22 112.526 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -93.28 -23.21 18.58 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.106 0.962 . . . . 72.32 112.25 177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.09 157.2 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 113.416 0.895 . . . . 64.14 113.416 -173.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 64' ' ' TYR . 2.3 m -133.4 144.21 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.162 1.385 . . . . 44.41 110.123 175.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.726 HG12 HD11 ' B' ' 41' ' ' LEU . 2.6 mp -108.82 128.3 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.609 0.763 . . . . 75.25 111.067 -171.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -115.21 119.09 35.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.457 1.103 . . . . 55.53 109.833 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HG2' HG12 ' A' ' 61' ' ' ILE . 98.6 mtt180 -100.38 125.72 46.67 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.104 0.478 . . . . 73.24 111.156 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.87 131.11 13.6 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.979 0.912 . . . . 72.33 109.951 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 60.3 28.51 18.12 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.781 1.232 . . . . 62.21 111.802 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.49 -8.26 62.33 Favored Glycine 0 CA--C 1.544 1.844 0 N-CA-C 113.87 0.308 . . . . 71.22 113.87 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.38 160.91 14.05 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.95 0.9 . . . . 70.02 111.358 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.65 HG23 HG23 ' A' ' 54' ' ' ILE . 78.9 mt -112.64 127.96 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.866 0.866 . . . . 60.42 110.705 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -112.57 140.97 46.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.999 0.92 . . . . 62.15 109.544 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.85 133.76 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.018 0.927 . . . . 75.43 108.726 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HB2' HG23 ' A' ' 53' ' ' VAL . 88.6 m-85 -129.91 169.31 15.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.91 1.284 . . . . 55.21 109.84 177.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -85.97 138.22 32.15 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.143 0.577 . . . . 65.22 110.311 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 CA--C 1.566 1.573 0 CA-C-O 121.457 0.646 . . . . 72.04 112.125 179.603 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.417 ' O ' HG22 ' B' ' 6' ' ' VAL . 87.7 tttt . . . . . 0 CA--C 1.565 1.548 0 CA-C-O 121.384 0.612 . . . . 63.11 110.679 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.36 -26.99 65.86 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.071 0.948 . . . . 75.24 111.935 173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.11 -43.18 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.525 0.73 . . . . 72.34 111.712 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.417 HG22 ' O ' ' B' ' 3' ' ' LYS . 25.5 m -65.36 -28.91 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-N 117.641 0.201 . . . . 64.42 111.319 176.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' B' ' 45' ' ' TRP . . . -67.74 -46.36 68.64 Favored Glycine 0 C--N 1.354 1.534 0 O-C-N 123.519 0.512 . . . . 72.43 113.7 175.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.48 99.12 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.646 0.778 . . . . 63.54 111.162 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -70.34 -30.58 67.57 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.944 0.898 . . . . 64.05 112.238 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.7 66.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.066 0.546 . . . . 73.52 111.371 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.81 -36.23 93.07 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 116.006 -0.543 . . . . 63.51 112.839 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -70.11 -43.32 71.26 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.315 1.046 . . . . 75.41 111.155 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.601 ' HA ' HG11 ' B' ' 32' ' ' VAL . 42.9 t -60.48 -46.37 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 124.257 1.023 . . . . 70.43 111.727 176.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.582 ' HA ' HD12 ' B' ' 17' ' ' LEU . 66.8 t90 -66.97 -33.61 75.95 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.851 -0.613 . . . . 53.45 112.056 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -64.38 -35.15 79.97 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.812 0.445 . . . . 63.15 110.645 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.525 ' HB1' ' HE3' ' B' ' 31' ' ' LYS . . . -72.02 -23.87 61.46 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.663 0.785 . . . . 71.45 112.833 174.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' B' ' 14' ' ' TRP . 84.9 mt -70.2 -47.08 63.09 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.57 0.748 . . . . 64.03 110.692 169.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.87 -28.29 67.41 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.554 0.742 . . . . 63.43 111.305 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -72.22 -51.43 21.09 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.048 0.939 . . . . 55.31 110.396 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.47 118.37 2.21 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.079 0.551 . . . . 73.45 112.127 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -82.72 -178.06 6.95 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.301 1.04 . . . . 60.14 112.04 172.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.07 26.16 73.03 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.823 -0.626 . . . . 71.53 112.242 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 tp -106.76 146.4 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 124.042 0.937 . . . . 73.13 109.715 -173.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -95.0 162.37 13.76 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.31 0.644 . . . . 63.53 109.922 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.521 HG21 ' HB2' ' B' ' 40' ' ' ALA . 76.4 mt -56.35 -49.1 95.34 Favored Pre-proline 0 CA--C 1.58 2.118 0 N-CA-C 114.025 1.12 . . . . 65.51 114.025 -173.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.69 -30.31 42.01 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.027 1.818 . . . . 73.22 114.106 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -79.12 -42.35 26.47 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.203 1.001 . . . . 62.14 110.442 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.438 HD21 HG13 ' B' ' 13' ' ' VAL . 65.7 tp -58.04 -40.66 81.49 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.625 -1.625 . . . . 64.33 111.112 170.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.24 78.61 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.928 0.891 . . . . 72.15 111.83 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -67.03 -37.62 84.44 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.166 0.587 . . . . 73.11 111.51 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.525 ' HE3' ' HB1' ' B' ' 16' ' ' ALA . 44.4 mtmt -66.79 -39.95 87.95 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.826 0.45 . . . . 71.22 111.315 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' B' ' 13' ' ' VAL . 33.9 m -96.09 7.14 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.823 0.675 . . . . 64.23 112.823 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 65.8 t30 65.33 12.38 8.04 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.176 0.99 . . . . 75.31 112.783 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 59.8 mt -97.11 168.59 10.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.674 -0.641 . . . . 72.33 110.747 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 68.3 m -74.68 159.8 31.6 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.597 0.359 . . . . 64.44 110.998 170.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 70.1 t -52.49 -57.72 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.303 1.041 . . . . 60.04 112.589 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -68.61 -30.52 69.27 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.639 0.775 . . . . 73.22 111.669 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 56.0 m -61.17 -39.82 91.56 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.733 0.813 . . . . 64.21 111.408 173.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.441 ' O ' HG23 ' B' ' 43' ' ' VAL . 90.4 m -76.72 -42.37 41.55 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.722 0.809 . . . . 64.32 111.536 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -59.6 -39.74 85.21 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 123.81 0.844 . . . . 73.03 111.921 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.726 HD11 HG12 ' A' ' 54' ' ' ILE . 1.1 tt -60.41 -50.32 74.07 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.808 1.243 . . . . 72.32 110.009 173.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 -27.06 68.65 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 114.843 -1.071 . . . . 63.12 112.089 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 39' ' ' THR . 65.7 t -68.48 -39.96 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 123.388 0.675 . . . . 61.33 110.649 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.12 -27.8 73.19 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-N 116.379 -0.373 . . . . 73.51 113.07 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' TRP . . . . . 0.524 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 64.6 t-105 -74.82 -32.22 61.9 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.494 0.718 . . . . 73.23 111.466 173.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.58 -27.15 62.95 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.243 0.617 . . . . 63.23 111.765 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.02 67.96 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 113.199 0.814 . . . . 51.4 113.199 172.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 36.8 ptt85 -74.31 -29.18 61.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.861 -0.524 . . . . 73.42 110.968 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.5 ' HB3' ' HE2' ' B' ' 51' ' ' LYS . 21.7 mm-40 -72.22 -22.78 61.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.056 0.942 . . . . 73.12 112.359 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 59.41 35.06 22.94 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.275 1.03 . . . . 74.31 112.452 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.5 ' HE2' ' HB3' ' B' ' 49' ' ' GLU . 51.3 mtmt -108.49 0.44 20.94 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.683 0.623 . . . . 74.42 112.683 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.52 147.93 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 112.644 0.609 . . . . 75.43 112.644 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.66 108.25 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.798 0.839 . . . . 72.01 109.807 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 2.6 mp -89.97 112.34 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 108.499 -0.926 . . . . 73.24 108.499 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -102.21 126.51 49.21 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.835 0.454 . . . . 70.03 110.352 174.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -90.79 96.29 10.56 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.356 -0.979 . . . . 75.03 108.356 168.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -104.78 109.33 21.23 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.903 1.281 . . . . 71.54 109.093 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 55.15 29.16 12.12 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.559 1.144 . . . . 75.11 111.004 -164.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.17 -20.73 35.11 Favored Glycine 0 CA--C 1.549 2.197 0 CA-C-N 115.478 -0.783 . . . . 64.23 114.58 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.73 130.15 34.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 117.821 0.811 . . . . 52.21 111.83 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -84.05 114.96 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 123.458 0.703 . . . . 72.12 111.508 -173.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.28 142.94 46.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.017 0.927 . . . . 74.25 109.107 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 6.4 tp -106.74 128.3 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 CA-C-O 121.607 0.717 . . . . 72.14 110.709 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -126.63 171.48 11.1 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.692 1.197 . . . . 71.03 110.001 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 39.4 t30 -100.51 152.54 20.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.444 1.098 . . . . 72.14 108.889 170.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 . . . . . 0 N--CA 1.486 1.364 0 C-N-CA 123.819 0.847 . . . . 72.12 112.545 -177.626 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' SD ' ' HB2' ' A' ' 4' ' ' LYS . 17.1 tmm? . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 109.637 -0.505 . . . . 61.13 109.637 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.54 -44.32 0.28 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.707 0.803 . . . . 75.43 111.611 -173.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.51 ' HA ' HG22 ' A' ' 6' ' ' VAL . 51.5 mttp -66.9 -22.86 65.95 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.228 0.825 . . . . 71.44 113.228 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 29.3 mtpp -75.88 -38.67 57.62 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.19 0.596 . . . . 73.14 111.162 173.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.408 HG13 ' SD ' ' A' ' 1' ' ' MET . 57.8 mt -65.55 -55.94 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.434 0.693 . . . . 74.2 110.888 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 3' ' ' LYS . 11.3 m -69.34 -26.22 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.071 -0.968 . . . . 74.41 111.223 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.79 -40.24 95.54 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 116.491 -0.322 . . . . 42.04 113.138 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.97 -54.47 13.14 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.623 0.769 . . . . 70.04 112.527 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -71.82 -20.97 61.76 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.171 0.804 . . . . 61.14 113.171 -174.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 -30.41 70.55 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.462 0.705 . . . . 74.3 111.818 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.86 -35.84 90.19 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 116.239 -0.437 . . . . 62.32 113.063 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.86 -42.65 60.49 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.562 0.745 . . . . 52.53 111.791 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.63 ' HA ' HG11 ' A' ' 32' ' ' VAL . 35.0 m -68.49 -38.75 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 122.282 0.233 . . . . 75.3 111.503 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.618 ' HA ' HD12 ' A' ' 17' ' ' LEU . 69.7 t90 -64.29 -36.42 84.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.973 0.909 . . . . 73.24 111.561 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.18 -40.7 98.27 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.952 0.901 . . . . 70.11 111.282 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.423 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -68.59 -24.23 64.57 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.394 0.678 . . . . 72.52 112.556 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 14' ' ' TRP . 52.1 mt -73.49 -33.87 65.02 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.835 0.854 . . . . 63.13 112.078 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -60.54 -36.58 78.78 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.609 0.764 . . . . 74.12 110.983 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.19 -59.86 4.33 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.384 1.074 . . . . 71.31 111.497 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.37 114.18 0.76 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.198 0.999 . . . . 61.44 110.275 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -98.16 -179.21 4.31 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.751 0.82 . . . . 75.54 111.721 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.43 26.32 47.64 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 116.17 -0.468 . . . . 74.41 112.6 -170.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.4 tt -104.29 147.63 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 C-N-CA 123.658 0.783 . . . . 74.31 111.367 -172.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.4 t -76.51 160.0 29.87 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.246 1.018 . . . . 73.24 111.938 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.5 mm -55.76 -56.61 28.14 Favored Pre-proline 0 CA--C 1.575 1.937 0 N-CA-C 113.523 0.934 . . . . 74.33 113.523 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.8 -22.47 27.25 Favored 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 121.691 1.594 . . . . 61.21 113.909 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -75.85 -47.92 23.6 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 122.273 1.035 . . . . 73.45 110.227 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.48 -40.51 78.72 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 113.511 -1.677 . . . . 71.2 111.291 170.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.09 70.29 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.272 1.029 . . . . 52.2 113.039 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -73.62 -35.91 65.4 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.285 0.634 . . . . 73.24 112.287 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.423 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 45.0 mtmt -71.81 -43.99 64.7 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 120.905 0.383 . . . . 72.2 111.255 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 13' ' ' VAL . 20.0 m -86.93 -11.56 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.037 0.535 . . . . 63.35 112.3 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 60.72 37.77 18.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.731 1.213 . . . . 73.15 113.12 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.5 mt -106.85 157.31 17.85 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.574 0.75 . . . . 72.24 110.585 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 m -61.05 150.18 34.6 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.226 0.611 . . . . 64.1 111.361 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.6 t -54.91 -48.89 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.547 0.739 . . . . 71.23 112.466 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -59.8 -39.77 86.12 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.128 0.571 . . . . 75.42 111.724 174.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.7 t -68.84 -37.31 79.05 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.527 0.731 . . . . 64.2 112.825 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.5 m -71.6 -47.89 51.71 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.618 0.767 . . . . 61.23 110.699 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.78 93.58 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.007 0.923 . . . . 74.32 112.174 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.77 -35.28 64.97 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.16 0.984 . . . . 72.21 111.345 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.32 98.85 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.464 0.65 . . . . 73.31 110.891 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.574 HG11 HD13 ' A' ' 63' ' ' ILE . 69.9 t -64.4 -31.47 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 C-N-CA 123.813 0.845 . . . . 71.24 111.672 172.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.34 -32.44 82.87 Favored Glycine 0 CA--C 1.544 1.87 0 N-CA-C 113.888 0.315 . . . . 23.51 113.888 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -68.58 -32.71 72.81 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.591 0.757 . . . . 64.43 111.282 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.53 -41.02 69.67 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.414 0.686 . . . . 74.14 110.89 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.59 -26.92 64.15 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.549 1.139 . . . . 72.25 112.6 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -52.95 -45.07 67.53 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.889 0.876 . . . . 63.3 112.102 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -103.87 3.78 34.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.031 0.932 . . . . 74.31 112.147 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.7 m120 54.7 36.63 26.66 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.149 0.98 . . . . 71.22 112.595 -170.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -67.66 -18.22 64.87 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.356 0.663 . . . . 75.11 110.441 166.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.15 148.44 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.207 1.003 . . . . 74.11 109.974 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 64' ' ' TYR . 20.3 m -128.96 134.75 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.906 0.882 . . . . 73.32 108.98 173.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.71 128.8 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 121.206 0.527 . . . . 72.14 112.278 -167.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -122.54 141.33 51.78 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.667 1.187 . . . . 70.54 109.54 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -117.25 110.54 18.24 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.819 0.342 . . . . 71.12 110.865 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -111.28 126.78 55.26 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.052 -0.721 . . . . 70.22 109.052 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 56.95 31.1 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.463 1.105 . . . . 71.55 112.103 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.29 -15.56 38.98 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 114.431 0.533 . . . . 73.54 114.431 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.9 mt -74.15 151.7 39.99 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.349 0.659 . . . . 75.45 111.469 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 mp -99.88 111.97 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 123.157 0.583 . . . . 71.1 110.055 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -98.38 141.06 31.73 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.492 0.717 . . . . 73.21 110.065 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.574 HD13 HG11 ' A' ' 43' ' ' VAL . 61.7 mt -116.04 113.32 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.046 0.538 . . . . 63.41 110.479 172.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.461 ' HB2' HG23 ' A' ' 53' ' ' VAL . 9.0 m-30 -97.29 150.15 21.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.685 0.794 . . . . 74.14 110.583 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 17.9 t-20 -92.71 141.57 28.32 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.264 0.626 . . . . 74.13 109.59 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.98 -18.56 46.67 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.154 0.798 . . . . 64.23 113.154 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.68 -32.28 73.57 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 115.278 0.871 . . . . 63.14 115.278 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -68.66 -8.83 45.95 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 118.245 1.022 . . . . 73.54 112.171 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -84.35 -54.16 4.97 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.283 0.633 . . . . 70.4 110.563 170.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -102.96 -76.1 0.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.342 0.657 . . . . 75.32 112.038 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -143.38 122.27 12.73 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.091 0.556 . . . . 73.22 111.362 -175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.1 t -138.44 147.15 42.97 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.64 0.776 . . . . 65.13 110.062 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -149.71 113.77 5.14 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.109 0.564 . . . . 75.21 110.714 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.84 41.6 3.06 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 112.372 -0.291 . . . . 64.44 112.372 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.37 -36.73 83.18 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.282 1.033 . . . . 64.13 111.225 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -69.07 109.39 3.98 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.867 -0.79 . . . . 73.31 108.867 169.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -71.79 84.37 0.92 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 122.775 0.43 . . . . 51.3 112.1 -170.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 50.29 99.9 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 125.628 1.571 . . . . 75.11 114.686 170.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -69.96 112.05 6.09 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.581 -0.526 . . . . 72.43 109.581 170.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -67.85 151.81 46.57 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.624 0.369 . . . . 74.04 110.895 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 44.8 p-80 -83.44 177.9 8.26 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.529 0.681 . . . . 72.43 112.382 -176.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.4 t60 . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 124.414 1.086 . . . . 75.05 109.577 172.039 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.556 1.209 0 CA-C-O 120.691 0.281 . . . . 72.2 111.013 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -48.66 -51.09 30.13 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 113.748 1.018 . . . . 75.25 113.748 -175.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.513 ' HA ' HG22 ' B' ' 6' ' ' VAL . 9.8 mtmp? -67.86 -28.09 67.24 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.191 0.812 . . . . 73.21 113.191 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -69.04 -45.76 69.61 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.24 0.616 . . . . 63.03 110.497 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 79.1 mt -63.05 -56.7 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.119 0.968 . . . . 65.13 111.433 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' B' ' 3' ' ' LYS . 12.6 m -66.13 -27.61 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 122.848 0.459 . . . . 54.11 111.503 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.03 -41.0 97.46 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.233 0.333 . . . . 73.24 112.995 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.07 -50.27 62.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.452 0.701 . . . . 53.34 111.606 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -68.22 -27.49 66.42 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.795 0.838 . . . . 71.32 112.384 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.485 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -72.83 -34.35 66.76 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.101 0.56 . . . . 44.42 111.518 177.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -35.19 91.63 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 123.388 0.43 . . . . 73.24 112.34 174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' B' ' 32' ' ' VAL . 1.6 ttmp? -68.14 -50.32 55.35 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.24 1.016 . . . . 74.14 112.216 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.525 ' HA ' HG11 ' B' ' 32' ' ' VAL . 24.4 m -69.09 -34.76 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 111.886 0.328 . . . . 71.14 111.886 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -71.9 -34.97 69.57 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.269 0.627 . . . . 74.24 111.081 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -57.05 -41.64 79.05 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.069 0.548 . . . . 64.34 110.489 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.53 -32.74 74.51 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.504 -0.771 . . . . 74.54 111.841 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 13' ' ' VAL . 83.3 mt -71.74 -34.0 69.15 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.401 0.681 . . . . 62.21 111.759 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.04 -31.49 71.13 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.76 0.824 . . . . 62.14 111.34 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -105.11 -25.78 12.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.159 0.984 . . . . 70.4 112.133 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.02 87.87 0.66 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.217 0.607 . . . . 74.32 111.524 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.17 -179.03 3.92 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.359 0.664 . . . . 72.02 111.825 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.25 18.18 79.76 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.084 -0.507 . . . . 63.52 112.85 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.73 152.39 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.391 1.076 . . . . 63.14 110.02 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -69.04 148.28 50.31 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.797 0.439 . . . . 52.23 111.045 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.624 HG21 ' HB2' ' B' ' 40' ' ' ALA . 36.5 mm -54.69 -48.35 95.61 Favored Pre-proline 0 CA--C 1.578 2.027 0 N-CA-C 113.719 1.007 . . . . 74.24 113.719 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -65.42 -31.23 52.23 Favored 'Trans proline' 0 C--N 1.393 2.905 0 C-N-CA 121.969 1.78 . . . . 74.23 113.965 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -71.64 -46.66 58.36 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.357 1.075 . . . . 75.05 109.778 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.406 HD22 HD11 ' B' ' 63' ' ' ILE . 60.9 tp -59.73 -38.7 82.43 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.301 -1.772 . . . . 64.12 111.51 172.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.79 98.01 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.984 0.913 . . . . 55.03 111.939 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -64.43 -35.81 82.12 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.1 -0.955 . . . . 75.33 110.681 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -66.63 -45.92 77.47 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.391 0.676 . . . . 64.42 112.298 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' B' ' 13' ' ' VAL . 30.5 m -90.51 10.7 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 112.718 0.636 . . . . 52.13 112.718 -173.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.68 16.82 9.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.408 1.083 . . . . 64.43 113.08 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.2 mt -106.16 168.69 8.97 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.743 0.817 . . . . 64.15 110.603 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 43.6 t -81.12 165.47 21.56 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.612 0.365 . . . . 64.25 111.243 169.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 74.4 t -52.92 -48.51 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 123.619 0.768 . . . . 53.21 111.836 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.91 -52.84 64.03 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.405 0.682 . . . . 64.31 111.96 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 23.0 m -59.26 -38.91 81.24 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.961 0.904 . . . . 50.41 112.379 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -72.44 -48.52 40.46 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.776 0.831 . . . . 72.34 111.767 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.624 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -63.61 -32.46 73.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.329 0.652 . . . . 73.34 112.027 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -71.79 -38.32 70.29 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.697 1.199 . . . . 74.23 110.508 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.25 -37.76 81.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.174 0.59 . . . . 74.45 111.405 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.512 HG13 HG11 ' B' ' 52' ' ' VAL . 60.7 t -64.1 -30.98 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.243 1.017 . . . . 75.13 110.867 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.57 86.32 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.495 -0.32 . . . . 61.11 113.513 171.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -72.7 -23.67 60.9 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.317 0.58 . . . . 73.12 111.198 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.44 HD11 HG23 ' B' ' 13' ' ' VAL . 76.4 mt -74.45 -40.93 61.62 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 121.518 -0.739 . . . . 54.3 111.08 169.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.24 -31.19 69.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.474 1.11 . . . . 63.41 113.488 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.59 ' HD3' ' HG3' ' B' ' 49' ' ' GLU . 0.0 OUTLIER -72.41 -14.1 61.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 112.735 0.643 . . . . 75.45 112.735 176.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.59 ' HG3' ' HD3' ' B' ' 48' ' ' ARG . 50.1 mt-10 -114.92 16.11 17.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.883 0.873 . . . . 61.2 110.965 169.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 47.53 28.38 1.17 Allowed 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 125.876 1.67 . . . . 41.13 114.314 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' B' ' 66' ' ' GLU . 53.0 mttp -71.52 -11.5 60.9 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.232 1.013 . . . . 72.32 112.95 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.512 HG11 HG13 ' B' ' 43' ' ' VAL . 12.6 m -124.52 145.85 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.637 0.775 . . . . 73.44 112.307 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 63.4 t -112.0 120.38 62.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 125.017 1.327 . . . . 64.31 108.949 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.21 110.59 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.703 -0.851 . . . . 72.54 108.703 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.28 112.49 18.67 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.794 0.438 . . . . 73.33 110.833 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.477 ' HG2' HG12 ' B' ' 61' ' ' ILE . 13.8 mtm-85 -93.36 96.89 10.23 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.746 0.819 . . . . 75.4 109.905 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -104.57 111.98 24.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.902 1.281 . . . . 73.42 109.414 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 57.74 30.45 18.95 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.295 1.038 . . . . 74.41 111.747 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.68 -22.81 28.85 Favored Glycine 0 CA--C 1.546 2.012 0 CA-C-N 115.654 -0.703 . . . . 73.1 113.992 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 88.4 mt -79.24 126.13 30.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.987 0.915 . . . . 45.01 111.527 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.477 HG12 ' HG2' ' B' ' 56' ' ' ARG . 40.4 mt -92.19 123.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 121.059 0.457 . . . . 44.34 112.068 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -117.83 139.72 50.7 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.385 1.074 . . . . 72.43 109.187 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.42 HG21 HG11 ' B' ' 43' ' ' VAL . 1.5 pp -113.66 104.59 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.926 0.87 . . . . 61.23 112.064 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 74.9 m-85 -83.61 167.06 17.64 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.659 0.784 . . . . 54.31 110.875 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -93.25 164.08 13.37 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.121 0.486 . . . . 74.45 112.294 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' B' ' 51' ' ' LYS . 40.1 tt0 -64.62 -20.65 66.4 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.847 0.859 . . . . 75.41 112.149 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.83 -11.67 31.54 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 115.305 0.882 . . . . 72.14 115.305 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -85.08 -34.44 22.24 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.272 0.536 . . . . 52.11 111.425 173.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -104.59 85.14 2.28 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.619 0.724 . . . . 75.33 109.655 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -83.77 34.9 0.5 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.192 0.997 . . . . 43.35 112.186 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -97.37 26.68 4.69 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.152 0.981 . . . . 60.33 110.485 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 25.4 m -82.17 -10.99 58.97 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.725 0.81 . . . . 73.23 112.008 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -71.65 177.91 3.86 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.614 0.766 . . . . 73.35 111.486 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.54 -151.74 6.25 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 116.248 -0.433 . . . . 62.4 112.45 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.38 150.07 28.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.801 0.84 . . . . 74.23 109.517 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.61 144.02 44.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.647 0.779 . . . . 75.25 111.443 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -70.15 99.5 1.5 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 120.921 0.391 . . . . 73.2 109.986 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -65.96 118.96 10.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.831 0.852 . . . . 62.31 111.352 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -134.76 160.61 37.63 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.931 0.892 . . . . 72.45 110.149 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -72.75 127.69 33.3 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.133 0.573 . . . . 75.42 111.113 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -72.12 128.72 36.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.825 0.45 . . . . 71.43 111.367 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 . . . . . 0 N--CA 1.479 0.988 0 C-N-CA 123.532 0.733 . . . . 53.44 110.091 177.013 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 112.604 0.594 . . . . 71.25 112.604 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.73 -34.86 74.44 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.265 0.468 . . . . 64.23 112.265 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -62.15 -46.71 87.77 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.541 0.736 . . . . 63.45 111.833 -174.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -67.86 -33.6 75.07 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.827 -0.624 . . . . 74.44 112.072 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.8 mt -69.0 -58.02 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.091 0.556 . . . . 62.22 110.966 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.67 -27.85 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.749 0.42 . . . . 61.43 111.711 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.23 -42.25 76.28 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 123.543 0.527 . . . . 41.0 112.875 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.78 96.02 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.012 0.925 . . . . 61.31 112.054 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.417 ' O ' ' HG2' ' A' ' 12' ' ' LYS . 57.2 m-80 -85.1 -21.26 29.39 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.166 0.586 . . . . 60.54 112.414 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.54 76.1 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 118.072 0.396 . . . . 73.0 111.448 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.0 -39.83 97.63 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 115.851 -0.613 . . . . 61.22 113.456 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.481 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 6.7 ptmm? -75.87 -30.63 58.94 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.5 -0.412 . . . . 71.44 111.488 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.575 ' HA ' HG11 ' A' ' 32' ' ' VAL . 71.4 t -67.37 -46.78 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.282 0.633 . . . . 74.21 110.84 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.438 ' HA ' HD12 ' A' ' 17' ' ' LEU . 21.7 t90 -64.07 -35.07 79.53 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.572 -0.74 . . . . 73.44 110.639 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.405 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 79.3 t60 -63.11 -40.55 97.95 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.845 0.458 . . . . 43.3 111.547 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.12 -31.66 72.93 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 120.862 0.363 . . . . 54.14 111.661 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.481 ' HB3' ' OD1' ' A' ' 65' ' ' ASN . 90.1 mt -69.34 -41.95 75.94 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.337 1.055 . . . . 74.34 111.733 170.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.74 -26.99 66.11 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.145 0.978 . . . . 72.15 111.425 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 15' ' ' HIS . 68.3 mt-10 -77.79 -49.85 13.52 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.225 0.61 . . . . 64.4 110.127 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.77 108.19 0.67 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.603 0.761 . . . . 73.02 111.264 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 11.1 p-10 -94.1 -178.79 4.74 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.146 0.978 . . . . 71.43 112.918 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.28 33.59 61.62 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-N 116.016 -0.538 . . . . 44.32 111.852 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 tt -113.12 145.09 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.026 0.931 . . . . 73.33 111.013 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.9 m -78.85 154.03 30.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.556 0.743 . . . . 64.45 110.943 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.732 HG21 ' HB2' ' A' ' 40' ' ' ALA . 44.7 mm -59.1 -44.34 98.52 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 114.777 1.399 . . . . 73.35 114.777 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -62.82 -32.61 77.5 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 121.942 1.761 . . . . 73.34 113.185 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -75.27 -37.46 60.93 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.587 1.184 . . . . 72.04 109.871 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.9 tp -70.73 -33.4 70.79 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 112.707 -2.042 . . . . 72.1 111.658 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.05 -37.06 81.27 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.086 0.954 . . . . 74.0 111.167 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -64.44 -39.22 93.41 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.175 0.99 . . . . 75.01 111.104 174.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -66.47 -43.72 84.71 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.663 0.785 . . . . 73.05 111.864 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.575 HG11 ' HA ' ' A' ' 13' ' ' VAL . 7.0 m -98.17 9.99 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 113.315 0.858 . . . . 73.21 113.315 -170.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 m120 66.87 10.51 7.66 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.587 1.155 . . . . 64.41 113.428 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.9 mt -108.31 178.08 4.61 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.247 0.619 . . . . 74.22 111.479 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.4 t -88.48 165.68 14.72 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.17 0.588 . . . . 73.34 110.991 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.38 -47.33 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 124.312 1.045 . . . . 51.23 112.26 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -61.22 -53.0 62.43 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.214 0.606 . . . . 71.1 112.088 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -63.01 -28.6 70.22 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.733 0.813 . . . . 72.52 112.518 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 43' ' ' VAL . 88.0 m -80.08 -53.65 6.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.75 0.82 . . . . 72.11 111.441 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.1 -30.75 69.46 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.106 0.962 . . . . 43.34 112.315 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -52.86 63.07 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.714 1.206 . . . . 73.32 110.225 174.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.24 -26.75 68.24 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.886 -1.052 . . . . 73.41 111.39 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 39' ' ' THR . 94.7 t -66.04 -40.11 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.166 0.586 . . . . 72.24 110.889 172.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.07 -33.24 86.72 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 116.309 -0.405 . . . . 64.11 113.107 173.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.485 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 63.7 t-105 -74.22 -25.18 59.51 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.586 0.754 . . . . 75.13 111.605 176.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.27 -47.72 48.01 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 122.115 -0.366 . . . . 61.2 110.39 166.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.72 68.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.3 1.04 . . . . 54.01 113.19 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.547 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 26.6 ptt85 -59.4 -39.71 84.29 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 112.558 0.577 . . . . 64.03 112.558 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.547 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 47.0 mt-10 -96.61 11.62 34.63 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.886 0.875 . . . . 65.55 111.147 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 62.33 38.1 13.38 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.671 1.189 . . . . 64.12 111.198 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -80.51 -19.08 46.66 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.411 0.685 . . . . 75.52 112.195 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.87 151.57 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.314 0.646 . . . . 72.34 111.238 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.17 122.01 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.815 0.846 . . . . 74.43 109.298 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.789 HG12 HD11 ' B' ' 41' ' ' LEU . 3.6 mp -98.9 136.03 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.065 0.946 . . . . 73.34 110.86 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.7 117.98 15.62 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.569 0.747 . . . . 55.43 110.764 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -81.53 111.39 17.8 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.752 0.821 . . . . 65.24 110.556 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.85 130.61 47.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.969 0.908 . . . . 63.15 110.617 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.9 p30 44.48 41.18 4.45 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 126.059 1.744 . . . . 73.32 114.035 -175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.41 -27.44 7.74 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.374 -0.83 . . . . 74.44 114.125 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.67 160.4 28.51 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.732 0.813 . . . . 71.45 110.99 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.4 tt -121.19 118.33 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 123.792 0.837 . . . . 75.13 109.683 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.87 142.68 46.24 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.116 0.966 . . . . 74.3 110.042 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.705 HG22 HG13 ' A' ' 54' ' ' ILE . 37.6 pt -115.07 140.36 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.555 0.693 . . . . 61.53 111.066 175.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 57.7 m-85 -123.8 167.8 13.58 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.681 1.192 . . . . 73.24 110.018 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.481 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 1.8 m-20 -76.06 152.37 36.88 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.337 0.255 . . . . 73.11 110.522 174.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -77.75 160.71 28.23 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 121.164 0.507 . . . . 70.2 110.327 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.92 -16.61 5.27 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.844 -1.302 . . . . 73.21 109.844 -165.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -73.02 -34.18 66.2 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.566 1.146 . . . . 61.54 110.264 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -102.18 20.99 15.68 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.701 1.201 . . . . 64.35 110.382 171.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 74.24 -55.52 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 126.336 1.854 . . . . 74.21 114.158 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -71.89 86.61 0.99 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.428 0.691 . . . . 65.33 112.205 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 94.4 p -100.4 17.46 21.49 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.716 0.807 . . . . 74.02 111.286 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -68.37 170.06 9.57 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.963 0.905 . . . . 73.13 112.389 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.6 75.49 1.23 Allowed Glycine 0 N--CA 1.472 1.081 0 N-CA-C 111.772 -0.531 . . . . 44.52 111.772 -173.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.79 165.82 16.56 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.868 0.867 . . . . 54.34 111.628 -171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.66 148.6 23.15 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.765 -0.652 . . . . 73.11 110.069 172.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -98.03 -50.49 4.37 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.378 0.671 . . . . 74.25 112.406 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -160.93 165.57 29.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.038 0.755 . . . . 63.41 113.038 -172.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -61.56 145.42 52.09 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.061 0.944 . . . . 74.24 111.323 172.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -98.78 165.41 11.79 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.939 1.089 . . . . 74.44 113.939 -168.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -112.98 160.07 18.48 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.15 1.38 . . . . 73.2 108.858 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.653 0.739 . . . . 65.34 112.368 -179.867 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttp . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.115 0.483 . . . . 44.33 111.004 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 12.7 p-10 -65.51 -35.06 79.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.167 0.987 . . . . 71.3 113.26 -171.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -29.15 68.96 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.429 0.692 . . . . 70.0 111.249 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.78 -43.13 56.45 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.755 0.822 . . . . 64.53 111.668 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.58 -51.38 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 122.619 0.368 . . . . 73.11 110.813 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -66.49 -30.85 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 122.611 0.364 . . . . 75.42 111.936 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.68 45.4 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.424 0.452 . . . . 73.22 112.74 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.6 -52.93 61.45 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.087 0.955 . . . . 72.51 111.845 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -75.17 -13.9 60.5 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.753 -0.658 . . . . 70.14 112.464 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -68.06 -29.09 67.98 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 117.943 0.338 . . . . 64.11 110.504 171.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.46 -41.95 94.01 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.867 -0.606 . . . . 43.51 112.963 173.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -69.76 -47.78 61.72 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.391 0.676 . . . . 62.5 111.922 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.547 ' HA ' HG11 ' B' ' 32' ' ' VAL . 22.7 m -67.21 -32.47 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 111.886 0.328 . . . . 53.52 111.886 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 57.9 t90 -68.65 -41.1 79.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.716 0.406 . . . . 71.23 111.162 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -69.64 -40.64 76.39 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.857 0.463 . . . . 72.15 111.248 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.61 73.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.108 0.563 . . . . 75.31 111.264 176.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.631 HD23 HG23 ' B' ' 63' ' ' ILE . 1.0 OUTLIER -67.32 -44.18 79.78 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.926 0.89 . . . . 75.1 110.439 169.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.17 -36.61 84.19 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.655 0.782 . . . . 62.54 111.679 -174.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.46 -30.13 25.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.371 0.668 . . . . 65.22 111.622 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.424 ' HB3' ' HZ2' ' B' ' 31' ' ' LYS . . . -135.06 108.04 7.6 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.21 0.604 . . . . 74.01 110.942 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.99 175.78 10.26 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.868 1.267 . . . . 62.4 112.674 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.89 40.56 12.53 Favored Glycine 0 C--N 1.365 2.14 0 N-CA-C 115.144 0.817 . . . . 75.34 115.144 163.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.549 HG21 ' HZ1' ' B' ' 31' ' ' LYS . 7.8 tp -112.95 127.97 69.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.363 0.665 . . . . 74.34 109.868 -168.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 92.5 p -68.06 158.44 32.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 122.083 -0.386 . . . . 63.14 111.162 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.662 HG21 ' HB2' ' B' ' 40' ' ' ALA . 69.6 mt -59.65 -44.38 97.36 Favored Pre-proline 0 CA--C 1.578 2.033 0 N-CA-C 114.422 1.268 . . . . 71.41 114.422 -171.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.49 -28.47 45.73 Favored 'Trans proline' 0 C--N 1.389 2.667 0 CA-C-N 121.744 1.659 . . . . 75.42 113.361 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLU . . . . . 0.478 ' HB3' HD11 ' B' ' 23' ' ' ILE . 14.0 mm-40 -79.96 -27.26 39.76 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.149 0.98 . . . . 71.04 111.419 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.574 ' HA ' ' HE2' ' B' ' 31' ' ' LYS . 58.3 tp -75.75 -37.82 58.98 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 125.255 1.422 . . . . 74.15 110.629 170.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.34 95.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.482 1.113 . . . . 75.31 112.842 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -67.65 -33.56 75.2 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.352 0.661 . . . . 71.3 112.248 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.574 ' HE2' ' HA ' ' B' ' 28' ' ' LEU . 48.9 mtmt -66.59 -43.38 85.05 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.217 0.532 . . . . 71.14 110.897 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' B' ' 13' ' ' VAL . 21.6 m -90.66 -4.83 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.662 0.785 . . . . 73.44 112.558 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 m120 64.99 22.62 12.46 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.63 1.172 . . . . 73.4 112.876 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 59.1 mt -104.65 162.04 13.62 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.621 0.769 . . . . 73.31 110.53 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 30.1 t -64.68 152.04 43.42 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.087 0.555 . . . . 54.43 110.822 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.95 -44.05 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 123.547 0.739 . . . . 72.32 111.19 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -58.52 -47.41 84.23 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 114.887 -1.051 . . . . 73.32 112.071 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 65.3 m -68.54 -36.53 78.96 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.934 0.893 . . . . 74.41 112.262 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 87.9 m -70.94 -52.24 21.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.918 0.887 . . . . 64.42 110.802 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.662 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -57.73 -32.36 67.35 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.956 0.902 . . . . 34.5 112.491 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.789 HD11 HG12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -64.65 -52.71 55.89 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.512 1.125 . . . . 72.52 110.281 176.269 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.59 -29.14 70.15 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.197 -0.91 . . . . 73.24 111.586 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.04 -39.93 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.627 0.771 . . . . 74.41 110.949 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -61.88 -27.75 69.1 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-N 116.341 -0.39 . . . . 74.01 113.125 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.448 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 61.1 t-105 -71.93 -34.53 69.13 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.546 0.738 . . . . 71.25 111.249 174.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.42 -32.88 68.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.25 0.62 . . . . 60.15 111.196 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.99 -32.02 71.6 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.672 0.789 . . . . 62.05 112.175 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 53.8 ttt180 -58.83 -50.43 74.01 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.517 0.675 . . . . 75.03 110.904 167.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -79.57 -6.59 57.36 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 114.64 -1.164 . . . . 63.23 112.27 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 63.62 23.2 13.47 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.025 1.33 . . . . 60.24 112.08 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -87.67 -4.31 58.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.486 1.114 . . . . 74.54 112.604 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.712 ' HB ' HD11 ' B' ' 63' ' ' ILE . 18.3 m -135.02 166.51 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 112.532 0.567 . . . . 62.21 112.532 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.746 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 24.7 t -116.1 131.75 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.067 0.947 . . . . 71.34 111.229 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 31.9 mm -113.5 133.05 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.696 0.798 . . . . 62.01 110.784 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' GLU . . . . . 0.458 ' HB2' ' HE2' ' B' ' 57' ' ' LYS . 42.5 mt-10 -134.16 157.96 44.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.451 0.7 . . . . 43.13 111.31 167.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -111.55 106.94 15.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.211 1.004 . . . . 73.14 109.168 168.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' B' ' 55' ' ' GLU . 0.0 OUTLIER -119.54 114.91 22.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.303 1.041 . . . . 63.3 110.13 -178.57 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 56.25 30.54 16.84 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.804 1.241 . . . . 74.14 111.823 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.8 -25.04 23.41 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 115.959 -0.564 . . . . 62.52 114.238 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -90.46 158.52 17.01 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.701 0.8 . . . . 60.23 111.037 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 mm -107.15 131.29 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.962 0.505 . . . . 74.41 110.052 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -121.97 136.1 54.9 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.063 -1.088 . . . . 72.13 108.063 168.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' B' ' 52' ' ' VAL . 10.9 tp -92.65 130.79 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 122.982 0.513 . . . . 73.41 110.232 -177.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.746 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 84.8 m-85 -116.62 167.8 10.75 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.578 0.751 . . . . 73.34 110.974 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.537 ' HA ' HD11 ' B' ' 17' ' ' LEU . 9.7 m120 -88.06 114.21 24.46 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.0 0.741 . . . . 54.12 113.0 -169.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 36.86 -149.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 116.975 2.213 . . . . 72.21 116.975 157.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.34 73.85 1.09 Allowed Glycine 0 C--N 1.362 1.983 0 N-CA-C 115.134 0.814 . . . . 65.2 115.134 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.413 ' NE2' ' HB2' ' B' ' 65' ' ' ASN . 6.2 p-80 -161.21 44.32 0.17 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.114 1.366 . . . . 74.42 108.569 163.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -93.81 20.1 8.03 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.253 -1.34 . . . . 74.4 112.364 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.79 -44.7 96.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.61 0.764 . . . . 74.52 110.025 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -132.89 122.67 24.71 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.655 1.182 . . . . 70.33 108.826 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 60.0 p -73.8 112.69 10.15 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.295 -0.631 . . . . 64.42 109.295 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -70.34 86.06 0.59 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.447 0.906 . . . . 74.25 113.447 -166.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.5 -21.05 59.01 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.12 -0.792 . . . . 71.12 111.12 164.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 62.3 tp -69.56 81.3 0.41 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.575 1.15 . . . . 60.42 110.236 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 63.69 120.97 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 125.621 1.568 . . . . 72.45 113.856 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -166.61 110.91 0.77 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.816 0.846 . . . . 65.13 110.515 167.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -92.06 -44.0 9.09 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.652 0.781 . . . . 74.21 112.824 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 42.04 75.86 0.08 Allowed 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 124.59 1.156 . . . . 72.44 112.689 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -68.28 148.18 51.14 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.752 1.221 . . . . 64.32 112.916 -172.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -72.2 102.78 3.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.629 0.771 . . . . 74.22 110.616 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 N--CA 1.484 1.26 0 C-N-CA 124.389 1.076 . . . . 73.13 112.681 178.205 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 111.973 0.361 . . . . 72.34 111.973 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.737 ' HB3' ' HB ' ' B' ' 54' ' ' ILE . 3.9 p-10 -56.08 -39.3 71.89 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 114.245 1.202 . . . . 75.34 114.245 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -61.46 -25.0 66.95 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.149 0.796 . . . . 63.44 113.149 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -79.54 -45.45 19.22 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.419 0.687 . . . . 75.35 111.354 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.59 -56.67 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.731 0.813 . . . . 72.53 112.01 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.449 HG12 HD22 ' A' ' 41' ' ' LEU . 28.5 m -53.9 -44.34 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.621 1.169 . . . . 72.43 113.197 -170.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.81 -40.34 52.83 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.159 0.287 . . . . 54.15 113.025 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.22 79.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.647 0.779 . . . . 74.44 112.354 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -87.56 -20.95 25.74 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.769 0.655 . . . . 43.42 112.769 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.84 -38.98 73.23 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 123.097 0.559 . . . . 61.35 112.03 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.74 -32.52 81.51 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 116.124 -0.489 . . . . 62.03 112.623 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -71.45 -48.29 50.33 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.014 0.925 . . . . 75.24 112.188 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -75.16 -32.85 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 112.475 0.546 . . . . 75.21 112.475 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.469 ' HA ' HD12 ' A' ' 17' ' ' LEU . 26.1 t90 -70.56 -35.16 72.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 120.966 0.412 . . . . 75.12 110.457 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -62.24 -35.41 78.84 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.521 0.728 . . . . 70.43 111.306 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.02 70.09 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.367 0.667 . . . . 52.51 112.455 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 14' ' ' TRP . 46.7 mt -68.36 -31.18 70.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.55 0.74 . . . . 61.02 111.255 170.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -75.04 -22.88 58.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.172 0.589 . . . . 72.04 111.704 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.31 -58.52 5.71 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 109.118 -0.697 . . . . 74.02 109.118 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.79 117.81 0.7 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.81 -1.087 . . . . 44.12 110.006 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.12 168.34 12.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.301 0.64 . . . . 63.34 109.845 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.76 60.53 1.96 Allowed Glycine 0 N--CA 1.475 1.294 0 N-CA-C 110.963 -0.855 . . . . 55.11 110.963 -170.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.6 tt -156.11 151.15 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.416 -0.892 . . . . 71.01 109.62 -173.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 t -85.96 158.9 19.77 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.874 0.469 . . . . 70.12 111.221 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.549 HG21 ' HB2' ' A' ' 40' ' ' ALA . 58.0 mt -56.81 -49.72 92.15 Favored Pre-proline 0 CA--C 1.575 1.936 0 N-CA-C 114.214 1.19 . . . . 75.34 114.214 -173.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 71.4 Cg_endo -70.81 -21.9 27.99 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.083 1.855 . . . . 63.23 113.743 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.27 -39.28 40.55 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.441 1.115 . . . . 74.23 109.691 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.2 tp -68.65 -34.4 75.65 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-N 113.019 -1.901 . . . . 73.22 111.375 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.8 70.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.179 0.992 . . . . 70.44 112.131 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 26' ' ' PRO . 79.8 mtt-85 -66.38 -34.92 79.04 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.908 0.883 . . . . 74.24 111.365 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -69.19 -45.65 69.41 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.577 0.751 . . . . 62.25 111.509 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.505 HG23 ' H ' ' A' ' 34' ' ' LEU . 31.4 m -90.45 -5.59 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 114.026 1.121 . . . . 73.25 114.026 -170.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 67.81 8.79 6.67 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.38 1.072 . . . . 74.41 112.051 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.505 ' H ' HG23 ' A' ' 32' ' ' VAL . 60.5 mt -92.4 157.38 16.63 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.581 -0.699 . . . . 63.23 110.335 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -61.79 151.66 33.58 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.083 0.553 . . . . 74.14 111.202 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -53.47 -41.76 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.552 0.692 . . . . 74.41 110.656 174.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.24 -40.75 94.45 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.652 -1.158 . . . . 71.3 111.672 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -68.06 -41.49 81.92 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.634 0.773 . . . . 65.44 111.463 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 43' ' ' VAL . 91.1 m -66.06 -49.58 67.15 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.16 0.984 . . . . 73.23 111.029 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.94 -43.01 99.28 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.742 0.817 . . . . 32.45 112.18 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.449 HD22 HG12 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -58.35 -49.16 78.19 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.492 0.717 . . . . 64.53 110.371 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.51 -30.98 70.97 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.815 -1.084 . . . . 75.4 112.254 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 39' ' ' THR . 60.7 t -65.89 -41.62 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.356 0.663 . . . . 72.41 110.861 174.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.06 -28.63 73.12 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 116.583 -0.28 . . . . 34.21 113.563 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -74.26 -43.33 57.39 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.607 0.763 . . . . 72.02 111.482 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.45 -32.9 73.84 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.045 0.538 . . . . 64.12 111.624 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.91 -25.19 60.54 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.395 1.078 . . . . 64.51 113.402 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -69.31 -40.03 77.89 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.254 -0.647 . . . . 75.3 109.254 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.7 7.79 42.01 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.263 1.025 . . . . 64.15 111.727 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 56.5 23.91 8.05 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.086 1.355 . . . . 74.25 113.414 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -74.02 -9.66 58.85 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.819 0.847 . . . . 71.12 113.044 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 m -122.71 142.23 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.279 0.632 . . . . 64.3 111.492 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 55.1 t -109.07 107.68 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.09 0.956 . . . . 74.0 108.456 172.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.414 HG13 HG22 ' A' ' 63' ' ' ILE . 3.0 mp -89.59 122.6 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 109.38 -0.6 . . . . 72.34 109.38 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -116.11 148.36 40.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.907 0.883 . . . . 73.11 109.888 174.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.437 ' HD2' HG21 ' B' ' 5' ' ' ILE . 45.2 mtp85 -118.96 114.65 22.89 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.757 0.423 . . . . 62.13 111.146 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -114.34 110.2 19.52 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.122 0.969 . . . . 74.45 109.785 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 58.4 30.02 19.04 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 124.795 1.238 . . . . 64.13 112.966 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.29 -13.3 62.2 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 113.944 0.338 . . . . 51.24 113.944 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.07 133.03 40.43 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.612 0.765 . . . . 75.12 110.686 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.428 HD13 ' HB2' ' B' ' 37' ' ' GLU . 3.0 mp -87.52 111.32 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 121.481 0.658 . . . . 74.21 110.714 -173.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -97.81 137.61 36.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.069 1.348 . . . . 73.13 108.901 171.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -123.1 139.12 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.744 0.783 . . . . 75.33 109.913 171.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.495 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 73.8 m-85 -129.01 167.02 18.09 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.588 1.155 . . . . 74.41 109.295 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -85.15 151.99 23.71 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.378 -0.601 . . . . 75.13 109.378 167.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.63 145.23 55.8 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 120.855 0.36 . . . . 65.33 110.735 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.77 -15.28 4.9 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 116.199 -0.455 . . . . 70.13 112.289 -172.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -66.77 -33.54 75.85 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.117 0.567 . . . . 71.33 112.46 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -74.16 152.0 39.92 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.621 0.368 . . . . 74.45 110.5 170.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.08 -48.82 61.68 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.934 0.494 . . . . 63.5 111.465 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -133.27 95.22 3.48 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.911 0.884 . . . . 75.32 108.92 175.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.3 m -72.4 109.05 5.83 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.068 0.547 . . . . 71.33 110.855 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -68.75 102.08 1.45 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.546 0.738 . . . . 72.23 110.322 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -121.97 26.28 6.52 Favored Glycine 0 N--CA 1.474 1.215 0 CA-C-N 116.112 -0.495 . . . . 55.23 113.371 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 mp -85.83 138.39 32.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.475 0.71 . . . . 75.45 110.11 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.465 ' HG3' ' HD2' ' A' ' 78' ' ' HIS . 10.2 pt-20 -60.46 141.39 56.49 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.315 0.646 . . . . 71.51 111.677 175.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -80.29 -30.3 38.27 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.012 0.525 . . . . 73.14 110.61 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.465 ' HD2' ' HG3' ' A' ' 76' ' ' GLU . 26.7 p80 42.68 55.09 4.38 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 126.009 1.724 . . . . 73.2 114.24 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -76.45 79.53 3.16 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.746 0.784 . . . . 75.23 110.955 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -67.57 -45.69 74.87 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.448 1.099 . . . . 72.03 111.687 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -76.4 91.04 3.26 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.648 -0.501 . . . . 71.02 109.648 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 123.845 0.858 . . . . 72.43 111.589 -176.188 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.718 ' SD ' HD11 ' B' ' 5' ' ' ILE . 1.1 pmm? . . . . . 0 CA--C 1.548 0.888 0 CA-C-O 120.675 0.274 . . . . 71.31 111.608 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.79 155.83 22.93 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.901 0.858 . . . . 73.21 112.529 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -77.93 -5.24 50.47 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 114.606 -1.179 . . . . 73.0 110.76 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -77.3 -28.33 53.29 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.904 0.882 . . . . 72.24 111.837 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.718 HD11 ' SD ' ' B' ' 1' ' ' MET . 67.0 mt -58.38 -55.32 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.348 0.659 . . . . 75.11 110.977 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 22.6 m -63.84 -28.42 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-N 115.034 -0.985 . . . . 63.55 111.976 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.23 -45.43 48.93 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 123.398 0.436 . . . . 63.3 113.057 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.72 93.18 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.669 0.788 . . . . 34.41 111.785 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -65.25 -45.26 85.31 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.216 0.606 . . . . 65.23 110.434 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.402 ' HB1' ' HG ' ' B' ' 46' ' ' LEU . . . -68.32 -32.03 71.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.658 0.783 . . . . 62.14 112.132 -174.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.68 96.76 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 116.712 -0.222 . . . . 60.23 113.125 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -71.53 -39.72 70.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.396 0.678 . . . . 75.43 111.241 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.571 HG11 HG22 ' B' ' 43' ' ' VAL . 74.3 t -61.85 -41.64 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.743 0.817 . . . . 53.42 111.15 174.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -67.79 -31.73 71.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.392 0.677 . . . . 61.5 111.598 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -61.36 -45.74 93.13 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.4 0.28 . . . . 73.22 111.003 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.13 -29.79 67.91 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.389 0.614 . . . . 71.54 111.23 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.71 ' HG ' HG12 ' B' ' 52' ' ' VAL . 2.5 tm? -72.73 -34.24 66.93 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.893 1.277 . . . . 65.43 110.541 174.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.1 -20.0 39.02 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.499 0.719 . . . . 71.33 110.643 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -76.63 -59.46 2.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.832 0.853 . . . . 63.42 109.889 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.42 110.72 3.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.199 1.0 . . . . 63.11 109.262 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -90.71 -179.82 5.62 Favored 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 112.566 0.58 . . . . 52.52 112.566 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.58 51.1 9.97 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.745 -0.661 . . . . 74.54 111.633 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tp -121.17 140.49 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.252 0.621 . . . . 71.33 111.71 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 17.0 m -72.23 144.68 48.36 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.863 0.865 . . . . 72.15 111.257 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.45 HG21 ' HB2' ' B' ' 40' ' ' ALA . 62.2 mt -53.46 -52.36 67.44 Favored Pre-proline 0 CA--C 1.573 1.844 0 N-CA-C 113.671 0.989 . . . . 74.35 113.671 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -68.96 -24.75 33.03 Favored 'Trans proline' 0 C--N 1.391 2.803 0 C-N-CA 121.692 1.595 . . . . 74.2 113.823 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -77.42 -47.21 20.35 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.959 0.885 . . . . 60.23 109.593 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 57.5 tp -56.32 -34.88 66.98 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 113.647 -1.615 . . . . 63.33 111.69 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.84 98.97 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.875 0.87 . . . . 45.42 111.708 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -66.26 -40.74 90.36 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.121 0.568 . . . . 73.44 110.571 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -60.4 -45.83 92.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.874 0.87 . . . . 62.22 111.405 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.67 4.2 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 112.56 0.578 . . . . 74.35 112.56 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 61.18 32.75 19.49 Favored 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 124.539 1.135 . . . . 52.43 112.195 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 85.8 mt -123.26 170.27 10.45 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.925 0.89 . . . . 75.44 111.034 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -69.14 155.26 40.68 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.453 0.701 . . . . 63.34 111.511 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.26 -48.85 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.514 0.725 . . . . 71.12 111.481 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.449 ' HB3' HD12 ' A' ' 25' ' ' ILE . 43.6 mt-10 -59.11 -52.54 65.26 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.882 0.873 . . . . 72.13 111.838 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.1 t -56.64 -32.49 65.4 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.339 1.056 . . . . 73.11 112.746 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.508 ' O ' HG23 ' B' ' 43' ' ' VAL . 89.5 m -81.48 -46.15 14.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.651 0.78 . . . . 64.32 110.853 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -58.48 -52.65 64.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.676 0.991 . . . . 75.21 113.676 -171.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -26.83 64.57 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 120.882 0.373 . . . . 72.32 111.092 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.85 -34.71 73.98 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.703 0.801 . . . . 62.01 111.538 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.573 HG12 HD11 ' B' ' 54' ' ' ILE . 51.2 t -63.18 -33.06 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 122.823 0.449 . . . . 75.4 109.843 169.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.4 83.59 Favored Glycine 0 CA--C 1.542 1.72 0 CA-C-N 116.535 -0.302 . . . . 64.33 113.131 172.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.482 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 70.5 t-105 -71.6 -25.26 62.1 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.546 0.738 . . . . 71.11 111.778 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.402 ' HG ' ' HB1' ' B' ' 10' ' ' ALA . 94.9 mt -76.68 -41.77 44.22 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.519 -0.738 . . . . 63.11 111.503 165.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.47 -26.76 68.11 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.674 1.189 . . . . 70.31 113.542 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.665 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 18.7 ptt180 -57.11 -31.5 65.35 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 122.715 0.406 . . . . 75.44 111.84 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.665 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 40.2 mt-10 -106.51 1.57 25.55 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.237 1.015 . . . . 73.54 111.798 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.38 23.33 10.65 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.966 1.306 . . . . 70.12 111.707 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.525 ' HG3' ' HB2' ' B' ' 49' ' ' GLU . 52.7 mtpt -68.34 -17.57 64.28 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 122.934 0.494 . . . . 74.42 111.598 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.71 HG12 ' HG ' ' B' ' 17' ' ' LEU . 28.2 m -125.95 155.25 35.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.665 1.186 . . . . 64.11 109.762 170.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.681 HG21 ' HB3' ' B' ' 69' ' ' PHE . 98.8 t -115.91 129.66 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.185 0.994 . . . . 71.44 109.132 173.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.737 ' HB ' ' HB3' ' A' ' 2' ' ' ASP . 91.6 mt -120.82 112.83 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-O 121.357 0.598 . . . . 72.52 109.969 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -140.93 127.69 20.35 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.604 1.161 . . . . 72.03 109.499 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -81.4 111.98 18.25 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.458 0.647 . . . . 73.31 110.936 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.58 115.02 29.74 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.552 1.141 . . . . 72.24 109.682 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 54.06 31.77 14.35 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.861 1.264 . . . . 64.03 111.796 -167.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.49 -28.02 7.3 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-N 115.624 -0.717 . . . . 60.3 113.488 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.78 117.23 17.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.3 0.64 . . . . 75.12 110.296 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 19.5 tt -72.69 114.23 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 123.683 0.793 . . . . 63.25 111.726 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -116.53 127.67 54.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.863 0.465 . . . . 64.03 109.99 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.444 HG13 HG12 ' B' ' 54' ' ' ILE . 2.3 mp -94.51 101.93 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.624 0.77 . . . . 61.3 108.982 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -88.28 170.71 10.76 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.256 1.022 . . . . 72.25 111.978 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -85.66 146.81 26.67 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.939 0.896 . . . . 72.22 110.598 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -57.94 -22.9 51.13 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 112.678 0.622 . . . . 74.23 112.678 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.95 -27.21 56.56 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 114.661 0.625 . . . . 73.33 114.661 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -149.63 123.24 9.16 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.394 0.678 . . . . 75.21 110.892 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.681 ' HB3' HG21 ' B' ' 53' ' ' VAL . 24.1 p90 -156.32 161.02 40.22 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.532 0.733 . . . . 65.33 111.374 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 27.1 t70 52.82 72.77 0.39 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.034 0.934 . . . . 71.04 111.927 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -85.86 155.77 20.82 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.007 0.523 . . . . 71.43 110.329 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.1 m -72.35 85.59 1.1 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.949 0.5 . . . . 75.41 110.236 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -74.45 -9.42 58.57 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.777 0.831 . . . . 74.14 112.91 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.33 -10.07 51.65 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.772 0.669 . . . . 51.41 114.772 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -64.76 -31.25 72.39 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 117.852 0.826 . . . . 63.14 111.747 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -95.22 -31.07 13.67 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.018 0.927 . . . . 74.44 110.821 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 64.92 -80.97 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.03 1.332 . . . . 74.32 110.769 -172.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 51.81 144.33 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 127.117 2.167 . . . . 70.41 114.217 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -71.57 163.14 28.29 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.369 -0.832 . . . . 73.22 111.607 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -95.21 169.23 10.23 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.755 0.822 . . . . 74.45 110.787 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -70.14 141.03 52.73 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.452 0.301 . . . . 51.03 110.977 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.483 1.206 0 C-N-CA 123.741 0.817 . . . . 72.4 112.55 -173.277 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 121.658 0.742 . . . . 62.42 111.056 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.573 ' O ' HG13 ' A' ' 6' ' ' VAL . 4.8 m-20 -94.51 9.83 36.99 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.532 0.938 . . . . 74.13 113.532 -165.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -65.09 -26.76 68.36 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 123.003 0.521 . . . . 73.21 112.369 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -87.67 -34.82 18.3 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.503 0.721 . . . . 74.21 111.146 170.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.5 -26.14 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 124.137 0.975 . . . . 74.3 111.649 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 2' ' ' ASP . 16.9 m -63.15 -32.94 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.009 0.524 . . . . 70.13 110.711 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.32 -42.83 40.8 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.68 0.612 . . . . 70.15 112.903 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.19 77.69 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.212 0.605 . . . . 72.14 111.635 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -75.68 -35.69 60.29 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.548 0.739 . . . . 74.21 111.279 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.33 66.83 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.381 0.672 . . . . 61.0 111.488 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.67 -34.62 90.17 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 116.064 -0.516 . . . . 51.51 112.767 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -66.14 -41.39 90.5 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.041 0.936 . . . . 73.12 111.329 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.502 ' HA ' HG11 ' A' ' 32' ' ' VAL . 60.9 t -62.65 -47.7 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.597 0.759 . . . . 74.52 111.462 174.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.431 ' HA ' HD12 ' A' ' 17' ' ' LEU . 12.1 t90 -67.21 -33.08 74.6 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.98 0.512 . . . . 71.44 111.69 -176.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -57.96 -37.8 74.83 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.539 0.735 . . . . 74.53 110.756 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.17 72.34 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.185 0.594 . . . . 64.43 111.141 174.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 14' ' ' TRP . 87.0 mt -64.8 -18.36 65.03 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.063 0.945 . . . . 63.54 113.438 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -58.21 -34.06 69.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.907 0.883 . . . . 61.12 112.458 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.85 -33.59 1.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.384 0.674 . . . . 75.23 111.838 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.9 92.27 7.32 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.433 0.693 . . . . 70.44 109.727 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -127.19 162.98 24.89 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.685 0.794 . . . . 65.12 111.411 -170.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.94 59.81 5.69 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 116.042 -0.526 . . . . 70.51 112.069 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.2 tt -142.42 130.68 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.409 0.684 . . . . 54.4 110.739 -167.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.0 t -73.87 160.13 31.86 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.049 0.54 . . . . 62.42 110.961 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 40' ' ' ALA . 79.0 mt -49.15 -50.94 60.64 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 114.574 1.324 . . . . 60.24 114.574 -174.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.94 -27.16 17.84 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 121.973 1.782 . . . . 75.13 113.731 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.19 -43.02 65.15 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.689 1.233 . . . . 54.12 109.121 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.06 -38.08 87.44 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 112.512 -2.131 . . . . 70.24 111.157 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.83 -39.39 81.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.726 1.211 . . . . 63.32 112.248 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -63.15 -44.01 96.71 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.325 0.65 . . . . 64.31 111.298 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -66.04 -42.74 89.14 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.437 0.695 . . . . 74.3 111.598 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.0 m -87.55 2.22 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.865 -0.607 . . . . 64.31 112.286 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 t30 60.66 27.61 17.33 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 124.281 1.032 . . . . 74.21 112.004 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 44.2 mt -111.66 162.92 14.68 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.742 0.817 . . . . 74.15 109.561 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.2 t -77.11 164.78 25.37 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.592 0.357 . . . . 72.44 111.152 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.95 -53.32 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 124.277 1.031 . . . . 51.23 112.536 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.44 -42.9 88.36 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.361 0.664 . . . . 71.42 111.943 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -64.97 -37.37 87.41 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.998 0.919 . . . . 73.11 112.373 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 43' ' ' VAL . 87.9 m -77.98 -45.13 24.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.458 0.703 . . . . 71.44 111.402 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -57.71 -49.61 75.96 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.227 1.011 . . . . 60.42 112.071 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.51 -31.36 72.38 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 114.214 -1.357 . . . . 73.2 111.037 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.06 -36.69 72.38 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.296 0.638 . . . . 40.32 112.021 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 39' ' ' THR . 98.6 t -64.48 -33.02 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 123.064 0.546 . . . . 71.24 111.027 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.89 -31.27 79.89 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-N 116.634 -0.257 . . . . 53.21 113.421 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.46 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 64.6 t-105 -74.15 -28.36 61.29 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 123.639 0.776 . . . . 71.42 111.28 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.77 -35.5 64.97 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.227 0.611 . . . . 72.33 111.727 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.85 -30.77 70.32 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.791 0.836 . . . . 71.44 111.614 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 11.4 ttp180 -52.21 -49.61 63.56 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.771 0.829 . . . . 73.31 111.158 167.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -77.09 -12.47 59.94 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.896 -1.047 . . . . 74.23 112.568 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 61.7 22.41 12.94 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.018 1.327 . . . . 70.04 112.488 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -89.01 -2.36 58.54 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.763 0.825 . . . . 71.51 111.752 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.64 154.41 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.811 0.845 . . . . 64.12 110.919 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 64' ' ' TYR . 6.8 m -134.46 132.35 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.399 1.08 . . . . 72.43 110.116 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.21 126.46 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.691 0.796 . . . . 51.23 109.909 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -110.84 139.82 45.83 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.81 0.844 . . . . 74.54 111.044 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.471 ' HG2' HG12 ' A' ' 61' ' ' ILE . 82.0 mtm180 -116.1 124.03 49.37 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.11 0.964 . . . . 74.31 109.61 173.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 118.13 12.71 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.948 0.899 . . . . 62.54 109.538 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.0 t30 58.29 31.88 21.38 Favored 'General case' 0 CA--C 1.577 2.004 0 CA-C-O 121.998 0.904 . . . . 72.02 111.363 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.94 -9.55 68.71 Favored Glycine 0 CA--C 1.542 1.762 0 CA-C-N 115.648 -0.705 . . . . 72.4 114.269 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.3 mt -83.33 122.16 28.09 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.126 0.971 . . . . 74.44 110.856 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.471 HG12 ' HG2' ' A' ' 56' ' ' ARG . 64.1 mt -95.39 126.79 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.283 0.633 . . . . 63.22 109.779 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -133.3 141.86 48.19 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.618 0.767 . . . . 70.35 110.434 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -96.91 117.93 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.002 0.921 . . . . 51.14 109.745 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.529 ' HB2' HG23 ' A' ' 53' ' ' VAL . 25.5 m-85 -108.05 164.21 12.48 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.595 1.158 . . . . 73.45 109.109 173.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . 20.1 p-10 -94.16 161.83 14.11 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.405 -0.591 . . . . 74.35 109.405 169.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -77.52 133.65 38.49 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 109.148 -0.686 . . . . 74.12 109.148 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.07 -5.85 1.97 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.998 -0.546 . . . . 74.43 112.414 -170.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -92.72 -17.26 24.46 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.575 0.75 . . . . 63.24 111.992 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.462 ' HE2' HG21 ' A' ' 53' ' ' VAL . 84.1 m-85 -101.79 -36.77 8.57 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.196 0.599 . . . . 70.31 111.671 -173.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.22 152.57 23.24 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.48 0.657 . . . . 62.41 111.329 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -79.98 -18.0 51.46 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 115.098 -0.955 . . . . 73.35 111.631 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.3 m -65.12 -37.61 87.98 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.677 0.791 . . . . 54.44 112.988 -174.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -74.53 141.62 44.83 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.649 0.38 . . . . 62.22 111.623 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.7 -99.48 0.19 Allowed Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.841 -0.904 . . . . 53.32 110.841 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 mp 64.14 -72.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.381 1.472 . . . . 63.31 113.048 172.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -155.34 125.02 6.45 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.132 0.573 . . . . 60.1 112.025 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -87.13 124.47 33.3 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.957 -0.757 . . . . 61.24 108.957 166.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -86.56 -66.42 0.91 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.967 0.507 . . . . 71.01 109.734 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.1 t60 58.02 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.861 1.264 . . . . 74.13 112.938 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 71.14 0.89 3.59 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.782 1.233 . . . . 74.35 112.477 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -70.78 101.27 2.06 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.496 0.718 . . . . 73.51 109.391 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.3 t60 . . . . . 0 N--CA 1.481 1.105 0 C-N-CA 124.0 0.92 . . . . 75.5 111.81 -175.842 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 111.598 0.221 . . . . 72.21 111.598 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.438 ' O ' HG22 ' B' ' 6' ' ' VAL . 5.7 p-10 -52.9 -41.74 64.69 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.86 1.264 . . . . 65.53 112.855 -175.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -51.09 -44.83 61.31 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.251 1.42 . . . . 61.43 112.628 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -77.45 -40.53 42.94 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.654 0.782 . . . . 74.44 111.546 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.73 -58.64 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.513 0.725 . . . . 63.54 111.218 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.438 HG22 ' O ' ' B' ' 2' ' ' ASP . 32.7 m -61.45 -27.6 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.361 0.664 . . . . 74.11 111.998 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.96 -49.85 71.45 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 123.47 0.482 . . . . 73.24 112.83 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.17 88.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.784 0.834 . . . . 70.42 112.043 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -85.2 -13.01 51.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.26 0.837 . . . . 55.32 113.26 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 -39.45 69.85 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.857 0.463 . . . . 71.21 111.367 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.23 -31.04 71.54 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 116.179 -0.464 . . . . 51.12 112.378 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -70.0 -45.74 66.65 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.892 0.877 . . . . 74.45 111.429 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.544 ' HA ' HG11 ' B' ' 32' ' ' VAL . 30.1 m -71.62 -32.46 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 122.533 0.333 . . . . 75.12 111.538 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.514 ' HA ' HD12 ' B' ' 17' ' ' LEU . 21.0 t90 -69.98 -33.36 71.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.499 0.32 . . . . 72.25 110.718 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -58.07 -45.87 86.38 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.932 0.493 . . . . 72.12 110.563 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.585 ' HB1' ' HE3' ' B' ' 31' ' ' LYS . . . -67.92 -29.59 68.71 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.677 -0.692 . . . . 64.52 111.712 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' B' ' 14' ' ' TRP . 58.6 mt -69.69 -33.02 71.95 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.153 0.981 . . . . 63.43 111.516 170.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.0 -29.72 64.49 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.915 0.886 . . . . 62.15 110.942 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -76.68 -49.03 17.11 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.649 0.78 . . . . 53.11 110.729 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.02 131.7 31.09 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.133 0.973 . . . . 63.33 109.502 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -114.61 147.34 39.68 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 122.911 0.484 . . . . 63.33 112.07 -163.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 24.45 69.6 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 115.984 -0.553 . . . . 64.34 113.266 -172.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.409 HD11 ' HG3' ' B' ' 27' ' ' GLU . 11.5 tt -77.05 143.35 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 124.169 0.987 . . . . 73.34 111.833 -170.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.6 m -61.24 141.73 57.31 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.756 0.822 . . . . 62.24 111.353 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' B' ' 40' ' ' ALA . 69.6 mt -57.63 -46.09 99.79 Favored Pre-proline 0 CA--C 1.576 1.952 0 N-CA-C 113.777 1.028 . . . . 75.2 113.777 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.25 -26.47 41.94 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 121.785 1.657 . . . . 63.42 113.871 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLU . . . . . 0.409 ' HG3' HD11 ' B' ' 23' ' ' ILE . 11.7 tp10 -76.67 -43.51 37.57 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.766 1.269 . . . . 70.45 109.773 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 58.8 tp -58.38 -40.22 81.71 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 112.833 -1.985 . . . . 73.01 111.013 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.15 75.43 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.536 1.134 . . . . 72.14 112.552 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -65.57 -42.05 92.23 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.48 0.712 . . . . 75.41 111.983 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.585 ' HE3' ' HB1' ' B' ' 16' ' ' ALA . 44.1 mtmt -72.67 -30.72 64.49 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.067 0.395 . . . . 75.42 112.067 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' B' ' 13' ' ' VAL . 25.4 m -96.45 -4.8 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 112.876 0.695 . . . . 52.45 112.876 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 65.83 15.87 10.24 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.442 1.097 . . . . 70.21 112.594 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt -96.89 163.84 12.8 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.699 -0.625 . . . . 63.24 110.967 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 37.5 m -66.45 151.44 47.18 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.935 -0.575 . . . . 75.01 110.152 171.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 58.1 t -55.51 -45.79 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 123.268 0.627 . . . . 64.44 111.857 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.38 -44.06 97.8 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.874 0.87 . . . . 70.34 112.374 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t -63.46 -38.5 91.37 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.563 0.745 . . . . 72.45 111.417 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.409 ' O ' HG23 ' B' ' 43' ' ' VAL . 89.6 m -68.36 -48.91 63.54 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.081 -0.963 . . . . 74.31 110.781 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.529 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -58.88 -36.85 75.32 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.0 0.92 . . . . 62.35 112.47 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.429 HD22 HG11 ' B' ' 6' ' ' VAL . 0.6 OUTLIER -66.28 -48.18 71.24 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.025 0.93 . . . . 75.45 110.078 178.003 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.04 68.9 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.53 -0.759 . . . . 62.3 111.62 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 39' ' ' THR . 73.8 t -77.63 -37.78 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 123.263 0.625 . . . . 61.21 111.057 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.46 -27.78 72.22 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 121.432 0.462 . . . . 50.1 112.326 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -73.39 -30.02 63.0 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.295 1.038 . . . . 73.14 110.956 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.451 HD13 ' HD1' ' B' ' 14' ' ' TRP . 96.2 mt -72.0 -34.17 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.199 0.6 . . . . 72.14 111.658 171.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.94 67.12 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.692 0.797 . . . . 61.03 111.926 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 48' ' ' ARG . 10.0 ptt-85 -60.88 -37.24 81.48 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.66 0.784 . . . . 71.23 111.517 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.547 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 41.4 mt-10 -93.9 5.24 52.31 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.861 0.864 . . . . 51.33 111.772 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 64.4 23.33 12.96 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.684 1.193 . . . . 73.52 112.931 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.547 ' HG3' ' HB2' ' B' ' 49' ' ' GLU . 28.3 mtpp -79.21 -13.08 59.92 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.752 0.649 . . . . 71.43 112.752 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' B' ' 64' ' ' TYR . 31.3 m -123.0 143.69 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.316 0.579 . . . . 64.41 112.185 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 33.4 t -113.11 105.1 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.307 0 C-N-CA 124.625 1.17 . . . . 73.3 109.959 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.504 HG23 HG23 ' B' ' 61' ' ' ILE . 3.4 mp -85.68 118.9 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 123.282 0.633 . . . . 62.51 110.925 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.17 117.38 19.82 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.899 0.88 . . . . 73.44 111.161 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -85.4 116.37 23.69 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.532 0.733 . . . . 72.14 110.352 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -125.03 115.4 20.47 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.577 1.151 . . . . 62.03 108.117 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 58.41 31.34 20.83 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.497 1.119 . . . . 65.43 111.163 -168.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.43 -19.37 32.37 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 115.442 -0.799 . . . . 63.51 113.867 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 mt -80.53 123.13 27.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.159 0.984 . . . . 51.0 111.206 -172.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.504 HG23 HG23 ' B' ' 54' ' ' ILE . 3.3 mp -80.65 127.85 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.666 0.786 . . . . 51.01 110.893 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.59 145.07 43.63 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.009 0.923 . . . . 74.3 109.3 168.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.538 HD13 ' H ' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -119.69 104.61 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-O 122.216 1.008 . . . . 73.4 109.876 174.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 77.5 m-85 -86.13 174.54 9.08 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.027 -0.988 . . . . 65.41 111.781 177.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -86.49 159.07 19.41 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.362 0.601 . . . . 63.04 111.334 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -50.78 96.12 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.863 1.265 . . . . 72.23 112.073 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.6 -40.15 0.24 Allowed Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.515 -0.766 . . . . 65.11 112.356 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -81.59 -10.27 59.47 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.629 0.772 . . . . 64.3 112.551 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -73.42 132.49 43.03 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.674 0.39 . . . . 61.2 111.856 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -129.82 147.74 51.62 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.15 0.58 . . . . 74.52 110.166 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -157.65 -74.5 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.636 0.775 . . . . 74.33 109.914 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 37.4 t -179.95 -170.5 0.15 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.742 1.217 . . . . 34.12 108.741 -171.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -64.97 143.08 58.19 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 110.002 -0.37 . . . . 73.33 110.002 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.74 26.66 3.8 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 112.122 -0.391 . . . . 70.02 112.122 -171.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 46.9 mt -76.7 132.53 39.4 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.407 1.083 . . . . 61.44 110.975 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -72.92 109.18 6.28 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.042 0.537 . . . . 72.33 109.61 173.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -75.07 85.65 2.33 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.635 0.774 . . . . 72.4 110.672 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -70.14 113.66 7.54 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.694 0.798 . . . . 75.22 111.066 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -93.58 128.41 39.72 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.353 1.061 . . . . 72.41 111.744 -171.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -159.39 162.93 35.87 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.204 1.001 . . . . 72.41 110.431 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -77.44 123.66 26.85 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.251 0.621 . . . . 60.22 111.193 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 p80 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 123.943 0.897 . . . . 62.14 111.832 176.082 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.76 -0.459 . . . . 74.1 109.76 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.63 125.05 18.28 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.959 0.903 . . . . 73.25 111.887 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.506 ' O ' HG22 ' A' ' 6' ' ' VAL . 86.1 tttt -80.19 -25.19 39.83 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.248 0.619 . . . . 71.3 111.616 -176.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.73 -15.88 62.14 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.923 0.712 . . . . 74.55 112.923 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.05 -40.27 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.221 0.609 . . . . 72.33 111.451 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 41' ' ' LEU . 13.5 m -66.11 -33.45 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 122.177 0.191 . . . . 61.14 111.449 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.09 -43.37 33.37 Favored Glycine 0 C--N 1.353 1.513 0 O-C-N 123.479 0.487 . . . . 35.45 113.281 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 -46.48 76.33 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.557 0.743 . . . . 72.42 111.6 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.84 -26.56 66.11 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.812 0.845 . . . . 62.43 111.8 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.11 -34.44 73.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.003 0.521 . . . . 55.03 111.324 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.16 -38.76 94.18 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 116.183 -0.462 . . . . 72.54 113.152 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -69.49 -48.52 60.37 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.308 0.643 . . . . 73.21 111.733 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.86 -36.8 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 122.333 0.253 . . . . 74.55 111.462 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.562 ' HA ' HD12 ' A' ' 17' ' ' LEU . 54.4 t90 -64.92 -40.16 94.62 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.416 0.286 . . . . 61.33 111.052 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -60.94 -39.82 90.92 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.848 0.459 . . . . 72.04 110.904 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.82 69.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.469 0.708 . . . . 63.22 111.926 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 14' ' ' TRP . 84.4 mt -66.11 -45.27 81.73 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.537 0.735 . . . . 52.21 111.663 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -62.39 -31.55 72.24 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 120.815 0.34 . . . . 62.41 111.283 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.36 -49.35 50.18 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.439 0.696 . . . . 62.24 110.698 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.64 105.09 0.51 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.748 0.819 . . . . 72.31 111.084 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.48 -179.6 3.92 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.847 0.859 . . . . 64.25 111.403 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.42 33.09 44.88 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.033 -0.53 . . . . 44.3 111.824 -171.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.4 tt -122.5 154.55 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 124.432 1.093 . . . . 52.35 110.096 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.9 m -63.16 145.98 54.32 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.838 0.455 . . . . 43.55 111.302 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' B' ' 37' ' ' GLU . 66.0 mt -58.33 -43.27 98.02 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 123.989 0.916 . . . . 72.22 113.363 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HA ' HG22 ' A' ' 36' ' ' VAL . 36.6 Cg_endo -62.69 -35.2 70.76 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 122.244 1.963 . . . . 71.45 114.284 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -69.84 -51.26 35.02 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.25 1.024 . . . . 73.15 109.187 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.8 tp -54.26 -37.79 65.07 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 112.811 -1.995 . . . . 73.41 112.123 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.15 92.43 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.191 0.997 . . . . 63.22 112.136 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -67.5 -26.5 66.37 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.279 0.631 . . . . 75.33 111.82 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.14 -47.15 46.46 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.548 0.739 . . . . 71.34 111.094 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -84.29 0.96 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.216 0.606 . . . . 74.03 111.945 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 69.26 12.04 8.31 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.404 1.482 . . . . 70.21 113.632 174.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.3 mt -93.66 169.19 10.51 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.298 0.639 . . . . 73.45 110.523 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.6 p -78.06 162.93 26.33 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 110.24 -0.281 . . . . 74.32 110.24 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 26' ' ' PRO . 40.8 t -56.19 -47.55 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.799 0.84 . . . . 74.33 111.418 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.19 -41.72 97.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.989 -1.005 . . . . 73.34 112.186 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -67.06 -39.19 86.84 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.404 0.682 . . . . 75.34 112.315 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . 78.4 m -69.15 -48.62 61.87 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.513 0.725 . . . . 73.43 111.615 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -61.61 -38.38 87.4 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.38 0.672 . . . . 72.55 112.144 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.554 HD23 HG23 ' B' ' 43' ' ' VAL . 1.6 tm? -65.75 -39.09 90.74 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 124.95 1.3 . . . . 72.33 110.792 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.97 -33.32 70.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.433 0.693 . . . . 72.45 111.797 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.651 HG11 HD12 ' A' ' 63' ' ' ILE . 89.8 t -66.43 -31.04 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.072 0.549 . . . . 64.0 111.18 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.48 -30.11 73.54 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-N 116.751 -0.204 . . . . 64.33 113.535 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -73.99 -31.12 62.83 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.505 0.722 . . . . 54.44 110.982 173.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.67 -30.27 65.53 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.459 0.704 . . . . 51.42 111.609 172.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.09 -27.65 68.91 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.739 0.816 . . . . 74.24 111.655 169.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.404 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 13.0 ttp180 -65.96 -42.44 89.92 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.297 0.57 . . . . 74.53 110.15 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.81 -22.47 61.56 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.08 -0.964 . . . . 55.42 111.834 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 t30 65.71 22.4 11.58 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 125.171 1.388 . . . . 72.11 111.167 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -97.26 6.0 49.09 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.7 0.8 . . . . 64.22 112.87 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.8 151.16 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.808 0.843 . . . . 61.41 110.875 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 69' ' ' PHE . 86.6 t -111.68 107.63 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.578 0.751 . . . . 71.44 109.381 172.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.5 mt -96.44 112.86 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.143 -0.688 . . . . 73.22 109.143 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -134.52 125.88 28.23 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 110.077 -0.342 . . . . 71.54 110.077 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -87.45 107.8 18.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.016 0.926 . . . . 75.53 111.155 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.432 ' O ' HD23 ' A' ' 60' ' ' LEU . 2.3 mptm? -105.19 141.61 36.43 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.294 1.038 . . . . 74.35 108.87 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.8 p30 44.18 29.33 0.34 Allowed 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 125.334 1.454 . . . . 71.32 113.76 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.07 -28.67 12.88 Favored Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.274 0.869 . . . . 70.13 115.274 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -90.73 154.33 19.62 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.757 1.278 . . . . 74.25 112.037 -174.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.32 116.29 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.899 0.88 . . . . 72.23 109.84 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.95 128.6 56.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.337 0.655 . . . . 74.44 110.235 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.651 HD12 HG11 ' A' ' 43' ' ' VAL . 23.0 mm -92.27 105.7 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.426 0.69 . . . . 75.04 110.221 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -97.6 172.64 7.59 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.234 1.014 . . . . 73.42 110.804 176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -98.93 170.58 8.63 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.23 0.612 . . . . 71.4 109.97 164.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.69 112.71 0.81 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.749 0.82 . . . . 72.42 112.351 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.87 -16.73 60.19 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 116.131 -0.486 . . . . 62.24 113.85 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -87.15 14.07 8.32 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.025 0.93 . . . . 74.02 113.036 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.597 ' HB3' HG11 ' A' ' 53' ' ' VAL . 49.6 p90 -60.46 -9.86 4.21 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.832 1.419 . . . . 55.14 114.832 -172.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -101.94 -32.99 9.93 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 112.838 0.681 . . . . 75.43 112.838 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -82.38 132.21 35.22 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 122.81 0.444 . . . . 62.23 112.073 -173.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.3 t -120.05 168.6 11.01 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.834 0.854 . . . . 74.42 112.132 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -79.02 169.83 17.6 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.761 1.224 . . . . 75.43 111.674 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.73 -135.99 7.43 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 116.383 -0.372 . . . . 61.1 112.931 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.6 mp -130.27 118.63 21.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 117.648 0.724 . . . . 63.43 110.569 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -146.0 137.45 24.83 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.675 1.19 . . . . 60.52 109.278 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -135.98 110.69 8.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.96 0.904 . . . . 72.1 109.8 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -68.6 141.13 55.53 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.846 0.858 . . . . 63.11 111.653 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.9 114.94 2.31 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.692 0.797 . . . . 74.51 110.656 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -74.84 -171.54 1.34 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.422 0.689 . . . . 64.01 111.671 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 67.99 78.42 0.23 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.514 1.126 . . . . 72.31 111.264 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 124.273 1.029 . . . . 73.15 110.003 176.957 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttp . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 120.88 0.371 . . . . 74.13 110.799 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -80.53 -6.41 58.17 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.925 1.083 . . . . 75.44 113.925 -172.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -60.52 -43.44 97.13 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.328 0.513 . . . . 64.45 111.609 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -86.4 -25.82 25.09 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.764 0.426 . . . . 62.23 111.861 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 72.3 mt -66.77 -46.34 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.839 0.456 . . . . 54.41 110.877 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.2 m -64.6 -26.24 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 122.916 0.487 . . . . 70.13 111.078 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' B' ' 45' ' ' TRP . . . -65.57 -51.97 43.26 Favored Glycine 0 C--N 1.354 1.581 0 O-C-N 123.665 0.603 . . . . 72.15 113.543 172.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.64 85.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.48 0.712 . . . . 34.5 111.745 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ASN . . . . . 0.478 ' HB3' HD11 ' B' ' 34' ' ' LEU . 5.7 m-20 -68.65 -29.02 67.41 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.22 1.008 . . . . 63.5 111.519 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.513 ' HB1' ' HG ' ' B' ' 46' ' ' LEU . . . -73.26 -39.0 65.75 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.857 0.463 . . . . 74.11 110.969 176.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.21 -32.34 82.21 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-O 121.358 0.421 . . . . 51.25 112.281 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.8 -35.66 77.3 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.675 1.19 . . . . 73.13 111.683 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.479 HG22 HG11 ' B' ' 32' ' ' VAL . 74.7 t -69.51 -40.41 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.488 0.715 . . . . 62.44 111.317 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -66.13 -32.5 73.98 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.264 0.626 . . . . 71.2 110.943 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -54.72 -42.28 71.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.776 0.83 . . . . 75.23 111.472 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.91 70.81 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.5 0.72 . . . . 52.31 112.528 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.652 HD11 HG12 ' B' ' 52' ' ' VAL . 82.7 mt -62.91 -42.67 99.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.531 0.733 . . . . 65.3 111.476 172.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -64.65 -22.11 66.9 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.377 0.671 . . . . 64.33 111.651 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.33 -50.73 13.51 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.48 0.712 . . . . 63.4 110.262 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.3 124.34 0.72 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.823 0.849 . . . . 55.44 111.137 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.404 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 7.9 p-10 -74.81 175.1 8.33 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.439 0.695 . . . . 71.34 112.593 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.42 20.5 78.34 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.961 -0.563 . . . . 75.33 112.974 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.468 HG13 ' HB2' ' B' ' 28' ' ' LEU . 8.9 tp -84.73 124.39 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.946 0.899 . . . . 63.11 110.285 -176.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -85.38 147.03 26.7 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.845 0.458 . . . . 62.43 110.584 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 88.0 mt -49.74 -44.98 79.12 Favored Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 114.965 1.468 . . . . 72.05 114.965 -173.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.61 -48.17 21.71 Favored 'Trans proline' 0 C--N 1.392 2.819 0 C-N-CA 122.332 2.021 . . . . 71.15 114.374 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -72.09 -38.43 69.38 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.835 1.302 . . . . 50.02 110.072 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.468 ' HB2' HG13 ' B' ' 23' ' ' ILE . 56.0 tp -60.88 -33.95 73.89 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 112.642 -2.072 . . . . 75.22 111.34 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.7 -35.87 79.27 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.299 1.04 . . . . 63.44 112.484 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -64.91 -43.9 91.32 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 122.857 0.463 . . . . 73.41 110.523 173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -64.74 -39.39 93.54 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.429 -0.805 . . . . 63.43 112.137 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.479 HG11 HG22 ' B' ' 13' ' ' VAL . 23.4 m -97.53 -3.1 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 112.947 0.721 . . . . 71.51 112.947 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.7 28.5 14.94 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 124.558 1.143 . . . . 72.34 111.672 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' B' ' 9' ' ' ASN . 92.4 mt -109.49 166.11 11.14 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.533 0.733 . . . . 74.35 110.564 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 43.6 t -73.87 161.64 29.93 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.1 0.56 . . . . 55.25 110.615 170.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.5 -47.46 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.239 0.616 . . . . 72.32 111.741 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.538 ' HB3' HD12 ' A' ' 25' ' ' ILE . 42.7 mt-10 -61.05 -42.2 98.04 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.024 0.93 . . . . 72.24 112.339 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 39.4 t -67.24 -34.95 78.54 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.383 0.673 . . . . 75.24 111.665 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 45.0 m -79.94 -34.54 38.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.939 0.896 . . . . 71.33 110.982 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.86 -33.58 72.46 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.747 0.819 . . . . 75.32 111.139 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -75.4 -34.26 61.04 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 115.398 -0.819 . . . . 61.44 110.511 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.98 90.42 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.945 0.498 . . . . 63.1 111.767 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.554 HG23 HD23 ' A' ' 41' ' ' LEU . 20.2 m -68.75 -29.16 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 122.483 0.313 . . . . 71.43 110.916 172.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.4 -34.36 89.09 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.188 -0.46 . . . . 63.5 113.198 171.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.408 ' CD1' ' HA2' ' B' ' 7' ' ' GLY . 61.1 t-105 -72.51 -33.84 67.19 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.683 0.393 . . . . 71.12 110.372 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.513 ' HG ' ' HB1' ' B' ' 10' ' ' ALA . 53.2 mt -66.64 -27.93 68.07 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.633 0.373 . . . . 74.04 111.875 170.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.73 74.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.986 0.515 . . . . 72.3 111.609 168.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.404 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 27.8 ttp85 -64.68 -43.41 93.62 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.081 0.467 . . . . 63.12 110.164 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -67.8 -25.52 65.63 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.344 -0.844 . . . . 65.42 111.654 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 67.0 22.91 9.92 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.509 1.524 . . . . 70.32 111.797 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -95.58 3.55 53.98 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.882 1.067 . . . . 73.11 113.882 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.652 HG12 HD11 ' B' ' 17' ' ' LEU . 15.7 m -123.32 153.35 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.485 0.66 . . . . 53.12 112.407 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 91.4 t -108.72 125.84 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.494 1.118 . . . . 62.23 109.309 171.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 mm -104.8 116.52 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.129 0.572 . . . . 74.01 109.881 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -117.72 123.59 46.42 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.435 0.694 . . . . 64.24 110.1 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -93.57 97.19 10.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.082 0.553 . . . . 74.35 109.823 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.6 ' HD3' ' HG3' ' B' ' 62' ' ' GLU . 8.7 mtpm? -105.11 113.2 26.65 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.041 0.936 . . . . 74.54 110.149 -175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 60.28 28.94 18.58 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.605 1.562 . . . . 44.55 111.733 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.62 -2.32 87.29 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 114.591 0.596 . . . . 73.32 114.591 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.67 149.37 22.88 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.009 0.905 . . . . 51.22 111.635 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.8 mm -87.14 119.1 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.178 0.591 . . . . 70.15 110.861 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLU . . . . . 0.6 ' HG3' ' HD3' ' B' ' 57' ' ' LYS . 7.2 mm-40 -116.1 121.63 42.73 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.286 1.034 . . . . 75.1 109.395 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.529 HG22 HD21 ' B' ' 17' ' ' LEU . 17.5 mm -100.75 122.35 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.19 0.596 . . . . 74.44 110.822 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.665 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 22.4 m-85 -116.18 169.15 9.5 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.109 0.964 . . . . 64.12 111.244 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.404 ' OD1' ' HB3' ' B' ' 21' ' ' ASP . 1.8 m-20 -77.62 141.28 39.56 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.633 -0.712 . . . . 73.34 111.225 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -49.84 -25.96 3.58 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.899 1.28 . . . . 65.31 114.217 172.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.88 -18.81 66.9 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 115.077 0.791 . . . . 61.53 115.077 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -145.06 127.3 15.76 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.34 0.57 . . . . 74.11 110.508 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -144.02 158.02 43.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.554 0.742 . . . . 51.04 111.26 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.08 123.93 22.39 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.47 0.708 . . . . 74.15 110.703 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -87.78 -177.91 5.93 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.671 0.788 . . . . 65.33 111.745 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 39.6 t -59.99 -51.67 68.68 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.651 -0.704 . . . . 62.21 110.33 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -90.89 80.8 5.76 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.424 -0.807 . . . . 71.34 109.315 171.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.36 -6.36 55.31 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 115.462 -0.79 . . . . 54.01 112.608 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 48.9 tp 75.31 -35.88 0.29 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 126.249 1.82 . . . . 73.41 113.115 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -54.67 131.93 44.43 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.423 1.089 . . . . 71.33 113.246 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -154.52 85.79 1.13 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.454 1.102 . . . . 73.52 108.449 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -61.88 160.56 11.89 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.854 1.262 . . . . 43.33 112.6 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -42.86 133.59 3.57 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.587 1.155 . . . . 74.23 111.871 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -58.25 125.27 22.53 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.185 0.594 . . . . 74.13 111.555 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -88.73 149.18 23.59 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.111 0.564 . . . . 72.22 111.158 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 21.7 p80 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 121.903 0.859 . . . . 64.31 112.29 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.539 0.209 . . . . 70.43 110.722 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -20.27 62.19 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 112.991 0.737 . . . . 75.11 112.991 -168.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -60.12 -38.38 82.84 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 119.376 0.989 . . . . 75.15 112.801 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -79.58 -41.06 27.95 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.84 0.456 . . . . 75.42 110.673 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.4 mt -65.44 -41.3 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.725 0.81 . . . . 71.31 112.335 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.536 HG12 HD11 ' A' ' 41' ' ' LEU . 29.5 m -65.13 -30.39 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 122.993 0.517 . . . . 45.24 111.517 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -42.52 85.08 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 112.498 -0.241 . . . . 63.25 112.498 172.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.89 -45.82 69.99 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.795 0.838 . . . . 72.4 111.949 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.412 ' HB2' HD11 ' A' ' 34' ' ' LEU . 31.7 p30 -77.37 -23.06 50.86 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 122.971 0.508 . . . . 73.41 111.946 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.03 -35.58 59.45 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.91 0.484 . . . . 54.41 111.209 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.61 -31.57 78.96 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 121.613 0.563 . . . . 75.32 112.231 172.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -68.92 -45.01 71.95 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 125.136 1.374 . . . . 74.34 110.79 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.45 ' HA ' HG11 ' A' ' 32' ' ' VAL . 39.2 t -64.48 -36.58 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 124.534 1.134 . . . . 72.14 111.652 173.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.411 ' NE1' ' HB3' ' A' ' 51' ' ' LYS . 15.9 t90 -71.5 -32.23 68.0 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.442 0.697 . . . . 72.22 110.908 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -59.84 -32.93 71.14 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.563 0.745 . . . . 71.32 111.545 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.77 -22.86 65.78 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.804 0.668 . . . . 73.23 112.804 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 52' ' ' VAL . 94.7 mt -68.8 -38.83 80.23 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.766 0.826 . . . . 64.41 112.687 173.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -56.86 -36.27 69.85 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.525 0.73 . . . . 74.34 111.303 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.62 -47.75 13.65 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.488 -0.778 . . . . 71.32 110.966 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.73 113.32 6.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.07 0.948 . . . . 54.21 111.392 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -94.94 128.3 41.63 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.404 -0.961 . . . . 72.2 108.404 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.8 47.81 4.66 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 111.896 -0.482 . . . . 74.12 111.896 -172.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.8 tp -114.35 137.27 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 C-N-CA 123.898 0.879 . . . . 73.3 110.731 -175.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.7 p -82.49 162.3 22.09 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.321 0.648 . . . . 61.42 111.99 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.9 mt -55.41 -54.34 52.1 Favored Pre-proline 0 CA--C 1.579 2.084 0 N-CA-C 113.84 1.052 . . . . 75.01 113.84 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.14 -30.61 20.24 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.03 1.82 . . . . 60.33 113.432 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -71.43 -44.33 65.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.265 0.626 . . . . 72.31 111.619 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.07 -30.65 63.86 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.91 0.484 . . . . 62.35 110.334 175.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.33 -41.86 76.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.551 0.74 . . . . 64.42 112.016 177.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -69.22 -30.82 69.06 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.079 0.552 . . . . 74.35 111.671 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -69.94 -40.48 75.44 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.079 0.552 . . . . 75.31 111.578 174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' ' 13' ' ' VAL . 21.5 m -96.72 7.74 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.365 0.666 . . . . 72.0 112.115 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.47 16.96 9.13 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.454 1.102 . . . . 53.11 113.935 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 9' ' ' ASN . 76.2 mt -99.85 159.43 15.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.53 0.732 . . . . 73.43 110.414 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.7 t -68.8 161.02 29.38 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.761 0.425 . . . . 74.12 110.847 169.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -59.3 -42.92 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 122.705 0.402 . . . . 65.33 111.491 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -64.82 -48.35 74.69 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.214 0.606 . . . . 73.32 111.784 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 t -57.08 -39.18 74.48 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.016 0.926 . . . . 75.51 112.101 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 43' ' ' VAL . 79.8 m -71.0 -52.28 20.55 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 123.905 0.882 . . . . 51.34 110.741 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.34 -30.95 67.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.018 0.927 . . . . 71.12 112.807 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.536 HD11 HG12 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -68.76 -45.05 72.39 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.388 1.075 . . . . 64.45 110.351 172.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.46 -31.38 72.57 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.586 0.754 . . . . 72.14 111.965 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 39' ' ' THR . 75.2 t -62.82 -43.14 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.551 1.141 . . . . 44.54 111.466 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.25 -31.13 75.93 Favored Glycine 0 CA--C 1.541 1.691 0 O-C-N 123.342 0.401 . . . . 52.15 113.055 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.461 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 51.3 t-105 -75.07 -27.7 60.06 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.849 0.86 . . . . 74.13 112.323 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 98.2 mt -76.68 -42.13 42.9 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.892 -0.505 . . . . 62.3 111.826 168.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.83 71.36 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.718 1.207 . . . . 72.12 113.327 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.701 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 14.1 ptt180 -61.05 -34.49 74.97 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.681 0.392 . . . . 64.41 111.718 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.701 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 36.4 mt-10 -98.41 1.05 46.47 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.421 1.088 . . . . 74.53 111.923 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 t30 61.89 28.1 17.13 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.623 1.169 . . . . 73.24 111.529 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 92.1 mttt -72.81 -21.35 60.98 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.59 0.756 . . . . 62.3 112.316 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.604 HG12 HD11 ' A' ' 17' ' ' LEU . 27.9 m -125.8 148.55 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 64.21 111.199 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.748 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 44.4 t -100.12 100.5 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.782 0.833 . . . . 73.15 108.8 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.3 mm -78.43 123.26 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 109.936 -0.394 . . . . 71.5 109.936 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.37 116.57 17.01 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.727 -0.842 . . . . 75.21 108.727 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -93.9 103.53 15.63 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.387 0.675 . . . . 63.24 110.387 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -111.16 129.04 56.07 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.563 0.745 . . . . 74.42 109.904 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 56.03 28.37 12.71 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.574 1.149 . . . . 72.05 112.467 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.64 -21.27 14.84 Favored Glycine 0 CA--C 1.542 1.722 0 N-CA-C 114.242 0.457 . . . . 53.32 114.242 -174.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.02 143.84 35.25 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.462 0.705 . . . . 54.13 110.877 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.81 138.13 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.494 -0.558 . . . . 52.3 109.494 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -147.35 142.57 27.24 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.454 0.645 . . . . 75.01 111.027 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.1 mt -111.01 137.51 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.042 0.937 . . . . 73.44 110.862 -173.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.748 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 90.1 m-85 -121.62 165.24 16.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.71 -1.132 . . . . 74.23 108.942 174.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HA ' HD13 ' A' ' 17' ' ' LEU . 20.9 t-20 -83.05 152.04 25.54 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.914 -0.772 . . . . 61.34 108.914 173.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -23.48 36.4 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.602 0.964 . . . . 75.14 113.602 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.52 -19.09 72.48 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 114.262 0.465 . . . . 73.31 114.262 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -69.6 -12.34 61.56 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.955 0.902 . . . . 74.41 112.424 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -59.06 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.008 0.523 . . . . 64.45 111.939 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.43 109.3 18.95 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.513 -0.921 . . . . 64.3 108.513 167.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -65.42 98.71 0.36 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.185 0.594 . . . . 74.24 111.648 -173.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.0 p -127.24 147.63 50.22 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.766 0.826 . . . . 72.5 110.686 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.454 ' HB3' HD23 ' A' ' 75' ' ' LEU . 93.8 m-85 -88.93 110.83 21.43 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.393 0.677 . . . . 71.43 110.95 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.92 54.52 0.7 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 123.316 0.484 . . . . 73.35 113.068 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.454 HD23 ' HB3' ' A' ' 73' ' ' PHE . 4.0 mm? -77.36 -19.76 55.8 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.64 0.776 . . . . 61.04 112.088 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.12 98.83 0.33 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.192 0.597 . . . . 71.4 111.065 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -56.29 128.07 33.99 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.448 1.099 . . . . 73.41 112.216 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -146.72 138.45 24.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.542 0.737 . . . . 61.43 110.479 -173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 60.59 16.74 6.79 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 124.137 0.975 . . . . 74.32 112.429 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -72.5 91.25 1.38 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.234 0.614 . . . . 73.24 110.567 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -67.98 128.38 36.32 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.347 -0.842 . . . . 73.14 111.332 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.3 m170 . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 121.603 0.716 . . . . 71.02 111.382 -176.302 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptm . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 111.999 0.37 . . . . 64.12 111.999 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.4 -39.71 81.57 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.793 0.837 . . . . 60.22 111.212 -173.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.644 ' HA ' HG22 ' B' ' 6' ' ' VAL . 99.0 mttt -70.37 -26.03 63.53 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.796 0.665 . . . . 63.31 112.796 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -70.05 -37.36 75.51 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.769 0.427 . . . . 71.15 110.81 171.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.93 -52.71 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 123.513 0.725 . . . . 72.34 111.438 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.644 HG22 ' HA ' ' B' ' 3' ' ' LYS . 19.5 m -70.52 -27.47 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 122.72 0.408 . . . . 61.22 111.741 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -38.87 89.17 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 116.783 -0.189 . . . . 32.41 112.764 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.03 32.02 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.437 0.695 . . . . 60.05 111.73 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ASN . . . . . 0.604 ' HB2' HD11 ' B' ' 34' ' ' LEU . 31.3 p30 -73.29 -20.97 60.7 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 112.953 0.723 . . . . 73.31 112.953 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.97 -23.38 64.12 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.083 0.553 . . . . 64.51 111.178 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.04 -31.91 79.2 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 116.222 -0.445 . . . . 64.1 113.12 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.62 -47.02 64.89 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.438 0.695 . . . . 71.1 111.101 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.19 -36.88 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.276 1.03 . . . . 75.52 111.59 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -72.66 -34.32 67.16 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.263 0.625 . . . . 74.33 110.979 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -65.03 -31.03 72.06 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.666 0.387 . . . . 62.24 111.475 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.68 -30.23 67.21 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.05 0.54 . . . . 75.33 112.146 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.705 HD11 HG12 ' B' ' 52' ' ' VAL . 80.3 mt -65.59 -45.96 81.22 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.772 0.829 . . . . 61.25 111.659 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -59.66 -28.18 67.03 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.692 0.797 . . . . 74.1 111.266 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -81.91 -47.57 12.59 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.877 0.871 . . . . 72.43 111.217 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.09 151.98 16.52 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.783 0.833 . . . . 44.35 111.736 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -112.22 156.16 22.81 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.297 0.639 . . . . 74.35 109.649 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.01 38.66 84.68 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 114.359 0.503 . . . . 61.04 114.359 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 tt -102.36 137.54 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.23 0.612 . . . . 73.33 110.275 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -73.11 156.4 38.72 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.386 0.674 . . . . 62.52 111.594 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.82 -52.18 76.28 Favored Pre-proline 0 CA--C 1.575 1.933 0 N-CA-C 113.617 0.969 . . . . 72.35 113.617 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.75 -23.91 55.24 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.149 1.899 . . . . 65.11 113.501 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -78.91 -42.66 26.6 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.741 0.816 . . . . 74.43 111.496 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.1 -31.58 61.21 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 122.157 -0.34 . . . . 74.55 111.078 174.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.53 -45.38 73.35 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.573 1.149 . . . . 74.55 113.393 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -65.01 -30.83 71.83 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 115.999 -0.546 . . . . 74.24 112.22 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -78.41 -40.93 34.55 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.015 0.526 . . . . 72.41 111.058 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 m -81.58 -3.4 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.076 0.551 . . . . 61.44 111.683 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 65.83 29.41 10.51 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.321 1.448 . . . . 73.14 112.906 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' B' ' 9' ' ' ASN . 66.5 mt -109.28 158.07 18.23 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.693 0.797 . . . . 72.3 110.395 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 34.0 t -65.09 152.82 42.56 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.781 0.433 . . . . 73.12 110.581 166.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.34 -41.97 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 123.073 0.549 . . . . 72.51 111.579 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.66 -48.21 80.33 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.087 0.955 . . . . 75.23 112.015 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.5 t -66.56 -30.82 71.22 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.713 0.805 . . . . 71.23 111.601 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 96.8 m -74.87 -44.17 50.44 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.916 0.886 . . . . 73.32 110.92 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.51 -34.3 77.47 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.872 0.869 . . . . 73.33 111.648 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -67.2 -44.08 80.52 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 124.27 1.028 . . . . 71.31 110.496 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.81 76.75 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.14 0.576 . . . . 73.54 111.793 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.19 -44.35 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.585 1.154 . . . . 74.32 110.828 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.47 -28.04 73.16 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 116.378 -0.374 . . . . 65.21 113.155 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 49.9 t-105 -74.18 -29.9 61.98 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.967 0.907 . . . . 73.45 111.232 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.06 -36.59 58.94 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.358 0.663 . . . . 73.42 112.186 167.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.96 76.86 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.202 1.001 . . . . 44.53 113.543 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 20.3 ptt85 -63.92 -30.68 71.74 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.303 0.573 . . . . 73.22 111.097 173.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -86.03 -15.78 40.3 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.374 1.07 . . . . 64.35 111.572 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 t30 60.43 43.62 13.04 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.717 1.207 . . . . 73.2 110.769 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -95.83 -9.07 32.48 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.312 -0.858 . . . . 64.42 111.777 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.705 HG12 HD11 ' B' ' 17' ' ' LEU . 27.7 m -125.17 146.47 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.222 1.009 . . . . 60.51 111.149 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' B' ' 66' ' ' GLU . 85.9 t -103.95 104.08 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.133 -1.062 . . . . 74.0 108.133 167.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 70.8 mt -91.21 118.18 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.146 0.578 . . . . 70.51 109.827 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.69 123.28 45.7 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.003 -0.74 . . . . 70.34 109.003 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -89.13 96.85 10.89 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.596 0.712 . . . . 64.41 109.341 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -116.66 119.06 34.3 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.077 -0.965 . . . . 72.43 109.502 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 60.07 28.79 18.38 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.783 1.233 . . . . 65.52 111.731 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.85 -3.93 72.82 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 114.452 0.541 . . . . 43.13 114.452 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.59 134.7 34.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.341 0.656 . . . . 75.44 110.736 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.6 mm -87.07 103.12 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 123.562 0.745 . . . . 74.24 109.045 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -117.75 123.84 47.0 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.486 0.715 . . . . 64.21 109.919 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 40.2 pt -97.76 138.29 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.074 0.94 . . . . 73.14 112.177 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.523 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 77.0 m-85 -120.7 169.4 10.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.165 1.386 . . . . 51.34 108.347 175.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -85.43 145.99 27.19 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.682 -0.858 . . . . 65.03 108.682 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.555 ' HA ' HG23 ' B' ' 53' ' ' VAL . 1.0 OUTLIER -60.51 142.76 54.87 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 112.394 0.516 . . . . 65.23 112.394 -178.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.99 -18.27 45.62 Favored Glycine 0 CA--C 1.539 1.555 0 CA-C-O 119.451 -0.638 . . . . 45.22 114.373 -178.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -57.96 -51.03 71.35 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.815 0.846 . . . . 73.03 111.941 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -85.72 -28.61 24.52 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.153 0.581 . . . . 75.05 111.783 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 27.4 t70 62.78 -128.74 0.58 Allowed 'General case' 0 CA--C 1.574 1.895 0 C-N-CA 123.622 0.769 . . . . 74.02 110.363 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.57 25.08 8.84 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 119.625 1.102 . . . . 71.54 111.624 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -80.74 -173.04 3.96 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.215 0.606 . . . . 74.53 112.021 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -68.08 171.16 7.26 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 123.628 0.771 . . . . 75.23 111.61 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.08 -133.88 1.19 Allowed Glycine 0 C--N 1.353 1.495 0 N-CA-C 112.379 -0.288 . . . . 44.43 112.379 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 14.1 tp -158.94 17.67 0.19 Allowed 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 117.412 0.606 . . . . 73.32 111.233 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.22 104.66 2.7 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.088 0.555 . . . . 73.01 110.852 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -138.19 108.38 6.43 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.035 0.934 . . . . 74.11 109.443 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -93.11 107.91 19.61 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.493 0.553 . . . . 74.14 112.493 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -132.21 172.57 12.24 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.353 1.061 . . . . 42.23 110.262 165.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -153.88 119.53 5.24 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.683 0.793 . . . . 71.53 109.968 -171.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -80.75 106.68 12.94 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.147 0.579 . . . . 64.25 111.777 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 80.0 t60 . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 124.169 0.988 . . . . 75.21 110.038 175.928 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptm . . . . . 0 N--CA 1.499 2.009 0 CA-C-O 121.734 0.778 . . . . 63.24 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.84 -28.35 69.42 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.662 1.185 . . . . 74.13 114.026 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -65.92 -33.89 76.86 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 113.793 1.035 . . . . 72.22 113.793 -164.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.37 -32.48 29.24 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 122.506 0.322 . . . . 74.33 111.339 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.658 HD13 HH22 ' B' ' 56' ' ' ARG . 68.4 mt -62.82 -47.53 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.433 0.693 . . . . 75.41 110.947 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.48 -34.46 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.772 0.829 . . . . 74.11 111.352 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.41 -37.12 94.32 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 112.634 -0.186 . . . . 60.22 112.634 173.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.0 -55.74 8.78 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.699 0.8 . . . . 71.2 112.296 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.615 ' HB2' HD11 ' A' ' 34' ' ' LEU . 36.6 p30 -78.14 -13.46 59.86 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.756 1.021 . . . . 74.52 113.756 -170.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.16 -27.77 64.8 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.651 0.38 . . . . 64.43 111.598 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.23 -45.45 80.48 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 116.15 -0.477 . . . . 21.53 113.552 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -39.17 75.57 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.811 0.444 . . . . 74.11 112.185 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.498 ' HA ' HG11 ' A' ' 32' ' ' VAL . 20.9 m -69.59 -36.19 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.72 0.236 . . . . 74.24 111.221 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.677 ' HA ' HD12 ' A' ' 17' ' ' LEU . 62.3 t90 -69.37 -33.64 73.37 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.91 0.484 . . . . 74.41 111.033 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.61 -33.96 77.12 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.048 0.539 . . . . 65.34 111.321 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.74 76.1 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.231 0.612 . . . . 72.22 111.551 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.677 HD12 ' HA ' ' A' ' 14' ' ' TRP . 31.3 mt -71.91 -33.93 68.69 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.009 0.924 . . . . 60.11 111.641 174.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -30.3 65.23 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.734 0.814 . . . . 65.55 109.944 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -77.23 -41.39 41.36 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.018 0.527 . . . . 64.35 110.492 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.2 107.13 1.8 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.136 0.574 . . . . 73.43 111.612 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.98 174.91 11.15 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.331 0.652 . . . . 63.31 111.148 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.67 42.43 97.27 Favored Glycine 0 N--CA 1.479 1.518 0 CA-C-O 121.406 0.448 . . . . 72.0 112.366 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.433 HD13 ' HB3' ' A' ' 28' ' ' LEU . 21.1 tt -114.92 144.79 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.826 0.851 . . . . 54.14 110.996 -169.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -79.8 151.26 30.4 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.08 0.552 . . . . 72.32 110.889 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.81 -47.1 99.33 Favored Pre-proline 0 CA--C 1.58 2.119 0 N-CA-C 113.326 0.862 . . . . 64.14 113.326 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.05 -22.81 47.14 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.076 1.851 . . . . 71.44 113.468 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -71.91 -48.9 42.27 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.633 0.773 . . . . 64.51 111.673 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.433 ' HB3' HD13 ' A' ' 23' ' ' ILE . 2.2 pt? -74.9 -29.62 61.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.816 -0.553 . . . . 71.5 111.826 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.39 -44.88 65.58 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.385 0.883 . . . . 51.03 113.385 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -70.44 -30.38 67.2 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.922 0.489 . . . . 73.12 112.081 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 25.7 mtpp -68.33 -44.34 75.54 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.575 0.75 . . . . 71.12 110.592 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 13' ' ' VAL . 16.9 m -86.41 -2.0 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.126 0.971 . . . . 64.24 111.805 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 m120 64.84 23.22 12.63 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.104 1.361 . . . . 74.24 112.946 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 9' ' ' ASN . 66.3 mt -101.63 168.2 9.63 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.67 0.788 . . . . 72.41 111.102 174.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 m -71.72 156.97 38.75 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.905 -0.589 . . . . 74.31 110.838 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.39 -48.37 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 123.235 0.614 . . . . 72.24 111.717 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.406 ' HB3' HD12 ' B' ' 25' ' ' ILE . 51.7 mt-10 -63.73 -38.64 91.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.38 0.672 . . . . 54.31 112.658 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.1 m -65.99 -31.14 71.88 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.606 0.762 . . . . 62.43 111.807 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.4 m -77.39 -44.18 30.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.802 0.841 . . . . 73.31 111.112 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.57 -33.55 72.87 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.305 0.642 . . . . 60.32 111.659 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -53.71 54.84 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.546 1.139 . . . . 71.24 110.04 171.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.28 -32.35 72.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.078 -0.965 . . . . 54.14 112.277 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.46 HG11 HD13 ' A' ' 63' ' ' ILE . 69.1 t -68.34 -39.71 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.24 0.616 . . . . 70.24 111.183 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.34 -31.8 81.99 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 116.633 -0.258 . . . . 61.34 113.108 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.403 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 69.2 t-105 -71.18 -30.3 66.25 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.605 0.762 . . . . 72.2 111.685 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.447 HD22 ' HE2' ' A' ' 51' ' ' LYS . 77.5 mt -75.61 -38.07 59.28 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.578 0.751 . . . . 74.25 112.274 170.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.29 -37.01 74.16 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.807 1.243 . . . . 63.31 114.117 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.599 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 25.7 ptt85 -60.39 -26.67 66.84 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 122.935 0.494 . . . . 72.22 111.886 175.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 40.0 mt-10 -103.3 4.96 37.08 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.856 1.262 . . . . 74.21 112.228 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 62.71 21.7 12.9 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 125.031 1.332 . . . . 64.24 113.0 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HE2' HD22 ' A' ' 46' ' ' LEU . 50.8 mtpt -80.2 -13.45 59.23 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.235 0.614 . . . . 74.22 112.283 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.488 HG12 HD13 ' A' ' 17' ' ' LEU . 19.0 m -121.61 142.95 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.759 0.823 . . . . 54.41 111.22 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 94.7 t -112.73 104.98 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 123.846 0.859 . . . . 71.03 109.872 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.583 HG23 HG23 ' A' ' 61' ' ' ILE . 2.6 mp -91.64 125.43 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.561 -0.533 . . . . 64.33 109.561 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.33 113.22 25.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.007 0.523 . . . . 72.32 109.644 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -87.23 96.22 10.25 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.77 -0.826 . . . . 73.44 108.77 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.54 118.12 34.86 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.825 0.85 . . . . 75.02 109.541 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.78 31.56 17.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.871 0.868 . . . . 63.24 111.569 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.52 2.36 74.53 Favored Glycine 0 CA--C 1.546 1.98 0 N-CA-C 114.472 0.549 . . . . 42.44 114.472 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.0 mt -94.92 133.07 39.05 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.945 0.898 . . . . 53.42 110.306 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.583 HG23 HG23 ' A' ' 54' ' ' ILE . 76.6 mt -96.87 118.07 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.489 0.715 . . . . 61.25 111.666 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.37 132.05 55.75 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.914 -0.773 . . . . 62.12 108.914 167.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.46 HD13 HG11 ' A' ' 43' ' ' VAL . 40.0 mt -102.04 132.05 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 121.325 0.583 . . . . 65.14 110.788 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.57 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 83.8 m-85 -124.55 173.55 8.41 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.318 1.047 . . . . 75.55 110.158 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -99.86 163.92 12.25 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.048 0.539 . . . . 74.22 109.727 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -53.17 148.41 8.35 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.441 1.097 . . . . 72.31 112.324 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.63 -6.09 33.3 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 116.469 -0.332 . . . . 65.02 112.979 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -81.88 3.69 25.23 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 123.945 0.898 . . . . 72.52 112.022 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -122.12 157.51 31.34 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.766 0.826 . . . . 64.52 111.522 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -103.04 118.52 37.0 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.569 0.748 . . . . 71.41 110.662 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -122.02 158.7 28.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.891 0.876 . . . . 53.52 110.327 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 t 67.71 -64.87 0.26 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.058 1.343 . . . . 61.31 111.465 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -69.01 111.62 5.12 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 109.265 -0.643 . . . . 75.55 109.265 168.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.26 79.56 1.04 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 115.251 0.86 . . . . 65.43 115.251 -167.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.1 mt -103.51 91.87 4.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.229 0.611 . . . . 62.43 109.706 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -89.43 128.69 35.97 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.893 -0.594 . . . . 74.45 109.784 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -75.82 105.9 7.1 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.272 0.629 . . . . 74.4 109.537 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -63.63 112.69 2.93 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.95 0.5 . . . . 75.14 111.168 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -72.55 139.84 47.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.452 0.701 . . . . 71.4 110.394 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -85.0 147.16 26.83 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.146 0.578 . . . . 75.04 111.421 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -71.11 138.22 49.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.941 0.496 . . . . 73.24 110.719 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.768 0.794 . . . . 64.24 111.137 -174.515 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 CA--C 1.546 0.813 0 CA-C-O 120.852 0.358 . . . . 64.51 110.908 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.43 ' O ' HG13 ' B' ' 6' ' ' VAL . 2.0 t70 -67.52 -33.05 74.28 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.458 0.703 . . . . 44.12 112.11 -171.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.507 ' HA ' HG22 ' B' ' 6' ' ' VAL . 37.5 ttmt -66.52 -35.19 79.65 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.323 0.49 . . . . 72.52 112.323 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -55.25 -41.24 71.9 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.403 0.621 . . . . 72.15 110.478 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' B' ' 2' ' ' ASP . 47.6 mt -66.55 -51.97 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-N 114.677 -1.147 . . . . 64.24 111.457 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' B' ' 3' ' ' LYS . 4.5 m -67.18 -32.3 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 122.584 0.354 . . . . 73.41 111.896 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.47 -44.09 66.19 Favored Glycine 0 C--N 1.349 1.302 0 O-C-N 123.201 0.313 . . . . 53.24 112.749 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.26 69.83 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.505 0.722 . . . . 73.42 112.25 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ASN . . . . . 0.408 ' OD1' HD11 ' B' ' 34' ' ' LEU . 9.0 t-20 -86.67 -28.05 23.4 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.637 0.775 . . . . 61.11 112.131 -175.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.25 72.36 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.275 0.63 . . . . 54.33 112.192 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.81 -42.31 95.17 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 116.11 -0.495 . . . . 64.21 112.373 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -65.11 -45.63 84.33 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.777 0.831 . . . . 73.21 111.479 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.617 ' HA ' HG11 ' B' ' 32' ' ' VAL . 30.9 m -68.83 -32.22 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 C-N-CA 122.772 0.429 . . . . 72.1 112.068 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.501 ' HA ' HD12 ' B' ' 17' ' ' LEU . 34.6 t90 -72.3 -35.77 68.75 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.834 0.454 . . . . 74.41 111.495 175.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -67.46 -32.24 72.95 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.069 0.548 . . . . 74.02 112.018 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.7 74.39 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 122.971 0.508 . . . . 62.23 111.939 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' B' ' 14' ' ' TRP . 82.6 mt -63.67 -30.89 71.94 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.944 0.898 . . . . 52.33 112.602 174.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.2 -5.48 22.89 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.158 0.799 . . . . 51.11 113.158 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -79.67 -61.48 1.98 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.022 0.529 . . . . 74.23 110.469 170.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.94 131.72 5.33 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.511 0.725 . . . . 63.32 110.947 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.525 ' HB3' ' HD1' ' B' ' 64' ' ' TYR . 4.6 m-20 -74.22 175.21 7.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.991 0.916 . . . . 74.42 112.468 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.72 54.81 5.24 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.535 -0.626 . . . . 72.41 111.535 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 tt -133.6 120.34 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.53 0.732 . . . . 71.13 110.994 -167.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -67.74 163.49 21.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.633 0.773 . . . . 54.01 111.911 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' B' ' 40' ' ' ALA . 48.5 mt -59.7 -47.12 98.26 Favored Pre-proline 0 CA--C 1.574 1.901 0 CA-C-O 118.525 -0.75 . . . . 73.02 112.434 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.02 -22.99 34.69 Favored 'Trans proline' 0 C--N 1.396 3.044 0 C-N-CA 121.871 1.714 . . . . 50.41 114.064 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -70.73 -50.45 36.08 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.686 1.231 . . . . 75.24 109.017 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.83 -39.1 83.97 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 112.612 -2.085 . . . . 72.51 111.679 175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.17 -43.11 87.28 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.105 0.962 . . . . 74.05 112.867 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -69.71 -36.93 76.34 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.003 0.521 . . . . 74.25 111.587 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -64.39 -44.85 90.04 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.244 0.618 . . . . 73.14 111.148 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' B' ' 13' ' ' VAL . 13.7 m -88.23 5.34 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.35 0.66 . . . . 73.13 112.727 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 69.32 17.81 8.14 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.798 1.239 . . . . 71.31 113.137 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.408 HD11 ' OD1' ' B' ' 9' ' ' ASN . 63.3 mt -110.65 174.95 5.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.627 0.771 . . . . 74.32 112.287 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -84.31 160.72 20.65 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.17 -0.923 . . . . 74.43 110.577 167.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 63.2 t -53.89 -49.82 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 124.1 0.96 . . . . 73.44 112.653 -175.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.37 -48.3 82.34 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.579 0.752 . . . . 73.51 111.985 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -62.67 -37.13 85.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.942 0.897 . . . . 64.55 111.892 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.485 ' O ' HG23 ' B' ' 43' ' ' VAL . 85.1 m -69.07 -51.31 40.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.578 0.751 . . . . 75.34 111.609 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -55.04 -44.51 74.73 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.802 0.841 . . . . 44.24 111.974 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.72 -36.19 82.91 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.393 1.077 . . . . 62.43 111.203 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.44 83.27 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.775 0.43 . . . . 74.35 112.151 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.485 HG23 ' O ' ' B' ' 39' ' ' THR . 24.8 t -67.54 -29.19 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.51 0.724 . . . . 72.33 111.449 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.73 -28.16 56.5 Favored Glycine 0 CA--C 1.551 2.282 0 N-CA-C 114.502 0.561 . . . . 40.41 114.502 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.488 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 72.6 t-105 -74.33 -24.69 59.23 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.443 0.697 . . . . 70.41 111.533 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.443 HD11 HG23 ' B' ' 13' ' ' VAL . 83.9 mt -72.77 -36.04 67.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.563 0.745 . . . . 42.13 111.636 173.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.97 -33.51 67.15 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.728 0.811 . . . . 74.44 112.363 172.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 33.1 ttt-85 -54.63 -49.78 69.7 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.971 0.908 . . . . 64.23 111.481 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.27 -1.35 57.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.51 0.724 . . . . 73.44 112.58 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 64.17 21.96 12.72 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.812 1.245 . . . . 63.52 113.177 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -86.61 1.37 52.02 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.08 0.77 . . . . 65.33 113.08 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.36 155.68 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 123.362 0.665 . . . . 73.22 112.027 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 45.8 t -120.43 96.57 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.532 -0.914 . . . . 63.13 108.532 169.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.475 HD11 HG12 ' B' ' 43' ' ' VAL . 35.7 mt -95.75 102.27 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.158 0.504 . . . . 63.32 109.676 -177.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -134.29 132.27 39.39 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.994 -0.441 . . . . 63.52 111.629 -166.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.658 HH22 HD13 ' A' ' 5' ' ' ILE . 6.7 mtm-85 -86.8 97.05 10.41 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.799 0.809 . . . . 63.03 110.405 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -108.35 128.31 54.64 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.653 -1.158 . . . . 72.21 109.151 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 59.31 29.9 19.54 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.492 1.117 . . . . 75.52 111.14 -170.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.99 -21.39 7.98 Favored Glycine 0 C--N 1.36 1.915 0 CA-C-N 115.879 -0.601 . . . . 44.22 114.514 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mp -89.7 135.52 33.57 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.453 0.701 . . . . 43.22 110.74 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.639 HG13 ' HG2' ' B' ' 56' ' ' ARG . 1.4 mp -73.93 107.99 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 C-N-CA 123.593 0.757 . . . . 63.44 109.682 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -107.53 120.27 41.74 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.014 0.926 . . . . 70.25 110.494 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.444 ' N ' HD12 ' B' ' 63' ' ' ILE . 2.2 mp -94.24 132.31 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 109.149 -0.685 . . . . 55.54 109.149 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.625 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 90.5 m-85 -123.5 174.0 7.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.473 1.109 . . . . 71.52 109.997 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -93.97 158.26 15.72 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 109.142 -0.688 . . . . 74.43 109.142 166.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -46.0 -63.01 1.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.358 1.063 . . . . 73.32 113.397 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.52 18.73 8.08 Favored Glycine 0 CA--C 1.543 1.795 0 N-CA-C 115.354 0.902 . . . . 40.14 115.354 -172.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -90.1 -10.74 43.55 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.961 0.88 . . . . 74.04 111.838 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -59.42 -38.61 81.08 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.176 0.513 . . . . 75.42 111.242 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -90.63 94.44 9.7 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 108.777 -0.823 . . . . 73.14 108.777 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -134.38 140.77 46.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.115 0.966 . . . . 64.34 110.092 -173.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 45.5 t -66.7 147.24 53.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.025 0.53 . . . . 63.33 112.044 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -89.19 129.48 35.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.58 0.752 . . . . 61.5 110.865 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.77 80.87 0.05 OUTLIER Glycine 0 C--N 1.346 1.135 0 N-CA-C 112.188 -0.365 . . . . 71.25 112.188 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 mp -91.11 138.75 31.36 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.64 0.776 . . . . 63.35 111.293 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -66.2 121.35 15.01 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.225 1.01 . . . . 55.53 110.977 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -91.35 120.68 32.43 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.596 0.758 . . . . 74.44 110.148 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -74.76 159.45 31.98 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.853 0.461 . . . . 72.22 111.832 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -93.89 170.49 9.51 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.61 0.764 . . . . 71.42 112.221 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -113.72 -167.96 1.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.306 1.042 . . . . 64.33 110.724 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -144.35 137.15 26.92 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.345 0.658 . . . . 74.05 110.745 175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 9.2 t60 . . . . . 0 N--CA 1.483 1.196 0 C-N-CA 123.689 0.795 . . . . 70.14 110.884 -178.509 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptt? . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 111.768 0.284 . . . . 73.44 111.768 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -96.51 150.38 20.69 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.037 0.535 . . . . 73.24 112.038 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.446 ' O ' HG22 ' A' ' 6' ' ' VAL . 71.6 mmtt -79.23 -18.81 52.16 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.992 -0.549 . . . . 75.32 109.78 167.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -54.56 -34.03 61.19 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.324 1.05 . . . . 72.33 112.438 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.4 mt -52.8 -58.13 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.118 0.967 . . . . 64.22 112.115 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 3' ' ' LYS . 32.1 m -60.79 -37.47 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 112.926 0.713 . . . . 75.24 112.926 -172.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.79 -38.84 41.2 Favored Glycine 0 N--CA 1.476 1.366 0 O-C-N 123.237 0.336 . . . . 24.21 113.041 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.72 -36.73 83.92 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.943 0.897 . . . . 74.13 111.971 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -84.15 -28.92 27.08 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.092 -0.504 . . . . 31.31 111.622 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.82 71.12 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 122.908 0.483 . . . . 72.34 111.986 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.7 97.23 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.245 -0.434 . . . . 72.22 112.975 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -72.67 -38.29 67.65 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.925 0.89 . . . . 75.4 111.579 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.741 ' HA ' HG11 ' A' ' 32' ' ' VAL . 54.2 t -62.98 -47.74 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.79 0.836 . . . . 75.0 111.28 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -66.17 -33.43 75.75 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.623 -0.717 . . . . 73.02 111.35 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -61.62 -42.42 98.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.402 0.681 . . . . 75.4 111.681 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.21 74.03 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.327 0.651 . . . . 72.14 111.491 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 21' ' ' ASP . 2.5 tm? -70.73 -30.7 67.31 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.213 1.405 . . . . 72.3 111.536 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -64.24 -42.95 96.31 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.945 0.898 . . . . 73.12 112.816 -169.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -81.69 -15.22 55.17 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.005 0.743 . . . . 53.14 113.005 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.53 96.06 1.14 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.961 0.504 . . . . 64.21 110.738 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.451 ' HA ' HD22 ' A' ' 17' ' ' LEU . 8.7 p-10 -86.02 169.2 13.41 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.09 0.556 . . . . 75.12 112.009 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.86 55.06 3.94 Favored Glycine 0 C--N 1.344 1.009 0 N-CA-C 111.698 -0.561 . . . . 60.13 111.698 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 tt -130.13 136.43 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.979 0.911 . . . . 75.33 110.421 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.9 p -74.97 154.59 38.04 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.783 0.433 . . . . 70.11 111.242 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.564 HG21 ' HB2' ' A' ' 40' ' ' ALA . 63.8 mt -52.36 -47.42 92.97 Favored Pre-proline 0 CA--C 1.573 1.837 0 N-CA-C 114.056 1.132 . . . . 64.15 114.056 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.69 -33.05 56.19 Favored 'Trans proline' 0 C--N 1.393 2.902 0 C-N-CA 121.714 1.609 . . . . 75.51 114.319 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 30' ' ' ARG . 37.6 mt-10 -76.74 -31.0 56.84 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.395 1.093 . . . . 73.33 110.453 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.81 -33.3 66.14 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 113.668 -1.605 . . . . 74.32 110.603 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.9 -39.4 87.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.895 0.878 . . . . 65.13 112.855 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 14.2 ptt180 -70.38 -28.08 64.82 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.401 0.28 . . . . 64.24 111.053 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -67.27 -37.74 83.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.961 0.904 . . . . 75.13 111.574 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.741 HG11 ' HA ' ' A' ' 13' ' ' VAL . 24.6 m -102.8 0.73 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 112.989 0.737 . . . . 73.0 112.989 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 65.71 28.47 11.06 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.808 1.243 . . . . 74.41 112.635 174.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.4 mt -109.0 175.12 5.57 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.943 0.897 . . . . 53.41 111.244 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 99.9 p -77.99 163.74 25.68 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.319 0.648 . . . . 70.4 110.37 168.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -58.18 -45.92 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.09 0.556 . . . . 63.42 111.17 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.71 -37.51 82.35 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.954 0.902 . . . . 73.11 112.648 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -69.69 -37.37 76.59 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.129 0.49 . . . . 62.54 111.563 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 43' ' ' VAL . 93.8 m -72.88 -44.66 61.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.494 0.717 . . . . 70.11 111.281 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -57.86 -35.63 71.22 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.966 0.906 . . . . 73.11 111.972 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -51.8 67.15 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 114.795 -1.093 . . . . 60.43 110.207 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.04 70.96 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.862 -1.063 . . . . 72.22 111.723 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 39' ' ' THR . 79.4 t -69.23 -38.25 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.367 0.667 . . . . 71.03 110.664 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.89 -31.77 82.02 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 116.359 -0.382 . . . . 74.24 113.459 172.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.507 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 66.9 t-105 -73.92 -30.15 62.42 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.449 0.699 . . . . 73.23 111.047 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.19 -37.44 69.29 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.922 0.489 . . . . 72.21 111.184 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.76 -30.09 71.19 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.95 0.9 . . . . 73.41 111.724 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 21.5 ttt180 -55.88 -50.6 70.2 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.564 0.745 . . . . 75.23 110.884 167.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -84.71 -3.23 58.46 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 115.197 -0.911 . . . . 75.02 111.961 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 62.25 22.22 13.02 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 125.258 1.423 . . . . 73.32 112.764 -175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -69.55 -24.82 63.77 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.41 1.084 . . . . 64.3 112.367 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.59 151.14 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.64 0.776 . . . . 63.44 110.813 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' A' ' 68' ' ' HIS . 44.6 t -116.92 111.45 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 123.712 0.805 . . . . 74.53 110.242 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.497 HG23 HG23 ' A' ' 61' ' ' ILE . 3.4 mp -86.56 107.98 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 N-CA-C 109.389 -0.596 . . . . 72.22 109.389 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG3' HG12 ' A' ' 53' ' ' VAL . 54.3 mt-10 -118.44 118.03 30.65 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.538 0.735 . . . . 65.12 110.382 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -85.24 100.96 12.13 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.136 0.974 . . . . 72.54 110.076 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -114.63 109.15 17.8 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.069 0.948 . . . . 62.52 109.885 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 57.63 32.67 22.2 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.171 0.988 . . . . 73.04 111.831 -169.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.3 -9.92 62.74 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 115.557 -0.747 . . . . 50.11 114.311 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.5 mt -80.0 107.55 12.87 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.191 0.596 . . . . 43.51 109.997 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.497 HG23 HG23 ' A' ' 54' ' ' ILE . 76.7 mt -69.88 102.63 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.321 -0.622 . . . . 75.21 109.321 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -110.19 124.11 50.98 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.923 0.889 . . . . 71.43 109.847 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.1 mp -91.72 103.25 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 108.602 -0.888 . . . . 74.03 108.602 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -91.81 175.77 6.77 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.073 0.949 . . . . 74.03 110.941 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -90.81 158.87 16.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.081 0.552 . . . . 74.35 110.525 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -51.22 119.54 4.13 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.517 0.727 . . . . 74.42 110.379 171.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.42 10.86 0.27 Allowed Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.093 -0.503 . . . . 72.11 112.996 -171.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.617 ' HB2' HG11 ' A' ' 53' ' ' VAL . 39.6 m-70 -120.18 -22.4 6.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.782 0.66 . . . . 72.31 112.782 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -79.55 13.93 1.83 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.273 0.842 . . . . 72.43 113.273 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.78 -21.82 66.04 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.638 0.977 . . . . 55.12 113.638 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -92.88 2.97 56.5 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.254 0.464 . . . . 75.32 112.254 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 91.2 p -61.07 136.15 57.99 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.369 0.877 . . . . 64.43 113.369 -170.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -132.37 165.12 24.97 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.661 1.184 . . . . 73.35 110.031 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.48 63.01 0.49 Allowed Glycine 0 N--CA 1.473 1.111 0 CA-C-N 116.635 -0.257 . . . . 65.54 113.45 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.34 114.61 26.99 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.158 0.583 . . . . 73.24 110.754 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.51 152.24 28.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.425 0.69 . . . . 70.55 110.674 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -128.78 130.16 46.65 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.31 0.644 . . . . 74.25 111.897 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p80 32.74 78.27 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 126.307 1.843 . . . . 75.43 115.947 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -74.62 -38.98 62.41 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.043 0.537 . . . . 71.13 111.696 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -78.17 140.44 38.98 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.073 0.463 . . . . 74.31 111.59 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -138.18 179.79 6.24 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.322 1.049 . . . . 75.34 109.966 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 . . . . . 0 N--CA 1.486 1.36 0 C-N-CA 122.854 0.462 . . . . 54.24 110.799 178.632 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 CA--C 1.553 1.085 0 CA-C-O 120.425 0.155 . . . . 70.12 111.286 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.408 ' O ' HG22 ' B' ' 6' ' ' VAL . 1.3 m-20 -61.05 -8.9 3.68 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.374 1.25 . . . . 70.02 114.374 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.0 -40.56 31.23 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 119.086 0.857 . . . . 75.53 113.063 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.24 -35.02 14.03 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.259 0.623 . . . . 74.43 112.344 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 58.8 mt -61.52 -40.71 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.502 0.721 . . . . 62.51 111.841 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.408 HG22 ' O ' ' B' ' 2' ' ' ASP . 28.6 m -61.49 -30.28 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.884 0.874 . . . . 74.3 112.091 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.03 -39.65 94.86 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 122.888 0.118 . . . . 24.11 113.057 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.94 -53.04 10.98 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.55 0.74 . . . . 72.12 112.496 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -70.29 -30.59 67.64 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.215 0.821 . . . . 65.22 113.215 -172.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.35 -25.21 61.45 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.265 0.626 . . . . 64.05 111.924 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.55 -38.71 96.08 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 116.166 -0.47 . . . . 73.4 112.816 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -70.85 -40.03 72.59 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.691 0.796 . . . . 74.34 111.174 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.4 ' HA ' HG11 ' B' ' 32' ' ' VAL . 92.3 t -63.03 -48.41 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.124 0.57 . . . . 34.35 111.332 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.475 ' HA ' HD12 ' B' ' 17' ' ' LEU . 40.4 t90 -65.55 -34.13 77.53 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.245 0.618 . . . . 74.53 110.989 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -62.46 -39.42 93.36 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.76 0.824 . . . . 73.22 110.636 173.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.15 -32.12 72.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.647 0.779 . . . . 63.41 111.683 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' B' ' 14' ' ' TRP . 69.3 mt -74.4 -31.91 62.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.455 0.702 . . . . 63.31 111.426 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.03 -25.97 62.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.008 0.523 . . . . 74.12 110.689 -177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -95.73 -29.41 14.28 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.521 0.728 . . . . 74.1 111.476 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.78 94.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.446 0.698 . . . . 70.12 111.74 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -96.87 179.4 4.97 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.286 0.634 . . . . 72.14 111.755 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.54 37.39 53.03 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.474 -0.33 . . . . 62.32 113.224 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 tt -119.27 151.17 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.064 0.946 . . . . 74.25 110.632 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -61.97 140.52 58.32 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.971 0.508 . . . . 73.23 111.348 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' B' ' 40' ' ' ALA . 64.8 mt -53.81 -45.9 98.65 Favored Pre-proline 0 CA--C 1.576 1.962 0 N-CA-C 113.219 0.822 . . . . 63.43 113.219 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.438 ' HA ' HG22 ' B' ' 36' ' ' VAL . 36.9 Cg_endo -63.13 -29.4 74.32 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.116 1.877 . . . . 71.44 115.072 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.22 -49.16 17.91 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.126 0.965 . . . . 71.1 109.759 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -55.05 -36.26 65.36 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 113.326 -1.761 . . . . 62.45 112.083 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.39 -42.79 87.85 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.007 0.923 . . . . 72.03 112.058 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -72.46 -24.7 61.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.832 -0.622 . . . . 61.51 111.28 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -76.09 -41.99 48.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.416 0.687 . . . . 54.24 111.391 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' B' ' 13' ' ' VAL . 24.1 m -89.77 3.76 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.168 0.587 . . . . 64.24 112.366 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 67.09 22.48 9.89 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.736 1.214 . . . . 71.22 112.424 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.85 171.29 7.68 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.337 0.655 . . . . 74.32 111.561 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.2 t -72.99 158.62 35.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.342 0.657 . . . . 42.21 111.093 170.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' B' ' 26' ' ' PRO . 41.7 t -57.33 -47.48 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.349 0.66 . . . . 52.04 111.306 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -64.0 -40.82 97.23 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.604 -0.726 . . . . 75.04 112.048 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -66.93 -34.08 77.0 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.367 0.667 . . . . 72.51 112.115 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.452 ' O ' HG23 ' B' ' 43' ' ' VAL . 90.3 m -76.6 -39.87 51.21 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.627 0.771 . . . . 61.34 111.07 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.435 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -63.78 -37.92 89.16 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.323 0.582 . . . . 55.34 111.127 174.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.97 -40.96 97.58 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.667 1.187 . . . . 63.45 110.519 172.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.48 -43.37 94.41 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.359 0.663 . . . . 42.2 112.005 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.618 HG11 HG21 ' B' ' 63' ' ' ILE . 84.5 t -61.24 -31.23 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.109 0.564 . . . . 71.33 111.321 176.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.36 -29.2 68.47 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 114.58 0.592 . . . . 74.43 114.58 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.454 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 76.9 t-105 -72.92 -34.34 66.55 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.712 0.805 . . . . 72.02 111.111 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 77.1 mt -71.42 -40.25 70.55 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.142 0.577 . . . . 41.54 110.322 174.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.91 -31.97 73.34 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.351 1.06 . . . . 73.33 111.708 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 16.1 ttp85 -52.64 -51.79 58.52 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.582 0.706 . . . . 61.21 110.945 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.434 ' HB2' ' HG2' ' B' ' 51' ' ' LYS . 35.2 mt-10 -83.89 -8.93 59.07 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.875 -1.057 . . . . 72.21 111.669 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 63.42 29.82 15.49 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.012 1.325 . . . . 73.4 112.115 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' B' ' 49' ' ' GLU . 8.4 mmmm -69.28 -9.59 53.9 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.486 1.515 . . . . 64.35 113.009 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.26 150.05 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 124.127 0.971 . . . . 73.04 111.24 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 94.7 t -93.21 129.2 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.985 0.914 . . . . 51.14 109.455 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.63 120.85 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.87 -1.159 . . . . 73.41 107.87 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' GLU . . . . . 0.436 ' HG2' ' NZ ' ' B' ' 57' ' ' LYS . 8.9 tp10 -137.95 158.62 43.97 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.201 0.601 . . . . 73.04 110.487 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -118.83 114.14 22.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.992 0.517 . . . . 64.44 110.252 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.493 ' HD3' ' HG3' ' B' ' 62' ' ' GLU . 13.9 mptt -101.99 107.49 18.65 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.01 0.924 . . . . 74.34 108.618 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 57.96 31.99 21.35 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.473 1.109 . . . . 63.54 111.847 -175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.51 34.69 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 115.949 -0.569 . . . . 62.41 113.812 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 75.6 mt -75.57 136.89 40.52 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.453 0.701 . . . . 62.41 111.215 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.58 117.7 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-O 121.271 0.557 . . . . 60.44 110.463 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLU . . . . . 0.493 ' HG3' ' HD3' ' B' ' 57' ' ' LYS . 39.1 mm-40 -108.14 142.6 38.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.491 1.516 . . . . 73.2 110.491 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.618 HG21 HG11 ' B' ' 43' ' ' VAL . 2.0 pp -133.5 122.5 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 CA-C-O 121.783 0.801 . . . . 75.02 111.206 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.671 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 55.3 m-85 -115.4 171.28 7.81 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.864 0.866 . . . . 75.25 110.295 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -100.79 153.45 19.46 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.102 0.561 . . . . 75.44 109.914 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.18 -29.18 67.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 122.079 -0.388 . . . . 61.35 111.755 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.59 -8.4 71.67 Favored Glycine 0 CA--C 1.54 1.625 0 CA-C-N 115.989 -0.551 . . . . 75.23 114.063 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -67.88 -40.94 83.47 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.567 0.747 . . . . 74.44 111.065 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -104.23 156.99 17.44 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.749 0.819 . . . . 65.45 109.834 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.467 ' HB2' ' NE2' ' B' ' 78' ' ' HIS . 8.4 p-10 -100.85 -43.98 5.92 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.969 -0.457 . . . . 75.3 111.511 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 69.9 t80 59.31 100.27 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.881 1.273 . . . . 75.32 112.458 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -118.64 166.59 12.56 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.268 0.627 . . . . 73.33 111.661 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -72.8 173.84 8.55 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.159 0.984 . . . . 71.24 110.381 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.55 58.41 3.36 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 114.189 0.436 . . . . 63.23 114.189 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.1 mt -130.74 -169.81 2.23 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.827 1.251 . . . . 74.02 109.739 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -93.22 -24.51 18.17 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.161 0.585 . . . . 75.54 111.692 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -70.9 121.59 18.38 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.303 0.641 . . . . 72.24 111.199 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.467 ' NE2' ' HB2' ' B' ' 70' ' ' ASP . 75.0 t60 66.53 10.79 7.64 Favored 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 124.962 1.305 . . . . 63.11 112.489 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -77.22 88.34 3.67 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.557 0.743 . . . . 72.43 111.361 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -136.53 -172.69 3.22 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.438 0.695 . . . . 70.22 112.646 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -101.95 -39.24 7.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.971 0.908 . . . . 62.34 111.762 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.467 0.651 . . . . 62.45 111.264 -173.963 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 110.272 -0.269 . . . . 72.14 110.272 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.72 100.69 0.41 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.539 0.736 . . . . 72.41 110.404 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -70.98 -19.02 62.59 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.458 0.703 . . . . 74.24 112.148 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -74.93 -11.98 60.25 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.698 0.999 . . . . 73.24 113.698 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -49.1 -52.8 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 118.585 0.63 . . . . 71.1 111.083 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.71 -28.22 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.04 0.536 . . . . 54.51 112.265 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.41 -42.66 33.45 Favored Glycine 0 C--N 1.351 1.371 0 O-C-N 123.302 0.376 . . . . 55.51 113.558 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.7 -44.42 81.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.809 0.844 . . . . 64.23 111.209 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -71.64 -28.89 64.08 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.84 -0.618 . . . . 61.21 111.707 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.402 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . . . -72.09 -29.03 63.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.679 0.392 . . . . 62.23 111.263 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.11 -37.28 92.92 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 115.997 -0.547 . . . . 70.32 112.46 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -75.26 -38.92 60.26 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 122.881 0.472 . . . . 75.21 111.271 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.445 HG13 HD11 ' A' ' 28' ' ' LEU . 53.1 t -64.14 -46.12 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.889 0.875 . . . . 74.35 111.284 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -67.67 -33.32 74.69 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.514 -0.312 . . . . 71.01 110.313 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -63.91 -33.0 74.72 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 122.416 -0.178 . . . . 73.3 111.027 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HB3' HD12 ' A' ' 28' ' ' LEU . . . -67.22 -28.5 68.12 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.82 0.448 . . . . 64.42 111.846 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.4 -45.46 54.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.784 0.834 . . . . 75.13 110.633 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -59.71 -29.86 68.41 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.495 1.118 . . . . 75.51 111.559 173.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -82.06 -52.94 6.52 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.07 0.948 . . . . 72.31 110.26 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.35 96.59 2.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.467 1.107 . . . . 34.42 109.567 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -73.94 154.16 39.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.607 0.763 . . . . 63.42 113.016 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.6 65.37 2.43 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 116.076 -0.511 . . . . 43.12 112.935 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.504 HD11 ' HG3' ' A' ' 27' ' ' GLU . 20.7 tt -134.25 143.76 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 122.871 0.468 . . . . 62.34 111.819 -169.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 49.4 m -67.61 146.08 54.22 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.546 0.738 . . . . 75.43 111.815 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.441 HG21 ' HB2' ' A' ' 40' ' ' ALA . 55.9 mt -53.4 -48.94 90.93 Favored Pre-proline 0 CA--C 1.577 1.994 0 C-N-CA 124.175 0.99 . . . . 75.42 113.581 -176.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.86 -27.59 43.54 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 121.765 1.643 . . . . 75.51 113.553 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' HG3' HD11 ' A' ' 23' ' ' ILE . 10.8 tp10 -73.12 -55.62 6.23 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 112.402 0.519 . . . . 73.22 112.402 -174.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 16' ' ' ALA . 2.2 pt? -66.41 -29.31 69.44 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.078 0.399 . . . . 74.23 111.245 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.37 -42.67 53.67 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.719 0.808 . . . . 73.23 112.168 171.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -63.81 -40.4 96.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.074 0.55 . . . . 74.41 111.596 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -69.04 -38.06 78.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.889 0.876 . . . . 74.51 111.473 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.1 m -94.85 4.66 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.524 0.73 . . . . 74.35 112.201 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 64.81 21.23 12.32 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 124.741 1.216 . . . . 64.04 112.336 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.6 mt -105.91 162.59 13.44 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.38 0.672 . . . . 75.41 111.527 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -69.81 158.48 35.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.433 -0.803 . . . . 73.5 111.249 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -56.91 -42.22 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.241 0.616 . . . . 74.32 110.744 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.16 -50.03 73.46 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.699 0.8 . . . . 75.35 111.497 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -58.15 -38.94 77.54 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.819 0.848 . . . . 71.51 111.856 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 43' ' ' VAL . 97.9 m -70.69 -52.69 19.37 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.661 0.785 . . . . 63.12 111.391 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.17 -32.58 74.2 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 123.797 0.839 . . . . 70.23 112.772 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -72.66 -41.17 65.71 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.171 0.988 . . . . 74.34 109.808 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -66.02 -30.52 71.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.307 0.643 . . . . 62.51 111.586 175.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 39' ' ' THR . 49.5 t -65.8 -43.97 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.339 1.056 . . . . 74.23 110.304 171.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.27 -28.37 72.89 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 116.11 -0.495 . . . . 71.3 112.713 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.424 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 77.2 t-105 -70.28 -44.4 68.47 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.207 0.603 . . . . 75.31 110.829 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 51' ' ' LYS . 88.0 mt -60.9 -31.37 70.86 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.267 0.627 . . . . 72.21 111.735 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.07 -25.0 57.95 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.574 1.15 . . . . 73.11 113.63 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.745 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 23.6 ptt180 -57.12 -35.59 69.65 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 123.07 0.548 . . . . 51.53 111.519 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.745 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 28.9 mt-10 -106.28 8.39 31.83 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.64 1.176 . . . . 75.1 110.93 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 63.39 23.8 13.89 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.037 1.335 . . . . 74.23 112.698 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG3' ' HB2' ' A' ' 49' ' ' GLU . 28.1 mtpp -70.16 -10.96 60.47 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.677 0.991 . . . . 75.32 113.677 -174.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 m -126.59 148.48 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.792 0.837 . . . . 65.21 111.545 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.629 HG23 ' HB2' ' A' ' 64' ' ' TYR . 6.7 m -131.0 112.41 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 C-N-CA 124.516 1.126 . . . . 74.42 109.84 170.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.606 HG13 HG22 ' A' ' 63' ' ' ILE . 3.0 mp -92.07 134.99 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.61 1.164 . . . . 73.04 110.745 -171.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -139.04 144.76 38.96 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.353 0.661 . . . . 73.23 110.486 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -116.06 112.61 22.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.504 0.669 . . . . 71.52 110.528 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -105.4 128.88 53.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.143 0.977 . . . . 64.41 109.447 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 58.64 31.76 21.45 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 124.635 1.174 . . . . 62.43 113.025 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.91 -9.86 54.81 Favored Glycine 0 CA--C 1.541 1.711 0 N-CA-C 114.469 0.548 . . . . 61.55 114.469 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.71 135.07 36.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.323 1.049 . . . . 74.05 109.342 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' B' ' 37' ' ' GLU . 19.5 mt -104.09 125.02 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 CA-C-O 121.544 0.688 . . . . 73.44 112.345 -170.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 8.8 mp0 -117.96 153.53 33.46 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.806 1.642 . . . . 45.34 109.725 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.606 HG22 HG13 ' A' ' 54' ' ' ILE . 48.1 pt -113.89 142.7 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.304 0.573 . . . . 63.35 110.69 171.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.629 ' HB2' HG23 ' A' ' 53' ' ' VAL . 80.9 m-85 -125.07 167.39 14.84 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.225 1.01 . . . . 52.13 110.135 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -86.87 148.9 25.17 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.539 0.736 . . . . 65.34 112.011 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -19.14 63.74 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 115.766 -0.652 . . . . 74.31 110.093 166.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.58 -15.55 33.28 Favored Glycine 0 C--N 1.36 1.867 0 N-CA-C 115.792 1.077 . . . . 52.05 115.792 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -88.1 2.21 52.52 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 117.402 0.601 . . . . 63.43 111.627 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.42 ' HE2' HG21 ' A' ' 53' ' ' VAL . 75.8 m-85 -134.6 -70.6 0.5 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.661 1.184 . . . . 75.22 109.949 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -127.67 93.03 3.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.342 1.057 . . . . 73.14 109.343 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -72.36 132.74 44.37 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.173 0.511 . . . . 71.31 112.146 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.6 t -152.35 120.47 6.25 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.125 0.97 . . . . 55.02 109.285 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -77.25 -83.83 0.07 Allowed 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 122.807 0.443 . . . . 72.33 110.222 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.76 -22.16 9.76 Favored Glycine 0 CA--C 1.542 1.765 0 N-CA-C 115.225 0.85 . . . . 73.01 115.225 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.66 123.35 23.89 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.691 0.796 . . . . 65.32 112.14 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -85.82 150.35 24.61 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.69 0.396 . . . . 71.42 110.097 166.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -83.1 71.79 10.14 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.268 0.556 . . . . 71.3 109.693 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -70.78 129.54 39.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.362 0.665 . . . . 64.21 111.443 -174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -142.03 -170.28 3.11 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.544 1.137 . . . . 63.24 111.191 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -63.6 -37.35 86.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.521 0.728 . . . . 63.23 111.411 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -126.37 98.6 5.5 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.267 1.027 . . . . 75.22 109.21 172.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 N--CA 1.484 1.258 0 C-N-CA 124.487 1.115 . . . . 71.52 112.105 179.074 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 CA--C 1.55 0.945 0 CA-C-O 120.842 0.353 . . . . 65.31 110.963 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 54' ' ' ILE . 8.2 p-10 -58.43 -37.89 76.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.386 1.074 . . . . 75.42 112.935 -173.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -18.77 65.57 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.822 0.849 . . . . 75.3 111.738 -172.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.26 -44.54 10.76 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.643 1.177 . . . . 62.3 110.119 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -56.18 -48.35 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 123.729 0.812 . . . . 64.45 111.612 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.444 HG12 HD11 ' B' ' 41' ' ' LEU . 32.6 m -63.38 -30.45 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.338 1.055 . . . . 74.13 112.297 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.43 -44.13 85.09 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.181 0.301 . . . . 72.13 112.78 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.66 69.23 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.513 0.725 . . . . 61.44 111.832 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -66.1 -48.65 70.24 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.733 1.213 . . . . 74.54 110.927 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 -20.93 63.8 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.365 0.666 . . . . 52.13 112.112 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.29 -43.74 94.72 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 123.172 0.295 . . . . 64.21 112.986 174.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -68.62 -45.93 70.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.706 0.802 . . . . 72.53 110.912 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.46 ' HA ' HG11 ' B' ' 32' ' ' VAL . 96.6 t -60.01 -49.65 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.808 0.843 . . . . 75.13 111.708 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -60.87 -44.35 97.18 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.581 0.753 . . . . 71.25 111.738 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -62.29 -43.68 98.27 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.025 0.53 . . . . 53.32 111.883 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.04 68.88 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.367 0.667 . . . . 73.24 111.407 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -72.42 -32.68 66.54 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.744 1.218 . . . . 73.55 110.578 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -81.77 -18.97 42.31 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.201 0.6 . . . . 54.13 110.6 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -67.54 -33.77 75.72 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.545 0.738 . . . . 64.2 110.227 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.12 108.59 1.12 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.256 1.022 . . . . 64.14 109.564 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -93.58 173.6 7.61 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 112.318 0.488 . . . . 73.54 112.318 -175.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.26 44.68 8.63 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.969 -0.56 . . . . 70.32 111.943 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 tt -134.33 137.71 51.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.844 0.857 . . . . 64.13 110.116 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 70.3 m -78.13 160.17 28.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.438 0.695 . . . . 72.1 112.732 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.484 HG21 ' HB2' ' B' ' 40' ' ' ALA . 81.2 mt -49.32 -53.56 38.58 Favored Pre-proline 0 CA--C 1.572 1.804 0 C-N-CA 125.817 1.647 . . . . 65.52 114.037 -177.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.68 -23.75 30.83 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 121.556 1.504 . . . . 71.53 113.387 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -76.5 -55.76 5.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.213 0.605 . . . . 73.12 110.596 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.3 -29.7 70.62 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.507 0.723 . . . . 64.34 111.601 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' B' ' 39' ' ' THR . . . -52.9 -37.75 61.0 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.803 0.841 . . . . 74.32 112.812 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -71.75 -34.79 69.78 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.25 0.833 . . . . 74.04 113.25 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -76.92 -31.43 56.68 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.548 0.613 . . . . 53.15 111.646 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' B' ' 13' ' ' VAL . 33.3 m -88.03 -4.72 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.555 0.342 . . . . 73.22 111.555 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t30 68.67 17.65 8.88 Favored 'General case' 0 CA--C 1.57 1.72 0 C-N-CA 124.779 1.232 . . . . 60.41 112.119 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 70.3 mt -102.8 163.75 12.03 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.548 0.739 . . . . 74.13 111.388 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 62.8 m -67.7 158.54 32.06 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.448 0.699 . . . . 63.44 111.785 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.424 HG13 HG22 ' B' ' 25' ' ' ILE . 61.8 t -64.43 -43.48 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.099 0.559 . . . . 74.43 111.946 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.678 ' HB2' HD12 ' A' ' 61' ' ' ILE . 45.8 mt-10 -62.97 -31.98 73.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.768 0.427 . . . . 72.12 111.946 175.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 42.3 m -63.63 -45.27 91.03 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.46 0.704 . . . . 72.34 111.114 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.501 HG21 ' HA ' ' B' ' 29' ' ' ALA . 17.0 p -76.46 -41.02 48.79 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.178 0.807 . . . . 75.24 113.178 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -56.0 -46.51 78.7 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 123.863 0.865 . . . . 41.43 111.974 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.444 HD11 HG12 ' B' ' 6' ' ' VAL . 0.9 OUTLIER -67.9 -40.32 83.5 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 114.256 -1.338 . . . . 74.31 111.112 177.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.27 84.77 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.219 0.608 . . . . 73.5 112.102 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.509 HG13 HG21 ' B' ' 52' ' ' VAL . 55.3 t -65.87 -34.47 70.53 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.071 0.948 . . . . 64.32 110.601 174.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -65.71 -37.04 93.09 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 116.545 -0.298 . . . . 70.21 112.925 171.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.511 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 77.2 t-105 -67.18 -30.45 70.41 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.668 0.787 . . . . 75.31 111.474 175.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.5 -39.37 67.7 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.075 0.55 . . . . 73.51 110.936 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.9 -25.85 67.81 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.446 1.099 . . . . 74.43 113.397 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.619 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 16.5 ptt180 -58.93 -36.45 74.77 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.017 0.437 . . . . 61.22 111.015 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.619 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 43.8 mt-10 -104.75 3.18 31.02 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.686 1.194 . . . . 65.05 111.033 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.1 t30 58.88 35.86 24.38 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 125.396 1.478 . . . . 70.11 111.584 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -70.59 -17.11 62.91 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.479 -0.782 . . . . 63.45 111.044 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.509 HG21 HG13 ' B' ' 43' ' ' VAL . 24.9 m -131.68 153.29 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.283 1.033 . . . . 74.22 109.304 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.579 HG23 ' HB2' ' B' ' 64' ' ' TYR . 7.2 m -115.51 116.63 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.537 0.735 . . . . 71.03 110.15 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 48.5 mm -81.3 104.96 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.849 0.859 . . . . 63.33 110.217 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -119.45 108.43 14.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.351 0.66 . . . . 44.33 109.807 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.511 ' HB3' HG13 ' B' ' 61' ' ' ILE . 29.0 ptt180 -92.03 106.34 18.38 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.955 0.883 . . . . 74.53 110.484 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -103.63 127.83 51.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.988 1.315 . . . . 71.4 109.607 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 57.74 29.66 17.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.711 1.204 . . . . 72.05 111.505 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.2 -27.65 6.71 Favored Glycine 0 CA--C 1.546 1.976 0 CA-C-N 115.231 -0.895 . . . . 33.52 113.858 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.87 123.43 27.75 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.874 0.87 . . . . 61.41 110.795 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.511 HG13 ' HB3' ' B' ' 56' ' ' ARG . 2.8 mp -74.57 123.21 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 122.739 0.416 . . . . 73.31 110.128 -174.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -119.53 138.33 53.24 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.204 1.002 . . . . 73.55 109.752 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.432 HD11 HG13 ' B' ' 25' ' ' ILE . 2.2 mp -107.09 112.09 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.075 0.55 . . . . 75.11 110.031 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.579 ' HB2' HG23 ' B' ' 53' ' ' VAL . 85.9 m-85 -107.11 159.29 16.42 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.321 1.048 . . . . 63.52 110.52 174.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -82.51 171.55 13.99 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.957 0.725 . . . . 71.41 112.957 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -56.83 -30.99 64.29 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.172 0.989 . . . . 74.33 112.694 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.53 -8.01 36.85 Favored Glycine 0 CA--C 1.545 1.965 0 N-CA-C 114.435 0.534 . . . . 72.02 114.435 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -60.47 -32.88 71.83 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.081 0.952 . . . . 75.43 111.456 171.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -117.23 153.41 32.93 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.569 0.748 . . . . 64.34 110.25 171.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 26.7 t70 55.31 42.62 30.1 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.934 0.894 . . . . 72.25 110.932 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -61.92 102.3 0.27 Allowed 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.224 -0.898 . . . . 74.24 111.058 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 57.6 m -73.48 172.06 12.0 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.823 0.849 . . . . 62.42 111.919 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -69.52 -61.66 1.69 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.845 0.458 . . . . 75.33 111.423 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.88 76.48 0.45 Allowed Glycine 0 C--N 1.351 1.406 0 CA-C-N 116.259 -0.428 . . . . 74.01 113.022 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.64 -20.81 63.59 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.081 0.952 . . . . 63.04 112.346 -174.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.33 -76.32 0.08 Allowed 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 124.323 1.049 . . . . 74.12 112.091 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 33.0 p80 37.25 63.7 0.7 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 125.954 1.702 . . . . 71.53 115.391 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -106.95 138.69 42.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.672 -0.643 . . . . 74.13 110.942 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -120.55 104.4 9.92 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.453 0.701 . . . . 62.12 111.241 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -75.62 -15.67 60.31 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.49 0.716 . . . . 71.23 110.71 167.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -61.6 96.14 0.06 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.409 1.084 . . . . 74.42 110.615 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 17.2 p80 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.865 0.841 . . . . 62.14 111.447 -178.621 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 111.72 0.267 . . . . 72.03 111.72 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -48.37 -40.9 27.14 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.008 1.323 . . . . 73.15 114.381 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.41 -34.99 73.15 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.979 0.911 . . . . 54.41 112.36 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -77.73 -37.28 49.61 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.295 0.638 . . . . 74.2 111.067 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.8 mt -62.86 -47.53 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.613 0.765 . . . . 75.42 111.627 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.42 -30.42 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.099 0.56 . . . . 73.12 111.264 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.93 -51.25 47.22 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.825 0.703 . . . . 63.02 112.269 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.42 81.83 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.844 0.858 . . . . 64.45 112.284 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -65.82 -29.47 69.95 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.507 0.723 . . . . 73.24 112.182 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.12 -44.88 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.033 0.533 . . . . 52.44 111.367 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.17 94.65 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.48 -0.648 . . . . 64.13 111.48 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -61.76 -50.01 74.11 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.328 1.051 . . . . 64.4 112.583 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.673 ' HA ' HG11 ' A' ' 32' ' ' VAL . 32.9 m -67.55 -29.54 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 120.656 0.265 . . . . 73.21 111.711 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.607 ' HA ' HD12 ' A' ' 17' ' ' LEU . 24.4 t90 -68.6 -32.83 73.0 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.286 0.634 . . . . 71.45 111.546 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -58.68 -36.84 74.84 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 122.813 0.445 . . . . 71.13 111.666 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.91 69.49 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.218 0.607 . . . . 75.35 112.162 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 14' ' ' TRP . 81.2 mt -66.54 -22.58 66.16 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.727 0.811 . . . . 72.25 112.194 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -64.58 -28.08 69.39 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.417 0.687 . . . . 71.13 111.463 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -77.01 -57.4 3.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.24 0.616 . . . . 75.05 110.521 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.34 107.6 3.27 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.481 0.712 . . . . 64.51 110.765 -174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 6.2 p-10 -95.72 164.57 12.7 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.509 0.724 . . . . 75.31 110.842 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.15 26.67 51.93 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 121.475 0.486 . . . . 73.21 112.128 -166.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 tt -96.63 153.71 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 124.46 1.104 . . . . 74.31 110.139 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -79.17 156.4 28.24 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.902 -0.499 . . . . 62.11 111.458 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.487 HG21 ' HB2' ' A' ' 40' ' ' ALA . 80.2 mt -56.32 -50.36 88.04 Favored Pre-proline 0 CA--C 1.575 1.908 0 C-N-CA 124.468 1.107 . . . . 64.43 113.908 -173.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.25 -24.07 38.18 Favored 'Trans proline' 0 C--N 1.394 2.93 0 CA-C-N 121.399 1.535 . . . . 73.21 114.049 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -76.5 -45.1 32.45 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.43 1.11 . . . . 71.53 109.683 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.442 HD22 HD11 ' A' ' 63' ' ' ILE . 63.1 tp -59.34 -40.6 86.91 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 113.129 -1.85 . . . . 74.4 111.09 172.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.15 81.82 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.325 1.05 . . . . 72.11 111.917 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -65.09 -40.87 95.2 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.626 0.77 . . . . 75.25 111.446 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -63.9 -40.82 97.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.153 0.581 . . . . 74.2 111.67 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.6 m -95.83 -1.93 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 112.966 0.728 . . . . 71.41 112.966 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.0 t30 68.02 13.64 9.17 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 124.483 1.113 . . . . 70.0 112.506 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -92.74 166.25 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.463 -0.773 . . . . 64.5 111.062 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.0 t -64.43 154.01 36.97 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.102 0.561 . . . . 65.44 111.701 171.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.38 -48.01 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.808 0.843 . . . . 71.4 110.615 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -62.6 -42.37 99.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.327 1.051 . . . . 73.34 111.676 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.494 ' HA ' HH21 ' B' ' 56' ' ' ARG . 67.7 m -65.48 -30.62 71.42 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.596 0.758 . . . . 31.44 112.256 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 43' ' ' VAL . 63.2 m -82.08 -43.01 18.42 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.784 0.834 . . . . 73.04 111.512 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.487 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -58.69 -50.81 72.52 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.001 0.921 . . . . 75.12 112.142 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -66.28 -32.48 73.92 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 114.087 -1.415 . . . . 71.35 110.831 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.35 -38.7 71.61 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.26 0.624 . . . . 73.52 111.961 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.569 HG11 HG21 ' A' ' 63' ' ' ILE . 69.3 t -64.89 -31.33 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.18 0.592 . . . . 61.11 110.835 175.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -58.79 -33.02 71.25 Favored Glycine 0 CA--C 1.544 1.858 0 CA-C-N 116.271 -0.422 . . . . 33.35 113.322 171.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -71.95 -30.63 65.5 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.543 0.737 . . . . 74.12 111.172 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.24 -38.79 71.94 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.675 0.39 . . . . 74.32 111.429 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.46 -34.95 78.88 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.562 0.745 . . . . 52.42 110.825 172.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.645 ' HG2' ' HB3' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -63.79 -43.97 94.75 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.013 1.325 . . . . 74.32 111.267 172.632 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -85.48 -1.14 56.74 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.606 0.762 . . . . 74.34 112.69 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 64.96 22.61 12.48 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.776 1.23 . . . . 75.11 112.729 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 61.5 mttp -77.49 -20.87 53.65 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.766 0.827 . . . . 72.01 112.454 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.92 154.74 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.48 0.657 . . . . 74.23 112.172 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 47.7 t -105.23 104.31 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.348 1.059 . . . . 71.13 109.065 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 mm -71.59 122.49 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 109.454 -0.572 . . . . 50.33 109.454 175.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.28 133.42 38.87 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.965 0.506 . . . . 74.2 110.385 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -116.94 141.91 47.63 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.402 0.681 . . . . 74.54 111.115 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 114.18 4.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.18 0.992 . . . . 74.45 109.892 -176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 54.07 30.81 12.58 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.4 1.08 . . . . 72.54 112.561 -173.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.26 -18.48 54.14 Favored Glycine 0 CA--C 1.545 1.968 0 CA-C-N 115.785 -0.643 . . . . 35.35 114.429 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -78.94 136.67 37.32 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.748 0.819 . . . . 63.31 111.275 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.1 mt -101.99 124.31 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 123.404 0.682 . . . . 73.34 111.081 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -123.48 124.92 43.93 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.895 1.278 . . . . 62.24 108.815 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.569 HG21 HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -106.09 112.0 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-O 122.152 0.977 . . . . 55.15 110.051 177.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 95.0 m-85 -90.15 175.65 7.07 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.083 0.953 . . . . 72.41 111.202 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.54 150.97 21.54 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.972 0.509 . . . . 72.24 109.911 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.62 168.37 11.84 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 120.912 0.387 . . . . 75.34 110.644 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.89 12.93 8.14 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 123.42 0.533 . . . . 74.03 112.867 -173.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -136.79 -15.31 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.975 1.102 . . . . 75.52 113.975 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -83.49 115.27 22.0 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.721 0.691 . . . . 72.23 111.061 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -116.46 157.22 25.51 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.737 0.815 . . . . 73.22 111.172 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -152.7 12.16 0.51 Allowed 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.153 0.981 . . . . 64.53 109.906 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.3 t -92.91 152.69 19.23 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.817 0.847 . . . . 74.53 111.537 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -73.22 96.78 2.31 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.13 0.572 . . . . 64.51 110.4 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.16 81.61 1.74 Allowed Glycine 0 CA--C 1.534 1.272 0 CA-C-N 116.355 -0.384 . . . . 71.22 113.6 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -123.83 128.42 49.49 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.138 0.575 . . . . 70.32 110.27 170.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.15 -30.22 69.29 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.251 1.021 . . . . 73.52 112.958 -175.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -87.63 179.84 6.45 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.424 0.69 . . . . 72.24 111.996 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -59.85 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.087 0.955 . . . . 72.13 113.528 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -75.72 88.36 2.79 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.583 -0.895 . . . . 74.22 108.583 164.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -60.99 95.54 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.53 1.132 . . . . 65.4 112.685 -165.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 74.78 -19.84 0.36 Allowed 'General case' 0 CA--C 1.571 1.769 0 C-N-CA 125.497 1.519 . . . . 72.13 114.006 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 . . . . . 0 N--CA 1.488 1.444 0 C-N-CA 124.603 1.161 . . . . 64.33 111.625 -178.379 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 CA--C 1.551 0.999 0 CA-C-O 120.982 0.42 . . . . 62.1 111.477 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -124.0 151.37 43.78 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.3 1.04 . . . . 62.54 110.657 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.505 ' O ' HG22 ' B' ' 6' ' ' VAL . 40.5 ttmt -79.51 -33.37 42.12 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.527 0.331 . . . . 75.01 110.483 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -61.26 -13.12 16.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.793 1.034 . . . . 73.31 113.793 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 70.3 mt -55.69 -45.93 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.616 0.766 . . . . 75.41 111.47 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.505 HG22 ' O ' ' B' ' 3' ' ' LYS . 16.3 m -66.46 -25.76 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 122.173 0.189 . . . . 64.42 111.064 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.28 -38.75 91.84 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.583 0.552 . . . . 63.13 113.259 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 -40.4 95.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.256 0.622 . . . . 71.42 110.939 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -70.53 -30.08 66.74 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.4 -0.818 . . . . 74.12 111.613 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -76.68 -36.35 57.33 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.603 0.761 . . . . 63.13 111.521 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.23 -30.97 79.3 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 115.809 -0.632 . . . . 63.53 112.55 172.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' B' ' 32' ' ' VAL . 4.3 ttmp? -72.59 -52.49 15.28 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.915 0.886 . . . . 73.01 112.006 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' B' ' 10' ' ' ALA . 33.0 m -68.53 -36.47 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 112.489 0.551 . . . . 74.14 112.489 -174.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.578 ' HA ' HD12 ' B' ' 17' ' ' LEU . 31.2 t90 -74.16 -32.55 63.17 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 111.903 0.334 . . . . 72.24 111.903 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -64.55 -33.49 76.02 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.001 0.429 . . . . 72.24 110.537 173.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.22 -32.45 71.72 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.928 0.891 . . . . 73.25 112.037 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' B' ' 14' ' ' TRP . 70.6 mt -70.99 -46.33 62.49 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.995 0.918 . . . . 71.41 111.097 173.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -63.11 -25.16 68.23 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.031 0.932 . . . . 74.43 110.609 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -76.08 -52.81 9.37 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.53 -0.759 . . . . 74.11 110.45 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.56 99.41 2.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.719 0.807 . . . . 41.03 110.657 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -98.35 -178.78 4.14 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.755 0.822 . . . . 74.4 111.335 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.84 37.39 44.71 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.743 -0.543 . . . . 74.22 111.743 -171.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 tt -122.61 139.85 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.891 0.877 . . . . 74.32 111.352 -168.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 20.4 m -64.09 151.24 43.66 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.163 0.985 . . . . 72.04 111.582 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.583 HG12 HD11 ' B' ' 63' ' ' ILE . 54.3 mt -53.63 -49.34 89.38 Favored Pre-proline 0 CA--C 1.579 2.071 0 N-CA-C 112.806 0.669 . . . . 72.23 112.806 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.64 -25.71 24.23 Favored 'Trans proline' 0 C--N 1.399 3.201 0 C-N-CA 121.926 1.75 . . . . 73.15 114.539 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.57 -41.88 37.29 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.61 1.195 . . . . 72.4 109.703 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.3 tp -61.26 -40.1 92.82 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.113 -1.858 . . . . 70.04 110.72 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.72 73.46 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.829 0.852 . . . . 73.2 111.962 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 64.2 mtp85 -65.06 -50.02 67.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.659 0.784 . . . . 71.32 111.916 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -73.84 -24.16 59.73 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 112.127 0.417 . . . . 61.22 112.127 -176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' B' ' 13' ' ' VAL . 13.9 m -94.85 -3.39 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 112.039 0.385 . . . . 72.14 112.039 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 65.05 21.64 12.28 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.233 1.013 . . . . 62.14 112.797 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.6 mt -108.56 169.26 8.77 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.81 0.844 . . . . 72.23 110.87 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 51.7 m -74.85 163.16 27.96 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.652 0.381 . . . . 54.21 111.336 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.3 -51.49 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.56 0.744 . . . . 65.34 111.86 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.63 -38.92 92.14 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.196 0.598 . . . . 73.41 111.989 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 29.4 t -64.43 -39.1 93.19 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.429 0.692 . . . . 41.43 111.525 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.439 ' O ' HG23 ' B' ' 43' ' ' VAL . 86.6 m -71.03 -48.5 52.61 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.768 0.827 . . . . 50.15 110.973 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.62 -35.34 72.33 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.789 0.836 . . . . 43.42 112.378 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.11 -48.51 70.65 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.183 0.993 . . . . 74.35 109.81 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.38 -30.36 70.49 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.259 -0.882 . . . . 72.13 111.681 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 39' ' ' THR . 95.2 t -72.87 -31.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 123.006 0.523 . . . . 61.44 110.615 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -66.11 -27.96 73.31 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 116.26 -0.427 . . . . 63.53 112.8 172.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -75.46 -25.75 57.68 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.976 0.51 . . . . 74.4 111.48 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.509 HD11 HG23 ' B' ' 13' ' ' VAL . 96.6 mt -71.6 -27.08 62.88 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.081 0.552 . . . . 34.51 111.686 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.3 -32.78 62.72 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.317 1.229 . . . . 63.03 114.317 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.645 ' HB3' ' HG2' ' A' ' 48' ' ' ARG . 13.5 ptm180 -72.27 -30.15 64.56 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 119.069 0.849 . . . . 72.01 111.512 171.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.76 -19.27 52.64 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.299 0.64 . . . . 74.04 110.758 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 60.42 21.83 11.44 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.744 1.618 . . . . 70.01 112.749 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.89 5.55 45.81 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 112.878 0.696 . . . . 74.44 112.878 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.81 146.17 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.344 0.657 . . . . 74.14 112.576 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.633 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 66.6 t -118.78 109.95 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 124.49 1.116 . . . . 74.32 109.5 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 39.6 mm -91.92 121.58 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.714 0.805 . . . . 63.23 111.401 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -117.16 141.53 48.15 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.506 -0.746 . . . . 71.21 111.787 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.58 ' HG2' HG12 ' B' ' 61' ' ' ILE . 84.0 mtt85 -113.51 111.6 22.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.077 0.951 . . . . 74.42 110.203 169.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' B' ' 57' ' ' LYS . 0.3 OUTLIER -144.6 126.94 15.82 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.315 1.046 . . . . 74.55 109.304 -178.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 60.74 28.68 18.4 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 125.027 1.331 . . . . 62.12 111.63 -171.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.19 -0.89 61.93 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-N 116.287 -0.415 . . . . 72.4 113.79 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.72 131.16 43.69 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.143 0.977 . . . . 70.34 110.936 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.58 HG12 ' HG2' ' B' ' 56' ' ' ARG . 43.8 mt -97.12 122.29 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.129 0.572 . . . . 61.51 110.339 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -125.74 139.98 53.08 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.35 0.66 . . . . 70.04 110.014 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.583 HD11 HG12 ' B' ' 25' ' ' ILE . 2.9 mp -100.54 126.97 54.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.666 0.786 . . . . 74.34 109.517 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.633 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 7.8 m-85 -111.15 169.59 8.68 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.913 1.285 . . . . 65.42 109.86 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -90.2 155.65 18.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.797 0.439 . . . . 73.14 111.405 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.24 103.66 0.25 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.684 0.794 . . . . 74.35 110.428 173.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.27 -18.73 2.67 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 115.821 -0.627 . . . . 74.44 111.745 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -109.35 72.91 0.82 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.116 0.967 . . . . 64.21 109.553 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -160.37 -32.9 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.066 0.546 . . . . 73.14 112.439 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -48.73 -40.29 28.01 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.843 1.257 . . . . 74.11 113.653 -174.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.442 ' HE2' HD11 ' B' ' 75' ' ' LEU . 39.4 t80 -161.49 127.99 3.86 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.592 0.757 . . . . 73.3 109.937 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 88.7 p -73.96 129.02 37.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.199 0.6 . . . . 71.43 110.451 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -81.4 102.63 10.61 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.802 0.441 . . . . 74.42 110.681 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.92 46.19 0.65 Allowed Glycine 0 N--CA 1.469 0.896 0 N-CA-C 110.912 -0.875 . . . . 52.5 110.912 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.442 HD11 ' HE2' ' B' ' 71' ' ' PHE . 6.6 mp -84.15 120.76 26.56 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.727 0.811 . . . . 52.32 110.889 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.11 140.83 50.76 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.543 0.337 . . . . 63.41 110.354 174.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -127.27 141.24 51.77 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.952 0.901 . . . . 62.35 109.465 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -53.19 119.42 4.72 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.212 0.605 . . . . 74.22 111.761 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -68.96 101.47 1.39 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.799 0.84 . . . . 52.23 111.361 -173.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -75.27 143.92 42.78 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.986 0.515 . . . . 52.33 110.647 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -110.21 139.17 45.65 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.885 0.474 . . . . 72.21 111.019 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 15.9 t60 . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 121.752 0.787 . . . . 65.32 109.726 -179.115 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 119.255 -0.402 . . . . 74.43 111.062 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 46.27 104.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 125.585 1.554 . . . . 71.13 114.301 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' O ' HG22 ' A' ' 6' ' ' VAL . 21.4 tptm -63.42 -16.41 60.48 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 123.727 0.811 . . . . 44.22 112.401 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -72.12 -24.2 61.43 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.74 0.644 . . . . 74.12 112.74 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -61.17 -47.64 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.444 0.698 . . . . 62.2 111.521 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 3' ' ' LYS . 22.8 m -61.27 -28.06 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 122.519 0.328 . . . . 73.15 111.39 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' HA2' ' CD1' ' A' ' 45' ' ' TRP . . . -69.25 -49.68 37.97 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.544 0.528 . . . . 74.42 113.501 173.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.18 93.65 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.668 0.787 . . . . 74.13 112.382 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -75.03 -28.9 60.63 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.245 0.618 . . . . 63.13 112.339 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.99 82.6 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 112.464 0.542 . . . . 71.51 112.464 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.03 -34.54 81.93 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 116.413 -0.358 . . . . 72.02 113.127 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -67.17 -45.87 75.71 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.78 0.832 . . . . 43.24 110.644 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.594 ' HA ' HG11 ' A' ' 32' ' ' VAL . 63.8 t -60.97 -40.8 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 123.898 0.879 . . . . 64.55 111.212 175.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -64.67 -35.64 81.7 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.97 -0.559 . . . . 74.54 111.065 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.443 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 80.6 t60 -62.9 -44.81 95.09 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.78 0.432 . . . . 61.23 111.249 176.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.657 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -67.46 -32.51 73.41 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.525 0.679 . . . . 33.34 111.284 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.515 HD11 ' HA ' ' A' ' 65' ' ' ASN . 2.8 tm? -73.48 -29.92 62.82 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.925 1.29 . . . . 74.51 110.874 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -75.07 -47.15 30.25 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.96 0.904 . . . . 70.13 111.59 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 22.9 mm-40 -61.04 -33.19 72.9 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.13 0.572 . . . . 71.51 111.683 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.08 112.43 0.99 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.243 1.017 . . . . 74.45 109.54 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.8 178.4 5.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.25 0.62 . . . . 72.25 112.256 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.57 39.61 86.58 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 110.534 -1.026 . . . . 45.51 110.534 -167.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 tp -114.13 114.41 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 124.393 1.077 . . . . 75.01 110.044 -169.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -58.72 144.98 41.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.264 0.625 . . . . 62.25 112.594 -170.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.582 HG21 ' HB2' ' A' ' 40' ' ' ALA . 57.6 mt -55.38 -46.19 99.74 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 113.847 1.054 . . . . 63.41 113.847 -170.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HA ' HG22 ' A' ' 36' ' ' VAL . 32.6 Cg_endo -63.09 -25.05 73.25 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 121.819 1.679 . . . . 65.33 114.177 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -80.16 -55.15 5.13 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.994 0.739 . . . . 64.44 112.994 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -66.61 -26.03 66.89 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.45 0.568 . . . . 65.34 111.37 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.39 -37.31 16.57 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.745 0.818 . . . . 73.42 112.806 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -74.28 -35.02 63.73 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.305 0.642 . . . . 74.21 111.955 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.657 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 51.9 mtmt -67.06 -31.19 71.53 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 122.807 0.443 . . . . 62.42 111.513 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 13' ' ' VAL . 27.3 m -97.7 -9.47 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.701 0.801 . . . . 25.32 112.36 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.4 t30 64.7 28.11 13.08 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.347 1.459 . . . . 73.42 112.167 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.81 164.91 11.57 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.878 0.871 . . . . 61.0 111.198 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.7 m -65.21 153.11 41.94 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.139 0.576 . . . . 42.13 111.156 172.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 26' ' ' PRO . 64.6 t -53.97 -51.07 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.49 0.716 . . . . 24.11 111.104 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.591 ' HB2' HG13 ' B' ' 61' ' ' ILE . 36.3 mt-10 -60.32 -41.37 93.35 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.497 1.119 . . . . 54.04 112.557 176.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.8 m -62.28 -37.58 86.06 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 123.366 0.666 . . . . 73.41 111.798 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 43' ' ' VAL . 88.2 m -71.78 -46.51 58.08 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.559 0.743 . . . . 53.44 111.182 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.582 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.72 -37.81 83.0 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 123.615 0.766 . . . . 70.4 112.493 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.69 -41.91 71.36 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.276 1.031 . . . . 71.11 110.554 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -31.85 73.18 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.158 0.583 . . . . 63.11 111.686 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 39' ' ' THR . 41.4 t -59.23 -35.69 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.899 0.88 . . . . 74.1 111.351 170.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -63.75 -32.28 83.64 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 114.049 0.38 . . . . 70.02 114.049 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.478 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 69.9 t-105 -73.89 -26.98 60.83 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.127 0.571 . . . . 75.02 111.361 175.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.98 -39.36 63.73 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 122.79 0.436 . . . . 70.43 111.173 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.87 69.81 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.261 1.024 . . . . 74.22 113.376 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 45' ' ' TRP . 5.7 ppt_? -71.45 -12.69 61.53 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.021 0.378 . . . . 63.35 112.021 174.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -110.35 -8.47 14.7 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.321 1.048 . . . . 73.33 111.915 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 63.51 28.73 15.35 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.625 1.17 . . . . 74.1 112.834 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -69.37 -13.9 62.62 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.375 0.67 . . . . 73.31 112.046 171.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.711 ' HB ' HD11 ' A' ' 63' ' ' ILE . 31.0 m -133.92 155.47 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.924 0.89 . . . . 72.24 110.855 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.557 HG11 ' HB3' ' A' ' 69' ' ' PHE . 31.2 m -127.37 143.19 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.179 0.991 . . . . 74.2 109.499 173.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.0 mt -120.72 134.57 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.186 0.595 . . . . 64.31 110.717 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -120.63 127.13 51.79 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.757 0.823 . . . . 62.14 111.409 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.508 ' HG2' HG12 ' A' ' 61' ' ' ILE . 84.8 mtt180 -95.45 102.62 14.43 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.209 0.528 . . . . 73.3 110.181 170.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -108.56 123.19 48.53 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.789 0.836 . . . . 71.55 109.99 178.006 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 55.98 29.38 14.22 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.792 1.237 . . . . 70.21 112.082 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.95 -25.92 9.24 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-N 116.154 -0.475 . . . . 74.34 114.116 -174.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.77 141.04 39.48 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.617 0.767 . . . . 75.13 111.195 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.508 HG12 ' HG2' ' A' ' 56' ' ' ARG . 32.2 mt -93.37 133.96 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.337 0.655 . . . . 65.03 111.791 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -132.17 139.74 48.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.999 0.92 . . . . 64.11 110.286 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.711 HD11 ' HB ' ' A' ' 52' ' ' VAL . 6.8 tp -102.49 126.28 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.35 0 CA-C-O 121.772 0.796 . . . . 63.1 111.487 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.454 ' HB2' HG23 ' A' ' 53' ' ' VAL . 89.6 m-85 -118.11 169.28 9.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.186 1.394 . . . . 74.13 111.45 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.515 ' HA ' HD11 ' A' ' 17' ' ' LEU . 28.6 t-20 -81.38 145.97 30.55 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.663 0.785 . . . . 72.42 110.671 175.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.422 ' HA ' HG13 ' A' ' 53' ' ' VAL . 10.9 pt-20 -40.63 -32.58 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.521 1.675 . . . . 62.23 115.521 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.57 22.1 6.79 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 114.788 0.675 . . . . 21.11 114.788 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -126.59 27.39 6.12 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.309 1.044 . . . . 73.2 110.906 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.557 ' HB3' HG11 ' A' ' 53' ' ' VAL . 31.9 p90 -79.45 152.61 30.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.11 0.564 . . . . 72.11 111.034 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -77.19 144.05 38.61 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 109.215 -0.661 . . . . 75.3 109.215 171.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -73.82 4.41 5.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.749 0.648 . . . . 74.43 112.749 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.3 t -73.55 79.57 1.46 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.718 0.807 . . . . 73.5 109.831 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -82.09 -56.3 4.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.619 0.768 . . . . 70.31 111.01 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.44 73.93 1.28 Allowed Glycine 0 CA--C 1.533 1.202 0 N-CA-C 111.915 -0.474 . . . . 65.23 111.915 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.94 -33.6 70.79 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.027 0.931 . . . . 75.04 113.413 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -68.17 -30.15 69.19 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.962 0.905 . . . . 73.34 111.876 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -92.64 18.13 9.2 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.8 0.84 . . . . 70.31 112.733 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -69.01 87.01 0.37 Allowed 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 109.179 -0.674 . . . . 74.33 109.179 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -73.27 159.86 32.77 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.325 0.65 . . . . 73.4 111.895 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -122.28 -152.25 0.51 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.655 0.782 . . . . 62.14 109.455 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -72.21 -13.96 61.67 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.5 0.926 . . . . 73.33 113.5 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.615 0.722 . . . . 72.31 110.665 173.75 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.545 0.777 0 CA-C-O 120.449 0.166 . . . . 70.31 111.347 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.82 -23.48 67.29 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.695 0.998 . . . . 74.31 113.695 -173.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -38.68 55.32 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.282 0.633 . . . . 74.13 112.363 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -74.03 -48.58 29.07 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.909 0.884 . . . . 54.11 111.297 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 65.3 mt -59.08 -60.0 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 114.935 -1.03 . . . . 71.5 111.844 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 m -59.4 -29.13 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.22 1.008 . . . . 71.25 112.65 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.72 -43.29 85.09 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 123.285 0.366 . . . . 75.51 112.758 173.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.28 96.67 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.919 0.887 . . . . 70.4 112.083 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -67.1 -40.95 86.99 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.051 0.54 . . . . 74.54 111.26 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.33 77.46 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.622 0.769 . . . . 64.43 112.808 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.62 -38.56 96.61 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 123.501 0.501 . . . . 34.04 112.853 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -69.29 -46.51 67.0 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.715 0.806 . . . . 71.23 111.792 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.604 ' HA ' HG11 ' B' ' 32' ' ' VAL . 72.7 t -59.25 -45.9 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.52 0.728 . . . . 74.04 111.644 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.6 ' HA ' HD12 ' B' ' 17' ' ' LEU . 21.1 t90 -68.45 -32.45 72.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.895 -0.593 . . . . 55.44 111.537 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' HIS . . . . . 0.408 ' HA ' ' OD1' ' B' ' 18' ' ' ASN . 8.1 t60 -59.01 -35.74 73.77 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.26 0.553 . . . . 70.34 110.834 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.03 -29.62 63.12 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.964 0.905 . . . . 51.53 112.093 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' B' ' 14' ' ' TRP . 84.7 mt -73.18 -39.86 65.26 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.067 0.947 . . . . 72.43 112.745 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' B' ' 15' ' ' HIS . 2.0 p-10 -74.64 -14.78 60.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.897 -0.502 . . . . 73.43 111.427 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.18 -45.59 16.15 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.337 0.655 . . . . 71.02 110.007 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.33 98.6 1.28 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.876 0.87 . . . . 75.24 110.599 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -85.93 159.99 19.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.29 0.636 . . . . 75.05 111.224 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.61 64.77 1.6 Allowed Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.555 -0.293 . . . . 45.32 112.634 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 tt -146.38 139.91 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.6 0.76 . . . . 75.0 110.841 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 37.5 m -62.8 145.79 54.12 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.756 0.423 . . . . 74.34 111.495 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.569 HD12 ' HB3' ' A' ' 37' ' ' GLU . 61.1 mt -52.28 -50.39 79.7 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 114.226 1.195 . . . . 62.13 114.226 -175.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.09 -23.44 39.9 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 121.828 1.685 . . . . 74.51 114.504 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -75.08 -52.43 11.06 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.141 0.972 . . . . 73.11 109.177 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -54.68 -37.1 65.35 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 113.122 -1.854 . . . . 75.22 112.048 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.65 95.38 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.3 1.04 . . . . 62.44 112.471 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -72.07 -28.7 63.49 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.264 0.625 . . . . 74.15 111.954 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.54 -35.03 65.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.414 0.686 . . . . 74.54 111.433 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' B' ' 13' ' ' VAL . 31.6 m -95.54 1.68 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.48 0.712 . . . . 50.24 112.109 177.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 61.9 16.27 7.89 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 124.553 1.141 . . . . 75.5 113.739 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 60.6 mt -102.66 158.37 16.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.752 0.821 . . . . 74.34 110.005 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 50.8 m -63.46 156.38 26.35 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.577 0.351 . . . . 64.24 111.313 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.0 t -49.4 -48.28 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 123.849 0.86 . . . . 62.22 111.713 171.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.62 -36.85 81.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.12 -0.946 . . . . 72.24 111.258 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -63.58 -43.04 98.15 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.461 0.704 . . . . 42.42 111.703 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.456 ' O ' HG23 ' B' ' 43' ' ' VAL . 92.1 m -74.71 -46.97 34.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.91 0.884 . . . . 74.51 111.445 -174.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -59.72 -46.12 90.09 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 124.235 1.014 . . . . 74.31 112.302 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -71.77 -35.22 69.99 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.672 -1.149 . . . . 75.25 111.001 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.84 81.89 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 122.574 0.349 . . . . 52.2 111.182 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.734 HG11 HD12 ' B' ' 63' ' ' ILE . 68.9 t -65.44 -31.87 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 123.585 0.754 . . . . 72.42 110.939 170.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -64.63 -33.57 87.58 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.909 -0.132 . . . . 73.14 113.425 171.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.484 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 73.8 t-105 -73.9 -29.78 62.24 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.479 0.712 . . . . 74.44 111.181 173.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.36 -34.58 70.58 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.839 0.456 . . . . 64.34 110.711 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.33 67.41 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.285 1.034 . . . . 74.4 111.753 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 20.1 ttt85 -56.68 -51.36 69.08 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.327 0.584 . . . . 74.2 110.882 167.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -80.07 -7.66 58.99 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.404 -0.816 . . . . 61.22 111.666 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 63.7 t30 63.91 32.9 12.92 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.577 1.551 . . . . 51.21 111.424 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -88.2 -1.68 58.16 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.744 0.818 . . . . 75.14 111.952 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.86 162.4 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.583 0.753 . . . . 73.55 112.306 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' B' ' 64' ' ' TYR . 11.7 m -128.22 156.79 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 124.45 1.1 . . . . 75.43 110.371 167.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 36.6 mm -116.97 119.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.447 0.699 . . . . 74.52 110.272 -175.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -115.49 115.02 25.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.147 0.579 . . . . 75.32 110.884 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -84.42 97.6 9.6 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.037 -0.727 . . . . 51.53 109.037 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.16 108.28 19.71 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.872 0.869 . . . . 63.0 110.163 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 54.65 31.45 15.22 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.369 1.067 . . . . 75.12 112.46 -173.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.77 -16.21 61.62 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-N 115.851 -0.613 . . . . 42.21 114.012 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -81.63 134.27 35.46 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.579 0.752 . . . . 63.24 110.845 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.591 HG13 ' HB2' ' A' ' 37' ' ' GLU . 23.1 mm -90.8 105.96 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.05 0.54 . . . . 65.13 109.816 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -115.72 130.5 56.87 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.845 0.858 . . . . 71.4 110.901 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.734 HD12 HG11 ' B' ' 43' ' ' VAL . 26.6 mm -93.22 115.7 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.052 0.941 . . . . 60.14 110.874 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.595 ' HB2' HG23 ' B' ' 53' ' ' VAL . 33.0 m-85 -107.06 158.98 16.65 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.005 0.922 . . . . 75.2 110.048 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -91.19 150.26 21.44 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.352 0.661 . . . . 62.24 109.6 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.551 ' HG2' HG13 ' B' ' 53' ' ' VAL . 0.2 OUTLIER -93.45 157.0 16.43 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.472 0.653 . . . . 72.21 110.664 176.303 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.5 -9.65 3.75 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.012 -0.835 . . . . 71.15 111.012 -170.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -95.36 -26.78 15.75 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.901 0.88 . . . . 71.12 113.168 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -64.89 142.69 58.35 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 118.21 0.459 . . . . 74.4 110.845 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -60.97 103.62 0.29 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.372 0.669 . . . . 71.14 111.24 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -113.1 117.11 31.05 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.424 0.63 . . . . 74.1 111.64 -175.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 91.3 p -160.68 166.91 27.99 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.719 1.208 . . . . 75.42 109.244 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.62 35.25 0.77 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.903 0.705 . . . . 71.44 112.903 -171.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.88 66.48 3.85 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 112.09 -0.404 . . . . 74.35 112.09 171.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 pp -137.5 155.19 49.56 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.822 0.849 . . . . 65.13 111.376 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -93.23 -171.89 2.79 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.047 0.539 . . . . 75.15 111.766 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 72.61 -59.58 0.56 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.317 1.447 . . . . 62.35 110.523 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -67.35 126.54 29.57 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.3 0.64 . . . . 62.35 110.58 168.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -127.74 158.76 36.78 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.197 0.999 . . . . 62.22 110.566 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -71.9 107.47 4.67 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.527 0.68 . . . . 70.21 110.602 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -84.38 116.91 23.29 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.994 0.518 . . . . 55.41 111.142 -175.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 N--CA 1.478 0.926 0 C-N-CA 123.507 0.723 . . . . 74.22 110.95 176.934 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 ttp . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.943 -0.391 . . . . 63.52 109.943 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 32.69 -81.71 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.766 2.506 . . . . 74.3 117.766 160.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -48.56 -49.19 37.52 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.928 1.825 . . . . 71.22 115.928 -159.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -71.71 -35.46 70.23 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 117.838 0.29 . . . . 71.51 111.454 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.2 mt -61.04 -60.33 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.181 0.592 . . . . 45.1 110.792 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 41' ' ' LEU . 34.8 m -64.0 -32.27 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.556 1.142 . . . . 35.55 112.192 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.6 69.8 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 123.353 0.408 . . . . 74.14 112.687 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.63 94.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.647 0.779 . . . . 43.21 111.651 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.39 -40.45 89.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.642 0.777 . . . . 51.03 111.421 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.84 -34.49 78.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.204 0.601 . . . . 61.12 111.913 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.77 -39.05 96.34 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 116.279 -0.419 . . . . 44.22 113.182 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -75.19 -41.12 58.62 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.752 0.821 . . . . 74.2 111.924 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.578 ' HA ' HG11 ' A' ' 32' ' ' VAL . 59.2 t -67.24 -45.5 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.496 0.719 . . . . 72.42 111.322 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.572 ' HA ' HD12 ' A' ' 17' ' ' LEU . 47.5 t90 -64.42 -34.63 78.62 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.504 0.502 . . . . 62.43 111.158 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.408 ' NE2' ' HB2' ' A' ' 76' ' ' GLU . 60.6 t60 -60.93 -45.09 96.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.362 0.665 . . . . 65.01 111.125 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -69.69 -36.17 75.74 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.753 -0.658 . . . . 74.32 111.654 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 14' ' ' TRP . 33.5 mt -59.51 -43.49 93.37 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.545 0.738 . . . . 75.41 111.474 175.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -59.34 -24.75 63.62 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.255 1.022 . . . . 63.53 112.254 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.543 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 59.4 mt-10 -66.02 -42.71 89.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.854 0.862 . . . . 74.33 111.062 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.73 110.57 2.19 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.44 0.696 . . . . 72.34 111.327 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -77.55 162.98 26.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.628 0.771 . . . . 73.22 111.27 174.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.87 61.91 3.15 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.999 -0.441 . . . . 71.43 111.999 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 tt -141.38 135.98 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.661 0.784 . . . . 62.44 111.06 -171.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -69.57 152.94 44.17 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.22 0.608 . . . . 65.25 111.413 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 40' ' ' ALA . 57.0 mt -56.38 -47.11 99.53 Favored Pre-proline 0 CA--C 1.58 2.123 0 N-CA-C 113.458 0.91 . . . . 41.14 113.458 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 55.9 Cg_endo -66.13 -30.29 46.91 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 122.145 1.896 . . . . 64.13 113.925 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.63 -46.52 66.0 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.422 1.105 . . . . 73.23 109.839 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.32 -36.87 78.92 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 113.152 -1.84 . . . . 70.3 112.175 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.3 80.21 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.567 0.747 . . . . 62.35 112.431 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 26' ' ' PRO . 2.8 mpt_? -69.69 -38.73 77.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.807 0.443 . . . . 61.23 111.447 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.43 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 40.8 mtmt -64.0 -41.77 97.37 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.538 0.335 . . . . 71.24 111.655 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 13' ' ' VAL . 22.4 m -84.24 -10.81 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.096 0.559 . . . . 62.43 111.573 175.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 69.26 16.9 8.38 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 125.53 1.532 . . . . 73.44 112.048 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.421 ' H ' HG23 ' A' ' 32' ' ' VAL . 70.2 mt -99.68 175.61 5.75 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.837 0.855 . . . . 61.41 110.604 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 t -76.99 159.25 30.07 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.144 0.577 . . . . 64.33 111.524 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -57.87 -44.69 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.091 0.556 . . . . 71.21 111.51 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.79 -46.37 89.83 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.752 0.821 . . . . 73.23 112.02 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.8 p -69.0 -30.82 69.29 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.209 0.604 . . . . 64.14 112.063 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . 96.7 m -74.92 -48.45 24.52 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.351 0.661 . . . . 73.42 111.248 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -61.77 -36.82 82.16 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 123.992 0.917 . . . . 31.05 111.831 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.651 HD11 HG12 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -61.33 -43.07 99.49 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.91 1.284 . . . . 74.23 110.802 173.609 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.59 71.73 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.228 0.611 . . . . 73.45 112.296 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.451 HG11 HD12 ' A' ' 63' ' ' ILE . 86.3 t -69.41 -33.73 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.33 0.652 . . . . 52.11 110.86 175.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.74 -32.7 85.08 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-N 116.501 -0.318 . . . . 55.22 112.745 172.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.419 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 71.5 t-105 -74.02 -31.1 62.77 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.606 0.762 . . . . 74.12 111.333 173.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.3 -34.89 75.38 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.727 0.411 . . . . 72.42 111.156 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.59 -28.95 69.72 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.37 0.668 . . . . 74.54 112.101 173.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' B' ' 48' ' ' ARG . 22.9 ttt180 -59.85 -51.16 70.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.763 0.825 . . . . 60.02 112.111 175.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -90.99 13.57 16.32 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.408 -0.815 . . . . 51.43 112.04 -173.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 51.33 47.45 24.82 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.001 1.32 . . . . 52.35 112.08 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -87.54 -32.95 19.11 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.757 -1.11 . . . . 64.33 111.921 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -132.74 148.27 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.637 0.775 . . . . 51.23 112.058 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG13 ' HG2' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -113.55 107.33 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.595 0.758 . . . . 63.23 108.957 171.779 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.48 HG23 HD13 ' A' ' 63' ' ' ILE . 60.1 mt -88.94 114.6 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 109.16 -0.681 . . . . 73.13 109.16 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -102.74 117.42 34.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.21 0.604 . . . . 75.33 111.107 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -81.9 108.18 15.21 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.957 -0.386 . . . . 72.45 109.957 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -104.09 106.15 16.56 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.658 0.783 . . . . 64.53 109.003 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 54.81 31.85 16.44 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 124.336 1.054 . . . . 73.43 112.423 -169.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.93 -20.12 50.64 Favored Glycine 0 CA--C 1.542 1.769 0 N-CA-C 114.408 0.523 . . . . 50.32 114.408 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.79 134.95 43.47 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.743 0.817 . . . . 74.21 111.076 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.25 103.78 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 122.995 0.518 . . . . 74.1 109.884 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -118.72 121.83 41.03 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.949 0.9 . . . . 72.33 109.914 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 54' ' ' ILE . 10.5 mm -91.96 120.93 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.214 0.606 . . . . 71.02 111.938 -169.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -108.84 163.14 13.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.489 0.715 . . . . 73.21 111.043 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 11.1 m-20 -91.33 155.26 18.64 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.428 -0.806 . . . . 74.42 108.921 171.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 69' ' ' PHE . 50.9 mt-10 -84.4 78.91 9.72 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.758 0.79 . . . . 74.43 110.022 169.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.52 -18.12 79.92 Favored Glycine 0 C--N 1.358 1.75 0 CA-C-N 114.71 -1.132 . . . . 60.12 113.974 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -84.59 -12.21 54.5 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.124 0.57 . . . . 70.33 110.89 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.582 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 83.9 m-85 -118.63 17.5 13.6 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.0 1.32 . . . . 63.31 110.638 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.19 159.36 29.18 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.437 0.903 . . . . 73.34 113.437 -168.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -124.48 -59.54 1.45 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.69 0.796 . . . . 65.01 110.61 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 t -135.78 161.76 34.68 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.219 0.608 . . . . 74.11 111.726 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -124.29 152.48 43.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.99 0.916 . . . . 74.41 110.571 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.71 82.18 0.1 Allowed Glycine 0 C--N 1.344 0.972 0 CA-C-N 116.167 -0.47 . . . . 71.24 112.094 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.543 ' HG ' ' HA ' ' A' ' 19' ' ' GLU . 7.0 mp -79.86 113.42 18.0 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.689 0.796 . . . . 74.34 109.629 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HB2' ' NE2' ' A' ' 15' ' ' HIS . 36.9 tt0 -105.67 147.58 28.35 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.676 0.79 . . . . 62.11 111.326 -172.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -80.88 72.7 7.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.924 0.869 . . . . 65.44 109.169 164.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -57.63 106.47 0.35 Allowed 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 125.312 1.445 . . . . 72.51 112.346 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -78.35 82.99 4.61 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.656 0.741 . . . . 74.32 111.346 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -74.49 122.02 22.39 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.024 -0.989 . . . . 73.4 110.347 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -73.64 -51.15 17.75 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.433 -0.581 . . . . 74.43 109.433 172.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 65.9 t60 . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 124.135 0.974 . . . . 71.04 110.16 175.347 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 120.929 0.395 . . . . 65.52 110.465 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.405 ' O ' HG22 ' B' ' 6' ' ' VAL . 28.4 t70 -73.08 -19.81 61.09 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.293 0.479 . . . . 74.23 112.293 -175.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -61.48 -22.78 65.39 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.018 0.372 . . . . 75.54 111.475 172.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -91.26 -41.82 10.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.077 0.951 . . . . 62.5 111.827 170.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.49 -45.33 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 122.993 0.517 . . . . 74.01 111.876 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.405 HG22 ' O ' ' B' ' 2' ' ' ASP . 35.9 m -60.03 -26.84 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 122.633 0.373 . . . . 71.11 111.811 174.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.2 -48.36 80.24 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.135 0.272 . . . . 54.45 112.869 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.79 -43.28 93.72 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.601 0.76 . . . . 73.11 111.609 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.85 -36.53 80.48 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.169 0.988 . . . . 72.54 111.532 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.427 ' HA ' ' HB1' ' B' ' 42' ' ' ALA . . . -68.69 -39.66 80.44 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.099 0.56 . . . . 71.24 110.914 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.74 -45.98 92.79 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.68 -0.691 . . . . 75.41 112.341 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -63.28 -41.95 99.05 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.425 1.09 . . . . 62.21 111.845 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.694 ' HA ' HG11 ' B' ' 32' ' ' VAL . 72.8 t -65.14 -37.05 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.775 0.83 . . . . 63.44 111.622 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -74.04 -33.49 63.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.208 0.603 . . . . 75.21 111.587 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -60.84 -30.7 70.26 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.92 0.488 . . . . 75.11 111.353 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.71 69.96 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.191 0.596 . . . . 44.12 112.466 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.489 ' HB3' ' ND2' ' B' ' 65' ' ' ASN . 53.3 mt -63.49 -34.24 77.33 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.262 0.625 . . . . 75.11 112.51 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.75 -25.7 66.67 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.3 0.64 . . . . 63.55 111.729 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.92 -41.03 8.2 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.734 0.813 . . . . 61.35 111.077 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' B' ' 17' ' ' LEU . . . -153.75 141.28 19.83 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.405 0.682 . . . . 50.32 111.808 -171.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -127.08 168.97 13.9 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.616 0.766 . . . . 65.42 111.129 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.8 10.24 64.02 Favored Glycine 0 N--CA 1.474 1.167 0 N-CA-C 114.596 0.598 . . . . 71.11 114.596 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.3 tt -86.26 132.02 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 123.465 0.706 . . . . 75.33 110.809 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -71.89 158.35 36.21 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.518 0.562 . . . . 45.34 112.518 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.551 HG21 ' HB2' ' B' ' 40' ' ' ALA . 73.9 mt -56.33 -43.3 99.23 Favored Pre-proline 0 CA--C 1.582 2.177 0 N-CA-C 115.274 1.583 . . . . 73.35 115.274 -169.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.54 -31.6 33.28 Favored 'Trans proline' 0 C--N 1.392 2.863 0 CA-C-N 122.448 1.91 . . . . 75.32 114.207 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -77.86 -41.32 37.23 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.313 1.054 . . . . 73.12 110.102 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.42 -39.61 84.06 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 113.206 -1.816 . . . . 52.25 111.125 171.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.01 88.91 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.985 0.914 . . . . 63.1 111.648 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -60.92 -43.42 98.59 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.584 0.754 . . . . 73.53 111.498 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -71.27 -37.97 71.88 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.284 0.634 . . . . 74.44 111.934 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.694 HG11 ' HA ' ' B' ' 13' ' ' VAL . 13.1 m -93.32 5.53 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.047 0.539 . . . . 61.02 112.15 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.4 t30 68.46 9.53 7.33 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.574 1.149 . . . . 74.21 113.303 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 47.8 mt -102.98 174.25 5.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.611 -0.68 . . . . 72.44 111.463 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 39.3 t -72.94 157.84 36.65 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.915 0.486 . . . . 73.21 111.264 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.14 -41.39 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.22 0.608 . . . . 71.23 111.198 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.19 -48.44 75.9 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.533 0.733 . . . . 74.11 112.207 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -71.04 -29.97 66.03 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.292 0.637 . . . . 62.53 111.98 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.422 ' O ' HG23 ' B' ' 43' ' ' VAL . 95.5 m -72.77 -46.23 54.46 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.182 0.593 . . . . 74.43 110.487 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.551 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -60.05 -36.35 77.1 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.528 0.731 . . . . 74.02 111.927 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -51.13 66.61 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.278 1.031 . . . . 71.33 109.606 174.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.427 ' HB1' ' HA ' ' B' ' 10' ' ' ALA . . . -61.39 -30.77 70.76 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.009 -0.996 . . . . 64.23 111.695 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.422 HG23 ' O ' ' B' ' 39' ' ' THR . 49.0 t -68.45 -37.51 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.76 0.824 . . . . 64.01 110.66 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.47 -33.3 86.04 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.216 -0.447 . . . . 53.42 113.037 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.437 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 61.9 t-105 -74.44 -25.63 59.55 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.398 0.679 . . . . 73.04 111.338 175.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.92 -36.73 70.04 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.875 0.47 . . . . 73.1 111.284 169.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.21 -33.02 75.01 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.959 0.503 . . . . 64.03 110.685 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.497 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 2.3 tmt_? -59.35 -45.29 91.82 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.246 1.018 . . . . 65.53 111.504 173.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.421 ' HG3' ' HD3' ' B' ' 48' ' ' ARG . 37.6 mt-10 -84.79 2.38 42.5 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.46 0.704 . . . . 60.3 112.508 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 63.2 22.41 13.35 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.148 1.379 . . . . 62.4 112.808 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -102.42 7.96 40.24 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.907 1.077 . . . . 45.2 113.907 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.403 HG12 HD11 ' B' ' 17' ' ' LEU . 20.9 m -131.87 151.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 123.093 0.557 . . . . 71.43 111.102 171.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 t -105.36 102.41 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.498 0.719 . . . . 74.35 109.492 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 27.8 mm -77.69 114.7 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 122.987 0.515 . . . . 43.12 110.274 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.18 156.5 38.33 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.89 0.876 . . . . 64.43 111.843 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -118.12 107.56 14.12 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.958 0.903 . . . . 73.01 110.864 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -119.07 129.86 55.3 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.02 0.528 . . . . 71.31 110.125 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 62.72 30.45 16.82 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.528 1.131 . . . . 73.53 112.115 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.05 12.97 81.33 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 115.979 -0.555 . . . . 73.24 113.465 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -122.52 136.66 54.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.178 0.991 . . . . 71.1 110.378 -172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mp -80.51 122.36 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 123.012 0.525 . . . . 75.03 110.244 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -124.94 132.36 53.3 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.278 1.031 . . . . 74.52 110.019 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 pp -100.06 126.53 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.434 0.694 . . . . 74.43 111.932 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -108.52 166.47 10.76 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.207 0.603 . . . . 61.53 111.252 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.489 ' ND2' ' HB3' ' B' ' 17' ' ' LEU . 15.0 m120 -67.43 141.45 57.01 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.632 0.773 . . . . 72.52 111.461 176.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -48.18 -39.81 22.09 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.512 1.301 . . . . 72.44 114.512 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.66 -16.29 7.19 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 117.426 1.73 . . . . 53.05 117.426 -166.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -99.16 -37.39 9.33 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 118.297 1.048 . . . . 74.34 111.953 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 52.07 40.98 29.6 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 123.989 0.916 . . . . 73.23 112.745 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.82 22.49 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 125.869 1.668 . . . . 72.14 114.87 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -149.32 114.96 5.61 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.126 0.97 . . . . 74.23 110.201 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 20.4 t -79.23 132.38 36.49 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.692 0.397 . . . . 70.44 110.824 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -142.39 147.52 36.37 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.963 0.505 . . . . 73.12 110.935 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.51 71.5 0.07 OUTLIER Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.337 -0.392 . . . . 71.15 112.984 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.6 mt -124.62 -64.81 1.08 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.388 0.675 . . . . 64.24 111.86 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -94.39 163.37 13.45 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.703 1.001 . . . . 74.35 113.703 -166.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -139.58 114.85 9.76 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.466 1.106 . . . . 73.32 110.248 172.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -73.97 -9.64 58.84 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.176 0.99 . . . . 51.41 112.549 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -68.49 5.41 1.04 Allowed 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 124.461 1.105 . . . . 75.1 113.543 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -64.09 84.68 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 O-C-N 121.601 -0.687 . . . . 74.01 111.902 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -172.19 137.67 0.92 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.371 1.068 . . . . 64.21 110.051 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 . . . . . 0 N--CA 1.489 1.509 0 C-N-CA 123.49 0.716 . . . . 64.43 111.593 175.855 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HG3' HD11 ' A' ' 5' ' ' ILE . 19.3 ptt? . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.784 -0.627 . . . . 73.41 110.478 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -44.99 130.55 7.46 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.804 1.242 . . . . 72.23 113.678 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' B' ' 50' ' ' ASN . 27.0 ttpp -75.66 -8.5 56.95 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.86 0.864 . . . . 75.43 110.415 169.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -63.18 -15.74 57.86 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.748 1.219 . . . . 74.55 112.682 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.41 HD11 ' HG3' ' A' ' 1' ' ' MET . 80.6 mt -58.28 -55.52 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.158 0.583 . . . . 73.32 110.802 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.6 m -67.31 -25.54 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 122.682 0.393 . . . . 72.43 111.232 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.491 ' HA2' ' NE1' ' A' ' 45' ' ' TRP . . . -68.27 -41.39 86.15 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 116.676 -0.238 . . . . 70.44 113.646 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.01 -54.84 13.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.822 0.849 . . . . 71.2 112.031 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -68.07 -19.68 64.89 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 112.793 0.664 . . . . 72.01 112.793 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 13' ' ' VAL . . . -69.32 -28.05 65.91 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.623 0.769 . . . . 24.4 112.205 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.68 -42.64 93.17 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 116.762 -0.199 . . . . 63.33 113.391 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -66.81 -46.65 74.51 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.797 0.839 . . . . 74.2 112.081 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.537 ' HA ' HG11 ' A' ' 32' ' ' VAL . 10.6 p -69.13 -32.17 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.533 0.333 . . . . 63.1 111.708 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.475 ' NE1' ' HB3' ' A' ' 51' ' ' LYS . 66.9 t90 -72.14 -33.94 68.16 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.067 0.547 . . . . 72.41 111.328 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -61.49 -35.24 77.1 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.384 0.673 . . . . 73.23 111.315 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.41 -32.44 73.88 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.581 0.753 . . . . 42.05 112.088 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 14' ' ' TRP . 50.9 mt -73.66 -33.04 64.3 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.869 0.867 . . . . 75.32 112.131 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -62.91 -33.26 74.95 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.208 0.603 . . . . 74.51 111.76 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -75.3 -54.3 7.32 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.283 0.633 . . . . 62.44 110.11 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.45 99.13 2.17 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.599 -0.728 . . . . 65.25 110.899 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.529 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 9.9 p-10 -93.5 150.84 20.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.7 0.4 . . . . 74.21 109.952 173.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.08 63.19 1.15 Allowed Glycine 0 N--CA 1.469 0.855 0 N-CA-C 110.758 -0.937 . . . . 61.33 110.758 -167.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.4 tt -145.17 125.44 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.479 1.112 . . . . 73.53 109.605 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.0 m -57.09 149.27 19.69 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.032 0.933 . . . . 63.23 112.097 -176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.618 HG12 HD11 ' A' ' 63' ' ' ILE . 21.2 mt -53.88 -48.07 94.88 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 113.419 0.896 . . . . 51.23 113.419 -174.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.46 -24.0 14.48 Favored 'Trans proline' 0 C--N 1.398 3.17 0 C-N-CA 121.881 1.721 . . . . 74.54 114.732 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -71.79 -45.86 60.21 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 123.037 1.398 . . . . 70.42 108.939 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 32' ' ' VAL . 60.5 tp -65.11 -40.14 94.11 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 112.443 -2.162 . . . . 72.52 111.466 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.25 93.93 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.048 0.939 . . . . 61.33 112.306 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -70.02 -39.26 75.92 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.287 0.635 . . . . 75.04 111.004 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -59.19 -52.12 67.07 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.577 0.751 . . . . 70.43 111.563 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 13' ' ' VAL . 24.9 m -85.89 0.37 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.357 0.663 . . . . 72.14 112.035 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 62.43 15.02 7.41 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 125.149 1.38 . . . . 73.14 114.196 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.7 mt -90.81 159.82 16.08 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.325 0.65 . . . . 63.42 110.0 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -66.66 151.86 46.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.486 0.314 . . . . 73.21 110.882 169.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.1 t -52.67 -47.03 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 123.835 0.854 . . . . 75.14 112.064 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.456 ' HB3' HD12 ' B' ' 25' ' ' ILE . 46.2 mt-10 -59.78 -44.63 93.81 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.726 0.81 . . . . 74.43 112.277 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.0 m -62.58 -36.74 83.68 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.722 0.809 . . . . 64.21 111.855 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -70.49 -52.34 22.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.786 0.835 . . . . 74.4 110.936 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' HD13 ' A' ' 25' ' ' ILE . . . -59.98 -33.91 72.6 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.801 0.84 . . . . 72.32 112.302 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -51.24 49.5 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.184 0.994 . . . . 74.31 110.354 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.94 70.06 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.331 -0.85 . . . . 52.23 111.686 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.22 -38.82 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 115.581 -0.736 . . . . 65.11 110.939 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.28 -28.06 72.47 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-O 121.116 0.287 . . . . 73.41 112.877 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.491 ' NE1' ' HA2' ' A' ' 7' ' ' GLY . 77.0 t-105 -70.02 -41.53 74.17 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.099 0.96 . . . . 72.52 111.265 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 76.4 mt -67.01 -34.09 76.99 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.512 0.725 . . . . 63.25 111.619 175.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.33 -27.22 63.93 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.361 1.064 . . . . 51.22 113.326 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -58.77 -31.87 68.76 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 112.244 0.461 . . . . 74.22 112.244 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -122.02 26.67 8.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.663 1.185 . . . . 64.42 111.063 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 61.43 22.61 12.99 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.329 1.451 . . . . 74.14 114.117 169.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 61.9 mttm -74.09 -18.05 60.87 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.85 0.685 . . . . 73.2 112.85 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.16 150.77 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.473 0.709 . . . . 74.22 111.93 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 42.5 t -107.7 123.93 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.991 0.917 . . . . 75.21 108.904 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.437 HG23 HG23 ' A' ' 61' ' ' ILE . 48.6 mm -103.81 118.66 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.595 0.758 . . . . 72.54 111.106 -173.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -124.61 112.05 16.35 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.298 0.639 . . . . 75.21 111.138 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.462 ' HG2' HG12 ' A' ' 61' ' ' ILE . 56.7 mtt180 -81.25 98.01 7.91 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.567 0.699 . . . . 71.24 110.078 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -106.39 111.93 24.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.482 1.113 . . . . 63.05 109.601 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 60.72 32.35 20.23 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 124.605 1.162 . . . . 64.14 112.891 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.42 -11.57 67.61 Favored Glycine 0 CA--C 1.541 1.697 0 N-CA-C 114.041 0.377 . . . . 41.43 114.041 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.76 137.21 36.98 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.748 0.819 . . . . 71.54 110.329 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 56' ' ' ARG . 50.7 mt -87.41 129.3 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.808 0.443 . . . . 62.1 111.173 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.04 136.34 49.44 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.308 1.043 . . . . 73.21 110.37 -178.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.618 HD11 HG12 ' A' ' 25' ' ' ILE . 3.0 mp -113.59 115.94 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.219 0.608 . . . . 75.11 110.194 -169.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.733 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 80.6 m-85 -113.54 173.74 6.26 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.994 0.918 . . . . 72.31 110.542 175.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -98.8 162.03 13.32 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.384 0.674 . . . . 63.34 110.862 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 51' ' ' LYS . 36.1 tt0 -55.75 -35.23 65.96 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.505 1.122 . . . . 75.04 111.895 170.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.44 1.18 37.25 Favored Glycine 0 CA--C 1.547 2.059 0 N-CA-C 114.626 0.61 . . . . 72.51 114.626 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -73.26 -24.71 60.49 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.52 0.66 . . . . 73.05 110.893 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -69.53 166.03 19.77 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.11 0.564 . . . . 53.41 112.345 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -61.51 148.84 40.71 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.953 0.901 . . . . 63.2 112.63 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.27 -15.55 63.76 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.47 0.915 . . . . 62.12 113.47 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 t -73.4 -53.56 10.41 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.803 0.441 . . . . 74.55 111.156 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 59.33 111.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.695 1.198 . . . . 72.5 111.939 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.97 -6.18 51.13 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 114.744 0.658 . . . . 64.21 114.744 -177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.17 107.86 0.97 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.833 0.853 . . . . 72.4 110.809 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 63.23 17.81 10.5 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.569 1.148 . . . . 73.35 111.741 -177.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -123.62 22.11 9.16 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.787 0.835 . . . . 74.11 111.989 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -141.68 149.62 40.81 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.206 0.527 . . . . 75.42 111.559 171.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -138.47 161.24 37.51 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.564 1.146 . . . . 62.13 109.802 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -80.01 121.89 26.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.156 -1.053 . . . . 74.34 108.156 167.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -55.83 89.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.611 1.164 . . . . 72.34 113.899 -162.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 N--CA 1.487 1.375 0 C-N-CA 124.95 1.3 . . . . 73.11 109.868 174.983 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 120.659 0.266 . . . . 73.31 111.343 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -54.35 -33.29 58.75 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.65 1.18 . . . . 55.4 113.809 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -63.38 -38.24 90.38 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.846 0.858 . . . . 65.53 111.788 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -75.05 -31.77 61.38 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.449 0.7 . . . . 65.02 111.71 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.04 -54.09 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 122.697 0.399 . . . . 72.05 110.749 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -65.28 -26.2 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 122.864 0.466 . . . . 65.02 111.536 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.81 -39.97 96.99 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.282 0.364 . . . . 43.02 113.303 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.11 -36.97 69.59 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.73 0.812 . . . . 55.54 111.346 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -64.68 -40.61 95.71 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.589 -0.732 . . . . 73.31 110.583 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.502 ' HA ' ' HB1' ' B' ' 42' ' ' ALA . . . -72.06 -41.45 67.39 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.869 0.868 . . . . 71.21 111.435 -176.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.01 -50.07 66.93 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.783 -0.644 . . . . 60.34 112.464 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.548 ' HG3' ' HB ' ' B' ' 32' ' ' VAL . 18.0 tppt? -60.0 -45.88 91.31 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.437 1.095 . . . . 75.24 112.065 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.469 ' HA ' HG11 ' B' ' 32' ' ' VAL . 53.0 t -56.99 -46.99 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.094 0.558 . . . . 74.43 111.346 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.511 ' HA ' HD12 ' B' ' 17' ' ' LEU . 69.7 t90 -68.34 -35.76 78.24 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.302 0.641 . . . . 74.3 112.015 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -63.97 -33.08 74.92 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.604 0.362 . . . . 55.33 110.553 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.09 -32.45 69.08 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.906 0.482 . . . . 61.23 111.582 171.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' B' ' 14' ' ' TRP . 69.2 mt -72.57 -30.51 64.47 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.347 0.659 . . . . 74.21 111.227 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.49 -29.4 68.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.644 0.778 . . . . 73.01 111.048 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.45 -29.24 12.86 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.523 0.729 . . . . 72.44 111.303 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.7 88.88 1.0 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.439 0.696 . . . . 44.0 111.812 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -92.28 173.44 7.82 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.183 0.593 . . . . 74.11 111.652 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.55 64.53 2.81 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.278 -0.419 . . . . 71.02 112.316 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 tt -144.02 143.27 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.315 0.646 . . . . 72.54 110.787 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -60.58 139.8 57.64 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.856 0.863 . . . . 63.13 111.418 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 37' ' ' GLU . 71.8 mt -52.31 -46.22 94.39 Favored Pre-proline 0 CA--C 1.581 2.14 0 N-CA-C 114.386 1.254 . . . . 63.54 114.386 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.11 -24.78 14.49 Favored 'Trans proline' 0 C--N 1.399 3.223 0 CA-C-N 121.856 1.699 . . . . 64.2 113.989 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 33.7 tt0 -77.1 -46.34 23.9 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 122.04 0.924 . . . . 60.13 108.846 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -55.65 -39.87 71.45 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.321 1.448 . . . . 61.43 111.263 170.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.85 92.19 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.874 0.869 . . . . 54.14 112.323 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' B' ' 27' ' ' GLU . 21.9 ptt180 -73.96 -23.36 59.48 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.384 0.274 . . . . 75.03 110.782 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 27' ' ' GLU . 30.9 mmmt -78.41 -43.93 26.14 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.142 0.577 . . . . 73.25 111.06 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' B' ' 12' ' ' LYS . 23.6 m -87.16 3.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 112.954 0.724 . . . . 74.32 112.954 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 63.62 11.47 5.75 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 125.081 1.352 . . . . 74.22 113.904 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 74.2 mt -99.77 162.9 12.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.478 0.711 . . . . 73.44 111.071 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 16.7 m -66.0 155.59 36.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.561 0.744 . . . . 72.25 111.627 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.46 -49.83 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.488 0.715 . . . . 61.13 111.709 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.62 -43.65 84.94 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.121 0.969 . . . . 55.41 111.474 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 68.4 m -61.75 -37.56 84.74 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.957 0.903 . . . . 73.53 112.265 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.479 ' O ' HG23 ' B' ' 43' ' ' VAL . 97.3 m -72.26 -48.49 42.17 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.471 0.708 . . . . 74.14 111.241 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -59.24 -43.14 92.4 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.553 0.741 . . . . 54.55 112.573 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.06 -49.5 75.72 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.883 0.873 . . . . 71.01 109.963 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' B' ' 10' ' ' ALA . . . -57.96 -28.67 64.56 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.794 -1.094 . . . . 73.13 112.006 -178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.647 HG11 HD12 ' B' ' 63' ' ' ILE . 77.8 t -69.27 -38.33 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.139 0.576 . . . . 74.32 110.964 175.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.64 -30.58 77.67 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-O 121.077 0.265 . . . . 74.52 112.591 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -75.86 -26.37 57.05 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.662 0.785 . . . . 73.23 111.951 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.99 -35.25 62.03 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.207 0.527 . . . . 74.1 111.352 166.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.34 -34.15 77.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.304 1.042 . . . . 65.22 112.793 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -64.51 -34.95 79.42 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.922 0.392 . . . . 71.55 111.317 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.62 -2.52 56.27 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.737 0.815 . . . . 61.3 111.532 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ASN . . . . . 0.542 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . 36.6 m-80 65.55 26.48 11.68 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.488 1.515 . . . . 73.04 112.43 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -95.36 -0.19 52.9 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.465 1.283 . . . . 75.42 114.465 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 17.6 m -127.95 151.5 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 118.566 0.621 . . . . 73.44 112.468 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.699 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 95.3 t -110.33 123.35 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.604 1.161 . . . . 74.43 108.465 168.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 76.0 mt -114.97 126.45 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.258 -0.645 . . . . 54.44 109.258 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' GLU . . . . . 0.588 ' HG3' ' HG3' ' B' ' 57' ' ' LYS . 10.6 tp10 -142.32 129.17 20.57 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.55 -0.75 . . . . 72.32 111.312 -169.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.404 ' HG2' HG12 ' B' ' 61' ' ' ILE . 92.7 mtt180 -95.12 98.86 10.95 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.51 0.672 . . . . 72.51 110.216 176.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.588 ' HG3' ' HG3' ' B' ' 55' ' ' GLU . 29.1 mtpp -105.48 123.39 47.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.346 -0.843 . . . . 74.04 109.476 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 59.11 29.48 19.05 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.077 1.351 . . . . 73.1 111.157 -171.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.54 -27.87 8.22 Favored Glycine 0 CA--C 1.543 1.83 0 CA-C-N 115.729 -0.669 . . . . 73.3 114.136 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.08 138.07 31.86 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.65 0.78 . . . . 55.14 111.795 -171.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.404 HG12 ' HG2' ' B' ' 56' ' ' ARG . 55.4 mt -79.56 136.42 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.926 0.891 . . . . 74.11 112.225 -177.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -121.19 131.99 54.57 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.175 0.99 . . . . 75.13 109.118 167.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.647 HD12 HG11 ' B' ' 43' ' ' VAL . 25.0 mm -91.69 109.25 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.369 0.668 . . . . 71.22 110.431 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.699 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 67.0 m-85 -97.72 169.24 9.82 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.6 1.16 . . . . 71.45 110.589 175.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -100.39 155.29 17.89 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.429 0.692 . . . . 74.41 110.934 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.63 -39.74 95.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.716 1.206 . . . . 74.33 111.158 173.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.16 58.4 3.62 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 121.191 0.328 . . . . 53.15 113.187 177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -143.4 -35.07 0.4 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.121 0.968 . . . . 73.02 109.496 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -102.17 24.05 10.74 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.246 0.618 . . . . 63.42 112.265 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -64.81 -12.82 52.11 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.295 1.22 . . . . 74.2 114.295 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.6 -28.69 45.76 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.168 0.587 . . . . 74.31 110.737 171.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 35.7 t -72.96 91.28 1.54 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.367 0.667 . . . . 63.04 109.559 171.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -74.49 82.68 1.98 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.608 0.763 . . . . 72.34 111.493 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -134.22 44.9 1.15 Allowed Glycine 0 CA--C 1.531 1.035 0 CA-C-N 114.934 -1.03 . . . . 71.4 111.339 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.16 7.63 37.02 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.146 0.978 . . . . 41.0 112.852 -173.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.96 121.11 15.38 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 118.506 0.594 . . . . 74.05 111.036 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -122.6 25.22 8.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.112 0.965 . . . . 73.41 111.15 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -69.02 86.24 0.36 Allowed 'General case' 0 CA--C 1.555 1.147 0 CA-C-O 121.588 0.709 . . . . 74.34 110.774 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -94.76 -179.43 4.86 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.989 0.916 . . . . 74.12 110.076 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -76.8 132.99 39.52 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.934 -0.395 . . . . 52.55 109.934 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -147.44 141.61 26.13 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.782 0.833 . . . . 73.4 110.348 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 N--CA 1.483 1.203 0 C-N-CA 123.428 0.691 . . . . 54.41 109.803 -177.998 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 120.966 0.412 . . . . 72.24 111.468 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -54.88 -32.69 61.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.218 1.407 . . . . 73.11 114.316 -174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -40.79 97.31 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.665 0.786 . . . . 74.44 112.203 -171.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -81.65 -25.78 35.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.477 0.311 . . . . 63.35 111.782 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.2 mt -64.44 -59.46 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.899 0.48 . . . . 71.31 110.694 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.53 -27.56 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.938 0.495 . . . . 62.52 111.764 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.76 -43.13 85.34 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.412 0.445 . . . . 44.35 113.283 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -46.36 80.97 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.644 0.778 . . . . 70.33 111.706 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -70.0 -27.95 65.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.972 -0.558 . . . . 60.32 112.362 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.58 76.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.24 0.616 . . . . 51.22 111.898 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.2 -37.65 94.88 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 116.074 -0.512 . . . . 64.4 113.071 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -76.61 -42.56 41.91 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 112.474 0.546 . . . . 42.04 112.474 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.592 HG12 HG21 ' A' ' 32' ' ' VAL . 26.0 m -64.56 -34.1 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 122.123 -0.36 . . . . 41.11 111.057 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.572 ' HA ' HD12 ' A' ' 17' ' ' LEU . 42.9 t90 -70.01 -33.28 71.81 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.086 0.555 . . . . 74.12 111.484 175.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -61.7 -39.14 90.41 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.127 0.571 . . . . 61.12 110.618 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.02 -32.53 70.72 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.49 0.716 . . . . 43.31 111.946 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 14' ' ' TRP . 75.5 mt -69.87 -35.37 74.62 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.878 0.871 . . . . 75.32 111.746 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.06 -25.82 65.54 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.938 0.495 . . . . 71.3 110.307 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.15 -46.86 19.48 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.737 0.815 . . . . 73.35 110.694 169.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.06 97.15 1.77 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.575 0.75 . . . . 74.13 111.417 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.12 172.46 10.56 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.324 0.65 . . . . 72.21 111.316 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.51 9.79 82.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 116.614 -0.266 . . . . 52.31 113.456 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 tt -77.83 158.19 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 124.33 1.052 . . . . 74.51 109.338 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 m -79.1 150.75 31.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.752 -0.592 . . . . 60.53 110.392 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.592 HG21 ' HB2' ' A' ' 40' ' ' ALA . 70.7 mt -54.75 -47.19 98.79 Favored Pre-proline 0 CA--C 1.578 2.057 0 N-CA-C 113.82 1.044 . . . . 72.14 113.82 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.94 -23.74 34.29 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 122.117 1.878 . . . . 74.32 113.961 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.47 -48.24 23.56 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.094 0.95 . . . . 62.21 108.984 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.431 HD22 HD11 ' A' ' 63' ' ' ILE . 64.5 tp -57.28 -38.62 74.21 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 113.324 -1.762 . . . . 60.52 111.613 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.9 -41.92 88.37 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.935 0.894 . . . . 32.0 111.774 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -66.06 -37.44 85.83 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.812 0.845 . . . . 73.43 111.695 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.14 -35.64 77.61 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.457 0.646 . . . . 64.35 111.706 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.592 HG21 HG12 ' A' ' 13' ' ' VAL . 29.7 m -105.15 5.38 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.71 0.804 . . . . 74.24 112.623 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 62.11 19.76 11.12 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 124.814 1.246 . . . . 73.03 114.05 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.4 mt -99.47 168.56 9.9 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.251 0.621 . . . . 62.03 110.615 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 t -75.89 157.02 33.76 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.762 0.425 . . . . 72.33 111.402 171.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 t -56.47 -44.14 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.076 0.95 . . . . 70.23 111.42 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.475 ' HB3' HD12 ' B' ' 25' ' ' ILE . 42.2 mt-10 -63.86 -39.41 94.14 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.039 0.936 . . . . 75.43 112.039 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.3 m -68.94 -35.39 76.72 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.663 0.785 . . . . 74.1 111.502 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 43' ' ' VAL . 99.5 m -76.97 -46.98 22.1 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.544 0.738 . . . . 63.04 111.893 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.592 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -59.31 -35.92 74.68 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 123.565 0.746 . . . . 75.32 111.737 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.451 HD11 HD13 ' B' ' 54' ' ' ILE . 0.9 OUTLIER -65.04 -49.73 68.99 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 114.908 -1.042 . . . . 44.5 110.181 174.335 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.56 70.21 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.645 0.778 . . . . 74.32 111.713 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 63' ' ' ILE . 53.5 t -68.27 -35.93 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.207 0.603 . . . . 72.31 110.495 173.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.654 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -63.96 -30.43 77.7 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 116.336 -0.393 . . . . 52.31 113.612 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.47 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 65.0 t-105 -70.62 -37.15 73.78 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.009 0.433 . . . . 75.24 110.923 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.17 -32.19 72.26 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 122.199 -0.313 . . . . 64.33 110.955 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.86 -31.05 71.78 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.672 0.789 . . . . 61.34 111.481 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.578 ' HA ' ' HD2' ' B' ' 48' ' ' ARG . 31.9 ttt180 -63.64 -50.62 68.6 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.985 0.514 . . . . 73.45 110.71 168.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -79.14 -2.02 38.8 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.171 0.988 . . . . 60.34 112.197 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 63.07 22.13 13.26 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.541 1.536 . . . . 75.4 112.688 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 63.1 mttp -78.7 -18.65 54.0 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.391 1.076 . . . . 71.31 112.961 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.55 157.86 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 112.807 0.669 . . . . 63.03 112.807 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.62 HG23 ' HB2' ' A' ' 64' ' ' TYR . 7.3 m -129.78 120.22 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 124.694 1.198 . . . . 72.32 109.773 172.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.427 HG13 HG22 ' A' ' 63' ' ' ILE . 3.4 mp -96.95 107.38 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.636 0.774 . . . . 62.43 109.906 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -117.38 137.34 52.53 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.909 0.484 . . . . 74.31 111.469 -172.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -89.11 100.96 13.63 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.846 0.859 . . . . 72.33 110.212 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -107.64 119.35 39.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.702 0.801 . . . . 73.53 110.394 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 58.47 30.97 20.44 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.955 1.302 . . . . 72.52 112.268 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.07 -21.2 25.22 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-N 115.386 -0.825 . . . . 71.21 114.197 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.65 137.7 33.67 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.788 0.835 . . . . 73.32 111.266 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.06 114.25 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.59 0.756 . . . . 72.43 109.197 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.1 138.38 54.47 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.751 -0.833 . . . . 74.32 108.751 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -103.38 124.4 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 122.265 1.031 . . . . 73.14 110.669 -177.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.62 ' HB2' HG23 ' A' ' 53' ' ' VAL . 89.0 m-85 -109.72 171.24 7.56 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.191 1.396 . . . . 65.2 109.582 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -93.75 168.25 11.12 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.576 0.703 . . . . 74.22 112.11 175.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -61.75 -20.64 63.77 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.237 1.015 . . . . 72.35 111.837 170.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.23 0.89 44.94 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 116.007 -0.542 . . . . 74.32 113.997 173.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -63.94 -32.65 74.25 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.94 0.896 . . . . 75.02 110.8 173.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -109.81 173.17 6.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.935 0.894 . . . . 65.01 110.488 173.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -74.51 90.58 2.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.863 0.465 . . . . 64.14 110.122 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -77.21 -45.78 25.45 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 122.874 0.47 . . . . 74.01 110.876 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -68.75 164.34 22.0 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.722 0.809 . . . . 63.41 111.89 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.49 -17.31 28.89 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.392 0.677 . . . . 74.53 111.943 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.58 48.37 29.67 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 121.047 0.249 . . . . 70.54 113.534 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.7 mt -84.45 -12.2 54.79 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.804 0.841 . . . . 73.32 113.246 -170.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.99 111.18 8.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.875 0.47 . . . . 52.25 110.963 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -113.85 120.19 39.88 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.653 0.781 . . . . 74.52 109.738 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -83.53 113.86 21.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.975 0.51 . . . . 73.2 111.053 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -145.75 127.21 15.02 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.024 0.93 . . . . 73.32 109.548 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -77.58 -26.5 50.84 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.074 0.549 . . . . 71.4 111.102 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -101.74 134.23 45.23 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.168 0.987 . . . . 72.31 108.72 168.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.9 p80 . . . . . 0 N--CA 1.492 1.646 0 C-N-CA 123.899 0.88 . . . . 64.15 112.994 -173.774 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 CA--C 1.549 0.909 0 CA-C-O 120.46 0.171 . . . . 74.34 111.394 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' B' ' 4' ' ' LYS . 53.6 m-20 -90.67 128.41 36.62 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.234 0.54 . . . . 52.32 111.215 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -69.76 -26.06 64.12 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 124.223 1.009 . . . . 73.24 111.817 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' B' ' 2' ' ' ASP . 21.7 ptmt -65.5 -24.09 67.06 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 113.145 0.794 . . . . 73.33 113.145 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 73.5 mt -64.34 -52.75 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.208 0.603 . . . . 54.42 111.348 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.48 -26.81 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 122.846 0.459 . . . . 71.41 111.887 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.38 -45.81 88.93 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 123.44 0.462 . . . . 74.11 112.984 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.92 91.9 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.701 0.8 . . . . 63.34 111.802 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.38 -41.85 97.78 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.678 0.791 . . . . 61.32 110.935 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.92 -24.05 55.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.95 0.9 . . . . 64.33 112.533 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.22 -41.51 99.51 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 121.354 0.419 . . . . 32.35 112.65 172.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -70.65 -41.1 72.58 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.081 0.953 . . . . 71.3 111.293 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.501 HG13 HD21 ' B' ' 28' ' ' LEU . 77.4 t -60.98 -46.1 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.887 0.875 . . . . 70.44 112.092 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -71.84 -31.79 66.87 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 116.286 -0.415 . . . . 75.12 111.424 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -56.62 -37.75 71.13 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.744 0.418 . . . . 72.14 111.471 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.18 75.4 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.038 0.535 . . . . 65.31 111.84 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.632 HD21 HG13 ' B' ' 63' ' ' ILE . 93.8 mt -73.83 -37.63 64.79 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.963 0.905 . . . . 55.22 112.158 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -59.08 -39.33 81.82 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.699 0.8 . . . . 73.21 110.636 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -79.17 -48.56 14.04 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.538 -0.755 . . . . 71.32 111.134 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.31 99.5 3.15 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.201 0.6 . . . . 63.33 111.566 -173.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.01 174.55 10.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.2 0.6 . . . . 65.44 112.272 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.94 13.32 83.52 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.224 -0.444 . . . . 63.32 113.977 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.402 HG21 HD13 ' B' ' 28' ' ' LEU . 11.0 tp -78.06 138.52 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 C-N-CA 123.15 0.58 . . . . 71.32 110.9 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.4 m -84.61 151.32 24.58 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.936 0.494 . . . . 64.14 111.015 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' A' ' 37' ' ' GLU . 54.2 mt -53.56 -45.84 98.45 Favored Pre-proline 0 CA--C 1.581 2.165 0 N-CA-C 114.711 1.375 . . . . 63.15 114.711 -172.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' B' ' 36' ' ' VAL . 65.8 Cg_endo -71.29 -29.15 17.47 Favored 'Trans proline' 0 C--N 1.396 3.038 0 CA-C-N 121.803 1.68 . . . . 71.5 113.415 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -73.6 -49.21 27.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.157 0.98 . . . . 72.24 109.863 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.501 HD21 HG13 ' B' ' 13' ' ' VAL . 62.5 tp -53.93 -36.24 62.56 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 113.013 -1.903 . . . . 74.35 111.775 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.05 83.35 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.658 0.783 . . . . 70.51 112.108 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' B' ' 26' ' ' PRO . 10.3 mpt_? -70.94 -39.88 72.37 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.942 0.497 . . . . 75.12 110.593 175.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.61 -43.18 93.84 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.311 0.644 . . . . 71.32 111.233 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.4 -5.88 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.58 0.752 . . . . 74.44 112.247 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 66.12 21.15 11.19 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.79 1.236 . . . . 63.55 113.01 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 68.5 mt -108.72 169.39 8.69 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.862 0.865 . . . . 73.1 110.553 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -72.34 155.5 40.09 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.003 0.521 . . . . 62.21 111.003 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' B' ' 26' ' ' PRO . 96.4 t -56.74 -44.04 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 123.579 0.751 . . . . 32.21 112.364 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.39 -49.25 78.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.626 0.77 . . . . 65.2 111.861 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -61.73 -38.68 88.81 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.556 1.142 . . . . 71.15 111.914 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.485 ' O ' HG23 ' B' ' 43' ' ' VAL . 92.4 m -70.08 -46.75 64.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.116 0.966 . . . . 71.23 111.037 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.472 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -62.09 -35.41 78.59 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.745 0.818 . . . . 64.14 112.137 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -69.64 -37.78 76.91 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.3 1.04 . . . . 74.53 110.156 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.55 -34.78 77.75 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.208 0.603 . . . . 73.54 111.428 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.485 HG23 ' O ' ' B' ' 39' ' ' THR . 98.4 t -61.8 -33.94 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.251 0.621 . . . . 74.42 110.921 172.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.654 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -62.05 -30.45 75.59 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 116.155 -0.475 . . . . 63.24 114.011 176.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.426 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 70.6 t-105 -68.49 -38.91 81.42 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.937 0.495 . . . . 54.22 110.899 172.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 93.1 mt -70.01 -33.07 71.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.926 0.491 . . . . 70.13 111.299 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.22 -31.27 72.34 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.923 0.889 . . . . 62.33 111.589 170.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' A' ' 48' ' ' ARG . 15.3 ttt180 -65.74 -44.84 84.76 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.742 0.817 . . . . 74.04 111.322 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -80.05 -3.99 50.83 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.409 0.683 . . . . 74.21 112.451 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 62.11 21.92 12.75 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.27 1.428 . . . . 74.5 112.983 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -86.5 -4.06 59.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.067 0.947 . . . . 65.1 113.074 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.74 146.69 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 112.41 0.522 . . . . 61.22 112.41 -177.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.68 120.15 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.227 -1.027 . . . . 72.22 108.227 172.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.558 HG12 HG22 ' B' ' 63' ' ' ILE . 62.4 mt -106.99 111.88 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-O 121.341 0.591 . . . . 65.02 110.973 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -114.02 140.71 48.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.144 0.978 . . . . 72.23 110.636 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -113.51 103.28 11.11 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.503 0.721 . . . . 64.53 110.8 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.9 113.72 26.22 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.587 1.155 . . . . 62.13 108.829 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 60.04 30.47 19.95 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.093 0.957 . . . . 73.33 112.653 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.58 -10.35 62.23 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 113.942 0.337 . . . . 74.34 113.942 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 44.5 tp -84.21 128.88 34.84 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.001 0.92 . . . . 73.04 110.281 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.8 126.85 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.076 0.55 . . . . 51.52 109.827 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.94 120.64 36.96 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.038 -1.097 . . . . 73.23 108.038 173.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.632 HG13 HD21 ' B' ' 17' ' ' LEU . 34.1 pt -103.48 138.94 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.245 0.545 . . . . 70.53 110.557 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -121.49 179.07 4.56 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.459 1.104 . . . . 63.15 110.025 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.421 ' OD1' ' HB3' ' B' ' 17' ' ' LEU . 1.6 m-20 -82.15 160.55 23.07 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.051 -0.351 . . . . 73.0 110.051 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -53.3 98.96 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.374 0.67 . . . . 52.32 111.187 172.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.52 -36.29 0.07 OUTLIER Glycine 0 C--N 1.349 1.25 0 CA-C-N 116.293 -0.412 . . . . 73.3 112.925 -175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -74.91 -2.62 27.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 112.156 0.428 . . . . 74.42 112.156 173.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -65.58 -44.45 86.62 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.595 -0.521 . . . . 74.12 109.595 163.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.77 146.28 51.57 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.392 -0.822 . . . . 75.4 110.284 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -139.96 147.99 41.29 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.246 0.546 . . . . 74.3 111.47 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 88.1 p -102.14 -173.76 2.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.074 0.949 . . . . 73.34 109.252 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -75.85 94.96 3.41 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 109.475 -0.565 . . . . 75.14 109.475 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.89 94.36 0.15 Allowed Glycine 0 C--N 1.344 1.025 0 CA-C-N 116.193 -0.458 . . . . 15.24 112.025 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.14 102.98 5.13 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.321 0.649 . . . . 75.44 110.598 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' B' ' 77' ' ' HIS . 22.6 tt0 -78.9 174.91 11.02 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.269 0.628 . . . . 75.15 109.834 176.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.45 ' H ' ' HG2' ' B' ' 76' ' ' GLU . 31.4 p80 -52.44 139.05 25.94 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.328 0.651 . . . . 72.14 111.885 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -63.95 135.37 56.44 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.969 0.508 . . . . 64.43 110.0 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -60.4 145.11 49.19 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.407 0.683 . . . . 74.11 111.843 -170.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -53.45 119.73 5.2 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.204 1.002 . . . . 63.43 113.185 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -71.04 137.15 48.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.93 0.892 . . . . 74.03 110.577 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 45.2 m80 . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.621 0.724 . . . . 74.21 112.336 -178.283 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HE3' ' HB ' ' B' ' 54' ' ' ILE . 18.7 ptm . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 112.924 0.713 . . . . 75.13 112.924 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 64.45 89.46 0.09 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.036 1.334 . . . . 73.23 110.39 -173.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' B' ' 50' ' ' ASN . 62.2 tttm -70.28 -15.14 62.86 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.773 1.397 . . . . 75.21 114.773 -162.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -67.69 -14.49 62.99 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.837 0.68 . . . . 64.33 112.837 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.4 mt -49.15 -50.04 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 124.07 0.948 . . . . 62.2 112.215 173.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 3' ' ' LYS . 33.4 m -61.78 -28.02 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 112.436 0.532 . . . . 50.32 112.436 -177.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.52 -38.4 86.48 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 122.953 0.158 . . . . 32.44 113.073 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.59 -52.52 25.38 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.668 0.787 . . . . 62.34 111.785 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -59.26 -43.0 92.5 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.053 0.941 . . . . 55.41 112.155 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.4 -27.56 63.4 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.341 0.497 . . . . 70.42 112.341 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.79 -38.9 96.84 Favored Glycine 0 CA--C 1.538 1.485 0 O-C-N 123.332 0.395 . . . . 60.31 112.718 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -70.42 -43.82 69.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.502 0.721 . . . . 62.25 111.277 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.563 ' HA ' HG11 ' A' ' 32' ' ' VAL . 95.2 t -59.27 -42.75 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.433 0.693 . . . . 64.04 111.195 176.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 64.5 t90 -66.41 -32.98 74.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.851 0.86 . . . . 74.43 111.393 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -60.5 -53.73 53.98 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.068 0.147 . . . . 70.42 111.342 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.08 -30.91 71.94 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.172 0.589 . . . . 61.12 111.461 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.49 -50.71 50.32 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.99 1.316 . . . . 72.44 111.366 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.69 -23.87 59.87 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.361 0.664 . . . . 74.12 111.06 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -79.8 -37.06 36.04 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.393 1.077 . . . . 74.42 110.46 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.22 103.54 1.64 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.802 0.841 . . . . 61.22 110.705 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.674 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 10.7 p-10 -95.04 166.42 11.94 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.298 0.639 . . . . 72.15 112.148 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.68 64.16 1.11 Allowed Glycine 0 N--CA 1.473 1.133 0 CA-C-N 116.095 -0.502 . . . . 50.04 112.201 -175.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 tt -156.36 149.76 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 123.428 0.691 . . . . 71.03 111.116 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -86.17 158.58 19.72 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.232 0.613 . . . . 71.52 111.649 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.502 HG21 ' HB2' ' A' ' 40' ' ' ALA . 74.4 mt -53.68 -52.59 65.89 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 114.185 1.18 . . . . 55.11 114.185 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.0 -26.18 43.72 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 121.773 1.649 . . . . 71.13 114.188 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -76.22 -45.57 32.39 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.455 1.121 . . . . 54.15 109.423 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.9 tp -60.1 -34.35 73.36 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 113.284 -1.78 . . . . 60.44 111.973 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.66 95.36 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.007 0.923 . . . . 64.44 112.438 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -71.49 -27.94 63.57 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.856 0.462 . . . . 63.43 112.044 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -66.67 -52.28 46.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.222 0.534 . . . . 63.13 110.914 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.563 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.0 m -79.07 -5.87 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 115.184 -0.916 . . . . 52.42 111.838 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 69.28 16.35 8.42 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.239 1.415 . . . . 70.0 112.171 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.8 mt -97.23 164.21 12.58 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.555 0.742 . . . . 71.11 110.254 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -68.23 153.58 43.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.414 0.286 . . . . 70.12 111.323 172.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.68 -44.92 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 123.486 0.714 . . . . 61.3 111.887 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -60.25 -42.8 96.09 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.95 0.9 . . . . 54.0 111.797 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 t -64.91 -42.68 94.52 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.587 0.755 . . . . 54.34 111.369 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 43' ' ' VAL . 61.6 m -71.49 -37.9 71.24 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.805 0.842 . . . . 54.25 111.775 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.94 -44.86 88.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 123.747 0.819 . . . . 75.13 111.504 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 6' ' ' VAL . 1.3 tm? -64.33 -37.33 87.13 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.461 -1.245 . . . . 61.33 110.357 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.04 -36.48 72.36 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.371 0.669 . . . . 73.1 112.449 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 39' ' ' THR . 88.0 t -66.75 -36.81 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.097 0.559 . . . . 52.42 110.452 173.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.51 -31.97 82.57 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-N 116.099 -0.5 . . . . 74.51 112.709 172.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.457 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 75.6 t-105 -74.03 -27.97 61.2 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.33 0.652 . . . . 72.24 111.582 173.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.76 -34.6 67.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.534 -0.729 . . . . 74.21 111.593 172.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.54 -26.59 55.33 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.11 0.964 . . . . 64.31 113.147 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.814 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 7.2 ptm180 -56.22 -36.65 68.7 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.387 0.884 . . . . 71.22 113.387 -174.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.814 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 39.3 mt-10 -112.22 15.76 20.32 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.117 0.967 . . . . 64.01 111.24 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.42 47.65 8.57 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.428 1.091 . . . . 54.2 110.048 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -87.68 -14.6 39.46 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.736 0.643 . . . . 64.53 112.736 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 m -133.23 150.64 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.92 0.888 . . . . 71.11 111.933 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 54.4 t -102.57 113.64 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.734 1.214 . . . . 60.2 108.772 171.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.458 HG23 HG23 ' A' ' 61' ' ' ILE . 50.4 mm -100.17 108.85 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 118.061 0.391 . . . . 73.2 110.983 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB3' ' NZ ' ' A' ' 57' ' ' LYS . 28.4 mm-40 -104.9 127.76 52.86 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.284 1.034 . . . . 72.02 110.356 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.535 HH22 ' HA ' ' B' ' 38' ' ' SER . 81.4 mtt-85 -113.61 105.55 13.47 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.872 -0.517 . . . . 71.25 111.529 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' NZ ' ' HB3' ' A' ' 55' ' ' GLU . 14.4 mptt -112.48 119.47 38.33 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.877 0.871 . . . . 61.43 109.843 176.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 57.97 32.61 22.19 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.148 0.979 . . . . 72.23 112.27 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.23 -6.39 72.15 Favored Glycine 0 CA--C 1.543 1.844 0 N-CA-C 114.269 0.468 . . . . 75.12 114.269 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.8 mt -88.24 125.66 34.76 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.602 0.761 . . . . 73.25 110.192 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.458 HG23 HG23 ' A' ' 54' ' ' ILE . 2.8 mp -86.01 126.31 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.512 0.725 . . . . 65.03 110.048 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -109.92 128.64 55.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.682 1.193 . . . . 74.14 108.9 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.9 mp -107.83 106.86 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 108.832 -0.803 . . . . 72.01 108.832 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.674 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 96.7 m-85 -107.55 167.16 10.14 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.573 1.149 . . . . 74.41 110.596 175.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -90.54 147.31 23.44 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.894 0.378 . . . . 71.31 110.873 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -85.05 5.03 31.21 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.075 0.464 . . . . 73.34 112.239 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.85 -58.51 11.74 Favored Glycine 0 C--N 1.351 1.363 0 N-CA-C 110.331 -1.108 . . . . 64.21 110.331 163.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -175.9 121.63 0.18 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.926 1.29 . . . . 64.04 109.573 166.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -68.71 145.65 53.66 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.106 0.562 . . . . 74.43 110.382 171.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -101.44 -58.85 1.8 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.061 0.457 . . . . 74.25 110.463 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -91.94 172.14 8.65 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.47 0.708 . . . . 73.52 111.957 -174.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.5 m -166.83 96.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.892 1.677 . . . . 52.33 108.182 166.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.621 ' HB2' HD22 ' A' ' 75' ' ' LEU . 16.6 p90 -129.22 -69.34 0.7 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 112.782 0.66 . . . . 73.51 112.782 -167.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 49.3 42.6 33.23 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 114.503 0.561 . . . . 52.11 114.503 -173.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 73' ' ' PHE . 2.0 pt? -103.46 142.56 34.04 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.252 0.549 . . . . 55.23 112.431 -171.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -170.18 142.07 2.19 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.014 1.326 . . . . 72.54 109.412 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -81.88 52.53 1.96 Allowed 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.548 0.69 . . . . 74.1 111.547 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -144.79 115.52 7.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.852 0.861 . . . . 71.44 110.116 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -78.46 175.58 10.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.888 0.875 . . . . 63.23 112.295 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -82.51 164.57 20.82 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.261 -0.881 . . . . 74.54 111.266 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -84.07 6.74 21.05 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 113.052 0.76 . . . . 73.42 113.052 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 N--CA 1.481 1.078 0 C-N-CA 123.666 0.787 . . . . 63.11 110.008 174.657 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 120.462 0.172 . . . . 74.43 110.877 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -54.28 -38.0 65.36 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.368 1.067 . . . . 73.31 112.754 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -23.96 62.17 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.925 -1.034 . . . . 74.22 111.417 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -91.68 -25.21 19.22 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.317 0.647 . . . . 61.11 112.112 175.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 75.2 mt -59.89 -46.19 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 122.97 0.508 . . . . 70.34 110.521 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.408 HG12 HD11 ' B' ' 41' ' ' LEU . 35.7 m -64.12 -30.95 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 122.884 0.473 . . . . 62.34 112.113 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.24 -41.54 59.34 Favored Glycine 0 CA--C 1.538 1.49 0 O-C-N 123.191 0.307 . . . . 73.33 113.174 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.76 -43.58 88.45 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.78 0.832 . . . . 53.25 111.469 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -65.55 -35.7 81.62 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.736 0.814 . . . . 63.44 111.27 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.45 70.96 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.164 0.586 . . . . 51.43 111.264 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.27 -36.87 92.32 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 116.299 -0.409 . . . . 74.14 112.57 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -63.97 -47.67 79.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.111 0.965 . . . . 65.32 111.878 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 75.8 t -62.32 -46.8 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.328 0.651 . . . . 62.41 111.153 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.571 ' HA ' HD12 ' B' ' 17' ' ' LEU . 17.9 t90 -64.02 -33.85 76.68 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.776 0.83 . . . . 74.41 111.436 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' HIS . . . . . 0.415 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 78.4 t60 -59.8 -47.99 83.48 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.974 0.509 . . . . 71.21 110.467 172.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.09 -26.84 68.73 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.23 0.612 . . . . 72.52 112.598 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' B' ' 14' ' ' TRP . 75.4 mt -68.84 -41.49 78.45 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.519 0.728 . . . . 63.43 111.166 172.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.01 -26.13 65.74 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.882 -0.599 . . . . 72.14 110.996 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 10.4 mm-40 -73.6 -47.18 42.24 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.413 0.685 . . . . 61.04 110.533 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.9 106.63 0.61 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.238 1.015 . . . . 71.44 110.554 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -95.6 179.67 5.05 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.485 0.714 . . . . 72.43 112.118 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.76 39.3 34.38 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 116.191 -0.459 . . . . 53.22 112.493 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.402 ' O ' HG22 ' B' ' 63' ' ' ILE . 17.4 tt -124.29 153.45 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.954 0.902 . . . . 63.13 110.751 -172.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -80.29 151.56 29.48 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.801 0.441 . . . . 75.2 111.462 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' B' ' 40' ' ' ALA . 87.3 mt -51.04 -49.14 82.79 Favored Pre-proline 0 CA--C 1.577 1.991 0 N-CA-C 114.451 1.278 . . . . 74.1 114.451 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.477 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 59.9 Cg_endo -67.33 -30.17 37.31 Favored 'Trans proline' 0 C--N 1.393 2.89 0 C-N-CA 121.711 1.607 . . . . 71.22 114.135 -176.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -76.68 -44.17 34.8 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.229 1.014 . . . . 60.53 110.307 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.33 -40.19 74.02 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 113.427 -1.715 . . . . 72.42 111.287 171.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.82 -38.33 85.05 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.102 0.961 . . . . 65.24 112.505 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' B' ' 26' ' ' PRO . 14.7 mmm-85 -63.29 -44.1 96.01 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.4 0.68 . . . . 75.44 110.651 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -67.21 -43.27 82.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.864 0.866 . . . . 75.41 111.833 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.3 m -83.03 -5.27 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 122.875 0.47 . . . . 64.13 111.768 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.21 11.56 8.23 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.422 1.489 . . . . 60.45 112.682 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.7 mt -93.17 165.79 12.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.531 0.732 . . . . 71.45 110.019 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -65.94 153.55 41.77 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 122.239 -0.288 . . . . 72.44 110.59 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 54.9 t -49.88 -52.26 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.104 0.962 . . . . 45.04 112.171 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -71.12 -30.64 66.75 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.295 1.038 . . . . 74.34 111.436 -176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.535 ' HA ' HH22 ' A' ' 56' ' ' ARG . 41.7 m -64.97 -42.17 94.81 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.629 0.772 . . . . 73.41 110.775 173.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.449 ' O ' HG23 ' B' ' 43' ' ' VAL . 84.9 m -70.06 -43.19 71.72 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.103 0.961 . . . . 75.25 111.075 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.522 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -62.06 -42.66 99.43 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 123.975 0.91 . . . . 75.33 112.106 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.408 HD11 HG12 ' B' ' 6' ' ' VAL . 1.5 tm? -64.67 -38.26 90.39 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.698 1.199 . . . . 74.5 110.365 176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.92 72.07 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.548 0.739 . . . . 74.4 111.958 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 39' ' ' THR . 75.0 t -63.7 -35.68 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.481 0.713 . . . . 72.41 110.67 172.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.35 -31.24 80.08 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 116.29 -0.414 . . . . 44.02 113.41 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.499 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 43.6 t-105 -74.39 -31.24 62.28 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.229 0.612 . . . . 73.01 111.331 176.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.27 -36.29 68.97 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.29 0.636 . . . . 65.14 111.433 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.31 82.9 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.825 0.85 . . . . 73.21 110.8 172.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.562 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 31.2 ttt180 -51.84 -50.6 60.58 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.636 0.775 . . . . 64.24 111.064 171.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -80.01 -2.31 43.58 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.947 -1.024 . . . . 72.14 112.737 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ASN . . . . . 0.533 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 57.2 m-20 64.75 26.63 13.05 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.754 1.222 . . . . 60.31 112.694 176.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -99.29 5.73 46.45 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.136 0.791 . . . . 61.1 113.136 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.492 ' HB ' HD11 ' B' ' 63' ' ' ILE . 28.5 m -135.31 156.8 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.398 0.618 . . . . 71.21 112.589 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 32.4 t -111.56 125.29 68.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 124.475 1.11 . . . . 72.44 109.262 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.432 ' HB ' ' HE3' ' A' ' 1' ' ' MET . 39.7 mm -111.83 103.42 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.42 -0.956 . . . . 74.02 108.42 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' GLU . . . . . 0.471 ' HB3' ' HE1' ' B' ' 64' ' ' TYR . 7.7 tp10 -118.86 115.79 25.15 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.938 0.399 . . . . 63.1 109.982 -173.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -84.69 107.05 16.69 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.544 0.687 . . . . 72.21 111.063 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -104.82 114.39 28.57 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.581 1.153 . . . . 62.01 109.912 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 58.44 32.44 22.11 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.063 0.945 . . . . 72.13 112.399 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.17 -20.02 31.88 Favored Glycine 0 CA--C 1.545 1.942 0 N-CA-C 114.06 0.384 . . . . 75.23 114.06 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 tt -88.41 138.34 31.52 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.456 1.102 . . . . 51.33 109.9 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -87.8 122.95 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.753 0.421 . . . . 62.43 111.704 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -108.45 127.08 53.59 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.089 0.956 . . . . 74.25 108.633 171.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.492 HD11 ' HB ' ' B' ' 52' ' ' VAL . 0.0 OUTLIER -104.75 121.91 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-O 121.887 0.851 . . . . 72.35 110.154 -176.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.62 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 45.3 m-85 -107.71 157.76 17.84 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.624 1.17 . . . . 73.12 110.141 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -85.16 162.97 19.01 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.039 0.536 . . . . 72.51 111.48 -175.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -52.99 121.8 8.09 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.227 1.011 . . . . 70.03 112.473 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.19 -71.9 0.28 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 111.551 -0.62 . . . . 74.14 111.551 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -93.49 73.62 4.43 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.318 0.647 . . . . 62.3 110.309 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.57 -38.39 55.03 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.521 0.728 . . . . 75.33 111.157 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.04 81.24 3.56 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.268 -0.641 . . . . 74.35 109.268 170.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.48 -46.46 76.23 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.81 -0.632 . . . . 73.12 110.662 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 73.4 p -87.56 108.94 19.29 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.398 -0.819 . . . . 65.24 110.208 170.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -81.08 80.5 7.53 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-O 121.586 0.708 . . . . 75.44 109.725 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.03 79.49 1.62 Allowed Glycine 0 C--N 1.354 1.56 0 CA-C-N 115.326 -0.852 . . . . 62.33 113.975 -170.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.06 -60.82 2.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.493 0.717 . . . . 72.25 111.287 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -91.17 29.25 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.031 0.92 . . . . 74.45 112.293 -173.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -72.65 105.15 4.15 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.026 -1.101 . . . . 73.41 108.026 166.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -52.44 130.49 31.65 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.188 0.995 . . . . 73.31 113.206 -168.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -147.05 155.8 42.5 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.19 0.996 . . . . 65.21 111.319 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -163.79 157.89 19.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.794 0.838 . . . . 73.41 110.173 173.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -129.17 164.35 23.58 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.591 0.757 . . . . 72.12 111.562 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 124.303 1.041 . . . . 74.53 111.153 -174.27 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.567 ' HG2' HD12 ' A' ' 5' ' ' ILE . 51.8 ttm . . . . . 0 CA--C 1.551 1.016 0 N-CA-C 109.986 -0.376 . . . . 74.35 109.986 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -54.99 146.58 17.49 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.549 1.14 . . . . 74.22 113.86 -175.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -78.13 -33.5 50.43 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.495 0.718 . . . . 54.51 112.815 -173.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 11.2 mmpt? -67.04 -17.12 64.76 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 112.37 0.507 . . . . 72.54 112.37 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.567 HD12 ' HG2' ' A' ' 1' ' ' MET . 54.6 mt -65.28 -46.92 89.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.34 0.656 . . . . 71.14 111.579 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 3' ' ' LYS . 9.9 m -68.81 -27.55 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 118.057 0.39 . . . . 70.21 111.676 177.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.04 -42.52 94.56 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.557 0.536 . . . . 33.51 112.491 172.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.11 81.1 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.487 0.715 . . . . 75.22 111.24 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -61.73 -36.12 80.03 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.569 0.747 . . . . 75.11 111.161 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.93 -36.61 69.97 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.533 0.733 . . . . 63.15 111.615 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.86 -31.41 75.54 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-N 116.41 -0.359 . . . . 74.43 112.545 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.554 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 53.8 tptt -71.0 -42.28 69.83 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.442 1.097 . . . . 63.42 111.186 175.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.59 -40.7 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.993 0.917 . . . . 44.23 111.343 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 13.4 t90 -69.33 -33.53 73.25 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 116.018 -0.537 . . . . 73.35 110.399 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -57.13 -46.05 83.01 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.134 0.573 . . . . 72.21 110.744 168.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.36 -29.57 66.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.517 0.727 . . . . 73.25 112.481 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.12 -49.1 60.1 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.627 0.771 . . . . 41.54 112.083 172.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -67.56 -22.31 65.4 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.067 0.461 . . . . 35.23 111.303 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -76.2 -48.72 19.37 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.292 1.037 . . . . 72.54 109.614 174.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.24 97.4 0.34 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.753 1.221 . . . . 52.54 110.263 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.98 173.75 11.5 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.732 0.813 . . . . 73.4 112.258 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.04 61.38 4.03 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.765 -0.534 . . . . 62.53 111.765 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.11 159.08 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 123.153 0.581 . . . . 71.11 111.185 -166.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 58.8 m -79.47 153.28 29.74 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.844 0.354 . . . . 72.44 111.09 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.645 HG21 ' HB2' ' A' ' 40' ' ' ALA . 95.8 mt -53.56 -54.8 41.73 Favored Pre-proline 0 CA--C 1.576 1.956 0 C-N-CA 124.494 1.118 . . . . 44.35 112.245 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 55.9 Cg_endo -66.36 -25.19 49.35 Favored 'Trans proline' 0 C--N 1.401 3.301 0 C-N-CA 121.764 1.643 . . . . 73.24 113.741 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -70.63 -51.84 25.36 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.383 0.673 . . . . 75.11 112.501 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.61 -33.01 74.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.312 0.245 . . . . 73.11 110.381 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.14 -41.25 64.91 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.622 1.169 . . . . 61.21 112.645 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 26' ' ' PRO . 46.9 mtt180 -62.62 -41.18 98.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.927 0.891 . . . . 72.25 111.553 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -72.61 -43.24 63.57 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.731 0.813 . . . . 75.43 111.243 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.554 ' HB ' ' HG3' ' A' ' 12' ' ' LYS . 26.2 m -85.69 -0.47 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 115.465 -0.789 . . . . 75.43 112.26 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.6 m120 67.08 11.21 8.26 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.897 1.279 . . . . 72.44 113.229 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.5 mt -89.24 148.01 23.83 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.374 -0.602 . . . . 63.23 109.374 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.3 t -63.25 153.4 34.84 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.45 0.3 . . . . 32.24 110.952 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.45 -42.44 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 123.278 0.631 . . . . 75.42 111.333 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.53 -43.39 98.94 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.417 0.687 . . . . 61.34 112.338 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.4 m -62.09 -33.02 73.65 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 123.302 0.641 . . . . 73.43 111.707 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 43' ' ' VAL . 79.0 m -77.4 -53.06 8.11 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.763 0.825 . . . . 71.01 111.641 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -59.73 -41.75 91.6 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.416 1.087 . . . . 43.11 112.884 -177.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -65.49 -39.02 91.42 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.405 1.082 . . . . 63.13 110.407 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.17 -31.12 69.53 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 123.241 0.616 . . . . 64.12 112.016 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 39' ' ' THR . 87.2 t -61.02 -38.13 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 123.765 0.826 . . . . 61.32 110.354 171.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.94 -32.03 82.88 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.794 -0.639 . . . . 75.3 113.943 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.437 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 70.8 t-105 -70.31 -37.38 74.73 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.059 0.457 . . . . 73.41 110.708 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.54 -35.63 79.44 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.774 0.43 . . . . 71.13 111.047 172.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.67 88.91 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.513 0.725 . . . . 74.04 111.421 172.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 22.7 ttt180 -55.61 -49.91 71.54 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.799 0.84 . . . . 62.0 111.128 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -78.4 -6.02 54.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.755 0.822 . . . . 71.42 111.718 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 62.07 22.87 13.42 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.601 1.56 . . . . 42.02 112.462 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -78.28 -5.63 52.61 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.458 1.103 . . . . 55.31 113.41 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 63' ' ' ILE . 25.6 m -133.14 151.98 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.171 0.589 . . . . 61.34 112.294 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 64' ' ' TYR . 17.3 m -123.27 121.04 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 C-N-CA 124.108 0.963 . . . . 55.1 109.014 169.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.532 HG12 HD11 ' B' ' 41' ' ' LEU . 3.6 mp -100.99 124.29 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 109.154 -0.684 . . . . 62.52 109.154 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.42 148.59 44.92 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.253 0.621 . . . . 72.11 112.16 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -100.61 112.63 25.04 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.446 0.699 . . . . 71.52 110.267 171.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -105.44 112.77 26.0 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.846 0.859 . . . . 71.4 108.942 173.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 55.88 30.77 16.52 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.631 1.172 . . . . 73.23 112.067 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.96 -27.2 13.48 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 115.431 -0.804 . . . . 54.12 113.986 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.31 132.3 42.93 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.781 0.832 . . . . 73.04 111.394 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.0 mt -89.7 123.98 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.449 0.699 . . . . 65.21 111.511 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -127.58 139.05 53.01 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.458 1.103 . . . . 73.35 109.748 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.46 HD11 HG11 ' A' ' 52' ' ' VAL . 6.1 tt -95.07 136.34 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.287 0.635 . . . . 73.34 110.533 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.56 ' HB2' HG23 ' A' ' 53' ' ' VAL . 98.8 m-85 -130.37 169.39 15.54 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.546 1.138 . . . . 64.53 110.374 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.54 155.43 20.49 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.425 0.69 . . . . 71.03 110.264 171.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -173.01 1.0 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 120.935 0.398 . . . . 73.22 111.86 169.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.33 25.89 71.77 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 116.612 -0.267 . . . . 43.24 112.903 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -111.27 -49.71 2.99 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.117 0.967 . . . . 73.42 109.626 176.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -92.26 123.85 35.9 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.375 0.67 . . . . 74.54 110.006 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.13 124.61 28.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.783 0.833 . . . . 73.22 112.202 -170.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -79.44 145.93 33.04 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.169 0.588 . . . . 73.52 110.42 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 t 66.6 29.99 8.59 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.63 1.172 . . . . 62.43 111.357 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -113.46 1.89 15.21 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.806 0.842 . . . . 73.23 111.38 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.28 -84.26 0.35 Allowed Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.993 -0.843 . . . . 54.2 110.993 -172.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.7 mt 71.68 -50.39 0.69 Allowed 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 125.822 1.649 . . . . 74.2 113.979 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -62.53 120.43 11.11 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.744 0.818 . . . . 64.45 111.704 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -117.06 135.18 53.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.361 1.064 . . . . 73.43 108.514 169.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -60.15 106.72 0.55 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.176 0.59 . . . . 72.42 110.827 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -64.9 157.19 28.67 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.638 . . . . 73.53 111.867 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -75.11 121.33 21.89 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.023 -0.535 . . . . 71.32 110.562 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -77.06 93.22 3.83 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.814 0.846 . . . . 64.21 110.074 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.6 t60 . . . . . 0 N--CA 1.483 1.203 0 C-N-CA 124.375 1.07 . . . . 74.31 111.486 -179.222 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 CA--C 1.55 0.945 0 N-CA-C 112.086 0.402 . . . . 74.13 112.086 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -144.2 154.42 43.11 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.61 0.764 . . . . 53.32 111.09 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -80.9 -25.87 37.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.166 0.586 . . . . 65.2 112.21 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -65.25 -20.25 66.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.302 -0.249 . . . . 71.21 111.603 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.58 -59.55 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.084 0.554 . . . . 75.31 110.91 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.66 -29.84 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 111.842 0.312 . . . . 74.42 111.842 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.29 -47.5 63.48 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.366 0.416 . . . . 70.4 113.138 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.68 96.61 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.935 0.894 . . . . 43.02 111.296 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.57 -42.26 87.31 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.636 -0.711 . . . . 73.22 111.581 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.72 -35.32 72.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.089 0.556 . . . . 64.45 112.105 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.66 -38.13 95.26 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 116.332 -0.394 . . . . 61.24 112.994 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -75.72 -42.45 50.67 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.744 0.818 . . . . 74.11 110.943 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.572 ' HA ' HG11 ' B' ' 32' ' ' VAL . 34.3 t -62.78 -48.05 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.384 1.074 . . . . 65.31 111.47 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.436 ' NE1' ' HB3' ' B' ' 51' ' ' LYS . 48.3 t90 -64.92 -35.12 80.13 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.024 0.53 . . . . 65.35 111.735 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' HIS . . . . . 0.451 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 38.9 t60 -65.4 -46.79 78.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.567 0.347 . . . . 70.35 110.419 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.15 62.51 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.37 0.668 . . . . 73.13 112.149 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.408 HD13 ' ND2' ' B' ' 65' ' ' ASN . 1.4 tm? -72.87 -31.77 64.95 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.569 1.148 . . . . 64.41 110.397 171.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.68 -36.46 73.32 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.569 -0.53 . . . . 65.13 109.569 175.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 12.3 mm-40 -72.49 -49.88 29.89 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.326 0.65 . . . . 73.13 110.617 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.8 86.75 2.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.013 0.925 . . . . 73.33 110.206 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -68.67 124.61 24.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.633 0.773 . . . . 54.5 111.778 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.61 63.07 2.4 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.451 -0.34 . . . . 62.33 112.389 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.6 tp -117.3 137.96 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.594 0.758 . . . . 71.23 110.764 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -67.68 147.75 52.25 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.563 0.745 . . . . 73.33 110.901 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.523 HG21 ' HB2' ' B' ' 40' ' ' ALA . 60.8 mt -56.99 -49.89 91.35 Favored Pre-proline 0 CA--C 1.58 2.119 0 N-CA-C 113.422 0.897 . . . . 61.35 113.422 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.63 -27.38 32.48 Favored 'Trans proline' 0 C--N 1.399 3.203 0 C-N-CA 121.799 1.666 . . . . 65.31 114.026 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -70.91 -52.68 18.57 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.067 0.937 . . . . 71.24 109.245 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.446 HD21 HG13 ' B' ' 13' ' ' VAL . 60.6 tp -54.56 -38.34 66.53 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 113.249 -1.796 . . . . 73.52 112.15 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.72 -45.14 93.08 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.993 0.917 . . . . 63.04 111.915 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -67.7 -37.71 82.65 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.23 0.612 . . . . 74.34 110.861 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -64.12 -30.01 71.1 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.781 0.832 . . . . 61.45 112.243 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' B' ' 13' ' ' VAL . 34.1 m -103.09 1.91 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 112.769 0.655 . . . . 74.12 112.769 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 64.3 27.79 13.79 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 124.868 1.267 . . . . 63.32 113.132 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 72.4 mt -113.18 166.54 11.35 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.752 0.821 . . . . 74.12 111.448 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 31.6 t -69.43 155.74 39.96 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.664 -0.698 . . . . 63.31 111.61 170.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 67.8 t -56.37 -42.39 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.586 0.754 . . . . 72.42 111.033 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.83 -47.31 86.24 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.005 0.922 . . . . 65.42 111.457 175.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 41.5 t -63.72 -38.09 89.79 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.106 0.963 . . . . 72.43 112.089 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.46 ' O ' HG23 ' B' ' 43' ' ' VAL . 94.1 m -75.12 -49.44 19.59 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.863 0.865 . . . . 74.54 111.866 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.523 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -60.25 -39.59 87.28 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.69 0.796 . . . . 63.12 112.257 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.532 HD11 HG12 ' A' ' 54' ' ' ILE . 1.2 tt -62.2 -48.71 78.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.182 0.993 . . . . 74.03 110.064 173.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.72 -29.99 68.5 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.98 -1.009 . . . . 64.02 112.116 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.616 HG11 HD12 ' B' ' 63' ' ' ILE . 72.8 t -68.84 -37.17 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 123.061 0.544 . . . . 73.34 110.768 176.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -68.9 -30.25 72.43 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 116.431 -0.349 . . . . 32.3 112.79 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.456 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 72.6 t-105 -73.67 -21.07 60.38 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.304 0.642 . . . . 70.35 110.991 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.72 -33.8 58.15 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.645 0.778 . . . . 52.14 112.29 167.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.76 -25.53 60.61 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.057 1.132 . . . . 71.13 114.057 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.582 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 35.7 ptt85 -61.75 -36.38 80.85 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.036 0.446 . . . . 70.31 111.878 174.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.582 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 41.0 mt-10 -96.37 -2.7 45.13 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.35 1.06 . . . . 64.25 111.344 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 63.55 20.55 12.3 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 125.395 1.478 . . . . 70.13 113.065 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.436 ' HB3' ' NE1' ' B' ' 14' ' ' TRP . 49.5 mtmt -75.46 -8.18 56.04 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.378 0.881 . . . . 74.23 113.378 -173.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -128.57 151.58 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.915 0.886 . . . . 71.41 110.693 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.606 HG23 ' HB2' ' B' ' 64' ' ' TYR . 8.3 m -123.95 123.61 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.166 0.986 . . . . 62.43 109.884 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.582 HG23 HG23 ' B' ' 61' ' ' ILE . 1.9 mp -91.3 119.77 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.224 1.01 . . . . 72.24 109.616 -176.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -116.98 136.55 52.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.348 0.659 . . . . 75.01 110.156 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -98.58 108.46 21.16 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.857 0.463 . . . . 71.13 111.297 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -104.88 109.33 21.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.924 0.89 . . . . 72.12 109.455 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 61.18 30.29 19.23 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.053 1.341 . . . . 74.21 112.25 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.96 -18.42 56.03 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 113.796 0.279 . . . . 43.22 113.796 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mp -89.84 149.11 22.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.935 0.894 . . . . 75.22 110.394 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.582 HG23 HG23 ' B' ' 54' ' ' ILE . 27.1 mm -92.66 134.94 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.596 0.358 . . . . 64.22 111.278 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -123.19 133.16 54.25 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.607 -0.886 . . . . 73.13 108.607 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.616 HD12 HG11 ' B' ' 43' ' ' VAL . 25.5 mm -93.15 119.46 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.421 0.688 . . . . 74.14 110.016 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.606 ' HB2' HG23 ' B' ' 53' ' ' VAL . 57.0 m-85 -113.73 169.33 9.06 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.856 0.862 . . . . 75.3 110.688 175.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.408 ' ND2' HD13 ' B' ' 17' ' ' LEU . 5.8 m120 -79.99 154.38 28.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.533 0.733 . . . . 63.14 110.469 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -53.52 139.13 32.15 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.574 0.702 . . . . 62.54 112.061 172.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.82 -142.57 14.01 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 114.396 -1.274 . . . . 75.52 110.893 -171.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.431 ' CD2' HG21 ' B' ' 53' ' ' VAL 0.258 10.7 p80 39.27 -53.48 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 127.287 2.235 . . . . 70.34 114.646 -158.409 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -59.21 143.7 48.22 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.618 0.767 . . . . 75.22 110.721 158.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.43 142.51 32.71 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.354 0.662 . . . . 72.25 110.086 175.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.97 127.12 29.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.623 0.769 . . . . 75.03 111.511 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.9 t 78.78 -28.95 0.15 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.839 1.656 . . . . 74.15 112.785 -173.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 54.1 t80 74.11 -27.08 0.19 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.974 1.709 . . . . 75.42 113.374 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.27 4.29 3.66 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.373 0.511 . . . . 62.02 112.637 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.84 136.94 38.15 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.151 0.58 . . . . 65.4 110.388 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.59 89.82 2.23 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.848 0.859 . . . . 63.4 111.835 -177.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -90.64 88.23 7.03 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.503 -0.925 . . . . 72.21 108.503 170.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -70.02 81.75 0.49 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.994 0.918 . . . . 75.14 111.826 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -145.41 -41.23 0.23 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.853 1.261 . . . . 61.44 109.882 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -154.97 156.97 36.98 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.844 0.857 . . . . 75.22 110.497 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -80.02 162.45 24.86 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.555 0.742 . . . . 62.42 111.595 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 123.714 0.806 . . . . 73.03 110.015 -177.18 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.574 ' HB2' ' HG3' ' B' ' 55' ' ' GLU . 62.0 ttp . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 120.312 0.101 . . . . 72.43 110.958 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -124.76 144.15 50.4 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.762 0.825 . . . . 74.21 110.459 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.474 ' O ' HG22 ' A' ' 6' ' ' VAL . 37.1 ttmt -82.08 -45.09 15.7 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.656 0.782 . . . . 74.13 112.081 -178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -68.32 -11.0 58.79 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.887 0.699 . . . . 65.11 112.887 -173.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.4 mt -44.69 -59.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 123.547 0.739 . . . . 63.32 111.101 166.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 3' ' ' LYS . 34.0 m -65.67 -27.16 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 112.507 0.558 . . . . 64.41 112.507 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.49 -42.67 88.63 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 120.899 0.166 . . . . 61.13 112.718 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.57 84.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.002 0.921 . . . . 61.34 111.301 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -60.21 -47.76 84.61 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.098 0.959 . . . . 72.22 111.289 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.78 -29.81 64.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.525 0.73 . . . . 63.2 112.168 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.45 -40.77 99.12 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.231 0.332 . . . . 72.12 112.873 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 60.3 tttp -75.87 -37.91 58.44 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.592 0.757 . . . . 63.13 111.931 177.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.599 ' HA ' HG11 ' A' ' 32' ' ' VAL . 60.0 t -61.23 -48.59 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 123.487 0.715 . . . . 65.51 111.586 177.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.46 ' HA ' HD12 ' A' ' 17' ' ' LEU . 30.6 t90 -65.65 -39.01 90.94 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.667 -0.697 . . . . 73.23 111.311 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -60.62 -38.64 85.43 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.204 0.602 . . . . 62.34 111.151 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.82 -23.2 63.27 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.419 0.687 . . . . 75.12 112.257 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 14' ' ' TRP . 70.2 mt -70.54 -44.88 66.6 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.332 0.653 . . . . 64.22 111.318 169.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -61.0 -32.79 72.36 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.002 0.521 . . . . 73.35 111.425 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.61 -52.31 32.92 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.383 0.673 . . . . 64.42 110.551 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.86 102.29 0.56 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.52 0.728 . . . . 63.45 111.206 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -97.12 -175.13 3.15 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.763 0.825 . . . . 72.02 110.819 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.05 49.85 7.27 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.365 -0.694 . . . . 75.41 111.365 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.4 tt -139.33 159.57 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.238 -0.981 . . . . 72.2 110.867 -163.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.9 m -72.99 146.28 46.1 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.66 0.384 . . . . 74.23 110.819 171.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 40' ' ' ALA . 70.6 mt -55.96 -46.06 99.81 Favored Pre-proline 0 CA--C 1.58 2.106 0 C-N-CA 124.126 0.97 . . . . 74.31 112.998 176.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.494 ' HA ' HG22 ' A' ' 36' ' ' VAL . 35.7 Cg_endo -62.54 -29.43 78.38 Favored 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 122.19 1.926 . . . . 53.02 114.524 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -74.75 -46.62 36.05 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 122.39 1.09 . . . . 72.54 110.146 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.468 HD22 HG21 ' A' ' 63' ' ' ILE . 58.2 tp -58.45 -38.18 76.98 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 113.259 -1.791 . . . . 73.44 111.6 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.15 -37.74 75.24 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.237 1.015 . . . . 73.33 112.345 177.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -67.67 -38.27 83.5 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.415 0.686 . . . . 74.13 111.712 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 28' ' ' LEU . 42.4 mtmt -69.12 -38.4 78.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.217 0.607 . . . . 52.31 111.367 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 13' ' ' VAL . 32.3 m -90.86 -1.68 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.731 0.641 . . . . 75.22 112.731 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 68.09 9.89 7.47 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.175 1.39 . . . . 73.41 112.46 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.5 mt -95.86 167.55 11.18 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.347 0.659 . . . . 65.33 111.409 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.5 t -66.47 149.51 50.32 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.661 0.784 . . . . 73.42 110.845 168.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 26' ' ' PRO . 55.6 t -55.14 -41.81 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.276 0.56 . . . . 72.35 110.921 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HB3' HD12 ' B' ' 25' ' ' ILE . 42.7 mt-10 -64.65 -39.06 93.03 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.37 1.068 . . . . 63.35 112.574 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 64.2 p -75.56 -26.56 58.06 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 122.616 0.367 . . . . 65.15 111.982 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 43' ' ' VAL . 84.9 m -78.57 -43.47 26.46 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.418 0.687 . . . . 63.42 111.178 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.38 -36.86 85.52 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.376 0.671 . . . . 71.03 111.263 175.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.511 HD11 HG21 ' B' ' 54' ' ' ILE . 1.0 OUTLIER -58.3 -53.22 60.77 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.512 1.125 . . . . 74.12 109.94 170.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.86 -31.29 71.55 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.917 -1.038 . . . . 73.52 111.721 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 39' ' ' THR . 41.7 t -65.86 -37.98 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.565 0.746 . . . . 74.44 110.687 173.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.48 -31.74 81.21 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-N 116.753 -0.203 . . . . 63.12 113.499 172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.549 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 66.7 t-105 -73.55 -31.07 63.45 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.656 0.782 . . . . 74.3 111.47 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.31 -38.83 63.23 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.267 0.627 . . . . 73.04 111.317 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.54 81.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.37 1.068 . . . . 74.11 112.317 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.618 ' HB2' ' HD2' ' B' ' 48' ' ' ARG . 9.7 ptt180 -62.65 -34.19 76.57 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 121.196 0.522 . . . . 74.42 110.543 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -85.97 -1.43 57.32 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.233 1.013 . . . . 64.22 111.898 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 65.3 22.2 12.06 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.26 1.424 . . . . 75.31 112.301 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.36 -8.41 50.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 113.078 0.77 . . . . 63.41 113.078 -173.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.633 ' HB ' HD11 ' A' ' 63' ' ' ILE . 30.2 m -132.15 157.1 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.023 0.529 . . . . 72.42 112.07 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 64' ' ' TYR . 11.9 m -128.63 123.99 60.63 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 123.83 0.852 . . . . 72.53 110.41 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.18 125.03 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.848 0.859 . . . . 65.02 110.075 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -99.66 122.36 42.57 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.05 0.54 . . . . 73.31 110.976 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.477 ' HG2' HG12 ' A' ' 61' ' ' ILE . 79.2 mtt85 -106.23 98.56 8.22 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.792 0.837 . . . . 74.43 110.111 173.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -127.59 128.67 45.97 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.596 0.758 . . . . 72.52 109.617 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 59.14 29.69 19.3 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.7 1.2 . . . . 75.43 112.137 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.19 1.83 64.97 Favored Glycine 0 CA--C 1.549 2.214 0 CA-C-N 116.05 -0.523 . . . . 63.52 114.224 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.4 mt -93.89 131.79 38.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.692 0.797 . . . . 53.44 111.19 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.477 HG12 ' HG2' ' A' ' 56' ' ' ARG . 72.4 mt -101.77 116.97 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 72.35 110.62 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -121.66 133.28 54.96 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.175 0.99 . . . . 72.31 109.828 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.633 HD11 ' HB ' ' A' ' 52' ' ' VAL . 7.0 tp -97.29 117.05 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 CA-C-O 121.801 0.81 . . . . 74.02 111.614 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.482 ' HB2' HG23 ' A' ' 53' ' ' VAL . 77.1 m-85 -109.07 165.88 11.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.957 1.303 . . . . 73.44 110.341 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.32 142.15 28.1 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.698 -0.853 . . . . 74.44 108.698 175.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -55.32 135.84 49.65 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.831 0.853 . . . . 72.43 111.98 -176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.35 -27.15 6.15 Favored Glycine 0 N--CA 1.476 1.321 0 CA-C-N 116.242 -0.435 . . . . 72.14 112.782 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -135.88 111.04 8.95 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.428 0.691 . . . . 64.21 111.158 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -147.12 21.3 1.23 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.878 1.271 . . . . 64.21 110.169 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -83.28 43.04 0.85 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.736 0.814 . . . . 74.23 111.609 -172.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 57.09 92.71 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.975 1.31 . . . . 75.22 113.11 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.1 t -52.3 99.62 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.286 0.634 . . . . 71.31 110.911 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -72.09 95.9 1.69 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.996 0.918 . . . . 74.15 111.283 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.05 70.52 0.24 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.728 -0.669 . . . . 54.32 111.934 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.36 89.22 6.56 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.093 0.949 . . . . 62.32 111.314 -177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -111.87 135.52 52.38 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.068 1.347 . . . . 74.14 109.91 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -87.32 62.76 7.39 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.828 0.823 . . . . 34.3 109.582 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -72.13 136.63 46.58 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.743 -1.117 . . . . 73.53 110.049 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -61.12 107.85 0.8 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.11 0.564 . . . . 74.34 110.457 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -147.3 128.78 14.97 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.59 0.756 . . . . 71.34 110.415 -175.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -72.41 125.26 26.96 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.192 0.597 . . . . 65.12 111.393 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.4 p80 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.849 0.833 . . . . 72.14 111.675 -178.416 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptm . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 120.807 0.337 . . . . 72.22 111.15 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.94 -28.41 62.42 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.958 0.903 . . . . 64.12 112.011 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.94 -23.69 58.36 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.335 0.654 . . . . 70.11 112.634 -173.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -87.87 -22.74 24.25 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 122.502 0.321 . . . . 75.31 110.727 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.61 -50.96 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.071 0.549 . . . . 73.42 110.426 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.534 HG12 HD11 ' B' ' 41' ' ' LEU . 26.8 m -61.02 -30.52 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 122.531 0.333 . . . . 64.24 111.471 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.15 -49.19 16.9 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 123.31 0.381 . . . . 74.24 113.317 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.32 -49.18 72.78 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.696 0.799 . . . . 70.34 111.78 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -58.89 -41.38 87.03 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.07 0.948 . . . . 74.33 111.92 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.449 ' HB1' ' HG ' ' B' ' 46' ' ' LEU . . . -66.48 -39.65 88.89 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.173 0.589 . . . . 72.12 111.952 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.91 -43.75 98.95 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 116.059 -0.519 . . . . 34.34 112.549 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -68.06 -42.96 79.7 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.978 0.911 . . . . 62.03 111.77 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.746 ' HA ' HG11 ' B' ' 32' ' ' VAL . 37.7 t -57.94 -44.18 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 124.117 0.967 . . . . 75.43 111.78 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 45.8 t90 -63.4 -33.42 75.52 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 115.221 -0.9 . . . . 73.22 112.194 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -61.09 -30.6 70.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.095 0.776 . . . . 73.44 113.095 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.33 65.88 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.341 0.497 . . . . 54.11 112.341 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.484 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 96.5 mt -70.55 -21.65 62.68 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.504 0.722 . . . . 73.5 112.619 174.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -64.78 -30.34 71.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.799 0.839 . . . . 65.41 111.891 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -91.55 -35.83 14.05 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.85 0.46 . . . . 51.1 111.168 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.43 112.23 1.09 Allowed 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.38 0.511 . . . . 73.52 112.38 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 9.4 p-10 -80.53 179.36 7.78 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.599 0.76 . . . . 71.3 110.704 166.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.46 61.14 4.95 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.611 -0.596 . . . . 75.22 111.611 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 tt -140.84 140.67 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.106 0.963 . . . . 65.32 110.03 -172.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 68.6 m -83.84 161.0 21.05 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.973 0.509 . . . . 52.32 110.885 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.483 HG21 ' HB2' ' B' ' 40' ' ' ALA . 58.8 mt -59.54 -44.92 98.62 Favored Pre-proline 0 CA--C 1.579 2.087 0 N-CA-C 113.9 1.074 . . . . 71.55 113.9 -174.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.88 -29.38 41.6 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 121.936 1.758 . . . . 43.2 114.237 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -71.7 -46.77 57.72 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.744 1.259 . . . . 70.13 109.654 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.499 HD22 HD11 ' B' ' 63' ' ' ILE . 65.3 tp -58.35 -43.62 88.4 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 112.946 -1.934 . . . . 52.11 111.681 173.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.68 91.21 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.497 1.119 . . . . 72.14 113.37 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -71.2 -23.58 62.06 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.073 0.549 . . . . 60.54 111.73 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -78.53 -44.6 23.92 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.772 0.829 . . . . 71.51 111.171 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' B' ' 13' ' ' VAL . 17.9 m -86.32 4.84 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.324 0.65 . . . . 64.44 112.414 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 65.34 17.75 11.1 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.815 1.246 . . . . 72.54 112.571 171.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 71.4 mt -109.72 158.32 18.22 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.468 0.707 . . . . 74.4 110.698 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -66.18 153.16 43.2 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.98 0.512 . . . . 44.04 111.168 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -53.6 -43.44 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 123.571 0.748 . . . . 61.52 111.964 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.402 ' HB2' HD12 ' A' ' 61' ' ' ILE . 45.7 mt-10 -61.99 -49.67 75.14 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.619 0.767 . . . . 74.23 112.037 175.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -61.33 -30.76 70.71 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.716 0.806 . . . . 65.43 112.236 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 87.4 m -77.44 -47.41 19.78 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.052 0.941 . . . . 63.51 111.304 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.483 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.62 -39.23 93.34 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.545 0.738 . . . . 42.1 111.99 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.534 HD11 HG12 ' B' ' 6' ' ' VAL . 1.3 tm? -62.41 -38.54 90.06 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.061 1.344 . . . . 75.34 110.431 174.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.52 -33.59 67.0 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.38 0.672 . . . . 53.13 111.914 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.71 -35.55 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.801 0.84 . . . . 71.45 111.482 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.08 -31.86 74.14 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 113.835 0.294 . . . . 60.24 113.835 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.404 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 72.2 t-105 -75.04 -36.7 61.85 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.426 0.691 . . . . 72.22 111.499 175.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.449 ' HG ' ' HB1' ' B' ' 10' ' ' ALA . 83.2 mt -66.4 -35.1 79.48 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.03 0.532 . . . . 60.22 111.311 173.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.73 -35.81 75.32 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.309 1.044 . . . . 41.31 112.449 172.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.618 ' HD2' ' HB2' ' A' ' 48' ' ' ARG . 49.4 ttt85 -57.17 -45.88 83.28 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.333 0.587 . . . . 73.23 110.691 171.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.38 -15.29 57.17 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 114.794 -1.093 . . . . 61.35 112.191 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 t30 65.37 26.7 12.01 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.868 1.267 . . . . 71.43 111.125 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -82.71 -19.11 38.67 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.507 -0.77 . . . . 75.35 111.854 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 24.4 m -114.53 140.04 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.19 0.596 . . . . 74.22 110.455 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 51.7 t -103.71 96.82 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.367 -0.975 . . . . 75.11 108.367 174.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.651 HG12 HG22 ' B' ' 63' ' ' ILE . 57.0 mt -81.93 123.68 38.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 115.783 -0.644 . . . . 65.4 109.766 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 13.6 tt0 -143.14 127.65 17.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.882 -0.599 . . . . 62.1 110.525 -172.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -83.77 103.82 13.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.397 0.679 . . . . 71.31 110.055 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -106.1 122.82 46.95 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.503 1.121 . . . . 71.11 111.15 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 59.22 31.03 20.88 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 125.162 1.385 . . . . 73.15 112.772 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.13 -27.87 6.52 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 115.988 -0.551 . . . . 73.32 113.66 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mp -81.56 165.15 21.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.762 0.825 . . . . 74.23 109.562 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.71 136.48 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.867 -0.521 . . . . 62.52 110.684 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -134.47 168.24 19.3 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.175 0.99 . . . . 73.1 110.851 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.651 HG22 HG12 ' B' ' 54' ' ' ILE . 0.2 OUTLIER -120.53 147.53 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.329 1.052 . . . . 62.53 110.313 171.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.555 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 93.6 m-85 -124.86 169.53 11.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.471 1.108 . . . . 74.3 110.405 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' B' ' 21' ' ' ASP . 4.4 m-20 -71.97 148.84 45.58 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.049 0.452 . . . . 64.04 111.844 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -50.66 103.66 0.06 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.297 1.039 . . . . 64.15 111.651 171.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.66 -32.05 0.83 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.332 -0.849 . . . . 55.24 112.511 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -77.29 -7.51 56.11 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.349 0.66 . . . . 71.11 112.372 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -78.33 178.22 7.83 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.67 0.788 . . . . 75.31 110.958 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 58.67 28.49 17.29 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.454 0.702 . . . . 72.15 110.99 -163.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -75.21 161.72 29.1 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 124.15 0.98 . . . . 65.22 111.047 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.5 t -61.31 138.56 58.24 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.444 0.698 . . . . 54.0 111.627 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -105.84 111.31 23.92 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.168 0.587 . . . . 64.04 111.283 -173.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -104.77 90.38 0.71 Allowed Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.387 -0.685 . . . . 74.45 111.387 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.9 100.29 0.4 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.1 0.56 . . . . 71.21 109.656 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -157.77 136.55 11.41 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.094 0.557 . . . . 71.44 110.879 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -166.49 131.4 2.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.674 1.589 . . . . 73.13 107.051 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -72.08 -5.26 34.02 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 113.327 0.862 . . . . 72.24 113.327 -166.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 41.86 97.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 126.255 1.822 . . . . 62.01 115.462 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -83.1 99.81 10.12 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.948 0.499 . . . . 65.11 110.049 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -148.39 141.63 25.1 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.201 1.0 . . . . 72.34 110.722 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 . . . . . 0 N--CA 1.483 1.186 0 C-N-CA 123.202 0.601 . . . . 71.32 110.796 177.196 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 112.251 0.463 . . . . 75.31 112.251 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.0 -34.55 75.46 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.604 0.964 . . . . 65.12 113.604 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -51.85 -30.1 22.32 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.382 1.253 . . . . 64.51 114.382 -164.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -92.54 -42.54 9.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.865 0.866 . . . . 75.04 112.439 172.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.1 mt -53.87 -47.54 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 123.853 0.861 . . . . 74.44 111.524 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.3 m -61.06 -29.29 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.967 1.307 . . . . 73.33 112.356 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.04 -41.71 70.23 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.679 0.612 . . . . 72.51 112.7 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.54 -43.03 98.28 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.315 0.646 . . . . 63.53 111.262 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -67.51 -35.03 78.32 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.693 0.797 . . . . 52.45 111.633 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.16 -35.03 68.92 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.496 0.718 . . . . 43.12 111.699 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.54 -35.96 92.53 Favored Glycine 0 CA--C 1.539 1.535 0 O-C-N 123.497 0.498 . . . . 74.45 112.631 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -67.74 -48.94 65.04 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.093 0.957 . . . . 73.44 111.64 175.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.93 -34.74 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.263 0.625 . . . . 50.41 111.9 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -71.03 -33.93 70.79 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.745 0.818 . . . . 74.14 110.959 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -66.92 -29.24 69.06 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 71.15 111.227 172.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.23 -31.35 67.46 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.991 0.516 . . . . 65.35 111.843 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.533 HD11 HG12 ' A' ' 52' ' ' VAL . 98.1 mt -59.35 -39.32 82.81 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.142 0.977 . . . . 73.02 113.521 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -67.84 -11.54 58.79 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 112.445 0.535 . . . . 71.02 112.445 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -103.61 -39.3 6.76 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.499 1.12 . . . . 61.42 110.004 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.53 91.67 2.68 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.684 0.794 . . . . 64.13 112.624 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -85.14 133.89 34.19 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.095 0.558 . . . . 63.55 110.298 167.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.37 61.79 2.89 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-O 121.155 0.308 . . . . 74.41 112.733 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.6 tt -126.78 145.34 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.505 0.722 . . . . 71.03 110.975 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.4 m -68.09 138.43 55.76 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.904 0.881 . . . . 74.1 110.62 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.744 HG21 ' HB2' ' A' ' 40' ' ' ALA . 76.2 mt -58.36 -42.27 93.84 Favored Pre-proline 0 CA--C 1.583 2.221 0 N-CA-C 114.059 1.133 . . . . 54.3 114.059 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 36' ' ' VAL . 29.8 Cg_endo -61.99 -32.36 84.29 Favored 'Trans proline' 0 C--N 1.394 2.961 0 C-N-CA 121.93 1.753 . . . . 65.43 114.123 174.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.17 -45.2 50.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.711 1.243 . . . . 74.11 109.47 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.588 HD22 HD11 ' A' ' 63' ' ' ILE . 66.7 tp -57.14 -38.89 74.15 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 112.75 -2.023 . . . . 75.12 111.818 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.17 78.05 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.323 1.049 . . . . 74.31 112.566 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.25 -42.85 87.98 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.255 0.622 . . . . 74.13 111.379 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -75.46 -35.13 60.93 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 112.473 0.546 . . . . 72.23 112.473 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 m -81.64 -9.89 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-O 120.772 0.32 . . . . 74.25 111.122 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 63.23 25.86 14.94 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.498 1.519 . . . . 71.43 113.203 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.3 mt -105.17 171.63 7.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.313 1.045 . . . . 74.23 109.887 173.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.7 m -68.07 158.98 31.78 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 122.551 0.34 . . . . 63.34 110.762 170.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.435 HG22 ' HA ' ' A' ' 26' ' ' PRO . 79.5 t -51.23 -57.06 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 123.286 0.634 . . . . 51.54 112.095 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.414 ' HG2' ' HB ' ' B' ' 25' ' ' ILE . 2.9 mp0 -66.65 -31.23 71.78 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.147 0.795 . . . . 73.14 113.147 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -61.67 -44.61 96.63 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.579 0.704 . . . . 74.53 110.881 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 43' ' ' VAL . 78.4 m -70.23 -41.57 73.42 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.629 -1.168 . . . . 62.01 111.385 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.744 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -67.5 -41.74 84.02 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.957 0.903 . . . . 64.35 112.071 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.06 -27.69 64.84 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.237 1.015 . . . . 75.01 110.518 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.85 -38.06 73.14 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.845 0.458 . . . . 70.53 111.261 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.531 HG11 HG21 ' A' ' 63' ' ' ILE . 90.3 t -61.88 -33.87 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.33 0.652 . . . . 75.33 110.089 169.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.48 90.17 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 115.918 -0.583 . . . . 73.34 113.802 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -67.92 -41.73 82.15 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.111 0.455 . . . . 71.24 110.229 173.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.38 -38.21 83.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.051 0.541 . . . . 72.24 110.927 173.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.84 96.49 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.628 0.771 . . . . 62.34 111.522 175.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 -56.8 -45.01 82.48 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.88 0.472 . . . . 74.42 111.114 171.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.89 -6.03 56.65 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.217 0.821 . . . . 75.33 113.217 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 68.53 30.81 5.05 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.115 1.366 . . . . 74.22 112.417 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -95.78 -13.83 23.79 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.945 1.298 . . . . 70.13 113.597 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.533 HG12 HD11 ' A' ' 17' ' ' LEU . 8.0 m -120.93 141.39 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.252 0.549 . . . . 75.31 112.263 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' ' 68' ' ' HIS . 94.7 t -107.63 107.09 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 124.271 1.028 . . . . 72.54 109.815 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 63' ' ' ILE . 2.9 mp -86.62 124.84 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 123.231 0.612 . . . . 63.24 110.001 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.23 116.0 13.06 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.755 0.822 . . . . 72.11 109.333 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -80.77 102.61 10.08 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.167 0.587 . . . . 64.04 110.029 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -112.74 124.98 53.81 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.481 0.712 . . . . 72.44 110.298 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 58.44 31.35 20.86 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.164 0.986 . . . . 74.52 112.112 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.06 -25.16 7.97 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 116.055 -0.521 . . . . 71.11 114.023 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.8 mt -79.14 146.22 33.28 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.905 0.882 . . . . 74.32 112.077 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.12 107.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.185 -0.672 . . . . 71.25 109.185 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.25 120.15 41.1 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.204 0.602 . . . . 64.52 109.725 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.588 HD11 HD22 ' A' ' 28' ' ' LEU . 2.7 pp -101.09 138.35 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.45 0.643 . . . . 71.12 111.032 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 93.5 m-85 -122.52 174.5 7.02 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.437 1.095 . . . . 72.32 110.19 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 63.6 t30 -90.64 158.28 17.02 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.91 0.484 . . . . 64.2 111.402 174.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.41 154.43 16.95 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.992 0.917 . . . . 74.53 112.179 173.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.1 62.02 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 115.396 -0.82 . . . . 62.04 112.594 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.633 ' HB3' HG21 ' A' ' 53' ' ' VAL . 48.8 t60 -74.84 -27.22 60.19 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.36 0.664 . . . . 75.15 110.832 175.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -95.79 143.57 26.91 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.309 0.643 . . . . 71.32 109.775 167.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.29 177.14 9.18 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.197 0.599 . . . . 61.35 112.047 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -103.93 92.49 4.42 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.193 0.597 . . . . 74.53 110.679 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.0 m -86.16 93.15 8.96 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.604 0.762 . . . . 60.52 111.58 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -90.49 91.21 8.35 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.919 0.488 . . . . 72.15 110.748 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.86 8.85 2.27 Favored Glycine 0 N--CA 1.478 1.488 0 CA-C-N 115.954 -0.566 . . . . 74.12 112.953 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.5 84.12 7.49 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.858 0.837 . . . . 50.45 111.592 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -79.55 90.85 5.13 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.217 -0.901 . . . . 70.42 109.397 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -82.43 95.94 7.83 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.315 -0.857 . . . . 71.12 109.945 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -89.92 48.18 1.55 Allowed 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.233 1.013 . . . . 72.05 110.983 -171.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -58.64 143.8 45.24 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.768 1.227 . . . . 74.51 113.717 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -131.51 -36.25 1.27 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.468 1.107 . . . . 73.45 110.479 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -101.21 129.36 47.12 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.459 0.704 . . . . 72.4 110.696 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.675 0.75 . . . . 70.52 110.23 177.926 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 121.028 0.442 . . . . 73.3 110.084 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.61 147.53 23.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.306 0.642 . . . . 71.33 110.678 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.402 ' O ' HG22 ' B' ' 6' ' ' VAL . 71.9 tttt -69.35 -23.46 63.76 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 115.191 -0.913 . . . . 72.24 110.809 169.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -56.0 -24.35 38.4 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 124.37 1.068 . . . . 63.43 112.968 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 69.6 mt -55.63 -44.01 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 123.994 0.918 . . . . 71.43 111.322 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 3' ' ' LYS . 2.9 m -61.71 -30.17 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 122.67 0.388 . . . . 43.04 111.461 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.32 92.15 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.485 0.491 . . . . 71.13 113.403 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.2 -38.11 87.2 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.641 0.776 . . . . 73.51 111.83 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -79.75 -19.62 48.27 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.159 0.583 . . . . 74.1 112.089 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.63 -39.5 52.16 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.305 0.642 . . . . 74.34 110.995 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.17 -30.92 75.09 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.435 -0.802 . . . . 74.02 112.472 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.452 ' HD2' HD11 ' B' ' 34' ' ' LEU . 4.7 ttmp? -70.72 -49.32 48.24 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.054 0.942 . . . . 71.32 112.374 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.534 HG13 HD11 ' B' ' 46' ' ' LEU . 2.5 p -66.2 -36.01 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 112.158 0.429 . . . . 70.01 112.158 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.458 ' HA ' HD12 ' B' ' 17' ' ' LEU . 26.0 t90 -73.17 -32.21 64.71 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.991 -0.443 . . . . 73.34 111.132 176.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -62.47 -36.32 82.1 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.213 0.605 . . . . 65.45 110.524 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.63 -32.73 74.47 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.469 -0.787 . . . . 54.11 111.932 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.49 HD21 HD13 ' B' ' 63' ' ' ILE . 84.8 mt -69.16 -44.38 72.37 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.763 0.825 . . . . 71.34 111.777 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -56.77 -39.87 74.82 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.933 0.893 . . . . 73.34 111.79 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -74.02 -50.36 20.11 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.49 0.716 . . . . 71.14 110.817 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.83 102.91 0.9 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.828 0.851 . . . . 71.51 110.757 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.2 173.94 10.61 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.802 0.441 . . . . 63.23 111.47 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.99 65.25 1.77 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.559 -0.291 . . . . 22.14 112.554 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 tt -151.01 144.93 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.305 0.642 . . . . 70.51 110.389 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 31.4 t -70.82 150.29 45.97 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.188 0.595 . . . . 64.52 111.138 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.633 HG21 ' HB2' ' B' ' 40' ' ' ALA . 82.4 mt -58.39 -51.02 84.8 Favored Pre-proline 0 CA--C 1.576 1.959 0 CA-C-O 118.177 -0.916 . . . . 72.45 113.408 -176.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.408 ' HA ' HG22 ' B' ' 36' ' ' VAL . 20.3 Cg_endo -59.23 -34.77 98.24 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.233 1.956 . . . . 75.52 113.438 176.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -66.05 -50.92 62.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.326 0.65 . . . . 75.24 112.226 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.618 HD22 HD11 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -69.9 -32.55 70.94 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.714 0.406 . . . . 71.53 110.838 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.68 -41.63 77.64 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.887 0.875 . . . . 53.14 111.637 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -60.11 -40.19 88.83 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.092 0.957 . . . . 74.41 111.26 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -75.38 -33.13 61.0 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.964 0.906 . . . . 55.14 112.791 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.4 m -96.57 5.25 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 123.584 0.754 . . . . 72.34 111.897 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 t30 68.93 10.92 8.17 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 125.212 1.405 . . . . 73.14 112.642 173.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.452 HD11 ' HD2' ' B' ' 12' ' ' LYS . 54.0 mt -94.57 155.31 16.96 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.662 -0.649 . . . . 74.24 110.607 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 47.6 m -67.79 152.45 45.56 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.42 0.288 . . . . 74.32 110.499 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' B' ' 26' ' ' PRO . 64.1 t -51.69 -44.2 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.401 0.681 . . . . 52.32 111.329 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.96 -47.91 83.41 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 114.918 -1.037 . . . . 70.01 112.242 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -58.97 -41.37 87.39 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.975 0.91 . . . . 44.13 112.769 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 95.5 m -72.65 -46.68 52.74 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.332 0.653 . . . . 71.31 111.907 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.633 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.89 -48.61 73.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.0 1.111 . . . . 73.14 114.0 -168.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -26.53 62.38 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 120.796 0.332 . . . . 71.22 110.93 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.43 -26.33 65.47 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.697 0.799 . . . . 75.14 111.99 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.69 -31.65 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 123.005 0.522 . . . . 61.11 110.991 169.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.27 -28.36 73.65 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.308 -0.405 . . . . 73.12 113.99 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.552 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 66.0 t-105 -72.11 -27.52 62.69 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.143 0.577 . . . . 63.3 111.034 172.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.534 HD11 HG13 ' B' ' 13' ' ' VAL . 73.6 mt -73.22 -36.12 66.41 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.751 -0.593 . . . . 65.34 110.715 169.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.39 -26.88 68.65 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.46 1.104 . . . . 62.41 113.818 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 12.9 ptt180 -62.1 -35.85 79.94 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 118.817 0.735 . . . . 74.03 110.288 172.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.472 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 32.6 mt-10 -93.98 -6.27 45.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.819 1.248 . . . . 73.53 111.687 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 t30 63.08 31.21 16.02 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.841 1.256 . . . . 72.02 111.56 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -85.68 -6.5 59.13 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.865 0.691 . . . . 50.34 112.865 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.88 145.81 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.405 0.622 . . . . 63.43 112.356 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' B' ' 64' ' ' TYR . 4.8 m -120.08 128.61 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.048 1.339 . . . . 71.34 108.304 167.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.436 HG12 HG22 ' B' ' 63' ' ' ILE . 68.2 mt -109.29 137.82 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.928 0.491 . . . . 41.12 110.754 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -134.99 125.82 27.35 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.707 0.803 . . . . 62.55 109.565 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -108.01 115.5 30.25 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.493 0.663 . . . . 55.44 110.606 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.64 126.84 55.71 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.84 1.256 . . . . 74.42 109.173 -175.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 59.84 29.11 18.68 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.37 1.068 . . . . 64.11 111.525 -175.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.6 -19.1 16.18 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-N 116.343 -0.39 . . . . 65.05 113.808 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 tp -78.4 112.01 14.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.062 0.945 . . . . 62.25 110.455 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 mt -83.44 125.14 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 122.512 0.325 . . . . 74.12 110.848 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -127.42 145.75 50.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.703 0.801 . . . . 74.51 109.902 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.618 HD11 HD22 ' B' ' 28' ' ' LEU . 2.2 pp -105.83 141.25 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-O 121.552 0.691 . . . . 43.04 111.63 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.472 ' HB2' HG23 ' B' ' 53' ' ' VAL . 73.2 m-85 -132.13 157.14 45.01 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.502 1.121 . . . . 73.02 109.228 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -102.98 153.55 20.12 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.051 0.54 . . . . 44.54 110.421 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -17.93 61.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 112.224 0.453 . . . . 73.13 112.224 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.96 -33.38 87.02 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.264 0.353 . . . . 73.5 113.602 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -70.48 -37.06 74.18 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.524 0.73 . . . . 74.12 111.369 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -87.45 86.11 7.2 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.557 0.743 . . . . 74.34 110.291 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -140.4 133.98 30.16 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.373 0.669 . . . . 65.33 109.948 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -129.08 27.57 5.38 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 122.992 0.517 . . . . 74.51 111.234 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 46.7 t -67.52 -60.49 2.52 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 112.864 0.69 . . . . 72.31 112.864 -175.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.05 170.98 15.54 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.468 0.707 . . . . 74.41 112.398 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.9 61.49 1.35 Allowed Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.637 -0.711 . . . . 72.11 111.714 -172.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.536 ' H ' HD23 ' B' ' 75' ' ' LEU . 2.2 pt? -122.18 146.48 47.21 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.965 0.906 . . . . 71.31 110.465 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.84 131.95 38.91 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.519 0.728 . . . . 61.23 110.639 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -88.71 -63.57 1.28 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.39 0.676 . . . . 72.4 109.354 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 57.21 87.42 0.06 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.938 1.295 . . . . 74.44 112.637 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -69.75 133.07 47.06 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.164 0.586 . . . . 64.35 111.199 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -105.53 128.28 53.49 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.047 0.939 . . . . 75.13 110.911 -173.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -75.13 133.58 41.47 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.95 0.5 . . . . 75.44 110.838 174.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 N--CA 1.479 1.012 0 C-N-CA 123.518 0.727 . . . . 71.15 110.317 175.089 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.46 0.171 . . . . 72.51 110.646 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.488 ' HB2' HG13 ' A' ' 5' ' ' ILE . 4.8 m-20 -66.65 156.48 35.09 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.718 0.807 . . . . 71.23 112.243 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -65.69 -25.09 67.17 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.807 -1.088 . . . . 73.25 111.484 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -77.32 -24.76 50.79 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.885 0.698 . . . . 73.01 112.885 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.488 HG13 ' HB2' ' A' ' 2' ' ' ASP . 59.4 mt -60.07 -42.74 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.264 0.626 . . . . 74.54 111.782 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.626 HG12 HD11 ' A' ' 41' ' ' LEU . 34.5 m -59.42 -33.6 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 111.77 0.285 . . . . 71.53 111.77 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.75 -39.53 93.62 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 123.213 0.321 . . . . 64.24 112.986 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.87 -50.51 62.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.254 0.622 . . . . 52.02 111.828 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -70.6 -31.96 69.14 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.352 0.661 . . . . 74.43 112.351 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.43 -33.24 60.9 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.856 0.462 . . . . 53.43 111.625 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.65 -31.35 79.68 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.922 -0.581 . . . . 41.31 113.265 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -75.25 -36.72 61.24 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.566 0.747 . . . . 75.25 111.549 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.8 t -63.29 -41.13 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.369 0.604 . . . . 62.45 110.92 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 51' ' ' LYS . 77.6 t90 -72.26 -32.31 66.54 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.671 0.788 . . . . 73.23 111.54 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -61.79 -34.87 76.67 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.161 0.584 . . . . 75.42 110.679 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.99 -33.93 76.95 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.166 0.586 . . . . 73.13 111.753 174.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.417 HD11 HG12 ' A' ' 52' ' ' VAL . 92.2 mt -63.62 -27.34 69.17 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.635 0.774 . . . . 74.34 111.897 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.14 -35.04 77.46 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.299 0.64 . . . . 71.01 111.651 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -106.72 -65.84 1.06 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.528 0.731 . . . . 73.52 111.786 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . . . -127.53 84.54 2.26 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.452 0.644 . . . . 72.35 111.245 -175.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.73 -179.08 5.93 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.514 1.126 . . . . 73.1 112.972 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.17 52.36 48.01 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 115.698 -0.683 . . . . 62.21 113.247 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.496 HD13 ' HD2' ' A' ' 31' ' ' LYS . 13.7 tt -140.15 125.31 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.451 0.7 . . . . 72.15 110.719 -175.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.4 m -50.49 149.41 3.16 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.1 1.36 . . . . 61.22 113.31 -170.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.456 HG21 ' HB2' ' A' ' 40' ' ' ALA . 80.6 mt -47.62 -48.89 58.22 Favored Pre-proline 0 CA--C 1.576 1.946 0 C-N-CA 124.414 1.086 . . . . 72.11 113.928 -172.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 36' ' ' VAL . 48.7 Cg_endo -65.79 -37.6 27.11 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 121.847 1.698 . . . . 73.14 113.702 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -70.01 -46.92 64.09 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.46 1.124 . . . . 72.32 110.139 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.563 HD22 HG21 ' A' ' 63' ' ' ILE . 54.9 tp -57.61 -34.36 69.19 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 113.28 -1.782 . . . . 74.1 112.216 170.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 -38.12 82.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.031 0.532 . . . . 74.05 111.703 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -28.04 63.34 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 111.895 0.332 . . . . 74.44 111.895 173.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HD2' HD13 ' A' ' 23' ' ' ILE . 26.8 mtpp -68.21 -45.87 72.16 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.016 0.436 . . . . 71.13 111.644 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.8 m -86.61 -1.91 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.178 0.591 . . . . 61.42 111.707 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.9 t30 65.92 27.07 10.93 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.147 1.379 . . . . 75.33 111.767 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.6 mt -114.99 173.05 6.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.098 0.959 . . . . 74.21 111.759 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 t -68.12 155.6 39.25 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.324 0.65 . . . . 52.1 111.869 170.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 26' ' ' PRO . 62.2 t -55.44 -41.42 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.484 0.714 . . . . 72.32 110.641 172.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.17 -49.0 79.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.66 -1.155 . . . . 63.54 111.427 176.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.8 m -58.18 -43.39 87.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.107 0.963 . . . . 63.2 111.464 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 43' ' ' VAL . 85.4 m -69.72 -48.06 60.88 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.104 -0.953 . . . . 72.22 111.811 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -62.09 -38.77 90.12 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 123.459 0.703 . . . . 70.31 112.32 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.626 HD11 HG12 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -66.85 -40.83 88.05 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.798 1.239 . . . . 74.14 110.213 174.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.65 -34.73 74.41 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.488 0.715 . . . . 70.2 112.2 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 39' ' ' THR . 81.0 t -67.0 -32.95 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.56 0.744 . . . . 51.45 110.405 173.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -66.97 -33.34 83.57 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.141 -0.482 . . . . 31.54 113.316 173.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -69.35 -38.18 78.0 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.876 0.471 . . . . 63.42 110.644 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 51' ' ' LYS . 76.5 mt -67.57 -30.52 70.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.819 0.448 . . . . 72.45 111.437 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.29 75.35 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.309 0.643 . . . . 61.32 112.133 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -62.36 -49.64 74.77 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 122.886 0.474 . . . . 74.35 110.953 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 64.1 mt-10 -80.05 -8.86 59.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.513 -0.767 . . . . 74.21 111.547 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.462 ' ND2' ' HA ' ' A' ' 72' ' ' SER . 19.9 m-80 63.42 27.04 15.13 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.9 1.28 . . . . 52.12 111.911 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 39.9 mmtm -69.86 -17.92 63.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.527 1.131 . . . . 61.42 112.308 175.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.417 HG12 HD11 ' A' ' 17' ' ' LEU . 34.6 m -129.24 154.48 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.145 0.578 . . . . 63.43 112.387 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 64' ' ' TYR . 34.9 m -120.77 132.27 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.494 0.718 . . . . 75.32 109.077 165.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 mm -110.45 123.63 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.206 0.602 . . . . 75.35 111.412 -173.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 49.5 mt-10 -106.16 155.62 19.27 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.166 0.586 . . . . 74.21 111.367 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.21 94.04 4.78 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.817 -1.549 . . . . 63.52 106.817 160.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.86 111.7 24.46 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.718 0.807 . . . . 73.24 108.886 -173.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 60.35 30.35 19.75 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.285 1.034 . . . . 64.14 110.114 -161.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.6 -12.98 25.26 Favored Glycine 0 C--N 1.36 1.904 0 CA-C-N 115.506 -0.77 . . . . 62.43 114.422 -173.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.79 117.48 19.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.299 0.64 . . . . 73.33 111.269 -177.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 67.1 mt -69.21 116.05 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.791 0.836 . . . . 72.32 111.254 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -126.01 140.49 52.56 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.891 0.876 . . . . 74.41 110.983 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.563 HG21 HD22 ' A' ' 28' ' ' LEU . 7.2 tt -92.74 133.17 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 124.235 1.014 . . . . 74.44 111.017 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.446 ' HB2' HG23 ' A' ' 53' ' ' VAL . 73.0 m-85 -131.63 173.22 11.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.492 1.117 . . . . 64.52 110.323 173.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -73.62 150.5 41.33 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.346 0.658 . . . . 72.44 111.196 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . 7.5 pt-20 -37.99 -53.52 1.36 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.843 1.257 . . . . 64.4 113.607 171.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.13 -82.83 0.01 OUTLIER Glycine 0 C--N 1.354 1.558 0 N-CA-C 115.223 0.849 . . . . 72.2 115.223 171.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -119.34 -20.2 7.97 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.025 0.93 . . . . 42.32 111.979 -172.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -112.04 33.34 4.89 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.822 0.849 . . . . 75.5 111.839 -171.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.5 p-10 -79.77 9.57 5.04 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.696 0.998 . . . . 72.42 113.696 -176.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -67.21 98.92 0.64 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.47 0.708 . . . . 73.42 111.616 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.462 ' HA ' ' ND2' ' A' ' 50' ' ' ASN . 67.5 p -88.43 12.74 13.47 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.907 0.883 . . . . 73.45 112.938 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -86.52 101.59 13.33 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.098 0.559 . . . . 63.5 110.846 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.553 ' H ' HD12 ' A' ' 75' ' ' LEU . . . 168.75 78.27 0.04 OUTLIER Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.388 -0.369 . . . . 65.43 112.453 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.553 HD12 ' H ' ' A' ' 74' ' ' GLY . 4.6 mp -120.36 100.79 7.37 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.718 0.807 . . . . 62.14 110.452 -176.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -141.15 119.14 11.9 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.036 0.446 . . . . 63.32 111.752 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -128.38 163.25 25.27 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.651 1.18 . . . . 72.41 109.57 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -65.57 131.55 46.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.889 0.475 . . . . 73.35 111.107 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -140.88 49.28 1.68 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.575 0.703 . . . . 61.23 111.875 -174.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -121.93 133.98 54.85 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.402 -0.592 . . . . 70.44 109.402 173.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -67.92 -4.06 11.76 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 114.388 1.255 . . . . 75.1 114.388 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 21.0 m80 . . . . . 0 N--CA 1.493 1.686 0 C-N-CA 124.288 1.035 . . . . 71.13 110.775 169.341 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 C--O 1.24 0.594 0 N-CA-C 111.63 0.233 . . . . 73.34 111.63 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -58.3 -33.66 69.7 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.2 0.6 . . . . 70.22 112.598 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -27.91 68.47 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.092 0.957 . . . . 63.34 112.965 -171.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -84.05 -44.29 14.25 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.473 0.709 . . . . 70.11 111.034 173.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.66 -45.56 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.815 0.846 . . . . 65.5 111.93 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.563 HG12 HD11 ' B' ' 41' ' ' LEU . 34.8 m -61.28 -32.16 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.753 0.821 . . . . 72.2 112.157 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.83 62.26 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.27 0.356 . . . . 74.21 112.647 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.74 -45.78 88.34 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.589 0.756 . . . . 64.43 111.883 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -64.67 -41.08 96.32 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.773 0.829 . . . . 72.44 111.799 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.95 -31.3 70.08 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.885 0.474 . . . . 72.21 111.646 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.59 -38.38 96.2 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.847 -0.615 . . . . 72.35 112.882 174.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -75.1 -36.65 61.67 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.71 0.804 . . . . 71.31 111.434 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.552 ' HA ' HG11 ' B' ' 32' ' ' VAL . 92.7 t -67.63 -42.71 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.135 0.574 . . . . 63.45 111.368 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.494 ' HA ' HD12 ' B' ' 17' ' ' LEU . 19.5 t90 -68.56 -33.23 73.72 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.984 -0.553 . . . . 61.23 110.521 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' HIS . . . . . 0.413 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 66.3 t60 -62.34 -31.41 72.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.715 0.806 . . . . 64.13 111.638 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.43 67.31 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.706 0.402 . . . . 52.23 111.868 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' B' ' 14' ' ' TRP . 98.5 mt -64.14 -45.04 90.29 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.838 0.855 . . . . 70.02 113.137 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -69.78 -12.77 61.88 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 111.733 0.272 . . . . 62.35 111.733 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 20.4 mm-40 -81.08 -57.71 3.4 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.398 0.679 . . . . 71.32 109.753 171.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.16 105.15 3.19 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.5 0.72 . . . . 73.14 110.756 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.95 168.56 14.06 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.723 0.809 . . . . 64.44 111.458 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.26 64.98 2.09 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 112.477 -0.249 . . . . 45.32 112.477 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.432 ' O ' HG22 ' B' ' 63' ' ' ILE . 18.1 tt -146.32 156.22 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 C-N-CA 123.663 0.785 . . . . 71.4 110.303 -175.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -81.18 156.64 25.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.806 -0.559 . . . . 73.44 111.547 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.58 HG21 ' HB2' ' B' ' 40' ' ' ALA . 59.8 mt -58.84 -48.37 96.93 Favored Pre-proline 0 CA--C 1.577 1.994 0 N-CA-C 113.598 0.962 . . . . 75.04 113.598 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.468 ' HA ' HG22 ' B' ' 36' ' ' VAL . 55.1 Cg_endo -66.41 -23.9 50.44 Favored 'Trans proline' 0 C--N 1.395 3.001 0 CA-C-N 121.951 1.733 . . . . 71.33 114.138 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.19 -46.36 18.06 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.015 0.912 . . . . 64.21 109.608 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.56 HD22 HG21 ' B' ' 63' ' ' ILE . 59.0 tp -58.23 -34.45 70.45 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 113.735 -1.575 . . . . 74.22 111.681 173.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.15 85.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.951 0.9 . . . . 65.22 111.898 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -69.33 -40.33 77.65 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.603 0.761 . . . . 74.45 110.349 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -62.34 -35.69 79.88 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.568 0.747 . . . . 72.4 111.741 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.552 HG11 ' HA ' ' B' ' 13' ' ' VAL . 19.6 m -97.52 -1.24 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.074 0.55 . . . . 72.42 112.457 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 69.38 11.12 8.02 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.853 1.261 . . . . 70.42 112.575 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt -101.37 171.15 7.76 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.421 0.688 . . . . 73.34 111.351 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 29.7 t -66.07 154.23 40.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.909 0.484 . . . . 32.44 111.144 169.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' B' ' 26' ' ' PRO . 55.0 t -56.84 -40.16 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.247 0.619 . . . . 72.35 111.096 177.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.08 -43.79 77.76 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.404 -0.816 . . . . 74.31 111.839 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -61.04 -32.29 71.91 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.464 0.706 . . . . 74.41 111.798 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.45 ' O ' HG23 ' B' ' 43' ' ' VAL . 74.5 m -80.74 -47.86 13.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.078 0.951 . . . . 45.15 111.496 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.58 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.1 -40.2 95.7 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.603 0.761 . . . . 75.31 112.41 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.563 HD11 HG12 ' B' ' 6' ' ' VAL . 1.1 tm? -64.2 -34.95 79.27 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 124.813 1.245 . . . . 60.41 110.368 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.0 -33.52 61.84 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.617 0.767 . . . . 60.12 112.11 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 39' ' ' THR . 54.3 t -62.53 -37.56 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.784 0.834 . . . . 71.1 110.361 172.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -64.38 -30.42 77.81 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-N 116.057 -0.519 . . . . 70.13 113.63 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.477 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 67.3 t-105 -74.1 -31.3 62.73 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.805 0.442 . . . . 74.14 111.304 175.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 96.2 mt -72.18 -38.19 69.14 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.813 0.445 . . . . 61.02 110.808 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.32 -28.82 69.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.094 0.958 . . . . 74.42 112.049 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 26.2 ttt-85 -53.34 -49.47 67.04 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.652 0.781 . . . . 75.13 110.841 168.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -94.46 6.15 49.64 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.903 0.881 . . . . 65.24 112.739 -175.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.38 23.8 14.13 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 124.66 1.184 . . . . 75.11 113.255 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -80.35 -0.67 37.86 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.17 0.804 . . . . 72.44 113.17 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.05 147.99 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.667 0.787 . . . . 72.51 111.739 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.749 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 39.0 t -106.77 118.99 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.567 0.747 . . . . 71.13 109.007 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 46.6 mm -113.59 130.79 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 123.129 0.572 . . . . 64.1 111.296 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -133.79 132.68 40.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.621 0.768 . . . . 74.34 111.06 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -88.04 103.91 16.16 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.253 0.621 . . . . 52.13 110.976 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -110.38 112.49 24.46 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.356 1.062 . . . . 75.22 110.006 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 62.03 30.4 17.92 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.921 1.289 . . . . 74.55 112.523 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.82 -15.59 60.28 Favored Glycine 0 CA--C 1.543 1.841 0 CA-C-N 116.458 -0.337 . . . . 40.31 113.717 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 mp -93.37 147.02 23.3 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.998 0.919 . . . . 54.14 111.059 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mm -82.64 126.96 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.164 0.586 . . . . 74.35 111.394 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -110.5 122.44 47.74 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.21 1.004 . . . . 64.04 109.459 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.56 HG21 HD22 ' B' ' 28' ' ' LEU . 10.2 tt -108.49 139.01 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.408 0.623 . . . . 61.13 111.829 -175.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.749 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 90.9 m-85 -128.53 170.41 13.23 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.459 1.104 . . . . 71.44 110.523 176.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -91.04 162.4 14.72 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.552 0.741 . . . . 73.13 110.226 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -170.28 1.83 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 122.837 0.455 . . . . 73.41 111.469 172.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.49 16.86 78.87 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 111.625 -0.59 . . . . 23.24 111.625 -160.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -115.17 -40.11 3.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.412 1.085 . . . . 75.44 111.033 -171.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -69.0 141.21 54.95 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.247 0.619 . . . . 52.21 111.442 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.86 160.46 28.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.731 0.812 . . . . 72.22 112.78 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -81.94 15.62 2.2 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.425 0.69 . . . . 64.23 112.676 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 53.8 p -65.9 99.08 0.46 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.116 0.966 . . . . 71.52 111.479 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -87.05 159.77 18.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.226 0.61 . . . . 64.3 111.017 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.39 -129.69 1.88 Allowed Glycine 0 N--CA 1.475 1.269 0 CA-C-N 116.432 -0.349 . . . . 52.01 113.251 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.47 -16.67 26.91 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.313 0.645 . . . . 71.24 110.604 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -72.94 99.88 2.81 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.523 1.129 . . . . 72.24 110.287 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -100.6 149.85 23.31 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.68 1.192 . . . . 63.05 110.954 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -83.77 82.1 8.47 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.667 0.746 . . . . 73.32 111.814 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -93.53 37.54 1.06 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.026 0.917 . . . . 74.03 110.549 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -135.2 134.94 40.61 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.799 0.84 . . . . 71.13 109.802 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -100.96 109.68 21.63 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.576 0.75 . . . . 74.23 110.823 -173.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 7.1 t60 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.46 0.647 . . . . 73.23 109.834 177.817 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.669 0.271 . . . . 75.11 110.992 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.84 -34.76 71.94 Favored 'General case' 0 C--O 1.206 -1.225 0 N-CA-C 114.877 1.436 . . . . 60.22 114.877 -171.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -53.46 -32.78 51.53 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 115.013 1.486 . . . . 64.4 115.013 -169.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -79.9 -39.74 29.76 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.605 0.362 . . . . 70.13 111.747 173.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.07 -50.93 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.539 0.736 . . . . 63.42 111.117 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.428 HG11 HD11 ' A' ' 41' ' ' LEU . 6.3 m -73.66 -27.71 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.787 1.235 . . . . 65.34 111.418 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.39 -35.67 87.75 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 112.421 -0.272 . . . . 35.21 112.421 171.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.79 -56.16 5.32 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.564 0.746 . . . . 55.25 111.954 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -71.12 -22.76 62.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.951 0.723 . . . . 73.25 112.951 -173.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.612 ' HA ' HG22 ' A' ' 13' ' ' VAL . . . -67.14 -26.68 66.79 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.623 0.369 . . . . 64.22 111.12 174.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.67 -36.19 92.03 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.11 -0.496 . . . . 72.43 112.861 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -76.86 -41.99 41.78 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.564 0.746 . . . . 73.52 112.303 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' A' ' 10' ' ' ALA . 12.4 m -69.83 -34.93 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 122.141 -0.349 . . . . 72.44 110.82 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -71.67 -32.62 68.07 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.238 0.615 . . . . 74.13 111.083 172.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -61.54 -46.42 89.99 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.706 0.403 . . . . 73.01 110.967 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB1' ' HE2' ' A' ' 31' ' ' LYS . . . -66.74 -34.58 78.16 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.913 0.885 . . . . 74.24 111.46 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.37 -45.45 72.75 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.609 1.164 . . . . 54.45 111.299 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -75.53 -25.76 57.47 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.358 0.663 . . . . 74.11 110.703 -175.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -71.25 -41.3 70.28 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.029 0.932 . . . . 73.43 110.283 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.9 107.03 2.28 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.657 0.783 . . . . 65.13 110.261 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.13 179.32 5.11 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.683 0.793 . . . . 71.35 112.363 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.51 56.43 7.58 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 111.956 -0.458 . . . . 44.01 111.956 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 28' ' ' LEU . 9.4 tp -130.3 125.54 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 123.359 0.664 . . . . 73.44 110.768 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -80.57 153.59 27.97 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.215 0.606 . . . . 72.32 111.117 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 40' ' ' ALA . 62.5 mt -52.06 -53.3 53.37 Favored Pre-proline 0 CA--C 1.577 2.003 0 N-CA-C 114.324 1.231 . . . . 70.21 114.324 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.12 -21.88 23.28 Favored 'Trans proline' 0 C--N 1.39 2.753 0 CA-C-N 121.197 1.463 . . . . 51.54 114.179 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -78.59 -44.7 23.42 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 122.107 0.956 . . . . 74.32 109.326 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.496 ' HB2' HG13 ' A' ' 23' ' ' ILE . 50.3 tp -57.2 -37.48 72.24 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 113.524 -1.671 . . . . 64.12 111.149 172.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.56 -39.79 85.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.991 0.916 . . . . 62.21 112.005 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -73.21 -34.21 65.81 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.316 0.646 . . . . 75.24 111.48 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HE2' ' HB1' ' A' ' 16' ' ' ALA . 55.5 mtpt -62.87 -44.11 96.99 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.323 0.649 . . . . 64.23 111.182 175.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 13' ' ' VAL . 19.2 m -93.05 -4.02 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.592 0.757 . . . . 71.14 112.315 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 68.67 13.89 8.95 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.272 1.429 . . . . 70.51 113.532 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 73.1 mt -95.9 170.65 9.15 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.377 0.671 . . . . 74.15 111.228 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -67.1 150.74 48.75 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.212 0.605 . . . . 74.11 111.538 170.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.8 t -56.11 -43.63 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.597 0.759 . . . . 73.34 111.14 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -60.74 -45.62 93.61 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.388 -0.824 . . . . 70.14 112.0 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.5 m -65.98 -30.79 71.4 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.453 0.701 . . . . 64.13 112.009 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -80.17 -39.26 29.65 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.474 0.71 . . . . 63.44 111.654 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.75 -38.74 92.0 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.67 0.748 . . . . 74.34 111.076 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.428 HD11 HG11 ' A' ' 6' ' ' VAL . 1.2 tm? -69.82 -38.01 76.42 Favored 'General case' 0 CA--C 1.562 1.44 0 CA-C-N 114.184 -1.371 . . . . 74.1 110.743 175.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.59 -39.62 84.81 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 122.995 0.518 . . . . 71.41 111.655 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.2 -38.51 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.905 0.882 . . . . 72.31 111.176 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.36 -33.0 86.08 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.365 -0.38 . . . . 61.44 112.823 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.43 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 74.1 t-105 -69.4 -40.53 77.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.548 0.739 . . . . 74.3 110.352 174.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.71 -32.92 74.54 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.948 0.499 . . . . 71.02 111.796 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.6 89.5 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.387 0.675 . . . . 51.11 110.968 171.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 12.4 ttt180 -59.69 -50.18 74.87 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.078 0.551 . . . . 74.41 111.216 168.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 45' ' ' TRP . 8.7 mm-40 -76.13 -1.43 26.14 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.917 0.887 . . . . 71.43 112.706 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.12 33.77 19.29 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.86 1.264 . . . . 73.22 112.526 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -93.28 -23.21 18.58 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.106 0.962 . . . . 72.32 112.25 177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.09 157.2 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 113.416 0.895 . . . . 64.14 113.416 -173.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 64' ' ' TYR . 2.3 m -133.4 144.21 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.162 1.385 . . . . 44.41 110.123 175.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.726 HG12 HD11 ' B' ' 41' ' ' LEU . 2.6 mp -108.82 128.3 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.609 0.763 . . . . 75.25 111.067 -171.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -115.21 119.09 35.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.457 1.103 . . . . 55.53 109.833 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HB2' ' SD ' ' B' ' 1' ' ' MET . 98.6 mtt180 -100.38 125.72 46.67 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.104 0.478 . . . . 73.24 111.156 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.87 131.11 13.6 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.979 0.912 . . . . 72.33 109.951 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 60.3 28.51 18.12 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.781 1.232 . . . . 62.21 111.802 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.49 -8.26 62.33 Favored Glycine 0 CA--C 1.544 1.844 0 N-CA-C 113.87 0.308 . . . . 71.22 113.87 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.38 160.91 14.05 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.95 0.9 . . . . 70.02 111.358 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.65 HG23 HG23 ' A' ' 54' ' ' ILE . 78.9 mt -112.64 127.96 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.866 0.866 . . . . 60.42 110.705 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -112.57 140.97 46.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.999 0.92 . . . . 62.15 109.544 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.85 133.76 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.018 0.927 . . . . 75.43 108.726 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HB2' HG23 ' A' ' 53' ' ' VAL . 88.6 m-85 -129.91 169.31 15.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.91 1.284 . . . . 55.21 109.84 177.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -85.97 138.22 32.15 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.143 0.577 . . . . 65.22 110.311 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.25 10.84 4.01 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-O 121.457 0.646 . . . . 72.04 112.125 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.669 ' HA2' ' HB2' ' A' ' 71' ' ' PHE . . . -60.0 -11.18 17.19 Favored Glycine 0 CA--C 1.541 1.692 0 N-CA-C 114.376 0.511 . . . . 71.41 114.376 169.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.57 -48.99 79.33 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.941 0.896 . . . . 74.31 111.535 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -86.13 -79.62 0.25 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.491 0.717 . . . . 72.23 111.146 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.11 120.9 13.47 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.902 0.881 . . . . 74.04 109.057 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.669 ' HB2' ' HA2' ' A' ' 67' ' ' GLY . 53.8 t80 -118.03 130.28 56.07 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.264 0.554 . . . . 64.31 110.952 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 p -137.01 161.97 34.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.467 1.107 . . . . 72.3 109.522 171.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.8 t80 66.32 111.19 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.661 1.184 . . . . 75.42 111.501 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -134.71 123.19 3.09 Favored Glycine 0 C--N 1.345 1.047 0 C-N-CA 123.282 0.468 . . . . 73.34 112.086 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.2 mp -70.01 117.14 11.2 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.928 0.891 . . . . 41.51 110.103 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.64 -172.99 3.0 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.524 0.564 . . . . 63.33 112.524 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -79.77 116.89 20.2 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.063 0.945 . . . . 74.12 110.911 -170.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -92.02 -6.99 50.08 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.281 0.632 . . . . 73.51 112.404 -177.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 69.99 -67.31 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.632 1.573 . . . . 73.53 111.867 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -81.45 145.82 30.56 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.217 0.607 . . . . 65.4 110.407 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -65.73 123.98 21.18 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.734 0.814 . . . . 64.31 112.57 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.9 m170 . . . . . 0 N--CA 1.484 1.246 0 C-N-CA 124.91 1.284 . . . . 74.31 109.76 171.829 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 56' ' ' ARG . 18.6 ttt . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 110.068 -0.345 . . . . 64.25 110.068 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.538 ' HB2' HG13 ' B' ' 5' ' ' ILE . 21.9 m-20 -63.28 126.31 27.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.814 0.445 . . . . 71.43 111.804 -175.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.417 ' O ' HG22 ' B' ' 6' ' ' VAL . 87.7 tttt -73.62 -12.46 60.75 Favored 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 123.665 0.786 . . . . 63.11 110.679 174.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.36 -26.99 65.86 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.071 0.948 . . . . 75.24 111.935 173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.538 HG13 ' HB2' ' B' ' 2' ' ' ASP . 88.4 mt -59.11 -43.18 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.525 0.73 . . . . 72.34 111.712 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.417 HG22 ' O ' ' B' ' 3' ' ' LYS . 25.5 m -65.36 -28.91 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-N 117.641 0.201 . . . . 64.42 111.319 176.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' B' ' 45' ' ' TRP . . . -67.74 -46.36 68.64 Favored Glycine 0 C--N 1.354 1.534 0 O-C-N 123.519 0.512 . . . . 72.43 113.7 175.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.48 99.12 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.646 0.778 . . . . 63.54 111.162 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -70.34 -30.58 67.57 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.944 0.898 . . . . 64.05 112.238 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.7 66.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.066 0.546 . . . . 73.52 111.371 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.81 -36.23 93.07 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 116.006 -0.543 . . . . 63.51 112.839 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -70.11 -43.32 71.26 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.315 1.046 . . . . 75.41 111.155 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.601 ' HA ' HG11 ' B' ' 32' ' ' VAL . 42.9 t -60.48 -46.37 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 124.257 1.023 . . . . 70.43 111.727 176.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.582 ' HA ' HD12 ' B' ' 17' ' ' LEU . 66.8 t90 -66.97 -33.61 75.95 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.851 -0.613 . . . . 53.45 112.056 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -64.38 -35.15 79.97 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.812 0.445 . . . . 63.15 110.645 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.525 ' HB1' ' HE3' ' B' ' 31' ' ' LYS . . . -72.02 -23.87 61.46 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.663 0.785 . . . . 71.45 112.833 174.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' B' ' 14' ' ' TRP . 84.9 mt -70.2 -47.08 63.09 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.57 0.748 . . . . 64.03 110.692 169.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.87 -28.29 67.41 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.554 0.742 . . . . 63.43 111.305 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -72.22 -51.43 21.09 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.048 0.939 . . . . 55.31 110.396 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.47 118.37 2.21 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.079 0.551 . . . . 73.45 112.127 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -82.72 -178.06 6.95 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.301 1.04 . . . . 60.14 112.04 172.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.07 26.16 73.03 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.823 -0.626 . . . . 71.53 112.242 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 tp -106.76 146.4 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 124.042 0.937 . . . . 73.13 109.715 -173.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -95.0 162.37 13.76 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.31 0.644 . . . . 63.53 109.922 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.521 HG21 ' HB2' ' B' ' 40' ' ' ALA . 76.4 mt -56.35 -49.1 95.34 Favored Pre-proline 0 CA--C 1.58 2.118 0 N-CA-C 114.025 1.12 . . . . 65.51 114.025 -173.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.69 -30.31 42.01 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.027 1.818 . . . . 73.22 114.106 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -79.12 -42.35 26.47 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.203 1.001 . . . . 62.14 110.442 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.438 HD21 HG13 ' B' ' 13' ' ' VAL . 65.7 tp -58.04 -40.66 81.49 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.625 -1.625 . . . . 64.33 111.112 170.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.24 78.61 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.928 0.891 . . . . 72.15 111.83 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -67.03 -37.62 84.44 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.166 0.587 . . . . 73.11 111.51 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.525 ' HE3' ' HB1' ' B' ' 16' ' ' ALA . 44.4 mtmt -66.79 -39.95 87.95 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.826 0.45 . . . . 71.22 111.315 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' B' ' 13' ' ' VAL . 33.9 m -96.09 7.14 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.823 0.675 . . . . 64.23 112.823 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 65.8 t30 65.33 12.38 8.04 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.176 0.99 . . . . 75.31 112.783 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 59.8 mt -97.11 168.59 10.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.674 -0.641 . . . . 72.33 110.747 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 68.3 m -74.68 159.8 31.6 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.597 0.359 . . . . 64.44 110.998 170.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 70.1 t -52.49 -57.72 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.303 1.041 . . . . 60.04 112.589 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -68.61 -30.52 69.27 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.639 0.775 . . . . 73.22 111.669 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 56.0 m -61.17 -39.82 91.56 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.733 0.813 . . . . 64.21 111.408 173.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.441 ' O ' HG23 ' B' ' 43' ' ' VAL . 90.4 m -76.72 -42.37 41.55 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.722 0.809 . . . . 64.32 111.536 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -59.6 -39.74 85.21 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 123.81 0.844 . . . . 73.03 111.921 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.726 HD11 HG12 ' A' ' 54' ' ' ILE . 1.1 tt -60.41 -50.32 74.07 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.808 1.243 . . . . 72.32 110.009 173.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 -27.06 68.65 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 114.843 -1.071 . . . . 63.12 112.089 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 39' ' ' THR . 65.7 t -68.48 -39.96 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 123.388 0.675 . . . . 61.33 110.649 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.12 -27.8 73.19 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-N 116.379 -0.373 . . . . 73.51 113.07 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' TRP . . . . . 0.524 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 64.6 t-105 -74.82 -32.22 61.9 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.494 0.718 . . . . 73.23 111.466 173.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.58 -27.15 62.95 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.243 0.617 . . . . 63.23 111.765 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.02 67.96 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 113.199 0.814 . . . . 51.4 113.199 172.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 36.8 ptt85 -74.31 -29.18 61.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.861 -0.524 . . . . 73.42 110.968 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.5 ' HB3' ' HE2' ' B' ' 51' ' ' LYS . 21.7 mm-40 -72.22 -22.78 61.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.056 0.942 . . . . 73.12 112.359 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 59.41 35.06 22.94 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.275 1.03 . . . . 74.31 112.452 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.5 ' HE2' ' HB3' ' B' ' 49' ' ' GLU . 51.3 mtmt -108.49 0.44 20.94 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.683 0.623 . . . . 74.42 112.683 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.52 147.93 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 112.644 0.609 . . . . 75.43 112.644 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.66 108.25 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.798 0.839 . . . . 72.01 109.807 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 2.6 mp -89.97 112.34 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 108.499 -0.926 . . . . 73.24 108.499 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -102.21 126.51 49.21 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.835 0.454 . . . . 70.03 110.352 174.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -90.79 96.29 10.56 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.356 -0.979 . . . . 75.03 108.356 168.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -104.78 109.33 21.23 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.903 1.281 . . . . 71.54 109.093 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 55.15 29.16 12.12 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.559 1.144 . . . . 75.11 111.004 -164.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.17 -20.73 35.11 Favored Glycine 0 CA--C 1.549 2.197 0 CA-C-N 115.478 -0.783 . . . . 64.23 114.58 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.73 130.15 34.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 117.821 0.811 . . . . 52.21 111.83 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -84.05 114.96 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 123.458 0.703 . . . . 72.12 111.508 -173.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.28 142.94 46.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.017 0.927 . . . . 74.25 109.107 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 6.4 tp -106.74 128.3 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 CA-C-O 121.607 0.717 . . . . 72.14 110.709 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -126.63 171.48 11.1 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.692 1.197 . . . . 71.03 110.001 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 39.4 t30 -100.51 152.54 20.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.444 1.098 . . . . 72.14 108.889 170.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -61.45 -41.22 96.88 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.819 0.847 . . . . 72.12 112.545 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.71 3.42 49.81 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 114.923 0.729 . . . . 54.35 114.923 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -72.42 -49.69 31.8 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.643 0.777 . . . . 64.22 111.914 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.55 120.99 22.52 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.43 0.692 . . . . 73.25 111.581 -171.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -129.38 156.78 43.51 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.43 0.692 . . . . 73.12 110.718 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -76.11 -18.22 59.25 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.986 0.914 . . . . 53.22 113.215 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 44.9 t -70.38 88.97 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.316 0.579 . . . . 75.21 110.675 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -65.95 -35.84 81.7 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.978 0.911 . . . . 73.34 112.505 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.47 58.78 0.08 OUTLIER Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.236 -0.438 . . . . 74.44 113.283 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -94.71 115.83 28.01 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.064 -0.717 . . . . 71.31 109.064 174.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -74.54 91.0 2.26 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.494 0.717 . . . . 74.21 112.189 -169.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -90.03 -23.24 21.52 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.105 -0.952 . . . . 64.53 109.995 166.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -66.29 114.95 5.74 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.141 0.576 . . . . 72.12 110.345 174.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -108.38 -172.2 2.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.62 0.768 . . . . 72.11 110.941 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -92.28 160.9 14.92 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.527 0.731 . . . . 73.41 112.139 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -64.84 110.7 2.51 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.74 1.216 . . . . 65.24 110.614 170.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.447 0.642 . . . . 74.44 111.893 -178.348 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp . . . . . 0 CA--C 1.555 1.142 0 CA-C-O 120.652 0.263 . . . . 73.140000000000001 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.8 mt -65.55 -55.94 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.434 0.693 . . . . 74.200000000000003 110.888 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.3 m -69.34 -26.22 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.071 -0.968 . . . . 74.409999999999997 111.223 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.79 -40.24 95.54 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 116.491 -0.322 . . . . 42.039999999999999 113.138 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.97 -54.47 13.14 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.623 0.769 . . . . 70.040000000000006 112.527 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -71.82 -20.97 61.76 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.171 0.804 . . . . 61.140000000000001 113.171 -174.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 -30.41 70.55 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.462 0.705 . . . . 74.299999999999997 111.818 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.86 -35.84 90.19 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 116.239 -0.437 . . . . 62.32 113.063 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.86 -42.65 60.49 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.562 0.745 . . . . 52.530000000000001 111.791 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.63 ' HA ' HG11 ' A' ' 32' ' ' VAL . 35.0 m -68.49 -38.75 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 122.282 0.233 . . . . 75.299999999999997 111.503 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.618 ' HA ' HD12 ' A' ' 17' ' ' LEU . 69.7 t90 -64.29 -36.42 84.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.973 0.909 . . . . 73.239999999999995 111.561 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.18 -40.7 98.27 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.952 0.901 . . . . 70.109999999999999 111.282 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.423 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -68.59 -24.23 64.57 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.394 0.678 . . . . 72.519999999999996 112.556 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 14' ' ' TRP . 52.1 mt -73.49 -33.87 65.02 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.835 0.854 . . . . 63.130000000000003 112.078 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.54 -36.58 78.78 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.609 0.764 . . . . 74.120000000000005 110.983 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.19 -59.86 4.33 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.384 1.074 . . . . 71.310000000000002 111.497 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.37 114.18 0.76 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.198 0.999 . . . . 61.439999999999998 110.275 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -98.16 -179.21 4.31 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.751 0.82 . . . . 75.540000000000006 111.721 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.43 26.32 47.64 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 112.6 -170.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.4 tt -104.29 147.63 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 C-N-CA 123.658 0.783 . . . . 74.310000000000002 111.367 -172.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.4 t -76.51 160.0 29.87 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.246 1.018 . . . . 73.239999999999995 111.938 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.5 mm -55.76 -56.61 28.14 Favored Pre-proline 0 CA--C 1.575 1.937 0 N-CA-C 113.523 0.934 . . . . 74.329999999999998 113.523 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.8 -22.47 27.25 Favored 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 121.691 1.594 . . . . 61.210000000000001 113.909 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -75.85 -47.92 23.6 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 122.273 1.035 . . . . 73.450000000000003 110.227 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.48 -40.51 78.72 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 113.511 -1.677 . . . . 71.200000000000003 111.291 170.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.09 70.29 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.272 1.029 . . . . 52.200000000000003 113.039 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -73.62 -35.91 65.4 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.285 0.634 . . . . 73.239999999999995 112.287 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.423 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 45.0 mtmt -71.81 -43.99 64.7 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 120.905 0.383 . . . . 72.200000000000003 111.255 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 13' ' ' VAL . 20.0 m -86.93 -11.56 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.037 0.535 . . . . 63.350000000000001 112.3 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 60.72 37.77 18.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.731 1.213 . . . . 73.150000000000006 113.12 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.5 mt -106.85 157.31 17.85 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.574 0.75 . . . . 72.239999999999995 110.585 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 m -61.05 150.18 34.6 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.226 0.611 . . . . 64.099999999999994 111.361 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.6 t -54.91 -48.89 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.547 0.739 . . . . 71.230000000000004 112.466 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -59.8 -39.77 86.12 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.128 0.571 . . . . 75.420000000000002 111.724 174.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.7 t -68.84 -37.31 79.05 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.527 0.731 . . . . 64.200000000000003 112.825 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.5 m -71.6 -47.89 51.71 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.618 0.767 . . . . 61.229999999999997 110.699 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.78 93.58 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.007 0.923 . . . . 74.319999999999993 112.174 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.77 -35.28 64.97 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.16 0.984 . . . . 72.209999999999994 111.345 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.32 98.85 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.464 0.65 . . . . 73.310000000000002 110.891 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.574 HG11 HD13 ' A' ' 63' ' ' ILE . 69.9 t -64.4 -31.47 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 C-N-CA 123.813 0.845 . . . . 71.239999999999995 111.672 172.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.34 -32.44 82.87 Favored Glycine 0 CA--C 1.544 1.87 0 N-CA-C 113.888 0.315 . . . . 23.510000000000002 113.888 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -68.58 -32.71 72.81 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.591 0.757 . . . . 64.430000000000007 111.282 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.53 -41.02 69.67 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.414 0.686 . . . . 74.140000000000001 110.89 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.59 -26.92 64.15 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.549 1.139 . . . . 72.25 112.6 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -52.95 -45.07 67.53 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.889 0.876 . . . . 63.299999999999997 112.102 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -103.87 3.78 34.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.031 0.932 . . . . 74.310000000000002 112.147 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.7 m120 54.7 36.63 26.66 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.149 0.98 . . . . 71.219999999999999 112.595 -170.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -67.66 -18.22 64.87 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.356 0.663 . . . . 75.109999999999999 110.441 166.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.15 148.44 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.207 1.003 . . . . 74.109999999999999 109.974 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 64' ' ' TYR . 20.3 m -128.96 134.75 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.906 0.882 . . . . 73.319999999999993 108.98 173.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.71 128.8 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 121.206 0.527 . . . . 72.140000000000001 112.278 -167.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -122.54 141.33 51.78 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.667 1.187 . . . . 70.540000000000006 109.54 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -117.25 110.54 18.24 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.819 0.342 . . . . 71.120000000000005 110.865 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -111.28 126.78 55.26 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.052 -0.721 . . . . 70.219999999999999 109.052 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 56.95 31.1 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.463 1.105 . . . . 71.549999999999997 112.103 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.29 -15.56 38.98 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 114.431 0.533 . . . . 73.540000000000006 114.431 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.9 mt -74.15 151.7 39.99 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.349 0.659 . . . . 75.450000000000003 111.469 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 mp -99.88 111.97 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 123.157 0.583 . . . . 71.099999999999994 110.055 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -98.38 141.06 31.73 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.492 0.717 . . . . 73.209999999999994 110.065 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.574 HD13 HG11 ' A' ' 43' ' ' VAL . 61.7 mt -116.04 113.32 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.046 0.538 . . . . 63.409999999999997 110.479 172.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.461 ' HB2' HG23 ' A' ' 53' ' ' VAL . 9.0 m-30 -97.29 150.15 21.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.685 0.794 . . . . 74.140000000000001 110.583 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 17.9 t-20 -92.71 141.57 28.32 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.264 0.626 . . . . 74.129999999999995 109.59 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 113.154 0.798 . . . . 64.230000000000004 113.154 179.129 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.513 ' HA ' HG22 ' B' ' 6' ' ' VAL . 9.8 mtmp? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 113.191 0.812 . . . . 73.209999999999994 113.191 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -69.04 -45.76 69.61 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.24 0.616 . . . . 63.030000000000001 110.497 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 79.1 mt -63.05 -56.7 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.119 0.968 . . . . 65.129999999999995 111.433 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' B' ' 3' ' ' LYS . 12.6 m -66.13 -27.61 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 122.848 0.459 . . . . 54.109999999999999 111.503 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.03 -41.0 97.46 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.233 0.333 . . . . 73.239999999999995 112.995 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.07 -50.27 62.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.452 0.701 . . . . 53.340000000000003 111.606 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -68.22 -27.49 66.42 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.795 0.838 . . . . 71.319999999999993 112.384 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.485 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -72.83 -34.35 66.76 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.101 0.56 . . . . 44.420000000000002 111.518 177.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -35.19 91.63 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 123.388 0.43 . . . . 73.239999999999995 112.34 174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' B' ' 32' ' ' VAL . 1.6 ttmp? -68.14 -50.32 55.35 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.24 1.016 . . . . 74.140000000000001 112.216 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.525 ' HA ' HG11 ' B' ' 32' ' ' VAL . 24.4 m -69.09 -34.76 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 111.886 0.328 . . . . 71.140000000000001 111.886 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -71.9 -34.97 69.57 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.269 0.627 . . . . 74.239999999999995 111.081 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -57.05 -41.64 79.05 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.069 0.548 . . . . 64.340000000000003 110.489 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.53 -32.74 74.51 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.504 -0.771 . . . . 74.540000000000006 111.841 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 13' ' ' VAL . 83.3 mt -71.74 -34.0 69.15 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.401 0.681 . . . . 62.210000000000001 111.759 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.04 -31.49 71.13 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.76 0.824 . . . . 62.140000000000001 111.34 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -105.11 -25.78 12.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.159 0.984 . . . . 70.400000000000006 112.133 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.02 87.87 0.66 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.217 0.607 . . . . 74.319999999999993 111.524 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.17 -179.03 3.92 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.359 0.664 . . . . 72.019999999999996 111.825 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.25 18.18 79.76 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.084 -0.507 . . . . 63.520000000000003 112.85 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.73 152.39 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.391 1.076 . . . . 63.140000000000001 110.02 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -69.04 148.28 50.31 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.797 0.439 . . . . 52.229999999999997 111.045 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.624 HG21 ' HB2' ' B' ' 40' ' ' ALA . 36.5 mm -54.69 -48.35 95.61 Favored Pre-proline 0 CA--C 1.578 2.027 0 N-CA-C 113.719 1.007 . . . . 74.239999999999995 113.719 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -65.42 -31.23 52.23 Favored 'Trans proline' 0 C--N 1.393 2.905 0 C-N-CA 121.969 1.78 . . . . 74.230000000000004 113.965 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -71.64 -46.66 58.36 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.357 1.075 . . . . 75.049999999999997 109.778 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.406 HD22 HD11 ' B' ' 63' ' ' ILE . 60.9 tp -59.73 -38.7 82.43 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.301 -1.772 . . . . 64.120000000000005 111.51 172.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.79 98.01 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.984 0.913 . . . . 55.030000000000001 111.939 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -64.43 -35.81 82.12 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.1 -0.955 . . . . 75.329999999999998 110.681 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -66.63 -45.92 77.47 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.391 0.676 . . . . 64.420000000000002 112.298 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' B' ' 13' ' ' VAL . 30.5 m -90.51 10.7 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 112.718 0.636 . . . . 52.130000000000003 112.718 -173.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.68 16.82 9.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.408 1.083 . . . . 64.430000000000007 113.08 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.2 mt -106.16 168.69 8.97 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.743 0.817 . . . . 64.150000000000006 110.603 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 43.6 t -81.12 165.47 21.56 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.612 0.365 . . . . 64.25 111.243 169.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 74.4 t -52.92 -48.51 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 123.619 0.768 . . . . 53.210000000000001 111.836 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.91 -52.84 64.03 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.405 0.682 . . . . 64.310000000000002 111.96 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 23.0 m -59.26 -38.91 81.24 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.961 0.904 . . . . 50.409999999999997 112.379 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -72.44 -48.52 40.46 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.776 0.831 . . . . 72.340000000000003 111.767 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.624 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -63.61 -32.46 73.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.329 0.652 . . . . 73.340000000000003 112.027 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -71.79 -38.32 70.29 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.697 1.199 . . . . 74.230000000000004 110.508 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.25 -37.76 81.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.174 0.59 . . . . 74.450000000000003 111.405 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.512 HG13 HG11 ' B' ' 52' ' ' VAL . 60.7 t -64.1 -30.98 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.243 1.017 . . . . 75.129999999999995 110.867 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.57 86.32 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.495 -0.32 . . . . 61.109999999999999 113.513 171.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -72.7 -23.67 60.9 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.317 0.58 . . . . 73.120000000000005 111.198 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.44 HD11 HG23 ' B' ' 13' ' ' VAL . 76.4 mt -74.45 -40.93 61.62 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 121.518 -0.739 . . . . 54.299999999999997 111.08 169.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.24 -31.19 69.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.474 1.11 . . . . 63.409999999999997 113.488 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.59 ' HD3' ' HG3' ' B' ' 49' ' ' GLU . 0.0 OUTLIER -72.41 -14.1 61.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 112.735 0.643 . . . . 75.450000000000003 112.735 176.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.59 ' HG3' ' HD3' ' B' ' 48' ' ' ARG . 50.1 mt-10 -114.92 16.11 17.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.883 0.873 . . . . 61.200000000000003 110.965 169.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 47.53 28.38 1.17 Allowed 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 125.876 1.67 . . . . 41.130000000000003 114.314 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' B' ' 66' ' ' GLU . 53.0 mttp -71.52 -11.5 60.9 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.232 1.013 . . . . 72.319999999999993 112.95 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.512 HG11 HG13 ' B' ' 43' ' ' VAL . 12.6 m -124.52 145.85 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.637 0.775 . . . . 73.439999999999998 112.307 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 63.4 t -112.0 120.38 62.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 125.017 1.327 . . . . 64.310000000000002 108.949 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.21 110.59 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.703 -0.851 . . . . 72.540000000000006 108.703 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.28 112.49 18.67 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.794 0.438 . . . . 73.329999999999998 110.833 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.477 ' HG2' HG12 ' B' ' 61' ' ' ILE . 13.8 mtm-85 -93.36 96.89 10.23 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.746 0.819 . . . . 75.400000000000006 109.905 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -104.57 111.98 24.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.902 1.281 . . . . 73.420000000000002 109.414 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 57.74 30.45 18.95 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 111.747 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.68 -22.81 28.85 Favored Glycine 0 CA--C 1.546 2.012 0 CA-C-N 115.654 -0.703 . . . . 73.099999999999994 113.992 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 88.4 mt -79.24 126.13 30.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.987 0.915 . . . . 45.009999999999998 111.527 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.477 HG12 ' HG2' ' B' ' 56' ' ' ARG . 40.4 mt -92.19 123.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 121.059 0.457 . . . . 44.340000000000003 112.068 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -117.83 139.72 50.7 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.385 1.074 . . . . 72.430000000000007 109.187 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.42 HG21 HG11 ' B' ' 43' ' ' VAL . 1.5 pp -113.66 104.59 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.926 0.87 . . . . 61.229999999999997 112.064 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 74.9 m-85 -83.61 167.06 17.64 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.659 0.784 . . . . 54.310000000000002 110.875 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -93.25 164.08 13.37 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.121 0.486 . . . . 74.450000000000003 112.294 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' B' ' 51' ' ' LYS . 40.1 tt0 . . . . . 0 N--CA 1.489 1.521 0 C-N-CA 123.847 0.859 . . . . 75.409999999999997 112.149 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt . . . . . 0 CA--C 1.553 1.09 0 N-CA-C 112.072 0.397 . . . . 74.439999999999998 112.072 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.8 mt -69.0 -58.02 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.091 0.556 . . . . 62.219999999999999 110.966 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.67 -27.85 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.749 0.42 . . . . 61.43 111.711 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.23 -42.25 76.28 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 123.543 0.527 . . . . 41.0 112.875 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.78 96.02 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.012 0.925 . . . . 61.310000000000002 112.054 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.417 ' O ' ' HG2' ' A' ' 12' ' ' LYS . 57.2 m-80 -85.1 -21.26 29.39 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.166 0.586 . . . . 60.539999999999999 112.414 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.54 76.1 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 118.072 0.396 . . . . 73.0 111.448 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.0 -39.83 97.63 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 115.851 -0.613 . . . . 61.219999999999999 113.456 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.481 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 6.7 ptmm? -75.87 -30.63 58.94 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.5 -0.412 . . . . 71.439999999999998 111.488 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.575 ' HA ' HG11 ' A' ' 32' ' ' VAL . 71.4 t -67.37 -46.78 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.282 0.633 . . . . 74.209999999999994 110.84 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.438 ' HA ' HD12 ' A' ' 17' ' ' LEU . 21.7 t90 -64.07 -35.07 79.53 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.572 -0.74 . . . . 73.439999999999998 110.639 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.405 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 79.3 t60 -63.11 -40.55 97.95 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.845 0.458 . . . . 43.299999999999997 111.547 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.12 -31.66 72.93 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 120.862 0.363 . . . . 54.140000000000001 111.661 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.481 ' HB3' ' OD1' ' A' ' 65' ' ' ASN . 90.1 mt -69.34 -41.95 75.94 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.337 1.055 . . . . 74.340000000000003 111.733 170.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.74 -26.99 66.11 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.145 0.978 . . . . 72.150000000000006 111.425 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 15' ' ' HIS . 68.3 mt-10 -77.79 -49.85 13.52 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.225 0.61 . . . . 64.400000000000006 110.127 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.77 108.19 0.67 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.603 0.761 . . . . 73.019999999999996 111.264 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 11.1 p-10 -94.1 -178.79 4.74 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.146 0.978 . . . . 71.430000000000007 112.918 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.28 33.59 61.62 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-N 116.016 -0.538 . . . . 44.32 111.852 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 tt -113.12 145.09 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.026 0.931 . . . . 73.329999999999998 111.013 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.9 m -78.85 154.03 30.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.556 0.743 . . . . 64.450000000000003 110.943 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.732 HG21 ' HB2' ' A' ' 40' ' ' ALA . 44.7 mm -59.1 -44.34 98.52 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 114.777 1.399 . . . . 73.349999999999994 114.777 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -62.82 -32.61 77.5 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 121.942 1.761 . . . . 73.340000000000003 113.185 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -75.27 -37.46 60.93 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.587 1.184 . . . . 72.040000000000006 109.871 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.9 tp -70.73 -33.4 70.79 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 112.707 -2.042 . . . . 72.099999999999994 111.658 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.05 -37.06 81.27 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.086 0.954 . . . . 74.0 111.167 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -64.44 -39.22 93.41 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.175 0.99 . . . . 75.010000000000005 111.104 174.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -66.47 -43.72 84.71 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.663 0.785 . . . . 73.049999999999997 111.864 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.575 HG11 ' HA ' ' A' ' 13' ' ' VAL . 7.0 m -98.17 9.99 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 113.315 0.858 . . . . 73.209999999999994 113.315 -170.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 m120 66.87 10.51 7.66 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.587 1.155 . . . . 64.409999999999997 113.428 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.9 mt -108.31 178.08 4.61 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.247 0.619 . . . . 74.219999999999999 111.479 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.4 t -88.48 165.68 14.72 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.17 0.588 . . . . 73.340000000000003 110.991 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.38 -47.33 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 124.312 1.045 . . . . 51.229999999999997 112.26 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -61.22 -53.0 62.43 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.214 0.606 . . . . 71.099999999999994 112.088 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -63.01 -28.6 70.22 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.733 0.813 . . . . 72.519999999999996 112.518 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 43' ' ' VAL . 88.0 m -80.08 -53.65 6.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.75 0.82 . . . . 72.109999999999999 111.441 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.1 -30.75 69.46 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.106 0.962 . . . . 43.340000000000003 112.315 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -52.86 63.07 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.714 1.206 . . . . 73.319999999999993 110.225 174.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.24 -26.75 68.24 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.886 -1.052 . . . . 73.409999999999997 111.39 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 39' ' ' THR . 94.7 t -66.04 -40.11 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.166 0.586 . . . . 72.239999999999995 110.889 172.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.07 -33.24 86.72 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 116.309 -0.405 . . . . 64.109999999999999 113.107 173.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.485 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 63.7 t-105 -74.22 -25.18 59.51 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.586 0.754 . . . . 75.129999999999995 111.605 176.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.27 -47.72 48.01 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 122.115 -0.366 . . . . 61.200000000000003 110.39 166.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.72 68.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.3 1.04 . . . . 54.009999999999998 113.19 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.547 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 26.6 ptt85 -59.4 -39.71 84.29 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 112.558 0.577 . . . . 64.030000000000001 112.558 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.547 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 47.0 mt-10 -96.61 11.62 34.63 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.886 0.875 . . . . 65.549999999999997 111.147 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 62.33 38.1 13.38 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.671 1.189 . . . . 64.120000000000005 111.198 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -80.51 -19.08 46.66 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.411 0.685 . . . . 75.519999999999996 112.195 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.87 151.57 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.314 0.646 . . . . 72.340000000000003 111.238 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.17 122.01 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.815 0.846 . . . . 74.430000000000007 109.298 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.789 HG12 HD11 ' B' ' 41' ' ' LEU . 3.6 mp -98.9 136.03 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.065 0.946 . . . . 73.340000000000003 110.86 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.7 117.98 15.62 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.569 0.747 . . . . 55.43 110.764 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -81.53 111.39 17.8 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.752 0.821 . . . . 65.239999999999995 110.556 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.85 130.61 47.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.969 0.908 . . . . 63.149999999999999 110.617 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.9 p30 44.48 41.18 4.45 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 126.059 1.744 . . . . 73.319999999999993 114.035 -175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.41 -27.44 7.74 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.374 -0.83 . . . . 74.439999999999998 114.125 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.67 160.4 28.51 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.732 0.813 . . . . 71.450000000000003 110.99 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.4 tt -121.19 118.33 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 109.683 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.87 142.68 46.24 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.116 0.966 . . . . 74.299999999999997 110.042 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.705 HG22 HG13 ' A' ' 54' ' ' ILE . 37.6 pt -115.07 140.36 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.555 0.693 . . . . 61.530000000000001 111.066 175.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 57.7 m-85 -123.8 167.8 13.58 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.681 1.192 . . . . 73.239999999999995 110.018 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.481 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 1.8 m-20 -76.06 152.37 36.88 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.337 0.255 . . . . 73.109999999999999 110.522 174.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 CA--C 1.554 1.106 0 CA-C-O 121.164 0.507 . . . . 70.200000000000003 110.327 167.283 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.562 1.424 0 CA-C-O 120.552 0.215 . . . . 70.0 111.249 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.78 -43.13 56.45 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.755 0.822 . . . . 64.530000000000001 111.668 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.58 -51.38 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 122.619 0.368 . . . . 73.109999999999999 110.813 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -66.49 -30.85 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 122.611 0.364 . . . . 75.420000000000002 111.936 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.68 45.4 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.424 0.452 . . . . 73.219999999999999 112.74 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.6 -52.93 61.45 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.087 0.955 . . . . 72.510000000000005 111.845 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -75.17 -13.9 60.5 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.753 -0.658 . . . . 70.140000000000001 112.464 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -68.06 -29.09 67.98 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 117.943 0.338 . . . . 64.109999999999999 110.504 171.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.46 -41.95 94.01 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.867 -0.606 . . . . 43.509999999999998 112.963 173.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -69.76 -47.78 61.72 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.391 0.676 . . . . 62.5 111.922 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.547 ' HA ' HG11 ' B' ' 32' ' ' VAL . 22.7 m -67.21 -32.47 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 111.886 0.328 . . . . 53.520000000000003 111.886 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 57.9 t90 -68.65 -41.1 79.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.716 0.406 . . . . 71.230000000000004 111.162 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -69.64 -40.64 76.39 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.857 0.463 . . . . 72.150000000000006 111.248 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.61 73.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.108 0.563 . . . . 75.310000000000002 111.264 176.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.631 HD23 HG23 ' B' ' 63' ' ' ILE . 1.0 OUTLIER -67.32 -44.18 79.78 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.926 0.89 . . . . 75.099999999999994 110.439 169.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.17 -36.61 84.19 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.655 0.782 . . . . 62.539999999999999 111.679 -174.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.46 -30.13 25.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.371 0.668 . . . . 65.219999999999999 111.622 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.424 ' HB3' ' HZ2' ' B' ' 31' ' ' LYS . . . -135.06 108.04 7.6 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.21 0.604 . . . . 74.010000000000005 110.942 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.99 175.78 10.26 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.868 1.267 . . . . 62.399999999999999 112.674 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.89 40.56 12.53 Favored Glycine 0 C--N 1.365 2.14 0 N-CA-C 115.144 0.817 . . . . 75.340000000000003 115.144 163.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.549 HG21 ' HZ1' ' B' ' 31' ' ' LYS . 7.8 tp -112.95 127.97 69.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.363 0.665 . . . . 74.340000000000003 109.868 -168.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 92.5 p -68.06 158.44 32.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 122.083 -0.386 . . . . 63.140000000000001 111.162 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.662 HG21 ' HB2' ' B' ' 40' ' ' ALA . 69.6 mt -59.65 -44.38 97.36 Favored Pre-proline 0 CA--C 1.578 2.033 0 N-CA-C 114.422 1.268 . . . . 71.409999999999997 114.422 -171.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.49 -28.47 45.73 Favored 'Trans proline' 0 C--N 1.389 2.667 0 CA-C-N 121.744 1.659 . . . . 75.420000000000002 113.361 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . 0.478 ' HB3' HD11 ' B' ' 23' ' ' ILE . 14.0 mm-40 -79.96 -27.26 39.76 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.149 0.98 . . . . 71.040000000000006 111.419 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.574 ' HA ' ' HE2' ' B' ' 31' ' ' LYS . 58.3 tp -75.75 -37.82 58.98 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 125.255 1.422 . . . . 74.150000000000006 110.629 170.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.34 95.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.482 1.113 . . . . 75.310000000000002 112.842 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -67.65 -33.56 75.2 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.352 0.661 . . . . 71.299999999999997 112.248 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.574 ' HE2' ' HA ' ' B' ' 28' ' ' LEU . 48.9 mtmt -66.59 -43.38 85.05 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.217 0.532 . . . . 71.140000000000001 110.897 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' B' ' 13' ' ' VAL . 21.6 m -90.66 -4.83 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.662 0.785 . . . . 73.439999999999998 112.558 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 m120 64.99 22.62 12.46 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.63 1.172 . . . . 73.400000000000006 112.876 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 59.1 mt -104.65 162.04 13.62 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.621 0.769 . . . . 73.310000000000002 110.53 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 30.1 t -64.68 152.04 43.42 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.087 0.555 . . . . 54.43 110.822 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.95 -44.05 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 123.547 0.739 . . . . 72.319999999999993 111.19 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -58.52 -47.41 84.23 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 114.887 -1.051 . . . . 73.319999999999993 112.071 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 65.3 m -68.54 -36.53 78.96 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.934 0.893 . . . . 74.409999999999997 112.262 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 87.9 m -70.94 -52.24 21.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.918 0.887 . . . . 64.420000000000002 110.802 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.662 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -57.73 -32.36 67.35 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.956 0.902 . . . . 34.5 112.491 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.789 HD11 HG12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -64.65 -52.71 55.89 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.512 1.125 . . . . 72.519999999999996 110.281 176.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.59 -29.14 70.15 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.197 -0.91 . . . . 73.239999999999995 111.586 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.04 -39.93 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.627 0.771 . . . . 74.409999999999997 110.949 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -61.88 -27.75 69.1 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-N 116.341 -0.39 . . . . 74.010000000000005 113.125 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.448 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 61.1 t-105 -71.93 -34.53 69.13 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.546 0.738 . . . . 71.25 111.249 174.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.42 -32.88 68.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.25 0.62 . . . . 60.149999999999999 111.196 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.99 -32.02 71.6 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.672 0.789 . . . . 62.049999999999997 112.175 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 53.8 ttt180 -58.83 -50.43 74.01 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.517 0.675 . . . . 75.030000000000001 110.904 167.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -79.57 -6.59 57.36 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 114.64 -1.164 . . . . 63.229999999999997 112.27 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 63.62 23.2 13.47 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.025 1.33 . . . . 60.240000000000002 112.08 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -87.67 -4.31 58.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.486 1.114 . . . . 74.540000000000006 112.604 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.712 ' HB ' HD11 ' B' ' 63' ' ' ILE . 18.3 m -135.02 166.51 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 112.532 0.567 . . . . 62.210000000000001 112.532 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.746 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 24.7 t -116.1 131.75 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.067 0.947 . . . . 71.340000000000003 111.229 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 31.9 mm -113.5 133.05 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.696 0.798 . . . . 62.009999999999998 110.784 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . 0.458 ' HB2' ' HE2' ' B' ' 57' ' ' LYS . 42.5 mt-10 -134.16 157.96 44.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.451 0.7 . . . . 43.130000000000003 111.31 167.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -111.55 106.94 15.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.211 1.004 . . . . 73.140000000000001 109.168 168.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' B' ' 55' ' ' GLU . 0.0 OUTLIER -119.54 114.91 22.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.303 1.041 . . . . 63.299999999999997 110.13 -178.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 56.25 30.54 16.84 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.804 1.241 . . . . 74.140000000000001 111.823 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.8 -25.04 23.41 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 115.959 -0.564 . . . . 62.520000000000003 114.238 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -90.46 158.52 17.01 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.701 0.8 . . . . 60.229999999999997 111.037 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 mm -107.15 131.29 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.962 0.505 . . . . 74.409999999999997 110.052 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -121.97 136.1 54.9 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.063 -1.088 . . . . 72.129999999999995 108.063 168.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' B' ' 52' ' ' VAL . 10.9 tp -92.65 130.79 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 122.982 0.513 . . . . 73.409999999999997 110.232 -177.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.746 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 84.8 m-85 -116.62 167.8 10.75 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.578 0.751 . . . . 73.340000000000003 110.974 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.537 ' HA ' HD11 ' B' ' 17' ' ' LEU . 9.7 m120 -88.06 114.21 24.46 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.0 0.741 . . . . 54.119999999999997 113.0 -169.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.505 2.289 0 N-CA-C 116.975 2.213 . . . . 72.209999999999994 116.975 157.205 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.623 0.249 . . . . 75.349999999999994 111.354 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.59 -56.67 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.731 0.813 . . . . 72.530000000000001 112.01 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.449 HG12 HD22 ' A' ' 41' ' ' LEU . 28.5 m -53.9 -44.34 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.621 1.169 . . . . 72.430000000000007 113.197 -170.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.81 -40.34 52.83 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.159 0.287 . . . . 54.149999999999999 113.025 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.22 79.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.647 0.779 . . . . 74.439999999999998 112.354 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -87.56 -20.95 25.74 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.769 0.655 . . . . 43.420000000000002 112.769 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.84 -38.98 73.23 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 123.097 0.559 . . . . 61.350000000000001 112.03 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.74 -32.52 81.51 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 116.124 -0.489 . . . . 62.030000000000001 112.623 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -71.45 -48.29 50.33 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.014 0.925 . . . . 75.239999999999995 112.188 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -75.16 -32.85 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 112.475 0.546 . . . . 75.209999999999994 112.475 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.469 ' HA ' HD12 ' A' ' 17' ' ' LEU . 26.1 t90 -70.56 -35.16 72.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 120.966 0.412 . . . . 75.120000000000005 110.457 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -62.24 -35.41 78.84 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.521 0.728 . . . . 70.430000000000007 111.306 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.02 70.09 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.367 0.667 . . . . 52.509999999999998 112.455 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 14' ' ' TRP . 46.7 mt -68.36 -31.18 70.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.55 0.74 . . . . 61.020000000000003 111.255 170.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -75.04 -22.88 58.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.172 0.589 . . . . 72.040000000000006 111.704 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.31 -58.52 5.71 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 109.118 -0.697 . . . . 74.019999999999996 109.118 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.79 117.81 0.7 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.81 -1.087 . . . . 44.119999999999997 110.006 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.12 168.34 12.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.301 0.64 . . . . 63.340000000000003 109.845 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.76 60.53 1.96 Allowed Glycine 0 N--CA 1.475 1.294 0 N-CA-C 110.963 -0.855 . . . . 55.109999999999999 110.963 -170.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.6 tt -156.11 151.15 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.416 -0.892 . . . . 71.010000000000005 109.62 -173.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 t -85.96 158.9 19.77 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.874 0.469 . . . . 70.120000000000005 111.221 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.549 HG21 ' HB2' ' A' ' 40' ' ' ALA . 58.0 mt -56.81 -49.72 92.15 Favored Pre-proline 0 CA--C 1.575 1.936 0 N-CA-C 114.214 1.19 . . . . 75.340000000000003 114.214 -173.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 71.4 Cg_endo -70.81 -21.9 27.99 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.083 1.855 . . . . 63.229999999999997 113.743 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.27 -39.28 40.55 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.441 1.115 . . . . 74.230000000000004 109.691 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.2 tp -68.65 -34.4 75.65 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-N 113.019 -1.901 . . . . 73.219999999999999 111.375 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.8 70.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.179 0.992 . . . . 70.439999999999998 112.131 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 26' ' ' PRO . 79.8 mtt-85 -66.38 -34.92 79.04 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.908 0.883 . . . . 74.239999999999995 111.365 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -69.19 -45.65 69.41 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.577 0.751 . . . . 62.25 111.509 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.505 HG23 ' H ' ' A' ' 34' ' ' LEU . 31.4 m -90.45 -5.59 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 114.026 1.121 . . . . 73.25 114.026 -170.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 67.81 8.79 6.67 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.38 1.072 . . . . 74.409999999999997 112.051 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.505 ' H ' HG23 ' A' ' 32' ' ' VAL . 60.5 mt -92.4 157.38 16.63 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.581 -0.699 . . . . 63.229999999999997 110.335 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -61.79 151.66 33.58 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.083 0.553 . . . . 74.140000000000001 111.202 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -53.47 -41.76 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.552 0.692 . . . . 74.409999999999997 110.656 174.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.24 -40.75 94.45 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.652 -1.158 . . . . 71.299999999999997 111.672 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -68.06 -41.49 81.92 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.634 0.773 . . . . 65.439999999999998 111.463 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 43' ' ' VAL . 91.1 m -66.06 -49.58 67.15 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.16 0.984 . . . . 73.230000000000004 111.029 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.94 -43.01 99.28 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.742 0.817 . . . . 32.450000000000003 112.18 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.449 HD22 HG12 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -58.35 -49.16 78.19 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.492 0.717 . . . . 64.530000000000001 110.371 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.51 -30.98 70.97 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.815 -1.084 . . . . 75.400000000000006 112.254 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 39' ' ' THR . 60.7 t -65.89 -41.62 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.356 0.663 . . . . 72.409999999999997 110.861 174.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.06 -28.63 73.12 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 116.583 -0.28 . . . . 34.210000000000001 113.563 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -74.26 -43.33 57.39 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.607 0.763 . . . . 72.019999999999996 111.482 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.45 -32.9 73.84 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.045 0.538 . . . . 64.120000000000005 111.624 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.91 -25.19 60.54 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.395 1.078 . . . . 64.510000000000005 113.402 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -69.31 -40.03 77.89 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.254 -0.647 . . . . 75.299999999999997 109.254 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.7 7.79 42.01 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.263 1.025 . . . . 64.150000000000006 111.727 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 56.5 23.91 8.05 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.086 1.355 . . . . 74.25 113.414 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -74.02 -9.66 58.85 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.819 0.847 . . . . 71.120000000000005 113.044 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 m -122.71 142.23 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.279 0.632 . . . . 64.299999999999997 111.492 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 55.1 t -109.07 107.68 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.09 0.956 . . . . 74.0 108.456 172.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.414 HG13 HG22 ' A' ' 63' ' ' ILE . 3.0 mp -89.59 122.6 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 109.38 -0.6 . . . . 72.340000000000003 109.38 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -116.11 148.36 40.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.907 0.883 . . . . 73.109999999999999 109.888 174.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.437 ' HD2' HG21 ' B' ' 5' ' ' ILE . 45.2 mtp85 -118.96 114.65 22.89 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.757 0.423 . . . . 62.130000000000003 111.146 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -114.34 110.2 19.52 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.122 0.969 . . . . 74.450000000000003 109.785 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 58.4 30.02 19.04 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 124.795 1.238 . . . . 64.129999999999995 112.966 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.29 -13.3 62.2 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 113.944 0.338 . . . . 51.240000000000002 113.944 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.07 133.03 40.43 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.612 0.765 . . . . 75.120000000000005 110.686 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.428 HD13 ' HB2' ' B' ' 37' ' ' GLU . 3.0 mp -87.52 111.32 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 121.481 0.658 . . . . 74.209999999999994 110.714 -173.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -97.81 137.61 36.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.069 1.348 . . . . 73.129999999999995 108.901 171.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.483 ' H ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -123.1 139.12 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.744 0.783 . . . . 75.329999999999998 109.913 171.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.495 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 73.8 m-85 -129.01 167.02 18.09 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.588 1.155 . . . . 74.409999999999997 109.295 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -85.15 151.99 23.71 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.378 -0.601 . . . . 75.129999999999995 109.378 167.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 CA--C 1.551 0.999 0 CA-C-O 120.855 0.36 . . . . 65.329999999999998 110.735 177.676 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp . . . . . 0 CA--C 1.559 1.324 0 CA-C-O 121.085 0.469 . . . . 73.0 110.76 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -77.3 -28.33 53.29 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.904 0.882 . . . . 72.239999999999995 111.837 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.437 HG21 ' HD2' ' A' ' 56' ' ' ARG . 67.0 mt -58.38 -55.32 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.348 0.659 . . . . 75.109999999999999 110.977 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 22.6 m -63.84 -28.42 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-N 115.034 -0.985 . . . . 63.549999999999997 111.976 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.23 -45.43 48.93 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 123.398 0.436 . . . . 63.299999999999997 113.057 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.72 93.18 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.669 0.788 . . . . 34.409999999999997 111.785 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -65.25 -45.26 85.31 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.216 0.606 . . . . 65.230000000000004 110.434 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.402 ' HB1' ' HG ' ' B' ' 46' ' ' LEU . . . -68.32 -32.03 71.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.658 0.783 . . . . 62.140000000000001 112.132 -174.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.68 96.76 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 116.712 -0.222 . . . . 60.229999999999997 113.125 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -71.53 -39.72 70.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.396 0.678 . . . . 75.430000000000007 111.241 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.571 HG11 HG22 ' B' ' 43' ' ' VAL . 74.3 t -61.85 -41.64 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.743 0.817 . . . . 53.420000000000002 111.15 174.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -67.79 -31.73 71.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.392 0.677 . . . . 61.5 111.598 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -61.36 -45.74 93.13 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.4 0.28 . . . . 73.219999999999999 111.003 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.13 -29.79 67.91 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.389 0.614 . . . . 71.540000000000006 111.23 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.71 ' HG ' HG12 ' B' ' 52' ' ' VAL . 2.5 tm? -72.73 -34.24 66.93 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.893 1.277 . . . . 65.430000000000007 110.541 174.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.1 -20.0 39.02 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.499 0.719 . . . . 71.329999999999998 110.643 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -76.63 -59.46 2.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.832 0.853 . . . . 63.420000000000002 109.889 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.42 110.72 3.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.199 1.0 . . . . 63.109999999999999 109.262 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -90.71 -179.82 5.62 Favored 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 112.566 0.58 . . . . 52.520000000000003 112.566 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.58 51.1 9.97 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.745 -0.661 . . . . 74.540000000000006 111.633 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tp -121.17 140.49 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.252 0.621 . . . . 71.329999999999998 111.71 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 17.0 m -72.23 144.68 48.36 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.863 0.865 . . . . 72.150000000000006 111.257 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.45 HG21 ' HB2' ' B' ' 40' ' ' ALA . 62.2 mt -53.46 -52.36 67.44 Favored Pre-proline 0 CA--C 1.573 1.844 0 N-CA-C 113.671 0.989 . . . . 74.349999999999994 113.671 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -68.96 -24.75 33.03 Favored 'Trans proline' 0 C--N 1.391 2.803 0 C-N-CA 121.692 1.595 . . . . 74.200000000000003 113.823 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -77.42 -47.21 20.35 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.959 0.885 . . . . 60.229999999999997 109.593 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 57.5 tp -56.32 -34.88 66.98 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 113.647 -1.615 . . . . 63.329999999999998 111.69 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.84 98.97 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.875 0.87 . . . . 45.420000000000002 111.708 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -66.26 -40.74 90.36 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.121 0.568 . . . . 73.439999999999998 110.571 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -60.4 -45.83 92.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.874 0.87 . . . . 62.219999999999999 111.405 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.67 4.2 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 112.56 0.578 . . . . 74.349999999999994 112.56 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 61.18 32.75 19.49 Favored 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 124.539 1.135 . . . . 52.43 112.195 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 85.8 mt -123.26 170.27 10.45 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.925 0.89 . . . . 75.439999999999998 111.034 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -69.14 155.26 40.68 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.453 0.701 . . . . 63.340000000000003 111.511 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.26 -48.85 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.514 0.725 . . . . 71.120000000000005 111.481 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.449 ' HB3' HD12 ' A' ' 25' ' ' ILE . 43.6 mt-10 -59.11 -52.54 65.26 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.882 0.873 . . . . 72.129999999999995 111.838 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.1 t -56.64 -32.49 65.4 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.339 1.056 . . . . 73.109999999999999 112.746 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.508 ' O ' HG23 ' B' ' 43' ' ' VAL . 89.5 m -81.48 -46.15 14.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.651 0.78 . . . . 64.319999999999993 110.853 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -58.48 -52.65 64.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.676 0.991 . . . . 75.209999999999994 113.676 -171.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -26.83 64.57 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 120.882 0.373 . . . . 72.319999999999993 111.092 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.85 -34.71 73.98 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.703 0.801 . . . . 62.009999999999998 111.538 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.573 HG12 HD11 ' B' ' 54' ' ' ILE . 51.2 t -63.18 -33.06 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 122.823 0.449 . . . . 75.400000000000006 109.843 169.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.4 83.59 Favored Glycine 0 CA--C 1.542 1.72 0 CA-C-N 116.535 -0.302 . . . . 64.329999999999998 113.131 172.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.482 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 70.5 t-105 -71.6 -25.26 62.1 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.546 0.738 . . . . 71.109999999999999 111.778 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.402 ' HG ' ' HB1' ' B' ' 10' ' ' ALA . 94.9 mt -76.68 -41.77 44.22 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.519 -0.738 . . . . 63.109999999999999 111.503 165.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.47 -26.76 68.11 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.674 1.189 . . . . 70.310000000000002 113.542 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.665 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 18.7 ptt180 -57.11 -31.5 65.35 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 122.715 0.406 . . . . 75.439999999999998 111.84 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.665 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 40.2 mt-10 -106.51 1.57 25.55 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.237 1.015 . . . . 73.540000000000006 111.798 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.38 23.33 10.65 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.966 1.306 . . . . 70.120000000000005 111.707 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.525 ' HG3' ' HB2' ' B' ' 49' ' ' GLU . 52.7 mtpt -68.34 -17.57 64.28 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 122.934 0.494 . . . . 74.420000000000002 111.598 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.71 HG12 ' HG ' ' B' ' 17' ' ' LEU . 28.2 m -125.95 155.25 35.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.665 1.186 . . . . 64.109999999999999 109.762 170.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.91 129.66 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.185 0.994 . . . . 71.439999999999998 109.132 173.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.573 HD11 HG12 ' B' ' 43' ' ' VAL . 91.6 mt -120.82 112.83 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-O 121.357 0.598 . . . . 72.519999999999996 109.969 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -140.93 127.69 20.35 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.604 1.161 . . . . 72.030000000000001 109.499 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -81.4 111.98 18.25 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.458 0.647 . . . . 73.310000000000002 110.936 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.58 115.02 29.74 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.552 1.141 . . . . 72.239999999999995 109.682 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 54.06 31.77 14.35 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.861 1.264 . . . . 64.030000000000001 111.796 -167.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.49 -28.02 7.3 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-N 115.624 -0.717 . . . . 60.299999999999997 113.488 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.78 117.23 17.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.3 0.64 . . . . 75.120000000000005 110.296 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 19.5 tt -72.69 114.23 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 123.683 0.793 . . . . 63.25 111.726 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -116.53 127.67 54.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.863 0.465 . . . . 64.030000000000001 109.99 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.444 HG13 HG12 ' B' ' 54' ' ' ILE . 2.3 mp -94.51 101.93 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.624 0.77 . . . . 61.299999999999997 108.982 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -88.28 170.71 10.76 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.256 1.022 . . . . 72.25 111.978 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -85.66 146.81 26.67 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.939 0.896 . . . . 72.219999999999999 110.598 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.5 2.035 0 N-CA-C 112.678 0.622 . . . . 74.230000000000004 112.678 176.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.16 0.505 . . . . 74.209999999999994 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.5 -26.14 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 124.137 0.975 . . . . 74.299999999999997 111.649 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.15 -32.94 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.009 0.524 . . . . 70.129999999999995 110.711 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.32 -42.83 40.8 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.68 0.612 . . . . 70.150000000000006 112.903 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.19 77.69 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.212 0.605 . . . . 72.140000000000001 111.635 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -75.68 -35.69 60.29 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.548 0.739 . . . . 74.209999999999994 111.279 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.33 66.83 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.381 0.672 . . . . 61.0 111.488 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.67 -34.62 90.17 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 116.064 -0.516 . . . . 51.509999999999998 112.767 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -66.14 -41.39 90.5 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.041 0.936 . . . . 73.120000000000005 111.329 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.502 ' HA ' HG11 ' A' ' 32' ' ' VAL . 60.9 t -62.65 -47.7 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.597 0.759 . . . . 74.519999999999996 111.462 174.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.431 ' HA ' HD12 ' A' ' 17' ' ' LEU . 12.1 t90 -67.21 -33.08 74.6 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.98 0.512 . . . . 71.439999999999998 111.69 -176.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -57.96 -37.8 74.83 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.539 0.735 . . . . 74.530000000000001 110.756 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.17 72.34 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.185 0.594 . . . . 64.430000000000007 111.141 174.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 14' ' ' TRP . 87.0 mt -64.8 -18.36 65.03 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.063 0.945 . . . . 63.539999999999999 113.438 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.21 -34.06 69.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.907 0.883 . . . . 61.119999999999997 112.458 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.85 -33.59 1.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.384 0.674 . . . . 75.230000000000004 111.838 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.9 92.27 7.32 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.433 0.693 . . . . 70.439999999999998 109.727 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -127.19 162.98 24.89 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.685 0.794 . . . . 65.120000000000005 111.411 -170.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.94 59.81 5.69 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 116.042 -0.526 . . . . 70.510000000000005 112.069 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.2 tt -142.42 130.68 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.409 0.684 . . . . 54.399999999999999 110.739 -167.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.0 t -73.87 160.13 31.86 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.049 0.54 . . . . 62.420000000000002 110.961 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 40' ' ' ALA . 79.0 mt -49.15 -50.94 60.64 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 114.574 1.324 . . . . 60.240000000000002 114.574 -174.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.94 -27.16 17.84 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 121.973 1.782 . . . . 75.129999999999995 113.731 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.19 -43.02 65.15 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.689 1.233 . . . . 54.119999999999997 109.121 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.06 -38.08 87.44 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 112.512 -2.131 . . . . 70.239999999999995 111.157 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.83 -39.39 81.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.726 1.211 . . . . 63.32 112.248 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -63.15 -44.01 96.71 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.325 0.65 . . . . 64.310000000000002 111.298 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -66.04 -42.74 89.14 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.437 0.695 . . . . 74.299999999999997 111.598 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.0 m -87.55 2.22 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.865 -0.607 . . . . 64.310000000000002 112.286 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 t30 60.66 27.61 17.33 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 124.281 1.032 . . . . 74.209999999999994 112.004 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 44.2 mt -111.66 162.92 14.68 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.742 0.817 . . . . 74.150000000000006 109.561 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.2 t -77.11 164.78 25.37 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.592 0.357 . . . . 72.439999999999998 111.152 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.95 -53.32 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 124.277 1.031 . . . . 51.229999999999997 112.536 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.44 -42.9 88.36 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.361 0.664 . . . . 71.420000000000002 111.943 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -64.97 -37.37 87.41 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.998 0.919 . . . . 73.109999999999999 112.373 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 43' ' ' VAL . 87.9 m -77.98 -45.13 24.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.458 0.703 . . . . 71.439999999999998 111.402 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -57.71 -49.61 75.96 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.227 1.011 . . . . 60.420000000000002 112.071 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.51 -31.36 72.38 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 114.214 -1.357 . . . . 73.200000000000003 111.037 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.06 -36.69 72.38 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.296 0.638 . . . . 40.32 112.021 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 39' ' ' THR . 98.6 t -64.48 -33.02 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 123.064 0.546 . . . . 71.239999999999995 111.027 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.89 -31.27 79.89 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-N 116.634 -0.257 . . . . 53.210000000000001 113.421 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.46 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 64.6 t-105 -74.15 -28.36 61.29 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 123.639 0.776 . . . . 71.420000000000002 111.28 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.77 -35.5 64.97 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.227 0.611 . . . . 72.329999999999998 111.727 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.85 -30.77 70.32 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.791 0.836 . . . . 71.439999999999998 111.614 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 11.4 ttp180 -52.21 -49.61 63.56 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.771 0.829 . . . . 73.310000000000002 111.158 167.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -77.09 -12.47 59.94 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.896 -1.047 . . . . 74.230000000000004 112.568 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.3 m120 61.7 22.41 12.94 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.018 1.327 . . . . 70.040000000000006 112.488 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -89.01 -2.36 58.54 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.763 0.825 . . . . 71.510000000000005 111.752 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.64 154.41 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.811 0.845 . . . . 64.120000000000005 110.919 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 64' ' ' TYR . 6.8 m -134.46 132.35 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.399 1.08 . . . . 72.430000000000007 110.116 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.21 126.46 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.691 0.796 . . . . 51.229999999999997 109.909 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -110.84 139.82 45.83 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.81 0.844 . . . . 74.540000000000006 111.044 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.471 ' HG2' HG12 ' A' ' 61' ' ' ILE . 82.0 mtm180 -116.1 124.03 49.37 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.11 0.964 . . . . 74.310000000000002 109.61 173.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 118.13 12.71 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.948 0.899 . . . . 62.539999999999999 109.538 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.0 t30 58.29 31.88 21.38 Favored 'General case' 0 CA--C 1.577 2.004 0 CA-C-O 121.998 0.904 . . . . 72.019999999999996 111.363 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.94 -9.55 68.71 Favored Glycine 0 CA--C 1.542 1.762 0 CA-C-N 115.648 -0.705 . . . . 72.400000000000006 114.269 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.3 mt -83.33 122.16 28.09 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.126 0.971 . . . . 74.439999999999998 110.856 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.471 HG12 ' HG2' ' A' ' 56' ' ' ARG . 64.1 mt -95.39 126.79 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.283 0.633 . . . . 63.219999999999999 109.779 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -133.3 141.86 48.19 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.618 0.767 . . . . 70.349999999999994 110.434 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -96.91 117.93 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.002 0.921 . . . . 51.140000000000001 109.745 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.529 ' HB2' HG23 ' A' ' 53' ' ' VAL . 25.5 m-85 -108.05 164.21 12.48 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.595 1.158 . . . . 73.450000000000003 109.109 173.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . 20.1 p-10 -94.16 161.83 14.11 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.405 -0.591 . . . . 74.349999999999994 109.405 169.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 109.148 -0.686 . . . . 74.120000000000005 109.148 170.317 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 112.628 0.603 . . . . 61.43 112.628 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -77.45 -40.53 42.94 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.654 0.782 . . . . 74.439999999999998 111.546 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.73 -58.64 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.513 0.725 . . . . 63.539999999999999 111.218 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.429 HG11 HD22 ' B' ' 41' ' ' LEU . 32.7 m -61.45 -27.6 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.361 0.664 . . . . 74.109999999999999 111.998 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.96 -49.85 71.45 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 123.47 0.482 . . . . 73.239999999999995 112.83 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.17 88.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.784 0.834 . . . . 70.420000000000002 112.043 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -85.2 -13.01 51.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.26 0.837 . . . . 55.32 113.26 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 -39.45 69.85 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.857 0.463 . . . . 71.209999999999994 111.367 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.23 -31.04 71.54 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 116.179 -0.464 . . . . 51.119999999999997 112.378 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -70.0 -45.74 66.65 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.892 0.877 . . . . 74.450000000000003 111.429 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.544 ' HA ' HG11 ' B' ' 32' ' ' VAL . 30.1 m -71.62 -32.46 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 122.533 0.333 . . . . 75.120000000000005 111.538 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.514 ' HA ' HD12 ' B' ' 17' ' ' LEU . 21.0 t90 -69.98 -33.36 71.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.499 0.32 . . . . 72.25 110.718 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -58.07 -45.87 86.38 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.932 0.493 . . . . 72.120000000000005 110.563 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.585 ' HB1' ' HE3' ' B' ' 31' ' ' LYS . . . -67.92 -29.59 68.71 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.677 -0.692 . . . . 64.519999999999996 111.712 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.66 ' HB3' HD21 ' B' ' 65' ' ' ASN . 58.6 mt -69.69 -33.02 71.95 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.153 0.981 . . . . 63.43 111.516 170.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.0 -29.72 64.49 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.915 0.886 . . . . 62.149999999999999 110.942 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -76.68 -49.03 17.11 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.649 0.78 . . . . 53.109999999999999 110.729 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.02 131.7 31.09 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.133 0.973 . . . . 63.329999999999998 109.502 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -114.61 147.34 39.68 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 122.911 0.484 . . . . 63.329999999999998 112.07 -163.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 24.45 69.6 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 115.984 -0.553 . . . . 64.340000000000003 113.266 -172.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.409 HD11 ' HG3' ' B' ' 27' ' ' GLU . 11.5 tt -77.05 143.35 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 124.169 0.987 . . . . 73.340000000000003 111.833 -170.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.6 m -61.24 141.73 57.31 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.756 0.822 . . . . 62.240000000000002 111.353 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' B' ' 40' ' ' ALA . 69.6 mt -57.63 -46.09 99.79 Favored Pre-proline 0 CA--C 1.576 1.952 0 N-CA-C 113.777 1.028 . . . . 75.200000000000003 113.777 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.25 -26.47 41.94 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 121.785 1.657 . . . . 63.420000000000002 113.871 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . 0.409 ' HG3' HD11 ' B' ' 23' ' ' ILE . 11.7 tp10 -76.67 -43.51 37.57 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.766 1.269 . . . . 70.450000000000003 109.773 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 58.8 tp -58.38 -40.22 81.71 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 112.833 -1.985 . . . . 73.010000000000005 111.013 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.15 75.43 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.536 1.134 . . . . 72.140000000000001 112.552 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -65.57 -42.05 92.23 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.48 0.712 . . . . 75.409999999999997 111.983 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.585 ' HE3' ' HB1' ' B' ' 16' ' ' ALA . 44.1 mtmt -72.67 -30.72 64.49 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.067 0.395 . . . . 75.420000000000002 112.067 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' B' ' 13' ' ' VAL . 25.4 m -96.45 -4.8 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 112.876 0.695 . . . . 52.450000000000003 112.876 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 65.83 15.87 10.24 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.442 1.097 . . . . 70.209999999999994 112.594 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt -96.89 163.84 12.8 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.699 -0.625 . . . . 63.240000000000002 110.967 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 37.5 m -66.45 151.44 47.18 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.935 -0.575 . . . . 75.010000000000005 110.152 171.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 58.1 t -55.51 -45.79 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 123.268 0.627 . . . . 64.439999999999998 111.857 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.38 -44.06 97.8 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.874 0.87 . . . . 70.340000000000003 112.374 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t -63.46 -38.5 91.37 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.563 0.745 . . . . 72.450000000000003 111.417 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.409 ' O ' HG23 ' B' ' 43' ' ' VAL . 89.6 m -68.36 -48.91 63.54 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.081 -0.963 . . . . 74.310000000000002 110.781 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.529 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -58.88 -36.85 75.32 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.0 0.92 . . . . 62.350000000000001 112.47 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.429 HD22 HG11 ' B' ' 6' ' ' VAL . 0.6 OUTLIER -66.28 -48.18 71.24 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.025 0.93 . . . . 75.450000000000003 110.078 178.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.04 68.9 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.53 -0.759 . . . . 62.299999999999997 111.62 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 39' ' ' THR . 73.8 t -77.63 -37.78 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 123.263 0.625 . . . . 61.210000000000001 111.057 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.46 -27.78 72.22 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 121.432 0.462 . . . . 50.100000000000001 112.326 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -73.39 -30.02 63.0 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.295 1.038 . . . . 73.140000000000001 110.956 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.451 HD13 ' HD1' ' B' ' 14' ' ' TRP . 96.2 mt -72.0 -34.17 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.199 0.6 . . . . 72.140000000000001 111.658 171.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.94 67.12 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.692 0.797 . . . . 61.030000000000001 111.926 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 48' ' ' ARG . 10.0 ptt-85 -60.88 -37.24 81.48 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.66 0.784 . . . . 71.230000000000004 111.517 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.547 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 41.4 mt-10 -93.9 5.24 52.31 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.861 0.864 . . . . 51.329999999999998 111.772 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 64.4 23.33 12.96 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.684 1.193 . . . . 73.519999999999996 112.931 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.547 ' HG3' ' HB2' ' B' ' 49' ' ' GLU . 28.3 mtpp -79.21 -13.08 59.92 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.752 0.649 . . . . 71.430000000000007 112.752 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' B' ' 64' ' ' TYR . 31.3 m -123.0 143.69 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.316 0.579 . . . . 64.409999999999997 112.185 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 33.4 t -113.11 105.1 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.307 0 C-N-CA 124.625 1.17 . . . . 73.299999999999997 109.959 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.504 HG23 HG23 ' B' ' 61' ' ' ILE . 3.4 mp -85.68 118.9 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 123.282 0.633 . . . . 62.509999999999998 110.925 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.17 117.38 19.82 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.899 0.88 . . . . 73.439999999999998 111.161 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -85.4 116.37 23.69 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.532 0.733 . . . . 72.140000000000001 110.352 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -125.03 115.4 20.47 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.577 1.151 . . . . 62.030000000000001 108.117 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 58.41 31.34 20.83 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.497 1.119 . . . . 65.430000000000007 111.163 -168.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.43 -19.37 32.37 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 115.442 -0.799 . . . . 63.509999999999998 113.867 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 mt -80.53 123.13 27.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.159 0.984 . . . . 51.0 111.206 -172.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.504 HG23 HG23 ' B' ' 54' ' ' ILE . 3.3 mp -80.65 127.85 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.666 0.786 . . . . 51.009999999999998 110.893 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.59 145.07 43.63 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.009 0.923 . . . . 74.299999999999997 109.3 168.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.538 HD13 ' H ' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -119.69 104.61 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-O 122.216 1.008 . . . . 73.400000000000006 109.876 174.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 77.5 m-85 -86.13 174.54 9.08 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.027 -0.988 . . . . 65.409999999999997 111.781 177.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.66 HD21 ' HB3' ' B' ' 17' ' ' LEU . 0.9 OUTLIER -86.49 159.07 19.41 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.362 0.601 . . . . 63.039999999999999 111.334 174.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 CA--C 1.56 1.337 0 C-N-CA 124.863 1.265 . . . . 72.230000000000004 112.073 170.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 112.923 0.712 . . . . 74.549999999999997 112.923 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.05 -40.27 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.221 0.609 . . . . 72.329999999999998 111.451 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 41' ' ' LEU . 13.5 m -66.11 -33.45 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 122.177 0.191 . . . . 61.140000000000001 111.449 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.09 -43.37 33.37 Favored Glycine 0 C--N 1.353 1.513 0 O-C-N 123.479 0.487 . . . . 35.450000000000003 113.281 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 -46.48 76.33 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.557 0.743 . . . . 72.420000000000002 111.6 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.84 -26.56 66.11 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.812 0.845 . . . . 62.43 111.8 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.11 -34.44 73.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.003 0.521 . . . . 55.030000000000001 111.324 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.16 -38.76 94.18 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 116.183 -0.462 . . . . 72.540000000000006 113.152 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -69.49 -48.52 60.37 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.308 0.643 . . . . 73.209999999999994 111.733 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.86 -36.8 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 122.333 0.253 . . . . 74.549999999999997 111.462 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.562 ' HA ' HD12 ' A' ' 17' ' ' LEU . 54.4 t90 -64.92 -40.16 94.62 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.416 0.286 . . . . 61.329999999999998 111.052 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -60.94 -39.82 90.92 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.848 0.459 . . . . 72.040000000000006 110.904 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.82 69.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.469 0.708 . . . . 63.219999999999999 111.926 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 14' ' ' TRP . 84.4 mt -66.11 -45.27 81.73 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.537 0.735 . . . . 52.210000000000001 111.663 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -62.39 -31.55 72.24 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 120.815 0.34 . . . . 62.409999999999997 111.283 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.36 -49.35 50.18 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.439 0.696 . . . . 62.240000000000002 110.698 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.64 105.09 0.51 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.748 0.819 . . . . 72.310000000000002 111.084 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.48 -179.6 3.92 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.847 0.859 . . . . 64.25 111.403 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.42 33.09 44.88 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.033 -0.53 . . . . 44.299999999999997 111.824 -171.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.4 tt -122.5 154.55 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 124.432 1.093 . . . . 52.350000000000001 110.096 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.9 m -63.16 145.98 54.32 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.838 0.455 . . . . 43.549999999999997 111.302 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' B' ' 37' ' ' GLU . 66.0 mt -58.33 -43.27 98.02 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 123.989 0.916 . . . . 72.219999999999999 113.363 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HA ' HG22 ' A' ' 36' ' ' VAL . 36.6 Cg_endo -62.69 -35.2 70.76 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 122.244 1.963 . . . . 71.450000000000003 114.284 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -69.84 -51.26 35.02 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.25 1.024 . . . . 73.150000000000006 109.187 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.8 tp -54.26 -37.79 65.07 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 112.811 -1.995 . . . . 73.409999999999997 112.123 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.15 92.43 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.191 0.997 . . . . 63.219999999999999 112.136 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -67.5 -26.5 66.37 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.279 0.631 . . . . 75.329999999999998 111.82 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.14 -47.15 46.46 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.548 0.739 . . . . 71.340000000000003 111.094 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -84.29 0.96 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.216 0.606 . . . . 74.030000000000001 111.945 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 69.26 12.04 8.31 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.404 1.482 . . . . 70.209999999999994 113.632 174.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.3 mt -93.66 169.19 10.51 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.298 0.639 . . . . 73.450000000000003 110.523 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.6 p -78.06 162.93 26.33 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 110.24 -0.281 . . . . 74.319999999999993 110.24 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 26' ' ' PRO . 40.8 t -56.19 -47.55 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.799 0.84 . . . . 74.329999999999998 111.418 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.19 -41.72 97.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.989 -1.005 . . . . 73.340000000000003 112.186 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -67.06 -39.19 86.84 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.404 0.682 . . . . 75.340000000000003 112.315 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . 78.4 m -69.15 -48.62 61.87 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.513 0.725 . . . . 73.430000000000007 111.615 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -61.61 -38.38 87.4 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.38 0.672 . . . . 72.549999999999997 112.144 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.554 HD23 HG23 ' B' ' 43' ' ' VAL . 1.6 tm? -65.75 -39.09 90.74 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 124.95 1.3 . . . . 72.329999999999998 110.792 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.97 -33.32 70.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.433 0.693 . . . . 72.450000000000003 111.797 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.651 HG11 HD12 ' A' ' 63' ' ' ILE . 89.8 t -66.43 -31.04 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.072 0.549 . . . . 64.0 111.18 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.48 -30.11 73.54 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-N 116.751 -0.204 . . . . 64.329999999999998 113.535 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -73.99 -31.12 62.83 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.505 0.722 . . . . 54.439999999999998 110.982 173.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.67 -30.27 65.53 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.459 0.704 . . . . 51.420000000000002 111.609 172.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.09 -27.65 68.91 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.739 0.816 . . . . 74.239999999999995 111.655 169.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.404 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 13.0 ttp180 -65.96 -42.44 89.92 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.297 0.57 . . . . 74.530000000000001 110.15 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.81 -22.47 61.56 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.08 -0.964 . . . . 55.420000000000002 111.834 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 t30 65.71 22.4 11.58 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 125.171 1.388 . . . . 72.109999999999999 111.167 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -97.26 6.0 49.09 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.7 0.8 . . . . 64.219999999999999 112.87 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.8 151.16 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.808 0.843 . . . . 61.409999999999997 110.875 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.6 t -111.68 107.63 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.578 0.751 . . . . 71.439999999999998 109.381 172.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.5 mt -96.44 112.86 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.143 -0.688 . . . . 73.219999999999999 109.143 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -134.52 125.88 28.23 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 110.077 -0.342 . . . . 71.540000000000006 110.077 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -87.45 107.8 18.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.016 0.926 . . . . 75.530000000000001 111.155 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.432 ' O ' HD23 ' A' ' 60' ' ' LEU . 2.3 mptm? -105.19 141.61 36.43 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.294 1.038 . . . . 74.349999999999994 108.87 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.8 p30 44.18 29.33 0.34 Allowed 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 125.334 1.454 . . . . 71.319999999999993 113.76 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.07 -28.67 12.88 Favored Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.274 0.869 . . . . 70.129999999999995 115.274 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -90.73 154.33 19.62 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.757 1.278 . . . . 74.25 112.037 -174.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.32 116.29 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.899 0.88 . . . . 72.230000000000004 109.84 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.95 128.6 56.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.337 0.655 . . . . 74.439999999999998 110.235 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.651 HD12 HG11 ' A' ' 43' ' ' VAL . 23.0 mm -92.27 105.7 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.426 0.69 . . . . 75.040000000000006 110.221 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -97.6 172.64 7.59 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.234 1.014 . . . . 73.420000000000002 110.804 176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -98.93 170.58 8.63 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.23 0.612 . . . . 71.400000000000006 109.97 164.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 N--CA 1.489 1.502 0 C-N-CA 123.749 0.82 . . . . 72.420000000000002 112.351 175.076 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.773 0.32 . . . . 64.450000000000003 111.609 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -86.4 -25.82 25.09 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.764 0.426 . . . . 62.229999999999997 111.861 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 72.3 mt -66.77 -46.34 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.839 0.456 . . . . 54.409999999999997 110.877 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.2 m -64.6 -26.24 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 122.916 0.487 . . . . 70.129999999999995 111.078 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' B' ' 45' ' ' TRP . . . -65.57 -51.97 43.26 Favored Glycine 0 C--N 1.354 1.581 0 O-C-N 123.665 0.603 . . . . 72.150000000000006 113.543 172.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.64 85.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.48 0.712 . . . . 34.5 111.745 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . 0.478 ' HB3' HD11 ' B' ' 34' ' ' LEU . 5.7 m-20 -68.65 -29.02 67.41 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.22 1.008 . . . . 63.5 111.519 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.513 ' HB1' ' HG ' ' B' ' 46' ' ' LEU . . . -73.26 -39.0 65.75 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.857 0.463 . . . . 74.109999999999999 110.969 176.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.21 -32.34 82.21 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-O 121.358 0.421 . . . . 51.25 112.281 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.8 -35.66 77.3 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.675 1.19 . . . . 73.129999999999995 111.683 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.479 HG22 HG11 ' B' ' 32' ' ' VAL . 74.7 t -69.51 -40.41 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.488 0.715 . . . . 62.439999999999998 111.317 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -66.13 -32.5 73.98 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.264 0.626 . . . . 71.200000000000003 110.943 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -54.72 -42.28 71.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.776 0.83 . . . . 75.230000000000004 111.472 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.91 70.81 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.5 0.72 . . . . 52.310000000000002 112.528 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.652 HD11 HG12 ' B' ' 52' ' ' VAL . 82.7 mt -62.91 -42.67 99.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.531 0.733 . . . . 65.299999999999997 111.476 172.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -64.65 -22.11 66.9 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.377 0.671 . . . . 64.329999999999998 111.651 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.33 -50.73 13.51 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.48 0.712 . . . . 63.399999999999999 110.262 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.3 124.34 0.72 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.823 0.849 . . . . 55.439999999999998 111.137 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.404 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 7.9 p-10 -74.81 175.1 8.33 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.439 0.695 . . . . 71.340000000000003 112.593 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.42 20.5 78.34 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.961 -0.563 . . . . 75.329999999999998 112.974 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.468 HG13 ' HB2' ' B' ' 28' ' ' LEU . 8.9 tp -84.73 124.39 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.946 0.899 . . . . 63.109999999999999 110.285 -176.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -85.38 147.03 26.7 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.845 0.458 . . . . 62.43 110.584 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 88.0 mt -49.74 -44.98 79.12 Favored Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 114.965 1.468 . . . . 72.049999999999997 114.965 -173.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.61 -48.17 21.71 Favored 'Trans proline' 0 C--N 1.392 2.819 0 C-N-CA 122.332 2.021 . . . . 71.150000000000006 114.374 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -72.09 -38.43 69.38 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.835 1.302 . . . . 50.020000000000003 110.072 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.468 ' HB2' HG13 ' B' ' 23' ' ' ILE . 56.0 tp -60.88 -33.95 73.89 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 112.642 -2.072 . . . . 75.219999999999999 111.34 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.7 -35.87 79.27 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.299 1.04 . . . . 63.439999999999998 112.484 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -64.91 -43.9 91.32 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 122.857 0.463 . . . . 73.409999999999997 110.523 173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -64.74 -39.39 93.54 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.429 -0.805 . . . . 63.43 112.137 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.479 HG11 HG22 ' B' ' 13' ' ' VAL . 23.4 m -97.53 -3.1 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 112.947 0.721 . . . . 71.510000000000005 112.947 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.7 28.5 14.94 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 124.558 1.143 . . . . 72.340000000000003 111.672 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' B' ' 9' ' ' ASN . 92.4 mt -109.49 166.11 11.14 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.533 0.733 . . . . 74.349999999999994 110.564 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 43.6 t -73.87 161.64 29.93 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.1 0.56 . . . . 55.25 110.615 170.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.5 -47.46 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.239 0.616 . . . . 72.319999999999993 111.741 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.538 ' HB3' HD12 ' A' ' 25' ' ' ILE . 42.7 mt-10 -61.05 -42.2 98.04 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.024 0.93 . . . . 72.239999999999995 112.339 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 39.4 t -67.24 -34.95 78.54 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.383 0.673 . . . . 75.239999999999995 111.665 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 45.0 m -79.94 -34.54 38.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.939 0.896 . . . . 71.329999999999998 110.982 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.86 -33.58 72.46 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.747 0.819 . . . . 75.319999999999993 111.139 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -75.4 -34.26 61.04 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 115.398 -0.819 . . . . 61.439999999999998 110.511 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.98 90.42 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.945 0.498 . . . . 63.100000000000001 111.767 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.554 HG23 HD23 ' A' ' 41' ' ' LEU . 20.2 m -68.75 -29.16 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 122.483 0.313 . . . . 71.430000000000007 110.916 172.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.4 -34.36 89.09 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.188 -0.46 . . . . 63.5 113.198 171.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.408 ' CD1' ' HA2' ' B' ' 7' ' ' GLY . 61.1 t-105 -72.51 -33.84 67.19 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.683 0.393 . . . . 71.120000000000005 110.372 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.513 ' HG ' ' HB1' ' B' ' 10' ' ' ALA . 53.2 mt -66.64 -27.93 68.07 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.633 0.373 . . . . 74.040000000000006 111.875 170.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.73 74.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.986 0.515 . . . . 72.299999999999997 111.609 168.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.404 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 27.8 ttp85 -64.68 -43.41 93.62 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.081 0.467 . . . . 63.119999999999997 110.164 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -67.8 -25.52 65.63 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.344 -0.844 . . . . 65.420000000000002 111.654 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 67.0 22.91 9.92 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.509 1.524 . . . . 70.319999999999993 111.797 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -95.58 3.55 53.98 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.882 1.067 . . . . 73.109999999999999 113.882 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.652 HG12 HD11 ' B' ' 17' ' ' LEU . 15.7 m -123.32 153.35 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.485 0.66 . . . . 53.119999999999997 112.407 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 91.4 t -108.72 125.84 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.494 1.118 . . . . 62.229999999999997 109.309 171.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 mm -104.8 116.52 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.129 0.572 . . . . 74.010000000000005 109.881 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -117.72 123.59 46.42 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.435 0.694 . . . . 64.239999999999995 110.1 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -93.57 97.19 10.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.082 0.553 . . . . 74.349999999999994 109.823 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . 0.6 ' HD3' ' HG3' ' B' ' 62' ' ' GLU . 8.7 mtpm? -105.11 113.2 26.65 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.041 0.936 . . . . 74.540000000000006 110.149 -175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 60.28 28.94 18.58 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.605 1.562 . . . . 44.549999999999997 111.733 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.62 -2.32 87.29 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 114.591 0.596 . . . . 73.319999999999993 114.591 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.67 149.37 22.88 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.009 0.905 . . . . 51.219999999999999 111.635 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.8 mm -87.14 119.1 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.178 0.591 . . . . 70.150000000000006 110.861 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . 0.6 ' HG3' ' HD3' ' B' ' 57' ' ' LYS . 7.2 mm-40 -116.1 121.63 42.73 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.286 1.034 . . . . 75.099999999999994 109.395 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.529 HG22 HD21 ' B' ' 17' ' ' LEU . 17.5 mm -100.75 122.35 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.19 0.596 . . . . 74.439999999999998 110.822 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.665 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 22.4 m-85 -116.18 169.15 9.5 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.109 0.964 . . . . 64.120000000000005 111.244 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.404 ' OD1' ' HB3' ' B' ' 21' ' ' ASP . 1.8 m-20 -77.62 141.28 39.56 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.633 -0.712 . . . . 73.340000000000003 111.225 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.491 1.597 0 C-N-CA 124.899 1.28 . . . . 65.310000000000002 114.217 172.931 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.0 tptp . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.005 0.431 . . . . 75.420000000000002 110.673 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.4 mt -65.44 -41.3 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.725 0.81 . . . . 71.310000000000002 112.335 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.536 HG12 HD11 ' A' ' 41' ' ' LEU . 29.5 m -65.13 -30.39 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 122.993 0.517 . . . . 45.240000000000002 111.517 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -42.52 85.08 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 112.498 -0.241 . . . . 63.25 112.498 172.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.89 -45.82 69.99 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.795 0.838 . . . . 72.400000000000006 111.949 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.412 ' HB2' HD11 ' A' ' 34' ' ' LEU . 31.7 p30 -77.37 -23.06 50.86 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 122.971 0.508 . . . . 73.409999999999997 111.946 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.03 -35.58 59.45 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.91 0.484 . . . . 54.409999999999997 111.209 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.61 -31.57 78.96 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 121.613 0.563 . . . . 75.319999999999993 112.231 172.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -68.92 -45.01 71.95 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 125.136 1.374 . . . . 74.340000000000003 110.79 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.45 ' HA ' HG11 ' A' ' 32' ' ' VAL . 39.2 t -64.48 -36.58 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 124.534 1.134 . . . . 72.140000000000001 111.652 173.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.411 ' NE1' ' HB3' ' A' ' 51' ' ' LYS . 15.9 t90 -71.5 -32.23 68.0 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.442 0.697 . . . . 72.219999999999999 110.908 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -59.84 -32.93 71.14 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.563 0.745 . . . . 71.319999999999993 111.545 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.77 -22.86 65.78 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.804 0.668 . . . . 73.230000000000004 112.804 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 52' ' ' VAL . 94.7 mt -68.8 -38.83 80.23 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.766 0.826 . . . . 64.409999999999997 112.687 173.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -56.86 -36.27 69.85 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.525 0.73 . . . . 74.340000000000003 111.303 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.62 -47.75 13.65 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.488 -0.778 . . . . 71.319999999999993 110.966 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.73 113.32 6.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.07 0.948 . . . . 54.210000000000001 111.392 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -94.94 128.3 41.63 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.404 -0.961 . . . . 72.200000000000003 108.404 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.8 47.81 4.66 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 111.896 -0.482 . . . . 74.120000000000005 111.896 -172.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.8 tp -114.35 137.27 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 C-N-CA 123.898 0.879 . . . . 73.299999999999997 110.731 -175.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.7 p -82.49 162.3 22.09 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.321 0.648 . . . . 61.420000000000002 111.99 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.9 mt -55.41 -54.34 52.1 Favored Pre-proline 0 CA--C 1.579 2.084 0 N-CA-C 113.84 1.052 . . . . 75.010000000000005 113.84 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.14 -30.61 20.24 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.03 1.82 . . . . 60.329999999999998 113.432 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -71.43 -44.33 65.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.265 0.626 . . . . 72.310000000000002 111.619 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.07 -30.65 63.86 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.91 0.484 . . . . 62.350000000000001 110.334 175.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.33 -41.86 76.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.551 0.74 . . . . 64.420000000000002 112.016 177.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -69.22 -30.82 69.06 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.079 0.552 . . . . 74.349999999999994 111.671 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -69.94 -40.48 75.44 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.079 0.552 . . . . 75.310000000000002 111.578 174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' ' 13' ' ' VAL . 21.5 m -96.72 7.74 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.365 0.666 . . . . 72.0 112.115 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.47 16.96 9.13 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.454 1.102 . . . . 53.109999999999999 113.935 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 9' ' ' ASN . 76.2 mt -99.85 159.43 15.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.53 0.732 . . . . 73.430000000000007 110.414 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.7 t -68.8 161.02 29.38 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.761 0.425 . . . . 74.120000000000005 110.847 169.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -59.3 -42.92 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 122.705 0.402 . . . . 65.329999999999998 111.491 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -64.82 -48.35 74.69 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.214 0.606 . . . . 73.319999999999993 111.784 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 t -57.08 -39.18 74.48 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.016 0.926 . . . . 75.510000000000005 112.101 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 43' ' ' VAL . 79.8 m -71.0 -52.28 20.55 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 123.905 0.882 . . . . 51.340000000000003 110.741 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.34 -30.95 67.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.018 0.927 . . . . 71.120000000000005 112.807 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.536 HD11 HG12 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -68.76 -45.05 72.39 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.388 1.075 . . . . 64.450000000000003 110.351 172.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.46 -31.38 72.57 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.586 0.754 . . . . 72.140000000000001 111.965 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 39' ' ' THR . 75.2 t -62.82 -43.14 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.551 1.141 . . . . 44.539999999999999 111.466 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.25 -31.13 75.93 Favored Glycine 0 CA--C 1.541 1.691 0 O-C-N 123.342 0.401 . . . . 52.149999999999999 113.055 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.461 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 51.3 t-105 -75.07 -27.7 60.06 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.849 0.86 . . . . 74.129999999999995 112.323 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 98.2 mt -76.68 -42.13 42.9 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.892 -0.505 . . . . 62.299999999999997 111.826 168.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.83 71.36 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.718 1.207 . . . . 72.120000000000005 113.327 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.701 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 14.1 ptt180 -61.05 -34.49 74.97 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.681 0.392 . . . . 64.409999999999997 111.718 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.701 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 36.4 mt-10 -98.41 1.05 46.47 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.421 1.088 . . . . 74.530000000000001 111.923 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 t30 61.89 28.1 17.13 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.623 1.169 . . . . 73.239999999999995 111.529 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.411 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 92.1 mttt -72.81 -21.35 60.98 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.59 0.756 . . . . 62.299999999999997 112.316 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.604 HG12 HD11 ' A' ' 17' ' ' LEU . 27.9 m -125.8 148.55 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 64.209999999999994 111.199 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.748 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 44.4 t -100.12 100.5 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.782 0.833 . . . . 73.150000000000006 108.8 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.3 mm -78.43 123.26 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 109.936 -0.394 . . . . 71.5 109.936 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.37 116.57 17.01 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.727 -0.842 . . . . 75.209999999999994 108.727 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -93.9 103.53 15.63 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.387 0.675 . . . . 63.240000000000002 110.387 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -111.16 129.04 56.07 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.563 0.745 . . . . 74.420000000000002 109.904 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 56.03 28.37 12.71 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.574 1.149 . . . . 72.049999999999997 112.467 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.64 -21.27 14.84 Favored Glycine 0 CA--C 1.542 1.722 0 N-CA-C 114.242 0.457 . . . . 53.32 114.242 -174.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.02 143.84 35.25 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.462 0.705 . . . . 54.130000000000003 110.877 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.81 138.13 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.494 -0.558 . . . . 52.299999999999997 109.494 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -147.35 142.57 27.24 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.454 0.645 . . . . 75.010000000000005 111.027 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.1 mt -111.01 137.51 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.042 0.937 . . . . 73.439999999999998 110.862 -173.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.748 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 90.1 m-85 -121.62 165.24 16.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.71 -1.132 . . . . 74.230000000000004 108.942 174.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HA ' HD13 ' A' ' 17' ' ' LEU . 20.9 t-20 -83.05 152.04 25.54 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.914 -0.772 . . . . 61.340000000000003 108.914 173.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 113.602 0.964 . . . . 75.140000000000001 113.602 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.644 ' HA ' HG22 ' B' ' 6' ' ' VAL . 99.0 mttt . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 112.796 0.665 . . . . 63.310000000000002 112.796 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -70.05 -37.36 75.51 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.769 0.427 . . . . 71.150000000000006 110.81 171.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.93 -52.71 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 123.513 0.725 . . . . 72.340000000000003 111.438 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.644 HG22 ' HA ' ' B' ' 3' ' ' LYS . 19.5 m -70.52 -27.47 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 122.72 0.408 . . . . 61.219999999999999 111.741 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -38.87 89.17 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 116.783 -0.189 . . . . 32.409999999999997 112.764 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.03 32.02 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.437 0.695 . . . . 60.049999999999997 111.73 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . 0.604 ' HB2' HD11 ' B' ' 34' ' ' LEU . 31.3 p30 -73.29 -20.97 60.7 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 112.953 0.723 . . . . 73.310000000000002 112.953 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.97 -23.38 64.12 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.083 0.553 . . . . 64.510000000000005 111.178 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.04 -31.91 79.2 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 116.222 -0.445 . . . . 64.099999999999994 113.12 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.62 -47.02 64.89 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.438 0.695 . . . . 71.099999999999994 111.101 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.19 -36.88 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.276 1.03 . . . . 75.519999999999996 111.59 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -72.66 -34.32 67.16 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.263 0.625 . . . . 74.329999999999998 110.979 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -65.03 -31.03 72.06 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.666 0.387 . . . . 62.240000000000002 111.475 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.68 -30.23 67.21 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.05 0.54 . . . . 75.329999999999998 112.146 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.705 HD11 HG12 ' B' ' 52' ' ' VAL . 80.3 mt -65.59 -45.96 81.22 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.772 0.829 . . . . 61.25 111.659 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -59.66 -28.18 67.03 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.692 0.797 . . . . 74.099999999999994 111.266 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -81.91 -47.57 12.59 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.877 0.871 . . . . 72.430000000000007 111.217 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.09 151.98 16.52 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.783 0.833 . . . . 44.350000000000001 111.736 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -112.22 156.16 22.81 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.297 0.639 . . . . 74.349999999999994 109.649 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.01 38.66 84.68 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 114.359 0.503 . . . . 61.039999999999999 114.359 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 tt -102.36 137.54 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.23 0.612 . . . . 73.329999999999998 110.275 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -73.11 156.4 38.72 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.386 0.674 . . . . 62.520000000000003 111.594 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.82 -52.18 76.28 Favored Pre-proline 0 CA--C 1.575 1.933 0 N-CA-C 113.617 0.969 . . . . 72.349999999999994 113.617 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.75 -23.91 55.24 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.149 1.899 . . . . 65.109999999999999 113.501 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -78.91 -42.66 26.6 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.741 0.816 . . . . 74.430000000000007 111.496 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.1 -31.58 61.21 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 122.157 -0.34 . . . . 74.549999999999997 111.078 174.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.53 -45.38 73.35 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.573 1.149 . . . . 74.549999999999997 113.393 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -65.01 -30.83 71.83 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 115.999 -0.546 . . . . 74.239999999999995 112.22 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -78.41 -40.93 34.55 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.015 0.526 . . . . 72.409999999999997 111.058 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 m -81.58 -3.4 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.076 0.551 . . . . 61.439999999999998 111.683 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 65.83 29.41 10.51 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.321 1.448 . . . . 73.140000000000001 112.906 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' B' ' 9' ' ' ASN . 66.5 mt -109.28 158.07 18.23 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.693 0.797 . . . . 72.299999999999997 110.395 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 34.0 t -65.09 152.82 42.56 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.781 0.433 . . . . 73.120000000000005 110.581 166.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.34 -41.97 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 123.073 0.549 . . . . 72.510000000000005 111.579 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.66 -48.21 80.33 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.087 0.955 . . . . 75.230000000000004 112.015 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.5 t -66.56 -30.82 71.22 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.713 0.805 . . . . 71.230000000000004 111.601 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 96.8 m -74.87 -44.17 50.44 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.916 0.886 . . . . 73.319999999999993 110.92 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.51 -34.3 77.47 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.872 0.869 . . . . 73.329999999999998 111.648 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -67.2 -44.08 80.52 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 124.27 1.028 . . . . 71.310000000000002 110.496 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.81 76.75 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.14 0.576 . . . . 73.540000000000006 111.793 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.19 -44.35 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.585 1.154 . . . . 74.319999999999993 110.828 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.47 -28.04 73.16 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 116.378 -0.374 . . . . 65.209999999999994 113.155 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 49.9 t-105 -74.18 -29.9 61.98 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.967 0.907 . . . . 73.450000000000003 111.232 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.06 -36.59 58.94 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.358 0.663 . . . . 73.420000000000002 112.186 167.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.96 76.86 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.202 1.001 . . . . 44.530000000000001 113.543 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 20.3 ptt85 -63.92 -30.68 71.74 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.303 0.573 . . . . 73.219999999999999 111.097 173.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -86.03 -15.78 40.3 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.374 1.07 . . . . 64.349999999999994 111.572 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 t30 60.43 43.62 13.04 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.717 1.207 . . . . 73.200000000000003 110.769 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -95.83 -9.07 32.48 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.312 -0.858 . . . . 64.420000000000002 111.777 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.705 HG12 HD11 ' B' ' 17' ' ' LEU . 27.7 m -125.17 146.47 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.222 1.009 . . . . 60.509999999999998 111.149 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' B' ' 66' ' ' GLU . 85.9 t -103.95 104.08 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.133 -1.062 . . . . 74.0 108.133 167.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 70.8 mt -91.21 118.18 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.146 0.578 . . . . 70.510000000000005 109.827 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.69 123.28 45.7 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.003 -0.74 . . . . 70.340000000000003 109.003 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -89.13 96.85 10.89 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.596 0.712 . . . . 64.409999999999997 109.341 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -116.66 119.06 34.3 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.077 -0.965 . . . . 72.430000000000007 109.502 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 60.07 28.79 18.38 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.783 1.233 . . . . 65.519999999999996 111.731 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.85 -3.93 72.82 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 114.452 0.541 . . . . 43.130000000000003 114.452 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.59 134.7 34.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.341 0.656 . . . . 75.439999999999998 110.736 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.6 mm -87.07 103.12 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 123.562 0.745 . . . . 74.239999999999995 109.045 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -117.75 123.84 47.0 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.486 0.715 . . . . 64.209999999999994 109.919 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 40.2 pt -97.76 138.29 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.074 0.94 . . . . 73.140000000000001 112.177 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.523 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 77.0 m-85 -120.7 169.4 10.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.165 1.386 . . . . 51.340000000000003 108.347 175.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -85.43 145.99 27.19 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.682 -0.858 . . . . 65.030000000000001 108.682 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.555 ' HA ' HG23 ' B' ' 53' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 112.394 0.516 . . . . 65.230000000000004 112.394 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.481 0.182 . . . . 74.329999999999998 111.339 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.658 HD13 HH22 ' B' ' 56' ' ' ARG . 68.4 mt -62.82 -47.53 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.433 0.693 . . . . 75.409999999999997 110.947 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.48 -34.46 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.772 0.829 . . . . 74.109999999999999 111.352 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.41 -37.12 94.32 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 112.634 -0.186 . . . . 60.219999999999999 112.634 173.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.0 -55.74 8.78 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.699 0.8 . . . . 71.200000000000003 112.296 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.615 ' HB2' HD11 ' A' ' 34' ' ' LEU . 36.6 p30 -78.14 -13.46 59.86 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.756 1.021 . . . . 74.519999999999996 113.756 -170.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.16 -27.77 64.8 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.651 0.38 . . . . 64.430000000000007 111.598 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.23 -45.45 80.48 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 116.15 -0.477 . . . . 21.530000000000001 113.552 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -39.17 75.57 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.811 0.444 . . . . 74.109999999999999 112.185 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.498 ' HA ' HG11 ' A' ' 32' ' ' VAL . 20.9 m -69.59 -36.19 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.72 0.236 . . . . 74.239999999999995 111.221 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.677 ' HA ' HD12 ' A' ' 17' ' ' LEU . 62.3 t90 -69.37 -33.64 73.37 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.91 0.484 . . . . 74.409999999999997 111.033 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.61 -33.96 77.12 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.048 0.539 . . . . 65.340000000000003 111.321 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.74 76.1 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.231 0.612 . . . . 72.219999999999999 111.551 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.677 HD12 ' HA ' ' A' ' 14' ' ' TRP . 31.3 mt -71.91 -33.93 68.69 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.009 0.924 . . . . 60.109999999999999 111.641 174.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -30.3 65.23 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.734 0.814 . . . . 65.549999999999997 109.944 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -77.23 -41.39 41.36 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.018 0.527 . . . . 64.349999999999994 110.492 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.2 107.13 1.8 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.136 0.574 . . . . 73.430000000000007 111.612 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.98 174.91 11.15 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.331 0.652 . . . . 63.310000000000002 111.148 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.67 42.43 97.27 Favored Glycine 0 N--CA 1.479 1.518 0 CA-C-O 121.406 0.448 . . . . 72.0 112.366 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.433 HD13 ' HB3' ' A' ' 28' ' ' LEU . 21.1 tt -114.92 144.79 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.826 0.851 . . . . 54.140000000000001 110.996 -169.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -79.8 151.26 30.4 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.08 0.552 . . . . 72.319999999999993 110.889 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.81 -47.1 99.33 Favored Pre-proline 0 CA--C 1.58 2.119 0 N-CA-C 113.326 0.862 . . . . 64.140000000000001 113.326 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.05 -22.81 47.14 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.076 1.851 . . . . 71.439999999999998 113.468 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -71.91 -48.9 42.27 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.633 0.773 . . . . 64.510000000000005 111.673 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.433 ' HB3' HD13 ' A' ' 23' ' ' ILE . 2.2 pt? -74.9 -29.62 61.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.816 -0.553 . . . . 71.5 111.826 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.39 -44.88 65.58 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.385 0.883 . . . . 51.030000000000001 113.385 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -70.44 -30.38 67.2 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.922 0.489 . . . . 73.120000000000005 112.081 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 25.7 mtpp -68.33 -44.34 75.54 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.575 0.75 . . . . 71.120000000000005 110.592 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 13' ' ' VAL . 16.9 m -86.41 -2.0 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.126 0.971 . . . . 64.239999999999995 111.805 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 m120 64.84 23.22 12.63 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.104 1.361 . . . . 74.239999999999995 112.946 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 9' ' ' ASN . 66.3 mt -101.63 168.2 9.63 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.67 0.788 . . . . 72.409999999999997 111.102 174.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 m -71.72 156.97 38.75 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.905 -0.589 . . . . 74.310000000000002 110.838 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.39 -48.37 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 123.235 0.614 . . . . 72.239999999999995 111.717 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.406 ' HB3' HD12 ' B' ' 25' ' ' ILE . 51.7 mt-10 -63.73 -38.64 91.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.38 0.672 . . . . 54.310000000000002 112.658 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.1 m -65.99 -31.14 71.88 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.606 0.762 . . . . 62.43 111.807 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.4 m -77.39 -44.18 30.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.802 0.841 . . . . 73.310000000000002 111.112 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.57 -33.55 72.87 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.305 0.642 . . . . 60.32 111.659 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -53.71 54.84 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.546 1.139 . . . . 71.239999999999995 110.04 171.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.28 -32.35 72.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.078 -0.965 . . . . 54.140000000000001 112.277 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.46 HG11 HD13 ' A' ' 63' ' ' ILE . 69.1 t -68.34 -39.71 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.24 0.616 . . . . 70.239999999999995 111.183 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.34 -31.8 81.99 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 116.633 -0.258 . . . . 61.340000000000003 113.108 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.403 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 69.2 t-105 -71.18 -30.3 66.25 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.605 0.762 . . . . 72.200000000000003 111.685 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.447 HD22 ' HE2' ' A' ' 51' ' ' LYS . 77.5 mt -75.61 -38.07 59.28 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.578 0.751 . . . . 74.25 112.274 170.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.29 -37.01 74.16 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.807 1.243 . . . . 63.310000000000002 114.117 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.599 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 25.7 ptt85 -60.39 -26.67 66.84 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 122.935 0.494 . . . . 72.219999999999999 111.886 175.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 40.0 mt-10 -103.3 4.96 37.08 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.856 1.262 . . . . 74.209999999999994 112.228 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 62.71 21.7 12.9 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 125.031 1.332 . . . . 64.239999999999995 113.0 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HE2' HD22 ' A' ' 46' ' ' LEU . 50.8 mtpt -80.2 -13.45 59.23 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.235 0.614 . . . . 74.219999999999999 112.283 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.488 HG12 HD13 ' A' ' 17' ' ' LEU . 19.0 m -121.61 142.95 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.759 0.823 . . . . 54.409999999999997 111.22 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 94.7 t -112.73 104.98 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 123.846 0.859 . . . . 71.030000000000001 109.872 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.583 HG23 HG23 ' A' ' 61' ' ' ILE . 2.6 mp -91.64 125.43 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.561 -0.533 . . . . 64.329999999999998 109.561 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.33 113.22 25.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.007 0.523 . . . . 72.319999999999993 109.644 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -87.23 96.22 10.25 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.77 -0.826 . . . . 73.439999999999998 108.77 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.54 118.12 34.86 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.825 0.85 . . . . 75.019999999999996 109.541 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.78 31.56 17.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.871 0.868 . . . . 63.240000000000002 111.569 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.52 2.36 74.53 Favored Glycine 0 CA--C 1.546 1.98 0 N-CA-C 114.472 0.549 . . . . 42.439999999999998 114.472 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.0 mt -94.92 133.07 39.05 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.945 0.898 . . . . 53.420000000000002 110.306 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.583 HG23 HG23 ' A' ' 54' ' ' ILE . 76.6 mt -96.87 118.07 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.489 0.715 . . . . 61.25 111.666 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.37 132.05 55.75 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.914 -0.773 . . . . 62.119999999999997 108.914 167.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.46 HD13 HG11 ' A' ' 43' ' ' VAL . 40.0 mt -102.04 132.05 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 121.325 0.583 . . . . 65.140000000000001 110.788 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.57 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 83.8 m-85 -124.55 173.55 8.41 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.318 1.047 . . . . 75.549999999999997 110.158 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -99.86 163.92 12.25 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.048 0.539 . . . . 74.219999999999999 109.727 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.49 1.574 0 C-N-CA 124.441 1.097 . . . . 72.310000000000002 112.324 175.106 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.507 ' HA ' HG22 ' B' ' 6' ' ' VAL . 37.5 ttmt . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 112.323 0.49 . . . . 72.519999999999996 112.323 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -55.25 -41.24 71.9 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.403 0.621 . . . . 72.150000000000006 110.478 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 47.6 mt -66.55 -51.97 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-N 114.677 -1.147 . . . . 64.239999999999995 111.457 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' B' ' 3' ' ' LYS . 4.5 m -67.18 -32.3 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 122.584 0.354 . . . . 73.409999999999997 111.896 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.47 -44.09 66.19 Favored Glycine 0 C--N 1.349 1.302 0 O-C-N 123.201 0.313 . . . . 53.240000000000002 112.749 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.26 69.83 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.505 0.722 . . . . 73.420000000000002 112.25 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . 0.408 ' OD1' HD11 ' B' ' 34' ' ' LEU . 9.0 t-20 -86.67 -28.05 23.4 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.637 0.775 . . . . 61.109999999999999 112.131 -175.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.25 72.36 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.275 0.63 . . . . 54.329999999999998 112.192 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.81 -42.31 95.17 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 116.11 -0.495 . . . . 64.209999999999994 112.373 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -65.11 -45.63 84.33 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.777 0.831 . . . . 73.209999999999994 111.479 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.617 ' HA ' HG11 ' B' ' 32' ' ' VAL . 30.9 m -68.83 -32.22 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 C-N-CA 122.772 0.429 . . . . 72.099999999999994 112.068 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.501 ' HA ' HD12 ' B' ' 17' ' ' LEU . 34.6 t90 -72.3 -35.77 68.75 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.834 0.454 . . . . 74.409999999999997 111.495 175.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -67.46 -32.24 72.95 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.069 0.548 . . . . 74.019999999999996 112.018 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.7 74.39 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 122.971 0.508 . . . . 62.229999999999997 111.939 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' B' ' 14' ' ' TRP . 82.6 mt -63.67 -30.89 71.94 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.944 0.898 . . . . 52.329999999999998 112.602 174.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -69.2 -5.48 22.89 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.158 0.799 . . . . 51.109999999999999 113.158 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -79.67 -61.48 1.98 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.022 0.529 . . . . 74.230000000000004 110.469 170.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.94 131.72 5.33 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.511 0.725 . . . . 63.32 110.947 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.525 ' HB3' ' HD1' ' B' ' 64' ' ' TYR . 4.6 m-20 -74.22 175.21 7.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.991 0.916 . . . . 74.420000000000002 112.468 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.72 54.81 5.24 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.535 -0.626 . . . . 72.409999999999997 111.535 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 tt -133.6 120.34 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.53 0.732 . . . . 71.129999999999995 110.994 -167.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -67.74 163.49 21.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.633 0.773 . . . . 54.009999999999998 111.911 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' B' ' 40' ' ' ALA . 48.5 mt -59.7 -47.12 98.26 Favored Pre-proline 0 CA--C 1.574 1.901 0 CA-C-O 118.525 -0.75 . . . . 73.019999999999996 112.434 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.02 -22.99 34.69 Favored 'Trans proline' 0 C--N 1.396 3.044 0 C-N-CA 121.871 1.714 . . . . 50.409999999999997 114.064 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -70.73 -50.45 36.08 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.686 1.231 . . . . 75.239999999999995 109.017 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.83 -39.1 83.97 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 112.612 -2.085 . . . . 72.510000000000005 111.679 175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.17 -43.11 87.28 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.105 0.962 . . . . 74.049999999999997 112.867 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -69.71 -36.93 76.34 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.003 0.521 . . . . 74.25 111.587 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -64.39 -44.85 90.04 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.244 0.618 . . . . 73.140000000000001 111.148 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' B' ' 13' ' ' VAL . 13.7 m -88.23 5.34 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.35 0.66 . . . . 73.129999999999995 112.727 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 69.32 17.81 8.14 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.798 1.239 . . . . 71.310000000000002 113.137 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.408 HD11 ' OD1' ' B' ' 9' ' ' ASN . 63.3 mt -110.65 174.95 5.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.627 0.771 . . . . 74.319999999999993 112.287 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -84.31 160.72 20.65 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.17 -0.923 . . . . 74.430000000000007 110.577 167.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 63.2 t -53.89 -49.82 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 124.1 0.96 . . . . 73.439999999999998 112.653 -175.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.37 -48.3 82.34 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.579 0.752 . . . . 73.510000000000005 111.985 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -62.67 -37.13 85.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.942 0.897 . . . . 64.549999999999997 111.892 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.485 ' O ' HG23 ' B' ' 43' ' ' VAL . 85.1 m -69.07 -51.31 40.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.578 0.751 . . . . 75.340000000000003 111.609 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -55.04 -44.51 74.73 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.802 0.841 . . . . 44.240000000000002 111.974 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.72 -36.19 82.91 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.393 1.077 . . . . 62.43 111.203 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.44 83.27 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.775 0.43 . . . . 74.349999999999994 112.151 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.485 HG23 ' O ' ' B' ' 39' ' ' THR . 24.8 t -67.54 -29.19 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.51 0.724 . . . . 72.329999999999998 111.449 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.73 -28.16 56.5 Favored Glycine 0 CA--C 1.551 2.282 0 N-CA-C 114.502 0.561 . . . . 40.409999999999997 114.502 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.488 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 72.6 t-105 -74.33 -24.69 59.23 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.443 0.697 . . . . 70.409999999999997 111.533 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.443 HD11 HG23 ' B' ' 13' ' ' VAL . 83.9 mt -72.77 -36.04 67.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.563 0.745 . . . . 42.130000000000003 111.636 173.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.97 -33.51 67.15 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.728 0.811 . . . . 74.439999999999998 112.363 172.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 33.1 ttt-85 -54.63 -49.78 69.7 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.971 0.908 . . . . 64.230000000000004 111.481 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.27 -1.35 57.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.51 0.724 . . . . 73.439999999999998 112.58 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 64.17 21.96 12.72 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.812 1.245 . . . . 63.520000000000003 113.177 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -86.61 1.37 52.02 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.08 0.77 . . . . 65.329999999999998 113.08 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.36 155.68 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 123.362 0.665 . . . . 73.219999999999999 112.027 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 45.8 t -120.43 96.57 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.532 -0.914 . . . . 63.130000000000003 108.532 169.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.475 HD11 HG12 ' B' ' 43' ' ' VAL . 35.7 mt -95.75 102.27 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.158 0.504 . . . . 63.32 109.676 -177.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -134.29 132.27 39.39 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.994 -0.441 . . . . 63.520000000000003 111.629 -166.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.658 HH22 HD13 ' A' ' 5' ' ' ILE . 6.7 mtm-85 -86.8 97.05 10.41 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.799 0.809 . . . . 63.030000000000001 110.405 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -108.35 128.31 54.64 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.653 -1.158 . . . . 72.209999999999994 109.151 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 59.31 29.9 19.54 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.492 1.117 . . . . 75.519999999999996 111.14 -170.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.99 -21.39 7.98 Favored Glycine 0 C--N 1.36 1.915 0 CA-C-N 115.879 -0.601 . . . . 44.219999999999999 114.514 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mp -89.7 135.52 33.57 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.453 0.701 . . . . 43.219999999999999 110.74 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.639 HG13 ' HG2' ' B' ' 56' ' ' ARG . 1.4 mp -73.93 107.99 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 C-N-CA 123.593 0.757 . . . . 63.439999999999998 109.682 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -107.53 120.27 41.74 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.014 0.926 . . . . 70.25 110.494 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.444 ' N ' HD12 ' B' ' 63' ' ' ILE . 2.2 mp -94.24 132.31 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 109.149 -0.685 . . . . 55.539999999999999 109.149 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.625 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 90.5 m-85 -123.5 174.0 7.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.473 1.109 . . . . 71.519999999999996 109.997 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -93.97 158.26 15.72 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 109.142 -0.688 . . . . 74.430000000000007 109.142 166.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 N--CA 1.488 1.46 0 C-N-CA 124.358 1.063 . . . . 73.319999999999993 113.397 -178.172 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 112.438 0.532 . . . . 72.329999999999998 112.438 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.4 mt -52.8 -58.13 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.118 0.967 . . . . 64.219999999999999 112.115 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -60.79 -37.47 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 112.926 0.713 . . . . 75.239999999999995 112.926 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.79 -38.84 41.2 Favored Glycine 0 N--CA 1.476 1.366 0 O-C-N 123.237 0.336 . . . . 24.210000000000001 113.041 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.72 -36.73 83.92 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.943 0.897 . . . . 74.129999999999995 111.971 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -84.15 -28.92 27.08 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.092 -0.504 . . . . 31.309999999999999 111.622 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.82 71.12 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 122.908 0.483 . . . . 72.340000000000003 111.986 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.7 97.23 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.245 -0.434 . . . . 72.219999999999999 112.975 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -72.67 -38.29 67.65 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.925 0.89 . . . . 75.400000000000006 111.579 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.741 ' HA ' HG11 ' A' ' 32' ' ' VAL . 54.2 t -62.98 -47.74 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.79 0.836 . . . . 75.0 111.28 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -66.17 -33.43 75.75 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.623 -0.717 . . . . 73.019999999999996 111.35 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -61.62 -42.42 98.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.402 0.681 . . . . 75.400000000000006 111.681 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.21 74.03 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.327 0.651 . . . . 72.140000000000001 111.491 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 21' ' ' ASP . 2.5 tm? -70.73 -30.7 67.31 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.213 1.405 . . . . 72.299999999999997 111.536 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -64.24 -42.95 96.31 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.945 0.898 . . . . 73.120000000000005 112.816 -169.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -81.69 -15.22 55.17 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.005 0.743 . . . . 53.140000000000001 113.005 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.53 96.06 1.14 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.961 0.504 . . . . 64.209999999999994 110.738 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.451 ' HA ' HD22 ' A' ' 17' ' ' LEU . 8.7 p-10 -86.02 169.2 13.41 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.09 0.556 . . . . 75.120000000000005 112.009 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.86 55.06 3.94 Favored Glycine 0 C--N 1.344 1.009 0 N-CA-C 111.698 -0.561 . . . . 60.130000000000003 111.698 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 tt -130.13 136.43 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.979 0.911 . . . . 75.329999999999998 110.421 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.9 p -74.97 154.59 38.04 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.783 0.433 . . . . 70.109999999999999 111.242 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.564 HG21 ' HB2' ' A' ' 40' ' ' ALA . 63.8 mt -52.36 -47.42 92.97 Favored Pre-proline 0 CA--C 1.573 1.837 0 N-CA-C 114.056 1.132 . . . . 64.150000000000006 114.056 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.69 -33.05 56.19 Favored 'Trans proline' 0 C--N 1.393 2.902 0 C-N-CA 121.714 1.609 . . . . 75.510000000000005 114.319 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 30' ' ' ARG . 37.6 mt-10 -76.74 -31.0 56.84 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.395 1.093 . . . . 73.329999999999998 110.453 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.81 -33.3 66.14 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 113.668 -1.605 . . . . 74.319999999999993 110.603 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.9 -39.4 87.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.895 0.878 . . . . 65.129999999999995 112.855 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 14.2 ptt180 -70.38 -28.08 64.82 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.401 0.28 . . . . 64.239999999999995 111.053 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -67.27 -37.74 83.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.961 0.904 . . . . 75.129999999999995 111.574 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.741 HG11 ' HA ' ' A' ' 13' ' ' VAL . 24.6 m -102.8 0.73 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 112.989 0.737 . . . . 73.0 112.989 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 65.71 28.47 11.06 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.808 1.243 . . . . 74.409999999999997 112.635 174.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.4 mt -109.0 175.12 5.57 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.943 0.897 . . . . 53.409999999999997 111.244 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 99.9 p -77.99 163.74 25.68 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.319 0.648 . . . . 70.400000000000006 110.37 168.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -58.18 -45.92 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.09 0.556 . . . . 63.420000000000002 111.17 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.71 -37.51 82.35 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.954 0.902 . . . . 73.109999999999999 112.648 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -69.69 -37.37 76.59 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.129 0.49 . . . . 62.539999999999999 111.563 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 43' ' ' VAL . 93.8 m -72.88 -44.66 61.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.494 0.717 . . . . 70.109999999999999 111.281 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -57.86 -35.63 71.22 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.966 0.906 . . . . 73.109999999999999 111.972 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -51.8 67.15 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 114.795 -1.093 . . . . 60.43 110.207 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.04 70.96 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.862 -1.063 . . . . 72.219999999999999 111.723 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 39' ' ' THR . 79.4 t -69.23 -38.25 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.367 0.667 . . . . 71.030000000000001 110.664 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.89 -31.77 82.02 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 116.359 -0.382 . . . . 74.239999999999995 113.459 172.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.507 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 66.9 t-105 -73.92 -30.15 62.42 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.449 0.699 . . . . 73.230000000000004 111.047 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.19 -37.44 69.29 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.922 0.489 . . . . 72.209999999999994 111.184 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.76 -30.09 71.19 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.95 0.9 . . . . 73.409999999999997 111.724 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 21.5 ttt180 -55.88 -50.6 70.2 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.564 0.745 . . . . 75.230000000000004 110.884 167.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -84.71 -3.23 58.46 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 115.197 -0.911 . . . . 75.019999999999996 111.961 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 62.25 22.22 13.02 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 125.258 1.423 . . . . 73.319999999999993 112.764 -175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -69.55 -24.82 63.77 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.41 1.084 . . . . 64.299999999999997 112.367 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.59 151.14 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.64 0.776 . . . . 63.439999999999998 110.813 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.494 HG12 ' HG3' ' A' ' 55' ' ' GLU . 44.6 t -116.92 111.45 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 123.712 0.805 . . . . 74.530000000000001 110.242 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.497 HG23 HG23 ' A' ' 61' ' ' ILE . 3.4 mp -86.56 107.98 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 N-CA-C 109.389 -0.596 . . . . 72.219999999999999 109.389 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG3' HG12 ' A' ' 53' ' ' VAL . 54.3 mt-10 -118.44 118.03 30.65 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.538 0.735 . . . . 65.120000000000005 110.382 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -85.24 100.96 12.13 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.136 0.974 . . . . 72.540000000000006 110.076 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -114.63 109.15 17.8 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.069 0.948 . . . . 62.520000000000003 109.885 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 57.63 32.67 22.2 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.171 0.988 . . . . 73.040000000000006 111.831 -169.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.3 -9.92 62.74 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 115.557 -0.747 . . . . 50.109999999999999 114.311 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.5 mt -80.0 107.55 12.87 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.191 0.596 . . . . 43.509999999999998 109.997 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.497 HG23 HG23 ' A' ' 54' ' ' ILE . 76.7 mt -69.88 102.63 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.321 -0.622 . . . . 75.209999999999994 109.321 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -110.19 124.11 50.98 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.923 0.889 . . . . 71.430000000000007 109.847 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.1 mp -91.72 103.25 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 108.602 -0.888 . . . . 74.030000000000001 108.602 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -91.81 175.77 6.77 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.073 0.949 . . . . 74.030000000000001 110.941 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.81 158.87 16.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.081 0.552 . . . . 74.349999999999994 110.525 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.483 1.218 0 C-N-CA 123.517 0.727 . . . . 74.420000000000002 110.379 171.564 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 113.063 0.764 . . . . 75.530000000000001 113.063 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.24 -35.02 14.03 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.259 0.623 . . . . 74.430000000000007 112.344 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 58.8 mt -61.52 -40.71 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.502 0.721 . . . . 62.509999999999998 111.841 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 28.6 m -61.49 -30.28 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.884 0.874 . . . . 74.299999999999997 112.091 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.03 -39.65 94.86 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 122.888 0.118 . . . . 24.109999999999999 113.057 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.94 -53.04 10.98 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.55 0.74 . . . . 72.120000000000005 112.496 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -70.29 -30.59 67.64 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.215 0.821 . . . . 65.219999999999999 113.215 -172.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.35 -25.21 61.45 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.265 0.626 . . . . 64.049999999999997 111.924 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.55 -38.71 96.08 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 116.166 -0.47 . . . . 73.400000000000006 112.816 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -70.85 -40.03 72.59 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.691 0.796 . . . . 74.340000000000003 111.174 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.4 ' HA ' HG11 ' B' ' 32' ' ' VAL . 92.3 t -63.03 -48.41 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.124 0.57 . . . . 34.350000000000001 111.332 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.475 ' HA ' HD12 ' B' ' 17' ' ' LEU . 40.4 t90 -65.55 -34.13 77.53 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.245 0.618 . . . . 74.530000000000001 110.989 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -62.46 -39.42 93.36 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.76 0.824 . . . . 73.219999999999999 110.636 173.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.15 -32.12 72.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.647 0.779 . . . . 63.409999999999997 111.683 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' B' ' 14' ' ' TRP . 69.3 mt -74.4 -31.91 62.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.455 0.702 . . . . 63.310000000000002 111.426 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.03 -25.97 62.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.008 0.523 . . . . 74.120000000000005 110.689 -177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -95.73 -29.41 14.28 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.521 0.728 . . . . 74.099999999999994 111.476 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.78 94.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.446 0.698 . . . . 70.120000000000005 111.74 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -96.87 179.4 4.97 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.286 0.634 . . . . 72.140000000000001 111.755 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.54 37.39 53.03 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.474 -0.33 . . . . 62.32 113.224 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 tt -119.27 151.17 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.064 0.946 . . . . 74.25 110.632 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -61.97 140.52 58.32 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.971 0.508 . . . . 73.230000000000004 111.348 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' B' ' 40' ' ' ALA . 64.8 mt -53.81 -45.9 98.65 Favored Pre-proline 0 CA--C 1.576 1.962 0 N-CA-C 113.219 0.822 . . . . 63.43 113.219 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.438 ' HA ' HG22 ' B' ' 36' ' ' VAL . 36.9 Cg_endo -63.13 -29.4 74.32 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.116 1.877 . . . . 71.439999999999998 115.072 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.22 -49.16 17.91 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.126 0.965 . . . . 71.099999999999994 109.759 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -55.05 -36.26 65.36 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 113.326 -1.761 . . . . 62.450000000000003 112.083 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.39 -42.79 87.85 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.007 0.923 . . . . 72.030000000000001 112.058 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -72.46 -24.7 61.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.832 -0.622 . . . . 61.509999999999998 111.28 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -76.09 -41.99 48.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.416 0.687 . . . . 54.240000000000002 111.391 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' B' ' 13' ' ' VAL . 24.1 m -89.77 3.76 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.168 0.587 . . . . 64.239999999999995 112.366 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 67.09 22.48 9.89 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.736 1.214 . . . . 71.219999999999999 112.424 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.85 171.29 7.68 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.337 0.655 . . . . 74.319999999999993 111.561 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.2 t -72.99 158.62 35.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.342 0.657 . . . . 42.210000000000001 111.093 170.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' B' ' 26' ' ' PRO . 41.7 t -57.33 -47.48 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.349 0.66 . . . . 52.039999999999999 111.306 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -64.0 -40.82 97.23 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.604 -0.726 . . . . 75.040000000000006 112.048 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -66.93 -34.08 77.0 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.367 0.667 . . . . 72.510000000000005 112.115 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.452 ' O ' HG23 ' B' ' 43' ' ' VAL . 90.3 m -76.6 -39.87 51.21 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.627 0.771 . . . . 61.340000000000003 111.07 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.435 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -63.78 -37.92 89.16 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.323 0.582 . . . . 55.340000000000003 111.127 174.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.97 -40.96 97.58 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.667 1.187 . . . . 63.450000000000003 110.519 172.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.48 -43.37 94.41 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.359 0.663 . . . . 42.200000000000003 112.005 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.618 HG11 HG21 ' B' ' 63' ' ' ILE . 84.5 t -61.24 -31.23 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.109 0.564 . . . . 71.329999999999998 111.321 176.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.36 -29.2 68.47 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 114.58 0.592 . . . . 74.430000000000007 114.58 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.454 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 76.9 t-105 -72.92 -34.34 66.55 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.712 0.805 . . . . 72.019999999999996 111.111 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 77.1 mt -71.42 -40.25 70.55 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.142 0.577 . . . . 41.539999999999999 110.322 174.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.91 -31.97 73.34 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.351 1.06 . . . . 73.329999999999998 111.708 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 16.1 ttp85 -52.64 -51.79 58.52 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.582 0.706 . . . . 61.210000000000001 110.945 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.434 ' HB2' ' HG2' ' B' ' 51' ' ' LYS . 35.2 mt-10 -83.89 -8.93 59.07 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.875 -1.057 . . . . 72.209999999999994 111.669 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 63.42 29.82 15.49 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.012 1.325 . . . . 73.400000000000006 112.115 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' B' ' 49' ' ' GLU . 8.4 mmmm -69.28 -9.59 53.9 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.486 1.515 . . . . 64.349999999999994 113.009 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.26 150.05 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 124.127 0.971 . . . . 73.040000000000006 111.24 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 94.7 t -93.21 129.2 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.985 0.914 . . . . 51.140000000000001 109.455 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.63 120.85 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.87 -1.159 . . . . 73.409999999999997 107.87 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . 0.436 ' HG2' ' NZ ' ' B' ' 57' ' ' LYS . 8.9 tp10 -137.95 158.62 43.97 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.201 0.601 . . . . 73.040000000000006 110.487 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -118.83 114.14 22.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.992 0.517 . . . . 64.439999999999998 110.252 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . 0.493 ' HD3' ' HG3' ' B' ' 62' ' ' GLU . 13.9 mptt -101.99 107.49 18.65 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.01 0.924 . . . . 74.340000000000003 108.618 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 57.96 31.99 21.35 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.473 1.109 . . . . 63.539999999999999 111.847 -175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.51 34.69 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 115.949 -0.569 . . . . 62.409999999999997 113.812 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 75.6 mt -75.57 136.89 40.52 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.453 0.701 . . . . 62.409999999999997 111.215 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.58 117.7 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-O 121.271 0.557 . . . . 60.439999999999998 110.463 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . 0.493 ' HG3' ' HD3' ' B' ' 57' ' ' LYS . 39.1 mm-40 -108.14 142.6 38.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.491 1.516 . . . . 73.200000000000003 110.491 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.618 HG21 HG11 ' B' ' 43' ' ' VAL . 2.0 pp -133.5 122.5 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 CA-C-O 121.783 0.801 . . . . 75.019999999999996 111.206 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.671 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 55.3 m-85 -115.4 171.28 7.81 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.864 0.866 . . . . 75.25 110.295 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -100.79 153.45 19.46 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.102 0.561 . . . . 75.439999999999998 109.914 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 . . . . . 0 N--CA 1.488 1.469 0 O-C-N 122.079 -0.388 . . . . 61.350000000000001 111.755 173.11 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 113.698 0.999 . . . . 73.239999999999995 113.698 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -49.1 -52.8 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 118.585 0.63 . . . . 71.099999999999994 111.083 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.71 -28.22 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.04 0.536 . . . . 54.509999999999998 112.265 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.41 -42.66 33.45 Favored Glycine 0 C--N 1.351 1.371 0 O-C-N 123.302 0.376 . . . . 55.509999999999998 113.558 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.7 -44.42 81.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.809 0.844 . . . . 64.230000000000004 111.209 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -71.64 -28.89 64.08 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.84 -0.618 . . . . 61.210000000000001 111.707 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.402 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . . . -72.09 -29.03 63.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.679 0.392 . . . . 62.229999999999997 111.263 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.11 -37.28 92.92 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 115.997 -0.547 . . . . 70.319999999999993 112.46 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -75.26 -38.92 60.26 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 122.881 0.472 . . . . 75.209999999999994 111.271 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.445 HG13 HD11 ' A' ' 28' ' ' LEU . 53.1 t -64.14 -46.12 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.889 0.875 . . . . 74.349999999999994 111.284 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -67.67 -33.32 74.69 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.514 -0.312 . . . . 71.010000000000005 110.313 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -63.91 -33.0 74.72 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 122.416 -0.178 . . . . 73.299999999999997 111.027 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HB3' HD12 ' A' ' 28' ' ' LEU . . . -67.22 -28.5 68.12 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.82 0.448 . . . . 64.420000000000002 111.846 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.4 -45.46 54.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.784 0.834 . . . . 75.129999999999995 110.633 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -59.71 -29.86 68.41 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.495 1.118 . . . . 75.510000000000005 111.559 173.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -82.06 -52.94 6.52 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.07 0.948 . . . . 72.310000000000002 110.26 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.35 96.59 2.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.467 1.107 . . . . 34.420000000000002 109.567 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -73.94 154.16 39.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.607 0.763 . . . . 63.420000000000002 113.016 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.6 65.37 2.43 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 116.076 -0.511 . . . . 43.119999999999997 112.935 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.504 HD11 ' HG3' ' A' ' 27' ' ' GLU . 20.7 tt -134.25 143.76 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 122.871 0.468 . . . . 62.340000000000003 111.819 -169.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 49.4 m -67.61 146.08 54.22 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.546 0.738 . . . . 75.430000000000007 111.815 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.441 HG21 ' HB2' ' A' ' 40' ' ' ALA . 55.9 mt -53.4 -48.94 90.93 Favored Pre-proline 0 CA--C 1.577 1.994 0 C-N-CA 124.175 0.99 . . . . 75.420000000000002 113.581 -176.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.86 -27.59 43.54 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 121.765 1.643 . . . . 75.510000000000005 113.553 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.504 ' HG3' HD11 ' A' ' 23' ' ' ILE . 10.8 tp10 -73.12 -55.62 6.23 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 112.402 0.519 . . . . 73.219999999999999 112.402 -174.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 16' ' ' ALA . 2.2 pt? -66.41 -29.31 69.44 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.078 0.399 . . . . 74.230000000000004 111.245 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.37 -42.67 53.67 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.719 0.808 . . . . 73.230000000000004 112.168 171.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -63.81 -40.4 96.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.074 0.55 . . . . 74.409999999999997 111.596 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -69.04 -38.06 78.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.889 0.876 . . . . 74.510000000000005 111.473 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.1 m -94.85 4.66 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.524 0.73 . . . . 74.349999999999994 112.201 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 64.81 21.23 12.32 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 124.741 1.216 . . . . 64.040000000000006 112.336 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.6 mt -105.91 162.59 13.44 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.38 0.672 . . . . 75.409999999999997 111.527 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -69.81 158.48 35.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.433 -0.803 . . . . 73.5 111.249 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -56.91 -42.22 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.241 0.616 . . . . 74.319999999999993 110.744 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.16 -50.03 73.46 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.699 0.8 . . . . 75.349999999999994 111.497 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -58.15 -38.94 77.54 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.819 0.848 . . . . 71.510000000000005 111.856 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 43' ' ' VAL . 97.9 m -70.69 -52.69 19.37 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.661 0.785 . . . . 63.119999999999997 111.391 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.17 -32.58 74.2 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 123.797 0.839 . . . . 70.230000000000004 112.772 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -72.66 -41.17 65.71 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.171 0.988 . . . . 74.340000000000003 109.808 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -66.02 -30.52 71.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.307 0.643 . . . . 62.509999999999998 111.586 175.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 39' ' ' THR . 49.5 t -65.8 -43.97 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.339 1.056 . . . . 74.230000000000004 110.304 171.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.27 -28.37 72.89 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 116.11 -0.495 . . . . 71.299999999999997 112.713 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.424 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 77.2 t-105 -70.28 -44.4 68.47 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.207 0.603 . . . . 75.310000000000002 110.829 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 51' ' ' LYS . 88.0 mt -60.9 -31.37 70.86 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.267 0.627 . . . . 72.209999999999994 111.735 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.07 -25.0 57.95 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.574 1.15 . . . . 73.109999999999999 113.63 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.745 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 23.6 ptt180 -57.12 -35.59 69.65 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 123.07 0.548 . . . . 51.530000000000001 111.519 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.745 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 28.9 mt-10 -106.28 8.39 31.83 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.64 1.176 . . . . 75.099999999999994 110.93 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 63.39 23.8 13.89 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.037 1.335 . . . . 74.230000000000004 112.698 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG3' ' HB2' ' A' ' 49' ' ' GLU . 28.1 mtpp -70.16 -10.96 60.47 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.677 0.991 . . . . 75.319999999999993 113.677 -174.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 m -126.59 148.48 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.792 0.837 . . . . 65.209999999999994 111.545 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.629 HG23 ' HB2' ' A' ' 64' ' ' TYR . 6.7 m -131.0 112.41 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 C-N-CA 124.516 1.126 . . . . 74.420000000000002 109.84 170.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.606 HG13 HG22 ' A' ' 63' ' ' ILE . 3.0 mp -92.07 134.99 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.61 1.164 . . . . 73.040000000000006 110.745 -171.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -139.04 144.76 38.96 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.353 0.661 . . . . 73.230000000000004 110.486 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -116.06 112.61 22.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.504 0.669 . . . . 71.519999999999996 110.528 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -105.4 128.88 53.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.143 0.977 . . . . 64.409999999999997 109.447 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 58.64 31.76 21.45 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 124.635 1.174 . . . . 62.43 113.025 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.91 -9.86 54.81 Favored Glycine 0 CA--C 1.541 1.711 0 N-CA-C 114.469 0.548 . . . . 61.549999999999997 114.469 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.71 135.07 36.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.323 1.049 . . . . 74.049999999999997 109.342 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' B' ' 37' ' ' GLU . 19.5 mt -104.09 125.02 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 CA-C-O 121.544 0.688 . . . . 73.439999999999998 112.345 -170.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 8.8 mp0 -117.96 153.53 33.46 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.806 1.642 . . . . 45.340000000000003 109.725 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.606 HG22 HG13 ' A' ' 54' ' ' ILE . 48.1 pt -113.89 142.7 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.304 0.573 . . . . 63.350000000000001 110.69 171.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.629 ' HB2' HG23 ' A' ' 53' ' ' VAL . 80.9 m-85 -125.07 167.39 14.84 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.225 1.01 . . . . 52.130000000000003 110.135 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -86.87 148.9 25.17 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.539 0.736 . . . . 65.340000000000003 112.011 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.555 1.139 0 CA-C-N 115.766 -0.652 . . . . 74.310000000000002 110.093 166.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.364 0 CA-C-O 121.105 0.479 . . . . 75.299999999999997 111.738 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.26 -44.54 10.76 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.643 1.177 . . . . 62.299999999999997 110.119 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -56.18 -48.35 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 123.729 0.812 . . . . 64.450000000000003 111.612 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.444 HG12 HD11 ' B' ' 41' ' ' LEU . 32.6 m -63.38 -30.45 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.338 1.055 . . . . 74.129999999999995 112.297 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.43 -44.13 85.09 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.181 0.301 . . . . 72.129999999999995 112.78 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.66 69.23 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.513 0.725 . . . . 61.439999999999998 111.832 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -66.1 -48.65 70.24 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.733 1.213 . . . . 74.540000000000006 110.927 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 -20.93 63.8 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.365 0.666 . . . . 52.130000000000003 112.112 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.29 -43.74 94.72 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 123.172 0.295 . . . . 64.209999999999994 112.986 174.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -68.62 -45.93 70.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.706 0.802 . . . . 72.530000000000001 110.912 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.46 ' HA ' HG11 ' B' ' 32' ' ' VAL . 96.6 t -60.01 -49.65 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.808 0.843 . . . . 75.129999999999995 111.708 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -60.87 -44.35 97.18 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.581 0.753 . . . . 71.25 111.738 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -62.29 -43.68 98.27 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.025 0.53 . . . . 53.32 111.883 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.04 68.88 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.367 0.667 . . . . 73.239999999999995 111.407 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -72.42 -32.68 66.54 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.744 1.218 . . . . 73.549999999999997 110.578 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -81.77 -18.97 42.31 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.201 0.6 . . . . 54.130000000000003 110.6 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -67.54 -33.77 75.72 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.545 0.738 . . . . 64.200000000000003 110.227 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.12 108.59 1.12 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.256 1.022 . . . . 64.140000000000001 109.564 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -93.58 173.6 7.61 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 112.318 0.488 . . . . 73.540000000000006 112.318 -175.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.26 44.68 8.63 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.969 -0.56 . . . . 70.319999999999993 111.943 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 tt -134.33 137.71 51.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.844 0.857 . . . . 64.129999999999995 110.116 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 70.3 m -78.13 160.17 28.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.438 0.695 . . . . 72.099999999999994 112.732 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.484 HG21 ' HB2' ' B' ' 40' ' ' ALA . 81.2 mt -49.32 -53.56 38.58 Favored Pre-proline 0 CA--C 1.572 1.804 0 C-N-CA 125.817 1.647 . . . . 65.519999999999996 114.037 -177.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.68 -23.75 30.83 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 121.556 1.504 . . . . 71.530000000000001 113.387 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -76.5 -55.76 5.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.213 0.605 . . . . 73.120000000000005 110.596 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.3 -29.7 70.62 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.507 0.723 . . . . 64.340000000000003 111.601 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' B' ' 39' ' ' THR . . . -52.9 -37.75 61.0 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.803 0.841 . . . . 74.319999999999993 112.812 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -71.75 -34.79 69.78 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.25 0.833 . . . . 74.040000000000006 113.25 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -76.92 -31.43 56.68 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.548 0.613 . . . . 53.149999999999999 111.646 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' B' ' 13' ' ' VAL . 33.3 m -88.03 -4.72 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.555 0.342 . . . . 73.219999999999999 111.555 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t30 68.67 17.65 8.88 Favored 'General case' 0 CA--C 1.57 1.72 0 C-N-CA 124.779 1.232 . . . . 60.409999999999997 112.119 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 70.3 mt -102.8 163.75 12.03 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.548 0.739 . . . . 74.129999999999995 111.388 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 62.8 m -67.7 158.54 32.06 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.448 0.699 . . . . 63.439999999999998 111.785 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.424 HG13 HG22 ' B' ' 25' ' ' ILE . 61.8 t -64.43 -43.48 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.099 0.559 . . . . 74.430000000000007 111.946 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.678 ' HB2' HD12 ' A' ' 61' ' ' ILE . 45.8 mt-10 -62.97 -31.98 73.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.768 0.427 . . . . 72.120000000000005 111.946 175.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 42.3 m -63.63 -45.27 91.03 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.46 0.704 . . . . 72.340000000000003 111.114 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.501 HG21 ' HA ' ' B' ' 29' ' ' ALA . 17.0 p -76.46 -41.02 48.79 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.178 0.807 . . . . 75.239999999999995 113.178 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -56.0 -46.51 78.7 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 123.863 0.865 . . . . 41.43 111.974 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.444 HD11 HG12 ' B' ' 6' ' ' VAL . 0.9 OUTLIER -67.9 -40.32 83.5 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 114.256 -1.338 . . . . 74.310000000000002 111.112 177.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.27 84.77 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.219 0.608 . . . . 73.5 112.102 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.509 HG13 HG21 ' B' ' 52' ' ' VAL . 55.3 t -65.87 -34.47 70.53 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.071 0.948 . . . . 64.319999999999993 110.601 174.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -65.71 -37.04 93.09 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 116.545 -0.298 . . . . 70.209999999999994 112.925 171.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.511 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 77.2 t-105 -67.18 -30.45 70.41 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.668 0.787 . . . . 75.310000000000002 111.474 175.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.5 -39.37 67.7 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.075 0.55 . . . . 73.510000000000005 110.936 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.9 -25.85 67.81 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.446 1.099 . . . . 74.430000000000007 113.397 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.619 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 16.5 ptt180 -58.93 -36.45 74.77 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.017 0.437 . . . . 61.219999999999999 111.015 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.619 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 43.8 mt-10 -104.75 3.18 31.02 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.686 1.194 . . . . 65.049999999999997 111.033 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.1 t30 58.88 35.86 24.38 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 125.396 1.478 . . . . 70.109999999999999 111.584 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -70.59 -17.11 62.91 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.479 -0.782 . . . . 63.450000000000003 111.044 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.509 HG21 HG13 ' B' ' 43' ' ' VAL . 24.9 m -131.68 153.29 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.283 1.033 . . . . 74.219999999999999 109.304 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.579 HG23 ' HB2' ' B' ' 64' ' ' TYR . 7.2 m -115.51 116.63 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.537 0.735 . . . . 71.030000000000001 110.15 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 48.5 mm -81.3 104.96 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.849 0.859 . . . . 63.329999999999998 110.217 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -119.45 108.43 14.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.351 0.66 . . . . 44.329999999999998 109.807 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.511 ' HB3' HG13 ' B' ' 61' ' ' ILE . 29.0 ptt180 -92.03 106.34 18.38 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.955 0.883 . . . . 74.530000000000001 110.484 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -103.63 127.83 51.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.988 1.315 . . . . 71.400000000000006 109.607 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 57.74 29.66 17.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.711 1.204 . . . . 72.049999999999997 111.505 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.2 -27.65 6.71 Favored Glycine 0 CA--C 1.546 1.976 0 CA-C-N 115.231 -0.895 . . . . 33.520000000000003 113.858 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.87 123.43 27.75 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.874 0.87 . . . . 61.409999999999997 110.795 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.511 HG13 ' HB3' ' B' ' 56' ' ' ARG . 2.8 mp -74.57 123.21 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 122.739 0.416 . . . . 73.310000000000002 110.128 -174.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -119.53 138.33 53.24 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.204 1.002 . . . . 73.549999999999997 109.752 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.432 HD11 HG13 ' B' ' 25' ' ' ILE . 2.2 mp -107.09 112.09 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.075 0.55 . . . . 75.109999999999999 110.031 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.579 ' HB2' HG23 ' B' ' 53' ' ' VAL . 85.9 m-85 -107.11 159.29 16.42 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.321 1.048 . . . . 63.520000000000003 110.52 174.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -82.51 171.55 13.99 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.957 0.725 . . . . 71.409999999999997 112.957 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 CA--C 1.56 1.356 0 C-N-CA 124.172 0.989 . . . . 74.329999999999998 112.694 171.072 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.0 mttt . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.614 0.245 . . . . 74.200000000000003 111.067 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.8 mt -62.86 -47.53 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.613 0.765 . . . . 75.420000000000002 111.627 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.42 -30.42 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.099 0.56 . . . . 73.120000000000005 111.264 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.93 -51.25 47.22 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.825 0.703 . . . . 63.020000000000003 112.269 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.42 81.83 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.844 0.858 . . . . 64.450000000000003 112.284 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -65.82 -29.47 69.95 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.507 0.723 . . . . 73.239999999999995 112.182 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.12 -44.88 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.033 0.533 . . . . 52.439999999999998 111.367 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.17 94.65 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.48 -0.648 . . . . 64.129999999999995 111.48 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -61.76 -50.01 74.11 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.328 1.051 . . . . 64.400000000000006 112.583 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.673 ' HA ' HG11 ' A' ' 32' ' ' VAL . 32.9 m -67.55 -29.54 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 120.656 0.265 . . . . 73.209999999999994 111.711 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.607 ' HA ' HD12 ' A' ' 17' ' ' LEU . 24.4 t90 -68.6 -32.83 73.0 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.286 0.634 . . . . 71.450000000000003 111.546 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -58.68 -36.84 74.84 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 122.813 0.445 . . . . 71.129999999999995 111.666 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.91 69.49 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.218 0.607 . . . . 75.349999999999994 112.162 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 14' ' ' TRP . 81.2 mt -66.54 -22.58 66.16 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.727 0.811 . . . . 72.25 112.194 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -64.58 -28.08 69.39 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.417 0.687 . . . . 71.129999999999995 111.463 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -77.01 -57.4 3.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.24 0.616 . . . . 75.049999999999997 110.521 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.34 107.6 3.27 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.481 0.712 . . . . 64.510000000000005 110.765 -174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 6.2 p-10 -95.72 164.57 12.7 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.509 0.724 . . . . 75.310000000000002 110.842 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.15 26.67 51.93 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 121.475 0.486 . . . . 73.209999999999994 112.128 -166.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 tt -96.63 153.71 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 124.46 1.104 . . . . 74.310000000000002 110.139 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -79.17 156.4 28.24 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.902 -0.499 . . . . 62.109999999999999 111.458 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.487 HG21 ' HB2' ' A' ' 40' ' ' ALA . 80.2 mt -56.32 -50.36 88.04 Favored Pre-proline 0 CA--C 1.575 1.908 0 C-N-CA 124.468 1.107 . . . . 64.430000000000007 113.908 -173.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.25 -24.07 38.18 Favored 'Trans proline' 0 C--N 1.394 2.93 0 CA-C-N 121.399 1.535 . . . . 73.209999999999994 114.049 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -76.5 -45.1 32.45 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.43 1.11 . . . . 71.530000000000001 109.683 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.442 HD22 HD11 ' A' ' 63' ' ' ILE . 63.1 tp -59.34 -40.6 86.91 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 113.129 -1.85 . . . . 74.400000000000006 111.09 172.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.15 81.82 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.325 1.05 . . . . 72.109999999999999 111.917 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -65.09 -40.87 95.2 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.626 0.77 . . . . 75.25 111.446 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -63.9 -40.82 97.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.153 0.581 . . . . 74.200000000000003 111.67 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.6 m -95.83 -1.93 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 112.966 0.728 . . . . 71.409999999999997 112.966 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.0 t30 68.02 13.64 9.17 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 124.483 1.113 . . . . 70.0 112.506 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -92.74 166.25 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.463 -0.773 . . . . 64.5 111.062 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.0 t -64.43 154.01 36.97 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.102 0.561 . . . . 65.439999999999998 111.701 171.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.38 -48.01 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.808 0.843 . . . . 71.400000000000006 110.615 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -62.6 -42.37 99.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.327 1.051 . . . . 73.340000000000003 111.676 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.494 ' HA ' HH21 ' B' ' 56' ' ' ARG . 67.7 m -65.48 -30.62 71.42 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.596 0.758 . . . . 31.440000000000001 112.256 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 43' ' ' VAL . 63.2 m -82.08 -43.01 18.42 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.784 0.834 . . . . 73.040000000000006 111.512 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.487 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -58.69 -50.81 72.52 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.001 0.921 . . . . 75.120000000000005 112.142 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -66.28 -32.48 73.92 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 114.087 -1.415 . . . . 71.349999999999994 110.831 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.35 -38.7 71.61 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.26 0.624 . . . . 73.519999999999996 111.961 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.569 HG11 HG21 ' A' ' 63' ' ' ILE . 69.3 t -64.89 -31.33 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.18 0.592 . . . . 61.109999999999999 110.835 175.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -58.79 -33.02 71.25 Favored Glycine 0 CA--C 1.544 1.858 0 CA-C-N 116.271 -0.422 . . . . 33.350000000000001 113.322 171.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -71.95 -30.63 65.5 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.543 0.737 . . . . 74.120000000000005 111.172 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.24 -38.79 71.94 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.675 0.39 . . . . 74.319999999999993 111.429 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.46 -34.95 78.88 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.562 0.745 . . . . 52.420000000000002 110.825 172.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.645 ' HG2' ' HB3' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -63.79 -43.97 94.75 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.013 1.325 . . . . 74.319999999999993 111.267 172.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -85.48 -1.14 56.74 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.606 0.762 . . . . 74.340000000000003 112.69 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 64.96 22.61 12.48 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.776 1.23 . . . . 75.109999999999999 112.729 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 61.5 mttp -77.49 -20.87 53.65 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.766 0.827 . . . . 72.010000000000005 112.454 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.92 154.74 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.48 0.657 . . . . 74.230000000000004 112.172 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 47.7 t -105.23 104.31 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.348 1.059 . . . . 71.129999999999995 109.065 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 mm -71.59 122.49 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 109.454 -0.572 . . . . 50.329999999999998 109.454 175.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.28 133.42 38.87 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.965 0.506 . . . . 74.200000000000003 110.385 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -116.94 141.91 47.63 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.402 0.681 . . . . 74.540000000000006 111.115 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 114.18 4.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.18 0.992 . . . . 74.450000000000003 109.892 -176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 54.07 30.81 12.58 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.4 1.08 . . . . 72.540000000000006 112.561 -173.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.26 -18.48 54.14 Favored Glycine 0 CA--C 1.545 1.968 0 CA-C-N 115.785 -0.643 . . . . 35.350000000000001 114.429 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -78.94 136.67 37.32 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.748 0.819 . . . . 63.310000000000002 111.275 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.1 mt -101.99 124.31 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 123.404 0.682 . . . . 73.340000000000003 111.081 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -123.48 124.92 43.93 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.895 1.278 . . . . 62.240000000000002 108.815 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.569 HG21 HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -106.09 112.0 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-O 122.152 0.977 . . . . 55.149999999999999 110.051 177.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 95.0 m-85 -90.15 175.65 7.07 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.083 0.953 . . . . 72.409999999999997 111.202 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.54 150.97 21.54 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.972 0.509 . . . . 72.239999999999995 109.911 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.912 0.387 . . . . 75.340000000000003 110.644 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.505 ' O ' HG22 ' B' ' 6' ' ' VAL . 40.5 ttmt . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 110.483 -0.191 . . . . 75.010000000000005 110.483 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -61.26 -13.12 16.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.793 1.034 . . . . 73.310000000000002 113.793 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 70.3 mt -55.69 -45.93 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.616 0.766 . . . . 75.409999999999997 111.47 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.505 HG22 ' O ' ' B' ' 3' ' ' LYS . 16.3 m -66.46 -25.76 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 122.173 0.189 . . . . 64.420000000000002 111.064 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.28 -38.75 91.84 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.583 0.552 . . . . 63.130000000000003 113.259 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 -40.4 95.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.256 0.622 . . . . 71.420000000000002 110.939 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -70.53 -30.08 66.74 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.4 -0.818 . . . . 74.120000000000005 111.613 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -76.68 -36.35 57.33 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.603 0.761 . . . . 63.130000000000003 111.521 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.23 -30.97 79.3 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 115.809 -0.632 . . . . 63.530000000000001 112.55 172.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' B' ' 32' ' ' VAL . 4.3 ttmp? -72.59 -52.49 15.28 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.915 0.886 . . . . 73.010000000000005 112.006 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' B' ' 10' ' ' ALA . 33.0 m -68.53 -36.47 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 112.489 0.551 . . . . 74.140000000000001 112.489 -174.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.578 ' HA ' HD12 ' B' ' 17' ' ' LEU . 31.2 t90 -74.16 -32.55 63.17 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 111.903 0.334 . . . . 72.239999999999995 111.903 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -64.55 -33.49 76.02 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.001 0.429 . . . . 72.239999999999995 110.537 173.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.22 -32.45 71.72 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.928 0.891 . . . . 73.25 112.037 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' B' ' 14' ' ' TRP . 70.6 mt -70.99 -46.33 62.49 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.995 0.918 . . . . 71.409999999999997 111.097 173.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -63.11 -25.16 68.23 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.031 0.932 . . . . 74.430000000000007 110.609 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -76.08 -52.81 9.37 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.53 -0.759 . . . . 74.109999999999999 110.45 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.56 99.41 2.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.719 0.807 . . . . 41.030000000000001 110.657 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -98.35 -178.78 4.14 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.755 0.822 . . . . 74.400000000000006 111.335 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.84 37.39 44.71 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.743 -0.543 . . . . 74.219999999999999 111.743 -171.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 tt -122.61 139.85 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.891 0.877 . . . . 74.319999999999993 111.352 -168.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 20.4 m -64.09 151.24 43.66 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.163 0.985 . . . . 72.040000000000006 111.582 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.583 HG12 HD11 ' B' ' 63' ' ' ILE . 54.3 mt -53.63 -49.34 89.38 Favored Pre-proline 0 CA--C 1.579 2.071 0 N-CA-C 112.806 0.669 . . . . 72.230000000000004 112.806 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.64 -25.71 24.23 Favored 'Trans proline' 0 C--N 1.399 3.201 0 C-N-CA 121.926 1.75 . . . . 73.150000000000006 114.539 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.57 -41.88 37.29 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.61 1.195 . . . . 72.400000000000006 109.703 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.3 tp -61.26 -40.1 92.82 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.113 -1.858 . . . . 70.040000000000006 110.72 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.72 73.46 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.829 0.852 . . . . 73.200000000000003 111.962 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 64.2 mtp85 -65.06 -50.02 67.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.659 0.784 . . . . 71.319999999999993 111.916 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -73.84 -24.16 59.73 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 112.127 0.417 . . . . 61.219999999999999 112.127 -176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' B' ' 13' ' ' VAL . 13.9 m -94.85 -3.39 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 112.039 0.385 . . . . 72.140000000000001 112.039 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 65.05 21.64 12.28 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.233 1.013 . . . . 62.140000000000001 112.797 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.6 mt -108.56 169.26 8.77 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.81 0.844 . . . . 72.230000000000004 110.87 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 51.7 m -74.85 163.16 27.96 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.652 0.381 . . . . 54.210000000000001 111.336 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.3 -51.49 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.56 0.744 . . . . 65.340000000000003 111.86 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.63 -38.92 92.14 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.196 0.598 . . . . 73.409999999999997 111.989 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 29.4 t -64.43 -39.1 93.19 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.429 0.692 . . . . 41.43 111.525 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.439 ' O ' HG23 ' B' ' 43' ' ' VAL . 86.6 m -71.03 -48.5 52.61 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.768 0.827 . . . . 50.149999999999999 110.973 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.62 -35.34 72.33 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.789 0.836 . . . . 43.420000000000002 112.378 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.11 -48.51 70.65 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.183 0.993 . . . . 74.349999999999994 109.81 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.38 -30.36 70.49 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.259 -0.882 . . . . 72.129999999999995 111.681 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 39' ' ' THR . 95.2 t -72.87 -31.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 123.006 0.523 . . . . 61.439999999999998 110.615 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -66.11 -27.96 73.31 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 116.26 -0.427 . . . . 63.530000000000001 112.8 172.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -75.46 -25.75 57.68 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.976 0.51 . . . . 74.400000000000006 111.48 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.509 HD11 HG23 ' B' ' 13' ' ' VAL . 96.6 mt -71.6 -27.08 62.88 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.081 0.552 . . . . 34.509999999999998 111.686 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.3 -32.78 62.72 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.317 1.229 . . . . 63.030000000000001 114.317 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.645 ' HB3' ' HG2' ' A' ' 48' ' ' ARG . 13.5 ptm180 -72.27 -30.15 64.56 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 119.069 0.849 . . . . 72.010000000000005 111.512 171.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.76 -19.27 52.64 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.299 0.64 . . . . 74.040000000000006 110.758 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 60.42 21.83 11.44 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.744 1.618 . . . . 70.010000000000005 112.749 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.89 5.55 45.81 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 112.878 0.696 . . . . 74.439999999999998 112.878 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.81 146.17 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.344 0.657 . . . . 74.140000000000001 112.576 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.633 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 66.6 t -118.78 109.95 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 124.49 1.116 . . . . 74.319999999999993 109.5 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 39.6 mm -91.92 121.58 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.714 0.805 . . . . 63.229999999999997 111.401 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -117.16 141.53 48.15 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.506 -0.746 . . . . 71.209999999999994 111.787 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.58 ' HG2' HG12 ' B' ' 61' ' ' ILE . 84.0 mtt85 -113.51 111.6 22.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.077 0.951 . . . . 74.420000000000002 110.203 169.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' B' ' 57' ' ' LYS . 0.3 OUTLIER -144.6 126.94 15.82 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.315 1.046 . . . . 74.549999999999997 109.304 -178.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 60.74 28.68 18.4 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 125.027 1.331 . . . . 62.119999999999997 111.63 -171.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.19 -0.89 61.93 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-N 116.287 -0.415 . . . . 72.400000000000006 113.79 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.72 131.16 43.69 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.143 0.977 . . . . 70.340000000000003 110.936 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.58 HG12 ' HG2' ' B' ' 56' ' ' ARG . 43.8 mt -97.12 122.29 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.129 0.572 . . . . 61.509999999999998 110.339 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -125.74 139.98 53.08 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.35 0.66 . . . . 70.040000000000006 110.014 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.583 HD11 HG12 ' B' ' 25' ' ' ILE . 2.9 mp -100.54 126.97 54.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.666 0.786 . . . . 74.340000000000003 109.517 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.633 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 7.8 m-85 -111.15 169.59 8.68 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.913 1.285 . . . . 65.420000000000002 109.86 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -90.2 155.65 18.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.797 0.439 . . . . 73.140000000000001 111.405 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.483 1.186 0 C-N-CA 123.684 0.794 . . . . 74.349999999999994 110.428 173.126 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 112.74 0.644 . . . . 74.120000000000005 112.74 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -61.17 -47.64 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.444 0.698 . . . . 62.200000000000003 111.521 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.8 m -61.27 -28.06 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 122.519 0.328 . . . . 73.150000000000006 111.39 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.461 ' HA2' ' CD1' ' A' ' 45' ' ' TRP . . . -69.25 -49.68 37.97 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.544 0.528 . . . . 74.420000000000002 113.501 173.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.18 93.65 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.668 0.787 . . . . 74.129999999999995 112.382 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -75.03 -28.9 60.63 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.245 0.618 . . . . 63.130000000000003 112.339 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.99 82.6 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 112.464 0.542 . . . . 71.510000000000005 112.464 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.03 -34.54 81.93 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 116.413 -0.358 . . . . 72.019999999999996 113.127 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -67.17 -45.87 75.71 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.78 0.832 . . . . 43.240000000000002 110.644 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.594 ' HA ' HG11 ' A' ' 32' ' ' VAL . 63.8 t -60.97 -40.8 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 123.898 0.879 . . . . 64.549999999999997 111.212 175.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -64.67 -35.64 81.7 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.97 -0.559 . . . . 74.540000000000006 111.065 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.443 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 80.6 t60 -62.9 -44.81 95.09 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.78 0.432 . . . . 61.229999999999997 111.249 176.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.657 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -67.46 -32.51 73.41 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.525 0.679 . . . . 33.340000000000003 111.284 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.515 HD11 ' HA ' ' A' ' 65' ' ' ASN . 2.8 tm? -73.48 -29.92 62.82 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.925 1.29 . . . . 74.510000000000005 110.874 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -75.07 -47.15 30.25 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.96 0.904 . . . . 70.129999999999995 111.59 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 22.9 mm-40 -61.04 -33.19 72.9 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.13 0.572 . . . . 71.510000000000005 111.683 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.08 112.43 0.99 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.243 1.017 . . . . 74.450000000000003 109.54 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.8 178.4 5.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.25 0.62 . . . . 72.25 112.256 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.57 39.61 86.58 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 110.534 -1.026 . . . . 45.509999999999998 110.534 -167.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 tp -114.13 114.41 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 124.393 1.077 . . . . 75.010000000000005 110.044 -169.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -58.72 144.98 41.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.264 0.625 . . . . 62.25 112.594 -170.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.582 HG21 ' HB2' ' A' ' 40' ' ' ALA . 57.6 mt -55.38 -46.19 99.74 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 113.847 1.054 . . . . 63.409999999999997 113.847 -170.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HA ' HG22 ' A' ' 36' ' ' VAL . 32.6 Cg_endo -63.09 -25.05 73.25 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 121.819 1.679 . . . . 65.329999999999998 114.177 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -80.16 -55.15 5.13 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.994 0.739 . . . . 64.439999999999998 112.994 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -66.61 -26.03 66.89 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.45 0.568 . . . . 65.340000000000003 111.37 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.39 -37.31 16.57 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.745 0.818 . . . . 73.420000000000002 112.806 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -74.28 -35.02 63.73 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.305 0.642 . . . . 74.209999999999994 111.955 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.657 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 51.9 mtmt -67.06 -31.19 71.53 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 122.807 0.443 . . . . 62.420000000000002 111.513 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 13' ' ' VAL . 27.3 m -97.7 -9.47 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.701 0.801 . . . . 25.32 112.36 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.4 t30 64.7 28.11 13.08 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.347 1.459 . . . . 73.420000000000002 112.167 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.81 164.91 11.57 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.878 0.871 . . . . 61.0 111.198 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.7 m -65.21 153.11 41.94 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.139 0.576 . . . . 42.130000000000003 111.156 172.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 26' ' ' PRO . 64.6 t -53.97 -51.07 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.49 0.716 . . . . 24.109999999999999 111.104 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.591 ' HB2' HG13 ' B' ' 61' ' ' ILE . 36.3 mt-10 -60.32 -41.37 93.35 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.497 1.119 . . . . 54.039999999999999 112.557 176.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.8 m -62.28 -37.58 86.06 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 123.366 0.666 . . . . 73.409999999999997 111.798 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 43' ' ' VAL . 88.2 m -71.78 -46.51 58.08 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.559 0.743 . . . . 53.439999999999998 111.182 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.582 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.72 -37.81 83.0 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 123.615 0.766 . . . . 70.400000000000006 112.493 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.69 -41.91 71.36 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.276 1.031 . . . . 71.109999999999999 110.554 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -31.85 73.18 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.158 0.583 . . . . 63.109999999999999 111.686 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 39' ' ' THR . 41.4 t -59.23 -35.69 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.899 0.88 . . . . 74.099999999999994 111.351 170.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -63.75 -32.28 83.64 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 114.049 0.38 . . . . 70.019999999999996 114.049 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.478 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 69.9 t-105 -73.89 -26.98 60.83 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.127 0.571 . . . . 75.019999999999996 111.361 175.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.98 -39.36 63.73 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 122.79 0.436 . . . . 70.430000000000007 111.173 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.87 69.81 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.261 1.024 . . . . 74.219999999999999 113.376 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 45' ' ' TRP . 5.7 ppt_? -71.45 -12.69 61.53 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.021 0.378 . . . . 63.350000000000001 112.021 174.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -110.35 -8.47 14.7 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.321 1.048 . . . . 73.329999999999998 111.915 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 63.51 28.73 15.35 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.625 1.17 . . . . 74.099999999999994 112.834 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -69.37 -13.9 62.62 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.375 0.67 . . . . 73.310000000000002 112.046 171.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.711 ' HB ' HD11 ' A' ' 63' ' ' ILE . 31.0 m -133.92 155.47 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.924 0.89 . . . . 72.239999999999995 110.855 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 64' ' ' TYR . 31.2 m -127.37 143.19 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.179 0.991 . . . . 74.200000000000003 109.499 173.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.0 mt -120.72 134.57 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.186 0.595 . . . . 64.310000000000002 110.717 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -120.63 127.13 51.79 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.757 0.823 . . . . 62.140000000000001 111.409 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.508 ' HG2' HG12 ' A' ' 61' ' ' ILE . 84.8 mtt180 -95.45 102.62 14.43 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.209 0.528 . . . . 73.299999999999997 110.181 170.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -108.56 123.19 48.53 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.789 0.836 . . . . 71.549999999999997 109.99 178.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 55.98 29.38 14.22 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.792 1.237 . . . . 70.209999999999994 112.082 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.95 -25.92 9.24 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 114.116 -174.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.77 141.04 39.48 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.617 0.767 . . . . 75.129999999999995 111.195 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.508 HG12 ' HG2' ' A' ' 56' ' ' ARG . 32.2 mt -93.37 133.96 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.337 0.655 . . . . 65.030000000000001 111.791 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -132.17 139.74 48.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.999 0.92 . . . . 64.109999999999999 110.286 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.711 HD11 ' HB ' ' A' ' 52' ' ' VAL . 6.8 tp -102.49 126.28 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.35 0 CA-C-O 121.772 0.796 . . . . 63.100000000000001 111.487 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.454 ' HB2' HG23 ' A' ' 53' ' ' VAL . 89.6 m-85 -118.11 169.28 9.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.186 1.394 . . . . 74.129999999999995 111.45 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.515 ' HA ' HD11 ' A' ' 17' ' ' LEU . 28.6 t-20 -81.38 145.97 30.55 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.663 0.785 . . . . 72.420000000000002 110.671 175.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.422 ' HA ' HG13 ' A' ' 53' ' ' VAL . 10.9 pt-20 . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 115.521 1.675 . . . . 62.229999999999997 115.521 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 112.363 0.505 . . . . 74.129999999999995 112.363 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -74.03 -48.58 29.07 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.909 0.884 . . . . 54.109999999999999 111.297 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 65.3 mt -59.08 -60.0 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 114.935 -1.03 . . . . 71.5 111.844 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 m -59.4 -29.13 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.22 1.008 . . . . 71.25 112.65 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.72 -43.29 85.09 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 123.285 0.366 . . . . 75.510000000000005 112.758 173.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.28 96.67 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.919 0.887 . . . . 70.400000000000006 112.083 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -67.1 -40.95 86.99 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.051 0.54 . . . . 74.540000000000006 111.26 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.33 77.46 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.622 0.769 . . . . 64.430000000000007 112.808 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.62 -38.56 96.61 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 123.501 0.501 . . . . 34.039999999999999 112.853 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -69.29 -46.51 67.0 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.715 0.806 . . . . 71.230000000000004 111.792 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.604 ' HA ' HG11 ' B' ' 32' ' ' VAL . 72.7 t -59.25 -45.9 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.52 0.728 . . . . 74.040000000000006 111.644 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.6 ' HA ' HD12 ' B' ' 17' ' ' LEU . 21.1 t90 -68.45 -32.45 72.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.895 -0.593 . . . . 55.439999999999998 111.537 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . 0.408 ' HA ' ' OD1' ' B' ' 18' ' ' ASN . 8.1 t60 -59.01 -35.74 73.77 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.26 0.553 . . . . 70.340000000000003 110.834 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.03 -29.62 63.12 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.964 0.905 . . . . 51.530000000000001 112.093 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' B' ' 14' ' ' TRP . 84.7 mt -73.18 -39.86 65.26 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.067 0.947 . . . . 72.430000000000007 112.745 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' B' ' 15' ' ' HIS . 2.0 p-10 -74.64 -14.78 60.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.897 -0.502 . . . . 73.430000000000007 111.427 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.18 -45.59 16.15 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.337 0.655 . . . . 71.019999999999996 110.007 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.33 98.6 1.28 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.876 0.87 . . . . 75.239999999999995 110.599 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -85.93 159.99 19.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.29 0.636 . . . . 75.049999999999997 111.224 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.61 64.77 1.6 Allowed Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.555 -0.293 . . . . 45.32 112.634 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 tt -146.38 139.91 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.6 0.76 . . . . 75.0 110.841 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 37.5 m -62.8 145.79 54.12 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.756 0.423 . . . . 74.340000000000003 111.495 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.569 HD12 ' HB3' ' A' ' 37' ' ' GLU . 61.1 mt -52.28 -50.39 79.7 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 114.226 1.195 . . . . 62.130000000000003 114.226 -175.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.09 -23.44 39.9 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 121.828 1.685 . . . . 74.510000000000005 114.504 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -75.08 -52.43 11.06 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.141 0.972 . . . . 73.109999999999999 109.177 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -54.68 -37.1 65.35 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 113.122 -1.854 . . . . 75.219999999999999 112.048 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.65 95.38 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.3 1.04 . . . . 62.439999999999998 112.471 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -72.07 -28.7 63.49 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.264 0.625 . . . . 74.150000000000006 111.954 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.54 -35.03 65.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.414 0.686 . . . . 74.540000000000006 111.433 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' B' ' 13' ' ' VAL . 31.6 m -95.54 1.68 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.48 0.712 . . . . 50.240000000000002 112.109 177.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 61.9 16.27 7.89 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 124.553 1.141 . . . . 75.5 113.739 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 60.6 mt -102.66 158.37 16.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.752 0.821 . . . . 74.340000000000003 110.005 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 50.8 m -63.46 156.38 26.35 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.577 0.351 . . . . 64.239999999999995 111.313 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.0 t -49.4 -48.28 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 123.849 0.86 . . . . 62.219999999999999 111.713 171.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.62 -36.85 81.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.12 -0.946 . . . . 72.239999999999995 111.258 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -63.58 -43.04 98.15 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.461 0.704 . . . . 42.420000000000002 111.703 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.456 ' O ' HG23 ' B' ' 43' ' ' VAL . 92.1 m -74.71 -46.97 34.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.91 0.884 . . . . 74.510000000000005 111.445 -174.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -59.72 -46.12 90.09 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 124.235 1.014 . . . . 74.310000000000002 112.302 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -71.77 -35.22 69.99 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.672 -1.149 . . . . 75.25 111.001 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.84 81.89 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 122.574 0.349 . . . . 52.200000000000003 111.182 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.734 HG11 HD12 ' B' ' 63' ' ' ILE . 68.9 t -65.44 -31.87 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 123.585 0.754 . . . . 72.420000000000002 110.939 170.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -64.63 -33.57 87.58 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.909 -0.132 . . . . 73.140000000000001 113.425 171.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.484 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 73.8 t-105 -73.9 -29.78 62.24 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.479 0.712 . . . . 74.439999999999998 111.181 173.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.36 -34.58 70.58 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.839 0.456 . . . . 64.340000000000003 110.711 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.33 67.41 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.285 1.034 . . . . 74.400000000000006 111.753 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 20.1 ttt85 -56.68 -51.36 69.08 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.327 0.584 . . . . 74.200000000000003 110.882 167.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -80.07 -7.66 58.99 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.404 -0.816 . . . . 61.219999999999999 111.666 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 63.7 t30 63.91 32.9 12.92 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.577 1.551 . . . . 51.210000000000001 111.424 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -88.2 -1.68 58.16 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.744 0.818 . . . . 75.140000000000001 111.952 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.86 162.4 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.583 0.753 . . . . 73.549999999999997 112.306 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' B' ' 64' ' ' TYR . 11.7 m -128.22 156.79 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 124.45 1.1 . . . . 75.430000000000007 110.371 167.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 36.6 mm -116.97 119.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.447 0.699 . . . . 74.519999999999996 110.272 -175.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -115.49 115.02 25.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.147 0.579 . . . . 75.319999999999993 110.884 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -84.42 97.6 9.6 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.037 -0.727 . . . . 51.530000000000001 109.037 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.16 108.28 19.71 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.872 0.869 . . . . 63.0 110.163 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 54.65 31.45 15.22 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.369 1.067 . . . . 75.120000000000005 112.46 -173.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.77 -16.21 61.62 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-N 115.851 -0.613 . . . . 42.210000000000001 114.012 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -81.63 134.27 35.46 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.579 0.752 . . . . 63.240000000000002 110.845 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.591 HG13 ' HB2' ' A' ' 37' ' ' GLU . 23.1 mm -90.8 105.96 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.05 0.54 . . . . 65.129999999999995 109.816 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -115.72 130.5 56.87 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.845 0.858 . . . . 71.400000000000006 110.901 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.734 HD12 HG11 ' B' ' 43' ' ' VAL . 26.6 mm -93.22 115.7 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.052 0.941 . . . . 60.140000000000001 110.874 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.595 ' HB2' HG23 ' B' ' 53' ' ' VAL . 33.0 m-85 -107.06 158.98 16.65 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.005 0.922 . . . . 75.200000000000003 110.048 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -91.19 150.26 21.44 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.352 0.661 . . . . 62.240000000000002 109.6 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.551 ' HG2' HG13 ' B' ' 53' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 121.472 0.653 . . . . 72.209999999999994 110.664 176.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 111.454 0.168 . . . . 71.510000000000005 111.454 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.2 mt -61.04 -60.33 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.181 0.592 . . . . 45.100000000000001 110.792 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 41' ' ' LEU . 34.8 m -64.0 -32.27 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.556 1.142 . . . . 35.549999999999997 112.192 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.6 69.8 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 123.353 0.408 . . . . 74.140000000000001 112.687 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.63 94.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.647 0.779 . . . . 43.210000000000001 111.651 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.39 -40.45 89.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.642 0.777 . . . . 51.030000000000001 111.421 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.84 -34.49 78.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.204 0.601 . . . . 61.119999999999997 111.913 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.77 -39.05 96.34 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 116.279 -0.419 . . . . 44.219999999999999 113.182 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -75.19 -41.12 58.62 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.752 0.821 . . . . 74.200000000000003 111.924 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.578 ' HA ' HG11 ' A' ' 32' ' ' VAL . 59.2 t -67.24 -45.5 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.496 0.719 . . . . 72.420000000000002 111.322 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.572 ' HA ' HD12 ' A' ' 17' ' ' LEU . 47.5 t90 -64.42 -34.63 78.62 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.504 0.502 . . . . 62.43 111.158 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -60.93 -45.09 96.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.362 0.665 . . . . 65.010000000000005 111.125 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -69.69 -36.17 75.74 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.753 -0.658 . . . . 74.319999999999993 111.654 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 14' ' ' TRP . 33.5 mt -59.51 -43.49 93.37 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.545 0.738 . . . . 75.409999999999997 111.474 175.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -59.34 -24.75 63.62 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.255 1.022 . . . . 63.530000000000001 112.254 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -66.02 -42.71 89.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.854 0.862 . . . . 74.329999999999998 111.062 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.73 110.57 2.19 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.44 0.696 . . . . 72.340000000000003 111.327 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -77.55 162.98 26.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.628 0.771 . . . . 73.219999999999999 111.27 174.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.87 61.91 3.15 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.999 -0.441 . . . . 71.430000000000007 111.999 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 tt -141.38 135.98 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.661 0.784 . . . . 62.439999999999998 111.06 -171.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -69.57 152.94 44.17 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.22 0.608 . . . . 65.25 111.413 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 40' ' ' ALA . 57.0 mt -56.38 -47.11 99.53 Favored Pre-proline 0 CA--C 1.58 2.123 0 N-CA-C 113.458 0.91 . . . . 41.140000000000001 113.458 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 55.9 Cg_endo -66.13 -30.29 46.91 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 122.145 1.896 . . . . 64.129999999999995 113.925 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.63 -46.52 66.0 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.422 1.105 . . . . 73.230000000000004 109.839 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.32 -36.87 78.92 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 113.152 -1.84 . . . . 70.299999999999997 112.175 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.3 80.21 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.567 0.747 . . . . 62.350000000000001 112.431 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 26' ' ' PRO . 2.8 mpt_? -69.69 -38.73 77.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.807 0.443 . . . . 61.229999999999997 111.447 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.43 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 40.8 mtmt -64.0 -41.77 97.37 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.538 0.335 . . . . 71.239999999999995 111.655 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 13' ' ' VAL . 22.4 m -84.24 -10.81 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.096 0.559 . . . . 62.43 111.573 175.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 69.26 16.9 8.38 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 125.53 1.532 . . . . 73.439999999999998 112.048 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.421 ' H ' HG23 ' A' ' 32' ' ' VAL . 70.2 mt -99.68 175.61 5.75 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.837 0.855 . . . . 61.409999999999997 110.604 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 t -76.99 159.25 30.07 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.144 0.577 . . . . 64.329999999999998 111.524 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -57.87 -44.69 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.091 0.556 . . . . 71.209999999999994 111.51 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.79 -46.37 89.83 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.752 0.821 . . . . 73.230000000000004 112.02 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.8 p -69.0 -30.82 69.29 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.209 0.604 . . . . 64.140000000000001 112.063 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . 96.7 m -74.92 -48.45 24.52 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.351 0.661 . . . . 73.420000000000002 111.248 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -61.77 -36.82 82.16 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 123.992 0.917 . . . . 31.050000000000001 111.831 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.651 HD11 HG12 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -61.33 -43.07 99.49 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.91 1.284 . . . . 74.230000000000004 110.802 173.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.59 71.73 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.228 0.611 . . . . 73.450000000000003 112.296 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.451 HG11 HD12 ' A' ' 63' ' ' ILE . 86.3 t -69.41 -33.73 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.33 0.652 . . . . 52.109999999999999 110.86 175.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.74 -32.7 85.08 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-N 116.501 -0.318 . . . . 55.219999999999999 112.745 172.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.419 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 71.5 t-105 -74.02 -31.1 62.77 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.606 0.762 . . . . 74.120000000000005 111.333 173.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.3 -34.89 75.38 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.727 0.411 . . . . 72.420000000000002 111.156 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.59 -28.95 69.72 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.37 0.668 . . . . 74.540000000000006 112.101 173.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' B' ' 48' ' ' ARG . 22.9 ttt180 -59.85 -51.16 70.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.763 0.825 . . . . 60.020000000000003 112.111 175.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -90.99 13.57 16.32 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.408 -0.815 . . . . 51.43 112.04 -173.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 51.33 47.45 24.82 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.001 1.32 . . . . 52.350000000000001 112.08 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -87.54 -32.95 19.11 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.757 -1.11 . . . . 64.329999999999998 111.921 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -132.74 148.27 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.637 0.775 . . . . 51.229999999999997 112.058 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG13 ' HG2' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -113.55 107.33 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.595 0.758 . . . . 63.229999999999997 108.957 171.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.48 HG23 HD13 ' A' ' 63' ' ' ILE . 60.1 mt -88.94 114.6 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 109.16 -0.681 . . . . 73.129999999999995 109.16 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -102.74 117.42 34.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.21 0.604 . . . . 75.329999999999998 111.107 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -81.9 108.18 15.21 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.957 -0.386 . . . . 72.450000000000003 109.957 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -104.09 106.15 16.56 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.658 0.783 . . . . 64.530000000000001 109.003 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 54.81 31.85 16.44 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 124.336 1.054 . . . . 73.430000000000007 112.423 -169.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.93 -20.12 50.64 Favored Glycine 0 CA--C 1.542 1.769 0 N-CA-C 114.408 0.523 . . . . 50.32 114.408 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.79 134.95 43.47 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.743 0.817 . . . . 74.209999999999994 111.076 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.25 103.78 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 122.995 0.518 . . . . 74.099999999999994 109.884 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -118.72 121.83 41.03 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.949 0.9 . . . . 72.329999999999998 109.914 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 54' ' ' ILE . 10.5 mm -91.96 120.93 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.214 0.606 . . . . 71.019999999999996 111.938 -169.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -108.84 163.14 13.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.489 0.715 . . . . 73.209999999999994 111.043 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 11.1 m-20 -91.33 155.26 18.64 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.428 -0.806 . . . . 74.420000000000002 108.921 171.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.449 ' HG2' HG13 ' A' ' 53' ' ' VAL . 50.9 mt-10 . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 121.758 0.79 . . . . 74.430000000000007 110.022 169.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 120.732 0.301 . . . . 75.540000000000006 111.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -91.26 -41.82 10.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.077 0.951 . . . . 62.5 111.827 170.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.49 -45.33 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 122.993 0.517 . . . . 74.010000000000005 111.876 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.03 -26.84 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 122.633 0.373 . . . . 71.109999999999999 111.811 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.2 -48.36 80.24 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.135 0.272 . . . . 54.450000000000003 112.869 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.79 -43.28 93.72 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.601 0.76 . . . . 73.109999999999999 111.609 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.85 -36.53 80.48 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.169 0.988 . . . . 72.540000000000006 111.532 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.427 ' HA ' ' HB1' ' B' ' 42' ' ' ALA . . . -68.69 -39.66 80.44 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.099 0.56 . . . . 71.239999999999995 110.914 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.74 -45.98 92.79 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.68 -0.691 . . . . 75.409999999999997 112.341 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -63.28 -41.95 99.05 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.425 1.09 . . . . 62.210000000000001 111.845 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.694 ' HA ' HG11 ' B' ' 32' ' ' VAL . 72.8 t -65.14 -37.05 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.775 0.83 . . . . 63.439999999999998 111.622 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -74.04 -33.49 63.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.208 0.603 . . . . 75.209999999999994 111.587 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -60.84 -30.7 70.26 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.92 0.488 . . . . 75.109999999999999 111.353 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.71 69.96 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.191 0.596 . . . . 44.119999999999997 112.466 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.489 ' HB3' ' ND2' ' B' ' 65' ' ' ASN . 53.3 mt -63.49 -34.24 77.33 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.262 0.625 . . . . 75.109999999999999 112.51 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.75 -25.7 66.67 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.3 0.64 . . . . 63.549999999999997 111.729 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.92 -41.03 8.2 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.734 0.813 . . . . 61.350000000000001 111.077 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' B' ' 17' ' ' LEU . . . -153.75 141.28 19.83 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.405 0.682 . . . . 50.32 111.808 -171.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -127.08 168.97 13.9 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.616 0.766 . . . . 65.420000000000002 111.129 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.8 10.24 64.02 Favored Glycine 0 N--CA 1.474 1.167 0 N-CA-C 114.596 0.598 . . . . 71.109999999999999 114.596 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.3 tt -86.26 132.02 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 123.465 0.706 . . . . 75.329999999999998 110.809 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -71.89 158.35 36.21 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.518 0.562 . . . . 45.340000000000003 112.518 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.551 HG21 ' HB2' ' B' ' 40' ' ' ALA . 73.9 mt -56.33 -43.3 99.23 Favored Pre-proline 0 CA--C 1.582 2.177 0 N-CA-C 115.274 1.583 . . . . 73.349999999999994 115.274 -169.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.54 -31.6 33.28 Favored 'Trans proline' 0 C--N 1.392 2.863 0 CA-C-N 122.448 1.91 . . . . 75.319999999999993 114.207 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -77.86 -41.32 37.23 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.313 1.054 . . . . 73.120000000000005 110.102 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.42 -39.61 84.06 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 113.206 -1.816 . . . . 52.25 111.125 171.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.01 88.91 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.985 0.914 . . . . 63.100000000000001 111.648 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -60.92 -43.42 98.59 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.584 0.754 . . . . 73.530000000000001 111.498 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -71.27 -37.97 71.88 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.284 0.634 . . . . 74.439999999999998 111.934 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.694 HG11 ' HA ' ' B' ' 13' ' ' VAL . 13.1 m -93.32 5.53 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.047 0.539 . . . . 61.020000000000003 112.15 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.4 t30 68.46 9.53 7.33 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.574 1.149 . . . . 74.209999999999994 113.303 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 47.8 mt -102.98 174.25 5.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.611 -0.68 . . . . 72.439999999999998 111.463 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 39.3 t -72.94 157.84 36.65 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.915 0.486 . . . . 73.209999999999994 111.264 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.14 -41.39 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.22 0.608 . . . . 71.230000000000004 111.198 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.19 -48.44 75.9 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.533 0.733 . . . . 74.109999999999999 112.207 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -71.04 -29.97 66.03 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.292 0.637 . . . . 62.530000000000001 111.98 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.422 ' O ' HG23 ' B' ' 43' ' ' VAL . 95.5 m -72.77 -46.23 54.46 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.182 0.593 . . . . 74.430000000000007 110.487 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.551 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -60.05 -36.35 77.1 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.528 0.731 . . . . 74.019999999999996 111.927 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -51.13 66.61 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.278 1.031 . . . . 71.329999999999998 109.606 174.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.427 ' HB1' ' HA ' ' B' ' 10' ' ' ALA . . . -61.39 -30.77 70.76 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.009 -0.996 . . . . 64.230000000000004 111.695 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.422 HG23 ' O ' ' B' ' 39' ' ' THR . 49.0 t -68.45 -37.51 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.76 0.824 . . . . 64.010000000000005 110.66 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.47 -33.3 86.04 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.216 -0.447 . . . . 53.420000000000002 113.037 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.437 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 61.9 t-105 -74.44 -25.63 59.55 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.398 0.679 . . . . 73.040000000000006 111.338 175.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.92 -36.73 70.04 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.875 0.47 . . . . 73.099999999999994 111.284 169.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.21 -33.02 75.01 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.959 0.503 . . . . 64.030000000000001 110.685 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.497 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 2.3 tmt_? -59.35 -45.29 91.82 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.246 1.018 . . . . 65.530000000000001 111.504 173.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.421 ' HG3' ' HD3' ' B' ' 48' ' ' ARG . 37.6 mt-10 -84.79 2.38 42.5 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.46 0.704 . . . . 60.299999999999997 112.508 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 63.2 22.41 13.35 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.148 1.379 . . . . 62.399999999999999 112.808 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -102.42 7.96 40.24 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.907 1.077 . . . . 45.200000000000003 113.907 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.403 HG12 HD11 ' B' ' 17' ' ' LEU . 20.9 m -131.87 151.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 123.093 0.557 . . . . 71.430000000000007 111.102 171.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 t -105.36 102.41 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.498 0.719 . . . . 74.349999999999994 109.492 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 27.8 mm -77.69 114.7 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 122.987 0.515 . . . . 43.119999999999997 110.274 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.18 156.5 38.33 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.89 0.876 . . . . 64.430000000000007 111.843 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -118.12 107.56 14.12 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.958 0.903 . . . . 73.010000000000005 110.864 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -119.07 129.86 55.3 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.02 0.528 . . . . 71.310000000000002 110.125 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 62.72 30.45 16.82 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.528 1.131 . . . . 73.530000000000001 112.115 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.05 12.97 81.33 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 115.979 -0.555 . . . . 73.239999999999995 113.465 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -122.52 136.66 54.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.178 0.991 . . . . 71.099999999999994 110.378 -172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mp -80.51 122.36 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 123.012 0.525 . . . . 75.030000000000001 110.244 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -124.94 132.36 53.3 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.278 1.031 . . . . 74.519999999999996 110.019 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 pp -100.06 126.53 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.434 0.694 . . . . 74.430000000000007 111.932 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -108.52 166.47 10.76 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.207 0.603 . . . . 61.530000000000001 111.252 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.489 ' ND2' ' HB3' ' B' ' 17' ' ' LEU . 15.0 m120 -67.43 141.45 57.01 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.632 0.773 . . . . 72.519999999999996 111.461 176.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 114.512 1.301 . . . . 72.439999999999998 114.512 178.647 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt . . . . . 0 CA--C 1.56 1.351 0 N-CA-C 112.682 0.623 . . . . 74.549999999999997 112.682 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -58.28 -55.52 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.158 0.583 . . . . 73.319999999999993 110.802 171.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.6 m -67.31 -25.54 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 122.682 0.393 . . . . 72.430000000000007 111.232 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.491 ' HA2' ' NE1' ' A' ' 45' ' ' TRP . . . -68.27 -41.39 86.15 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 116.676 -0.238 . . . . 70.439999999999998 113.646 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.01 -54.84 13.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.822 0.849 . . . . 71.200000000000003 112.031 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -68.07 -19.68 64.89 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 112.793 0.664 . . . . 72.010000000000005 112.793 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 13' ' ' VAL . . . -69.32 -28.05 65.91 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.623 0.769 . . . . 24.399999999999999 112.205 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.68 -42.64 93.17 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 116.762 -0.199 . . . . 63.329999999999998 113.391 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -66.81 -46.65 74.51 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.797 0.839 . . . . 74.200000000000003 112.081 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.537 ' HA ' HG11 ' A' ' 32' ' ' VAL . 10.6 p -69.13 -32.17 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.533 0.333 . . . . 63.100000000000001 111.708 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.475 ' NE1' ' HB3' ' A' ' 51' ' ' LYS . 66.9 t90 -72.14 -33.94 68.16 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.067 0.547 . . . . 72.409999999999997 111.328 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -61.49 -35.24 77.1 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.384 0.673 . . . . 73.230000000000004 111.315 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.41 -32.44 73.88 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.581 0.753 . . . . 42.049999999999997 112.088 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 14' ' ' TRP . 50.9 mt -73.66 -33.04 64.3 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.869 0.867 . . . . 75.319999999999993 112.131 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -62.91 -33.26 74.95 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.208 0.603 . . . . 74.510000000000005 111.76 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -75.3 -54.3 7.32 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.283 0.633 . . . . 62.439999999999998 110.11 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.45 99.13 2.17 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.599 -0.728 . . . . 65.25 110.899 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.529 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 9.9 p-10 -93.5 150.84 20.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.7 0.4 . . . . 74.209999999999994 109.952 173.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.08 63.19 1.15 Allowed Glycine 0 N--CA 1.469 0.855 0 N-CA-C 110.758 -0.937 . . . . 61.329999999999998 110.758 -167.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.4 tt -145.17 125.44 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.479 1.112 . . . . 73.530000000000001 109.605 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.0 m -57.09 149.27 19.69 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.032 0.933 . . . . 63.229999999999997 112.097 -176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.618 HG12 HD11 ' A' ' 63' ' ' ILE . 21.2 mt -53.88 -48.07 94.88 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 113.419 0.896 . . . . 51.229999999999997 113.419 -174.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.46 -24.0 14.48 Favored 'Trans proline' 0 C--N 1.398 3.17 0 C-N-CA 121.881 1.721 . . . . 74.540000000000006 114.732 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -71.79 -45.86 60.21 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 123.037 1.398 . . . . 70.420000000000002 108.939 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 32' ' ' VAL . 60.5 tp -65.11 -40.14 94.11 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 112.443 -2.162 . . . . 72.519999999999996 111.466 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.25 93.93 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.048 0.939 . . . . 61.329999999999998 112.306 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -70.02 -39.26 75.92 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.287 0.635 . . . . 75.040000000000006 111.004 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -59.19 -52.12 67.07 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.577 0.751 . . . . 70.430000000000007 111.563 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 13' ' ' VAL . 24.9 m -85.89 0.37 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.357 0.663 . . . . 72.140000000000001 112.035 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 62.43 15.02 7.41 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 125.149 1.38 . . . . 73.140000000000001 114.196 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.7 mt -90.81 159.82 16.08 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.325 0.65 . . . . 63.420000000000002 110.0 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -66.66 151.86 46.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.486 0.314 . . . . 73.209999999999994 110.882 169.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.1 t -52.67 -47.03 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 123.835 0.854 . . . . 75.140000000000001 112.064 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.456 ' HB3' HD12 ' B' ' 25' ' ' ILE . 46.2 mt-10 -59.78 -44.63 93.81 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.726 0.81 . . . . 74.430000000000007 112.277 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.0 m -62.58 -36.74 83.68 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.722 0.809 . . . . 64.209999999999994 111.855 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -70.49 -52.34 22.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.786 0.835 . . . . 74.400000000000006 110.936 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' HD13 ' A' ' 25' ' ' ILE . . . -59.98 -33.91 72.6 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.801 0.84 . . . . 72.319999999999993 112.302 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -51.24 49.5 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.184 0.994 . . . . 74.310000000000002 110.354 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.94 70.06 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.331 -0.85 . . . . 52.229999999999997 111.686 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.22 -38.82 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 115.581 -0.736 . . . . 65.109999999999999 110.939 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.28 -28.06 72.47 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-O 121.116 0.287 . . . . 73.409999999999997 112.877 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.491 ' NE1' ' HA2' ' A' ' 7' ' ' GLY . 77.0 t-105 -70.02 -41.53 74.17 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.099 0.96 . . . . 72.519999999999996 111.265 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 76.4 mt -67.01 -34.09 76.99 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.512 0.725 . . . . 63.25 111.619 175.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.33 -27.22 63.93 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.361 1.064 . . . . 51.219999999999999 113.326 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -58.77 -31.87 68.76 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 112.244 0.461 . . . . 74.219999999999999 112.244 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -122.02 26.67 8.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.663 1.185 . . . . 64.420000000000002 111.063 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 61.43 22.61 12.99 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.329 1.451 . . . . 74.140000000000001 114.117 169.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 61.9 mttm -74.09 -18.05 60.87 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.85 0.685 . . . . 73.200000000000003 112.85 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.16 150.77 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.473 0.709 . . . . 74.219999999999999 111.93 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 42.5 t -107.7 123.93 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.991 0.917 . . . . 75.209999999999994 108.904 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.437 HG23 HG23 ' A' ' 61' ' ' ILE . 48.6 mm -103.81 118.66 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.595 0.758 . . . . 72.540000000000006 111.106 -173.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -124.61 112.05 16.35 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.298 0.639 . . . . 75.209999999999994 111.138 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.462 ' HG2' HG12 ' A' ' 61' ' ' ILE . 56.7 mtt180 -81.25 98.01 7.91 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.567 0.699 . . . . 71.239999999999995 110.078 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -106.39 111.93 24.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.482 1.113 . . . . 63.049999999999997 109.601 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 60.72 32.35 20.23 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 124.605 1.162 . . . . 64.140000000000001 112.891 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.42 -11.57 67.61 Favored Glycine 0 CA--C 1.541 1.697 0 N-CA-C 114.041 0.377 . . . . 41.43 114.041 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.76 137.21 36.98 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.748 0.819 . . . . 71.540000000000006 110.329 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 56' ' ' ARG . 50.7 mt -87.41 129.3 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.808 0.443 . . . . 62.100000000000001 111.173 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.04 136.34 49.44 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.308 1.043 . . . . 73.209999999999994 110.37 -178.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.618 HD11 HG12 ' A' ' 25' ' ' ILE . 3.0 mp -113.59 115.94 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.219 0.608 . . . . 75.109999999999999 110.194 -169.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.733 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 80.6 m-85 -113.54 173.74 6.26 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.994 0.918 . . . . 72.310000000000002 110.542 175.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -98.8 162.03 13.32 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.384 0.674 . . . . 63.340000000000003 110.862 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 51' ' ' LYS . 36.1 tt0 . . . . . 0 N--CA 1.49 1.538 0 C-N-CA 124.505 1.122 . . . . 75.040000000000006 111.895 170.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 111.788 0.292 . . . . 65.530000000000001 111.788 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -75.05 -31.77 61.38 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.449 0.7 . . . . 65.019999999999996 111.71 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.04 -54.09 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 122.697 0.399 . . . . 72.049999999999997 110.749 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -65.28 -26.2 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 122.864 0.466 . . . . 65.019999999999996 111.536 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.81 -39.97 96.99 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.282 0.364 . . . . 43.020000000000003 113.303 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.11 -36.97 69.59 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.73 0.812 . . . . 55.539999999999999 111.346 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -64.68 -40.61 95.71 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.589 -0.732 . . . . 73.310000000000002 110.583 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.502 ' HA ' ' HB1' ' B' ' 42' ' ' ALA . . . -72.06 -41.45 67.39 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.869 0.868 . . . . 71.209999999999994 111.435 -176.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.01 -50.07 66.93 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.783 -0.644 . . . . 60.340000000000003 112.464 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.548 ' HG3' ' HB ' ' B' ' 32' ' ' VAL . 18.0 tppt? -60.0 -45.88 91.31 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.437 1.095 . . . . 75.239999999999995 112.065 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.469 ' HA ' HG11 ' B' ' 32' ' ' VAL . 53.0 t -56.99 -46.99 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.094 0.558 . . . . 74.430000000000007 111.346 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.511 ' HA ' HD12 ' B' ' 17' ' ' LEU . 69.7 t90 -68.34 -35.76 78.24 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.302 0.641 . . . . 74.299999999999997 112.015 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -63.97 -33.08 74.92 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.604 0.362 . . . . 55.329999999999998 110.553 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.09 -32.45 69.08 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.906 0.482 . . . . 61.229999999999997 111.582 171.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' B' ' 14' ' ' TRP . 69.2 mt -72.57 -30.51 64.47 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.347 0.659 . . . . 74.209999999999994 111.227 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.49 -29.4 68.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.644 0.778 . . . . 73.010000000000005 111.048 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.45 -29.24 12.86 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.523 0.729 . . . . 72.439999999999998 111.303 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.7 88.88 1.0 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.439 0.696 . . . . 44.0 111.812 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -92.28 173.44 7.82 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.183 0.593 . . . . 74.109999999999999 111.652 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.55 64.53 2.81 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.278 -0.419 . . . . 71.019999999999996 112.316 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 tt -144.02 143.27 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.315 0.646 . . . . 72.540000000000006 110.787 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -60.58 139.8 57.64 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.856 0.863 . . . . 63.130000000000003 111.418 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 37' ' ' GLU . 71.8 mt -52.31 -46.22 94.39 Favored Pre-proline 0 CA--C 1.581 2.14 0 N-CA-C 114.386 1.254 . . . . 63.539999999999999 114.386 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.11 -24.78 14.49 Favored 'Trans proline' 0 C--N 1.399 3.223 0 CA-C-N 121.856 1.699 . . . . 64.200000000000003 113.989 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 33.7 tt0 -77.1 -46.34 23.9 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 122.04 0.924 . . . . 60.130000000000003 108.846 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -55.65 -39.87 71.45 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.321 1.448 . . . . 61.43 111.263 170.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.85 92.19 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.874 0.869 . . . . 54.140000000000001 112.323 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' B' ' 27' ' ' GLU . 21.9 ptt180 -73.96 -23.36 59.48 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.384 0.274 . . . . 75.030000000000001 110.782 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 27' ' ' GLU . 30.9 mmmt -78.41 -43.93 26.14 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.142 0.577 . . . . 73.25 111.06 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' B' ' 12' ' ' LYS . 23.6 m -87.16 3.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 112.954 0.724 . . . . 74.319999999999993 112.954 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 63.62 11.47 5.75 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 125.081 1.352 . . . . 74.219999999999999 113.904 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 74.2 mt -99.77 162.9 12.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.478 0.711 . . . . 73.439999999999998 111.071 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 16.7 m -66.0 155.59 36.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.561 0.744 . . . . 72.25 111.627 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.46 -49.83 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.488 0.715 . . . . 61.130000000000003 111.709 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.62 -43.65 84.94 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.121 0.969 . . . . 55.409999999999997 111.474 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 68.4 m -61.75 -37.56 84.74 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.957 0.903 . . . . 73.530000000000001 112.265 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.479 ' O ' HG23 ' B' ' 43' ' ' VAL . 97.3 m -72.26 -48.49 42.17 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.471 0.708 . . . . 74.140000000000001 111.241 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -59.24 -43.14 92.4 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.553 0.741 . . . . 54.549999999999997 112.573 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.06 -49.5 75.72 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.883 0.873 . . . . 71.010000000000005 109.963 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' B' ' 10' ' ' ALA . . . -57.96 -28.67 64.56 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.794 -1.094 . . . . 73.129999999999995 112.006 -178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.647 HG11 HD12 ' B' ' 63' ' ' ILE . 77.8 t -69.27 -38.33 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.139 0.576 . . . . 74.319999999999993 110.964 175.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.64 -30.58 77.67 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-O 121.077 0.265 . . . . 74.519999999999996 112.591 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -75.86 -26.37 57.05 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.662 0.785 . . . . 73.230000000000004 111.951 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.99 -35.25 62.03 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.207 0.527 . . . . 74.099999999999994 111.352 166.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.34 -34.15 77.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.304 1.042 . . . . 65.219999999999999 112.793 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -64.51 -34.95 79.42 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.922 0.392 . . . . 71.549999999999997 111.317 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.62 -2.52 56.27 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.737 0.815 . . . . 61.299999999999997 111.532 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 65.55 26.48 11.68 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.488 1.515 . . . . 73.040000000000006 112.43 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -95.36 -0.19 52.9 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.465 1.283 . . . . 75.420000000000002 114.465 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 17.6 m -127.95 151.5 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 118.566 0.621 . . . . 73.439999999999998 112.468 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.699 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 95.3 t -110.33 123.35 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.604 1.161 . . . . 74.430000000000007 108.465 168.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 76.0 mt -114.97 126.45 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.258 -0.645 . . . . 54.439999999999998 109.258 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . 0.588 ' HG3' ' HG3' ' B' ' 57' ' ' LYS . 10.6 tp10 -142.32 129.17 20.57 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.55 -0.75 . . . . 72.319999999999993 111.312 -169.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.404 ' HG2' HG12 ' B' ' 61' ' ' ILE . 92.7 mtt180 -95.12 98.86 10.95 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.51 0.672 . . . . 72.510000000000005 110.216 176.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . 0.588 ' HG3' ' HG3' ' B' ' 55' ' ' GLU . 29.1 mtpp -105.48 123.39 47.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.346 -0.843 . . . . 74.040000000000006 109.476 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 59.11 29.48 19.05 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.077 1.351 . . . . 73.099999999999994 111.157 -171.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.54 -27.87 8.22 Favored Glycine 0 CA--C 1.543 1.83 0 CA-C-N 115.729 -0.669 . . . . 73.299999999999997 114.136 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.08 138.07 31.86 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.65 0.78 . . . . 55.140000000000001 111.795 -171.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.404 HG12 ' HG2' ' B' ' 56' ' ' ARG . 55.4 mt -79.56 136.42 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.926 0.891 . . . . 74.109999999999999 112.225 -177.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -121.19 131.99 54.57 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.175 0.99 . . . . 75.129999999999995 109.118 167.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.647 HD12 HG11 ' B' ' 43' ' ' VAL . 25.0 mm -91.69 109.25 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.369 0.668 . . . . 71.219999999999999 110.431 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.699 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 67.0 m-85 -97.72 169.24 9.82 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.6 1.16 . . . . 71.450000000000003 110.589 175.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -100.39 155.29 17.89 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.429 0.692 . . . . 74.409999999999997 110.934 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 . . . . . 0 N--CA 1.486 1.351 0 C-N-CA 124.716 1.206 . . . . 74.329999999999998 111.158 173.515 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 111.782 0.29 . . . . 63.350000000000001 111.782 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.2 mt -64.44 -59.46 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.899 0.48 . . . . 71.310000000000002 110.694 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.53 -27.56 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.938 0.495 . . . . 62.520000000000003 111.764 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.76 -43.13 85.34 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.412 0.445 . . . . 44.350000000000001 113.283 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -46.36 80.97 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.644 0.778 . . . . 70.329999999999998 111.706 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -70.0 -27.95 65.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.972 -0.558 . . . . 60.32 112.362 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.58 76.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.24 0.616 . . . . 51.219999999999999 111.898 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.2 -37.65 94.88 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 116.074 -0.512 . . . . 64.400000000000006 113.071 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -76.61 -42.56 41.91 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 112.474 0.546 . . . . 42.039999999999999 112.474 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.592 HG12 HG21 ' A' ' 32' ' ' VAL . 26.0 m -64.56 -34.1 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 122.123 -0.36 . . . . 41.109999999999999 111.057 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.572 ' HA ' HD12 ' A' ' 17' ' ' LEU . 42.9 t90 -70.01 -33.28 71.81 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.086 0.555 . . . . 74.120000000000005 111.484 175.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -61.7 -39.14 90.41 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.127 0.571 . . . . 61.119999999999997 110.618 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.02 -32.53 70.72 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.49 0.716 . . . . 43.310000000000002 111.946 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 14' ' ' TRP . 75.5 mt -69.87 -35.37 74.62 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.878 0.871 . . . . 75.319999999999993 111.746 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.06 -25.82 65.54 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.938 0.495 . . . . 71.299999999999997 110.307 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.15 -46.86 19.48 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.737 0.815 . . . . 73.349999999999994 110.694 169.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.06 97.15 1.77 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.575 0.75 . . . . 74.129999999999995 111.417 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.12 172.46 10.56 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.324 0.65 . . . . 72.209999999999994 111.316 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.51 9.79 82.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 116.614 -0.266 . . . . 52.310000000000002 113.456 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 tt -77.83 158.19 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 124.33 1.052 . . . . 74.510000000000005 109.338 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 m -79.1 150.75 31.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.752 -0.592 . . . . 60.530000000000001 110.392 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.592 HG21 ' HB2' ' A' ' 40' ' ' ALA . 70.7 mt -54.75 -47.19 98.79 Favored Pre-proline 0 CA--C 1.578 2.057 0 N-CA-C 113.82 1.044 . . . . 72.140000000000001 113.82 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.94 -23.74 34.29 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 122.117 1.878 . . . . 74.319999999999993 113.961 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.47 -48.24 23.56 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.094 0.95 . . . . 62.210000000000001 108.984 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.431 HD22 HD11 ' A' ' 63' ' ' ILE . 64.5 tp -57.28 -38.62 74.21 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 113.324 -1.762 . . . . 60.520000000000003 111.613 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.9 -41.92 88.37 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.935 0.894 . . . . 32.0 111.774 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -66.06 -37.44 85.83 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.812 0.845 . . . . 73.430000000000007 111.695 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.14 -35.64 77.61 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.457 0.646 . . . . 64.349999999999994 111.706 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.592 HG21 HG12 ' A' ' 13' ' ' VAL . 29.7 m -105.15 5.38 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.71 0.804 . . . . 74.239999999999995 112.623 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 62.11 19.76 11.12 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 124.814 1.246 . . . . 73.030000000000001 114.05 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.4 mt -99.47 168.56 9.9 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.251 0.621 . . . . 62.030000000000001 110.615 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 t -75.89 157.02 33.76 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.762 0.425 . . . . 72.329999999999998 111.402 171.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 t -56.47 -44.14 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.076 0.95 . . . . 70.230000000000004 111.42 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.475 ' HB3' HD12 ' B' ' 25' ' ' ILE . 42.2 mt-10 -63.86 -39.41 94.14 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.039 0.936 . . . . 75.430000000000007 112.039 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.3 m -68.94 -35.39 76.72 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.663 0.785 . . . . 74.099999999999994 111.502 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 43' ' ' VAL . 99.5 m -76.97 -46.98 22.1 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.544 0.738 . . . . 63.039999999999999 111.893 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.592 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -59.31 -35.92 74.68 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 123.565 0.746 . . . . 75.319999999999993 111.737 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.451 HD11 HD13 ' B' ' 54' ' ' ILE . 0.9 OUTLIER -65.04 -49.73 68.99 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 114.908 -1.042 . . . . 44.5 110.181 174.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.56 70.21 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.645 0.778 . . . . 74.319999999999993 111.713 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 63' ' ' ILE . 53.5 t -68.27 -35.93 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.207 0.603 . . . . 72.310000000000002 110.495 173.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.654 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -63.96 -30.43 77.7 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 116.336 -0.393 . . . . 52.310000000000002 113.612 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.47 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 65.0 t-105 -70.62 -37.15 73.78 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.009 0.433 . . . . 75.239999999999995 110.923 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.17 -32.19 72.26 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 122.199 -0.313 . . . . 64.329999999999998 110.955 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.86 -31.05 71.78 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.672 0.789 . . . . 61.340000000000003 111.481 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.578 ' HA ' ' HD2' ' B' ' 48' ' ' ARG . 31.9 ttt180 -63.64 -50.62 68.6 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.985 0.514 . . . . 73.450000000000003 110.71 168.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -79.14 -2.02 38.8 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.171 0.988 . . . . 60.340000000000003 112.197 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 63.07 22.13 13.26 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.541 1.536 . . . . 75.400000000000006 112.688 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 63.1 mttp -78.7 -18.65 54.0 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.391 1.076 . . . . 71.310000000000002 112.961 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.55 157.86 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 112.807 0.669 . . . . 63.030000000000001 112.807 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.62 HG23 ' HB2' ' A' ' 64' ' ' TYR . 7.3 m -129.78 120.22 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 124.694 1.198 . . . . 72.319999999999993 109.773 172.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.427 HG13 HG22 ' A' ' 63' ' ' ILE . 3.4 mp -96.95 107.38 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.636 0.774 . . . . 62.43 109.906 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -117.38 137.34 52.53 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.909 0.484 . . . . 74.310000000000002 111.469 -172.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -89.11 100.96 13.63 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.846 0.859 . . . . 72.329999999999998 110.212 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -107.64 119.35 39.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.702 0.801 . . . . 73.530000000000001 110.394 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 58.47 30.97 20.44 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.955 1.302 . . . . 72.519999999999996 112.268 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.07 -21.2 25.22 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-N 115.386 -0.825 . . . . 71.209999999999994 114.197 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.65 137.7 33.67 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.788 0.835 . . . . 73.319999999999993 111.266 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.06 114.25 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.59 0.756 . . . . 72.430000000000007 109.197 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.1 138.38 54.47 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.751 -0.833 . . . . 74.319999999999993 108.751 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.565 ' H ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -103.38 124.4 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 122.265 1.031 . . . . 73.140000000000001 110.669 -177.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.62 ' HB2' HG23 ' A' ' 53' ' ' VAL . 89.0 m-85 -109.72 171.24 7.56 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.191 1.396 . . . . 65.200000000000003 109.582 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -93.75 168.25 11.12 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.576 0.703 . . . . 74.219999999999999 112.11 175.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 124.237 1.015 . . . . 72.349999999999994 111.837 170.629 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt . . . . . 0 CA--C 1.557 1.239 0 CA-C-O 121.063 0.458 . . . . 73.239999999999995 111.817 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -65.5 -24.09 67.06 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 113.145 0.794 . . . . 73.329999999999998 113.145 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 73.5 mt -64.34 -52.75 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.208 0.603 . . . . 54.420000000000002 111.348 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.48 -26.81 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 122.846 0.459 . . . . 71.409999999999997 111.887 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.38 -45.81 88.93 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 123.44 0.462 . . . . 74.109999999999999 112.984 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.92 91.9 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.701 0.8 . . . . 63.340000000000003 111.802 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.38 -41.85 97.78 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.678 0.791 . . . . 61.32 110.935 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.92 -24.05 55.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.95 0.9 . . . . 64.329999999999998 112.533 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.22 -41.51 99.51 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 121.354 0.419 . . . . 32.350000000000001 112.65 172.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -70.65 -41.1 72.58 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.081 0.953 . . . . 71.299999999999997 111.293 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.501 HG13 HD21 ' B' ' 28' ' ' LEU . 77.4 t -60.98 -46.1 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.887 0.875 . . . . 70.439999999999998 112.092 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -71.84 -31.79 66.87 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 116.286 -0.415 . . . . 75.120000000000005 111.424 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -56.62 -37.75 71.13 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.744 0.418 . . . . 72.140000000000001 111.471 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.18 75.4 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.038 0.535 . . . . 65.310000000000002 111.84 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.632 HD21 HG13 ' B' ' 63' ' ' ILE . 93.8 mt -73.83 -37.63 64.79 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.963 0.905 . . . . 55.219999999999999 112.158 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -59.08 -39.33 81.82 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.699 0.8 . . . . 73.209999999999994 110.636 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -79.17 -48.56 14.04 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.538 -0.755 . . . . 71.319999999999993 111.134 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.31 99.5 3.15 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.201 0.6 . . . . 63.329999999999998 111.566 -173.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.01 174.55 10.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.2 0.6 . . . . 65.439999999999998 112.272 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.94 13.32 83.52 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.224 -0.444 . . . . 63.32 113.977 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.402 HG21 HD13 ' B' ' 28' ' ' LEU . 11.0 tp -78.06 138.52 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 C-N-CA 123.15 0.58 . . . . 71.319999999999993 110.9 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.4 m -84.61 151.32 24.58 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.936 0.494 . . . . 64.140000000000001 111.015 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' A' ' 37' ' ' GLU . 54.2 mt -53.56 -45.84 98.45 Favored Pre-proline 0 CA--C 1.581 2.165 0 N-CA-C 114.711 1.375 . . . . 63.149999999999999 114.711 -172.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' B' ' 36' ' ' VAL . 65.8 Cg_endo -71.29 -29.15 17.47 Favored 'Trans proline' 0 C--N 1.396 3.038 0 CA-C-N 121.803 1.68 . . . . 71.5 113.415 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -73.6 -49.21 27.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.157 0.98 . . . . 72.239999999999995 109.863 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.501 HD21 HG13 ' B' ' 13' ' ' VAL . 62.5 tp -53.93 -36.24 62.56 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 113.013 -1.903 . . . . 74.349999999999994 111.775 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.05 83.35 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.658 0.783 . . . . 70.510000000000005 112.108 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' B' ' 26' ' ' PRO . 10.3 mpt_? -70.94 -39.88 72.37 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.942 0.497 . . . . 75.120000000000005 110.593 175.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.61 -43.18 93.84 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.311 0.644 . . . . 71.319999999999993 111.233 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.4 -5.88 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.58 0.752 . . . . 74.439999999999998 112.247 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 66.12 21.15 11.19 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.79 1.236 . . . . 63.549999999999997 113.01 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 68.5 mt -108.72 169.39 8.69 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.862 0.865 . . . . 73.099999999999994 110.553 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -72.34 155.5 40.09 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.003 0.521 . . . . 62.210000000000001 111.003 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' B' ' 26' ' ' PRO . 96.4 t -56.74 -44.04 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 123.579 0.751 . . . . 32.210000000000001 112.364 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.39 -49.25 78.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.626 0.77 . . . . 65.200000000000003 111.861 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -61.73 -38.68 88.81 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.556 1.142 . . . . 71.150000000000006 111.914 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.485 ' O ' HG23 ' B' ' 43' ' ' VAL . 92.4 m -70.08 -46.75 64.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.116 0.966 . . . . 71.230000000000004 111.037 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.472 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -62.09 -35.41 78.59 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.745 0.818 . . . . 64.140000000000001 112.137 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -69.64 -37.78 76.91 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.3 1.04 . . . . 74.530000000000001 110.156 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.55 -34.78 77.75 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.208 0.603 . . . . 73.540000000000006 111.428 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.485 HG23 ' O ' ' B' ' 39' ' ' THR . 98.4 t -61.8 -33.94 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.251 0.621 . . . . 74.420000000000002 110.921 172.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.654 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -62.05 -30.45 75.59 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 116.155 -0.475 . . . . 63.240000000000002 114.011 176.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.426 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 70.6 t-105 -68.49 -38.91 81.42 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.937 0.495 . . . . 54.219999999999999 110.899 172.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 93.1 mt -70.01 -33.07 71.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.926 0.491 . . . . 70.129999999999995 111.299 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.22 -31.27 72.34 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.923 0.889 . . . . 62.329999999999998 111.589 170.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' A' ' 48' ' ' ARG . 15.3 ttt180 -65.74 -44.84 84.76 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.742 0.817 . . . . 74.040000000000006 111.322 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -80.05 -3.99 50.83 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.409 0.683 . . . . 74.209999999999994 112.451 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 62.11 21.92 12.75 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.27 1.428 . . . . 74.5 112.983 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -86.5 -4.06 59.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.067 0.947 . . . . 65.099999999999994 113.074 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.74 146.69 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 112.41 0.522 . . . . 61.219999999999999 112.41 -177.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.68 120.15 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.227 -1.027 . . . . 72.219999999999999 108.227 172.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.558 HG12 HG22 ' B' ' 63' ' ' ILE . 62.4 mt -106.99 111.88 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-O 121.341 0.591 . . . . 65.019999999999996 110.973 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -114.02 140.71 48.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.144 0.978 . . . . 72.230000000000004 110.636 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -113.51 103.28 11.11 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.503 0.721 . . . . 64.530000000000001 110.8 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.9 113.72 26.22 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.587 1.155 . . . . 62.130000000000003 108.829 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 60.04 30.47 19.95 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.093 0.957 . . . . 73.329999999999998 112.653 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.58 -10.35 62.23 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 113.942 0.337 . . . . 74.340000000000003 113.942 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 44.5 tp -84.21 128.88 34.84 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.001 0.92 . . . . 73.040000000000006 110.281 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.8 126.85 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.076 0.55 . . . . 51.520000000000003 109.827 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.94 120.64 36.96 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.038 -1.097 . . . . 73.230000000000004 108.038 173.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.632 HG13 HD21 ' B' ' 17' ' ' LEU . 34.1 pt -103.48 138.94 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.245 0.545 . . . . 70.530000000000001 110.557 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -121.49 179.07 4.56 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.459 1.104 . . . . 63.149999999999999 110.025 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.421 ' OD1' ' HB3' ' B' ' 17' ' ' LEU . 1.6 m-20 -82.15 160.55 23.07 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.051 -0.351 . . . . 73.0 110.051 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 CA--C 1.56 1.335 0 C-N-CA 123.374 0.67 . . . . 52.32 111.187 172.063 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 112.837 0.68 . . . . 64.329999999999998 112.837 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.4 mt -49.15 -50.04 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 124.07 0.948 . . . . 62.200000000000003 112.215 173.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.418 HG12 HD11 ' A' ' 41' ' ' LEU . 33.4 m -61.78 -28.02 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 112.436 0.532 . . . . 50.32 112.436 -177.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.52 -38.4 86.48 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 122.953 0.158 . . . . 32.439999999999998 113.073 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.59 -52.52 25.38 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.668 0.787 . . . . 62.340000000000003 111.785 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -59.26 -43.0 92.5 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.053 0.941 . . . . 55.409999999999997 112.155 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.4 -27.56 63.4 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.341 0.497 . . . . 70.420000000000002 112.341 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.79 -38.9 96.84 Favored Glycine 0 CA--C 1.538 1.485 0 O-C-N 123.332 0.395 . . . . 60.310000000000002 112.718 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -70.42 -43.82 69.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.502 0.721 . . . . 62.25 111.277 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.563 ' HA ' HG11 ' A' ' 32' ' ' VAL . 95.2 t -59.27 -42.75 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.433 0.693 . . . . 64.040000000000006 111.195 176.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 64.5 t90 -66.41 -32.98 74.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.851 0.86 . . . . 74.430000000000007 111.393 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -60.5 -53.73 53.98 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.068 0.147 . . . . 70.420000000000002 111.342 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.08 -30.91 71.94 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.172 0.589 . . . . 61.119999999999997 111.461 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.49 -50.71 50.32 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.99 1.316 . . . . 72.439999999999998 111.366 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.69 -23.87 59.87 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.361 0.664 . . . . 74.120000000000005 111.06 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -79.8 -37.06 36.04 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.393 1.077 . . . . 74.420000000000002 110.46 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.22 103.54 1.64 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.802 0.841 . . . . 61.219999999999999 110.705 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.674 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 10.7 p-10 -95.04 166.42 11.94 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.298 0.639 . . . . 72.150000000000006 112.148 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.68 64.16 1.11 Allowed Glycine 0 N--CA 1.473 1.133 0 CA-C-N 116.095 -0.502 . . . . 50.039999999999999 112.201 -175.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 tt -156.36 149.76 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 123.428 0.691 . . . . 71.030000000000001 111.116 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -86.17 158.58 19.72 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.232 0.613 . . . . 71.519999999999996 111.649 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.502 HG21 ' HB2' ' A' ' 40' ' ' ALA . 74.4 mt -53.68 -52.59 65.89 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 114.185 1.18 . . . . 55.109999999999999 114.185 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.0 -26.18 43.72 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 121.773 1.649 . . . . 71.129999999999995 114.188 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -76.22 -45.57 32.39 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.455 1.121 . . . . 54.149999999999999 109.423 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.9 tp -60.1 -34.35 73.36 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 113.284 -1.78 . . . . 60.439999999999998 111.973 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.66 95.36 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.007 0.923 . . . . 64.439999999999998 112.438 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -71.49 -27.94 63.57 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.856 0.462 . . . . 63.43 112.044 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -66.67 -52.28 46.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.222 0.534 . . . . 63.130000000000003 110.914 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.563 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.0 m -79.07 -5.87 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 115.184 -0.916 . . . . 52.420000000000002 111.838 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 69.28 16.35 8.42 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.239 1.415 . . . . 70.0 112.171 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.8 mt -97.23 164.21 12.58 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.555 0.742 . . . . 71.109999999999999 110.254 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -68.23 153.58 43.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.414 0.286 . . . . 70.120000000000005 111.323 172.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.68 -44.92 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 123.486 0.714 . . . . 61.299999999999997 111.887 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -60.25 -42.8 96.09 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.95 0.9 . . . . 54.0 111.797 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 t -64.91 -42.68 94.52 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.587 0.755 . . . . 54.340000000000003 111.369 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 43' ' ' VAL . 61.6 m -71.49 -37.9 71.24 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.805 0.842 . . . . 54.25 111.775 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.94 -44.86 88.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 123.747 0.819 . . . . 75.129999999999995 111.504 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 6' ' ' VAL . 1.3 tm? -64.33 -37.33 87.13 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.461 -1.245 . . . . 61.329999999999998 110.357 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.04 -36.48 72.36 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.371 0.669 . . . . 73.099999999999994 112.449 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 39' ' ' THR . 88.0 t -66.75 -36.81 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.097 0.559 . . . . 52.420000000000002 110.452 173.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.51 -31.97 82.57 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-N 116.099 -0.5 . . . . 74.510000000000005 112.709 172.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.457 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 75.6 t-105 -74.03 -27.97 61.2 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.33 0.652 . . . . 72.239999999999995 111.582 173.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.76 -34.6 67.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.534 -0.729 . . . . 74.209999999999994 111.593 172.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.54 -26.59 55.33 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.11 0.964 . . . . 64.310000000000002 113.147 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.814 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 7.2 ptm180 -56.22 -36.65 68.7 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.387 0.884 . . . . 71.219999999999999 113.387 -174.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.814 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 39.3 mt-10 -112.22 15.76 20.32 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.117 0.967 . . . . 64.010000000000005 111.24 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.42 47.65 8.57 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.428 1.091 . . . . 54.200000000000003 110.048 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -87.68 -14.6 39.46 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.736 0.643 . . . . 64.530000000000001 112.736 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 m -133.23 150.64 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.92 0.888 . . . . 71.109999999999999 111.933 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 54.4 t -102.57 113.64 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.734 1.214 . . . . 60.200000000000003 108.772 171.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.458 HG23 HG23 ' A' ' 61' ' ' ILE . 50.4 mm -100.17 108.85 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 118.061 0.391 . . . . 73.200000000000003 110.983 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB3' ' NZ ' ' A' ' 57' ' ' LYS . 28.4 mm-40 -104.9 127.76 52.86 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.284 1.034 . . . . 72.019999999999996 110.356 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.535 HH22 ' HA ' ' B' ' 38' ' ' SER . 81.4 mtt-85 -113.61 105.55 13.47 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.872 -0.517 . . . . 71.25 111.529 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' NZ ' ' HB3' ' A' ' 55' ' ' GLU . 14.4 mptt -112.48 119.47 38.33 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.877 0.871 . . . . 61.43 109.843 176.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 57.97 32.61 22.19 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.148 0.979 . . . . 72.230000000000004 112.27 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.23 -6.39 72.15 Favored Glycine 0 CA--C 1.543 1.844 0 N-CA-C 114.269 0.468 . . . . 75.120000000000005 114.269 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.8 mt -88.24 125.66 34.76 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.602 0.761 . . . . 73.25 110.192 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.458 HG23 HG23 ' A' ' 54' ' ' ILE . 2.8 mp -86.01 126.31 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.512 0.725 . . . . 65.030000000000001 110.048 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -109.92 128.64 55.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.682 1.193 . . . . 74.140000000000001 108.9 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.9 mp -107.83 106.86 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 108.832 -0.803 . . . . 72.010000000000005 108.832 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.674 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 96.7 m-85 -107.55 167.16 10.14 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.573 1.149 . . . . 74.409999999999997 110.596 175.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -90.54 147.31 23.44 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.894 0.378 . . . . 71.310000000000002 110.873 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 CA--C 1.565 1.522 0 CA-C-O 121.075 0.464 . . . . 73.340000000000003 112.239 -179.542 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 120.989 0.424 . . . . 74.219999999999999 111.417 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -91.68 -25.21 19.22 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.317 0.647 . . . . 61.109999999999999 112.112 175.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 75.2 mt -59.89 -46.19 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 122.97 0.508 . . . . 70.340000000000003 110.521 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.408 HG12 HD11 ' B' ' 41' ' ' LEU . 35.7 m -64.12 -30.95 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 122.884 0.473 . . . . 62.340000000000003 112.113 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.24 -41.54 59.34 Favored Glycine 0 CA--C 1.538 1.49 0 O-C-N 123.191 0.307 . . . . 73.329999999999998 113.174 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.76 -43.58 88.45 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.78 0.832 . . . . 53.25 111.469 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -65.55 -35.7 81.62 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.736 0.814 . . . . 63.439999999999998 111.27 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.45 70.96 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.164 0.586 . . . . 51.43 111.264 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.27 -36.87 92.32 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 116.299 -0.409 . . . . 74.140000000000001 112.57 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -63.97 -47.67 79.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.111 0.965 . . . . 65.319999999999993 111.878 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 75.8 t -62.32 -46.8 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.328 0.651 . . . . 62.409999999999997 111.153 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.571 ' HA ' HD12 ' B' ' 17' ' ' LEU . 17.9 t90 -64.02 -33.85 76.68 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.776 0.83 . . . . 74.409999999999997 111.436 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . 0.415 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 78.4 t60 -59.8 -47.99 83.48 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.974 0.509 . . . . 71.209999999999994 110.467 172.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.09 -26.84 68.73 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.23 0.612 . . . . 72.519999999999996 112.598 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' B' ' 14' ' ' TRP . 75.4 mt -68.84 -41.49 78.45 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.519 0.728 . . . . 63.43 111.166 172.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . 0.432 ' N ' HD22 ' B' ' 18' ' ' ASN . 0.8 OUTLIER -68.01 -26.13 65.74 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.882 -0.599 . . . . 72.140000000000001 110.996 175.093 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 10.4 mm-40 -73.6 -47.18 42.24 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.413 0.685 . . . . 61.039999999999999 110.533 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.9 106.63 0.61 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.238 1.015 . . . . 71.439999999999998 110.554 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -95.6 179.67 5.05 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.485 0.714 . . . . 72.430000000000007 112.118 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.76 39.3 34.38 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 116.191 -0.459 . . . . 53.219999999999999 112.493 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.402 ' O ' HG22 ' B' ' 63' ' ' ILE . 17.4 tt -124.29 153.45 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.954 0.902 . . . . 63.130000000000003 110.751 -172.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -80.29 151.56 29.48 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.801 0.441 . . . . 75.200000000000003 111.462 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' B' ' 40' ' ' ALA . 87.3 mt -51.04 -49.14 82.79 Favored Pre-proline 0 CA--C 1.577 1.991 0 N-CA-C 114.451 1.278 . . . . 74.099999999999994 114.451 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.477 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 59.9 Cg_endo -67.33 -30.17 37.31 Favored 'Trans proline' 0 C--N 1.393 2.89 0 C-N-CA 121.711 1.607 . . . . 71.219999999999999 114.135 -176.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -76.68 -44.17 34.8 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.229 1.014 . . . . 60.530000000000001 110.307 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.33 -40.19 74.02 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 113.427 -1.715 . . . . 72.420000000000002 111.287 171.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.82 -38.33 85.05 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.102 0.961 . . . . 65.239999999999995 112.505 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' B' ' 26' ' ' PRO . 14.7 mmm-85 -63.29 -44.1 96.01 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.4 0.68 . . . . 75.439999999999998 110.651 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -67.21 -43.27 82.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.864 0.866 . . . . 75.409999999999997 111.833 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.3 m -83.03 -5.27 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 122.875 0.47 . . . . 64.129999999999995 111.768 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 69.21 11.56 8.23 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.422 1.489 . . . . 60.450000000000003 112.682 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.7 mt -93.17 165.79 12.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.531 0.732 . . . . 71.450000000000003 110.019 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -65.94 153.55 41.77 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 122.239 -0.288 . . . . 72.439999999999998 110.59 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 54.9 t -49.88 -52.26 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.104 0.962 . . . . 45.039999999999999 112.171 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -71.12 -30.64 66.75 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.295 1.038 . . . . 74.340000000000003 111.436 -176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.535 ' HA ' HH22 ' A' ' 56' ' ' ARG . 41.7 m -64.97 -42.17 94.81 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.629 0.772 . . . . 73.409999999999997 110.775 173.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.449 ' O ' HG23 ' B' ' 43' ' ' VAL . 84.9 m -70.06 -43.19 71.72 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.103 0.961 . . . . 75.25 111.075 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.522 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -62.06 -42.66 99.43 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 123.975 0.91 . . . . 75.329999999999998 112.106 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.408 HD11 HG12 ' B' ' 6' ' ' VAL . 1.5 tm? -64.67 -38.26 90.39 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.698 1.199 . . . . 74.5 110.365 176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.92 72.07 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.548 0.739 . . . . 74.400000000000006 111.958 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 39' ' ' THR . 75.0 t -63.7 -35.68 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.481 0.713 . . . . 72.409999999999997 110.67 172.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.35 -31.24 80.08 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 116.29 -0.414 . . . . 44.020000000000003 113.41 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.499 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 43.6 t-105 -74.39 -31.24 62.28 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.229 0.612 . . . . 73.010000000000005 111.331 176.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.27 -36.29 68.97 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.29 0.636 . . . . 65.140000000000001 111.433 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.31 82.9 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.825 0.85 . . . . 73.209999999999994 110.8 172.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.562 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 31.2 ttt180 -51.84 -50.6 60.58 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.636 0.775 . . . . 64.239999999999995 111.064 171.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -80.01 -2.31 43.58 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.947 -1.024 . . . . 72.140000000000001 112.737 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 64.75 26.63 13.05 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.754 1.222 . . . . 60.310000000000002 112.694 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -99.29 5.73 46.45 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.136 0.791 . . . . 61.100000000000001 113.136 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.492 ' HB ' HD11 ' B' ' 63' ' ' ILE . 28.5 m -135.31 156.8 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.398 0.618 . . . . 71.209999999999994 112.589 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 32.4 t -111.56 125.29 68.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 124.475 1.11 . . . . 72.439999999999998 109.262 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.83 103.42 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.42 -0.956 . . . . 74.019999999999996 108.42 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . 0.471 ' HB3' ' HE1' ' B' ' 64' ' ' TYR . 7.7 tp10 -118.86 115.79 25.15 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.938 0.399 . . . . 63.100000000000001 109.982 -173.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -84.69 107.05 16.69 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.544 0.687 . . . . 72.209999999999994 111.063 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -104.82 114.39 28.57 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.581 1.153 . . . . 62.009999999999998 109.912 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 58.44 32.44 22.11 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.063 0.945 . . . . 72.129999999999995 112.399 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.17 -20.02 31.88 Favored Glycine 0 CA--C 1.545 1.942 0 N-CA-C 114.06 0.384 . . . . 75.230000000000004 114.06 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 tt -88.41 138.34 31.52 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.456 1.102 . . . . 51.329999999999998 109.9 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -87.8 122.95 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.753 0.421 . . . . 62.43 111.704 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -108.45 127.08 53.59 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.089 0.956 . . . . 74.25 108.633 171.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.492 HD11 ' HB ' ' B' ' 52' ' ' VAL . 0.0 OUTLIER -104.75 121.91 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-O 121.887 0.851 . . . . 72.349999999999994 110.154 -176.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.62 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 45.3 m-85 -107.71 157.76 17.84 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.624 1.17 . . . . 73.120000000000005 110.141 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -85.16 162.97 19.01 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.039 0.536 . . . . 72.510000000000005 111.48 -175.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.487 1.388 0 C-N-CA 124.227 1.011 . . . . 70.030000000000001 112.473 175.56 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 4' ' ' LYS . 11.2 mmpt? . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 112.37 0.507 . . . . 72.540000000000006 112.37 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.6 mt -65.28 -46.92 89.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.34 0.656 . . . . 71.140000000000001 111.579 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.81 -27.55 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 118.057 0.39 . . . . 70.209999999999994 111.676 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.04 -42.52 94.56 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.557 0.536 . . . . 33.509999999999998 112.491 172.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.11 81.1 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.487 0.715 . . . . 75.219999999999999 111.24 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -61.73 -36.12 80.03 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.569 0.747 . . . . 75.109999999999999 111.161 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.93 -36.61 69.97 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.533 0.733 . . . . 63.149999999999999 111.615 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.86 -31.41 75.54 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-N 116.41 -0.359 . . . . 74.430000000000007 112.545 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.554 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 53.8 tptt -71.0 -42.28 69.83 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.442 1.097 . . . . 63.420000000000002 111.186 175.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.59 -40.7 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.993 0.917 . . . . 44.229999999999997 111.343 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 13.4 t90 -69.33 -33.53 73.25 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 116.018 -0.537 . . . . 73.349999999999994 110.399 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -57.13 -46.05 83.01 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.134 0.573 . . . . 72.209999999999994 110.744 168.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.36 -29.57 66.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.517 0.727 . . . . 73.25 112.481 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.12 -49.1 60.1 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.627 0.771 . . . . 41.539999999999999 112.083 172.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -67.56 -22.31 65.4 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.067 0.461 . . . . 35.229999999999997 111.303 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -76.2 -48.72 19.37 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.292 1.037 . . . . 72.540000000000006 109.614 174.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.24 97.4 0.34 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.753 1.221 . . . . 52.539999999999999 110.263 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.98 173.75 11.5 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.732 0.813 . . . . 73.400000000000006 112.258 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.04 61.38 4.03 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.765 -0.534 . . . . 62.530000000000001 111.765 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.11 159.08 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 123.153 0.581 . . . . 71.109999999999999 111.185 -166.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 58.8 m -79.47 153.28 29.74 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.844 0.354 . . . . 72.439999999999998 111.09 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.645 HG21 ' HB2' ' A' ' 40' ' ' ALA . 95.8 mt -53.56 -54.8 41.73 Favored Pre-proline 0 CA--C 1.576 1.956 0 C-N-CA 124.494 1.118 . . . . 44.350000000000001 112.245 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 55.9 Cg_endo -66.36 -25.19 49.35 Favored 'Trans proline' 0 C--N 1.401 3.301 0 C-N-CA 121.764 1.643 . . . . 73.239999999999995 113.741 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -70.63 -51.84 25.36 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.383 0.673 . . . . 75.109999999999999 112.501 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.61 -33.01 74.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.312 0.245 . . . . 73.109999999999999 110.381 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.14 -41.25 64.91 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.622 1.169 . . . . 61.210000000000001 112.645 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 26' ' ' PRO . 46.9 mtt180 -62.62 -41.18 98.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.927 0.891 . . . . 72.25 111.553 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -72.61 -43.24 63.57 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.731 0.813 . . . . 75.430000000000007 111.243 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.554 ' HB ' ' HG3' ' A' ' 12' ' ' LYS . 26.2 m -85.69 -0.47 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 115.465 -0.789 . . . . 75.430000000000007 112.26 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.6 m120 67.08 11.21 8.26 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.897 1.279 . . . . 72.439999999999998 113.229 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.5 mt -89.24 148.01 23.83 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.374 -0.602 . . . . 63.229999999999997 109.374 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.3 t -63.25 153.4 34.84 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.45 0.3 . . . . 32.240000000000002 110.952 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.45 -42.44 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 123.278 0.631 . . . . 75.420000000000002 111.333 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.53 -43.39 98.94 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.417 0.687 . . . . 61.340000000000003 112.338 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.4 m -62.09 -33.02 73.65 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 123.302 0.641 . . . . 73.430000000000007 111.707 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 43' ' ' VAL . 79.0 m -77.4 -53.06 8.11 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.763 0.825 . . . . 71.010000000000005 111.641 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -59.73 -41.75 91.6 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.416 1.087 . . . . 43.109999999999999 112.884 -177.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -65.49 -39.02 91.42 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.405 1.082 . . . . 63.130000000000003 110.407 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.17 -31.12 69.53 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 123.241 0.616 . . . . 64.120000000000005 112.016 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 39' ' ' THR . 87.2 t -61.02 -38.13 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 123.765 0.826 . . . . 61.32 110.354 171.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.94 -32.03 82.88 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.794 -0.639 . . . . 75.299999999999997 113.943 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.437 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 70.8 t-105 -70.31 -37.38 74.73 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.059 0.457 . . . . 73.409999999999997 110.708 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.54 -35.63 79.44 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.774 0.43 . . . . 71.129999999999995 111.047 172.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.67 88.91 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.513 0.725 . . . . 74.040000000000006 111.421 172.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 22.7 ttt180 -55.61 -49.91 71.54 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.799 0.84 . . . . 62.0 111.128 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -78.4 -6.02 54.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.755 0.822 . . . . 71.420000000000002 111.718 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 62.07 22.87 13.42 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.601 1.56 . . . . 42.020000000000003 112.462 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -78.28 -5.63 52.61 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.458 1.103 . . . . 55.310000000000002 113.41 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 63' ' ' ILE . 25.6 m -133.14 151.98 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.171 0.589 . . . . 61.340000000000003 112.294 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 64' ' ' TYR . 17.3 m -123.27 121.04 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 C-N-CA 124.108 0.963 . . . . 55.100000000000001 109.014 169.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.532 HG12 HD11 ' B' ' 41' ' ' LEU . 3.6 mp -100.99 124.29 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 109.154 -0.684 . . . . 62.520000000000003 109.154 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.42 148.59 44.92 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.253 0.621 . . . . 72.109999999999999 112.16 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -100.61 112.63 25.04 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.446 0.699 . . . . 71.519999999999996 110.267 171.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -105.44 112.77 26.0 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.846 0.859 . . . . 71.400000000000006 108.942 173.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 55.88 30.77 16.52 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.631 1.172 . . . . 73.230000000000004 112.067 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.96 -27.2 13.48 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 115.431 -0.804 . . . . 54.119999999999997 113.986 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.31 132.3 42.93 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.781 0.832 . . . . 73.040000000000006 111.394 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.0 mt -89.7 123.98 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.449 0.699 . . . . 65.209999999999994 111.511 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -127.58 139.05 53.01 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.458 1.103 . . . . 73.349999999999994 109.748 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.46 HD11 HG11 ' A' ' 52' ' ' VAL . 6.1 tt -95.07 136.34 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.287 0.635 . . . . 73.340000000000003 110.533 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.56 ' HB2' HG23 ' A' ' 53' ' ' VAL . 98.8 m-85 -130.37 169.39 15.54 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.546 1.138 . . . . 64.530000000000001 110.374 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.54 155.43 20.49 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.425 0.69 . . . . 71.030000000000001 110.264 171.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.935 0.398 . . . . 73.219999999999999 111.86 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 112.21 0.448 . . . . 65.200000000000003 112.21 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -65.25 -20.25 66.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.302 -0.249 . . . . 71.209999999999994 111.603 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.58 -59.55 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.084 0.554 . . . . 75.310000000000002 110.91 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.66 -29.84 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 111.842 0.312 . . . . 74.420000000000002 111.842 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.29 -47.5 63.48 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.366 0.416 . . . . 70.400000000000006 113.138 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.68 96.61 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.935 0.894 . . . . 43.020000000000003 111.296 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.57 -42.26 87.31 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.636 -0.711 . . . . 73.219999999999999 111.581 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.72 -35.32 72.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.089 0.556 . . . . 64.450000000000003 112.105 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.66 -38.13 95.26 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 116.332 -0.394 . . . . 61.240000000000002 112.994 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -75.72 -42.45 50.67 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.744 0.818 . . . . 74.109999999999999 110.943 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.572 ' HA ' HG11 ' B' ' 32' ' ' VAL . 34.3 t -62.78 -48.05 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.384 1.074 . . . . 65.310000000000002 111.47 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.436 ' NE1' ' HB3' ' B' ' 51' ' ' LYS . 48.3 t90 -64.92 -35.12 80.13 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.024 0.53 . . . . 65.349999999999994 111.735 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . 0.451 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 38.9 t60 -65.4 -46.79 78.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.567 0.347 . . . . 70.349999999999994 110.419 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.15 62.51 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.37 0.668 . . . . 73.129999999999995 112.149 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.408 HD13 ' ND2' ' B' ' 65' ' ' ASN . 1.4 tm? -72.87 -31.77 64.95 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.569 1.148 . . . . 64.409999999999997 110.397 171.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.68 -36.46 73.32 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.569 -0.53 . . . . 65.129999999999995 109.569 175.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 12.3 mm-40 -72.49 -49.88 29.89 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.326 0.65 . . . . 73.129999999999995 110.617 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.8 86.75 2.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.013 0.925 . . . . 73.329999999999998 110.206 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -68.67 124.61 24.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.633 0.773 . . . . 54.5 111.778 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.61 63.07 2.4 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.451 -0.34 . . . . 62.329999999999998 112.389 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.6 tp -117.3 137.96 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.594 0.758 . . . . 71.230000000000004 110.764 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -67.68 147.75 52.25 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.563 0.745 . . . . 73.329999999999998 110.901 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.523 HG21 ' HB2' ' B' ' 40' ' ' ALA . 60.8 mt -56.99 -49.89 91.35 Favored Pre-proline 0 CA--C 1.58 2.119 0 N-CA-C 113.422 0.897 . . . . 61.350000000000001 113.422 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.63 -27.38 32.48 Favored 'Trans proline' 0 C--N 1.399 3.203 0 C-N-CA 121.799 1.666 . . . . 65.310000000000002 114.026 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -70.91 -52.68 18.57 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.067 0.937 . . . . 71.239999999999995 109.245 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.446 HD21 HG13 ' B' ' 13' ' ' VAL . 60.6 tp -54.56 -38.34 66.53 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 113.249 -1.796 . . . . 73.519999999999996 112.15 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.72 -45.14 93.08 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.993 0.917 . . . . 63.039999999999999 111.915 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -67.7 -37.71 82.65 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.23 0.612 . . . . 74.340000000000003 110.861 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -64.12 -30.01 71.1 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.781 0.832 . . . . 61.450000000000003 112.243 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' B' ' 13' ' ' VAL . 34.1 m -103.09 1.91 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 112.769 0.655 . . . . 74.120000000000005 112.769 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 64.3 27.79 13.79 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 124.868 1.267 . . . . 63.32 113.132 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 72.4 mt -113.18 166.54 11.35 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.752 0.821 . . . . 74.120000000000005 111.448 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 31.6 t -69.43 155.74 39.96 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.664 -0.698 . . . . 63.310000000000002 111.61 170.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 67.8 t -56.37 -42.39 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.586 0.754 . . . . 72.420000000000002 111.033 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.83 -47.31 86.24 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.005 0.922 . . . . 65.420000000000002 111.457 175.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 41.5 t -63.72 -38.09 89.79 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.106 0.963 . . . . 72.430000000000007 112.089 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.46 ' O ' HG23 ' B' ' 43' ' ' VAL . 94.1 m -75.12 -49.44 19.59 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.863 0.865 . . . . 74.540000000000006 111.866 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.523 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -60.25 -39.59 87.28 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.69 0.796 . . . . 63.119999999999997 112.257 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.532 HD11 HG12 ' A' ' 54' ' ' ILE . 1.2 tt -62.2 -48.71 78.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.182 0.993 . . . . 74.030000000000001 110.064 173.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.72 -29.99 68.5 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.98 -1.009 . . . . 64.019999999999996 112.116 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.616 HG11 HD12 ' B' ' 63' ' ' ILE . 72.8 t -68.84 -37.17 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 123.061 0.544 . . . . 73.340000000000003 110.768 176.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -68.9 -30.25 72.43 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 116.431 -0.349 . . . . 32.299999999999997 112.79 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.456 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 72.6 t-105 -73.67 -21.07 60.38 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.304 0.642 . . . . 70.349999999999994 110.991 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.72 -33.8 58.15 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.645 0.778 . . . . 52.140000000000001 112.29 167.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.76 -25.53 60.61 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.057 1.132 . . . . 71.129999999999995 114.057 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.582 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 35.7 ptt85 -61.75 -36.38 80.85 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.036 0.446 . . . . 70.310000000000002 111.878 174.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.582 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 41.0 mt-10 -96.37 -2.7 45.13 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.35 1.06 . . . . 64.25 111.344 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 63.55 20.55 12.3 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 125.395 1.478 . . . . 70.129999999999995 113.065 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.436 ' HB3' ' NE1' ' B' ' 14' ' ' TRP . 49.5 mtmt -75.46 -8.18 56.04 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.378 0.881 . . . . 74.230000000000004 113.378 -173.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -128.57 151.58 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.915 0.886 . . . . 71.409999999999997 110.693 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.606 HG23 ' HB2' ' B' ' 64' ' ' TYR . 8.3 m -123.95 123.61 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.166 0.986 . . . . 62.43 109.884 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.582 HG23 HG23 ' B' ' 61' ' ' ILE . 1.9 mp -91.3 119.77 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.224 1.01 . . . . 72.239999999999995 109.616 -176.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -116.98 136.55 52.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.348 0.659 . . . . 75.010000000000005 110.156 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -98.58 108.46 21.16 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.857 0.463 . . . . 71.129999999999995 111.297 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -104.88 109.33 21.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.924 0.89 . . . . 72.120000000000005 109.455 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 61.18 30.29 19.23 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.053 1.341 . . . . 74.209999999999994 112.25 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.96 -18.42 56.03 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 113.796 0.279 . . . . 43.219999999999999 113.796 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mp -89.84 149.11 22.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.935 0.894 . . . . 75.219999999999999 110.394 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.582 HG23 HG23 ' B' ' 54' ' ' ILE . 27.1 mm -92.66 134.94 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.596 0.358 . . . . 64.219999999999999 111.278 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -123.19 133.16 54.25 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.607 -0.886 . . . . 73.129999999999995 108.607 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.616 HD12 HG11 ' B' ' 43' ' ' VAL . 25.5 mm -93.15 119.46 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.421 0.688 . . . . 74.140000000000001 110.016 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.606 ' HB2' HG23 ' B' ' 53' ' ' VAL . 57.0 m-85 -113.73 169.33 9.06 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.856 0.862 . . . . 75.299999999999997 110.688 175.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.408 ' ND2' HD13 ' B' ' 17' ' ' LEU . 5.8 m120 -79.99 154.38 28.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.533 0.733 . . . . 63.140000000000001 110.469 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.574 0.702 . . . . 62.539999999999999 112.061 172.603 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 112.887 0.699 . . . . 65.109999999999999 112.887 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.4 mt -44.69 -59.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 123.547 0.739 . . . . 63.32 111.101 166.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.0 m -65.67 -27.16 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 112.507 0.558 . . . . 64.409999999999997 112.507 -177.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.49 -42.67 88.63 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 120.899 0.166 . . . . 61.130000000000003 112.718 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.57 84.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.002 0.921 . . . . 61.340000000000003 111.301 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -60.21 -47.76 84.61 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.098 0.959 . . . . 72.219999999999999 111.289 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.78 -29.81 64.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.525 0.73 . . . . 63.200000000000003 112.168 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.45 -40.77 99.12 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.231 0.332 . . . . 72.120000000000005 112.873 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 60.3 tttp -75.87 -37.91 58.44 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.592 0.757 . . . . 63.130000000000003 111.931 177.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.599 ' HA ' HG11 ' A' ' 32' ' ' VAL . 60.0 t -61.23 -48.59 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 123.487 0.715 . . . . 65.510000000000005 111.586 177.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.46 ' HA ' HD12 ' A' ' 17' ' ' LEU . 30.6 t90 -65.65 -39.01 90.94 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.667 -0.697 . . . . 73.230000000000004 111.311 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -60.62 -38.64 85.43 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.204 0.602 . . . . 62.340000000000003 111.151 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.82 -23.2 63.27 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.419 0.687 . . . . 75.120000000000005 112.257 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 14' ' ' TRP . 70.2 mt -70.54 -44.88 66.6 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.332 0.653 . . . . 64.219999999999999 111.318 169.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -61.0 -32.79 72.36 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.002 0.521 . . . . 73.349999999999994 111.425 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.61 -52.31 32.92 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.383 0.673 . . . . 64.420000000000002 110.551 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.86 102.29 0.56 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.52 0.728 . . . . 63.450000000000003 111.206 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -97.12 -175.13 3.15 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.763 0.825 . . . . 72.019999999999996 110.819 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.05 49.85 7.27 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.365 -0.694 . . . . 75.409999999999997 111.365 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.4 tt -139.33 159.57 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.238 -0.981 . . . . 72.200000000000003 110.867 -163.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.9 m -72.99 146.28 46.1 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.66 0.384 . . . . 74.230000000000004 110.819 171.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 40' ' ' ALA . 70.6 mt -55.96 -46.06 99.81 Favored Pre-proline 0 CA--C 1.58 2.106 0 C-N-CA 124.126 0.97 . . . . 74.310000000000002 112.998 176.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.494 ' HA ' HG22 ' A' ' 36' ' ' VAL . 35.7 Cg_endo -62.54 -29.43 78.38 Favored 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 122.19 1.926 . . . . 53.020000000000003 114.524 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -74.75 -46.62 36.05 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 122.39 1.09 . . . . 72.540000000000006 110.146 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.468 HD22 HG21 ' A' ' 63' ' ' ILE . 58.2 tp -58.45 -38.18 76.98 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 113.259 -1.791 . . . . 73.439999999999998 111.6 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.15 -37.74 75.24 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.237 1.015 . . . . 73.329999999999998 112.345 177.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -67.67 -38.27 83.5 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.415 0.686 . . . . 74.129999999999995 111.712 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 28' ' ' LEU . 42.4 mtmt -69.12 -38.4 78.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.217 0.607 . . . . 52.310000000000002 111.367 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 13' ' ' VAL . 32.3 m -90.86 -1.68 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.731 0.641 . . . . 75.219999999999999 112.731 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 68.09 9.89 7.47 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.175 1.39 . . . . 73.409999999999997 112.46 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.5 mt -95.86 167.55 11.18 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.347 0.659 . . . . 65.329999999999998 111.409 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.5 t -66.47 149.51 50.32 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.661 0.784 . . . . 73.420000000000002 110.845 168.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 26' ' ' PRO . 55.6 t -55.14 -41.81 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.276 0.56 . . . . 72.349999999999994 110.921 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HB3' HD12 ' B' ' 25' ' ' ILE . 42.7 mt-10 -64.65 -39.06 93.03 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.37 1.068 . . . . 63.350000000000001 112.574 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 64.2 p -75.56 -26.56 58.06 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 122.616 0.367 . . . . 65.150000000000006 111.982 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 43' ' ' VAL . 84.9 m -78.57 -43.47 26.46 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.418 0.687 . . . . 63.420000000000002 111.178 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.38 -36.86 85.52 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.376 0.671 . . . . 71.030000000000001 111.263 175.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.511 HD11 HG21 ' B' ' 54' ' ' ILE . 1.0 OUTLIER -58.3 -53.22 60.77 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.512 1.125 . . . . 74.120000000000005 109.94 170.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.86 -31.29 71.55 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.917 -1.038 . . . . 73.519999999999996 111.721 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 39' ' ' THR . 41.7 t -65.86 -37.98 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.565 0.746 . . . . 74.439999999999998 110.687 173.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.48 -31.74 81.21 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-N 116.753 -0.203 . . . . 63.119999999999997 113.499 172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.549 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 66.7 t-105 -73.55 -31.07 63.45 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.656 0.782 . . . . 74.299999999999997 111.47 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.31 -38.83 63.23 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.267 0.627 . . . . 73.040000000000006 111.317 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.54 81.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.37 1.068 . . . . 74.109999999999999 112.317 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.618 ' HB2' ' HD2' ' B' ' 48' ' ' ARG . 9.7 ptt180 -62.65 -34.19 76.57 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 121.196 0.522 . . . . 74.420000000000002 110.543 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -85.97 -1.43 57.32 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.233 1.013 . . . . 64.219999999999999 111.898 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 65.3 22.2 12.06 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.26 1.424 . . . . 75.310000000000002 112.301 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.36 -8.41 50.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 113.078 0.77 . . . . 63.409999999999997 113.078 -173.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.633 ' HB ' HD11 ' A' ' 63' ' ' ILE . 30.2 m -132.15 157.1 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.023 0.529 . . . . 72.420000000000002 112.07 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 64' ' ' TYR . 11.9 m -128.63 123.99 60.63 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 123.83 0.852 . . . . 72.530000000000001 110.41 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.18 125.03 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.848 0.859 . . . . 65.019999999999996 110.075 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -99.66 122.36 42.57 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.05 0.54 . . . . 73.310000000000002 110.976 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.477 ' HG2' HG12 ' A' ' 61' ' ' ILE . 79.2 mtt85 -106.23 98.56 8.22 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.792 0.837 . . . . 74.430000000000007 110.111 173.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -127.59 128.67 45.97 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.596 0.758 . . . . 72.519999999999996 109.617 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 59.14 29.69 19.3 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.7 1.2 . . . . 75.430000000000007 112.137 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.19 1.83 64.97 Favored Glycine 0 CA--C 1.549 2.214 0 CA-C-N 116.05 -0.523 . . . . 63.520000000000003 114.224 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.4 mt -93.89 131.79 38.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.692 0.797 . . . . 53.439999999999998 111.19 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.477 HG12 ' HG2' ' A' ' 56' ' ' ARG . 72.4 mt -101.77 116.97 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 72.349999999999994 110.62 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -121.66 133.28 54.96 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.175 0.99 . . . . 72.310000000000002 109.828 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.633 HD11 ' HB ' ' A' ' 52' ' ' VAL . 7.0 tp -97.29 117.05 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 CA-C-O 121.801 0.81 . . . . 74.019999999999996 111.614 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.482 ' HB2' HG23 ' A' ' 53' ' ' VAL . 77.1 m-85 -109.07 165.88 11.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.957 1.303 . . . . 73.439999999999998 110.341 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.32 142.15 28.1 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.698 -0.853 . . . . 74.439999999999998 108.698 175.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.613 0 C-N-CA 123.831 0.853 . . . . 72.430000000000007 111.98 -176.813 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 112.634 0.605 . . . . 70.109999999999999 112.634 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -87.87 -22.74 24.25 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 122.502 0.321 . . . . 75.310000000000002 110.727 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.61 -50.96 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.071 0.549 . . . . 73.420000000000002 110.426 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.534 HG12 HD11 ' B' ' 41' ' ' LEU . 26.8 m -61.02 -30.52 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 122.531 0.333 . . . . 64.239999999999995 111.471 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.15 -49.19 16.9 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 123.31 0.381 . . . . 74.239999999999995 113.317 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.32 -49.18 72.78 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.696 0.799 . . . . 70.340000000000003 111.78 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -58.89 -41.38 87.03 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.07 0.948 . . . . 74.329999999999998 111.92 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.449 ' HB1' ' HG ' ' B' ' 46' ' ' LEU . . . -66.48 -39.65 88.89 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.173 0.589 . . . . 72.120000000000005 111.952 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.91 -43.75 98.95 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 116.059 -0.519 . . . . 34.340000000000003 112.549 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -68.06 -42.96 79.7 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.978 0.911 . . . . 62.030000000000001 111.77 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.746 ' HA ' HG11 ' B' ' 32' ' ' VAL . 37.7 t -57.94 -44.18 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 124.117 0.967 . . . . 75.430000000000007 111.78 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 45.8 t90 -63.4 -33.42 75.52 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 115.221 -0.9 . . . . 73.219999999999999 112.194 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -61.09 -30.6 70.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.095 0.776 . . . . 73.439999999999998 113.095 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.33 65.88 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.341 0.497 . . . . 54.109999999999999 112.341 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.484 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 96.5 mt -70.55 -21.65 62.68 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.504 0.722 . . . . 73.5 112.619 174.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -64.78 -30.34 71.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.799 0.839 . . . . 65.409999999999997 111.891 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -91.55 -35.83 14.05 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.85 0.46 . . . . 51.100000000000001 111.168 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.43 112.23 1.09 Allowed 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.38 0.511 . . . . 73.519999999999996 112.38 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 9.4 p-10 -80.53 179.36 7.78 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.599 0.76 . . . . 71.299999999999997 110.704 166.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.46 61.14 4.95 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.611 -0.596 . . . . 75.219999999999999 111.611 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 tt -140.84 140.67 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.106 0.963 . . . . 65.319999999999993 110.03 -172.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 68.6 m -83.84 161.0 21.05 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.973 0.509 . . . . 52.32 110.885 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.483 HG21 ' HB2' ' B' ' 40' ' ' ALA . 58.8 mt -59.54 -44.92 98.62 Favored Pre-proline 0 CA--C 1.579 2.087 0 N-CA-C 113.9 1.074 . . . . 71.549999999999997 113.9 -174.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.88 -29.38 41.6 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 121.936 1.758 . . . . 43.200000000000003 114.237 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -71.7 -46.77 57.72 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.744 1.259 . . . . 70.129999999999995 109.654 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.499 HD22 HD11 ' B' ' 63' ' ' ILE . 65.3 tp -58.35 -43.62 88.4 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 112.946 -1.934 . . . . 52.109999999999999 111.681 173.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.68 91.21 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.497 1.119 . . . . 72.140000000000001 113.37 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -71.2 -23.58 62.06 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.073 0.549 . . . . 60.539999999999999 111.73 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -78.53 -44.6 23.92 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.772 0.829 . . . . 71.510000000000005 111.171 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' B' ' 13' ' ' VAL . 17.9 m -86.32 4.84 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.324 0.65 . . . . 64.439999999999998 112.414 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 65.34 17.75 11.1 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.815 1.246 . . . . 72.540000000000006 112.571 171.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 71.4 mt -109.72 158.32 18.22 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.468 0.707 . . . . 74.400000000000006 110.698 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -66.18 153.16 43.2 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.98 0.512 . . . . 44.039999999999999 111.168 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -53.6 -43.44 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 123.571 0.748 . . . . 61.520000000000003 111.964 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.402 ' HB2' HD12 ' A' ' 61' ' ' ILE . 45.7 mt-10 -61.99 -49.67 75.14 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.619 0.767 . . . . 74.230000000000004 112.037 175.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -61.33 -30.76 70.71 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.716 0.806 . . . . 65.430000000000007 112.236 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 87.4 m -77.44 -47.41 19.78 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.052 0.941 . . . . 63.509999999999998 111.304 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.483 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.62 -39.23 93.34 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.545 0.738 . . . . 42.100000000000001 111.99 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.534 HD11 HG12 ' B' ' 6' ' ' VAL . 1.3 tm? -62.41 -38.54 90.06 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.061 1.344 . . . . 75.340000000000003 110.431 174.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.52 -33.59 67.0 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.38 0.672 . . . . 53.130000000000003 111.914 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.71 -35.55 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.801 0.84 . . . . 71.450000000000003 111.482 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.08 -31.86 74.14 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 113.835 0.294 . . . . 60.240000000000002 113.835 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.404 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 72.2 t-105 -75.04 -36.7 61.85 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.426 0.691 . . . . 72.219999999999999 111.499 175.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.449 ' HG ' ' HB1' ' B' ' 10' ' ' ALA . 83.2 mt -66.4 -35.1 79.48 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.03 0.532 . . . . 60.219999999999999 111.311 173.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.73 -35.81 75.32 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.309 1.044 . . . . 41.310000000000002 112.449 172.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.618 ' HD2' ' HB2' ' A' ' 48' ' ' ARG . 49.4 ttt85 -57.17 -45.88 83.28 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.333 0.587 . . . . 73.230000000000004 110.691 171.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.38 -15.29 57.17 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 114.794 -1.093 . . . . 61.350000000000001 112.191 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 t30 65.37 26.7 12.01 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.868 1.267 . . . . 71.430000000000007 111.125 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -82.71 -19.11 38.67 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.507 -0.77 . . . . 75.349999999999994 111.854 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 24.4 m -114.53 140.04 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.19 0.596 . . . . 74.219999999999999 110.455 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 51.7 t -103.71 96.82 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.367 -0.975 . . . . 75.109999999999999 108.367 174.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.651 HG12 HG22 ' B' ' 63' ' ' ILE . 57.0 mt -81.93 123.68 38.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 115.783 -0.644 . . . . 65.400000000000006 109.766 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . 0.489 ' HB3' ' HE2' ' B' ' 64' ' ' TYR . 13.6 tt0 -143.14 127.65 17.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.882 -0.599 . . . . 62.100000000000001 110.525 -172.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -83.77 103.82 13.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.397 0.679 . . . . 71.310000000000002 110.055 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -106.1 122.82 46.95 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.503 1.121 . . . . 71.109999999999999 111.15 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 59.22 31.03 20.88 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 125.162 1.385 . . . . 73.150000000000006 112.772 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.13 -27.87 6.52 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 115.988 -0.551 . . . . 73.319999999999993 113.66 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mp -81.56 165.15 21.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.762 0.825 . . . . 74.230000000000004 109.562 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.71 136.48 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.867 -0.521 . . . . 62.520000000000003 110.684 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -134.47 168.24 19.3 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.175 0.99 . . . . 73.099999999999994 110.851 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.651 HG22 HG12 ' B' ' 54' ' ' ILE . 0.2 OUTLIER -120.53 147.53 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.329 1.052 . . . . 62.530000000000001 110.313 171.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.555 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 93.6 m-85 -124.86 169.53 11.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.471 1.108 . . . . 74.299999999999997 110.405 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' B' ' 21' ' ' ASP . 4.4 m-20 -71.97 148.84 45.58 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.049 0.452 . . . . 64.040000000000006 111.844 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 CA--C 1.55 0.974 0 C-N-CA 124.297 1.039 . . . . 64.150000000000006 111.651 171.084 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 112.439 0.533 . . . . 75.040000000000006 112.439 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.1 mt -53.87 -47.54 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 123.853 0.861 . . . . 74.439999999999998 111.524 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.3 m -61.06 -29.29 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.967 1.307 . . . . 73.329999999999998 112.356 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.04 -41.71 70.23 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.679 0.612 . . . . 72.510000000000005 112.7 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.54 -43.03 98.28 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.315 0.646 . . . . 63.530000000000001 111.262 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -67.51 -35.03 78.32 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.693 0.797 . . . . 52.450000000000003 111.633 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.16 -35.03 68.92 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.496 0.718 . . . . 43.119999999999997 111.699 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.54 -35.96 92.53 Favored Glycine 0 CA--C 1.539 1.535 0 O-C-N 123.497 0.498 . . . . 74.450000000000003 112.631 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -67.74 -48.94 65.04 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.093 0.957 . . . . 73.439999999999998 111.64 175.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.93 -34.74 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.263 0.625 . . . . 50.409999999999997 111.9 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -71.03 -33.93 70.79 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.745 0.818 . . . . 74.140000000000001 110.959 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -66.92 -29.24 69.06 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 71.150000000000006 111.227 172.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.23 -31.35 67.46 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.991 0.516 . . . . 65.349999999999994 111.843 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.533 HD11 HG12 ' A' ' 52' ' ' VAL . 98.1 mt -59.35 -39.32 82.81 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.142 0.977 . . . . 73.019999999999996 113.521 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -11.54 58.79 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 112.445 0.535 . . . . 71.019999999999996 112.445 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -103.61 -39.3 6.76 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.499 1.12 . . . . 61.420000000000002 110.004 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.53 91.67 2.68 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.684 0.794 . . . . 64.129999999999995 112.624 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -85.14 133.89 34.19 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.095 0.558 . . . . 63.549999999999997 110.298 167.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.37 61.79 2.89 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-O 121.155 0.308 . . . . 74.409999999999997 112.733 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.6 tt -126.78 145.34 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.505 0.722 . . . . 71.030000000000001 110.975 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.4 m -68.09 138.43 55.76 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.904 0.881 . . . . 74.099999999999994 110.62 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.744 HG21 ' HB2' ' A' ' 40' ' ' ALA . 76.2 mt -58.36 -42.27 93.84 Favored Pre-proline 0 CA--C 1.583 2.221 0 N-CA-C 114.059 1.133 . . . . 54.299999999999997 114.059 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 36' ' ' VAL . 29.8 Cg_endo -61.99 -32.36 84.29 Favored 'Trans proline' 0 C--N 1.394 2.961 0 C-N-CA 121.93 1.753 . . . . 65.430000000000007 114.123 174.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.17 -45.2 50.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.711 1.243 . . . . 74.109999999999999 109.47 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.588 HD22 HD11 ' A' ' 63' ' ' ILE . 66.7 tp -57.14 -38.89 74.15 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 112.75 -2.023 . . . . 75.120000000000005 111.818 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.17 78.05 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.323 1.049 . . . . 74.310000000000002 112.566 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.25 -42.85 87.98 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.255 0.622 . . . . 74.129999999999995 111.379 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -75.46 -35.13 60.93 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 112.473 0.546 . . . . 72.230000000000004 112.473 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 m -81.64 -9.89 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-O 120.772 0.32 . . . . 74.25 111.122 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 63.23 25.86 14.94 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.498 1.519 . . . . 71.430000000000007 113.203 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.3 mt -105.17 171.63 7.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.313 1.045 . . . . 74.230000000000004 109.887 173.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.7 m -68.07 158.98 31.78 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 122.551 0.34 . . . . 63.340000000000003 110.762 170.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.435 HG22 ' HA ' ' A' ' 26' ' ' PRO . 79.5 t -51.23 -57.06 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 123.286 0.634 . . . . 51.539999999999999 112.095 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.414 ' HG2' ' HB ' ' B' ' 25' ' ' ILE . 2.9 mp0 -66.65 -31.23 71.78 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.147 0.795 . . . . 73.140000000000001 113.147 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -61.67 -44.61 96.63 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.579 0.704 . . . . 74.530000000000001 110.881 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 43' ' ' VAL . 78.4 m -70.23 -41.57 73.42 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.629 -1.168 . . . . 62.009999999999998 111.385 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.744 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -67.5 -41.74 84.02 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.957 0.903 . . . . 64.349999999999994 112.071 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.06 -27.69 64.84 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.237 1.015 . . . . 75.010000000000005 110.518 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.85 -38.06 73.14 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.845 0.458 . . . . 70.530000000000001 111.261 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.531 HG11 HG21 ' A' ' 63' ' ' ILE . 90.3 t -61.88 -33.87 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.33 0.652 . . . . 75.329999999999998 110.089 169.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.48 90.17 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 115.918 -0.583 . . . . 73.340000000000003 113.802 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -67.92 -41.73 82.15 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.111 0.455 . . . . 71.239999999999995 110.229 173.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.38 -38.21 83.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.051 0.541 . . . . 72.239999999999995 110.927 173.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.84 96.49 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.628 0.771 . . . . 62.340000000000003 111.522 175.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 -56.8 -45.01 82.48 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.88 0.472 . . . . 74.420000000000002 111.114 171.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.89 -6.03 56.65 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.217 0.821 . . . . 75.329999999999998 113.217 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 68.53 30.81 5.05 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.115 1.366 . . . . 74.219999999999999 112.417 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -95.78 -13.83 23.79 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.945 1.298 . . . . 70.129999999999995 113.597 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.533 HG12 HD11 ' A' ' 17' ' ' LEU . 8.0 m -120.93 141.39 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.252 0.549 . . . . 75.310000000000002 112.263 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 94.7 t -107.63 107.09 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 124.271 1.028 . . . . 72.540000000000006 109.815 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 63' ' ' ILE . 2.9 mp -86.62 124.84 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 123.231 0.612 . . . . 63.240000000000002 110.001 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.23 116.0 13.06 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.755 0.822 . . . . 72.109999999999999 109.333 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -80.77 102.61 10.08 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.167 0.587 . . . . 64.040000000000006 110.029 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -112.74 124.98 53.81 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.481 0.712 . . . . 72.439999999999998 110.298 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 58.44 31.35 20.86 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.164 0.986 . . . . 74.519999999999996 112.112 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.06 -25.16 7.97 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 116.055 -0.521 . . . . 71.109999999999999 114.023 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.8 mt -79.14 146.22 33.28 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.905 0.882 . . . . 74.319999999999993 112.077 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.12 107.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.185 -0.672 . . . . 71.25 109.185 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.25 120.15 41.1 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.204 0.602 . . . . 64.519999999999996 109.725 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.588 HD11 HD22 ' A' ' 28' ' ' LEU . 2.7 pp -101.09 138.35 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.45 0.643 . . . . 71.120000000000005 111.032 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 93.5 m-85 -122.52 174.5 7.02 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.437 1.095 . . . . 72.319999999999993 110.19 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 63.6 t30 -90.64 158.28 17.02 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.91 0.484 . . . . 64.200000000000003 111.402 174.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.554 1.114 0 C-N-CA 123.992 0.917 . . . . 74.530000000000001 112.179 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.402 ' O ' HG22 ' B' ' 6' ' ' VAL . 71.9 tttt . . . . . 0 CA--C 1.56 1.333 0 CA-C-O 120.641 0.258 . . . . 72.239999999999995 110.809 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -56.0 -24.35 38.4 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 124.37 1.068 . . . . 63.43 112.968 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 69.6 mt -55.63 -44.01 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 123.994 0.918 . . . . 71.430000000000007 111.322 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 3' ' ' LYS . 2.9 m -61.71 -30.17 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 122.67 0.388 . . . . 43.039999999999999 111.461 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.32 92.15 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.485 0.491 . . . . 71.129999999999995 113.403 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.2 -38.11 87.2 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.641 0.776 . . . . 73.510000000000005 111.83 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -79.75 -19.62 48.27 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.159 0.583 . . . . 74.099999999999994 112.089 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.63 -39.5 52.16 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.305 0.642 . . . . 74.340000000000003 110.995 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.17 -30.92 75.09 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.435 -0.802 . . . . 74.019999999999996 112.472 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.452 ' HD2' HD11 ' B' ' 34' ' ' LEU . 4.7 ttmp? -70.72 -49.32 48.24 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.054 0.942 . . . . 71.319999999999993 112.374 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.534 HG13 HD11 ' B' ' 46' ' ' LEU . 2.5 p -66.2 -36.01 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 112.158 0.429 . . . . 70.010000000000005 112.158 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.458 ' HA ' HD12 ' B' ' 17' ' ' LEU . 26.0 t90 -73.17 -32.21 64.71 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.991 -0.443 . . . . 73.340000000000003 111.132 176.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -62.47 -36.32 82.1 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.213 0.605 . . . . 65.450000000000003 110.524 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.63 -32.73 74.47 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.469 -0.787 . . . . 54.109999999999999 111.932 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.49 HD21 HD13 ' B' ' 63' ' ' ILE . 84.8 mt -69.16 -44.38 72.37 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.763 0.825 . . . . 71.340000000000003 111.777 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -56.77 -39.87 74.82 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.933 0.893 . . . . 73.340000000000003 111.79 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -74.02 -50.36 20.11 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.49 0.716 . . . . 71.140000000000001 110.817 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.83 102.91 0.9 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.828 0.851 . . . . 71.510000000000005 110.757 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.2 173.94 10.61 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.802 0.441 . . . . 63.229999999999997 111.47 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.99 65.25 1.77 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.559 -0.291 . . . . 22.140000000000001 112.554 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 tt -151.01 144.93 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.305 0.642 . . . . 70.510000000000005 110.389 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 31.4 t -70.82 150.29 45.97 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.188 0.595 . . . . 64.519999999999996 111.138 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.633 HG21 ' HB2' ' B' ' 40' ' ' ALA . 82.4 mt -58.39 -51.02 84.8 Favored Pre-proline 0 CA--C 1.576 1.959 0 CA-C-O 118.177 -0.916 . . . . 72.450000000000003 113.408 -176.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.408 ' HA ' HG22 ' B' ' 36' ' ' VAL . 20.3 Cg_endo -59.23 -34.77 98.24 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.233 1.956 . . . . 75.519999999999996 113.438 176.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -66.05 -50.92 62.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.326 0.65 . . . . 75.239999999999995 112.226 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.618 HD22 HD11 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -69.9 -32.55 70.94 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.714 0.406 . . . . 71.530000000000001 110.838 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.68 -41.63 77.64 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.887 0.875 . . . . 53.140000000000001 111.637 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -60.11 -40.19 88.83 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.092 0.957 . . . . 74.409999999999997 111.26 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -75.38 -33.13 61.0 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.964 0.906 . . . . 55.140000000000001 112.791 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.4 m -96.57 5.25 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 123.584 0.754 . . . . 72.340000000000003 111.897 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 t30 68.93 10.92 8.17 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 125.212 1.405 . . . . 73.140000000000001 112.642 173.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.452 HD11 ' HD2' ' B' ' 12' ' ' LYS . 54.0 mt -94.57 155.31 16.96 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.662 -0.649 . . . . 74.239999999999995 110.607 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 47.6 m -67.79 152.45 45.56 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.42 0.288 . . . . 74.319999999999993 110.499 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' B' ' 26' ' ' PRO . 64.1 t -51.69 -44.2 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.401 0.681 . . . . 52.32 111.329 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.96 -47.91 83.41 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 114.918 -1.037 . . . . 70.010000000000005 112.242 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -58.97 -41.37 87.39 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.975 0.91 . . . . 44.130000000000003 112.769 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 95.5 m -72.65 -46.68 52.74 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.332 0.653 . . . . 71.310000000000002 111.907 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.633 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.89 -48.61 73.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.0 1.111 . . . . 73.140000000000001 114.0 -168.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -26.53 62.38 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 120.796 0.332 . . . . 71.219999999999999 110.93 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.43 -26.33 65.47 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.697 0.799 . . . . 75.140000000000001 111.99 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.69 -31.65 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 123.005 0.522 . . . . 61.109999999999999 110.991 169.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.27 -28.36 73.65 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.308 -0.405 . . . . 73.120000000000005 113.99 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.552 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 66.0 t-105 -72.11 -27.52 62.69 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.143 0.577 . . . . 63.299999999999997 111.034 172.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.534 HD11 HG13 ' B' ' 13' ' ' VAL . 73.6 mt -73.22 -36.12 66.41 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.751 -0.593 . . . . 65.340000000000003 110.715 169.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.39 -26.88 68.65 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.46 1.104 . . . . 62.409999999999997 113.818 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 12.9 ptt180 -62.1 -35.85 79.94 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 118.817 0.735 . . . . 74.030000000000001 110.288 172.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.472 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 32.6 mt-10 -93.98 -6.27 45.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.819 1.248 . . . . 73.530000000000001 111.687 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 t30 63.08 31.21 16.02 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.841 1.256 . . . . 72.019999999999996 111.56 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -85.68 -6.5 59.13 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.865 0.691 . . . . 50.340000000000003 112.865 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.88 145.81 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.405 0.622 . . . . 63.43 112.356 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' B' ' 64' ' ' TYR . 4.8 m -120.08 128.61 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.048 1.339 . . . . 71.340000000000003 108.304 167.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.436 HG12 HG22 ' B' ' 63' ' ' ILE . 68.2 mt -109.29 137.82 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.928 0.491 . . . . 41.119999999999997 110.754 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -134.99 125.82 27.35 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.707 0.803 . . . . 62.549999999999997 109.565 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -108.01 115.5 30.25 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.493 0.663 . . . . 55.439999999999998 110.606 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.64 126.84 55.71 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.84 1.256 . . . . 74.420000000000002 109.173 -175.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 59.84 29.11 18.68 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.37 1.068 . . . . 64.109999999999999 111.525 -175.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.6 -19.1 16.18 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-N 116.343 -0.39 . . . . 65.049999999999997 113.808 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 tp -78.4 112.01 14.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.062 0.945 . . . . 62.25 110.455 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 mt -83.44 125.14 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 122.512 0.325 . . . . 74.120000000000005 110.848 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -127.42 145.75 50.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.703 0.801 . . . . 74.510000000000005 109.902 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.618 HD11 HD22 ' B' ' 28' ' ' LEU . 2.2 pp -105.83 141.25 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-O 121.552 0.691 . . . . 43.039999999999999 111.63 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.472 ' HB2' HG23 ' B' ' 53' ' ' VAL . 73.2 m-85 -132.13 157.14 45.01 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.502 1.121 . . . . 73.019999999999996 109.228 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -102.98 153.55 20.12 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.051 0.54 . . . . 44.539999999999999 110.421 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 112.224 0.453 . . . . 73.129999999999995 112.224 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 112.885 0.698 . . . . 73.010000000000005 112.885 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.4 mt -60.07 -42.74 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.264 0.626 . . . . 74.540000000000006 111.782 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.626 HG12 HD11 ' A' ' 41' ' ' LEU . 34.5 m -59.42 -33.6 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 111.77 0.285 . . . . 71.530000000000001 111.77 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.75 -39.53 93.62 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 123.213 0.321 . . . . 64.239999999999995 112.986 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.87 -50.51 62.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.254 0.622 . . . . 52.020000000000003 111.828 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -70.6 -31.96 69.14 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.352 0.661 . . . . 74.430000000000007 112.351 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.43 -33.24 60.9 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.856 0.462 . . . . 53.43 111.625 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.65 -31.35 79.68 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.922 -0.581 . . . . 41.310000000000002 113.265 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -75.25 -36.72 61.24 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.566 0.747 . . . . 75.25 111.549 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.8 t -63.29 -41.13 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.369 0.604 . . . . 62.450000000000003 110.92 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 51' ' ' LYS . 77.6 t90 -72.26 -32.31 66.54 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.671 0.788 . . . . 73.230000000000004 111.54 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -61.79 -34.87 76.67 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.161 0.584 . . . . 75.420000000000002 110.679 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.99 -33.93 76.95 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.166 0.586 . . . . 73.129999999999995 111.753 174.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.417 HD11 HG12 ' A' ' 52' ' ' VAL . 92.2 mt -63.62 -27.34 69.17 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.635 0.774 . . . . 74.340000000000003 111.897 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.14 -35.04 77.46 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.299 0.64 . . . . 71.010000000000005 111.651 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -106.72 -65.84 1.06 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.528 0.731 . . . . 73.519999999999996 111.786 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . . . -127.53 84.54 2.26 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.452 0.644 . . . . 72.349999999999994 111.245 -175.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.73 -179.08 5.93 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.514 1.126 . . . . 73.099999999999994 112.972 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.17 52.36 48.01 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 115.698 -0.683 . . . . 62.210000000000001 113.247 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.496 HD13 ' HD2' ' A' ' 31' ' ' LYS . 13.7 tt -140.15 125.31 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.451 0.7 . . . . 72.150000000000006 110.719 -175.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.4 m -50.49 149.41 3.16 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.1 1.36 . . . . 61.219999999999999 113.31 -170.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.456 HG21 ' HB2' ' A' ' 40' ' ' ALA . 80.6 mt -47.62 -48.89 58.22 Favored Pre-proline 0 CA--C 1.576 1.946 0 C-N-CA 124.414 1.086 . . . . 72.109999999999999 113.928 -172.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 36' ' ' VAL . 48.7 Cg_endo -65.79 -37.6 27.11 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 121.847 1.698 . . . . 73.140000000000001 113.702 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -70.01 -46.92 64.09 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.46 1.124 . . . . 72.319999999999993 110.139 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.563 HD22 HG21 ' A' ' 63' ' ' ILE . 54.9 tp -57.61 -34.36 69.19 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 113.28 -1.782 . . . . 74.099999999999994 112.216 170.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 -38.12 82.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.031 0.532 . . . . 74.049999999999997 111.703 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -28.04 63.34 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 111.895 0.332 . . . . 74.439999999999998 111.895 173.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HD2' HD13 ' A' ' 23' ' ' ILE . 26.8 mtpp -68.21 -45.87 72.16 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.016 0.436 . . . . 71.129999999999995 111.644 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.8 m -86.61 -1.91 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.178 0.591 . . . . 61.420000000000002 111.707 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.9 t30 65.92 27.07 10.93 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.147 1.379 . . . . 75.329999999999998 111.767 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.6 mt -114.99 173.05 6.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.098 0.959 . . . . 74.209999999999994 111.759 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 t -68.12 155.6 39.25 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.324 0.65 . . . . 52.100000000000001 111.869 170.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 26' ' ' PRO . 62.2 t -55.44 -41.42 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.484 0.714 . . . . 72.319999999999993 110.641 172.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.17 -49.0 79.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.66 -1.155 . . . . 63.539999999999999 111.427 176.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.8 m -58.18 -43.39 87.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.107 0.963 . . . . 63.200000000000003 111.464 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 43' ' ' VAL . 85.4 m -69.72 -48.06 60.88 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.104 -0.953 . . . . 72.219999999999999 111.811 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -62.09 -38.77 90.12 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 123.459 0.703 . . . . 70.310000000000002 112.32 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.626 HD11 HG12 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -66.85 -40.83 88.05 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.798 1.239 . . . . 74.140000000000001 110.213 174.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.65 -34.73 74.41 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.488 0.715 . . . . 70.200000000000003 112.2 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 39' ' ' THR . 81.0 t -67.0 -32.95 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.56 0.744 . . . . 51.450000000000003 110.405 173.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -66.97 -33.34 83.57 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.141 -0.482 . . . . 31.539999999999999 113.316 173.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -69.35 -38.18 78.0 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.876 0.471 . . . . 63.420000000000002 110.644 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 51' ' ' LYS . 76.5 mt -67.57 -30.52 70.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.819 0.448 . . . . 72.450000000000003 111.437 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.29 75.35 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.309 0.643 . . . . 61.32 112.133 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -62.36 -49.64 74.77 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 122.886 0.474 . . . . 74.349999999999994 110.953 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 64.1 mt-10 -80.05 -8.86 59.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.513 -0.767 . . . . 74.209999999999994 111.547 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 63.42 27.04 15.13 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.9 1.28 . . . . 52.119999999999997 111.911 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 39.9 mmtm -69.86 -17.92 63.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.527 1.131 . . . . 61.420000000000002 112.308 175.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.417 HG12 HD11 ' A' ' 17' ' ' LEU . 34.6 m -129.24 154.48 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.145 0.578 . . . . 63.43 112.387 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 64' ' ' TYR . 34.9 m -120.77 132.27 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.494 0.718 . . . . 75.319999999999993 109.077 165.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 mm -110.45 123.63 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.206 0.602 . . . . 75.349999999999994 111.412 -173.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 49.5 mt-10 -106.16 155.62 19.27 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.166 0.586 . . . . 74.209999999999994 111.367 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.21 94.04 4.78 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.817 -1.549 . . . . 63.520000000000003 106.817 160.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.86 111.7 24.46 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.718 0.807 . . . . 73.239999999999995 108.886 -173.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 60.35 30.35 19.75 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.285 1.034 . . . . 64.140000000000001 110.114 -161.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.6 -12.98 25.26 Favored Glycine 0 C--N 1.36 1.904 0 CA-C-N 115.506 -0.77 . . . . 62.43 114.422 -173.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.79 117.48 19.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.299 0.64 . . . . 73.329999999999998 111.269 -177.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 67.1 mt -69.21 116.05 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.791 0.836 . . . . 72.319999999999993 111.254 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -126.01 140.49 52.56 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.891 0.876 . . . . 74.409999999999997 110.983 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.563 HG21 HD22 ' A' ' 28' ' ' LEU . 7.2 tt -92.74 133.17 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 124.235 1.014 . . . . 74.439999999999998 111.017 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.446 ' HB2' HG23 ' A' ' 53' ' ' VAL . 73.0 m-85 -131.63 173.22 11.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.492 1.117 . . . . 64.519999999999996 110.323 173.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -73.62 150.5 41.33 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.346 0.658 . . . . 72.439999999999998 111.196 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.484 1.271 0 C-N-CA 124.843 1.257 . . . . 64.400000000000006 113.607 171.704 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.556 1.201 0 N-CA-C 112.965 0.728 . . . . 63.340000000000003 112.965 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -84.05 -44.29 14.25 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.473 0.709 . . . . 70.109999999999999 111.034 173.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.66 -45.56 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.815 0.846 . . . . 65.5 111.93 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.563 HG12 HD11 ' B' ' 41' ' ' LEU . 34.8 m -61.28 -32.16 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.753 0.821 . . . . 72.200000000000003 112.157 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.83 62.26 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.27 0.356 . . . . 74.209999999999994 112.647 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.74 -45.78 88.34 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.589 0.756 . . . . 64.430000000000007 111.883 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -64.67 -41.08 96.32 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.773 0.829 . . . . 72.439999999999998 111.799 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.95 -31.3 70.08 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.885 0.474 . . . . 72.209999999999994 111.646 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.59 -38.38 96.2 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.847 -0.615 . . . . 72.349999999999994 112.882 174.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -75.1 -36.65 61.67 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.71 0.804 . . . . 71.310000000000002 111.434 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.552 ' HA ' HG11 ' B' ' 32' ' ' VAL . 92.7 t -67.63 -42.71 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.135 0.574 . . . . 63.450000000000003 111.368 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.494 ' HA ' HD12 ' B' ' 17' ' ' LEU . 19.5 t90 -68.56 -33.23 73.72 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.984 -0.553 . . . . 61.229999999999997 110.521 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . 0.413 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 66.3 t60 -62.34 -31.41 72.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.715 0.806 . . . . 64.129999999999995 111.638 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.43 67.31 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.706 0.402 . . . . 52.229999999999997 111.868 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' B' ' 14' ' ' TRP . 98.5 mt -64.14 -45.04 90.29 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.838 0.855 . . . . 70.019999999999996 113.137 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -12.77 61.88 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 111.733 0.272 . . . . 62.350000000000001 111.733 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 20.4 mm-40 -81.08 -57.71 3.4 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.398 0.679 . . . . 71.319999999999993 109.753 171.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.16 105.15 3.19 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.5 0.72 . . . . 73.140000000000001 110.756 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.95 168.56 14.06 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.723 0.809 . . . . 64.439999999999998 111.458 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.26 64.98 2.09 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 112.477 -0.249 . . . . 45.32 112.477 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.432 ' O ' HG22 ' B' ' 63' ' ' ILE . 18.1 tt -146.32 156.22 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 C-N-CA 123.663 0.785 . . . . 71.400000000000006 110.303 -175.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -81.18 156.64 25.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.806 -0.559 . . . . 73.439999999999998 111.547 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.58 HG21 ' HB2' ' B' ' 40' ' ' ALA . 59.8 mt -58.84 -48.37 96.93 Favored Pre-proline 0 CA--C 1.577 1.994 0 N-CA-C 113.598 0.962 . . . . 75.040000000000006 113.598 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.468 ' HA ' HG22 ' B' ' 36' ' ' VAL . 55.1 Cg_endo -66.41 -23.9 50.44 Favored 'Trans proline' 0 C--N 1.395 3.001 0 CA-C-N 121.951 1.733 . . . . 71.329999999999998 114.138 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.19 -46.36 18.06 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.015 0.912 . . . . 64.209999999999994 109.608 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.56 HD22 HG21 ' B' ' 63' ' ' ILE . 59.0 tp -58.23 -34.45 70.45 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 113.735 -1.575 . . . . 74.219999999999999 111.681 173.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.15 85.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.951 0.9 . . . . 65.219999999999999 111.898 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -69.33 -40.33 77.65 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.603 0.761 . . . . 74.450000000000003 110.349 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -62.34 -35.69 79.88 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.568 0.747 . . . . 72.400000000000006 111.741 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.552 HG11 ' HA ' ' B' ' 13' ' ' VAL . 19.6 m -97.52 -1.24 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.074 0.55 . . . . 72.420000000000002 112.457 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 69.38 11.12 8.02 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.853 1.261 . . . . 70.420000000000002 112.575 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt -101.37 171.15 7.76 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.421 0.688 . . . . 73.340000000000003 111.351 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 29.7 t -66.07 154.23 40.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.909 0.484 . . . . 32.439999999999998 111.144 169.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' B' ' 26' ' ' PRO . 55.0 t -56.84 -40.16 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.247 0.619 . . . . 72.349999999999994 111.096 177.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.08 -43.79 77.76 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.404 -0.816 . . . . 74.310000000000002 111.839 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -61.04 -32.29 71.91 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.464 0.706 . . . . 74.409999999999997 111.798 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.45 ' O ' HG23 ' B' ' 43' ' ' VAL . 74.5 m -80.74 -47.86 13.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.078 0.951 . . . . 45.149999999999999 111.496 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.58 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.1 -40.2 95.7 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.603 0.761 . . . . 75.310000000000002 112.41 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.563 HD11 HG12 ' B' ' 6' ' ' VAL . 1.1 tm? -64.2 -34.95 79.27 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 124.813 1.245 . . . . 60.409999999999997 110.368 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.0 -33.52 61.84 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.617 0.767 . . . . 60.119999999999997 112.11 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 39' ' ' THR . 54.3 t -62.53 -37.56 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.784 0.834 . . . . 71.099999999999994 110.361 172.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -64.38 -30.42 77.81 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-N 116.057 -0.519 . . . . 70.129999999999995 113.63 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.477 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 67.3 t-105 -74.1 -31.3 62.73 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.805 0.442 . . . . 74.140000000000001 111.304 175.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 96.2 mt -72.18 -38.19 69.14 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.813 0.445 . . . . 61.020000000000003 110.808 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.32 -28.82 69.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.094 0.958 . . . . 74.420000000000002 112.049 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 26.2 ttt-85 -53.34 -49.47 67.04 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.652 0.781 . . . . 75.129999999999995 110.841 168.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -94.46 6.15 49.64 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.903 0.881 . . . . 65.239999999999995 112.739 -175.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.38 23.8 14.13 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 124.66 1.184 . . . . 75.109999999999999 113.255 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -80.35 -0.67 37.86 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.17 0.804 . . . . 72.439999999999998 113.17 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.05 147.99 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.667 0.787 . . . . 72.510000000000005 111.739 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.749 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 39.0 t -106.77 118.99 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.567 0.747 . . . . 71.129999999999995 109.007 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 46.6 mm -113.59 130.79 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 123.129 0.572 . . . . 64.099999999999994 111.296 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -133.79 132.68 40.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.621 0.768 . . . . 74.340000000000003 111.06 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -88.04 103.91 16.16 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.253 0.621 . . . . 52.130000000000003 110.976 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -110.38 112.49 24.46 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.356 1.062 . . . . 75.219999999999999 110.006 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 62.03 30.4 17.92 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.921 1.289 . . . . 74.549999999999997 112.523 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.82 -15.59 60.28 Favored Glycine 0 CA--C 1.543 1.841 0 CA-C-N 116.458 -0.337 . . . . 40.310000000000002 113.717 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 mp -93.37 147.02 23.3 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.998 0.919 . . . . 54.140000000000001 111.059 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mm -82.64 126.96 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.164 0.586 . . . . 74.349999999999994 111.394 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -110.5 122.44 47.74 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.21 1.004 . . . . 64.040000000000006 109.459 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.56 HG21 HD22 ' B' ' 28' ' ' LEU . 10.2 tt -108.49 139.01 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.408 0.623 . . . . 61.130000000000003 111.829 -175.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.749 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 90.9 m-85 -128.53 170.41 13.23 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.459 1.104 . . . . 71.439999999999998 110.523 176.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -91.04 162.4 14.72 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.552 0.741 . . . . 73.129999999999995 110.226 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.569 1.674 0 C-N-CA 122.837 0.455 . . . . 73.409999999999997 111.469 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 111.747 0.277 . . . . 70.129999999999995 111.747 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.07 -50.93 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.539 0.736 . . . . 63.420000000000002 111.117 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.428 HG11 HD11 ' A' ' 41' ' ' LEU . 6.3 m -73.66 -27.71 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.787 1.235 . . . . 65.340000000000003 111.418 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.39 -35.67 87.75 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 112.421 -0.272 . . . . 35.210000000000001 112.421 171.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.79 -56.16 5.32 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.564 0.746 . . . . 55.25 111.954 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -71.12 -22.76 62.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.951 0.723 . . . . 73.25 112.951 -173.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.612 ' HA ' HG22 ' A' ' 13' ' ' VAL . . . -67.14 -26.68 66.79 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.623 0.369 . . . . 64.219999999999999 111.12 174.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.67 -36.19 92.03 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.11 -0.496 . . . . 72.430000000000007 112.861 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -76.86 -41.99 41.78 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.564 0.746 . . . . 73.519999999999996 112.303 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' A' ' 10' ' ' ALA . 12.4 m -69.83 -34.93 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 122.141 -0.349 . . . . 72.439999999999998 110.82 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -71.67 -32.62 68.07 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.238 0.615 . . . . 74.129999999999995 111.083 172.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -61.54 -46.42 89.99 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.706 0.403 . . . . 73.010000000000005 110.967 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB1' ' HE2' ' A' ' 31' ' ' LYS . . . -66.74 -34.58 78.16 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.913 0.885 . . . . 74.239999999999995 111.46 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.37 -45.45 72.75 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.609 1.164 . . . . 54.450000000000003 111.299 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -75.53 -25.76 57.47 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.358 0.663 . . . . 74.109999999999999 110.703 -175.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -71.25 -41.3 70.28 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.029 0.932 . . . . 73.430000000000007 110.283 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.9 107.03 2.28 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.657 0.783 . . . . 65.129999999999995 110.261 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.13 179.32 5.11 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.683 0.793 . . . . 71.349999999999994 112.363 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.51 56.43 7.58 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 111.956 -0.458 . . . . 44.009999999999998 111.956 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 28' ' ' LEU . 9.4 tp -130.3 125.54 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 123.359 0.664 . . . . 73.439999999999998 110.768 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -80.57 153.59 27.97 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.215 0.606 . . . . 72.319999999999993 111.117 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 40' ' ' ALA . 62.5 mt -52.06 -53.3 53.37 Favored Pre-proline 0 CA--C 1.577 2.003 0 N-CA-C 114.324 1.231 . . . . 70.209999999999994 114.324 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.12 -21.88 23.28 Favored 'Trans proline' 0 C--N 1.39 2.753 0 CA-C-N 121.197 1.463 . . . . 51.539999999999999 114.179 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -78.59 -44.7 23.42 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 122.107 0.956 . . . . 74.319999999999993 109.326 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.496 ' HB2' HG13 ' A' ' 23' ' ' ILE . 50.3 tp -57.2 -37.48 72.24 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 113.524 -1.671 . . . . 64.120000000000005 111.149 172.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.56 -39.79 85.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.991 0.916 . . . . 62.210000000000001 112.005 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -73.21 -34.21 65.81 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.316 0.646 . . . . 75.239999999999995 111.48 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HE2' ' HB1' ' A' ' 16' ' ' ALA . 55.5 mtpt -62.87 -44.11 96.99 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.323 0.649 . . . . 64.230000000000004 111.182 175.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 13' ' ' VAL . 19.2 m -93.05 -4.02 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.592 0.757 . . . . 71.140000000000001 112.315 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 68.67 13.89 8.95 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.272 1.429 . . . . 70.510000000000005 113.532 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 73.1 mt -95.9 170.65 9.15 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.377 0.671 . . . . 74.150000000000006 111.228 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -67.1 150.74 48.75 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.212 0.605 . . . . 74.109999999999999 111.538 170.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.8 t -56.11 -43.63 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.597 0.759 . . . . 73.340000000000003 111.14 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -60.74 -45.62 93.61 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.388 -0.824 . . . . 70.140000000000001 112.0 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.5 m -65.98 -30.79 71.4 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.453 0.701 . . . . 64.129999999999995 112.009 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -80.17 -39.26 29.65 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.474 0.71 . . . . 63.439999999999998 111.654 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.75 -38.74 92.0 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.67 0.748 . . . . 74.340000000000003 111.076 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.428 HD11 HG11 ' A' ' 6' ' ' VAL . 1.2 tm? -69.82 -38.01 76.42 Favored 'General case' 0 CA--C 1.562 1.44 0 CA-C-N 114.184 -1.371 . . . . 74.099999999999994 110.743 175.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.59 -39.62 84.81 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 122.995 0.518 . . . . 71.409999999999997 111.655 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.2 -38.51 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.905 0.882 . . . . 72.310000000000002 111.176 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.36 -33.0 86.08 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.365 -0.38 . . . . 61.439999999999998 112.823 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.43 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 74.1 t-105 -69.4 -40.53 77.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.548 0.739 . . . . 74.299999999999997 110.352 174.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.71 -32.92 74.54 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.948 0.499 . . . . 71.019999999999996 111.796 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.6 89.5 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.387 0.675 . . . . 51.109999999999999 110.968 171.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 12.4 ttt180 -59.69 -50.18 74.87 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.078 0.551 . . . . 74.409999999999997 111.216 168.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 45' ' ' TRP . 8.7 mm-40 -76.13 -1.43 26.14 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.917 0.887 . . . . 71.430000000000007 112.706 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.12 33.77 19.29 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.86 1.264 . . . . 73.219999999999999 112.526 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -93.28 -23.21 18.58 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.106 0.962 . . . . 72.319999999999993 112.25 177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.09 157.2 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 113.416 0.895 . . . . 64.140000000000001 113.416 -173.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 64' ' ' TYR . 2.3 m -133.4 144.21 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.162 1.385 . . . . 44.409999999999997 110.123 175.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.726 HG12 HD11 ' B' ' 41' ' ' LEU . 2.6 mp -108.82 128.3 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.609 0.763 . . . . 75.25 111.067 -171.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -115.21 119.09 35.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.457 1.103 . . . . 55.530000000000001 109.833 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HG2' HG12 ' A' ' 61' ' ' ILE . 98.6 mtt180 -100.38 125.72 46.67 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.104 0.478 . . . . 73.239999999999995 111.156 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.87 131.11 13.6 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.979 0.912 . . . . 72.329999999999998 109.951 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 60.3 28.51 18.12 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.781 1.232 . . . . 62.210000000000001 111.802 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.49 -8.26 62.33 Favored Glycine 0 CA--C 1.544 1.844 0 N-CA-C 113.87 0.308 . . . . 71.219999999999999 113.87 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.38 160.91 14.05 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.95 0.9 . . . . 70.019999999999996 111.358 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.65 HG23 HG23 ' A' ' 54' ' ' ILE . 78.9 mt -112.64 127.96 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.866 0.866 . . . . 60.420000000000002 110.705 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -112.57 140.97 46.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.999 0.92 . . . . 62.149999999999999 109.544 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.85 133.76 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.018 0.927 . . . . 75.430000000000007 108.726 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HB2' HG23 ' A' ' 53' ' ' VAL . 88.6 m-85 -129.91 169.31 15.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.91 1.284 . . . . 55.210000000000001 109.84 177.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -85.97 138.22 32.15 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.143 0.577 . . . . 65.219999999999999 110.311 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 CA--C 1.566 1.573 0 CA-C-O 121.457 0.646 . . . . 72.040000000000006 112.125 179.603 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.417 ' O ' HG22 ' B' ' 6' ' ' VAL . 87.7 tttt . . . . . 0 CA--C 1.565 1.548 0 CA-C-O 121.384 0.612 . . . . 63.109999999999999 110.679 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.36 -26.99 65.86 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.071 0.948 . . . . 75.239999999999995 111.935 173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.11 -43.18 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.525 0.73 . . . . 72.340000000000003 111.712 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.417 HG22 ' O ' ' B' ' 3' ' ' LYS . 25.5 m -65.36 -28.91 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-N 117.641 0.201 . . . . 64.420000000000002 111.319 176.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' B' ' 45' ' ' TRP . . . -67.74 -46.36 68.64 Favored Glycine 0 C--N 1.354 1.534 0 O-C-N 123.519 0.512 . . . . 72.430000000000007 113.7 175.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.48 99.12 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.646 0.778 . . . . 63.539999999999999 111.162 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -70.34 -30.58 67.57 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.944 0.898 . . . . 64.049999999999997 112.238 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.7 66.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.066 0.546 . . . . 73.519999999999996 111.371 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.81 -36.23 93.07 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 116.006 -0.543 . . . . 63.509999999999998 112.839 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -70.11 -43.32 71.26 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.315 1.046 . . . . 75.409999999999997 111.155 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.601 ' HA ' HG11 ' B' ' 32' ' ' VAL . 42.9 t -60.48 -46.37 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 124.257 1.023 . . . . 70.430000000000007 111.727 176.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.582 ' HA ' HD12 ' B' ' 17' ' ' LEU . 66.8 t90 -66.97 -33.61 75.95 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.851 -0.613 . . . . 53.450000000000003 112.056 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -64.38 -35.15 79.97 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.812 0.445 . . . . 63.149999999999999 110.645 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.525 ' HB1' ' HE3' ' B' ' 31' ' ' LYS . . . -72.02 -23.87 61.46 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.663 0.785 . . . . 71.450000000000003 112.833 174.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' B' ' 14' ' ' TRP . 84.9 mt -70.2 -47.08 63.09 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.57 0.748 . . . . 64.030000000000001 110.692 169.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.87 -28.29 67.41 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.554 0.742 . . . . 63.43 111.305 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -72.22 -51.43 21.09 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.048 0.939 . . . . 55.310000000000002 110.396 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.47 118.37 2.21 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.079 0.551 . . . . 73.450000000000003 112.127 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -82.72 -178.06 6.95 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.301 1.04 . . . . 60.140000000000001 112.04 172.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.07 26.16 73.03 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.823 -0.626 . . . . 71.530000000000001 112.242 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 tp -106.76 146.4 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 124.042 0.937 . . . . 73.129999999999995 109.715 -173.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -95.0 162.37 13.76 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.31 0.644 . . . . 63.530000000000001 109.922 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.521 HG21 ' HB2' ' B' ' 40' ' ' ALA . 76.4 mt -56.35 -49.1 95.34 Favored Pre-proline 0 CA--C 1.58 2.118 0 N-CA-C 114.025 1.12 . . . . 65.510000000000005 114.025 -173.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.69 -30.31 42.01 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.027 1.818 . . . . 73.219999999999999 114.106 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -79.12 -42.35 26.47 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.203 1.001 . . . . 62.140000000000001 110.442 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.438 HD21 HG13 ' B' ' 13' ' ' VAL . 65.7 tp -58.04 -40.66 81.49 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.625 -1.625 . . . . 64.329999999999998 111.112 170.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.24 78.61 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.928 0.891 . . . . 72.150000000000006 111.83 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -67.03 -37.62 84.44 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.166 0.587 . . . . 73.109999999999999 111.51 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.525 ' HE3' ' HB1' ' B' ' 16' ' ' ALA . 44.4 mtmt -66.79 -39.95 87.95 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.826 0.45 . . . . 71.219999999999999 111.315 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' B' ' 13' ' ' VAL . 33.9 m -96.09 7.14 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.823 0.675 . . . . 64.230000000000004 112.823 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 65.8 t30 65.33 12.38 8.04 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.176 0.99 . . . . 75.310000000000002 112.783 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 59.8 mt -97.11 168.59 10.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.674 -0.641 . . . . 72.329999999999998 110.747 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 68.3 m -74.68 159.8 31.6 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.597 0.359 . . . . 64.439999999999998 110.998 170.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 70.1 t -52.49 -57.72 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.303 1.041 . . . . 60.039999999999999 112.589 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -68.61 -30.52 69.27 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.639 0.775 . . . . 73.219999999999999 111.669 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 56.0 m -61.17 -39.82 91.56 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.733 0.813 . . . . 64.209999999999994 111.408 173.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.441 ' O ' HG23 ' B' ' 43' ' ' VAL . 90.4 m -76.72 -42.37 41.55 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.722 0.809 . . . . 64.319999999999993 111.536 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -59.6 -39.74 85.21 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 123.81 0.844 . . . . 73.030000000000001 111.921 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.726 HD11 HG12 ' A' ' 54' ' ' ILE . 1.1 tt -60.41 -50.32 74.07 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.808 1.243 . . . . 72.319999999999993 110.009 173.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 -27.06 68.65 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 114.843 -1.071 . . . . 63.119999999999997 112.089 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 39' ' ' THR . 65.7 t -68.48 -39.96 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 123.388 0.675 . . . . 61.329999999999998 110.649 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.12 -27.8 73.19 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-N 116.379 -0.373 . . . . 73.510000000000005 113.07 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' TRP . . . . . 0.524 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 64.6 t-105 -74.82 -32.22 61.9 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.494 0.718 . . . . 73.230000000000004 111.466 173.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.58 -27.15 62.95 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.243 0.617 . . . . 63.229999999999997 111.765 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.02 67.96 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 113.199 0.814 . . . . 51.399999999999999 113.199 172.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 36.8 ptt85 -74.31 -29.18 61.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.861 -0.524 . . . . 73.420000000000002 110.968 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.5 ' HB3' ' HE2' ' B' ' 51' ' ' LYS . 21.7 mm-40 -72.22 -22.78 61.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.056 0.942 . . . . 73.120000000000005 112.359 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 59.41 35.06 22.94 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.275 1.03 . . . . 74.310000000000002 112.452 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.5 ' HE2' ' HB3' ' B' ' 49' ' ' GLU . 51.3 mtmt -108.49 0.44 20.94 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.683 0.623 . . . . 74.420000000000002 112.683 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.52 147.93 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 112.644 0.609 . . . . 75.430000000000007 112.644 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.66 108.25 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.798 0.839 . . . . 72.010000000000005 109.807 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 2.6 mp -89.97 112.34 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 108.499 -0.926 . . . . 73.239999999999995 108.499 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -102.21 126.51 49.21 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.835 0.454 . . . . 70.030000000000001 110.352 174.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -90.79 96.29 10.56 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.356 -0.979 . . . . 75.030000000000001 108.356 168.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -104.78 109.33 21.23 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.903 1.281 . . . . 71.540000000000006 109.093 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 55.15 29.16 12.12 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.559 1.144 . . . . 75.109999999999999 111.004 -164.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.17 -20.73 35.11 Favored Glycine 0 CA--C 1.549 2.197 0 CA-C-N 115.478 -0.783 . . . . 64.230000000000004 114.58 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.73 130.15 34.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 117.821 0.811 . . . . 52.210000000000001 111.83 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -84.05 114.96 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 123.458 0.703 . . . . 72.120000000000005 111.508 -173.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.28 142.94 46.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.017 0.927 . . . . 74.25 109.107 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 6.4 tp -106.74 128.3 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 CA-C-O 121.607 0.717 . . . . 72.140000000000001 110.709 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -126.63 171.48 11.1 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.692 1.197 . . . . 71.030000000000001 110.001 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 39.4 t30 -100.51 152.54 20.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.444 1.098 . . . . 72.140000000000001 108.889 170.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 . . . . . 0 N--CA 1.486 1.364 0 C-N-CA 123.819 0.847 . . . . 72.120000000000005 112.545 -177.626 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' SD ' ' HB2' ' A' ' 4' ' ' LYS . 17.1 tmm? . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 109.637 -0.505 . . . . 61.130000000000003 109.637 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.54 -44.32 0.28 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.707 0.803 . . . . 75.430000000000007 111.611 -173.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.51 ' HA ' HG22 ' A' ' 6' ' ' VAL . 51.5 mttp -66.9 -22.86 65.95 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.228 0.825 . . . . 71.439999999999998 113.228 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 29.3 mtpp -75.88 -38.67 57.62 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.19 0.596 . . . . 73.140000000000001 111.162 173.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.408 HG13 ' SD ' ' A' ' 1' ' ' MET . 57.8 mt -65.55 -55.94 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.434 0.693 . . . . 74.200000000000003 110.888 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 3' ' ' LYS . 11.3 m -69.34 -26.22 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.071 -0.968 . . . . 74.409999999999997 111.223 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.79 -40.24 95.54 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 116.491 -0.322 . . . . 42.039999999999999 113.138 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.97 -54.47 13.14 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.623 0.769 . . . . 70.040000000000006 112.527 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -71.82 -20.97 61.76 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.171 0.804 . . . . 61.140000000000001 113.171 -174.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 -30.41 70.55 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.462 0.705 . . . . 74.299999999999997 111.818 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.86 -35.84 90.19 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 116.239 -0.437 . . . . 62.32 113.063 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.86 -42.65 60.49 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.562 0.745 . . . . 52.530000000000001 111.791 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.63 ' HA ' HG11 ' A' ' 32' ' ' VAL . 35.0 m -68.49 -38.75 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 122.282 0.233 . . . . 75.299999999999997 111.503 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.618 ' HA ' HD12 ' A' ' 17' ' ' LEU . 69.7 t90 -64.29 -36.42 84.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.973 0.909 . . . . 73.239999999999995 111.561 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.18 -40.7 98.27 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.952 0.901 . . . . 70.109999999999999 111.282 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.423 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -68.59 -24.23 64.57 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.394 0.678 . . . . 72.519999999999996 112.556 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 14' ' ' TRP . 52.1 mt -73.49 -33.87 65.02 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.835 0.854 . . . . 63.130000000000003 112.078 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.502 HD21 ' H ' ' A' ' 73' ' ' PHE . 3.5 t-20 -60.54 -36.58 78.78 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.609 0.764 . . . . 74.120000000000005 110.983 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.19 -59.86 4.33 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.384 1.074 . . . . 71.310000000000002 111.497 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.37 114.18 0.76 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.198 0.999 . . . . 61.439999999999998 110.275 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -98.16 -179.21 4.31 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.751 0.82 . . . . 75.540000000000006 111.721 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.43 26.32 47.64 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 112.6 -170.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.4 tt -104.29 147.63 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 C-N-CA 123.658 0.783 . . . . 74.310000000000002 111.367 -172.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.4 t -76.51 160.0 29.87 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.246 1.018 . . . . 73.239999999999995 111.938 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.5 mm -55.76 -56.61 28.14 Favored Pre-proline 0 CA--C 1.575 1.937 0 N-CA-C 113.523 0.934 . . . . 74.329999999999998 113.523 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.8 -22.47 27.25 Favored 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 121.691 1.594 . . . . 61.210000000000001 113.909 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -75.85 -47.92 23.6 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 122.273 1.035 . . . . 73.450000000000003 110.227 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.48 -40.51 78.72 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 113.511 -1.677 . . . . 71.200000000000003 111.291 170.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.09 70.29 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.272 1.029 . . . . 52.200000000000003 113.039 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -73.62 -35.91 65.4 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.285 0.634 . . . . 73.239999999999995 112.287 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.423 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 45.0 mtmt -71.81 -43.99 64.7 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 120.905 0.383 . . . . 72.200000000000003 111.255 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 13' ' ' VAL . 20.0 m -86.93 -11.56 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.037 0.535 . . . . 63.350000000000001 112.3 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 60.72 37.77 18.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.731 1.213 . . . . 73.150000000000006 113.12 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.5 mt -106.85 157.31 17.85 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.574 0.75 . . . . 72.239999999999995 110.585 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 m -61.05 150.18 34.6 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.226 0.611 . . . . 64.099999999999994 111.361 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.6 t -54.91 -48.89 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.547 0.739 . . . . 71.230000000000004 112.466 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -59.8 -39.77 86.12 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.128 0.571 . . . . 75.420000000000002 111.724 174.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.7 t -68.84 -37.31 79.05 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.527 0.731 . . . . 64.200000000000003 112.825 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.5 m -71.6 -47.89 51.71 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.618 0.767 . . . . 61.229999999999997 110.699 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.78 93.58 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.007 0.923 . . . . 74.319999999999993 112.174 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.77 -35.28 64.97 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.16 0.984 . . . . 72.209999999999994 111.345 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.32 98.85 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.464 0.65 . . . . 73.310000000000002 110.891 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.574 HG11 HD13 ' A' ' 63' ' ' ILE . 69.9 t -64.4 -31.47 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 C-N-CA 123.813 0.845 . . . . 71.239999999999995 111.672 172.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.34 -32.44 82.87 Favored Glycine 0 CA--C 1.544 1.87 0 N-CA-C 113.888 0.315 . . . . 23.510000000000002 113.888 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -68.58 -32.71 72.81 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.591 0.757 . . . . 64.430000000000007 111.282 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.53 -41.02 69.67 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.414 0.686 . . . . 74.140000000000001 110.89 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.59 -26.92 64.15 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.549 1.139 . . . . 72.25 112.6 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -52.95 -45.07 67.53 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.889 0.876 . . . . 63.299999999999997 112.102 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -103.87 3.78 34.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.031 0.932 . . . . 74.310000000000002 112.147 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.7 m120 54.7 36.63 26.66 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.149 0.98 . . . . 71.219999999999999 112.595 -170.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -67.66 -18.22 64.87 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.356 0.663 . . . . 75.109999999999999 110.441 166.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.15 148.44 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.207 1.003 . . . . 74.109999999999999 109.974 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 64' ' ' TYR . 20.3 m -128.96 134.75 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.906 0.882 . . . . 73.319999999999993 108.98 173.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.71 128.8 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 121.206 0.527 . . . . 72.140000000000001 112.278 -167.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -122.54 141.33 51.78 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.667 1.187 . . . . 70.540000000000006 109.54 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -117.25 110.54 18.24 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.819 0.342 . . . . 71.120000000000005 110.865 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -111.28 126.78 55.26 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.052 -0.721 . . . . 70.219999999999999 109.052 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 56.95 31.1 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.463 1.105 . . . . 71.549999999999997 112.103 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.29 -15.56 38.98 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 114.431 0.533 . . . . 73.540000000000006 114.431 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.9 mt -74.15 151.7 39.99 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.349 0.659 . . . . 75.450000000000003 111.469 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 mp -99.88 111.97 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 123.157 0.583 . . . . 71.099999999999994 110.055 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -98.38 141.06 31.73 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.492 0.717 . . . . 73.209999999999994 110.065 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.574 HD13 HG11 ' A' ' 43' ' ' VAL . 61.7 mt -116.04 113.32 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.046 0.538 . . . . 63.409999999999997 110.479 172.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.461 ' HB2' HG23 ' A' ' 53' ' ' VAL . 9.0 m-30 -97.29 150.15 21.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.685 0.794 . . . . 74.140000000000001 110.583 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 17.9 t-20 -92.71 141.57 28.32 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.264 0.626 . . . . 74.129999999999995 109.59 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.98 -18.56 46.67 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.154 0.798 . . . . 64.230000000000004 113.154 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.68 -32.28 73.57 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 115.278 0.871 . . . . 63.140000000000001 115.278 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -68.66 -8.83 45.95 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 118.245 1.022 . . . . 73.540000000000006 112.171 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -84.35 -54.16 4.97 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.283 0.633 . . . . 70.400000000000006 110.563 170.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -102.96 -76.1 0.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.342 0.657 . . . . 75.319999999999993 112.038 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -143.38 122.27 12.73 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.091 0.556 . . . . 73.219999999999999 111.362 -175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.1 t -138.44 147.15 42.97 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.64 0.776 . . . . 65.129999999999995 110.062 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.502 ' H ' HD21 ' A' ' 18' ' ' ASN . 10.8 p90 -149.71 113.77 5.14 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.109 0.564 . . . . 75.209999999999994 110.714 -174.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.84 41.6 3.06 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 112.372 -0.291 . . . . 64.439999999999998 112.372 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.37 -36.73 83.18 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.282 1.033 . . . . 64.129999999999995 111.225 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -69.07 109.39 3.98 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.867 -0.79 . . . . 73.310000000000002 108.867 169.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -71.79 84.37 0.92 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 122.775 0.43 . . . . 51.299999999999997 112.1 -170.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 50.29 99.9 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 125.628 1.571 . . . . 75.109999999999999 114.686 170.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -69.96 112.05 6.09 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.581 -0.526 . . . . 72.430000000000007 109.581 170.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -67.85 151.81 46.57 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.624 0.369 . . . . 74.040000000000006 110.895 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 44.8 p-80 -83.44 177.9 8.26 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.529 0.681 . . . . 72.430000000000007 112.382 -176.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.4 t60 . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 124.414 1.086 . . . . 75.049999999999997 109.577 172.039 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.556 1.209 0 CA-C-O 120.691 0.281 . . . . 72.200000000000003 111.013 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -48.66 -51.09 30.13 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 113.748 1.018 . . . . 75.25 113.748 -175.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.513 ' HA ' HG22 ' B' ' 6' ' ' VAL . 9.8 mtmp? -67.86 -28.09 67.24 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.191 0.812 . . . . 73.209999999999994 113.191 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -69.04 -45.76 69.61 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.24 0.616 . . . . 63.030000000000001 110.497 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 79.1 mt -63.05 -56.7 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.119 0.968 . . . . 65.129999999999995 111.433 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' B' ' 3' ' ' LYS . 12.6 m -66.13 -27.61 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 122.848 0.459 . . . . 54.109999999999999 111.503 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.03 -41.0 97.46 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.233 0.333 . . . . 73.239999999999995 112.995 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.07 -50.27 62.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.452 0.701 . . . . 53.340000000000003 111.606 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -68.22 -27.49 66.42 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.795 0.838 . . . . 71.319999999999993 112.384 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.485 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -72.83 -34.35 66.76 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.101 0.56 . . . . 44.420000000000002 111.518 177.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -35.19 91.63 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 123.388 0.43 . . . . 73.239999999999995 112.34 174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' B' ' 32' ' ' VAL . 1.6 ttmp? -68.14 -50.32 55.35 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.24 1.016 . . . . 74.140000000000001 112.216 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.525 ' HA ' HG11 ' B' ' 32' ' ' VAL . 24.4 m -69.09 -34.76 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 111.886 0.328 . . . . 71.140000000000001 111.886 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -71.9 -34.97 69.57 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.269 0.627 . . . . 74.239999999999995 111.081 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -57.05 -41.64 79.05 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.069 0.548 . . . . 64.340000000000003 110.489 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.53 -32.74 74.51 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.504 -0.771 . . . . 74.540000000000006 111.841 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 13' ' ' VAL . 83.3 mt -71.74 -34.0 69.15 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.401 0.681 . . . . 62.210000000000001 111.759 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.04 -31.49 71.13 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.76 0.824 . . . . 62.140000000000001 111.34 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -105.11 -25.78 12.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.159 0.984 . . . . 70.400000000000006 112.133 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.02 87.87 0.66 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.217 0.607 . . . . 74.319999999999993 111.524 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.17 -179.03 3.92 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.359 0.664 . . . . 72.019999999999996 111.825 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.25 18.18 79.76 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.084 -0.507 . . . . 63.520000000000003 112.85 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.73 152.39 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.391 1.076 . . . . 63.140000000000001 110.02 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -69.04 148.28 50.31 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.797 0.439 . . . . 52.229999999999997 111.045 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.624 HG21 ' HB2' ' B' ' 40' ' ' ALA . 36.5 mm -54.69 -48.35 95.61 Favored Pre-proline 0 CA--C 1.578 2.027 0 N-CA-C 113.719 1.007 . . . . 74.239999999999995 113.719 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -65.42 -31.23 52.23 Favored 'Trans proline' 0 C--N 1.393 2.905 0 C-N-CA 121.969 1.78 . . . . 74.230000000000004 113.965 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -71.64 -46.66 58.36 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.357 1.075 . . . . 75.049999999999997 109.778 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.406 HD22 HD11 ' B' ' 63' ' ' ILE . 60.9 tp -59.73 -38.7 82.43 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.301 -1.772 . . . . 64.120000000000005 111.51 172.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.79 98.01 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.984 0.913 . . . . 55.030000000000001 111.939 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -64.43 -35.81 82.12 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.1 -0.955 . . . . 75.329999999999998 110.681 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -66.63 -45.92 77.47 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.391 0.676 . . . . 64.420000000000002 112.298 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' B' ' 13' ' ' VAL . 30.5 m -90.51 10.7 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 112.718 0.636 . . . . 52.130000000000003 112.718 -173.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.68 16.82 9.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.408 1.083 . . . . 64.430000000000007 113.08 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.2 mt -106.16 168.69 8.97 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.743 0.817 . . . . 64.150000000000006 110.603 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 43.6 t -81.12 165.47 21.56 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.612 0.365 . . . . 64.25 111.243 169.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 74.4 t -52.92 -48.51 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 123.619 0.768 . . . . 53.210000000000001 111.836 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.91 -52.84 64.03 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.405 0.682 . . . . 64.310000000000002 111.96 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 23.0 m -59.26 -38.91 81.24 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.961 0.904 . . . . 50.409999999999997 112.379 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -72.44 -48.52 40.46 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.776 0.831 . . . . 72.340000000000003 111.767 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.624 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -63.61 -32.46 73.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.329 0.652 . . . . 73.340000000000003 112.027 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -71.79 -38.32 70.29 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.697 1.199 . . . . 74.230000000000004 110.508 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.25 -37.76 81.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.174 0.59 . . . . 74.450000000000003 111.405 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.512 HG13 HG11 ' B' ' 52' ' ' VAL . 60.7 t -64.1 -30.98 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.243 1.017 . . . . 75.129999999999995 110.867 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.57 86.32 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.495 -0.32 . . . . 61.109999999999999 113.513 171.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -72.7 -23.67 60.9 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.317 0.58 . . . . 73.120000000000005 111.198 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.44 HD11 HG23 ' B' ' 13' ' ' VAL . 76.4 mt -74.45 -40.93 61.62 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 121.518 -0.739 . . . . 54.299999999999997 111.08 169.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.24 -31.19 69.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.474 1.11 . . . . 63.409999999999997 113.488 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.59 ' HD3' ' HG3' ' B' ' 49' ' ' GLU . 0.0 OUTLIER -72.41 -14.1 61.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 112.735 0.643 . . . . 75.450000000000003 112.735 176.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.59 ' HG3' ' HD3' ' B' ' 48' ' ' ARG . 50.1 mt-10 -114.92 16.11 17.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.883 0.873 . . . . 61.200000000000003 110.965 169.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 47.53 28.38 1.17 Allowed 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 125.876 1.67 . . . . 41.130000000000003 114.314 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' B' ' 66' ' ' GLU . 53.0 mttp -71.52 -11.5 60.9 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.232 1.013 . . . . 72.319999999999993 112.95 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.512 HG11 HG13 ' B' ' 43' ' ' VAL . 12.6 m -124.52 145.85 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.637 0.775 . . . . 73.439999999999998 112.307 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 63.4 t -112.0 120.38 62.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 125.017 1.327 . . . . 64.310000000000002 108.949 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.21 110.59 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.703 -0.851 . . . . 72.540000000000006 108.703 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.28 112.49 18.67 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.794 0.438 . . . . 73.329999999999998 110.833 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.477 ' HG2' HG12 ' B' ' 61' ' ' ILE . 13.8 mtm-85 -93.36 96.89 10.23 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.746 0.819 . . . . 75.400000000000006 109.905 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -104.57 111.98 24.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.902 1.281 . . . . 73.420000000000002 109.414 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 57.74 30.45 18.95 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 111.747 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.68 -22.81 28.85 Favored Glycine 0 CA--C 1.546 2.012 0 CA-C-N 115.654 -0.703 . . . . 73.099999999999994 113.992 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 88.4 mt -79.24 126.13 30.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.987 0.915 . . . . 45.009999999999998 111.527 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.477 HG12 ' HG2' ' B' ' 56' ' ' ARG . 40.4 mt -92.19 123.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 121.059 0.457 . . . . 44.340000000000003 112.068 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -117.83 139.72 50.7 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.385 1.074 . . . . 72.430000000000007 109.187 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.42 HG21 HG11 ' B' ' 43' ' ' VAL . 1.5 pp -113.66 104.59 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.926 0.87 . . . . 61.229999999999997 112.064 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 74.9 m-85 -83.61 167.06 17.64 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.659 0.784 . . . . 54.310000000000002 110.875 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -93.25 164.08 13.37 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.121 0.486 . . . . 74.450000000000003 112.294 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' B' ' 51' ' ' LYS . 40.1 tt0 -64.62 -20.65 66.4 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.847 0.859 . . . . 75.409999999999997 112.149 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.83 -11.67 31.54 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 115.305 0.882 . . . . 72.140000000000001 115.305 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -85.08 -34.44 22.24 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.272 0.536 . . . . 52.109999999999999 111.425 173.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -104.59 85.14 2.28 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.619 0.724 . . . . 75.329999999999998 109.655 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -83.77 34.9 0.5 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.192 0.997 . . . . 43.350000000000001 112.186 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -97.37 26.68 4.69 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.152 0.981 . . . . 60.329999999999998 110.485 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 25.4 m -82.17 -10.99 58.97 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.725 0.81 . . . . 73.230000000000004 112.008 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -71.65 177.91 3.86 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.614 0.766 . . . . 73.349999999999994 111.486 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.54 -151.74 6.25 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 116.248 -0.433 . . . . 62.399999999999999 112.45 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.38 150.07 28.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.801 0.84 . . . . 74.230000000000004 109.517 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.61 144.02 44.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.647 0.779 . . . . 75.25 111.443 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -70.15 99.5 1.5 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 120.921 0.391 . . . . 73.200000000000003 109.986 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -65.96 118.96 10.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.831 0.852 . . . . 62.310000000000002 111.352 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -134.76 160.61 37.63 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.931 0.892 . . . . 72.450000000000003 110.149 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -72.75 127.69 33.3 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.133 0.573 . . . . 75.420000000000002 111.113 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -72.12 128.72 36.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.825 0.45 . . . . 71.430000000000007 111.367 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 . . . . . 0 N--CA 1.479 0.988 0 C-N-CA 123.532 0.733 . . . . 53.439999999999998 110.091 177.013 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 112.604 0.594 . . . . 71.25 112.604 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.73 -34.86 74.44 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.265 0.468 . . . . 64.230000000000004 112.265 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -62.15 -46.71 87.77 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.541 0.736 . . . . 63.450000000000003 111.833 -174.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -67.86 -33.6 75.07 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.827 -0.624 . . . . 74.439999999999998 112.072 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.8 mt -69.0 -58.02 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.091 0.556 . . . . 62.219999999999999 110.966 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.67 -27.85 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.749 0.42 . . . . 61.43 111.711 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.23 -42.25 76.28 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 123.543 0.527 . . . . 41.0 112.875 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.78 96.02 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.012 0.925 . . . . 61.310000000000002 112.054 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.417 ' O ' ' HG2' ' A' ' 12' ' ' LYS . 57.2 m-80 -85.1 -21.26 29.39 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.166 0.586 . . . . 60.539999999999999 112.414 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.54 76.1 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 118.072 0.396 . . . . 73.0 111.448 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.0 -39.83 97.63 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 115.851 -0.613 . . . . 61.219999999999999 113.456 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.481 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 6.7 ptmm? -75.87 -30.63 58.94 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.5 -0.412 . . . . 71.439999999999998 111.488 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.575 ' HA ' HG11 ' A' ' 32' ' ' VAL . 71.4 t -67.37 -46.78 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.282 0.633 . . . . 74.209999999999994 110.84 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.438 ' HA ' HD12 ' A' ' 17' ' ' LEU . 21.7 t90 -64.07 -35.07 79.53 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.572 -0.74 . . . . 73.439999999999998 110.639 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.405 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 79.3 t60 -63.11 -40.55 97.95 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.845 0.458 . . . . 43.299999999999997 111.547 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.12 -31.66 72.93 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 120.862 0.363 . . . . 54.140000000000001 111.661 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.481 ' HB3' ' OD1' ' A' ' 65' ' ' ASN . 90.1 mt -69.34 -41.95 75.94 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.337 1.055 . . . . 74.340000000000003 111.733 170.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.74 -26.99 66.11 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.145 0.978 . . . . 72.150000000000006 111.425 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 15' ' ' HIS . 68.3 mt-10 -77.79 -49.85 13.52 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.225 0.61 . . . . 64.400000000000006 110.127 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.77 108.19 0.67 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.603 0.761 . . . . 73.019999999999996 111.264 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 11.1 p-10 -94.1 -178.79 4.74 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.146 0.978 . . . . 71.430000000000007 112.918 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.28 33.59 61.62 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-N 116.016 -0.538 . . . . 44.32 111.852 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 tt -113.12 145.09 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.026 0.931 . . . . 73.329999999999998 111.013 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.9 m -78.85 154.03 30.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.556 0.743 . . . . 64.450000000000003 110.943 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.732 HG21 ' HB2' ' A' ' 40' ' ' ALA . 44.7 mm -59.1 -44.34 98.52 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 114.777 1.399 . . . . 73.349999999999994 114.777 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -62.82 -32.61 77.5 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 121.942 1.761 . . . . 73.340000000000003 113.185 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -75.27 -37.46 60.93 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.587 1.184 . . . . 72.040000000000006 109.871 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.9 tp -70.73 -33.4 70.79 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 112.707 -2.042 . . . . 72.099999999999994 111.658 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.05 -37.06 81.27 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.086 0.954 . . . . 74.0 111.167 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -64.44 -39.22 93.41 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.175 0.99 . . . . 75.010000000000005 111.104 174.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -66.47 -43.72 84.71 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.663 0.785 . . . . 73.049999999999997 111.864 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.575 HG11 ' HA ' ' A' ' 13' ' ' VAL . 7.0 m -98.17 9.99 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 113.315 0.858 . . . . 73.209999999999994 113.315 -170.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 m120 66.87 10.51 7.66 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.587 1.155 . . . . 64.409999999999997 113.428 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.9 mt -108.31 178.08 4.61 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.247 0.619 . . . . 74.219999999999999 111.479 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.4 t -88.48 165.68 14.72 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.17 0.588 . . . . 73.340000000000003 110.991 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.38 -47.33 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 124.312 1.045 . . . . 51.229999999999997 112.26 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -61.22 -53.0 62.43 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.214 0.606 . . . . 71.099999999999994 112.088 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -63.01 -28.6 70.22 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.733 0.813 . . . . 72.519999999999996 112.518 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 43' ' ' VAL . 88.0 m -80.08 -53.65 6.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.75 0.82 . . . . 72.109999999999999 111.441 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.1 -30.75 69.46 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.106 0.962 . . . . 43.340000000000003 112.315 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -52.86 63.07 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.714 1.206 . . . . 73.319999999999993 110.225 174.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.24 -26.75 68.24 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.886 -1.052 . . . . 73.409999999999997 111.39 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 39' ' ' THR . 94.7 t -66.04 -40.11 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.166 0.586 . . . . 72.239999999999995 110.889 172.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.07 -33.24 86.72 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 116.309 -0.405 . . . . 64.109999999999999 113.107 173.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.485 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 63.7 t-105 -74.22 -25.18 59.51 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.586 0.754 . . . . 75.129999999999995 111.605 176.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.27 -47.72 48.01 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 122.115 -0.366 . . . . 61.200000000000003 110.39 166.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.72 68.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.3 1.04 . . . . 54.009999999999998 113.19 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.547 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 26.6 ptt85 -59.4 -39.71 84.29 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 112.558 0.577 . . . . 64.030000000000001 112.558 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.547 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 47.0 mt-10 -96.61 11.62 34.63 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.886 0.875 . . . . 65.549999999999997 111.147 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 62.33 38.1 13.38 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.671 1.189 . . . . 64.120000000000005 111.198 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -80.51 -19.08 46.66 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.411 0.685 . . . . 75.519999999999996 112.195 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.87 151.57 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.314 0.646 . . . . 72.340000000000003 111.238 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.17 122.01 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.815 0.846 . . . . 74.430000000000007 109.298 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.789 HG12 HD11 ' B' ' 41' ' ' LEU . 3.6 mp -98.9 136.03 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.065 0.946 . . . . 73.340000000000003 110.86 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.7 117.98 15.62 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.569 0.747 . . . . 55.43 110.764 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -81.53 111.39 17.8 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.752 0.821 . . . . 65.239999999999995 110.556 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.85 130.61 47.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.969 0.908 . . . . 63.149999999999999 110.617 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.9 p30 44.48 41.18 4.45 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 126.059 1.744 . . . . 73.319999999999993 114.035 -175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.41 -27.44 7.74 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.374 -0.83 . . . . 74.439999999999998 114.125 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.67 160.4 28.51 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.732 0.813 . . . . 71.450000000000003 110.99 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.4 tt -121.19 118.33 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 123.792 0.837 . . . . 75.129999999999995 109.683 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.87 142.68 46.24 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.116 0.966 . . . . 74.299999999999997 110.042 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.705 HG22 HG13 ' A' ' 54' ' ' ILE . 37.6 pt -115.07 140.36 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.555 0.693 . . . . 61.530000000000001 111.066 175.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 57.7 m-85 -123.8 167.8 13.58 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.681 1.192 . . . . 73.239999999999995 110.018 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.481 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 1.8 m-20 -76.06 152.37 36.88 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.337 0.255 . . . . 73.109999999999999 110.522 174.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -77.75 160.71 28.23 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 121.164 0.507 . . . . 70.200000000000003 110.327 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.92 -16.61 5.27 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.844 -1.302 . . . . 73.209999999999994 109.844 -165.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -73.02 -34.18 66.2 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.566 1.146 . . . . 61.539999999999999 110.264 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -102.18 20.99 15.68 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.701 1.201 . . . . 64.349999999999994 110.382 171.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 74.24 -55.52 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 126.336 1.854 . . . . 74.209999999999994 114.158 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -71.89 86.61 0.99 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.428 0.691 . . . . 65.329999999999998 112.205 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 94.4 p -100.4 17.46 21.49 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.716 0.807 . . . . 74.019999999999996 111.286 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -68.37 170.06 9.57 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.963 0.905 . . . . 73.129999999999995 112.389 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.6 75.49 1.23 Allowed Glycine 0 N--CA 1.472 1.081 0 N-CA-C 111.772 -0.531 . . . . 44.520000000000003 111.772 -173.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.79 165.82 16.56 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.868 0.867 . . . . 54.340000000000003 111.628 -171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.66 148.6 23.15 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.765 -0.652 . . . . 73.109999999999999 110.069 172.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -98.03 -50.49 4.37 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.378 0.671 . . . . 74.25 112.406 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -160.93 165.57 29.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.038 0.755 . . . . 63.409999999999997 113.038 -172.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -61.56 145.42 52.09 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.061 0.944 . . . . 74.239999999999995 111.323 172.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -98.78 165.41 11.79 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.939 1.089 . . . . 74.439999999999998 113.939 -168.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -112.98 160.07 18.48 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.15 1.38 . . . . 73.200000000000003 108.858 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.653 0.739 . . . . 65.340000000000003 112.368 -179.867 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttp . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.115 0.483 . . . . 44.329999999999998 111.004 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 12.7 p-10 -65.51 -35.06 79.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.167 0.987 . . . . 71.299999999999997 113.26 -171.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -29.15 68.96 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.429 0.692 . . . . 70.0 111.249 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.78 -43.13 56.45 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.755 0.822 . . . . 64.530000000000001 111.668 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.58 -51.38 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 122.619 0.368 . . . . 73.109999999999999 110.813 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.1 m -66.49 -30.85 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 122.611 0.364 . . . . 75.420000000000002 111.936 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.68 45.4 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.424 0.452 . . . . 73.219999999999999 112.74 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.6 -52.93 61.45 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.087 0.955 . . . . 72.510000000000005 111.845 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -75.17 -13.9 60.5 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.753 -0.658 . . . . 70.140000000000001 112.464 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -68.06 -29.09 67.98 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 117.943 0.338 . . . . 64.109999999999999 110.504 171.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.46 -41.95 94.01 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.867 -0.606 . . . . 43.509999999999998 112.963 173.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -69.76 -47.78 61.72 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.391 0.676 . . . . 62.5 111.922 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.547 ' HA ' HG11 ' B' ' 32' ' ' VAL . 22.7 m -67.21 -32.47 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 111.886 0.328 . . . . 53.520000000000003 111.886 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 57.9 t90 -68.65 -41.1 79.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.716 0.406 . . . . 71.230000000000004 111.162 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -69.64 -40.64 76.39 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.857 0.463 . . . . 72.150000000000006 111.248 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.61 73.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.108 0.563 . . . . 75.310000000000002 111.264 176.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.631 HD23 HG23 ' B' ' 63' ' ' ILE . 1.0 OUTLIER -67.32 -44.18 79.78 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.926 0.89 . . . . 75.099999999999994 110.439 169.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.17 -36.61 84.19 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.655 0.782 . . . . 62.539999999999999 111.679 -174.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.46 -30.13 25.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.371 0.668 . . . . 65.219999999999999 111.622 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.424 ' HB3' ' HZ2' ' B' ' 31' ' ' LYS . . . -135.06 108.04 7.6 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.21 0.604 . . . . 74.010000000000005 110.942 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.99 175.78 10.26 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.868 1.267 . . . . 62.399999999999999 112.674 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.89 40.56 12.53 Favored Glycine 0 C--N 1.365 2.14 0 N-CA-C 115.144 0.817 . . . . 75.340000000000003 115.144 163.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.549 HG21 ' HZ1' ' B' ' 31' ' ' LYS . 7.8 tp -112.95 127.97 69.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.363 0.665 . . . . 74.340000000000003 109.868 -168.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 92.5 p -68.06 158.44 32.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 122.083 -0.386 . . . . 63.140000000000001 111.162 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.662 HG21 ' HB2' ' B' ' 40' ' ' ALA . 69.6 mt -59.65 -44.38 97.36 Favored Pre-proline 0 CA--C 1.578 2.033 0 N-CA-C 114.422 1.268 . . . . 71.409999999999997 114.422 -171.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.49 -28.47 45.73 Favored 'Trans proline' 0 C--N 1.389 2.667 0 CA-C-N 121.744 1.659 . . . . 75.420000000000002 113.361 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . 0.478 ' HB3' HD11 ' B' ' 23' ' ' ILE . 14.0 mm-40 -79.96 -27.26 39.76 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.149 0.98 . . . . 71.040000000000006 111.419 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.574 ' HA ' ' HE2' ' B' ' 31' ' ' LYS . 58.3 tp -75.75 -37.82 58.98 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 125.255 1.422 . . . . 74.150000000000006 110.629 170.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.34 95.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.482 1.113 . . . . 75.310000000000002 112.842 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -67.65 -33.56 75.2 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.352 0.661 . . . . 71.299999999999997 112.248 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.574 ' HE2' ' HA ' ' B' ' 28' ' ' LEU . 48.9 mtmt -66.59 -43.38 85.05 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.217 0.532 . . . . 71.140000000000001 110.897 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' B' ' 13' ' ' VAL . 21.6 m -90.66 -4.83 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.662 0.785 . . . . 73.439999999999998 112.558 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 m120 64.99 22.62 12.46 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.63 1.172 . . . . 73.400000000000006 112.876 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 59.1 mt -104.65 162.04 13.62 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.621 0.769 . . . . 73.310000000000002 110.53 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 30.1 t -64.68 152.04 43.42 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.087 0.555 . . . . 54.43 110.822 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.95 -44.05 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 123.547 0.739 . . . . 72.319999999999993 111.19 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -58.52 -47.41 84.23 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 114.887 -1.051 . . . . 73.319999999999993 112.071 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 65.3 m -68.54 -36.53 78.96 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.934 0.893 . . . . 74.409999999999997 112.262 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 87.9 m -70.94 -52.24 21.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.918 0.887 . . . . 64.420000000000002 110.802 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.662 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -57.73 -32.36 67.35 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.956 0.902 . . . . 34.5 112.491 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.789 HD11 HG12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -64.65 -52.71 55.89 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.512 1.125 . . . . 72.519999999999996 110.281 176.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.59 -29.14 70.15 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.197 -0.91 . . . . 73.239999999999995 111.586 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.04 -39.93 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.627 0.771 . . . . 74.409999999999997 110.949 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -61.88 -27.75 69.1 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-N 116.341 -0.39 . . . . 74.010000000000005 113.125 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.448 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 61.1 t-105 -71.93 -34.53 69.13 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.546 0.738 . . . . 71.25 111.249 174.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.42 -32.88 68.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.25 0.62 . . . . 60.149999999999999 111.196 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.99 -32.02 71.6 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.672 0.789 . . . . 62.049999999999997 112.175 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 53.8 ttt180 -58.83 -50.43 74.01 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.517 0.675 . . . . 75.030000000000001 110.904 167.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -79.57 -6.59 57.36 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 114.64 -1.164 . . . . 63.229999999999997 112.27 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 63.62 23.2 13.47 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.025 1.33 . . . . 60.240000000000002 112.08 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -87.67 -4.31 58.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.486 1.114 . . . . 74.540000000000006 112.604 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.712 ' HB ' HD11 ' B' ' 63' ' ' ILE . 18.3 m -135.02 166.51 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 112.532 0.567 . . . . 62.210000000000001 112.532 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.746 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 24.7 t -116.1 131.75 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.067 0.947 . . . . 71.340000000000003 111.229 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 31.9 mm -113.5 133.05 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.696 0.798 . . . . 62.009999999999998 110.784 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . 0.458 ' HB2' ' HE2' ' B' ' 57' ' ' LYS . 42.5 mt-10 -134.16 157.96 44.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.451 0.7 . . . . 43.130000000000003 111.31 167.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -111.55 106.94 15.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.211 1.004 . . . . 73.140000000000001 109.168 168.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' B' ' 55' ' ' GLU . 0.0 OUTLIER -119.54 114.91 22.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.303 1.041 . . . . 63.299999999999997 110.13 -178.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 56.25 30.54 16.84 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.804 1.241 . . . . 74.140000000000001 111.823 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.8 -25.04 23.41 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 115.959 -0.564 . . . . 62.520000000000003 114.238 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -90.46 158.52 17.01 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.701 0.8 . . . . 60.229999999999997 111.037 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 mm -107.15 131.29 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.962 0.505 . . . . 74.409999999999997 110.052 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -121.97 136.1 54.9 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.063 -1.088 . . . . 72.129999999999995 108.063 168.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' B' ' 52' ' ' VAL . 10.9 tp -92.65 130.79 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 122.982 0.513 . . . . 73.409999999999997 110.232 -177.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.746 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 84.8 m-85 -116.62 167.8 10.75 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.578 0.751 . . . . 73.340000000000003 110.974 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.537 ' HA ' HD11 ' B' ' 17' ' ' LEU . 9.7 m120 -88.06 114.21 24.46 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.0 0.741 . . . . 54.119999999999997 113.0 -169.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 36.86 -149.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 116.975 2.213 . . . . 72.209999999999994 116.975 157.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.34 73.85 1.09 Allowed Glycine 0 C--N 1.362 1.983 0 N-CA-C 115.134 0.814 . . . . 65.200000000000003 115.134 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.413 ' NE2' ' HB2' ' B' ' 65' ' ' ASN . 6.2 p-80 -161.21 44.32 0.17 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.114 1.366 . . . . 74.420000000000002 108.569 163.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -93.81 20.1 8.03 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.253 -1.34 . . . . 74.400000000000006 112.364 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.79 -44.7 96.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.61 0.764 . . . . 74.519999999999996 110.025 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -132.89 122.67 24.71 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.655 1.182 . . . . 70.329999999999998 108.826 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 60.0 p -73.8 112.69 10.15 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.295 -0.631 . . . . 64.420000000000002 109.295 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -70.34 86.06 0.59 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.447 0.906 . . . . 74.25 113.447 -166.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.5 -21.05 59.01 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.12 -0.792 . . . . 71.120000000000005 111.12 164.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 62.3 tp -69.56 81.3 0.41 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.575 1.15 . . . . 60.420000000000002 110.236 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 63.69 120.97 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 125.621 1.568 . . . . 72.450000000000003 113.856 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -166.61 110.91 0.77 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.816 0.846 . . . . 65.129999999999995 110.515 167.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -92.06 -44.0 9.09 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.652 0.781 . . . . 74.209999999999994 112.824 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 42.04 75.86 0.08 Allowed 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 124.59 1.156 . . . . 72.439999999999998 112.689 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -68.28 148.18 51.14 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.752 1.221 . . . . 64.319999999999993 112.916 -172.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -72.2 102.78 3.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.629 0.771 . . . . 74.219999999999999 110.616 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 N--CA 1.484 1.26 0 C-N-CA 124.389 1.076 . . . . 73.129999999999995 112.681 178.205 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 111.973 0.361 . . . . 72.340000000000003 111.973 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.737 ' HB3' ' HB ' ' B' ' 54' ' ' ILE . 3.9 p-10 -56.08 -39.3 71.89 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 114.245 1.202 . . . . 75.340000000000003 114.245 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -61.46 -25.0 66.95 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.149 0.796 . . . . 63.439999999999998 113.149 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -79.54 -45.45 19.22 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.419 0.687 . . . . 75.349999999999994 111.354 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.59 -56.67 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.731 0.813 . . . . 72.530000000000001 112.01 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.449 HG12 HD22 ' A' ' 41' ' ' LEU . 28.5 m -53.9 -44.34 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.621 1.169 . . . . 72.430000000000007 113.197 -170.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.81 -40.34 52.83 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.159 0.287 . . . . 54.149999999999999 113.025 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.22 79.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.647 0.779 . . . . 74.439999999999998 112.354 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -87.56 -20.95 25.74 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.769 0.655 . . . . 43.420000000000002 112.769 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.84 -38.98 73.23 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 123.097 0.559 . . . . 61.350000000000001 112.03 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.74 -32.52 81.51 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 116.124 -0.489 . . . . 62.030000000000001 112.623 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -71.45 -48.29 50.33 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.014 0.925 . . . . 75.239999999999995 112.188 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -75.16 -32.85 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 112.475 0.546 . . . . 75.209999999999994 112.475 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.469 ' HA ' HD12 ' A' ' 17' ' ' LEU . 26.1 t90 -70.56 -35.16 72.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 120.966 0.412 . . . . 75.120000000000005 110.457 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -62.24 -35.41 78.84 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.521 0.728 . . . . 70.430000000000007 111.306 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.02 70.09 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.367 0.667 . . . . 52.509999999999998 112.455 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 14' ' ' TRP . 46.7 mt -68.36 -31.18 70.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.55 0.74 . . . . 61.020000000000003 111.255 170.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -75.04 -22.88 58.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.172 0.589 . . . . 72.040000000000006 111.704 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.31 -58.52 5.71 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 109.118 -0.697 . . . . 74.019999999999996 109.118 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.79 117.81 0.7 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.81 -1.087 . . . . 44.119999999999997 110.006 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.12 168.34 12.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.301 0.64 . . . . 63.340000000000003 109.845 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.76 60.53 1.96 Allowed Glycine 0 N--CA 1.475 1.294 0 N-CA-C 110.963 -0.855 . . . . 55.109999999999999 110.963 -170.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.6 tt -156.11 151.15 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.416 -0.892 . . . . 71.010000000000005 109.62 -173.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 t -85.96 158.9 19.77 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.874 0.469 . . . . 70.120000000000005 111.221 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.549 HG21 ' HB2' ' A' ' 40' ' ' ALA . 58.0 mt -56.81 -49.72 92.15 Favored Pre-proline 0 CA--C 1.575 1.936 0 N-CA-C 114.214 1.19 . . . . 75.340000000000003 114.214 -173.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 71.4 Cg_endo -70.81 -21.9 27.99 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.083 1.855 . . . . 63.229999999999997 113.743 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.27 -39.28 40.55 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.441 1.115 . . . . 74.230000000000004 109.691 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.2 tp -68.65 -34.4 75.65 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-N 113.019 -1.901 . . . . 73.219999999999999 111.375 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.8 70.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.179 0.992 . . . . 70.439999999999998 112.131 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 26' ' ' PRO . 79.8 mtt-85 -66.38 -34.92 79.04 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.908 0.883 . . . . 74.239999999999995 111.365 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -69.19 -45.65 69.41 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.577 0.751 . . . . 62.25 111.509 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.505 HG23 ' H ' ' A' ' 34' ' ' LEU . 31.4 m -90.45 -5.59 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 114.026 1.121 . . . . 73.25 114.026 -170.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 67.81 8.79 6.67 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.38 1.072 . . . . 74.409999999999997 112.051 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.505 ' H ' HG23 ' A' ' 32' ' ' VAL . 60.5 mt -92.4 157.38 16.63 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.581 -0.699 . . . . 63.229999999999997 110.335 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -61.79 151.66 33.58 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.083 0.553 . . . . 74.140000000000001 111.202 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -53.47 -41.76 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.552 0.692 . . . . 74.409999999999997 110.656 174.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.24 -40.75 94.45 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.652 -1.158 . . . . 71.299999999999997 111.672 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -68.06 -41.49 81.92 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.634 0.773 . . . . 65.439999999999998 111.463 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 43' ' ' VAL . 91.1 m -66.06 -49.58 67.15 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.16 0.984 . . . . 73.230000000000004 111.029 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.94 -43.01 99.28 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.742 0.817 . . . . 32.450000000000003 112.18 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.449 HD22 HG12 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -58.35 -49.16 78.19 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.492 0.717 . . . . 64.530000000000001 110.371 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.51 -30.98 70.97 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.815 -1.084 . . . . 75.400000000000006 112.254 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 39' ' ' THR . 60.7 t -65.89 -41.62 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.356 0.663 . . . . 72.409999999999997 110.861 174.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.06 -28.63 73.12 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 116.583 -0.28 . . . . 34.210000000000001 113.563 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -74.26 -43.33 57.39 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.607 0.763 . . . . 72.019999999999996 111.482 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.45 -32.9 73.84 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.045 0.538 . . . . 64.120000000000005 111.624 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.91 -25.19 60.54 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.395 1.078 . . . . 64.510000000000005 113.402 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -69.31 -40.03 77.89 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.254 -0.647 . . . . 75.299999999999997 109.254 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.7 7.79 42.01 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.263 1.025 . . . . 64.150000000000006 111.727 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 56.5 23.91 8.05 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.086 1.355 . . . . 74.25 113.414 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -74.02 -9.66 58.85 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.819 0.847 . . . . 71.120000000000005 113.044 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 m -122.71 142.23 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.279 0.632 . . . . 64.299999999999997 111.492 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 55.1 t -109.07 107.68 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.09 0.956 . . . . 74.0 108.456 172.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.414 HG13 HG22 ' A' ' 63' ' ' ILE . 3.0 mp -89.59 122.6 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 109.38 -0.6 . . . . 72.340000000000003 109.38 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -116.11 148.36 40.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.907 0.883 . . . . 73.109999999999999 109.888 174.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.437 ' HD2' HG21 ' B' ' 5' ' ' ILE . 45.2 mtp85 -118.96 114.65 22.89 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.757 0.423 . . . . 62.130000000000003 111.146 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -114.34 110.2 19.52 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.122 0.969 . . . . 74.450000000000003 109.785 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 58.4 30.02 19.04 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 124.795 1.238 . . . . 64.129999999999995 112.966 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.29 -13.3 62.2 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 113.944 0.338 . . . . 51.240000000000002 113.944 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.07 133.03 40.43 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.612 0.765 . . . . 75.120000000000005 110.686 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.428 HD13 ' HB2' ' B' ' 37' ' ' GLU . 3.0 mp -87.52 111.32 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 121.481 0.658 . . . . 74.209999999999994 110.714 -173.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -97.81 137.61 36.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.069 1.348 . . . . 73.129999999999995 108.901 171.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.483 ' H ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -123.1 139.12 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.744 0.783 . . . . 75.329999999999998 109.913 171.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.495 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 73.8 m-85 -129.01 167.02 18.09 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.588 1.155 . . . . 74.409999999999997 109.295 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -85.15 151.99 23.71 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.378 -0.601 . . . . 75.129999999999995 109.378 167.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.63 145.23 55.8 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 120.855 0.36 . . . . 65.329999999999998 110.735 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.77 -15.28 4.9 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 116.199 -0.455 . . . . 70.129999999999995 112.289 -172.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -66.77 -33.54 75.85 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.117 0.567 . . . . 71.329999999999998 112.46 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -74.16 152.0 39.92 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.621 0.368 . . . . 74.450000000000003 110.5 170.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.08 -48.82 61.68 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.934 0.494 . . . . 63.5 111.465 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -133.27 95.22 3.48 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.911 0.884 . . . . 75.319999999999993 108.92 175.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.3 m -72.4 109.05 5.83 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.068 0.547 . . . . 71.329999999999998 110.855 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -68.75 102.08 1.45 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.546 0.738 . . . . 72.230000000000004 110.322 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -121.97 26.28 6.52 Favored Glycine 0 N--CA 1.474 1.215 0 CA-C-N 116.112 -0.495 . . . . 55.229999999999997 113.371 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 mp -85.83 138.39 32.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.475 0.71 . . . . 75.450000000000003 110.11 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.465 ' HG3' ' HD2' ' A' ' 78' ' ' HIS . 10.2 pt-20 -60.46 141.39 56.49 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.315 0.646 . . . . 71.510000000000005 111.677 175.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.412 ' HD2' ' HB2' ' A' ' 79' ' ' HIS . 28.8 t60 -80.29 -30.3 38.27 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.012 0.525 . . . . 73.140000000000001 110.61 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.465 ' HD2' ' HG3' ' A' ' 76' ' ' GLU . 26.7 p80 42.68 55.09 4.38 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 126.009 1.724 . . . . 73.200000000000003 114.24 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.412 ' HB2' ' HD2' ' A' ' 77' ' ' HIS . 8.4 t-80 -76.45 79.53 3.16 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.746 0.784 . . . . 75.230000000000004 110.955 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -67.57 -45.69 74.87 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.448 1.099 . . . . 72.030000000000001 111.687 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -76.4 91.04 3.26 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.648 -0.501 . . . . 71.019999999999996 109.648 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 123.845 0.858 . . . . 72.430000000000007 111.589 -176.188 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.718 ' SD ' HD11 ' B' ' 5' ' ' ILE . 1.1 pmm? . . . . . 0 CA--C 1.548 0.888 0 CA-C-O 120.675 0.274 . . . . 71.310000000000002 111.608 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.79 155.83 22.93 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.901 0.858 . . . . 73.209999999999994 112.529 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -77.93 -5.24 50.47 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 114.606 -1.179 . . . . 73.0 110.76 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -77.3 -28.33 53.29 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.904 0.882 . . . . 72.239999999999995 111.837 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.718 HD11 ' SD ' ' B' ' 1' ' ' MET . 67.0 mt -58.38 -55.32 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.348 0.659 . . . . 75.109999999999999 110.977 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 22.6 m -63.84 -28.42 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-N 115.034 -0.985 . . . . 63.549999999999997 111.976 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.23 -45.43 48.93 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 123.398 0.436 . . . . 63.299999999999997 113.057 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.72 93.18 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.669 0.788 . . . . 34.409999999999997 111.785 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -65.25 -45.26 85.31 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.216 0.606 . . . . 65.230000000000004 110.434 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.402 ' HB1' ' HG ' ' B' ' 46' ' ' LEU . . . -68.32 -32.03 71.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.658 0.783 . . . . 62.140000000000001 112.132 -174.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.68 96.76 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 116.712 -0.222 . . . . 60.229999999999997 113.125 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -71.53 -39.72 70.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.396 0.678 . . . . 75.430000000000007 111.241 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.571 HG11 HG22 ' B' ' 43' ' ' VAL . 74.3 t -61.85 -41.64 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.743 0.817 . . . . 53.420000000000002 111.15 174.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -67.79 -31.73 71.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.392 0.677 . . . . 61.5 111.598 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -61.36 -45.74 93.13 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.4 0.28 . . . . 73.219999999999999 111.003 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.13 -29.79 67.91 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.389 0.614 . . . . 71.540000000000006 111.23 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.71 ' HG ' HG12 ' B' ' 52' ' ' VAL . 2.5 tm? -72.73 -34.24 66.93 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.893 1.277 . . . . 65.430000000000007 110.541 174.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.1 -20.0 39.02 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.499 0.719 . . . . 71.329999999999998 110.643 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -76.63 -59.46 2.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.832 0.853 . . . . 63.420000000000002 109.889 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.42 110.72 3.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.199 1.0 . . . . 63.109999999999999 109.262 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -90.71 -179.82 5.62 Favored 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 112.566 0.58 . . . . 52.520000000000003 112.566 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.58 51.1 9.97 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.745 -0.661 . . . . 74.540000000000006 111.633 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tp -121.17 140.49 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.252 0.621 . . . . 71.329999999999998 111.71 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 17.0 m -72.23 144.68 48.36 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.863 0.865 . . . . 72.150000000000006 111.257 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.45 HG21 ' HB2' ' B' ' 40' ' ' ALA . 62.2 mt -53.46 -52.36 67.44 Favored Pre-proline 0 CA--C 1.573 1.844 0 N-CA-C 113.671 0.989 . . . . 74.349999999999994 113.671 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -68.96 -24.75 33.03 Favored 'Trans proline' 0 C--N 1.391 2.803 0 C-N-CA 121.692 1.595 . . . . 74.200000000000003 113.823 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -77.42 -47.21 20.35 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.959 0.885 . . . . 60.229999999999997 109.593 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 57.5 tp -56.32 -34.88 66.98 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 113.647 -1.615 . . . . 63.329999999999998 111.69 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.84 98.97 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.875 0.87 . . . . 45.420000000000002 111.708 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -66.26 -40.74 90.36 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.121 0.568 . . . . 73.439999999999998 110.571 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -60.4 -45.83 92.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.874 0.87 . . . . 62.219999999999999 111.405 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.67 4.2 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 112.56 0.578 . . . . 74.349999999999994 112.56 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 61.18 32.75 19.49 Favored 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 124.539 1.135 . . . . 52.43 112.195 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 85.8 mt -123.26 170.27 10.45 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.925 0.89 . . . . 75.439999999999998 111.034 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -69.14 155.26 40.68 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.453 0.701 . . . . 63.340000000000003 111.511 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.26 -48.85 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.514 0.725 . . . . 71.120000000000005 111.481 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.449 ' HB3' HD12 ' A' ' 25' ' ' ILE . 43.6 mt-10 -59.11 -52.54 65.26 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.882 0.873 . . . . 72.129999999999995 111.838 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.1 t -56.64 -32.49 65.4 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.339 1.056 . . . . 73.109999999999999 112.746 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.508 ' O ' HG23 ' B' ' 43' ' ' VAL . 89.5 m -81.48 -46.15 14.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.651 0.78 . . . . 64.319999999999993 110.853 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -58.48 -52.65 64.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.676 0.991 . . . . 75.209999999999994 113.676 -171.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -26.83 64.57 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 120.882 0.373 . . . . 72.319999999999993 111.092 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.85 -34.71 73.98 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.703 0.801 . . . . 62.009999999999998 111.538 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.573 HG12 HD11 ' B' ' 54' ' ' ILE . 51.2 t -63.18 -33.06 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 122.823 0.449 . . . . 75.400000000000006 109.843 169.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.4 83.59 Favored Glycine 0 CA--C 1.542 1.72 0 CA-C-N 116.535 -0.302 . . . . 64.329999999999998 113.131 172.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.482 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 70.5 t-105 -71.6 -25.26 62.1 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.546 0.738 . . . . 71.109999999999999 111.778 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.402 ' HG ' ' HB1' ' B' ' 10' ' ' ALA . 94.9 mt -76.68 -41.77 44.22 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.519 -0.738 . . . . 63.109999999999999 111.503 165.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.47 -26.76 68.11 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.674 1.189 . . . . 70.310000000000002 113.542 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.665 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 18.7 ptt180 -57.11 -31.5 65.35 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 122.715 0.406 . . . . 75.439999999999998 111.84 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.665 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 40.2 mt-10 -106.51 1.57 25.55 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.237 1.015 . . . . 73.540000000000006 111.798 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.38 23.33 10.65 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.966 1.306 . . . . 70.120000000000005 111.707 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.525 ' HG3' ' HB2' ' B' ' 49' ' ' GLU . 52.7 mtpt -68.34 -17.57 64.28 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 122.934 0.494 . . . . 74.420000000000002 111.598 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.71 HG12 ' HG ' ' B' ' 17' ' ' LEU . 28.2 m -125.95 155.25 35.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.665 1.186 . . . . 64.109999999999999 109.762 170.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.681 HG21 ' HB3' ' B' ' 69' ' ' PHE . 98.8 t -115.91 129.66 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.185 0.994 . . . . 71.439999999999998 109.132 173.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.737 ' HB ' ' HB3' ' A' ' 2' ' ' ASP . 91.6 mt -120.82 112.83 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-O 121.357 0.598 . . . . 72.519999999999996 109.969 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -140.93 127.69 20.35 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.604 1.161 . . . . 72.030000000000001 109.499 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -81.4 111.98 18.25 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.458 0.647 . . . . 73.310000000000002 110.936 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.58 115.02 29.74 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.552 1.141 . . . . 72.239999999999995 109.682 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 54.06 31.77 14.35 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.861 1.264 . . . . 64.030000000000001 111.796 -167.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.49 -28.02 7.3 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-N 115.624 -0.717 . . . . 60.299999999999997 113.488 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.78 117.23 17.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.3 0.64 . . . . 75.120000000000005 110.296 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 19.5 tt -72.69 114.23 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 123.683 0.793 . . . . 63.25 111.726 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -116.53 127.67 54.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.863 0.465 . . . . 64.030000000000001 109.99 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.444 HG13 HG12 ' B' ' 54' ' ' ILE . 2.3 mp -94.51 101.93 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.624 0.77 . . . . 61.299999999999997 108.982 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -88.28 170.71 10.76 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.256 1.022 . . . . 72.25 111.978 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -85.66 146.81 26.67 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.939 0.896 . . . . 72.219999999999999 110.598 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -57.94 -22.9 51.13 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 112.678 0.622 . . . . 74.230000000000004 112.678 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.95 -27.21 56.56 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 114.661 0.625 . . . . 73.329999999999998 114.661 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -149.63 123.24 9.16 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.394 0.678 . . . . 75.209999999999994 110.892 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.681 ' HB3' HG21 ' B' ' 53' ' ' VAL . 24.1 p90 -156.32 161.02 40.22 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.532 0.733 . . . . 65.329999999999998 111.374 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 27.1 t70 52.82 72.77 0.39 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.034 0.934 . . . . 71.040000000000006 111.927 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -85.86 155.77 20.82 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.007 0.523 . . . . 71.430000000000007 110.329 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.1 m -72.35 85.59 1.1 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.949 0.5 . . . . 75.409999999999997 110.236 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -74.45 -9.42 58.57 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.777 0.831 . . . . 74.140000000000001 112.91 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.33 -10.07 51.65 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.772 0.669 . . . . 51.409999999999997 114.772 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -64.76 -31.25 72.39 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 117.852 0.826 . . . . 63.140000000000001 111.747 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -95.22 -31.07 13.67 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.018 0.927 . . . . 74.439999999999998 110.821 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 64.92 -80.97 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.03 1.332 . . . . 74.319999999999993 110.769 -172.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 51.81 144.33 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 127.117 2.167 . . . . 70.409999999999997 114.217 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -71.57 163.14 28.29 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.369 -0.832 . . . . 73.219999999999999 111.607 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -95.21 169.23 10.23 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.755 0.822 . . . . 74.450000000000003 110.787 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -70.14 141.03 52.73 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.452 0.301 . . . . 51.030000000000001 110.977 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.483 1.206 0 C-N-CA 123.741 0.817 . . . . 72.400000000000006 112.55 -173.277 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 121.658 0.742 . . . . 62.420000000000002 111.056 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.573 ' O ' HG13 ' A' ' 6' ' ' VAL . 4.8 m-20 -94.51 9.83 36.99 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.532 0.938 . . . . 74.129999999999995 113.532 -165.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -65.09 -26.76 68.36 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 123.003 0.521 . . . . 73.209999999999994 112.369 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -87.67 -34.82 18.3 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.503 0.721 . . . . 74.209999999999994 111.146 170.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.5 -26.14 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 124.137 0.975 . . . . 74.299999999999997 111.649 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 2' ' ' ASP . 16.9 m -63.15 -32.94 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.009 0.524 . . . . 70.129999999999995 110.711 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.32 -42.83 40.8 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.68 0.612 . . . . 70.150000000000006 112.903 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.19 77.69 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.212 0.605 . . . . 72.140000000000001 111.635 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -75.68 -35.69 60.29 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.548 0.739 . . . . 74.209999999999994 111.279 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.33 66.83 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.381 0.672 . . . . 61.0 111.488 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.67 -34.62 90.17 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 116.064 -0.516 . . . . 51.509999999999998 112.767 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -66.14 -41.39 90.5 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.041 0.936 . . . . 73.120000000000005 111.329 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.502 ' HA ' HG11 ' A' ' 32' ' ' VAL . 60.9 t -62.65 -47.7 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.597 0.759 . . . . 74.519999999999996 111.462 174.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.431 ' HA ' HD12 ' A' ' 17' ' ' LEU . 12.1 t90 -67.21 -33.08 74.6 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.98 0.512 . . . . 71.439999999999998 111.69 -176.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -57.96 -37.8 74.83 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.539 0.735 . . . . 74.530000000000001 110.756 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.17 72.34 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.185 0.594 . . . . 64.430000000000007 111.141 174.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 14' ' ' TRP . 87.0 mt -64.8 -18.36 65.03 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.063 0.945 . . . . 63.539999999999999 113.438 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.21 -34.06 69.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.907 0.883 . . . . 61.119999999999997 112.458 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.85 -33.59 1.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.384 0.674 . . . . 75.230000000000004 111.838 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.9 92.27 7.32 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.433 0.693 . . . . 70.439999999999998 109.727 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -127.19 162.98 24.89 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.685 0.794 . . . . 65.120000000000005 111.411 -170.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.94 59.81 5.69 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 116.042 -0.526 . . . . 70.510000000000005 112.069 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.2 tt -142.42 130.68 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.409 0.684 . . . . 54.399999999999999 110.739 -167.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.0 t -73.87 160.13 31.86 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.049 0.54 . . . . 62.420000000000002 110.961 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 40' ' ' ALA . 79.0 mt -49.15 -50.94 60.64 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 114.574 1.324 . . . . 60.240000000000002 114.574 -174.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.94 -27.16 17.84 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 121.973 1.782 . . . . 75.129999999999995 113.731 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.19 -43.02 65.15 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.689 1.233 . . . . 54.119999999999997 109.121 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.06 -38.08 87.44 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 112.512 -2.131 . . . . 70.239999999999995 111.157 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.83 -39.39 81.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.726 1.211 . . . . 63.32 112.248 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -63.15 -44.01 96.71 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.325 0.65 . . . . 64.310000000000002 111.298 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -66.04 -42.74 89.14 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.437 0.695 . . . . 74.299999999999997 111.598 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.0 m -87.55 2.22 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.865 -0.607 . . . . 64.310000000000002 112.286 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 t30 60.66 27.61 17.33 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 124.281 1.032 . . . . 74.209999999999994 112.004 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 44.2 mt -111.66 162.92 14.68 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.742 0.817 . . . . 74.150000000000006 109.561 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.2 t -77.11 164.78 25.37 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.592 0.357 . . . . 72.439999999999998 111.152 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.95 -53.32 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 124.277 1.031 . . . . 51.229999999999997 112.536 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.44 -42.9 88.36 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.361 0.664 . . . . 71.420000000000002 111.943 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -64.97 -37.37 87.41 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.998 0.919 . . . . 73.109999999999999 112.373 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 43' ' ' VAL . 87.9 m -77.98 -45.13 24.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.458 0.703 . . . . 71.439999999999998 111.402 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -57.71 -49.61 75.96 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.227 1.011 . . . . 60.420000000000002 112.071 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.51 -31.36 72.38 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 114.214 -1.357 . . . . 73.200000000000003 111.037 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.06 -36.69 72.38 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.296 0.638 . . . . 40.32 112.021 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 39' ' ' THR . 98.6 t -64.48 -33.02 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 123.064 0.546 . . . . 71.239999999999995 111.027 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.89 -31.27 79.89 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-N 116.634 -0.257 . . . . 53.210000000000001 113.421 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.46 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 64.6 t-105 -74.15 -28.36 61.29 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 123.639 0.776 . . . . 71.420000000000002 111.28 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.77 -35.5 64.97 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.227 0.611 . . . . 72.329999999999998 111.727 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.85 -30.77 70.32 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.791 0.836 . . . . 71.439999999999998 111.614 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 11.4 ttp180 -52.21 -49.61 63.56 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.771 0.829 . . . . 73.310000000000002 111.158 167.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -77.09 -12.47 59.94 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.896 -1.047 . . . . 74.230000000000004 112.568 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.3 m120 61.7 22.41 12.94 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.018 1.327 . . . . 70.040000000000006 112.488 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -89.01 -2.36 58.54 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.763 0.825 . . . . 71.510000000000005 111.752 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.64 154.41 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.811 0.845 . . . . 64.120000000000005 110.919 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 64' ' ' TYR . 6.8 m -134.46 132.35 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.399 1.08 . . . . 72.430000000000007 110.116 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.21 126.46 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.691 0.796 . . . . 51.229999999999997 109.909 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -110.84 139.82 45.83 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.81 0.844 . . . . 74.540000000000006 111.044 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.471 ' HG2' HG12 ' A' ' 61' ' ' ILE . 82.0 mtm180 -116.1 124.03 49.37 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.11 0.964 . . . . 74.310000000000002 109.61 173.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 118.13 12.71 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.948 0.899 . . . . 62.539999999999999 109.538 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.0 t30 58.29 31.88 21.38 Favored 'General case' 0 CA--C 1.577 2.004 0 CA-C-O 121.998 0.904 . . . . 72.019999999999996 111.363 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.94 -9.55 68.71 Favored Glycine 0 CA--C 1.542 1.762 0 CA-C-N 115.648 -0.705 . . . . 72.400000000000006 114.269 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.3 mt -83.33 122.16 28.09 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.126 0.971 . . . . 74.439999999999998 110.856 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.471 HG12 ' HG2' ' A' ' 56' ' ' ARG . 64.1 mt -95.39 126.79 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.283 0.633 . . . . 63.219999999999999 109.779 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -133.3 141.86 48.19 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.618 0.767 . . . . 70.349999999999994 110.434 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -96.91 117.93 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.002 0.921 . . . . 51.140000000000001 109.745 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.529 ' HB2' HG23 ' A' ' 53' ' ' VAL . 25.5 m-85 -108.05 164.21 12.48 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.595 1.158 . . . . 73.450000000000003 109.109 173.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . 20.1 p-10 -94.16 161.83 14.11 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.405 -0.591 . . . . 74.349999999999994 109.405 169.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -77.52 133.65 38.49 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 109.148 -0.686 . . . . 74.120000000000005 109.148 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.07 -5.85 1.97 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.998 -0.546 . . . . 74.430000000000007 112.414 -170.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -92.72 -17.26 24.46 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.575 0.75 . . . . 63.240000000000002 111.992 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.462 ' HE2' HG21 ' A' ' 53' ' ' VAL . 84.1 m-85 -101.79 -36.77 8.57 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.196 0.599 . . . . 70.310000000000002 111.671 -173.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.22 152.57 23.24 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.48 0.657 . . . . 62.409999999999997 111.329 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -79.98 -18.0 51.46 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 115.098 -0.955 . . . . 73.349999999999994 111.631 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.3 m -65.12 -37.61 87.98 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.677 0.791 . . . . 54.439999999999998 112.988 -174.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -74.53 141.62 44.83 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.649 0.38 . . . . 62.219999999999999 111.623 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.7 -99.48 0.19 Allowed Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.841 -0.904 . . . . 53.32 110.841 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 mp 64.14 -72.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.381 1.472 . . . . 63.310000000000002 113.048 172.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -155.34 125.02 6.45 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.132 0.573 . . . . 60.100000000000001 112.025 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -87.13 124.47 33.3 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.957 -0.757 . . . . 61.240000000000002 108.957 166.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -86.56 -66.42 0.91 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.967 0.507 . . . . 71.010000000000005 109.734 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.1 t60 58.02 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.861 1.264 . . . . 74.129999999999995 112.938 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 71.14 0.89 3.59 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.782 1.233 . . . . 74.349999999999994 112.477 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -70.78 101.27 2.06 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.496 0.718 . . . . 73.510000000000005 109.391 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.3 t60 . . . . . 0 N--CA 1.481 1.105 0 C-N-CA 124.0 0.92 . . . . 75.5 111.81 -175.842 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 111.598 0.221 . . . . 72.209999999999994 111.598 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.438 ' O ' HG22 ' B' ' 6' ' ' VAL . 5.7 p-10 -52.9 -41.74 64.69 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.86 1.264 . . . . 65.530000000000001 112.855 -175.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -51.09 -44.83 61.31 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.251 1.42 . . . . 61.43 112.628 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -77.45 -40.53 42.94 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.654 0.782 . . . . 74.439999999999998 111.546 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.73 -58.64 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.513 0.725 . . . . 63.539999999999999 111.218 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.438 HG22 ' O ' ' B' ' 2' ' ' ASP . 32.7 m -61.45 -27.6 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.361 0.664 . . . . 74.109999999999999 111.998 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.96 -49.85 71.45 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 123.47 0.482 . . . . 73.239999999999995 112.83 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.17 88.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.784 0.834 . . . . 70.420000000000002 112.043 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -85.2 -13.01 51.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.26 0.837 . . . . 55.32 113.26 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 -39.45 69.85 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.857 0.463 . . . . 71.209999999999994 111.367 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.23 -31.04 71.54 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 116.179 -0.464 . . . . 51.119999999999997 112.378 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -70.0 -45.74 66.65 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.892 0.877 . . . . 74.450000000000003 111.429 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.544 ' HA ' HG11 ' B' ' 32' ' ' VAL . 30.1 m -71.62 -32.46 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 122.533 0.333 . . . . 75.120000000000005 111.538 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.514 ' HA ' HD12 ' B' ' 17' ' ' LEU . 21.0 t90 -69.98 -33.36 71.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.499 0.32 . . . . 72.25 110.718 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -58.07 -45.87 86.38 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.932 0.493 . . . . 72.120000000000005 110.563 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.585 ' HB1' ' HE3' ' B' ' 31' ' ' LYS . . . -67.92 -29.59 68.71 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.677 -0.692 . . . . 64.519999999999996 111.712 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.66 ' HB3' HD21 ' B' ' 65' ' ' ASN . 58.6 mt -69.69 -33.02 71.95 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.153 0.981 . . . . 63.43 111.516 170.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.0 -29.72 64.49 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.915 0.886 . . . . 62.149999999999999 110.942 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -76.68 -49.03 17.11 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.649 0.78 . . . . 53.109999999999999 110.729 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.02 131.7 31.09 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.133 0.973 . . . . 63.329999999999998 109.502 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -114.61 147.34 39.68 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 122.911 0.484 . . . . 63.329999999999998 112.07 -163.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 24.45 69.6 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 115.984 -0.553 . . . . 64.340000000000003 113.266 -172.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.409 HD11 ' HG3' ' B' ' 27' ' ' GLU . 11.5 tt -77.05 143.35 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 124.169 0.987 . . . . 73.340000000000003 111.833 -170.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.6 m -61.24 141.73 57.31 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.756 0.822 . . . . 62.240000000000002 111.353 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' B' ' 40' ' ' ALA . 69.6 mt -57.63 -46.09 99.79 Favored Pre-proline 0 CA--C 1.576 1.952 0 N-CA-C 113.777 1.028 . . . . 75.200000000000003 113.777 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.25 -26.47 41.94 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 121.785 1.657 . . . . 63.420000000000002 113.871 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . 0.409 ' HG3' HD11 ' B' ' 23' ' ' ILE . 11.7 tp10 -76.67 -43.51 37.57 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.766 1.269 . . . . 70.450000000000003 109.773 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 58.8 tp -58.38 -40.22 81.71 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 112.833 -1.985 . . . . 73.010000000000005 111.013 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.15 75.43 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.536 1.134 . . . . 72.140000000000001 112.552 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -65.57 -42.05 92.23 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.48 0.712 . . . . 75.409999999999997 111.983 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.585 ' HE3' ' HB1' ' B' ' 16' ' ' ALA . 44.1 mtmt -72.67 -30.72 64.49 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.067 0.395 . . . . 75.420000000000002 112.067 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' B' ' 13' ' ' VAL . 25.4 m -96.45 -4.8 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 112.876 0.695 . . . . 52.450000000000003 112.876 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 65.83 15.87 10.24 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.442 1.097 . . . . 70.209999999999994 112.594 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt -96.89 163.84 12.8 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.699 -0.625 . . . . 63.240000000000002 110.967 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 37.5 m -66.45 151.44 47.18 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.935 -0.575 . . . . 75.010000000000005 110.152 171.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 58.1 t -55.51 -45.79 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 123.268 0.627 . . . . 64.439999999999998 111.857 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.38 -44.06 97.8 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.874 0.87 . . . . 70.340000000000003 112.374 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t -63.46 -38.5 91.37 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.563 0.745 . . . . 72.450000000000003 111.417 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.409 ' O ' HG23 ' B' ' 43' ' ' VAL . 89.6 m -68.36 -48.91 63.54 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.081 -0.963 . . . . 74.310000000000002 110.781 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.529 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -58.88 -36.85 75.32 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.0 0.92 . . . . 62.350000000000001 112.47 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.429 HD22 HG11 ' B' ' 6' ' ' VAL . 0.6 OUTLIER -66.28 -48.18 71.24 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.025 0.93 . . . . 75.450000000000003 110.078 178.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.04 68.9 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.53 -0.759 . . . . 62.299999999999997 111.62 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 39' ' ' THR . 73.8 t -77.63 -37.78 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 123.263 0.625 . . . . 61.210000000000001 111.057 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.46 -27.78 72.22 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 121.432 0.462 . . . . 50.100000000000001 112.326 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -73.39 -30.02 63.0 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.295 1.038 . . . . 73.140000000000001 110.956 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.451 HD13 ' HD1' ' B' ' 14' ' ' TRP . 96.2 mt -72.0 -34.17 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.199 0.6 . . . . 72.140000000000001 111.658 171.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.94 67.12 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.692 0.797 . . . . 61.030000000000001 111.926 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 48' ' ' ARG . 10.0 ptt-85 -60.88 -37.24 81.48 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.66 0.784 . . . . 71.230000000000004 111.517 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.547 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 41.4 mt-10 -93.9 5.24 52.31 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.861 0.864 . . . . 51.329999999999998 111.772 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 64.4 23.33 12.96 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.684 1.193 . . . . 73.519999999999996 112.931 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.547 ' HG3' ' HB2' ' B' ' 49' ' ' GLU . 28.3 mtpp -79.21 -13.08 59.92 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.752 0.649 . . . . 71.430000000000007 112.752 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' B' ' 64' ' ' TYR . 31.3 m -123.0 143.69 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.316 0.579 . . . . 64.409999999999997 112.185 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 33.4 t -113.11 105.1 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.307 0 C-N-CA 124.625 1.17 . . . . 73.299999999999997 109.959 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.504 HG23 HG23 ' B' ' 61' ' ' ILE . 3.4 mp -85.68 118.9 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 123.282 0.633 . . . . 62.509999999999998 110.925 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.17 117.38 19.82 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.899 0.88 . . . . 73.439999999999998 111.161 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -85.4 116.37 23.69 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.532 0.733 . . . . 72.140000000000001 110.352 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -125.03 115.4 20.47 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.577 1.151 . . . . 62.030000000000001 108.117 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 58.41 31.34 20.83 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.497 1.119 . . . . 65.430000000000007 111.163 -168.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.43 -19.37 32.37 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 115.442 -0.799 . . . . 63.509999999999998 113.867 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 mt -80.53 123.13 27.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.159 0.984 . . . . 51.0 111.206 -172.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.504 HG23 HG23 ' B' ' 54' ' ' ILE . 3.3 mp -80.65 127.85 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.666 0.786 . . . . 51.009999999999998 110.893 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.59 145.07 43.63 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.009 0.923 . . . . 74.299999999999997 109.3 168.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.538 HD13 ' H ' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -119.69 104.61 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-O 122.216 1.008 . . . . 73.400000000000006 109.876 174.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 77.5 m-85 -86.13 174.54 9.08 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.027 -0.988 . . . . 65.409999999999997 111.781 177.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.66 HD21 ' HB3' ' B' ' 17' ' ' LEU . 0.9 OUTLIER -86.49 159.07 19.41 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.362 0.601 . . . . 63.039999999999999 111.334 174.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -50.78 96.12 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.863 1.265 . . . . 72.230000000000004 112.073 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.6 -40.15 0.24 Allowed Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.515 -0.766 . . . . 65.109999999999999 112.356 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -81.59 -10.27 59.47 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.629 0.772 . . . . 64.299999999999997 112.551 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -73.42 132.49 43.03 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.674 0.39 . . . . 61.200000000000003 111.856 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -129.82 147.74 51.62 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.15 0.58 . . . . 74.519999999999996 110.166 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -157.65 -74.5 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.636 0.775 . . . . 74.329999999999998 109.914 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 37.4 t -179.95 -170.5 0.15 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.742 1.217 . . . . 34.119999999999997 108.741 -171.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -64.97 143.08 58.19 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 110.002 -0.37 . . . . 73.329999999999998 110.002 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.74 26.66 3.8 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 112.122 -0.391 . . . . 70.019999999999996 112.122 -171.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 46.9 mt -76.7 132.53 39.4 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.407 1.083 . . . . 61.439999999999998 110.975 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -72.92 109.18 6.28 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.042 0.537 . . . . 72.329999999999998 109.61 173.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -75.07 85.65 2.33 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.635 0.774 . . . . 72.400000000000006 110.672 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -70.14 113.66 7.54 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.694 0.798 . . . . 75.219999999999999 111.066 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -93.58 128.41 39.72 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.353 1.061 . . . . 72.409999999999997 111.744 -171.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -159.39 162.93 35.87 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.204 1.001 . . . . 72.409999999999997 110.431 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -77.44 123.66 26.85 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.251 0.621 . . . . 60.219999999999999 111.193 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 p80 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 123.943 0.897 . . . . 62.140000000000001 111.832 176.082 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.76 -0.459 . . . . 74.099999999999994 109.76 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.63 125.05 18.28 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.959 0.903 . . . . 73.25 111.887 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.506 ' O ' HG22 ' A' ' 6' ' ' VAL . 86.1 tttt -80.19 -25.19 39.83 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.248 0.619 . . . . 71.299999999999997 111.616 -176.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.73 -15.88 62.14 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.923 0.712 . . . . 74.549999999999997 112.923 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.05 -40.27 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.221 0.609 . . . . 72.329999999999998 111.451 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 41' ' ' LEU . 13.5 m -66.11 -33.45 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 122.177 0.191 . . . . 61.140000000000001 111.449 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.09 -43.37 33.37 Favored Glycine 0 C--N 1.353 1.513 0 O-C-N 123.479 0.487 . . . . 35.450000000000003 113.281 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 -46.48 76.33 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.557 0.743 . . . . 72.420000000000002 111.6 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.84 -26.56 66.11 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.812 0.845 . . . . 62.43 111.8 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.11 -34.44 73.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.003 0.521 . . . . 55.030000000000001 111.324 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.16 -38.76 94.18 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 116.183 -0.462 . . . . 72.540000000000006 113.152 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -69.49 -48.52 60.37 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.308 0.643 . . . . 73.209999999999994 111.733 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.86 -36.8 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 122.333 0.253 . . . . 74.549999999999997 111.462 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.562 ' HA ' HD12 ' A' ' 17' ' ' LEU . 54.4 t90 -64.92 -40.16 94.62 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.416 0.286 . . . . 61.329999999999998 111.052 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -60.94 -39.82 90.92 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.848 0.459 . . . . 72.040000000000006 110.904 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.82 69.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.469 0.708 . . . . 63.219999999999999 111.926 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 14' ' ' TRP . 84.4 mt -66.11 -45.27 81.73 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.537 0.735 . . . . 52.210000000000001 111.663 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -62.39 -31.55 72.24 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 120.815 0.34 . . . . 62.409999999999997 111.283 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.36 -49.35 50.18 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.439 0.696 . . . . 62.240000000000002 110.698 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.64 105.09 0.51 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.748 0.819 . . . . 72.310000000000002 111.084 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.48 -179.6 3.92 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.847 0.859 . . . . 64.25 111.403 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.42 33.09 44.88 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.033 -0.53 . . . . 44.299999999999997 111.824 -171.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.4 tt -122.5 154.55 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 124.432 1.093 . . . . 52.350000000000001 110.096 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.9 m -63.16 145.98 54.32 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.838 0.455 . . . . 43.549999999999997 111.302 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' B' ' 37' ' ' GLU . 66.0 mt -58.33 -43.27 98.02 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 123.989 0.916 . . . . 72.219999999999999 113.363 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HA ' HG22 ' A' ' 36' ' ' VAL . 36.6 Cg_endo -62.69 -35.2 70.76 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 122.244 1.963 . . . . 71.450000000000003 114.284 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -69.84 -51.26 35.02 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.25 1.024 . . . . 73.150000000000006 109.187 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.8 tp -54.26 -37.79 65.07 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 112.811 -1.995 . . . . 73.409999999999997 112.123 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.15 92.43 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.191 0.997 . . . . 63.219999999999999 112.136 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -67.5 -26.5 66.37 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.279 0.631 . . . . 75.329999999999998 111.82 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.14 -47.15 46.46 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.548 0.739 . . . . 71.340000000000003 111.094 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -84.29 0.96 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.216 0.606 . . . . 74.030000000000001 111.945 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 69.26 12.04 8.31 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.404 1.482 . . . . 70.209999999999994 113.632 174.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.3 mt -93.66 169.19 10.51 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.298 0.639 . . . . 73.450000000000003 110.523 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.6 p -78.06 162.93 26.33 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 110.24 -0.281 . . . . 74.319999999999993 110.24 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 26' ' ' PRO . 40.8 t -56.19 -47.55 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.799 0.84 . . . . 74.329999999999998 111.418 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.19 -41.72 97.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.989 -1.005 . . . . 73.340000000000003 112.186 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -67.06 -39.19 86.84 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.404 0.682 . . . . 75.340000000000003 112.315 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . 78.4 m -69.15 -48.62 61.87 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.513 0.725 . . . . 73.430000000000007 111.615 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -61.61 -38.38 87.4 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.38 0.672 . . . . 72.549999999999997 112.144 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.554 HD23 HG23 ' B' ' 43' ' ' VAL . 1.6 tm? -65.75 -39.09 90.74 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 124.95 1.3 . . . . 72.329999999999998 110.792 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.97 -33.32 70.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.433 0.693 . . . . 72.450000000000003 111.797 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.651 HG11 HD12 ' A' ' 63' ' ' ILE . 89.8 t -66.43 -31.04 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.072 0.549 . . . . 64.0 111.18 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.48 -30.11 73.54 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-N 116.751 -0.204 . . . . 64.329999999999998 113.535 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -73.99 -31.12 62.83 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.505 0.722 . . . . 54.439999999999998 110.982 173.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.67 -30.27 65.53 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.459 0.704 . . . . 51.420000000000002 111.609 172.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.09 -27.65 68.91 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.739 0.816 . . . . 74.239999999999995 111.655 169.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.404 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 13.0 ttp180 -65.96 -42.44 89.92 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.297 0.57 . . . . 74.530000000000001 110.15 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.81 -22.47 61.56 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.08 -0.964 . . . . 55.420000000000002 111.834 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 t30 65.71 22.4 11.58 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 125.171 1.388 . . . . 72.109999999999999 111.167 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -97.26 6.0 49.09 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.7 0.8 . . . . 64.219999999999999 112.87 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.8 151.16 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.808 0.843 . . . . 61.409999999999997 110.875 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 69' ' ' PHE . 86.6 t -111.68 107.63 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.578 0.751 . . . . 71.439999999999998 109.381 172.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.5 mt -96.44 112.86 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.143 -0.688 . . . . 73.219999999999999 109.143 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -134.52 125.88 28.23 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 110.077 -0.342 . . . . 71.540000000000006 110.077 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -87.45 107.8 18.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.016 0.926 . . . . 75.530000000000001 111.155 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.432 ' O ' HD23 ' A' ' 60' ' ' LEU . 2.3 mptm? -105.19 141.61 36.43 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.294 1.038 . . . . 74.349999999999994 108.87 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.8 p30 44.18 29.33 0.34 Allowed 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 125.334 1.454 . . . . 71.319999999999993 113.76 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.07 -28.67 12.88 Favored Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.274 0.869 . . . . 70.129999999999995 115.274 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -90.73 154.33 19.62 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.757 1.278 . . . . 74.25 112.037 -174.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.32 116.29 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.899 0.88 . . . . 72.230000000000004 109.84 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.95 128.6 56.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.337 0.655 . . . . 74.439999999999998 110.235 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.651 HD12 HG11 ' A' ' 43' ' ' VAL . 23.0 mm -92.27 105.7 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.426 0.69 . . . . 75.040000000000006 110.221 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -97.6 172.64 7.59 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.234 1.014 . . . . 73.420000000000002 110.804 176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -98.93 170.58 8.63 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.23 0.612 . . . . 71.400000000000006 109.97 164.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.69 112.71 0.81 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.749 0.82 . . . . 72.420000000000002 112.351 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.87 -16.73 60.19 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 116.131 -0.486 . . . . 62.240000000000002 113.85 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -87.15 14.07 8.32 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.025 0.93 . . . . 74.019999999999996 113.036 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.597 ' HB3' HG11 ' A' ' 53' ' ' VAL . 49.6 p90 -60.46 -9.86 4.21 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.832 1.419 . . . . 55.140000000000001 114.832 -172.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -101.94 -32.99 9.93 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 112.838 0.681 . . . . 75.430000000000007 112.838 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -82.38 132.21 35.22 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 122.81 0.444 . . . . 62.229999999999997 112.073 -173.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.3 t -120.05 168.6 11.01 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.834 0.854 . . . . 74.420000000000002 112.132 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -79.02 169.83 17.6 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.761 1.224 . . . . 75.430000000000007 111.674 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.73 -135.99 7.43 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 116.383 -0.372 . . . . 61.100000000000001 112.931 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.6 mp -130.27 118.63 21.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 117.648 0.724 . . . . 63.43 110.569 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -146.0 137.45 24.83 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.675 1.19 . . . . 60.520000000000003 109.278 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -135.98 110.69 8.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.96 0.904 . . . . 72.099999999999994 109.8 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -68.6 141.13 55.53 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.846 0.858 . . . . 63.109999999999999 111.653 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.9 114.94 2.31 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.692 0.797 . . . . 74.510000000000005 110.656 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -74.84 -171.54 1.34 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.422 0.689 . . . . 64.010000000000005 111.671 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 67.99 78.42 0.23 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.514 1.126 . . . . 72.310000000000002 111.264 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 124.273 1.029 . . . . 73.150000000000006 110.003 176.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttp . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 120.88 0.371 . . . . 74.129999999999995 110.799 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -80.53 -6.41 58.17 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.925 1.083 . . . . 75.439999999999998 113.925 -172.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -60.52 -43.44 97.13 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.328 0.513 . . . . 64.450000000000003 111.609 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -86.4 -25.82 25.09 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.764 0.426 . . . . 62.229999999999997 111.861 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 72.3 mt -66.77 -46.34 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.839 0.456 . . . . 54.409999999999997 110.877 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.2 m -64.6 -26.24 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 122.916 0.487 . . . . 70.129999999999995 111.078 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' B' ' 45' ' ' TRP . . . -65.57 -51.97 43.26 Favored Glycine 0 C--N 1.354 1.581 0 O-C-N 123.665 0.603 . . . . 72.150000000000006 113.543 172.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.64 85.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.48 0.712 . . . . 34.5 111.745 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.478 ' HB3' HD11 ' B' ' 34' ' ' LEU . 5.7 m-20 -68.65 -29.02 67.41 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.22 1.008 . . . . 63.5 111.519 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.513 ' HB1' ' HG ' ' B' ' 46' ' ' LEU . . . -73.26 -39.0 65.75 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.857 0.463 . . . . 74.109999999999999 110.969 176.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.21 -32.34 82.21 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-O 121.358 0.421 . . . . 51.25 112.281 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.8 -35.66 77.3 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.675 1.19 . . . . 73.129999999999995 111.683 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.479 HG22 HG11 ' B' ' 32' ' ' VAL . 74.7 t -69.51 -40.41 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.488 0.715 . . . . 62.439999999999998 111.317 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -66.13 -32.5 73.98 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.264 0.626 . . . . 71.200000000000003 110.943 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -54.72 -42.28 71.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.776 0.83 . . . . 75.230000000000004 111.472 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.91 70.81 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.5 0.72 . . . . 52.310000000000002 112.528 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.652 HD11 HG12 ' B' ' 52' ' ' VAL . 82.7 mt -62.91 -42.67 99.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.531 0.733 . . . . 65.299999999999997 111.476 172.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -64.65 -22.11 66.9 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.377 0.671 . . . . 64.329999999999998 111.651 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.33 -50.73 13.51 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.48 0.712 . . . . 63.399999999999999 110.262 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.3 124.34 0.72 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.823 0.849 . . . . 55.439999999999998 111.137 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.404 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 7.9 p-10 -74.81 175.1 8.33 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.439 0.695 . . . . 71.340000000000003 112.593 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.42 20.5 78.34 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.961 -0.563 . . . . 75.329999999999998 112.974 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.468 HG13 ' HB2' ' B' ' 28' ' ' LEU . 8.9 tp -84.73 124.39 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.946 0.899 . . . . 63.109999999999999 110.285 -176.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -85.38 147.03 26.7 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.845 0.458 . . . . 62.43 110.584 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 88.0 mt -49.74 -44.98 79.12 Favored Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 114.965 1.468 . . . . 72.049999999999997 114.965 -173.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.61 -48.17 21.71 Favored 'Trans proline' 0 C--N 1.392 2.819 0 C-N-CA 122.332 2.021 . . . . 71.150000000000006 114.374 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -72.09 -38.43 69.38 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.835 1.302 . . . . 50.020000000000003 110.072 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.468 ' HB2' HG13 ' B' ' 23' ' ' ILE . 56.0 tp -60.88 -33.95 73.89 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 112.642 -2.072 . . . . 75.219999999999999 111.34 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.7 -35.87 79.27 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.299 1.04 . . . . 63.439999999999998 112.484 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -64.91 -43.9 91.32 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 122.857 0.463 . . . . 73.409999999999997 110.523 173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -64.74 -39.39 93.54 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.429 -0.805 . . . . 63.43 112.137 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.479 HG11 HG22 ' B' ' 13' ' ' VAL . 23.4 m -97.53 -3.1 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 112.947 0.721 . . . . 71.510000000000005 112.947 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.7 28.5 14.94 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 124.558 1.143 . . . . 72.340000000000003 111.672 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' B' ' 9' ' ' ASN . 92.4 mt -109.49 166.11 11.14 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.533 0.733 . . . . 74.349999999999994 110.564 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 43.6 t -73.87 161.64 29.93 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.1 0.56 . . . . 55.25 110.615 170.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.5 -47.46 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.239 0.616 . . . . 72.319999999999993 111.741 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.538 ' HB3' HD12 ' A' ' 25' ' ' ILE . 42.7 mt-10 -61.05 -42.2 98.04 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.024 0.93 . . . . 72.239999999999995 112.339 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 39.4 t -67.24 -34.95 78.54 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.383 0.673 . . . . 75.239999999999995 111.665 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 45.0 m -79.94 -34.54 38.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.939 0.896 . . . . 71.329999999999998 110.982 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.86 -33.58 72.46 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.747 0.819 . . . . 75.319999999999993 111.139 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -75.4 -34.26 61.04 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 115.398 -0.819 . . . . 61.439999999999998 110.511 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.98 90.42 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.945 0.498 . . . . 63.100000000000001 111.767 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.554 HG23 HD23 ' A' ' 41' ' ' LEU . 20.2 m -68.75 -29.16 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 122.483 0.313 . . . . 71.430000000000007 110.916 172.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.4 -34.36 89.09 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.188 -0.46 . . . . 63.5 113.198 171.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.408 ' CD1' ' HA2' ' B' ' 7' ' ' GLY . 61.1 t-105 -72.51 -33.84 67.19 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.683 0.393 . . . . 71.120000000000005 110.372 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.513 ' HG ' ' HB1' ' B' ' 10' ' ' ALA . 53.2 mt -66.64 -27.93 68.07 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.633 0.373 . . . . 74.040000000000006 111.875 170.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.73 74.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.986 0.515 . . . . 72.299999999999997 111.609 168.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.404 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 27.8 ttp85 -64.68 -43.41 93.62 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.081 0.467 . . . . 63.119999999999997 110.164 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -67.8 -25.52 65.63 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.344 -0.844 . . . . 65.420000000000002 111.654 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 67.0 22.91 9.92 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.509 1.524 . . . . 70.319999999999993 111.797 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -95.58 3.55 53.98 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.882 1.067 . . . . 73.109999999999999 113.882 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.652 HG12 HD11 ' B' ' 17' ' ' LEU . 15.7 m -123.32 153.35 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.485 0.66 . . . . 53.119999999999997 112.407 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 91.4 t -108.72 125.84 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.494 1.118 . . . . 62.229999999999997 109.309 171.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 mm -104.8 116.52 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.129 0.572 . . . . 74.010000000000005 109.881 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -117.72 123.59 46.42 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.435 0.694 . . . . 64.239999999999995 110.1 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -93.57 97.19 10.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.082 0.553 . . . . 74.349999999999994 109.823 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.6 ' HD3' ' HG3' ' B' ' 62' ' ' GLU . 8.7 mtpm? -105.11 113.2 26.65 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.041 0.936 . . . . 74.540000000000006 110.149 -175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 60.28 28.94 18.58 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.605 1.562 . . . . 44.549999999999997 111.733 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.62 -2.32 87.29 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 114.591 0.596 . . . . 73.319999999999993 114.591 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.67 149.37 22.88 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.009 0.905 . . . . 51.219999999999999 111.635 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.8 mm -87.14 119.1 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.178 0.591 . . . . 70.150000000000006 110.861 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . 0.6 ' HG3' ' HD3' ' B' ' 57' ' ' LYS . 7.2 mm-40 -116.1 121.63 42.73 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.286 1.034 . . . . 75.099999999999994 109.395 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.529 HG22 HD21 ' B' ' 17' ' ' LEU . 17.5 mm -100.75 122.35 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.19 0.596 . . . . 74.439999999999998 110.822 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.665 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 22.4 m-85 -116.18 169.15 9.5 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.109 0.964 . . . . 64.120000000000005 111.244 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.404 ' OD1' ' HB3' ' B' ' 21' ' ' ASP . 1.8 m-20 -77.62 141.28 39.56 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.633 -0.712 . . . . 73.340000000000003 111.225 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -49.84 -25.96 3.58 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.899 1.28 . . . . 65.310000000000002 114.217 172.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.88 -18.81 66.9 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 115.077 0.791 . . . . 61.530000000000001 115.077 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -145.06 127.3 15.76 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.34 0.57 . . . . 74.109999999999999 110.508 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -144.02 158.02 43.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.554 0.742 . . . . 51.039999999999999 111.26 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.08 123.93 22.39 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.47 0.708 . . . . 74.150000000000006 110.703 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -87.78 -177.91 5.93 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.671 0.788 . . . . 65.329999999999998 111.745 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 39.6 t -59.99 -51.67 68.68 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.651 -0.704 . . . . 62.210000000000001 110.33 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -90.89 80.8 5.76 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.424 -0.807 . . . . 71.340000000000003 109.315 171.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.36 -6.36 55.31 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 115.462 -0.79 . . . . 54.009999999999998 112.608 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 48.9 tp 75.31 -35.88 0.29 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 126.249 1.82 . . . . 73.409999999999997 113.115 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -54.67 131.93 44.43 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.423 1.089 . . . . 71.329999999999998 113.246 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -154.52 85.79 1.13 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.454 1.102 . . . . 73.519999999999996 108.449 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -61.88 160.56 11.89 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.854 1.262 . . . . 43.329999999999998 112.6 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -42.86 133.59 3.57 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.587 1.155 . . . . 74.230000000000004 111.871 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -58.25 125.27 22.53 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.185 0.594 . . . . 74.129999999999995 111.555 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -88.73 149.18 23.59 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.111 0.564 . . . . 72.219999999999999 111.158 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 21.7 p80 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 121.903 0.859 . . . . 64.310000000000002 112.29 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.539 0.209 . . . . 70.430000000000007 110.722 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -20.27 62.19 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 112.991 0.737 . . . . 75.109999999999999 112.991 -168.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -60.12 -38.38 82.84 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 119.376 0.989 . . . . 75.150000000000006 112.801 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -79.58 -41.06 27.95 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.84 0.456 . . . . 75.420000000000002 110.673 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.4 mt -65.44 -41.3 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.725 0.81 . . . . 71.310000000000002 112.335 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.536 HG12 HD11 ' A' ' 41' ' ' LEU . 29.5 m -65.13 -30.39 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 122.993 0.517 . . . . 45.240000000000002 111.517 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -42.52 85.08 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 112.498 -0.241 . . . . 63.25 112.498 172.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.89 -45.82 69.99 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.795 0.838 . . . . 72.400000000000006 111.949 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.412 ' HB2' HD11 ' A' ' 34' ' ' LEU . 31.7 p30 -77.37 -23.06 50.86 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 122.971 0.508 . . . . 73.409999999999997 111.946 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.03 -35.58 59.45 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.91 0.484 . . . . 54.409999999999997 111.209 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.61 -31.57 78.96 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 121.613 0.563 . . . . 75.319999999999993 112.231 172.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -68.92 -45.01 71.95 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 125.136 1.374 . . . . 74.340000000000003 110.79 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.45 ' HA ' HG11 ' A' ' 32' ' ' VAL . 39.2 t -64.48 -36.58 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 124.534 1.134 . . . . 72.140000000000001 111.652 173.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.411 ' NE1' ' HB3' ' A' ' 51' ' ' LYS . 15.9 t90 -71.5 -32.23 68.0 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.442 0.697 . . . . 72.219999999999999 110.908 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -59.84 -32.93 71.14 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.563 0.745 . . . . 71.319999999999993 111.545 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.77 -22.86 65.78 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.804 0.668 . . . . 73.230000000000004 112.804 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 52' ' ' VAL . 94.7 mt -68.8 -38.83 80.23 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.766 0.826 . . . . 64.409999999999997 112.687 173.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -56.86 -36.27 69.85 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.525 0.73 . . . . 74.340000000000003 111.303 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.62 -47.75 13.65 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.488 -0.778 . . . . 71.319999999999993 110.966 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.73 113.32 6.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.07 0.948 . . . . 54.210000000000001 111.392 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -94.94 128.3 41.63 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.404 -0.961 . . . . 72.200000000000003 108.404 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.8 47.81 4.66 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 111.896 -0.482 . . . . 74.120000000000005 111.896 -172.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.8 tp -114.35 137.27 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 C-N-CA 123.898 0.879 . . . . 73.299999999999997 110.731 -175.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.7 p -82.49 162.3 22.09 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.321 0.648 . . . . 61.420000000000002 111.99 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.9 mt -55.41 -54.34 52.1 Favored Pre-proline 0 CA--C 1.579 2.084 0 N-CA-C 113.84 1.052 . . . . 75.010000000000005 113.84 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.14 -30.61 20.24 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.03 1.82 . . . . 60.329999999999998 113.432 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -71.43 -44.33 65.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.265 0.626 . . . . 72.310000000000002 111.619 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.07 -30.65 63.86 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.91 0.484 . . . . 62.350000000000001 110.334 175.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.33 -41.86 76.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.551 0.74 . . . . 64.420000000000002 112.016 177.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -69.22 -30.82 69.06 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.079 0.552 . . . . 74.349999999999994 111.671 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -69.94 -40.48 75.44 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.079 0.552 . . . . 75.310000000000002 111.578 174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' ' 13' ' ' VAL . 21.5 m -96.72 7.74 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.365 0.666 . . . . 72.0 112.115 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.47 16.96 9.13 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.454 1.102 . . . . 53.109999999999999 113.935 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 9' ' ' ASN . 76.2 mt -99.85 159.43 15.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.53 0.732 . . . . 73.430000000000007 110.414 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.7 t -68.8 161.02 29.38 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.761 0.425 . . . . 74.120000000000005 110.847 169.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -59.3 -42.92 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 122.705 0.402 . . . . 65.329999999999998 111.491 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -64.82 -48.35 74.69 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.214 0.606 . . . . 73.319999999999993 111.784 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 t -57.08 -39.18 74.48 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.016 0.926 . . . . 75.510000000000005 112.101 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 43' ' ' VAL . 79.8 m -71.0 -52.28 20.55 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 123.905 0.882 . . . . 51.340000000000003 110.741 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.34 -30.95 67.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.018 0.927 . . . . 71.120000000000005 112.807 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.536 HD11 HG12 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -68.76 -45.05 72.39 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.388 1.075 . . . . 64.450000000000003 110.351 172.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.46 -31.38 72.57 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.586 0.754 . . . . 72.140000000000001 111.965 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 39' ' ' THR . 75.2 t -62.82 -43.14 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.551 1.141 . . . . 44.539999999999999 111.466 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.25 -31.13 75.93 Favored Glycine 0 CA--C 1.541 1.691 0 O-C-N 123.342 0.401 . . . . 52.149999999999999 113.055 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.461 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 51.3 t-105 -75.07 -27.7 60.06 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.849 0.86 . . . . 74.129999999999995 112.323 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 98.2 mt -76.68 -42.13 42.9 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.892 -0.505 . . . . 62.299999999999997 111.826 168.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.83 71.36 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.718 1.207 . . . . 72.120000000000005 113.327 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.701 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 14.1 ptt180 -61.05 -34.49 74.97 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.681 0.392 . . . . 64.409999999999997 111.718 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.701 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 36.4 mt-10 -98.41 1.05 46.47 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.421 1.088 . . . . 74.530000000000001 111.923 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 t30 61.89 28.1 17.13 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.623 1.169 . . . . 73.239999999999995 111.529 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 92.1 mttt -72.81 -21.35 60.98 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.59 0.756 . . . . 62.299999999999997 112.316 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.604 HG12 HD11 ' A' ' 17' ' ' LEU . 27.9 m -125.8 148.55 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 64.209999999999994 111.199 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.748 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 44.4 t -100.12 100.5 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.782 0.833 . . . . 73.150000000000006 108.8 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.3 mm -78.43 123.26 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 109.936 -0.394 . . . . 71.5 109.936 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.37 116.57 17.01 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.727 -0.842 . . . . 75.209999999999994 108.727 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -93.9 103.53 15.63 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.387 0.675 . . . . 63.240000000000002 110.387 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -111.16 129.04 56.07 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.563 0.745 . . . . 74.420000000000002 109.904 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 56.03 28.37 12.71 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.574 1.149 . . . . 72.049999999999997 112.467 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.64 -21.27 14.84 Favored Glycine 0 CA--C 1.542 1.722 0 N-CA-C 114.242 0.457 . . . . 53.32 114.242 -174.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.02 143.84 35.25 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.462 0.705 . . . . 54.130000000000003 110.877 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.81 138.13 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.494 -0.558 . . . . 52.299999999999997 109.494 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -147.35 142.57 27.24 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.454 0.645 . . . . 75.010000000000005 111.027 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.1 mt -111.01 137.51 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.042 0.937 . . . . 73.439999999999998 110.862 -173.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.748 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 90.1 m-85 -121.62 165.24 16.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.71 -1.132 . . . . 74.230000000000004 108.942 174.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HA ' HD13 ' A' ' 17' ' ' LEU . 20.9 t-20 -83.05 152.04 25.54 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.914 -0.772 . . . . 61.340000000000003 108.914 173.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -23.48 36.4 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.602 0.964 . . . . 75.140000000000001 113.602 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.52 -19.09 72.48 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 114.262 0.465 . . . . 73.310000000000002 114.262 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -69.6 -12.34 61.56 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.955 0.902 . . . . 74.409999999999997 112.424 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -59.06 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.008 0.523 . . . . 64.450000000000003 111.939 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.43 109.3 18.95 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.513 -0.921 . . . . 64.299999999999997 108.513 167.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -65.42 98.71 0.36 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.185 0.594 . . . . 74.239999999999995 111.648 -173.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.0 p -127.24 147.63 50.22 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.766 0.826 . . . . 72.5 110.686 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.454 ' HB3' HD23 ' A' ' 75' ' ' LEU . 93.8 m-85 -88.93 110.83 21.43 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.393 0.677 . . . . 71.430000000000007 110.95 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.92 54.52 0.7 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 123.316 0.484 . . . . 73.349999999999994 113.068 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.454 HD23 ' HB3' ' A' ' 73' ' ' PHE . 4.0 mm? -77.36 -19.76 55.8 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.64 0.776 . . . . 61.039999999999999 112.088 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.12 98.83 0.33 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.192 0.597 . . . . 71.400000000000006 111.065 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -56.29 128.07 33.99 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.448 1.099 . . . . 73.409999999999997 112.216 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -146.72 138.45 24.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.542 0.737 . . . . 61.43 110.479 -173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 60.59 16.74 6.79 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 124.137 0.975 . . . . 74.319999999999993 112.429 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -72.5 91.25 1.38 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.234 0.614 . . . . 73.239999999999995 110.567 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -67.98 128.38 36.32 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.347 -0.842 . . . . 73.140000000000001 111.332 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.3 m170 . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 121.603 0.716 . . . . 71.019999999999996 111.382 -176.302 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptm . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 111.999 0.37 . . . . 64.120000000000005 111.999 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.4 -39.71 81.57 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.793 0.837 . . . . 60.219999999999999 111.212 -173.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.644 ' HA ' HG22 ' B' ' 6' ' ' VAL . 99.0 mttt -70.37 -26.03 63.53 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.796 0.665 . . . . 63.310000000000002 112.796 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -70.05 -37.36 75.51 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.769 0.427 . . . . 71.150000000000006 110.81 171.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.93 -52.71 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 123.513 0.725 . . . . 72.340000000000003 111.438 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.644 HG22 ' HA ' ' B' ' 3' ' ' LYS . 19.5 m -70.52 -27.47 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 122.72 0.408 . . . . 61.219999999999999 111.741 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -38.87 89.17 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 116.783 -0.189 . . . . 32.409999999999997 112.764 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.03 32.02 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.437 0.695 . . . . 60.049999999999997 111.73 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.604 ' HB2' HD11 ' B' ' 34' ' ' LEU . 31.3 p30 -73.29 -20.97 60.7 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 112.953 0.723 . . . . 73.310000000000002 112.953 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.97 -23.38 64.12 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.083 0.553 . . . . 64.510000000000005 111.178 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.04 -31.91 79.2 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 116.222 -0.445 . . . . 64.099999999999994 113.12 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.62 -47.02 64.89 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.438 0.695 . . . . 71.099999999999994 111.101 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.19 -36.88 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.276 1.03 . . . . 75.519999999999996 111.59 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -72.66 -34.32 67.16 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.263 0.625 . . . . 74.329999999999998 110.979 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -65.03 -31.03 72.06 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.666 0.387 . . . . 62.240000000000002 111.475 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.68 -30.23 67.21 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.05 0.54 . . . . 75.329999999999998 112.146 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.705 HD11 HG12 ' B' ' 52' ' ' VAL . 80.3 mt -65.59 -45.96 81.22 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.772 0.829 . . . . 61.25 111.659 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -59.66 -28.18 67.03 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.692 0.797 . . . . 74.099999999999994 111.266 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -81.91 -47.57 12.59 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.877 0.871 . . . . 72.430000000000007 111.217 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.09 151.98 16.52 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.783 0.833 . . . . 44.350000000000001 111.736 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -112.22 156.16 22.81 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.297 0.639 . . . . 74.349999999999994 109.649 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.01 38.66 84.68 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 114.359 0.503 . . . . 61.039999999999999 114.359 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 tt -102.36 137.54 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.23 0.612 . . . . 73.329999999999998 110.275 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -73.11 156.4 38.72 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.386 0.674 . . . . 62.520000000000003 111.594 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.82 -52.18 76.28 Favored Pre-proline 0 CA--C 1.575 1.933 0 N-CA-C 113.617 0.969 . . . . 72.349999999999994 113.617 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.75 -23.91 55.24 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.149 1.899 . . . . 65.109999999999999 113.501 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -78.91 -42.66 26.6 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.741 0.816 . . . . 74.430000000000007 111.496 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.1 -31.58 61.21 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 122.157 -0.34 . . . . 74.549999999999997 111.078 174.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.53 -45.38 73.35 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.573 1.149 . . . . 74.549999999999997 113.393 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -65.01 -30.83 71.83 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 115.999 -0.546 . . . . 74.239999999999995 112.22 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -78.41 -40.93 34.55 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.015 0.526 . . . . 72.409999999999997 111.058 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 m -81.58 -3.4 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.076 0.551 . . . . 61.439999999999998 111.683 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 65.83 29.41 10.51 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.321 1.448 . . . . 73.140000000000001 112.906 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' B' ' 9' ' ' ASN . 66.5 mt -109.28 158.07 18.23 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.693 0.797 . . . . 72.299999999999997 110.395 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 34.0 t -65.09 152.82 42.56 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.781 0.433 . . . . 73.120000000000005 110.581 166.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.34 -41.97 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 123.073 0.549 . . . . 72.510000000000005 111.579 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.66 -48.21 80.33 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.087 0.955 . . . . 75.230000000000004 112.015 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.5 t -66.56 -30.82 71.22 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.713 0.805 . . . . 71.230000000000004 111.601 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 96.8 m -74.87 -44.17 50.44 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.916 0.886 . . . . 73.319999999999993 110.92 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.51 -34.3 77.47 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.872 0.869 . . . . 73.329999999999998 111.648 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -67.2 -44.08 80.52 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 124.27 1.028 . . . . 71.310000000000002 110.496 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.81 76.75 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.14 0.576 . . . . 73.540000000000006 111.793 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.19 -44.35 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.585 1.154 . . . . 74.319999999999993 110.828 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.47 -28.04 73.16 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 116.378 -0.374 . . . . 65.209999999999994 113.155 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 49.9 t-105 -74.18 -29.9 61.98 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.967 0.907 . . . . 73.450000000000003 111.232 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.06 -36.59 58.94 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.358 0.663 . . . . 73.420000000000002 112.186 167.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.96 76.86 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.202 1.001 . . . . 44.530000000000001 113.543 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 20.3 ptt85 -63.92 -30.68 71.74 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.303 0.573 . . . . 73.219999999999999 111.097 173.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -86.03 -15.78 40.3 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.374 1.07 . . . . 64.349999999999994 111.572 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 t30 60.43 43.62 13.04 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.717 1.207 . . . . 73.200000000000003 110.769 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -95.83 -9.07 32.48 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.312 -0.858 . . . . 64.420000000000002 111.777 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.705 HG12 HD11 ' B' ' 17' ' ' LEU . 27.7 m -125.17 146.47 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.222 1.009 . . . . 60.509999999999998 111.149 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' B' ' 66' ' ' GLU . 85.9 t -103.95 104.08 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.133 -1.062 . . . . 74.0 108.133 167.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 70.8 mt -91.21 118.18 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.146 0.578 . . . . 70.510000000000005 109.827 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.69 123.28 45.7 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.003 -0.74 . . . . 70.340000000000003 109.003 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -89.13 96.85 10.89 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.596 0.712 . . . . 64.409999999999997 109.341 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -116.66 119.06 34.3 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.077 -0.965 . . . . 72.430000000000007 109.502 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 60.07 28.79 18.38 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.783 1.233 . . . . 65.519999999999996 111.731 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.85 -3.93 72.82 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 114.452 0.541 . . . . 43.130000000000003 114.452 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.59 134.7 34.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.341 0.656 . . . . 75.439999999999998 110.736 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 18.6 mm -87.07 103.12 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 123.562 0.745 . . . . 74.239999999999995 109.045 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -117.75 123.84 47.0 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.486 0.715 . . . . 64.209999999999994 109.919 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 40.2 pt -97.76 138.29 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.074 0.94 . . . . 73.140000000000001 112.177 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.523 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 77.0 m-85 -120.7 169.4 10.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.165 1.386 . . . . 51.340000000000003 108.347 175.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -85.43 145.99 27.19 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.682 -0.858 . . . . 65.030000000000001 108.682 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.555 ' HA ' HG23 ' B' ' 53' ' ' VAL . 1.0 OUTLIER -60.51 142.76 54.87 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 112.394 0.516 . . . . 65.230000000000004 112.394 -178.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.99 -18.27 45.62 Favored Glycine 0 CA--C 1.539 1.555 0 CA-C-O 119.451 -0.638 . . . . 45.219999999999999 114.373 -178.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -57.96 -51.03 71.35 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.815 0.846 . . . . 73.030000000000001 111.941 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -85.72 -28.61 24.52 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.153 0.581 . . . . 75.049999999999997 111.783 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 27.4 t70 62.78 -128.74 0.58 Allowed 'General case' 0 CA--C 1.574 1.895 0 C-N-CA 123.622 0.769 . . . . 74.019999999999996 110.363 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.57 25.08 8.84 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 119.625 1.102 . . . . 71.540000000000006 111.624 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -80.74 -173.04 3.96 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.215 0.606 . . . . 74.530000000000001 112.021 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -68.08 171.16 7.26 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 123.628 0.771 . . . . 75.230000000000004 111.61 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.08 -133.88 1.19 Allowed Glycine 0 C--N 1.353 1.495 0 N-CA-C 112.379 -0.288 . . . . 44.43 112.379 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 14.1 tp -158.94 17.67 0.19 Allowed 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 117.412 0.606 . . . . 73.319999999999993 111.233 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.22 104.66 2.7 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.088 0.555 . . . . 73.010000000000005 110.852 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -138.19 108.38 6.43 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.035 0.934 . . . . 74.109999999999999 109.443 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -93.11 107.91 19.61 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.493 0.553 . . . . 74.140000000000001 112.493 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -132.21 172.57 12.24 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.353 1.061 . . . . 42.229999999999997 110.262 165.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -153.88 119.53 5.24 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.683 0.793 . . . . 71.530000000000001 109.968 -171.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -80.75 106.68 12.94 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.147 0.579 . . . . 64.25 111.777 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 80.0 t60 . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 124.169 0.988 . . . . 75.209999999999994 110.038 175.928 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptm . . . . . 0 N--CA 1.499 2.009 0 CA-C-O 121.734 0.778 . . . . 63.240000000000002 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.84 -28.35 69.42 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.662 1.185 . . . . 74.129999999999995 114.026 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -65.92 -33.89 76.86 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 113.793 1.035 . . . . 72.219999999999999 113.793 -164.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.37 -32.48 29.24 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 122.506 0.322 . . . . 74.329999999999998 111.339 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.658 HD13 HH22 ' B' ' 56' ' ' ARG . 68.4 mt -62.82 -47.53 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.433 0.693 . . . . 75.409999999999997 110.947 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.48 -34.46 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.772 0.829 . . . . 74.109999999999999 111.352 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.41 -37.12 94.32 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 112.634 -0.186 . . . . 60.219999999999999 112.634 173.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.0 -55.74 8.78 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.699 0.8 . . . . 71.200000000000003 112.296 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.615 ' HB2' HD11 ' A' ' 34' ' ' LEU . 36.6 p30 -78.14 -13.46 59.86 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.756 1.021 . . . . 74.519999999999996 113.756 -170.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.16 -27.77 64.8 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.651 0.38 . . . . 64.430000000000007 111.598 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.23 -45.45 80.48 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 116.15 -0.477 . . . . 21.530000000000001 113.552 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -39.17 75.57 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.811 0.444 . . . . 74.109999999999999 112.185 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.498 ' HA ' HG11 ' A' ' 32' ' ' VAL . 20.9 m -69.59 -36.19 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.72 0.236 . . . . 74.239999999999995 111.221 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.677 ' HA ' HD12 ' A' ' 17' ' ' LEU . 62.3 t90 -69.37 -33.64 73.37 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.91 0.484 . . . . 74.409999999999997 111.033 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.61 -33.96 77.12 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.048 0.539 . . . . 65.340000000000003 111.321 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.74 76.1 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.231 0.612 . . . . 72.219999999999999 111.551 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.677 HD12 ' HA ' ' A' ' 14' ' ' TRP . 31.3 mt -71.91 -33.93 68.69 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.009 0.924 . . . . 60.109999999999999 111.641 174.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -30.3 65.23 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.734 0.814 . . . . 65.549999999999997 109.944 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -77.23 -41.39 41.36 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.018 0.527 . . . . 64.349999999999994 110.492 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.2 107.13 1.8 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.136 0.574 . . . . 73.430000000000007 111.612 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.98 174.91 11.15 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.331 0.652 . . . . 63.310000000000002 111.148 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.67 42.43 97.27 Favored Glycine 0 N--CA 1.479 1.518 0 CA-C-O 121.406 0.448 . . . . 72.0 112.366 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.433 HD13 ' HB3' ' A' ' 28' ' ' LEU . 21.1 tt -114.92 144.79 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.826 0.851 . . . . 54.140000000000001 110.996 -169.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -79.8 151.26 30.4 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.08 0.552 . . . . 72.319999999999993 110.889 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.81 -47.1 99.33 Favored Pre-proline 0 CA--C 1.58 2.119 0 N-CA-C 113.326 0.862 . . . . 64.140000000000001 113.326 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.05 -22.81 47.14 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.076 1.851 . . . . 71.439999999999998 113.468 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -71.91 -48.9 42.27 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.633 0.773 . . . . 64.510000000000005 111.673 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.433 ' HB3' HD13 ' A' ' 23' ' ' ILE . 2.2 pt? -74.9 -29.62 61.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.816 -0.553 . . . . 71.5 111.826 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.39 -44.88 65.58 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.385 0.883 . . . . 51.030000000000001 113.385 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -70.44 -30.38 67.2 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.922 0.489 . . . . 73.120000000000005 112.081 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 25.7 mtpp -68.33 -44.34 75.54 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.575 0.75 . . . . 71.120000000000005 110.592 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 13' ' ' VAL . 16.9 m -86.41 -2.0 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.126 0.971 . . . . 64.239999999999995 111.805 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 m120 64.84 23.22 12.63 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.104 1.361 . . . . 74.239999999999995 112.946 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 9' ' ' ASN . 66.3 mt -101.63 168.2 9.63 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.67 0.788 . . . . 72.409999999999997 111.102 174.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 m -71.72 156.97 38.75 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.905 -0.589 . . . . 74.310000000000002 110.838 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.39 -48.37 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 123.235 0.614 . . . . 72.239999999999995 111.717 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.406 ' HB3' HD12 ' B' ' 25' ' ' ILE . 51.7 mt-10 -63.73 -38.64 91.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.38 0.672 . . . . 54.310000000000002 112.658 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.1 m -65.99 -31.14 71.88 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.606 0.762 . . . . 62.43 111.807 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.4 m -77.39 -44.18 30.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.802 0.841 . . . . 73.310000000000002 111.112 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.57 -33.55 72.87 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.305 0.642 . . . . 60.32 111.659 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -53.71 54.84 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.546 1.139 . . . . 71.239999999999995 110.04 171.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.28 -32.35 72.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.078 -0.965 . . . . 54.140000000000001 112.277 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.46 HG11 HD13 ' A' ' 63' ' ' ILE . 69.1 t -68.34 -39.71 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.24 0.616 . . . . 70.239999999999995 111.183 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.34 -31.8 81.99 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 116.633 -0.258 . . . . 61.340000000000003 113.108 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.403 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 69.2 t-105 -71.18 -30.3 66.25 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.605 0.762 . . . . 72.200000000000003 111.685 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.447 HD22 ' HE2' ' A' ' 51' ' ' LYS . 77.5 mt -75.61 -38.07 59.28 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.578 0.751 . . . . 74.25 112.274 170.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.29 -37.01 74.16 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.807 1.243 . . . . 63.310000000000002 114.117 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.599 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 25.7 ptt85 -60.39 -26.67 66.84 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 122.935 0.494 . . . . 72.219999999999999 111.886 175.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 40.0 mt-10 -103.3 4.96 37.08 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.856 1.262 . . . . 74.209999999999994 112.228 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 62.71 21.7 12.9 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 125.031 1.332 . . . . 64.239999999999995 113.0 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HE2' HD22 ' A' ' 46' ' ' LEU . 50.8 mtpt -80.2 -13.45 59.23 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.235 0.614 . . . . 74.219999999999999 112.283 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.488 HG12 HD13 ' A' ' 17' ' ' LEU . 19.0 m -121.61 142.95 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.759 0.823 . . . . 54.409999999999997 111.22 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 94.7 t -112.73 104.98 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 123.846 0.859 . . . . 71.030000000000001 109.872 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.583 HG23 HG23 ' A' ' 61' ' ' ILE . 2.6 mp -91.64 125.43 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.561 -0.533 . . . . 64.329999999999998 109.561 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.33 113.22 25.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.007 0.523 . . . . 72.319999999999993 109.644 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -87.23 96.22 10.25 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.77 -0.826 . . . . 73.439999999999998 108.77 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.54 118.12 34.86 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.825 0.85 . . . . 75.019999999999996 109.541 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.78 31.56 17.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.871 0.868 . . . . 63.240000000000002 111.569 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.52 2.36 74.53 Favored Glycine 0 CA--C 1.546 1.98 0 N-CA-C 114.472 0.549 . . . . 42.439999999999998 114.472 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.0 mt -94.92 133.07 39.05 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.945 0.898 . . . . 53.420000000000002 110.306 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.583 HG23 HG23 ' A' ' 54' ' ' ILE . 76.6 mt -96.87 118.07 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.489 0.715 . . . . 61.25 111.666 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.37 132.05 55.75 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.914 -0.773 . . . . 62.119999999999997 108.914 167.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.46 HD13 HG11 ' A' ' 43' ' ' VAL . 40.0 mt -102.04 132.05 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 121.325 0.583 . . . . 65.140000000000001 110.788 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.57 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 83.8 m-85 -124.55 173.55 8.41 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.318 1.047 . . . . 75.549999999999997 110.158 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -99.86 163.92 12.25 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.048 0.539 . . . . 74.219999999999999 109.727 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -53.17 148.41 8.35 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.441 1.097 . . . . 72.310000000000002 112.324 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.63 -6.09 33.3 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 116.469 -0.332 . . . . 65.019999999999996 112.979 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -81.88 3.69 25.23 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 123.945 0.898 . . . . 72.519999999999996 112.022 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -122.12 157.51 31.34 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.766 0.826 . . . . 64.519999999999996 111.522 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -103.04 118.52 37.0 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.569 0.748 . . . . 71.409999999999997 110.662 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -122.02 158.7 28.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.891 0.876 . . . . 53.520000000000003 110.327 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 t 67.71 -64.87 0.26 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.058 1.343 . . . . 61.310000000000002 111.465 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -69.01 111.62 5.12 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 109.265 -0.643 . . . . 75.549999999999997 109.265 168.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.26 79.56 1.04 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 115.251 0.86 . . . . 65.430000000000007 115.251 -167.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.1 mt -103.51 91.87 4.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.229 0.611 . . . . 62.43 109.706 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -89.43 128.69 35.97 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.893 -0.594 . . . . 74.450000000000003 109.784 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -75.82 105.9 7.1 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.272 0.629 . . . . 74.400000000000006 109.537 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -63.63 112.69 2.93 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.95 0.5 . . . . 75.140000000000001 111.168 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -72.55 139.84 47.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.452 0.701 . . . . 71.400000000000006 110.394 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -85.0 147.16 26.83 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.146 0.578 . . . . 75.040000000000006 111.421 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -71.11 138.22 49.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.941 0.496 . . . . 73.239999999999995 110.719 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.768 0.794 . . . . 64.239999999999995 111.137 -174.515 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 CA--C 1.546 0.813 0 CA-C-O 120.852 0.358 . . . . 64.510000000000005 110.908 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.43 ' O ' HG13 ' B' ' 6' ' ' VAL . 2.0 t70 -67.52 -33.05 74.28 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.458 0.703 . . . . 44.119999999999997 112.11 -171.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.507 ' HA ' HG22 ' B' ' 6' ' ' VAL . 37.5 ttmt -66.52 -35.19 79.65 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.323 0.49 . . . . 72.519999999999996 112.323 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -55.25 -41.24 71.9 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.403 0.621 . . . . 72.150000000000006 110.478 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' B' ' 2' ' ' ASP . 47.6 mt -66.55 -51.97 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-N 114.677 -1.147 . . . . 64.239999999999995 111.457 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' B' ' 3' ' ' LYS . 4.5 m -67.18 -32.3 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 122.584 0.354 . . . . 73.409999999999997 111.896 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.47 -44.09 66.19 Favored Glycine 0 C--N 1.349 1.302 0 O-C-N 123.201 0.313 . . . . 53.240000000000002 112.749 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.26 69.83 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.505 0.722 . . . . 73.420000000000002 112.25 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.408 ' OD1' HD11 ' B' ' 34' ' ' LEU . 9.0 t-20 -86.67 -28.05 23.4 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.637 0.775 . . . . 61.109999999999999 112.131 -175.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.25 72.36 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.275 0.63 . . . . 54.329999999999998 112.192 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.81 -42.31 95.17 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 116.11 -0.495 . . . . 64.209999999999994 112.373 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -65.11 -45.63 84.33 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.777 0.831 . . . . 73.209999999999994 111.479 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.617 ' HA ' HG11 ' B' ' 32' ' ' VAL . 30.9 m -68.83 -32.22 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 C-N-CA 122.772 0.429 . . . . 72.099999999999994 112.068 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.501 ' HA ' HD12 ' B' ' 17' ' ' LEU . 34.6 t90 -72.3 -35.77 68.75 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.834 0.454 . . . . 74.409999999999997 111.495 175.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -67.46 -32.24 72.95 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.069 0.548 . . . . 74.019999999999996 112.018 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.7 74.39 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 122.971 0.508 . . . . 62.229999999999997 111.939 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' B' ' 14' ' ' TRP . 82.6 mt -63.67 -30.89 71.94 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.944 0.898 . . . . 52.329999999999998 112.602 174.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -69.2 -5.48 22.89 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.158 0.799 . . . . 51.109999999999999 113.158 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -79.67 -61.48 1.98 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.022 0.529 . . . . 74.230000000000004 110.469 170.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.94 131.72 5.33 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.511 0.725 . . . . 63.32 110.947 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.525 ' HB3' ' HD1' ' B' ' 64' ' ' TYR . 4.6 m-20 -74.22 175.21 7.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.991 0.916 . . . . 74.420000000000002 112.468 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.72 54.81 5.24 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.535 -0.626 . . . . 72.409999999999997 111.535 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 tt -133.6 120.34 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.53 0.732 . . . . 71.129999999999995 110.994 -167.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -67.74 163.49 21.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.633 0.773 . . . . 54.009999999999998 111.911 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' B' ' 40' ' ' ALA . 48.5 mt -59.7 -47.12 98.26 Favored Pre-proline 0 CA--C 1.574 1.901 0 CA-C-O 118.525 -0.75 . . . . 73.019999999999996 112.434 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.02 -22.99 34.69 Favored 'Trans proline' 0 C--N 1.396 3.044 0 C-N-CA 121.871 1.714 . . . . 50.409999999999997 114.064 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -70.73 -50.45 36.08 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.686 1.231 . . . . 75.239999999999995 109.017 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.83 -39.1 83.97 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 112.612 -2.085 . . . . 72.510000000000005 111.679 175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.17 -43.11 87.28 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.105 0.962 . . . . 74.049999999999997 112.867 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -69.71 -36.93 76.34 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.003 0.521 . . . . 74.25 111.587 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -64.39 -44.85 90.04 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.244 0.618 . . . . 73.140000000000001 111.148 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' B' ' 13' ' ' VAL . 13.7 m -88.23 5.34 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.35 0.66 . . . . 73.129999999999995 112.727 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 69.32 17.81 8.14 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.798 1.239 . . . . 71.310000000000002 113.137 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.408 HD11 ' OD1' ' B' ' 9' ' ' ASN . 63.3 mt -110.65 174.95 5.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.627 0.771 . . . . 74.319999999999993 112.287 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -84.31 160.72 20.65 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.17 -0.923 . . . . 74.430000000000007 110.577 167.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 63.2 t -53.89 -49.82 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 124.1 0.96 . . . . 73.439999999999998 112.653 -175.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.37 -48.3 82.34 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.579 0.752 . . . . 73.510000000000005 111.985 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -62.67 -37.13 85.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.942 0.897 . . . . 64.549999999999997 111.892 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.485 ' O ' HG23 ' B' ' 43' ' ' VAL . 85.1 m -69.07 -51.31 40.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.578 0.751 . . . . 75.340000000000003 111.609 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -55.04 -44.51 74.73 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.802 0.841 . . . . 44.240000000000002 111.974 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.72 -36.19 82.91 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.393 1.077 . . . . 62.43 111.203 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.44 83.27 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.775 0.43 . . . . 74.349999999999994 112.151 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.485 HG23 ' O ' ' B' ' 39' ' ' THR . 24.8 t -67.54 -29.19 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.51 0.724 . . . . 72.329999999999998 111.449 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.73 -28.16 56.5 Favored Glycine 0 CA--C 1.551 2.282 0 N-CA-C 114.502 0.561 . . . . 40.409999999999997 114.502 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.488 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 72.6 t-105 -74.33 -24.69 59.23 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.443 0.697 . . . . 70.409999999999997 111.533 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.443 HD11 HG23 ' B' ' 13' ' ' VAL . 83.9 mt -72.77 -36.04 67.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.563 0.745 . . . . 42.130000000000003 111.636 173.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.97 -33.51 67.15 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.728 0.811 . . . . 74.439999999999998 112.363 172.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 33.1 ttt-85 -54.63 -49.78 69.7 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.971 0.908 . . . . 64.230000000000004 111.481 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.27 -1.35 57.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.51 0.724 . . . . 73.439999999999998 112.58 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 64.17 21.96 12.72 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.812 1.245 . . . . 63.520000000000003 113.177 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -86.61 1.37 52.02 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.08 0.77 . . . . 65.329999999999998 113.08 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.36 155.68 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 123.362 0.665 . . . . 73.219999999999999 112.027 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 45.8 t -120.43 96.57 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.532 -0.914 . . . . 63.130000000000003 108.532 169.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.475 HD11 HG12 ' B' ' 43' ' ' VAL . 35.7 mt -95.75 102.27 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.158 0.504 . . . . 63.32 109.676 -177.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -134.29 132.27 39.39 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.994 -0.441 . . . . 63.520000000000003 111.629 -166.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.658 HH22 HD13 ' A' ' 5' ' ' ILE . 6.7 mtm-85 -86.8 97.05 10.41 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.799 0.809 . . . . 63.030000000000001 110.405 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -108.35 128.31 54.64 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.653 -1.158 . . . . 72.209999999999994 109.151 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 59.31 29.9 19.54 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.492 1.117 . . . . 75.519999999999996 111.14 -170.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.99 -21.39 7.98 Favored Glycine 0 C--N 1.36 1.915 0 CA-C-N 115.879 -0.601 . . . . 44.219999999999999 114.514 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mp -89.7 135.52 33.57 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.453 0.701 . . . . 43.219999999999999 110.74 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.639 HG13 ' HG2' ' B' ' 56' ' ' ARG . 1.4 mp -73.93 107.99 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 C-N-CA 123.593 0.757 . . . . 63.439999999999998 109.682 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -107.53 120.27 41.74 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.014 0.926 . . . . 70.25 110.494 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.444 ' N ' HD12 ' B' ' 63' ' ' ILE . 2.2 mp -94.24 132.31 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 109.149 -0.685 . . . . 55.539999999999999 109.149 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.625 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 90.5 m-85 -123.5 174.0 7.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.473 1.109 . . . . 71.519999999999996 109.997 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -93.97 158.26 15.72 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 109.142 -0.688 . . . . 74.430000000000007 109.142 166.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -46.0 -63.01 1.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.358 1.063 . . . . 73.319999999999993 113.397 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.52 18.73 8.08 Favored Glycine 0 CA--C 1.543 1.795 0 N-CA-C 115.354 0.902 . . . . 40.140000000000001 115.354 -172.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -90.1 -10.74 43.55 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.961 0.88 . . . . 74.040000000000006 111.838 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -59.42 -38.61 81.08 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.176 0.513 . . . . 75.420000000000002 111.242 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -90.63 94.44 9.7 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 108.777 -0.823 . . . . 73.140000000000001 108.777 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -134.38 140.77 46.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.115 0.966 . . . . 64.340000000000003 110.092 -173.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 45.5 t -66.7 147.24 53.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.025 0.53 . . . . 63.329999999999998 112.044 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -89.19 129.48 35.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.58 0.752 . . . . 61.5 110.865 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.77 80.87 0.05 OUTLIER Glycine 0 C--N 1.346 1.135 0 N-CA-C 112.188 -0.365 . . . . 71.25 112.188 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 mp -91.11 138.75 31.36 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.64 0.776 . . . . 63.350000000000001 111.293 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -66.2 121.35 15.01 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.225 1.01 . . . . 55.530000000000001 110.977 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -91.35 120.68 32.43 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.596 0.758 . . . . 74.439999999999998 110.148 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -74.76 159.45 31.98 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.853 0.461 . . . . 72.219999999999999 111.832 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -93.89 170.49 9.51 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.61 0.764 . . . . 71.420000000000002 112.221 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -113.72 -167.96 1.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.306 1.042 . . . . 64.329999999999998 110.724 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -144.35 137.15 26.92 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.345 0.658 . . . . 74.049999999999997 110.745 175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 9.2 t60 . . . . . 0 N--CA 1.483 1.196 0 C-N-CA 123.689 0.795 . . . . 70.140000000000001 110.884 -178.509 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptt? . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 111.768 0.284 . . . . 73.439999999999998 111.768 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -96.51 150.38 20.69 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.037 0.535 . . . . 73.239999999999995 112.038 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.446 ' O ' HG22 ' A' ' 6' ' ' VAL . 71.6 mmtt -79.23 -18.81 52.16 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.992 -0.549 . . . . 75.319999999999993 109.78 167.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -54.56 -34.03 61.19 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.324 1.05 . . . . 72.329999999999998 112.438 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.4 mt -52.8 -58.13 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.118 0.967 . . . . 64.219999999999999 112.115 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 3' ' ' LYS . 32.1 m -60.79 -37.47 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 112.926 0.713 . . . . 75.239999999999995 112.926 -172.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.79 -38.84 41.2 Favored Glycine 0 N--CA 1.476 1.366 0 O-C-N 123.237 0.336 . . . . 24.210000000000001 113.041 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.72 -36.73 83.92 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.943 0.897 . . . . 74.129999999999995 111.971 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -84.15 -28.92 27.08 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.092 -0.504 . . . . 31.309999999999999 111.622 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.82 71.12 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 122.908 0.483 . . . . 72.340000000000003 111.986 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.7 97.23 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.245 -0.434 . . . . 72.219999999999999 112.975 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -72.67 -38.29 67.65 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.925 0.89 . . . . 75.400000000000006 111.579 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.741 ' HA ' HG11 ' A' ' 32' ' ' VAL . 54.2 t -62.98 -47.74 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.79 0.836 . . . . 75.0 111.28 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -66.17 -33.43 75.75 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.623 -0.717 . . . . 73.019999999999996 111.35 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -61.62 -42.42 98.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.402 0.681 . . . . 75.400000000000006 111.681 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.21 74.03 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.327 0.651 . . . . 72.140000000000001 111.491 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 21' ' ' ASP . 2.5 tm? -70.73 -30.7 67.31 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.213 1.405 . . . . 72.299999999999997 111.536 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -64.24 -42.95 96.31 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.945 0.898 . . . . 73.120000000000005 112.816 -169.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -81.69 -15.22 55.17 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.005 0.743 . . . . 53.140000000000001 113.005 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.53 96.06 1.14 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.961 0.504 . . . . 64.209999999999994 110.738 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.451 ' HA ' HD22 ' A' ' 17' ' ' LEU . 8.7 p-10 -86.02 169.2 13.41 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.09 0.556 . . . . 75.120000000000005 112.009 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.86 55.06 3.94 Favored Glycine 0 C--N 1.344 1.009 0 N-CA-C 111.698 -0.561 . . . . 60.130000000000003 111.698 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 tt -130.13 136.43 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.979 0.911 . . . . 75.329999999999998 110.421 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.9 p -74.97 154.59 38.04 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.783 0.433 . . . . 70.109999999999999 111.242 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.564 HG21 ' HB2' ' A' ' 40' ' ' ALA . 63.8 mt -52.36 -47.42 92.97 Favored Pre-proline 0 CA--C 1.573 1.837 0 N-CA-C 114.056 1.132 . . . . 64.150000000000006 114.056 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.69 -33.05 56.19 Favored 'Trans proline' 0 C--N 1.393 2.902 0 C-N-CA 121.714 1.609 . . . . 75.510000000000005 114.319 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 30' ' ' ARG . 37.6 mt-10 -76.74 -31.0 56.84 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.395 1.093 . . . . 73.329999999999998 110.453 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.81 -33.3 66.14 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 113.668 -1.605 . . . . 74.319999999999993 110.603 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.9 -39.4 87.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.895 0.878 . . . . 65.129999999999995 112.855 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 14.2 ptt180 -70.38 -28.08 64.82 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.401 0.28 . . . . 64.239999999999995 111.053 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -67.27 -37.74 83.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.961 0.904 . . . . 75.129999999999995 111.574 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.741 HG11 ' HA ' ' A' ' 13' ' ' VAL . 24.6 m -102.8 0.73 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 112.989 0.737 . . . . 73.0 112.989 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 65.71 28.47 11.06 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.808 1.243 . . . . 74.409999999999997 112.635 174.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.4 mt -109.0 175.12 5.57 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.943 0.897 . . . . 53.409999999999997 111.244 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 99.9 p -77.99 163.74 25.68 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.319 0.648 . . . . 70.400000000000006 110.37 168.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -58.18 -45.92 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.09 0.556 . . . . 63.420000000000002 111.17 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.71 -37.51 82.35 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.954 0.902 . . . . 73.109999999999999 112.648 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -69.69 -37.37 76.59 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.129 0.49 . . . . 62.539999999999999 111.563 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 43' ' ' VAL . 93.8 m -72.88 -44.66 61.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.494 0.717 . . . . 70.109999999999999 111.281 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -57.86 -35.63 71.22 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.966 0.906 . . . . 73.109999999999999 111.972 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -51.8 67.15 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 114.795 -1.093 . . . . 60.43 110.207 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.04 70.96 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.862 -1.063 . . . . 72.219999999999999 111.723 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 39' ' ' THR . 79.4 t -69.23 -38.25 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.367 0.667 . . . . 71.030000000000001 110.664 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.89 -31.77 82.02 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 116.359 -0.382 . . . . 74.239999999999995 113.459 172.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.507 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 66.9 t-105 -73.92 -30.15 62.42 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.449 0.699 . . . . 73.230000000000004 111.047 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.19 -37.44 69.29 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.922 0.489 . . . . 72.209999999999994 111.184 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.76 -30.09 71.19 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.95 0.9 . . . . 73.409999999999997 111.724 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 21.5 ttt180 -55.88 -50.6 70.2 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.564 0.745 . . . . 75.230000000000004 110.884 167.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -84.71 -3.23 58.46 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 115.197 -0.911 . . . . 75.019999999999996 111.961 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 62.25 22.22 13.02 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 125.258 1.423 . . . . 73.319999999999993 112.764 -175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -69.55 -24.82 63.77 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.41 1.084 . . . . 64.299999999999997 112.367 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.59 151.14 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.64 0.776 . . . . 63.439999999999998 110.813 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' A' ' 68' ' ' HIS . 44.6 t -116.92 111.45 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 123.712 0.805 . . . . 74.530000000000001 110.242 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.497 HG23 HG23 ' A' ' 61' ' ' ILE . 3.4 mp -86.56 107.98 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 N-CA-C 109.389 -0.596 . . . . 72.219999999999999 109.389 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG3' HG12 ' A' ' 53' ' ' VAL . 54.3 mt-10 -118.44 118.03 30.65 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.538 0.735 . . . . 65.120000000000005 110.382 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -85.24 100.96 12.13 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.136 0.974 . . . . 72.540000000000006 110.076 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -114.63 109.15 17.8 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.069 0.948 . . . . 62.520000000000003 109.885 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 57.63 32.67 22.2 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.171 0.988 . . . . 73.040000000000006 111.831 -169.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.3 -9.92 62.74 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 115.557 -0.747 . . . . 50.109999999999999 114.311 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.5 mt -80.0 107.55 12.87 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.191 0.596 . . . . 43.509999999999998 109.997 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.497 HG23 HG23 ' A' ' 54' ' ' ILE . 76.7 mt -69.88 102.63 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.321 -0.622 . . . . 75.209999999999994 109.321 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -110.19 124.11 50.98 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.923 0.889 . . . . 71.430000000000007 109.847 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.1 mp -91.72 103.25 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 108.602 -0.888 . . . . 74.030000000000001 108.602 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -91.81 175.77 6.77 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.073 0.949 . . . . 74.030000000000001 110.941 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.81 158.87 16.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.081 0.552 . . . . 74.349999999999994 110.525 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -51.22 119.54 4.13 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.517 0.727 . . . . 74.420000000000002 110.379 171.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.42 10.86 0.27 Allowed Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.093 -0.503 . . . . 72.109999999999999 112.996 -171.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.617 ' HB2' HG11 ' A' ' 53' ' ' VAL . 39.6 m-70 -120.18 -22.4 6.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.782 0.66 . . . . 72.310000000000002 112.782 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -79.55 13.93 1.83 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.273 0.842 . . . . 72.430000000000007 113.273 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.78 -21.82 66.04 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.638 0.977 . . . . 55.119999999999997 113.638 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -92.88 2.97 56.5 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.254 0.464 . . . . 75.319999999999993 112.254 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 91.2 p -61.07 136.15 57.99 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.369 0.877 . . . . 64.430000000000007 113.369 -170.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -132.37 165.12 24.97 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.661 1.184 . . . . 73.349999999999994 110.031 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.48 63.01 0.49 Allowed Glycine 0 N--CA 1.473 1.111 0 CA-C-N 116.635 -0.257 . . . . 65.540000000000006 113.45 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.34 114.61 26.99 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.158 0.583 . . . . 73.239999999999995 110.754 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.51 152.24 28.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.425 0.69 . . . . 70.549999999999997 110.674 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -128.78 130.16 46.65 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.31 0.644 . . . . 74.25 111.897 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p80 32.74 78.27 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 126.307 1.843 . . . . 75.430000000000007 115.947 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -74.62 -38.98 62.41 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.043 0.537 . . . . 71.129999999999995 111.696 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -78.17 140.44 38.98 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.073 0.463 . . . . 74.310000000000002 111.59 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -138.18 179.79 6.24 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.322 1.049 . . . . 75.340000000000003 109.966 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 . . . . . 0 N--CA 1.486 1.36 0 C-N-CA 122.854 0.462 . . . . 54.240000000000002 110.799 178.632 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 CA--C 1.553 1.085 0 CA-C-O 120.425 0.155 . . . . 70.120000000000005 111.286 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.408 ' O ' HG22 ' B' ' 6' ' ' VAL . 1.3 m-20 -61.05 -8.9 3.68 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.374 1.25 . . . . 70.019999999999996 114.374 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.0 -40.56 31.23 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 119.086 0.857 . . . . 75.530000000000001 113.063 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.24 -35.02 14.03 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.259 0.623 . . . . 74.430000000000007 112.344 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 58.8 mt -61.52 -40.71 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.502 0.721 . . . . 62.509999999999998 111.841 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.408 HG22 ' O ' ' B' ' 2' ' ' ASP . 28.6 m -61.49 -30.28 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.884 0.874 . . . . 74.299999999999997 112.091 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.03 -39.65 94.86 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 122.888 0.118 . . . . 24.109999999999999 113.057 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.94 -53.04 10.98 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.55 0.74 . . . . 72.120000000000005 112.496 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -70.29 -30.59 67.64 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.215 0.821 . . . . 65.219999999999999 113.215 -172.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.35 -25.21 61.45 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.265 0.626 . . . . 64.049999999999997 111.924 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.55 -38.71 96.08 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 116.166 -0.47 . . . . 73.400000000000006 112.816 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -70.85 -40.03 72.59 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.691 0.796 . . . . 74.340000000000003 111.174 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.4 ' HA ' HG11 ' B' ' 32' ' ' VAL . 92.3 t -63.03 -48.41 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.124 0.57 . . . . 34.350000000000001 111.332 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.475 ' HA ' HD12 ' B' ' 17' ' ' LEU . 40.4 t90 -65.55 -34.13 77.53 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.245 0.618 . . . . 74.530000000000001 110.989 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -62.46 -39.42 93.36 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.76 0.824 . . . . 73.219999999999999 110.636 173.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.15 -32.12 72.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.647 0.779 . . . . 63.409999999999997 111.683 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' B' ' 14' ' ' TRP . 69.3 mt -74.4 -31.91 62.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.455 0.702 . . . . 63.310000000000002 111.426 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.03 -25.97 62.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.008 0.523 . . . . 74.120000000000005 110.689 -177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -95.73 -29.41 14.28 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.521 0.728 . . . . 74.099999999999994 111.476 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.78 94.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.446 0.698 . . . . 70.120000000000005 111.74 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -96.87 179.4 4.97 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.286 0.634 . . . . 72.140000000000001 111.755 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.54 37.39 53.03 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.474 -0.33 . . . . 62.32 113.224 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 tt -119.27 151.17 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.064 0.946 . . . . 74.25 110.632 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -61.97 140.52 58.32 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.971 0.508 . . . . 73.230000000000004 111.348 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' B' ' 40' ' ' ALA . 64.8 mt -53.81 -45.9 98.65 Favored Pre-proline 0 CA--C 1.576 1.962 0 N-CA-C 113.219 0.822 . . . . 63.43 113.219 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.438 ' HA ' HG22 ' B' ' 36' ' ' VAL . 36.9 Cg_endo -63.13 -29.4 74.32 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.116 1.877 . . . . 71.439999999999998 115.072 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.22 -49.16 17.91 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.126 0.965 . . . . 71.099999999999994 109.759 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -55.05 -36.26 65.36 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 113.326 -1.761 . . . . 62.450000000000003 112.083 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.39 -42.79 87.85 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.007 0.923 . . . . 72.030000000000001 112.058 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -72.46 -24.7 61.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.832 -0.622 . . . . 61.509999999999998 111.28 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -76.09 -41.99 48.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.416 0.687 . . . . 54.240000000000002 111.391 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' B' ' 13' ' ' VAL . 24.1 m -89.77 3.76 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.168 0.587 . . . . 64.239999999999995 112.366 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 67.09 22.48 9.89 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.736 1.214 . . . . 71.219999999999999 112.424 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.85 171.29 7.68 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.337 0.655 . . . . 74.319999999999993 111.561 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.2 t -72.99 158.62 35.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.342 0.657 . . . . 42.210000000000001 111.093 170.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' B' ' 26' ' ' PRO . 41.7 t -57.33 -47.48 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.349 0.66 . . . . 52.039999999999999 111.306 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -64.0 -40.82 97.23 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.604 -0.726 . . . . 75.040000000000006 112.048 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -66.93 -34.08 77.0 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.367 0.667 . . . . 72.510000000000005 112.115 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.452 ' O ' HG23 ' B' ' 43' ' ' VAL . 90.3 m -76.6 -39.87 51.21 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.627 0.771 . . . . 61.340000000000003 111.07 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.435 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -63.78 -37.92 89.16 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.323 0.582 . . . . 55.340000000000003 111.127 174.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.97 -40.96 97.58 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.667 1.187 . . . . 63.450000000000003 110.519 172.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.48 -43.37 94.41 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.359 0.663 . . . . 42.200000000000003 112.005 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.618 HG11 HG21 ' B' ' 63' ' ' ILE . 84.5 t -61.24 -31.23 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.109 0.564 . . . . 71.329999999999998 111.321 176.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.36 -29.2 68.47 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 114.58 0.592 . . . . 74.430000000000007 114.58 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.454 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 76.9 t-105 -72.92 -34.34 66.55 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.712 0.805 . . . . 72.019999999999996 111.111 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 77.1 mt -71.42 -40.25 70.55 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.142 0.577 . . . . 41.539999999999999 110.322 174.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.91 -31.97 73.34 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.351 1.06 . . . . 73.329999999999998 111.708 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 16.1 ttp85 -52.64 -51.79 58.52 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.582 0.706 . . . . 61.210000000000001 110.945 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.434 ' HB2' ' HG2' ' B' ' 51' ' ' LYS . 35.2 mt-10 -83.89 -8.93 59.07 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.875 -1.057 . . . . 72.209999999999994 111.669 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 63.42 29.82 15.49 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.012 1.325 . . . . 73.400000000000006 112.115 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' B' ' 49' ' ' GLU . 8.4 mmmm -69.28 -9.59 53.9 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.486 1.515 . . . . 64.349999999999994 113.009 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.26 150.05 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 124.127 0.971 . . . . 73.040000000000006 111.24 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 94.7 t -93.21 129.2 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.985 0.914 . . . . 51.140000000000001 109.455 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.63 120.85 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.87 -1.159 . . . . 73.409999999999997 107.87 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . 0.436 ' HG2' ' NZ ' ' B' ' 57' ' ' LYS . 8.9 tp10 -137.95 158.62 43.97 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.201 0.601 . . . . 73.040000000000006 110.487 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -118.83 114.14 22.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.992 0.517 . . . . 64.439999999999998 110.252 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.493 ' HD3' ' HG3' ' B' ' 62' ' ' GLU . 13.9 mptt -101.99 107.49 18.65 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.01 0.924 . . . . 74.340000000000003 108.618 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 57.96 31.99 21.35 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.473 1.109 . . . . 63.539999999999999 111.847 -175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.51 34.69 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 115.949 -0.569 . . . . 62.409999999999997 113.812 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 75.6 mt -75.57 136.89 40.52 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.453 0.701 . . . . 62.409999999999997 111.215 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.58 117.7 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-O 121.271 0.557 . . . . 60.439999999999998 110.463 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . 0.493 ' HG3' ' HD3' ' B' ' 57' ' ' LYS . 39.1 mm-40 -108.14 142.6 38.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.491 1.516 . . . . 73.200000000000003 110.491 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.618 HG21 HG11 ' B' ' 43' ' ' VAL . 2.0 pp -133.5 122.5 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 CA-C-O 121.783 0.801 . . . . 75.019999999999996 111.206 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.671 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 55.3 m-85 -115.4 171.28 7.81 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.864 0.866 . . . . 75.25 110.295 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -100.79 153.45 19.46 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.102 0.561 . . . . 75.439999999999998 109.914 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.18 -29.18 67.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 122.079 -0.388 . . . . 61.350000000000001 111.755 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.59 -8.4 71.67 Favored Glycine 0 CA--C 1.54 1.625 0 CA-C-N 115.989 -0.551 . . . . 75.230000000000004 114.063 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -67.88 -40.94 83.47 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.567 0.747 . . . . 74.439999999999998 111.065 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -104.23 156.99 17.44 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.749 0.819 . . . . 65.450000000000003 109.834 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.467 ' HB2' ' NE2' ' B' ' 78' ' ' HIS . 8.4 p-10 -100.85 -43.98 5.92 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.969 -0.457 . . . . 75.299999999999997 111.511 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 69.9 t80 59.31 100.27 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.881 1.273 . . . . 75.319999999999993 112.458 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -118.64 166.59 12.56 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.268 0.627 . . . . 73.329999999999998 111.661 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -72.8 173.84 8.55 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.159 0.984 . . . . 71.239999999999995 110.381 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.55 58.41 3.36 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 114.189 0.436 . . . . 63.229999999999997 114.189 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.1 mt -130.74 -169.81 2.23 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.827 1.251 . . . . 74.019999999999996 109.739 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -93.22 -24.51 18.17 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.161 0.585 . . . . 75.540000000000006 111.692 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -70.9 121.59 18.38 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.303 0.641 . . . . 72.239999999999995 111.199 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.467 ' NE2' ' HB2' ' B' ' 70' ' ' ASP . 75.0 t60 66.53 10.79 7.64 Favored 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 124.962 1.305 . . . . 63.109999999999999 112.489 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -77.22 88.34 3.67 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.557 0.743 . . . . 72.430000000000007 111.361 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -136.53 -172.69 3.22 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.438 0.695 . . . . 70.219999999999999 112.646 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -101.95 -39.24 7.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.971 0.908 . . . . 62.340000000000003 111.762 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.467 0.651 . . . . 62.450000000000003 111.264 -173.963 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 110.272 -0.269 . . . . 72.140000000000001 110.272 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.72 100.69 0.41 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.539 0.736 . . . . 72.409999999999997 110.404 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -70.98 -19.02 62.59 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.458 0.703 . . . . 74.239999999999995 112.148 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -74.93 -11.98 60.25 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.698 0.999 . . . . 73.239999999999995 113.698 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -49.1 -52.8 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 118.585 0.63 . . . . 71.099999999999994 111.083 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.71 -28.22 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.04 0.536 . . . . 54.509999999999998 112.265 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.41 -42.66 33.45 Favored Glycine 0 C--N 1.351 1.371 0 O-C-N 123.302 0.376 . . . . 55.509999999999998 113.558 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.7 -44.42 81.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.809 0.844 . . . . 64.230000000000004 111.209 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -71.64 -28.89 64.08 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.84 -0.618 . . . . 61.210000000000001 111.707 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.402 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . . . -72.09 -29.03 63.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.679 0.392 . . . . 62.229999999999997 111.263 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.11 -37.28 92.92 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 115.997 -0.547 . . . . 70.319999999999993 112.46 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -75.26 -38.92 60.26 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 122.881 0.472 . . . . 75.209999999999994 111.271 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.445 HG13 HD11 ' A' ' 28' ' ' LEU . 53.1 t -64.14 -46.12 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.889 0.875 . . . . 74.349999999999994 111.284 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -67.67 -33.32 74.69 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.514 -0.312 . . . . 71.010000000000005 110.313 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -63.91 -33.0 74.72 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 122.416 -0.178 . . . . 73.299999999999997 111.027 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HB3' HD12 ' A' ' 28' ' ' LEU . . . -67.22 -28.5 68.12 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.82 0.448 . . . . 64.420000000000002 111.846 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.4 -45.46 54.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.784 0.834 . . . . 75.129999999999995 110.633 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -59.71 -29.86 68.41 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.495 1.118 . . . . 75.510000000000005 111.559 173.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -82.06 -52.94 6.52 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.07 0.948 . . . . 72.310000000000002 110.26 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.35 96.59 2.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.467 1.107 . . . . 34.420000000000002 109.567 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -73.94 154.16 39.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.607 0.763 . . . . 63.420000000000002 113.016 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.6 65.37 2.43 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 116.076 -0.511 . . . . 43.119999999999997 112.935 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.504 HD11 ' HG3' ' A' ' 27' ' ' GLU . 20.7 tt -134.25 143.76 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 122.871 0.468 . . . . 62.340000000000003 111.819 -169.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 49.4 m -67.61 146.08 54.22 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.546 0.738 . . . . 75.430000000000007 111.815 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.441 HG21 ' HB2' ' A' ' 40' ' ' ALA . 55.9 mt -53.4 -48.94 90.93 Favored Pre-proline 0 CA--C 1.577 1.994 0 C-N-CA 124.175 0.99 . . . . 75.420000000000002 113.581 -176.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.86 -27.59 43.54 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 121.765 1.643 . . . . 75.510000000000005 113.553 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' HG3' HD11 ' A' ' 23' ' ' ILE . 10.8 tp10 -73.12 -55.62 6.23 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 112.402 0.519 . . . . 73.219999999999999 112.402 -174.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 16' ' ' ALA . 2.2 pt? -66.41 -29.31 69.44 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.078 0.399 . . . . 74.230000000000004 111.245 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.37 -42.67 53.67 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.719 0.808 . . . . 73.230000000000004 112.168 171.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -63.81 -40.4 96.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.074 0.55 . . . . 74.409999999999997 111.596 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -69.04 -38.06 78.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.889 0.876 . . . . 74.510000000000005 111.473 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.1 m -94.85 4.66 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.524 0.73 . . . . 74.349999999999994 112.201 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 64.81 21.23 12.32 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 124.741 1.216 . . . . 64.040000000000006 112.336 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.6 mt -105.91 162.59 13.44 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.38 0.672 . . . . 75.409999999999997 111.527 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -69.81 158.48 35.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.433 -0.803 . . . . 73.5 111.249 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -56.91 -42.22 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.241 0.616 . . . . 74.319999999999993 110.744 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.16 -50.03 73.46 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.699 0.8 . . . . 75.349999999999994 111.497 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -58.15 -38.94 77.54 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.819 0.848 . . . . 71.510000000000005 111.856 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 43' ' ' VAL . 97.9 m -70.69 -52.69 19.37 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.661 0.785 . . . . 63.119999999999997 111.391 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.17 -32.58 74.2 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 123.797 0.839 . . . . 70.230000000000004 112.772 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -72.66 -41.17 65.71 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.171 0.988 . . . . 74.340000000000003 109.808 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -66.02 -30.52 71.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.307 0.643 . . . . 62.509999999999998 111.586 175.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 39' ' ' THR . 49.5 t -65.8 -43.97 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.339 1.056 . . . . 74.230000000000004 110.304 171.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.27 -28.37 72.89 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 116.11 -0.495 . . . . 71.299999999999997 112.713 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.424 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 77.2 t-105 -70.28 -44.4 68.47 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.207 0.603 . . . . 75.310000000000002 110.829 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 51' ' ' LYS . 88.0 mt -60.9 -31.37 70.86 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.267 0.627 . . . . 72.209999999999994 111.735 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.07 -25.0 57.95 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.574 1.15 . . . . 73.109999999999999 113.63 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.745 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 23.6 ptt180 -57.12 -35.59 69.65 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 123.07 0.548 . . . . 51.530000000000001 111.519 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.745 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 28.9 mt-10 -106.28 8.39 31.83 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.64 1.176 . . . . 75.099999999999994 110.93 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 63.39 23.8 13.89 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.037 1.335 . . . . 74.230000000000004 112.698 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG3' ' HB2' ' A' ' 49' ' ' GLU . 28.1 mtpp -70.16 -10.96 60.47 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.677 0.991 . . . . 75.319999999999993 113.677 -174.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 m -126.59 148.48 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.792 0.837 . . . . 65.209999999999994 111.545 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.629 HG23 ' HB2' ' A' ' 64' ' ' TYR . 6.7 m -131.0 112.41 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 C-N-CA 124.516 1.126 . . . . 74.420000000000002 109.84 170.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.606 HG13 HG22 ' A' ' 63' ' ' ILE . 3.0 mp -92.07 134.99 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.61 1.164 . . . . 73.040000000000006 110.745 -171.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -139.04 144.76 38.96 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.353 0.661 . . . . 73.230000000000004 110.486 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -116.06 112.61 22.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.504 0.669 . . . . 71.519999999999996 110.528 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -105.4 128.88 53.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.143 0.977 . . . . 64.409999999999997 109.447 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 58.64 31.76 21.45 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 124.635 1.174 . . . . 62.43 113.025 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.91 -9.86 54.81 Favored Glycine 0 CA--C 1.541 1.711 0 N-CA-C 114.469 0.548 . . . . 61.549999999999997 114.469 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.71 135.07 36.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.323 1.049 . . . . 74.049999999999997 109.342 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' B' ' 37' ' ' GLU . 19.5 mt -104.09 125.02 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 CA-C-O 121.544 0.688 . . . . 73.439999999999998 112.345 -170.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 8.8 mp0 -117.96 153.53 33.46 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.806 1.642 . . . . 45.340000000000003 109.725 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.606 HG22 HG13 ' A' ' 54' ' ' ILE . 48.1 pt -113.89 142.7 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.304 0.573 . . . . 63.350000000000001 110.69 171.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.629 ' HB2' HG23 ' A' ' 53' ' ' VAL . 80.9 m-85 -125.07 167.39 14.84 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.225 1.01 . . . . 52.130000000000003 110.135 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -86.87 148.9 25.17 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.539 0.736 . . . . 65.340000000000003 112.011 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -19.14 63.74 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 115.766 -0.652 . . . . 74.310000000000002 110.093 166.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.58 -15.55 33.28 Favored Glycine 0 C--N 1.36 1.867 0 N-CA-C 115.792 1.077 . . . . 52.049999999999997 115.792 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -88.1 2.21 52.52 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 117.402 0.601 . . . . 63.43 111.627 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.42 ' HE2' HG21 ' A' ' 53' ' ' VAL . 75.8 m-85 -134.6 -70.6 0.5 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.661 1.184 . . . . 75.219999999999999 109.949 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -127.67 93.03 3.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.342 1.057 . . . . 73.140000000000001 109.343 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -72.36 132.74 44.37 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.173 0.511 . . . . 71.310000000000002 112.146 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.6 t -152.35 120.47 6.25 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.125 0.97 . . . . 55.020000000000003 109.285 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -77.25 -83.83 0.07 Allowed 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 122.807 0.443 . . . . 72.329999999999998 110.222 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.76 -22.16 9.76 Favored Glycine 0 CA--C 1.542 1.765 0 N-CA-C 115.225 0.85 . . . . 73.010000000000005 115.225 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.66 123.35 23.89 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.691 0.796 . . . . 65.319999999999993 112.14 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -85.82 150.35 24.61 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.69 0.396 . . . . 71.420000000000002 110.097 166.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -83.1 71.79 10.14 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.268 0.556 . . . . 71.299999999999997 109.693 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -70.78 129.54 39.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.362 0.665 . . . . 64.209999999999994 111.443 -174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -142.03 -170.28 3.11 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.544 1.137 . . . . 63.240000000000002 111.191 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -63.6 -37.35 86.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.521 0.728 . . . . 63.229999999999997 111.411 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -126.37 98.6 5.5 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.267 1.027 . . . . 75.219999999999999 109.21 172.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 N--CA 1.484 1.258 0 C-N-CA 124.487 1.115 . . . . 71.519999999999996 112.105 179.074 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 CA--C 1.55 0.945 0 CA-C-O 120.842 0.353 . . . . 65.310000000000002 110.963 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 54' ' ' ILE . 8.2 p-10 -58.43 -37.89 76.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.386 1.074 . . . . 75.420000000000002 112.935 -173.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -18.77 65.57 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.822 0.849 . . . . 75.299999999999997 111.738 -172.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.26 -44.54 10.76 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.643 1.177 . . . . 62.299999999999997 110.119 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -56.18 -48.35 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 123.729 0.812 . . . . 64.450000000000003 111.612 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.444 HG12 HD11 ' B' ' 41' ' ' LEU . 32.6 m -63.38 -30.45 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.338 1.055 . . . . 74.129999999999995 112.297 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.43 -44.13 85.09 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.181 0.301 . . . . 72.129999999999995 112.78 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.66 69.23 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.513 0.725 . . . . 61.439999999999998 111.832 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -66.1 -48.65 70.24 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.733 1.213 . . . . 74.540000000000006 110.927 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 -20.93 63.8 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.365 0.666 . . . . 52.130000000000003 112.112 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.29 -43.74 94.72 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 123.172 0.295 . . . . 64.209999999999994 112.986 174.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -68.62 -45.93 70.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.706 0.802 . . . . 72.530000000000001 110.912 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.46 ' HA ' HG11 ' B' ' 32' ' ' VAL . 96.6 t -60.01 -49.65 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.808 0.843 . . . . 75.129999999999995 111.708 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -60.87 -44.35 97.18 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.581 0.753 . . . . 71.25 111.738 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -62.29 -43.68 98.27 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.025 0.53 . . . . 53.32 111.883 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.04 68.88 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.367 0.667 . . . . 73.239999999999995 111.407 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -72.42 -32.68 66.54 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.744 1.218 . . . . 73.549999999999997 110.578 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -81.77 -18.97 42.31 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.201 0.6 . . . . 54.130000000000003 110.6 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -67.54 -33.77 75.72 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.545 0.738 . . . . 64.200000000000003 110.227 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.12 108.59 1.12 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.256 1.022 . . . . 64.140000000000001 109.564 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -93.58 173.6 7.61 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 112.318 0.488 . . . . 73.540000000000006 112.318 -175.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.26 44.68 8.63 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.969 -0.56 . . . . 70.319999999999993 111.943 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 tt -134.33 137.71 51.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.844 0.857 . . . . 64.129999999999995 110.116 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 70.3 m -78.13 160.17 28.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.438 0.695 . . . . 72.099999999999994 112.732 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.484 HG21 ' HB2' ' B' ' 40' ' ' ALA . 81.2 mt -49.32 -53.56 38.58 Favored Pre-proline 0 CA--C 1.572 1.804 0 C-N-CA 125.817 1.647 . . . . 65.519999999999996 114.037 -177.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.68 -23.75 30.83 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 121.556 1.504 . . . . 71.530000000000001 113.387 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -76.5 -55.76 5.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.213 0.605 . . . . 73.120000000000005 110.596 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.3 -29.7 70.62 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.507 0.723 . . . . 64.340000000000003 111.601 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' B' ' 39' ' ' THR . . . -52.9 -37.75 61.0 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.803 0.841 . . . . 74.319999999999993 112.812 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -71.75 -34.79 69.78 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.25 0.833 . . . . 74.040000000000006 113.25 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -76.92 -31.43 56.68 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.548 0.613 . . . . 53.149999999999999 111.646 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' B' ' 13' ' ' VAL . 33.3 m -88.03 -4.72 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.555 0.342 . . . . 73.219999999999999 111.555 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t30 68.67 17.65 8.88 Favored 'General case' 0 CA--C 1.57 1.72 0 C-N-CA 124.779 1.232 . . . . 60.409999999999997 112.119 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 70.3 mt -102.8 163.75 12.03 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.548 0.739 . . . . 74.129999999999995 111.388 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 62.8 m -67.7 158.54 32.06 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.448 0.699 . . . . 63.439999999999998 111.785 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.424 HG13 HG22 ' B' ' 25' ' ' ILE . 61.8 t -64.43 -43.48 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.099 0.559 . . . . 74.430000000000007 111.946 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.678 ' HB2' HD12 ' A' ' 61' ' ' ILE . 45.8 mt-10 -62.97 -31.98 73.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.768 0.427 . . . . 72.120000000000005 111.946 175.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 42.3 m -63.63 -45.27 91.03 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.46 0.704 . . . . 72.340000000000003 111.114 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.501 HG21 ' HA ' ' B' ' 29' ' ' ALA . 17.0 p -76.46 -41.02 48.79 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.178 0.807 . . . . 75.239999999999995 113.178 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -56.0 -46.51 78.7 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 123.863 0.865 . . . . 41.43 111.974 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.444 HD11 HG12 ' B' ' 6' ' ' VAL . 0.9 OUTLIER -67.9 -40.32 83.5 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 114.256 -1.338 . . . . 74.310000000000002 111.112 177.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.27 84.77 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.219 0.608 . . . . 73.5 112.102 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.509 HG13 HG21 ' B' ' 52' ' ' VAL . 55.3 t -65.87 -34.47 70.53 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.071 0.948 . . . . 64.319999999999993 110.601 174.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -65.71 -37.04 93.09 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 116.545 -0.298 . . . . 70.209999999999994 112.925 171.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.511 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 77.2 t-105 -67.18 -30.45 70.41 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.668 0.787 . . . . 75.310000000000002 111.474 175.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.5 -39.37 67.7 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.075 0.55 . . . . 73.510000000000005 110.936 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.9 -25.85 67.81 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.446 1.099 . . . . 74.430000000000007 113.397 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.619 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 16.5 ptt180 -58.93 -36.45 74.77 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.017 0.437 . . . . 61.219999999999999 111.015 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.619 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 43.8 mt-10 -104.75 3.18 31.02 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.686 1.194 . . . . 65.049999999999997 111.033 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.1 t30 58.88 35.86 24.38 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 125.396 1.478 . . . . 70.109999999999999 111.584 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -70.59 -17.11 62.91 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.479 -0.782 . . . . 63.450000000000003 111.044 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.509 HG21 HG13 ' B' ' 43' ' ' VAL . 24.9 m -131.68 153.29 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.283 1.033 . . . . 74.219999999999999 109.304 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.579 HG23 ' HB2' ' B' ' 64' ' ' TYR . 7.2 m -115.51 116.63 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.537 0.735 . . . . 71.030000000000001 110.15 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 48.5 mm -81.3 104.96 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.849 0.859 . . . . 63.329999999999998 110.217 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -119.45 108.43 14.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.351 0.66 . . . . 44.329999999999998 109.807 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.511 ' HB3' HG13 ' B' ' 61' ' ' ILE . 29.0 ptt180 -92.03 106.34 18.38 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.955 0.883 . . . . 74.530000000000001 110.484 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -103.63 127.83 51.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.988 1.315 . . . . 71.400000000000006 109.607 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 57.74 29.66 17.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.711 1.204 . . . . 72.049999999999997 111.505 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.2 -27.65 6.71 Favored Glycine 0 CA--C 1.546 1.976 0 CA-C-N 115.231 -0.895 . . . . 33.520000000000003 113.858 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.87 123.43 27.75 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.874 0.87 . . . . 61.409999999999997 110.795 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.511 HG13 ' HB3' ' B' ' 56' ' ' ARG . 2.8 mp -74.57 123.21 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 122.739 0.416 . . . . 73.310000000000002 110.128 -174.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -119.53 138.33 53.24 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.204 1.002 . . . . 73.549999999999997 109.752 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.432 HD11 HG13 ' B' ' 25' ' ' ILE . 2.2 mp -107.09 112.09 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.075 0.55 . . . . 75.109999999999999 110.031 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.579 ' HB2' HG23 ' B' ' 53' ' ' VAL . 85.9 m-85 -107.11 159.29 16.42 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.321 1.048 . . . . 63.520000000000003 110.52 174.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -82.51 171.55 13.99 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.957 0.725 . . . . 71.409999999999997 112.957 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -56.83 -30.99 64.29 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.172 0.989 . . . . 74.329999999999998 112.694 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.53 -8.01 36.85 Favored Glycine 0 CA--C 1.545 1.965 0 N-CA-C 114.435 0.534 . . . . 72.019999999999996 114.435 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -60.47 -32.88 71.83 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.081 0.952 . . . . 75.430000000000007 111.456 171.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -117.23 153.41 32.93 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.569 0.748 . . . . 64.340000000000003 110.25 171.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 26.7 t70 55.31 42.62 30.1 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.934 0.894 . . . . 72.25 110.932 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -61.92 102.3 0.27 Allowed 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.224 -0.898 . . . . 74.239999999999995 111.058 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 57.6 m -73.48 172.06 12.0 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.823 0.849 . . . . 62.420000000000002 111.919 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -69.52 -61.66 1.69 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.845 0.458 . . . . 75.329999999999998 111.423 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.88 76.48 0.45 Allowed Glycine 0 C--N 1.351 1.406 0 CA-C-N 116.259 -0.428 . . . . 74.010000000000005 113.022 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.64 -20.81 63.59 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.081 0.952 . . . . 63.039999999999999 112.346 -174.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.33 -76.32 0.08 Allowed 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 124.323 1.049 . . . . 74.120000000000005 112.091 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 33.0 p80 37.25 63.7 0.7 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 125.954 1.702 . . . . 71.530000000000001 115.391 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -106.95 138.69 42.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.672 -0.643 . . . . 74.129999999999995 110.942 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -120.55 104.4 9.92 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.453 0.701 . . . . 62.119999999999997 111.241 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -75.62 -15.67 60.31 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.49 0.716 . . . . 71.230000000000004 110.71 167.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -61.6 96.14 0.06 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.409 1.084 . . . . 74.420000000000002 110.615 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 17.2 p80 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.865 0.841 . . . . 62.140000000000001 111.447 -178.621 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 111.72 0.267 . . . . 72.030000000000001 111.72 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -48.37 -40.9 27.14 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.008 1.323 . . . . 73.150000000000006 114.381 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.41 -34.99 73.15 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.979 0.911 . . . . 54.409999999999997 112.36 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -77.73 -37.28 49.61 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.295 0.638 . . . . 74.200000000000003 111.067 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.8 mt -62.86 -47.53 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.613 0.765 . . . . 75.420000000000002 111.627 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.42 -30.42 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.099 0.56 . . . . 73.120000000000005 111.264 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.93 -51.25 47.22 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.825 0.703 . . . . 63.020000000000003 112.269 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.42 81.83 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.844 0.858 . . . . 64.450000000000003 112.284 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -65.82 -29.47 69.95 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.507 0.723 . . . . 73.239999999999995 112.182 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.12 -44.88 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.033 0.533 . . . . 52.439999999999998 111.367 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.17 94.65 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.48 -0.648 . . . . 64.129999999999995 111.48 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -61.76 -50.01 74.11 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.328 1.051 . . . . 64.400000000000006 112.583 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.673 ' HA ' HG11 ' A' ' 32' ' ' VAL . 32.9 m -67.55 -29.54 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 120.656 0.265 . . . . 73.209999999999994 111.711 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.607 ' HA ' HD12 ' A' ' 17' ' ' LEU . 24.4 t90 -68.6 -32.83 73.0 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.286 0.634 . . . . 71.450000000000003 111.546 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -58.68 -36.84 74.84 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 122.813 0.445 . . . . 71.129999999999995 111.666 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.91 69.49 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.218 0.607 . . . . 75.349999999999994 112.162 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 14' ' ' TRP . 81.2 mt -66.54 -22.58 66.16 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.727 0.811 . . . . 72.25 112.194 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -64.58 -28.08 69.39 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.417 0.687 . . . . 71.129999999999995 111.463 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -77.01 -57.4 3.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.24 0.616 . . . . 75.049999999999997 110.521 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.34 107.6 3.27 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.481 0.712 . . . . 64.510000000000005 110.765 -174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 6.2 p-10 -95.72 164.57 12.7 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.509 0.724 . . . . 75.310000000000002 110.842 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.15 26.67 51.93 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 121.475 0.486 . . . . 73.209999999999994 112.128 -166.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 tt -96.63 153.71 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 124.46 1.104 . . . . 74.310000000000002 110.139 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -79.17 156.4 28.24 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.902 -0.499 . . . . 62.109999999999999 111.458 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.487 HG21 ' HB2' ' A' ' 40' ' ' ALA . 80.2 mt -56.32 -50.36 88.04 Favored Pre-proline 0 CA--C 1.575 1.908 0 C-N-CA 124.468 1.107 . . . . 64.430000000000007 113.908 -173.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.25 -24.07 38.18 Favored 'Trans proline' 0 C--N 1.394 2.93 0 CA-C-N 121.399 1.535 . . . . 73.209999999999994 114.049 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -76.5 -45.1 32.45 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.43 1.11 . . . . 71.530000000000001 109.683 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.442 HD22 HD11 ' A' ' 63' ' ' ILE . 63.1 tp -59.34 -40.6 86.91 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 113.129 -1.85 . . . . 74.400000000000006 111.09 172.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.15 81.82 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.325 1.05 . . . . 72.109999999999999 111.917 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -65.09 -40.87 95.2 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.626 0.77 . . . . 75.25 111.446 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -63.9 -40.82 97.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.153 0.581 . . . . 74.200000000000003 111.67 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.6 m -95.83 -1.93 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 112.966 0.728 . . . . 71.409999999999997 112.966 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.0 t30 68.02 13.64 9.17 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 124.483 1.113 . . . . 70.0 112.506 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -92.74 166.25 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.463 -0.773 . . . . 64.5 111.062 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.0 t -64.43 154.01 36.97 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.102 0.561 . . . . 65.439999999999998 111.701 171.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.38 -48.01 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.808 0.843 . . . . 71.400000000000006 110.615 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -62.6 -42.37 99.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.327 1.051 . . . . 73.340000000000003 111.676 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.494 ' HA ' HH21 ' B' ' 56' ' ' ARG . 67.7 m -65.48 -30.62 71.42 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.596 0.758 . . . . 31.440000000000001 112.256 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 43' ' ' VAL . 63.2 m -82.08 -43.01 18.42 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.784 0.834 . . . . 73.040000000000006 111.512 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.487 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -58.69 -50.81 72.52 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.001 0.921 . . . . 75.120000000000005 112.142 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -66.28 -32.48 73.92 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 114.087 -1.415 . . . . 71.349999999999994 110.831 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.35 -38.7 71.61 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.26 0.624 . . . . 73.519999999999996 111.961 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.569 HG11 HG21 ' A' ' 63' ' ' ILE . 69.3 t -64.89 -31.33 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.18 0.592 . . . . 61.109999999999999 110.835 175.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -58.79 -33.02 71.25 Favored Glycine 0 CA--C 1.544 1.858 0 CA-C-N 116.271 -0.422 . . . . 33.350000000000001 113.322 171.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -71.95 -30.63 65.5 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.543 0.737 . . . . 74.120000000000005 111.172 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.24 -38.79 71.94 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.675 0.39 . . . . 74.319999999999993 111.429 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.46 -34.95 78.88 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.562 0.745 . . . . 52.420000000000002 110.825 172.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.645 ' HG2' ' HB3' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -63.79 -43.97 94.75 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.013 1.325 . . . . 74.319999999999993 111.267 172.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -85.48 -1.14 56.74 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.606 0.762 . . . . 74.340000000000003 112.69 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 64.96 22.61 12.48 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.776 1.23 . . . . 75.109999999999999 112.729 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 61.5 mttp -77.49 -20.87 53.65 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.766 0.827 . . . . 72.010000000000005 112.454 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.92 154.74 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.48 0.657 . . . . 74.230000000000004 112.172 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 47.7 t -105.23 104.31 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.348 1.059 . . . . 71.129999999999995 109.065 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 mm -71.59 122.49 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 109.454 -0.572 . . . . 50.329999999999998 109.454 175.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.28 133.42 38.87 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.965 0.506 . . . . 74.200000000000003 110.385 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -116.94 141.91 47.63 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.402 0.681 . . . . 74.540000000000006 111.115 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 114.18 4.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.18 0.992 . . . . 74.450000000000003 109.892 -176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 54.07 30.81 12.58 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.4 1.08 . . . . 72.540000000000006 112.561 -173.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.26 -18.48 54.14 Favored Glycine 0 CA--C 1.545 1.968 0 CA-C-N 115.785 -0.643 . . . . 35.350000000000001 114.429 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -78.94 136.67 37.32 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.748 0.819 . . . . 63.310000000000002 111.275 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.1 mt -101.99 124.31 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 123.404 0.682 . . . . 73.340000000000003 111.081 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -123.48 124.92 43.93 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.895 1.278 . . . . 62.240000000000002 108.815 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.569 HG21 HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -106.09 112.0 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-O 122.152 0.977 . . . . 55.149999999999999 110.051 177.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 95.0 m-85 -90.15 175.65 7.07 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.083 0.953 . . . . 72.409999999999997 111.202 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.54 150.97 21.54 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.972 0.509 . . . . 72.239999999999995 109.911 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.62 168.37 11.84 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 120.912 0.387 . . . . 75.340000000000003 110.644 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.89 12.93 8.14 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 123.42 0.533 . . . . 74.030000000000001 112.867 -173.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -136.79 -15.31 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.975 1.102 . . . . 75.519999999999996 113.975 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -83.49 115.27 22.0 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.721 0.691 . . . . 72.230000000000004 111.061 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -116.46 157.22 25.51 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.737 0.815 . . . . 73.219999999999999 111.172 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -152.7 12.16 0.51 Allowed 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.153 0.981 . . . . 64.530000000000001 109.906 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.3 t -92.91 152.69 19.23 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.817 0.847 . . . . 74.530000000000001 111.537 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -73.22 96.78 2.31 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.13 0.572 . . . . 64.510000000000005 110.4 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.16 81.61 1.74 Allowed Glycine 0 CA--C 1.534 1.272 0 CA-C-N 116.355 -0.384 . . . . 71.219999999999999 113.6 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -123.83 128.42 49.49 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.138 0.575 . . . . 70.319999999999993 110.27 170.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.15 -30.22 69.29 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.251 1.021 . . . . 73.519999999999996 112.958 -175.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -87.63 179.84 6.45 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.424 0.69 . . . . 72.239999999999995 111.996 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -59.85 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.087 0.955 . . . . 72.129999999999995 113.528 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -75.72 88.36 2.79 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.583 -0.895 . . . . 74.219999999999999 108.583 164.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -60.99 95.54 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.53 1.132 . . . . 65.400000000000006 112.685 -165.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 74.78 -19.84 0.36 Allowed 'General case' 0 CA--C 1.571 1.769 0 C-N-CA 125.497 1.519 . . . . 72.129999999999995 114.006 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 . . . . . 0 N--CA 1.488 1.444 0 C-N-CA 124.603 1.161 . . . . 64.329999999999998 111.625 -178.379 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 CA--C 1.551 0.999 0 CA-C-O 120.982 0.42 . . . . 62.100000000000001 111.477 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -124.0 151.37 43.78 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.3 1.04 . . . . 62.539999999999999 110.657 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.505 ' O ' HG22 ' B' ' 6' ' ' VAL . 40.5 ttmt -79.51 -33.37 42.12 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.527 0.331 . . . . 75.010000000000005 110.483 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -61.26 -13.12 16.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.793 1.034 . . . . 73.310000000000002 113.793 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 70.3 mt -55.69 -45.93 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.616 0.766 . . . . 75.409999999999997 111.47 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.505 HG22 ' O ' ' B' ' 3' ' ' LYS . 16.3 m -66.46 -25.76 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 122.173 0.189 . . . . 64.420000000000002 111.064 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.28 -38.75 91.84 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.583 0.552 . . . . 63.130000000000003 113.259 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 -40.4 95.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.256 0.622 . . . . 71.420000000000002 110.939 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -70.53 -30.08 66.74 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.4 -0.818 . . . . 74.120000000000005 111.613 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' B' ' 13' ' ' VAL . . . -76.68 -36.35 57.33 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.603 0.761 . . . . 63.130000000000003 111.521 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.23 -30.97 79.3 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 115.809 -0.632 . . . . 63.530000000000001 112.55 172.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' B' ' 32' ' ' VAL . 4.3 ttmp? -72.59 -52.49 15.28 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.915 0.886 . . . . 73.010000000000005 112.006 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' B' ' 10' ' ' ALA . 33.0 m -68.53 -36.47 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 112.489 0.551 . . . . 74.140000000000001 112.489 -174.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.578 ' HA ' HD12 ' B' ' 17' ' ' LEU . 31.2 t90 -74.16 -32.55 63.17 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 111.903 0.334 . . . . 72.239999999999995 111.903 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -64.55 -33.49 76.02 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.001 0.429 . . . . 72.239999999999995 110.537 173.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.22 -32.45 71.72 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.928 0.891 . . . . 73.25 112.037 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' B' ' 14' ' ' TRP . 70.6 mt -70.99 -46.33 62.49 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.995 0.918 . . . . 71.409999999999997 111.097 173.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -63.11 -25.16 68.23 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.031 0.932 . . . . 74.430000000000007 110.609 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -76.08 -52.81 9.37 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.53 -0.759 . . . . 74.109999999999999 110.45 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.56 99.41 2.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.719 0.807 . . . . 41.030000000000001 110.657 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -98.35 -178.78 4.14 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.755 0.822 . . . . 74.400000000000006 111.335 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.84 37.39 44.71 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.743 -0.543 . . . . 74.219999999999999 111.743 -171.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 tt -122.61 139.85 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.891 0.877 . . . . 74.319999999999993 111.352 -168.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 20.4 m -64.09 151.24 43.66 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.163 0.985 . . . . 72.040000000000006 111.582 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.583 HG12 HD11 ' B' ' 63' ' ' ILE . 54.3 mt -53.63 -49.34 89.38 Favored Pre-proline 0 CA--C 1.579 2.071 0 N-CA-C 112.806 0.669 . . . . 72.230000000000004 112.806 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.64 -25.71 24.23 Favored 'Trans proline' 0 C--N 1.399 3.201 0 C-N-CA 121.926 1.75 . . . . 73.150000000000006 114.539 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.57 -41.88 37.29 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.61 1.195 . . . . 72.400000000000006 109.703 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.3 tp -61.26 -40.1 92.82 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.113 -1.858 . . . . 70.040000000000006 110.72 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.72 73.46 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.829 0.852 . . . . 73.200000000000003 111.962 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 64.2 mtp85 -65.06 -50.02 67.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.659 0.784 . . . . 71.319999999999993 111.916 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -73.84 -24.16 59.73 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 112.127 0.417 . . . . 61.219999999999999 112.127 -176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' B' ' 13' ' ' VAL . 13.9 m -94.85 -3.39 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 112.039 0.385 . . . . 72.140000000000001 112.039 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 65.05 21.64 12.28 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.233 1.013 . . . . 62.140000000000001 112.797 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.6 mt -108.56 169.26 8.77 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.81 0.844 . . . . 72.230000000000004 110.87 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 51.7 m -74.85 163.16 27.96 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.652 0.381 . . . . 54.210000000000001 111.336 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.3 -51.49 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.56 0.744 . . . . 65.340000000000003 111.86 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.63 -38.92 92.14 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.196 0.598 . . . . 73.409999999999997 111.989 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 29.4 t -64.43 -39.1 93.19 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.429 0.692 . . . . 41.43 111.525 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.439 ' O ' HG23 ' B' ' 43' ' ' VAL . 86.6 m -71.03 -48.5 52.61 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.768 0.827 . . . . 50.149999999999999 110.973 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.62 -35.34 72.33 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.789 0.836 . . . . 43.420000000000002 112.378 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.11 -48.51 70.65 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.183 0.993 . . . . 74.349999999999994 109.81 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.38 -30.36 70.49 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.259 -0.882 . . . . 72.129999999999995 111.681 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 39' ' ' THR . 95.2 t -72.87 -31.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 123.006 0.523 . . . . 61.439999999999998 110.615 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -66.11 -27.96 73.31 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 116.26 -0.427 . . . . 63.530000000000001 112.8 172.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -75.46 -25.75 57.68 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.976 0.51 . . . . 74.400000000000006 111.48 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.509 HD11 HG23 ' B' ' 13' ' ' VAL . 96.6 mt -71.6 -27.08 62.88 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.081 0.552 . . . . 34.509999999999998 111.686 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.3 -32.78 62.72 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.317 1.229 . . . . 63.030000000000001 114.317 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.645 ' HB3' ' HG2' ' A' ' 48' ' ' ARG . 13.5 ptm180 -72.27 -30.15 64.56 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 119.069 0.849 . . . . 72.010000000000005 111.512 171.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.76 -19.27 52.64 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.299 0.64 . . . . 74.040000000000006 110.758 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 60.42 21.83 11.44 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.744 1.618 . . . . 70.010000000000005 112.749 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.89 5.55 45.81 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 112.878 0.696 . . . . 74.439999999999998 112.878 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.81 146.17 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.344 0.657 . . . . 74.140000000000001 112.576 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.633 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 66.6 t -118.78 109.95 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 124.49 1.116 . . . . 74.319999999999993 109.5 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 39.6 mm -91.92 121.58 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.714 0.805 . . . . 63.229999999999997 111.401 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -117.16 141.53 48.15 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.506 -0.746 . . . . 71.209999999999994 111.787 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.58 ' HG2' HG12 ' B' ' 61' ' ' ILE . 84.0 mtt85 -113.51 111.6 22.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.077 0.951 . . . . 74.420000000000002 110.203 169.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' B' ' 57' ' ' LYS . 0.3 OUTLIER -144.6 126.94 15.82 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.315 1.046 . . . . 74.549999999999997 109.304 -178.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 60.74 28.68 18.4 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 125.027 1.331 . . . . 62.119999999999997 111.63 -171.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.19 -0.89 61.93 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-N 116.287 -0.415 . . . . 72.400000000000006 113.79 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.72 131.16 43.69 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.143 0.977 . . . . 70.340000000000003 110.936 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.58 HG12 ' HG2' ' B' ' 56' ' ' ARG . 43.8 mt -97.12 122.29 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.129 0.572 . . . . 61.509999999999998 110.339 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -125.74 139.98 53.08 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.35 0.66 . . . . 70.040000000000006 110.014 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.583 HD11 HG12 ' B' ' 25' ' ' ILE . 2.9 mp -100.54 126.97 54.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.666 0.786 . . . . 74.340000000000003 109.517 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.633 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 7.8 m-85 -111.15 169.59 8.68 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.913 1.285 . . . . 65.420000000000002 109.86 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -90.2 155.65 18.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.797 0.439 . . . . 73.140000000000001 111.405 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.24 103.66 0.25 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.684 0.794 . . . . 74.349999999999994 110.428 173.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.27 -18.73 2.67 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 115.821 -0.627 . . . . 74.439999999999998 111.745 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -109.35 72.91 0.82 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.116 0.967 . . . . 64.209999999999994 109.553 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -160.37 -32.9 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.066 0.546 . . . . 73.140000000000001 112.439 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -48.73 -40.29 28.01 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.843 1.257 . . . . 74.109999999999999 113.653 -174.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.442 ' HE2' HD11 ' B' ' 75' ' ' LEU . 39.4 t80 -161.49 127.99 3.86 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.592 0.757 . . . . 73.299999999999997 109.937 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 88.7 p -73.96 129.02 37.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.199 0.6 . . . . 71.430000000000007 110.451 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -81.4 102.63 10.61 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.802 0.441 . . . . 74.420000000000002 110.681 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.92 46.19 0.65 Allowed Glycine 0 N--CA 1.469 0.896 0 N-CA-C 110.912 -0.875 . . . . 52.5 110.912 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.442 HD11 ' HE2' ' B' ' 71' ' ' PHE . 6.6 mp -84.15 120.76 26.56 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.727 0.811 . . . . 52.32 110.889 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.11 140.83 50.76 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.543 0.337 . . . . 63.409999999999997 110.354 174.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -127.27 141.24 51.77 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.952 0.901 . . . . 62.350000000000001 109.465 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -53.19 119.42 4.72 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.212 0.605 . . . . 74.219999999999999 111.761 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -68.96 101.47 1.39 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.799 0.84 . . . . 52.229999999999997 111.361 -173.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -75.27 143.92 42.78 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.986 0.515 . . . . 52.329999999999998 110.647 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -110.21 139.17 45.65 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.885 0.474 . . . . 72.209999999999994 111.019 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 15.9 t60 . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 121.752 0.787 . . . . 65.319999999999993 109.726 -179.115 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 119.255 -0.402 . . . . 74.430000000000007 111.062 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 46.27 104.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 125.585 1.554 . . . . 71.129999999999995 114.301 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' O ' HG22 ' A' ' 6' ' ' VAL . 21.4 tptm -63.42 -16.41 60.48 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 123.727 0.811 . . . . 44.219999999999999 112.401 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -72.12 -24.2 61.43 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.74 0.644 . . . . 74.120000000000005 112.74 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -61.17 -47.64 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.444 0.698 . . . . 62.200000000000003 111.521 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 3' ' ' LYS . 22.8 m -61.27 -28.06 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 122.519 0.328 . . . . 73.150000000000006 111.39 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' HA2' ' CD1' ' A' ' 45' ' ' TRP . . . -69.25 -49.68 37.97 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.544 0.528 . . . . 74.420000000000002 113.501 173.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.18 93.65 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.668 0.787 . . . . 74.129999999999995 112.382 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -75.03 -28.9 60.63 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.245 0.618 . . . . 63.130000000000003 112.339 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.99 82.6 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 112.464 0.542 . . . . 71.510000000000005 112.464 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.03 -34.54 81.93 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 116.413 -0.358 . . . . 72.019999999999996 113.127 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -67.17 -45.87 75.71 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.78 0.832 . . . . 43.240000000000002 110.644 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.594 ' HA ' HG11 ' A' ' 32' ' ' VAL . 63.8 t -60.97 -40.8 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 123.898 0.879 . . . . 64.549999999999997 111.212 175.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -64.67 -35.64 81.7 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.97 -0.559 . . . . 74.540000000000006 111.065 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.443 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 80.6 t60 -62.9 -44.81 95.09 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.78 0.432 . . . . 61.229999999999997 111.249 176.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.657 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -67.46 -32.51 73.41 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.525 0.679 . . . . 33.340000000000003 111.284 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.515 HD11 ' HA ' ' A' ' 65' ' ' ASN . 2.8 tm? -73.48 -29.92 62.82 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.925 1.29 . . . . 74.510000000000005 110.874 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -75.07 -47.15 30.25 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.96 0.904 . . . . 70.129999999999995 111.59 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 22.9 mm-40 -61.04 -33.19 72.9 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.13 0.572 . . . . 71.510000000000005 111.683 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.08 112.43 0.99 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.243 1.017 . . . . 74.450000000000003 109.54 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.8 178.4 5.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.25 0.62 . . . . 72.25 112.256 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.57 39.61 86.58 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 110.534 -1.026 . . . . 45.509999999999998 110.534 -167.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 tp -114.13 114.41 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 124.393 1.077 . . . . 75.010000000000005 110.044 -169.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -58.72 144.98 41.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.264 0.625 . . . . 62.25 112.594 -170.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.582 HG21 ' HB2' ' A' ' 40' ' ' ALA . 57.6 mt -55.38 -46.19 99.74 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 113.847 1.054 . . . . 63.409999999999997 113.847 -170.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HA ' HG22 ' A' ' 36' ' ' VAL . 32.6 Cg_endo -63.09 -25.05 73.25 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 121.819 1.679 . . . . 65.329999999999998 114.177 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -80.16 -55.15 5.13 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.994 0.739 . . . . 64.439999999999998 112.994 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -66.61 -26.03 66.89 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.45 0.568 . . . . 65.340000000000003 111.37 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.39 -37.31 16.57 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.745 0.818 . . . . 73.420000000000002 112.806 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -74.28 -35.02 63.73 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.305 0.642 . . . . 74.209999999999994 111.955 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.657 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 51.9 mtmt -67.06 -31.19 71.53 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 122.807 0.443 . . . . 62.420000000000002 111.513 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 13' ' ' VAL . 27.3 m -97.7 -9.47 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.701 0.801 . . . . 25.32 112.36 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.4 t30 64.7 28.11 13.08 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.347 1.459 . . . . 73.420000000000002 112.167 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.81 164.91 11.57 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.878 0.871 . . . . 61.0 111.198 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.7 m -65.21 153.11 41.94 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.139 0.576 . . . . 42.130000000000003 111.156 172.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 26' ' ' PRO . 64.6 t -53.97 -51.07 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.49 0.716 . . . . 24.109999999999999 111.104 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.591 ' HB2' HG13 ' B' ' 61' ' ' ILE . 36.3 mt-10 -60.32 -41.37 93.35 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.497 1.119 . . . . 54.039999999999999 112.557 176.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.8 m -62.28 -37.58 86.06 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 123.366 0.666 . . . . 73.409999999999997 111.798 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 43' ' ' VAL . 88.2 m -71.78 -46.51 58.08 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.559 0.743 . . . . 53.439999999999998 111.182 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.582 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -60.72 -37.81 83.0 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 123.615 0.766 . . . . 70.400000000000006 112.493 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.69 -41.91 71.36 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.276 1.031 . . . . 71.109999999999999 110.554 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -31.85 73.18 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.158 0.583 . . . . 63.109999999999999 111.686 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 39' ' ' THR . 41.4 t -59.23 -35.69 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.899 0.88 . . . . 74.099999999999994 111.351 170.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -63.75 -32.28 83.64 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 114.049 0.38 . . . . 70.019999999999996 114.049 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.478 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 69.9 t-105 -73.89 -26.98 60.83 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.127 0.571 . . . . 75.019999999999996 111.361 175.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.98 -39.36 63.73 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 122.79 0.436 . . . . 70.430000000000007 111.173 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.87 69.81 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.261 1.024 . . . . 74.219999999999999 113.376 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 45' ' ' TRP . 5.7 ppt_? -71.45 -12.69 61.53 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.021 0.378 . . . . 63.350000000000001 112.021 174.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -110.35 -8.47 14.7 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.321 1.048 . . . . 73.329999999999998 111.915 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 63.51 28.73 15.35 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.625 1.17 . . . . 74.099999999999994 112.834 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -69.37 -13.9 62.62 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.375 0.67 . . . . 73.310000000000002 112.046 171.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.711 ' HB ' HD11 ' A' ' 63' ' ' ILE . 31.0 m -133.92 155.47 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.924 0.89 . . . . 72.239999999999995 110.855 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.557 HG11 ' HB3' ' A' ' 69' ' ' PHE . 31.2 m -127.37 143.19 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.179 0.991 . . . . 74.200000000000003 109.499 173.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.0 mt -120.72 134.57 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.186 0.595 . . . . 64.310000000000002 110.717 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -120.63 127.13 51.79 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.757 0.823 . . . . 62.140000000000001 111.409 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.508 ' HG2' HG12 ' A' ' 61' ' ' ILE . 84.8 mtt180 -95.45 102.62 14.43 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.209 0.528 . . . . 73.299999999999997 110.181 170.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -108.56 123.19 48.53 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.789 0.836 . . . . 71.549999999999997 109.99 178.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 55.98 29.38 14.22 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.792 1.237 . . . . 70.209999999999994 112.082 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.95 -25.92 9.24 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 114.116 -174.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.77 141.04 39.48 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.617 0.767 . . . . 75.129999999999995 111.195 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.508 HG12 ' HG2' ' A' ' 56' ' ' ARG . 32.2 mt -93.37 133.96 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.337 0.655 . . . . 65.030000000000001 111.791 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -132.17 139.74 48.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.999 0.92 . . . . 64.109999999999999 110.286 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.711 HD11 ' HB ' ' A' ' 52' ' ' VAL . 6.8 tp -102.49 126.28 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.35 0 CA-C-O 121.772 0.796 . . . . 63.100000000000001 111.487 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.454 ' HB2' HG23 ' A' ' 53' ' ' VAL . 89.6 m-85 -118.11 169.28 9.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.186 1.394 . . . . 74.129999999999995 111.45 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.515 ' HA ' HD11 ' A' ' 17' ' ' LEU . 28.6 t-20 -81.38 145.97 30.55 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.663 0.785 . . . . 72.420000000000002 110.671 175.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.422 ' HA ' HG13 ' A' ' 53' ' ' VAL . 10.9 pt-20 -40.63 -32.58 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.521 1.675 . . . . 62.229999999999997 115.521 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.57 22.1 6.79 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 114.788 0.675 . . . . 21.109999999999999 114.788 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -126.59 27.39 6.12 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.309 1.044 . . . . 73.200000000000003 110.906 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.557 ' HB3' HG11 ' A' ' 53' ' ' VAL . 31.9 p90 -79.45 152.61 30.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.11 0.564 . . . . 72.109999999999999 111.034 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -77.19 144.05 38.61 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 109.215 -0.661 . . . . 75.299999999999997 109.215 171.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -73.82 4.41 5.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.749 0.648 . . . . 74.430000000000007 112.749 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.3 t -73.55 79.57 1.46 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.718 0.807 . . . . 73.5 109.831 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -82.09 -56.3 4.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.619 0.768 . . . . 70.310000000000002 111.01 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.44 73.93 1.28 Allowed Glycine 0 CA--C 1.533 1.202 0 N-CA-C 111.915 -0.474 . . . . 65.230000000000004 111.915 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.94 -33.6 70.79 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.027 0.931 . . . . 75.040000000000006 113.413 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -68.17 -30.15 69.19 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.962 0.905 . . . . 73.340000000000003 111.876 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -92.64 18.13 9.2 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.8 0.84 . . . . 70.310000000000002 112.733 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -69.01 87.01 0.37 Allowed 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 109.179 -0.674 . . . . 74.329999999999998 109.179 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -73.27 159.86 32.77 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.325 0.65 . . . . 73.400000000000006 111.895 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -122.28 -152.25 0.51 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.655 0.782 . . . . 62.140000000000001 109.455 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -72.21 -13.96 61.67 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.5 0.926 . . . . 73.329999999999998 113.5 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.615 0.722 . . . . 72.310000000000002 110.665 173.75 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.545 0.777 0 CA-C-O 120.449 0.166 . . . . 70.310000000000002 111.347 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.82 -23.48 67.29 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.695 0.998 . . . . 74.310000000000002 113.695 -173.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -38.68 55.32 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.282 0.633 . . . . 74.129999999999995 112.363 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -74.03 -48.58 29.07 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.909 0.884 . . . . 54.109999999999999 111.297 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 65.3 mt -59.08 -60.0 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 114.935 -1.03 . . . . 71.5 111.844 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 m -59.4 -29.13 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.22 1.008 . . . . 71.25 112.65 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.72 -43.29 85.09 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 123.285 0.366 . . . . 75.510000000000005 112.758 173.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.28 96.67 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.919 0.887 . . . . 70.400000000000006 112.083 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -67.1 -40.95 86.99 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.051 0.54 . . . . 74.540000000000006 111.26 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.33 77.46 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.622 0.769 . . . . 64.430000000000007 112.808 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.62 -38.56 96.61 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 123.501 0.501 . . . . 34.039999999999999 112.853 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -69.29 -46.51 67.0 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.715 0.806 . . . . 71.230000000000004 111.792 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.604 ' HA ' HG11 ' B' ' 32' ' ' VAL . 72.7 t -59.25 -45.9 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.52 0.728 . . . . 74.040000000000006 111.644 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.6 ' HA ' HD12 ' B' ' 17' ' ' LEU . 21.1 t90 -68.45 -32.45 72.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.895 -0.593 . . . . 55.439999999999998 111.537 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . 0.408 ' HA ' ' OD1' ' B' ' 18' ' ' ASN . 8.1 t60 -59.01 -35.74 73.77 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.26 0.553 . . . . 70.340000000000003 110.834 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.03 -29.62 63.12 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.964 0.905 . . . . 51.530000000000001 112.093 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' B' ' 14' ' ' TRP . 84.7 mt -73.18 -39.86 65.26 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.067 0.947 . . . . 72.430000000000007 112.745 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' B' ' 15' ' ' HIS . 2.0 p-10 -74.64 -14.78 60.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.897 -0.502 . . . . 73.430000000000007 111.427 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.18 -45.59 16.15 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.337 0.655 . . . . 71.019999999999996 110.007 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.33 98.6 1.28 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.876 0.87 . . . . 75.239999999999995 110.599 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -85.93 159.99 19.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.29 0.636 . . . . 75.049999999999997 111.224 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.61 64.77 1.6 Allowed Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.555 -0.293 . . . . 45.32 112.634 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 tt -146.38 139.91 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.6 0.76 . . . . 75.0 110.841 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 37.5 m -62.8 145.79 54.12 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.756 0.423 . . . . 74.340000000000003 111.495 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.569 HD12 ' HB3' ' A' ' 37' ' ' GLU . 61.1 mt -52.28 -50.39 79.7 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 114.226 1.195 . . . . 62.130000000000003 114.226 -175.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.09 -23.44 39.9 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 121.828 1.685 . . . . 74.510000000000005 114.504 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -75.08 -52.43 11.06 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.141 0.972 . . . . 73.109999999999999 109.177 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -54.68 -37.1 65.35 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 113.122 -1.854 . . . . 75.219999999999999 112.048 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.65 95.38 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.3 1.04 . . . . 62.439999999999998 112.471 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -72.07 -28.7 63.49 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.264 0.625 . . . . 74.150000000000006 111.954 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.54 -35.03 65.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.414 0.686 . . . . 74.540000000000006 111.433 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' B' ' 13' ' ' VAL . 31.6 m -95.54 1.68 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.48 0.712 . . . . 50.240000000000002 112.109 177.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 61.9 16.27 7.89 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 124.553 1.141 . . . . 75.5 113.739 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 60.6 mt -102.66 158.37 16.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.752 0.821 . . . . 74.340000000000003 110.005 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 50.8 m -63.46 156.38 26.35 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.577 0.351 . . . . 64.239999999999995 111.313 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.0 t -49.4 -48.28 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 123.849 0.86 . . . . 62.219999999999999 111.713 171.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.62 -36.85 81.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.12 -0.946 . . . . 72.239999999999995 111.258 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -63.58 -43.04 98.15 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.461 0.704 . . . . 42.420000000000002 111.703 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.456 ' O ' HG23 ' B' ' 43' ' ' VAL . 92.1 m -74.71 -46.97 34.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.91 0.884 . . . . 74.510000000000005 111.445 -174.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -59.72 -46.12 90.09 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 124.235 1.014 . . . . 74.310000000000002 112.302 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -71.77 -35.22 69.99 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.672 -1.149 . . . . 75.25 111.001 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.84 81.89 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 122.574 0.349 . . . . 52.200000000000003 111.182 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.734 HG11 HD12 ' B' ' 63' ' ' ILE . 68.9 t -65.44 -31.87 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 123.585 0.754 . . . . 72.420000000000002 110.939 170.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -64.63 -33.57 87.58 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.909 -0.132 . . . . 73.140000000000001 113.425 171.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.484 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 73.8 t-105 -73.9 -29.78 62.24 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.479 0.712 . . . . 74.439999999999998 111.181 173.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.36 -34.58 70.58 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.839 0.456 . . . . 64.340000000000003 110.711 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.33 67.41 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.285 1.034 . . . . 74.400000000000006 111.753 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 20.1 ttt85 -56.68 -51.36 69.08 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.327 0.584 . . . . 74.200000000000003 110.882 167.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -80.07 -7.66 58.99 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.404 -0.816 . . . . 61.219999999999999 111.666 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 63.7 t30 63.91 32.9 12.92 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.577 1.551 . . . . 51.210000000000001 111.424 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -88.2 -1.68 58.16 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.744 0.818 . . . . 75.140000000000001 111.952 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.86 162.4 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.583 0.753 . . . . 73.549999999999997 112.306 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' B' ' 64' ' ' TYR . 11.7 m -128.22 156.79 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 124.45 1.1 . . . . 75.430000000000007 110.371 167.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 36.6 mm -116.97 119.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.447 0.699 . . . . 74.519999999999996 110.272 -175.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -115.49 115.02 25.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.147 0.579 . . . . 75.319999999999993 110.884 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -84.42 97.6 9.6 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.037 -0.727 . . . . 51.530000000000001 109.037 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.16 108.28 19.71 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.872 0.869 . . . . 63.0 110.163 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 54.65 31.45 15.22 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.369 1.067 . . . . 75.120000000000005 112.46 -173.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.77 -16.21 61.62 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-N 115.851 -0.613 . . . . 42.210000000000001 114.012 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -81.63 134.27 35.46 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.579 0.752 . . . . 63.240000000000002 110.845 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.591 HG13 ' HB2' ' A' ' 37' ' ' GLU . 23.1 mm -90.8 105.96 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.05 0.54 . . . . 65.129999999999995 109.816 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -115.72 130.5 56.87 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.845 0.858 . . . . 71.400000000000006 110.901 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.734 HD12 HG11 ' B' ' 43' ' ' VAL . 26.6 mm -93.22 115.7 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.052 0.941 . . . . 60.140000000000001 110.874 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.595 ' HB2' HG23 ' B' ' 53' ' ' VAL . 33.0 m-85 -107.06 158.98 16.65 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.005 0.922 . . . . 75.200000000000003 110.048 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -91.19 150.26 21.44 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.352 0.661 . . . . 62.240000000000002 109.6 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.551 ' HG2' HG13 ' B' ' 53' ' ' VAL . 0.2 OUTLIER -93.45 157.0 16.43 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.472 0.653 . . . . 72.209999999999994 110.664 176.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.5 -9.65 3.75 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.012 -0.835 . . . . 71.150000000000006 111.012 -170.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -95.36 -26.78 15.75 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.901 0.88 . . . . 71.120000000000005 113.168 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -64.89 142.69 58.35 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 118.21 0.459 . . . . 74.400000000000006 110.845 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -60.97 103.62 0.29 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.372 0.669 . . . . 71.140000000000001 111.24 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -113.1 117.11 31.05 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.424 0.63 . . . . 74.099999999999994 111.64 -175.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 91.3 p -160.68 166.91 27.99 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.719 1.208 . . . . 75.420000000000002 109.244 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.62 35.25 0.77 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.903 0.705 . . . . 71.439999999999998 112.903 -171.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.88 66.48 3.85 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 112.09 -0.404 . . . . 74.349999999999994 112.09 171.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 pp -137.5 155.19 49.56 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.822 0.849 . . . . 65.129999999999995 111.376 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -93.23 -171.89 2.79 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.047 0.539 . . . . 75.150000000000006 111.766 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 72.61 -59.58 0.56 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.317 1.447 . . . . 62.350000000000001 110.523 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -67.35 126.54 29.57 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.3 0.64 . . . . 62.350000000000001 110.58 168.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -127.74 158.76 36.78 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.197 0.999 . . . . 62.219999999999999 110.566 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -71.9 107.47 4.67 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.527 0.68 . . . . 70.209999999999994 110.602 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -84.38 116.91 23.29 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.994 0.518 . . . . 55.409999999999997 111.142 -175.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 N--CA 1.478 0.926 0 C-N-CA 123.507 0.723 . . . . 74.219999999999999 110.95 176.934 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 ttp . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.943 -0.391 . . . . 63.520000000000003 109.943 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 32.69 -81.71 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.766 2.506 . . . . 74.299999999999997 117.766 160.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -48.56 -49.19 37.52 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.928 1.825 . . . . 71.219999999999999 115.928 -159.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -71.71 -35.46 70.23 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 117.838 0.29 . . . . 71.510000000000005 111.454 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.2 mt -61.04 -60.33 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.181 0.592 . . . . 45.100000000000001 110.792 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 41' ' ' LEU . 34.8 m -64.0 -32.27 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.556 1.142 . . . . 35.549999999999997 112.192 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.6 69.8 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 123.353 0.408 . . . . 74.140000000000001 112.687 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.63 94.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.647 0.779 . . . . 43.210000000000001 111.651 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.39 -40.45 89.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.642 0.777 . . . . 51.030000000000001 111.421 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.84 -34.49 78.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.204 0.601 . . . . 61.119999999999997 111.913 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.77 -39.05 96.34 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 116.279 -0.419 . . . . 44.219999999999999 113.182 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -75.19 -41.12 58.62 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.752 0.821 . . . . 74.200000000000003 111.924 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.578 ' HA ' HG11 ' A' ' 32' ' ' VAL . 59.2 t -67.24 -45.5 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.496 0.719 . . . . 72.420000000000002 111.322 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.572 ' HA ' HD12 ' A' ' 17' ' ' LEU . 47.5 t90 -64.42 -34.63 78.62 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.504 0.502 . . . . 62.43 111.158 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.408 ' NE2' ' HB2' ' A' ' 76' ' ' GLU . 60.6 t60 -60.93 -45.09 96.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.362 0.665 . . . . 65.010000000000005 111.125 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -69.69 -36.17 75.74 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.753 -0.658 . . . . 74.319999999999993 111.654 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 14' ' ' TRP . 33.5 mt -59.51 -43.49 93.37 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.545 0.738 . . . . 75.409999999999997 111.474 175.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -59.34 -24.75 63.62 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.255 1.022 . . . . 63.530000000000001 112.254 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.543 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 59.4 mt-10 -66.02 -42.71 89.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.854 0.862 . . . . 74.329999999999998 111.062 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.73 110.57 2.19 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.44 0.696 . . . . 72.340000000000003 111.327 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -77.55 162.98 26.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.628 0.771 . . . . 73.219999999999999 111.27 174.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.87 61.91 3.15 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.999 -0.441 . . . . 71.430000000000007 111.999 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 tt -141.38 135.98 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.661 0.784 . . . . 62.439999999999998 111.06 -171.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -69.57 152.94 44.17 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.22 0.608 . . . . 65.25 111.413 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 40' ' ' ALA . 57.0 mt -56.38 -47.11 99.53 Favored Pre-proline 0 CA--C 1.58 2.123 0 N-CA-C 113.458 0.91 . . . . 41.140000000000001 113.458 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 55.9 Cg_endo -66.13 -30.29 46.91 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 122.145 1.896 . . . . 64.129999999999995 113.925 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.63 -46.52 66.0 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.422 1.105 . . . . 73.230000000000004 109.839 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.32 -36.87 78.92 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 113.152 -1.84 . . . . 70.299999999999997 112.175 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.3 80.21 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.567 0.747 . . . . 62.350000000000001 112.431 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 26' ' ' PRO . 2.8 mpt_? -69.69 -38.73 77.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.807 0.443 . . . . 61.229999999999997 111.447 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.43 ' HE3' ' HB1' ' A' ' 16' ' ' ALA . 40.8 mtmt -64.0 -41.77 97.37 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.538 0.335 . . . . 71.239999999999995 111.655 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 13' ' ' VAL . 22.4 m -84.24 -10.81 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.096 0.559 . . . . 62.43 111.573 175.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 69.26 16.9 8.38 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 125.53 1.532 . . . . 73.439999999999998 112.048 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.421 ' H ' HG23 ' A' ' 32' ' ' VAL . 70.2 mt -99.68 175.61 5.75 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.837 0.855 . . . . 61.409999999999997 110.604 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 t -76.99 159.25 30.07 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.144 0.577 . . . . 64.329999999999998 111.524 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -57.87 -44.69 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.091 0.556 . . . . 71.209999999999994 111.51 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.79 -46.37 89.83 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.752 0.821 . . . . 73.230000000000004 112.02 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.8 p -69.0 -30.82 69.29 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.209 0.604 . . . . 64.140000000000001 112.063 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . 96.7 m -74.92 -48.45 24.52 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.351 0.661 . . . . 73.420000000000002 111.248 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -61.77 -36.82 82.16 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 123.992 0.917 . . . . 31.050000000000001 111.831 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.651 HD11 HG12 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -61.33 -43.07 99.49 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.91 1.284 . . . . 74.230000000000004 110.802 173.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.59 71.73 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.228 0.611 . . . . 73.450000000000003 112.296 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.451 HG11 HD12 ' A' ' 63' ' ' ILE . 86.3 t -69.41 -33.73 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.33 0.652 . . . . 52.109999999999999 110.86 175.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.74 -32.7 85.08 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-N 116.501 -0.318 . . . . 55.219999999999999 112.745 172.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.419 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 71.5 t-105 -74.02 -31.1 62.77 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.606 0.762 . . . . 74.120000000000005 111.333 173.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.3 -34.89 75.38 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.727 0.411 . . . . 72.420000000000002 111.156 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.59 -28.95 69.72 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.37 0.668 . . . . 74.540000000000006 112.101 173.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' B' ' 48' ' ' ARG . 22.9 ttt180 -59.85 -51.16 70.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.763 0.825 . . . . 60.020000000000003 112.111 175.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -90.99 13.57 16.32 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.408 -0.815 . . . . 51.43 112.04 -173.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 51.33 47.45 24.82 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.001 1.32 . . . . 52.350000000000001 112.08 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -87.54 -32.95 19.11 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.757 -1.11 . . . . 64.329999999999998 111.921 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -132.74 148.27 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.637 0.775 . . . . 51.229999999999997 112.058 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG13 ' HG2' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -113.55 107.33 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.595 0.758 . . . . 63.229999999999997 108.957 171.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.48 HG23 HD13 ' A' ' 63' ' ' ILE . 60.1 mt -88.94 114.6 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 109.16 -0.681 . . . . 73.129999999999995 109.16 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -102.74 117.42 34.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.21 0.604 . . . . 75.329999999999998 111.107 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -81.9 108.18 15.21 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.957 -0.386 . . . . 72.450000000000003 109.957 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -104.09 106.15 16.56 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.658 0.783 . . . . 64.530000000000001 109.003 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 54.81 31.85 16.44 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 124.336 1.054 . . . . 73.430000000000007 112.423 -169.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.93 -20.12 50.64 Favored Glycine 0 CA--C 1.542 1.769 0 N-CA-C 114.408 0.523 . . . . 50.32 114.408 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.79 134.95 43.47 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.743 0.817 . . . . 74.209999999999994 111.076 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.25 103.78 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 122.995 0.518 . . . . 74.099999999999994 109.884 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -118.72 121.83 41.03 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.949 0.9 . . . . 72.329999999999998 109.914 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 54' ' ' ILE . 10.5 mm -91.96 120.93 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.214 0.606 . . . . 71.019999999999996 111.938 -169.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -108.84 163.14 13.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.489 0.715 . . . . 73.209999999999994 111.043 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 11.1 m-20 -91.33 155.26 18.64 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.428 -0.806 . . . . 74.420000000000002 108.921 171.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 69' ' ' PHE . 50.9 mt-10 -84.4 78.91 9.72 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.758 0.79 . . . . 74.430000000000007 110.022 169.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.52 -18.12 79.92 Favored Glycine 0 C--N 1.358 1.75 0 CA-C-N 114.71 -1.132 . . . . 60.119999999999997 113.974 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -84.59 -12.21 54.5 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.124 0.57 . . . . 70.329999999999998 110.89 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.582 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 83.9 m-85 -118.63 17.5 13.6 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.0 1.32 . . . . 63.310000000000002 110.638 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.19 159.36 29.18 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.437 0.903 . . . . 73.340000000000003 113.437 -168.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -124.48 -59.54 1.45 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.69 0.796 . . . . 65.010000000000005 110.61 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 t -135.78 161.76 34.68 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.219 0.608 . . . . 74.109999999999999 111.726 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -124.29 152.48 43.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.99 0.916 . . . . 74.409999999999997 110.571 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.71 82.18 0.1 Allowed Glycine 0 C--N 1.344 0.972 0 CA-C-N 116.167 -0.47 . . . . 71.239999999999995 112.094 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.543 ' HG ' ' HA ' ' A' ' 19' ' ' GLU . 7.0 mp -79.86 113.42 18.0 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.689 0.796 . . . . 74.340000000000003 109.629 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HB2' ' NE2' ' A' ' 15' ' ' HIS . 36.9 tt0 -105.67 147.58 28.35 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.676 0.79 . . . . 62.109999999999999 111.326 -172.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -80.88 72.7 7.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.924 0.869 . . . . 65.439999999999998 109.169 164.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -57.63 106.47 0.35 Allowed 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 125.312 1.445 . . . . 72.510000000000005 112.346 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -78.35 82.99 4.61 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.656 0.741 . . . . 74.319999999999993 111.346 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -74.49 122.02 22.39 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.024 -0.989 . . . . 73.400000000000006 110.347 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -73.64 -51.15 17.75 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.433 -0.581 . . . . 74.430000000000007 109.433 172.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 65.9 t60 . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 124.135 0.974 . . . . 71.040000000000006 110.16 175.347 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 120.929 0.395 . . . . 65.519999999999996 110.465 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.405 ' O ' HG22 ' B' ' 6' ' ' VAL . 28.4 t70 -73.08 -19.81 61.09 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.293 0.479 . . . . 74.230000000000004 112.293 -175.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -61.48 -22.78 65.39 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.018 0.372 . . . . 75.540000000000006 111.475 172.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -91.26 -41.82 10.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.077 0.951 . . . . 62.5 111.827 170.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.49 -45.33 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 122.993 0.517 . . . . 74.010000000000005 111.876 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.405 HG22 ' O ' ' B' ' 2' ' ' ASP . 35.9 m -60.03 -26.84 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 122.633 0.373 . . . . 71.109999999999999 111.811 174.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.2 -48.36 80.24 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.135 0.272 . . . . 54.450000000000003 112.869 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.79 -43.28 93.72 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.601 0.76 . . . . 73.109999999999999 111.609 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.85 -36.53 80.48 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.169 0.988 . . . . 72.540000000000006 111.532 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.427 ' HA ' ' HB1' ' B' ' 42' ' ' ALA . . . -68.69 -39.66 80.44 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.099 0.56 . . . . 71.239999999999995 110.914 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.74 -45.98 92.79 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.68 -0.691 . . . . 75.409999999999997 112.341 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -63.28 -41.95 99.05 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.425 1.09 . . . . 62.210000000000001 111.845 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.694 ' HA ' HG11 ' B' ' 32' ' ' VAL . 72.8 t -65.14 -37.05 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.775 0.83 . . . . 63.439999999999998 111.622 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -74.04 -33.49 63.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.208 0.603 . . . . 75.209999999999994 111.587 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -60.84 -30.7 70.26 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.92 0.488 . . . . 75.109999999999999 111.353 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.71 69.96 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.191 0.596 . . . . 44.119999999999997 112.466 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.489 ' HB3' ' ND2' ' B' ' 65' ' ' ASN . 53.3 mt -63.49 -34.24 77.33 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.262 0.625 . . . . 75.109999999999999 112.51 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.75 -25.7 66.67 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.3 0.64 . . . . 63.549999999999997 111.729 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.92 -41.03 8.2 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.734 0.813 . . . . 61.350000000000001 111.077 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' B' ' 17' ' ' LEU . . . -153.75 141.28 19.83 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.405 0.682 . . . . 50.32 111.808 -171.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -127.08 168.97 13.9 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.616 0.766 . . . . 65.420000000000002 111.129 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.8 10.24 64.02 Favored Glycine 0 N--CA 1.474 1.167 0 N-CA-C 114.596 0.598 . . . . 71.109999999999999 114.596 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.3 tt -86.26 132.02 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 123.465 0.706 . . . . 75.329999999999998 110.809 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -71.89 158.35 36.21 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.518 0.562 . . . . 45.340000000000003 112.518 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.551 HG21 ' HB2' ' B' ' 40' ' ' ALA . 73.9 mt -56.33 -43.3 99.23 Favored Pre-proline 0 CA--C 1.582 2.177 0 N-CA-C 115.274 1.583 . . . . 73.349999999999994 115.274 -169.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.54 -31.6 33.28 Favored 'Trans proline' 0 C--N 1.392 2.863 0 CA-C-N 122.448 1.91 . . . . 75.319999999999993 114.207 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -77.86 -41.32 37.23 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.313 1.054 . . . . 73.120000000000005 110.102 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.42 -39.61 84.06 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 113.206 -1.816 . . . . 52.25 111.125 171.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.01 88.91 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.985 0.914 . . . . 63.100000000000001 111.648 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -60.92 -43.42 98.59 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.584 0.754 . . . . 73.530000000000001 111.498 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -71.27 -37.97 71.88 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.284 0.634 . . . . 74.439999999999998 111.934 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.694 HG11 ' HA ' ' B' ' 13' ' ' VAL . 13.1 m -93.32 5.53 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.047 0.539 . . . . 61.020000000000003 112.15 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.4 t30 68.46 9.53 7.33 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.574 1.149 . . . . 74.209999999999994 113.303 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 47.8 mt -102.98 174.25 5.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.611 -0.68 . . . . 72.439999999999998 111.463 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 39.3 t -72.94 157.84 36.65 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.915 0.486 . . . . 73.209999999999994 111.264 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.14 -41.39 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.22 0.608 . . . . 71.230000000000004 111.198 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.19 -48.44 75.9 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.533 0.733 . . . . 74.109999999999999 112.207 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -71.04 -29.97 66.03 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.292 0.637 . . . . 62.530000000000001 111.98 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.422 ' O ' HG23 ' B' ' 43' ' ' VAL . 95.5 m -72.77 -46.23 54.46 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.182 0.593 . . . . 74.430000000000007 110.487 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.551 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -60.05 -36.35 77.1 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.528 0.731 . . . . 74.019999999999996 111.927 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -51.13 66.61 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.278 1.031 . . . . 71.329999999999998 109.606 174.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.427 ' HB1' ' HA ' ' B' ' 10' ' ' ALA . . . -61.39 -30.77 70.76 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.009 -0.996 . . . . 64.230000000000004 111.695 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.422 HG23 ' O ' ' B' ' 39' ' ' THR . 49.0 t -68.45 -37.51 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.76 0.824 . . . . 64.010000000000005 110.66 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.47 -33.3 86.04 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.216 -0.447 . . . . 53.420000000000002 113.037 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.437 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 61.9 t-105 -74.44 -25.63 59.55 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.398 0.679 . . . . 73.040000000000006 111.338 175.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.92 -36.73 70.04 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.875 0.47 . . . . 73.099999999999994 111.284 169.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.21 -33.02 75.01 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.959 0.503 . . . . 64.030000000000001 110.685 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.497 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 2.3 tmt_? -59.35 -45.29 91.82 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.246 1.018 . . . . 65.530000000000001 111.504 173.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.421 ' HG3' ' HD3' ' B' ' 48' ' ' ARG . 37.6 mt-10 -84.79 2.38 42.5 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.46 0.704 . . . . 60.299999999999997 112.508 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 63.2 22.41 13.35 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.148 1.379 . . . . 62.399999999999999 112.808 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -102.42 7.96 40.24 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.907 1.077 . . . . 45.200000000000003 113.907 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.403 HG12 HD11 ' B' ' 17' ' ' LEU . 20.9 m -131.87 151.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 123.093 0.557 . . . . 71.430000000000007 111.102 171.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 t -105.36 102.41 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.498 0.719 . . . . 74.349999999999994 109.492 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 27.8 mm -77.69 114.7 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 122.987 0.515 . . . . 43.119999999999997 110.274 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.18 156.5 38.33 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.89 0.876 . . . . 64.430000000000007 111.843 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -118.12 107.56 14.12 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.958 0.903 . . . . 73.010000000000005 110.864 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -119.07 129.86 55.3 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.02 0.528 . . . . 71.310000000000002 110.125 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 62.72 30.45 16.82 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.528 1.131 . . . . 73.530000000000001 112.115 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.05 12.97 81.33 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 115.979 -0.555 . . . . 73.239999999999995 113.465 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -122.52 136.66 54.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.178 0.991 . . . . 71.099999999999994 110.378 -172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mp -80.51 122.36 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 123.012 0.525 . . . . 75.030000000000001 110.244 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -124.94 132.36 53.3 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.278 1.031 . . . . 74.519999999999996 110.019 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 pp -100.06 126.53 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.434 0.694 . . . . 74.430000000000007 111.932 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -108.52 166.47 10.76 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.207 0.603 . . . . 61.530000000000001 111.252 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.489 ' ND2' ' HB3' ' B' ' 17' ' ' LEU . 15.0 m120 -67.43 141.45 57.01 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.632 0.773 . . . . 72.519999999999996 111.461 176.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -48.18 -39.81 22.09 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.512 1.301 . . . . 72.439999999999998 114.512 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.66 -16.29 7.19 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 117.426 1.73 . . . . 53.049999999999997 117.426 -166.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -99.16 -37.39 9.33 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 118.297 1.048 . . . . 74.340000000000003 111.953 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 52.07 40.98 29.6 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 123.989 0.916 . . . . 73.230000000000004 112.745 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.82 22.49 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 125.869 1.668 . . . . 72.140000000000001 114.87 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -149.32 114.96 5.61 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.126 0.97 . . . . 74.230000000000004 110.201 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 20.4 t -79.23 132.38 36.49 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.692 0.397 . . . . 70.439999999999998 110.824 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -142.39 147.52 36.37 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.963 0.505 . . . . 73.120000000000005 110.935 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.51 71.5 0.07 OUTLIER Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.337 -0.392 . . . . 71.150000000000006 112.984 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.6 mt -124.62 -64.81 1.08 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.388 0.675 . . . . 64.239999999999995 111.86 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -94.39 163.37 13.45 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.703 1.001 . . . . 74.349999999999994 113.703 -166.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -139.58 114.85 9.76 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.466 1.106 . . . . 73.319999999999993 110.248 172.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -73.97 -9.64 58.84 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.176 0.99 . . . . 51.409999999999997 112.549 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -68.49 5.41 1.04 Allowed 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 124.461 1.105 . . . . 75.099999999999994 113.543 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -64.09 84.68 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 O-C-N 121.601 -0.687 . . . . 74.010000000000005 111.902 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -172.19 137.67 0.92 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.371 1.068 . . . . 64.209999999999994 110.051 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 . . . . . 0 N--CA 1.489 1.509 0 C-N-CA 123.49 0.716 . . . . 64.430000000000007 111.593 175.855 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HG3' HD11 ' A' ' 5' ' ' ILE . 19.3 ptt? . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.784 -0.627 . . . . 73.409999999999997 110.478 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -44.99 130.55 7.46 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.804 1.242 . . . . 72.230000000000004 113.678 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' B' ' 50' ' ' ASN . 27.0 ttpp -75.66 -8.5 56.95 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.86 0.864 . . . . 75.430000000000007 110.415 169.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -63.18 -15.74 57.86 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.748 1.219 . . . . 74.549999999999997 112.682 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.41 HD11 ' HG3' ' A' ' 1' ' ' MET . 80.6 mt -58.28 -55.52 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.158 0.583 . . . . 73.319999999999993 110.802 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.6 m -67.31 -25.54 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 122.682 0.393 . . . . 72.430000000000007 111.232 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.491 ' HA2' ' NE1' ' A' ' 45' ' ' TRP . . . -68.27 -41.39 86.15 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 116.676 -0.238 . . . . 70.439999999999998 113.646 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.01 -54.84 13.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.822 0.849 . . . . 71.200000000000003 112.031 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -68.07 -19.68 64.89 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 112.793 0.664 . . . . 72.010000000000005 112.793 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 13' ' ' VAL . . . -69.32 -28.05 65.91 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.623 0.769 . . . . 24.399999999999999 112.205 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.68 -42.64 93.17 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 116.762 -0.199 . . . . 63.329999999999998 113.391 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -66.81 -46.65 74.51 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.797 0.839 . . . . 74.200000000000003 112.081 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.537 ' HA ' HG11 ' A' ' 32' ' ' VAL . 10.6 p -69.13 -32.17 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.533 0.333 . . . . 63.100000000000001 111.708 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.475 ' NE1' ' HB3' ' A' ' 51' ' ' LYS . 66.9 t90 -72.14 -33.94 68.16 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.067 0.547 . . . . 72.409999999999997 111.328 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -61.49 -35.24 77.1 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.384 0.673 . . . . 73.230000000000004 111.315 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.41 -32.44 73.88 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.581 0.753 . . . . 42.049999999999997 112.088 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 14' ' ' TRP . 50.9 mt -73.66 -33.04 64.3 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.869 0.867 . . . . 75.319999999999993 112.131 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -62.91 -33.26 74.95 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.208 0.603 . . . . 74.510000000000005 111.76 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -75.3 -54.3 7.32 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.283 0.633 . . . . 62.439999999999998 110.11 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.45 99.13 2.17 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.599 -0.728 . . . . 65.25 110.899 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.529 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 9.9 p-10 -93.5 150.84 20.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.7 0.4 . . . . 74.209999999999994 109.952 173.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.08 63.19 1.15 Allowed Glycine 0 N--CA 1.469 0.855 0 N-CA-C 110.758 -0.937 . . . . 61.329999999999998 110.758 -167.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.4 tt -145.17 125.44 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.479 1.112 . . . . 73.530000000000001 109.605 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.0 m -57.09 149.27 19.69 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.032 0.933 . . . . 63.229999999999997 112.097 -176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.618 HG12 HD11 ' A' ' 63' ' ' ILE . 21.2 mt -53.88 -48.07 94.88 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 113.419 0.896 . . . . 51.229999999999997 113.419 -174.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.46 -24.0 14.48 Favored 'Trans proline' 0 C--N 1.398 3.17 0 C-N-CA 121.881 1.721 . . . . 74.540000000000006 114.732 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -71.79 -45.86 60.21 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 123.037 1.398 . . . . 70.420000000000002 108.939 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 32' ' ' VAL . 60.5 tp -65.11 -40.14 94.11 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 112.443 -2.162 . . . . 72.519999999999996 111.466 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.25 93.93 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.048 0.939 . . . . 61.329999999999998 112.306 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -70.02 -39.26 75.92 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.287 0.635 . . . . 75.040000000000006 111.004 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -59.19 -52.12 67.07 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.577 0.751 . . . . 70.430000000000007 111.563 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 13' ' ' VAL . 24.9 m -85.89 0.37 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.357 0.663 . . . . 72.140000000000001 112.035 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 62.43 15.02 7.41 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 125.149 1.38 . . . . 73.140000000000001 114.196 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.7 mt -90.81 159.82 16.08 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.325 0.65 . . . . 63.420000000000002 110.0 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -66.66 151.86 46.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.486 0.314 . . . . 73.209999999999994 110.882 169.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.1 t -52.67 -47.03 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 123.835 0.854 . . . . 75.140000000000001 112.064 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.456 ' HB3' HD12 ' B' ' 25' ' ' ILE . 46.2 mt-10 -59.78 -44.63 93.81 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.726 0.81 . . . . 74.430000000000007 112.277 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.0 m -62.58 -36.74 83.68 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.722 0.809 . . . . 64.209999999999994 111.855 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -70.49 -52.34 22.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.786 0.835 . . . . 74.400000000000006 110.936 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' HD13 ' A' ' 25' ' ' ILE . . . -59.98 -33.91 72.6 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.801 0.84 . . . . 72.319999999999993 112.302 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -51.24 49.5 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.184 0.994 . . . . 74.310000000000002 110.354 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.94 70.06 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.331 -0.85 . . . . 52.229999999999997 111.686 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.22 -38.82 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 115.581 -0.736 . . . . 65.109999999999999 110.939 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.28 -28.06 72.47 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-O 121.116 0.287 . . . . 73.409999999999997 112.877 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.491 ' NE1' ' HA2' ' A' ' 7' ' ' GLY . 77.0 t-105 -70.02 -41.53 74.17 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.099 0.96 . . . . 72.519999999999996 111.265 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 76.4 mt -67.01 -34.09 76.99 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.512 0.725 . . . . 63.25 111.619 175.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.33 -27.22 63.93 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.361 1.064 . . . . 51.219999999999999 113.326 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -58.77 -31.87 68.76 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 112.244 0.461 . . . . 74.219999999999999 112.244 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -122.02 26.67 8.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.663 1.185 . . . . 64.420000000000002 111.063 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 61.43 22.61 12.99 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.329 1.451 . . . . 74.140000000000001 114.117 169.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 61.9 mttm -74.09 -18.05 60.87 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.85 0.685 . . . . 73.200000000000003 112.85 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.16 150.77 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.473 0.709 . . . . 74.219999999999999 111.93 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 42.5 t -107.7 123.93 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.991 0.917 . . . . 75.209999999999994 108.904 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.437 HG23 HG23 ' A' ' 61' ' ' ILE . 48.6 mm -103.81 118.66 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.595 0.758 . . . . 72.540000000000006 111.106 -173.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -124.61 112.05 16.35 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.298 0.639 . . . . 75.209999999999994 111.138 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.462 ' HG2' HG12 ' A' ' 61' ' ' ILE . 56.7 mtt180 -81.25 98.01 7.91 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.567 0.699 . . . . 71.239999999999995 110.078 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -106.39 111.93 24.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.482 1.113 . . . . 63.049999999999997 109.601 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 60.72 32.35 20.23 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 124.605 1.162 . . . . 64.140000000000001 112.891 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.42 -11.57 67.61 Favored Glycine 0 CA--C 1.541 1.697 0 N-CA-C 114.041 0.377 . . . . 41.43 114.041 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.76 137.21 36.98 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.748 0.819 . . . . 71.540000000000006 110.329 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 56' ' ' ARG . 50.7 mt -87.41 129.3 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.808 0.443 . . . . 62.100000000000001 111.173 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.04 136.34 49.44 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.308 1.043 . . . . 73.209999999999994 110.37 -178.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.618 HD11 HG12 ' A' ' 25' ' ' ILE . 3.0 mp -113.59 115.94 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.219 0.608 . . . . 75.109999999999999 110.194 -169.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.733 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 80.6 m-85 -113.54 173.74 6.26 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.994 0.918 . . . . 72.310000000000002 110.542 175.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -98.8 162.03 13.32 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.384 0.674 . . . . 63.340000000000003 110.862 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 51' ' ' LYS . 36.1 tt0 -55.75 -35.23 65.96 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.505 1.122 . . . . 75.040000000000006 111.895 170.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.44 1.18 37.25 Favored Glycine 0 CA--C 1.547 2.059 0 N-CA-C 114.626 0.61 . . . . 72.510000000000005 114.626 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -73.26 -24.71 60.49 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.52 0.66 . . . . 73.049999999999997 110.893 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -69.53 166.03 19.77 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.11 0.564 . . . . 53.409999999999997 112.345 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -61.51 148.84 40.71 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.953 0.901 . . . . 63.200000000000003 112.63 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.27 -15.55 63.76 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.47 0.915 . . . . 62.119999999999997 113.47 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 t -73.4 -53.56 10.41 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.803 0.441 . . . . 74.549999999999997 111.156 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 59.33 111.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.695 1.198 . . . . 72.5 111.939 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.97 -6.18 51.13 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 114.744 0.658 . . . . 64.209999999999994 114.744 -177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.17 107.86 0.97 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.833 0.853 . . . . 72.400000000000006 110.809 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 63.23 17.81 10.5 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.569 1.148 . . . . 73.349999999999994 111.741 -177.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -123.62 22.11 9.16 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.787 0.835 . . . . 74.109999999999999 111.989 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -141.68 149.62 40.81 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.206 0.527 . . . . 75.420000000000002 111.559 171.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -138.47 161.24 37.51 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.564 1.146 . . . . 62.130000000000003 109.802 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -80.01 121.89 26.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.156 -1.053 . . . . 74.340000000000003 108.156 167.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -55.83 89.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.611 1.164 . . . . 72.340000000000003 113.899 -162.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 N--CA 1.487 1.375 0 C-N-CA 124.95 1.3 . . . . 73.109999999999999 109.868 174.983 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 120.659 0.266 . . . . 73.310000000000002 111.343 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -54.35 -33.29 58.75 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.65 1.18 . . . . 55.399999999999999 113.809 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -63.38 -38.24 90.38 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.846 0.858 . . . . 65.530000000000001 111.788 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -75.05 -31.77 61.38 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.449 0.7 . . . . 65.019999999999996 111.71 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.04 -54.09 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 122.697 0.399 . . . . 72.049999999999997 110.749 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -65.28 -26.2 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 122.864 0.466 . . . . 65.019999999999996 111.536 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.81 -39.97 96.99 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.282 0.364 . . . . 43.020000000000003 113.303 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.11 -36.97 69.59 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.73 0.812 . . . . 55.539999999999999 111.346 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -64.68 -40.61 95.71 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.589 -0.732 . . . . 73.310000000000002 110.583 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.502 ' HA ' ' HB1' ' B' ' 42' ' ' ALA . . . -72.06 -41.45 67.39 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.869 0.868 . . . . 71.209999999999994 111.435 -176.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.01 -50.07 66.93 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.783 -0.644 . . . . 60.340000000000003 112.464 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.548 ' HG3' ' HB ' ' B' ' 32' ' ' VAL . 18.0 tppt? -60.0 -45.88 91.31 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.437 1.095 . . . . 75.239999999999995 112.065 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.469 ' HA ' HG11 ' B' ' 32' ' ' VAL . 53.0 t -56.99 -46.99 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.094 0.558 . . . . 74.430000000000007 111.346 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.511 ' HA ' HD12 ' B' ' 17' ' ' LEU . 69.7 t90 -68.34 -35.76 78.24 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.302 0.641 . . . . 74.299999999999997 112.015 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -63.97 -33.08 74.92 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.604 0.362 . . . . 55.329999999999998 110.553 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.09 -32.45 69.08 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.906 0.482 . . . . 61.229999999999997 111.582 171.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' B' ' 14' ' ' TRP . 69.2 mt -72.57 -30.51 64.47 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.347 0.659 . . . . 74.209999999999994 111.227 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.49 -29.4 68.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.644 0.778 . . . . 73.010000000000005 111.048 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.45 -29.24 12.86 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.523 0.729 . . . . 72.439999999999998 111.303 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.7 88.88 1.0 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.439 0.696 . . . . 44.0 111.812 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -92.28 173.44 7.82 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.183 0.593 . . . . 74.109999999999999 111.652 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.55 64.53 2.81 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.278 -0.419 . . . . 71.019999999999996 112.316 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 tt -144.02 143.27 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.315 0.646 . . . . 72.540000000000006 110.787 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -60.58 139.8 57.64 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.856 0.863 . . . . 63.130000000000003 111.418 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 37' ' ' GLU . 71.8 mt -52.31 -46.22 94.39 Favored Pre-proline 0 CA--C 1.581 2.14 0 N-CA-C 114.386 1.254 . . . . 63.539999999999999 114.386 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.11 -24.78 14.49 Favored 'Trans proline' 0 C--N 1.399 3.223 0 CA-C-N 121.856 1.699 . . . . 64.200000000000003 113.989 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 33.7 tt0 -77.1 -46.34 23.9 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 122.04 0.924 . . . . 60.130000000000003 108.846 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -55.65 -39.87 71.45 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.321 1.448 . . . . 61.43 111.263 170.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.85 92.19 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.874 0.869 . . . . 54.140000000000001 112.323 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' B' ' 27' ' ' GLU . 21.9 ptt180 -73.96 -23.36 59.48 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.384 0.274 . . . . 75.030000000000001 110.782 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 27' ' ' GLU . 30.9 mmmt -78.41 -43.93 26.14 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.142 0.577 . . . . 73.25 111.06 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' B' ' 12' ' ' LYS . 23.6 m -87.16 3.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 112.954 0.724 . . . . 74.319999999999993 112.954 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 63.62 11.47 5.75 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 125.081 1.352 . . . . 74.219999999999999 113.904 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 74.2 mt -99.77 162.9 12.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.478 0.711 . . . . 73.439999999999998 111.071 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 16.7 m -66.0 155.59 36.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.561 0.744 . . . . 72.25 111.627 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.46 -49.83 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.488 0.715 . . . . 61.130000000000003 111.709 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.62 -43.65 84.94 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.121 0.969 . . . . 55.409999999999997 111.474 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 68.4 m -61.75 -37.56 84.74 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.957 0.903 . . . . 73.530000000000001 112.265 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.479 ' O ' HG23 ' B' ' 43' ' ' VAL . 97.3 m -72.26 -48.49 42.17 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.471 0.708 . . . . 74.140000000000001 111.241 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -59.24 -43.14 92.4 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.553 0.741 . . . . 54.549999999999997 112.573 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.06 -49.5 75.72 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.883 0.873 . . . . 71.010000000000005 109.963 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' B' ' 10' ' ' ALA . . . -57.96 -28.67 64.56 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.794 -1.094 . . . . 73.129999999999995 112.006 -178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.647 HG11 HD12 ' B' ' 63' ' ' ILE . 77.8 t -69.27 -38.33 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.139 0.576 . . . . 74.319999999999993 110.964 175.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.64 -30.58 77.67 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-O 121.077 0.265 . . . . 74.519999999999996 112.591 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -75.86 -26.37 57.05 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.662 0.785 . . . . 73.230000000000004 111.951 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.99 -35.25 62.03 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.207 0.527 . . . . 74.099999999999994 111.352 166.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.34 -34.15 77.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.304 1.042 . . . . 65.219999999999999 112.793 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -64.51 -34.95 79.42 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.922 0.392 . . . . 71.549999999999997 111.317 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.62 -2.52 56.27 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.737 0.815 . . . . 61.299999999999997 111.532 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . 0.542 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . 36.6 m-80 65.55 26.48 11.68 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.488 1.515 . . . . 73.040000000000006 112.43 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -95.36 -0.19 52.9 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.465 1.283 . . . . 75.420000000000002 114.465 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 17.6 m -127.95 151.5 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 118.566 0.621 . . . . 73.439999999999998 112.468 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.699 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 95.3 t -110.33 123.35 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.604 1.161 . . . . 74.430000000000007 108.465 168.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 76.0 mt -114.97 126.45 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.258 -0.645 . . . . 54.439999999999998 109.258 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . 0.588 ' HG3' ' HG3' ' B' ' 57' ' ' LYS . 10.6 tp10 -142.32 129.17 20.57 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.55 -0.75 . . . . 72.319999999999993 111.312 -169.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.404 ' HG2' HG12 ' B' ' 61' ' ' ILE . 92.7 mtt180 -95.12 98.86 10.95 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.51 0.672 . . . . 72.510000000000005 110.216 176.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.588 ' HG3' ' HG3' ' B' ' 55' ' ' GLU . 29.1 mtpp -105.48 123.39 47.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.346 -0.843 . . . . 74.040000000000006 109.476 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 59.11 29.48 19.05 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.077 1.351 . . . . 73.099999999999994 111.157 -171.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.54 -27.87 8.22 Favored Glycine 0 CA--C 1.543 1.83 0 CA-C-N 115.729 -0.669 . . . . 73.299999999999997 114.136 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.08 138.07 31.86 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.65 0.78 . . . . 55.140000000000001 111.795 -171.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.404 HG12 ' HG2' ' B' ' 56' ' ' ARG . 55.4 mt -79.56 136.42 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.926 0.891 . . . . 74.109999999999999 112.225 -177.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -121.19 131.99 54.57 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.175 0.99 . . . . 75.129999999999995 109.118 167.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.647 HD12 HG11 ' B' ' 43' ' ' VAL . 25.0 mm -91.69 109.25 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.369 0.668 . . . . 71.219999999999999 110.431 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.699 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 67.0 m-85 -97.72 169.24 9.82 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.6 1.16 . . . . 71.450000000000003 110.589 175.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -100.39 155.29 17.89 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.429 0.692 . . . . 74.409999999999997 110.934 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.63 -39.74 95.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.716 1.206 . . . . 74.329999999999998 111.158 173.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.16 58.4 3.62 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 121.191 0.328 . . . . 53.149999999999999 113.187 177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -143.4 -35.07 0.4 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.121 0.968 . . . . 73.019999999999996 109.496 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -102.17 24.05 10.74 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.246 0.618 . . . . 63.420000000000002 112.265 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -64.81 -12.82 52.11 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.295 1.22 . . . . 74.200000000000003 114.295 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.6 -28.69 45.76 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.168 0.587 . . . . 74.310000000000002 110.737 171.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 35.7 t -72.96 91.28 1.54 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.367 0.667 . . . . 63.039999999999999 109.559 171.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -74.49 82.68 1.98 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.608 0.763 . . . . 72.340000000000003 111.493 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -134.22 44.9 1.15 Allowed Glycine 0 CA--C 1.531 1.035 0 CA-C-N 114.934 -1.03 . . . . 71.400000000000006 111.339 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.16 7.63 37.02 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.146 0.978 . . . . 41.0 112.852 -173.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.96 121.11 15.38 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 118.506 0.594 . . . . 74.049999999999997 111.036 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -122.6 25.22 8.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.112 0.965 . . . . 73.409999999999997 111.15 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -69.02 86.24 0.36 Allowed 'General case' 0 CA--C 1.555 1.147 0 CA-C-O 121.588 0.709 . . . . 74.340000000000003 110.774 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -94.76 -179.43 4.86 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.989 0.916 . . . . 74.120000000000005 110.076 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -76.8 132.99 39.52 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.934 -0.395 . . . . 52.549999999999997 109.934 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -147.44 141.61 26.13 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.782 0.833 . . . . 73.400000000000006 110.348 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 N--CA 1.483 1.203 0 C-N-CA 123.428 0.691 . . . . 54.409999999999997 109.803 -177.998 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 120.966 0.412 . . . . 72.239999999999995 111.468 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -54.88 -32.69 61.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.218 1.407 . . . . 73.109999999999999 114.316 -174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -40.79 97.31 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.665 0.786 . . . . 74.439999999999998 112.203 -171.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -81.65 -25.78 35.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.477 0.311 . . . . 63.350000000000001 111.782 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.2 mt -64.44 -59.46 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.899 0.48 . . . . 71.310000000000002 110.694 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.53 -27.56 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.938 0.495 . . . . 62.520000000000003 111.764 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.76 -43.13 85.34 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.412 0.445 . . . . 44.350000000000001 113.283 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -46.36 80.97 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.644 0.778 . . . . 70.329999999999998 111.706 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -70.0 -27.95 65.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.972 -0.558 . . . . 60.32 112.362 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.58 76.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.24 0.616 . . . . 51.219999999999999 111.898 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.2 -37.65 94.88 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 116.074 -0.512 . . . . 64.400000000000006 113.071 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -76.61 -42.56 41.91 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 112.474 0.546 . . . . 42.039999999999999 112.474 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.592 HG12 HG21 ' A' ' 32' ' ' VAL . 26.0 m -64.56 -34.1 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 122.123 -0.36 . . . . 41.109999999999999 111.057 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.572 ' HA ' HD12 ' A' ' 17' ' ' LEU . 42.9 t90 -70.01 -33.28 71.81 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.086 0.555 . . . . 74.120000000000005 111.484 175.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -61.7 -39.14 90.41 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.127 0.571 . . . . 61.119999999999997 110.618 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.02 -32.53 70.72 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.49 0.716 . . . . 43.310000000000002 111.946 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 14' ' ' TRP . 75.5 mt -69.87 -35.37 74.62 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.878 0.871 . . . . 75.319999999999993 111.746 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.06 -25.82 65.54 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.938 0.495 . . . . 71.299999999999997 110.307 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.15 -46.86 19.48 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.737 0.815 . . . . 73.349999999999994 110.694 169.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.06 97.15 1.77 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.575 0.75 . . . . 74.129999999999995 111.417 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.12 172.46 10.56 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.324 0.65 . . . . 72.209999999999994 111.316 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.51 9.79 82.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 116.614 -0.266 . . . . 52.310000000000002 113.456 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 tt -77.83 158.19 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 124.33 1.052 . . . . 74.510000000000005 109.338 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 m -79.1 150.75 31.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.752 -0.592 . . . . 60.530000000000001 110.392 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.592 HG21 ' HB2' ' A' ' 40' ' ' ALA . 70.7 mt -54.75 -47.19 98.79 Favored Pre-proline 0 CA--C 1.578 2.057 0 N-CA-C 113.82 1.044 . . . . 72.140000000000001 113.82 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.94 -23.74 34.29 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 122.117 1.878 . . . . 74.319999999999993 113.961 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.47 -48.24 23.56 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.094 0.95 . . . . 62.210000000000001 108.984 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.431 HD22 HD11 ' A' ' 63' ' ' ILE . 64.5 tp -57.28 -38.62 74.21 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 113.324 -1.762 . . . . 60.520000000000003 111.613 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.9 -41.92 88.37 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.935 0.894 . . . . 32.0 111.774 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -66.06 -37.44 85.83 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.812 0.845 . . . . 73.430000000000007 111.695 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.14 -35.64 77.61 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.457 0.646 . . . . 64.349999999999994 111.706 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.592 HG21 HG12 ' A' ' 13' ' ' VAL . 29.7 m -105.15 5.38 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.71 0.804 . . . . 74.239999999999995 112.623 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 62.11 19.76 11.12 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 124.814 1.246 . . . . 73.030000000000001 114.05 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.4 mt -99.47 168.56 9.9 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.251 0.621 . . . . 62.030000000000001 110.615 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 t -75.89 157.02 33.76 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.762 0.425 . . . . 72.329999999999998 111.402 171.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 t -56.47 -44.14 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.076 0.95 . . . . 70.230000000000004 111.42 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.475 ' HB3' HD12 ' B' ' 25' ' ' ILE . 42.2 mt-10 -63.86 -39.41 94.14 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.039 0.936 . . . . 75.430000000000007 112.039 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.3 m -68.94 -35.39 76.72 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.663 0.785 . . . . 74.099999999999994 111.502 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 43' ' ' VAL . 99.5 m -76.97 -46.98 22.1 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.544 0.738 . . . . 63.039999999999999 111.893 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.592 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -59.31 -35.92 74.68 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 123.565 0.746 . . . . 75.319999999999993 111.737 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.451 HD11 HD13 ' B' ' 54' ' ' ILE . 0.9 OUTLIER -65.04 -49.73 68.99 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 114.908 -1.042 . . . . 44.5 110.181 174.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.56 70.21 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.645 0.778 . . . . 74.319999999999993 111.713 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 63' ' ' ILE . 53.5 t -68.27 -35.93 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.207 0.603 . . . . 72.310000000000002 110.495 173.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.654 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -63.96 -30.43 77.7 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 116.336 -0.393 . . . . 52.310000000000002 113.612 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.47 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 65.0 t-105 -70.62 -37.15 73.78 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.009 0.433 . . . . 75.239999999999995 110.923 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.17 -32.19 72.26 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 122.199 -0.313 . . . . 64.329999999999998 110.955 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.86 -31.05 71.78 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.672 0.789 . . . . 61.340000000000003 111.481 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.578 ' HA ' ' HD2' ' B' ' 48' ' ' ARG . 31.9 ttt180 -63.64 -50.62 68.6 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.985 0.514 . . . . 73.450000000000003 110.71 168.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -79.14 -2.02 38.8 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.171 0.988 . . . . 60.340000000000003 112.197 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 63.07 22.13 13.26 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.541 1.536 . . . . 75.400000000000006 112.688 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HB3' ' NE1' ' A' ' 14' ' ' TRP . 63.1 mttp -78.7 -18.65 54.0 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.391 1.076 . . . . 71.310000000000002 112.961 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.55 157.86 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 112.807 0.669 . . . . 63.030000000000001 112.807 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.62 HG23 ' HB2' ' A' ' 64' ' ' TYR . 7.3 m -129.78 120.22 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 124.694 1.198 . . . . 72.319999999999993 109.773 172.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.427 HG13 HG22 ' A' ' 63' ' ' ILE . 3.4 mp -96.95 107.38 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.636 0.774 . . . . 62.43 109.906 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -117.38 137.34 52.53 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.909 0.484 . . . . 74.310000000000002 111.469 -172.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -89.11 100.96 13.63 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.846 0.859 . . . . 72.329999999999998 110.212 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -107.64 119.35 39.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.702 0.801 . . . . 73.530000000000001 110.394 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 58.47 30.97 20.44 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.955 1.302 . . . . 72.519999999999996 112.268 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.07 -21.2 25.22 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-N 115.386 -0.825 . . . . 71.209999999999994 114.197 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.65 137.7 33.67 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.788 0.835 . . . . 73.319999999999993 111.266 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.06 114.25 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.59 0.756 . . . . 72.430000000000007 109.197 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.1 138.38 54.47 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.751 -0.833 . . . . 74.319999999999993 108.751 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.565 ' H ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -103.38 124.4 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 122.265 1.031 . . . . 73.140000000000001 110.669 -177.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.62 ' HB2' HG23 ' A' ' 53' ' ' VAL . 89.0 m-85 -109.72 171.24 7.56 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.191 1.396 . . . . 65.200000000000003 109.582 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -93.75 168.25 11.12 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.576 0.703 . . . . 74.219999999999999 112.11 175.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -61.75 -20.64 63.77 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.237 1.015 . . . . 72.349999999999994 111.837 170.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.23 0.89 44.94 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 116.007 -0.542 . . . . 74.319999999999993 113.997 173.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -63.94 -32.65 74.25 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.94 0.896 . . . . 75.019999999999996 110.8 173.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -109.81 173.17 6.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.935 0.894 . . . . 65.010000000000005 110.488 173.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -74.51 90.58 2.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.863 0.465 . . . . 64.140000000000001 110.122 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -77.21 -45.78 25.45 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 122.874 0.47 . . . . 74.010000000000005 110.876 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -68.75 164.34 22.0 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.722 0.809 . . . . 63.409999999999997 111.89 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.49 -17.31 28.89 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.392 0.677 . . . . 74.530000000000001 111.943 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.58 48.37 29.67 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 121.047 0.249 . . . . 70.540000000000006 113.534 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.7 mt -84.45 -12.2 54.79 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.804 0.841 . . . . 73.319999999999993 113.246 -170.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.99 111.18 8.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.875 0.47 . . . . 52.25 110.963 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -113.85 120.19 39.88 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.653 0.781 . . . . 74.519999999999996 109.738 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -83.53 113.86 21.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.975 0.51 . . . . 73.200000000000003 111.053 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -145.75 127.21 15.02 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.024 0.93 . . . . 73.319999999999993 109.548 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -77.58 -26.5 50.84 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.074 0.549 . . . . 71.400000000000006 111.102 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -101.74 134.23 45.23 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.168 0.987 . . . . 72.310000000000002 108.72 168.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.9 p80 . . . . . 0 N--CA 1.492 1.646 0 C-N-CA 123.899 0.88 . . . . 64.150000000000006 112.994 -173.774 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 CA--C 1.549 0.909 0 CA-C-O 120.46 0.171 . . . . 74.340000000000003 111.394 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' B' ' 4' ' ' LYS . 53.6 m-20 -90.67 128.41 36.62 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.234 0.54 . . . . 52.32 111.215 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -69.76 -26.06 64.12 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 124.223 1.009 . . . . 73.239999999999995 111.817 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' B' ' 2' ' ' ASP . 21.7 ptmt -65.5 -24.09 67.06 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 113.145 0.794 . . . . 73.329999999999998 113.145 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 73.5 mt -64.34 -52.75 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.208 0.603 . . . . 54.420000000000002 111.348 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.48 -26.81 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 122.846 0.459 . . . . 71.409999999999997 111.887 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.38 -45.81 88.93 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 123.44 0.462 . . . . 74.109999999999999 112.984 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.92 91.9 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.701 0.8 . . . . 63.340000000000003 111.802 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.38 -41.85 97.78 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.678 0.791 . . . . 61.32 110.935 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.92 -24.05 55.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.95 0.9 . . . . 64.329999999999998 112.533 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.22 -41.51 99.51 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 121.354 0.419 . . . . 32.350000000000001 112.65 172.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -70.65 -41.1 72.58 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.081 0.953 . . . . 71.299999999999997 111.293 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.501 HG13 HD21 ' B' ' 28' ' ' LEU . 77.4 t -60.98 -46.1 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.887 0.875 . . . . 70.439999999999998 112.092 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -71.84 -31.79 66.87 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 116.286 -0.415 . . . . 75.120000000000005 111.424 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -56.62 -37.75 71.13 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.744 0.418 . . . . 72.140000000000001 111.471 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.18 75.4 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.038 0.535 . . . . 65.310000000000002 111.84 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.632 HD21 HG13 ' B' ' 63' ' ' ILE . 93.8 mt -73.83 -37.63 64.79 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.963 0.905 . . . . 55.219999999999999 112.158 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -59.08 -39.33 81.82 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.699 0.8 . . . . 73.209999999999994 110.636 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -79.17 -48.56 14.04 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.538 -0.755 . . . . 71.319999999999993 111.134 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.31 99.5 3.15 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.201 0.6 . . . . 63.329999999999998 111.566 -173.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.01 174.55 10.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.2 0.6 . . . . 65.439999999999998 112.272 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.94 13.32 83.52 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.224 -0.444 . . . . 63.32 113.977 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.402 HG21 HD13 ' B' ' 28' ' ' LEU . 11.0 tp -78.06 138.52 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 C-N-CA 123.15 0.58 . . . . 71.319999999999993 110.9 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.4 m -84.61 151.32 24.58 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.936 0.494 . . . . 64.140000000000001 111.015 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' A' ' 37' ' ' GLU . 54.2 mt -53.56 -45.84 98.45 Favored Pre-proline 0 CA--C 1.581 2.165 0 N-CA-C 114.711 1.375 . . . . 63.149999999999999 114.711 -172.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' B' ' 36' ' ' VAL . 65.8 Cg_endo -71.29 -29.15 17.47 Favored 'Trans proline' 0 C--N 1.396 3.038 0 CA-C-N 121.803 1.68 . . . . 71.5 113.415 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -73.6 -49.21 27.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.157 0.98 . . . . 72.239999999999995 109.863 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.501 HD21 HG13 ' B' ' 13' ' ' VAL . 62.5 tp -53.93 -36.24 62.56 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 113.013 -1.903 . . . . 74.349999999999994 111.775 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.05 83.35 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.658 0.783 . . . . 70.510000000000005 112.108 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' B' ' 26' ' ' PRO . 10.3 mpt_? -70.94 -39.88 72.37 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.942 0.497 . . . . 75.120000000000005 110.593 175.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.61 -43.18 93.84 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.311 0.644 . . . . 71.319999999999993 111.233 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.4 -5.88 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.58 0.752 . . . . 74.439999999999998 112.247 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 66.12 21.15 11.19 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.79 1.236 . . . . 63.549999999999997 113.01 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 68.5 mt -108.72 169.39 8.69 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.862 0.865 . . . . 73.099999999999994 110.553 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -72.34 155.5 40.09 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.003 0.521 . . . . 62.210000000000001 111.003 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' B' ' 26' ' ' PRO . 96.4 t -56.74 -44.04 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 123.579 0.751 . . . . 32.210000000000001 112.364 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.39 -49.25 78.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.626 0.77 . . . . 65.200000000000003 111.861 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -61.73 -38.68 88.81 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.556 1.142 . . . . 71.150000000000006 111.914 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.485 ' O ' HG23 ' B' ' 43' ' ' VAL . 92.4 m -70.08 -46.75 64.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.116 0.966 . . . . 71.230000000000004 111.037 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.472 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -62.09 -35.41 78.59 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.745 0.818 . . . . 64.140000000000001 112.137 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -69.64 -37.78 76.91 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.3 1.04 . . . . 74.530000000000001 110.156 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.55 -34.78 77.75 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.208 0.603 . . . . 73.540000000000006 111.428 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.485 HG23 ' O ' ' B' ' 39' ' ' THR . 98.4 t -61.8 -33.94 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.251 0.621 . . . . 74.420000000000002 110.921 172.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.654 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -62.05 -30.45 75.59 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 116.155 -0.475 . . . . 63.240000000000002 114.011 176.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.426 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 70.6 t-105 -68.49 -38.91 81.42 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.937 0.495 . . . . 54.219999999999999 110.899 172.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 93.1 mt -70.01 -33.07 71.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.926 0.491 . . . . 70.129999999999995 111.299 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.22 -31.27 72.34 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.923 0.889 . . . . 62.329999999999998 111.589 170.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' A' ' 48' ' ' ARG . 15.3 ttt180 -65.74 -44.84 84.76 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.742 0.817 . . . . 74.040000000000006 111.322 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -80.05 -3.99 50.83 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.409 0.683 . . . . 74.209999999999994 112.451 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 62.11 21.92 12.75 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.27 1.428 . . . . 74.5 112.983 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -86.5 -4.06 59.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.067 0.947 . . . . 65.099999999999994 113.074 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.74 146.69 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 112.41 0.522 . . . . 61.219999999999999 112.41 -177.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.68 120.15 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.227 -1.027 . . . . 72.219999999999999 108.227 172.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.558 HG12 HG22 ' B' ' 63' ' ' ILE . 62.4 mt -106.99 111.88 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-O 121.341 0.591 . . . . 65.019999999999996 110.973 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -114.02 140.71 48.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.144 0.978 . . . . 72.230000000000004 110.636 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -113.51 103.28 11.11 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.503 0.721 . . . . 64.530000000000001 110.8 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.9 113.72 26.22 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.587 1.155 . . . . 62.130000000000003 108.829 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 60.04 30.47 19.95 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.093 0.957 . . . . 73.329999999999998 112.653 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.58 -10.35 62.23 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 113.942 0.337 . . . . 74.340000000000003 113.942 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 44.5 tp -84.21 128.88 34.84 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.001 0.92 . . . . 73.040000000000006 110.281 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.8 126.85 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.076 0.55 . . . . 51.520000000000003 109.827 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.94 120.64 36.96 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.038 -1.097 . . . . 73.230000000000004 108.038 173.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.632 HG13 HD21 ' B' ' 17' ' ' LEU . 34.1 pt -103.48 138.94 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.245 0.545 . . . . 70.530000000000001 110.557 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -121.49 179.07 4.56 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.459 1.104 . . . . 63.149999999999999 110.025 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.421 ' OD1' ' HB3' ' B' ' 17' ' ' LEU . 1.6 m-20 -82.15 160.55 23.07 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.051 -0.351 . . . . 73.0 110.051 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -53.3 98.96 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.374 0.67 . . . . 52.32 111.187 172.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.52 -36.29 0.07 OUTLIER Glycine 0 C--N 1.349 1.25 0 CA-C-N 116.293 -0.412 . . . . 73.299999999999997 112.925 -175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -74.91 -2.62 27.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 112.156 0.428 . . . . 74.420000000000002 112.156 173.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -65.58 -44.45 86.62 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.595 -0.521 . . . . 74.120000000000005 109.595 163.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.77 146.28 51.57 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.392 -0.822 . . . . 75.400000000000006 110.284 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -139.96 147.99 41.29 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.246 0.546 . . . . 74.299999999999997 111.47 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 88.1 p -102.14 -173.76 2.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.074 0.949 . . . . 73.340000000000003 109.252 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -75.85 94.96 3.41 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 109.475 -0.565 . . . . 75.140000000000001 109.475 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.89 94.36 0.15 Allowed Glycine 0 C--N 1.344 1.025 0 CA-C-N 116.193 -0.458 . . . . 15.24 112.025 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.14 102.98 5.13 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.321 0.649 . . . . 75.439999999999998 110.598 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' B' ' 77' ' ' HIS . 22.6 tt0 -78.9 174.91 11.02 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.269 0.628 . . . . 75.150000000000006 109.834 176.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.45 ' H ' ' HG2' ' B' ' 76' ' ' GLU . 31.4 p80 -52.44 139.05 25.94 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.328 0.651 . . . . 72.140000000000001 111.885 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -63.95 135.37 56.44 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.969 0.508 . . . . 64.430000000000007 110.0 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -60.4 145.11 49.19 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.407 0.683 . . . . 74.109999999999999 111.843 -170.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -53.45 119.73 5.2 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.204 1.002 . . . . 63.43 113.185 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -71.04 137.15 48.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.93 0.892 . . . . 74.030000000000001 110.577 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 45.2 m80 . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.621 0.724 . . . . 74.209999999999994 112.336 -178.283 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HE3' ' HB ' ' B' ' 54' ' ' ILE . 18.7 ptm . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 112.924 0.713 . . . . 75.129999999999995 112.924 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 64.45 89.46 0.09 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.036 1.334 . . . . 73.230000000000004 110.39 -173.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' B' ' 50' ' ' ASN . 62.2 tttm -70.28 -15.14 62.86 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.773 1.397 . . . . 75.209999999999994 114.773 -162.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -67.69 -14.49 62.99 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.837 0.68 . . . . 64.329999999999998 112.837 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.4 mt -49.15 -50.04 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 124.07 0.948 . . . . 62.200000000000003 112.215 173.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 3' ' ' LYS . 33.4 m -61.78 -28.02 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 112.436 0.532 . . . . 50.32 112.436 -177.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.52 -38.4 86.48 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 122.953 0.158 . . . . 32.439999999999998 113.073 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.59 -52.52 25.38 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.668 0.787 . . . . 62.340000000000003 111.785 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -59.26 -43.0 92.5 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.053 0.941 . . . . 55.409999999999997 112.155 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.4 -27.56 63.4 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.341 0.497 . . . . 70.420000000000002 112.341 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.79 -38.9 96.84 Favored Glycine 0 CA--C 1.538 1.485 0 O-C-N 123.332 0.395 . . . . 60.310000000000002 112.718 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -70.42 -43.82 69.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.502 0.721 . . . . 62.25 111.277 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.563 ' HA ' HG11 ' A' ' 32' ' ' VAL . 95.2 t -59.27 -42.75 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.433 0.693 . . . . 64.040000000000006 111.195 176.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 64.5 t90 -66.41 -32.98 74.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.851 0.86 . . . . 74.430000000000007 111.393 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -60.5 -53.73 53.98 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.068 0.147 . . . . 70.420000000000002 111.342 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.08 -30.91 71.94 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.172 0.589 . . . . 61.119999999999997 111.461 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.49 -50.71 50.32 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.99 1.316 . . . . 72.439999999999998 111.366 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.69 -23.87 59.87 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.361 0.664 . . . . 74.120000000000005 111.06 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -79.8 -37.06 36.04 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.393 1.077 . . . . 74.420000000000002 110.46 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.22 103.54 1.64 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.802 0.841 . . . . 61.219999999999999 110.705 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.674 ' HB2' ' HA ' ' A' ' 64' ' ' TYR . 10.7 p-10 -95.04 166.42 11.94 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.298 0.639 . . . . 72.150000000000006 112.148 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.68 64.16 1.11 Allowed Glycine 0 N--CA 1.473 1.133 0 CA-C-N 116.095 -0.502 . . . . 50.039999999999999 112.201 -175.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 tt -156.36 149.76 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 123.428 0.691 . . . . 71.030000000000001 111.116 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -86.17 158.58 19.72 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.232 0.613 . . . . 71.519999999999996 111.649 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.502 HG21 ' HB2' ' A' ' 40' ' ' ALA . 74.4 mt -53.68 -52.59 65.89 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 114.185 1.18 . . . . 55.109999999999999 114.185 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.0 -26.18 43.72 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 121.773 1.649 . . . . 71.129999999999995 114.188 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -76.22 -45.57 32.39 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.455 1.121 . . . . 54.149999999999999 109.423 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.9 tp -60.1 -34.35 73.36 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 113.284 -1.78 . . . . 60.439999999999998 111.973 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.66 95.36 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.007 0.923 . . . . 64.439999999999998 112.438 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -71.49 -27.94 63.57 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.856 0.462 . . . . 63.43 112.044 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -66.67 -52.28 46.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.222 0.534 . . . . 63.130000000000003 110.914 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.563 HG11 ' HA ' ' A' ' 13' ' ' VAL . 33.0 m -79.07 -5.87 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 115.184 -0.916 . . . . 52.420000000000002 111.838 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 69.28 16.35 8.42 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.239 1.415 . . . . 70.0 112.171 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.8 mt -97.23 164.21 12.58 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.555 0.742 . . . . 71.109999999999999 110.254 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -68.23 153.58 43.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.414 0.286 . . . . 70.120000000000005 111.323 172.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.68 -44.92 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 123.486 0.714 . . . . 61.299999999999997 111.887 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -60.25 -42.8 96.09 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.95 0.9 . . . . 54.0 111.797 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 t -64.91 -42.68 94.52 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.587 0.755 . . . . 54.340000000000003 111.369 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 43' ' ' VAL . 61.6 m -71.49 -37.9 71.24 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.805 0.842 . . . . 54.25 111.775 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.94 -44.86 88.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 123.747 0.819 . . . . 75.129999999999995 111.504 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 6' ' ' VAL . 1.3 tm? -64.33 -37.33 87.13 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.461 -1.245 . . . . 61.329999999999998 110.357 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.04 -36.48 72.36 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.371 0.669 . . . . 73.099999999999994 112.449 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 39' ' ' THR . 88.0 t -66.75 -36.81 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.097 0.559 . . . . 52.420000000000002 110.452 173.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.51 -31.97 82.57 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-N 116.099 -0.5 . . . . 74.510000000000005 112.709 172.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.457 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 75.6 t-105 -74.03 -27.97 61.2 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.33 0.652 . . . . 72.239999999999995 111.582 173.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.76 -34.6 67.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.534 -0.729 . . . . 74.209999999999994 111.593 172.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.54 -26.59 55.33 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.11 0.964 . . . . 64.310000000000002 113.147 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.814 ' HG3' ' HG3' ' A' ' 49' ' ' GLU . 7.2 ptm180 -56.22 -36.65 68.7 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.387 0.884 . . . . 71.219999999999999 113.387 -174.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.814 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 39.3 mt-10 -112.22 15.76 20.32 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.117 0.967 . . . . 64.010000000000005 111.24 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.42 47.65 8.57 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.428 1.091 . . . . 54.200000000000003 110.048 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -87.68 -14.6 39.46 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.736 0.643 . . . . 64.530000000000001 112.736 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 m -133.23 150.64 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.92 0.888 . . . . 71.109999999999999 111.933 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 64' ' ' TYR . 54.4 t -102.57 113.64 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.734 1.214 . . . . 60.200000000000003 108.772 171.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.458 HG23 HG23 ' A' ' 61' ' ' ILE . 50.4 mm -100.17 108.85 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 118.061 0.391 . . . . 73.200000000000003 110.983 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB3' ' NZ ' ' A' ' 57' ' ' LYS . 28.4 mm-40 -104.9 127.76 52.86 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.284 1.034 . . . . 72.019999999999996 110.356 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.535 HH22 ' HA ' ' B' ' 38' ' ' SER . 81.4 mtt-85 -113.61 105.55 13.47 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.872 -0.517 . . . . 71.25 111.529 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' NZ ' ' HB3' ' A' ' 55' ' ' GLU . 14.4 mptt -112.48 119.47 38.33 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.877 0.871 . . . . 61.43 109.843 176.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 57.97 32.61 22.19 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.148 0.979 . . . . 72.230000000000004 112.27 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.23 -6.39 72.15 Favored Glycine 0 CA--C 1.543 1.844 0 N-CA-C 114.269 0.468 . . . . 75.120000000000005 114.269 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.8 mt -88.24 125.66 34.76 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.602 0.761 . . . . 73.25 110.192 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.458 HG23 HG23 ' A' ' 54' ' ' ILE . 2.8 mp -86.01 126.31 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.512 0.725 . . . . 65.030000000000001 110.048 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -109.92 128.64 55.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.682 1.193 . . . . 74.140000000000001 108.9 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.9 mp -107.83 106.86 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 108.832 -0.803 . . . . 72.010000000000005 108.832 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.674 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 96.7 m-85 -107.55 167.16 10.14 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.573 1.149 . . . . 74.409999999999997 110.596 175.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -90.54 147.31 23.44 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.894 0.378 . . . . 71.310000000000002 110.873 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -85.05 5.03 31.21 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.075 0.464 . . . . 73.340000000000003 112.239 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.85 -58.51 11.74 Favored Glycine 0 C--N 1.351 1.363 0 N-CA-C 110.331 -1.108 . . . . 64.209999999999994 110.331 163.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -175.9 121.63 0.18 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.926 1.29 . . . . 64.040000000000006 109.573 166.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -68.71 145.65 53.66 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.106 0.562 . . . . 74.430000000000007 110.382 171.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -101.44 -58.85 1.8 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.061 0.457 . . . . 74.25 110.463 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -91.94 172.14 8.65 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.47 0.708 . . . . 73.519999999999996 111.957 -174.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.5 m -166.83 96.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.892 1.677 . . . . 52.329999999999998 108.182 166.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.621 ' HB2' HD22 ' A' ' 75' ' ' LEU . 16.6 p90 -129.22 -69.34 0.7 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 112.782 0.66 . . . . 73.510000000000005 112.782 -167.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 49.3 42.6 33.23 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 114.503 0.561 . . . . 52.109999999999999 114.503 -173.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 73' ' ' PHE . 2.0 pt? -103.46 142.56 34.04 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.252 0.549 . . . . 55.229999999999997 112.431 -171.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -170.18 142.07 2.19 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.014 1.326 . . . . 72.540000000000006 109.412 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -81.88 52.53 1.96 Allowed 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.548 0.69 . . . . 74.099999999999994 111.547 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -144.79 115.52 7.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.852 0.861 . . . . 71.439999999999998 110.116 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -78.46 175.58 10.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.888 0.875 . . . . 63.229999999999997 112.295 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -82.51 164.57 20.82 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.261 -0.881 . . . . 74.540000000000006 111.266 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -84.07 6.74 21.05 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 113.052 0.76 . . . . 73.420000000000002 113.052 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 N--CA 1.481 1.078 0 C-N-CA 123.666 0.787 . . . . 63.109999999999999 110.008 174.657 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 120.462 0.172 . . . . 74.430000000000007 110.877 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -54.28 -38.0 65.36 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.368 1.067 . . . . 73.310000000000002 112.754 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -23.96 62.17 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.925 -1.034 . . . . 74.219999999999999 111.417 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -91.68 -25.21 19.22 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.317 0.647 . . . . 61.109999999999999 112.112 175.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 75.2 mt -59.89 -46.19 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 122.97 0.508 . . . . 70.340000000000003 110.521 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.408 HG12 HD11 ' B' ' 41' ' ' LEU . 35.7 m -64.12 -30.95 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 122.884 0.473 . . . . 62.340000000000003 112.113 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.24 -41.54 59.34 Favored Glycine 0 CA--C 1.538 1.49 0 O-C-N 123.191 0.307 . . . . 73.329999999999998 113.174 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.76 -43.58 88.45 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.78 0.832 . . . . 53.25 111.469 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -65.55 -35.7 81.62 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.736 0.814 . . . . 63.439999999999998 111.27 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.45 70.96 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.164 0.586 . . . . 51.43 111.264 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.27 -36.87 92.32 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 116.299 -0.409 . . . . 74.140000000000001 112.57 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -63.97 -47.67 79.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.111 0.965 . . . . 65.319999999999993 111.878 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 75.8 t -62.32 -46.8 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.328 0.651 . . . . 62.409999999999997 111.153 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.571 ' HA ' HD12 ' B' ' 17' ' ' LEU . 17.9 t90 -64.02 -33.85 76.68 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.776 0.83 . . . . 74.409999999999997 111.436 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . 0.415 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 78.4 t60 -59.8 -47.99 83.48 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.974 0.509 . . . . 71.209999999999994 110.467 172.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.09 -26.84 68.73 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.23 0.612 . . . . 72.519999999999996 112.598 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' B' ' 14' ' ' TRP . 75.4 mt -68.84 -41.49 78.45 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.519 0.728 . . . . 63.43 111.166 172.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . 0.432 ' N ' HD22 ' B' ' 18' ' ' ASN . 0.8 OUTLIER -68.01 -26.13 65.74 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.882 -0.599 . . . . 72.140000000000001 110.996 175.093 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 10.4 mm-40 -73.6 -47.18 42.24 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.413 0.685 . . . . 61.039999999999999 110.533 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.9 106.63 0.61 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.238 1.015 . . . . 71.439999999999998 110.554 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -95.6 179.67 5.05 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.485 0.714 . . . . 72.430000000000007 112.118 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.76 39.3 34.38 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 116.191 -0.459 . . . . 53.219999999999999 112.493 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.402 ' O ' HG22 ' B' ' 63' ' ' ILE . 17.4 tt -124.29 153.45 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.954 0.902 . . . . 63.130000000000003 110.751 -172.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -80.29 151.56 29.48 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.801 0.441 . . . . 75.200000000000003 111.462 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' B' ' 40' ' ' ALA . 87.3 mt -51.04 -49.14 82.79 Favored Pre-proline 0 CA--C 1.577 1.991 0 N-CA-C 114.451 1.278 . . . . 74.099999999999994 114.451 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.477 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 59.9 Cg_endo -67.33 -30.17 37.31 Favored 'Trans proline' 0 C--N 1.393 2.89 0 C-N-CA 121.711 1.607 . . . . 71.219999999999999 114.135 -176.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -76.68 -44.17 34.8 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.229 1.014 . . . . 60.530000000000001 110.307 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.33 -40.19 74.02 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 113.427 -1.715 . . . . 72.420000000000002 111.287 171.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.82 -38.33 85.05 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.102 0.961 . . . . 65.239999999999995 112.505 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' B' ' 26' ' ' PRO . 14.7 mmm-85 -63.29 -44.1 96.01 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.4 0.68 . . . . 75.439999999999998 110.651 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -67.21 -43.27 82.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.864 0.866 . . . . 75.409999999999997 111.833 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.3 m -83.03 -5.27 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 122.875 0.47 . . . . 64.129999999999995 111.768 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 69.21 11.56 8.23 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.422 1.489 . . . . 60.450000000000003 112.682 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.7 mt -93.17 165.79 12.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.531 0.732 . . . . 71.450000000000003 110.019 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -65.94 153.55 41.77 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 122.239 -0.288 . . . . 72.439999999999998 110.59 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 54.9 t -49.88 -52.26 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.104 0.962 . . . . 45.039999999999999 112.171 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -71.12 -30.64 66.75 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.295 1.038 . . . . 74.340000000000003 111.436 -176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.535 ' HA ' HH22 ' A' ' 56' ' ' ARG . 41.7 m -64.97 -42.17 94.81 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.629 0.772 . . . . 73.409999999999997 110.775 173.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.449 ' O ' HG23 ' B' ' 43' ' ' VAL . 84.9 m -70.06 -43.19 71.72 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.103 0.961 . . . . 75.25 111.075 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.522 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -62.06 -42.66 99.43 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 123.975 0.91 . . . . 75.329999999999998 112.106 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.408 HD11 HG12 ' B' ' 6' ' ' VAL . 1.5 tm? -64.67 -38.26 90.39 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.698 1.199 . . . . 74.5 110.365 176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.92 72.07 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.548 0.739 . . . . 74.400000000000006 111.958 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 39' ' ' THR . 75.0 t -63.7 -35.68 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.481 0.713 . . . . 72.409999999999997 110.67 172.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.35 -31.24 80.08 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 116.29 -0.414 . . . . 44.020000000000003 113.41 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.499 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 43.6 t-105 -74.39 -31.24 62.28 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.229 0.612 . . . . 73.010000000000005 111.331 176.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.27 -36.29 68.97 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.29 0.636 . . . . 65.140000000000001 111.433 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.31 82.9 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.825 0.85 . . . . 73.209999999999994 110.8 172.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.562 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 31.2 ttt180 -51.84 -50.6 60.58 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.636 0.775 . . . . 64.239999999999995 111.064 171.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -80.01 -2.31 43.58 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.947 -1.024 . . . . 72.140000000000001 112.737 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . 0.533 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 57.2 m-20 64.75 26.63 13.05 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.754 1.222 . . . . 60.310000000000002 112.694 176.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -99.29 5.73 46.45 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.136 0.791 . . . . 61.100000000000001 113.136 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.492 ' HB ' HD11 ' B' ' 63' ' ' ILE . 28.5 m -135.31 156.8 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.398 0.618 . . . . 71.209999999999994 112.589 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 32.4 t -111.56 125.29 68.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 124.475 1.11 . . . . 72.439999999999998 109.262 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.432 ' HB ' ' HE3' ' A' ' 1' ' ' MET . 39.7 mm -111.83 103.42 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.42 -0.956 . . . . 74.019999999999996 108.42 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . 0.471 ' HB3' ' HE1' ' B' ' 64' ' ' TYR . 7.7 tp10 -118.86 115.79 25.15 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.938 0.399 . . . . 63.100000000000001 109.982 -173.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -84.69 107.05 16.69 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.544 0.687 . . . . 72.209999999999994 111.063 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -104.82 114.39 28.57 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.581 1.153 . . . . 62.009999999999998 109.912 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 58.44 32.44 22.11 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.063 0.945 . . . . 72.129999999999995 112.399 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.17 -20.02 31.88 Favored Glycine 0 CA--C 1.545 1.942 0 N-CA-C 114.06 0.384 . . . . 75.230000000000004 114.06 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 tt -88.41 138.34 31.52 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.456 1.102 . . . . 51.329999999999998 109.9 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -87.8 122.95 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.753 0.421 . . . . 62.43 111.704 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -108.45 127.08 53.59 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.089 0.956 . . . . 74.25 108.633 171.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.492 HD11 ' HB ' ' B' ' 52' ' ' VAL . 0.0 OUTLIER -104.75 121.91 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-O 121.887 0.851 . . . . 72.349999999999994 110.154 -176.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.62 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 45.3 m-85 -107.71 157.76 17.84 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.624 1.17 . . . . 73.120000000000005 110.141 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -85.16 162.97 19.01 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.039 0.536 . . . . 72.510000000000005 111.48 -175.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -52.99 121.8 8.09 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.227 1.011 . . . . 70.030000000000001 112.473 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.19 -71.9 0.28 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 111.551 -0.62 . . . . 74.140000000000001 111.551 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -93.49 73.62 4.43 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.318 0.647 . . . . 62.299999999999997 110.309 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.57 -38.39 55.03 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.521 0.728 . . . . 75.329999999999998 111.157 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.04 81.24 3.56 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.268 -0.641 . . . . 74.349999999999994 109.268 170.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.48 -46.46 76.23 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.81 -0.632 . . . . 73.120000000000005 110.662 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 73.4 p -87.56 108.94 19.29 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.398 -0.819 . . . . 65.239999999999995 110.208 170.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -81.08 80.5 7.53 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-O 121.586 0.708 . . . . 75.439999999999998 109.725 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.03 79.49 1.62 Allowed Glycine 0 C--N 1.354 1.56 0 CA-C-N 115.326 -0.852 . . . . 62.329999999999998 113.975 -170.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.06 -60.82 2.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.493 0.717 . . . . 72.25 111.287 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -91.17 29.25 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.031 0.92 . . . . 74.450000000000003 112.293 -173.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -72.65 105.15 4.15 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.026 -1.101 . . . . 73.409999999999997 108.026 166.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -52.44 130.49 31.65 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.188 0.995 . . . . 73.310000000000002 113.206 -168.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -147.05 155.8 42.5 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.19 0.996 . . . . 65.209999999999994 111.319 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -163.79 157.89 19.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.794 0.838 . . . . 73.409999999999997 110.173 173.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -129.17 164.35 23.58 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.591 0.757 . . . . 72.120000000000005 111.562 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 124.303 1.041 . . . . 74.530000000000001 111.153 -174.27 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.567 ' HG2' HD12 ' A' ' 5' ' ' ILE . 51.8 ttm . . . . . 0 CA--C 1.551 1.016 0 N-CA-C 109.986 -0.376 . . . . 74.349999999999994 109.986 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -54.99 146.58 17.49 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.549 1.14 . . . . 74.219999999999999 113.86 -175.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -78.13 -33.5 50.43 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.495 0.718 . . . . 54.509999999999998 112.815 -173.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 4' ' ' LYS . 11.2 mmpt? -67.04 -17.12 64.76 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 112.37 0.507 . . . . 72.540000000000006 112.37 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.567 HD12 ' HG2' ' A' ' 1' ' ' MET . 54.6 mt -65.28 -46.92 89.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.34 0.656 . . . . 71.140000000000001 111.579 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 3' ' ' LYS . 9.9 m -68.81 -27.55 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 118.057 0.39 . . . . 70.209999999999994 111.676 177.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.04 -42.52 94.56 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.557 0.536 . . . . 33.509999999999998 112.491 172.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.11 81.1 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.487 0.715 . . . . 75.219999999999999 111.24 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -61.73 -36.12 80.03 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.569 0.747 . . . . 75.109999999999999 111.161 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.93 -36.61 69.97 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.533 0.733 . . . . 63.149999999999999 111.615 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.86 -31.41 75.54 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-N 116.41 -0.359 . . . . 74.430000000000007 112.545 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.554 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 53.8 tptt -71.0 -42.28 69.83 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.442 1.097 . . . . 63.420000000000002 111.186 175.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.59 -40.7 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.993 0.917 . . . . 44.229999999999997 111.343 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 13.4 t90 -69.33 -33.53 73.25 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 116.018 -0.537 . . . . 73.349999999999994 110.399 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -57.13 -46.05 83.01 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.134 0.573 . . . . 72.209999999999994 110.744 168.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.36 -29.57 66.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.517 0.727 . . . . 73.25 112.481 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.12 -49.1 60.1 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.627 0.771 . . . . 41.539999999999999 112.083 172.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -67.56 -22.31 65.4 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.067 0.461 . . . . 35.229999999999997 111.303 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -76.2 -48.72 19.37 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.292 1.037 . . . . 72.540000000000006 109.614 174.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.24 97.4 0.34 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.753 1.221 . . . . 52.539999999999999 110.263 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.98 173.75 11.5 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.732 0.813 . . . . 73.400000000000006 112.258 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.04 61.38 4.03 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.765 -0.534 . . . . 62.530000000000001 111.765 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.11 159.08 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 123.153 0.581 . . . . 71.109999999999999 111.185 -166.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 58.8 m -79.47 153.28 29.74 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.844 0.354 . . . . 72.439999999999998 111.09 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.645 HG21 ' HB2' ' A' ' 40' ' ' ALA . 95.8 mt -53.56 -54.8 41.73 Favored Pre-proline 0 CA--C 1.576 1.956 0 C-N-CA 124.494 1.118 . . . . 44.350000000000001 112.245 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 55.9 Cg_endo -66.36 -25.19 49.35 Favored 'Trans proline' 0 C--N 1.401 3.301 0 C-N-CA 121.764 1.643 . . . . 73.239999999999995 113.741 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -70.63 -51.84 25.36 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.383 0.673 . . . . 75.109999999999999 112.501 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.61 -33.01 74.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.312 0.245 . . . . 73.109999999999999 110.381 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.14 -41.25 64.91 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.622 1.169 . . . . 61.210000000000001 112.645 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 26' ' ' PRO . 46.9 mtt180 -62.62 -41.18 98.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.927 0.891 . . . . 72.25 111.553 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -72.61 -43.24 63.57 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.731 0.813 . . . . 75.430000000000007 111.243 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.554 ' HB ' ' HG3' ' A' ' 12' ' ' LYS . 26.2 m -85.69 -0.47 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 115.465 -0.789 . . . . 75.430000000000007 112.26 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.6 m120 67.08 11.21 8.26 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.897 1.279 . . . . 72.439999999999998 113.229 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.5 mt -89.24 148.01 23.83 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.374 -0.602 . . . . 63.229999999999997 109.374 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.3 t -63.25 153.4 34.84 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.45 0.3 . . . . 32.240000000000002 110.952 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.45 -42.44 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 123.278 0.631 . . . . 75.420000000000002 111.333 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.53 -43.39 98.94 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.417 0.687 . . . . 61.340000000000003 112.338 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.4 m -62.09 -33.02 73.65 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 123.302 0.641 . . . . 73.430000000000007 111.707 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 43' ' ' VAL . 79.0 m -77.4 -53.06 8.11 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.763 0.825 . . . . 71.010000000000005 111.641 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -59.73 -41.75 91.6 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.416 1.087 . . . . 43.109999999999999 112.884 -177.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -65.49 -39.02 91.42 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.405 1.082 . . . . 63.130000000000003 110.407 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.17 -31.12 69.53 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 123.241 0.616 . . . . 64.120000000000005 112.016 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 39' ' ' THR . 87.2 t -61.02 -38.13 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 123.765 0.826 . . . . 61.32 110.354 171.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -64.94 -32.03 82.88 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.794 -0.639 . . . . 75.299999999999997 113.943 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.437 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 70.8 t-105 -70.31 -37.38 74.73 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.059 0.457 . . . . 73.409999999999997 110.708 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.54 -35.63 79.44 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.774 0.43 . . . . 71.129999999999995 111.047 172.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.67 88.91 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.513 0.725 . . . . 74.040000000000006 111.421 172.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 22.7 ttt180 -55.61 -49.91 71.54 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.799 0.84 . . . . 62.0 111.128 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -78.4 -6.02 54.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.755 0.822 . . . . 71.420000000000002 111.718 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 62.07 22.87 13.42 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.601 1.56 . . . . 42.020000000000003 112.462 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -78.28 -5.63 52.61 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.458 1.103 . . . . 55.310000000000002 113.41 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 63' ' ' ILE . 25.6 m -133.14 151.98 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.171 0.589 . . . . 61.340000000000003 112.294 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 64' ' ' TYR . 17.3 m -123.27 121.04 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 C-N-CA 124.108 0.963 . . . . 55.100000000000001 109.014 169.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.532 HG12 HD11 ' B' ' 41' ' ' LEU . 3.6 mp -100.99 124.29 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 109.154 -0.684 . . . . 62.520000000000003 109.154 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.42 148.59 44.92 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.253 0.621 . . . . 72.109999999999999 112.16 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -100.61 112.63 25.04 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.446 0.699 . . . . 71.519999999999996 110.267 171.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -105.44 112.77 26.0 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.846 0.859 . . . . 71.400000000000006 108.942 173.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 55.88 30.77 16.52 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.631 1.172 . . . . 73.230000000000004 112.067 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.96 -27.2 13.48 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 115.431 -0.804 . . . . 54.119999999999997 113.986 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.31 132.3 42.93 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.781 0.832 . . . . 73.040000000000006 111.394 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.0 mt -89.7 123.98 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.449 0.699 . . . . 65.209999999999994 111.511 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -127.58 139.05 53.01 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.458 1.103 . . . . 73.349999999999994 109.748 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.46 HD11 HG11 ' A' ' 52' ' ' VAL . 6.1 tt -95.07 136.34 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.287 0.635 . . . . 73.340000000000003 110.533 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.56 ' HB2' HG23 ' A' ' 53' ' ' VAL . 98.8 m-85 -130.37 169.39 15.54 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.546 1.138 . . . . 64.530000000000001 110.374 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.54 155.43 20.49 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.425 0.69 . . . . 71.030000000000001 110.264 171.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -173.01 1.0 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 120.935 0.398 . . . . 73.219999999999999 111.86 169.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.33 25.89 71.77 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 116.612 -0.267 . . . . 43.240000000000002 112.903 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -111.27 -49.71 2.99 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.117 0.967 . . . . 73.420000000000002 109.626 176.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -92.26 123.85 35.9 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.375 0.67 . . . . 74.540000000000006 110.006 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.13 124.61 28.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.783 0.833 . . . . 73.219999999999999 112.202 -170.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -79.44 145.93 33.04 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.169 0.588 . . . . 73.519999999999996 110.42 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 t 66.6 29.99 8.59 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.63 1.172 . . . . 62.43 111.357 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -113.46 1.89 15.21 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.806 0.842 . . . . 73.230000000000004 111.38 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.28 -84.26 0.35 Allowed Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.993 -0.843 . . . . 54.200000000000003 110.993 -172.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.7 mt 71.68 -50.39 0.69 Allowed 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 125.822 1.649 . . . . 74.200000000000003 113.979 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -62.53 120.43 11.11 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.744 0.818 . . . . 64.450000000000003 111.704 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -117.06 135.18 53.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.361 1.064 . . . . 73.430000000000007 108.514 169.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -60.15 106.72 0.55 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.176 0.59 . . . . 72.420000000000002 110.827 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -64.9 157.19 28.67 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.638 . . . . 73.530000000000001 111.867 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -75.11 121.33 21.89 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.023 -0.535 . . . . 71.319999999999993 110.562 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -77.06 93.22 3.83 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.814 0.846 . . . . 64.209999999999994 110.074 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.6 t60 . . . . . 0 N--CA 1.483 1.203 0 C-N-CA 124.375 1.07 . . . . 74.310000000000002 111.486 -179.222 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 CA--C 1.55 0.945 0 N-CA-C 112.086 0.402 . . . . 74.129999999999995 112.086 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -144.2 154.42 43.11 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.61 0.764 . . . . 53.32 111.09 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -80.9 -25.87 37.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.166 0.586 . . . . 65.200000000000003 112.21 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -65.25 -20.25 66.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.302 -0.249 . . . . 71.209999999999994 111.603 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.58 -59.55 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.084 0.554 . . . . 75.310000000000002 110.91 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.66 -29.84 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 111.842 0.312 . . . . 74.420000000000002 111.842 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.29 -47.5 63.48 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.366 0.416 . . . . 70.400000000000006 113.138 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.68 96.61 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.935 0.894 . . . . 43.020000000000003 111.296 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.57 -42.26 87.31 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.636 -0.711 . . . . 73.219999999999999 111.581 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.72 -35.32 72.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.089 0.556 . . . . 64.450000000000003 112.105 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.66 -38.13 95.26 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 116.332 -0.394 . . . . 61.240000000000002 112.994 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -75.72 -42.45 50.67 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.744 0.818 . . . . 74.109999999999999 110.943 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.572 ' HA ' HG11 ' B' ' 32' ' ' VAL . 34.3 t -62.78 -48.05 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.384 1.074 . . . . 65.310000000000002 111.47 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.436 ' NE1' ' HB3' ' B' ' 51' ' ' LYS . 48.3 t90 -64.92 -35.12 80.13 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.024 0.53 . . . . 65.349999999999994 111.735 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . 0.451 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 38.9 t60 -65.4 -46.79 78.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.567 0.347 . . . . 70.349999999999994 110.419 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.15 62.51 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.37 0.668 . . . . 73.129999999999995 112.149 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.408 HD13 ' ND2' ' B' ' 65' ' ' ASN . 1.4 tm? -72.87 -31.77 64.95 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.569 1.148 . . . . 64.409999999999997 110.397 171.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.68 -36.46 73.32 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.569 -0.53 . . . . 65.129999999999995 109.569 175.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 12.3 mm-40 -72.49 -49.88 29.89 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.326 0.65 . . . . 73.129999999999995 110.617 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.8 86.75 2.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.013 0.925 . . . . 73.329999999999998 110.206 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -68.67 124.61 24.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.633 0.773 . . . . 54.5 111.778 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.61 63.07 2.4 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.451 -0.34 . . . . 62.329999999999998 112.389 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.6 tp -117.3 137.96 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.594 0.758 . . . . 71.230000000000004 110.764 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -67.68 147.75 52.25 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.563 0.745 . . . . 73.329999999999998 110.901 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.523 HG21 ' HB2' ' B' ' 40' ' ' ALA . 60.8 mt -56.99 -49.89 91.35 Favored Pre-proline 0 CA--C 1.58 2.119 0 N-CA-C 113.422 0.897 . . . . 61.350000000000001 113.422 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.63 -27.38 32.48 Favored 'Trans proline' 0 C--N 1.399 3.203 0 C-N-CA 121.799 1.666 . . . . 65.310000000000002 114.026 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -70.91 -52.68 18.57 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.067 0.937 . . . . 71.239999999999995 109.245 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.446 HD21 HG13 ' B' ' 13' ' ' VAL . 60.6 tp -54.56 -38.34 66.53 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 113.249 -1.796 . . . . 73.519999999999996 112.15 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.72 -45.14 93.08 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.993 0.917 . . . . 63.039999999999999 111.915 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -67.7 -37.71 82.65 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.23 0.612 . . . . 74.340000000000003 110.861 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -64.12 -30.01 71.1 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.781 0.832 . . . . 61.450000000000003 112.243 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' B' ' 13' ' ' VAL . 34.1 m -103.09 1.91 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 112.769 0.655 . . . . 74.120000000000005 112.769 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 64.3 27.79 13.79 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 124.868 1.267 . . . . 63.32 113.132 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 72.4 mt -113.18 166.54 11.35 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.752 0.821 . . . . 74.120000000000005 111.448 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 31.6 t -69.43 155.74 39.96 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.664 -0.698 . . . . 63.310000000000002 111.61 170.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 67.8 t -56.37 -42.39 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.586 0.754 . . . . 72.420000000000002 111.033 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.83 -47.31 86.24 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.005 0.922 . . . . 65.420000000000002 111.457 175.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 41.5 t -63.72 -38.09 89.79 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.106 0.963 . . . . 72.430000000000007 112.089 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.46 ' O ' HG23 ' B' ' 43' ' ' VAL . 94.1 m -75.12 -49.44 19.59 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.863 0.865 . . . . 74.540000000000006 111.866 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.523 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -60.25 -39.59 87.28 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.69 0.796 . . . . 63.119999999999997 112.257 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.532 HD11 HG12 ' A' ' 54' ' ' ILE . 1.2 tt -62.2 -48.71 78.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.182 0.993 . . . . 74.030000000000001 110.064 173.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.72 -29.99 68.5 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.98 -1.009 . . . . 64.019999999999996 112.116 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.616 HG11 HD12 ' B' ' 63' ' ' ILE . 72.8 t -68.84 -37.17 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 123.061 0.544 . . . . 73.340000000000003 110.768 176.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -68.9 -30.25 72.43 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 116.431 -0.349 . . . . 32.299999999999997 112.79 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.456 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 72.6 t-105 -73.67 -21.07 60.38 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.304 0.642 . . . . 70.349999999999994 110.991 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.72 -33.8 58.15 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.645 0.778 . . . . 52.140000000000001 112.29 167.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.76 -25.53 60.61 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.057 1.132 . . . . 71.129999999999995 114.057 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.582 ' HG3' ' HG3' ' B' ' 49' ' ' GLU . 35.7 ptt85 -61.75 -36.38 80.85 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.036 0.446 . . . . 70.310000000000002 111.878 174.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.582 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 41.0 mt-10 -96.37 -2.7 45.13 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.35 1.06 . . . . 64.25 111.344 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 63.55 20.55 12.3 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 125.395 1.478 . . . . 70.129999999999995 113.065 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.436 ' HB3' ' NE1' ' B' ' 14' ' ' TRP . 49.5 mtmt -75.46 -8.18 56.04 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.378 0.881 . . . . 74.230000000000004 113.378 -173.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -128.57 151.58 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.915 0.886 . . . . 71.409999999999997 110.693 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.606 HG23 ' HB2' ' B' ' 64' ' ' TYR . 8.3 m -123.95 123.61 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.166 0.986 . . . . 62.43 109.884 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.582 HG23 HG23 ' B' ' 61' ' ' ILE . 1.9 mp -91.3 119.77 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.224 1.01 . . . . 72.239999999999995 109.616 -176.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -116.98 136.55 52.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.348 0.659 . . . . 75.010000000000005 110.156 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -98.58 108.46 21.16 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.857 0.463 . . . . 71.129999999999995 111.297 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -104.88 109.33 21.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.924 0.89 . . . . 72.120000000000005 109.455 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 61.18 30.29 19.23 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.053 1.341 . . . . 74.209999999999994 112.25 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.96 -18.42 56.03 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 113.796 0.279 . . . . 43.219999999999999 113.796 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mp -89.84 149.11 22.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.935 0.894 . . . . 75.219999999999999 110.394 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.582 HG23 HG23 ' B' ' 54' ' ' ILE . 27.1 mm -92.66 134.94 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.596 0.358 . . . . 64.219999999999999 111.278 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -123.19 133.16 54.25 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.607 -0.886 . . . . 73.129999999999995 108.607 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.616 HD12 HG11 ' B' ' 43' ' ' VAL . 25.5 mm -93.15 119.46 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.421 0.688 . . . . 74.140000000000001 110.016 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.606 ' HB2' HG23 ' B' ' 53' ' ' VAL . 57.0 m-85 -113.73 169.33 9.06 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.856 0.862 . . . . 75.299999999999997 110.688 175.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.408 ' ND2' HD13 ' B' ' 17' ' ' LEU . 5.8 m120 -79.99 154.38 28.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.533 0.733 . . . . 63.140000000000001 110.469 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -53.52 139.13 32.15 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.574 0.702 . . . . 62.539999999999999 112.061 172.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.82 -142.57 14.01 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 114.396 -1.274 . . . . 75.519999999999996 110.893 -171.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.431 ' CD2' HG21 ' B' ' 53' ' ' VAL 0.258 10.7 p80 39.27 -53.48 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 127.287 2.235 . . . . 70.340000000000003 114.646 -158.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -59.21 143.7 48.22 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.618 0.767 . . . . 75.219999999999999 110.721 158.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.43 142.51 32.71 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.354 0.662 . . . . 72.25 110.086 175.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.97 127.12 29.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.623 0.769 . . . . 75.030000000000001 111.511 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.9 t 78.78 -28.95 0.15 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.839 1.656 . . . . 74.150000000000006 112.785 -173.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 54.1 t80 74.11 -27.08 0.19 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.974 1.709 . . . . 75.420000000000002 113.374 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.27 4.29 3.66 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.373 0.511 . . . . 62.020000000000003 112.637 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.84 136.94 38.15 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.151 0.58 . . . . 65.400000000000006 110.388 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.59 89.82 2.23 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.848 0.859 . . . . 63.399999999999999 111.835 -177.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -90.64 88.23 7.03 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.503 -0.925 . . . . 72.209999999999994 108.503 170.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -70.02 81.75 0.49 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.994 0.918 . . . . 75.140000000000001 111.826 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -145.41 -41.23 0.23 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.853 1.261 . . . . 61.439999999999998 109.882 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -154.97 156.97 36.98 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.844 0.857 . . . . 75.219999999999999 110.497 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -80.02 162.45 24.86 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.555 0.742 . . . . 62.420000000000002 111.595 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 123.714 0.806 . . . . 73.030000000000001 110.015 -177.18 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.574 ' HB2' ' HG3' ' B' ' 55' ' ' GLU . 62.0 ttp . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 120.312 0.101 . . . . 72.430000000000007 110.958 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -124.76 144.15 50.4 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.762 0.825 . . . . 74.209999999999994 110.459 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.474 ' O ' HG22 ' A' ' 6' ' ' VAL . 37.1 ttmt -82.08 -45.09 15.7 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.656 0.782 . . . . 74.129999999999995 112.081 -178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -68.32 -11.0 58.79 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.887 0.699 . . . . 65.109999999999999 112.887 -173.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.4 mt -44.69 -59.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 123.547 0.739 . . . . 63.32 111.101 166.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 3' ' ' LYS . 34.0 m -65.67 -27.16 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 112.507 0.558 . . . . 64.409999999999997 112.507 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.49 -42.67 88.63 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 120.899 0.166 . . . . 61.130000000000003 112.718 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.57 84.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.002 0.921 . . . . 61.340000000000003 111.301 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -60.21 -47.76 84.61 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.098 0.959 . . . . 72.219999999999999 111.289 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.78 -29.81 64.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.525 0.73 . . . . 63.200000000000003 112.168 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.45 -40.77 99.12 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.231 0.332 . . . . 72.120000000000005 112.873 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 60.3 tttp -75.87 -37.91 58.44 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.592 0.757 . . . . 63.130000000000003 111.931 177.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.599 ' HA ' HG11 ' A' ' 32' ' ' VAL . 60.0 t -61.23 -48.59 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 123.487 0.715 . . . . 65.510000000000005 111.586 177.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.46 ' HA ' HD12 ' A' ' 17' ' ' LEU . 30.6 t90 -65.65 -39.01 90.94 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.667 -0.697 . . . . 73.230000000000004 111.311 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -60.62 -38.64 85.43 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.204 0.602 . . . . 62.340000000000003 111.151 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.82 -23.2 63.27 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.419 0.687 . . . . 75.120000000000005 112.257 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 14' ' ' TRP . 70.2 mt -70.54 -44.88 66.6 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.332 0.653 . . . . 64.219999999999999 111.318 169.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -61.0 -32.79 72.36 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.002 0.521 . . . . 73.349999999999994 111.425 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.61 -52.31 32.92 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.383 0.673 . . . . 64.420000000000002 110.551 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.86 102.29 0.56 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.52 0.728 . . . . 63.450000000000003 111.206 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -97.12 -175.13 3.15 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.763 0.825 . . . . 72.019999999999996 110.819 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.05 49.85 7.27 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.365 -0.694 . . . . 75.409999999999997 111.365 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.4 tt -139.33 159.57 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.238 -0.981 . . . . 72.200000000000003 110.867 -163.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.9 m -72.99 146.28 46.1 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.66 0.384 . . . . 74.230000000000004 110.819 171.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 40' ' ' ALA . 70.6 mt -55.96 -46.06 99.81 Favored Pre-proline 0 CA--C 1.58 2.106 0 C-N-CA 124.126 0.97 . . . . 74.310000000000002 112.998 176.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.494 ' HA ' HG22 ' A' ' 36' ' ' VAL . 35.7 Cg_endo -62.54 -29.43 78.38 Favored 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 122.19 1.926 . . . . 53.020000000000003 114.524 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -74.75 -46.62 36.05 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 122.39 1.09 . . . . 72.540000000000006 110.146 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.468 HD22 HG21 ' A' ' 63' ' ' ILE . 58.2 tp -58.45 -38.18 76.98 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 113.259 -1.791 . . . . 73.439999999999998 111.6 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.15 -37.74 75.24 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.237 1.015 . . . . 73.329999999999998 112.345 177.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -67.67 -38.27 83.5 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.415 0.686 . . . . 74.129999999999995 111.712 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 28' ' ' LEU . 42.4 mtmt -69.12 -38.4 78.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.217 0.607 . . . . 52.310000000000002 111.367 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 13' ' ' VAL . 32.3 m -90.86 -1.68 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.731 0.641 . . . . 75.219999999999999 112.731 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 68.09 9.89 7.47 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.175 1.39 . . . . 73.409999999999997 112.46 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.5 mt -95.86 167.55 11.18 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.347 0.659 . . . . 65.329999999999998 111.409 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.5 t -66.47 149.51 50.32 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.661 0.784 . . . . 73.420000000000002 110.845 168.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 26' ' ' PRO . 55.6 t -55.14 -41.81 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.276 0.56 . . . . 72.349999999999994 110.921 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HB3' HD12 ' B' ' 25' ' ' ILE . 42.7 mt-10 -64.65 -39.06 93.03 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.37 1.068 . . . . 63.350000000000001 112.574 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 64.2 p -75.56 -26.56 58.06 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 122.616 0.367 . . . . 65.150000000000006 111.982 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 43' ' ' VAL . 84.9 m -78.57 -43.47 26.46 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.418 0.687 . . . . 63.420000000000002 111.178 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.38 -36.86 85.52 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.376 0.671 . . . . 71.030000000000001 111.263 175.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.511 HD11 HG21 ' B' ' 54' ' ' ILE . 1.0 OUTLIER -58.3 -53.22 60.77 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.512 1.125 . . . . 74.120000000000005 109.94 170.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.86 -31.29 71.55 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.917 -1.038 . . . . 73.519999999999996 111.721 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 39' ' ' THR . 41.7 t -65.86 -37.98 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.565 0.746 . . . . 74.439999999999998 110.687 173.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.48 -31.74 81.21 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-N 116.753 -0.203 . . . . 63.119999999999997 113.499 172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.549 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 66.7 t-105 -73.55 -31.07 63.45 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.656 0.782 . . . . 74.299999999999997 111.47 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.31 -38.83 63.23 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.267 0.627 . . . . 73.040000000000006 111.317 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.54 81.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.37 1.068 . . . . 74.109999999999999 112.317 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.618 ' HB2' ' HD2' ' B' ' 48' ' ' ARG . 9.7 ptt180 -62.65 -34.19 76.57 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 121.196 0.522 . . . . 74.420000000000002 110.543 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -85.97 -1.43 57.32 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.233 1.013 . . . . 64.219999999999999 111.898 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 65.3 22.2 12.06 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.26 1.424 . . . . 75.310000000000002 112.301 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.36 -8.41 50.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 113.078 0.77 . . . . 63.409999999999997 113.078 -173.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.633 ' HB ' HD11 ' A' ' 63' ' ' ILE . 30.2 m -132.15 157.1 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.023 0.529 . . . . 72.420000000000002 112.07 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 64' ' ' TYR . 11.9 m -128.63 123.99 60.63 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 123.83 0.852 . . . . 72.530000000000001 110.41 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.18 125.03 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.848 0.859 . . . . 65.019999999999996 110.075 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -99.66 122.36 42.57 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.05 0.54 . . . . 73.310000000000002 110.976 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.477 ' HG2' HG12 ' A' ' 61' ' ' ILE . 79.2 mtt85 -106.23 98.56 8.22 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.792 0.837 . . . . 74.430000000000007 110.111 173.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -127.59 128.67 45.97 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.596 0.758 . . . . 72.519999999999996 109.617 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 59.14 29.69 19.3 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.7 1.2 . . . . 75.430000000000007 112.137 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.19 1.83 64.97 Favored Glycine 0 CA--C 1.549 2.214 0 CA-C-N 116.05 -0.523 . . . . 63.520000000000003 114.224 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.4 mt -93.89 131.79 38.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.692 0.797 . . . . 53.439999999999998 111.19 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.477 HG12 ' HG2' ' A' ' 56' ' ' ARG . 72.4 mt -101.77 116.97 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 72.349999999999994 110.62 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -121.66 133.28 54.96 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.175 0.99 . . . . 72.310000000000002 109.828 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.633 HD11 ' HB ' ' A' ' 52' ' ' VAL . 7.0 tp -97.29 117.05 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 CA-C-O 121.801 0.81 . . . . 74.019999999999996 111.614 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.482 ' HB2' HG23 ' A' ' 53' ' ' VAL . 77.1 m-85 -109.07 165.88 11.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.957 1.303 . . . . 73.439999999999998 110.341 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.32 142.15 28.1 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.698 -0.853 . . . . 74.439999999999998 108.698 175.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -55.32 135.84 49.65 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.831 0.853 . . . . 72.430000000000007 111.98 -176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.35 -27.15 6.15 Favored Glycine 0 N--CA 1.476 1.321 0 CA-C-N 116.242 -0.435 . . . . 72.140000000000001 112.782 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -135.88 111.04 8.95 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.428 0.691 . . . . 64.209999999999994 111.158 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -147.12 21.3 1.23 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.878 1.271 . . . . 64.209999999999994 110.169 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -83.28 43.04 0.85 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.736 0.814 . . . . 74.230000000000004 111.609 -172.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 57.09 92.71 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.975 1.31 . . . . 75.219999999999999 113.11 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.1 t -52.3 99.62 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.286 0.634 . . . . 71.310000000000002 110.911 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -72.09 95.9 1.69 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.996 0.918 . . . . 74.150000000000006 111.283 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.05 70.52 0.24 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.728 -0.669 . . . . 54.32 111.934 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.36 89.22 6.56 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.093 0.949 . . . . 62.32 111.314 -177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -111.87 135.52 52.38 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.068 1.347 . . . . 74.140000000000001 109.91 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -87.32 62.76 7.39 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.828 0.823 . . . . 34.299999999999997 109.582 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -72.13 136.63 46.58 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.743 -1.117 . . . . 73.530000000000001 110.049 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -61.12 107.85 0.8 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.11 0.564 . . . . 74.340000000000003 110.457 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -147.3 128.78 14.97 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.59 0.756 . . . . 71.340000000000003 110.415 -175.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -72.41 125.26 26.96 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.192 0.597 . . . . 65.120000000000005 111.393 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.4 p80 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.849 0.833 . . . . 72.140000000000001 111.675 -178.416 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptm . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 120.807 0.337 . . . . 72.219999999999999 111.15 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.94 -28.41 62.42 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.958 0.903 . . . . 64.120000000000005 112.011 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.94 -23.69 58.36 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.335 0.654 . . . . 70.109999999999999 112.634 -173.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -87.87 -22.74 24.25 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 122.502 0.321 . . . . 75.310000000000002 110.727 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.61 -50.96 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.071 0.549 . . . . 73.420000000000002 110.426 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.534 HG12 HD11 ' B' ' 41' ' ' LEU . 26.8 m -61.02 -30.52 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 122.531 0.333 . . . . 64.239999999999995 111.471 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.15 -49.19 16.9 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 123.31 0.381 . . . . 74.239999999999995 113.317 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.32 -49.18 72.78 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.696 0.799 . . . . 70.340000000000003 111.78 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -58.89 -41.38 87.03 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.07 0.948 . . . . 74.329999999999998 111.92 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.449 ' HB1' ' HG ' ' B' ' 46' ' ' LEU . . . -66.48 -39.65 88.89 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.173 0.589 . . . . 72.120000000000005 111.952 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.91 -43.75 98.95 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 116.059 -0.519 . . . . 34.340000000000003 112.549 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -68.06 -42.96 79.7 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.978 0.911 . . . . 62.030000000000001 111.77 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.746 ' HA ' HG11 ' B' ' 32' ' ' VAL . 37.7 t -57.94 -44.18 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 124.117 0.967 . . . . 75.430000000000007 111.78 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . . . . . . . . . 45.8 t90 -63.4 -33.42 75.52 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 115.221 -0.9 . . . . 73.219999999999999 112.194 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -61.09 -30.6 70.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.095 0.776 . . . . 73.439999999999998 113.095 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.33 65.88 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.341 0.497 . . . . 54.109999999999999 112.341 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.484 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 96.5 mt -70.55 -21.65 62.68 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.504 0.722 . . . . 73.5 112.619 174.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -64.78 -30.34 71.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.799 0.839 . . . . 65.409999999999997 111.891 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -91.55 -35.83 14.05 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.85 0.46 . . . . 51.100000000000001 111.168 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.43 112.23 1.09 Allowed 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.38 0.511 . . . . 73.519999999999996 112.38 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' B' ' 65' ' ' ASN . 9.4 p-10 -80.53 179.36 7.78 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.599 0.76 . . . . 71.299999999999997 110.704 166.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.46 61.14 4.95 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.611 -0.596 . . . . 75.219999999999999 111.611 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 tt -140.84 140.67 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.106 0.963 . . . . 65.319999999999993 110.03 -172.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 68.6 m -83.84 161.0 21.05 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.973 0.509 . . . . 52.32 110.885 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.483 HG21 ' HB2' ' B' ' 40' ' ' ALA . 58.8 mt -59.54 -44.92 98.62 Favored Pre-proline 0 CA--C 1.579 2.087 0 N-CA-C 113.9 1.074 . . . . 71.549999999999997 113.9 -174.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.88 -29.38 41.6 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 121.936 1.758 . . . . 43.200000000000003 114.237 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -71.7 -46.77 57.72 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.744 1.259 . . . . 70.129999999999995 109.654 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.499 HD22 HD11 ' B' ' 63' ' ' ILE . 65.3 tp -58.35 -43.62 88.4 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 112.946 -1.934 . . . . 52.109999999999999 111.681 173.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.68 91.21 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.497 1.119 . . . . 72.140000000000001 113.37 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -71.2 -23.58 62.06 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.073 0.549 . . . . 60.539999999999999 111.73 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -78.53 -44.6 23.92 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.772 0.829 . . . . 71.510000000000005 111.171 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' B' ' 13' ' ' VAL . 17.9 m -86.32 4.84 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.324 0.65 . . . . 64.439999999999998 112.414 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 65.34 17.75 11.1 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.815 1.246 . . . . 72.540000000000006 112.571 171.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 71.4 mt -109.72 158.32 18.22 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.468 0.707 . . . . 74.400000000000006 110.698 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -66.18 153.16 43.2 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.98 0.512 . . . . 44.039999999999999 111.168 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -53.6 -43.44 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 123.571 0.748 . . . . 61.520000000000003 111.964 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.402 ' HB2' HD12 ' A' ' 61' ' ' ILE . 45.7 mt-10 -61.99 -49.67 75.14 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.619 0.767 . . . . 74.230000000000004 112.037 175.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -61.33 -30.76 70.71 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.716 0.806 . . . . 65.430000000000007 112.236 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 87.4 m -77.44 -47.41 19.78 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.052 0.941 . . . . 63.509999999999998 111.304 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.483 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.62 -39.23 93.34 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.545 0.738 . . . . 42.100000000000001 111.99 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.534 HD11 HG12 ' B' ' 6' ' ' VAL . 1.3 tm? -62.41 -38.54 90.06 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.061 1.344 . . . . 75.340000000000003 110.431 174.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.52 -33.59 67.0 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.38 0.672 . . . . 53.130000000000003 111.914 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.71 -35.55 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.801 0.84 . . . . 71.450000000000003 111.482 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.08 -31.86 74.14 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 113.835 0.294 . . . . 60.240000000000002 113.835 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.404 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 72.2 t-105 -75.04 -36.7 61.85 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.426 0.691 . . . . 72.219999999999999 111.499 175.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.449 ' HG ' ' HB1' ' B' ' 10' ' ' ALA . 83.2 mt -66.4 -35.1 79.48 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.03 0.532 . . . . 60.219999999999999 111.311 173.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.73 -35.81 75.32 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.309 1.044 . . . . 41.310000000000002 112.449 172.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.618 ' HD2' ' HB2' ' A' ' 48' ' ' ARG . 49.4 ttt85 -57.17 -45.88 83.28 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.333 0.587 . . . . 73.230000000000004 110.691 171.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.38 -15.29 57.17 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 114.794 -1.093 . . . . 61.350000000000001 112.191 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 t30 65.37 26.7 12.01 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.868 1.267 . . . . 71.430000000000007 111.125 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -82.71 -19.11 38.67 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.507 -0.77 . . . . 75.349999999999994 111.854 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 24.4 m -114.53 140.04 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.19 0.596 . . . . 74.219999999999999 110.455 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 51.7 t -103.71 96.82 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.367 -0.975 . . . . 75.109999999999999 108.367 174.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.651 HG12 HG22 ' B' ' 63' ' ' ILE . 57.0 mt -81.93 123.68 38.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 115.783 -0.644 . . . . 65.400000000000006 109.766 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 13.6 tt0 -143.14 127.65 17.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.882 -0.599 . . . . 62.100000000000001 110.525 -172.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -83.77 103.82 13.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.397 0.679 . . . . 71.310000000000002 110.055 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -106.1 122.82 46.95 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.503 1.121 . . . . 71.109999999999999 111.15 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 59.22 31.03 20.88 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 125.162 1.385 . . . . 73.150000000000006 112.772 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.13 -27.87 6.52 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 115.988 -0.551 . . . . 73.319999999999993 113.66 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mp -81.56 165.15 21.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.762 0.825 . . . . 74.230000000000004 109.562 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.71 136.48 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.867 -0.521 . . . . 62.520000000000003 110.684 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -134.47 168.24 19.3 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.175 0.99 . . . . 73.099999999999994 110.851 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.651 HG22 HG12 ' B' ' 54' ' ' ILE . 0.2 OUTLIER -120.53 147.53 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.329 1.052 . . . . 62.530000000000001 110.313 171.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.555 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 93.6 m-85 -124.86 169.53 11.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.471 1.108 . . . . 74.299999999999997 110.405 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' B' ' 21' ' ' ASP . 4.4 m-20 -71.97 148.84 45.58 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.049 0.452 . . . . 64.040000000000006 111.844 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -50.66 103.66 0.06 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.297 1.039 . . . . 64.150000000000006 111.651 171.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.66 -32.05 0.83 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.332 -0.849 . . . . 55.240000000000002 112.511 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -77.29 -7.51 56.11 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.349 0.66 . . . . 71.109999999999999 112.372 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -78.33 178.22 7.83 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.67 0.788 . . . . 75.310000000000002 110.958 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 58.67 28.49 17.29 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.454 0.702 . . . . 72.150000000000006 110.99 -163.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -75.21 161.72 29.1 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 124.15 0.98 . . . . 65.219999999999999 111.047 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.5 t -61.31 138.56 58.24 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.444 0.698 . . . . 54.0 111.627 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -105.84 111.31 23.92 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.168 0.587 . . . . 64.040000000000006 111.283 -173.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -104.77 90.38 0.71 Allowed Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.387 -0.685 . . . . 74.450000000000003 111.387 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.9 100.29 0.4 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.1 0.56 . . . . 71.209999999999994 109.656 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -157.77 136.55 11.41 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.094 0.557 . . . . 71.439999999999998 110.879 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -166.49 131.4 2.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.674 1.589 . . . . 73.129999999999995 107.051 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -72.08 -5.26 34.02 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 113.327 0.862 . . . . 72.239999999999995 113.327 -166.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 41.86 97.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 126.255 1.822 . . . . 62.009999999999998 115.462 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -83.1 99.81 10.12 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.948 0.499 . . . . 65.109999999999999 110.049 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -148.39 141.63 25.1 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.201 1.0 . . . . 72.340000000000003 110.722 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 . . . . . 0 N--CA 1.483 1.186 0 C-N-CA 123.202 0.601 . . . . 71.319999999999993 110.796 177.196 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 112.251 0.463 . . . . 75.310000000000002 112.251 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.0 -34.55 75.46 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.604 0.964 . . . . 65.120000000000005 113.604 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -51.85 -30.1 22.32 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.382 1.253 . . . . 64.510000000000005 114.382 -164.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -92.54 -42.54 9.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.865 0.866 . . . . 75.040000000000006 112.439 172.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.1 mt -53.87 -47.54 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 123.853 0.861 . . . . 74.439999999999998 111.524 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.3 m -61.06 -29.29 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.967 1.307 . . . . 73.329999999999998 112.356 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.04 -41.71 70.23 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.679 0.612 . . . . 72.510000000000005 112.7 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.54 -43.03 98.28 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.315 0.646 . . . . 63.530000000000001 111.262 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -67.51 -35.03 78.32 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.693 0.797 . . . . 52.450000000000003 111.633 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.16 -35.03 68.92 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.496 0.718 . . . . 43.119999999999997 111.699 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.54 -35.96 92.53 Favored Glycine 0 CA--C 1.539 1.535 0 O-C-N 123.497 0.498 . . . . 74.450000000000003 112.631 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -67.74 -48.94 65.04 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.093 0.957 . . . . 73.439999999999998 111.64 175.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.93 -34.74 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.263 0.625 . . . . 50.409999999999997 111.9 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -71.03 -33.93 70.79 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.745 0.818 . . . . 74.140000000000001 110.959 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -66.92 -29.24 69.06 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 71.150000000000006 111.227 172.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.23 -31.35 67.46 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.991 0.516 . . . . 65.349999999999994 111.843 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.533 HD11 HG12 ' A' ' 52' ' ' VAL . 98.1 mt -59.35 -39.32 82.81 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.142 0.977 . . . . 73.019999999999996 113.521 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -11.54 58.79 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 112.445 0.535 . . . . 71.019999999999996 112.445 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -103.61 -39.3 6.76 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.499 1.12 . . . . 61.420000000000002 110.004 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.53 91.67 2.68 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.684 0.794 . . . . 64.129999999999995 112.624 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -85.14 133.89 34.19 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.095 0.558 . . . . 63.549999999999997 110.298 167.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.37 61.79 2.89 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-O 121.155 0.308 . . . . 74.409999999999997 112.733 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.6 tt -126.78 145.34 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.505 0.722 . . . . 71.030000000000001 110.975 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.4 m -68.09 138.43 55.76 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.904 0.881 . . . . 74.099999999999994 110.62 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.744 HG21 ' HB2' ' A' ' 40' ' ' ALA . 76.2 mt -58.36 -42.27 93.84 Favored Pre-proline 0 CA--C 1.583 2.221 0 N-CA-C 114.059 1.133 . . . . 54.299999999999997 114.059 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 36' ' ' VAL . 29.8 Cg_endo -61.99 -32.36 84.29 Favored 'Trans proline' 0 C--N 1.394 2.961 0 C-N-CA 121.93 1.753 . . . . 65.430000000000007 114.123 174.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.17 -45.2 50.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.711 1.243 . . . . 74.109999999999999 109.47 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.588 HD22 HD11 ' A' ' 63' ' ' ILE . 66.7 tp -57.14 -38.89 74.15 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 112.75 -2.023 . . . . 75.120000000000005 111.818 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.17 78.05 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.323 1.049 . . . . 74.310000000000002 112.566 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.25 -42.85 87.98 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.255 0.622 . . . . 74.129999999999995 111.379 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -75.46 -35.13 60.93 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 112.473 0.546 . . . . 72.230000000000004 112.473 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 m -81.64 -9.89 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-O 120.772 0.32 . . . . 74.25 111.122 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 63.23 25.86 14.94 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.498 1.519 . . . . 71.430000000000007 113.203 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.3 mt -105.17 171.63 7.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.313 1.045 . . . . 74.230000000000004 109.887 173.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.7 m -68.07 158.98 31.78 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 122.551 0.34 . . . . 63.340000000000003 110.762 170.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.435 HG22 ' HA ' ' A' ' 26' ' ' PRO . 79.5 t -51.23 -57.06 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 123.286 0.634 . . . . 51.539999999999999 112.095 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.414 ' HG2' ' HB ' ' B' ' 25' ' ' ILE . 2.9 mp0 -66.65 -31.23 71.78 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.147 0.795 . . . . 73.140000000000001 113.147 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -61.67 -44.61 96.63 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.579 0.704 . . . . 74.530000000000001 110.881 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 43' ' ' VAL . 78.4 m -70.23 -41.57 73.42 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.629 -1.168 . . . . 62.009999999999998 111.385 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.744 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -67.5 -41.74 84.02 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.957 0.903 . . . . 64.349999999999994 112.071 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.06 -27.69 64.84 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.237 1.015 . . . . 75.010000000000005 110.518 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.85 -38.06 73.14 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.845 0.458 . . . . 70.530000000000001 111.261 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.531 HG11 HG21 ' A' ' 63' ' ' ILE . 90.3 t -61.88 -33.87 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.33 0.652 . . . . 75.329999999999998 110.089 169.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.48 90.17 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 115.918 -0.583 . . . . 73.340000000000003 113.802 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -67.92 -41.73 82.15 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.111 0.455 . . . . 71.239999999999995 110.229 173.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.38 -38.21 83.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.051 0.541 . . . . 72.239999999999995 110.927 173.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.84 96.49 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.628 0.771 . . . . 62.340000000000003 111.522 175.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 -56.8 -45.01 82.48 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.88 0.472 . . . . 74.420000000000002 111.114 171.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.89 -6.03 56.65 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.217 0.821 . . . . 75.329999999999998 113.217 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 68.53 30.81 5.05 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.115 1.366 . . . . 74.219999999999999 112.417 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -95.78 -13.83 23.79 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.945 1.298 . . . . 70.129999999999995 113.597 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.533 HG12 HD11 ' A' ' 17' ' ' LEU . 8.0 m -120.93 141.39 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.252 0.549 . . . . 75.310000000000002 112.263 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' ' 68' ' ' HIS . 94.7 t -107.63 107.09 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 124.271 1.028 . . . . 72.540000000000006 109.815 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 63' ' ' ILE . 2.9 mp -86.62 124.84 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 123.231 0.612 . . . . 63.240000000000002 110.001 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.23 116.0 13.06 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.755 0.822 . . . . 72.109999999999999 109.333 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -80.77 102.61 10.08 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.167 0.587 . . . . 64.040000000000006 110.029 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -112.74 124.98 53.81 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.481 0.712 . . . . 72.439999999999998 110.298 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 58.44 31.35 20.86 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.164 0.986 . . . . 74.519999999999996 112.112 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.06 -25.16 7.97 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 116.055 -0.521 . . . . 71.109999999999999 114.023 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.8 mt -79.14 146.22 33.28 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.905 0.882 . . . . 74.319999999999993 112.077 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.12 107.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.185 -0.672 . . . . 71.25 109.185 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.25 120.15 41.1 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.204 0.602 . . . . 64.519999999999996 109.725 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.588 HD11 HD22 ' A' ' 28' ' ' LEU . 2.7 pp -101.09 138.35 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.45 0.643 . . . . 71.120000000000005 111.032 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 93.5 m-85 -122.52 174.5 7.02 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.437 1.095 . . . . 72.319999999999993 110.19 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 63.6 t30 -90.64 158.28 17.02 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.91 0.484 . . . . 64.200000000000003 111.402 174.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.41 154.43 16.95 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.992 0.917 . . . . 74.530000000000001 112.179 173.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.1 62.02 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 115.396 -0.82 . . . . 62.039999999999999 112.594 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.633 ' HB3' HG21 ' A' ' 53' ' ' VAL . 48.8 t60 -74.84 -27.22 60.19 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.36 0.664 . . . . 75.150000000000006 110.832 175.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -95.79 143.57 26.91 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.309 0.643 . . . . 71.319999999999993 109.775 167.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.29 177.14 9.18 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.197 0.599 . . . . 61.350000000000001 112.047 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -103.93 92.49 4.42 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.193 0.597 . . . . 74.530000000000001 110.679 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.0 m -86.16 93.15 8.96 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.604 0.762 . . . . 60.520000000000003 111.58 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -90.49 91.21 8.35 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.919 0.488 . . . . 72.150000000000006 110.748 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.86 8.85 2.27 Favored Glycine 0 N--CA 1.478 1.488 0 CA-C-N 115.954 -0.566 . . . . 74.120000000000005 112.953 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.5 84.12 7.49 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.858 0.837 . . . . 50.450000000000003 111.592 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -79.55 90.85 5.13 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.217 -0.901 . . . . 70.420000000000002 109.397 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -82.43 95.94 7.83 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.315 -0.857 . . . . 71.120000000000005 109.945 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -89.92 48.18 1.55 Allowed 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.233 1.013 . . . . 72.049999999999997 110.983 -171.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -58.64 143.8 45.24 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.768 1.227 . . . . 74.510000000000005 113.717 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -131.51 -36.25 1.27 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.468 1.107 . . . . 73.450000000000003 110.479 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -101.21 129.36 47.12 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.459 0.704 . . . . 72.400000000000006 110.696 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.675 0.75 . . . . 70.519999999999996 110.23 177.926 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 121.028 0.442 . . . . 73.299999999999997 110.084 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.61 147.53 23.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.306 0.642 . . . . 71.329999999999998 110.678 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.402 ' O ' HG22 ' B' ' 6' ' ' VAL . 71.9 tttt -69.35 -23.46 63.76 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 115.191 -0.913 . . . . 72.239999999999995 110.809 169.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -56.0 -24.35 38.4 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 124.37 1.068 . . . . 63.43 112.968 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 69.6 mt -55.63 -44.01 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 123.994 0.918 . . . . 71.430000000000007 111.322 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 3' ' ' LYS . 2.9 m -61.71 -30.17 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 122.67 0.388 . . . . 43.039999999999999 111.461 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.32 92.15 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.485 0.491 . . . . 71.129999999999995 113.403 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.2 -38.11 87.2 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.641 0.776 . . . . 73.510000000000005 111.83 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -79.75 -19.62 48.27 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.159 0.583 . . . . 74.099999999999994 112.089 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.63 -39.5 52.16 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.305 0.642 . . . . 74.340000000000003 110.995 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.17 -30.92 75.09 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.435 -0.802 . . . . 74.019999999999996 112.472 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.452 ' HD2' HD11 ' B' ' 34' ' ' LEU . 4.7 ttmp? -70.72 -49.32 48.24 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.054 0.942 . . . . 71.319999999999993 112.374 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.534 HG13 HD11 ' B' ' 46' ' ' LEU . 2.5 p -66.2 -36.01 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 112.158 0.429 . . . . 70.010000000000005 112.158 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.458 ' HA ' HD12 ' B' ' 17' ' ' LEU . 26.0 t90 -73.17 -32.21 64.71 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.991 -0.443 . . . . 73.340000000000003 111.132 176.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -62.47 -36.32 82.1 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.213 0.605 . . . . 65.450000000000003 110.524 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.63 -32.73 74.47 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.469 -0.787 . . . . 54.109999999999999 111.932 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.49 HD21 HD13 ' B' ' 63' ' ' ILE . 84.8 mt -69.16 -44.38 72.37 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.763 0.825 . . . . 71.340000000000003 111.777 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -56.77 -39.87 74.82 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.933 0.893 . . . . 73.340000000000003 111.79 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -74.02 -50.36 20.11 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.49 0.716 . . . . 71.140000000000001 110.817 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.83 102.91 0.9 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.828 0.851 . . . . 71.510000000000005 110.757 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.2 173.94 10.61 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.802 0.441 . . . . 63.229999999999997 111.47 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.99 65.25 1.77 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.559 -0.291 . . . . 22.140000000000001 112.554 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 tt -151.01 144.93 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 123.305 0.642 . . . . 70.510000000000005 110.389 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 31.4 t -70.82 150.29 45.97 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.188 0.595 . . . . 64.519999999999996 111.138 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.633 HG21 ' HB2' ' B' ' 40' ' ' ALA . 82.4 mt -58.39 -51.02 84.8 Favored Pre-proline 0 CA--C 1.576 1.959 0 CA-C-O 118.177 -0.916 . . . . 72.450000000000003 113.408 -176.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.408 ' HA ' HG22 ' B' ' 36' ' ' VAL . 20.3 Cg_endo -59.23 -34.77 98.24 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.233 1.956 . . . . 75.519999999999996 113.438 176.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -66.05 -50.92 62.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.326 0.65 . . . . 75.239999999999995 112.226 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.618 HD22 HD11 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -69.9 -32.55 70.94 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.714 0.406 . . . . 71.530000000000001 110.838 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.68 -41.63 77.64 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.887 0.875 . . . . 53.140000000000001 111.637 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -60.11 -40.19 88.83 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.092 0.957 . . . . 74.409999999999997 111.26 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -75.38 -33.13 61.0 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.964 0.906 . . . . 55.140000000000001 112.791 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.4 m -96.57 5.25 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 123.584 0.754 . . . . 72.340000000000003 111.897 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 t30 68.93 10.92 8.17 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 125.212 1.405 . . . . 73.140000000000001 112.642 173.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.452 HD11 ' HD2' ' B' ' 12' ' ' LYS . 54.0 mt -94.57 155.31 16.96 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.662 -0.649 . . . . 74.239999999999995 110.607 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 47.6 m -67.79 152.45 45.56 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.42 0.288 . . . . 74.319999999999993 110.499 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' B' ' 26' ' ' PRO . 64.1 t -51.69 -44.2 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.401 0.681 . . . . 52.32 111.329 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.96 -47.91 83.41 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 114.918 -1.037 . . . . 70.010000000000005 112.242 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -58.97 -41.37 87.39 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.975 0.91 . . . . 44.130000000000003 112.769 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 95.5 m -72.65 -46.68 52.74 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.332 0.653 . . . . 71.310000000000002 111.907 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.633 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.89 -48.61 73.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.0 1.111 . . . . 73.140000000000001 114.0 -168.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -26.53 62.38 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 120.796 0.332 . . . . 71.219999999999999 110.93 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.43 -26.33 65.47 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.697 0.799 . . . . 75.140000000000001 111.99 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.69 -31.65 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 123.005 0.522 . . . . 61.109999999999999 110.991 169.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.27 -28.36 73.65 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.308 -0.405 . . . . 73.120000000000005 113.99 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.552 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 66.0 t-105 -72.11 -27.52 62.69 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.143 0.577 . . . . 63.299999999999997 111.034 172.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.534 HD11 HG13 ' B' ' 13' ' ' VAL . 73.6 mt -73.22 -36.12 66.41 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.751 -0.593 . . . . 65.340000000000003 110.715 169.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.39 -26.88 68.65 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.46 1.104 . . . . 62.409999999999997 113.818 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 12.9 ptt180 -62.1 -35.85 79.94 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 118.817 0.735 . . . . 74.030000000000001 110.288 172.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.472 ' HG3' ' HG3' ' B' ' 48' ' ' ARG . 32.6 mt-10 -93.98 -6.27 45.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.819 1.248 . . . . 73.530000000000001 111.687 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 t30 63.08 31.21 16.02 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.841 1.256 . . . . 72.019999999999996 111.56 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -85.68 -6.5 59.13 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.865 0.691 . . . . 50.340000000000003 112.865 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.88 145.81 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.405 0.622 . . . . 63.43 112.356 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' B' ' 64' ' ' TYR . 4.8 m -120.08 128.61 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.048 1.339 . . . . 71.340000000000003 108.304 167.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.436 HG12 HG22 ' B' ' 63' ' ' ILE . 68.2 mt -109.29 137.82 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.928 0.491 . . . . 41.119999999999997 110.754 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -134.99 125.82 27.35 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.707 0.803 . . . . 62.549999999999997 109.565 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -108.01 115.5 30.25 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.493 0.663 . . . . 55.439999999999998 110.606 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.64 126.84 55.71 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.84 1.256 . . . . 74.420000000000002 109.173 -175.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 59.84 29.11 18.68 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.37 1.068 . . . . 64.109999999999999 111.525 -175.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.6 -19.1 16.18 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-N 116.343 -0.39 . . . . 65.049999999999997 113.808 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 tp -78.4 112.01 14.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.062 0.945 . . . . 62.25 110.455 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 mt -83.44 125.14 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 122.512 0.325 . . . . 74.120000000000005 110.848 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -127.42 145.75 50.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.703 0.801 . . . . 74.510000000000005 109.902 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.618 HD11 HD22 ' B' ' 28' ' ' LEU . 2.2 pp -105.83 141.25 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-O 121.552 0.691 . . . . 43.039999999999999 111.63 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.472 ' HB2' HG23 ' B' ' 53' ' ' VAL . 73.2 m-85 -132.13 157.14 45.01 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.502 1.121 . . . . 73.019999999999996 109.228 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -102.98 153.55 20.12 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.051 0.54 . . . . 44.539999999999999 110.421 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -17.93 61.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 112.224 0.453 . . . . 73.129999999999995 112.224 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.96 -33.38 87.02 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.264 0.353 . . . . 73.5 113.602 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -70.48 -37.06 74.18 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.524 0.73 . . . . 74.120000000000005 111.369 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -87.45 86.11 7.2 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.557 0.743 . . . . 74.340000000000003 110.291 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -140.4 133.98 30.16 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.373 0.669 . . . . 65.329999999999998 109.948 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -129.08 27.57 5.38 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 122.992 0.517 . . . . 74.510000000000005 111.234 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 46.7 t -67.52 -60.49 2.52 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 112.864 0.69 . . . . 72.310000000000002 112.864 -175.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.05 170.98 15.54 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.468 0.707 . . . . 74.409999999999997 112.398 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.9 61.49 1.35 Allowed Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.637 -0.711 . . . . 72.109999999999999 111.714 -172.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.536 HD23 ' H ' ' B' ' 75' ' ' LEU . 2.2 pt? -122.18 146.48 47.21 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.965 0.906 . . . . 71.310000000000002 110.465 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.84 131.95 38.91 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.519 0.728 . . . . 61.229999999999997 110.639 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -88.71 -63.57 1.28 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.39 0.676 . . . . 72.400000000000006 109.354 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 57.21 87.42 0.06 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.938 1.295 . . . . 74.439999999999998 112.637 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -69.75 133.07 47.06 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.164 0.586 . . . . 64.349999999999994 111.199 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -105.53 128.28 53.49 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.047 0.939 . . . . 75.129999999999995 110.911 -173.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -75.13 133.58 41.47 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.95 0.5 . . . . 75.439999999999998 110.838 174.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 N--CA 1.479 1.012 0 C-N-CA 123.518 0.727 . . . . 71.150000000000006 110.317 175.089 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.46 0.171 . . . . 72.510000000000005 110.646 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.488 ' HB2' HG13 ' A' ' 5' ' ' ILE . 4.8 m-20 -66.65 156.48 35.09 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.718 0.807 . . . . 71.230000000000004 112.243 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -65.69 -25.09 67.17 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.807 -1.088 . . . . 73.25 111.484 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -77.32 -24.76 50.79 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.885 0.698 . . . . 73.010000000000005 112.885 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.488 HG13 ' HB2' ' A' ' 2' ' ' ASP . 59.4 mt -60.07 -42.74 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.264 0.626 . . . . 74.540000000000006 111.782 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.626 HG12 HD11 ' A' ' 41' ' ' LEU . 34.5 m -59.42 -33.6 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 111.77 0.285 . . . . 71.530000000000001 111.77 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.75 -39.53 93.62 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 123.213 0.321 . . . . 64.239999999999995 112.986 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.87 -50.51 62.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.254 0.622 . . . . 52.020000000000003 111.828 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -70.6 -31.96 69.14 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.352 0.661 . . . . 74.430000000000007 112.351 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.43 -33.24 60.9 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.856 0.462 . . . . 53.43 111.625 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.65 -31.35 79.68 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.922 -0.581 . . . . 41.310000000000002 113.265 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -75.25 -36.72 61.24 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.566 0.747 . . . . 75.25 111.549 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.8 t -63.29 -41.13 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.369 0.604 . . . . 62.450000000000003 110.92 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 51' ' ' LYS . 77.6 t90 -72.26 -32.31 66.54 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.671 0.788 . . . . 73.230000000000004 111.54 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -61.79 -34.87 76.67 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.161 0.584 . . . . 75.420000000000002 110.679 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.99 -33.93 76.95 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.166 0.586 . . . . 73.129999999999995 111.753 174.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.417 HD11 HG12 ' A' ' 52' ' ' VAL . 92.2 mt -63.62 -27.34 69.17 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.635 0.774 . . . . 74.340000000000003 111.897 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.14 -35.04 77.46 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.299 0.64 . . . . 71.010000000000005 111.651 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -106.72 -65.84 1.06 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.528 0.731 . . . . 73.519999999999996 111.786 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . . . -127.53 84.54 2.26 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.452 0.644 . . . . 72.349999999999994 111.245 -175.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.73 -179.08 5.93 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.514 1.126 . . . . 73.099999999999994 112.972 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.17 52.36 48.01 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 115.698 -0.683 . . . . 62.210000000000001 113.247 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.496 HD13 ' HD2' ' A' ' 31' ' ' LYS . 13.7 tt -140.15 125.31 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.451 0.7 . . . . 72.150000000000006 110.719 -175.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.4 m -50.49 149.41 3.16 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.1 1.36 . . . . 61.219999999999999 113.31 -170.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.456 HG21 ' HB2' ' A' ' 40' ' ' ALA . 80.6 mt -47.62 -48.89 58.22 Favored Pre-proline 0 CA--C 1.576 1.946 0 C-N-CA 124.414 1.086 . . . . 72.109999999999999 113.928 -172.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 36' ' ' VAL . 48.7 Cg_endo -65.79 -37.6 27.11 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 121.847 1.698 . . . . 73.140000000000001 113.702 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -70.01 -46.92 64.09 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.46 1.124 . . . . 72.319999999999993 110.139 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.563 HD22 HG21 ' A' ' 63' ' ' ILE . 54.9 tp -57.61 -34.36 69.19 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 113.28 -1.782 . . . . 74.099999999999994 112.216 170.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 -38.12 82.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.031 0.532 . . . . 74.049999999999997 111.703 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -28.04 63.34 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 111.895 0.332 . . . . 74.439999999999998 111.895 173.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HD2' HD13 ' A' ' 23' ' ' ILE . 26.8 mtpp -68.21 -45.87 72.16 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.016 0.436 . . . . 71.129999999999995 111.644 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.8 m -86.61 -1.91 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.178 0.591 . . . . 61.420000000000002 111.707 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.9 t30 65.92 27.07 10.93 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.147 1.379 . . . . 75.329999999999998 111.767 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.6 mt -114.99 173.05 6.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.098 0.959 . . . . 74.209999999999994 111.759 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 t -68.12 155.6 39.25 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.324 0.65 . . . . 52.100000000000001 111.869 170.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 26' ' ' PRO . 62.2 t -55.44 -41.42 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.484 0.714 . . . . 72.319999999999993 110.641 172.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.17 -49.0 79.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.66 -1.155 . . . . 63.539999999999999 111.427 176.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.8 m -58.18 -43.39 87.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.107 0.963 . . . . 63.200000000000003 111.464 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 43' ' ' VAL . 85.4 m -69.72 -48.06 60.88 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.104 -0.953 . . . . 72.219999999999999 111.811 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -62.09 -38.77 90.12 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 123.459 0.703 . . . . 70.310000000000002 112.32 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.626 HD11 HG12 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -66.85 -40.83 88.05 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.798 1.239 . . . . 74.140000000000001 110.213 174.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.65 -34.73 74.41 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.488 0.715 . . . . 70.200000000000003 112.2 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 39' ' ' THR . 81.0 t -67.0 -32.95 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.56 0.744 . . . . 51.450000000000003 110.405 173.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' B' ' 44' ' ' GLY . . . -66.97 -33.34 83.57 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.141 -0.482 . . . . 31.539999999999999 113.316 173.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -69.35 -38.18 78.0 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.876 0.471 . . . . 63.420000000000002 110.644 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 51' ' ' LYS . 76.5 mt -67.57 -30.52 70.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.819 0.448 . . . . 72.450000000000003 111.437 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.29 75.35 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.309 0.643 . . . . 61.32 112.133 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -62.36 -49.64 74.77 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 122.886 0.474 . . . . 74.349999999999994 110.953 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 64.1 mt-10 -80.05 -8.86 59.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.513 -0.767 . . . . 74.209999999999994 111.547 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.462 ' ND2' ' HA ' ' A' ' 72' ' ' SER . 19.9 m-80 63.42 27.04 15.13 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.9 1.28 . . . . 52.119999999999997 111.911 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 39.9 mmtm -69.86 -17.92 63.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.527 1.131 . . . . 61.420000000000002 112.308 175.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.417 HG12 HD11 ' A' ' 17' ' ' LEU . 34.6 m -129.24 154.48 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.145 0.578 . . . . 63.43 112.387 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 64' ' ' TYR . 34.9 m -120.77 132.27 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.494 0.718 . . . . 75.319999999999993 109.077 165.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 mm -110.45 123.63 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.206 0.602 . . . . 75.349999999999994 111.412 -173.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 49.5 mt-10 -106.16 155.62 19.27 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.166 0.586 . . . . 74.209999999999994 111.367 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.21 94.04 4.78 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.817 -1.549 . . . . 63.520000000000003 106.817 160.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.86 111.7 24.46 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.718 0.807 . . . . 73.239999999999995 108.886 -173.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 60.35 30.35 19.75 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.285 1.034 . . . . 64.140000000000001 110.114 -161.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.6 -12.98 25.26 Favored Glycine 0 C--N 1.36 1.904 0 CA-C-N 115.506 -0.77 . . . . 62.43 114.422 -173.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.79 117.48 19.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.299 0.64 . . . . 73.329999999999998 111.269 -177.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 67.1 mt -69.21 116.05 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.791 0.836 . . . . 72.319999999999993 111.254 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -126.01 140.49 52.56 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.891 0.876 . . . . 74.409999999999997 110.983 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.563 HG21 HD22 ' A' ' 28' ' ' LEU . 7.2 tt -92.74 133.17 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 124.235 1.014 . . . . 74.439999999999998 111.017 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.446 ' HB2' HG23 ' A' ' 53' ' ' VAL . 73.0 m-85 -131.63 173.22 11.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.492 1.117 . . . . 64.519999999999996 110.323 173.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -73.62 150.5 41.33 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.346 0.658 . . . . 72.439999999999998 111.196 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . 7.5 pt-20 -37.99 -53.52 1.36 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.843 1.257 . . . . 64.400000000000006 113.607 171.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.13 -82.83 0.01 OUTLIER Glycine 0 C--N 1.354 1.558 0 N-CA-C 115.223 0.849 . . . . 72.200000000000003 115.223 171.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -119.34 -20.2 7.97 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.025 0.93 . . . . 42.32 111.979 -172.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -112.04 33.34 4.89 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.822 0.849 . . . . 75.5 111.839 -171.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.5 p-10 -79.77 9.57 5.04 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.696 0.998 . . . . 72.420000000000002 113.696 -176.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -67.21 98.92 0.64 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.47 0.708 . . . . 73.420000000000002 111.616 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.462 ' HA ' ' ND2' ' A' ' 50' ' ' ASN . 67.5 p -88.43 12.74 13.47 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.907 0.883 . . . . 73.450000000000003 112.938 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -86.52 101.59 13.33 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.098 0.559 . . . . 63.5 110.846 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.553 ' H ' HD12 ' A' ' 75' ' ' LEU . . . 168.75 78.27 0.04 OUTLIER Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.388 -0.369 . . . . 65.430000000000007 112.453 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.553 HD12 ' H ' ' A' ' 74' ' ' GLY . 4.6 mp -120.36 100.79 7.37 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.718 0.807 . . . . 62.140000000000001 110.452 -176.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -141.15 119.14 11.9 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.036 0.446 . . . . 63.32 111.752 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -128.38 163.25 25.27 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.651 1.18 . . . . 72.409999999999997 109.57 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -65.57 131.55 46.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.889 0.475 . . . . 73.349999999999994 111.107 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -140.88 49.28 1.68 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.575 0.703 . . . . 61.229999999999997 111.875 -174.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -121.93 133.98 54.85 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.402 -0.592 . . . . 70.439999999999998 109.402 173.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -67.92 -4.06 11.76 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 114.388 1.255 . . . . 75.099999999999994 114.388 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 21.0 m80 . . . . . 0 N--CA 1.493 1.686 0 C-N-CA 124.288 1.035 . . . . 71.129999999999995 110.775 169.341 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 C--O 1.24 0.594 0 N-CA-C 111.63 0.233 . . . . 73.340000000000003 111.63 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -58.3 -33.66 69.7 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.2 0.6 . . . . 70.219999999999999 112.598 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -27.91 68.47 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.092 0.957 . . . . 63.340000000000003 112.965 -171.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -84.05 -44.29 14.25 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.473 0.709 . . . . 70.109999999999999 111.034 173.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.66 -45.56 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.815 0.846 . . . . 65.5 111.93 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.563 HG12 HD11 ' B' ' 41' ' ' LEU . 34.8 m -61.28 -32.16 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.753 0.821 . . . . 72.200000000000003 112.157 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.83 62.26 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.27 0.356 . . . . 74.209999999999994 112.647 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.74 -45.78 88.34 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.589 0.756 . . . . 64.430000000000007 111.883 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -64.67 -41.08 96.32 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.773 0.829 . . . . 72.439999999999998 111.799 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.95 -31.3 70.08 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.885 0.474 . . . . 72.209999999999994 111.646 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.59 -38.38 96.2 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.847 -0.615 . . . . 72.349999999999994 112.882 174.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -75.1 -36.65 61.67 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.71 0.804 . . . . 71.310000000000002 111.434 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.552 ' HA ' HG11 ' B' ' 32' ' ' VAL . 92.7 t -67.63 -42.71 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.135 0.574 . . . . 63.450000000000003 111.368 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.494 ' HA ' HD12 ' B' ' 17' ' ' LEU . 19.5 t90 -68.56 -33.23 73.72 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.984 -0.553 . . . . 61.229999999999997 110.521 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . 0.413 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 66.3 t60 -62.34 -31.41 72.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.715 0.806 . . . . 64.129999999999995 111.638 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.43 67.31 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.706 0.402 . . . . 52.229999999999997 111.868 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' B' ' 14' ' ' TRP . 98.5 mt -64.14 -45.04 90.29 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.838 0.855 . . . . 70.019999999999996 113.137 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -12.77 61.88 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 111.733 0.272 . . . . 62.350000000000001 111.733 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' B' ' 15' ' ' HIS . 20.4 mm-40 -81.08 -57.71 3.4 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.398 0.679 . . . . 71.319999999999993 109.753 171.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.16 105.15 3.19 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.5 0.72 . . . . 73.140000000000001 110.756 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.95 168.56 14.06 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.723 0.809 . . . . 64.439999999999998 111.458 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.26 64.98 2.09 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 112.477 -0.249 . . . . 45.32 112.477 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.432 ' O ' HG22 ' B' ' 63' ' ' ILE . 18.1 tt -146.32 156.22 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 C-N-CA 123.663 0.785 . . . . 71.400000000000006 110.303 -175.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -81.18 156.64 25.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.806 -0.559 . . . . 73.439999999999998 111.547 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.58 HG21 ' HB2' ' B' ' 40' ' ' ALA . 59.8 mt -58.84 -48.37 96.93 Favored Pre-proline 0 CA--C 1.577 1.994 0 N-CA-C 113.598 0.962 . . . . 75.040000000000006 113.598 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.468 ' HA ' HG22 ' B' ' 36' ' ' VAL . 55.1 Cg_endo -66.41 -23.9 50.44 Favored 'Trans proline' 0 C--N 1.395 3.001 0 CA-C-N 121.951 1.733 . . . . 71.329999999999998 114.138 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.19 -46.36 18.06 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.015 0.912 . . . . 64.209999999999994 109.608 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.56 HD22 HG21 ' B' ' 63' ' ' ILE . 59.0 tp -58.23 -34.45 70.45 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 113.735 -1.575 . . . . 74.219999999999999 111.681 173.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.15 85.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.951 0.9 . . . . 65.219999999999999 111.898 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -69.33 -40.33 77.65 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.603 0.761 . . . . 74.450000000000003 110.349 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -62.34 -35.69 79.88 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.568 0.747 . . . . 72.400000000000006 111.741 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.552 HG11 ' HA ' ' B' ' 13' ' ' VAL . 19.6 m -97.52 -1.24 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.074 0.55 . . . . 72.420000000000002 112.457 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 69.38 11.12 8.02 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.853 1.261 . . . . 70.420000000000002 112.575 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt -101.37 171.15 7.76 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.421 0.688 . . . . 73.340000000000003 111.351 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 29.7 t -66.07 154.23 40.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.909 0.484 . . . . 32.439999999999998 111.144 169.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' B' ' 26' ' ' PRO . 55.0 t -56.84 -40.16 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.247 0.619 . . . . 72.349999999999994 111.096 177.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.08 -43.79 77.76 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.404 -0.816 . . . . 74.310000000000002 111.839 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -61.04 -32.29 71.91 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.464 0.706 . . . . 74.409999999999997 111.798 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.45 ' O ' HG23 ' B' ' 43' ' ' VAL . 74.5 m -80.74 -47.86 13.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.078 0.951 . . . . 45.149999999999999 111.496 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.58 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -64.1 -40.2 95.7 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.603 0.761 . . . . 75.310000000000002 112.41 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.563 HD11 HG12 ' B' ' 6' ' ' VAL . 1.1 tm? -64.2 -34.95 79.27 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 124.813 1.245 . . . . 60.409999999999997 110.368 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.0 -33.52 61.84 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.617 0.767 . . . . 60.119999999999997 112.11 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 39' ' ' THR . 54.3 t -62.53 -37.56 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.784 0.834 . . . . 71.099999999999994 110.361 172.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -64.38 -30.42 77.81 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-N 116.057 -0.519 . . . . 70.129999999999995 113.63 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.477 ' O ' ' HB3' ' B' ' 48' ' ' ARG . 67.3 t-105 -74.1 -31.3 62.73 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.805 0.442 . . . . 74.140000000000001 111.304 175.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 96.2 mt -72.18 -38.19 69.14 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.813 0.445 . . . . 61.020000000000003 110.808 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.32 -28.82 69.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.094 0.958 . . . . 74.420000000000002 112.049 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' B' ' 45' ' ' TRP . 26.2 ttt-85 -53.34 -49.47 67.04 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.652 0.781 . . . . 75.129999999999995 110.841 168.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -94.46 6.15 49.64 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.903 0.881 . . . . 65.239999999999995 112.739 -175.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.38 23.8 14.13 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 124.66 1.184 . . . . 75.109999999999999 113.255 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -80.35 -0.67 37.86 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.17 0.804 . . . . 72.439999999999998 113.17 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.05 147.99 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.667 0.787 . . . . 72.510000000000005 111.739 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.749 ' HB ' ' HB2' ' B' ' 64' ' ' TYR . 39.0 t -106.77 118.99 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.567 0.747 . . . . 71.129999999999995 109.007 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 46.6 mm -113.59 130.79 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 123.129 0.572 . . . . 64.099999999999994 111.296 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -133.79 132.68 40.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.621 0.768 . . . . 74.340000000000003 111.06 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -88.04 103.91 16.16 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.253 0.621 . . . . 52.130000000000003 110.976 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -110.38 112.49 24.46 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.356 1.062 . . . . 75.219999999999999 110.006 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 62.03 30.4 17.92 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.921 1.289 . . . . 74.549999999999997 112.523 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.82 -15.59 60.28 Favored Glycine 0 CA--C 1.543 1.841 0 CA-C-N 116.458 -0.337 . . . . 40.310000000000002 113.717 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 mp -93.37 147.02 23.3 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.998 0.919 . . . . 54.140000000000001 111.059 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mm -82.64 126.96 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.164 0.586 . . . . 74.349999999999994 111.394 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -110.5 122.44 47.74 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.21 1.004 . . . . 64.040000000000006 109.459 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.56 HG21 HD22 ' B' ' 28' ' ' LEU . 10.2 tt -108.49 139.01 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.408 0.623 . . . . 61.130000000000003 111.829 -175.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.749 ' HB2' ' HB ' ' B' ' 53' ' ' VAL . 90.9 m-85 -128.53 170.41 13.23 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.459 1.104 . . . . 71.439999999999998 110.523 176.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -91.04 162.4 14.72 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.552 0.741 . . . . 73.129999999999995 110.226 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -170.28 1.83 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 122.837 0.455 . . . . 73.409999999999997 111.469 172.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.49 16.86 78.87 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 111.625 -0.59 . . . . 23.239999999999998 111.625 -160.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -115.17 -40.11 3.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.412 1.085 . . . . 75.439999999999998 111.033 -171.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -69.0 141.21 54.95 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.247 0.619 . . . . 52.210000000000001 111.442 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.86 160.46 28.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.731 0.812 . . . . 72.219999999999999 112.78 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -81.94 15.62 2.2 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.425 0.69 . . . . 64.230000000000004 112.676 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 53.8 p -65.9 99.08 0.46 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.116 0.966 . . . . 71.519999999999996 111.479 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -87.05 159.77 18.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.226 0.61 . . . . 64.299999999999997 111.017 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.39 -129.69 1.88 Allowed Glycine 0 N--CA 1.475 1.269 0 CA-C-N 116.432 -0.349 . . . . 52.009999999999998 113.251 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.47 -16.67 26.91 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.313 0.645 . . . . 71.239999999999995 110.604 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -72.94 99.88 2.81 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.523 1.129 . . . . 72.239999999999995 110.287 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -100.6 149.85 23.31 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.68 1.192 . . . . 63.049999999999997 110.954 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -83.77 82.1 8.47 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.667 0.746 . . . . 73.319999999999993 111.814 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -93.53 37.54 1.06 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.026 0.917 . . . . 74.030000000000001 110.549 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -135.2 134.94 40.61 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.799 0.84 . . . . 71.129999999999995 109.802 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -100.96 109.68 21.63 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.576 0.75 . . . . 74.230000000000004 110.823 -173.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 7.1 t60 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.46 0.647 . . . . 73.230000000000004 109.834 177.817 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.669 0.271 . . . . 75.109999999999999 110.992 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.84 -34.76 71.94 Favored 'General case' 0 C--O 1.206 -1.225 0 N-CA-C 114.877 1.436 . . . . 60.219999999999999 114.877 -171.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -53.46 -32.78 51.53 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 115.013 1.486 . . . . 64.400000000000006 115.013 -169.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -79.9 -39.74 29.76 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.605 0.362 . . . . 70.129999999999995 111.747 173.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.07 -50.93 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.539 0.736 . . . . 63.420000000000002 111.117 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.428 HG11 HD11 ' A' ' 41' ' ' LEU . 6.3 m -73.66 -27.71 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.787 1.235 . . . . 65.340000000000003 111.418 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.39 -35.67 87.75 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 112.421 -0.272 . . . . 35.210000000000001 112.421 171.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.79 -56.16 5.32 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.564 0.746 . . . . 55.25 111.954 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -71.12 -22.76 62.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.951 0.723 . . . . 73.25 112.951 -173.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.612 ' HA ' HG22 ' A' ' 13' ' ' VAL . . . -67.14 -26.68 66.79 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.623 0.369 . . . . 64.219999999999999 111.12 174.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.67 -36.19 92.03 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.11 -0.496 . . . . 72.430000000000007 112.861 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -76.86 -41.99 41.78 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.564 0.746 . . . . 73.519999999999996 112.303 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' A' ' 10' ' ' ALA . 12.4 m -69.83 -34.93 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 122.141 -0.349 . . . . 72.439999999999998 110.82 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -71.67 -32.62 68.07 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.238 0.615 . . . . 74.129999999999995 111.083 172.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -61.54 -46.42 89.99 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.706 0.403 . . . . 73.010000000000005 110.967 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB1' ' HE2' ' A' ' 31' ' ' LYS . . . -66.74 -34.58 78.16 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.913 0.885 . . . . 74.239999999999995 111.46 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.37 -45.45 72.75 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.609 1.164 . . . . 54.450000000000003 111.299 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -75.53 -25.76 57.47 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.358 0.663 . . . . 74.109999999999999 110.703 -175.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -71.25 -41.3 70.28 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.029 0.932 . . . . 73.430000000000007 110.283 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.9 107.03 2.28 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.657 0.783 . . . . 65.129999999999995 110.261 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.13 179.32 5.11 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.683 0.793 . . . . 71.349999999999994 112.363 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.51 56.43 7.58 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 111.956 -0.458 . . . . 44.009999999999998 111.956 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 28' ' ' LEU . 9.4 tp -130.3 125.54 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 123.359 0.664 . . . . 73.439999999999998 110.768 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -80.57 153.59 27.97 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.215 0.606 . . . . 72.319999999999993 111.117 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 40' ' ' ALA . 62.5 mt -52.06 -53.3 53.37 Favored Pre-proline 0 CA--C 1.577 2.003 0 N-CA-C 114.324 1.231 . . . . 70.209999999999994 114.324 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.12 -21.88 23.28 Favored 'Trans proline' 0 C--N 1.39 2.753 0 CA-C-N 121.197 1.463 . . . . 51.539999999999999 114.179 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -78.59 -44.7 23.42 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 122.107 0.956 . . . . 74.319999999999993 109.326 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.496 ' HB2' HG13 ' A' ' 23' ' ' ILE . 50.3 tp -57.2 -37.48 72.24 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 113.524 -1.671 . . . . 64.120000000000005 111.149 172.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.56 -39.79 85.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.991 0.916 . . . . 62.210000000000001 112.005 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -73.21 -34.21 65.81 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.316 0.646 . . . . 75.239999999999995 111.48 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HE2' ' HB1' ' A' ' 16' ' ' ALA . 55.5 mtpt -62.87 -44.11 96.99 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.323 0.649 . . . . 64.230000000000004 111.182 175.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 13' ' ' VAL . 19.2 m -93.05 -4.02 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.592 0.757 . . . . 71.140000000000001 112.315 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 68.67 13.89 8.95 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.272 1.429 . . . . 70.510000000000005 113.532 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 73.1 mt -95.9 170.65 9.15 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.377 0.671 . . . . 74.150000000000006 111.228 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -67.1 150.74 48.75 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.212 0.605 . . . . 74.109999999999999 111.538 170.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.8 t -56.11 -43.63 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.597 0.759 . . . . 73.340000000000003 111.14 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -60.74 -45.62 93.61 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.388 -0.824 . . . . 70.140000000000001 112.0 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.5 m -65.98 -30.79 71.4 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.453 0.701 . . . . 64.129999999999995 112.009 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -80.17 -39.26 29.65 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.474 0.71 . . . . 63.439999999999998 111.654 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB2' HG21 ' A' ' 25' ' ' ILE . . . -64.75 -38.74 92.0 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.67 0.748 . . . . 74.340000000000003 111.076 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.428 HD11 HG11 ' A' ' 6' ' ' VAL . 1.2 tm? -69.82 -38.01 76.42 Favored 'General case' 0 CA--C 1.562 1.44 0 CA-C-N 114.184 -1.371 . . . . 74.099999999999994 110.743 175.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.59 -39.62 84.81 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 122.995 0.518 . . . . 71.409999999999997 111.655 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.2 -38.51 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.905 0.882 . . . . 72.310000000000002 111.176 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.36 -33.0 86.08 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.365 -0.38 . . . . 61.439999999999998 112.823 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.43 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 74.1 t-105 -69.4 -40.53 77.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.548 0.739 . . . . 74.299999999999997 110.352 174.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.71 -32.92 74.54 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.948 0.499 . . . . 71.019999999999996 111.796 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.6 89.5 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.387 0.675 . . . . 51.109999999999999 110.968 171.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 45' ' ' TRP . 12.4 ttt180 -59.69 -50.18 74.87 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.078 0.551 . . . . 74.409999999999997 111.216 168.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 45' ' ' TRP . 8.7 mm-40 -76.13 -1.43 26.14 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.917 0.887 . . . . 71.430000000000007 112.706 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.12 33.77 19.29 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.86 1.264 . . . . 73.219999999999999 112.526 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -93.28 -23.21 18.58 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.106 0.962 . . . . 72.319999999999993 112.25 177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.09 157.2 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 113.416 0.895 . . . . 64.140000000000001 113.416 -173.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 64' ' ' TYR . 2.3 m -133.4 144.21 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.162 1.385 . . . . 44.409999999999997 110.123 175.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.726 HG12 HD11 ' B' ' 41' ' ' LEU . 2.6 mp -108.82 128.3 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.609 0.763 . . . . 75.25 111.067 -171.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -115.21 119.09 35.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.457 1.103 . . . . 55.530000000000001 109.833 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HB2' ' SD ' ' B' ' 1' ' ' MET . 98.6 mtt180 -100.38 125.72 46.67 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.104 0.478 . . . . 73.239999999999995 111.156 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.87 131.11 13.6 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.979 0.912 . . . . 72.329999999999998 109.951 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 60.3 28.51 18.12 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.781 1.232 . . . . 62.210000000000001 111.802 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.49 -8.26 62.33 Favored Glycine 0 CA--C 1.544 1.844 0 N-CA-C 113.87 0.308 . . . . 71.219999999999999 113.87 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.38 160.91 14.05 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.95 0.9 . . . . 70.019999999999996 111.358 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.65 HG23 HG23 ' A' ' 54' ' ' ILE . 78.9 mt -112.64 127.96 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.866 0.866 . . . . 60.420000000000002 110.705 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -112.57 140.97 46.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.999 0.92 . . . . 62.149999999999999 109.544 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.85 133.76 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.018 0.927 . . . . 75.430000000000007 108.726 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HB2' HG23 ' A' ' 53' ' ' VAL . 88.6 m-85 -129.91 169.31 15.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.91 1.284 . . . . 55.210000000000001 109.84 177.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -85.97 138.22 32.15 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.143 0.577 . . . . 65.219999999999999 110.311 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.25 10.84 4.01 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-O 121.457 0.646 . . . . 72.040000000000006 112.125 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.669 ' HA2' ' HB2' ' A' ' 71' ' ' PHE . . . -60.0 -11.18 17.19 Favored Glycine 0 CA--C 1.541 1.692 0 N-CA-C 114.376 0.511 . . . . 71.409999999999997 114.376 169.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.57 -48.99 79.33 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.941 0.896 . . . . 74.310000000000002 111.535 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -86.13 -79.62 0.25 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.491 0.717 . . . . 72.230000000000004 111.146 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.11 120.9 13.47 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.902 0.881 . . . . 74.040000000000006 109.057 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.669 ' HB2' ' HA2' ' A' ' 67' ' ' GLY . 53.8 t80 -118.03 130.28 56.07 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.264 0.554 . . . . 64.310000000000002 110.952 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 p -137.01 161.97 34.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.467 1.107 . . . . 72.299999999999997 109.522 171.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.8 t80 66.32 111.19 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.661 1.184 . . . . 75.420000000000002 111.501 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -134.71 123.19 3.09 Favored Glycine 0 C--N 1.345 1.047 0 C-N-CA 123.282 0.468 . . . . 73.340000000000003 112.086 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.2 mp -70.01 117.14 11.2 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.928 0.891 . . . . 41.509999999999998 110.103 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.64 -172.99 3.0 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.524 0.564 . . . . 63.329999999999998 112.524 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -79.77 116.89 20.2 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.063 0.945 . . . . 74.120000000000005 110.911 -170.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -92.02 -6.99 50.08 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.281 0.632 . . . . 73.510000000000005 112.404 -177.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 69.99 -67.31 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.632 1.573 . . . . 73.530000000000001 111.867 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -81.45 145.82 30.56 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.217 0.607 . . . . 65.400000000000006 110.407 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -65.73 123.98 21.18 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.734 0.814 . . . . 64.310000000000002 112.57 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.9 m170 . . . . . 0 N--CA 1.484 1.246 0 C-N-CA 124.91 1.284 . . . . 74.310000000000002 109.76 171.829 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 56' ' ' ARG . 18.6 ttt . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 110.068 -0.345 . . . . 64.25 110.068 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.538 ' HB2' HG13 ' B' ' 5' ' ' ILE . 21.9 m-20 -63.28 126.31 27.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.814 0.445 . . . . 71.430000000000007 111.804 -175.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.417 ' O ' HG22 ' B' ' 6' ' ' VAL . 87.7 tttt -73.62 -12.46 60.75 Favored 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 123.665 0.786 . . . . 63.109999999999999 110.679 174.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.36 -26.99 65.86 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.071 0.948 . . . . 75.239999999999995 111.935 173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.538 HG13 ' HB2' ' B' ' 2' ' ' ASP . 88.4 mt -59.11 -43.18 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.525 0.73 . . . . 72.340000000000003 111.712 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.417 HG22 ' O ' ' B' ' 3' ' ' LYS . 25.5 m -65.36 -28.91 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-N 117.641 0.201 . . . . 64.420000000000002 111.319 176.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' B' ' 45' ' ' TRP . . . -67.74 -46.36 68.64 Favored Glycine 0 C--N 1.354 1.534 0 O-C-N 123.519 0.512 . . . . 72.430000000000007 113.7 175.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.48 99.12 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.646 0.778 . . . . 63.539999999999999 111.162 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -70.34 -30.58 67.57 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.944 0.898 . . . . 64.049999999999997 112.238 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.7 66.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.066 0.546 . . . . 73.519999999999996 111.371 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.81 -36.23 93.07 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 116.006 -0.543 . . . . 63.509999999999998 112.839 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -70.11 -43.32 71.26 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.315 1.046 . . . . 75.409999999999997 111.155 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.601 ' HA ' HG11 ' B' ' 32' ' ' VAL . 42.9 t -60.48 -46.37 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 124.257 1.023 . . . . 70.430000000000007 111.727 176.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.582 ' HA ' HD12 ' B' ' 17' ' ' LEU . 66.8 t90 -66.97 -33.61 75.95 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.851 -0.613 . . . . 53.450000000000003 112.056 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -64.38 -35.15 79.97 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.812 0.445 . . . . 63.149999999999999 110.645 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.525 ' HB1' ' HE3' ' B' ' 31' ' ' LYS . . . -72.02 -23.87 61.46 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.663 0.785 . . . . 71.450000000000003 112.833 174.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' B' ' 14' ' ' TRP . 84.9 mt -70.2 -47.08 63.09 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.57 0.748 . . . . 64.030000000000001 110.692 169.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.87 -28.29 67.41 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.554 0.742 . . . . 63.43 111.305 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -72.22 -51.43 21.09 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.048 0.939 . . . . 55.310000000000002 110.396 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.47 118.37 2.21 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.079 0.551 . . . . 73.450000000000003 112.127 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -82.72 -178.06 6.95 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.301 1.04 . . . . 60.140000000000001 112.04 172.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.07 26.16 73.03 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.823 -0.626 . . . . 71.530000000000001 112.242 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 tp -106.76 146.4 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 124.042 0.937 . . . . 73.129999999999995 109.715 -173.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -95.0 162.37 13.76 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.31 0.644 . . . . 63.530000000000001 109.922 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.521 HG21 ' HB2' ' B' ' 40' ' ' ALA . 76.4 mt -56.35 -49.1 95.34 Favored Pre-proline 0 CA--C 1.58 2.118 0 N-CA-C 114.025 1.12 . . . . 65.510000000000005 114.025 -173.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.69 -30.31 42.01 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.027 1.818 . . . . 73.219999999999999 114.106 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -79.12 -42.35 26.47 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.203 1.001 . . . . 62.140000000000001 110.442 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.438 HD21 HG13 ' B' ' 13' ' ' VAL . 65.7 tp -58.04 -40.66 81.49 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.625 -1.625 . . . . 64.329999999999998 111.112 170.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.24 78.61 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.928 0.891 . . . . 72.150000000000006 111.83 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -67.03 -37.62 84.44 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.166 0.587 . . . . 73.109999999999999 111.51 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.525 ' HE3' ' HB1' ' B' ' 16' ' ' ALA . 44.4 mtmt -66.79 -39.95 87.95 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.826 0.45 . . . . 71.219999999999999 111.315 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' B' ' 13' ' ' VAL . 33.9 m -96.09 7.14 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.823 0.675 . . . . 64.230000000000004 112.823 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 65.8 t30 65.33 12.38 8.04 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.176 0.99 . . . . 75.310000000000002 112.783 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 59.8 mt -97.11 168.59 10.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.674 -0.641 . . . . 72.329999999999998 110.747 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 68.3 m -74.68 159.8 31.6 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.597 0.359 . . . . 64.439999999999998 110.998 170.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 70.1 t -52.49 -57.72 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.303 1.041 . . . . 60.039999999999999 112.589 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -68.61 -30.52 69.27 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.639 0.775 . . . . 73.219999999999999 111.669 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 56.0 m -61.17 -39.82 91.56 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.733 0.813 . . . . 64.209999999999994 111.408 173.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.441 ' O ' HG23 ' B' ' 43' ' ' VAL . 90.4 m -76.72 -42.37 41.55 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.722 0.809 . . . . 64.319999999999993 111.536 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' B' ' 25' ' ' ILE . . . -59.6 -39.74 85.21 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 123.81 0.844 . . . . 73.030000000000001 111.921 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.726 HD11 HG12 ' A' ' 54' ' ' ILE . 1.1 tt -60.41 -50.32 74.07 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.808 1.243 . . . . 72.319999999999993 110.009 173.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 -27.06 68.65 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 114.843 -1.071 . . . . 63.119999999999997 112.089 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 39' ' ' THR . 65.7 t -68.48 -39.96 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 123.388 0.675 . . . . 61.329999999999998 110.649 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.12 -27.8 73.19 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-N 116.379 -0.373 . . . . 73.510000000000005 113.07 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' TRP . . . . . 0.524 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 64.6 t-105 -74.82 -32.22 61.9 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.494 0.718 . . . . 73.230000000000004 111.466 173.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.58 -27.15 62.95 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.243 0.617 . . . . 63.229999999999997 111.765 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.02 67.96 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 113.199 0.814 . . . . 51.399999999999999 113.199 172.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' B' ' 45' ' ' TRP . 36.8 ptt85 -74.31 -29.18 61.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.861 -0.524 . . . . 73.420000000000002 110.968 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.5 ' HB3' ' HE2' ' B' ' 51' ' ' LYS . 21.7 mm-40 -72.22 -22.78 61.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.056 0.942 . . . . 73.120000000000005 112.359 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 59.41 35.06 22.94 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.275 1.03 . . . . 74.310000000000002 112.452 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.5 ' HE2' ' HB3' ' B' ' 49' ' ' GLU . 51.3 mtmt -108.49 0.44 20.94 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.683 0.623 . . . . 74.420000000000002 112.683 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.52 147.93 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 112.644 0.609 . . . . 75.430000000000007 112.644 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.66 108.25 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.798 0.839 . . . . 72.010000000000005 109.807 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 2.6 mp -89.97 112.34 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 108.499 -0.926 . . . . 73.239999999999995 108.499 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -102.21 126.51 49.21 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.835 0.454 . . . . 70.030000000000001 110.352 174.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -90.79 96.29 10.56 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.356 -0.979 . . . . 75.030000000000001 108.356 168.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -104.78 109.33 21.23 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.903 1.281 . . . . 71.540000000000006 109.093 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 55.15 29.16 12.12 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.559 1.144 . . . . 75.109999999999999 111.004 -164.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.17 -20.73 35.11 Favored Glycine 0 CA--C 1.549 2.197 0 CA-C-N 115.478 -0.783 . . . . 64.230000000000004 114.58 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.73 130.15 34.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 117.821 0.811 . . . . 52.210000000000001 111.83 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -84.05 114.96 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 123.458 0.703 . . . . 72.120000000000005 111.508 -173.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.28 142.94 46.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.017 0.927 . . . . 74.25 109.107 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 6.4 tp -106.74 128.3 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 CA-C-O 121.607 0.717 . . . . 72.140000000000001 110.709 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -126.63 171.48 11.1 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.692 1.197 . . . . 71.030000000000001 110.001 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 39.4 t30 -100.51 152.54 20.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.444 1.098 . . . . 72.140000000000001 108.889 170.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -61.45 -41.22 96.88 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.819 0.847 . . . . 72.120000000000005 112.545 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.71 3.42 49.81 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 114.923 0.729 . . . . 54.350000000000001 114.923 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -72.42 -49.69 31.8 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.643 0.777 . . . . 64.219999999999999 111.914 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.55 120.99 22.52 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.43 0.692 . . . . 73.25 111.581 -171.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -129.38 156.78 43.51 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.43 0.692 . . . . 73.120000000000005 110.718 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -76.11 -18.22 59.25 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.986 0.914 . . . . 53.219999999999999 113.215 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 44.9 t -70.38 88.97 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.316 0.579 . . . . 75.209999999999994 110.675 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -65.95 -35.84 81.7 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.978 0.911 . . . . 73.340000000000003 112.505 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.47 58.78 0.08 OUTLIER Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.236 -0.438 . . . . 74.439999999999998 113.283 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -94.71 115.83 28.01 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.064 -0.717 . . . . 71.310000000000002 109.064 174.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -74.54 91.0 2.26 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.494 0.717 . . . . 74.209999999999994 112.189 -169.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -90.03 -23.24 21.52 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.105 -0.952 . . . . 64.530000000000001 109.995 166.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -66.29 114.95 5.74 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.141 0.576 . . . . 72.120000000000005 110.345 174.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -108.38 -172.2 2.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.62 0.768 . . . . 72.109999999999999 110.941 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -92.28 160.9 14.92 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.527 0.731 . . . . 73.409999999999997 112.139 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -64.84 110.7 2.51 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.74 1.216 . . . . 65.239999999999995 110.614 170.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.447 0.642 . . . . 74.439999999999998 111.893 -178.348 . . . . . . . . 0 0 . 1 stop_ save_